DRAMP_ID,Sequence,Sequence_Length,Name,Swiss_Prot_Entry,Family,Gene,Source,Activity,Protein_existence,Structure,Structure_Description,PDB_ID,Comments,Target_Organism,Hemolytic_activity,Linear/Cyclic/Branched,N-terminal_Modification,C-terminal_Modification,Other_Modifications,Stereochemistry,Cytotoxicity,Binding_Traget,Pubmed_ID,Reference,Author,Title,length,length_bin
DRAMP00017,VTSWSLCTPGCTSPGGGSNCSFCC,24,Microbisporicin A1 (Bacteriocin),No entry found,Belongs to the lantibiotic family (Class I bacteriocin),Not found,Microbispora corallina (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Rich,Not found,,"Function: Microbisporicins A1 displayed similar antibacterial activity by selectively blocking peptidoglycan biosynthesis, leading to cytoplasmic accumulation of the UDP-linked precursor.
PTM: Microbisporicin A1 contains five ether rings: S3-C7, T8-C11, S13-C20, S18-C23, and S21-C24. Also, residues T2 and S5 are dehydrated, Trp4 is chlorinated and Pro14 is hydroxylated (3,4-dihydroxylation).","Human pathogens: L100 Staphylococcus aureus ATCC6538P (MIC≤0.13 μg/ml), L819 Staphylococcus aureus Smith ATCC19636 (MIC≤0.13 μg/ml), L1400 S. aureus MRSA (MIC≤0.13 μg/ml), L613 S. aureus MRSA (MIC≤0.13 μg/ml), L3798 S. aureus VISA (MIC=2 μg/ml), L3798 Staphylococcus epidermidis ATCC12228 (MIC≤0.13 μg/ml), L1729 Staphylococcus haemolyticus met-r (MIC=8 μg/ml), L49 Streptococcus pyogenes (MIC≤0.13 μg/ml), L44 Streptococcus pneumoniae (MIC≤0.13 μg/ml), L559 Enterococcus faecalis (MIC=1 μg/ml), L560 Enterococcus faecalis Van A (MIC=0.5 μg/ml), LA533 Enterococcus faecalis Van A (MIC=1 μg/ml), L568 Enterococcus faecium (MIC=2 μg/ml), L569 Enterococcus faecium Van A (MIC=1 μg/ml), LB518 E. faecium Van A (MIC=2 μg/ml), L884 Lactobacillus garviae (MIC=1 μg/ml), L148 Lactobacillus delbrueckii ATCC04797 (MIC=4 μg/ml), L3607 Clostridium perfringens ATCC13124 (MIC≤0.125 μg/ml), L4018 Clostridium difficile (MIC≤0.125 μg/ml), L4043 Clostridium butyricum (MIC≤0.125 μg/ml), Propionibacterium granulosum ATCC25564 (MIC=0.03 μg/ml), L1329 Propionibacterium acnes (MIC=0.5 μg/ml), Propionibacterium limphophylum ATCC27250 (MIC=0.015 μg/ml), L970 Haemophilus influenzae ATCC19418 (MIC=32 μg/ml), L76 Moraxella catarrhalis ATCC8176 (MIC=0.25 μg/ml), L1613 Neisseria meningitidis ATCC13090V (MIC=0.5 μg/ml), L997 Neisseria gonorrhoeae (MIC=0.25 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Amidation and Cyclization,"①There are five thioether intramolecular bridges which link Ala3 and Ala7, Ala8 and Ala11, Ala13 and Ala20, Ala18 and Ala23, respectively. ②The residue at position 2 is (Z)-2,3-didehydrobutyrine (Dhb). ③The residue at position 4 is chloro-tryptophan (ClTrp). ④The residue at position 5 is 2,3-didehydroalanine. ⑤The residue at position 8 is 2-Aminobutyric acid (Abu). ⑥The residue at position 14 is bis-hydroxylated proline.",L,No cytotoxicity information found,Not found,18215770,Chem Biol. 2008 Jan;15(1):22-31.,"Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F.","Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.",24,21-24
DRAMP00032,GNGVLKTISHECNMNTWQFLFTCC,24,Ruminococcin A (RumA; Bacteriocin),"P83674, P83676, P83677, Q8VLK0, Q9K381, P83675, P83679, P83680, Q8VLK0",Belongs to the type A lantibiotic family (Class I bacteriocin),rumA1 AND rumA2 AND ,Ruminococcus gnavus & Ruminococcus hansenii (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. Ruminococcin A is a broad spectrum bacteriocin exhibiting activity against a wide range of pathogenic clostridia and B.longum.
Developmental stage: Highest expression in mid to late logarithmic growth phase, after which expression decreases slowly before leveling off in the stationary growth phase.
Induction: By trypsin.
PTM: There are one didehydrobutyrine (Dhb) at T16, one lanthionine (S9-23) and two Beta-methyllanthionines (T7-C12; T22-C24).","Gram-positive bacteria: Bifidobacterium longum (strain: ATCC 15707) (MIC=75 µg/ml), Bacillus cereus (strain: Z4222, TZ415) (MIC=75 µg/ml), Eubacterium contortum (strain: ATCC 25540) (MIC=32.5 µg/ml), Ruminococcus obeum (strain: ATCC 29174) (MIC=32.5 µg/ml), R. gnavus (strain: ATCC 29149) (MIC=75 µg/ml), Clostridium perfringens (strain: CpA) (MIC=75 µg/ml), Clostridium difficile serogroup A (strain: B-1) (MIC=75 µg/ml), C. difficile serogroup C (strain: C253) (MIC=75 µg/ml), C. difficile serogroup S3 (strain: 79685) (MIC=75 µg/ml), C. botulinum type A (strain: CIP 38) (MIC=75 µg/ml), C. botulinum type B (strain: NCTC 7273) (MIC=75 µg/ml), C. botulinum type E (strain: NCTC 8266) (MIC=75 µg/ml), C. bifermentans (strain: NCTC 506) (MIC=75 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic (very possibly),Free,Cyclization (possibly),"① It is highly probable that (i) Ser9 and the putative Cys23 and (ii) the putative His22 and Thr24 are associated in a Lanthionine (Lan) and a 3-methyllanthionine (Me-Lan) residue, respectively. ②The residues at position 7 and 16 are (Z)-2,3-didehydrobutyrine (Dhb).",L,No cytotoxicity information found,Cell membrane,11526013##11741840##12089024,Appl Environ Microbiol. 2001 Sep;67(9):4111-4118.##J Bacteriol. 2002 Jan;184(1):18-28.##Appl Environ Microbiol. 2002 Jul;68(7):3424-3431.,"Dabard J, Bridonneau C, Phillipe C, Anglade P, Molle D, Nardi M, Ladiré M, Girardin H, Marcille F, Gomez A, Fons M.##Gomez A, Ladiré M, Marcille F, Fons M.##Marcille F, Gomez A, Joubert P, Ladiré M, Veau G, Clara A, Gavini F, Willems A, Fons M.","Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces.##Trypsin mediates growth phase-dependent transcriptional tegulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota.##Distribution of genes encoding the trypsin-dependent lantibiotic ruminococcin A among bacteria isolated from human fecal microbiota.",24,21-24
DRAMP00063,SSSGWLCTLTIECGTIICACR,21,Lantibiotic michiganin-A (Bacteriocin),Q09T02,Belongs to the type B lantibiotic family (Class I bacteriocin),micA,Clavibacter michiganensis subsp. Michiganensis (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"MOA: The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. The 62-67 beta-methyllanthionine thioether bond is oxidized to a sulfoxide. This is followed by membrane translocation and cleavage of the modified precursor",Clavibacter michiganensis subspecies sepedonicus strain 2136 (MIC=30 pmol/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,"All of the threonine residues undergo dehydration, and three of them interact with cysteines via thioether bonds to form methyllanthionine bridges",L,No cytotoxicity information found,Not found,16957199,Appl Environ Microbiol. 2006 Sep;72(9):5814-5821.,"Holtsmark I, Mantzilas D, Eijsink VG, Brurberg MB.","Purification, characterization, and gene sequence of michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis.",21,18-21
DRAMP00128,GAWKNFWSSLRKGFYDGEAGRAIRR,25,Plantaricin J (PlnJ; Bacteriocin),"P71461, Q7AKW6",Belongs to the class IIb bacteriocin,plnJ,Lactobacillus plantarum C11 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Alpha helix,"In DPC micelles, PlnJ has an N-terminal amphiphilic alpha-helix between Trp-3 and Tyr-15. Crucial residues: Gly-13 in PlnJ is very sensitive, giving more than a 100-fold reduction in activity when large residues replace glycine. Gly-20 in PlnJ was replaced, the activity was reduced less than 10-fold.","2KHF, 2KHG resolved by NMR.",Function: A 1:1 ratio of PlnK and PlanJ is at least 1000 times more active than the individual peptide. ,"Gram-positive bacteria: Pediococcus pentosaceus Pac 1.0 (MIC=50 nM), Lactobacillus plantarum 965 (MIC=0.1 nM), L. sake NCDO 2714 (MIC=50 nM), Leptostylus viridescens NCDO 1655 (MIC=5 nM). [PlnJ:PlnK=1:1]",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found,Not found,9603847##19538999,Appl Environ Microbiol. 1998 Jun;64(6):2269-2272.##Peptides. 2009 Sep;30(9):1613-1621.,"Anderssen EL, Diep DB, Nes IF, Eijsink VG, Nissen-Meyer J.##Rogne P, Haugen C, Fimland G, Nissen-Meyer J, Kristiansen PE.","Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.##Three-dimensional structure of the two-peptide bacteriocin plantaricin JK.",25,24-27
DRAMP00191,GGAGHVPEYFVGIGTPISFYG,21,Microcin J25 (MccJ25; Bacteriocin),Q9X2V7,Belongs to the class I microcin,mcjA,Escherichia coli AY25 (Gram-negative bacteria),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Beta strand,"MccJ25 does not have a head-to-tail cyclic structure but rather a side chain to backbone cyclization between Glu8 and the N-terminus. This creates an embedded ring that is threaded by the C-terminal tail of the molecule, forming a noose-like feature. The three-dimensional structure deduced from NMR data suggests that slippage of the noose is prevented by two aromatic residues flanking the embedded ring.","1Q71, 1PP5 resolved by NMR.","Function: Microcin J25 is a 21 amino acid bacterial peptide that has potent antibacterial activity against Gram-negative bacteria, resulting from its interaction with RNA polymerase.
Induction: At the onset of stationary growth phase.
PTM: Isoglutamyl glycine isopeptide between G1 and E8.","Gram-negative bacteria: Escherichia coli BM21 (MIC=0.08 µg/ml), E. coli AB1133 (MIC=0.02 µg/ml), E. coli RYC816 (MIC=0.04 µg/ml), E. coli AY29 (MIC=0.04 µg/ml), Salmonella species, Shigella flexneri.",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Cyclization of a N-terminal between Gly and Glu,Free,,L,No cytotoxicity information found,Not found,1429464##10092860##14531690##14531661,J Bacteriol. 1992 Nov;174(22):7428-7435.##Eur J Biochem. 1999 Feb;259(3):747-755.##J Am Chem Soc. 2003 Oct 15;125(41):12464-74.##J Am Chem Soc. 2003 Oct 15;125(41):12382-3.,"Salom³n RA, Far­as RN.##Blond A, P©duzzi J, Goulard C, Chiuchiolo MJ, Barth©l©my M, Prigent Y, Salom³n RA, Far­as RN, Moreno F, Rebuffat S.##Rosengren KJ, Clark RJ, Daly NL, Göransson U, Jones A, Craik DJ.##Bayro MJ, Mukhopadhyay J, Swapna GV, Huang JY, Ma LC, Sineva E, Dawson PE, Montelione GT, Ebright RH.","Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.##The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli.##Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone.##Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot.",21,18-21
DRAMP00232,ATPATPTVAQFVIQGSTICLVC,22,Cypemycin (Bacteriocin),E5KIB6,Belongs to the linaridin family,cypA,Streptomyces sp. OH-4156 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Antibiotic peptide structurally related to lantibiotics. Has cytotoxic activity against mouse P388 leukemia cells (IC50=1.3 μg/ml).,Micrococcus luteus (MIC=0.2 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,[Ref. 10.1016/S0040-4039(00)78407-3] Dimethylation on Ala1,[Ref. 10.1016/S0040-4039(00)78407-3] Decarboxylation and Cyclization on D-Cys64,"[Ref. 10.1016/S0040-4039(00)78407-3] ①Thr2, Thr5, Thr7 and Thr17 converts to (E)-2,3-didehydrobutyrine. ②Ile13 and Ile18 converts to L-allo-isoleucine. ③Maturation involves the enzymatic conversion of Cys-19 into 2,3-didehydroalanine followed by formation of a thioether bond with Cys-22. The C-terminal meso-lanthionine then undergoes decarboxylation.",[Ref. 10.1016/S0040-4039(00)78407-3] Mixed (D-Cys19),[Ref.7802859] IC50 = 1.3 μg/mL against P388 leukemia cells in vitro.,Not found,7802859##Pubmed ID is not available,J Antibiot (Tokyo). 1993 Nov;46(11):1666-1671.##Tetrahedron Lett. 1994 Oct;35(43):8001-8004.,"Komiyama K, Otoguro K, Segawa T, Shiomi K, Yang H, Takahashi Y, Hayashi M, Otani T, Omura S.##Minami Y, Yoshida K, Azuma R, Urakawa A, Kawauchi T, Otani T, Komiyama K, Omura S","A new antibiotic, cypemycin. Taxonomy, fermentation, isolation and biological characteristics. ##STRUCTURE OF CYPEMYCIN, A NEW PEPTIDE ANTIBIOTIC.",22,21-24
DRAMP00244,XTPATPFTPAITEITAAVIAX,21,Hominicin (Bacteriocin),No entry found,Not found,Not found,Staphylococcus hominis MBBL 2-9 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Function: Hominicin exhibited heat stability up to 121 degrees C for 15min and activity under both acidic and basic conditions (from pH 2.0 to 10.0). ,"Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=0.06 µg/ml), S. aureus ATCC (MRSA) 11435 (MIC=0.96 µg/ml), S. aureus (vancomycin-intermediate VISA) CCARM 3501 (MIC=3.82 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Dimethylation on Ile1,Free,"①The residue X at position 1 is DmIle (N1, N1-dimethyl-isoleucine).②The residues T at position 2, 5, 8 and 15 are dehydrobutyrine. ③The residue at position 21 is a distinct residue Dmp (N2, N2-dimethyl-1,2-propanediamine) rarely found from biosynthetic antimicrobial peptides.",L,No cytotoxicity information found,Not found,20654578,Biochem Biophys Res Commun. 2010 Aug 20;399(2):133-138. ,"Kim PI, Sohng JK, Sung C, Joo HS, Kim EM, Yamaguchi T, Park D, Kim BG.","Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.",21,18-21
DRAMP00764,KSLRPRCWIKIKFRCKSLKF,20,Piceain 1 (Plants),No entry found,Not found,Not found,Picea sitchensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Beta strand (CD),Not found,,"Function: Active against both Gram-postive and Gram-negative bacteria, fungi. It showed weak hemolysis activity against human and rabbit red cells.
PTM: Contains one disulfide bond.","Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=9.38 µg/ml), S. aureus ATCC 43300 (MIC=9.38 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=18.75 µg/ml), Escherichia coli ML-35P (MIC=18.75 µg/ml), Escherichia coli 08040722 (CI) (MIC=75 µg/ml), Escherichia coli 08A866 (CI) (MIC=37.5 µg/ml), Pseudomonas aeruginosa PA01 (MIC=9.38 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=9.38 µg/ml), Pseudomonas aeruginosa 08031014 (CI) (MIC=37.5 µg/ml).##Yeast: Candida albicans ATCC 20032 (MIC=9.38 µg/ml).","[Ref.21644248] At the concentration of 0.0625 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 0.7% & 1.5%; At the concentration of 0.125 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 0.8% & 7.2%; At the concentration of 0.25 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 5.9%&7.8%; At the concentration of 0.5 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 7.6% & 9.5%; At the concentration of 1 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 7.8% & 57.1%.",Cyclic,Free,Free,There is one intra-molecular disulfide bridge formed by Cys7 and Cys15.,L,No cytotoxicity information found,Not found,21644248,J Pept Sci. 2011 Sep;17(9):627-631.,"Liu R, Mu L, Liu H, Wei L, Yan T, Chen M, Zhang K, Li J, You D, Lai R.",Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.,20,18-21
DRAMP00765,RPRCWIKIKFRCKSLKF,17,Piceain 2 (Plants),No entry found,Not found,Not found,Picea sitchensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Active against both Gram-postive and Gram-negative bacteria, fungi. It showed weak hemolysis activity against human and rabbit red cells.
PTM: Contains one disulfide bond.","Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=9.38 µg/ml), S. aureus ATCC 43300 (MIC=18.75 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=37.5 µg/ml), Escherichia coli ML-35P (MIC=37.5 µg/ml), Escherichia coli 08040722 (CI) (MIC=75 µg/ml), Escherichia coli 08A866 (CI) (MIC=37.5 µg/ml), Pseudomonas aeruginosa PA01 (MIC=9.38 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=18.75 µg/ml), Pseudomonas aeruginosa 08031014 (CI) (MIC=37.5 µg/ml).##Yeast: Candida albicans ATCC 20032 (MIC=18.75 µg/ml).","[Ref.21644248] At the concentration of 0.0625 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 0.6% & 2.2%; At the concentration of 0.125 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 0.8% & 4.7%; At the concentration of 0.25 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 5.2%&5.2%; At the concentration of 0.5 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 5.3% & 12.4%; At the concentration of 1 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 11.3% & 66.3%.",Cyclic,Free,Free,There is one intra-molecular disulfide bridge formed by Cys4 and Cys12.,L,No cytotoxicity information found,Not found,21644248,J Pept Sci. 2011 Sep;17(9):627-631.,"Liu R, Mu L, Liu H, Wei L, Yan T, Chen M, Zhang K, Li J, You D, Lai R.",Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.,17,15-18
DRAMP01372,AALKGCWTKSIPPKPCFGKR,20,"Odorranain-B1 (OdB1; Frogs, amphibians, animals)",E7EKD9,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Not found,Odorrana hainanensis (Odor frog) (Rana hainanensis),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Homology,Not found,Odorranain-B1 adopts 5.9 % ,,"Function: Odorranain-B1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell. 
Tissue specificity: Expressed by the skin glands.","[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=3.21 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=5.83 μg/ml), Bacillus subtilis (MIC=1.85 μg/ml).##Yeast: Candida albicans (MIC=2.4 μg/ml).",[Ref:17272268] No detectable hemolytic activity against rabbit red blood cells.,Cyclic,Free,Free,[Ref:17272268] There are one disulfide bond between Cys6 and Cys16,L,No cytotoxicity information found,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,20,18-21
DRAMP01004,PQRGEGGRAGNLLREEQEI,19,Cucurmoschin (Plants),P84158,Not found,Not found,Cucurbita maxima (winter squash),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Function: Has antifungal activity. Inhibits cell-free translation in rabbit reticulocyte lysate system.,"Fungi: Botrytis cinerea (MIC=375 µM), Fusarium oxysporum (MIC=375 µM), Mycosphaerella arachidicola (MIC=375 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found,Not found,14499274,Peptides. 2003 Jul;24(7):969-972.,"Wang HX, Ng TB.","Isolation of cucurmoschin, a novel antifungal peptide abundant in arginine, glutamate and glycine residues from black pumpkin seeds.",19,18-21
DRAMP01066,PVVDTTGNNPLQQQEEYYV,19,Kunitz-type serine protease inhibitor 1 (Xb-KTI; Plants),P86930,Not found,Not found,Xanthosoma sagittifolium (Elephant's ear) (Arum sagittifolium),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Function: Serine protease inhibitor. Displays antimicrobial activity against the Gram-negative bacterium S. typhimurium ATCC 14028. Displays a weak hemolytic activity.,[Ref.21520894]Gram-negative bacterium: Salmonella typhimurium ATCC 14028 (MIC=10 µM).,[Ref.21520894] No hemolytic activity was observed for Xb-KTI. The peptide induced a hemolysis of 12% at the highest concentration of 250 μg/mL. Values(OD540) were normalized against 100% lysed erythrocytes (0.1% Triton X-100) and PDB (untreated control),Linear,Free,Free,,L,No cytotoxicity information found,Not found,21520894,J Nat Prod. 2011 May 27;74(5):969-975.,"Lima TB, Silva ON, Migliolo L, Souza-Filho CR, Gonçalves EG, Vasconcelos IM, Oliveira JT, Amaral AC, Franco OL.",A Kunitz proteinase inhibitor from corms of Xanthosoma blandum with bactericidal activity.,19,18-21
DRAMP01081,GLKDIFKAGLGSLVKGIAAHVAN,23,"Alyteserin-1a (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes obstetricans (European midwife toad),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,"Function: The alyteserin-1 peptides show selective growth inhibitory activity against the Gram-negative bacterium Escherichia coli. The hemolytic activity against human erythrocytes of all peptides tested is relatively weak.
Structural similarity: The alyteserin-1 peptides show limited structural similarity to the ascaphins from the skins of frogs of the family Leiopelmatidae.",[Ref.19463738]Gram-negative bacterium: Escherichia coli (MIC=25 µM).,[Ref:19463738] LC50 > 100 μM against human erthrocytes. Alyteserin-1a induced a hemolysis of 11% at the concentration of 100 μM.,Linear,Free,α-Amidation,,L (to be determined),No cytotoxicity information found,Not found,19463738,Peptides. 2009 Jun;30(6):1069-1073.,"Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,23,21-24
DRAMP01082,ILGKLLSTAAGLLSNL,16,"Alyteserin-2a (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes obstetricans (European midwife toad),"Antimicrobial, Antibacterial, Anti-Gram+,  Cytotoxicity",Not found,Alpha helix,It is helical in 50% TFE.,,"Function: The alyteserin-2a is more potent against the Gram-positive bacteria Staphylococcus aureus. The hemolytic activity against human erythrocytes of all peptides tested is relatively weak.
Structural similarity: Alyteserin-2a and alyteserin-2b and -2c show limited sequence identity with bombinin H6, present in the skins of frogs of the family Bombinatoridae.",[Ref.19463738]Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM).,[Ref:19463738] LC50 = 135 μM against human erthrocytes.,Linear,Free,α-Amidation,,L (to be determined),No cytotoxicity information found,Not found,19463738,Peptides. 2009 Jun;30(6):1069-1073.,"Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,16,15-18
DRAMP01083,GLKEIFKAGLGSLVKGIAAHVAN,23,"Alyteserin-1b (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes obstetricans (European midwife toad),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Amtimicrobial peptide. (By similarity),Gram-negative bacterium: Escherichia coli (MIC=25 µM).,[Ref:19463738] LC50 = 210 μM against human erthrocytes. ,Linear,Free,α-Amidation,,L (to be determined),No cytotoxicity information found,Not found,19463738,Peptides. 2009 Jun;30(6):1069-1073.,"Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,23,21-24
DRAMP01085,GLKEIFKAGLGSLVKGIAAHVAS,23,"Alyteserin-1c (toads, amphibians, animals)",H0USY4,Not found,Not found,Alytes obstetricans (Common midwife toad) (Bufo obstetricans),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Alpha helix,"Solution structural studies in the membrane mimicking environments, sodium dodecyl sulphate (SDS), dodecylphosphocholine (DPC), and 1,2-dihexanoyl-sn-glycero-3-phosphatidylcholine (DHPC) micelles, indicate that these peptides display an alpha helical structure between residues Lys(3) and Val(21).(Ref.1)",2L5R resolved by NMR.,Function: Alyteserin-1c shows selective growth-inhibitory activity against Gram-negative bacteria.,Gram-negative bacterium: Escherichia coli (MIC=25 µM).,[Ref:19463738] LC50 = 145 μM against human erthrocytes.,Linear,Free,α-Amidation,,L (to be determined),No cytotoxicity information found,Not found,21565166##19463738,Biochim Biophys Acta. 2011 Aug;1808(8):1975-1984.##Peptides. 2009 Jun;30(6):1069-1073.,"Subasinghage AP, O'Flynn D, Conlon JM, Hewage CM.##Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",Conformational and membrane interaction studies of the antimicrobial peptide alyteserin-1c and its analogue [E4K]alyteserin-1c.##The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,23,21-24
DRAMP01088,GFKEVLKADLGSLVKGIAAHVAN,23,"Alyteserin-1Ma (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes maurus (Midwife toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Alyteserin-1Ma has lower antimicrobial potencies (MIC>200 µM).,Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=214 µM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=214 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,α-Amidation,,L,No cytotoxicity information found,Not found,22800568,Toxicon. 2012 Nov;60(6):967-981.,"König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.","Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.",23,21-24
DRAMP01089,GFKEVLKAGLGSLVKGIPAHVAN,23,"Alyteserin-1Mb (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes maurus (Midwife toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Alyteserin-2Ma has lower antimicrobial potencies (MIC>200 µM).,Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=217 µM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=434 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,α-Amidation,,L,No cytotoxicity information found,Not found,22800568,Toxicon. 2012 Nov;60(6):967-981.,"König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.","Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.",23,21-24
DRAMP01090,FIGKLISAASGLLSHL,16,"Alyteserin-2Ma (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes maurus (Midwife toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacteria E. coli and Gram-positive bacteria S. aures. It only inhibits C. albicans at very high concentration of 150 microM.,Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=38.4 µM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=9.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,α-Amidation,,L,No cytotoxicity information found,Not found,22800568,Toxicon. 2012 Nov;60(6):967-981.,"König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.","Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.",16,15-18
DRAMP01091,ILGAIIPLVSGLLSHL,16,"Alyteserin-2Mb (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes maurus (Midwife toad),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacteria S. aures. It only inhibits C. albicans at very high concentration of 310 microM.,Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=19.3 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,α-Amidation,,L,No cytotoxicity information found,Not found,22800568,Toxicon. 2012 Nov;60(6):967-981.,"König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.","Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.",16,15-18
DRAMP01098,GIGAAILSAGKSALKGLAKGLAEHF,25,"Bombinin-like peptide 3 (BLP-3; toads, amphibians, animals)",P29004,Belongs to the bombinin family,Not found,Bombina orientalis (Oriental fire-bellied toad),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Alpha helix,Not found,,"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands.","[Ref.1744108]Gram-postive bacterium:Bacillus megaterium BmII (MIC=0.3 µM), Staphylococcus aureus Cowan1 (MIC=1.7 µM);##Gram-negative bacterium:59% inhibition Neisseria meningitidis 118V C (MIC=20 µg/ml), 99% inhibition Neisseria meningitidis 15240 IAI (MIC=20 µg/ml), 99% inhibition Neisseria meningitidis 126E IC1 (MIC=20 µg/ml), 99% inhibition Neisseria gonorrhoeoe F62 (MIC=20 µg/ml), 97% inhibitionNeisseria Iactamica 15323 (MIC=20 µg/ml), 100% inhibition Neisseria Iactamica 15215A (MIC=20 µg/ml), 97% inhibition Neisseria cinerea 15461 (MIC=20 µg/ml), Escherichia coli D21 (MIC=1.7 µM), Escherichia coli D22 (MIC=1.5 µM), Yersinia pseudotubercolosis (MIC=0.6 µM), Pseudomonas aeruginosa ATCC 15692 (MIC=9.2 µM);##Fungus:Candida albicans (MIC=0.4 µM).",[Ref:1744108] No significant hemolytic activity was found which suggests a selectivity for prokaryotic over eukaryotic membranes.,Cyclic,Free,Amidation,,L,No cytotoxicity information found,Not found,1744108,J Biol Chem. 1991 Dec 5;266(34):23103-23111.,"Gibson BW, Tang DZ, Mandrell R, Kelly M, Spindel ER.","Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.",25,24-27
DRAMP01105,RSNKGFNFMVDMIQALSK,18,"Maximin-S4 (chain of Maximins-S type B/C; toads, amphibians, animals)",Q5GC92,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Maximin-S3 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. Has no hemolytic activity. Tissue specificity: Expressed by the skin dorsal glands. PTM: Lysine amide at position 18.,"[Ref.15649437]Mycoplasma humenis (MIC=46 µM), Ureaplasma urealyticum (MIC=46 µM).",[Ref:15649437] Maximin S1 and S4 had no hemolytic activity.,Linear,Free,Amidation,,L,No cytotoxicity information found,Not found,15649437,Biochem Biophys Res Commun. 2005 Feb 18;327(3):945-951.,"Wang T, Zhang J, Shen JH, Jin Y, Lee WH, Zhang Y.","Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.",18,15-18
DRAMP02090,FLPMLAGLAASMVPKFVCLITKKC,24,"Brevinin-1Lb (Frogs, amphibians, animals)",P82826,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana luteiventris (Spotted frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=8 μM);##Gram-negative bacterium: Escherichia coli (MIC=16 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,There is a disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02091,FLPFIAGMAAKFLPKIFCAISKKC,24,"Brevinin-1Ba (Frogs, amphibians, animals)",P82833,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria. 
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02077,FLPIIAGIAAKVFPKIFCAISKKC,24,"Brevinin-1Pb (Frogs, amphibians, animals)",Q8QFQ5,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=5 μM);##Gram-negative bacterium: Escherichia coli (MIC=14 μM).##Yeast: Candida albicans (MIC=7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization of a C-terminal Cys residue (forming a disulfide bond),There is a disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,10651828##12413397,Eur J Biochem. 2000 Feb;267(3):894-900.##Biochem J. 2003 Apr 1;371(Pt 1):125-130.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.##Chen T, Farragher S.M, Bjourson A.J, Orr D.F, Rao P, Shaw C.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.##Granular gland transcriptomes in stimulated amphibian skin secretions.",24,21-24
DRAMP01151,GVGDLIRKAVSVIKNIV,17,"Uperin-3.5 (toads, amphibians, animals)",P82042,Not found,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Lactococcus lactis (MIC=3 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12.5 µg/ml), Staphylococcus aureus (MIC=50 µg/ml), Staphylococcus epidermidis (MIC=12.5 µg/ml), Streptococcus uberis (MIC=12.5 µg/ml).(Ref.2)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found,Not found,PubMed ID is not available##15203252,Aust. J. Chem. 1996; 49:475-484.##Peptides. 2004 Jun;25(6):1035-1054.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",17,15-18
DRAMP01152,GVIDAAKKVVNVLKNLP,17,"Uperin-3.6 (toads, amphibians, animals)",P82043,Not found,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Alpha helix ,"In 50% (by vol.) trifluoroethanol, an NMR study and structure calculations indicate that uperin 3.6 adopts a well-defined amphipathic alpha-helix with distinct hydrophilic and hydrophobic faces.(Ref.1)",,Function: Shows antibacterial activity gaginst several Gram-positive bacteria. This peptide could inhibit HIV infection at a concentration that is also toxic to T cells (J Virol 2005; 79:11598-11606).,"Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Lactococcus lactis (MIC=3 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=25 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=12.5 µg/ml), Streptococcus uberis (MIC=12.5 µg/ml).(Ref.2)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found,Not found,10461748##15203252,J Pept Res. 1999 Aug;54(2):137-145.##Peptides. 2004 Jun;25(6):1035-1054.,"Chia BC, Carver JA, Mulhern TD, Bowie JH.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",17,15-18
DRAMP01153,GVIAAAKKVVNVLKNLF,17,"Ala4-uperin 3.6 (toads, amphibians, animals)",No entry found,Not found,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Function: Shows antibacterial activity gaginst several Gram-positive bacteria.,"Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found,Not found,10461748,J Pept Res. 1999 Aug;54(2):137-145.,"Chia BC, Carver JA, Mulhern TD, Bowie JH.","The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.",17,15-18
DRAMP01154,GVIDAAAKVVNVLKNLF,17,"Ala7-uperin 3.6 (toads, amphibians, animals)",No entry found,Not found,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Function: Shows antibacterial activity gaginst several Gram-positive bacteria.,"Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=12 µg/ml), Streptococcus uberis (MIC=50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found,Not found,10461748,J Pept Res. 1999 Aug;54(2):137-145.,"Chia BC, Carver JA, Mulhern TD, Bowie JH.","The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.",17,15-18
DRAMP01155,GVIDAAKKVVNVLANLF,17,"Ala14-uperin 3.6 (toads, amphibians, animals)",No entry found,Not found,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Function: Shows antibacterial activity gaginst several Gram-positive bacteria.,"Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=12 µg/ml), Streptococcus uberis (MIC=50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found,Not found,10461748,J Pept Res. 1999 Aug;54(2):137-145.,"Chia BC, Carver JA, Mulhern TD, Bowie JH.","The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.",17,15-18
DRAMP01163,TRSSRAGLQFPVGRVHRLLRK,21,"Buforin-2 (Buforin II; Fragment of Histone H2A; toads, amphibians, animals)",P0DQL2,Belongs to the histone H2A family,Not found,Bufo gargarizans (Asian toad) (Bufo bufo gargarizans),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix,Not found,,"Function: Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. Both buforin II and its derivative buforin IIb (sequence: RAGLQFPVGRLLRRLLRRLLR) showed selective anticancer activity against 62 cancer cell lines (Lee 2008 Cancer Lett 271: 47-51). Buforin II is more potent than buforin I.
PTM: Monoubiquitination of C-terminus gives a specific tag for epigenetic transcriptional repression. Following DNA double-strand breaks (DSBs), it is ubiquitinated through 'Lys-63' linkage of ubiquitin moieties.","Gram-positive bacteria: Bacillus subtilis (MIC=2 µg/ml), Staphylococcus aureus (MIC=4 µg/ml), Streptococcus mutans (MIC=2 µg/ml), Streptococcus pneumoniae (MIC=4 µg/ml), Pseudomonas putida (MIC=2 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=4 µg/ml), Salmonella typhimurium (MIC=1 µg/ml), Serratia sp. (MIC=4 µg/ml).##Fungi: Candida albicans (MIC=1 µg/ml), Cryptococcus neoformans (MIC=1 µg/ml), Saccharomyces cerevisiae (MIC=1 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,① The residue at position 21 is N6-(2-hydroxyisobutyryl)lysine,L,No cytotoxicity information found,DNA,8573171##8946958,Biochem Biophys Res Commun. 1996 Jan 5;218(1):408-413.##FEBS Lett. 1996 Nov 25;398(1):87-90.,"Park C.B, Kim M.S, Kim S.C.##Yi G.-S, Park C.B, Kim S.C, Cheong C.",A novel antimicrobial peptide from Bufo bufo gargarizans.##Solution structure of an antimicrobial peptide buforin II.,21,18-21
DRAMP01164,GIGALSAKGALKGLAKGLAEHFAN,24,"Bombinin (toads, amphibians, animals)",P01505,Not found,Not found,Bombina variegata (Yellow-bellied toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antimicrobial and hemolytic activities.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.
Caution: Residue 20 is assigned as E by similarity to other bombin sequences instead of Z (Glutamic acid or Gutamine) given ",[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=3 µM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=14 µM).,"[Ref.8223491] The lethal concentration (LC, the lowest concentration that inhibits growth) was over 50 μM",Linear,Free,Amidation,,L,No cytotoxicity information found,Not found,PubMed ID is not available##8223491,Monatsh. Chem. 1970;101:182-189.##EMBO J. 1993; 12:4829-4832.,"Csordas A, Michl H.##Mignogna G, Simmaco M, Kreil G, Barra D.",Isolation and structural resolution of a haemolytically active polypeptide from the immune secretion of a European toad.##Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.,24,21-24
DRAMP01165,FLPVILPVIGKLLNGILGK,19,"Preprotemporin-1SKa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana sakuraii (Japanese brown frog),Antimicrobial,Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found,Not found,17174009,Peptides. 2007 Mar;28(3):505-514.,"Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.",Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,19,18-21
DRAMP01170,NLVSGLIEARKYLEQLHRKLKNCKV,25,"Distinctin 2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Phyllomedusa distincta (Tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Alpha helix (1 helices; 17 residues),Not found,1XKM resolved by NMR,Comment: Distinctin is constituted of two different polypeptide chains connected by an intermolecular disulphide bridge. The entry is the chain 2 of Distinctin,"Note: Distinctin chain 2 links to Distinctin chain 1 to form a heterodimeric peptide to exert antibacterial function. ##Gram-positive bacteria: Enterococcus faecalis (MIC=14.5 µM), Staphylococcus aureus (MIC=28.0 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=28.0 µM), Escherichia coli (MIC=14.5 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,There is an intermolecular disulphide bridge between Distinctin chain 1 (Cys19) and Distinctin chain 2 (Cys22). ,L,No cytotoxicity information found,Not found,11297740,FEBS Lett. 2001 Apr 6;494(1-2):85-89.,"Batista CV, Scaloni A, Rigden DJ, Silva LR, Rodrigues Romero A, Dukor R, Sebben A, Talamo F, Bloch C.",A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta.,25,24-27
DRAMP01174,GLLDFVTGVGKDIFAQLIKQI,21,"Ocellatin-4 (Frogs, amphibians, animals)",P85090,Not found,Not found,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has hemolytic activity against human erythrocytes (HC50=14.3 µM). Has antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.",[Ref.17884127]Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=64 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=64 µM).,[Ref.17884127] HC50 = 14.3 μM against human O+ red blood cells,Linear,Free,Amidation,,L,No cytotoxicity information found,Not found,17884127,Toxicon 2007; 50: 1095-1104.,Nascimento A et al Castro MS.,"Purification, characterization and homology analysis of ocellatin 4, a cytolytic peptide from the skin secretion of the frog Leptodactylus ocellatus.",21,18-21
DRAMP01177,GVVDILKGAAKDIAGHLASKVMNKL,25,"Ocellatin-F1 (Fallaxin; Frogs, amphibians, animals)",No entry found,Not found,Not found,Leptodactylus fallax (Mountain chicken frog),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,5U9S##5U9Y##5UA8##5U9R##5U9X##5UA7##5U9Q##5U9V##5UA6,Function: Has low hemolytic activity of fallaxin (HC50>200 µM). ,"[Ref.15544856]Gram-negative bacteria: Escherichia coli (MIC=40 µM), Pseudomonas aeruginosa (MIC=80 µM), Enterobacter cloacae (MIC=20 µM), Klebsiella pneumoniae (MIC=80 µM).",[Ref:15544856]HC50>200 μM hemolytic activity of fallaxin,Linear,Free,Amidation,Free,L,[Ref.15544856]No cytotoxicity information found,Not found,15544856,Regul Pept. 2005 Jan 15;124(1-3):173-178.,"Rollins-Smith LA, King JD, Nielsen PF, Sonnevend A, Conlon JM.",An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura:Leptodactylidae). ,25,24-27
DRAMP01182,GLLDTLKGAAKNVVGSLASKVMEKL,25,"Ocellatin-P1 (Pentadactylin; Frogs, amphibians, animals)",No entry found,Not found,Not found,Leptodactylus pentadactylus (South American bullfrog) ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 µM), Klebsiella pneumoniae KK3 9904 (MIC=100 µM), Enterobacter cloacae HNTCC 53001 (MIC=50 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=100 µM);##Gram-positive bacteria: Staphylococcus epidermidis RP62A (MIC=100 µM), Streptococcus Group B HNTCC 80130 (MIC=50 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.16236555]No cytotoxicity information found,Not found,16236555,Comp Biochem Physiol C Toxicol Pharmacol. 2005 Aug;141(4):393-397.,"King JD, Al-Ghaferi N, Abraham B, Sonnevend A, Leprince J, Nielsen PF, Conlon JM.",Pentadactylin: an antimicrobial peptide from the skin secretions of the South American bullfrog Leptodactylus pentadactylus.,25,24-27
DRAMP01184,GVLDILKGAAKDLAGHVATKVI,22,"SPX(1-22)(truncated peptide of Syphaxin; Frogs, amphibians, animals)",No entry found,Not found,Not found,Leptodactylus syphax (Burgundy thin-toed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus ATCC 29213 (MIC=14.6 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=40.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.17628627]No cytotoxicity information found,Not found,17628627,Toxicon. 2007 Sep 15;50(4):572-580.,"Dourado F.S, Leite J.R.S.A, Silva L.P, Melo J.A.T, Bloch C. Jr, Schwartz E.F.",Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,22,21-24
DRAMP01185,GVLDILKGAAKDLAGH,16,"SPX(1-16)(truncated peptide of Syphaxin; Frogs, amphibians, animals)",No entry found,Not found,Not found,Leptodactylus syphax (Burgundy thin-toed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus ATCC 29213 (MIC=40.5 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=10.1 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.17628627]No cytotoxicity information found,Not found,17628627,Toxicon. 2007 Sep 15;50(4):572-580.,"Dourado F.S, Leite J.R.S.A, Silva L.P, Melo J.A.T, Bloch C. Jr, Schwartz E.F.",Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,16,15-18
DRAMP01188,LALKSGGWLRLFGLKDKKH,19,"Chensinin-1ZHa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana zhenhaiensis (Chinese brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=17 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=35 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=9 µM).##Yeast: Candida albicans ATCC 2002 (MIC=35 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.22943378]No cytotoxicity information found,Not found,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",19,18-21
DRAMP01189,ATNIPFKVHFRCKAAFC,17,"Andersonin-W1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Golden crossband frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=23.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>47 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>47 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=47 µg/ml).",[Ref:22029824] It has no hemolytic activity against human red blood cells,Cyclic,Free,Cyclization (Cys12 and Cys17),Disulfide bond between Cys12 and Cys17.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,17,15-18
DRAMP01190,AVNIPFKVHFRCKAAFC,17,"Andersonin-W2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Golden crossband frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.1 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=20.2 µg/ml).",[Ref:22029824] It has no hemolytic activity against human red blood cells,Cyclic,Free,Cyclization (Cys12 and Cys17),Disulfide bond between Cys12 and Cys17.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,17,15-18
DRAMP01191,GLFSKFAGKGIVNFLIEGVE,20,"Andersonin-X1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Golden crossband frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=15.3 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=15.3 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30.5 µg/ml).",[Ref:22029824]Not found,Linear,Free,Free,Free,L,[Ref.22029824]No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,20,18-21
DRAMP01192,FLPKLFAKITKKNMAHIR,18,"Andersonin-Y1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Golden crossband frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=3.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=1.6 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=1.6 µg/ml).",[Ref:22029824]Not found,Linear,Free,Free,Free,L,[Ref.22029824]No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,18,15-18
DRAMP01195,FIFPKKNIINSLFGR,15,"Andersonin-D1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Golden crossband frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Weakly active against bacteria and fungi. Andersonin-D1 showes obvious insulin-stimulating activity at the concentration of 50 Î¼g/mL.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>126 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=16 µg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=16 µg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=16 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.22029824]No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,15,12-15
DRAMP01199,RFIYMKGFGKPRFGKR,16,"Hejiangin-A1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana hejiangensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Hejiangin-A1 showes killing effects against the tested strains.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=100 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=25 µg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=25 µg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.22029824]No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,16,15-18
DRAMP01200,IPWKLPATFRPVERPFSKPFCRKD,24,"Hejiangin-F1 (frog, amphibians, animals)",No entry found,Not found,Not found,Odorrana hejiangensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>100 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=100 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=100 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=100 µg/ml).",[Ref:22029824]Non-hemolytic activity against human red blood cells,Linear,Free,Free,Free,L,[Ref.22029824]No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP01201,AAPRGGKGFFCKLFKDC,17,"Schmackerin-C1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana schmackeri,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Schmackerin-C1 showes killing effects against the tested strains. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=100 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=50 µg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=50 µg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=100 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys11 and Cys17),Disulfide bond between Cys11 and Cys17.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,17,15-18
DRAMP01202,GLLDFAKHVIGIASKLG,17,"Fallaxidin 3.2 (Frogs, amphibians, animals)","B5LUQ7, B5LUR0, B5LUR1, B5LUQ3",Not found,Not found,Litoria fallax (Eastern dwarf tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Fallaxidin-3.2 shows antibacterial activity against the Gram-positive bacteria.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Enterococcus faecalis (MIC=100 µM), Lactococcus lactis (MIC=500 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.18803332]No cytotoxicity information found,Not found,18803332,Rapid Commun Mass Spectrom. 2008 Oct;22(20):3207-3216.,"Jackway RJ, Bowie JH, Bilusich D, Musgrave IF, Surinya-Johnson KH, Tyler MJ, Eichinger PC.",The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins.,17,15-18
DRAMP01203,GLLDLAKHVIGIASKL,16,"Fallaxidin 3.1 (Frogs, amphibians, animals)","B5LUQ8, B5LUQ3",Not found,Not found,Litoria fallax (Eastern dwarf tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Fallaxidin-3.1 shows antibacterial activity against the Gram-positive bacteria.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Enterococcus faecalis (MIC=100 µM), Lactococcus lactis (MIC=100 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.18803332]No cytotoxicity information found,Not found,18803332,Rapid Commun Mass Spectrom. 2008 Oct;22(20):3207-3216.,"Jackway RJ, Bowie JH, Bilusich D, Musgrave IF, Surinya-Johnson KH, Tyler MJ, Eichinger PC.",The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins.,16,15-18
DRAMP01204,GLLSFLPKVIGVIGHLIHPPS,21,"Fallaxidin 4.1 (Frogs, amphibians, animals)",B5LUQ4,Not found,Not found,Litoria fallax (Eastern dwarf tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Fallaxidin-4.1 shows antibacterial activity against the Gram-positive bacteria. Inhibits the formation of NO by neuronal nitric oxide synthase (IC50=13.3 µM).
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Lactococcus lactis (MIC=12 µM), Micrococcus luteus (MIC=100 µM), Staphylococcus epidermidis (MIC=100 µM), Streptococcus uberis (MIC=50 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Free,Free,L,[Ref.18803332]No cytotoxicity information found,Not found,18803332,Rapid Commun Mass Spectrom. 2008 Oct;22(20):3207-3216.,"Jackway RJ, Bowie JH, Bilusich D, Musgrave IF, Surinya-Johnson KH, Tyler MJ, Eichinger PC.",The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins.,21,18-21
DRAMP01214,FLGAIAAALPHVINAVTNAL,20,"Kassinatuerin-2Ma (Frogs, amphibians, animals)",No entry found,Not found,Not found,Kassina maculata (African hyperoliid frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Alpha helix,"Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.",,"Function: Natural kassinatuerin-2Ma and their synthetic replicates possessed relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli at concentrations up to 200 µM and were relatively ineffective against the pathogenic yeast, C. albicans (120 µM). Also possessed hemolytic activity as demonstrated using horse erythrocytes.",[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus (NCTC 10788) (MIC=16 µM);##Gram-negative bacterium: Escherichia coli (NCTC 10418) (MIC>200 µM) (MIC=120 µM);##Yeast: Candida albicans (NCPF 1467) (MIC=120 µM).,"[Ref:19427345]18% hemolytic activity at 16 μM, 45–50% hemolytic activity at 120 μM against horse erythrocytes",Linear ,Free,Amidation,Free,L,[Ref.19427345]No cytotoxicity information found,Not found,19427345,Peptides. 2009 Aug;30(8):1428-1433.,"Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.","A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",20,18-21
DRAMP01218,GFMKYIGPLIPHAVKAISDLI,21,"Kassinatuerin-1 (Frogs, amphibians, animals)",P0C010,Not found,Not found,Kassina senegalensis (Senegal running frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix,Not found,,"Function: Shows broad-spectrum antimicrobial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-negative bacteria: Escherichia coli (MIC=6.25 µM), Klebsiella pneumoniae (MIC=25 µM), Enterobacter cloacae (MIC=6.25 µM), Pseudomonas aeruginosa (MIC=25 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.25 µM), Staphylococcus epidermidis (MIC=6.25 µM), Enterococcus faecalis (MIC=12.5 µM).##Yeast: Candida albicans (MIC=100 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15885852]Display cytotoxicity against L929 fibroblasts (LD50=12μM).,Not found,10679222##15885852,Biochem Biophys Res Commun. 2000 Feb 16;268(2):433-436.##Peptides. 2005 Nov;26(11):2104-2110.,"Mattute B, Knoop FC, Conlon JM.##Conlon JM, Abraham B, Galadari S, Knoop FC, Sonnevend A, P¡l T.","Kassinatuerin-1: a peptide with broad-spectrum antimicrobial activity isolated from the skin of the hyperoliid frog, Kassina senegalensis.##Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",21,18-21
DRAMP01246,FGLPMLSILPKALCILLKRKC,21,"Japonicin-2 (Frogs, amphibians, animals)",P83306,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana japonica (Japanese brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli (MIC=12 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=20 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys14 and Cys21),Disulfide bond between Cys14 and Cys21.,L,No cytotoxicity information found,Not found,11835990,Peptides. 2002;23:419-425.,"Isaacson T, Soto A, Iwamuro S, Knoop FC, Conlon JM.",Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica.,21,18-21
DRAMP01248,FLIGMTHGLICLISRKC,17,"Dybowskin-1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana dybowskii (Korea brown frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Function: Dybowskin-1 has low hemolytic activity against human red blood cells (hRBCs).,"[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=12.5 µg/ml), Staphylococcus aureus KCTC3881 (MIC=25 µg/ml), Bacillus subtilis ATCC6633 (MIC=50 µg/ml), Staphylococcus epidermidis ATCC 12228 (MIC=60 µg/ml).",[Ref:17698251] It has 0.99% hemolytic activity at 100 μg/ml against huamn red blood cells,Cyclic,Free,Cyclization (Cys11 and Cys17),Disulfide bond between Cys11 and Cys17.,L,No cytotoxicity information found,Not found,17698251,Peptides 2007; 28: 1532-1539. ,"Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.",Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,17,15-18
DRAMP01249,FLIGMTQGLICLITRKC,17,"Dybowskin-2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana dybowskii (Korea brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Dybowskin-2 has hemolytic activity against human red blood cells (hRBCs).,"[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=6.25 µg/ml), Staphylococcus aureus KCTC3881 (MIC=15 µg/ml), Bacillus subtilis ATCC6633 (MIC=25 µg/ml), Staphylococcus epidermidis ATCC12228 (MIC=25 µg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=50 µg/ml), Escherichia coli KCTC2433 (MIC=60 µg/ml), Klebsiella pneumoniae ATCC10031 (MIC=60 µg/ml), Proteus mirabilis ATCC25933 (MIC>100 µg/ml);##Yeast: Candida albicans ATCC36232 (MIC=100 µg/ml).",[Ref:17698251] It has 10.99% hemolytic activity at 100 μg/ml against human red blood cells,Cyclic,Free,Cyclization (Cys11 and Cys17),Disulfide bond between Cys11 and Cys17.,L,No cytotoxicity information found,Not found,17698251,Peptides 2007; 28: 1532-1539. ,"Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.",Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,17,15-18
DRAMP01251,VWPLGLVICKALKIC,15,"Dybowskin-4 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana dybowskii (Korea brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Dybowskin-4 has relatively greater hemolytic activity against human red blood cells (hRBCs).,"[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=1.56 µg/ml), Staphylococcus aureus KCTC3881 (MIC=3.13 µg/ml), Bacillus subtilis ATCC6633 (MIC=6.25 µg/ml), Staphylococcus epidermidis ATCC12228 (MIC=6.25 µg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=30 µg/ml), Escherichia coli KCTC2433 (MIC=15 µg/ml), Klebsiella pneumoniae ATCC10031 (MIC=15 µg/ml);##Yeast: Candida albicans ATCC36232 (MIC=25 µg/ml).",[Ref:17698251] It has 47.58% hemolytic activity at 100 μg/ml against human red blood cells,Cyclic,Free,Cyclization (Cys9 and Cys15),Disulfide bond between Cys9 and Cys15.,L,No cytotoxicity information found,Not found,17698251,Peptides 2007; 28: 1532-1539. ,"Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.",Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,15,12-15
DRAMP01253,FLPLLLAGLPLKLCFLFKKC,20,"Dybowskin-6 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana dybowskii (Korea brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Not found,Not found,Not found,,Function: Dybowskin-6 has relatively greater hemolytic activity against human red blood cells (hRBCs).,"Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=6.25 µg/ml), Staphylococcus aureus KCTC3881 (MIC=12.5 µg/ml), Bacillus subtilis ATCC6633 (MIC=50 µg/ml), Staphylococcus epidermidis ATCC12228 (MIC=50 µg/ml).##Yeast: Candida albicans (MIC=50 µg/ml).",[Ref:17698251] It has 59.39% hemolytic activity at 100 μg/ml against huamn red blood cells,Cyclic,Free,Cyclization (Cys14 and Cys20),Disulfide bond between Cys14 and Cys20.,L,No cytotoxicity information found,[Ref:17698251]59.39% hemolytic activity at 100 μg/ml against huamn red blood cells,17698251,Peptides. 2007 Aug;28(8):1532-1539.,"Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.",Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,20,18-21
DRAMP01255,SAVGRHGRRFGLRKHRKH,18,"Dybowskin-2CDYa (Chensinin-1; Frogs, amphibians, animals)",B5A9T1,Not found,Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Not found,,"Function: Antimicrobial peptide. Has activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E. coli. Lacks hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.","[Ref.19539775] Gram-negative bacterium: Escherichia coli (MIC=3 µM);##Gram-negative bacterium: Staphylococcus aureus (MIC=6 µM).##[Ref.19341344] Gram-positive bacteria: Staphylococcus aureus (MIC=14.4 µM), Bacillus cereus (MIC=14.4 µM), Streptococcus lactis (MIC=14.4 µM).",[Ref:19539775]HC50>300 μM against human red blood cells,Linear ,Free,Free,Free,L,[Ref.19539775]No cytotoxicity information found##[Ref.19341344]No cytotoxicity information found,Not found,19539775##19341344,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.##Zoolog Sci. 2009 Mar;26(3):220-226.,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.##Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.##Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.",18,15-18
DRAMP01261,GLWSKIKEAAKTAGLMAMGFVNDMV,25,"Dermadistinctin-Q2 (DD Q2; Frogs, amphibians, animals)",P83642,Not found,Not found,Phyllomedusa distincta (Monkey frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Staphylococcus aureus (MIC=22 µM), Enterococcus faecalis (MIC=11 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=22 µM), Escherichia coli (MIC=5.6 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.10477123]To produce hemolysis more than 38 μM peptide concentrations was required. ,Not found,10477123,Peptides. 1999;20(6):679-686.,"Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.",Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,25,24-27
DRAMP01288,FLSLIPHIVSGVASIAKHF,19,"Phylloseptin-1 (PSN-1; Frogs, amphibians, animals)",E3PQH3,Not found,PSN-1,Phyllomedusa sauvagei (Sauvage's leaf frog),"Antimicrobial, Antibacterial, Antifungal",Homology,Not found,Not found,,Function: PSN-1 displayed broad-spectrum activity against a range of planktonic organisms.,"S. aureus (MIC=5 µM), Escherichia coli and Candida albicans.",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.20451254]No cytotoxicity information found,Not found,20451254,Mol Immunol. 2010 Jul;47(11-12):2030-2037.,"Zhang R, Zhou M, Wang L, McGrath S, Chen T, Chen X, Shaw C.",Phylloseptin-1 (PSN-1) from Phyllomedusa sauvagei skin secretion: a novel broad-spectrum antimicrobial peptide with antibiofilm activity.,19,18-21
DRAMP01301,FLSLIPHAINAVSAIAKHN,19,"Phylloseptin-1 (PS-1; Frogs, amphibians, animals)",P84566,Not found,psn1,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal",Protein level,Alpha helix (1 helices; 14 residues),The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2),2JQ0 resolved by NMR.,"Function: Atomic force microscopy experiments indicated that the bacteriolytic properties of these peptides might be related to their disruptive action on the cell membrane. PS-1 did not exhibit significant hemolytic activity on human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.15752569]Gram-positive bacteria: Staphylococcus aureus (MIC=7.9 µM), Enterococcus faecalis (MIC=4.0 µM);##Gram-negative bacteria: Escherichia coli (MIC=7.9 µM), Psecdomonas aeruginosa (MIC=4 µM), Psecdomonas aeruginosa wt (MIC=3 µM).","[Ref:15752569]0.3% hemolytic activity at 4 μM, 0.57% hemolytic activity at 8 μM, 0.6% hemolytic activity at 16 μM, 0.98% hemolytic activity at 32 μM, 1.98% hemolytic activity at 64 μM against human red blood cells",Linear ,Free,Amidation,Free,L,[REf.15752569]No cytotoxicity information found##[Ref.18656510]No cytotoxicity information found,Cell membrane,15752569##18656510,Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644. ,"Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, PilÃ³-Veloso D, Bechinger B.","Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.",19,18-21
DRAMP01302,FLSLIPHAINAVSTLVHHF,19,"Phylloseptin-2 (PS-2; Frogs, amphibians, animals)","P85881, P84567, Q0VZ43",Not found,psn2,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix (1 helices; 14 residues),The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2),2JPY resolved by NMR.,"Function: Has antimicrobial activity. PS-2 did not exhibit significant hemolytic activity on human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.18656510][ATCC Strains]: Gram-positive bacteria: S. aureus (MIC=15.1 µM);##Gram-negative bacteria: Escherichia coli (MIC=60.4 µM), Klebsiella pneumoniae (MIC=60.4 µM), Pseudomonas aeruginosa (MIC=60.4 µM);##[Wild Type]: Gram-positive bacteria: S. aureus (MIC=7.6 µM), S. agalactiae (MIC=1.9 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=60.4 µM), A. calcoaceticus (MIC=3.7 µM);##Fungi: Candida albicans (MIC=15.1 µM).","[Ref:15752569]0.1% hemolytic activity at 4 μM, 0.28% hemolytic activity at 4 μM, 0.7% hemolytic activity at 8 μM, 0.8% hemolytic activity at 16 μM, 1.05% hemolytic activity at 32 μM, 2.05% hemolytic activity at 64 μM against human red blood cells",Linear ,Free,Amidation,Free,L,[REf.15752569]No cytotoxicity information found##[Ref.18656510]No cytotoxicity information found,Cell membrane,15752569##18656510,Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644. ,"Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, PilÃ³-Veloso D, Bechinger B.","Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.",19,18-21
DRAMP01303,FLSLIPHAINAVSALANHG,19,"Phylloseptin-3 (PS-3; Frogs, amphibians, animals)",P84568,Not found,psn3,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix (1 helices; 11 residues),The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2),2JQ1 resolved by NMR.,"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[ATCC Strains]: Gram-positive bacteria: S. aureus (MIC=32.9 µM);##Gram-negative bacteria: Escherichia coli (MIC=65.6 µM), Klebsiella pneumoniae (MIC=65.6 µM), Pseudomonas aeruginosa (MIC=65.6 µM). NOTE: Initial inoculum of 108 cells/Ml.##[Wild Type]: Gram-positive bacteria: S. aureus (MIC=8.2 µM), S. agalactiae (MIC=4.1 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=32.8 µM), A. calcoaceticus (MIC=4.1 µM).##Fungi: Candida albicans (MIC=8.2 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.15752569]No cytotoxicity information found##[Ref.18656510]No cytotoxicity information found,Cell membrane,15752569##18656510,Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644. ,"Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, PilÃ³-Veloso D, Bechinger B.","Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.",19,18-21
DRAMP01305,FLSLIPHAINAVSAIAKHFG,20,"Phylloseptin-7 (PS-7; Frogs, amphibians, animals)","P84572, Q0VZ42",Not found,psn7,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity against the Gram-negative bacteria E. coli and P. aeruginosa, and the Gram-positive bacteria: S. aureus. No hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.16963159]Gram-negative bacteria: Escherichia coli (MIC=6 µM), Pseudomonas aeruginosa (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM)",[Ref:16963159]Non-hemolytic activity at 6 μM against human erythrocytes,Linear ,Free,Amidation,Free,L,[Ref.16713656]No cytotoxicity information found,Not found,16963159##16713656,Peptides. 2006 Dec;27(12):3092-3999.##Peptides. 2006 Sep;27(9):2129-2136.,"ConceiÃ§Ã£o K, Konno K, Richardson M, Antoniazzi MM, Jared C, Daffre S, Camargo AC, Pimenta DC.##Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.","Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis.##Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.",20,18-21
DRAMP01306,FLSLIPHAINAVSAIAKHF,19,"Phylloseptin-7 (PS-7; Frogs, amphibians, animals)",P85882,Not found,Not found,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity but does not inhibit the growth of the fungus C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: Phenylalanine amide at F19.","Gram-negative bacterium: Escherichia coli ATCC 11775 (MIC=7.2 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 12600 (MIC=3.6 µM), Micrococcus luteus ATCC 49732 (MIC=1.8 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.16963159]No cytotoxicity information found##[Ref.17553595]No cytotoxicity information found,Not found,17553595##16963159,Peptides. 2007 Jul;28(7):1331-1343.##Peptides. 2006 Dec;27(12):3092-3099.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.##Conceição K, Konno K, Richardson M, Antoniazzi MM, Jared C, Daffre S, Camargo AC, Pimenta DC.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.##Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis. ,19,18-21
DRAMP01314,FLSLLPSIVSGAVSLAKKLG,20,"Phylloseptin 12 (PS-12; Frogs, amphibians, animals)",Q17UY9,Not found,psn-12,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Has antibacterial activity against the Gram-positive bacterium M. luteus. Does not inhibit the growth of the fungus C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",Gram-positive bacterium: Micrococcus luteus ATCC 49732 (MIC=1.3 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.17553595]No cytotoxicity information found,Not found,17553595,Peptides. 2007 Jul;28(7):1331-1343.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,20,18-21
DRAMP01320,AAFRGCWTKNYSPKPCL,17,"Ranacyclin-B-AL1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Amolops loloensis (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Function: Has antibacterial activity.,"Gram-positive bacteria: Staphylococcus aureus (MIC=51 µM), Bacillus subtilis (MIC=26 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,17,15-18
DRAMP01339,FLPIVGKLLSGLSGLL,16,"Amolopin-2a (Frogs, amphibians, animals)",No entry found,Not found,Not found,Amolops loloensis (Rufous-spotted torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus (MIC=2.00 µg/ml), Bacillus dysenteriae (MIC=1.50 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=3.00 µg/ml).##Candida albicans (MIC=6.50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.17000029]Display cytotoxicity against HepG2(IC50=77 mg/ml).,Not found,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",16,15-18
DRAMP01341,FLPLAVSLAANFLPKLFCKITKKC,24,"Amolopin-1b (Frogs, amphibians, animals)",A0SN42,Not found,Not found,Amolops loloensis (Rufous-spotted torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus (MIC=5.50 µg/ml), Bacillus dysenteriae (MIC=2.20 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=6.50 µg/ml).##Yeast: Candida albicans (MIC=7.50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization(Cys18 and Cys24),Disulfide bridge between Cys18 and Cys24.,L,[Ref.17000029]Display cytotoxicity against HepG2(IC50=58 mg/ml).,Not found,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",24,21-24
DRAMP01346,VIGSILGALASGLPTLISWIKNR,23,"Prepromelittin-related peptide (Frogs, amphibians, animals)",A7BJK5,Not found,prMRP,Rana sakuraii (Japanese brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).##Yeast: Candida albicans (MIC=25 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.17174009]No cytotoxicity information found##[Ref.17826868]No cytotoxicity information found,Not found,17174009##17826868,Peptides. 2007;28(3):505-514.##Peptides. 2007 Oct;28(10):2061-2068.,"Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.##Suzuki H, Conlon JM, Iwamuro S.",Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.##Evidence that the genes encoding the melittin-related peptides in the skins of the Japanese frogs Rana sakuraii and Rana tagoi are not orthologous to bee venom melittin genes: developmental- and tissue-dependent gene expression.,23,21-24
DRAMP01347,AIGSILGALAKGLPTLISWIKNR,23,"Prepromelittin-related peptide (Frogs, amphibians, animals)",A7BJK6,Not found,prMRP,Rana tagoi (Tago frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Alpha helix,Not found,6dst resolved by NMR (related PDB_ID),Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against C. albicans.,"[Ref.12804591]Gram-positive bacterium: Staphylococcus aureus (MIC=3.5 µM);##Gram-negative bacterium: Escherichia coli (MIC=20 µM).##Yeast: Candida albicans (MIC=19 µM).##EL4 T-lymphoma cells (MIC=14 µM).##[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=6.25 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)",[Ref.27271216] 100% hemolysis at 20 μM against human red blood cells,Linear,Free,Amidation,Free,L,[Ref.12804591]Display cytotoxic against L929 fibroblasts(LC50=20 μM);EL4 T-lymphoma cells(LC50=14 μM).##[Ref.27271216]L929 cells:Cell viability is approximately 10% at the concentration of 6.25 μM.,Not found,12804591##17174009##27271216,Biochem Biophys Res Commun. 2003 Jun 27;306(2):496-500.##Peptides. 2007;28(3):505-514.##Sci Rep. 2016 Jun 8;6:27394.,"Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T##Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.##Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji","A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties##Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii##Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity",23,21-24
DRAMP01354,LVRGCWTKSYPPKPCFVR,18,"Peptide leucine arginine (pLR; Frogs, amphibians, animals)","Q90WP7, P82110",Not found,Not found,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Not found,Not found,,"Function: Mast cell degranulating peptide. Antiproliferative activity against human breast and ovarian tumor cell lines in vitro. Inhibits granulopoiesis in rat in vitro. Causes histamine release from rat peritoneal mast cells in vitro. Has antibacterial activity against Gram-positive bacteria: B.megaterium Bm11, S. lentus and M.luteus, and antifungal activity against C.tropicalis, C.guiller-mondii and P.nicotianae spores. Has hemolytic activity. The mature peptide inserts into the hydrophobic core of the bacterial cell membrane and increases permeability without disrupting membrane integrity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores.","[Ref.11099505]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=20 µM), Staphylococcus lentus (MIC=50 µM), Micrococcus luteus (MIC=10 µM);##Fungi: Candida tropicalis (MIC=11 µM), Candida guillermondii (MIC=6.6 µM), Phytophthora nicotianae spores (MIC=75 µM).",[Ref:11099505] It has 2.5% hemolytic activity at 100 μM against human red blood,Cyclic,Free,Free,Disulfide bond between Cys5 and Cys15.,L,No cytotoxicity information found,Not found,11099505,J. Biol. Chem. 2001;276:10145-10152.,"Salmon A.L, Cross L.J.M, Irvine A.E, Lappin T.R.J, Dathe M, Krause G, Canning P, Thim L, Beyermann M, Rothemund S, Bienert M, Shaw C.","Peptide leucine arginine, a potent immunomodulatory peptide, isolated and structurally characterized from the skin of the Northern Leopard frog, Rana pipiens.",18,15-18
DRAMP01355,FLGGLIKIVPAMICAVTKKC,20,"Ranalexin (Frogs, amphibians, animals)",P39084,Not found,Not found,Lithobates catesbeiana (American bullfrog) (Rana catesbeiana),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Potent microbicidal activity, active against S.aureus and E.coli. It acts as well as a membrane-disruptive agent at higher concentrations.
Tissue specificity: Expressed by the skin dorsal glands.
Developmental stage: Expression starts at metamorphosis and continues into adulthood.
PTM: Contains one disulfide bond 14-20.","Gram-positive bacterium: Staphylococcus aureus (MIC=4 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=32 µg/ml), Pseudomonas aeruginosa (MIC=128 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys14 and Cys20),Disulfide bond between Cys14 and Cys20.,L,No cytotoxicity information found,Not found,8144672##9578480,J Biol Chem. 1994 Apr 8;269(14):10849-10855.##Eur J Biochem. 1998 Apr 1;253(1):221-228.,"Clark DP, Durell S, Maloy WL, Zasloff M.##Vignal E, Chavanieu A, Roch P, Chiche L, Grassy G, Calas B, Aumelas A.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.##Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micelles.",20,18-21
DRAMP01358,FLGGLFKLVPSVICAVTKKC,20,"Ranalexin-Vb (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana virgatipes (Ranidae) (Aquarana),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=12 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys14 and Cys20),Disulfide bond between Cys14 and Cys20.,L,No cytotoxicity information found,Not found,15996769,Regul Pept 2005; 131: 38-45.,Conlon JM et al Bevier CR.,"Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). ",20,18-21
DRAMP01359,FLGGLMKIIPAAFCAVTKKC,20,"Ranalexin-1G (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana grylio (North American pig frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Homology,Not found,Not found,,"Function: Has growth-inhibitory activity against the gram-positive bacterium Staphylococcus aureus, the gram-negative bacterium Escherichia coli and the yeast, Candida albicans.",Gram-negative bacterium: Escherichia coli (MIC=9 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=18 µM).##Yeast: Candida albicans (MIC=70 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys14 and Cys20),Disulfide bond between Cys14 and Cys20.,L,No cytotoxicity information found,Not found,10828493,Regul Pept. 2000 Jun 30;90(1-3):53-60.,"Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.",Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,20,18-21
DRAMP01361,GLLGTLGNLLNGLGL,15,"Frenatin-2 (Frogs, amphibians, animals)",P82022,Not found,Not found,Litoria infrafrenata (Giant tree frog) (White-lipped tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Wide spectrum antimicrobial peptide. Considered to interact with the outer lipid layer of the bacterial cell, penetrate the bacterial membrane, form ion channels, and ultimately kill the cell.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation.",Gram-positive bacteria: Micrococcus luteus (MIC=50 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.9225251]No cytotoxicity information found,Not found,9225251,J Pept Sci. 1996 Mar-Apr;2(2):117-124.,"Raftery MJ, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.,15,12-15
DRAMP01362,GLMSVLGHAVGNVLGGLFKS,20,"Frenatin-3 (Frogs, amphibians, animals)",P56249,Not found,Not found,Litoria infrafrenata (Giant tree frog) (White-lipped tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Wide spectrum antimicrobial peptide. Considered to interact with the outer lipid layer of the bacterial cell, penetrate the bacterial membrane, form ion channels, and ultimately kill the cell.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.","Gram-negative bacterium: Escherichia coli (MIC=50 µg/ml);##Gram-positive bacteria: Leuconostoc mesenteroides (MIC=25 µg/ml), Bacillus cereus (MIC=12.5 µg/ml), Micrococcus luteus (MIC=1.5 µg/ml), Pastewella haemolytica (MIC=0.8 µg/ml), Streptococcus uberis (MIC=50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.9225251]No cytotoxicity information found,Not found,9225251,J Pept Sci. 1996 Mar-Apr;2(2):117-124.,"Raftery MJ, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.,20,18-21
DRAMP01364,GLFGVLAKVAAHVVPAIAEHF,21,"Maculatin-1.1 (Frogs, amphibians, animals)",P82066,Not found,Not found,Litoria genimaculata (Green-eyed tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral",Protein level,Alpha helix,Not found,,"Function: Maculatin-1.1 shows significant antibacterial activity against Gram-positive bacteria, less against Gram-negative bacteria.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","[Ref.15203252]Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Bacillus cereus (MIC=3 µg/ml), Listeria innocua (MIC=100 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=6 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=3 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 µg/ml). ##[Ref.16140737]Virus:HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=11.3 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,No cytotoxicity information found in the reference(s) presented,Not found,16140737##9620615##15203252,J Virol. 2005 Sep;79(18):11598-606. ##J Pept Sci. 1998 Apr;4(2):111-115.##Peptides. 2004; 25: 1035-1054.,"VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D. ##Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.##The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",21,18-21
DRAMP01367,GLLGLLGSVVSHVLPAITQHL,21,"Maculatin-1.4 (frog, amphibia, animals)",No entry found,Not found,Not found,Litoria eucnemis (Australian anurans),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,"Function: Shows antibacterial activity against the Gram-positive bacteria.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Bacillus cereus (MIC=6 µg/ml), Listeria innocua (MIC=100 µg/ml), Micrococcus luteus (MIC=50 µg/ml), Staphylococcus aureus (MIC=50 µg/ml), Staphylococcus epidermidis (MIC=50 µg/ml), Streptococcus uberis (MIC=50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found,Not found,15203252,Peptides. 2004 Jun; 25: 1035-1054.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",21,18-21
DRAMP01368,GFVDFLKKVAGTIANVVT,18,"Maculatin-2.1 (Frogs, amphibians, animals)",P82068,Not found,Not found,Litoria genimaculata (brown-spotted treefrog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows antibacterial activity against the Gram-positive bacteria.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Micrococcus luteus (MIC=100 µg/ml), Staphylococcus aureus (MIC=100 µg/ml), Staphylococcus epidermidis (MIC=50 µg/ml), Streptococcus uberis (MIC=25 µg/ml). (Ref.2)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found##[Ref.9620615]No cytotoxicity information found,Not found,9620615##15203252,J Pept Sci. 1998 Apr;4(2):111-115.##Peptides. 2004; 25: 1035-1054.,"Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",18,15-18
DRAMP01371,GLLSGILGAGKHIVCGLTGCAKA,23,"Odorranain-NR (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Combine helix and strand structure,"Odorranain-NR has a large proportion of beta-sheet. In Tris HCl + SDS, odorranain-NR has a major conformation of beta-sheet (79.2%) and a minor conformation of beta-turn (1.3%). In Tris HCl, the beta-sheet has been decreased to 57.1% and the beta-turn has been increased to 10.5%. The beta-sheet has been decreased to 39.8% in water.",,"Function: Odorranain-NR exhibits antimicrobial activity against the tested strains except E. coli ATCC25922. Odorranain-NR has little hemolytic activity on red blood cells even with peptide concentration up to 100 mg/ml.
PTM: Odorranain-NR has an intramolecular disulfide-bridged hexapeptide segment, which is a new type of disulfide-bridge motif in amphibian antimicrobial peptides.","[Ref.18282640]Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=9.375 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>100 µg/ml), Bacillus dysenteriae (MIC=37.5 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=18.75 µg/ml).",[Ref:18282640] It has little hemolytic activity at 100 μg/ml against rabbit red blood cells,Cyclic,Free,Free,Disulfide bond between Cys15 and Cys20.,L,No cytotoxicity information found,Not found,18282640,Peptides. 2008 Apr;29(4):529-535. ,Che Q et al Lai R.,A novel antimicrobial peptide from amphibian skin secretions of Odorrana grahami.,23,21-24
DRAMP02997,GNNRPVYIPQPRPPHPRL,18,"Apidaecin-1B (Apidaecin IB; Insects, animals)","P35581, Q06602, Q06601, Q8WSY8",Belongs to the apidaecin family,Not found,Apis mellifera (Honeybee),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,4E81 resolved by X-ray.,Function: Apidaecins have bactericidal activity; predominantly against Gram-negative bacteria. They seem to interfere with cell propagation.,"[Ref.2676519] Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 μg/ml), Erwinia salicis (MIC=0.02 μg/ml), Escherichia coli (MIC=0.1 μg/ml), Pseudomonas syringae (MIC=0.1 μg/ml), Rhizobium meliloti (MIC=0.02 μg/ml), Salmonella Newport (MIC=0.2 μg/ml), Salmonella typhimurium (MIC=0.1 μg/ml), Shigella flexneri (MIC=0.1 μg/ml);##Gram-positive bacteria: Corynebacterium insidiosum (MIC=50 μg/ml), Bacillus megaterium (MIC=100 μg/ml).##[Ref.2298215] Gram-negative bacteria: Agrobacterium tumefaciens Gembloux A (MIC≤1 µg/ml), Erwinia salicis NCPPB 2530 (MIC≤1 µg/ml), Escherichia coli NCTC 9001 (MIC≤1 µg/ml), Escherichia coli K514 (MIC=25-50 µg/ml), Pseudomonas syringae pv.tomato NCPPB 1105 (MIC≤1 µg/ml), Xanthomonas campestris pv. vesicatoria LMG 905 (MIC≥100 µg/ml);##Gram-positive bacteria: Bacillus megateriurn QMB 1551 (MIC=25-50 µg/ml), Bacillus alvei LMG 6922 (MIC=50-100 µg/ml),Micrococcus lysodeikticus LMG 4050 (MIC=25-50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.2298215]No cytotoxicity information found##[Ref.2676519]No cytotoxicity information found,Not found,2676519##2298215,EMBO J. 1989 Aug;8(8):2387-2391.##Eur J Biochem. 1990 Jan 26;187(2):381-386.,"Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.##Casteels P, Ampe C, Riviere L, Van Damme J, Elicone C, Fleming M, Jacobs F, Tempst P.","Apidaecins: antibacterial peptides from honeybees.##Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera).",18,15-18
DRAMP18322,ITPATPFTPAIITEITAAVIA,21,Hominicin (Bacteriocin),No entry found,Not found,Not found,Staphylococcus hominis MBBL 2-9,"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,"NMR played a critical role in establishing the peptide primary structure. While the N-terminal residue is an N,N-dimethyl Ile (DmIle), the C-terminus is a N2, N2-dimethyl-1,2-propanediamine (Dmp). In addition, threonines are dehydrated into Dhb. In this sense, this peptide may be classified as a class I variant bacteriocin.",,"Function: Hominicin exhibited heat stability up to 121 degrees C for 15min and activity under both acidic and basic conditions (from pH 2.0 to 10.0). Hominicin exhibited distinct structural and attractive biochemical characteristics with a high bactericidal activity against MRSA and VISA, heat-tolerance and pH stability.","[Ref.20654578] Gram-positive bacteria:  Staphylococcus aureus  (MIC=0.06 µg/ml), MRSA (MIC=0.96 µg/ml), VISA (MIC=3.82 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,"1-DmIle(N,N-dimethyl Ile)-I; 2,5,8,15-DHB(dehydrated threonine)-T;21-Dmp(N2, N2-dimethyl-1,2-propanediamine)-A",L,[Ref.20654578]No cytotoxicity information found,Not found,20654578,Biochem Biophys Res Commun. 2010 Aug 20;399(2):133-138.,"Kim PI, Sohng JK, Sung C, Joo HS, Kim EM, Yamaguchi T, Park D, Kim BG. ","Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9. ",21,18-21
DRAMP02840,FKCRRWQWRMKKLGAPSITCVRRAF,25,"Lactoferricin B (Lfcin B; mammals, animals)","P24627, E6YCQ7, B3VTM3, B9VPZ5, C7FE01, Q6LBN7, Q19KS1",Belongs to the transferrin family,LTF,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Beta strand (4 strands; 8 residues),"Residues 7-9 form beta1 and residues 17-19 form beta2 (in membrane). This contrasts with X-ray structure where residues 1-13 is helical. Thus, this peptide appears to be able to adopt a different conformation depending on environmental conditions. disulfide bond is not required for the antimicrobial potency.",1LFC resolved by NMR.,"Function: Lactoferricin B  function contributes to the antimicrobial activity. Shows a preferential cleavage at -Arg-Ser-Arg-Arg-|- and -Arg-Arg-Ser-Arg-|-, and of Z-Phe-Arg-|-aminomethylcoumarin sites.
Activity regulation: Inhibited by PMSF and Pefabloc.
PTM: Contains one disulfide bond 3-20","[Ref.8980754] Gram-negative bacteria:  Escherichia coli L361 (MIC=4 µM or 12.5 µg/ml), Salmonella Salford (MIC=4 µM or 12.5 µg/ml), Escherichia coli O:9 (MIC=6 µM or 18.8 µg/ml), Pseudomonas ﬂuorescens (MIC=10 µM or 31.3 µg/ml)  ;##Gram-positive bacteria: Listeria monocytogenes (MIC=2 µM or 6.3 µg/ml), Staphylococcus aureus (MIC=6 µM or 18.8 µg/ml), Bacillus cereus (MIC=6 µM or 18.8 µg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys3 and Cys20.,L,No cytotoxicity information found,Not found,8980754##9521752##1490908 ,"Antimicrob Agents Chemother. 1997 Jan;41(1):54-59. ##Biochemistry. 1998 Mar 24;37(12):4288-4298.##
J Appl Bacteriol. 1992 Dec;73(6):472-9.","Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R. ##Hwang PM, Zhou N, Shan X, Arrowsmith CH, Vogel HJ. ##Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M.1992","Antibacterial activity in bovine lactoferrin-derived peptides. ##Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. ##
Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. ",25,24-27
DRAMP01357,FLGGLMKAFPAIICAVTKKC,20,"Ranalexin-1Cb (Ranatuerin 1Cb; Frogs, amphibians, animals)",P82877,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Not found,Rana clamitans (Green frog) (Lithobates clamitans),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial peptide has defense response to Gram-positive bacterium, defense response to Gram-negative bacterium, male-specific defense response to bacterium, antibacterial humoral response, antibacterial humoral response,  induced systemic resistance, antifungal innate immune response, antifungal humoral response, defense response to fungus (incompatible interaction) in GO analysis.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys14 and Cys20),Disulfide bond between Cys14 and Cys20.,L,No cytotoxicity information found,Not found,10822101,Peptides. 2000 Apr;21(4):469-476.,"Halverson T, Basir YJ, Knoop FC, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,20,18-21
DRAMP02246,SMLSVLKNLGKVGLGLVACKINKQC,25,"Ranatuerin-1C (Ranatuerin 1C; Frogs, amphibians, animals)",P82875,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Not found,Rana clamitans (Green frog) (Lithobates clamitans),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands.",[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=55 μM);##Gram-negative bacterium: Escherichia coli (MIC=1.5 μM).##Yeast: Candida albicans (MIC=58 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys19 and Cys25),Disulfide bond between Cys19 and Cys25.,L,No cytotoxicity information found,Not found,10822101,Peptides. 2000 Apr;21(4):469-476.,"Halverson T, Basir YJ, Knoop FC, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,25,24-27
DRAMP01394,GLLRASSVWGRKYYVDLAGCAKA,23,"Odorranain-W2 (Frogs, amphibians, animals)",A7YL71,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Function: Shows antibacterial and antifungal activities.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µg/ml), Bacillus dysenteriae (MIC=30 µg/ml), Helicobacter pylori NCTC 11637 (MIC=20 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 µg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Free,Free,L,[Ref.17698252]No cytotoxicity information found,Not found,17698252,Peptides. 2007 Aug;28(8):1527-1531. ,"Chen L, Li Y, Li J, Xu X, Lai R, Zou Q.",An antimicrobial peptide with antimicrobial activity against Helicobacter pylori.,23,21-24
DRAMP01395,VVKCSYRLGSPDSQCN,16,"Odorranain-A-OA1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=35.2 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=35.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=17.6 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=17.6 µg/ml).",[Ref:22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Free,Disulfide bond between Cys4 and Cys15.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,16,15-18
DRAMP18395,FFGHLFRGIINVGKHIHGLLSG,22,"moroPC-NH2 (moronecidin-like peptide; fish, animals)",No entry found,Not found,Not found,Parachaenichthys charcoti,"Antimicrobial, Antibacterial, Antifungal",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against Gram- E. cloacae ATCC 13047 (MIC 25 uM), S. sonnei (ATCC 29930) (MIC 5 uM), Psychrobacter sp. (PAMC 25501) (MIC 2.5 uM), E. coli DH5alpha (MIC 5 uM), Gram+ E. faecalis (ATCC 29212) (MIC 25 uM), S. pyogenes (ATCC 19615) (MIC 2.5 uM), S. aureus (ATCC 33591), L. monocytogenes (ATCC 15313) (MIC 5 uM), and yeast C. tropicalis (ATCC 20115) (MIC 5 uM). ",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.28122029]No cytotoxicity information found,Not found,28122029,PLoS One. 2017 Jan 25;12(1):e0170821.,"Shin SC, Ahn IH, Ahn DH, Lee YM, Lee J, Lee JH, Kim HW, Park H",Characterization of Two Antimicrobial Peptides from Antarctic Fishes (Notothenia coriiceps and Parachaenichthys charcoti),22,21-24
DRAMP01402,GLFTLIKGAYKLDAPTVACN,20,"Odorranain-J-OA1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=40.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.1 µg/ml)；##Yeast: Candida albicans ATCC 2002 (MIC=20.1 µg/ml).",[Ref:22029824]Not found,Linear,Free,Free,Free,L,[Ref.22029824]No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,20,18-21
DRAMP01403,GLFTLIKGAYKNDAPTVACN,20,"Odorranain-J-OA2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=40.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.1 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=20.1 µg/ml).",[Ref:22029824]Not found,Linear,Free,Free,Free,L,[Ref.22029824]No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,20,18-21
DRAMP01409,GILSGILGVGKKLVCGLSGLC,21,"Nigrocin-OR1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana rotodora (Chinese odorous frogs),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=4 µM), Pseudomonas aeruginosa (MIC=7 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=2 µM).##Yeast: Candida albicans (MIC=4 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01410,GILSGILGVGKMLVCGLSGLC,21,"Nigrocin-OR2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana rotodora (Chinese odorous frogs),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 µM), Bacillus pyocyaneus CMCCB 10104 (MIC=5 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 µM).##Yeast: Candida albicans ATCC 2002 (MIC=3 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01411,GILSGLLGVGKMLVCGLSGLC,21,"Nigrocin-OR3 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana rotodora (Chinese odorous frogs),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 µM), Bacillus pyocyaneus CMCCB 10104 (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6 µM).##Yeast: Candida albicans ATCC 2002 (MIC=3 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01412,GLLGSLFGAGKKVACALSGLC,21,"Nigrocin-2HSa (Frogs, amphibians, animals)",P0C8U0,Not found,Not found,Odorrana hosii (Hose's rock frog) ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. 
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 15-21.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=56 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=28 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",21,18-21
DRAMP01413,GLLGSIFGAGKKIACALSGLC,21,"Nigrocin-2HSb (Frogs, amphibians, animals)",P0C8U1,Not found,Not found,Odorrana hosii (Hose's rock frog) ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. 
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 15-21.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=28 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=14 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",21,18-21
DRAMP01414,GIFSTVFKAGKGIVCGLTGLC,21,"Nigrocin-2ISa (Frogs, amphibians, animals)",F1T156,Not found,Not found,Odorrana ishikawae (Ishikawa's frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), Staphylococcus aureus (MRSA) (MIC=12.5 µM), Bacillus subtilis (MIC=12.5 µM).##Yeast: Candida albicans (MIC=50 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,[Ref.21193000]No cytotoxicity information found,Not found,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,21,18-21
DRAMP01415,GILGTVFKAGKGIVCGLTGLC,21,"Nigrocin-2ISb (Frogs, amphibians, animals)",F1T157,Not found,Not found,Odorrana ishikawae (Ishikawa's frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), Staphylococcus aureus (MRSA) (MIC=12.5 µM), Bacillus subtilis (MIC=12.5 µM).##Yeast: Candida albicans (MIC=50 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,21,18-21
DRAMP01416,GILSTVFKAGKGIVCGLSGLC,21,"Nigrocin-2ISc (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana ishikawae (Ishikawa's frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=3 µM).##Yeast: Candida albicans (MIC=100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,21867685,Biochem Biophys Res Commun. 2011 Sep 9;412(4):673-677. ,"Iwakoshi-Ukena E, Soga M, Okada G, Fujii T, Sumida M, Ukena K.",Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning.,21,18-21
DRAMP01417,GLLSGILGAGKHIVCGLSGLC,21,"Nigrocin-2GRa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana grahami (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Has antibacterial against Gram-negative bacterium E. coli. Also has a weak hemolytic activity against human erythrocytes.,[Ref.16621155]Gram-negative bacterium: Escherichia coli (MIC=25 µM).,[Ref:16621155] LC50=295 μM against human erythrocytes,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,16621155,Peptides. 2006 Sep;27(9):2111-2117.,"Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",21,18-21
DRAMP01418,GLFGKILGVGKKVLCGLSGMC,21,"Nigrocin-2GRb (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana grahami (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial against the Gram-negative bacterium E. coli and the Gram-positive bacterium S. aureus. Also has a weak hemolytic activity against human erythrocytes.,[Ref.16621155]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 µM);##Gram-negative bacterium: Escherichia coli (MIC=3 µM);##Yeast: Candida albicans (MIC=50 µM).,[Ref:16621155] LC50=40 μM against human erythrocytes,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,16621155,Peptides. 2006 Sep;27(9):2111-2117.,"Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",21,18-21
DRAMP01419,GLLSGILGAGKNIVCGLSGLC,21,"Nigrocin-2GRc (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana grahami (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Has antibacterial against Gram-negative bacterium E. coli. Also has a weak hemolytic activity against human erythrocytes.,[Ref.16621155]Gram-negative bacterium: Escherichia coli (MIC=50 µM).,[Ref:16621155] LC50>500 μM against human erythrocytes,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,16621155,Peptides. 2006 Sep;27(9):2111-2117.,"Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",21,18-21
DRAMP01420,GLLSGILGAGKHIICGLSGLC,21,"Nigrocin-OG4 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC>100 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC>100 µg/ml), Bacillus subtilis (MIC>100 µg/ml).##Yeast: Candida albicans (MIC=1.10 µg/ml).","[Ref.17272268] RCH=65.5 ± 7.7% against rabbit red blood cells at 50 μg/ml. RCH, red cell hemolysis.",Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,21,18-21
DRAMP01421,GLLSGILGAGKQKVCGLSGLC,21,"Nigrocin-OG5 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=9.37 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=18.75 µg/ml), Bacillus subtilis (MIC=37.50 µg/ml).##Yeast: Candida albicans (MIC=4.68 µg/ml).","[Ref.17272268] RCH=87.2 ± 2.6% against rabbit red blood cells at 50 μg/ml. RCH, red cell hemolysis.",Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,21,18-21
DRAMP01422,GLLSGVLGVGKKVLCGLSGLC,21,"Nigrosin-OG21 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=4.68 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=9.37 µg/ml), Bacillus subtilis (MIC=18.75 µg/ml).##Yeast: Candida albicans (MIC=4.68 µg/ml).","[Ref.17272268] RCH=100% against rabbit red blood cells at 50 μg/ml. RCH, red cell hemolysis.",Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,21,18-21
DRAMP01423,GLLSGILGAGKHIVCGLSGLR,21,"Nigrosin-OG13 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=4.68 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=9.37 µg/ml), Bacillus subtilis (MIC=18.75 µg/ml).##Yeast: Candida albicans (MIC=1.10 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.17272268]No cytotoxicity information found,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,21,18-21
DRAMP01426,GLLSGVLGVGKKIVCGLSGLC,21,"Nigrocin-1-OA1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=10.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.4 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=5.2 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01427,GIFGKILGVGKKTLCELSGMC,21,"Nigrocin-1-OA2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.3 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.3 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.3 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3.2 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01428,GIFLKVLGVGKKVLCGVSGLC,21,"Nigrocin-1-OA3 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=21.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.4 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=10.8 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01429,GLISGILGVGKKLVCGLSGLC,21,"Nigrocin-1-OR1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=23 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.8 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=11.5 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01430,GLISGILGVGKMLVCGLSGLC,21,"Nigrocin-1-OR2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=17.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.6 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=8.6 µg/ml)",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01431,GLISGLLGVGKMLVCGLSGLC,21,"Nigrocin-1-OR3 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=20.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.4 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=10.2 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01432,GILGNIVGMGKKIVCGLSGLC,21,"Nigrocin-1-OW2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.2 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3.1 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01433,GILGNIVGMGKKVVCGLSGLC,21,"Nigrocin-1-OW3 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.3 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=22.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.3 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=6.7 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01434,GILSGVLGMGKKIVCGLRGLC,21,"Nigrocin-1-OW4 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=14.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3.6 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=7.2 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01435,GILGNIVGMGKQVVCGLSGLC,21,"Nigrocin-1-OW5 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=10.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.1 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=5.1 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01436,GILSGVLGMGKKIVCGLSGLC,21,"Nigrocin-1-OW1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4.4 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=8.8 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.8 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=4.4 µg/ml).",[Ref:22029824] Not found in the literature,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,21,18-21
DRAMP01438,GIFGKILGAGKKVLCGLSGLC,21,"Nigrocin-2JDa (Frogs, amphibians, animals)",B3A0M6,Not found,Not found,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has hemolytic activity against rabbit erythrocytes. 
PTM: contains one disulfide bond 15-21. ","[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=16 µM), Staphylococcus aureus CIB 85462 (MIC=8 µM);##Gram-negative bacteria: Escherichia coli ATCC 25992 (MIC=16 µM), Escherichia coli CIB 84492 (MIC=16 µM);##Yeast: Candida albicans (MIC=63 µM).",[Ref:22917879] It has 80.3 ± 5.5% hemolytic activity at 128 μg/ml against rabbit red blood cells,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.",21,18-21
DRAMP01439,GIFGKILGVGKKVLCGLSGMC,21,"Nigrocin-2JDb (Odorranain-H2; Frogs, amphibians, animals)",B3A0M7,Not found,Not found,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has hemolytic activity against rabbit erythrocytes.
PTM: contains one disulfide bond 15-21. ","[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=15 µM), Staphylococcus aureus CIB 85462 (MIC=15 µM);##Gram-negative bacteria: Escherichia coli ATCC 25992 (MIC=8 µM), Escherichia coli CIB 84492 (MIC=8 µM);##Yeast: Candida albicans (MIC=31 µM).",[Ref:22917879] It has 88.4 ± 4.2% hemolytic activity at 128 μg/ml against rabbit red blood cells,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.",21,18-21
DRAMP01440,GILSGILGMGKKLVCGLSGLC,21,"Nigrocin-2LVb (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana livida (Chinese Odorrana frogs),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. ,Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM);##Gram-negative bacterium: Escherichia coli (MIC=15 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,20158520,FEBS J. 2010 Mar;277(6):1519-1531.,"Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.",Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,21,18-21
DRAMP01441,SILSGNFGVGKKIVCGLSGLC,21,"Nigrocin-2VB (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana livida (Chinese Odorrana frogs),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacterium E. coli. ,Gram-negative bacterium: Escherichia coli (MIC=25 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,20158520,FEBS J. 2010 Mar;277(6):1519-1531.,"Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.",Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,21,18-21
DRAMP01442,GILSGILGAGKSLVCGLSGLC,21,"Nigrocin-2SCa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana schmackeri (Chinese Odorrana frogs),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacterium E. coli. ,Gram-negative bacterium: Escherichia coli (MIC=50 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,20158520,FEBS J. 2010 Mar;277(6):1519-1531.,"Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.",Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,21,18-21
DRAMP01443,GILSNVLGMGKKIVCGLSGLC,21,"Nigrocin-2SCc (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana schmackeri (Chinese Odorrana frogs),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacterium E. coli. ,Gram-negative bacterium: Escherichia coli (MIC=70 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Not found,20158520,FEBS J. 2010 Mar;277(6):1519-1531.,"Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.",Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,21,18-21
DRAMP18393,AVKPKTAKPKTAKPKTA,17,VK6 (histone derived; reptiles; animals),No entry found,Not found,Not found,"blood plasma, Komodo dragon, Varanus komodoensis","Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,Active against P. eruginosa ATCC9027 (EC50 3.6 uM) and S. aureus ATCC 25923 (EC50 3.3 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.28164707]No cytotoxicity information found,Not found,28164707,J Proteome Res. 2017 Apr 7;16(4):1470-1482.,"Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML",Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry,17,15-18
DRAMP18392,AKKPVAKKAAGGVKKPK,17,VK7 (histone derived; reptiles; animals),No entry found,Not found,Not found,"blood plasma, Komodo dragon, Varanus komodoensis","Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,Active against P. eruginosa ATCC9027 (EC50 38.4 uM) and S. aureus ATCC 25923 (EC50 1.3 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.28164707]No cytotoxicity information found,Not found,28164707,J Proteome Res. 2017 Apr 7;16(4):1470-1482.,"Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML",Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry,17,15-18
DRAMP01533,CVISAGWNHKIRCKLTGNC,19,"Nigroain-B1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Bridge,Not found,,PTM: Contains one disulfide bridge.,"Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=4.69 µg/ml), S. aureus ATCC43300 (MIC=50.00 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa PA01 (MIC=25.00 µg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=25.00 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys13 and Cys19),Disulfide bridge between Cys13 and Cys19.,L,[Ref.19778602]No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",19,18-21
DRAMP01539,FKTWKRPPFQTSCWGIIKE,19,"Nigroain-C2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=27.50 µg/ml), S. aureus ATCC43300 (MIC=55.00 µg/ml), Bacillus subtilis (MIC=110.00 µg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=110.00 µg/ml), Pseudomonas aeruginosa PA01 (MIC=55.00 µg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=55.00 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=13.75 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.19778602]No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",19,18-21
DRAMP01542,CVHWQTNTARTSCIGP,16,"Nigroain-D3 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,PTM: Contains one disulfide bridge.,Gram-positive bacterium: Bacillus subtilis (MIC=55 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=110 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Cyclization (Cys1 and Cys13),Free,Disulfide bridge between Cys1 and Cys13.,L,[Ref.19778602]No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",16,15-18
DRAMP01543,DCTRWIIGINGRICRD,16,"Nigroain-E1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Not found,Not found,Not found,,Function: Has hemolytic activity against rabbit red cells.,[Ref.19778602]Gram-positive bacterium: Staphylococcus aureus ATCC25923 (MIC=18.75 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=75 µg/ml).,[Ref:19778602]7.62±1.6% hemolytic activity at 100 µg/ml against rabbit red cells,Cyclic,Free,Free,Disulfide bridge between Cys2 and Cys14.,L,[Ref.19778602]No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",16,15-18
DRAMP01546,SLWETIKNAGKGFIQNLDKIR,21,"Nigroain-K1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has antibacterial and antifungal activity. Also has hemolytic activity against rabbit red cells.,"[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=9.38 µg/ml), Bacillus subtilis (MIC=21.88 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=37.50 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=32.74 µg/ml).",[Ref:19778602]22.49 ± 4.8% hemolytic activity at 100 µg/ml against rabbit red cells,Linear,Free,Free,Free,L,[Ref.19778602]No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",21,18-21
DRAMP01549,GLLSVLGSVAKHVLPHVVPVIAEHL,25,"Caerin-1.1 (Frogs, amphibians, animals)","P62568, P62569, Q800R2, P56226",Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria splendida (Magnificent tree frog) (Litoria gilleni) (Litoria caerulea),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral",Protein level,Alpha helix ,The peptide adopts two well-defined helices from Leu2 to Lys11 and from Val17 to His24 separated by a region of less-defined helicity and greater flexibility.,,"Function: Antibacterial and antiviral peptides that adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Secreted by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility.
Miscellaneous: Caerin 1.1 completely inhibits HIV infection of T cells within minutes of exposure to virus at concentrations that were not toxic to target cells (J Virol. 2005 Sep;79(18):11598-606).
PTM: C-terminal amidation.","[Ref.15203252]Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=1.5 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12.5 µg/ml), Staphylococcus aureus (MIC=3-12 µg/ml), Staphylococcus epidermis (MIC=12.5 µg/ml), Streptococcus uberis (MIC=12.5 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 µg/ml).##[Ref.16140737]Virus:HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=7.8 μM);inhibition of HIV transfer by dendritic cells to T cells(IC50=12.6 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,No cytotoxicity information found in the reference(s) presented,Cell membrane,16140737##9266696##12709067##15203252,J Virol. 2005 Sep;79(18):11598-606. ##Eur J Biochem. 1997 Jul 15;247(2):545-557.##Eur J Biochem. 2003 May;270(9):2068-2081.##Peptides. 2004 Jun;25(6):1035-1054.,"VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D.##Wong H, Bowie JH, Carver JA.##Vanhoye D, Bruston F, Nicolas P, Amiche M.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.##The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida.##Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",25,24-27
DRAMP01550,GLLGAMFKVASKVLPHVVPAITEHF,25,"Caerin-1.11 (Frogs, amphibians, animals)",Q800R9,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog) ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Homology,Not found,Not found,,"Function: Antibacterial and antiviral peptides that adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity (By similarity).
PTM: C-terminal amidation.","Gram-negative bacteria: Escherichia coli B (MIC=25 µM), Enterobacter cloacae (MIC=50 µM), Klebsiella pneumoniae (MIC=25 µM);##Gram-positive bacterium: Staphylococcus haemolyticus (MIC=50 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.12709067]No cytotoxicity information found##[Ref.22771617]No cytotoxicity information found,Not found,12709067##22771617,Eur J Biochem. 2003 May;270(9):2068-2081.##Peptides. 2012 Sep;37(1):174-188.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.##Bowie JH, Separovic F, Tyler MJ.","Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.##Host-defense peptides of Australian anurans. Part 2. Structure, activity, mechanism of action, and evolutionary significance.",25,24-27
DRAMP01552,GLLSVLGSVAQHVLPHVVPVIAEHL,25,"Caerin-1.3 (Frogs, amphibians, animals)",P56228,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Australian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=25 µg/ml), Staphylococcus aureus (MIC=6-12 µg/ml), Staphylococcus epidermis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 µg/ml). (Ref.2)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found,Not found,15203252##PubMed ID is not available,Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.",25,24-27
DRAMP01553,GLLSSLSSVAKHVLPHVVPVIAEHL,25,"Caerin-1.4 (Frogs, amphibians, animals)","P62544, P56229, P62545, P56229",Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog) (also Litoria gilleni) (Centralian tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=12 µg/ml), Listeria innocua (MIC=100 µg/ml), Micrococcus luteus (MIC=0.4 µg/ml), Staphylococcus aureus (MIC=100 µg/ml), Staphylococcus epidermis (MIC=25 µg/ml), Streptococcus uberis (MIC=100 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=50 µg/ml), Pasteurella multocida (MIC=25 µg/ml). (Ref.2)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found,Not found,15203252##PubMed ID is not available,Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.",25,24-27
DRAMP01555,GLLSVLGSVVKHVIPHVVPVIAEHL,25,"Caerin-1.5 (Frogs, amphibians, animals)",P56230,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,Antiviral",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.","[Ref.15203252]Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermis (MIC=25 µg/ml), Streptococcus uberis (MIC=50 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 µg/ml). ##[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=3 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 12.5 µM.,Not found,26026377##15203252##PubMed ID is not available,Peptides. 2015 Sep;71:296-303. ##Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.","Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.",25,24-27
DRAMP01560,GLFGVLGSIAKHVLPHVVPVIAEKL,25,"Caerin-1.9 (Frogs, amphibians, animals)",P81252,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria chloris (Blue-thighed frog) (frog skin active peptide family),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.
Miscellaneous: Caerin 1.9 completely inhibited HIV infection of T cells within minutes of exposure to virus at concentrations that were not toxic to target cells (J Virol. 2005 Sep;79(18):11598-606).","[Ref.15203252]Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=12 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=50 µg/ml), Staphylococcus aureus (MIC=100 µg/ml), Staphylococcus epidermis (MIC=25 µg/ml), Streptococcus uberis (MIC=50 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 µg/ml). ##[Ref.16140737]Virus:HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=1.2 μM);inhibition of HIV transfer by dendritic cells to T cells(IC50=1.6 μM).##[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=4 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 20	µM.,Not found,26026377##16140737##15203252##9516047,Peptides. 2015 Sep;71:296-303. ##J Virol. 2005 Sep;79(18):11598-606. ##Peptides. 2004 Jun;25(6):1035-1054.##J Pept Res. 1998 Feb;51(2):121-126.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.","Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.",25,24-27
DRAMP01562,GLVSSIGRALGGLLADVVKSKGQPA,25,"Caerin-2.1 (Frogs, amphibians, animals)","P56233, P86485",Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria splendida (Magnificent tree frog) (Emerald spotted tree frog),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",Gram-negative bacterium: Pasteurella multocida (MIC=25 µg/ml). (Ref.2),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.15203252]No  cytotoxicity information found##[Ref.19642086]No  cytotoxicity information found,Not found,15203252##19642086,Peptides. 2004 Jun;25(6):1035-1054.##Rapid Commun Mass Spectrom. 2009 Sep;23(17):2628-2636.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Bilusich D, Jackway RJ, Musgrave IF, Tyler MJ, Bowie JH.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.",25,24-27
DRAMP01563,GLVSSIGRALGGLLADVVKSKEQPA,25,"Caerin-2.2 (Frogs, amphibians, animals)","P62570, P62571, P56234",Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria gilleni (Centralian tree frog) (also Litoria caerulea) (Green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",Gram-positive bacterium: Micrococcus luteus (MIC=50 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.15203252]No cytotoxicity information found,Not found,15203252##PubMed ID is not available,Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.",25,24-27
DRAMP01567,GLVSSIGKVLGGLLADVVKSKGQPA,25,"Caerin-2.6 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,the skin secretions) (hybrid between female Litoria splendida; also male Litoria caerulea ,"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity (By similarity).
PTM: C-terminal amidation.",Gram-positive bacterium: Leuconostoc lactis (MIC=25 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Free,Free,L,[Ref.16824041]No cytotoxicity information found,Not found,16824041,FEBS J. 2006 Aug;273(15):3511-3519.,"Pukala TL, Bertozzi T, Donnellan SC, Bowie JH, Surinya-Johnson KH, Liu Y, Jackway RJ, Doyle JR, Llewellyn LE, Tyler MJ.","Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea.",25,24-27
DRAMP01568,GLVSSIGKALGGLLVDVVKSKGQPA,25,"Caerin-2.7 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,the skin secretions) (hybrid between female Litoria splendida; also male Litoria caerulea ,"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity (By similarity).
PTM: C-terminal amidation.",Gram-positive bacterium: Leuconostoc lactis (MIC=50 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Free,Free,L,[Ref.16824041]No cytotoxicity information found,Not found,16824041,FEBS J. 2006 Aug;273(15):3511-3519.,"Pukala TL, Bertozzi T, Donnellan SC, Bowie JH, Surinya-Johnson KH, Liu Y, Jackway RJ, Doyle JR, Llewellyn LE, Tyler MJ.","Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea.",25,24-27
DRAMP01570,GLWEKIKEKASELVSGIVEGVK,22,"Caerin-3.2 (Frogs, amphibians, animals)",P56239,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation.",Gram-positive bacterium: Micrococcus luteus (MIC=3 µg/ml). (Ref.2),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found,Not found,15203252##PubMed ID is not available,Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.",22,21-24
DRAMP01573,GLWEKVKEKANELVSGIVEGVK,22,"Caerin-3.5 (Frogs, amphibians, animals)",P0C2A9,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria gracilenta (Dainty green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.",Gram-positive bacterium: Leuconostoc lactis (MIC=100 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.16554081]No cytotoxicity information found,Not found,16554081,Toxicon. 2006 May;47(6):664-675.,"Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.",New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.,22,21-24
DRAMP01574,GLWQKIKSAAGDLASGIVEGIKS,23,"Caerin-4.1 (Frogs, amphibians, animals)",P56242,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,Antiviral",Protein level,Alpha helix ,Not found,,"PTM: adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",[Ref.15203252]Gram-positive bacterium: Micrococcus luteus (MIC=12 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=25 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found,Not found,15203252##PubMed ID is not available,Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.",23,21-24
DRAMP01576,GLWQKIKNAAGDLASGIVEGIKS,23,"Caerin-4.3 (Frogs, amphibians, animals)",P56244,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation.",Gram-positive bacterium: Micrococcus luteus (MIC=25 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=50 µg/ml).(Ref.2),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found,Not found,15203252##PubMed ID is not available,Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.",23,21-24
DRAMP01577,GLLSVLGSVAKHVLPHVVPVIAEKL,25,"Caerin-1.10 (Frogs, amphibians, animals)","P86502, P82104",Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria rothii (Roth's tree frog); also Litoria splendida (Magnificent tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,Antiviral",Protein level,Not found,Not found,,"Function: Antibacterial peptide with wide spectrum of activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.10601876]Gram-positive bacteria: Leuconostoc lactis (MIC=6 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=25 µg/ml), Streptococcus uberis (MIC=50 µg/ml), Staphylococcus epidermidis (MIC=100 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=100 µg/ml).##[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 22	µM.,Not found,26026377##16124032##10601876,Peptides. 2015 Sep;71:296-303. ##Rapid Commun Mass Spectrom. 2005;19(18):2716-2724.##Eur J Biochem. 2000 Jan;267(1):269-275.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Brinkworth CS, Bowie JH, Bilusich D, Tyler MJ.##Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC, Smith BP.","Inhibition of HIV infection by caerin 1 antimicrobial peptides.##The rothein peptides from the skin secretion of Roth's tree frog Litoria rothii. Sequence determination using positive and negative ion electrospray mass spectrometry.##Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with phe8 caerulein and a new antibiotic peptide caerin 1.10.",25,24-27
DRAMP18389,AKKPVAKKAAGGVKKPKK,18,VK12 (histone derived; animals),No entry found,Not found,Not found,"blood plasma, Komodo dragon, Varanus komodoensis","Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,Active against P. eruginosa ATCC9027 (EC50 0.7 uM) and S. aureus ATCC 25923 (EC50 0.8 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.28164707]No cytotoxicity information found,Not found,28164707,J Proteome Res. 2017 Apr 7;16(4):1470-1482.,"Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML",Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry,18,15-18
DRAMP18390,AKAVKPKTAKPKTAKPKTAKA,21,VK11 (histone derived; reptiles; animals),No entry found,Not found,Not found,"blood plasma, Komodo dragon, Varanus komodoensis","Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,Active against P. eruginosa ATCC9027 (EC50 2.8 uM) and S. aureus ATCC 25923 (EC50 4.7 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.28164707]No cytotoxicity information found,Not found,28164707,J Proteome Res. 2017 Apr 7;16(4):1470-1482.,"Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML",Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry,21,18-21
DRAMP18391,ARTKQTARKSTGGKAPRKQLAT,22,VK10 (histone derived; reptiles; animals),No entry found,Not found,Not found,"blood plasma, Komodo dragon, Varanus komodoensis","Antimicrobial, Antibacterial",,Not found,Not found,"2PY0, 2NQB, 2IO5, 2FJ7, 1ZLA, 1KX3, 1KX4, 1KX5,1HIO",Comment: No comments found on DRAMP database,Active against P. eruginosa ATCC9027 (EC50 1.3 uM) and S. aureus ATCC 25923 (EC50 2.5 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.28164707]No cytotoxicity information found,Not found,28164707,J Proteome Res. 2017 Apr 7;16(4):1470-1482.,"Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML",Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry,22,21-24
DRAMP01584,GLFSVLGSVAKHLLPHVAPIIAEKL,25,"Caerin-1.17 (Frogs, amphibians, animals)",P0C2A6,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria gracilenta (Dainty green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Caerin-1.17 shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus Strain ATCC 25923 (MIC=50 µg/ml), Staphylococcus aureus Strain ATCC 29213 (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml), Pasteurella multocida (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.16554081]No cytotoxicity information found,Not found,16554081,Toxicon. 2006 May;47(6):664-675.,"Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.",New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.,25,24-27
DRAMP01585,GLFSVLGSVAKHLLPHVVPVIAEKL,25,"Caerin-1.18 (Frogs, amphibians, animals)",P0C2A7,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria gracilenta (Dainty green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=25 µg/ml), Listeria innocua (MIC=12 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus ATCC 25923 (MIC=12 µg/ml), Staphylococcus aureus ATCC 29213 (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=25 µg/ml), Streptococcus uberis (MIC=25 µg/ml);##Gram-negative bacteria: Pasteurella multocida (MIC=50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.16554081]No cytotoxicity information found,Not found,16554081,Toxicon. 2006 May;47(6):664-675.,"Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.",New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.,25,24-27
DRAMP01586,GLFKVLGSVAKHLLPHVAPIIAEKL,25,"Caerin-1.19 (Frogs, amphibians, animals)",P0C2A8,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria gracilenta (Dainty green tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,Antiviral",Protein level,Not found,Not found,,"Function: Caerin-1.19 shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","[Ref.16554081]Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=12 µg/ml), Micrococcus luteus (MIC=25 µg/ml), Staphylococcus aureus Strain ATCC 25923 (MIC=12 µg/ml), Staphylococcus aureus Strain ATCC 29213 (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml);##Gram-negative bacteria: Pasteurella multocida (MIC=50 µg/ml).##[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,No cytotoxicity information found in the reference(s) presented,Not found,26026377##16554081,Peptides. 2015 Sep;71:296-303. ##Toxicon. 2006 May;47(6):664-675.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.",Inhibition of HIV infection by caerin 1 antimicrobial peptides.##New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.,25,24-27
DRAMP01587,GLFDVIKKVASVIGGL,16,"Citropin-1.1 (Frogs, amphibians, animals)","P81835, P81836, P81837",Not found,Not found,Litoria citropa (Australian blue mountains tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Alpha helix,Not found,,"Function: Bacteriostatic action for Gram-positive bacteria.
Tissue specificity: Expressed by the dorsal and submental skin glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=6 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10504394]No cytotoxicity information found,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,16,15-18
DRAMP01588,GLFAVIKKVASVIGGL,16,"Citropin-1.1 sm1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Synthesized modify,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.","Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Escherichia coli (MIC=100 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10504394]No cytotoxicity information found,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,16,15-18
DRAMP01589,GLFDVIAKVASVIGGL,16,"Citropin-1.1 sm2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Synthesized modify,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.","Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=25 µg/ml), Micrococcus luteus (MIC=100 µg/ml), Staphylococcus aureus (MIC=100 µg/ml), Staphylococcus epidermidis (MIC=100 µg/ml), Streptococcus uberis (MIC=100 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10504394]No cytotoxicity information found,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,16,15-18
DRAMP01590,GLFDVIAKVASVIKKL,16,"Citropin 1.1 M14 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: E. coli (MIC=53 µM);##Gram-positive bacterium: S. aureus (MIC=3 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.20564028]No cytotoxicity information found,Not found,20564028,Biopolymers. 2011;96(2):147-157.,"Chia CS, Gong Y, Bowie JH, Zuegg J, Cooper MA. ","Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin.",16,15-18
DRAMP01591,GLFAVIKKVASVIKKL,16,"Citropin 1.1 M15 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacterium: E. coli (MIC=53 µM);##Gram-positive bacteria: S. aureus (MIC=3 µM), B. subtilis (MIC=3 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.20564028]No cytotoxicity information found,Not found,20564028,Biopolymers. 2011;96(2):147-157.,"Chia CS, Gong Y, Bowie JH, Zuegg J, Cooper MA. ","Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin.",16,15-18
DRAMP01594,GLFDIIKKVASVVGGL,16,"Citropin-1.2 (Frogs, amphibians, animals)","P81840, P81841, P81842, P81843",Not found,Not found,Litoria citropa (Australian blue mountains tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.","Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=100 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=25 µg/ml), Streptococcus uberis (MIC=12 µg/ml). (Ref.2)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found##[Ref.10504394]No cytotoxicity information found,Not found,10504394##15203252,Eur J Biochem. 1999 Oct;265(2):627-637.##Peptides. 2004 Jun;25(6):1035-1054.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP01600,GLFDIIKKVASVIGGL,16,"Citropin-1.3 (Frogs, amphibians, animals)",P81846,Not found,Not found,Litoria citropa (Australian blue mountains tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.","Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Leuconostoc lactis (MIC=6 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=25 µg/ml), Streptococcus uberis (MIC=25 µg/ml). (Ref.2)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.15203252]No cytotoxicity information found##[Ref.10504394]No cytotoxicity information found,Not found,10504394##15203252,Eur J Biochem. 1999 Oct;265(2):627-637.##Peptides. 2004 Jun;25(6):1035-1054.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP01601,GLIGSIGKALGGLLVDVLKPKL,22,"Citropin-2.1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Litoria citropa (Australian blue mountains tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.",Gram-positive bacterium: Leuconostoc lactis (MIC=50 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.10504394]No cytotoxicity information found,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,22,21-24
DRAMP01603,GLFDVIKKVASVIGLASP,18,"Citropin 1.1.3 (Frogs, amphibians, animals)",P81838,Not found,Not found,Litoria citropa (Australian blue mountains tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=50 µg/ml), Streptococcus uberis (MIC=100 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10504394]No cytotoxicity information found,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,18,15-18
DRAMP01608,GLLDIVKKVVGAFGSL,16,"Aurein-2.1 (Frogs, amphibians, animals)","P69016, P69017, P82388",Not found,Not found,Litoria aurea (Green; also golden bell frog); also Litoria raniformis (Southern bell frog),"Antimicrobial, Anti-cancer, Anti-Gram+",Protein level,Not found,Not found,,"Function:Antimicrobial activity against Gram-positive bacteria. Probably acts by disturbing membrane functions with its amphipathic structure. The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=6 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=100 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10951191]No cytotoxicity information found,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP01612,GLFDIVKKVVGAFGSL,16,"Aurein-2.5 (Frogs, amphibians, animals)","P69018, P69019, P82392",Not found,Not found,Litoria raniformis (Southern bell frog); also Litoria aurea (Green; also golden bell frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",Protein level,Not found,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=100 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10951191]No cytotoxicity information found,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP01613,GLFDIAKKVIGVIGSL,16,"Aurein-2.6 (Frogs, amphibians, animals)",P82393,Not found,Not found,Litoria raniformis (Southern bell frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",Protein level,Not found,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10951191]No cytotoxicity information found,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP01614,GLFDIVKKIAGHIAGSI,17,"Aurein-3.1 (Frogs, amphibians, animals)","P69020, P69021, P82394",Not found,Not found,Litoria raniformis (Southern bell frog); also Litoria aurea (Green; also golden bell frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",Protein level,Not found,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.10951191]Gram-positive bacteria: Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=100 μg/ml), Streptococcus uberis (MIC=100 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10951191]No cytotoxicity information found,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",17,15-18
DRAMP01617,GLFDIVKKIAGHIASSI,17,"Aurein-3.2 (Frogs, amphibians, animals)","P69022, P69023, P82395",Not found,Not found,Litoria aurea (green; also golden bell frog); also Litoria raniformis (blue-thighed treefrog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",Protein level,Not found,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=50 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10951191]No cytotoxicity information found,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",17,15-18
DRAMP01618,GLFDIVKKIAGHIVSSI,17,"Aurein-3.3 (Frogs, amphibians, animals)",P82396,Not found,Not found,Litoria raniformis (blue-thighed treefrog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer",Protein level,Not found,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=12 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=25 μg/ml), Staphylococcus aureus (MIC=100 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=100 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10951191]No cytotoxicity information found,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",17,15-18
DRAMP01620,GLMSSIGKALGGLIVDVLKPKTPAS,25,"Aurein-5.2 (Frogs, amphibians, animals)","P69030, P82402, P69031, P82402",Not found,Not found,Litoria raniformis (blue-thighed treefrog); also Litoria aurea (Green; also golden bell frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",Protein level,Not found,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=100 μg/ml), Streptococcus uberis (MIC=50 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.10951191]No cytotoxicity information found,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",25,24-27
DRAMP01621,IIGPVLGMVGSALGGLLKKI,20,"Bombinin-H1 (Frogs, amphibians, animals)","P82282, P82283",Belongs to the bombinin family,Not found,Bombina variegata (European frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antimicrobial.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation and D-amino acid.",[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=3.8 µM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=2.1 µM).,[Ref:8223491]Not determined hemolytic activity against human red blood cells.,Linear,Free,Amidation,Free,L,[Ref.8223491]No cytotoxicity information found,Not found,8223491,EMBO J. 1993 Dec;12(12):4829-4832.,"Mignogna G, Simmaco M, Kreil G, Barra D.",Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.,20,18-21
DRAMP01626,IIGPVLGLVGSALGGLLKKI,20,"Bombinin-H5 (Frogs, amphibians, animals)",P82285,Belongs to the bombinin family,Not found,Bombina variegata (European frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix (1 helices; 16 residues),Not found,"2AP7, 2AP8 resolved by NMR.","Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation and D-amino acid.",[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=5.0 µM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=3.0 µM).,[Ref:8223491]Not found,Linear,Free,Amidation,Free,Mixed (2D-aIle(alloisoleucine)),[Ref.8223491]No cytotoxicity information found,Not found,8223491##PubMed ID is not available,EMBO J. 1993 Dec;12(12):4829-4832##TO BE PUBLISHED,"Mignogna G, Simmaco M, Kreil G, Barra D.##Zangger K, Jilek A, Khatai L.",Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.##Solution structure and orientation of bombinin H2 and H4 in a membrane-mimetic environment.,20,18-21
DRAMP01628,GWMSKIASGIGTFLSGMQQ,19,"Phylloxin (Frogs, amphibians, animals)","P81565, Q9PT74",Belongs to the frog skin active peptide family (Dermaseptin subfamily),PLX,Phyllomedusa bicolor (Two-colored leaf frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix,Not found,,"Function: Antimicrobial peptide against the Gram-positive bacteria and the Gram-negative-bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","Gram-negative bacteria: Acholeplasma laidlawii A-PG8 (MIC=12.5 µM), Spiroplasma melliferum BC3 (MIC=50 µM), Rhizobium meliloti 102F34 (MIC=12.5 µM), Escherichia coli K12 (MIC=10 µM);##Gram-positive bacteria: Bacillus megaterium KM (MIC=3.12 µM), Corynebacterium glutamicum ATCC 27853 (MIC=1.56 µM), Micrococcus luteus ATCC 27853 (MIC=3.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.10632707]No cytotoxicity information found,Not found,10632707,Eur J Biochem. 2000 Jan;267(2):370-378.,"Pierre TN, Seon AA, Amiche M, Nicolas P.","Phylloxin, a novel peptide antibiotic of the dermaseptin family of antimicrobial/opioid peptide precursors.",19,18-21
DRAMP01639,GLWSTIKNVGKEAAIAAGKAALGAL,25,"Dermaseptin-1 (DShypo01, DPh-1; Frogs, amphibians, animals)",P84596,Not found,Not found,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiprotozoal",Protein level,Not found,Not found,,"Function: Has antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Also has antiprotozoal activity against L. amazonensis. No hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.16963159]Gram-positive bacteria: Micrococcus luteus A270 (MIC=6 µM), Staphylococcus aureus ATCC 6538 (MIC=6 µM);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=6 µM), Pseudomonas aeruginosa ATCC 14502 (MIC=6.6 µM).",[Ref:16844081]Non-hemolytic activity upto 53 μM against human red blood cells;##[Ref.16963159]Non-hemolytic activity at 6 μM against erythrocytes,Linear ,Free,Amidation,Free,L,[Ref.16844081]No cytotoxicity information found##[Ref.16963159]No cytotoxicity information found,Not found,16844081##16963159,Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-746.##Peptides. 2006 Dec;27(12):3092-3099.,"Brand GD, Leite JR, de SÃ¡ Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado JR Jr, Andrade AC, Bloch C Jr.##ConceiÃ§Ã£o K, Konno K, Richardson M, Antoniazzi MM, Jared C, Daffre S, Camargo AC, Pimenta DC.",Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia).##Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis.,25,24-27
DRAMP01647,FLSLIPHIVSGVAALAKHLG,20,"DRP-PBN1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Phyllomedusa bicolor,"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: S. aureus (MIC=12 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.15222751]No cytotoxicity information found,Not found,15222751,Biochemistry. 2004 Jul 6;43(26):8391-8409.,"Vanhoye D, Bruston F, El Amri S, Ladram A, Amiche M, Nicolas P.","Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions.",20,18-21
DRAMP18387,KAAAAKKSPKKPKKPAAAKK,20,VK14 (histone derived;reptiles; animals),No entry found,Not found,Not found,"blood plasma, Komodo dragon, Varanus komodoensis","Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,Active against P. eruginosa ATCC9027 (EC50 0.6 uM) and S. aureus ATCC 25923 (EC50 1.2 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,[Ref.28164707]No cytotoxicity information found,Not found,28164707,J Proteome Res. 2017 Apr 7;16(4):1470-1482.,"Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML",Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry,20,18-21
DRAMP01702,GLWSTIKNVGKEAAIAAGKAVLGSL,25,"Dermaseptin-H5 (Dermaseptin-like peptide 5, DMS5; Frogs, amphibians, animals)",Q1EJP4,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).,"Gram-negative bacterium: Escherichia coliEscherichia coli ATCC 11775 (MIC=0.5 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 12600 (MIC=0.5 µM), Micrococcus luteus ATCC 49732 (MIC=2.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.17553595]No cytotoxicity information found,Not found,17553595,Peptides. 2007 Jul;28(7):1331-1343.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,25,24-27
DRAMP02231,FLPFIARLAAKVFPSIICSVTKKC,24,"Ranatuerin-4 (Frogs, amphibians, animals)",P82819 ,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates catesbeiana (American bullfrog) (Rana catesbeiana),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacterium S.aureus. Has no detectable hemolytic activity.,[Ref.9784389] Gram-positive bacterium: Staphylococcus aureus (MIC=55 µM).,[Ref.9784389] Have no detectable hemolytic activity at aconcentration of 20µg/ml against human red blood cell.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bridge between Cys18 and Cys24.,L,[Ref.9784389]No cytotoxicity information found,Not found,9784389,Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.,"Goraya J, Knoop FC, Conlon JM.","Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.",24,21-24
DRAMP01731,FLPIAGKLLSGLSGLL,16,"Temporin-ALd (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops loloensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Temporin-ALd exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.25 µg/mL), Bacillus pumilus (MIC=2.5 µg/mL), Bacillus cereus (MIC=15 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=1.25 µg/mL), Bacillus dysenteriae (MIC=5 µg/mL), Acinetobacter calcoaceticus (MIC=15 µg/mL), Psecdomonas aeruginosa (MIC=5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 µg/mL).",[Ref:19843479]12% hemolytic activity at 100 μg/mL against rabbit red blood cells,Linear,Free,Amidation,Free,L,[Ref.19843479]No cytotoxicity information found,Not found,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",16,15-18
DRAMP01732,FFPIVGKLLFGLSGLL,16,"Temporin-ALe (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops loloensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Temporin-ALe exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.25 µg/mL), Bacillus pumilus (MIC=5 µg/mL), Bacillus cereus (MIC=15 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=1.25 µg/mL), Bacillus dysenteriae (MIC=5 µg/mL), Acinetobacter calcoaceticus (MIC=15 µg/mL), Psecdomonas aeruginosa (MIC=5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 µg/mL).",[Ref:19843479]10% hemolytic activity at 100 μg/mL against rabbit red blood cells,Linear,Free,Amidation,Free,L,[Ref.19843479]No cytotoxicity information found,Not found,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",16,15-18
DRAMP01733,FFPIVGKLLSGLSGLL,16,"Temporin-ALf (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops loloensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Temporin-ALf exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 µg/mL), Bacillus pumilus (MIC=5 µg/mL), Bacillus cereus (MIC=30 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=2.5 µg/mL), Bacillus dysenteriae (MIC=5 µg/mL), Acinetobacter calcoaceticus (MIC=30 µg/mL), Psecdomonas aeruginosa (MIC=5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 µg/mL).",[Ref:19843479]7% hemolytic activity at 100 μg/mL against rabbit red blood cells.,Linear,Free,Amidation,Free,L,[Ref.19843479]No cytotoxicity information found,Not found,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",16,15-18
DRAMP01734,FFPIVGKLLFGLFGLL,16,"Temporin-ALg (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops loloensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Temporin-ALg exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 µg/mL), Bacillus pumilus (MIC=2.5 µg/mL), Bacillus cereus (MIC=30 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=5 µg/mL), Bacillus dysenteriae (MIC=10 µg/mL), Acinetobacter calcoaceticus (MIC=30 µg/mL), Psecdomonas aeruginosa (MIC=7.5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 µg/mL).",[Ref:19843479]16% hemolytic activity at 100 μg/mL against rabbit red blood cells.,Linear,Free,Amidation,Free,L,[Ref.19843479]No cytotoxicity information found,Not found,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",16,15-18
DRAMP01735,FLPIVGKLLSGLSGLS,16,"Temporin-ALh (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops loloensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Temporin-ALh exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 µg/mL), Bacillus pumilus (MIC=7.5 µg/mL), Bacillus cereus (MIC=75 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=5 µg/mL), Bacillus dysenteriae (MIC=20 µg/mL), Acinetobacter calcoaceticus (MIC=60 µg/mL), Psecdomonas aeruginosa (MIC=2.5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 µg/mL).",[Ref:19843479]13% hemolytic activity at 100 μg/mL against rabbit red blood cells.,Linear,Free,Amidation,Free,L,[Ref.19843479]No cytotoxicity information found,Not found,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",16,15-18
DRAMP01752,FLPIALKALGSIFPKIL,17,"Temporin-LT2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana latouchii ,"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Function: Temporin-LT2 shows hemolytic activities against rabbit red blood cells (LD50>200 µg/ml).,"[Ref.19340924]Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 µM), Bacillus subtilis (MIC=50 µM).",[Ref:19340924]LD50>200 µg/ml against rabbit red blood cells,Linear,Free,Amidation,Free,L,[Ref.19340924]No cytotoxicity information found,Not found,19340924,Biochimie. 2009 Apr;91(4):540-547.,"Wang H, Yan X, Yu H, Hu Y, Yu Z, Zheng H, Chen Z, Zhang Z, Liu J.","Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).",17,15-18
DRAMP01753,FVDLKKIANIINSIFGK,17,"Temporin-1CEa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana chensinensis (Chinese brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Alpha helix ,Not found,,Function: Temporin-1CEa exhibits the greatest ability to inhibit the growth of MCF-7 cells. Also temporin-1CEa shows hemolytic effect to human erythrocytes and has no significant cytotoxicity to normal HUVSMCs at concentrations showed potent antitumor activity. ,"[Ref.21871946]Gram-positive bacteria: Staphylococcus aureus (MIC=14.4 µM), Bacillus cereus (MIC=14.4 µM), Streptococcus lactis (MIC=14.4 µM);##Gram-negative bacterium: Escherichia coli (MIC>100 µM).",[Ref:21871946]LD50=99.08 μM against human erythrocytes,Linear,Free,Amidation,Free,L,[Ref.19341344]No cytotoxicity information found##[Ref.21871946]No determined cytotoxic against SMCs at the concentration between 20-60 μM.,Not found,21871946##19341344,Biochimie. 2012 Feb;94(2):434-441.##Zoolog Sci. 2009 Mar;26(3):220-226.,"Wang C, Li HB, Li S, Tian LL, Shang DJ.##Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.","Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).##Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.",17,15-18
DRAMP01765,AVDLAKIANKVLSSLF,16,"Temporin-1TGb (Frogs, amphibians, animals)",Q2PGA7,Belongs to the frog skin active peptide family (Brevinin subfamily),tmpTGb,Rana tagoi (Tago frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC>150 µM);##Gram-negative bacterium: Escherichia coli (MIC=37.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.16675060]No cytotoxicity information found,Not found,16675060,Peptides. 2006 Sep;27(9):2124-2128.,"Iwamuro S, Nakamura M, Ohnuma A, Conlon JM.",Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi.,16,15-18
DRAMP01766,FLPVILPVIGKLLSGIL,17,"Temporin-1TGc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana tagoi (Tago's brown frog); also Rana sakuraii,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=37.5 µM);##Gram-negative bacterium: Escherichia coli (MIC>150 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.16675060]No cytotoxicity information found,Not found,16675060,Peptides. 2006 Sep;27(9):2124-2128.,"Iwamuro S, Nakamura M, Ohnuma A, Conlon JM.",Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi.,17,15-18
DRAMP01768,FLPVILPVIGKLLNGIL,17,"Temporin-1SKa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana sakuraii (stream brown frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacteria: Escherichia coli (MIC>50 µM);##Gram-negative bacteria: Staphylococcus aureus (MIC=25 µM).##Fungi: Candida albicans (MIC>50 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.17174009]No cytotoxicity information found,Not found,17174009,Peptides. 2007 Mar;28(3):505-514.,"Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.",Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,17,15-18
DRAMP01775,FLSGIVGMLGKLFGK,15,"Temporin-1Sa (Frogs, amphibians, animals)",B3KYH4,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-1Sa,Pelophylax saharicus (Sahara frog) (Rana saharica),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Not found,,"Function: Activity against Gram-positive and Gram-negative bacteria, and has hemolytic activity against human erythrocytes.","[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3 µM), Enterococcus faecalis ATCC 29212 (MIC=10 µM), Bacillus megaterium (MIC=2 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10 µM), Escherichia coli ATCC 35218 (MIC=10 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=31 µM);##Fungi: Candida albicans ATCC 90028 (MIC=16 µM), Candida parapsilosis ATCC 22019 (MIC=31 µM), Saccharomyces cerevisiae (MIC=8 µM).",[Ref:18584916]LC50=25 μM against human erythrocytes,Linear,Free,Amidation,Free,L,[Ref.18584916]No cytotoxicity information found,Not found,18584916,Peptides. 2008 Sep;29(9):1526-1523.,"Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A","Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.",15,12-15
DRAMP01776,FLPIVTNLLSGLLGK,15,"Temporin-1Sb (Temporin-SHb; Frogs, amphibians, animals)",B3KYH5,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-1Sb,Pelophylax saharicus (Sahara frog) (Rana saharica),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,,"Function: Activity against Gram-positive and Gram-negative bacteria, and has strong hemolytic activity against human erythrocytes.","[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=58 µM), Enterococcus faecalis ATCC 29212 (MIC>116 µM), Bacillus megaterium (MIC=46 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=231 µM), Escherichia coli ATCC 35218 (MIC>116 µM);##Fungi: Aspergillus flavus (MIC=58 µM).",[Ref:18584916]LC50>116 μM against human erythrocytes,Linear,Free,Amidation,Free,L,[Ref.18584916]No cytotoxicity information found,Not found,18584916,Peptides. 2008 Sep;29(9):1526-1523.,"Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A","Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.",15,12-15
DRAMP01777,FLSHIAGFLSNLFGK,15,"Temporin-1Sc (Temporin-SHc; Frogs, amphibians, animals)",B3KYH6,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-1Sc,Pelophylax saharicus (Sahara frog) (Rana saharica),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Alpha helix,Not found,,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, and has hemolytic activity against human erythrocytes.","[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=10 µg/ml), Enterococcus faecalis ATCC 29212 (MIC>80 µg/ml), Bacillus megaterium (MIC=4 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=161 µg/ml), Escherichia coli ATCC 35218 (MIC>80 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC>161 µg/ml);##Fungi: Aspergillus flavus (MIC=10 µg/ml), Candida albicans ATCC 90028 (MIC=20 µg/ml), Candida parapsilosis ATCC 22019 (MIC=20 µg/ml), Saccharomyces cerevisiae (MIC=10 µg/ml).",[Ref:18584916]LC50>80 μM against human erythrocytes,Linear,Free,Amidation,Free,L,[Ref.18584916]No cytotoxicity information found,Not found,18584916,Peptides. 2008 Sep;29(9):1526-1523.,"Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A","Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.",15,12-15
DRAMP01782,FFPLVLGALGSILPKIF,17,"Temporin-LTa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana latouchii (broad-folded frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacteria: Staphylococcus aureus (MIC=20 µg/ml) and Bacillus subtilis (MIC=10 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,Free,L,[Ref.19022312]No cytotoxicity information found,Cell membrance,19022312,Peptides. 2009 Feb;30(2):273-282.,"Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.","The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).",17,15-18
DRAMP01784,SLSRFLSFLKIVYPPAF,17,"Temporin-LTc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana latouchii (broad-folded frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral",Not found,Not found,Not found,,Comment: A mutant of the peptide is also HIV inhibitory (Wang G et al. 2010 Antimicrob. Agents Chemother. 54: 1343-1346).,"Gram-positive bacteria: Staphylococcus aureus (MIC=50 µg/ml), Bacillus subtilis (MIC=50 µg/ml);##Gram-negative bacterium: Pseudomonas fluorescens (MIC=100 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.19022312]No cytotoxicity information found,Not found,19022312,Peptides. 2009 Feb;30(2):273-282.,"Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.","The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).",17,15-18
DRAMP01807,FLPLVLGALSGILPKIL,17,"Temporin-RN1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana nigrovittata,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=4.69 µg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa PAO1 (MIC=4.7 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.19778602]No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",17,15-18
DRAMP01808,FFPLLFGALSSHLPKLF,17,"Temporin-RN3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana nigrovittata,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=3.75 µg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa PAO1 (MIC=3.75 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.19778602]No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",17,15-18
DRAMP01391,GCSRWIIGIHGQICRD,16,"Odorranain-U1 (OdU1; Frogs, amphibians, animals)",A6MBS4,Not found,Not found,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Odorranain-U1 adopts 60.2% ,,Function: Odorranain-U1 exhibites moderate antimicrobial activities against all of the tested microbes.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC>100 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=75.00 μg/ml), Bacillus subtilis (MIC=9.37 μg/ml).##Yeast: Candida albicans (MIC=9.37 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,16,15-18
DRAMP01833,RAGLKFPVGRVHRLLR,16,"Buforin-EC (Frogs, amphibians, animals)",C0HJB7,Belongs to the histone H2A family,Not found,Euphlyctis cyanophlyctis (Skittering frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity. Has no or very limited (<3%) hemolytic activity at concentrations of 15 µg/ml and 60 µg/ml, respectively.
Tissue specificity: Expressed by the skin glands.","[Swiss_Prot Entry C0HJB7]Gram-negative bacteria: Escherichia coli HP101BA (MIC=9.6 µM), Klebsiella pneumoniae PTCC1388 (MIC=10.6 µM);##Gram-positive bacteria: Micrococcus luteus PTCC1625 (MIC=6.0 µM), Staphylococcus aureus PTCC1431 (MIC=8.1 µM).",[Ref.Int J Pept Res Ther(2012)18;107.]<3% hemolytic activity at 60 µg/ml against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Int. J. Pept. Res. Ther. 2012;18:107-115.,"Asoodeh A, Ghorani-Azam A, Chamani JK.",Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,16,15-18
DRAMP01834,FLNALKNFAKTAGKRLKSLLN,21,"Cyanophlyctin (Frogs, amphibians, animals)",C0HJB8,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Euphlyctis cyanophlyctis (Skittering frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity. Has no or very limited (<3%) hemolytic activity at concentrations of 15 µg/ml and 60 µg/ml.
Tissue specificity: Expressed by the skin glands.","[Swiss_Prot Entry C0HJB8]Gram-negative bacteria: Escherichia coli HP101BA (MIC=6.4 µM), Klebsiella pneumoniae PTCC1388 (MIC=7.3 µM);##Gram-positive bacteria: Micrococcus luteus PTCC1625 (MIC=4.7 µM), Staphylococcus aureus PTCC1431 (MIC=5.3 µM).",[Ref.Int J Pept Res Ther(2012)18;107.]<3% hemolytic activity at 60 µg/ml against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Int. J. Pept. Res. Ther. 2012;18:107-115.,"oodeh A, Ghorani-Azam A, Chamani JK.",Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,21,18-21
DRAMP01840,GFRDVLKGAAKAFVKTVAGHIAN,23,"Ascaphin-1 (Frogs, amphibians, animals)",P0CJ25,Belongs to the ascaphin family,Not found,Ascaphus truei (Coastal tailed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: Asparagine amide at position 23.,[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 µM).,[Ref.15207717]HC50>200 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",23,21-24
DRAMP01842,GFRDVLKGAAKAFVKTVAGHIANI,24,"Ascaphin-3 (Frogs, amphibians, animals)",P0CJ27,Belongs to the ascaphin family,Not found,Ascaphus truei (Coastal tailed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands.,[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 µM).,[Ref.15207717]HC50>200 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",24,21-24
DRAMP01844,GIKDWIKGAAKKLIKTVASNIANQ,24,"Ascaphin-5 (Frogs, amphibians, animals)",P0CJ29,Belongs to the ascaphin family,Not found,Ascaphus truei (Coastal tailed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.,"[Ref.15207717]Gram-negative bacteria: Escherichia coli (MIC=6 µM), Pseudomonas aeruginosa (MIC=13 µM), Enterobacter cloacae (MIC=6 µM), Klebsiella pneumoniae (MIC=13 µM), Proteus mirabilis (MIC>100 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=50 µM), Staphylococcus epidermidis (MIC=13 µM), Enterococcus faecalis (MIC>100 µM), Streptococcus Group B (MIC=6 µM);##Yeast: Candida albicans (MIC=100 µM).",[Ref.15207717]Not found,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",24,21-24
DRAMP01846,GFKDWIKGAAKKLIKTVASSIANQ,24,"Ascaphin-7 (Frogs, amphibians, animals)",P0CJ31,Belongs to the ascaphin family,Not found,Ascaphus truei (Coastal tailed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands.,[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=3 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 µM).,[Ref.15207717]HC50>200 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",24,21-24
DRAMP01847,GFKDLLKGAAKALVKTVLF,19,"Ascaphin-8 (Frogs, amphibians, animals)",P0CJ32,Belongs to the ascaphin family,Not found,Ascaphus truei (Coastal tailed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral",Protein level,Not found,Not found,,Function: Antimicrobial peptide that shows similar potency against Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: Phenylalanine amide at position 19.,[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).,[Ref.15207717]HC50=50 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",19,18-21
DRAMP01849,DSMGAVKLAKLLIDKMKCEVTKAC,24,"Jindongenin-1a (JD1a; Frogs, amphibians, animals)",G3ETQ2,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops jingdongensis (Chinese torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Displays broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Also displays antifungal activity against C. albicans ATCC 2002. Has hemolytic activity, low cytotoxicity and low antioxidant activity.","[Ref.21816202]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=17 µM), Enterococcus faecalis ATCC29212 (MIC=60 µM), Staphylococcus aureus (IS 10#)(MIC=40 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=10 µM), Enterobacter cloacae ATCC13047 (MIC=40 µM), Klebsiella pneumoniae ATCC700603 (MIC=15 µM), Bacillus pyocyaneus CMCCB1010 (MIC=17 µM), Pseudomonas aeruginosa ATCC27853 (MIC=23 µM), Bacillus dysenteriae (MIC=40 µM);##Yeast: Candida albicans ATCC2002 (MIC=60 µM).",[Ref.21816202] IC50=150 μM against washed human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,[Ref.21816202] Cytotoxicity: the K562 (IC50=46μM)and HT29 mammalian cell lines(IC50=40μM).,Not found,21816202,Biochimie. 2012 Feb;94(2):328-334.,"Chen Z, Yang X, Liu Z, Zeng L, Lee W, Zhang Y.","Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.",24,21-24
DRAMP01869,FFPIIAGMAAKLIPSLFCKITKKC,24,"Brevinin-1SPa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana septentrionalis (mink frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.,[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM);##Yeast: Candida albicans (MIC=7 µM).,[Ref.15556063]HC50=7 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,24,21-24
DRAMP01870,FLPIIAGMAAKVICAITKKC,20,"Brevinin-1SPb (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana septentrionalis (mink frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes (HC50=6 µM).,[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=13 µM);##Yeast: Candida albicans (MIC=25 µM).,[Ref.15556063]HC50=25 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,20,18-21
DRAMP01872,FFPIIAGMAAKVICAITKKC,20,"Brevinin-1SPd (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana septentrionalis (mink frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.,[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=3 µM);##Yeast: Candida albicans (MIC=8 µM).,[Ref.15556063]HC50=8 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,20,18-21
DRAMP01873,GIWDTIKSMGKVFAGKILQNL,21,"Brevinin-2-related peptide (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana septentrionalis (mink frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.
Sequence similarity: This peptide shows limited structural similarity with the N-terminal region of brevinin-2 peptides previously isolated from R. temporaria skin but lacks the C-terminal cyclic heptapeptide domain associated with this family.
PTM: C-terminal amidation.",[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 µM);##Yeast: Candida albicans (MIC=70 µM).,[Ref.15556063]HC50=70 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,21,18-21
DRAMP01885,FFGPLIKIATGVLPNLICKALGKC,24,"Brevinin-1TEa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Hylarana temporalis (Indian bronzed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Showes higher antimicrobial activity against Gram-negative than against Gram-positive bacteria.,"Gram-negative bacteria: E. coli (NCLM 2064) (MIC=30 µg/ml), P. aeruginosa (ATCC 10145) (MIC=150 µg/ml), V. cholerae (PL 91) (MIC=150 µg/ml);##Gram-positive bacteria: B. cereus (NCLM 2156) (MIC=100 µg/ml), S. aureus (ATCC25923) (MIC>150 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21412958,J Pept Sci. 2011 May;17(5):342-347.,"Reshmy V, Preeji V, Parvin A, Santhoshkumar K, George S.",Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,24,21-24
DRAMP01888,FFPTIAGLTKLFCAITKKC,19,"Brevinin-1CHc (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana chiricahuensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: E. coli (MIC=80 µM);##Gram-positive bacterium: S. aureus (MIC=20 µM).##Yeast: C. albicans (MIC=20 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys13 and Cys19),Disulfide bond between Cys13 and Cys19.,L,No cytotoxicity information found,Not found,21262304,Peptides. 2011 Apr;32(4):664-669.,"Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,19,18-21
DRAMP01889,GIGSILGVIAKGLPTLISWIKNR,23,"Brevinin-1TOa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana tagoi okiensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: E. coli (MIC=20 µM);##Gram-positive bacterium: S. aureus (MIC=5 µM).##Yeast: C. albicans (MIC=20 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19799928,Toxicon. 2010 Feb-Mar;55(2-3):430-435.,"Conlon JM, Coquet L, Jouenne T, Leprince J, Vaudry H, Iwamuro S.",Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies.,23,21-24
DRAMP01890,FLGAIAGVAAKFLPKVFCFITKKC,24,"Brevinin-1VLa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana vaillanti (Central American frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Brevinin-1VLa showes particularly high growth-inhibitory potency (MIC < or =3 microM) against a Gram-positive microorganism Staphylococcus aureus and the opportunistic yeast pathogen Candida albicans and potent cytolytic activity (LC(50)< or =8 microM) against both human erythrocytes and HepG2 hepatoma-derived cells. The peptide ia also active against a Gram-negative microorganism Escherichia coli (MIC< or =50 microM).,Gram-negative bacterium: E. coli (MIC=25 µM);##Gram-positive bacterium: S. aureus (MIC=3 µM).##Yeast: C. albicans (MIC=3 µM).,[Ref.19379837] LC50=8 mM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,[Ref.19379837] LC50=4mM against HepG2 hepatoma-derived cells,Not found,19379837,Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.,"Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",24,21-24
DRAMP01891,FLPVIASVAAKVLPKVFCFITKKC,24,"Brevinin-1VLc (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana vaillanti (Central American frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Brevinin-1VLc showes particularly high growth-inhibitory potency (MIC < or =3 microM) against a Gram-positive microorganism Staphylococcus aureus and the opportunistic yeast pathogen Candida albicans and potent cytolytic activity (LC(50)< or =8 microM) against both human erythrocytes and HepG2 hepatoma-derived cells. The peptide ia also active against a Gram-negative microorganism Escherichia coli (MIC< or =50 microM).,Gram-negative bacterium: E. coli (MIC=50 µM);##Gram-positive bacterium: S. aureus (MIC=1.5 µM).##Yeast: C. albicans (MIC=3 µM).,[Ref.19379837] LC50=7 mM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,[Ref.19379837] LC50=4mM against HepG2 hepatoma-derived cells,Not found,19379837,Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.,"Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",24,21-24
DRAMP01892,FLPLIAGVAANFLPKIFCLISKKC,24,"Brevinin-1VLd (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana vaillanti (Central American frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Inhibits the growth of reference strains of S. aureus, E. coli and C. albicans and to lyse human erythrocytes from a healthy donor and HepG2 human hepatoma-derived cells",Gram-negative bacterium: E. coli (MIC>100 µM);##Gram-positive bacterium: S. aureus (MIC=3 µM).##Yeast: C. albicans (MIC=3 µM).,[Ref.19379837] LC50=5 mM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,[Ref.19379837] LC50=6mM against HepG2 hepatoma-derived cells,Not found,19379837,Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.,"Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",24,21-24
DRAMP01893,FLPLIAGVAASILPKIFCFITKKC,24,"Brevinin-1VLe (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana vaillanti (Central American frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Inhibits the growth of reference strains of S. aureus, E. coli and C. albicans and to lyse human erythrocytes from a healthy donor and HepG2 human hepatoma-derived cells",Gram-negative bacterium: E. coli (MIC>100 µM);##Gram-positive bacterium: S. aureus (MIC=3 µM).##Yeast: C. albicans (MIC=3 µM).,[Ref.19379837] LC50=5 mM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,[Ref.19379837] LC50=7mM against HepG2 hepatoma-derived cells,Not found,19379837,Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.,"Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",24,21-24
DRAMP01896,FLSTALKVAANVVPTLFCKITKKC,24,"Brevinin-1CG1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Amolops chunganensis (Chungan torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=9 µM), Bacillus licheniformis X39 (IS) (MIC=75 µM);##Gram-negative bacterium: Escherichia coli (ATCC 25922) (MIC=150 µM).##Fungi: Slime mold 090223 (IS) (MIC=75 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,24,21-24
DRAMP01897,FLPIVAGLAANFLPKIVCKITKKC,24,"Brevinin-1CG2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Amolops chunganensis (Chungan torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=9 µM), Bacillus licheniformis X39 (IS) (MIC=75 µM), Enterococcus faecalis 981 (MIC=19 µM), Staphylococcus carnosus KHS (IS) (MIC=9 µM), Staphylococcus aureus (ATCC 25923) (MIC=9 µM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=150 µM), Psychrobacter faecalis X29 (IS) (MIC=19 µM), Serratia rubidaea X01 (IS) (MIC=19 µM).##Fungi: Slime mold 090223 (IS) (MIC=4.5 µM), Candida albicans (ATCC 10231) (MIC=150 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,24,21-24
DRAMP01898,FLSTLLNVASNVVPTLICKITKKC,24,"Brevinin-1CG3 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Amolops chunganensis (Chungan torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Primarily active against Gram-positive bacteria. Also highly active against Gram-negative P. faecalis X29 and S. rubidaea.,"Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=2.3 µM), Bacillus licheniformis X39 (IS) (MIC=9 µM), Enterococcus faecalis 981 (MIC=75 µM), Staphylococcus carnosus KHS (IS) (MIC=19 µM), Staphylococcus aureus (ATCC 25923) (MIC=19 µM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=150 µM), Psychrobacter faecalis X29 (IS) (MIC=4.5 µM), Serratia rubidaea X01 (IS) (MIC=9 µM).##Fungi: Slime mold 090223 (IS) (MIC=9 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,24,21-24
DRAMP01899,FLSTLLNVASKVVPTLFCKITKKC,24,"Brevinin-1CG4 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Amolops chunganensis (Chungan torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=2.3 µM), Bacillus licheniformis X39 (IS) (MIC=9 µM), Enterococcus faecalis 981 (MIC=9 µM), Staphylococcus carnosus KHS (IS) (MIC=9 µM), Staphylococcus aureus (ATCC 25923) (MIC=9 µM);##Gram-negative bacterium: Escherichia coli (ATCC 25922) (MIC=150 µM), Pseudomonas aeruginosa 11053 (IS) (MIC=75 µM), Psychrobacter faecalis X29 (IS) (MIC=9 µM), Serratia rubidaea X01 (IS) (MIC=9 µM).##Fungi: Slime mold 090223 (IS) (MIC=9 µM), Candida albicans (ATCC 10231) (MIC=150 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,24,21-24
DRAMP01900,FLPMLAGLAANFLPKIVCKITKKC,24,"Brevinin-1CG5 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Amolops chunganensis (Chungan torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Primarily active against Gram-positive bacteria, escecially R. rhodochrous. Also highly active against Gram-negative P. faecalis X29 and S. rubidaea.","Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=0.6 µM), Bacillus licheniformis X39 (IS) (MIC=2.3 µM), Enterococcus faecalis 981 (MIC=9 µM), Staphylococcus carnosus KHS (IS) (MIC=1.2 µM), Staphylococcus aureus (ATCC 25923) (MIC=9 µM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=75 µM), Pseudomonas aeruginosa (CGMCC 1.50) (MIC=75 µM), Pseudomonas aeruginosa 11053 (IS) (MIC=75 µM), Klebsiella pneumoniae 08040724 (IS) (MIC=150 µM), Psychrobacter faecalis X29 (IS) (MIC=9 µM), Serratia rubidaea X01 (IS) (MIC=4.6 µM).##Fungi: Slime mold 090223 (IS) (MIC=4.5 µM), Candida albicans (ATCC 10231) (MIC=437.5 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,24,21-24
DRAMP01913,FLPLLAGLAANFLPKIFCKITKKC,24,"Brevinin-1GRa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana grahami (Asian frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,16621155,Peptides. 2006 Sep;27(9):2111-2117.," Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H. ","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. ",24,21-24
DRAMP01918,FLPLIAGLAANFLPKIFCAITKKC,24,"Brevinin-1PLb (Frogs, amphibians, animals)",A7WNV3,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana palustris (Pickerel frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.",Gram-positive bacterium: Staphylococcus aureus (MIC=9 µM);##Gram-negative bacterium: Escherichia coli(MIC=26 µM).##Yeast: Candida albicans (MIC=6 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17698247##11087945,Peptides. 2007 Aug;28(8):1605-1610.##Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Zhou M, Wang L, Owens DE, Chen T, Walker B, Shaw C.##Basir YJ, Knoop FC, Dulka J, Conlon JM.","Rapid identification of precursor cDNAs encoding five structural classes of antimicrobial peptides from pickerel frog (Rana palustris) skin secretion by single step shotgun cloning.##Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",24,21-24
DRAMP01919,FLPVIAGVAAKFLPKIFCAITKKC,24,"Brevinin-1PLc (Frogs, amphibians, animals)",A7WNV4,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana palustris (Pickerel frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=4 µM);##Gram-negative bacterium: Escherichia coli(MIC=7 µM).##Yeast: Candida albicans (MIC=8 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17698247##11087945,Peptides. 2007 Aug;28(8):1605-1610.##Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Zhou M, Wang L, Owens DE, Chen T, Walker B, Shaw C.##Basir YJ, Knoop FC, Dulka J, Conlon JM.","Rapid identification of precursor cDNAs encoding five structural classes of antimicrobial peptides from pickerel frog (Rana palustris) skin secretion by single step shotgun cloning.##Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",24,21-24
DRAMP01920,FLPILAGLAAKIVPKLFCLATKKC,24,"Brevinin-1CSa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana cascadae (Cascades frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Brevinin-1CSa was strongly hemolytic against human erythrocytes. ,[Ref.17451843]Gram-negative bacterium: Escherichia coli (MIC=32 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=2 µM).,[Ref.17451843] LD50=5 µM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,17451843,Peptides. 2007 Jun;28(6):1268-1274.,"Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.",Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,24,21-24
DRAMP01940,FLPIIAGVAAKVLPKLFCAITKKC,24,"Brevinin-1CHa (Frogs, amphibians, animals)",A7YJE2,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana chiricahuensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,PTM: Contains disulfide bond.,"Gram-negative bacteria: E. coli (MIC=10 µM), K. pneumoniae (MIC=40 µM), P. aeruginosa (MIC=20 µM);##Gram-positive bacterium: S. aureus (MIC=2.5 µM).##Yeast: C. albicans (MIC=2.5 µM).(Ref.2)",[Ref.21262304] LC50=5 µM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,17938991##21262304,J Mol Evol. 2007 Nov;65(5):605-615.##Peptides. 2011 Apr;32(4):664-669.,"Tennessen JA, Blouin MS.##Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.##Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,24,21-24
DRAMP01941,FLPVIAGLAAKVLPKLFCAITKKC,24,"Brevinin-1CHb (Frogs, amphibians, animals)",A7YJE4,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana chiricahuensis ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,PTM: Contains disulfide bond.,"Gram-negative bacteria: E. coli (MIC=10 µM), K. pneumoniae (MIC=40 µM), P. aeruginosa (MIC=10 µM);##Gram-positive bacterium: S. aureus (MIC=2.5 µM).##Yeast: C. albicans (MIC=2.5 µM).(Ref.2)",[Ref.21262304] LC50=5 µM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,17938991##21262304,J Mol Evol. 2007 Nov;65(5):605-615.##Peptides. 2011 Apr;32(4):664-669.,"Tennessen JA, Blouin MS.##Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.##Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,24,21-24
DRAMP01942,FLPAIVGAAGQFLPKIFCAISKKC,24,"Brevinin-1Sa (Frogs, amphibians, animals)",P82904,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana sphenocephala (Southern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=55 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10604597,J Pept Res. 1999 Dec;54(6):522-527.,"Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.","Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.",24,21-24
DRAMP01943,FLPAIVGAAGKFLPKIFCAISKKC,24,"Brevinin-1Sb (Frogs, amphibians, animals)",P82905,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana sphenocephala (Southern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=17 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10604597,J Pept Res. 1999 Dec;54(6):522-527.,"Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.","Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.",24,21-24
DRAMP01944,FFPIVAGVAGQVLKKIYCTISKKC,24,"Brevinin-1Sc (Frogs, amphibians, animals)",P82906,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana sphenocephala (Southern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=14 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10604597,J Pept Res. 1999 Dec;54(6):522-527.,"Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.","Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.",24,21-24
DRAMP01949,FLPAVLRVAAKIVPTVFCAISKKC,24,"Brevinin-1HSa (Frogs, amphibians, animals)",P0C8S7,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana hosii (Hose's rock frog) (Odorrana hosii),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=24 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",24,21-24
DRAMP01950,FLPAVLRVAAQVVPTVFCAISKKC,24,"Brevinin-1HSb (Brevinin-1JDb; Frogs, amphibians, animals)",P0C8S8,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana hosii (Hose's rock frog) (Odorrana hosii),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC>48 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",24,21-24
DRAMP01951,FMGGLIKAATKIVPAAYCAITKKC,24,"Brevinin-1PTa (Frogs, amphibians, animals)",P0C8T1,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=24 µM)., ,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",24,21-24
DRAMP01963,FLPAIVGAAAKFLPKIFCAISKKC,24,"Brevinin-1BLa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates blairi (plains leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus",[Ref.19254736] Gram-positive bacteria : Staphylococcus aureus(MIC=1.5 μM);##Gram-negative bacteria : Escherichia coli(MIC=25 μM);##Fungi : Candida albicans(MIC=6 μM),[Ref.19254736] LC50=14 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19254736,Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",24,21-24
DRAMP01965,FLPIIAGIAAKFLPKIFCTISKKC,24,"Brevinin-1BLc (Frogs, amphibians, animals)",B6CPR0,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates blairi (leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.19254736]Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.5 µM);##Yeast: Candida albicans (MIC=3 µM);##Cancer cells HepG2: (LC50=6 µM)..,[Ref.19254736] LC50=9 μM against human red blood cells.##[Ref.14531844]Non-hemolytic activity against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19254736,Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",24,21-24
DRAMP01968,FLPIIAGAAAKVVEKIFCAISKKC,24,"Brevinin-1Yc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates yavapaiensis (North American leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.19254736] Gram-positive bacteria : Staphylococcus aureus(MIC=6 μM);##Gram-negative bacteria : Escherichia coli(MIC=100 μM);##Fungi : Candida albicans(MIC=6 μM)Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).##Yeast: Candida albicans (MIC=6 µM).##cancer cells HepG2 (LC50=14 µM). ,[Ref.19254736] LC50=13 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19254736,Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",24,21-24
DRAMP01969,FLGSLIGAAIPAIKQLLGLKK,21,"Brevinin-1Ja (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana japonica (Japanese brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,It can produced cell death of mammalian COS7 cells (LD50=28 µM).,Gram-positive bacterium: Staphylococcus aureus (MIC=15 µM);##Gram-negative bacterium: Escherichia coli (MIC=119 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18558801,Zoolog Sci 2008; 25: 487-491.,"Koyama T, Iwamuro S.","Molecular cloning of a cDNA encoding atypical antimicrobial and cytotoxic brevinin-1Ja from the skin of the Japanese brown frog, Rana japonica.",21,18-21
DRAMP01970,FLPFLLSALPKVFCFFSKKC,20,"Brevinin-1ZHa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana zhenhaiensis (Chinese brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=8 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=32 µM).##Yeast: Candida albicans ATCC 2002 (MIC>43 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",20,18-21
DRAMP01971,FLPLLLSALPSFLCLVFKKC,20,"Brevinin-1ZHb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana zhenhaiensis (Chinese brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=17 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=33 µM), Pseudomonas aeruginosa ATCC 9027 (MIC>44 µM).##Yeast: Candida albicans ATCC 2002 (MIC>44 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",20,18-21
DRAMP01990,FMGSALRIAAKVLPAALCQIFKKC,24,"Brevinin-1LT1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana latouchii (Chinese broad-folded frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity against rabbit red blood cells.","[Ref.19340924]Gram-positive bacteria: Staphylococcus aureus (MIC=6.25 µM), Bacillus subtilis (MIC=6.25 µM);##Gram-negative bacterium: Pseudomonas fluorescens (MIC=100 µM);##Yeast: Candida albicans (MIC=50 µM).",[Ref.19340924]LC50>200 µg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19340924,Biochimie. 2009 Apr;91(4):540-547.,"Wang H, Yan X, Yu H, Hu Y, Yu Z, Zheng H, Chen Z, Zhang Z, Liu J.","Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).",24,21-24
DRAMP02001,FLPLIASLAANFVPKIFCKITKKC,24,"Brevinin-1HN1 (Frogs, amphibians, animals)",E7EKC4,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana hainanensis (Hainan odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antimicrobial activity against Gram-positive bacteria and fungi but has weak or no activity against a range of Gram-negative bacteria except P. faecalis. Has hemolytic activity against human erythrocytes (LC50=75 µM).

Tissue specificity: Expressed by the skin glands.

PTM: Contains one disulfide bond.","[Ref.22450466]Gram-positive bacteria: Enterococcus faecium 091299 (MIC=19 µM), Enterococcus faecalis 981 (MIC=19 µM), Staphylococcus aureus ATCC2592 (MIC=1.2 µM), Staphylococcus carnosus KHS (MIC=4.8 µM), Bacillus licheniformis X39 (MIC=2.4 µM), Rhodococcus rhodochrous X15 (MIC=1.2 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=150 µM), Psychrobacter faecalis X29 (MIC=4.8 µM);##Fungi: Slime mould 090223 (MIC=1.2 µM), Candida albicans ATCC2002 (MIC=2.4 µM).",[Ref.22450466] LC50=75 µM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22450466,Peptides. 2012 Jun;35(2):285-290.,"Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.","Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",24,21-24
DRAMP02004,FLPLIASVAANLVPKIFCKITKKC,24,"Brevinin-1V (Frogs, amphibians, animals)","Q2UXV8, E7EKC5",Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana versabilis (Chinese bamboo leaf odorous frog) (Rana versabilis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,,"Function: Has antimicrobial activity against Gram-positive bacteria and fungi but has weak or no activity against a range of Gram-negative bacteria except P. faecalis. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond.","[Ref.22450466]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=19 µM), Bacillus licheniformis X39 (MIC=37.5 µM), Rhodococcus rhodochrous X15 (MIC=9.5 µM), Enterococcus faecium 091299 (MIC=19 µM), E. faecalis 981 (MIC=19 µM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=9.5 µM);##Fungi: Slime mould 090223 (MIC=1.2 µM), Candida albicans ATCC2002 (MIC=19-37.5 µM).",[Ref.22450466] LC50=75 µM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,16139929##22450466,Peptides. 2006 Jan;27(1):42-48.##Peptides. 2012 Jun;35(2):285-290.,"Chen T, Li L, Zhou M, Rao P, Walker B, Shaw C.##Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.","Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: identification of novel brevinins from three species of Chinese frogs.##Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",24,21-24
DRAMP02006,GIWDTLKNVGKAVLGKVLENV,21,"Brevinin-2Va (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana virgatipes (Ranidae) (Aquarana),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=12 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15996769,Regul Pept. 2005 Nov;131(1-3):38-45.,"Conlon JM, Abraham B, Sonnevend A, Jouenne T, Cosette P, Leprince J, Vaudry H, Bevier CR.","Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). ",21,18-21
DRAMP02009,FLPVLAGIAAKVVPALFCKITKKC,24,"Brevinin-1 (Frogs, amphibians, animals)",P32423,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana brevipoda porsa (Japanese frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and a very high hemolytic activity.",[Ref.1449472]Gram-positive bacterium: Staphylococcus aureus (MIC=8 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=34 µg/ml).,[Ref.1449472] high hemolytic activity,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,1449472,Biochem Biophys Res Commun. 1992 Nov 30;189(1):184-190.,"Morikawa N, Hagiwara K, Nakajima T.","Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa.",24,21-24
DRAMP18381,VVYALKRNGRTLYGF,15,H4-(86-100) (histone-derived),No entry found,Not found,Not found,rat,"Antimicrobial, Antibacterial",,Not found,Not found,,"Fuction: ATP can enahnce its activity, implying its involvement in inhibiting the DNA gyrase activity.","Active against E. coli (LD90 6.68 ug/ml), P. aeruginosa (LD90 4.8 ug/ml), B. subtilis (LD90 17 ug/ml), and S. aureus (14.7 ug.ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18803668,FEBS J. 2008 Nov;275(21):5286-97.,"Lemaire S, Trinh TT, Le HT, Tang SC, Hincke M, Wellman-Labadie O, Ziai S.","Antimicrobial effects of H4-(86-100), histogranin and related compounds--possible involvement of DNA gyrase.",15,12-15
DRAMP18382,VVYTLKRNGRTLYGF,15,HNr (histone-derived),No entry found,Not found,Not found,rat,"Antimicrobial, Antibacterial",,Not found,Not found,,"Fuction: ATP can enahnce its activity, implying its involvement in inhibiting the DNA gyrase activity.","Active against E. coli (LD90 10.3 ug/ml), P. aeruginosa LD90 8.7 ug/ml), and B. subtilis (LD90 14 ug/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18803668,FEBS J. 2008 Nov;275(21):5286-97.,"Lemaire S, Trinh TT, Le HT, Tang SC, Hincke M, Wellman-Labadie O, Ziai S.","Antimicrobial effects of H4-(86-100), histogranin and related compounds--possible involvement of DNA gyrase.",15,12-15
DRAMP02026,LLSLALAALPKLFCLIFKKC,20,"Brevinin-1CDYa (Frogs, amphibians, animals)",B3VZU0,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has low activity against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E. coli. Has hemolytic activity against human erythrocytes (HC50=125 µM).
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20.",[Swiss_Prot Entry B3VZU0]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 µM);##Gram-negative bacterium: Escherichia coli (MIC=25 µM),[Ref.19539775]HC50=125 μM against human red blood cells,Cyclic,Free,Cyclization (Cys14 and Cys20),Disulfide bond between Cys14 and Cys20.,L,No cytotoxicity information found,Not found,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",20,18-21
DRAMP02031,ILPLLLGKVVCAITKKC,17,"Brevinin-1Da (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana dalmatina (European frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,"Sequence alignment suggests that the peptide is derived from brevinin-1 by multiple residue deletions (D for ""dalmatina"" and 'a' to denote the first isoform identified). ",Gram-positive bacterium: Staphylococcus aureus (MIC=7 µM);##Gram-negative bacterium: Escherichia coli (MIC=30 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys11 and Cys17),Disulfide bond between Cys11 and Cys17.,L,No cytotoxicity information found,Not found,15050930,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Feb;137(2):191-196.,"Conlon JM, Seidel B, Nielsen PF.",An atypical member of the brevinin-1 family of antimicrobial peptides isolated from the skin of the European frog Rana dalmatina.,17,15-18
DRAMP02032,FLGSIVGALASALPSLISKIRN,22,"Brevinin-1TSa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana tsushimensis (Tsushima brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, but hemolytic activity against human erythrocytes.","[Ref.16413829]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 µM), Klebsiella pneumoniae KK3 9904 (MIC>100 µM), Enterobacter cloacae HNTCC 53001 (MIC=50 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=50 µM), Proteus mirabilis ATCC 25933 (MIC>100 µM);##Gram-positive bacteria: Staphylococcus aureus NCTC 8325 (MIC=25 µM), Methicillin-resistant Staphylococcus aureus T7/20 (MIC=25 µM), Staphylococcus epidermidis RP62A (MIC=12.5 µM), Enterococcus faecalis ATCC 29212 (MIC=50 µM), Streptococcus group B HNTCC 80130 (MIC=50 µM);##Yeast: Candida albicans ATCC 90028 (MIC=50 µM)",[Ref.16413829]LD50=12 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16413829,Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-49. ,"Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.",Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.,22,21-24
DRAMP02034,FLPILAGLAAKLVPKVFCSITKKC,24,"Brevinin-1AUa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana aurora aurora (Northern red-legged frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, and also shows hemolytic. ","[Ref.15325526]Gram-negative bacteria: Escherichia coli (MIC=13 µM), Pseudomonas aeruginosa (MIC=25 µM), Enterobacter cloacae (MIC=13 µM), Klebsiella pneumoniae (MIC=50 µM), Proteus mirabilis (MIC>50 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3 µM), Staphylococcus epidermidis (MIC=6 µM), Enterococcus faecalis (MIC=13 µM), Streptococcus Group B (MIC=13 µM);##Yeast: Candida albicans (MIC>40 µM).",[Ref.15325526] HC50=5 μM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,15325526,Dev Comp Immunol. 2005;29(1):83-90.,"Conlon JM, Sonnevend A, Davidson C, Demandt A, Jouenne T.",Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,24,21-24
DRAMP02035,FLPILAGLAANILPKVFCSITKKC,24,"Brevinin-1AUb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana aurora aurora (Northern red-legged frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, and also shows hemolytic activity. ","[Ref.15325526]Gram-negative bacteria: Escherichia coli (MIC=25 µM), Pseudomonas aeruginosa (MIC=25 µM), Enterobacter cloacae (MIC=25 µM), Klebsiella pneumoniae (MIC>50 µM), Proteus mirabilis (MIC>50 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3 µM), Staphylococcus epidermidis (MIC=6 µM), Enterococcus faecalis (MIC=6 µM), Streptococcus Group B (MIC=13 µM);##Yeast: Candida albicans (MIC=3 µM).",[Ref.15325526] HC50=7 μM against human erythrocytes,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,15325526,Dev Comp Immunol. 2005;29(1):83-90.,"Conlon JM, Sonnevend A, Davidson C, Demandt A, Jouenne T.",Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,24,21-24
DRAMP02038,VIVFVASVAAEMMQHVYCAASKKC,24,"Brevinin-1-OA1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana andersonii (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.4 µg/ml);##Gram-negative bacteria: Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 µg/ml), Escherichia coli ATCC 25922 (MIC=6.2 µg/ml).##Yeast: Candida albicans (MIC=24.8 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP18378,ILELAGNAARDNKKTRIIPRHLQL,24,Acipensin 6 (Ac6),No entry found,Not found,Not found,"Leukocytes; the Russian Sturgeon, Acipenser gueldenstaedtii","Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,Active against E. coli ML35p (MIC 2.5 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,25558400,Acta Naturae. 2014 Oct;6(4):99-109. ,"Shamova OV, Orlov DS, Balandin SV, Shramova EI, Tsvetkova EV, Panteleev PV, Leonova YF, Tagaev AA, Kokryakov VN, Ovchinnikova TV.",Acipensins - Novel Antimicrobial Peptides from Leukocytes of the Russian Sturgeon Acipenser gueldenstaedtii,24,21-24
DRAMP02040,FLPAVIRVAANVLPTAFCAISKKC,24,"Brevinin-1-OA12 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana andersonii (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.6 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=13.2 µg/ml).##Yeast: Candida albicans (MIC=3.3 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02041,LPFVAGVAAEMMQHVYCAASKKC,23,"Brevinin-1-OR1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.3 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=42.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.6 µg/ml).##Yeast: Candida albicans (MIC=10.6 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys17 and Cys23),Disulfide bond between Cys17 and Cys23.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,23,21-24
DRAMP02042,IDPFVAGVAAEMMQHVYCAASKKC,24,"Brevinin-1-OR3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=9.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=18.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=18.2 µg/ml).##Yeast: Candida albicans (MIC=18.2 µg/ml). ",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02043,INPFVAGVAAEMMQHVYCAASKKC,24,"Brevinin-1-OR4 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=8.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.6 µg/ml).##Yeast: Candida albicans (MIC=8.6 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02044,ILPFVAGVAAEMMKHVYCAASKKC,24,"Brevinin-1-OR5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,It differs from AP1824 only at position 14: Q vs. K.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=30.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=15.2 µg/ml).##Yeast: Candida albicans (MIC=7.6 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02045,IIPFVAGVAAEMMEHVYCAASKKC,24,"Brevinin-1-OR6 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,It differs from AP1827 at two positions: 2: I vs. L and 14: K vs. E.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=22.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=22.2 µg/ml).##Yeast: Candida albicans (MIC=11.1 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02046,QLPFVAGVACEMCQCVYCAASKKC,24,"Brevinin-1-OR7 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.7 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=5.7 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.4 µg/ml).##Yeast: Candida albicans (MIC=11.4 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02047,ILPFVAGVAAEMMEHVYCAASKKC,24,"Brevinin-1-OR8 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=52.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=26.2 µg/ml).##Yeast: Candida albicans (MIC=13.1 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02048,ILPFVAGVAAMEMEHVYCAASKKC,24,"Brevinin-1-OR9 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=9.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=9.8 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=4.9 µg/ml).##Yeast: Candida albicans (MIC=9.8 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02049,FLPAVLLVATHVLPTVFCAITRKC,24,"Brevinin-1-OR10 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.4 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=27.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.8 µg/ml).##Yeast: Candida albicans (MIC=6.8 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,24,21-24
DRAMP02050,LAFVAGVAAEMMQHVYCAASKKC,23,"Brevinin-1-OR11 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.4 µg/ml).##Yeast: Candida albicans (MIC=12.4 µg/ml).",[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.,Cyclic,Free,Cyclization (Cys17 and Cys23),Disulfide bond between Cys17 and Cys23.,L,No cytotoxicity information found,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,23,21-24
DRAMP02051,ILPFVAGVAAEMMQHVYCAASKKC,24,"Lividin-1 (Brevinin-1-OR2; Frogs, amphibians, animals)",Q2UXR4,Belongs to the frog skin active peptide family (Brevinin subfamily),lividin-1,Odorrana rotodora (Chinese odorous frog) (Odorrana livida),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains disulfide bond.","Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=11.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.6 µg/ml).##Yeast: Candida albicans (MIC=5.8 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,16713657##22029824,Peptides. 2006 Sep;27(9):2118-2123.##J Proteome Res. 2012 Jan 1;11(1):306-319.,"Zhou M, Chen T, Walker B, Shaw C.##Yang X, Lee WH, Zhang Y.","Lividins: novel antimicrobial peptide homologs from the skin secretion of the Chinese Large Odorous frog, Rana (Odorrana) livida. Identification by shotgun cDNA cloning and sequence analysis.##Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.",24,21-24
DRAMP02073,FLPAVIRVAANVLPTVFCAISKKC,24,"Brevinin-1JDa (Frogs, amphibians, animals)",B3A0M4,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antibacterial and antifungal activity. Has hemolytic activity against rabbit erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bonds.","[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), S. aureus (MRSA) (MIC=32 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=128 µg/ml);##Fungi: Candida albicans (MIC=128 µg/ml).",[Ref.22917879] It has 79.2 ± 6.8% hemolytic activity at 128 μg/mL against rabbit red blood cells,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.",24,21-24
DRAMP02075,FLPAVLRVAAKVVPTVFCLISKKC,24,"Brevinin-1JDc (Frogs, amphibians, animals)",B3A0N0,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial and antifungal activity. Has hemolytic activity against rabbit erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bonds.","[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), S. aureus (MRSA) (MIC=8 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=128 µg/ml).",[Ref.22917879] It has 11.7 ± 3.2% hemolytic activity at 64 μg/mL and 88.4 ± 4.2% hemolytic activity at 128 μg/mL against rabbit red blood cells,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.",24,21-24
DRAMP02078,FLPVVAGLAAKVLPSIICAVTKKC,24,"Brevinin-1SY (Frogs, amphibians, animals)",P82871,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana sylvatica (Wood frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=7 µM);##Gram-negative bacterium: Escherichia coli (MIC=45 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11042268,FEBS Lett. 2000 Oct 20;483(2-3):135-138.,"Matutte B, Storey KB, Knoop FC, Conlon JM.","Induction: of synthesis of an antimicrobial peptide in the skin of the freeze-tolerant frog, Rana sylvatica, in response to environmental stimuli.",24,21-24
DRAMP02101,FLPLLAGVVANFLPQIICKIARKC,24,"Brevinin-1RTa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops ricketti (Chinese sucker frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,"Function: Brevinin-2RTb has antibacterial activity and hemolytic activity against rabbit red blood cells (LD50=100.0 µg/ml) in vitro.
PTM: Contains one disulfide bond 27-33.","[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=6.3 µg/ml), Bacillus licheniformis X39 (MIC=25.0 µg/ml), Rhodococcus rhodochrous X15 (MIC=3.1 µg/ml);##Gram-negative bacteria: Serratia rubidaea X01 (MIC=NA µg/ml), Pseudomonas aeruginosa 1.50 (MIC=NA µg/ml), Psychrobacter faecalis X29 (MIC=12.5 µg/ml).",[Ref.22100518]LD50=100 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22100518,Peptides. 2012 Jan;33(1):27-34.,"Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.",Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,24,21-24
DRAMP02102,FLGSLLGLVGKVVPTLFCKISKKC,24,"Brevinin-1RTb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops ricketti (Chinese sucker frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,"Function: Brevinin-2RTb has antibacterial activity and hemolytic activity against rabbit red blood cells (LD50=200.0 µg/ml) in vitro.
PTM: Contains one disulfide bond 27-33.","[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=3.1 µg/ml), Bacillus licheniformis X39 (MIC=25.0 µg/ml), Staphylococcus carnosus KHS (MIC=12.5 µg/ml), Rhodococcus rhodochrous X15 (MIC=3.1 µg/ml);##Gram-negative bacteria: Psychrobacter faecalis X29 (MIC=12.5 µg/ml)",[Ref.22100518]LD50=200 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22100518,Peptides. 2012 Jan;33(1):27-34.,"Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.",Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,24,21-24
DRAMP02125,IFGAILPLALGALKNLIK,18,"Hylin-a1 (Hy-a1; Frogs, amphibians, animals)",P85982,Not found,Not found,Hypsiboas albopunctatus (Spotted tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix,Not found,2N0O resolved by NMR.,"Function: Has antibacterial activity against the Gram-positive bacteria and the Gram-negative bacteria. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.","[Ref.19056441]Gram-positive bacteria: Staphylococcus aureus ATCC 25926 (MIC=8 µM), Enterococcus faecalis ATCC 29212 (MIC=16 µM), Bacillus subtilis ATCC 19659 (MIC=8 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=32 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=64 µM);##Fungi: Candida albicans ATCC 90028 (MIC=16.7 µM), C. krusei ATCC 6258 (MIC=16.7 µM), C. parapsilosis ATCC 22019 (MIC=67 µM), Cryptococcus neoformans ATCC 90012 (MIC=33.5 µM)",[Ref.19056441]HC50=18 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19056441,Peptides. 2009 Feb;30(2):291-296.,"Castro MS, Ferreira TC, Cilli EM, Crusca E Jr, Mendes-Giannini MJ, Sebben A, Ricart CA, Sousa MV, Fontes W.","Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus (spotted treefrog).",18,15-18
DRAMP02127,GLLGGLLGPLLGGGGGGGGGLL,22,"Leptoglycin (Gly-rich; Frogs, amphibians, animals)",P86267,Not found,Not found,Leptodactylus pentadactylus (Smokey jungle frog) (Rana pentadactyla),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antimicrobial protein. Has antibacterial activity but not against Gram-positive bacteria Staphylococcus aureus, Micrococcus luteus and Enterococcus faecalis, yeasts Candida albicans and Candida tropicalis and dermatophytes fungi Microsporum canis and Trichophyton rubrum. No hemolytic activity was observed at the 2-200 microM range concentration.
Tissue specificity: Expressed by the skin glands.","[Ref.19298834]Gram-negative bacteria: Escherichia coli ATCC 28922 (MIC=50 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=8 µM);##Fungi: Citrobacter freundii ATCC 8090 (MIC=75 µM)",[Ref.19298834]Non-hemolytic activity was observed at 2-200 μM concentration,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19298834,Toxicon. 2009 Jul;54(1):23-32.,"Sousa JC, Berto RF, Gois EA, Fontenele-Cardi NC, Honório JE Jr, Konno K, Richardson M, Rocha MF, Camargo AA, Pimenta DC, Cardi BA, Carvalho KM.",Leptoglycin: a new glycine/leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog Leptodactylus pentadactylus (Leptodactylidae).,22,21-24
DRAMP02129,FIKELLPHLSGIIDSVANAIK,21,"Kasstasin (Frogs, amphibians, animals)",G0LWV9,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Kassina maculata (African rhacophorid frog) (Hylambates maculatus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Peptide with potent vasoconstrictor properties. Has moderate antimicrobial activity. Not active against fungus C. albicans. Has hemolytic activity against horse erythrocytes.
Tissue specificity: Expressed by the skin dorsal glands.
Miscellaneous: Kasstasin is a derivation of Kassina, the taxon of origin, and the Ancient Greek word 'stasis' meaning 'stoppage of flow'.",[Ref.21624426]Gram-positive bacterium: Staphylococcus aureus (MIC=55 µM);##Gram-negative bacterium: Escherichia coli (MIC=110 µM).,[Ref.21624426]12.8% hemolytic activity at 125 μM against defibrinated horse blood,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21624426,Biochimie. 2011 Sep;93(9):1537-1542.,"Li X, Feng W, Zhou M, Ma C, Chen T, Zeller M, Hornshaw M, Wang L, Shaw C.","Kasstasin: A novel potent vasoconstrictor peptide from the skin secretion of the African red-legged running frog, Kassina maculata.",21,18-21
DRAMP02131,GVWSTVLGGLKKFAKGGLEAIVNPK,25,"Antimicrobial peptide 2 (XT-2; Frogs, amphibians, animals)",P84382,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has very strong antibacterial activity against Gram-positive bacterium S. aureus and very weak activity against Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.",Gram-positive bacteria: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacteria: Escherichia coli (MIC=8 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",25,24-27
DRAMP02133,GVFLDALKKFAKGGMNAVLNPK,22,"Antimicrobial peptide 4 (XT-4; Frogs, amphibians, animals)",P84384,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus and yeast C. albicans, and very weak activity against Gram-negative bacterium E.coli. Has strong hemolytic activity against human red blood cells.
Tissue specificity: Expressed by the skin glands.",[Ref.11738090]Gram-positive bacteria: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacteria: Escherichia coli (MIC=18 µM);##Fungi: Candida albicans (MIC>100 µM).,[Ref.11738090]HC50>150 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",22,21-24
DRAMP02135,GFLGSLLKTGLKVGSNLL,18,"Antimicrobial peptide 6 (XT-6; Frogs, amphibians, animals)",P84386,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus and Gram-negative bacterium E.coli and strong activity against yeast C. albicans. Enhances the antibacterial activity of XT3. Has hemolytic activity against human red blood cells.
Tissue specificity: Expressed by the skin glands.","[Ref.11738090]Gram-positive bacterium: Staphylococcus aureus (MIC=5 µM);##Gram-negative bacterium: Escherichia coli (MIC=5 µM);##Yeast: Candida albicans (MIC=40 µM);##Clinical isolates: Staphylococcus aureus 8325 (MIC=6 µM), Staphylococcus aureus (MRSA) (MIC=7 µM), Staphylococcus epidermidis 1420129 (MIC=3 µM), S. saprophyticus 1950556 (MIC=13 µM), Escherichia coli 25922 (MIC=6 µM), Streptococcus group C 1541035 (MIC=3 µM), Shigella sonnei 1840187 (MIC=35 µM), Pseudomonas aeruginosa 0380972 (MIC=60 µM), Enterobacter cloacae 1441323 (MIC=35 µM)",[Ref.11738090]HC50=70 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",18,15-18
DRAMP02136,GLLGPLLKIAAKVGSNLL,18,"Antimicrobial peptide 7 (XT-7; Frogs, amphibians, animals)",P84381,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Has very strong antibacterial activity against many Gram-negative bacteria and the Gram-positive bacteria S.pneumoniae and Enterococcus sp. There is moderate antimicrobial activity against the Gram-negative bacterium P.aeruginosa and yeast C. albicans and weaker activity against the Streptococcal strains and E.coli. Has hemolytic activity against human red blood cells (HC50=70 µM). Seems to disrupt the membranes by adopting an alpha-helical conformation.
Tissue specificity: Expressed by the skin glands.
PTM: Amidation on Leu-18 is required to adopt an alpha-helical conformation in a hydrophobic solvent. The absence of amidation leads to a decrease in cationicity leading to a more than a 10-fold decrease in antimicrobial activities.","Gram-positive bacterium: Staphylococcus aureus (MIC=5 µM);##Gram-negative bacterium: Escherichia coli (MIC=5 µM);##yeast Candida albicans (MIC=40 µM).##Clinical isolates: Staphylococcus aureus 8325 (MIC=6 µM), Staphylococcus aureus (MRSA) (MIC=7 µM), Staphylococcus epidermidis 1420129 (MIC=3 µM), S. saprophyticus 1950556 (MIC=13 µM), Escherichia coli 25922 (MIC=6 µM), Streptococcus group C 1541035 (MIC=3 µM), Shigella sonnei 1840187 (MIC=35 µM), Pseudomonas aeruginosa 0380972 (MIC=60 µM), Enterobacter cloacae 1441323 (MIC=35 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",18,15-18
DRAMP18494,FIHHIIGGLFSAGKAIHRLIRRRRR,25,TP4,L0CKG3,Piscidin,TP4,Oreochromis niloticus (Nile tilapia) (Tilapia nilotica),"Antibacterial, Antifungal, anticancer, wound healing, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,"1.0x sarkosyl can drive TP4 into a conformational change from a non-structure to an alpha-helical structure, and that LPS can also drive TP4 to an alpha-helical structure but with high hydrophobicity and low solubility.",5H2S,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. Has hemolytic activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml; MBC=16 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=16 μg/ml; MBC=32 μg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa (MIC=64 μg/ml; MBC=128 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 2% hemolysis at 0.78 μg/ml, 5% hemolysis at 1.56 μg/ml, 45% hemolysis at 3.13 μg/ml, 85% hemolysis at 6.25 μg/ml, 98% hemolysis at 12.50 μg/ml, 100% hemolysis at 25.00 μg/ml against mouse red blood cell",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,"bacterial outer membrane target protein, OprI-binding",29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP02239,SMISVLKNLGKVGLGFVACKVNKQC,25,"Ranatuerin-1Ga (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana grylio (North American pig frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=3.5 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=60 µM).##Yeast: Candida albicans (MIC=110 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10828493,Regul Pept. 2000 Jun 30;90(1-3):53-60.,"Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.",Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,25,24-27
DRAMP01390,TSRCYIGYRRKVVCS,15,"Odorranain-T1 (OdT1; Frogs, amphibians, animals)",A6MBS1,Not found,Not found,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Odorranain-T1 adopts 28.2% turn structure in water solution.,,Function: Odorranain-T1 exhibites moderate antimicrobial activities against all of the tested microbes.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=17.50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=35.00 μg/ml), Bacillus subtilis (MIC=17.50 μg/ml).##Yeast: Candida albicans (MIC=8.75 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,15,12-15
DRAMP02268,GWASKIGQTLGKIAKVGLKELIQPK,25,"Xenopsin precursor fragment (XPF; Frogs, amphibians, animals)",P07198,Belongs to the magainin family,Not found,Xenopus laevis (African clawed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: XPF has antimicrobial activity.
Tissue specificity: XPF is synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa, it is stored as active, processed peptides in large granules within the granular gland secretions of the skin.","Gram-negative bacteria: Escherichia coli (MIC=16-31 µg/ml), K. Pneumonae (MIC=62-125 µg/ml), Pseudomonas aeruginosa (MIC=125-250 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=250-500 µg/ml), Streptococcus faecalis (MIC=250-500 µg/ml).##Yeast: Candida albicans (MIC=250-500 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1717472,J Biol Chem. 1991 Oct 15;266(29):19851-19857.,"Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.",Antimicrobial peptides in the stomach of Xenopus laevis.,25,24-27
DRAMP02269,GVLSNVIGYLKKLGTGALNAVLKQ,24,"Antimicrobial peptide PGQ (PGQ; Frogs, amphibians, animals)",P39080,Belongs to the magainin family,pgq,Xenopus laevis (African clawed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix(potential),Not found,,"Function: Antimicrobial peptide.
Tissue specificity: Is synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. It is stored as active, processed peptides in large granules within the granular gland secretions of the skin.","Gram-negative bacteria: Escherichia coli (MIC=62-250 µg/ml), K. Pneumonae (MIC=125-250 µg/ml), Pseudomonas aeruginosa (MIC=250-500 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=250-500 µg/ml), Streptococcus faecalis (MIC=250-500 µg/ml).##Yeast: Candida albicans (MIC=250-500 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1717472,J Biol Chem. 1991 Oct 15;266(29):19851-19857.,"Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.",Antimicrobial peptides in the stomach of Xenopus laevis.,24,21-24
DRAMP02271,GIGKFLHSAKKFGKAFVGEIMNS,23,"Magainin-2 (Magainin II; chain of Magainins; Frogs, amphibians, animals)",C0HKN6,Belongs to the gastrin/cholecystokinin family. Magainin subfamily.,,Xenopus ruwenzoriensis (Uganda clawed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal",Protein level,Alpha helix,"The secondary structure is shown to be helical in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution.","2MAG, 2LSA resolved by NMR.","Function: Antimicrobial peptides that inhibit the growth of numerous species of bacteria and fungi and induce osmotic lysis of protozoa. Magainins are membrane lytic agents.
Tissue specificity: Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. It is stored as active, processed peptides in large granules within the granular gland secretions of the skin.","Gram-negative bacteria: Escherichia coli D31 (MIC=5 µg/ml), Klebsiella pneumoniae (MIC=10 µg/ml), Escherichia coli (MIC=50 µg/ml), Pseudomonas putida (MIC=10 µg/ml), Citrobacter freundii (MIC=30 µg/ml), Enterobacter cloacae (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=100 µg/ml), Serratia marcescens (MIC=100 µg/ml), Proteus mirabilis (MIC>100 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (MIC=10 µg/ml), Staphylococcus aureus (MIC=50 µg/ml), Streptococcus fecalis (MIC>100 µg/ml).##Protozoa: Paramecium caudatum (MIC=10 µg/ml).##Yeast: Candida albicans (MIC=80 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,3299384##9090128##PubMed ID is not available,Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449-5453.##J Biomol NMR. 1997 Feb;9(2):127-135.##To be Published.,"Zasloff M.##Gesell J, Zasloff M, Opella SJ.##Vermeer LS, Kozlowska J, Lorenz CD, Mason JA.","Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.##Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution.##All Atom Simulations of the Initial Binding of Magainin and Pleurocidin to Membranes Comprising a Mixture of Anionic and Zwitterionic",23,21-24
DRAMP02272,GMASKAGAIAGKIAKVALKAL,21,"PGLa (chain of PYLa/PGLa A; Frogs, amphibians, animals)","Q99134, B7ZSG6, Q91826",Belongs to the gastrin/cholecystokinin family (Magainin subfamily),pgla-a AND pgla-b,Xenopus laevis (African clawed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: PGLa display a broad-spectrum of antibacterial activity against a range of Gram-positive and Gram-negative bacteria. PGLa also displays antifungal activity against C. albicans ATCC 14053.
Tissue specificity: Expressed by the skin glands. Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. Stored as active, processed peptides in large granules within the granular gland secretions of the skin.
PTM: Leucine amide at position 21.","Gram-negative bacteria: Escherichia coli 25922 (MIC=62-125 µg/ml), Klebsiella pneumoniae 13883 (MIC=250-500 µg/ml), Pseudomonas aeruginosa 27853 (MIC=250-500 µg/ml);##Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=125-500 µg/ml), Strepococcus faecalis (MIC>500 µg/ml).##Yeast: Candida albicans 14053 (MIC=250-500 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,3606567##1717472,Biochem J. 1987 Apr 1;243(1):113-120.##J Biol Chem. 1991 Oct 15;266(29):19851-19857.,"Giovannini MG, Poulter L, Gibson BW, Williams DH.##Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.",Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones.##Antimicrobial peptides in the stomach of Xenopus laevis.,21,18-21
DRAMP02274,SAPRGCWTKSYPPKPCK,17,"Ranacyclin-E (Frogs, amphibians, animals)",P83663,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antibacterial activity. The mature peptide inserts into the hydrophobic core of the bacterial cell membrane and increases permeability without disrupting membrane integrity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores. Has hemolytic activity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores.
Tissue specificity: Expressed by the skin granular glands.","[Ref.14636071]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3 µM), Staphylococcus lentus (MIC=7 µM), Micrococcus luteus (MIC=5 µM);##Gram-negative bacteria: Yersinia pseudotuberculosis YP III (MIC=9 µM), Pseudomonas syringae pv tabaci (MIC=80 µM);##Fungi: Candida tropicalis (MIC=7.4 µM), C. guillermondii (MIC=3.4 µM), Phytophthora nicotianae spores (MIC=32 µM).",[Ref.14636071] It has 55% hemolytic activity at 100 μM against human erythrocytes,Cyclic,Free,Amidation,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Cell membrane,14636071,Biochemistry. 2003 Dec 2;42(47):14023-14035.,"Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M.","Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.",17,15-18
DRAMP02275,GALRGCWTKSYPPKPCK,17,"Ranacyclin-T (Frogs, amphibians, animals)",P83719,Belongs to the frog skin active peptide family (Brevinin subfamily),RNCT,Rana temporaria (European common frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,MOA: The mature peptide inserts into the hydrophobic core of the bacterial cell membrane and increases permeability without disrupting membrane integrity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores. Has hemolytic activity.,"[Ref.14636071]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3 µM), Staphylococcus lentus (MIC=10 µM), Micrococcus luteus (MIC=8 µM);##Gram-negative bacteria: Escherichia coli D21 (MIC=30 µM), Yersinia pseudotuberculosis YP III (MIC=5 µM), Pseudomonas syringae pv tabaci (MIC=16 µM);##Fungi: Candida albicans ATCC 10231 (MIC=22 µM), Candida tropicalis (MIC=14 µM), C. guillermondii (MIC=1 µM), Phytophthora nicotianae spores (MIC=16 µM).",[Ref.14636071] It has 20% hemolytic activity at 100 μM against human erythrocytes,Cyclic,Free,Amidation,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Cell membrane,14636071,Biochemistry. 2003 Dec 2;42(47):14023-14035.,"Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M.","Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.",17,15-18
DRAMP02276,AALKGCWTKSIPPKPCSGKR,20,"Ranacyclin B3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana grahami (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=11.7 µM).##Yeast: Candida albicans (MIC=23.4 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,20,18-21
DRAMP02277,AALRGCWTKSIPPKPCSGKR,20,"Ranacyclin B5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana grahami (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=5.8 µM).##Yeast: Candida albicans (MIC=23.1 µM),No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,20,18-21
DRAMP02278,AALRGCWTKSIPPKPCPGKR,20,"Ranacyclin-B-RL1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana livida (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus (MIC=5.8 µM), Bacillus subtilis (MIC=46.2 µM);##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,20,18-21
DRAMP02279,SALVGCWTKSYPPKPCFGR,19,"Ranacyclin-B-RN1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana nigrovittata (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,19,18-21
DRAMP02280,SALVGCGTKSYPPKPCFGR,19,"Ranacyclin-B-RN2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana nigrovittata (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=12.7 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,19,18-21
DRAMP02281,SALVGCWTKSYPPNPCFGRG,20,"Ranacyclin-B-RN6 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana nigrovittata (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=11.7 µM).##Yeast: Candida albicans (MIC=46.7 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,20,18-21
DRAMP02282,SALVGCWTKSWPPKPCFGRG,20,"Ranacyclin-B-LK1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana nigrovittata (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=23 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,20,18-21
DRAMP02283,SALVGCWTKSWPPKPCFGR,19,"Ranacyclin-B-LK2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana nigrovittata (Ranidae frogs),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=11.8 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys16.,L,No cytotoxicity information found,Not found,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,19,18-21
DRAMP02288,FIGPVLKIAAGILPTAICKIFKKC,24,"Gaegurin-RN1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has hemolytic activity against rabbit red cells..,"[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=2.34 µg/ml), Staphylococcus aureus ATCC43300 (MIC=9.38 µg/ml), Bacillus subtilis (MIC=4.69 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=18.75 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=4.69 µg/ml)",[Ref.19778602] It has 46.13 ± 1.49% hemolytic activity at 100 μg/ml against rabbit red blood cells,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71.,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",24,21-24
DRAMP02289,FVGPVLKIAAGILPTAICKIYKKC,24,"Gaegurin-RN4 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata ,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Not found,Not found,Not found,,Function: Has hemolytic activity against rabbit red cells.,"[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=1.17 µg/ml), Staphylococcus aureus ATCC43300 (MIC=9.38 µg/ml), Bacillus subtilis (MIC=2.34 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=2.34 µg/ml).",[Ref.19778602] It has 18.64 ± 0.25% hemolytic activity at 100 μg/ml against rabbit red blood cells,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71.,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",24,21-24
DRAMP02290,FLGPIIKIATGILPTAICKFLKKC,24,"Gaegurin-RN5 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Has hemolytic activity against rabbit red cells.,"[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=3.75 µg/ml), Staphylococcus aureus ATCC43300 (MIC=62.50 µg/ml), Bacillus subtilis (MIC=4.69 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=37.50 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=4.69 µg/ml).",[Ref.19778602] It has no detectable hemolysis at the concentration up to 100 μg/ml,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,19778602,Genomics. 2010 Jan;95(1):66-71.,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",24,21-24
DRAMP02295,FLGALFKVASKVLPSVFCAITKKC,24,"Gaegurin-5 (Gaegurin 5; GGN5; Brevinin-1EMa; Frogs, amphibians, animals)","P80399, Q91329",Belongs to the frog skin active peptide family (Brevinin subfamily),GGN5,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal",Protein level,Not found,Not found,,"Function: Has low hemolytic activity. Has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, fungi and protozoa. PTM: Problely contains one disulfide bond 18-24.","[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Staphylococcus epidermidis (MIC=10 µg/ml), Bacillus subtilis (MIC=10 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=50 µg/ml), Shigella dysentariae (MIC=50 µg/ml), Pseudomonas putida (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=100 µg/ml), Eshchericia coli (MIC=50 µg/ml);##Fungi: Saccharomyces cerevisiae (MIC=50 µg/ml), Candida albicans (MIC=50 µg/ml), Salmonella typhimurium (MIC=200 µg/ml), Proteus mirabilis (MIC>200 µg/ml).","[Ref.7999137] It has 0.19% hemolytic activity at 0.1 μg/ml, 0.31% hemolytic activity at 1 μg/ml, 0.78% hemolytic activity at 10 μg/ml, 1.01% hemolytic activity at 100 μg/ml against human red blood cells",Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,7999137,Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.,"Park JM, Jung JE, Lee BJ.","Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",24,21-24
DRAMP02296,FLPLLAGLAANFLPTIICKISYKC,24,"Gaegurin-6 (Gaegurin 6; GGN6; Frogs, amphibians, animals)",P80400,Belongs to the frog skin active peptide family (Brevinin subfamily),GGN6,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has low hemolytic activity. Has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, fungi and protozoa. PTM: Problely contains one disulfide bond 18-24.","[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Staphylococcus epidermidis (MIC=10 µg/ml), Bacillus subtilis (MIC=10 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=50 µg/ml), Shigella dysentariae (MIC=50 µg/ml), Pseudomonas putida (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=100 µg/ml), Eshchericia coli (MIC=50 µg/ml);##Fungi: Saccharomyces cerevisiae (MIC=50 µg/ml), Candida albicans (MIC=50 µg/ml), Salmonella typhimurium (MIC=200 µg/ml), Proteus mirabilis (MIC>200 µg/ml), Serratia marcescens (MIC>200 µg/ml).","[Ref.7999137] It has 0.39% hemolytic activity at 0.1 μg/ml, 0.62% hemolytic activity at 1 μg/ml, 0.78% hemolytic activity at 10 μg/ml, 0.86% hemolytic activity at 100 μg/ml against human red blood cells",Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,7999137,Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.,"Park JM, Jung JE, Lee BJ.","Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",24,21-24
DRAMP02306,IIEKLVNTALGLLSGL,16,"Riparin-2.1 (Frogs, amphibians, animals)",P86127,Not found,Not found,Crinia riparia (Streambank froglet) (Flinders Ranges froglet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Has antibacterial activity. Lacks antibacterial activity against the Gram-negative bacteria E. cloacae and E. coli, and against the Gram-positive bacteria B. cereus, E. faecalis, L. innocua, M. luteus, S. aureus, S. epidermidis and S. uberis. Does not inhibit the formation of NO by neuronal nitric oxide synthase. 
Tissue specificity: Expressed by the skin glands.",Gram-positive bacterium: Lactococcus lactis (MIC=25 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16470724,Rapid Commun Mass Spectrom. 2006;20(5):797-803.,"Maselli VM, Bilusich D, Bowie JH, Tyler MJ.",Host-defence skin peptides of the Australian streambank froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.,16,15-18
DRAMP02307,GLADFLNKAVGKVVDFVKS,19,"Deserticolin-1 (Frogs, amphibians, animals)",P86136,Not found,Not found,Crinia deserticola (Desert froglet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Has antibacterial activity against the Gram-positive bacteria. Inhibits the formation of NO by neuronal nitric oxide synthase with an IC50 of 2.4 µM.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=25 µM), Streptococcus uberis (MIC=50 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18601958,Regul Pept. 2008 Nov 29;151(1-3):80-87.,"Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.","Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.",19,18-21
DRAMP02308,IIGHLIKTALGMLGL,15,"Signiferin-2.1 (Frogs, amphibians, animals)",P86131,Not found,Not found,Crinia signifera (Common eastern froglet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Has antibacterial activity against a wide spectrum of Gram-positive bacteria. Lacks antibacterial activity against the Gram-negative bacteria E. cloacae and E. coli. Inhibits the formation of NO by neuronal nitric oxide synthase with an IC50 of 12.4 µM.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Bacillus cereus (MIC=25 µM), Enterococcus faecalis ATCC 29212 (MIC=100 µM), Leuconostoc lactis (MIC=12 µM), Listeria innocua (MIC=50 µM), Micrococcus luteus ATCC 9341 (MIC=25 µM), Staphylococcus aureus ATCC 29213 (MIC=12 µM), Staphylococcus epidermidis ATCC14990 (MIC=25 µM), Streptococcus uberis (MIC=25 µM). ",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15317042##16470724##18601958,Rapid Commun Mass Spectrom. 2004;18(18):2155-2161.##Rapid Commun Mass Spectrom. 2006;20(5):797-803.##Regul Pept. 2008 Nov 29;151(1-3):80-87.,"Maselli VM, Brinkworth CS, Bowie JH, Tyler MJ.##Maselli VM, Bilusich D, Bowie JH, Tyler MJ.##Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.","Host-defence skin peptides of the Australian Common Froglet Crinia signifera: sequence determination using positive and negative ion electrospray mass spectra.##Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.##Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.",15,12-15
DRAMP02314,RCRFCCRCCPRMRGCGICCRF,21,"Hepcidin (fish, chordates, animals)",A1Z0M0,Belongs to the hepcidin family,hamp,Larimichthys crocea (Croceine croaker) (Pseudosciaena crocea),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages.
Tissue specificity: Expressed in all tissues tested, with highest levels of expression in kidney and lowest levels in liver. Intra-peritoneal injection of lipopolysaccharide results in increased expression in heart, spleen and stomach, but not in kidney or liver.
PTM: Contains four disulfide bonds 2-19; 5-8; 6-15; 9-18.","Gram-negative bacteria: Vibrio alginolyticus(MIC=24 µM), V. fluvialis, V. harveyis (MIC=12 µM) and Vibrio parahaemolyticus (MIC=6 µM), Aeromonas hydrophila (MIC=6 µM), Escherichia coli (MIC=24 µM), Escherichia coli BL21(DE3)plysS (MIC=6 µM);##Gram-positive bacteria: Bacillus cereus (MIC=24 µM), Bacillus subtilis (MIC=6 µM), C. glutamicum (MIC=3 µM), Micrococcus luteus (MIC=3 µM), M. lysodeikticus, Staphylococcus aureus (MIC=6 µM) and S.epidermis (MIC=12 µM).##Fungi: Aspergillus niger (MIC=24 µM), F;##Graminearum (MIC=24 µM) and Fusarium solani (MIC=24 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,"Disulfide bonds between Cys2 and Cys19; Cys5 and Cys8; Cys6 and Cys15,Cys9 and Cys18.",L,No cytotoxicity information found,Not found,19150638##19344770,Peptides. 2009 Apr;30(4):638-646.##Fish Shellfish Immunol. 2009 Jun;26(6):864-870.,"Wang KJ, Cai JJ, Cai L, Qu HD, Yang M, Zhang M.##Zhang J, Yan Q, Ji R, Zou W, Guo G.","Cloning and expression of a hepcidin gene from a marine fish (Pseudosciaena crocea) and the antimicrobial activity of its synthetic peptide.##Isolation and characterization of a hepcidin peptide from the head kidney of large yellow croaker, Pseudosciaena crocea.",21,18-21
DRAMP02315,FFGWLIKGAIHAGKAIHGLIHRRRH,25,"Chrysophsin-1 (fish, chordates, animals)",P83545,Belongs to the pleurocidin family,Not found,Chrysophrys major (Red sea bream) ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix ,Not found,,Function: Shows hemolytic activity human red blood cells.,"[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 µM), Lactococcus garvieae ATCC 49156 (MIC=10 µM), S.iniae F-8502 (MIC=2.5 µM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 µM), Vibrio anguillarum ATCC 19264 (MIC=2.5 µM), Vibriopenaeicida KHA (MIC=10 µM), V. harveyi ATCC 14126 (MIC=2.5 µM), V. vulnificus ATCC 33148 (MIC=5 µM), Aeromonas salmonicida NCMB 1102 (MIC=10 µM), Pseudomonas putida ATCC 12633 (MIC=40 µM).","[Ref.12581207]10% hemolytic activity at 0.25 μM, 80% hemolytic activity at 1 μM against human erythrocytes",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,12581207,Eur J Biochem. 2003 Feb;270(4):675-686.,"Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.","Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.",25,24-27
DRAMP02316,FFGWLIRGAIHAGKAIHGLIHRRRH,25,"Chrysophsin-2 (fish, chordates, animals)",P83546,Belongs to the pleurocidin family,Not found,Chrysophrys major (Red sea bream) ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix ,Not found,,Function: Shows hemolytic activity human red blood cells.,"[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 µM), Lactococcus garvieae ATCC 49156 (MIC=5 µM), S.iniae F-8502 (MIC=1.5 µM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 µM), Vibrio anguillarum ATCC 19264 (MIC=1.25 µM), Vibriopenaeicida KHA (MIC=5 µM), V. harveyi ATCC 14126 (MIC=5 µM), V. vulnificus ATCC 33148 (MIC=2.5 µM).","[Ref.12581207]10% hemolytic activity at 0.25 μM, 70% hemolytic activity at 1 μM against human erythrocytes",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,12581207,Eur J Biochem. 2003 Feb;270(4):675-686.,"Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.","Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.",25,24-27
DRAMP02317,FIGLLISAGKAIHDLIRRRH,20,"Chrysophsin-3 (fish, chordates, animals)",P83547,Belongs to the pleurocidin family,Not found,Chrysophrys major (Red sea bream) ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix ,Not found,,Function: Shows hemolytic activity human red blood cells.,"[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 µM), Lactococcus garvieae ATCC 49156 (MIC=10 µM), S.iniae F-8502 (MIC=10 µM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 µM), Vibrio anguillarum ATCC 19264 (MIC=10 µM), Vibriopenaeicida KHA (MIC=10 µM), V. harveyi ATCC 14126 (MIC=5 µM), V. vulnificus ATCC 33148 (MIC=10 µM), Aeromonas salmonicida NCMB 1102 (MIC=10 µM), Pseudomonas putida ATCC 12633 (MIC=40 µM).","[Ref.12581207]0% hemolytic activity at 0.25 μM, 10% hemolytic activity at 1 μM against human erythrocytes.",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,12581207,Eur J Biochem. 2003 Feb;270(4):675-686.,"Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.","Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.",20,18-21
DRAMP02321,NWRKILGQIASVGAGLLGSLLAGYE,25,"Grammistin Pp3 (Group III grammistin; fish, chordates, animals)",P69847,Belongs to the grammistin family (Group 3 subfamily),Not found,Pogonoperca punctata (Clown grouper) (Bearded grouper),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function:  Has hemolytic activity. Thanks to its abundant amphiphilic alpha-helices, it may integrate into membrane phospholipids, leading to lysis of the membrane.","[Ref.Fish. Sci. 2001 Oct;67:928-933.]Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=50 µg/ml), Staphylococcus aureus IAM 1011 (MIC=50 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 µg/ml), Escherichia coli JCM 1649 (MIC>50 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=25 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=12.5 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=50 µg/ml), Vibrio parahaemolyticus (MIC=50 µg/ml).",[Ref.Fish. Sci. 2001 Oct;67:928-933.]75 HU/mg hemolytic activity against horse erythrocytes(1 HU was defined as the amount of peptide causing 50% hemolysis),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Fish. Sci. 2001 Oct;67:928-933.,"Yokota H, Nagashima Y, Shiomi K.",Interaction of grammistins with lipids and their antibacterial activity.,25,24-27
DRAMP02330,FFHHIFRGIVHVGKTIHRLVTG,22,"Piscidin-1 (Pis-1; Piscidin 1; fish, chordates, animals)",Q8UUG0,Belongs to the pleurocidin family,Not found,Morone saxatilis (Striped bass),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,"2JOS, 2OJM resolved by NMR.",Function: Exhibits broad spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria. Also has hemolytic activity. Seems to disrupt the membranes by adopting an alpha helical conformation and forming toroidal pores.,"[Ref.11713517]Gram-positive bacteria: Enterococcus faecalis VRE (MIC=5-10 µM), E. faecalis (MIC=2.5-5 µM), Listeria monocytogenes (MIC=2.5-5 µM), Micrococcus luteus (MIC=10-20 µM), Staphylococcus aureus MRSA (MIC=1.25-2.5 µM), S. epidermitis (MIC=5-10 µM), S. saprophiticus (MIC=5-10 µM), Staphylococcus xylosus (MIC>20 µM), S. agalactiae (MIC=1.25-2.5 µM), S. bovis (MIC=1.25-2.5 µM), S. equisimilis (MIC=2.5-5 µM), S. mitis (MIC=1.25-2.5 µM), S. Pneumonae (MIC=1.25-2.5 µM), S. pyrogenes (MIC=1.25-2.5 µM), Streptococcus iniae KST740 ak (MIC=1.25-2.5 µM), S. iniae KSTSi 6P (MIC=1.25-2.5 µM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>20 µM), Burkholderia cepacia (MIC>20 µM), Vibrio Cholera (MIC=2.5-5 µM), Escherichia coli (MIC=5-10 µM), Enterobacter cloacae (MIC=10-20 µM), E. Aerogenes (MIC=10-20 µM), Klebsiella pneumoniae (MIC=2.5-5 µM), K. oxytoca (MIC=5-10 µM), Salmonella choleraesuis (MIC=10-20 µM), S. typhimurium (MIC=10-20 µM), S. arizonae (MIC=10-20 µM), Serratia marcescens (MIC>20 µM), Shigella flexneri (MIC=2.5-5 µM), S. sonnei (MIC=5-10 µM), Yersinia enterocolitica (MIC=2.5-5 µM); Fungi: Neurospora crassa (MIC=1.56-3.12 µM), A. fumigatus (MIC=50-100 µM), F. axysporum (MIC=0.78-1.56 µM), F. culmorum (MIC=0.39-0.78 µM), C. ablicans (MIC=10-20 µM), C. glabrata (MIC=10-20 µM), C. lusitania (MIC=10-20 µM), C. tropacalis (MIC=10-20 µM).","[Ref.11713517]10% hemolytic activity at 5 μg/mL, 60% hemolytic activity at 10 μg/mL, 100% hemolytic activity at 50 μg/mL against human erythrocytes ",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11713517,Nature. 2001 Nov 15;414(6861):268-269.,"Silphaduang U, Noga EJ.",Peptide antibiotics in mast cells of fish.,22,21-24
DRAMP02331,FFHHIFRGIVHVGKTIHKLVTG,22,"Piscidin-2 (Pis-2; fish, chordates, animals)",Q8UUG2,Belongs to the pleurocidin family,Not found,Morone chrysops (White bass),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Exhibits broad spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria as well as against a variety of fungi. Seems to disrupt the membranes by adopting an alpha helical conformation.
Tissue specificity: Expressed in gill, skin, intestine, spleen, anterior kidney, and blood cells.","Gram-positive bacteria: Enterococcus faecalis (MIC=5-10 µM), E. faecalis (MIC=2.5-5 µM), Listeria monocytogenes (MIC=2.5-5 µM), Micrococcus luteus (MIC=10-20 µM), Staphylococcus aureus (MIC=1.25-2.5 µM), S. epidermidis (MIC=5-10 µM), S. saprophiticus (MIC=5-10 µM), S. xylosus (MIC>20 µM), Streptococcus agalactiae (MIC=1.25-2.5 µM), S. bovis (MIC=1.25-2.5 µM), S. equisimilis (MIC=2.5-5 µM), S. mitis (MIC=1.25-2.5 µM), Streptococcus pneumoniae (MIC=1.25-2.5 µM), Streptococcus pyogenes (MIC=1.25-2.5 µM), S. iniae KST740ak (MIC=1.25-2.5 µM), S. iniae KSTSi 6P (MIC=1.25-2.5 µM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>20 µM), Burkholderia cepacia (MIC>20 µM), Vibrio cholera (MIC=2.5-5 µM), Escherichia coli (MIC=5-10 µM), Moraxella catarrhalis (MIC=2.5-5 µM), Neisseria gonorrhoeae (MIC>20 µM), Pseudomonas aeruginosa (MIC=5-10 µM), Enterobacter cloacae (MIC=10-20 µM), E. aerogenes (MIC=10-20 µM), Klebsiella pneumoniae (MIC=2.5-5 µM), K. oxytoca (MIC=5-10 µM), Salmonella choleraesuis (MIC=10-20 µM), Salmonella typhimurium (MIC=10-20 µM), S. arizonae (MIC=10-20 µM), Serratia marcescens (MIC>20 µM), Shigella flexneri (MIC=2.5-5 µM), S. sonnei (MIC=5-10 µM), Yersinia enterocolitica (MIC=2.5-5 µM).##Fungi: Neurospora crassa (MIC=1.56-3.12 µM), Aspergillus fumigatus (MIC=50-100 µM), Fusarium oxysporum (MIC=0.78-1.56 µM), F. culmorum (MIC=0.39-0.78 µM), Candida albicans (MIC=10-20 µM), C. glabrata (MIC=10-20 µM), C. lusitania (MIC=10-20 µM), C. tropicalis (MIC=10-20 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11739390,J Biol Chem. 2002 Feb 15;277(7):5030-5039.,"Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.","Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.",22,21-24
DRAMP02347,GKGRWLERIGKAGGIIIGGALDHL,24,"NRC-1 (fish, chordates, animals)",No entry found,Not found,Not found,Pseudopleuronectes americanus (Winter flounder 1),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"C-terminal NH2, this NRC seris of peptides was identified by gene analysis and biological activity verified using synthetic peptides. ","Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=64 µg/ml), Aeromonas salmonicida 97-4 (MIC=64 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 µg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=32 µg/ml), Escherichia coli CGSC 4908 (MIC=32 µg/ml), Escherichia coli UB1005 (MIC=32 µg/ml), Escherichia coli DC2 (MIC=32 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 µg/ml).##Yeast: Candida albicans C627 (MIC=64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,24,21-24
DRAMP02348,WLRRIGKGVKIIGGAALDHL,20,"NRC-2 (fish, chordates, animals)",No entry found,Not found,Not found,Pseudopleuronectes americanus (Winter flounder 1a),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>128 µg/ml), Aeromonas salmonicida 97-4 (MIC=128 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=64 µg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC=64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=32 µg/ml), Escherichia coli CGSC 4908 (MIC=64 µg/ml), E. coli UB1005 (MIC=64 µg/ml), E. coli DC2 (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,20,18-21
DRAMP02350,GWGSFFKKAAHVGKHVGKAALTHYL,25,"Pleurocidin (NRC-4; fish, chordates, animals)","P81941, P81619, Q9PRJ9, Q90ZY0, Q90VW6",Belongs to the pleurocidin family,ple1 AND ple2,Pseudopleuronectes americanus (Winter flounder 2-2.1),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix (1 helices; 19 residues),"From NMR structural studies with the uniformly (15)N-labeled peptide, a structure of pleurocidin is determined to be in a random coil conformation in aqueous solution whereas it assumes an alpha-helical structure in TFE and in dodecylphosphocholine (DPC) micelles.(Ref.2)",1Z64 resolved by NMR.,May play a role in innate host defense.,"Gram-negative bacteria: Escherichia coli (MIC=2.2-3.3 µM), Leucothrix mucor (MIC>35.0 µM), Serratia marcescens (MIC>35.0 µM), Pseudomonas aeruginosa (MIC>35.0 µM), Aeromonas salmonicida (MIC=17.7-35.0 µM), Cytophaga aquatilis (MIC=2.2-4.4 µM), Pasteurella haemolytica (MIC=4.4-8.8 µM), Salmonella typhimurium I (MIC=8.8-17.7 µM), Salmonella typhimurium II (MIC=8.8-17.7 µM);##Gram-positive bacteria: Bacillus subtilis (MIC=1.1-2.2 µM), Staphylococcus aureus (MIC=17.7-35.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9115266,J Biol Chem. 1997 May 2;272(18):12008-12013.,"Cole A.M, Weis P, Diamond G.","Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder.",25,24-27
DRAMP02351,FFRLLFHGVHHVGKIKPRA,19,"NRC-10 (fish, chordates, animals)",No entry found,Not found,Not found,Pseudopleuronectes americanus (Winter flounder Z),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 µg/ml), Aeromonas salmonicida 97-4 (MIC=32 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 µg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC=32 µg/ml), Pseudomonas aeruginosa Z61 (MIC=8 µg/ml), Escherichia coli CGSC 4908 (MIC=32 µg/ml), Escherichia coli UB1005 (MIC=32 µg/ml), Escherichia coli DC2 (MIC=32 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 µg/ml), Staphylococcus aureus C623 (MRSA) (MIC=64 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,19,18-21
DRAMP02352,GWKKWLRKGAKHLGQAAIK,19,"NRC-16 (fish, chordates, animals)",No entry found,Not found,Not found,Glyptocephalus cynoglossus (Witch flounder GC3.8-t),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 µg/ml), A. salmonicida 97-4 (MIC=1 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=0.5 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=16 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=1 µg/ml), Escherichia coli CGSC 4908 (MIC=1 µg/ml), E. coli UB1005 (MIC=2 µg/ml), E. coli DC2 (MIC=0.5 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=16 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 µg/ml).##Yeast: Candida albicans C627 (MIC=8 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,19,18-21
DRAMP02354,FFRLLFHGVHHGGGYLNAA,19,"Pleurocidin-like peptide WFY (fish, chordates, animals)",No entry found,Not found,Not found,Pseudopleuronectes americanus (Winter flounder) (Pleuronectes americanus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida A449 field isolate (MIC>64 µg/ml), A. salmonicida 97-4 field isolate (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=64 µg/ml), Escherichia coli CGSC4908 triple (MIC=64 µg/ml), Salmonella typhimurium 14028s (MIC>64 µg/ml), Salmonella typhimurium MS7953s (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (human clinical isolates) (MIC>64 µg/ml), Staphylococcus aureus (MRSA) (MIC>64 µg/ml).##Fungi: Candida albica (MIC>64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12950255,Eur J Biochem. 2003 Sep;270(18):3720-3730.,"Douglas SE, Patrzykat A, Pytyck J, Gallant JW.","Identification, structure and differential expression of novel pleurocidins clustered on the genome of the winter flounder, Pseudopleuronectes americanus (Walbaum).",19,18-21
DRAMP02357,FLGALIKGAIHGGRFIHGMIQNHH,24,"Pleurocidin-like peptide WF3 (NRC-5; fish, chordates, animals)",Q90VW7,Belongs to the pleurocidin family,ple3,Pseudopleuronectes americanus (Winter flounder 3),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 µg/ml), A. salmonicida 97-4 (MIC>64 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=64 µg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=32 µg/ml), Escherichia coli CGSC 4908 (MIC=64 µg/ml), Escherichia coli UB1005 (MIC=64 µg/ml), Escherichia coli DC2 (MIC>64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506##11113283,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.##Dev Comp Immunol. 2001 Mar;25(2):137-147.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.##Douglas SE, Gallant JW, Gong Z, Hew C.","Novel antimicrobial peptides derived from flatfish genes.##Cloning and developmental expression of a family of pleurocidin-like antimicrobial peptides from winter flounder, Pleuronectes americanus (Walbaum).",24,21-24
DRAMP02358,GWGSIFKHGRHAAKHIGHAAVNHYL,25,"Pleurocidin-like peptide WF4 (NRC-6; fish, chordates, animals)","Q90ZX8, Q90ZX9",Belongs to the pleurocidin family,ple4,Pseudopleuronectes americanus (Winter flounder 4-1.1),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,6RZC,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 µg/ml), A. salmonicida 97-4 (MIC=4 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=4 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=64 µg/ml), Pseudomonas aeruginosa K799 (MIC=16 µg/ml), Pseudomonas aeruginosa Z61 (MIC=4 µg/ml), Escherichia coli CGSC 4908 (MIC=4 µg/ml), E. coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=2 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 µg/ml).##Yeast: Candida albicans C627 (MIC=32 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506##11113283,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.##Dev Comp Immunol. 2001 Mar;25(2):137-147.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.##Douglas SE, Gallant JW, Gong Z, Hew C.","Novel antimicrobial peptides derived from flatfish genes.##Cloning and developmental expression of a family of pleurocidin-like antimicrobial peptides from winter flounder, Pleuronectes americanus (Walbaum).",25,24-27
DRAMP02359,RWGKWFKKATHVGKHVGKAALTAYL,25,"Pleurocidin-like peptide YT2 (NRC-7; fish, chordates, animals; Predicted)",Q7SZH1,Not found,ple,Limanda ferruginea (Yellowtail flounder YT2),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 µg/ml), A. salmonicida 97-4 (MIC=2 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=2 µg/ml), Escherichia coli CGSC 4908 (MIC=4 µg/ml), E. coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=4 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=64 µg/ml).##Yeast: Candida albicans C627 (MIC=16 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,25,24-27
DRAMP02362,GWRTLLKKAEVKTVGKLALKHYL,23,"Pleurocidin-like peptide AP3 (NRC-13; fish, chordates, animals; Predicted)",Q7SZH2,Not found,ple,Hippoglossoides platessoides (American plaice AP3),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 µg/ml), A. salmonicida 97-4 (MIC=2 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=1 µg/ml), Escherichia coli CGSC 4908 (MIC=2 µg/ml), E. coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=2 µg/ml).##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=4 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=4 µg/ml).##Yeast: Candida albicans C627 (MIC=4 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,23,21-24
DRAMP02364,GFWGKLFKLGLHGIGLLHLHL,21,"Pleurocidin-like peptide GcSc4B7 (NRC-15; fish, chordates, animals; Predicted)",Q7SZG9,Not found,ple,Glyptocephalus cynoglossus (Witch flounder GcSc4B7),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=8 µg/ml), A. salmonicida 97-4 (MIC=16 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=4 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=16 µg/ml), Pseudomonas aeruginosa K799 (MIC=8 µg/ml), Pseudomonas aeruginosa Z61 (MIC=4 µg/ml), Escherichia coli CGSC 4908 (MIC=8 µg/ml), E. coli UB1005 (MIC=8 µg/ml), E. coli DC2 (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=4 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=4 µg/ml).##Yeast: Candida albicans C627 (MIC=16 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,21,18-21
DRAMP02365,GWKKWLRKGAKHLGQAAIKGLAS,23,"Pleurocidin-like peptide GC3.8 (NRC-17; fish, chordates, animals; Predicted)",Q7SZG8,Not found,ple,Glyptocephalus cynoglossus (Witch flounder GC3.8),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 µg/ml), A. salmonicida 97-4 (MIC=1 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=1 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=2 µg/ml), Escherichia coli CGSC 4908 (MIC=1 µg/ml), E. coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=1 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=16 µg/ml).##Yeast: Candida albicans C627 (MIC=8 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,23,21-24
DRAMP02366,GWKKWFTKGERLSQRHFA,18,"Pleurocidin-like peptide GC3.2 (NRC-18; fish, chordates, animals; Predicted)",Q7SZG7,Not found,ple,Glyptocephalus cynoglossus (Witch flounder GC3.2),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 µg/ml), A. salmonicida 97-4 (MIC=128 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=32 µg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=64 µg/ml), Escherichia coli CGSC 4908 (MIC=64 µg/ml), E. coli UB1005 (MIC=64 µg/ml), E. coli DC2 (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,18,15-18
DRAMP02367,FLGLLFHGVHHVGKWIHGLIHGHH,24,"Pleurocidin-like peptide Hb26 (NRC-19; fish, chordates, animals; Predicted)",Q7SZG6,Not found,ple,Hippoglossus hippoglossus (Halibut Hb26),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=64 µg/ml), A. salmonicida 97-4 (MIC>64 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=64 µg/ml), Pseudomonas aeruginosa K799 (MIC=32 µg/ml), Pseudomonas aeruginosa Z61 (MIC=8 µg/ml), Escherichia coli CGSC 4908 (MIC=32 µg/ml), E. coli UB1005 (MIC=16 µg/ml), E. coli DC2 (MIC=32 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=8 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=8 µg/ml).##Yeast: Candida albicans C627 (MIC=64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,24,21-24
DRAMP02374,GCRFCCNCCPNMSGCGVCCRF,21,"Bass hepcidin (fish, chordates, animals)",P82951,Belongs to the hepcidin family,hamp,Morone chrysops x Morone saxatilis (white bass x striped sea-bass),"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Protein level,Beta strand (2 strands; 6 residues),"Solution structure by NMR indicates that bass hepcidin is very similar to that of human hepcidin, including the presence of an antiparallel beta-sheet, a conserved disulfide-bonding pattern, and a rare vicinal disulfide bond.",1S6W resolved by NMR.,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages (By similarity). Synthetic bass hepcidin is active in vitro against Gram-negative pathogens and fungi but showes no activity against key Gram-positive pathogens and a single yeast strain tested.
Tissue specificity: Predominantly expressed in liver.
Induction: By bacterial challenge.
PTM: Contains four disulfide bonds 2-19; 5-8; 6-15; 9-18.","Gram-negative bacteria: Escherichia coli ATCC 25,922,351,50 (MIC=22 µM), Escherichia coli ATCC D31K (MIC=11 µM), Klebsiella pneumoniae ATCC 10,031 (MIC=22 µM), P. shigelloides ATCC KST (MIC=11 µM), S. flexneri ATCC 12,022 (MIC=22 µM), Shigella sonnei ATCC 9290 (MIC=44 µM), Y. enterocolitica ATCC 23,715 (MIC=22 µM).##Fungi: Aspergillus niger (MIC=44 µM).",[Ref.15546886] It displays essentially no hemolytic activity toward HSB erythrocytes,Cyclic,Free,Free,"Disulfide bonds between Cys2 and Cys19; Cys5 and Cys8; Cys6 and Cys15,Cys9 and Cys18.",L,No cytotoxicity information found,Not found,11985602##15546886,Eur J Biochem. 2002 Apr;269(8):2232-2237.##J Biol Chem. 2005 Mar 11;280(10):9272-9282.,"Shike H, Lauth X, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Shimizu C, Bulet P, Burns JC.##Lauth X, Babon JJ, Stannard JA, Singh S, Nizet V, Carlberg JM, Ostland VE, Pennington MW, Norton RS, Westerman ME.","Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge.##Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections.",21,18-21
DRAMP02376,LFGFLIKLIPSLFGALSNIGRNRNQ,25,"Grammistin Gs 1 (Grammistin Gs F; Group I grammistin; soapfish, chordates, animals)",P69835,Belongs to the grammistin family (Group 1 subfamily),Not found,Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=25 µg/ml), Staphylococcus aureus IAM 1011 (MIC=6.25 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 µg/ml), Escherichia coli JCM 1649 (MIC=50 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=12.5 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=12.5 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=50 µg/ml), Vibrio parahaemolyticus (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Fish. Sci. 2001 Oct;67:928-933.,"Yokota H, Nagashima Y, Shiomi K.",Interaction of grammistins with lipids and their antibacterial activity.,25,24-27
DRAMP02377,LFGFLIPLLPHIIGAIPQVIGAIR,24,"Grammistin Gs 2 (Grammistin Gs G; Group I grammistin; soapfish, chordates, animals)",P69836,Belongs to the grammistin family (Group 1 subfamily),Not found,Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=12.5 µg/ml), Staphylococcus aureus IAM 1011 (MIC=6.25 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 µg/ml), Escherichia coli JCM 1649 (MIC=50 µg/ml), Photobacterium damselae subsp. Piscicida Sp 9587 (MIC=6.25 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=6.25 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=25 µg/ml), Vibrio parahaemolyticus (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Fish. Sci. 2001 Oct;67:928-933.,"Yokota H, Nagashima Y, Shiomi K.",Interaction of grammistins with lipids and their antibacterial activity.,24,21-24
DRAMP02386,KGRGKQGGKVRAKAKTRSS,19,"Parasin I (histone-H2A-derived; catfishes, chordates, animals)",No entry found,Not found,Not found,Parasilurus asotus (Amur catfish),"Antimicrobial, Antibacterial",Not found,Alpha helix ,Not found,,Comment: No comments found on DRAMP database,"Aeromonas salmonicida (MIC=10 µg/ml), Cytophaga aquatilis (MIC=5 µg/ml), Yersinia rukeri (MIC=15 µg/ml), Edwardsiella ictaluri (MIC=10 µg/ml), Lactococcus garvieae (MIC=10 µg/ml). ",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,9824303,FEBS Lett 1998; 437: 258-262.,"Park IY, Park CB, Kim MS, Kim SC.","Parasin I, an antimicrobial peptide derived from histon H2A in the catfish, Parasilurus asotus.",19,18-21
DRAMP02402,FLPKMSTKLRVPYRRGTKDYH,21,Antimicrobial peptide scolopin-1,P0CH48,Not found,Not found,Scolopendra mutilans (Chinese red-headed centipede) (Scolopendrasubspinipes mutilans),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial peptide against both Gram-positive, Gram-positive and yeast. Also induces histamine release by mast cells and shows hemolytic activities against both human and rabbit red cells.
Tissue specificity: Expressed by the venom gland.","[Ref.19716842]Gram-negative bacteria: Escherichia coli standard strain (MIC=12.5 µg/ml), E. coli drug-resistant strain (MIC=15 µg/ml);##Gram-positive bacteria: Staphylococcus aureus standard strain (MIC=1.2 µg/ml), S. aureus drug-resistant strain (MIC=5.0 µg/ml), Bacillus dysenteriae standard and drug-resistant strains (MIC=7.5 µg/ml);##Yeast: Candida albicans (MIC=15 µg/ml).",[Ref.19716842]25 ± 2% hemolytic activity at 50 μg/ml against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19716842,Toxicon. 2010 Feb-Mar;55(2-3):274-279.,"Peng K, Kong Y, Zhai L, Wu X, Jia P, Liu J, Yu H.",Two novel antimicrobial peptides from centipede venoms.,21,18-21
DRAMP02403,GILKKFMLHRGTKVYKMRTLSKRSH,25,Antimicrobial peptide scolopin-2,P0CH49,Not found,Not found,Scolopendra mutilans (Chinese red-headed centipede) (Scolopendrasubspinipes mutilans),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial peptide against both Gram-positive, -negative and yeast. Also induces histamine release by mast cells and shows hemolytic activities against both human and rabbit red cells.
Tissue specificity: Expressed by the venom gland.","[Ref.19716842]Gram-negative bacteria: Escherichia coli standard and drug-resistant strains (MIC=5.0 µg/ml);##Gram-positive bacteria: Staphylococcus aureus standard strain (MIC=0.5 µg/ml), S. aureus drug-resistant strain (MIC=1.0 µg/ml), Bacillus dysenteriae standard strain (MIC=2.5 µg/ml), B. dysenteriae drug-resistant strain (MIC=5.0 µg/ml);##Yeast: Candida albicans (MIC=7.5 µg/ml).",[Ref.19716842]32 ± 7% hemolytic activity at 50 μg/ml against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19716842,Toxicon. 2010 Feb-Mar;55(2-3):274-279.,"Peng K, Kong Y, Zhai L, Wu X, Jia P, Liu J, Yu H.",Two novel antimicrobial peptides from centipede venoms.,25,24-27
DRAMP02422,NCIQQCVSKGAQGGYCTNEKCTCY,24,"Hlsal-defensin (H. longicornis salivary gland defensin; Ticks, Arthropods, animals)",A4GUC4,Not found,Not found,Haemaphysalis longicornis (Bush tick),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Predicted,Not found,Not found,,"Function: Both Hlgut-defensin and Hlsal-defensin sequences have antibactrrial activity against a variety of Gram-positive and Gram-negative bacteria.
Induction: By a lipopolysaccharide (LPS) injection.",Gram-positive bacterium: Staphylococcus aureus (MIC=5-25 mg/mL);##Gram-negative bacterium: Escherichia coli (MIC=10-25 mg/mL).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17521774,Peptides. 2007 Jun;28(6):1304-1310.,"Zhou J, Liao M, Ueda M, Gong H, Xuan X, Fujisaki K.",Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis.,24,21-24
DRAMP02430,GLHKVMREVLGYERNSYKKFFLR,23,"Ixosin (Ticks, Arthropods, animals)",Q2LKX9,Not found,Not found,Ixodes sinensis (Hard tick),"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Has antifungal activity against C. albicans. Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. Little hemolytic activity against rabbit erythrocytes.,[Ref.16087274]Gram-postive bacteria: Staphylococcus aureus (MIC=3.7 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=30 µg/ml);##Fungi: Candida albicans (MIC=7.5 µg/ml).,[Ref.16087274]Little hemolytic activity on rabbit red blood cells up to 50 μg/mL,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16087274,Peptides. 2006 Jan;27(1):31-5.,"Yu D, Sheng Z, Xu X, Li J, Yang H, Liu Z, Rees HH, Lai R.","A novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis.",23,21-24
DRAMP02474,KFFRKLKKSVKKRAK,15,"cathelicidin-BF15 (Snakes, reptiles, animals)",B6D434,Not found,Not found,Bungarus fasciatus (Banded krait),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Pseudomonas aeruginosa ATCC27853 (MIC=4.7 µg/ml), P. aeruginosa IS/DR (MIC=37.5 µg/ml), P. aeruginosa 08031205 IS/DR (MIC=18.7 µg/ml), P. aeruginosa 08031014 IS/DR (MIC=75 µg/ml), Escherichia coli ATCC25922 (MIC=18.7 µg/ml), E. coli 08A852 IS/DR (MIC=18.7 µg/ml), E. coli 08A866 IS/DR (MIC=18.7 µg/ml), E. coli 08031017 IS/DR (MIC=37.5 µg/ml), E. coli 08040722 IS/DR (MIC=9.4 µg/ml), K. pneumoniae 08040202 IS/DR (MIC=75 µg/ml), Salmonella Typhi IS/DR (MIC=1.2 µg/ml), Saccharibacillus kuerlensis (MIC=4.7 µg/ml).##Gram-positive bacteria: Bacillus subtilis (MIC=75 µg/ml), Staphylococcus aureus ATCC2592 (MIC=75 µg/ml), S. aureus 08A875 IS/DR (MIC=75 µg/ml), S. aureus 08031002 IS/DR (MIC>100 µg/ml).##Fungi: Candida albicans ATCC2002 (MIC=18.7 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18795096,PLoS One. 2008 Sep 16;3(9):e3217.,"Wang Y, Hong J, Liu X, Yang H, Liu R, Wu J, Wang A, Lin D, Lai R.",Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.,15,12-15
DRAMP02522,HVINLEESFQEPEYENHLA,19,"L-amino-acid oxidase (LAAO, LAO, Oh-LAAO; Snakes, reptiles, animals)","P81383, A8QL50",Not found,Not found,Ophiophagus hannah (King cobra) (Naja hannah),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: It binds to bacteria and shows antibacterial activities by generating hydrogen peroxide. Binding and antibacterial activities are higher against Gram-positive than against Gram-negative bacteria. May also have an ability to induce hemorrhage, hemolysis, edema, apoptosis.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 5 mg/kg by intravenous injection into mice.
Temperature dependence: Exhibits unusual thermal stability. At pH 7.4, the enzyme retains full activity after incubation at 25 degrees Celsius for 30 days. Is stable at alkaline condition and is not inactivated by freezing.","Gram-negative bacteria: Klebsiella pneumonia (MIC=0.4 µM), Pseudomonas aeruginosa (MIC=0.2 µM), Escherichia coli (MIC=0.4 µM), Escherichia coli ATCC 25922 (MIC=0.8 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=0.006 µM), S. epidermidis (MIC=0.012 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Bacterial cell,9304806##2619759##2044840##7886693##21059402,Int J Biochem Cell Biol. 1997 Jun;29(6):911-919.##Biochem Int. 1989 Oct;19(4):937-944.##Int J Biochem. 1991;23(3):323-327.##Toxicon. 1994 Nov;32(11):1349-1358.##Comp Biochem Physiol C Toxicol Pharmacol. 2011 M,"Ahn MY, Lee BM, Kim YS.##Tan NH, Saifuddin MN.##Tan NH, Saifuddin MN.##Li ZY, Yu TF, Lian EC.##Lee ML, Tan NH, Fung SY, Sekaran SD.",Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah).##Isolation and characterization of an unusual form of L-amino acid oxidase from King cobra (Ophiophagus hannah) venom.##Substrate specificity of king cobra (Ophiophagus hannah) venom L-amino acid oxidase.##Purification and characterization of L-amino acid oxidase from king cobra (Ophiophagus hannah) venom and its effects on human platelet aggregation.##Antibacterial action of a heat-stabl,19,18-21
DRAMP01623,LIGPVLGLVGSALGGLLKKI,20,"Bombinin-H4 (bombinin H isomers; Frogs, amphibians, animals)",P82284,Belongs to the bombinin family,Not found,Bombina variegata (European frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, hemolytic against mammalian cells, Antifungal",Protein level,Alpha helix,"The epimerization reaction is incomplete, or, after racemization, the peptides still containing the L-amino acid in position 2 are partly degraded.",,Function: Have antimicrobial activity. Have some hemolytic activity.,[Ref.8223491] Gram-negative bacterium: Escherichia coli D21 (MIC=4.8 µM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=3.3 µM).,[Ref.8223491] Lethal concentration is 14.6 µM against human red blood cell.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8223491,EMBO J. 1993; 12:4829-4832.,"Mignogna G, Simmaco M, Kreil G, Barra D.1993",Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.,20,18-21
DRAMP02813,FHPSLWVLIPQYIQLIRKILKSG,23,Conolysin-Mt1,P0C8S6,Not found,Not found,Conus mustelinus (Weasel cone),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: This cytolytic peptide has ability to disrupt the integrity of cell membranes from both prokaryotes and eukaryotes. It permeabilizes both negatively charged prokaryotic (PE:PG) and zwitterionic eukaryotic (PC:cholesterol) model membranes. It has potent hemolytic activity on human erythrocytes and exhibits low antimicrobial activity against the Gram-negative bacterium E. coli and the Gram-positive bacterium S. aureus. Intracranial injection causes mice to shuffle backward until the encounter an obstacle, at which time the mouse jump into the air. The backward shuffle is reminiscent to the signature dance 'moonwalk' that gained widespread popularity after being performed by Michael Jackson.
Tissue specificity: Expressed by the venom duct.
Miscellaneous: The mature peptide does not contain cysteine residue. Mt1 and Mt2 peptides are found in a ratio of 1:4. Mt1 is more active when intracranially injected.",[Ref.17927208]Gram-positive bacterium: Staphylococcus aureus (MIC=25-50 µM);##Gram-positive bacterium: Escherichia coli (MIC>50 µM).,[Ref.17927208]95% hemolytic activity at 25 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17927208,Biochemistry. 2007 Nov 6;46(44):12586-12593. ,"Biggs J.S, Rosenfeld Y, Shai Y, Olivera B.M.",Conolysin-Mt: a conus peptide that disrupts cellular membranes.,23,21-24
DRAMP02817,VDKGSYLPRPTPPRPIYNRN,20,Pyrrhocoricin,"P37362, P80307",Belongs to the drosocin family,Not found,Pyrrhocoris apterus (Sap sucking bug) (Cimex apterus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Combine helix and strand structure,Not found,4EZN resolved by X-ray.,"Function: Antibacterial peptide. Affects Gram-negative bacteria E.coli 1106, P.aeruginosa, E.coli D22 and E.cloacae and Gram-positive bacteria M.luteus and B.subtilis.","Gram-positive bacteria: Micrococcus luteus (MIC>80 µM in L.B, P.B), Bacillus megaterium (MIC>80 µM in L.B, P.B);##Gram-negative bacteria: Escherichia coliD22 (MIC=0.3 µM in L.B, P.B), A.tumefaciens (MIC=1.25 µM in LB and 3 µM in PB), Salmonella typhimurium (MIC=5 µM in L.B and 10 µM in P.B).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10076062##8002963##23562829,Biochim Biophys Acta. 1999 Feb 2;1426(3):459-467.##Biochem J. 1994 Jun 1;300 (Pt 2):567-575.##J Mol Biol. 2013 Jul 24;425(14):2463-2479.,"Hoffmann R, Bulet P, Urge L, Otvös L Jr.##Cociancich S, Dupont A, Hegy G, Lanot R, Holder F, Hetru C, Hoffmann JA, Bulet P.##Zahn M, Berthold N, Kieslich B, Knappe D, Hoffmann R, Sträter N.","Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects.##Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus.##Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK.",20,18-21
DRAMP02845,ICLKKWPWWPWRRCKX,16,"CP-11 (cathelicidin; mammals, animals)",No entry found,Not found,Not found,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Non helix or strand structure,Not found,1QX9 resolved by NMR.,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=16 µg/ml), Pseudomonas aeruginosa (MIC=64 µg/ml), Salmonella typhimurium(MIC=64 µg/ml), S. typhimurium defensin sensitive (MIC=4 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Staphylococcus aureus (MRSA) (MIC=16 µg/ml), S. epidermidis(MIC=8 µg/ml), Enterococcus faecalis (MIC=64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11123901##14640680 ,Biochemistry. 2000 Dec 26;39(51):15765-15774.##Biochemistry. 2003 Dec 9;42(48):14130-14138.,"Rozek A, Friedrich CL, Hancock RE.##Rozek, A.; Powers, JP.; Friedrich, CL.; Hancock, RE. ",Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles.##Structure-based design of an indolicidin peptide analogue with increased protease stability. ,16,15-18
DRAMP02872,GRFKRFRKKFKKLFKKLS,18,"Myeloid antimicrobial peptide BMAP-27 (1-18) (mammals, animals)",No entry found,Not found,Not found,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Also has antifungal activity.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µM), Escherichia coli ML35 (MIC=4 µM), Escherichia coli D21 (MIC=4 µM), Salmonella typhimurium ATCC 14028 (MIC=4 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 µM), Serratia marcescens ATCC 8100 (MIC=2 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µM), Staphylococcus aureus Cowan 1 (MIC=2 µM), Staphylococcus aureus (MRSA) (MIC=4 µM), Staphylococcus epidermidis ATCC 12228 (MIC=1 µM), Bacillus megaterium Bm11 (MIC=2 µM).##Fungi: Candida albicans (MIC=16 µM), Cryptococcus neoformans (MIC=4 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8910461,J Biol Chem. 1996 Nov 8;271(45):28375-28381.,"Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.",Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.,18,15-18
DRAMP02873,GGLRSLGRKILRAWKKYG,18,"Myeloid antimicrobial peptide BMAP-28 (1-18) (mammals, animals)",No entry found,Not found,Not found,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Shows antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Also has antifungal activity.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 µM), Escherichia coli ML35 (MIC=0.5 µM), Escherichia coli D21 (MIC=0.5 µM), Salmonella typhimurium ATCC14028 (MIC=2 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 µM), Serratia marcescens ATCC 8100 (MIC=2 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µM), Staphylococcus aureus Cowan 1 (MIC=1 µM), Staphylococcus aureus (MIC=4 µM), Staphylococcus epidermidis ATCC 12228 (MIC=1 µM), Bacillus megaterium Bm11 (MIC=2 µM).##Fungi: Candida albicans (MIC=16 µM), Cryptococcus neoformans (MIC=2 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8910461,J Biol Chem. 1996 Nov 8;271(45):28375-28381.,"Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.",Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.,18,15-18
DRAMP02903,ILGPILGLVSNALGGLL,17,Bombin H7,No entry found,Not found,Not found,Bombina orientalis ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Bacillus megaterium Bm11 (MIC=3.3 µM);##Gram-negative bacterium: Escherichia coli D22 (MIC=3.7 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10333736,Biopolymers. 1998;47(6):435-450.,"Simmaco M, Mignogna G, Barra D.",Antimicrobial peptides from amphibian skin: what do they tell us?,17,15-18
DRAMP18367,GFGSKPLDSFGLNFF,15,"Chaxapeptin (a class 2 lasso peptide; class 1 microcin, bacteriocins)",No entry found,Not found,Not found,Streptomyces leeuwenhoekii Strain C58,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",,Not found,Not found,,Fuction: No activity against the Gram-negative bacteria. It showed dose dependent inhibition of A549 cancer cells.,Gram-positive bacteria: S. aureus and B. subtilis (MIC 30-35 ug/mL).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,26402731,J Org Chem. 2015 Oct 16;80(20):10252-60.,"Elsayed SS, Trusch F, Deng H, Raab A, Prokes I, Busarakam K, Asenjo JA, Andrews BA, van West P, Bull AT, Goodfellow M, Yi Y, Ebel R, Jaspars M, Rateb ME","Chaxapeptin, a Lasso Peptide from Extremotolerant Streptomyces leeuwenhoekii Strain C58 from the Hyperarid Atacama Desert",15,12-15
DRAMP02933,RRWCFRVCYRGFCYRKCR,18,"Polyphemusin-1 (PM1; crabs, Arthropods, animals)",P14215,Belongs to the tachyplesin/polyphemusin family,Not found,Limulus polyphemus (Atlantic horseshoe crab),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Beta strand (2 strands; 4 residues),"The solution structure of polyphemusin I is determined using (1)H-NMR spectroscopy. Polyphemusin I is found to be an amphipathic, beta-hairpin connected by a type I' beta-turn.",1RKK resolved by NMR.,"Function: PM1 showes high antimicrobial activity against the Gram-negative, Gram-positive and fungal specimens tested.
Tissue specificity: Hemocytes.
PTM: Contains two disulfide bonds 4-17; 8-13 and C-terminal amidation.","Gram-negative bacteria: Escherichia coli UB1005 (MIC=0.5 µg/ml), E. coli DC2 (MIC=1 µg/ml), Salmonella typhimurium (defensin-sensitive) (MIC=0.25 µg/ml), S. typhimurium (MIC=1 µg/ml), Pseudomonas aeruginosa K799 (MIC=2 µg/ml), P. aeruginosa Z61 (MIC=1 µg/ml);##Gram-positive bacteria: Staphylococcus aureus SAP0017 (MIC=2 µg/ml), Staphylococcus epidermidis (MIC=1 µg/ml), Enterococcus faecalis (MIC=1 µg/ml).##Yeasy: Candida albicans (MIC=4 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Amidation,"Disulfide bond between Cys4 and Cys17,Cys8 and Cys13.",L,No cytotoxicity information found,Not found,2514185##15134657,J Biochem. 1989 Oct;106(4):663-668.##Biochim Biophys Acta. 2004 May 6;1698(2):239-250.,"Miyata T, Tokunaga F, Yonega T, Yoshikawa K, Iwanaga S, Niwa M, Takao T, Shimonishi Y.##Powers JP, Rozek A, Hancock RE.","Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.##Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.",18,15-18
DRAMP02934,RRWSFRVSYRGFSYRKSR,18,PM1-S (linear derivative of PM1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,No secondary structure (CD),"The CD spectra of PM1-S indicates that, in all environments (phosphate buffer, TFE, and liposomes), the peptide displays no observable patterns that could be related to structural features. This indicates that PM1-S is a flexible molecule with no favoured conformation.",,Function: PM1-S remaines active against Gram-negative bacteria but displayed poor activity to both Gram-positive and fungal microorganisms.,"Gram-negative bacteria: Escherichia coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=4 µg/ml), Salmonella typhimurium (defensin-sensitive) (MIC=2 µg/ml), S. typhimurium (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=32 µg/ml), P. aeruginosa Z61 (MIC=16 µg/ml);##Gram-positive bacteria: Staphylococcus aureus SAP0017 (MIC=32 µg/ml), Staphylococcus epidermidis (MIC=16 µg/ml), Enterococcus faecalis (MIC=2 µg/ml).##Yeasy: Candida albicans (MIC=64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15134657,Biochim Biophys Acta. 2004 May 6;1698(2):239-250.,"Powers JP, Rozek A, Hancock RE.",Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.,18,15-18
DRAMP02960,RIIDLLWRVRRPQKPKFVTVWVR,23,"Antibacterial peptide PMAP-23 (Myeloid antibacterial peptide 23; pigs, mammals, animals)",P49930,Belongs to the cathelicidin family,PMAP23,Sus scrofa (Pig),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Alpha helix ,Not found,,"Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria at concentrations of 2-16 micro molar. Its activity appears to be mediated by its ability to damage bacterial membranes.
PTM: Contains two disulfide bonds (By similarity).","Gram-negative bacteria: Escherichia coli ML35 (MIC=2 µM), Escherichia coli ATCC 25922 (MIC=4 µM), Salmonella typhimurium ATCC 14028 (MIC=8 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=16 µM).##Gram-positive bacteria: Bacillus megaterium (MIC=2 µM), Staphylococcus aureus ATCC 25923 (MIC=4 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,8132502,J Biol Chem. 1994 Mar 18;269(11):7855-7858.,"Zanetti M, Storici P, Tossi A, Scocchi M, Gennaro R.",Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells.,23,21-24
DRAMP02228,SMLSVLKNLGKVGLGFVACKINKQC,25,"RANATUERIN 1 (Frogs, amphibians, animals)",P82741 ,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates catesbeiana (American bullfrog) (Rana catesbeiana),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacterium S.aureus and Gram-negative bacterium E.coli. Has activity against C.albicans. Has no detectable hemolytic activity.,[Ref.9784389] Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM);##Gram-negative bacterium: Escherichia coli (MIC=2 µM);##Yeast: Candida albicans (MIC=70 µM).,[Ref.9784389] It has no detectable hemolytic activity at aconcentration of 20µg/ml against human red blood cell.,Cyclic,Free,Cyclization (Cys19 and Cys25),Disulfide bond between Cys19 and Cys25.,L,No cytotoxicity information found,Not found,9784389,Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.,"Goraya J, Knoop FC, Conlon JM.","Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.",25,24-27
DRAMP02963,GRFRRLRKKTRKRLKKIGKV,20,PMAP-36(1-20),No entry found,Not found,Not found,Sus scrofa (Pig),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria. ,"Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=6 µM), Bacillus megaterium Bm11 (MIC=3 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12 µM), E. coli ML35 (MIC=12 µM), S. enterica ser. Typhimurium ATCC 14028 (MIC=48 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=3 µM).##Fungi: Candida albicans c.i. (MIC>64 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16128809,FEBS J. 2005 Sep;272(17):4398-4406.,"Scocchi M, Zelezetsky I, Benincasa M, Gennaro R, Mazzoli A, Tossi A.",Structural aspects and biological properties of the cathelicidin PMAP-36.,20,18-21
DRAMP02970,RGGRLCYCRRRFCVCVGR,18,"Protegrin-1 (Protegrin 1; PG-1; pigs, mammals, animals)",P32194,Belongs to the cathelicidin family,NPG1,Sus scrofa (Pig),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Beta strand,Not found,1PG1 resolved by NMR.,The sequence of IB-367 is RGGLCYCRGRFCVCVGR and the peptide is active against bacteria and fungi. This peptide showed synergistic effect with LL-37 against P. aeruginosa and E. coli (Yan H & Hancock REW 2001 Antimicrob Agents Chemother 45: 1558-60). PG-1 derivatives were subjected to clinical trials. ,"Gram-negative bacteria: Escherichia coli (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=64 µg/ml), Staphylococcus epidermidis (MIC=2 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,"Disulfide bond between Cys6 and Cys15,Cys8 and Cys13.",L,"[Ref.31399625] Cytotoxicity: 661W cells(IC50=353.4±70.5μM), HEK293T cells(IC50=2760±54.1μM), NIH-3T3 cells(IC50=719.2±59.5μM), SH-SY5Y cells(IC50=590.4±58.2μM), PMN cells(IC50=948.9±64.1μM), and 3D4/2 cells(IC50=391.1±71.3μM)",Cell membrane,8647100,Chem Pharm Bull (Tokyo). 1995 May;43(5):853-858.,"Tamamura H, Murakami T, Horiuchi S, Sugihara K, Otaka A, Takada W, Ibuka T, Waki M, Yamamoto N, Fujii N.",Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.,18,15-18
DRAMP02996,GNNRPIYIPQPRPPHPRL,18,"Apidaecin-2 (Apidaecin II; Insects, animals)","Q06601, P11525, P11526, P11527",Belongs to the apidaecin family,APID14,Apis mellifera (Honeybee),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 µg/ml), Erwinia salicis (MIC=0.02 µg/ml), Escherichia coli (MIC=0.2 µg/ml), Pseudomonas syringae (MIC=0.1 µg/ml), Rhizobium meliloti (MIC=0.02 µg/ml), Salmonella Newport (MIC=0.2 µg/ml), Salmonella typhimurium (MIC=0.1 µg/ml);##Gram-positive bacteria: Shigella flexneri (MIC=0.1 µg/ml), Corynebacterium insidiosum (MIC=100 µg/ml), Bacillus megaterium (MIC=100 µg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2676519,EMBO J. 1989 Aug;8(8):2387-2391.,"Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.",Apidaecins: antibacterial peptides from honeybees.,18,15-18
DRAMP02998,GNNRPVYIPQPRPPHPRI,18,"Apidaecin-1A (Apidaecin IA; Insects, animals)","Q06602, P11525, P11526",Belongs to the apidaecin family,APID73,Apis mellifera (Honeybee),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 µg/ml), Erwinia salicis (MIC=0.02 µg/ml), Escherichia coli (MIC=0.1 µg/ml), Pseudomonas syringae (MIC=0.2 µg/ml), Rhizobium meliloti (MIC=0.1 µg/ml), Salmonella Newport (MIC=0.2 µg/ml), Salmonella typhimurium (MIC=0.1 µg/ml), Shigella flexneri (MIC=0.1 µg/ml);##Gram-positive bacteria: Corynebacterium insidiosum (MIC=50 µg/ml), Bacillus megaterium (MIC=150 µg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2676519,EMBO J. 1989 Aug;8(8):2387-2391.,"Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.",Apidaecins: antibacterial peptides from honeybees.,18,15-18
DRAMP03057,GSKKPVPIIYCNRRTGKCQRM,21,"Thanatin(insects, arthropods, invertebrates, animals)",P55788 ,Not found,Not found,Podisus maculiventris,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Beta strand,"Contain C-terminally a loop of 6 residues, delineated by an intramolecular disulfide bridge. This loop carries a strong positive charge in both molecules and contains a central threonine residue, which separates two subgroups of electropositivity.",8TFV,Function: Insect defense peptide with a broad spectrum of activity against Gram-positive and Gram-negative bacteria and fungi. No activity against S.aureus. Stops respiration in bacteria but does not permeabilize their inner membranes. Has no detectable hemolytic activity. ,"[Ref.8577744] Gram-positive bacteria: Aerococcus viridans (MIC=0.6-1.2 µM), Micrococcus luteus (MIC=1.2-2.5 µM), Bacillus megaterium (MIC=2.5-5 µM), Bacillus subtilis (MIC=2.5-5 µM), Pediococcus acidilactici (MIC=20-40 µM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.3-0.6 µM), Escherichia coli D31 (MIC=0.3-0.6 µM), Escherichia coli 1106 (MIC=0.6-1.2 µM), Salmonella typhimurium (MIC=0.6-1.2 µM), Klebsiella pneumoniae (MIC=0.6-1.2 µM), Enterobacter cloacae (MIC=1.2-2.5 µM), Erwinia carotovora (MIC=10-20 µM), Pseudomonas aeruginosa (MIC=20-40 µM);##Fungi: Neurospora crassa (MIC=0.6-1.2 µM), Botrytis cinerea (MIC=1.2-2.5 µM), Nectria haematococca (MIC=1.2-2.5 µM), Trichoderma viride (MIC=1.2-2.5 µM), Alternaria brassicicola (MIC=2.5-5 µM), Fusarium culmorum (MIC=2.5-5 µM), Ascochyta pisi (MIC=5-10µM), Fusarium oxysporum (MIC=10-20 µM).",[Ref.8577744] It exhibits no hemolytic activity at 40 µM against porcine erythrocytes.,Cyclic,Free,Free,Disulfide bond between Cys11 and Cys18.,L,No cytotoxicity information found,Not found,8577744##9760181,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.##Eur J Biochem. 1998 Sep 1;256(2):404-410.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.##Mandard N, Sodano P, Labbe H, Bonmatin JM, Bulet P, Hetru C, Ptak M, Vovelle F.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.##Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data.",21,18-21
DRAMP03003,GFLSILKKVLPKVMAHMK,18,"Melectin (MEP; Insects, animals)",P86170,Not found,Not found,Melecta albifrons (Cuckoo bee) (Melecta punctata),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antimicrobial activity against Gram-positive bacteria as well as Gram-negative bacteria. Stimulates degranulation from rat peritoneal mast cells with an EC50 of 19.4 µM. Has weak hemolytic activity towards rat erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","[Ref.18942691]Gram-positive bacteria: Bacillus subtilis (MIC=0.8 µM), Staphylococcus aureus (MIC=6.8 µM);##Gram-negative bacteria: Escherichia coli (MIC=2.0 µM), Pseudomonas aeruginosa (MIC=18.5 µM).",[Ref.18942691]LC50>100 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18942691,Chembiochem. 2008 Nov 24;9(17):2815-2821.,"Cerovský V, Hovorka O, Cvacka J, Voburka Z, Bednárová L, Borovicková L, Slaninová J, Fucík V.",Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons.,18,15-18
DRAMP03007,GFLSALKKYLPIVLKHV,17,"Osmin (Insects, animals)",P0CD70,Not found,Not found,Osmia rufa (Red mason bee),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix (CD),"In absence of TFE, the spectrum shows a random coil type structure. When increasing the concentration of TFE from 0 to 20%, a transition into an α-helix structure is observed.",,"Function: Synthetic peptide exhibits hemolytic activity to human erythrocytes and inhibits bacterial and fungal growth at micromolar concentrations. A synthetic peptide with a free C-terminus shows weaker hemolytic (5.0 HU/mg), antibacterial and antifungal activities.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.",[Ref.19109988]Gram-positive bacterium: Micrococcus luteus (MIC=1.56-0.78 µM);##Gram-negative bacterium: Escherichia coli SBS363 (MIC=3.125-1.56 µM);##fungi: Fusarium oxysporum (MIC=0.78-0.39 µM).,[Ref.19109988]5.0 HU/mg hemolytic activity against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19109988,Toxicon. 2010 Jan;55(1):20-27.,"öcklin R, Favreau P, Thai R, Pflugfelder J, Bulet P, Mebs D.",Structural identification by mass spectrometry of a novel antimicrobial peptide from the venom of the solitary bee Osmia rufa (hymenoptera: megachilidae).,17,15-18
DRAMP03021,INWKKIASIGKEVLKAL,17,Mastoparan PMM,No entry found,Belongs to the mastoparan family,Not found,Polistes major major,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Has antibacterial activity. Shows hemolytic activity.,[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=7.3 µM);##Gram-negative bacterium: Escherichia coli (MIC=25.8 µM).,[Ref.18375018]IC50=80 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,17,15-18
DRAMP03035,INLKAIAALAKKLLG,15,"Mastoparan-like peptide 12c (Insects, animals)",A0SPI0,Not found,Not found,Vespa magnifica (Hornet),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Shows mast cell degranulation and antimicrobial activities.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14). ",Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.0 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.0 µg/ml).##Fungi: Candida albicans ATCC 2002 (MIC=12.0 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17046111,Peptides. 2006 Dec;27(12):3053-3057.,"Xu X, Yang H, Yu H, Li J, Lai R.",The mastoparanogen from wasp.,15,12-15
DRAMP03037,LNLKGIFKKVASLLT,15,"Eumenitin (Er-12; Insects, animals)",P0C931,Not found,Not found,Eumenes rubronotatus (Solitary wasp),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Cationic linear alpha-helical antimicrobial peptide that binds preferentially to charged lipid membranes as compared with zwitterionic ones. It exhibits inhibitory activity against both Gram-positive and Gram-negative bacteria, and moderately stimulates degranulation from the rat peritoneal mast cells. Does not show hemolytic activity. May play a role in preventing infection by microorganisms during prey consumption by their larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16762455]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC>60 µM), Staphylococcus aureus ATCC 25923 (MIC=6 µM), Staphylococcus saprophytius (CS) (MIC=6 µM), Staphylococcus epidermius (CS) (MIC>60 µM), Bacillus subtilis CCT 2471 (MIC=60 µM), Bacillus thuringiensis (WT) (MIC>60 µM);##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=6 µM), Escherichia coli ATCC 25922 (MIC=6 µM), Escherichia cloacae ATCC 23355 (MIC>60 µM), Proteus mirabilis (CS) (MIC>60 µM), Pseudomonas aeruginosa ATCC 15442 (MIC=30 µM).",[Ref.16762455]Non-hemolytic activity against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,16762455##18206199,Peptides. 2006 Nov;27(11):2624-2631.##Toxicon. 2008 Apr;51(5):736-745.,"Konno K, Hisada M, Naoki H, Itagaki Y, Fontana R, Rangel M, Oliveira JS, Cabrera MP, Neto JR, Hide I, Nakata Y, Yasuhara T, Nakajima T.##Arcisio-Miranda M, dos Santos Cabrera MP, Konno K, Rangel M, Procopio J.","Eumenitin, a novel antimicrobial peptide from the venom of the solitary eumenine wasp Eumenes rubronotatus.##Effects of the cationic antimicrobial peptide eumenitin from the venom of solitary wasp Eumenes rubronotatus in planar lipid bilayers: surface charge and pore formation activity.",15,12-15
DRAMP03038,LNLKGLIKKVASLLN,15,"Eumenitin-R (Insects, animals)",P0CJ36,Not found,Not found,Eumenes rubrofemoratus (Solitary wasp),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac.","[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=60 µM), Staphylococcus epidermidis (clinical sample) (MIC=30 µM), Micrococcus luteus ATCC 10240 (MIC=15 µM), Streptococcus pyogenes (clinical sample) (MIC=15 µM), Bacillus subtilis ATCC 6633 (MIC=7.5 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µM), Proteus mirabilis (clinical sample) (MIC=60 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=30 µM), Stenotrophomonas maltophilia ATCC 13637 (MIC=15 µM);##Fungi: Candida albicans ATCC 90112 (MIC<7.5 µM).",[Ref.21549739]EC50=530.3 μM against mice erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,21549739,Toxicon. 2011 Jun;57(7-8):1081-1092.,"Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.",Chemical and biological characterization of four new linear cationic Î±-helical peptides from the venoms of two solitary eumenine wasps.,15,12-15
DRAMP03039,LNLKGLFKKVASLLT,15,"Eumenitin-F (Insects, animals)",P0CJ37,Not found,Not found,Eumenes fraterculus (Solitary wasp),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac.","[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>60 µM), Staphylococcus epidermidis (clinical sample) (MIC=30 µM), Micrococcus luteus ATCC 10240 (MIC=30 µM), Streptococcus pyogenes (clinical sample) (MIC=30 µM), Bacillus subtilis ATCC 6633 (MIC=30 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µM), Proteus mirabilis (clinical sample) (MIC>60 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=30 µM), Stenotrophomonas maltophilia ATCC 13637 (MIC=15 µM);##Fungi: Candida albicans ATCC 90112 (MIC=7.5 µM).",[Ref.21549739]EC50=353.4 μM against mice erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,21549739,Toxicon. 2011 Jun;57(7-8):1081-1092.,"Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.",Chemical and biological characterization of four new linear cationic Î±-helical peptides from the venoms of two solitary eumenine wasps.,15,12-15
DRAMP03050,INWKKIAEVGGKILSSL,17,"Dominulin-A (Insects, animals)",P0C1M6,Belongs to the MCD family (Mastoparan subfamily),Not found,Polistes dominulus (European paper wasp),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Shows antimicrobial activity.,Gram-positive bacterium: Bacillus subtilis ATCC 6633 (MIC=2 µg/ml);##Gram-negative bacterium: Escherichia coli JM109 (MIC=8 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Not found,16446098,J Am Soc Mass Spectrom. 2006 Mar;17(3):376-383.,"Turillazzi S, Mastrobuoni G, Dani FR, Moneti G, Pieraccini G, la Marca G, Bartolucci G, Perito B, Lambardi D, Cavallini V, Dapporto L.","Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap.",17,15-18
DRAMP03051,INWKKIAEIGKQVLSAL,17,"Dominulin-B (Insects, animals)",P0C1M7,Belongs to the MCD family (Mastoparan subfamily),Not found,Polistes dominulus (European paper wasp),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Shows antimicrobial activity.,Gram-positive bacterium: Bacillus subtilis ATCC 6633 (MIC=2 µg/ml);##Gram-negative bacterium: Escherichia coli JM109 (MIC=8 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Not found,16446098,J Am Soc Mass Spectrom. 2006 Mar;17(3):376-383.,"Turillazzi S, Mastrobuoni G, Dani FR, Moneti G, Pieraccini G, la Marca G, Bartolucci G, Perito B, Lambardi D, Cavallini V, Dapporto L.","Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap.",17,15-18
DRAMP03052,GAARKSIRLHRLYTWKATIYTR,22,"PP13 (Insects, animals)",No entry found,Not found,Not found,Pteromalus puparum (wasp),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Alpha helix (CD),Not found,,"Function: These peptides have net positive charges and are active against both Gram-negative and -positive bacteria, but are not active against fungi tested.","Gram-positive bacteria: Staphylococcus aureus CVCC1882 (MIC=23.3 µM), Sarcina lutea CVCC1600 (MIC=8 µM), Bacillus pumilus CVCC709 (MIC=9 µM), Bacillus subtilis CVCC717 (MIC=13.3 µM).##Gram-positive bacterium: Escherichia coli CVCC1570 (MIC=16.7 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Cell membrane,19950104,J Pept Sci. 2010 Jan;16(1):58-64.,"Shen X, Ye G, Cheng X, Yu C, Yao H, Hu C.",Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.,22,21-24
DRAMP03055,YVPPVQKPHPNGPKFPTFP,19,"PP30 (Pro-rich; abaecin-like; Insects, animals)",No entry found,Not found,Not found,Pteromalus puparum (wasp),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=23.3±2.1 µM);##Gram-positive bacteria: Bacillus subtilis (MIC=16.7±2.1 µM), Staphylococcus aureus (MIC=133.3±11.6 µM), Sarcina lutea (MIC=13.3±1.2 µM), Bacillus pumilu (MIC=13.3±2.1 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,20466006,J Invertebr Pathol. 2010 Sep;105(1):24-29.,"Shen X, Ye G, Cheng X, Yu C, Altosaar I, Hu C.",Characterization of an abaecin-like antimicrobial peptide identified from a Pteromaluspuparum cDNA clone.,19,18-21
DRAMP18493,FIHHIIGGLISVGKHIHGLIHGH,23,TP3,L0CMD2,Piscidin,TP3,Oreochromis niloticus (Nile tilapia) (Tilapia nilotica),"Antibacterial, wound healing, immunomodulatory, Anti-Gram+, Antimicrobial",Protein level,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity. Has hemolytic activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=256 μg/ml; MBC=256 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=256 μg/ml; MBC>256 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 2% hemolysis at 3.13 μg/ml, 5% hemolysis at 6.25 μg/ml, 10% hemolysis at 12.50 μg/ml, 55% hemolysis at 25.00 μg/ml, 85% hemolysis at 50.00 μg/ml, 100% hemolysis at 100.00 μg/ml against mouse red blood cell",Linear,Free,Free,Free,L,Not included yet,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",23,21-24
DRAMP03096,RRQGPIFDTRPSPFNPNQPRPGPIY,25,"Metchnikowin-2 (Insects, animals)",No entry found,Not found,Not found,Drosophila melanogaster (Fruit fly),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Micrococcus luteus (MIC=0.5-1.0 µM).##Fungi: Neurospora crassa (MIC=0.5-1.0 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,7588819,Eur J Biochem. 1995 Oct 15;233(2):694-700.,"Levashina EA, Ohresser S, Bulet P, Reichhart JM, Hetru C, Hoffmann JA.","Metchnikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibacterial and antifungal properties.",25,24-27
DRAMP18495,QCRRLCYKQRCVTYCRGR,18,"Gomesin (Gm; Spiders, arachnids, Chelicerata, arthropods, invertebrates, animals)",P82358 ,Belongs to the tachyplesin family,Not found,Acanthoscurria gomesiana (Tarantula spider) (Phormictopus pheopygus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antimalarial, Antic",Protein level,Beta sheet,Not found,1KFP resolved by NMR.,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi. It shows hemolytic activity.
Tissue specificity: In hemocytes only, but not in all hemocytes observed.","[Ref.10942757] Gram-positive bacteria: Aerococcus viridans (MIC=0.8-1.6 μM), Bacillus cereus (MIC=6.25-12.5 μM), Bacillus megaterium (MIC=0.2-0.4 μM), Bacillus thuringiensis (MIC=1.6-3.15 μM), Enterococcus faecalis (MIC=6.2-12.5 μM), Listeria monocytogenes (MIC=0.8-1.6 μM), Micrococcus luteus (MIC=0.4-0.8 μM), Pediococcus acidolacrici (MIC=3.15-6.25 μM), Staphylococcus aureus (MIC=1.6-3.15 μM), Staphylococcus epidermidis (MIC=0.8-1.6 μM), Staphylococcus haemolyticus (MIC=0.8-1.6 μM), Staphylococcus saprophyticus (MIC=0.8-1.6 μM), Streptococcus pyogenes (MIC=1.6-3.15 μM), Nocardia asteroides (MIC=1.6-3.15 μM);##Gram-negative bacteria: Escherichia coli 1106 (MIC=0.8-1.6 μM), Escherichia coli D22 (MIC=0.4-0.8 μM), Escherichia coli D31 (MIC=0.8-1.6 μM), Escherichia coli SBS363 (MIC=0.4-0.8 μM), Erwinia carolovora (MIC=3.15-6.25 μM), Enterobacter cloacae β12 (MIC=3.15-6.25 μM), Klebsiella pneumoniae (MIC=3.15-6.25 μM), Pseudomonas aeruginosa (MIC=1.6-3.15 μM), Salmonella thyphinurium (MIC=0.8-1.6 μM), Xhantomonas campestris pv. orizae (MIC=3.15-6.25 μM);##Fungi: Alternaria brassicola (MIC=0.4-0.8 μM), Aspergillus fumigatus (MIC=1.6-3.15 μM), Beauveria bassiana (MIC=12.5-25 μM), Fusarium culmorum (MIC=0.4-0.8 μM), Fusarium oxysporum (MIC=0.4-0.8 μM), Neurospora crassa (MIC=0.4-0.8 μM), Nectria haematococca (MIC=0.2-0.4 μM), Tricoderma viridae (MIC=0.4-0.8 μM), Tricophvton mentagrophytes (MIC=0.8-1.6 μM);##Yeasts: Candida albicans (MIC=0.15-0.3 μM), Candida glabrata (MIC=12.5-25 μM), Candida tropicalis (MIC=3.15-6.25 μM), Cryptococcus neoformans (MIC=0.8-1.6 μM), Saccharomyces cerevisiae (MIC=1.6-3.15 μM).",[Ref.10942757] It exhibits 16% hemolysis at 1 μM and 100 μM against human erythrocytes,Cyclic,pyroglutamic acid,Amidation,"Disulfide bond between Cys2 and Cys15,Cys6 and Cys11.",L,No cytotoxicity information found,Not found,10942757,J Biol Chem. 2000 Oct 27;275(43):33464-70.,"Silva PI Jr, Daffre S, Bulet P.","Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.",18,15-18
DRAMP03153,GIGGKPVQTAFVDNDGIYD,19,27 kDa antibacterial protein,P81925,Not found,Not found,Cyprinus carpio (common carp),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Has antibacterial activity. Forms large ion channels responsible for disrupting the cellular envelope of bacteria leading to cell lysis.,"Gram-positive bacteria: Staphylococcus aureus (MIC=5 µg/ml), Micrococcus luteus (MIC=0. 5 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=5 µg/ml), Pseudomonas fluorescens (MIC=10 µg/ml), Aeromonas hydrophila (MIC=5 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,8797847,Eur J Biochem. 1996 Aug 15;240(1):143-149.,"LemaÃ®tre C, Orange N, Saglio P, Saint N, Gagnon J, Molle G.",Characterization and ion channel activities of novel antibacterial proteins from the skin mucosa of carp (Cyprinus carpio).,19,18-21
DRAMP03173,RWCVYAYVRVRGVLVRYRRCW,21,"Arenicin-1 (Ar-1; marine polychaeta, animals)","Q5SC60, P84105",Not found,Not found,Arenicola marina (Lugworm) (Lumbricus marinus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Cytotoxic",Protein level,Beta strand (2 strands; 16 residues),"Arenicin-1 is a two-stranded antiparallel β-sheet (Cys3-Val10 and Val13-Cys20) stabilized by nine intra-backbone hydrogen bonds and a disulfide bond between Cys3 and Cys20. The strands of the β-sheet are connected by a type I´ β-turn. The surface of arenicin is amphiphilic, with distinct hydrophobic and hydrophilic areas (ref.2).",2JSB resolved by NMR.,"Function: Has antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteriua as well as yeast C. albicans. Bacterial killing occurs within minutes and is accompanied by membrane permeabilization, membrane detachment and release of cytoplasm. Interaction of arenicin with reconstituted membranes that mimic the lipopolysaccharide-containing outer membrane or the phospholipid-containing plasma membrane of Gram-negative bacteria exhibited no pronounced lipid specificity.
PTM: Contains one disulfide bond 3-20.
Domian: Contains 1 BRICHOS domain.","Gram-positive bacterium: Listeria monocytogenes EGD (MIC=0.6 µg/ml);##Gram-negative bacteria: Escherichia coli ML-35p (MIC=4 µg/ml), E. coli WBB01 (MIC=0.3 mM), E. coli ATCC 23716 (MIC=0.6 mM), Salmonella enterica R595 (MIC=0.3 mM), S. enterica R60 (MIC=1.25 mM), Proteus mirabilis R45 (MIC=0.6 mM).##Yeast: Candida albicans 820 (MIC=20 µg/ml).##Human Jurkat T-cells: LD50>40 mM (35.5% lysis at 30 mM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys3 and Cys20.,L,"[Ref.27940358] Cytotoxicity: human embryonic fibroblasts (HEF) and human red blood cells (hRBC)(IC50 for arenicin-1 in the presence or absence of 10% FBS were of 35 and 8 μM,HC50 indicating 50% hemolysis after 24 h incubation, equaled to 16μM).",Anionic lipid vesicles,15527787##17935487,FEBS Lett. 2004 Nov 5;577(1-2):209-214.##Biochem J. 2008 Feb 15;410(1):113-122.,"Ovchinnikova TV, Aleshina GM, Balandin SV, Krasnosdembskaya AD, Markelov ML, Frolova EI, Leonova YF, Tagaev AA, Krasnodembsky EG, Kokryakov VN.##Andrä J, Jakovkin I, Grötzinger J, Hecht O, Krasnosdembskaya AD, Goldmann T, Gutsmann T, Leippe M.","Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina.##Structure and mode of action of the antimicrobial peptide arenicin.",21,18-21
DRAMP03181,HVDKKVADKVLLLKQLRIMRLLTRL,25,"Spinigerin (Insects, animals)",P82357,Not found,Not found,Pseudacanthotermes spiniger (Termite),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,"1ZRW, 1ZRV resolved by NMR.",Function: Active against Gram-positive bacteria and Gram-negative bacteria and fungi.,"Gram-positive bacteria: Bacillus megaterium (MIC=0.8-1.5 µM), Micrococcus luteus (MIC=0.8-1.5 µM);##Gram-negative bacteria: Escherichia coli SBS363 (MIC=3-6 µM), E. coli D22 (MIC=3-6 µM), Klebsiella pneumoniae (MIC=50-100 µM), Salmonella typhimurium (MIC=3-6 µM), Pseudomonas aeruginosa (MIC=50-100 µM).##Fungi: Trichoderma viride (MIC=1.5-3 µM), Neurospora crassa (MIC=3-6 µM), Fusarium culmorum (MIC=1.5-3 µM), Nectria haematococca (MIC=0.4-0.8 µM), Candida albicans (MIC=3-6 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,11053427##16170803,J Biol Chem. 2001 Feb 9;276(6):4085-4092.##Biopolymers. 2006 Feb 5;81(2):92-103. ,"Lamberty M, Zachary D, Lanot R, Bordereau C, Robert A, Hoffmann JA, Bulet P.##Landon C, Meudal H, Boulanger N, Bulet P, Vovelle F.","Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect.##Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation.",25,24-27
DRAMP03196,RCVCRRGVCRCVCTRGFC,18,"PhTD-1 (PhTD1; primates, mammals, animals)","P86722, P86723",Not found,Not found,Papio hamadryas (Hamadryas baboon),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"In low salt conditions: Escherichia coli ML35p (MIC=1.5 µM), Listeria monocytogenes EGD (MIC=1.6 µM) and methicillin-resistant Staphylococcus aureus ATCC 33591 (MIC=2.5 µM),.##Fungi: Candida albicans 820 (MIC=1.6 µM);##At high physiological salt concentrations: Escherichia coli ML35p (MIC=2.0 µM), Listeria monocytogenes EGD (MIC=1.7 µM), Staphylococcus aureus ATCC 33591 (MIC=3.6 µM), Candida albicans 820 (MIC=6.5 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,No specific N-terminal,No specific C-terminal,Disulfide bonds between Cys2 and Cys11; Cys4 and Cys9; Cys13 and Cys18.,L,No cytotoxicity information found,Not found,20155756,Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):599-604.,"Stegemann C, Tsvetkova EV, Aleshina GM, Lehrer RI, Kokryakov VN, Hoffmann R.",De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.,18,15-18
DRAMP03197,RCVCTRGFCRCVCTRGFC,18,"PhTD-3 (PhTD3; primates, mammals, animals)","P86722, P86723",Not found,Not found,Papio hamadryas (Hamadryas baboon),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"In low salt conditions: Escherichia coli ML35p (MIC=1.7 µM), Listeria monocytogenes EGD (MIC=1.5 µM), Staphylococcus aureus ATCC 33591 (MIC=1.7 µM), Candida albicans 820 (MIC=1.4 µM);##At high physiological salt concentrations: Escherichia coli ML35p (MIC=2.2 µM), Listeria monocytogenes EGD (MIC=1.9 µM), Staphylococcus aureus ATCC 33591 (MIC=4.5 µM), Candida albicans 820 (MIC=7.4 µM). ",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,No specific N-terminal,No specific C-terminal,Disulfide bonds between Cys2 and Cys11; Cys4 and Cys9; Cys13 and Cys18.,L,No cytotoxicity information found,Not found,20155756,Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):599-604.,"Stegemann C, Tsvetkova EV, Aleshina GM, Lehrer RI, Kokryakov VN, Hoffmann R.",De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.,18,15-18
DRAMP03215,ZCRRLCYKQRCVTYCRGR,18,"Gomesin (Gm; spiders, Arthropods, animals)","P82358, Q86RA2",Not found,Not found,Acanthoscurria gomesiana (Tarantula spider),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Protein level,Beta strand,"Gm adopts a well-defined β-hairpin-like struc ture, and the disulfide bonds have been reported to be important for the maintenance of this structure.",1KFP resolved by NMR.,"[Ref.10942757]Function: Gomesin bound to the cell surface of cryptococci neoformans, which resulted in cell death associated with membrane permeabilization (FEMS Microbiol Lett. 2007 Sep;274(2):279-86). Also, this peptide triggers SH-SY5Y cell death through L-type channel calcium influx, MAPK/ERK, PKC and PI3K signaling and generation of reactive oxygen species (Soletti RC et al 2010 Chem Biol Interact 186: 135-43). Although represented by E, the N-terminal residue is a pyroglutamate. In hemocytes only, but not in all hemocytes observed.##[Ref.28741926]Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.10942757]Gram-positive bacteria: Aerococcus viridans (MIC=0.8-1.6 µM), Bacillus cereus (MIC=6.25-12.5 µM), Bacillus megaterium (MIC=0.2-0.4 µM), Bacillus thuringiensis (MIC=1.6-3.15 µM), Enterococcus faecalis (MIC=6.2-12.5 µM), Listeria monocytogenes (MIC=0.8-1.6 µM), Micrococcus luteus (MIC=0.4-0.8 µM), Pediococcus acidolacrici (MIC=3.15-6.25 µM), Staphylococcus aureus (MIC=1.6-3.15 µM), S. epidermidis (MIC=0.8-1.6 µM), S. haemolyticus (MIC=0.8-1.6 µM), S. saprophyticus (MIC=0.8-1.6 µM), Streptococcus pyogenes (MIC=1.6-3.15 µM), Nocardia asteroides (MIC=1.6-3.15 µM);##Gram-negative bacteria: Alcaligenes faecalis (MIC>100 µM), Escherichia coli 1106 (MIC=0.8-1.6 µM), E. coli D22 (MIC=0.4-0.8 µM), E. coli D31 (MIC=0.8-1.6 µM), E. coli SBS363 (MIC=0.4-0.8 µM), Erwinia carolovora carolovora (MIC=3.15-6.25 µM), Enterobacter cloacae beta 12 (MIC=3.15-6.25 µM), Klebsiella pneumoniae (MIC=3.15-6.25 µM), Pseudomonas aeruginosa (MIC=1.6-3.15 µM), Salmonella typhimurium (MIC=0.8-1.6 µM), Xhantomonas campestris pv. orizae (MIC=3.15-6.25 µM).##Fungi: Alternaria brassicola (MIC=0.4-0.8 µM), Aspergillus fumigatus (MIC=1.6-3.15 µM), Beauveria bassiana (MIC=12.5-25 µM), Fusarium culmorum (MIC=0.4-0.8 µM), F. oxysporum (MIC=0.4-0.8 µM), Neurospora crassa (MIC=0.4-0.8 µM), Nectria haematococca (MIC=0.2-0.4 µM), Tricoderma viridae (MIC=0.4-0.8 µM), Tricophvton mentagrophytes (MIC=0.8-1.6 µM), C. albicans (MIC=0.15-0.3 µM), C. glabrata (MIC=12.5-25 µM), C. tropicalis (MIC=3.15-6.25 µM), C. neoformans (MIC=0.8-1.6 µM), Saccharomyces cerevisiae (MIC=1.6-3.15 µM).##[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4 μM), Klebsiella pneumoniae ATCC 700603 (MIC=32 μM), Acinetobacter baumannii ATCC 19606 (MIC=4-8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=8-16 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)","[Ref.28741926] It has 0% hemolysis at 6 μM , 3% hemolysis at 10 μM , 10% hemolysis at 5 μM , 41.2-53.2% hemolysis at 64 μM , 50% hemolysis at 100 μM against human red blood cells",Cyclic,pyroglutamic acid,Amidation ,"Disulfide bond between Cys2 and Cys15,Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 67.0 ± 5.0 μM against CRL-1739, CC50 = 3.7 ± 0.2 μM against MM96L, CC50 = 49.9 ±16.6μM against HFF-1, CC50 =54.1±5.0 μM against HeLa, CC50 = 3.8 ± 0.3 μM against K-562.",Not found,10942757##28741926,J Biol Chem. 2000 Oct 27;275(43):33464-33470.##ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459. ,"Silva PI Jr, Daffre S, Bulet P.##Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik","Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.##Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties",18,15-18
DRAMP03226,SMWSGMWRRKLKKLRNALKKKLKGE,25,"M-zodatoxin-Lt1a (M-ZDTX-Lt1a; Latarcin-1, Ltc-1, Ltc1; spiders, Arthropods, animals)",Q1ELT9,Belongs to the latarcin family,Not found,Lachesana tarabaevi (Spider),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix (1 helices; 16 residues),The Ltc1 molecule is found to form a straight uninterrupted amphiphilic helix comprising 8-23 residues. The hydrophobic surface of the Ltc1 helix is narrow-shaped and extends with no gradient along the axis. (Ref.2),2PCO resolved by NMR.,"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.5 µM), Bacillus subtilis VKM B-501 (MIC=1.0 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=1.0 µM), Escherichia coli MH1 (MIC=0.7µM), Pseudomonas aeruginosa PAO1 (MIC=4.1 µM);##Fungi: Pichia pastoris GS115 (MIC=17 µM), Saccharomyces cerevisiae Y190 (MIC>33 µM).",[Ref.16735513]20% hemolytic activity at 80 μM against rabbit erythrocytes ,Linear,Free,Free,Free,L,Not included yet,Not found,16735513##18293934,J Biol Chem. 2006 Jul 28;281(30):20983-20992.##Biochemistry. 2008 Mar 18;47(11):3525-3533.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.##Dubovskii PV, Volynsky PE, Polyansky AA, Karpunin DV, Chupin VV, Efremov RG, Arseniev AS.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.##Three-dimensional structure/hydrophobicity of latarcins specifies their mode of membrane activity.",25,24-27
DRAMP03229,SWKSMAKKLKEYMEKLKQRA,20,"M-zodatoxin-Lt3a (M-ZDTX-Lt3a; Latarcin-3a, Ltc-3a; spiders, Arthropods, animals)",Q1ELU3,Belongs to the latarcin family,Not found,Lachesana tarabaevi (Spider),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 µM), Bacillus subtilis VKM B-501 MIC=1.2 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=2.5 µM), Escherichia coli MH1 (MIC=6.0 µM), Pseudomonas aeruginosa PAO1 (MIC>40 µM);##Fungi: Pichia pastoris GS115 (MIC=20 µM), Saccharomyces cerevisiae Y190 (MIC=20 µM).",[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes ,Linear,Free,Amidation ,Free,L,Not included yet,Not found,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-209892.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",20,18-21
DRAMP03230,SWASMAKKLKEYMEKLKQRA,20,"M-zodatoxin-Lt3b (M-ZDTX-Lt3b; Latarcin-3b, Ltc-3b; spiders, Arthropods, animals)",Q1ELU2,Belongs to the latarcin family,Not found,Lachesana tarabaevi (Spider),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Has hemolytic against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.7 µM), Bacillus subtilis VKM B-501 (MIC=2.9 µM);Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=23 µM), Escherichia coli MH1 (MIC=28 µM), Pseudomonas aeruginosa PAO1 (MIC>45 µM);##Fungi: Pichia pastoris GS115 (MIC=23 µM), Saccharomyces cerevisiae Y190 (MIC=23 µM).",[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes ,Linear,Free,Amidation ,Free,L,Not included yet,Not found,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-209892.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",20,18-21
DRAMP03231,GLKDKFKSMGEKLKQYIQTWKAKF,24,"M-zodatoxin-Lt4a (M-ZDTX-Lt4a; Latarcin-4a, Ltc-4a; spiders, Arthropods, animals)",Q1ELU5,Belongs to the latarcin family,Not found,Lachesana tarabaevi (Spider),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 µM), Bacillus subtilis VKM B-501 (MIC=1.1 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=4.5 µM), Escherichia coli MH1 (MIC=3.2 µM), Pseudomonas aeruginosa PAO1 (MIC>35 µM);##Fungi: Pichia pastoris GS115 (MIC=36 µM), Saccharomyces cerevisiae Y190 (MIC=18 µM).",[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes ,Linear,Free,Amidation ,Free,L,Not included yet,Not found,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-209892.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",24,21-24
DRAMP03232,SLKDKVKSMGEKLKQYIQTWKAKF,24,"M-zodatoxin-Lt4b (M-ZDTX-Lt4b; Latarcin-4b, Ltc-4b; spiders, Arthropods, animals)",Q1ELU4,Belongs to the latarcin family,Not found,Lachesana tarabaevi (Spider),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 µM), Bacillus subtilis VKM B-501 (MIC=1.1 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=4.4 µM), Escherichia coli MH1 (MIC=4.4 µM), Pseudomonas aeruginosa PAO1 (MIC>35 µM);##Fungi: Pichia pastoris GS115 (MIC>35 µM), Saccharomyces cerevisiae Y190 (MIC=35 µM).",[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes ,Linear,Free,Amidation ,Free,L,Not included yet,Not found,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-209892.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",24,21-24
DRAMP03253,GKLQAFLAKMKEIAAQTL,18,"M-lycotoxin-Ls3a (M-LCTX-Ls3a; Lycocitin-1; spiders, Arthropods, animals)",P0C2U6,Not found,Not found,Lycosa singoriensis (Wolf spider) (Aranea singoriensis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Inhibits growth of Gram-positive and Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus, Bacillus subtilis ATCC6633 (MIC=1.6-3.2 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=3.2-6.4 µM), Pseudomonas aeruginosa.##Yeast: Candida albicans.",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation ,Free,L,Not included yet,Not found,14991689,J Mass Spectrom. 2004 Feb;39(2):193-201.,"Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA.",De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.,18,15-18
DRAMP03254,GRLQAFLAKMKEIAAQTL,18,"M-lycotoxin-Ls3b (M-LCTX-Ls3b; Lycocitin-2; spiders, Arthropods, animals)",P0C2U7,Not found,Not found,Lycosa singoriensis (Wolf spider) (Aranea singoriensis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Inhibits growth of Gram-positive and Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus 209P, Bacillus subtilis ATCC 6633 (MIC=1.57-3.14 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=3.14-6.29 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=5.02-10.05 µM).##Fungi: Candida albicans. ",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation ,Free,L,Not included yet,Not found,14991689,J Mass Spectrom. 2004 Feb;39(2):193-201.,"Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA.",De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.,18,15-18
DRAMP03278,IWLTALKFLGKHAAKHLAKQQLSKL,25,"M-lycotoxin-Hc1a (M-LCTX-Hc1a; Lycotoxin I; spiders, Arthropods, animals)",P61507,Not found,Not found,Hogna carolinensis (Carolina wolf spider) (Lycosa carolinensis) ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Forms pore that permeabilize the cell membrane. Promotes efflux of calcium from synaptosomes, causes hemolysis, and dissipates voltage gradients across muscle membrane. Potently inhibits the growth of bacteria, yeast and Leishmania. Is lethal to lepidopteran larvae. May Function: both in the prey capture strategy as well as protection from infectious organisms arising from prey ingestion.","Gram-positive bacteria: Bacillus thuringiensis subsp. Israelensis (MIC<5.0 µM);##Gram-negative bacteria: Escherichia coli D31 (MIC=10-20 µM), Escherichia coli DH5 (MIC=80-150 µM).##Fungi: Candida glabrata ATCC 2001 (MIC=100-150 µM), Candida albicans clinical isolate (MIC=100-200 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation ,Free,L,Not included yet,Cell membrane,9442044##18098329 ,J Biol Chem. 1998 Jan 23;273(4):2059-2066.##J Pept Sci. 2008 Apr;14(4):528-534.,"Yan L, Adams ME.##Adão R, Seixas R, Gomes P, Pessoa JC, Bastos M.","Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis.##Membrane structure and interactions of a short Lycotoxin I analogue.",25,24-27
DRAMP03312,VDKPDYRPRPRPPNM,15,"Metalnikowin-1 (Metalnikowin I; Insects, animals)",P80408,Not found,Not found,Palomena prasina (Green shield bug) (Cimex prasinus),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Rich,Not found,,"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection.","Gram-negative bacteria: Escherichia coli D22 (MIC=50-100 µM), Salmonella typhimurium (MIC=50-100 µM), Alcaligenes faecalis (MIC=50-100 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,PubMed ID is not available,J. Insect Physiol. 1996; 42: 81-89.,"Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.",The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.,15,12-15
DRAMP03464,GLLNGLALRLGKRALKKIIKRLCR,24,"Cryptonin (Insects, animals)",P85028,Not found,Not found,Cryptotympana dubia (Korean horse cicada),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,Function: Has very low hemolytic activity on rat erythrocytes. ,"[Ref.18000874]Gram-positive bacteria: Bacillus subtilis KCTC 3086 (MIC=3.12 µg/ml), Staphylococcus aureus KCTC 1928 (MIC=25 µg/ml), Micrococcus luteus KCTC 3063 (MIC=1.56 µg/ml), Staphylococcus aureus (MRSA) (MIC=25 µg/ml), VRE (MIC=25 µg/ml);##Gram-negative bacteria: Escherichia coli K12-594 (MIC=3.12 µg/ml);##Fungi: Candida albicans KCTC 7965 (MIC=50 µg/ml), Candida tropicalis KCTC 1925 (MIC=3.12 µg/ml).",[Ref.18000874]<5% hemolytic activity at 25-200 µg/ml against rat erythrocytes,Linear,Free,Free,Free,L,Not included yet,Not found,18000874,Arch Insect Biochem Physiol. 2007 Dec;66(4):204-213.,"Leem JY, Park DS, Suh EY, Hur JH, Oh HW, Park HY.","Isolation and functional analysis of a 24-residue linear alpha-helical antimicrobial peptide from Korean blackish cicada, Cryptotympana dubia (Homoptera).",24,21-24
DRAMP03467,PAQPFRFPKHPQGPQTRPPI,20,Antibacterial napin (Plants),P84529,Belongs to the 2S seed storage albumins family,Not found,Brassica rapa subsp. chinensis (Pak-choi),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: The small, basic, water-soluble napins are one of the two major kinds of storage proteins synthesized in the seed during its maturation. Inhibits cell-free protein synthesis. Has antibacterial activity against Gram-negative bacterium P. fluorescens, and the Gram-positive bacteria B. subtilis, B. cereus, B. megaterium and M. phei. No antibacterial activity against the Gram-positive bacterium S. aureus or the Gram-negative bacteria E. coli, E. aerogenes and P. aeruginosa.
Subunit structure: The mature protein consists of a small and a large chain linked by disulfide bonds.","Gram-negative bacterium: Pseudomonas fluorescens (MIC=66±3.7 µM);##Gram-positive bacteria: Bacillus subtilis (MIC=236±10.2 µM), Bacillus cereus (MIC=222±9.1 µM), Bacillus megaterium (MIC=215±6.8 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,15062997,Peptides. 2004 Feb;25(2):171-176.,"Ngai PH, Ng TB.","A napin-like polypeptide from dwarf Chinese white cabbage seeds with translation-inhibitory, trypsin-inhibitory, and antibacterial activities.",20,18-21
DRAMP03539,EWEPVQNGGSSYYMVPRIWA,20,Antifungal protein (Psc-AFP),No entry found,Not found,Not found,Cullen corylifolium,"Antimicrobial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Fungi: Alternaria brassicae (MIC=10 µM), Aspergillus niger (MIC=10 µM), Fusarium oxysporum (MIC=10 µM), Rhizoctonia cerealis (MIC=10 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,16530884,Peptides. 27:1726-1731(2006),"Yang X, Li J, Wang X, Fang W, Bidochka M.J, She R, Xiao Y, Pei Y.","Psc-AFP, an antifungal protein with trypsin inhibitor activity from Psoralea corylifolia seeds",20,18-21
DRAMP03562,FLAKAVAKAAAKALAKAL,18,"P1 (Human, mammals, animals)",No entry found,Not found,Not found,Homo sapiens (Human),"Antimicrobial, Antifungal",Not found,Not found,Not found,,Function: Presentes antifungal activity against Candida albicans. ,Yeast: Candida albicans (MIC=82 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Not found,22884922,Peptides. 2012 Oct;37(2):301-308.,"Amaral AC, Silva ON, Mundim NC, de Carvalho MJ, Migliolo L, Leite JR, Prates MV, Bocca AL, Franco OL, Felipe MS.",Predicting antimicrobial peptides from eukaryotic genomes: In silico strategies to develop antibiotics.,18,15-18
DRAMP03563,KAGLAFPVGRVHRLLRK,17,"P2 (Human, mammals, animals)",No entry found,Not found,Not found,Homo sapiens (Human),"Antimicrobial, Antifungal",Not found,Not found,Not found,,Function: Presentes antifungal activity against Candida albicans. ,Yeast: Candida albicans (MIC=133 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Not found,22884922,Peptides. 2012 Oct;37(2):301-308.,"Amaral AC, Silva ON, Mundim NC, de Carvalho MJ, Migliolo L, Leite JR, Prates MV, Bocca AL, Franco OL, Felipe MS.",Predicting antimicrobial peptides from eukaryotic genomes: In silico strategies to develop antibiotics.,17,15-18
DRAMP03567,KRIVQRIKDFLRNLVPRTES,20,KR-20 (Derived from LL-37),No entry found,Not found,Not found,Homo sapiens (Human sweat),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix ,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus mprF (MIC=16 µM), Staphylococcus aureus ATCC 25923 (MIC>64 µM), Staphylococcus aureus (GAS) (MIC=4 µM);##Gram-negative bacterium: Escherichia coli O29 (MIC>64 µM).##Yeast: Candida albicans ATCC 14053 (MIC=10 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Lipopolysaccharide (LPS)-binding,14978112,J Immunol 2004; 172: 3070-3077.,"Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL.",Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.,20,18-21
DRAMP03570,LLGDFFRKSKEKIGKEFKRIVQR,23,LL-23 (Derived from LL-37),"P49913, Q71SN9",Not found,Not found,Homo sapiens (Human sweat),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix (1 helices; 19 residues),"The Ser9 site splits the hydrophobic surface of the amphipathic helix into two domains, which explains its poor antimicrobial activity (active against only susceptible bacterial strains). ",2LMF resolved by NMR.,"Its structure, dynamics, and antimicrobial and immune modulating activities have been characterized (Biochemistry 2012).","Gram-negative bacterium: Escherichia coli DC2 (MIC=9 µM);##Gram-positive bacteria: Staphylococcus aureus mprF (presence of carbonate) (MIC=3 µM), S. aureu mprF (absence of carbonate) (MIC=24 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,17012259##22185690,"FASEB J 2006; 20, 2068-2080.##Biochemistry. 2012 Jan 17;51(2):653-664. ","Yamasaki K et al. Gallo RL.##Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.","Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin.##Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",23,21-24
DRAMP03573,IGKEFKRIVQRIKDFLRNLVPRTES,25,"LL-37(13-37)(C-terminal fragment of LL-37; Human, mammals, animals)","P49913, Q71SN9",Not found,Not found,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram-, Anticancer",Protein level,Alpha helix (1 helices; 14 residues),Residues 17-29 of LL-37(13-37) are helical.,2FCG resolved by NMR.,The slightly lower activity of LL-37(13-37) may result from the interference of the disordered regions with membrane binding of the peptide.,"Gram-negative bacterium: Escherichia coli K12 (MIC=80 µM).##Drug-resistant KBv cancer cells (LC50=39 µM), Drug-sensitive KB cancer cells (LC50=40 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Amidation,Disulfide bonds,L,Not included yet,Not found,16637646,J Am Chem Soc. 2006 May 3;128(17):5776-5785.,"Li X, Li Y, Han H, Miller DW, Wang G. ",Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. ,25,24-27
DRAMP03574,FKRIVQRIKDFLRNLV,16,"LL-37(17-32)(C-terminal fragment of LL-37; Human, mammals, animals)","P49913, Q71SN9",Not found,Not found,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram-, Anticancer",Protein level,Not found,"To achieve selective membrane targeting, D-amino acids were incorporated into LL-37(17-32). The D-peptide showed similar antibacterial activity to the L-diastereomer, it lost toxicity to human cells. ",,Antibacterial and anticancer assays found that LL-37(17-32) was more active than LL-37(13-37). ,"Gram-negative bacteria: Escherichia coli K12(MIC=20 µM).##Drug-resistant KBv cancer cells (LC50=30 µM), Drug-sensitive KB cancer cells (LC50=30 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Amidation,Disulfide bonds,L,Not included yet,Not found,16637646,J Am Chem Soc. 2006 May 3;128(17):5776-5785.,"Li X, Li Y, Han H, Miller DW, Wang G. ",Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. ,16,15-18
DRAMP01378,GIFGKILGVGKKVLCGLSGVC,21,"Odorranain-H1 (OdH1; Frogs, amphibians, animals)",A6MBN4,Not found,Not found,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Odorranain-H1 adopts 50.3 β-sheet structure in water solution.,,Function: Odorranain-H1 exhibites antimicrobial activities against Gram-positive and Gram-negative bacteria and fungi. Also has hemolytic activity against rabbit red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=23.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=5.90 μg/ml), Bacillus subtilis (MIC=5.90 μg/ml).##Yeast: Candida albicans (MIC=11.80 μg/ml).","[Ref.17272268] RCH=21.6 ± 7.3% against rabbit red blood cells. RCH, red cell hemolysis.",Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,21,18-21
DRAMP01386,VIPFVASVAAEMMQHVYCAASKKC,24,"Odorranain-P1a (OdP1a; Brevinin-1HS1; Brevinin-1-OA2; Frogs, amphibians, animals)","A6MBQ8, A6MBQ6",Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Not found,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,,Function: Odorranain-P1a exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Also has hemolytic activity against rabbit red cell. ,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=3.50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.50 μg/ml), Bacillus subtilis (MIC=1.75 μg/ml).##Yeast: Candida albicans (MIC=1.75 μg/ml).","[Ref.17272268] RCH=11.2 ± 2.9% against rabbit red blood cells. RCH, red cell hemolysis.",Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,24,21-24
DRAMP03677,SKCYQWQRRMRKLGAPSITCIRRTS,25,GLFcin II (Lactoferrin fragment),"Q29477, Q29479",Belongs to the transferrin family,LTF,Capra hircus (Goat),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: GLFcin is thermal-stable and with high antibacterial activity.,"Gram-negative bacteria: Escherichia coli (MIC=6.80 µg/ml), Propioni bacterium acnes (MIC=10.50 µg/ml), Pseudemonas aeruginosa (MIC=14.50 µg/ml);##Gram-positive bacteria: Bacillus cereus (MIC=16.00 µg/ml), Staphylococcus aureus (MIC=6.80 µg/ml), Listeria monocytogene (MIC=9.92 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,19780544,J Agric Food Chem. 2009 Oct 28;57(20):9509-9515.,"Chen GH, Chen WM, Huang GT, Chen YW, Jiang ST.",Expression of recombinant antibacterial lactoferricin-related peptides from Pichia pastoris expression system.,25,24-27
DRAMP18366,GFGSKPIDSFGLSWL,15,Sungsanpin (a class 2 lasso peptide; bacteriocins),No entry found,Not found,Not found,a Marine Streptomyces species,Anti-cancer,,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,"Form a lactam bond at position 1 and 8(Gly1, Asp8)",L,Not included yet,Not found,23662937,J Nat Prod. 2013 May 24;76(5):873-9,"Um S, Kim YJ, Kwon H, Wen H, Kim SH, Kwon HC, Park S, Shin J, Oh DC.","Sungsanpin, a lasso peptide from a deep-sea streptomycete",15,12-15
DRAMP03687,FLSLIPSLVGGSISAFK,17,"TsAP-1 (T. serrulatus antimicrobial peptide 1; scorpions, arachnids, invertebrates, animals)",S6CWV8,Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short antimicrobial peptide (group 4) family.,Not found,Tityus serrulatus (Brazilian yellow scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer",Protein level,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer activity against HI57 and H838.","[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=120 μM, MBC>160 μM);##Gram-negative bacteria : Escherichia coli(MIC=160 μM, MBC>160 μM);##Fungi : Candida albicans(MIC=160 μM, MBC>160 μM)","[Ref.23770440] 0% hemolysis at 40 μM , 2% hemolysis at 80 μM , 5% hemolysis at 120 μM , 7% hemolysis at 160 μM against horse red blood cells",Linear,Free,Amidation,Free,L,Not included yet,Not found,23770440,Biochimie. 2013 Jun 14. doi: 10.1016/j.biochi.2013.06.003.,"Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C.","Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",17,15-18
DRAMP03688,FLGMIPGLIGGLISAFK,17,"TsAP-2 (T. serrulatus antimicrobial peptide 2; scorpions, arachnids, invertebrates, animals)",No entry found,Not found,Not found,Tityus serrulatus (Brazilian yellow scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal, Anti-cancer",Not found,Not found,Not found,,"Function: TsAP-2 was of high potency against the Gram-positive bacterium, Staphylococcus aureus and the yeast Candida albicans.",Gram-positive bacterium: Staphylococcus aureus (MIC=5 µM).##Yeast: Candida albicans (MIC=10 µM). ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Not found,23770440,Biochimie. 2013 Jun 14. pii: S0300-9084(13)00164-8.,"Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C.","Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",17,15-18
DRAMP03700,FLWGLIPGAISAVTSLIKK,19,"Antimicrobial peptide ctriporin (Riporin; Arthropods, animals)",G1FE62,Not found,Not found,Chaerilus tricostatus (Scorpion),"Antimicrobial, Antibacterial, Anti-Gram+",Transcript level,Not found,Not found,,"Function: Antimicrobial peptide that acts by breaking the cell wall. Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Is efficient in curing staphylococcal skin infection in mice, when externally applied.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Has no activity against Gram-negative bacteria (E.coli and P.aeruginosa).","Gram-positive bacteria: Staphylococcus aureus (MIC=5 µg/ml), Micrococcus luteus (MIC=5 µg/ml), Bacillus thuringiensis (MIC=10 µg/ml), B. subtilis (MIC=10 µg/ml).##Fungi: Candida albicans (MIC=20 µg/ml).##Antibiotic-resistant pathogens: methicillin-resistant Staphylococcus aureus (MIC=5-10 µg/ml), penicillin-resistant S. epidermidis (MIC=10 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Cell membrane,21876042,Antimicrob Agents Chemother. 2011 Nov;55(11):5220-9.,"Fan Z, Cao L, He Y, Hu J, Di Z, Wu Y, Li W, Cao Z.","Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus.",19,18-21
DRAMP03702,LFGLIPSLIGGLVSAFK,17,"Mucroporin (Antimicrobial peptide 36.21; Arthropods, animals)",B9UIY3,Belongs to the short cationic antimicrobial peptide family,Not found,Lychas mucronatus (Chinese swimming scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria. Its synthetic analog mucroporin-M1 is more effective.
Tissue specificity: Expressed by the venom gland. 
Miscellaneous: Minimum inhibitory concentrations (MIC) for Mucroporin-1 analog are the following: MIC=12.5 µg/ml against E.coli AB94012, MIC=100 µg/ml against P.aeruginosa AB93066, MIC=25 µg/ml against B.thuringiensis AB92037, MIC=25 µg/ml against B.subtilis AB91021, MIC=5 µg/ml against S.aureus AB94004, and MIC=5 µg/ml against the methicillin-resistant coagulase-negative Staphylococcus. Furthermore, this analog is as effective against antibiotic-resistant pathogens as it is against antibiotic-sensitive pathogens.","Gram-negative bacteria: Escherichia coli AB94012 (MIC>100 µg/ml), Pseudomonas aeruginosa AB93066 (MIC>100 µg/ml);##Gram-positive bacteria: Bacillus thuringiensis AB92037 (MIC=25 µg/ml), Bacillus subtilis AB91021 (MIC=50 µg/ml), Staphylococcus aureus AB94004 (MIC=25 µg/ml), Methicillin-resistant coagulase-negative S. aureus (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Cell membrane,20663230##18779362,BMC Genomics. 2010 Jul 28;11:452.##Antimicrob Agents Chemother. 2008 Nov;52(11):3967-3972.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.##Dai C, Ma Y, Zhao Z, Zhao R, Wang Q, Wu Y, Cao Z, Li W.","Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.##Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus.",17,15-18
DRAMP03706,FLFSLIPHAIGGLISAFK,18,"Antimicrobial peptide 1 (AamAP1; Arthropods, animals)",G8YYA5,Not found,ap1,Androctonus amoreuxi (African fattail scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antibacterial and antifungal activity. Causes hemolysis on horse erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-termianal amidation.",Gram-positive bacterium: Staphylococcus aureus (MIC=20 µM);##Gram-negative bacterium: Escherichia coli (MIC=150 µM).##Yeast: Candida albicans (MIC=64 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Cell membrane,22484288,Peptides. 2012 Jun;35(2):291-299.,"Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.","Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog.",18,15-18
DRAMP03707,FPFSLIPHAIGGLISAIK,18,"Antimicrobial peptide 2 (AamAP2; Arthropods, animals)",G8YYA6,Not found,ap2,Androctonus amoreuxi (African fattail scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antibacterial and antifungal activity. Causes hemolysis on horse erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-termianal amidation.",Gram-positive bacterium: Staphylococcus aureus (MIC=48 µM);##Gram-negative bacterium: Escherichia coli (MIC=120 µM).##Yeast: Candida albicans (MIC=64 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Cell membrane,22484288,Peptides. 2012 Jun;35(2):291-299.,"Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.","Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog.",18,15-18
DRAMP01393,GLFGKSSVWGRKYYVDLAGCAKA,23,"Odorranain-W1 (OdW1; Frogs, amphibians, animals)",A6MBS8,Not found,Not found,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,,Function: Odorranain-W1 has hemolytic activity against rabbit red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=12.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.30 μg/ml), Bacillus subtilis (MIC=6.30 μg/ml).##Yeast: Candida albicans (MIC=3.15 μg/ml).","[Ref.17272268] RCH=17.6 ± 2.2% against rabbit red blood cells. RCH, red cell hemolysis.",Linear,Free,Free,Free,L,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,23,21-24
DRAMP03724,FWGALAKGALKLIPSLFSSFSKKD,24,"Pandinin-2 (Pin2; Arthropods, animals)",P83240,Belongs to the scorpion NDBP 4 family,Not found,Pandinus imperator (Emperor scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Hemolytic",Protein level,Alpha helix ,Not found,,"Function: Disrupts cell membranes through formation of pores. Has strong antimicrobial activity against Gram-positive bacteria and less active against Gram-negative bacteria. Possesses antifungal activity against C. albicans and hemolytic activity against sheep and pig erythrocytes.
Tissue specificity: Expressed by the venom gland.","[Ref.11563967]Gram-negative bacteria: Pseudomonas aeruginosa (MIC=38.2 µM), Escherichia coli (MIC=19.1 µM);#Gram-positive bacteria: Enterococcus faecalis (MIC=2.4 µM), Bacillus subtilis (MIC=4.8 µM), Staphylococcus epidermidis (MIC=4.8 µM), Staphylococcus aureus (MIC=2.4 µM);##Yeast: Candida albicans (MIC=19.1 µM).",[Ref.11563967]Strong hemolytic activity (11.1-44.5 microM) against sheep erythrocytes,Linear,Free,Free,Free,L,Not included yet,Cell membrane,11563967##15328050##15298871,Biochem J. 2001 Oct 1;359(Pt 1):35-45.##Biochim Biophys Acta. 2004 Aug 30;1664(2):182-188.##Biophys J. 2004 Oct;87(4):2497-507. ,"Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T.##Belokoneva OS, Satake H, Mal'tseva EL, Pal'mina NP, Villegas E, Nakajima T, Corzo G.##Nomura K, Corzo G, Nakajima T, Iwashita T.",Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.##Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size.##Orientation and pore-forming mechanism of a scorpion pore-forming peptide bound to magnetically oriented lipid bilayers.,24,21-24
DRAMP02926,KWCFRVCYRGICYRRCR,17,"Tachyplesin I (Tac; TP1; Horseshoe Crab, arachnids, Chelicerata, arthropods, invertebrates, animals)",P14213,Belongs to the tachyplesin/polyphemusin family.,Not found,Tachypleus tridentatus (Japanese horseshoe crab),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Anti-HIV, Anti-cancer",Protein level,Beta strand,This stability is due to the rigid structure imposed by the two disulfide linkages. Its amphipathic nature is closely associated with biological activity. A ,"1MA2, 1MA5, 6PIN, 1WO0, 1WO1, 2MDB, 2RTV resolved by NMR.","Function:  Significantly inhibits the growth of Gram-negative and Gram-positive bacteria, also anti-HIV activity may be due to the inhibition of virual adsorption to cells.
PTM: Contains two disulfide bonds 3-16; 7-12 and Arginine amide at R17.",No MICs found in DRAMP database,[Ref.29870123] 9.6% hemolytic activity at 8 μg/mL and 72.8% hemolytic activity at 512 μg/mL against human red blood cells.,Cyclic,Free,Amidation (Arg17),"Disulfide bond between Cys3 and Cys16,Cys7 and Cys12.",L,"[Ref.28429216]It possessed a cytotoxic effect on HL-60 cells (acutehuman promyelocytic leukemia cells) , K562 cells(myelogenous leukemia cells) , TSU cells (prostatecancer cells) .",Cell membrane,12369825##2229025##31455019,Biochemistry 2002; 41: 12359.##J Biochem. 1990 Aug;108(2):261-266.##Int J Mol Sci. 2019 Aug 26;20(17):4184.,"Laederach A, Andreotti AH, Fulton, DB.##Muta T, Fujimoto T, Nakajima H, Iwanaga S.##Vernen F, Harvey PJ, Dias SA, Veiga AS, Huang YH, Craik DJ, Lawrence N, Troeira Henriques S.","Solution and Micelle-Bound Structures of Tachyplesin I and its Active Aromatic Linear Derivatives.##Tachyplesins isolated from hemocytes of Southeast Asian horseshoe crabs (Carcinoscorpius rotundicauda and Tachypleus gigas): identification of a new tachyplesin, tachyplesin III, and a processing intermediate of its precursor.##Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.",17,15-18
DRAMP03751,FFGHLFKLATKIIPSLFQ,18,"Venom antimicrobial peptide-9 (Meucin-18; NDBP-5; Arthropods, animals)",E4VP50,Belongs to the ponericin-W family,Not found,Mesobuthus eupeus (Lesser Asian scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix,Not found,,"Function: Amphipathic peptide that exhibits extensive cytolytic activities against both prokaryotic and eukaryotic cells. Is more potent against Gram-positive bacteria (lethal concentration (LC=1.5-10.9 µM) than against Gram-negative bacteria (LC=6.2-50 µM), and fungi (LC=25.1-8.3 µM). Is lethal to the fungus Beauveria sp (LC=1.9 µM), a highly lethal pathogenic fungus to insects and resistant to many AMPs. Shows hemolytic activity against rabbit erythrocytes and cytolysis against rat dorsal root ganglions. In vivo, intravenous injection into mice tail provokes uncomfortable symptoms with a death rate of 12.5%.
Tissue specificity: Expressed by the venom gland.","[Ref.19088182]Gram-positive bacteria: Bacillus sp. DM-1 (MIC=0.60 µM), Micrococcus luteus (MIC=0.60 µM), Bacillus megaterium (MIC=0.25 µM);##Gram-negative bacteria: Agrobacterium tumefaciens (MIC=6.00 µM), Escherichia coli (MIC=2.40 µM), Shewanella oneidensis (MIC=1.50 µM), Stenotrophomonus sp. YC-1(MIC=2.60 µM), Salmonella typhimurium (MIC=10.9 µM);##Fungi: Beauveria spp.(MIC=1.9 µM), Neurospora crassa (MIC=5.2 µM), Candida albicans (MIC=25.1 µM), Saccharomyces cerevisiae (MIC=25.1 µM), Aspergillus fumigatus (MIC=8.3 µM), Geotrichum candidum (MIC=3.5 µM).","[Ref.19088182]74% hemolytic activity at 6.25 M, 100% hemolytic activity at 12.5 M against rabbit red blood cells",Linear,Free,Free,Free,L,Not included yet,Cell membrane,19088182,FASEB J. 2009 Apr;23(4):1230-1245.,"Gao B, Sherman P, Luo L, Bowie J, Zhu S.",Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides.,18,15-18
DRAMP03752,FLFSLIPSAISGLISAFK,18,"Peptide BmKb1 (Non-disulfide-bridged peptide 4.2, NDBP-4.2; Arthropods, animals)","Q718F4, Q2M5D6 Q95P85",Not found,Kb1,Mesobuthus martensii (Manchurian scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Micrococcus luteus(MIC=81.5 µg/ml), Bacillus subtilis (MIC=48.8 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=18.1 µg/ml), Pseudomonas aeruginosa (MIC=90.8 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,Not included yet,Cell membrane (Forms a helical membrane channel in the prey),15062994##16040157,Peptides. 2004 Feb;25(2):143-150.##Peptides. 2005 Dec;26(12):2427-2433.,"Zeng XC, Wang SX, Zhu Y, Zhu SY, Li WX.##Luo F, Zeng XC, Hahin R, Cao ZJ, Liu H, Li WX.",Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch.##Genomic organization of four novel nondisulfide-bridged peptides from scorpion Mesobuthus martensii Karsch: gaining insight into evolutionary mechanism.,18,15-18
DRAMP03815,GILDTLKQFAKGVGKWLVKGAAQ,23,D16W-N23 (single amino acid substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Comment: Single substitution of aspartic acid 16 by tryptophan (D16W) in the Delta24-37 GGN4, which is a peptide analogue with 14 residues truncated from the C-terminus of GGN4.","Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Bacillus subtilis (MIC=25 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 µg/ml), Shigella dysentariae (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=125 µg/ml), Eshchericia coli (MIC=25 µg/ml), Salmonella typhimurium (MIC=125 µg/ml).","[Ref.12199716] 0.02% hemolytic activity at 10 µg/mL, 0.38% hemolytic activity at 100 µg/mL against human red blood cells.",Linear,Free,Free,Free,L,Not included yet,Not found,12199716,Eur J Biochem. 2002 Sep;269(17):4367-4374.,"Won HS, Park SH, Kim HE, Hyun B, Kim M, Lee BJ, Lee BJ.",Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,23,21-24
DRAMP03816,GILDTLKQFAKGVGKFLVKGAAQ,23,D16F-N23 (single amino acid substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Comment: Single substitution of aspartic acid 16 by phenylalanine (D16F) in the Delta24-37 GGN4, which is a peptide analogue with 14 residues truncated from the C-terminus of GGN4.","Gram-positive bacterium: Bacillus subtilis (MIC=25 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=100 µg/ml), Shigella dysentariae (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=200 µg/ml), Eshchericia coli (MIC=25 µg/ml).","[Ref.12199716] 0.06% hemolytic activity at 10 µg/mL, 0.32% hemolytic activity at 100 µg/mL against human red blood cells.",Linear,Free,Free,Free,L,Not included yet,Not found,12199716,Eur J Biochem. 2002 Sep;269(17):4367-4374.,"Won HS, Park SH, Kim HE, Hyun B, Kim M, Lee BJ, Lee BJ.",Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,23,21-24
DRAMP03825,KKLGAPSITCVRRAFA,16,CNBr-cleaved lactoferricin Subfragment 2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Subfragment 2 had weak antibacterial activity against L. monocytogenes and both E. coli isolates, being effective in the range of 40 to 60 µM.","Gram-negative bacteria: Escherichia coli L361 (MIC=50 µM), Pseudomonas fluorescens (MIC>100 µM), Salmonella Salford (MIC>100 µM), Escherichia coli O:9 (MIC=60 µM);##Gram-positive bacteria: Bacillus cereus (MIC>100 µM), Listeria monocytogenes (MIC=40 µM), Staphylococcus aureus (MIC>100 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,8980754,Antimicrob Agents Chemother. 1997 Jan;41(1):54-59.,"Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R.",Antibacterial activity in bovine lactoferrin-derived peptides.,16,15-18
DRAMP03826,KNLRRIIRKIIHIIKKYG,18,Ovispirin-1 (OV-1; N-terminal 18 amino acids of SMAP-29),No entry found,Not found,Not found,Synthetic construct,"Antibacterial, Cytotoxic, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 13 residues),Ovispirin-1 is a uniform α-helix over residues 4-16. ,1HU5 resolved by NMR.,"Function: Possess potently antimicrobial activity. It is also highly cytotoxic to human epithelial cells (ME-180 cervical cells: 100% at 200 µg/ml, 93.6% at 50 µg/ml, 55.3% at 25 µg/ml) and A-549 pulmonary cells: 99.7% at 200 µg/ml, 99.4% at 50 µg/ml, 90.9% at 25 µg/ml) and hemolytic for human Human red blood cells.","[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.7-5.6 µg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.5-2.2 µg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD [n=3] (MIC=1.5±0.3 µg/ml), Staphylococcus aureus 930918 [n=3] (MIC=1.0±0.13 µg/ml).","[Ref.11932493]55% hemolytic at 40 µg/mL, 70.2% hemolytic activity at 80 µg/mL against human red blood cells",Linear,Free,Free,Free,L,Not included yet,Not found,11932493,Protein Eng. 2002 Mar;15(3):225-232.,"Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.",Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.,18,15-18
DRAMP03827,KNLRRIIRKGIHIIKKYG,18,Novispirin G-10 (mutation of Ovispirin-1),No entry found,Not found,Not found,Synthetic construct,"Antibacterial, Cytotoxic, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (2 helices; 11 residues),"Novispirin G-10 shows an α-helix-hinge-310 helix structural motif with residues 4-11 forming the α-helix, residues 12 and 13 forming the hinge and residues 14-16 forming the 310 helix.",1HU6 resolved by NMR.,"Function: Possess potently antimicrobial activity. Also has hemolytic activity against Human red blood cells, and has cytotoxicity activity against ME-180 cervical cells (33.2% at 200 µg/ml, 5.0% at 50 µg/ml, 7.1% at 25 µg/ml) and A-549 pulmonary cells (33.2% at 200 µg/ml, 14.6% at 50 µg/ml, 10.0% at 25 µg/ml).","[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.11-12.7 µg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.29-3.6 µg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD [n=3] (MIC=1.4±0.4 µg/ml), Staphylococcus aureus 930918 [n=3] (MIC=4.6±1.7 µg/ml).","[Ref.11932493]1.8% hemolytic at 40 µg/mL, 2.5% hemolytic activity at 80 µg/mL against human red blood cells",Linear,Free,Free,Free,L,Not included yet,Not found,11932493,Protein Eng. 2002 Mar;15(3):225-232.,"Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.",Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.,18,15-18
DRAMP03828,KNLRRITRKIIHIIKKYG,18,Novispirin T-7 (mutation of Ovispirin-1),No entry found,Not found,Not found,Synthetic construct,"Antibacterial, Cytotoxic, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 11 residues),Novispirin T-7 is a well-defined α-helix over residues 7-17 with residues 3-6 forming a type IV turn.,1HU7 resolved by NMR.,"Function: Possess potently antimicrobial activity. Also has hemolytic activity against Human red blood cells, and has cytotoxicity activity against ME-180 cervical cells (81.5% at 200 µg/ml, 28.4% at 50 µg/ml, 15.6% at 25 µg/ml) and A-549 pulmonary cells (81.5% at 200 µg/ml, 22.9% at 50 µg/ml, 15.4% at 25 µg/ml).","[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.26-27.8 µg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.32-1.75 µg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD (MIC=2.4±1.5 [n=3] µg/ml), Staphylococcus aureus 930918 (MIC=3.3±1.5 [n=3] µg/ml).","[Ref.11932493]3% hemolytic at 40 µg/mL, 10% hemolytic activity at 80 µg/mL against human red blood cells",Linear,Free,Free,Free,L,Not included yet,Not found,11932493,Protein Eng. 2002 Mar;15(3):225-232.,"Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.",Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.,18,15-18
DRAMP03829,GLKKLLGKLLKKLGKLLLK,19,GLK-19,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Anticancer",Synthetic,Not found,Not found,,Function: GLK-19 showed a higher activity against Escherichia coli than human LL-37.,Gram-negative bacterium: Escherichia coli K12 (MIC=10 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,Free,L,Not included yet,Not found,18957441,Nucleic Acids Res. 2009 Jan;37(Database issue):D933-937.,"Wang G, Li X, Wang Z.",APD2: the updated antimicrobial peptide database and its application in peptide design.,19,18-21
DRAMP03835,GKKLFVNVLDKIRCKVAGGC,20,Palustrin-2ISb-des-C7-des-N9,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antifungal",Synthetic,Not found,Not found,,Function: Possess antifungal activity.,Yeast: Candida albicans (MIC=100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization(Cys14 and Cys20).,Disulfide bond between Cys14 and Cys20.,L,No cytotoxicity information found,Not found,21911019,Peptides. 2011 Oct;32(10):2052-2057.,"Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.",Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-8 family isolated from the skin of the endangered frog Odorrana ishikawae.,20,18-21
DRAMP03882,SKCYQWQRRMRKLGA,15,"LFC (fragment of mature caprine lactoferrin, residues 17 to 31)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=252 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03883,TKCFQWQWNMRKVRG,15,LFH W8 (tryptophan-modified human lactoferricin derivative),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=74 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03884,SKCYQWQWRMRKLGA,15,LFC W8 (tryptophan-modified caprine lactoferricin derivative),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=174 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03885,SKCRQWQWKIRRTNP,15,LFP W8 (tryptophan-modified porcine lactoferricin derivative),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=219 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03886,FKCRRWQWRMKKLGA,15,"LFB (fragment of bovine lalctoferricin, residues 17 to 31)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=24 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=48 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives.,15,12-15
DRAMP03887,AKCRRWQWRMKKLGA,15,"LFB A1 (derivative of LFB, residue substitution with alanine at position 1)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=35 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03888,FACRRWQWRMKKLGA,15,"LFB A2 (derivative of LFB, residue substitution with alanine at position 2)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=40 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03889,FKARRWQWRMKKLGA,15,"LFB A3 (derivative of LFB, residue substitution with alanine at position 3)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=51 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=4 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03890,FKCARWQWRMKKLGA,15,"LFB A4 (derivative of LFB, residue substitution with alanine at position 4)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=35 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03891,FKCRAWQWRMKKLGA,15,"LFB A5 (derivative of LFB, residue substitution with alanine at position 5)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=61 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03892,FKCRRWAWRMKKLGA,15,"LFB A7 (derivative of LFB, residue substitution with alanine at position 7)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=15 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=75 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03893,FKCRRWQWAMKKLGA,15,"LFB A9 (derivative of LFB, residue substitution with alanine at position 9)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=28 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03894,FKCRRWQWRAKKLGA,15,"LFB A10 (derivative of LFB, residue substitution with alanine at position 10)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=70 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03895,FKCRRWQWRMAKLGA,15,"LFB A11 (derivative of LFB, residue substitution with alanine at position 11)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=35 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03896,FKCRRWQWRMKALGA,15,"LFB A12 (derivative of LFB, residue substitution with alanine at position 12)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03897,FKCRRWQWRMKKAGA,15,"LFB A13 (derivative of LFB, residue substitution with alanine at position 13)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03898,FKCRRWQWRMKKLAA,15,"LFB A14 (derivative of LFB, residue substitution with alanine at position 14)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=12 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=77 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"StrÃ¸m MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,15,12-15
DRAMP03899,AKCLRWQWEMRKVGG,15,LFM A1 W8 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=391 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03900,AKCLRWQWAMRKVGG,15,"LFM A1,9 W8 (LFM W8 derivative with residues substitution)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=134 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03901,RKCLRWQWEMRKVGG,15,LFM R1 W8 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=37 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=374 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03902,EKCLRWQWRMRKVGG,15,LFM R9 W8 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03903,AKCLRWQWRMRKVGG,15,LFM A1 R9 W8 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=31 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=257 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03904,RKCLRWQWAMRKVGG,15,LFM A9 R1 W8 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=31 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=257 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03905,RKCLRWQWRMRKVGG,15,"LFM R1,9 W8 (LFM W8 derivative with residues substitution)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=10 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=37 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03906,AKCLRWQWEMRKYGG,15,LFM A1 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=151 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03907,AKCLRWQWAMRKYGG,15,"LFM A1,9 W8 Y13 (LFM W8 derivative with residues substitution)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=88 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03908,RKCLRWQWEMRKYGG,15,LFM R1 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=19 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=73 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03909,EKCLRWQWRMRKYGG,15,LFM R9 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=63 µM),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03910,AKCLRWQWRMRKYGG,15,LFM A1 R9 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=40 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03911,RKCLRWQWAMRKYGG,15,LFM A9 R1 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=12 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03912,RKCLRWQWRMRKYGG,15,"LFM R1,9 W8 Y13 (LFM W8 derivative with residues substitution)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=10 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,15,12-15
DRAMP03922,KWKLFKKIGIGAVLKVLTTG,20,Cecropin A (1-8)-melittin (1-12)hybrid peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.4 µM), Pseudomonas aeruginosa OT97 (MIC=0.9 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 µM), Bacillus megaterium Bm11 (MIC=0.2 µM), Staphylococcus aureus Cowan 1 (MIC=2 µM), Streptococcus pyogenes (MIC=0.1 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,20,18-21
DRAMP03923,KWKLFKKIGIGAVLKVLT,18,Cecropin A (1-8)-melittin (1-10)hybrid peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 µM), Pseudomonas aeruginosa OT97 (MIC=3 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 µM), Bacillus megaterium Bm11 (MIC=0.5 µM), Staphylococcus aureus Cowan 1 (MIC=7 µM), Streptococcus pyogenes (MIC=0.8 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,18,15-18
DRAMP03924,KWKLFKKGIGAVLKV,15,Cecropin A (1-7)-melittin (1-8)hybrid peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=4 µM), Pseudomonas aeruginosa OT97 (MIC=15 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=1.4 µM), Bacillus megaterium Bm11 (MIC=0.8 µM), Staphylococcus aureus Cowan 1 (MIC=29 µM), Streptococcus pyogenes (MIC=0.7 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,15,12-15
DRAMP03925,KWKLFKKGAVLKVLT,15,Cecropin A (1-7)-melittin (3-10)hybrid peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=3 µM), Pseudomonas aeruginosa OT97 (MIC=15 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=3 µM), Bacillus megaterium Bm11 (MIC=0.9 µM), Staphylococcus aureus Cowan 1 (MIC>200 µM), Streptococcus pyogenes (MIC=1 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,15,12-15
DRAMP03927,KWKLFKKIGAVLKVL,15,Cecropin A (1-7)-melittin (2-9)hybrid peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix (1 helices; 10 residues),Adopts an amphipathic helix almost parallel to the surface of the micelle.,2JMY resolved by NMR.,CAMEL is also a hybrid peptide obtained by combining residues 1-7 of cecropin (CA) and residues 2-9 of melittin (M).,"Gram-negative bacteria: Escherichia coli D21 (MIC=1 µM), Pseudomonas aeruginosa OT97 (MIC=4 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.5 µM), Bacillus megaterium Bm11 (MIC=0.7 µM), Staphylococcus aureus Cowan 1 (MIC=2 µM), Streptococcus pyogenes (MIC=0.5 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1733777##17397158,FEBS Lett. 1992 Jan 20;296(2):190-194.##J Am Chem Soc. 2007 Apr 25;129(16):5228-5234.,"Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.##Respondek M, Madl T, Göbl C, Golser R, Zangger K.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.##Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves.,15,12-15
DRAMP03928,KWKLFKKAVLKVLTT,15,Cecropin A (1-7)-melittin (4-11)hybrid peptide (CAM),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.6 µM), Pseudomonas aeruginosa OT97 (MIC=4 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.6 µM), Bacillus megaterium Bm11 (MIC=0.5 µM), Staphylococcus aureus Cowan 1 (MIC=8 µM), Streptococcus pyogenes (MIC=0.7 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1733777##20111863,FEBS Lett. 1992 Jan 20;296(2):190-194.##Curr Microbiol. 2010 Sep;61(3):169-175.,"Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.##Cao Y, Yu RQ, Liu Y, Zhou HX, Song LL, Cao Y, Qiao DR.","Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.##Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides.",15,12-15
DRAMP03929,KWKLFKKVLKVLTTG,15,Cecropin A (1-7)-melittin (5-12)hybrid peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 µM), Pseudomonas aeruginosa OT97 (MIC=2 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 µM), Bacillus megaterium Bm11 (MIC=0.5 µM), Staphylococcus aureus Cowan 1 (MIC=8 µM), Streptococcus pyogenes (MIC=0.4 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,15,12-15
DRAMP03930,KWKLFKKLKVLTTGL,15,Cecropin A (1-7)-melittin (6-13)hybrid peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=2 µM), Pseudomonas aeruginosa OT97 (MIC=8 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=1 µM), Bacillus megaterium Bm11 (MIC=0.5 µM), Staphylococcus aureus Cowan 1 (MIC=51 µM), Streptococcus pyogenes (MIC=0.4 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,15,12-15
DRAMP03935,VPIIYCNRRTGKCQRM,16,"V16M (truncated isoform of thanatin, residue 6-21)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-positive bacteria: Aerococcus viridans (MIC=1.2-2.5 µM), Micrococcus luteus (MIC=2.5-5 µM), Bacillus megaterium (MIC=5-10 µM), Bacillus subtilis (MIC=20-40 µM), Pediococcus acidilactici (MIC=20-40 µM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.6-1.2 µM), Escherichia coli D31 (MIC=0.6-1.2 µM), Klebsiella pneumoniae (MIC=2.5-5 µM), Enterobacter cloacae (MIC=5-10 µM), E. carotovora (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=10-20 µM), Botrytis cinerea (MIC=10-20 µM), Nectria haematococca (MIC=5-10 µM), Trichoderma viride (MIC=20-40 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=10-20 µM), A. pisi (MIC=20-40 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8577744,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",16,15-18
DRAMP03936,KPVPIIYCNRRTGKCQRM,18,"K18M (truncated isoform of thanatin, residue 4-21)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-positive bacteria: Aerococcus viridans (MIC=0.6-1.2 µM), Micrococcus luteus (MIC=1.2-2.5 µM), Bacillus megaterium (MIC=2.5-5 µM), Bacillus subtilis (MIC=20-40 µM), Pediococcus acidilactici (MIC=20-40 µM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.3-0.6 µM), Escherichia coli D31 (MIC=0.3-0.6 µM), Escherichia coli 1106 (MIC=0.6-1.2 µM), Salmonella typhimuriumn (MIC=1.2-2.5 µM), Klebsiella pneumoniae (MIC=1.2-2.5 µM), Enterobacter cloacae (MIC1.2-2.5 µM), E. carotovora (MIC=20-40 µM), Pseudomonas aeruginosa (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=2.5-5 µM), Botrytis cinerea (MIC=1.2-2.5 µM), Nectria haematococca (MIC=5-10 µM), Trichoderma viride (MIC=2.5-5 µM), Alternaria brassicicola (MIC=2.5-5 µM), Fusarium culmorum (MIC=5-10 µM), A. pisi (MIC=10-20 µM), Fusarium oxysporumn (MIC=20-40 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8577744,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",18,15-18
DRAMP03937,GSKKPVPIIYCNRRTGKC,18,"G18C (truncated isoform of thanatin, residue 1-18)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-positive bacteria: Aerococcus viridans (MIC=2.5-5 µM), Micrococcus luteus (MIC=1.2-2.5 µM), Bacillus megaterium (MIC=5-10 µM), Bacillus subtilis (MIC=5-10 µM), Pediococcus acidilactici (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=10-20 µM), Botrytis cinerea (MIC=5-10 µM), Nectria haematococca (MIC=5-10 µM), Trichoderma viride (MIC=20-40 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=10-20 µM), A. pisi (MIC=20-40 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8577744,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",18,15-18
DRAMP03938,GSKKPVPIIYCNRRTGKCQ,19,"G19Q (truncated isoform of thanatin, residue 1-19)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-positive bacteria: Aerococcus viridans (MIC=2.5-5 µM), Micrococcus luteus (MIC=5-10 µM), Bacillus megaterium (MIC=5-10 µM), Pediococcus acidilactici (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=10-20 µM), Botrytis cinerea (MIC=5-10 µM), Nectria haematococca (MIC=5-10 µM), Trichoderma viride (MIC=10-20 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=10-20 µM), A. pisi (MIC=20-40 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8577744,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",19,18-21
DRAMP03939,GSKKPVPIIYCNRRTGKCQR,20,"G20R (truncated isoform of thanatin, residue 1-20)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-positive bacteria: Aerococcus viridans (MIC=2.5-5 µM), Micrococcus luteus (MIC=2.5-5 µM), Bacillus megaterium (MIC=2.5-5 µM), Bacillus subtilis (MIC20-40 µM), Pediococcus acidilactici (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=5-10 µM), Botrytis cinerea (MIC=5-10 µM), Nectria haematococca (MIC=2.5-5 µM), Trichoderma viride (MIC=10-20 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=10-20 µM), A. pisi (MIC=10-20 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8577744,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",20,18-21
DRAMP03945,LIKIVPAMICAVTKKC,16,Del 1-4 (Ranalexin analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC=256 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 µg/ml), Pseudomonas aeruginosa (MIC=256 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",16,15-18
DRAMP03947,GGLIKIVPAMICAVTKKC,18,Del 1-2 (Ranalexin analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC=256 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC>256 µg/ml), Pseudomonas aeruginosa (MIC>256 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",18,15-18
DRAMP03948,LGGLIKIVPAMICAVTKKC,19,Del 1 (Ranalexin analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC=256 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 µg/ml), Pseudomonas aeruginosa (MIC>256 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",19,18-21
DRAMP03949,FLGGLIKIVPAMICAVTKK,19,Del 20 (Ranalexin analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC=128 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 µg/ml), Pseudomonas aeruginosa (MIC=128 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",19,18-21
DRAMP03958,TLRGDERILSILRHQNLLKE,20,CGA41-60 (hrVS-1-derived peptide),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Fungi: Neurospora crassa (MIC=100 µM), Nectria haematococca (MIC=30 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10753865,J Biol Chem. 2000 Apr 14;275(15):10745-10753.,"Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.","Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",20,18-21
DRAMP03960,RILSILRHQNLLKELQDLALQGAK,24,CGA47-70 (hrVS-1-derived peptide),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Fungi: Neurospora crassa (MIC=5 µM), Aspergillus fumigatus (MIC=30 µM), Alternaria brassicicola (MIC=10 µM), Nectria haematococca (MIC=7 µM), Fusarium culmorum (MIC=10 µM), F. oxyporum (MIC=30 µM), Trichophyton mentagrophytes (MIC=30 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10753865,J Biol Chem. 2000 Apr 14;275(15):10745-10753.,"Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.","Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",24,21-24
DRAMP03967,KWKLFKKIPKFLHLAKKF,18,P18 (Cecropin A(1-8)-Magainin 2(1−12) hybrid peptide analogue),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Alpha helix ,Not found,,MOA: P18 kills cancer cells by disrupting membranes (Tang C et al 2010 Org Biomol Che 8:984-7). ,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=1.56 µM), Bacillus megaterium KCTC 1096 (MIC=0.78 µM).##Tumor cells: MDA-MB-361 (IC50=8.0 µM), Jurkat (IC50=4.0 µM), K-562 (IC50=3.5 µM), Normal cells NIH 3T3 (IC50=75.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,12005420##12370027,J Pept Res. 2001 Dec;58(6):504-514.##Protein Pept Lett. 2002 Oct;9(5):395-402.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.##Lee SH, Lee DG, Yang ST, Kim Y, Kim JI, Hahm KS, Shin SY.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.##Antibiotic activity of reversed peptides of alpha-helical antimicrobial peptide, P18.",18,15-18
DRAMP03968,KWKLFKKILKFLHLAKKF,18,[L9]-P18 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 µM), Proteus vulgaris (MIC=6.25 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=3.0 µM), Jurkat (IC50=9.0 µM), K-562 (IC50=3.0 µM), Normal cells NIH 3T3 (IC50=70.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",18,15-18
DRAMP03969,KWKLFKKISKFLHLAKKF,18,[S9]-P18 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=25.0 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=6.25 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=4.0 µM), Jurkat (IC50=7.0 µM), K-562 (IC50=3.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",18,15-18
DRAMP03970,WKLFKKIPKFLHLAKKF,17,N-1 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=9.5 µM), Jurkat (IC50=12.0 µM), K-562 (IC50=6.0 µM), Normal cells NIH 3T3 (IC50=75.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",17,15-18
DRAMP03971,FKLFKKIPKFLHLAKKF,17,N-2 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=0.78 µM).##Tumor cells: MDA-MB-361 (IC50=11.0 µM), Jurkat (IC50=11.0 µM), K-562 (IC50=7.0 µM), Normal cells NIH 3T3 (IC50=70.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",17,15-18
DRAMP03972,KWFKKIPKFLHLAKKF,16,N-3 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=17.0 µM), Jurkat (IC50=17.0 µM), K-562 (IC50=11.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",16,15-18
DRAMP03973,WFKKIPKFLHLAKKF,15,N-4 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=32.0 µM), Jurkat (IC50=23.0 µM), K-562 (IC50=24.0 µM), Normal cells NIH 3T3 (IC50=100.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",15,12-15
DRAMP03975,KWFKKIPKFLHLLKKF,16,N-3L (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=1.56 µM), Bacillus megaterium KCTC 1096 (MIC=0.78 µM).##Tumor cells: MDA-MB-361 (IC50=5.0 µM), Jurkat (IC50=4.0 µM), K-562 (IC50=4.2 µM), Normal cells NIH 3T3 (IC50=50.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",16,15-18
DRAMP03976,WFKKIPKFLHLLKKF,15,N-4L (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=12.5 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=0.78 µM).##Tumor cells: MDA-MB-361 (IC50=5.0 µM), Jurkat (IC50=6.0 µM), K-562 (IC50=3.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",15,12-15
DRAMP03978,KWKLFKKIPFLHLAKKF,17,C-1 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=26.0 µM), Jurkat (IC50=32.0 µM), K-562 (IC50=31.0 µM), Normal cells NIH 3T3 (IC50=100.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",17,15-18
DRAMP03979,KWKLFKKIPKFLHLAKK,17,C-2 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=38.0 µM), Jurkat (IC50=26.0 µM), K-562 (IC50=23.0 µM), Normal cells NIH 3T3 (IC50=100.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",17,15-18
DRAMP03980,KWKLFKKIPLHLAKKF,16,C-3 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25-12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78-1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=79.0 µM), Jurkat (IC50=74.0 µM), K-562 (IC50=62.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",16,15-18
DRAMP03981,KWKLFKKIPKFLHLAK,16,C-4 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125-6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=54.0 µM), Jurkat (IC50=31.0 µM), K-562 (IC50=25.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",16,15-18
DRAMP03982,KWKLFKKIPHLAKKF,15,C-5 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=12.5 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=100.0 µM), Jurkat (IC50=81.0 µM), K-562 (IC50=67.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",15,12-15
DRAMP03983,KWKLFKKIPKFLHLA,15,C-6 (analog of P18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25-12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=47.0 µM), Jurkat (IC50=21.0 µM), K-562 (IC50=27.0 µM), Normal cells NIH 3T3 (IC50=100.0 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",15,12-15
DRAMP04011,GVVTDLLKTAGKLLGNLFGSLSG,23,Plasticin PD36 KF (analog of PD36),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.,"[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=6.5 µM), Bacillus megaterium ATCC 9885 (MIC=50.25 µM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=6.5 µM), Salmonella typhimurium CIP 6062 (MIC=25.25 µM), Enterobacter cloacae ATCC 11775 (MIC=12.5 µM).","[Ref.17128968]25% hemolytic at 50 μM, 50% hemolytic activity at 100 μM against rat red blood cells",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17128968,Biochemistry 2006; 45: 14285-14297.,Amri CE et al Bruston F.,"The plasticins: membrane adsortpion, lipid disorders, and biological activity.",23,21-24
DRAMP04012,GVVTDLLKTAGKLLGNLVGSLSG,23,Plasticin PD36 K (analog of PD36),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.,"[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=50.5 µM), Bacillus megaterium ATCC 9885 (MIC=12.5 µM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=12.5 µM).","[Ref.17128968]35% hemolytic at 50 μM, 71% hemolytic activity at 100 μM against rat red blood cells",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17128968,Biochemistry 2006; 45: 14285-14297.,Amri CE et al Bruston F.,"The plasticins: membrane adsortpion, lipid disorders, and biological activity.",23,21-24
DRAMP04013,GLVTGLLKTAGKLLGDLFGSLTG,23,Plasticin ANC KF (analog of natural peptide ANC),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.,"[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=12.5 µM), Bacillus megaterium ATCC 9885 (MIC=12.5 µM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=25 µM).","[Ref.17128968]22% hemolytic at 50 μM, 48% hemolytic activity at 100 μM against rat red blood cells",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17128968,Biochemistry 2006; 45: 14285-14297.,Amri CE et al Bruston F.,"The plasticins: membrane adsortpion, lipid disorders, and biological activity.",23,21-24
DRAMP04016,LLGDFFRKAKEKIGKEFKRIVQR,23,LL-23A9 (LL-23 variants),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negagtive bacteria: Escherichia coli DC2 (MIC=9 µM), Escherichia coli K12 (MIC=80 µM);##Gram-positive bacteria: Staphylococcus aureus mprF (presence of carbonate) (MIC=0.35-0.7 µM), S. aureus mprF (absence of carbonate) (MIC=6 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22185690,Biochemistry. 2012 Jan 17;51(2):653-664. ,"Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.","Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",23,21-24
DRAMP04017,LLGDFFRKVKEKIGKEFKRIVQR,23,LL-23V9 (LL-23 variants),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli DC2 (MIC=2 µM), Escherichia coli K12 (MIC=40 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 µM), S. aureus mprF (presence of carbonate) (MIC=0.35-0.7 µM), S. aureus mprF (absence of carbonate) (MIC=6 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22185690,Biochemistry. 2012 Jan 17;51(2):653-664. ,"Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.","Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",23,21-24
DRAMP04055,RRLCRIVWVIRVCRR,15,BacW2R (cyclic derivative of bactenecin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=2 µg/ml), Pseudomonas aeruginosa K799 (MIC=2 µg/ml), Salmonella typhimurium 14028s (MIC=2 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µg/ml), Staphylococcus epidermidis C621 (MIC=1 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=2 µg/ml), Listeria monocytogenes (MIC=0.25 µg/ml), Corynebacterium xerosis (MIC=0.25 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=1 µg/ml), S. mitis (MIC=0.25 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=8 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",15,12-15
DRAMP18363,CVWGGDCTDFLGCGTAWICV,20,Sviceucin (bacteriocin),No entry found,Not found,Not found,Streptomyces sviceus,"Antimicrobial, Antibacterial, Anti-Gram+",,Beta,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: B. megaterium, L. bulgaricus 340, S. aureus subsp. aureus ATCC 6538, L. sakei subsp. sakei DSM 20017.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipid II,26343290,ACS Chem Biol. 2015 Nov 20;10(11):2641-9.,"Li Y, Ducasse R, Zirah S, Blond A, Goulard C, Lescop E, Giraud C, Hartke A, Guittet E, Pernodet JL, Rebuffat S.",Characterization of Sviceucin from Streptomyces Provides Insight into Enzyme Exchangeability and Disulfide Bond Formation in Lasso Peptides,20,18-21
DRAMP04064,CVKCKCKCGSGVKVKVKVC,19,Cyclic cationic V1 peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antibacterial activiy. Has hemolytic activity against human erythrocytes, and also Cytotoxic activity against THP-1 cells (EC50=0.045 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=5 nM), Pseudomonas aeruginosa ATTC 27853 (MIC>619 nM), Klebsiella pneumoniae ATTC 13883 (MIC=145 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).",[Ref.15328096]EC50=880000 nM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,19,18-21
DRAMP04065,CVKVSVKVGSGVKVSVKVC,19,Cyclic cationic V2 peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=5.6 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=5 nM), Pseudomonas aeruginosa ATTC 27853 (MIC>643 nM), Klebsiella pneumoniae ATTC 13883 (MIC=643 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).",[Ref.15328096]EC50=589000 nM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,19,18-21
DRAMP04066,CVKVRVKVGSGVKVRVKVC,19,Cyclic cationic V3 peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.042 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=300 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC=10 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=300 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).",[Ref.15328096]EC50=590000 nM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,19,18-21
DRAMP04067,CVKVQVKVGSGVKVQVKVC,19,Cyclic cationic V4 peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.047 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=10 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC<5 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=10 nM).",[Ref.15328096]EC50=3226000 nM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,19,18-21
DRAMP04068,CAKAKAKAGSGAKAKAKAC,19,Cyclic cationic V5 peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.14 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=173 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC>692 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=692 nM).",[Ref.15328096]EC50=1055000 nM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,19,18-21
DRAMP04069,CFKFKFKFGSGFKFKFKFC,19,Cyclic cationic V6 peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.045 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=518 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=4 nM), Klebsiella pneumoniae ATTC 13883 (MIC=4 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=528 nM), Shigella sonnei ATTC 25931 (MIC=4 nM).",[Ref.15328096]EC50=35000 nM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,19,18-21
DRAMP04070,CWKWKWKWGSGWKWKWKWC,19,Cyclic cationic V7 peptide,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.085 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=114 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=4 nM), Klebsiella pneumoniae ATTC 13883 (MIC=458 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=4 nM), Shigella sonnei ATTC 25931 (MIC=7 nM).",[Ref.15328096]EC50=45000 nM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,19,18-21
DRAMP04075,AKKVFKRLEKLFSKIQNDK,19,Antimicrobial peptide HP (2-20),P56029,Not found,rplA,Synthetic construct (amino acid substitution),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix (1 helices; 11 residues),Not found,1P0G resolved by NMR.,Function: Peptides originating from the N-terminal end of L1 have antibacterial activity against bacteria such as E. coli and Bacillus megaterium and modest antifungal activities. Has no effect on H. pylori itself. Peptides are not hemolytic against mammalian cells. These peptides may be released in the stomach during altruistic lysis to kill other fast growing bacteria.,"[Ref.16255716]Gram-positive bacteria: Bacillus subtilis (MIC=3.13 µg/ml), Staphylococcus epidermidis (MIC=6.25 µg/ml), Staphylococcus aureus (MIC=12.5 µg/ml), Listeria monocytogenes (MIC=6.25 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 µg/ml), Salmonella typhimurium (MIC=1.56 µg/ml), Proteus vulgaris (MIC=6.25 µg/ml), Pseudomonas aeruginosa (MIC=6.25 µg/ml), Escherichia coli O157 (MIC=12.5 µg/ml);##Fungi: Trichosporon beigelii (MIC=3.13 µg/ml), Candida albicans (MIC>25 µg/ml), Saccharomyces cerevisiae (MIC>25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC=12.5 µg/ml), Fusarium moniliforme (MIC=25 µg/ml).",[Swiss_Prot Entry P56029]Non-hemolytic against mammalian cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Phospholipids,16255716##PubMed ID is not available##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##Submitted (SEP-2004) to the PDB data bank.##To be published,"Lee KH, Lee DG, Park YK, Harm KS, Kim YM.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Structure of antimicrobial peptide, HP (2-20) and its analogues derived from Helicobacter pylori, as determined by 1H NMR spectroscopy.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",19,18-21
DRAMP04076,AKKVFKRLEKLFSKIQNWK,19,Anal 1 (antimicrobial peptide HP (2-20)analogue),P56029,Not found,Not found,Synthetic construct (amino acid substitution),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix (1 helices; 14 residues),Not found,1P0J resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=3.13 µg/ml), Staphylococcus aureus (MIC=3.13 µg/ml), Listeria monocytogenes (MIC=0.78 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=0.78 µg/ml), Salmonella typhimurium (MIC=0.39 µg/ml), Proteus vulgaris (MIC=3.13 µg/ml), Pseudomonas aeruginosa (MIC=3.13 µg/ml), Escherichia coli O157 (MIC=6.25 µg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 µg/ml), Candida albicans (MIC=25 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC=6.25 µg/ml), Fusarium moniliforme (MIC=12.5 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",19,18-21
DRAMP04077,AKKVFKRLEKLFSKIWNDK,19,Anal 2 (antimicrobial peptide HP (2-20)analogue),P56029,Not found,Not found,Synthetic construct (amino acid substitution),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix (1 helices; 14 residues),Not found,1P0L resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=3.13 µg/ml), Staphylococcus aureus (MIC=6.25 µg/ml), Listeria monocytogenes (MIC=1.56 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 µg/ml), Salmonella typhimurium (MIC=0.78 µg/ml), Proteus vulgaris (MIC=3.13 µg/ml), Pseudomonas aeruginosa (MIC=6.25 µg/ml), Escherichia coli O157 (MIC=6.25 µg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 µg/ml), Candida albicans (MIC=25 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC=6.25 µg/ml), Fusarium moniliforme (MIC=25 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",19,18-21
DRAMP04078,AKKVFKRLEKLFSKIWNWK,19,Anal 3 (antimicrobial peptide HP (2-20)analogue),P56029,Not found,Not found,Synthetic construct (amino acid substitution),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix (1 helices; 14 residues),Not found,1P0O resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=3.13 µg/ml), Staphylococcus aureus (MIC=1.56 µg/ml), Listeria monocytogenes (MIC=0.39 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=1.56 µg/ml), Salmonella typhimurium (MIC=0.39 µg/ml), Proteus vulgaris (MIC=3.13 µg/ml), Pseudomonas aeruginosa (MIC=3.13 µg/ml), Escherichia coli O157 (MIC=3.13 µg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 µg/ml), Candida albicans (MIC=12.5 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=25 µg/ml), Aspergillus fumigatus (MIC=25 µg/ml), Botrytis cinerea (MIC=3.13 µg/ml), Fusarium moniliforme (MIC=12.5 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",19,18-21
DRAMP04079,AKKVFKRLEKSFSKIQNDK,19,Anal 4 (antimicrobial peptide HP (2-20)analogue),P56029,Not found,Not found,Synthetic construct (amino acid substitution),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix (1 helices; 13 residues),Not found,1P5K resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=6.25 µg/ml), Staphylococcus epidermidis (MIC>12.5 µg/ml), Staphylococcus aureus (MIC>12.5 µg/ml), Listeria monocytogenes (MIC>12.5 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=12.5 µg/ml), Salmonella typhimurium (MIC=12.5 µg/ml), Proteus vulgaris (MIC>12.5 µg/ml), Pseudomonas aeruginosa (MIC=12.5 µg/ml), Escherichia coli O157 (MIC>12.5 µg/ml).##Fungi: Trichosporon beigelii (MIC=12.5 µg/ml), Candida albicans (MIC>25 µg/ml), Saccharomyces cerevisiae (MIC>25 µg/ml), Aspergillus flavus (MIC>50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC>50 µg/ml), Fusarium moniliforme (MIC>50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",19,18-21
DRAMP04080,AKKVSKRLEKLFSKIQNDK,19,Anal 5 (antimicrobial peptide HP (2-20)analogue),P56029,Not found,Not found,Synthetic construct (amino acid substitution),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix (1 helices; 12 residues),Not found,1P5L resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=3.13 µg/ml), Staphylococcus epidermidis (MIC=12.5 µg/ml), Staphylococcus aureus (MIC>12.5 µg/ml), Listeria monocytogenes (MIC>12.5 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=6.25 µg/ml), Salmonella typhimurium (MIC=12.5 µg/ml), Proteus vulgaris (MIC>12.5 µg/ml), Pseudomonas aeruginosa (MIC=12.5 µg/ml), Escherichia coli O157 (MIC=6.25 µg/ml).##Fungi: Trichosporon beigelii (MIC=12.5 µg/ml), Candida albicans (MIC>25 µg/ml), Saccharomyces cerevisiae (MIC>25 µg/ml), Aspergillus flavus (MIC>50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC>50 µg/ml), Fusarium moniliforme (MIC>50 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",19,18-21
DRAMP04081,AKKVFKRLEKLFSKIFNFK,19,Anal 6 (antimicrobial peptide HP (2-20)analogue),P56029,Not found,Not found,Synthetic construct (amino acid substitution),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix ,Not found,,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=6.25 µg/ml), Staphylococcus aureus (MIC=3.13 µg/ml), Listeria monocytogenes (MIC=0.78 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 µg/ml), Salmonella typhimurium (MIC=0.39 µg/ml), Proteus vulgaris (MIC=3.125 µg/ml), Pseudomonas aeruginosa (MIC=6.25 µg/ml), Escherichia coli O157 (MIC=6.25 µg/ml).##Fungi: Trichosporon beigelii (MIC=3.13 µg/ml), Candida albicans (MIC>25 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC=50-25 µg/ml), Botrytis cinerea (MIC=12.5 µg/ml), Fusarium moniliforme (MIC=12.5 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",19,18-21
DRAMP04082,AKKVFKRLEKLFSKIYNYK,19,Anal 7 (antimicrobial peptide HP (2-20)analogue),P56029,Not found,Not found,Synthetic construct (amino acid substitution),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix ,Not found,,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=3.13 µg/ml), Staphylococcus aureus (MIC=3.13 µg/ml), Listeria monocytogenes (MIC=0.78 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 µg/ml), Salmonella typhimurium (MIC=0.39 µg/ml), Proteus vulgaris (MIC=6.25-3.13 µg/ml), Pseudomonas aeruginosa (MIC=3.13 µg/ml), Escherichia coli O157 (MIC=3.13 µg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 µg/ml), Candida albicans (MIC=12.5 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC=50-25 µg/ml), Botrytis cinerea (MIC=6.25 µg/ml), Fusarium moniliforme (MIC=12.5 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",19,18-21
DRAMP04083,GIGKFLKKAKKFGKAFVKILKK,22,D-amino-acid pexiganan (MSI-214),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,MSI-214 is a peptide identical in sequence to pexiganan but comprising all D-amino acids.,"Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=16 µg/ml), Enterococcus faecium ATCC 51559 (vancomycin resistant) (MIC=4 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=16 µg/ml), Streptococcus bovis ATCC 49133 (MIC=4 µg/ml), Micrococcus luteus ATCC 4698 (MIC=2-4 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8-16 µg/ml), Proteus mirabilis ATCC 29245 (MIC>256 µg/ml), Serratia marcescens ATCC 8100 (MIC>256 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16-32 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10103181,Antimicrob Agents Chemother. 1999 Apr;43(4):782-788.,"Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M.","In vitro antibacterial properties of pexiganan, an analog of magainin.",22,21-24
DRAMP04096,EQEENVVKIQAFWKGYKQRKEYM,23,2IQ2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=2.1 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=32 µM).##Yeast: Candida albicans (MIC=28 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,23,21-24
DRAMP04097,DNTDSVVKIQSWFRMATARKSYL,23,2IQ3,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=1.2 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=26 µM).##Yeast: Candida albicans (MIC=25 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,23,21-24
DRAMP04098,ANVGFVIQLQARLRGFLVRQKFA,23,3IQ1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=1.7 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.7 µM).##Yeast: Candida albicans (MIC>94 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,23,21-24
DRAMP04099,TWLPAVIKIQAHWRGYRQRKIYL,23,3IQ2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=1.9 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.6 µM).##Yeast: Candida albicans (MIC=25 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,23,21-24
DRAMP04100,ANLDAIIKIQAWARMWAARRQYL,23,3IQ3,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=2 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=11 µM).##Yeast: Candida albicans (MIC>89 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,23,21-24
DRAMP04101,KNVNSIVKIQAFFRARKAQDDYR,23,3IQ4,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=3.5 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=4.6 µM).##Yeast: Candida albicans (MIC=30 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,23,21-24
DRAMP04102,KWKSFIKKLTSKFLHLAKKF,20,CP-P,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.,[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml).,[Ref.22518150]MHC=250 µg/mL against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,Not found,Not found,Not found,Not found,20,18-21
DRAMP04103,KWKSFIKKLTSKFLHSAKKF,20,S16 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,"Gram-negative bacterium: Pseudomonas aeruginosa (MIC=3.125 µg/ml).##Clinical isolates: Acinetobacter baumannii b-01 (MIC=3.125 µg/mL), Acinetobacter baumannii b-02 (MIC=6.25 µg/mL), Acinetobacter baumannii b-03 (MIC=6.25 µg/mL), Acinetobacter baumannii b-04 (MIC=3.125 µg/mL).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04104,KFKSFIKKLTSKFLHSAKKF,20,F2 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.,[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml).,[Ref.22518150]MHC=250 µg/mL against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04105,KWNSFIKKLTSKFLHSAKKF,20,N3 (derivative of CP-P),No entry found,Derived from the peptide CP-P,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04106,KWKSFKKKLTSKFLHSAKKF,20,K6 (derivative of CP-P),No entry found,Derived from the peptide CP-P,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04107,KWKSFINKLTSKFLHSAKKF,20,N7 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04108,KWKSFIKKAKTSFLHSAKKF,20,A9 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04111,KWKSFIKKSTSKFLHSAKKF,20,S9 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=50 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04112,KWKSFIKKLLSKFLHSAKKF,20,L10 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.,[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml).,[Ref.22518150]MHC<125 µg/mL against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04113,KWKSFIKKLASKFLHSAKKF,20,A10 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.,[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml).,[Ref.22518150]MHC=250 µg/mL against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04114,KWKSFIKKLTDKFLHSAKKF,20,D11 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04115,KWKSFIKKLTKKFLHSAKKF,20,K11 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix (CD),Not found,,Function: Has antibacterial activity.,"Gram-positive bacteria: Staphylococcus aureus CMCC26003 (MIC=0.5 µg/mL), Bacillus subtilis DB430 (MIC=2 µg/mL), Bacillus pumilus CMCC63202 (MIC=0.5 µg/mL), Soluble wall Micrococcus S1.634 (MIC=1 µg/mL), Micrococcus luteus CMCC28001 (MIC=2 µg/mL).##Gram-negative bacteria: E. coli ATCC8099 (MIC=0.5 µg/mL), Klebsiella pneumoniae CMCC46117 (MIC=2 µg/mL), Salmonella paratyphi BCMCC50094 (MIC=2 µg/mL), Pseudomonas aeruginosa CMCC10104 (MIC=4 µg/mL).##Clinical isolates: Acinetobacter baumannii b-01 (MIC=0.8 µg/mL), Acinetobacter baumannii b-02 (MIC=3.125 µg/mL), Acinetobacter baumannii b-03 (MIC=3.25 µg/mL), Acinetobacter baumannii b-04 (MIC=1.6 µg/mL).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04117,KWKSFIKKLTSKALHSAKKF,20,A13 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04119,KWKSFIKKLTSKFLHSKKKF,20,K17 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04120,KWKSFIKKLTSKFLHSADKF,20,D18 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04121,KWKSFIKKLTSKFLHSANKF,20,N18 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04122,KWKSFIKKLTSKFLHSAKKN,20,N20 (derivative of CP-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 µg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,20,18-21
DRAMP04137,LRRLWLRANRLLRRLWLRANRL,22,LRR-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: E. coli ATCC 25922 (MIC=4 µM), P. aeruginosa ATCC 27853 (MIC=4 µM), S. typhimurium C7731 (MIC=2 µM);##Gram-positive bacteria: S. epidermidis ATCC12228 (MIC=2 µM), E. faecalis ATCC 29212 (MIC=2 µM), S. aureus ATCC 29213 (MIC=2 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23430306,Amino Acids. 2013 Apr;44(4):1215-1224.,"Ma QQ, Lv YF, Gu Y, Dong N, Li DS, Shan AS.",Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat.,22,21-24
DRAMP04159,RIKRFWPVVIRTVVAGYNLYRAIKK,25,LR2 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,25,24-27
DRAMP04160,RIKRFWPVVIRTVVAGYNLYRAIK,24,LR3 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=7.032 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=2.344 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=0.586 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,24,21-24
DRAMP04161,RIKRFWPVVIRTVVAGYNLYRAI,23,LR4 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=37.5 µg/ml), Staphylococcus aureus ATCC25923 (MIC=37.5 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=9.375 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,23,21-24
DRAMP04162,RIKRFWPVVIRTVVAGYNLYRA,22,LR5 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus ATCC25923 (MIC=75 µg/ml);##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=4.688 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=4.688 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,22,21-24
DRAMP04163,RIKRFWPVVIRTVVAGYNLYR,21,LR6 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,21,18-21
DRAMP04164,RIKRFWPVVIRTVVAGYNLY,20,LR7 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,20,18-21
DRAMP04165,RIKRFWPVVIRTVVAGYNL,19,LR8 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,19,18-21
DRAMP04166,RIKRFWPVVIRTVVAGYN,18,LR9 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,18,15-18
DRAMP04167,RIKRFWPVVIRTVVAGY,17,LR10 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,17,15-18
DRAMP04168,RIKRFWPVVIRTVVAG,16,LR11 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,16,15-18
DRAMP04233,FLGVVFKLASKVFPAVFGKV,20,D28 (Rational design peptide),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Not found,Not found,,"Function: Has strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis.","Gram-positive bacteria: Staphylococcus aureus (MIC=8 µg/ml), Bacillus anthracis (MIC=16 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17051220,Nature. 2006 Oct 19;443(7113):867-869.,"Loose C, Jensen K, Rigoutsos I, Stephanopoulos G.",A linguistic model for the rational design of antimicrobial peptides.,20,18-21
DRAMP04234,FLFRVASKVFPALIGKFKKK,20,D51 (Rational design peptide),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Not found,Not found,,"Function: Has strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis.","Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Bacillus anthracis (MIC=16 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17051220,Nature. 2006 Oct 19;443(7113):867-869.,"Loose C, Jensen K, Rigoutsos I, Stephanopoulos G.",A linguistic model for the rational design of antimicrobial peptides.,20,18-21
DRAMP04235,LGALFRVASKVFPAVISMVK,20,D22 (Rational design peptide),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Not found,Not found,,"Function: Has strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis.","Gram-positive bacteria: Staphylococcus aureus (MIC=64 µg/ml), Bacillus anthracis (MIC=64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17051220,Nature. 2006 Oct 19;443(7113):867-869.,"Loose C, Jensen K, Rigoutsos I, Stephanopoulos G.",A linguistic model for the rational design of antimicrobial peptides.,20,18-21
DRAMP04380,INWKKIASIGKEVLKAI,17,PMM-1 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=5.5 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=27.2 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,17,15-18
DRAMP04381,NWKKIASIGKEVLKAL,16,PMM-2 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=21 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=46 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,16,15-18
DRAMP04382,WKKIASIGKEVLKAL,15,PMM-3 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=62 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=125 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,15,12-15
DRAMP04385,INWKKIASIGKEVLKA,16,PMM-6 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=75 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=70 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,16,15-18
DRAMP04386,INWKKIASIGKEVLK,15,PMM-7 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,15,12-15
DRAMP04389,IWNKIAKSIGKVLEKAL,17,PMM-10 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=15 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=35 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,17,15-18
DRAMP04391,NIWKKIASIAKEVLKAL,17,PMM-12 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=6.25 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=10 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,17,15-18
DRAMP04392,KNWKKIASIGKEVLKAL,17,PMM-13 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=12.5 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=60 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,17,15-18
DRAMP04393,SNWKKIASIGKEVLKAL,17,PMM-14 (PMM analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=30 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,17,15-18
DRAMP04545,SFPFFPPGICKRLKRC,16,"Limnonectin-1Fa (Frogs, amphibians, animals)",No entry found,Not found,Not found,Limnonectes fujianensis (Fujian large-headed frog),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Possesses relatively potent growth inhibitory activity against the Gram-negative bacterium E. coli. Ineffective against the Gram-positive bacterium S. aureus and the potentially pathogenic yeast C. albicans at concentrations up to 160 µM.,Gram-negative bacterium: Escherichia coli (MIC=35 µM),[Ref.21396976] It exhibits no hemolytic activity at a concentration of up to 160 μM.,Cyclic,Free,Cyclization(Cys10 and Cys16).,Disulfide bond between Cys10 and Cys16.,L,No cytotoxicity information found,Not found,21396976,Biochimie. 2011 Jun;93(6):981-987.,"Wu Y, Wang L, Zhou M, Ma C, Chen X, Bai B, Chen T, Shaw C.",Limnonectins: A new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).,16,15-18
DRAMP04546,SFHVFPPWMCKSLKKC,16,"Limnonectin-1Fb (Frogs, amphibians, animals)",No entry found,Not found,Not found,Limnonectes fujianensis (Fujian large-headed frog),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Possesses relatively potent growth inhibitory activity against the Gram-negative bacterium E. coli. Ineffective against the Gram-positive bacterium S. aureus and the potentially pathogenic yeast C. albicans at concentrations up to 160 µM.,Gram-negative bacterium: Escherichia coli (MIC=70 µM),[Ref.21396976] It exhibits no hemolytic activity at a concentration of up to 160 μM.,Cyclic,Free,Cyclization(Cys10 and Cys16).,Disulfide bond between Cys10 and Cys16.,L,No cytotoxicity information found,Not found,21396976,Biochimie. 2011 Jun;93(6):981-987.,"Wu Y, Wang L, Zhou M, Ma C, Chen X, Bai B, Chen T, Shaw C.",Limnonectins: A new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).,16,15-18
DRAMP04553,GVIKSVLKGVAKTVALGML,19,H. erythraea B2RP,No entry found,Not found,Not found,Hylarana erythraea,"Antimicrobial, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=12.5 microM);##Gram-poaitive bacteria: Staphylococcus aureus (MIC=12.5 microM), multidrug-resistant clinical isolates of Acetinobacter baumannii (MIC in the range 6-12.5 microM).##Yeast: Candida albicans (MIC=50 microM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20015460,Peptides. 2010 Apr;31(4):548-554.,"Al-Ghaferi N, Kolodziejek J, Nowotny N, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD, Conlon JM.",Antimicrobial peptides from the skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae).,19,18-21
DRAMP04640,GMASKAGSVLGKLAKVAIGAL,21,PGLa-AN2,No entry found,Not found,Not found,Xenopus andrei,"Antimicrobial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: E. coli (MIC=25 µM);##Gram-positive bacterium: S. aureus (MIC=100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21498136,Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.,"Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.",Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,21,18-21
DRAMP04679,FLPFLIPALTSLISSL,16,Senegalin,L0P323,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Kassina senegalensis (Senegal running frog),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Not found,Not found,,Function: Antimicrobial peptide with activity against the Gram-positive bacterium S. aureus NCTC 10788 and the yeast C. albicans NCPF 1467. Ineffective against the Gram-negative bacterium E. coli NCTC 10418. Induces a dose-dependent contraction of rat urinary bladder smooth muscle (EC50=2.9 nM) and a dose-dependent relaxation of rat tail artery smooth muscle (EC50=37.7 nM).,Gram-positive bacterium: S. aureus NCTC 10788 (MIC=50 µM). Yeast: C. albicans NCPF 1467 (MIC=150 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23430307,Amino Acids. 2013 May;44(5):1347-1355. ,"Wang H, Li R, Xi X, Meng T, Zhou M, Wang L, Zhang Y, Chen T, Shaw C.","Senegalin: a novel antimicrobial/myotropic hexadecapeptide from the skin secretion of the African running frog, Kassina senegalensis.",16,15-18
DRAMP00001,GSGVIPTISHECHMNSFQFVFTCCS,25,Variacin (Bacteriocin),No entry found,Belongs to the lantibiotic family (Class I bacteriocin),Not found,Micrococcus varians (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Has a broad host range of inhibition against Gram-positive food spoilage bacteria. Variacin is resistant to heat and pH conditions from 2 to 10.
Biophysicochemical properties: Variacin is resistant to heat and pH conditions from 2 to 10.","Gram-positive bacteria: Lactobacillus helveticus (+++), L. bulgaricus (+++), Lactobacillus lactis (++), Lactobacillus delbrueckii (+++), Lactobacillus acidophilus (++), Lactobacillus plantarum (+), Lactobacillus sake (LSK) (++), Lactobacillus curvatus (++), Leuconostoc mesenteroides (+), Streptococcus thermophilus (++), Lactococcus lactis (SL2) (++), Enterococcus faecalis (++), Enterococcus faecium (++), Listeria innocua (++), Listeria monocytogenes (++++), Listeria welhia (++).##Note: Inhibitory activity tested with supernatant adjusted to pH 7.",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Not included yet,Not included yet,Not included yet,L,Not found,Not found,8633879,Appl Environ Microbiol. 1996 May;62(5):1799-1802.,"Pridmore D, Rekhif N, Pittet AC, Suri B, Mollet B.","Variacin, a new lanthionine-containing bacteriocin produced by Micrococcus varians: comparison to lacticin 481 of Lactococcus lactis.",25,24-27
DRAMP00006,GNGVIKTISHECHMNTWQFIFTCCS,25,Butyrivibriocin OR79 (Bacteriocin),O85355,Belongs to the lantibiotic family (Class I bacteriocin),bvi79,Butyrivibrio fibrisolvens (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Predicted,Not found,Not found,,"Function: Lanthionine-containing peptide antibiotic (lantibiotic). The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor.","Gram-positive bacteria: Fibrisolvens, Butyrivibrio crossotus, Clostridium clostridiforme, Lachnospira multiparus, Ruminococcus flavefaciens.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,10224011,Appl Environ Microbiol. 1999 May;65(5):2128-2135.,"Kalmokoff ML, Lu D, Whitford MF, Teather RM.",Evidence for production of a new lantibiotic (butyrivibriocin OR79A) by the ruminal anaerobe Butyrivibrio fibrisolvens OR79: characterization of the structural gene encoding butyrivibriocin OR79A.,25,24-27
DRAMP18350,CLGIGSCNDFAGCGYAIVCFW,21,Siamycin II(Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Streptomyces strains AA3891,"Antiviral, Anti-HIV, Antimicrobial",,Beta strand,"It differs from Siamycin I only by one amino acid. Siamycin I has a valine residue at position 4. In both peptides, disulfide bonds link Cys1 with Cys13 and Cys7 with Cys19, and the side chain of Asp9 forms an amide bond with the N-terminus (XXJ). The original has been replaced since antimicrobial assays revealed no activity.",,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7787424,J Biomol NMR. 1995 Apr;5(3):271-86.,"Constantine KL, Friedrichs MS, Detlefsen D, Nishio M, Tsunakawa M, Furumai T, Ohkuma H, Oki T, Hill S, Bruccoleri RE, et al.",High-resolution solution structure of siamycin II: novel amphipathic character of a 21-residue peptide that inhibits HIV fusion.,21,18-21
DRAMP00016,GNGVVLTLTHECNLATWTKKLKCC,24,Salivaricin 9 (Sal9; Bacteriocin),No entry found,Belongs to the lantibiotic family (Class I bacteriocin),sivA,Streptococcus salivarius (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Note: The Sal9 genetic determinants appear generally (but not always) to be megaplasmid-associated, and production seems often to occur in strains that also produce SalA. As is the case for SalA, the production of Sal9 appears to be autoinducible.",Gram-positive bacteria: Streptococcus pyogenes and some Enterococci.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21310787,Microbiology. 2011 May;157(Pt 5):1290-1299.,"Wescombe PA, Upton M, Renault P, Wirawan RE, Power D, Burton JP, Chilcott CN, Tagg JR.","Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.",24,21-24
DRAMP00021,TTWPCATVGVSVALCPTTKCTSQC,24,HalA2 (one chain of haloduracin; Bacteriocin),No entry found,Belongs to the lantibiotic family (Class I bacteriocin),Not found,Bacillus halodurans C-125 (Gram-positive bacteria) ,"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Function: Active on certain Gram-positive bacteria. HalA2 causes pore formation and K+ efflux.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17085596,Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17243-17248. ,"McClerren AL, Cooper LE, Quan C, Thomas PM, Kelleher NL, van der Donk WA.","Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.",24,21-24
DRAMP00024,TTPACFTIGLGVGALFSAKFC,21,CylLS (a structural subunit of cytolysin; Bacteriocin),No entry found,Belongs to the lantibiotic family (Class I bacteriocin),Not found,Enterococcus faecalis (Gram-positive bacteria),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,"CylLL and CylLS are activated by an extracellular protease, CylA.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8898386,Mol Microbiol. 1996 Sep;21(6):1175-1184.,"Booth MC, Bogie CP, Sahl HG, Siezen RJ, Hatter KL, Gilmore MS.","Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic.",21,18-21
DRAMP00026,KRGSGWIATITDDCPNSVFVCC,22,Salivaricin A (SalA; Bacteriocin; Preclinical),P36500,Belongs to the type A lantibiotic family (Class I bacteriocin),salA,Streptococcus salivarius 20P3 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Rich,Not found,,"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Contains one lanthionine (S17-C22) and two Beta-methyllanthionines (T9-C14; T11-C21), which is followed by membrane translocation and cleavage of the modified precursor. ",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8357242,Appl Environ Microbiol. 1993 Jul;59(7):2014-2021.,"Ross KF, Ronson CW, Tagg JR.",Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3.,22,21-24
DRAMP00027,GGGVIQTISHECRMNSWQFLFTCCS,25,Salivaricin B (SboB; Bacteriocin; Preclinical),No entry found,Belongs to the type A lantibiotic family (Class I bacteriocin),Not found,Streptococcus salivarius K12 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,PTM: Thioether bonds are predicted between 7-12; 9-23; 16-24.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17194838,Appl Environ Microbiol. 2007 Feb;73(4):1107-1113.,"Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR.",Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.,25,24-27
DRAMP00028,IASKFICTPGCAKTGSFNSYCC,22,Lantibiotic epidermin (Bacteriocin),"P08136, Q54093",Belongs to the type A lantibiotic family (Class I bacteriocin),epiA,Staphylococcus epidermidis TU 3298 / DSM 3095 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Rich,Not found,,"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one didehydrobutyrine (T14), two lanthionines (S3-C7; S16-C21) and one Beta-methyllanthionine (T8-C11) and one S-(2-aminovinyl)-D-cysteine (S19-C22).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipid II,2835685##3769923,Nature. 1988 May 19;333(6170):276-268.##Eur J Biochem. 1986 Oct 1;160(1):9-22.,"Schnell N, Entian KD, Schneider U, Götz F, Zähner H, Kellner R, Jung G.##Allgaier H, Jung G, Werner RG, Schneider U, Zähner H.","Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings.##Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic.",22,21-24
DRAMP18349,CLGVGSCNDFAGCGYAVVCFW,21,Siamycin I (Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Streptomyces strain AA6532,"Antiviral, Anti-HIV, Antimicrobial",,Beta strand,"It differs from Siamycin I only by one amino acid. Siamycin I has a valine residue at position 4. In both peptides, disulfide bonds link Cys1 with Cys13 and Cys7 with Cys19, and the side chain of Asp9 forms an amide bond with the N-terminus (XXJ). The original has been replaced since antimicrobial assays revealed no activity.",,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8557614,J Antibiot (Tokyo). 1995 Dec;48(12):1515-7.,"Detlefsen DJ, Hill SE, Volk KJ, Klohr SE, Tsunakawa M, Furumai T, Lin PF, Nishio M, Kawano K, Oki T, et al.","Siamycins I and II, new anti-HIV-1 peptides: II. Sequence analysis and structure determination of siamycin I.",21,18-21
DRAMP00040,IASKFLCTPGCAKTGSFNSYCC,22,Gallidermin (Bacteriocin; Preclinical),P21838,Belongs to the type A lantibiotic family (Class I bacteriocin),gdmA,Staphylococcus gallinarum TU 3928 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Rich,Not found,,"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one didehydrobutyrine (Dhb): T14; two lanthionines: S3-C7, S16-C21; one Beta-methyllanthionine: T8-C11; and S-(2-aminovinyl)-D-cysteine (Ser-Cys): S19-C22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,3181159,Eur J Biochem. 1988 Oct 15;177(1):53-59.,"Kellner R, Jung G, Hörner T, Zähner H, Schnell N, Entian KD, Götz F.",Gallidermin: a new lanthionine-containing polypeptide antibiotic.,22,21-24
DRAMP00041,FKSWSLCTPGCARTGSFNSYCC,22,Mutacin-1140 (Mutacin III; Bacteriocin),O68586,Belongs to the type A lantibiotic family (Class I bacteriocin),lanA,Streptococcus mutans (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one dihydroalanine (Dha): S5; one didehydrobutyrine (Dhb): T14; two lanthionines: S3-C7, S16-C21; one Beta-methyllanthionine: T8-C11; and S-(2-aminovinyl)-D-cysteine (Ser-Cys): S19-C22.","Gram-positive bacteria: Streptococcus cricetus E49, Streptococcus rattus BHT-2, Streptococcus mutans NG8, S. mutans OMZ175, S. mutans V100, Streptococcus sobrinus SL1, S. sobrinus ATCC 27352, Streptococcus downeii ATCC 33748, Streptococcus salivarius ATCC 25975, Streptococcus salivariusATCC 27945, Streptococcus mitis ATCC 19950, Streptococcus sanguinis.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11082191,Eur J Biochem. 2000 Dec;267(23):6810-6816.,"Smith L, Nov¡k J, Rocca J, McClung S, Hillman JD, Edison AS.",Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics.,22,21-24
DRAMP00042,FKSWSFCTPGCAKTGSFNSYCC,22,Bacteriocin mutacin B-Ny266 (Preclinical),P80666,Belongs to the type A lantibiotic family (Class I bacteriocin),Not found,Streptococcus mutans Ny266 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Rich,Not found,,"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one dihydroalanines (Dha): S5; one didehydrobutyrine (Dhb): T14; two lanthionines: S3-C7, S16-C21; one Beta-methyllanthionine: T8-C11; and S-(2-aminovinyl)-D-cysteine (Ser-Cys): S19-C22.",Gram-positive bacterium: Micrococcus luteus ATCC 272.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,9237644,FEBS Lett. 1997 Jun 30;410(2-3):275-279.,"Mota-Meira M, Lacroix C, LaPointe G, Lavoie MC.",Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans.,22,21-24
DRAMP18347,CLGVGSCNDFAGCGYAIVCFW,21,Siamycin(Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Streptomyces sp. No. 73264,"Antiviral, Anti-HIV, Antimicrobial",,Not found,It differs from siamycin I only at position 17 (V to I).,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8619594,Antimicrob Agents Chemother. 1995 Oct;39(10):2345-7.,"Chokekijchai S, Kojima E, Anderson S, Nomizu M, Tanaka M, Machida M, Date T, Toyota K, Ishida S, Watanabe K, et al.",NP-06: a novel anti-human immunodeficiency virus polypeptide produced by a Streptomyces species.,21,18-21
DRAMP18348,GNWHGTAPDWFFNYYW,16,RES-701-1(Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Streptomyces spp.,Unknown,,Not found,Not found,,RES-701-1 is an endothelin B receptor (ET) selective peptidic antagonist.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Letters in Peptide Science. 1997 Jun;4(3):167-170.,"Shibata K,Yano K,Tanaka T,Matsuda Y,Yamasaki M.",C-terminal modifications of an endothelin antagonist RES-701-1: Production of ETA/ETB dual selective analogs. ,16,15-18
DRAMP00046,GSRYLCTPGSCWKLVCFTTTVK,22,Lantibiotic streptin (Bacteriocin),"P0C0H8, Q9FDV1, P0C0H9, Q48YZ4, Q9FDV1",Belongs to the type A lantibiotic family (Class I bacteriocin),srtA,Streptococcus pyogenes & Streptococcus pyogenes serotype M1 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on certain Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
Induction: Induces its own expression in at least strain M25.
Miscellaneous: A longer form (streptin 2, with three more amino acids at the N-terminus) is probably due to incomplete processing. Other forms also exist, some of which are due to differing levels of dehydration.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor.",Active on certain Gram-positive bacteria.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11328600##12732544##11296296##16088826,J Biochem. 2001 May;129(5):769-775.##Appl Environ Microbiol. 2003 May;69(5):2737-2747.##Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4658-4663.##J Infect Dis. 2005 Sep 1;192(5):771-782.,"Karaya K, Shimizu T, Taketo A.##Wescombe PA, Tagg JR.##Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, Primeaux C, Sezate S, Suvorov AN, Kenton S, Lai HS, Lin SP, Qian Y, Jia HG, Najar FZ, Ren Q, Zhu H, Song L, White J, Yuan X, Clifton SW, Roe BA, McLaughlin R.##Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM.","New gene cluster for lantibiotic streptin possibly involved in streptolysin S formation.##Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.##Complete genome sequence of an M1 strain of Streptococcus pyogenes.##Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events.",22,21-24
DRAMP00047,VGSRYLCTPGSCWKLVCFTTTVK,23,Streptin 1 (Bacteriocin),No entry found,Belongs to the type A lantibiotic family (Class I bacteriocin),Not found,Bacillus subtilis A1/3 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Not found,Rich ,Not found,,"Two possible structures have been proposed for streptin 1 due to insufficient info. The first lanthionine S3-C7 and the second methyllanthionine T8-C12 are identical in the two proposed structures. A third intra-bond is either S11-C17 or C17-T19 (or C17-T20 or C17-T21). Compared to Streptin 1, Streptin 2 contains 3 additional residues TPY at the N-terminus. Small quantities of peptides at various degrees of dehydration were also detected.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12732544,Appl Environ Microbiol. 2003 May;69(5):2737-2747.,"Wescombe PA, Tagg JR.","Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.",23,21-24
DRAMP18345,CLGIGSCNNFAGCGYAVVCFW,21,Tricyclic peptide RP 71955 (Bacteriocin),P37046,Not found,Not found,Streptomyces sp. (strain SP9440),"Antiviral, Anti-HIV, Antimicrobial",,Beta strand,"An internal amide bond between the NH2 of C1 and the gamma-COOH of D9 was observed, as well as two disulfide bridges, one between C1 and C13 and one between C7 and C19.","1RPB, 1RPC resolved by NMR","Caution:The isopeptide linked residue 9 is shown as Asn rather than Asp as mentioned in PubMed:8286361, because it is not known whether Asp or Asn is encoded and the isopeptide bonds are almost always formed between the amides Asn or Gln and N6-lysine or alpha amino groups, with the liberation of an ammonia that makes the reaction essentially irreversible.(From Swiss-prot)",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8270499,J Antibiot (Tokyo). 1993 Nov;46(11):1756-7.,"Helynck G, Dubertret C, Mayaux JF, Leboul J.","Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite.",21,18-21
DRAMP00051,FSSLSLCSLGCTGVKNPSFNSYCC,24,Mutacin I (Bacteriocin),No entry found,Belongs to the type A lantibiotic family (Class I bacteriocin),Not found,Streptococcus mutans CH43); also Streptococcus mutans UA140 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus, Staphylococcus epidermidis, enterococci, pneumococci, group A streptococci.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10919773##11133423,Appl Environ Microbiol. 2000 Aug;66(8):3221-3229.##Appl Environ Microbiol. 2001 Jan;67(1):15-21. ,"Qi F, Chen P, Caufield PW.##Qi F, Chen P, Caufield PW.","Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes.##The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.",24,21-24
DRAMP00055,ITSVSWCTPGCTSEGGGSGCSHCC,24,Bacteriocin 97518,No entry found,Belongs to the type A lantibiotic family (Class I bacteriocin),Not found,Planomonospora sp. (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Rich ,Not found,,"Function: It inhibits cell wall synthesis of Gram-positive bacteria, including Staphylococcus aureus (MRSA).","Gram-negative bacteria: Escherichia coli, Moraxella catarrhalis.##Yeast: Candida albicans.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17469849,Biochemistry. 2007 May 22;46(20):5884-5895.,"Castiglione F, Cavaletti L, Losi D, Lazzarini A, Carrano L, Feroggio M, Ciciliato I, Corti E, Candiani G, Marinelli F, Selva E.",A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.,24,21-24
DRAMP00056,CVQSCSFGPLTWSCDGNTK,19,Bacteriocin ancovenin,P38655,Belongs to the type B lantibiotic family (Class I bacteriocin),Not found,Streptomyces sp. A647P-2 (Gram-positive bacteria),Antimicrobial,Protein level,Not found,Not found,,"MOA: Acts as an inhibitor of angiotensin I converting enzyme.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine or the formation of dialkylamine bonds with lysine. This is followed by membrane translocation and cleavage of the modified precursor.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Tetrahedron Lett. 1985;26:665-668.,"Wakamiya T, Ueki Y, Shiba T, Kido Y, Motoki Y.","The structure of ancovenin, a new peptide inhibitor of angiotensin I converting enzyme.",19,18-21
DRAMP00057,CKQSCSFGPFTFVCDGNTK,19,Bacteriocin duramycin (Leucopeptin; Bacteriocin),P36504,Belongs to the type B lantibiotic family (Class I bacteriocin),Not found,Streptoverticillium griseoverticillatum (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Rich ,Not found,,"Function: Acts as inhibitor of human phospholipase A2.
PTM: Methyllanthionine rings between residues 1 and18 as well as between residues 5 and 11; a lanthionine occurs between Cys14 and residue 4. In addition, addition of Lys19 to dehydralanine at position 6 forms a lysinoalanine bridge. The Asp residue at position 15 is hydroxylated. ",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,phosphatidylethanolamine,2272918##2125590,J Antibiot (Tokyo). 1990 Nov;43(11):1421-1430.##J Antibiot (Tokyo). 1990 Nov;43(11):1403-1412.,"Hayashi F, Nagashima K, Terui Y, Kawamura Y, Matsumoto K, Itazaki H.##Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH.","The structure of PA48009: the revised structure of duramycin.##Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.",19,18-21
DRAMP00058,CRQSCSFGPLTFVCDGNTK,19,Lantibiotic duramycin B (Bacteriocin),P36502,Belongs to the type B lantibiotic family (Class I bacteriocin),Not found,Streptoverticillium strain R2075 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Rich,Not found,,"Methyllanthionine rings between residues 1 and18 as well as between residues 5 and 11; a lanthionine occurs between Cys14 and residue 4. In addition, addition of Lys19 to dehydralanine at position 6 forms a lysinoalanine bridge. The Asp residue at position 15 is hydroxylated. Duramycins and cinnamycin specifically binds to phosphatidylethanolamine, thereby indirectly inhibiting the activity of phospholipase A2.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Phosphatidylethanolamine,2125590,J Antibiot (Tokyo). 1990 Nov;43(11):1403-1412.,"Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH.","Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.",19,18-21
DRAMP00059,CANSCSYGPLTWSCDGNTK,19,Lantibiotic duramycin C (Bacteriocin),P36503,Belongs to the type B lantibiotic family (Class I bacteriocin),Not found,Streptomyces griseoluteus R2107 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Rich,Not found,,"Function: Acts as inhibitor of phospholipase A2.
PTM: Methyllanthionine rings between residues 1 and 18 as well as between residues 5 and 11; a lanthionine occurs between Cys14 and residue 4. In addition, addition of Lys19 to dehydralanine at position 6 forms a lysinoalanine bridge. The Asp residue at position 15 is hydroxylated.",Bacillus ,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,phosphatidylethanolamine,2125590##8375380,J Antibiot (Tokyo). 1990 Nov;43(11):1403-1412.##Eur J Biochem. 1993 Sep 1;216(2):419-428.,"Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH. Zimmermann N, Freund S, Fredenhagen A, Jung G.","Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A3. Structural revision of duramycin and cinnamycin.Solution structures of the lantibiotics duramycin B and C.",19,18-21
DRAMP00060,CRQSCSFGPFTFVCDGNTK,19,Bacteriocin cinnamycin (Lanthiopeptin Ro 09-0198),P29827,Belongs to the type B lantibiotic family (Class I bacteriocin),cinA,Streptomyces cinnamoneus cinnamoneus DSM 40005 (Gram-positive bacteria),"Antimicrobial, Antbacterial, Antiviral",Protein level,Beta strand (2 strands; 2 residues),The peptide has a hydrophobic pocket surrounded by residues Phe-7 through Ala(S)-14 to bind to the head group of the ligand. Fitting of the head group to the hydrophobic pocket was so good that other than a glycerophosphoethanolamine head group would be unable to fit the pocket.,2DDE resolved by NMR.,"Function: Can act as inhibitor of the enzyme phospholipase A2, and of the angiotensin-converting enzyme. Shows inhibitory activities against herpes simplex virus and immunopotentiating activities. Its antimicrobial activities are not very pronounced.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine or the formation of dialkylamine bonds with lysine. This is followed by membrane translocation and cleavage of the modified precursor.","Bacillus, herpes simplex virus.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,phosphatidylethanolamine,2125590##2544544##8882709,J Antibiot (Tokyo). 1990 Nov;43(11):1403-1412.##J Antibiot (Tokyo). 1989 Jun;42(6):837-845.##J Biochem. 1996 Feb;119(2):226-230.,"Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH.##Naruse N, Tenmyo O, Tomita K, Konishi M, Miyaki T, Kawaguchi H, Fukase K, Wakamiya T, Shiba T.##Hosoda K, Ohya M, Kohno T, Maeda T, Endo S, Wakamatsu K.","Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.##Lanthiopeptin, a new peptide antibiotic. Production, isolation and properties of lanthiopeptin.##Structure determination of an immunopotentiator peptide, cinnamycin, complexed with lysophosphatidylethanolamine by 1H-NMR1.",19,18-21
DRAMP00061,ASGWVCTLTIECGTVICAC,19,Actagardine (Gardimycin; Bacteriocin),P56650,Belongs to the type B lantibiotic family (Class I bacteriocin),Not found,Actinoplanes liguriae (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Non helix or strand structure,"Actagardine shows a rigid compact globular shape based on the constraining bridging pattern, which is composed of an N-terminal lanthionine ring from residues 1-6 and three intertwined C-terminal methyllanthionine rings comprising residues 7-12, 9-17 and 14-19. In addition, this C-terminal ring system is stabilised by a short antiparallel beta sheet. A feature of the actagardine structure is the presence of two putative binding pockets.",1AJ1 resolved by NMR.,"Function: The molecule has a compact shape. Like mersacidin, this peptide inhibits cell wall biosynthesis by binding to lipid II.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. The 14-19 beta-methyllanthionine thioether bond is oxidized to a sulfoxide. This is followed by membrane translocation and cleavage of the modified precursor.","Gram-positive bacteria: streptococci, Streptococcus pyogenes.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipid II,2211371##9219543,J Antibiot (Tokyo). 1990 Sep;43(9):1082-1088.##Eur J Biochem. 1997 Jun 15;246(3):809-819.,"Kettenring JK, Malabarba A, V©key K, Cavalleri B.##Zimmermann N, Jung G.","Sequence determination of actagardine, a novel lantibiotic, by homonuclear 2D NMR spectroscopy.##The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR.",19,18-21
DRAMP00062,CTFTLPGGGGVCTLTSECIC,20,Mersacidin (Bacteriocin; Preclinical),P43683,Belongs to the type B lantibiotic family (Class I bacteriocin),mrsA,Bacillus sp. HIL-Y85/54728 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Non helix or strand structure (Turn),Not found,1QOW resolved by NMR. ,"Function: Kills a number of Gram-positive bacteria. Acts at the level of cell wall biosynthesis by interfering with bacterial peptidoglycan biosynthesis. Specifically inhibits the conversion of the lipid II intermediate into polymeric nascent glycan strands by transglycosylation. May interact with the peptidoglycan precursor rather than with the enzyme.
PTM: There are one dihydroalanine (Dha): S16; three Beta-methyllanthionines: C1-T2, T4-C12, T13-C18; and S-(2-aminovinyl)-3-methyl-D-cysteine: T15-C20.","Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus, Clostridium difficile.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,The sugar phosphate head group of the peptidoglycan precursorLipid II,7737474##9119018##10831439##10818347,FEMS Microbiol Lett. 1995 Mar 15;127(1-2):121-126.##Eur J Biochem. 1997 Mar 1;244(2):501-512.##Appl Environ Microbiol. 2000 Jun;66(6):2565-2571.##Acta Crystallogr D Biol Crystallogr. 2000 Jun;56(Pt 6):705-713.,"Bierbaum G, Brötz H, Koller KP, Sahl HG.##Prasch T, Naumann T, Markert RL, Sattler M, Schubert W, Schaal S, Bauch M, Kogler H, Griesinger C.##Altena K, Guder A, Cramer C, Bierbaum G.##Schneider TR, Kärcher J, Pohl E, Lubini P, Sheldrick GM.","Cloning, sequencing and production of the lantibiotic mersacidin.##Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics.##Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster.##Ab initio structure determination of the lantibiotic mersacidin.",20,18-21
DRAMP00084,KYYGNGVTCGKHSXSVDWXKXT,22,Mutacin F-59.1 (Bacteriocin),P86386,Belongs to the class IIa bacteriocin,Not found,Streptococcus mutans (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Bactericidal activity (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (OCT-2009) to UniProtKB,"Nicolas GG, Lavoie MC, Lapointe G, Mota-Meira M.","Characterization of mutacin F-59.1, a pediocin-like bacteriocin produced by Streptococcus mutans 59.1.",22,21-24
DRAMP18344,CLGIGSCNNFAGCGYAVVCFW,21,Tricyclic peptide RP 71955 (Bacteriocin),P37046,Belongs to the class I bacteriocin,Not found,Streptomyces sp. (strain SP9440),"Antiviral, Anti-HIV, Antimicrobial",,Beta strand,"An internal amide bond between the NH2 of C1 and the gamma-COOH of D9 was observed, as well as two disulfide bridges, one between C1 and C13 and one between C7 and C19. In contrast. Class 2 lassos do not have disulfide bonds.","1RPB, 1RPC resolved by NMR","Caution:The isopeptide linked residue 9 is shown as Asn rather than Asp as mentioned in PubMed:8286361, because it is not known whether Asp or Asn is encoded and the isopeptide bonds are almost always formed between the amides Asn or Gln and N6-lysine or alpha amino groups, with the liberation of an ammonia that makes the reaction essentially irreversible.(From Swiss-prot)",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8270499,J Antibiot (Tokyo). 1993 Nov;46(11):1756-7.,"Helynck G, Dubertret C, Mayaux JF, Leboul J.","Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite.",21,18-21
DRAMP18343,GLPWGCPSDIPGWNTPWAC,19,BI-32169(Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Streptomyces sp. (DSM 14996),Antidiabetic,,Not found,BI-32169 consists exclusively of protein amino acids and is cyclized from the side chain of Asp9 to the N-terminus of Gly1. One disulfide bond between Cys6 and Cys19 forms a bicyclic structure.,,"BI-32169 and its methyl ester derivative (2) showed potent inhibitory activity against the human glucagon receptor (IC50 440 and 320 nM, respectively) in a functional cell-based assay.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15387654,J Nat Prod. 2004 Sep;67(9):1528-31.,"Potterat O, Wagner K, Gemmecker G, Mack J, Puder C, Vettermann R, Streicher R.","BI-32169, a bicyclic 19-peptide with strong glucagon receptor antagonist activity from Streptomyces sp.",19,18-21
DRAMP18342,GLPWGCPSDIPGWNTPWAC,19,BI-32169(Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Streptomyces sp. (DSM 14996),Unknown,,Not found,"Its structure has been established by amino acid analysis, mass spectrometry, and 2D NMR analysis. BI-32169 consists exclusively of protein amino acids and is cyclized from the side chain of Asp9 to the N-terminus of Gly1. One disulfide bond between Cys6 and Cys19 forms a bicyclic structure.",,BI-32169 showed potent inhibitory activity against the human glucagon receptor (IC50 440 nM) in a functional cell-based assay. ,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2004391##15387654 ,Cas Lek Cesk. 1991 Jan 18;130(3):76-8.##J Nat Prod. 2004 Sep;67(9):1528-31.,"Marel M, Mel","[Pleural exudates in patients with lung cancer. Comparative study].
##BI-32169, a bicyclic 19-peptide with strong glucagon receptor antagonist activity from Streptomyces sp.",19,18-21
DRAMP00138,NPKVAHCASQIGRSTAWGAVSGA,23,Acidocin J1132 alpha peptide (Bacteriocin),Q9R4A0,Belongs to the class IIb bacteriocin,Not found,Lactobacillus acidophilus JCM 1132 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Comment: Acidocin J1132 is a pore-forming bacteriocin that creates cell membrane channels through the ""barrel-stave"" mechanism. Both alpha and beta had inhibitory activity, and an increase in activity by the complementary action of the two components was observed.",Lactobacillus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8975617,Appl Environ Microbiol. 1996 Mar;62(3):892-897.,"Tahara T, Oshimura M, Umezawa C, Kanatani K.","Isolation, partial characterization, and mode of action of Acidocin J1132, a two-component bacteriocin produced by Lactobacillus acidophilus JCM 1132.",23,21-24
DRAMP00139,GNPKVAHCASQIGRSTAWGAVSGA,24,Acidocin J1132 beta peptide (Bacteriocin),Q9R499,Belongs to the class IIb bacteriocin,Not found,Lactobacillus acidophilus JCM 1132 (Gram-positive bacteria),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Comment: Acidocin J1132 is a pore-forming bacteriocin that creates cell membrane channels through the ""barrel-stave"" mechanism. Both alpha and beta had inhibitory activity, and an increase in activity by the complementary action of the two components was observed.",Lactobacillus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8975617,Appl Environ Microbiol. 1996 Mar;62(3):892-897.,"Tahara T, Oshimura M, Umezawa C, Kanatani K.","Isolation, partial characterization, and mode of action of Acidocin J1132, a two-component bacteriocin produced by Lactobacillus acidophilus JCM 1132.",24,21-24
DRAMP18339,GFIGWGNNIFGHYSGDF,17,Anantin(Bacteriocin),Q7M0J9,Not found,Not found,Streptomyces coerulescens,Unknown,,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available##PubMed ID is not available,The Journal of antibiotics. 1991 Feb;44(2):164-71.##The Journal of antibiotics. 1991 Feb;44(2):172-80.,"Weber W,Fischli W,Hochuli E,Kupfer E,Weibel E K.##Wyss D F,Lahm H W,Manneberg M,Labhardt A M.","Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity.##Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments.",17,15-18
DRAMP00182,DWTXWSXLVXAACSVELL,18,Thuricin-S (Bacteriocin),P84763,Belongs to the class IId bacteriocin,Not found,Bacillus thuringiensis subsp. entomocidus (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Thuricin S has the same N-terminal sequence (DWTXWSXL) as bacthuricin F4 and thuricin 17, produced by Bacillus thuringiensis strains BUPM4 and NEB17, respectively, and could therefore be classified as a new subBelongs to the class IId bacteriocin.","Gram-positive bacteria: Listeria monocytogenes, Bacillus subtilis and other Bacillus, Enterobacter cloacae, L. acidophilus, Lactococcus lactis, Pediococcus acidilactici, S. thermophilus;##Gram-negative bacteria: S. cholerae, Shigella flexneri and Pseudomonas aeruginosa.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17496978,Can J Microbiol. 2007 Feb;53(2):284-290.,"Chehimi S, Delalande F, Sabl© S, Hajlaoui MR, Van Dorsselaer A, Limam F, Pons AM.","Purification and partial amino acid sequence of thuricin S, a new anti-Listeria bacteriocin from Bacillus thuringiensis.",18,15-18
DRAMP00186,KRKCPKTPFDNTPGAWFAHLILGC,24,LSEI_2163 (m2163; Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Not found,Lactobacillus casei ATCC 334 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: mature LSEI_2163 peptide was a class IId bacteriocin that exhibited antimicrobial activity against some lactobacilli and several Listeria species. The activities of both peptides tolerat 121°C for 30 min but not treatment with proteinase K or trypsin.,"Gram-negative bacteria: Lactobacillus casei ATCC 393 (++), L. casei ATCC 27139 (++), Lactobacillus rhamnosus ATCC 21052 (+++++), L. rhamnosus ATCC 14957 (+), Lactobacillus plantarum ATCC 8014 (+), Listeria innocua ATCC 33091 (++), L. innocua CIP 78.44 (++), Listeria monocytogens ATCC 19112 (+++), Listeria welshimeri ATCC 43551 (++), Listeria seeligeri CIP79.46 (++++).##Note: + indistinct inhibit zone with diameter 8-12 mm, ++ indistinct inhibit zone with diameter ≥12 mm, +++ clear inhibit zone with diameter 12-16 mm, ++++ clear inhibit zone with diameter 16-20 mm, and +++++ clear inhibit zone with diameter ≥20 mm.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22688903,Appl Microbiol Biotechnol. 2012 Jun 12.,"Kuo YC, Liu CF, Lin JF, Li AC, Lo TC, Lin TH.",Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,24,21-24
DRAMP00187,DSIRDVSPTFNKIRRWFDGLFK,22,LSEI_2386 (m2386; Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Not found,Lactobacillus casei ATCC 334 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: mature LSEI_2386 was a putative pheromone peptide that also had significant bacteriocin activity against several Listeria species. The activities of both peptides tolerat 121°C for 30 min but not treatment with proteinase K or trypsin.,"Gram-negative bacteria: Listeria innocua ATCC 33091 (++++), L. innocua CIP 78.44 (++++), Listeria monocytogens ATCC 19112 (+++++), Listeria welshimeri ATCC 43551 (+++++), Listeria seeligeri CIP79.46 (+++++).##Note: ++++ clear inhibit zone with diameter 16-20 mm, and +++++ clear inhibit zone with diameter ≥20 mm.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22688903,Appl Microbiol Biotechnol. 2012 Jun 12.,"Kuo YC, Liu CF, Lin JF, Li AC, Lo TC, Lin TH.",Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,22,21-24
DRAMP00194,GTPGFQTPDARVISRFGFN,19,Capistruin (Bacteriocin),No entry found,Belongs to the class I microcin,Not found,Burkholderia thailandensis E264 (Gram-negative bacteria),"Antimicrobial, Antibacterial",Not found,Beta strand,Not found,,"Discovered by genome mining based on the known MccJ25-gene coding cluster McjABCD. Capistruin is endoded by the capABCD gene cluster, where capA encodes the precursor polypeptide, capB cleaves the presursor and is likely to promote the cyclization, capC encodes an enzyme that activates the side chain of Asp9 for cyclization, and capD encodes a immunity protein. Showed activity against closely related Burkholderia and Pseudomonas strains. Different from the lasso structure of MccJ25, where the N-terminal Gly forms an amide bond with the carboxyl group of Glu8, capistruin forms a 9-residue macrolactam ring formed between NH of Gly1 and the carboxylic side chain of Asp9. In addition, Arg15 is reponsible for the trapping of the tail in the ring structure. ",Burkholderia and Pseudomonas strains,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18671394,J Am Chem Soc. 2008 Aug 27;130(34):11446-11454.,"Knappe TA, Linne U, Zirah S, Rebuffat S, Xie X, Marahiel MA.","Isolation and structural characterization of capistruin, a lasso peptide predicted from the genome sequence of Burkholderia thailandensis E264.",19,18-21
DRAMP00205,CLGIGSCNDFAGCGYAVVCFW,21,Tricyclic peptide RP 71955 (Bacteriocin),"P37046, Q7M104",Belongs to the class 1 lasso peptide,Not found,Streptomyces sp. (strain SP9440) (Gram-positive bacteria),"Antimicrobial, Antiviral",Protein level,Beta strand,Not found,"1RPB, 1RPC resolved by NMR.",Function: Active against HIV-1 virus in vitro.,Virus: HIV-1,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Cyclization of a N-terminal between Cys1 and Asp9,Free,"Disulfide bonds between Cys1 and Cys 13,Cys 7 and Cys19.",L,No cytotoxicity information found,Not found,8270499##8286361,J Antibiot (Tokyo). 1993 Nov;46(11):1756-1757.##Biochemistry. 1994 Jan 11;33(1):42-50.,"Helynck G, Dubertret C, Mayaux JF, Leboul J.##Fréchet D, Guitton JD, Herman F, Faucher D, Helynck G, Monegier du Sorbier B, Ridoux JP, James-Surcouf E, Vuilhorgne M.","Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite.##Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virus.",21,18-21
DRAMP00214,MVPTTFTLTTNNFLSDYQQLFI,22,Lactococcin K (Bacteriocin),No entry found,Not found,Not found,Lactococcus lactis subsp. lactis MY23 ,"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16614924,Biotechnol Lett. 2006 Mar;28(5):357-362.,"Kim YS, Kim MJ, Kim P, Kim JH.","Cloning and production of a novel bacteriocin, lactococcin K, from Lactococcus lactis subsp. lactis MY23.",22,21-24
DRAMP00219,YSLQMGATAIKQVKKLFKKWGW,22,PlnA-22 (Bacteriocin),No entry found,Not found,Not found,Lactobacillus plantarum (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Lactobacillus sake NCDO 2714 (IC50=40 nM), Lactobacillus plantarum 965 (IC50=300 nM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15805109,J Biol Chem. 2005 Jun 17;280(24):22945-22950.,"Kristiansen PE, Fimland G, Mantzilas D, Nissen-Meyer J.",Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A.,22,21-24
DRAMP00220,GATAIKQVKKLFKKWGW,17,PlnA-17 (Bacteriocin),No entry found,Not found,Not found,Lactobacillus plantarum (Gram-positive bacteria),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-positive bacteria: Lactobacillus sake NCDO 2714 (IC50=15 nM), Lactobacillus plantarum 965 (IC50=400 nM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15805109,J Biol Chem. 2005 Jun 17;280(24):22945-22950.,"Kristiansen PE, Fimland G, Mantzilas D, Nissen-Meyer J.",Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A.,17,15-18
DRAMP18335,GNGVFKTISHECHLNTWAFLATCCS,25,Salivaricin G32(Bacteriocin),H6VLK4,Belongs to the lantibiotics family (Class I bacteriocin),slnA,Streptococcus salivarius strain G32,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,"The first modified amino acid was found to be a dehydrobutyrine (Dhb) at position 8 that could form a beta-methyl-lanthionine bond with Cys13. A second beta-methyl-lanthionine formation between Dhb and Cys was found at positions 10 and 32, respectively. A disulfide bridge was between the two Cys residues at positions 21 and 29. The data is in accordance with the sequence analysis of bovicin HJ50 and thermophilin 1277.",,The inhibitory peptide differs from the Streptococcus pyogenes-produced SA-FF22 in the absence of lysine in position 2.,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22567013##23122510 ,Int J Microbiol. 2012;2012:738503.##Food Microbiol. 2013 Feb;33(1):124-30.,"Wescombe PA, Dyet KH, Dierksen KP, Power DA, Jack RW, Burton JP, Inglis MA, Wescombe AL, Tagg JR.##Georgalaki M, Papadimitriou K, Anastasiou R, Pot B, Van Driessche G, Devreese B, Tsakalidou E.","Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.##Macedovicin, the second food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198.",25,24-27
DRAMP00224,KQQLATEAESAGPIL,15,BTL (Bacteriocin),No entry found,Not found,Not found,Bacillus subtilis B-TL2 (Gram-positive bacteria),"Antimicrobial, Antifungal",Not found,Not found,Not found,,"Function: The peptide exhibits strong inhibitory activity against mycelial growth of Bipolaris maydis, Alternaria brassicae, Aspergillus niger, Cercospora personata.
Biophysicochemical properties: The purified BTL displays thermostability, almost retaining 100% activity at 100 degrees C for 15 min.","Fungi: Bipolaris maydis, Alternaria brassicae, Aspergillus niger, Cercospora personata.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18241956,Peptides. 2008 Mar;29(3):350-355.,"Zhang B, Xie C, Yang X.",A novel small antifungal peptide from Bacillus strain B-TL2 isolated from tobacco stems.,15,12-15
DRAMP00230,GSQLVYREWVGHSNVIKP,18,Lariatins A (lasso peptide; Bacteriocin),No entry found,Not found,Not found,Rhodococcus jostii K01-B0171 (Gram-positive bacteria) ,"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacteria: Mycobacterium smegmatis and Mycobacterium tuberculosis.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16756302,J Am Chem Soc. 2006 Jun 14;128(23):7486-7891.,"Iwatsuki M, Tomoda H, Uchida R, Gouda H, Hirono S, Omura S.","Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure.",18,15-18
DRAMP00231,GSQLVYREWVGHSNVIKGPP,20,Lariatins B (lasso peptide; Bacteriocin),No entry found,Not found,Not found,Rhodococcus jostii K01-B0171 (Gram-positive bacteria) ,"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacteria: Mycobacterium smegmatis and Mycobacterium tuberculosis.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16756302,J Am Chem Soc. 2006 Jun 14;128(23):7486-7891.,"Iwatsuki M, Tomoda H, Uchida R, Gouda H, Hirono S, Omura S.","Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure.",20,18-21
DRAMP00237,DIDITGCSACKYAAG,15,Halocin-C8 (HalC8; Bacteriocin),P83716,Not found,Not found,Halobacterium sp. (strain AS7092),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"MOA: Causes cell lysis and death, possibly by disrupting the cell wall. boiled, subjected to organic solvents, and stored at 4 degrees Celsius for extended periods without losing activity.",A wide variety of haloarchaeons.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell wall,12811620,Extremophiles. 2003 Oct;7(5):401-407.,"Li Y, Xiang H, Liu J, Zhou M, Tan H.","Purification and biological characterization of halocin C8, a novel peptide antibiotic from Halobacterium strain AS7092.",15,12-15
DRAMP00245,VGALAVVVWLWLWLW,15,Gramicidin A (GA; Nonribosomally synthesized bacteriocin),No entry found,Not found,Not found,Bacillus brevis (soil bacterium) (Gram-positive bacteria),"Antimicrobial, Antbacterial, Antiviral",Not found,Beta strand (1 strands; 13 residues),"Amino acids 4, 6, 8, 10, and 12 are D-amino acids, allowing the formation of a special helical structure that head-to-head dimerizes into a cation channel in lipid bilayer with the C-terminus exposed. Structures solved in organic solvents by x-ray diffraction are believed to be non-channel forms. ",1MAG resolved by NMR.,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19870884##8810522,J Exp Med. 1939 Jun 30;70(1):1-10.##J Biomol NMR. 1996 Jul;8(1):1-14.,"Dubos RJ.##Ketchem RR, Lee KC, Huo S, Cross TA.",STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS : I. PREPARATION OF THE AGENT. ITS ACTIVITY IN VIT.##Macromolecular structural elucidation with solid-state NMR-derived orientational constraints.,15,12-15
DRAMP00246,VGALAVVVWLFLWLW,15,Gramicidin B (GB; Bacteriocin),No entry found,Not found,Not found,Bacillus brevis (soil bacterium) (Gram-positive bacteria),"Antimicrobial, Antbacterial, Antiviral",Not found,Beta strand (1 strands; 13 residues),Not found,1JO3 resolved by NMR.,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11570868,Biochemistry 2001; 40: 11676-11686.,"Townsley, L.E, Tucker, W.A, Sham, S, Hinton, J.F.","Structures of gramicidins A, B, and C incorporated into sodium dodecyl sulfate micelles.",15,12-15
DRAMP00247,VGALAVVVWLYLWLW,15,Gramicidin C (GC; Bacteriocin),No entry found,Not found,Not found,Bacillus brevis (soil bacterium) (Gram-positive bacteria),"Antimicrobial, Antbacterial, Antiviral",Not found,Beta strand (1 strands; 13 residues),Not found,1JO4 resolved by NMR.,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11570868,Biochemistry 2001; 40: 11676-11686.,"Townsley, L.E, Tucker, W.A, Sham, S, Hinton, J.F.","Structures of gramicidins A, B, and C incorporated into sodium dodecyl sulfate micelles.",15,12-15
DRAMP00249,YSLQMGATAIKQVKKLFKKKGG,22,Pln149 (Plantaricin 149; Bacteriocin; Derivatives: Pln149a),No entry found,Not found,Not found,Lactobacillus plantarum NRIC 149 (Gram-positive bacteria),"Antimicrobial, Antibacterial, Antifungal",Not found,Alpha helix,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrance,17266050,J. Fermentation Bioeng. 1994;77(3):277-282.,"Kato T, Matsuda T, Ogawa E, Ogawa H, Kato H, Doi U.","Plantaricin-149, a bacteriocin produced by Lactobacillus plantarum NRIC 149.",22,21-24
DRAMP00251,ALPKKLKYLNLFNDGFNYMGVV,22,Bacteriocin serracin-P 23 kDa subunit (Bacteriocin),P83378,Not found,Not found,Serratia plymuthica J7 (Gram-negative bacteria),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Function: Major component of a prophage tail tube. Antibacterial activity against Gram-negative bacteria E.amylovora.,Gram-negative bacterium: Erwinia amylovora.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12406768,Appl Environ Microbiol. 2002 Nov;68(11):5704-5710.,"Jabrane A, Sabri A, Comp¨re P, Jacques P, Vandenberghe I, Van Beeumen J, Thonart P.","Characterization of serracin P, a phage-tail-like bacteriocin, and its activity against Erwinia amylovora, the fire blight pathogen.",22,21-24
DRAMP00265,EALYNSEDLYEETSDSDD,18,Putative antimicrobial protein 1 (Ls-AMP1; Plant defensin),P86895,Not found,Not found,Lippia sidoides (Pepper-rosmarin),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: May possess antifungal activity.
Caution: Antifungal activity was tested using a fraction containing a number of different peptides. It is not clear which peptide actually has antifungal activity.",Fungi: Botrytis cinerea.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21210197,Protein J. 2011 Jan;30(1):32-38.,"Moreira JS, Almeida RG, Tavares LS, Santos MO, Viccini LF, Vasconcelos IM, Oliveira JT, Raposo NR, Dias SC, Franco OL.",Identification of botryticidal proteins with similarity to NBS-LRR proteins in rosemary pepper (Lippia sidoides Cham.) flowers.,18,15-18
DRAMP00266,SPPEAAYGPGNTNSDSGDK,19,Putative antimicrobial protein 2 (Ls-AMP2; Plant defensin),P86896,Not found,Not found,Lippia sidoides (Pepper-rosmarin),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: May possess antifungal activity.
Caution: Antifungal activity was tested using a fraction containing a number of different peptides. It is not clear which peptide actually has antifungal activity.",Fungi: Botrytis cinerea.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21210197,Protein J. 2011 Jan;30(1):32-38.,"Moreira JS, Almeida RG, Tavares LS, Santos MO, Viccini LF, Vasconcelos IM, Oliveira JT, Raposo NR, Dias SC, Franco OL.",Identification of botryticidal proteins with similarity to NBS-LRR proteins in rosemary pepper (Lippia sidoides Cham.) flowers.,19,18-21
DRAMP00267,ESGINLQGDATLANN,15,Antifungal lectin AMML (AMML; Plant defensin),P85004,Not found,Not found,Astragalus mongholicus (Huang qi) (Astragalus membranaceus varmongholicus),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Lectin that binds strongly to galactose, lactose, D-raffinose, L-rhamnose and cellobiose, and less strongly to D-glucose, D-xylose and L-arabinose. Does not bind D-galacturonic acid, D-fructose, D-mannose, D-ribose, L-sorbose, maltose and sucrose. Has hemagglutinating activity towards human type O and rabbit erythrocytes. Has strong antifungal activity against B. cinera, and weaker antifungal activity against D. turcia, F. oxysporum and Colletorichum sp. but not against Rhizoctonia solani and Mycosphaerella arachidicola.
Miscellaneous: Hemagglutinating activity stable when incubated at 65 degrees Celsius for 30 minutes. Hemagglutinating activity is reduced by 50% when incubated at 75 degrees Celsius for 30 minutes and is abolished by incubation at 85 degrees Celsius for 30 minutes. Hemagglutinating activity is stable between pH 4.5 and 7.5, but is completely inhibited by incubation below pH 3.0 or above pH 10.","Fungi: Botrytis cinerea (IC50=1.2 µM), Drechslera turcia, Fusarium oxysporum and Colletorichum sp.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Galactose and Glucose,16140255,Arch Biochem Biophys. 2005 Oct 1;442(1):72-81.,"Yan Q, Jiang Z, Yang S, Deng W, Han L.",A novel homodimeric lectin from Astragalus mongholicus with antifungal activity.,15,12-15
DRAMP00268,QGIGVGDNDGKRGKR,15,Antifungal protein Pr-2 (Pr-2; Plant defensin),P86796,Not found,Not found,Cucurbita maxima (Pumpkin) (Winter squash),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Has strong antifungal activity. Lacks antifungal activity against P.verrucosum var. verrucosum. Lacks antibacterial activity against the Gram-negative bacterium E.coli and against the Gram-positive bacterium S.aureus. Has very low hemolytic activity against human erythrocytes. Increases fungal cell membrane permeability, probably by disrupting the membrane structure.","[Ref.19807165]Fungi: Botrytis cinerea (EC50=20 µM), Candida albicans (EC50=20 µM), Colletotrichum coccodes (EC50=10 µM), Fusarium oxysporum (EC50=10 µM), Fusarium solani (EC50=10 µM), Trichoderma harzianum (EC50=20 µM), Trichoderma viride (EC50=20 µM), Aspergillus fumigatus EC50=40 µM), Aspergillus parasiticus (EC50=80 µM), Didymella bryoniae (EC50=40 µM).",[Ref:19807165]0% hemolytic activity at 80 µM and 8% hemolytic activity at 160 µM against huamn red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19807165,J Agric Food Chem. 2009 Oct 14;57(19):9299-9304.,"Park SC, Kim JY, Lee JK, Hwang I, Cheong H, Nah JW, Hahm KS, Park Y.",Antifungal mechanism of a novel antifungal protein from Pumpkin rinds against various fungal pathogens.,15,12-15
DRAMP00269,LDSLSFSYNNFEEDD,15,Antifungal protein 1 (GAFP-1; Plant defensin),P86920,Not found,Not found,Arachis hypogaea (Peanut),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Function: Has strong antifungal activity against fungal phytopathogens.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (MAY-2011) to UniProtKB,Indira S.,GAFP-1 from roots of Arachis hypogeae L.,15,12-15
DRAMP00272,AKITFTNNHPRTIWP,15,Thaumatin-like protein (Plants),P83957,Belongs to the thaumatin family,Not found,Castanopsis chinensis (Chinese chinquapin) (Kweilin chestnut),"Antimicrobial, Antifungal, Antiviral",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Fungi: Botrytis cinerea, Fusarium oxysporum (IC50=0.5 µM), Mycosphaerella arachidicola, Psylla piricola.##HIV-1 reverse transcriptase (IC50=1.6 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12565869,Biochem Biophys Res Commun. 2003 Feb 7;301(2):364-370.,"Chu KT, Ng TB.",Isolation of a large thaumatin-like antifungal protein from seeds of the Kweilin chestnut Castanopsis chinensis.,15,12-15
DRAMP00274,QKIQEIDLQTYLQPQ,15,Amaryllin (Plant defensin),P86781,Not found,Not found,Amaryllis belladonna (Naked lady lily),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Function: Has antifungal activity.,Fungi: Aspergillus flavus and Fusarium oxysporum.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19478451,Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jun 1;65(Pt 6):635-637.,"Kumar S, Singh N, Sinha M, Kaur P, Srinivasan A, Sharma S, Singh TP.","Isolation, purification, crystallization and preliminary crystallographic studies of amaryllin, a plant pathogenesis-related protein from Amaryllis belladonna.",15,12-15
DRAMP00278,LPSDATLVLDQTGKELDARL,20,Antifungal protein J (AFP-J; Plants),P84794,Belongs to the protease inhibitor I3,Not found,Solanum tuberosum (Potato),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Inhibitor of serine proteases chymotrypsin, pepsin and trypsin. Has strong antifungal activity. Non-hemolytic activity against human erythrocytes.","[Ref.16076139]Fungi: Candida albicans TIMM 1768(MIC=6.25μg/mL)), Saccharomyces cerevisiae KCTC 7296(MIC=6.25μg/mL)), Trichosporon beigelii KCTC 7707(MIC=6.25μg/mL))",[Ref:16076139]Non-hemolytic activity against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16076139,J Agric Food Chem. 2005 Aug 10;53(16):6491-6496.,"Park Y, Choi BH, Kwak JS, Kang CW, Lim HT, Cheong HS, Hahm KS.",Kunitz-type serine protease inhibitor from potato (Solanum tuberosum L. cv. Jopung).,20,18-21
DRAMP00295,ADPTFGFTPLGLSEKANLQIMKAYD,25,Soybean toxin 27 kDa chain (SBTX 27 kDa chain; Plant defensin),P86520,Not found,Not found,Glycine max (Soybean) (Glycine hispida),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Involved in plant defense. Has antifungal activity against C. sojina but not A. niger and F. solani. Does not have urease or hemagglutination activities. Does not inhibit trypsin. Injection into mice produces toxic effects such as dyspnea, tonic-clonic convulsion and death.
Subunit structure Heterodimer of a 27 kDa subunit and a 17 kDa subunit; disulfide-linked.
Tissue specificity: Expressed in seeds, leaves, roots and stem (at protein level).
Induction: In seeds, induced by jasmonate.
Post-translational modification: SBTX is known to be glycosylated but it is not known which one of its two subunits is modified; contains 5% carbohydrates.
Toxic dose: LD50 is 5.6 mg/kg by intraperitoneal injection into mice.
Miscellaneous: On the 2D-gel the determined pI of SBTX is: 8.2, its MW is: 44 kDa.
Biophysicochemical properties: pH dependence (Activity decreases below pH 5.5 and above pH 8.0).",Fungi: C. sojina.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18328522,Toxicon. 2008 May;51(6):952-963.,"Vasconcelos IM, Morais JK, Siebra EA, Carlini CR, Sousa DO, Beltramini LM, Melo VM, Oliveira JT.","SBTX, a new toxic protein distinct from soyatoxin and other toxic soybean [Glycine max] proteins, and its inhibitory effect on Cercospora sojina growth.",25,24-27
DRAMP00296,PNPKVFFDMTIGGQSAGRIVMEEYA,25,Soybean toxin 17 kDa chain (SBTX 17 kDa chain; Plant defensin),P86548,Not found,Not found,Glycine max (Soybean) (Glycine hispida),"Antimicrobial, Antifungal, Cytotoxic",Protein level,Not found,Not found,,"Function: Involved in plant defense. Has antifungal activity against C.sojina but not A.niger and F.solani. Does not have urease or hemagglutination activities. Does not inhibit trypsin. Injection into mice produces toxic effects such as dyspnea, tonic-clonic convulsion and death.
Subunit structure: Heterodimer of a 27 kDa subunit and a 17 kDa subunit; disulfide-linked.
Tissue specificity: Expressed in seeds, leaves, roots and stem (at protein level).
Induction: In seeds, induced by jasmonate.
Post-translational modification: SBTX is known to be glycosylated but it is not known which one of its two subunits is modified; contains 5% carbohydrates.
Toxic dose: LD50 is 5.6 mg/kg by intraperitoneal injection into mice.
Miscellaneous: On the 2D-gel the determined pI of SBTX is: 8.2, its MW is: 44 kDa.
Biophysicochemical properties: pH dependence (Activity decreases below pH 5.5 and above pH 8.0). ",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18328522,Toxicon. 2008 May;51(6):952-963.,"Vasconcelos IM, Morais JK, Siebra EA, Carlini CR, Sousa DO, Beltramini LM, Melo VM, Oliveira JT.","SBTX, a new toxic protein distinct from soyatoxin and other toxic soybean [Glycine max] proteins, and its inhibitory effect on Cercospora sojina growth.",25,24-27
DRAMP00299,DADIAVWAPPVNAQN,15,Ribonuclease (Plants),P84784,Not found,Not found,Thelephora ganbajun (Mushroom),"Antimicrobial, Antiviral",Protein level,Not found,Not found,,"Function: Inhibits HIV-1 reverse transcriptase.
Miscellaneous: Inhibits HIV-1 reverse transcriptase with an IC50 of 300 nM.
Biophysicochemical properties: pH dependence (Optimum pH is 6-7); Temperature dependence (Optimum temperature is 45 degrees Celsius. Activity decreases sharply above 50 degrees Celsius and below 40 degrees Celsius).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15474506,Biochem Biophys Res Commun. 2004 Nov 12;324(2):855-859.,"Wang HX, Ng TB.",Purification of a novel ribonuclease from dried fruiting bodies of the edible wild mushroom Thelephora ganbajun.,15,12-15
DRAMP00304,SIGFDGLNDPDIVAR,15,Endochitinase 1 (Plant defensin),P86078,Belongs to the glycosyl hydrolase 20 family (Chitinase class I subfamily),Not found,Capsicum annuum var. annuum (Red pepper),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Defense against chitin containing fungal pathogens. 
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not availbale,Submitted (JUL-2008) to UniProtKB,"Belchi-Navarro S, Almagro L, Pedreno M.A.",Not found,15,12-15
DRAMP00306,GPLQLSWNYNYGAAGK,16,Endochitinase 1 (Plant defensin),P85343,Belongs to the glycosyl hydrolase 22 family (Chitinase class I subfamily),Not found,Ginkgo biloba (Ginkgo) (Maidenhair tree),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19157640,J Plant Physiol. 2009 May 15;166(8):831-843.,"Uzal EN, Gómez-Ros LV, Hernández JA, Pedreño MA, Cuello J, Ros Barceló A.",Analysis of the soluble cell wall proteome of gymnosperms.,16,15-18
DRAMP00307,EQCGNQAGGXVPPNG,15,Endochitinase A1 (Plant defensin),P21225,Belongs to the glycosyl hydrolase 23 family (Chitinase class I subfamily),Not found,Pisum sativum (Garden pea),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: By infection with the fungal pathogen Ascochyta pisi.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not availbale,Planta 184:24-29(1991).,"Vad K, Mikkelsen JD, Collinge DB.","Induction, purification and characterization of chitinase isolated from pea leaves inoculated with Ascochyta pisi.",15,12-15
DRAMP00308,AIGFDGLNDPDIVAR,15,Endochitinase 1 (Plant defensin),P85337,Belongs to the glycosyl hydrolase 24 family (Chitinase class I subfamily),Not found,Taxus baccata (English yew),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19157640,J Plant Physiol. 2009 May 15;166(8):831-843.,"Uzal EN, Gómez-Ros LV, Hernández JA, Pedreño MA, Cuello J, Ros Barceló A.",Analysis of the soluble cell wall proteome of gymnosperms.,15,12-15
DRAMP00312,TAGFGVFTNIINGGLECGK,19,Endochitinase 2 (Plant defensin),P85338,Belongs to the glycosyl hydrolase 28 family (Chitinase class I subfamily),Not found,Taxus baccata (English yew),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
PTM: Contians one disulfide bond (By similarity).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19157640,J Plant Physiol. 2009 May 15;166(8):831-843.,"Uzal EN, Gómez-Ros LV, Hernández JA, Pedreño MA, Cuello J, Ros Barceló A.",Analysis of the soluble cell wall proteome of gymnosperms.,19,18-21
DRAMP00318,EQCGRQAGGATCPNNLCCSQYGY,23,Endochitinase B (Plant defensin),P21227,Belongs to the glycosyl hydrolase 34 family (Chitinase class I subfamily),Not found,Pisum sativum (Garden pea),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: By infection with the fungal pathogen Ascochyta pisi.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Chitin-binding,PubMed ID is not availbale,Planta 184:24-29(1991).,"Vad K, Mikkelsen JD, Collinge DB.","Induction, purification and characterization of chitinase isolated from pea leaves inoculated with Ascochyta pisi.",23,21-24
DRAMP00324,GIFTFEDESTSTVAPAKLYK,20,Protein PR-L1 (Plant defensin),P83363,Belongs to the BetVI family,Not found,Lupinus luteus (European yellow lupin),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not availbale,J. Plant Physiol. 1999;154:703-708.,"Przymusinski R, Gwozdz E.A.",Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.,20,18-21
DRAMP00325,SVFAFENEQSSTIAPARLYK,20,Protein PR-L2 (Plant defensin),P83364,Belongs to the BetVI family,Not found,Lupinus luteus (European yellow lupin),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not availbale,J. Plant Physiol. 1999;154:703-708.,"Przymusinski R, Gwozdz E.A.",Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.,20,18-21
DRAMP00326,GIFTFEDESTTTVAPAKLYK,20,Protein PR-L3 (Plant defensin),P83365,Belongs to the BetVI family,Not found,Lupinus luteus (European yellow lupin),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not availbale,J. Plant Physiol. 1999;154:703-708.,"Przymusinski R, Gwozdz E.A.",Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.,20,18-21
DRAMP00327,SVFAFQDESTSTIAQARLFI,20,Protein PR-L4 (Plant defensin),P83366,Belongs to the BetVI family,Not found,Lupinus luteus (European yellow lupin),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not availbale,J. Plant Physiol. 1999;154:703-708.,"Przymusinski R, Gwozdz E.A.",Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.,20,18-21
DRAMP00328,SIFAFQDESPSAIAQAKLFK,20,Protein PR-L5 (Plant defensin),P83367,Belongs to the BetVI family,Not found,Lupinus luteus (European yellow lupin),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not availbale,J. Plant Physiol. 1999;154:703-708.,"Przymusinski R, Gwozdz E.A.",Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.,20,18-21
DRAMP00329,GVFTFEDESTSTVAPAKLYK,20,Protein PR-L6 (Plant defensin),P83368,Belongs to the BetVI family,Not found,Lupinus luteus (European yellow lupin),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not availbale,J. Plant Physiol. 1999;154:703-708.,"Przymusinski R, Gwozdz E.A.",Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.,20,18-21
DRAMP00335,NVRFDLSGATSSSYKTFIKN,20,Ribosome-inactivating protein (rRNA N-glycosidase; Plant defensin),P80750,Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily),Not found,Cucurbita pepo (Vegetable marrow) (Summer squash),Unknown,Protein level,Not found,Not found,,Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S Rrna.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9022685,Eur J Biochem. 1996 Dec 15;242(3):585-591.,"Yoshinari S, Yokota S, Sawamoto H, Koresawa S, Tamura M, Endo Y.","Purification, characterization and subcellular localization of a type-1 ribosome-inactivating protein from the sarcocarp of Cucurbita pepo.",20,18-21
DRAMP00339,GADFQECMKEHSQKQHQHQG,20,Alpha-basrubrin (Fragment; Plants),P83186,Not found,Not found,Basella alba (Malabar spinach) (Basella rubra),"Antimicrobial, Antifungal, Antiviral",Protein level,Not found,Not found,,Function: Inhibits HIV-1 reverse transcriptase and cell-free translation.,"Fungi: Botrytis cinerea, Mycosphaerella arachidicola, Fusarium oxysporum.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11688973,Biochem Biophys Res Commun. 2001 Nov 9;288(4):765-770.,"Wang H, Ng T.B.",Novel antifungal peptides from ceylon spinach seeds.,20,18-21
DRAMP00340,KIMAKPSKFYEQLRGR,16,Beta-basrubin (Plants),P83187,Not found,Not found,Basella alba (Malabar spinach) (Basella rubra),"Antimicrobial, Antifungal, Antiviral",Protein level,Not found,Not found,,Function: Possesses antifungal activity. Inhibits HIV-1 reverse transcriptase and cell-free translation.,"Fungi: Botrytis cinerea, Mycosphaerella arachidicola, Fusarium oxysporum.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11688973,Biochem Biophys Res Commun. 2001 Nov 9;288(4):765-770.,"Wang H, Ng T.B.",Novel antifungal peptides from ceylon spinach seeds.,16,15-18
DRAMP00360,ISCQDVKQSLAPCLPYVTGRAPKPA,25,Non-specific lipid-transfer protein 1 (LTP 1; Plants),P86527,Belongs to the plant LTP family,Not found,Nigella sativa (Black cumin),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.,Fungi: Fusarium oxysporum and Phytophthora infestans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipid-binding,19621049,Bioorg Khim. 2009 May-Jun;35(3):344-349.,"Oshchepkova IuI, Veshkurova ON, Rogozhin EA, Musoliamov AKh, Smirnov AN, Odintsova TI, Egorov TsA, Grishin EV, Salikhov ShI.",Isolation of the lipid-transporting protein Ns-LTP1 from seeds of the garden fennel flower (Nigella sativa).,25,24-27
DRAMP00361,ITCPQVTQSLAPCVPYLISG,20,Non-specific lipid-transfer protein (LTP; Harmalin; Plants),B3EWH4,Belongs to the plant LTP family,Not found,Peganum harmala (Syrian rue) (Harmal peganum),"Antimicrobial, Antifungal, Antiviral, Anti-cancer",Protein level,Not found,Not found,,"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues. Inhibits cell proliferation of cervical carcinoma cell line HeLa (IC50=2.74 µM), gastric carcinoma cell line MGC-7 (IC50=3.13 µM), esophageal carcinoma cell line Eca-109 (IC50=0.7 µM) and melanoma B16 cells (IC50=1.47 µM). Has antifungal activity. Induces caspase-dependent apoptosis in cell line Eca-109. Demonstrates inhibitory effect on HIV-1 reverse transcriptase (IC50=1.26 µM).
Biophysicochemical properties: pH dependence (Stable between pH 4 and 10); Temperature dependence (Thermostable. Retains antifungal activity between 4 degrees Celsius and 60 degrees Celsius. Activity reduced after 30 min at 80 degrees Celsius).","Fungi: Penicillium digitatum (IC50=37.5 µM), Alternaria alternata (IC50=1.5 µM), Rhizopus stolonifer (IC50=8.44 µM) and Magnaporthe grisea (IC50=12.19 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipid-binding,PubMed ID is not available,Submitted (MAR-2012) to UniProtKB,"Ma XJ, Liu DL, Tang HS, Wang Y, Sun SR.","Purification and characterization of a novel protein from Peganum harmala seeds with antifungal, antiproliferation and anti-HIV-1 reverse transcriptase activities.",20,18-21
DRAMP00375,PAGPFRIPPRXRXEFQ,16,Antifungal protein 1 small subunit (CW-1; Plants),P83140,Not found,Not found,Malva parviflora (Little mallow) (Cheeseweed mallow),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Possesses very potent antifungal activity against F. graminearum.
Subunit structure: Heterodimer of a large and a small subunit.
Miscellaneous: Antimicrobial activity is not affected by salt concentration.",Fungi:##At low salt condition: Fusarium graminearum (IC50=2.5 ppm).##At high salt condition: Fusarium graminearum (IC50=10 ppm).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11118343,Biochem Biophys Res Commun. 2000 Dec 20;279(2):669-673.,"Wang X, Bunkers GJ.",Potent heterologous antifungal proteins from cheeseweed (Malva parviflora).,16,15-18
DRAMP00376,VAGPFRIPPLRREFQ,15,Antifungal protein 1 large subunit (CW-1; Plants),P83141,Not found,Not found,Malva parviflora (Little mallow) (Cheeseweed mallow),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Possesses antifungal activity against P. infestans but not F. graminearum.
Subunit structure: Heterodimer of a large and a small subunit.
Miscellaneous: Antimicrobial activity is not affected by salt concentration.",Fungi: Phytophthora infestans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11118343,Biochem Biophys Res Commun. 2000 Dec 20;279(2):669-673.,"Wang X, Bunkers GJ.",Potent heterologous antifungal proteins from cheeseweed (Malva parviflora).,15,12-15
DRAMP00377,SDYSRKRDPPQKYEEE,16,Antifungal protein 2 small subunit (CW-2; Plants),P83142,Not found,Not found,Malva parviflora (Little mallow) (Cheeseweed mallow),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Possesses antifungal activity against P. infestans but not F. graminearum.
Subunit structure: Heterodimer of a large and a small subunit. 
Miscellaneous: Antimicrobial activity is not affected by salt concentration.",Fungi: Phytophthora infestans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11118343,Biochem Biophys Res Commun. 2000 Dec 20;279(2):669-673.,"Wang X, Bunkers GJ.",Potent heterologous antifungal proteins from cheeseweed (Malva parviflora).,16,15-18
DRAMP00378,PEDPQRRYQEXQREXRXQQE,20,Antifungal protein 2 large subunit (CW-2; Plants),P83143,Not found,Not found,Malva parviflora (Little mallow) (Cheeseweed mallow),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Possesses antifungal activity against P. infestans but not F. graminearum.
Subunit structure: Heterodimer of a large and a small subunit.
Miscellaneous: Antimicrobial activity is not affected by salt concentration.",Fungi: Phytophthora infestans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11118343,Biochem Biophys Res Commun. 2000 Dec 20;279(2):669-673.,"Wang X, Bunkers GJ.",Potent heterologous antifungal proteins from cheeseweed (Malva parviflora).,20,18-21
DRAMP00379,PEDPQRRYQEEQRRE,15,Antifungal protein 3 (CW-3; Plants),P83137,Not found,Not found,Malva parviflora (Little mallow) (Cheeseweed mallow),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Possesses antifungal activity.
Miscellaneous: Antimicrobial activity is not affected by salt concentration.",Fungi: Phytophthora infestans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11302747,Biochem Biophys Res Commun. 2001 Apr 20;282(5):1224-1228.,"Wang X, Bunkers GJ, Walters MR, Thoma RS.",Purification and characterization of three antifungal proteins from cheeseweed (Malva parviflora).,15,12-15
DRAMP00394,FSGSVNQACSGFGWK,15,Antimicrobial peptide1 (Plant defensin),P85484,Not found,Not found,Pinus halepensis (Aleppo pine),Antimicrobial,Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19157640,J Plant Physiol. 2009 May 15;166(8):831-143.,"Uzal EN, G³mez-Ros LV, Hern¡ndez JA, Pedre±o MA, Cuello J, Ros Barcel³ A.",Analysis of the soluble cell wall proteome of gymnosperms.,15,12-15
DRAMP00402,XTCESPSHKFKGPCATNRNCES,22,Defensin D1 (So-D1; Antimicrobial peptide D1; Plant defensin),P81572,Belongs to the DEFL family,Not found,Spinacia oleracea (Spinach),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antimicrobial peptide. Active against Gram-positive and Gram-negative bacterial pathogens.,Gram-positive bacterium: Clavibacter michiganensis;##Gram-negative bacterium: Ralstonia solanacearum.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, Garc­a-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,22,21-24
DRAMP00404,GIFSSRKCKTVSKTFRGICTRNANC,25,Defensin D3 (So-D3; Antimicrobial peptide D3; Plant defensin),P81570,Belongs to the DEFL family,Not found,Spinacia oleracea (Spinach),"Antimicrobial, Antibacterial, Antifungal",Protein level,Bridge,Not found,,"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.",Fungi: Fusarium spp.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, Garcia-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,25,24-27
DRAMP00405,MFFSSKKCKTVSKTFRGPCVRNA,23,Defensin D4 (So-D4; Antimicrobial peptide D4; Plant defensin),P81569,Belongs to the DEFL family,Not found,Spinacia oleracea (Spinach),"Antimicrobial, Antibacterial, Antifungal",Protein level,Bridge,Not found,,"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.",Fungi: Fusarium spp.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, Garcia-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,23,21-24
DRAMP00406,MFFSSKKCKTVXKTFRGPCVRNAN,24,Defensin D5 (So-D5; Antimicrobial peptide D5; Plant defensin),P81568,Belongs to the DEFL family,Not found,Spinacia oleracea (Spinach),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.","Gram-positive bacterium: Clavibacter michiganensis;##Gram-negative bacterium: Ralstonia solanacearum.##Fungi: Fusarium culmorum, Fusarium solani, Bipolaris maydis and Colletotrichum lagenarium.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, Garcia-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,24,21-24
DRAMP00407,GIFSNMYXRTPAGYFRGPXGYXXN,24,Defensin D6 (So-D6; Antimicrobial peptide D6; Plant defensin),P81567,Belongs to the DEFL family,Not found,Spinacia oleracea (Spinach),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.",Gram-positive bacterium: Clavibacter michiganensis (EC50=1 µM);##Gram-negative bacterium: Ralstonia solanacearum (EC50=6 µM).##Fungi: Fusarium solani (EC50=11 µM). ,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, Garcia-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,24,21-24
DRAMP00411,QKLCERPSGTWSGVCGNNNACKN,23,Defensin-like protein 2 (Bn-AFP2; Plant defensin),P30226,Belongs to the DEFL family,Not found,Brassica napus (Rape),"Antimicrobial, Antifungal",Protein level,Rich,Not found,,"Function: Possesses antifungal activity sensitive to inorganic cations.
Subunit structure: Forms oligomers in its native state.","Fungi: Alternaria brassicola (IC50=75 µg/ml), Botrytis cinerea(IC50> 100 µg/ml), Fusarium culmorum (IC50=38 µg/ml), Fusarium oxysporum f.sp.lycopersici (IC50=42 µg/ml), Pyricularia oryzae (IC50=3 µg/ml), Verticiliium dahliae (IC50=15 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8422949,FEBS Lett. 1993 Feb 1;316(3):233-240.,"Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.",A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.,23,21-24
DRAMP00750,EVCEKASKTWSGNCGNTGHC,20,Defensin-like protein 2 (Dm-AMP2; Plant defensin),No entry found,Belongs to the DEFL family,Not found,Dahlia merckii (Bedding dahlia),"Antimicrobial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Medium A: Botrytis cinerea (IC50=10 µg/ml), Cladosporium sphaerospermum (IC50=3 µg/ml), Fusarium culmorum (IC50=5 µg/ml), Leptosphaeria maculans (IC50=1 µg/ml), Penicillium digitatum (IC50=2 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=1 µg/ml), Verticilium albo-atrum (IC50=2 µg/ml). NOTE: Medium A = 1/2 strength potato dextrose broth.##Medium B: Botrytis cinerea (IC50>100 µg/ml), Cladosporium sphaerospermum (IC50=12 µg/ml), Fusarium culmorum (IC50=12 µg/ml), Leptosphaeria maculans (IC50=20 µg/ml), Penicillium digitatum (IC50=50 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=2 µg/ml), Verticilium albo-atrum (IC50>100 µg/ml).##NOTE: Medium B = Medium A supplemented with 1 mM CaCl2 and 50 mM KCI.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,cell membrabce,8422949##7628617,FEBS Lett. 1993 Feb 1;316(3):233-240.##FEBS Lett. 1995 Jul 17;368(2):257-262.,"Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.##Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF.","A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.##Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.",20,18-21
DRAMP00753,ATKVKAKQRGKEKVSSGRPGQHN,23,Elicitor peptide 1 (AtPep1; Plant defensin),"Q9LV87, Q8LCK9",Belongs to the brassicaceae elicitor peptide family,PEP1,Arabidopsis thaliana (Mouse-ear cress),"Antimicrobial, Antifungal",Protein level,Not found,"Sequential removal of N-terminal amino acids has little effect on activity. Activity is completely abolished when nine C-terminal amino acids remained. Removal of the C-terminal asparagine from AtPep1(9-23), resultes in a decrease in activity (12 max approximately 100 nM).",,"Function: Elicitor of plant defense. Induces the production of plant defensin (PDF1.2) and of H2O2. Promotes resistance to the root fungal pathogen P. irregulare.
Subunit structure: Interacts with its receptor PEPR1.
Induction: By wounding, methyl jasmonate (MeJA), ethylene. The expression of the peptide PEP1 precursor is induced by the mature peptide PEP1.",Pythium irregulare,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16785434##16785433##18824048,Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10104-9.##Peptides. 2008 Dec;29(12):2083-9.,"Huffaker A, Pearce G, Ryan CA.##The cell surface leucine-rich repeat receptor for AtPep1, an endogenous peptide elicitor in Arabidopsis, is functional in transgenic tobacco cells.##Pearce G, Yamaguchi Y, Munske G, Ryan CA.","An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##The cell surface leucine-rich repeat receptor for AtPep1, an endogenous peptide elicitor in Arabidopsis, is functional in transgenic tobacco cells.##Structure-activity studies of AtPep1, a plant peptide signal involved in the innate immune response.",23,21-24
DRAMP00755,EIKARGKNKTKPTPSSGKGGKHN,23,Elicitor peptide 3 (AtPep3; Plant defensin),Q8LAX3,Belongs to the brassicaceae elicitor peptide family,PEP3,Arabidopsis thaliana (Mouse-ear cress),Not found,Homology,Not found,Not found,,Function: Elicitor of plant defense (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16785434##10718197,"Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.","Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.","An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.",23,21-24
DRAMP00758,ITAVLRRRPRPPPYSSGRPGQNN,23,Elicitor peptide 6 (AtPep6; Plant defensin),Q9SIZ9,Belongs to the brassicaceae elicitor peptide family,PEP6,Arabidopsis thaliana (Mouse-ear cress),Not found,Homology,Not found,Not found,,Function: Elicitor of plant defense (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16785434##10718197,"Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.","Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.","An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.",23,21-24
DRAMP00759,VSGNVAARKGKQQTSSGKGGGTN,23,Elicitor peptide 7 (AtPep7; Plant defensin),"P0C1T5, Q1G3G0",Belongs to the brassicaceae elicitor peptide family,PEP7,Arabidopsis thaliana (Mouse-ear cress),Not found,Homology,Not found,Not found,,Function: Elicitor of plant defense (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16785434##10718197##17147637,"Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.##Plan","Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.##Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.","An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.##Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.",23,21-24
DRAMP00772,KLCGETCFKFKCYTPGCSCSYPFCK,25,Psyle C (uncyclotides; Plants),No entry found,Not found,Not found,Psychotria leptothyrsa,Anti-cancer,Not found,Not found,Not found,,Cyclotide cytotoxicity on the human lymphoma cell line U-937 GTB (IC50=3.5 µM).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20575512,J Nat Prod. 2010 Jul 23;73(7):1207-1213.,"Gerlach SL, Burman R, Bohlin L, Mondal D, Göransson U.","Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.",25,24-27
DRAMP18325,MAADIISTIGDLVKLIINTVKKFQK,25,delta-lysin I (Bacteriocin),No entry found,Not found,Not found,Staphylococcus warneri RK,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,"Warnericin RK and delta-lysin I displayed the same antibacterial spectrum, which is almost restricted to the Legionella genus. Also, both peptides have a hemolytic activity.","[Ref.18339450]Gram-positive bacteria: Bacillus megaterium F04(+), Bacillus subtilis(–), Enterococcus faecalis V583(–), Listeria monocytogenes EGDe(–), Micrococcus luteus(–), Pediococcus acidilactici 583(–), Staphylococcus aureus 971(–), Staphylococcus chromogenes(–), Staphylococcus cohnii 898(–), Staphylococcus epidermidis 567(-), Staphylococcus haemolyticus 694(-), Staphylococcus hominis 373(-), Staphylococcus lentus 982(-), Staphylococcus lugdunensis 967(-), Staphylococcus saprophyticus 715(-), Staphylococcus warneri 447(-), Staphylococcus warneri RK(-);## Gram-negative bacteria:  Enterobacter cloacae D03(-), Escherichia coli MG1655(-), Hafnia alvei(-), Klebsiella pneumoniae 0502083(-), Legionella bozemanii ATCC 33217(+),  Legionella dumofii ATCC 33279(+), Legionella feeleii ATCC 35072(+), Legionella like bacteria (LLAP10)(+), Legionella longbeachae ATCC 33484(+), Legionella micdadei ATCC 33218(+), Legionella oakridgensis ATCC 33761(+), Legionella pneumophila Corby (sg1)(+), Legionella pneumophila Lens (sg1)(+), Legionella pneumophila Paris (sg1)(+), Legionella pneumophila ATCC 33155 (sg3)(+), Legionella pneumophila ATCC 33216 (sg5)(+), Legionella pneumophila ATCC 33215 (sg6)(+), Proteus mirabilis ATCC 35659(-), Pseudomonas aeruginosa DSMZ1128(-), Pseudomonas aeruginosa 910704(-), Salmonella typhimurium(-)","[Ref.18339450]10% hemolytic activity at 1.56 μM, 40% hemolytic activity at 6.25 μM, 62% hemolytic activity at 25 μM, 80% hemolytic activity at 50 μM against human erythrocytes ",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18339450,Peptides. 2008 Jun;29(6):978-84. ,"Verdon J, Berjeaud JM, Lacombe C, H",Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.,25,24-27
DRAMP18324,MQFITDLIKKAVDFFKGLFGNK,22,Warnericin RK (Bacteriocin),No entry found,Not found,Not found,Staphylococcus warneri RK,"Antimicrobial, Antibacterial, Anti-Gram-",,Alpha Helix,Not found,,Warnericin RK acts as a specific anti-Legionella AMP by permeabilizing the bacterial membrane.,Gram-negative(Narrow),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18339450##19804724 ,Peptides. 2008 Jun;29(6):978-84.##Biophys J. 2009 Oct 7;97(7):1933-40. ,"Verdon J, Berjeaud JM, Lacombe C, H","Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.##Detergent-like activity and alpha-helical structure of warnericin RK, an anti-Legionella peptide.",22,21-24
DRAMP00899,CVWIPCISGIAGCSCKNKVCYLN,23,Cyclotide hyfl-P (Plant defensin),No entry found,Belongs to the cyclotide family,Not found,Hybanthus floribundus (Greenviolet),Not found,Not found,Bridge,Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. ,,Function: Probably participates in a plant defense mechanism.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16199617,Plant Cell. 2005 Nov;17(11):3176-3189.,"Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.",A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).,23,21-24
DRAMP00901,CGETCVTGTCYTPGCACDWPVCKRD,25,Hymo B (Plant defensin),No entry found,Belongs to the cyclotide family,Not found,Hybanthus monopetalus,Not found,Not found,Bridge,Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. ,,Caution: The sequence is incomplete!,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16199617,Plant Cell. 2005 Nov;17(11):3176-3189.,"Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.",A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).,25,24-27
DRAMP00905,CVWIPCISAAIGCSCKSKVCYRN,23,Hyde A (Plant defensin),No entry found,Belongs to the cyclotide family,Not found,Australian Hybanthus debilissimus,Not found,Not found,Bridge,Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. ,,Caution: The sequence is incomplete!,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16199617,Plant Cell. 2005 Nov;17(11):3176-3189.,"Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.",A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).,23,21-24
DRAMP00935,DVSFSLSGGGTASYEK,16,Ribosome-inactivating protein trichokirin (rRNA N-glycosidase; Plant defensin),P16093,Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily),Not found,Trichosanthes kirilowii (Chinese snake gourd) (Chinese cucumber),Cytotoxic,Protein level,Not found,Not found,,"Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S rRNA.
PTM: Glycosylated.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,3262509,Eur J Biochem. 1988 Oct 1;176(3):581-588.,"Casellas P, Dussossoy D, Falasca AI, Barbieri L, Guillemot JC, Ferrara P, Bolognesi A, Cenini P, Stirpe F.","Trichokirin, a ribosome-inactivating protein from the seeds of Trichosanthes kirilowii Maximowicz. Purification, partial characterization and use for preparation of immunotoxins.",16,15-18
DRAMP00938,KSCCRNTTARNCYNVCRIPG,20,Tu-AMP2 (Plant defensin),No entry found,Belongs to the thionin family,Not found,Tulipa gesneriana L. ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Gram-negative bacteria: Erwinia carotovora (IC50=15 µg/ml), Agrobacterium radiobacter (IC50=17 µg/ml), Agrobacterium rhizogenes (IC50=20 µg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=17 µg/ml), Curtobacterium flaccumfaciens (IC50=15 µg/ml).##Fungi: Fusarium oxysporum (IC50=2 µg/ml), Geotrichum candidum (IC50=2 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15056889,Biosci Biotechnol Biochem. 2004 Mar;68(3):571-577.,"Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.","Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).",20,18-21
DRAMP00962,RNCESLSHRFKGPCTRDSNC,20,Pseudothionin Solanum tuberosum 1 (Pth-St1; Plant defensin),No entry found,Belongs to the thionin family,Not found,Solanum tuberosum (potato),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Clavibacter michiganensis subspecies sepedonicus, Pseudomonas solanacearum and Fusarium solani.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8033886,Eur J Biochem. 1994 Jul 1;223(1):135-139.,"Moreno M, Segura A, Garc­a-Olmedo F."," Pseudothionin-St1, a potato peptide active against potato pathogens.",20,18-21
DRAMP01380,GLFTLIKCAYQLIAPTVACN,20,"Odorranain-J1 (OdJ1; Frogs, amphibians, animals)",A6MBN6,Not found,Not found,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Odorranain-J1 adopts 50.1% β-sheet and 13.7% turn structure in water solution.,,Function: Odorranain-J1 exhibites moderate antimicrobial activities against Gram-positive and Gram-negative bacteria and fungi.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=35.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=17.80 μg/ml), Bacillus subtilis (MIC=35.60 μg/ml).##Yeast: Candida albicans (MIC=8.90 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,20,18-21
DRAMP00994,QWGRRCCGWGPGRRYCVRWC,20,IB-AMP1 (IBAMP1; Basic peptide AMP1; Plants),O24006,Not found,AMP,Impatiens balsamina (Balsam),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Bridge,Not found,,"Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed. The peptide IB-AMP1 is also detected at early stages of germination (24 hours and 48 hours postgermination).
PTM: Contains two disulfide bonds C6-C16; C7-C2","Gram-positive bacteria: Bacillus subtilis (IC50=10 µg/ml), Micrococcus luteus (IC50=10 µg/ml), Staphylococcus aureus (IC50=30 µg/ml), Streptococcus faecalis (IC50=6 µg/ml).##Fungi: Alternaria longipes (IC50=3 µg/ml), Botrytis cinerea (IC50=12 µg/ml), Cladosporium sphaerospermum (IC50=1 µg/ml), Fusarium culmorum (IC50=1 µg/ml), Penicillium digitatum (IC50=3 µg/ml), Trichoderma viride (IC50=6 µg/ml), Verticillium alboatrum (IC50=3 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9305910##9454588,J Biol Chem. 1997 Sep 26;272(39):24480-24487.##Biochemistry. 1998 Jan 27;37(4):983-990.,"Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.##Patel SU, Osborn R, Rees S, Thornton JM.",A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.##Structural studies of Impatiens balsamina antimicrobial protein (Ib-AMP1).,20,18-21
DRAMP00995,QYGRRCCNWGPGRRYCKRWC,20,IB-AMP2 (IBAMP2; Basic peptide AMP2; Plants),O24006,Not found,Not found,Impatiens balsamina (Balsam),"Antimicrobial, Antifungal",Protein level,Bridge,Not found,,"Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed.
PTM: Contains two disulfide bonds C6-C16; C7-C20 and Pyrrolidone carboxylic acid at position 1 (Probable).","Fungi: Alternaria longipes (IC50=12 µg/ml), Botrytis cinerea (IC50=25 µg/ml), Cladosporium sphaerospermum (IC50=6 µg/ml), Fusarium culmorum (IC50=6 µg/ml), Penicillium digitatum (IC50=6 µg/ml), Trichoderma viride (IC50=12 µg/ml), Verticillium alboatrum (IC50=12 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9305910,J Biol Chem. 1997 Sep 26;272(39):24480-24487.,"Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.",A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.,20,18-21
DRAMP00996,QYRHRCCAWGPGRKYCKRWC,20,IB-AMP3 (IBAMP3; Basic peptide AMP3; Plants),O24006,Not found,Not found,Impatiens balsamina (Balsam),"Antimicrobial, Antifungal",Protein level,Bridge,Not found,,"Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed.
PTM: Contains two disulfide bonds C6-C16; C7-C20 and Pyrrolidone carboxylic acid at position 1 (Probable).","Fungi: Alternaria longipes (IC50=6 µg/ml), Botrytis cinerea (IC50=6 µg/ml), Cladosporium sphaerospermum (IC50=3 µg/ml), Fusarium culmorum (IC50=6 µg/ml), Penicillium digitatum (IC50=3 µg/ml), Trichoderma viride (IC50=12 µg/ml), Verticillium alboatrum (IC50=6 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9305910,J Biol Chem. 1997 Sep 26;272(39):24480-24487.,"Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.",A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.,20,18-21
DRAMP00997,QWGRRCCGWGPGRRYCRRWC,20,IB-AMP4 (IBAMP4; Basic peptide AMP4; Plants),O24006,Not found,Not found,Impatiens balsamina (Balsam),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Bridge,Not found,,Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed. PTM: Contains two disulfide bonds C6-C16; C7-C20 and Pyrrolidone carboxylic acid at position 1 (Probable). Note: Peptide IB-AMP4 has a higher antifungal act,"Gram-positive bacteria: Bacillus subtilis (IC50=5 µg/ml), Micrococcus luteus (IC50=5 µg/ml), Staphylococcus aureus (IC50=20 µg/ml), Streptococcus faecalis (IC50=5 µg/ml);##Gram-negative bacteria: Xanthomonas campestris (IC50=6 µg/ml), Xanthomonas oryzae (IC50=15 µg/ml).##Fungi: Alternaria longipes (IC50=3 µg/ml), Botrytis cinerea (IC50=6 µg/ml), Cladosporium sphaerospermum (IC50=1 µg/ml), Fusarium culmorum (IC50=1 µg/ml), Penicillium digitatum (IC50=3 µg/ml), Trichoderma viride (IC50=6 µg/ml), Verticillium alboatrum (IC50=6 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9305910##9454588,J Biol Chem. 1997 Sep 26;272(39):24480-24487.##Biochemistry. 1998 Jan 27;37(4):983-990.,"Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.##Patel SU, Osborn R, Rees S, Thornton JM.",A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.##Structural studies of Impatiens balsamina antimicrobial protein (Ib-AMP1).,20,18-21
DRAMP01001,GVGYKVVVTTTAAADDDDVV,20,Arietin (Plants),P83988,Not found,Not found,Cicer arietinum (chickpea),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Function: Has antifungal activity. Inhibits cell-free translation in rabbit reticulocyte lysate system. Does not have mitogenic and anti-HIV-1 reverse transcriptase activities.,"Fungi: Botrytis cinerea, Fusarium oxysporum, Mycosphaerella arachidicola.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12084511,Peptides. 2002 May;23(5):817-822.,"Ye XY, Ng TB, Rao PF.","Cicerin and arietin, novel chickpea peptides with different antifungal potencies.",20,18-21
DRAMP01005,VKSTGRADDDLAVKTKYLPP,20,Cicerarin (Plant defensin),P83986,Not found,Not found,Cicer arietinum (chickpea),"Antimicrobial, Antifungal, Antiviral",Protein level,Not found,Not found,,Function: Has antifungal activity. Also inhibits HIV-1 reverse transcriptase.,"Fungi: Botrytis cinerea (IC50=20.6 µM), Mycosphaerella arachidicola (IC50=15.3 µM), Pseudocercospora piricola (IC50=8.2 µM).##Virus: HIV-1 RT (IC50=87.5 µM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12895650,Peptides. 2003 May;24(5):659-663.,"Chu KT, Liu KH, Ng TB.","Cicerarin, a novel antifungal peptide from the green chickpea.",20,18-21
DRAMP01006,ARCENFADSYRQPPISSSQT,20,Cicerin (Plant defensin),P83987,Not found,Not found,Cicer arietinum (chickpea),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Function: Has antifungal activity. Inhibits cell-free translation in rabbit reticulocyte lysate system.,"Fungi: Mycosphaerella arachidicola, Fusarium oxysporum, Botrytis cinerea (IC50=12 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12084511,Peptides. 2003 May;24(5):665-669.,"Cai YD, Liu XJ, Li YX, Xu XB, Chou KC.","Cicerin and arietin, novel chickpea peptides with different antifungal potencies.",20,18-21
DRAMP01010,KTCENLADTFRGPCFATSNC,20,Lunatusin (Plants),No entry found,Not found,Not found,Phaseolus lunatus L.(Chinese lima bean),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Antifungal",Not found,Not found,Not found,,Function: It also inhibited proliferation in the breast cancer cell line MCF-7. Lunatusin reduced the activity of HIV-1 reverse transcriptase and it also inhibited translation in a cell-free rabbit reticulocyte lysate system. Its anti-fungal activity was ,"Fungi: Fusarium oxysporum, Mycosphaerella arachidicola and Botrytis cinerea.##Gram-positive bacteria: Bacillus megaterium, Bacillus subtilis;##Gram-negative bacteria: Proteus vulgaris, Mycobacterium phlei.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16269344,Peptides. 2005 Nov;26(11):2086-2092.,"Wong JH, Ng TB.","Lunatusin, a trypsin-stable antimicrobial peptide from lima beans (Phaseolus lunatus L.).",20,18-21
DRAMP01013,KTCENLADTYKGPCFTTGSCD,21,PvD1 (P. vulgaris defensin 1; Plants),F8QXP9,Not found,Not found,Phaseolus vulgaris (Seeds),"Antimicrobial, Antifungal",Predicted,Bridge,Not found,,"Its activity involves membrane permeabilization, inhibition of medium acifification, and induction of ROS in fungi cells (Curr Microbiol. 2010 Dec 19. 62: 1209-1217). ","Fungi: Candida albicans, C. parapsilosis, Candida tropicalis, Candida guilliermondii, K. marxiannus, Saccharomyces cerevisiae, Fusarium oxysporum, F. solani, F. lateritium and R. solani.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18786582,Peptides. 2008 Dec;29(12):2090-2100.,"Games PD, Dos Santos IS, Mello EO, Diz MS, Carvalho AO, de Souza-Filho GA, Da Cunha M, Vasconcelos IM, Ferreira Bdos S, Gomes VM.","Isolation, characterization and cloning of a cDNA encoding a new antifungal defensin from Phaseolus vulgaris L. seeds.",21,18-21
DRAMP01053,ATITFTNKCTRTVWPGG,17,Thaumatin-like protein (CdTLP; Plants),P84334,Not found,Not found,Cassia didymobotrya (Popcorn cassia),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Has antifungal activity.
Induction: By salicylic acid and by laminarin oligosaccharides.
PTM: Contains one disulfide bond (By similarity).","Fungi: Candida albicans 586 (EC50=6.2 µM), Candida parapsilosis ATCC 22019 (EC50=2.2 µM), Candida krusei ATCC 14243 (EC50=2.5 µM), C. krusei 80 (EC50=5.4 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17056265,Plant Physiol Biochem. 2006 Oct;44(10):604-610.,"Vitali A, Pacini L, Bordi E, De Mori P, Pucillo L, Maras B, Botta B, Brancaccio A, Giardina B.",Purification and characterization of an antifungal thaumatin-like protein from Cassia didymobotrya cell culture.,17,15-18
DRAMP01057,XXTKFDFFTLALQXPAXF,18,30 kDa antifungal protein (Plants),Q10722,Not found,Not found,Engelmannia peristenia (Engelmann's daisy) (Engelmannia pinnatifida),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Has antifungal activity against the plant fungal pathogens. Does not have antifungal activity against the human pathogen C. albicans. Does not have ribonuclease activity.
Tissue specificity: Leaves.
Developmental stage: Expressed in young plants, no expression in mature plants.
Miscellaneous: Resistant to heat and proteolysis.
Biophysicochemical properties: Temperature dependence (Thermostable).","Fungi: Gaeumannomyces graminis, Phytophthora infestans, Phytophthora megasperma, Sclerotinia sclerotiorum.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8670144,Biochem J. 1996 Jun 15;316 ( Pt 3):723-727.,"Huynh QK, Borgmeyer JR, Smith CE, Bell LD, Shah DM.",Isolation and characterization of a 30 kDa protein with antifungal activity from leaves of Engelmannia pinnatifida.,18,15-18
DRAMP01059,VLSHNNESSYSDTSSCTSQ,19,Putative antimicrobial protein 1 (Plants),B3EWI5,Not found,Not found,Cenchritis muricatus (Beaded periwinkle),Antimicrobial,Protein level,Not found,Not found,,Function: May have antimicrobial activity.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22367403,Curr Microbiol. 2012 May;64(5):501-505.,"López-Abarrategui C, Alba A, Lima LA, Maria-Neto S, Vasconcelos IM, Oliveira JT, Dias SC, Otero-Gonzalez AJ, Franco OL.",Screening of antimicrobials from Caribbean sea animals and isolation of bactericidal proteins from the littoral mollusk Cenchritis muricatus.,19,18-21
DRAMP01060,DLPECCSATELELDSGKQTS,20,Putative antimicrobial protein 2 (Plants),B3EWI6,Not found,Not found,Cenchritis muricatus (Beaded periwinkle),Antimicrobial,Protein level,Not found,Not found,,Function: May have antimicrobial activity.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22367403,Curr Microbiol. 2012 May;64(5):501-505.,"López-Abarrategui C, Alba A, Lima LA, Maria-Neto S, Vasconcelos IM, Oliveira JT, Dias SC, Otero-Gonzalez AJ, Franco OL.",Screening of antimicrobials from Caribbean sea animals and isolation of bactericidal proteins from the littoral mollusk Cenchritis muricatus.,20,18-21
DRAMP01062,SESILIVHQQQSRSSGS,17,Putative antimicrobial protein 3 (Cm-p2; Plants),B3EWI8,Not found,Not found,Cenchritis muricatus (Beaded periwinkle),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: This peptide demonstrated the capacity to prevent the development of yeasts and filamentous fungi. Otherwise, Cm-p1 displayed no toxic effects against mammalian cells.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22210491,Biochimie. 2012 Apr;94(4):968-974.,"L³pez-Abarrategui C, Alba A, Silva ON, Reyes-Acosta O, Vasconcelos IM, Oliveira JT, Migliolo L, Costa MP, Costa CR, Silva MR, Garay HE, Dias SC, Franco OL, Otero-Gonz¡lez AJ.",Functional characterization of a synthetic hydrophilic antifungal peptide derived from the marine snail Cenchritis muricatus.,17,15-18
DRAMP01065,NSMERVEELRKKLQD,15,Chitin-binding protein HM30 (Plants),P83630,Belongs to the parathyroid hormone family,Not found,Hydrangea macrophylla (Bigleaf hydrangea),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Function: Has antifungal activity against phytopathogenic fungi. Has no chitinase or agglutination activities.,"Fungi: Alternria alternate, Alternaria cucumerina, Aspergillus niger, Collectotrichum gossypii, Fusarium oxysporum, F. oxysporum subsp melonis, Fusarium moniliforme, Thanatephorus cucumeris, Verticillium dahliae, Pyricularia oryzae Cav..",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Chitin-binding,11812226,Protein Expr Purif. 2002 Feb;24(1):76-82.,"Yang Q, Gong ZZ.",Purification and characterization of an ethylene-induced antifungal protein from leaves of Guilder rose (Hydrangea macrophylla).,15,12-15
DRAMP01084,ILGAILPLVSGLLSNKL,17,"Alyteserin-2b (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes obstetricans (European midwife toad),"Antimicrobial, Antibacterial, Antifungal, Antiviral",Predicted,Not found,Not found,,Function: Amtimicrobial peptide. (By similarity),No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19463738,Peptides. 2009 Jun;30(6):1069-1073.,"Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,17,15-18
DRAMP01086,ILGAILPLVSGLLSSKL,17,"Alyteserin-2c (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes obstetricans (European midwife toad),"Antimicrobial, Antibacterial, Antifungal, Antiviral",Predicted,Not found,Not found,,Function: Amtimicrobial peptide. (By similarity),No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19463738,Peptides. 2009 Jun;30(6):1069-1073.,"Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,17,15-18
DRAMP01087,GLKDIFKAGLGSLVKNIAAHVAN,23,"Alyteserin-1d (toads, amphibians, animals)",No entry found,Not found,Not found,Alytes obstetricans (European midwife toad),"Antimicrobial, Antibacterial, Antifungal, Antiviral",Predicted,Not found,Not found,,Function: Amtimicrobial peptide. (By similarity),No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19463738,Peptides. 2009 Jun;30(6):1069-1073.,"Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,23,21-24
DRAMP01093,IIGPVLGLVGKPLESLLE,18,"Bombinin GH-1L (bombinin H isomers; toads, amphibians, animals)",No entry found,Belongs to the bombinin family,Not found,Bombina orientalis (Oriental fire-bellied toad) ,"Antimicrobial, Antibacterial",Predicted,Not found,Not found,,"Function: Bombinins GH-1D showes only 2.5% hemolysis at 30 µM concentration.
PTM: C-terminal amidation.",GH-1L does not display any microbicidal activity against all the microorganisms tested.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11090921,Peptides. 2000 Nov;21(11):1673-1679.,"Mangoni ML, Grovale N, Giorgi A, Mignogna G, Simmaco M, Barra D.","Structure-Function: relationships in bombinins H, antimicrobial peptides from Bombina skin secretions.",18,15-18
DRAMP01099,GIGAAILSAGKSIIKGLANGLAEHF,25,"Bombinin-like peptide 4 (BLP-4; toads, amphibians, animals)",P29005,Belongs to the bombinin family,Not found,Bombina orientalis (Oriental fire-bellied toad),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Alpha helix,Not found,,"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands.","[Ref.1744108]Gram-negative bacteria: Neisseria meningitidis, Neisseria gonorrhoeoe, Neisseria Iactamica, Neisseria cinerea.",[Ref:1744108]Non-hemolytic activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1744108,J Biol Chem. 1991 Dec 5;266(34):23103-23111.,"Gibson BW, Tang DZ, Mandrell R, Kelly M, Spindel ER.","Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.",25,24-27
DRAMP01101,ILGPVLGLVGNALGGLIKNE,20,"Maximin-Ht (Maximin-7; toads, amphibians, animals)",P83086 ,Belongs to the bombinin family,Not found,Bombina maxima (Chinese large-webbed bell toad),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (JUN-2001) to UniProtKB,"Chen TB, McClean S, Orr DF, Bjourson AJ, Rao PF, Shaw C.",Isolation and structural characterisation of antimicrobial peptides from the venom of the Chinese large-webbed bell toad (Bombina maxima).,20,18-21
DRAMP01102,ILGPVLSLVGNALGGLLKNE,20,"Maximin-Hu (Maximin-8; toads, amphibians, animals)",P83087,Belongs to the bombinin family,Not found,Bombina maxima (Chinese large-webbed bell toad),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11835991##PubMed ID is not available,Peptides 2002; 23:427-435.##Submitted (JUL-2001) to UniProtKB.,"Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.##Chen TB, McClean S, Orr DF, Bjourson AJ, Rao PF, Shaw C.",Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.##Isolation and structural characterisation of antimicrobial peptides from the venom of the Chinese large-webbed bell toad (Bombina maxima).,20,18-21
DRAMP01103,GSNKGFNFMVDMIQALSN,18,"Maximin-S2 (chain of Maximins-S type B/C; toads, amphibians, animals)",Q5GC92,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Maximin-S2 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. Has no hemolytic activity. Tissue specificity: Expressed by the skin dorsal glands. PTM: Asparagine amide at position 18.,No MICs found in DRAMP database,[Ref:15649437]Non-hemolytic activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15649437,Biochem Biophys Res Commun. 2005 Feb 18;327(3):945-951.,"Wang T, Zhang J, Shen JH, Jin Y, Lee WH, Zhang Y.","Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.",18,15-18
DRAMP01104,GSNKGFNFMVDMINALSN,18,"Maximin-S3 (chain of Maximins-S type B/C; toads, amphibians, animals)",Q5GC92,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Maximin-S3 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. Has no hemolytic activity. Tissue specificity: Expressed by the skin dorsal glands. PTM: Asparagine amide at position 18.,No MICs found in DRAMP database,[Ref:15649437]Non-hemolytic activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15649437,Biochem Biophys Res Commun. 2005 Feb 18;327(3):945-951.,"Wang T, Zhang J, Shen JH, Jin Y, Lee WH, Zhang Y.","Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.",18,15-18
DRAMP01106,GSNKGFNFMVDMIQALSK,18,"Maximin-S5 (chain of Maximins-S type B/C; toads, amphibians, animals)",Q5GC92,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Maximin-S3 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. Has no hemolytic activity. Tissue specificity: Expressed by the skin dorsal glands. PTM: Lysine amide at position 18.,Mycoplasma,[Ref:15649437]Non-hemolytic activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15649437,Biochem Biophys Res Commun. 2005 Feb 18;327(3):945-951.,"Wang T, Zhang J, Shen JH, Jin Y, Lee WH, Zhang Y.","Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.",18,15-18
DRAMP01118,GIGGALLSAGKAALKGLAKGFAEHF,25,"Maximin y type 2 (toads, amphibians, animals)",Q58T94,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703,Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,25,24-27
DRAMP01119,GIGGALLSAGKSALKGLAKGFAEHF,25,"Maximin-y (toads, amphibians, animals)",Q58T91,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703,Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,25,24-27
DRAMP01120,ILGPVLSLVGSALGGLIKKI,20,"Maximin-Hv (toads, amphibians, animals)","Q58T91 , Q58T89 , Q58T94",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703,Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,20,18-21
DRAMP01121,ILGPVLGLVSNAIGGLIKKI,20,"Maximin-Hw (toads, amphibians, animals)",Q58T92,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703,Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,20,18-21
DRAMP01127,ILGPVLGLVSDTLDDVLGIL,20,"Maximin-H5 (toads, amphibians, animals)","Q8JHE1, Q58T54",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,Comment: A arginine mutant (i.e. 3D to 3R) was found to be HIV inhibitory (Wang G et al. 2010 Antimicrob. Agents Chemother. 54: 1343-1346).,Gram-positive bacterium: Staphylococcus aureus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12127963,Biochem Biophys Res Commun 2002 Jul 26;295(4):796-799.,"Lai R, Liu H, Hui Lee W, Zhang Y.",An anionic antimicrobial peptide from toad Bombina maxima.,20,18-21
DRAMP01128,ILGPVIGTIGNVLGGLLKNL,20,"Maximin-H6 (toads, amphibians, animals)",Q58T72,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703,Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,20,18-21
DRAMP01129,ILGPVIKTIGGVIGGLLKNL,20,"Maximin-H7 (toads, amphibians, animals)",Q58T56,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703,Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,20,18-21
DRAMP01130,ILGPVLGLVSNALGGLLKNI,20,"Maximin-H8 (toads, amphibians, animals)","Q58T86, Q58T49",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP01131,ILGPVLGLVSNALGGLIKKI,20,"Maximin-H9 (toads, amphibians, animals)","Q58T80, Q58T69",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP01132,ILGPVLGLVSNALGGLLKNL,20,"Maximin-H10 (toads, amphibians, animals)",Q58T59,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Function: Shows strong hemolytic activity.,[Swiss_Prot Entry Q58T59]Yeast: Candida albicans,[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703,Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,20,18-21
DRAMP01133,ILGPVLGLVGSALGGLIKKI,20,"Maximin-H11 (toads, amphibians, animals)","Q58T95, Q58T65, Q58T64, Q58T48",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Function: Shows strong hemolytic activity.,[Swiss_Prot Entry Q58T95]Yeast: Candida albicans,[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP01134,ILGPVIKTIGGVLGGLLKNL,20,"Maximin-H13 (toads, amphibians, animals)",Q58T58,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703,Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lee W.-H, Li Y, Lai R, Li S, Zhang Y, Wang W.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,20,18-21
DRAMP01135,LLGPVLGLVSNALGGLLKNI,20,"Maximin-H12 (toads, amphibians, animals)",Q58T87,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11835991##15770703,Peptides. 2002 Mar;23(3):427-435.##Eur J Immunol. 2005 Apr;35(4):1220-1229.,"Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.##Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.",Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.##Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.,20,18-21
DRAMP01136,ILGPVLGLVGEPLGGLIKKI,20,"Maximin-H14 (toads, amphibians, animals)",Q58T46,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP01137,ILGPVLGLVGNALGGLLKNL,20,"Maximin-H15 (toads, amphibians, animals)","Q58T43, Q58T39",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP01138,ILGPVLSLVGNALGGLIKKI,20,"Maximin-H16 (toads, amphibians, animals)","Q58T93, Q58T40",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal",Transcript level,Not found,Not found,,Shows strong hemolytic activity. ,[Swiss_Prot Entry Q58T93]Yeast: Candida albicans,[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP01139,GIVDFAKKVVGGIRNALGI,19,"Uperin-2.1 (toads, amphibians, animals)",P82027,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Shows a medium antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Leuconostoc mesenteroides, Micrococcus luteus, Streptococcus uberis (medium antibacterial activity).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,19,18-21
DRAMP01140,GFVDLAKKVVGGIRNALGI,19,"Uperin-2.2 (toads, amphibians, animals)",P82028,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Shows a weak antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus, Leuconostoc mesenteroides, L. innocua, Micrococcus luteus, Staphylococcus aureus and Streptococcus uberis.##Gram-negative bacteria: Pasteurella haemolytica, Escherichia coli.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,19,18-21
DRAMP01141,GFFDLAKKVVGGIRNALGI,19,"Uperin-2.3 (toads, amphibians, animals)",P82029,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows a medium antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus, Leuconostoc mesenteroides, Streptococcus uberis.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,19,18-21
DRAMP01142,GILDFAKTVVGGIRNALGI,19,"Uperin-2.4 (toads, amphibians, animals)",P82030,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows a weak antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus, Escherichia coli, Leuconostoc mesenteroides, L. innocua, Micrococcus luteus, Pasteurella haemolytica, Staphylococcus aureus and Streptococcus uberis.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,19,18-21
DRAMP01143,GIVDFAKGVLGKIKNVLGI,19,"Uperin-2.5 (toads, amphibians, animals)",P82031,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows a medium antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Micrococcus luteus, Leuconostoc mesenteroides, Streptococcus uberis.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,19,18-21
DRAMP01144,GILDIAKKLVGGIRNVLGI,19,"Uperin-2.6 (toads, amphibians, animals)",P82095,Not found,Not found,Uperoleia mjobergii (Australian toadlet),Unknown,Protein level,Not found,Not found,,"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996;49:1325-1331.,"Bradford A.M, Bowie J.H, Tyler M.J, Wallace J.C.",New antibiotic uperin peptides from the dorsal glands of the australian toadlet Uperoleia mjobergii.,19,18-21
DRAMP01145,GIIDIAKKLVGGIRNVLGI,19,"Uperin-2.7 (toads, amphibians, animals)",P82039,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,19,18-21
DRAMP01146,GILDVAKTLVGKLRNVLGI,19,"Uperin-2.8 (toads, amphibians, animals)",P82040,Not found,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus, Lactococcus lactis, Staphylococcus epidermidis, Streptococcus uberis.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,19,18-21
DRAMP01147,GVLDAFRKIATVVKNVV,17,"Uperin-3.1 (toads, amphibians, animals)",P82032,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows a medium antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Staphylococcus aureus, Leuconostoc mesenteroides.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,17,15-18
DRAMP01148,GVLDAFRKIATVVKNLV,17,"Uperin-3.2 (toads, amphibians, animals)",P82033,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,17,15-18
DRAMP01149,GVLDAFKKIATVVKNLV,17,"Uperin-3.3 (toads, amphibians, animals)",P82034,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,17,15-18
DRAMP01150,GVGDLIRKAVAAIKNIV,17,"Uperin-3.4 (toads, amphibians, animals)",P82041,Not found,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,17,15-18
DRAMP01156,GVGDIFRKIVSTIKNVV,17,"Uperin-3.7 (toads, amphibians, animals)",P82044,Not found,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,17,15-18
DRAMP01157,GVGSFIHKVVSAIKNVA,17,"Uperin-4.1 (toads, amphibians, animals)",P82035,Not found,Not found,Uperoleia inundata (Floodplain toadlet),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows a medium antibacterial activity against L. mesenteriodes.
PTM: Alanine amide at position 17.",Gram-positive bacterium: Leuconostoc mesenteroides.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,17,15-18
DRAMP01166,FLPMLAKLLSGFLGK,15,"Preprotemporin-1SKd (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana sakuraii (Japanese brown frog),Antimicrobial,Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17174009,Peptides. 2007 Mar;28(3):505-514.,"Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.",Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,15,12-15
DRAMP01168,RAEAVPPGFTPFRKP,15,"Ranakinin-N (bradykinin-like peptide; Frogs, amphibians, animals)",P86093,Belongs to the bradykinin family,Not found,Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata),Unknown,Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17994619,J Pept Sci. 2008 May;14(5):626-630.,"Liu X, You D, Chen L, Wang X, Zhang K, Lai R.","A novel bradykinin-like peptide from skin secretions of the frog, Rana nigrovittata.",15,12-15
DRAMP01169,ENREVPPGFTALIKTLRKCKII,22,"Distinctin 1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Phyllomedusa distincta (Tree frog),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"Note: Distinctin chain 1 links to Distinctin chain 2 to form a heterodimeric peptide to exert antibacterial function. ##Gram-positive bacteria: Enterococcus faecalis (MIC=14.5 µM), Staphylococcus aureus (MIC=28.0 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=28.0 µM), Escherichia coli (MIC=14.5 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,"There is an intermolecular disulphide bridge between Distinctin chain 1 (Cys19) and Distinctin chain 2 (Cys22). 
There is an intermolecular disulphide bridge between Distinctin chain 1 (Cys19) and Distinctin chain 2 (Cys22).",L,No cytotoxicity information found,Not found,19189273,J Pept Sci. 2009 Apr;15(4):278-284.,"Vidovic V, Prongidi-Fix L, Bechinger B, Werten S.",Production and isotope labeling of antimicrobial peptides in Escherichia coli by means of a novel fusion partner that enables high-yield insoluble expression and fast purification.,22,21-24
DRAMP01171,GVVDILKGAGKDLLAHLVGKISEKV,25,"Ocellatin-1 (Frogs, amphibians, animals)",P83951,Not found,Not found,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands.",[Swiss_Prot Entry P83951]Gram-negative bacterium: Escherichia coli,[Ref:15648972]Show hemolytic activity against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15648972,Protein J. 2004 Nov;23(8):501-508.,"Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.",Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).,25,24-27
DRAMP01172,GVLDIFKDAAKQILAHAAEKQI,22,"Ocellatin-2 (Frogs, amphibians, animals)",P83866,Not found,Not found,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands.",[Swiss_Prot Entry P83866]Gram-negative bacterium: Escherichia coli,[Ref:15648972]Show hemolytic activity against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15648972,Protein J. 2004 Nov;23(8):501-508.,"Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.",Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).,22,21-24
DRAMP01173,GVLDILKNAAKNILAHAAEQI,21,"Ocellatin-3 (Frogs, amphibians, animals)",P83867,Not found,Not found,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.",[Swiss_Prot Entry P83867]Gram-negative bacterium: Escherichia coli,[Ref:15648972]Show hemolytic activity against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15648972,Protein J. 2004 Nov;23(8):501-508.,"Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.",Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).,21,18-21
DRAMP01175,AVLDILKDVGKGLLSHFMEKV,21,"Ocellatin-5 (Frogs, amphibians, animals)",P85443,Not found,Not found,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has hemolytic and antibacterial activities.
Tissue specificity: Expressed by the skin dorsal glands.",[Ref.19739090]Gram-postive bacterium: Staphylococcus aureus(100% inhibition at 64μg/mL);##Gram-negative bacterium: Escherichia coli(100% inhibition at 32μg/mL).,[Ref:19739090]Show hemolytic activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19739090##,"J Exp Zool A Ecol Genet Physiol. 2010 Jan 1;313(1):1-8.##Thesis (2007), University of Brasilia, Brazil","Leite JM Jr, Silva LP, Silva-Leite RR, Ferrari AS, Noronha SE, Silva HR, Bloch C Jr, Leite JR.##Nascimento A.C.C.",Leptodactylus ocellatus (Amphibia): mechanism of defense in the skin and molecular phylogenetic relationships.##Cytolytic peptides and proteases from the skin secretion of the frog Leptodactylus ocellatus).,21,18-21
DRAMP01176,AVLDFIKAAGKGLVTNIMEKVG,22,"Ocellatin-6 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19739090,J Exp Zool A Ecol Genet Physiol. 2010 Jan 1;313(1):1-8.,"Leite JM Jr, Silva LP, Silva-Leite RR, Ferrari AS, Noronha SE, Silva HR, Bloch C Jr, Leite JR.",Leptodactylus ocellatus (Amphibia): mechanism of defense in the skin and molecular phylogenetic relationships.,22,21-24
DRAMP01178,GVVDILKGAAKDLAGHLASKVMNKI,25,"Ocellatin-K1 (Frogs, amphibians, animals)",P86711,Not found,Not found,Leptodactylus knudseni (Knudsen's thin-toed frog) (Amazonian toad-frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Has antibacterial activity. Tissue specificity: Expressed by the skin glands. PTM: Isoleucine amide at position 25.,[Swiss_Prot Entry P86711]show antibacterial activity,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (JUL-2010) to UniProtKB,"Cardozo-Filho J.L, Soares A.A, Bloch C. Jr, Silva L.P, Stabeli R.G, Calderon L.A.",Identification of peptides from Amazonian Leptodactylus knudseni skin secretion by MALDI TOF/TOF.,25,24-27
DRAMP01179,GVVDILKGAGKDLLAHALSKLSEKV,25,"Ocellatin-V1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Leptodactylus validus Garman (Caribbean frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Function: The very low antimicrobial potency (MIC>200 µM) against Escherichia coli and Staphylococcus aureus associated with the peptides is probably a consequence of their lack of amphipathicity and reduced cationicity compared with active members of the ocellatin family from related species.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18501993,Peptides. 2008 Aug;29(8):1287-1292.,"King JD, Leprince J, Vaudry H, Coquet L, Jouenne T, Conlon JM.","Purification and characterization of antimicrobial peptides from the Caribbean frog, Leptodactylus validus (Anura: Leptodactylidae).",25,24-27
DRAMP01180,GVLDILKGAGKDLLAHALSKISEKV,25,"Ocellatin-V2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Leptodactylus validus Garman (Caribbean frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Function: The very low antimicrobial potency (MIC>200 µM) against Escherichia coli and Staphylococcus aureus associated with the peptides is probably a consequence of their lack of amphipathicity and reduced cationicity compared with active members of the ocellatin family from related species.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18501993,Peptides. 2008 Aug;29(8):1287-1292.,"King JD, Leprince J, Vaudry H, Coquet L, Jouenne T, Conlon JM.","Purification and characterization of antimicrobial peptides from the Caribbean frog, Leptodactylus validus (Anura: Leptodactylidae).",25,24-27
DRAMP01181,GVLDILTGAGKDLLAHALSKLSEKV,25,"Ocellatin-V3 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Leptodactylus validus Garman (Caribbean frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Function: The very low antimicrobial potency (MIC>200 µM) against Escherichia coli and Staphylococcus aureus associated with the peptides is probably a consequence of their lack of amphipathicity and reduced cationicity compared with active members of the ocellatin family from related species.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18501993,Peptides. 2008 Aug;29(8):1287-1292.,"King JD, Leprince J, Vaudry H, Coquet L, Jouenne T, Conlon JM.","Purification and characterization of antimicrobial peptides from the Caribbean frog, Leptodactylus validus (Anura: Leptodactylidae).",25,24-27
DRAMP01183,GVLDILKGAAKDLAGHVATKVINKI,25,"Syphaxin (SPX; Frogs, amphibians, animals)",P85279,Not found,Not found,Leptodactylus syphax (Burgundy thin-toed frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Has hemolytic and antibacterial activity. PTM: Isoleucine amide at position 25. Tissue specificity: Expressed by the skin dorsal glands.,[Swiss_Prot Entry P85279]show antibacterial activity,[Ref:17628627]Show hemolytic activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17628627,Toxicon. 2007 Sep 15;50(4):572-580.,"Dourado F.S, Leite J.R.S.A, Silva L.P, Melo J.A.T, Bloch C. Jr, Schwartz E.F.",Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,25,24-27
DRAMP01196,KEKLKLKCKAPKCYNDKLACT,21,"Andersonin-G1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Golden crossband frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 µg/ml).",[Ref:22029824]Non-hemolytic activity against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,21,18-21
DRAMP01197,ENMFNIKSSVESDSFWG,17,"Andersonin-N1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Golden crossband frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 µg/ml).",[Ref:22029824]Non-hemolytic activity against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,17,15-18
DRAMP01198,EMLKKKKEVKMERKT,15,"Andersonin-Q1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana andersonii (Golden crossband frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 µg/ml).",[Ref:22029824]Non-hemolytic activity against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,15,12-15
DRAMP01207,CYSAAKYPGFQEFINRKYKSSRF,23,"Galensin (Frogs, amphibians, animals)",Q90W78,Not found,Not found,Kassina senegalensis (Senegal running frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial activity against the Gram-positive bacteria: M. luteus and the Gram-negative bacteria E. coli. 
Tissue specificity: Expressed by the skin dorsal glands.",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases,"Reid C.N, Bjourson A.J, Shaw C.","Galensin, a novel homodimeric antimicrobial peptide from the defensive skin secretion of Kassina senegalensis: isolation, structural characterisation and cloning of precursor cDNA.",23,21-24
DRAMP01215,FFGAIAAALPHVISAIKNAL,20,"Kassinatuerin-2Mb (Frogs, amphibians, animals)",No entry found,Not found,Not found,Kassina maculata (African hyperoliid frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Alpha helix,"Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.",,"Function: Has relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli and were relatively ineffective against the pathogenic yeast, C. albicans. Has hemolytic activity as demonstrated using horse erythrocytes.",[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus,"[Ref:19427345]18% hemolytic activity at 16 μM, 45–50% hemolytic activity at 120 μM against horse erythrocytes",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19427345,Peptides. 2009 Aug;30(8):1428-1433.,"Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.","A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",20,18-21
DRAMP01216,FVGAIAAALPHVISAIKNAL,20,"Kassinatuerin-2Mc (Frogs, amphibians, animals)",No entry found,Not found,Not found,Kassina maculata (African hyperoliid frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Alpha helix,"Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.",,"Function: Has relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli and were relatively ineffective against the pathogenic yeast, C. albicans. Has hemolytic activity as demonstrated using horse erythrocytes.",[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus,"[Ref:19427345]18% hemolytic activity at 16 μM, 45–50% hemolytic activity at 120 μM against horse erythrocytes",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19427345,Peptides. 2009 Aug;30(8):1428-1433.,"Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.","A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",20,18-21
DRAMP01217,IIGAIAAALPHVINAIKNTF,20,"Kassinatuerin-2Md (Frogs, amphibians, animals)",No entry found,Not found,Not found,Kassina maculata (African hyperoliid frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Alpha helix,"Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.",,"Function: Has relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli and were relatively ineffective against the pathogenic yeast, C. albicans. Has hemolytic activity as demonstrated using horse erythrocytes.",[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus,"[Ref:19427345]18% hemolytic activity at 16 μM, 45–50% hemolytic activity at 120 μM against horse erythrocytes",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19427345,Peptides. 2009 Aug;30(8):1428-1433.,"Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.","A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",20,18-21
DRAMP01241,IGTISLSLCEQERDADEDEGETLEE,25,"Palustrin-RA2 antimicrobial peptide (Frogs, amphibians, animals)",D2K8I5,Not found,Not found,Rana andersonii (golden crossband frog),Antimicrobial,Homology,Not found,Not found,,Function: Amphibian defense peptide.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (NOV-2009) to the EMBL/GenBank/DDBJ databases,"Yang X, Liang X, Zhang Y, Lee WH.","The highest antimicrobial peptide diversity, skin antimicrobial peptide peptidomics of amphibian, Rana andersonii.",25,24-27
DRAMP01256,SAVGRHSRRFGLRKHRKH,18,"Dybowskin-2CDYb (Frogs, amphibians, animals)",B5A9T0,Not found,Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Has antimicrobial active against Gram-negative bacteria and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",18,15-18
DRAMP01275,FLSLIPHIVSGVASIAKHFG,20,"Phylloseptin-s1 (Frogs, amphibians, animals)",F7UI84,Not found,preproPLS-S1,Phyllomedusa sauvagei (Sauvage's leaf frog),Antimicrobial ,Homology,Not found,Not found,,"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: Pyrrolidone carboxylic acid at Q1.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases,"Abbassi F, Galanth C, Piesse C, Nicolas P, Amiche M, Ladram A.",Phylloseptins from phyllomedusa sauvagei.,20,18-21
DRAMP01276,FLSLIPHIVSGVASLAKHFG,20,"Phylloseptin-s2 (Frogs, amphibians, animals)",F7UI85,Not found,preproPLS-S2,Phyllomedusa sauvagei (Sauvage's leaf frog),Antimicrobial ,Homology,Not found,Not found,,"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: Pyrrolidone carboxylic acid at Q1.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases,"Abbassi F, Galanth C, Piesse C, Nicolas P, Amiche M, Ladram A.",Phylloseptins from phyllomedusa sauvagei.,20,18-21
DRAMP01277,FLSLIPHIVSGVASLAIHFG,20,"Phylloseptin-s3 (Frogs, amphibians, animals)",F7UI86,Not found,preproPLS-S3,Phyllomedusa sauvagei (Sauvage's leaf frog),Antimicrobial ,Homology,Not found,Not found,,"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: Pyrrolidone carboxylic acid at Q1.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases,"Abbassi F, Galanth C, Piesse C, Nicolas P, Amiche M, Ladram A.",Phylloseptins from phyllomedusa sauvagei.,20,18-21
DRAMP18319,ITSHSLCTPGCAKTGSFNSFCC,22,BsaA2(Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),Not found,Staphylococcus aureus strain 26,"Antimicrobial, Antibacterial, Anti-Gram+",,Bridge,"Tandem MS analysis identified two sequence tags (Dhb-PGCAK/Q-Dhb-G and I/L-Dhb-Dha-H [due to the use of CID, Dha/Dhb represents either a dehydrated amino acid or a site of thioether bridge cleavage]) that matched the deduced amino acid sequence of BsaA2.Thioether bonds between residues 3 and 7, 8-11, 16-21, and 19-22.",,This bacteriocin is identical to staphylococcin Au-26 initially reported in 1992.,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20023032,J Bacteriol. 2010 Feb;192(4):1131-42.,"Daly KM, Upton M, Sandiford SK, Draper LA, Wescombe PA, Jack RW, O'Connor PM, Rossney A, G?tz F, Hill C, Cotter PD, Ross RP, Tagg JR.",Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.,22,21-24
DRAMP01279,FLISIPYSASIGGTATLTGTA,21,"Phylloseptin Bu-1 (Frogs, amphibians, animals)",P86282,Not found,Not found,Phyllomedusa burmeisteri (Brazilian common walking leaf frog) ,Antimicrobial ,Protein level,Not found,Not found,,"Function: Amphibian defense peptide. May have antimicriobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Alanine amide at A21.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (APR-2009) to UniProtKB,"Conceicao K, Klitzke C.F, Brito R.C, Andrade D.F, Junca F.A, Biondi I, Lopes-Ferreira M.",Identification of peptides from Phyllomedusa burmesteri skin secretomics by nano LC MS/MS.,21,18-21
DRAMP01280,FLLSLPHLASGLASLVLSK,19,"Phylloseptin Bu-2 (Frogs, amphibians, animals)",P86283,Not found,Not found,Phyllomedusa burmeisteri (Brazilian common walking leaf frog) ,Antimicrobial ,Protein level,Not found,Not found,,"Function: Amphibian defense peptide. May have antimicriobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Lysine amide at L19.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (APR-2009) to UniProtKB,"Conceicao K, Klitzke C.F, Brito R.C, Andrade D.F, Junca F.A, Biondi I, Lopes-Ferreira M.",Identification of peptides from Phyllomedusa burmesteri skin secretomics by nano LC MS/MS.,19,18-21
DRAMP01281,FLSLIPHAINAISAIANHF,19,"Phylloseptin-J1 (PLS-J1; PS-J1; Frogs, amphibians, animals)",P86614,Not found,Not found,Phasmahyla jandaia (Jandaia leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20932854,Toxicon. 2011 Jan;57(1):35-52.,"Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.","Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).",19,18-21
DRAMP01282,FLSLIPHAINAISAIADHF,19,"Phylloseptin-J2 (PLS-J2; PS-J2; Frogs, amphibians, animals)",P86615,Not found,Not found,Phasmahyla jandaia (Jandaia leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20932854,Toxicon. 2011 Jan;57(1):35-52.,"Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.","Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).",19,18-21
DRAMP01283,FLSLIPHAINAISAIANHL,19,"Phylloseptin-J3 (PLS-J3; PS-J3; Frogs, amphibians, animals)",P86616,Not found,Not found,Phasmahyla jandaia (Jandaia leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20932854,Toxicon. 2011 Jan;57(1):35-52.,"Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.","Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1979) (Anura, Hylidae, Phyllomedusinae).",19,18-21
DRAMP01284,FLSLIPHAINAISAIAHHL,19,"Phylloseptin-J4 (PLS-J4; PS-J4; Frogs, amphibians, animals)",P86617,Not found,Not found,Phasmahyla jandaia (Jandaia leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20932854,Toxicon. 2011 Jan;57(1):35-52.,"Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.","Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1980) (Anura, Hylidae, Phyllomedusinae).",19,18-21
DRAMP01285,FLSLIPHAISAISAIAHHL,19,"Phylloseptin-J5 (PLS-J5; PS-J5; Frogs, amphibians, animals)",P86618,Not found,Not found,Phasmahyla jandaia (Jandaia leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20932854,Toxicon. 2011 Jan;57(1):35-52.,"Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.","Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1980) (Anura, Hylidae, Phyllomedusinae).",19,18-21
DRAMP01286,FLSLIPHAISAISAIANHL,19,"Phylloseptin-J6 (PLS-J6; PS-J6; Frogs, amphibians, animals)",P86619,Not found,Not found,Phasmahyla jandaia (Jandaia leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20932854,Toxicon. 2011 Jan;57(1):35-52.,"Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.","Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1980) (Anura, Hylidae, Phyllomedusinae).",19,18-21
DRAMP01287,FLSLIPHAISAISAIADHL,19,"Phylloseptin-J7 (PLS-J7; PS-J7; Frogs, amphibians, animals)",P86620,Not found,Not found,Phasmahyla jandaia (Jandaia leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20932854,Toxicon. 2011 Jan;57(1):35-52.,"Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.","Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1980) (Anura, Hylidae, Phyllomedusinae).",19,18-21
DRAMP01289,FLSLIPKIAGGIASLVKNL,19,"Phylloseptin-1 (PStar 01; Frogs, amphibians, animals)",P84929,Not found,Not found,Phyllomedusa tarsius (Brownbelly leaf frog) (Phyllomedusa tarsia),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (AUG-2006) to UniProtKB,"Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.",Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).,19,18-21
DRAMP01290,FLSLIPHIATGIAALAKHL,19,"Phylloseptin-2 (PStar 02; Frogs, amphibians, animals)",P84930,Not found,Not found,Phyllomedusa tarsius (Brownbelly leaf frog) (Phyllomedusa tarsia),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (AUG-2006) to UniProtKB,"Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.",Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).,19,18-21
DRAMP01291,FFSMIPKIATGIASLVKNL,19,"Phylloseptin-3 (PStar 03; Frogs, amphibians, animals)",P84931,Not found,Not found,Phyllomedusa tarsius (Brownbelly leaf frog) (Phyllomedusa tarsia),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (AUG-2006) to UniProtKB,"Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.",Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).,19,18-21
DRAMP01292,FLSLIPHAINAVSTLVHHSG,20,"Phylloseptin-4 (PS-4; Frogs, amphibians, animals)",P84569,Not found,psn4,Phyllomedusa oreades (Orange-legged leaf frog) (Monkey frog),Antiprotozoal ,Protein level,Not found,Not found,,"Function: Has antiprotozoal activity against Trypanosoma cruzi.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",Trypanosoma cruzi (IC50=5.1 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15752569,Peptides. 2005 Apr;26(4):565-573.,"Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr. ",Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.,20,18-21
DRAMP01293,FLSLIPHAINAVSAIAKHS,19,"Phylloseptin-5 (PS-5; Frogs, amphibians, animals)",P84570,Not found,psn5,Phyllomedusa oreades (Orange-legged leaf frog) (Monkey frog),Antiprotozoal ,Protein level,Not found,Not found,,"Function: Has antiprotozoal activity against Trypanosoma cruzi.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",Trypanosoma cruzi (IC50=4.9 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15752569,Peptides. 2005 Apr;26(4):565-573.,"Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr. ",Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.,19,18-21
DRAMP18399,FPFLLSLIPSAISAIKRL,18,"Uy234 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)",No entry found,Not found,Not found,Urodacus yaschenkoi,"Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against M. luteus (MIC 2 uM), L. grayi (MIC 4 uM), and L. monocytogenes (MIC 8 uM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,28067810,"Toxins (Basel). 2017 Jan 6;9, 22. doi: 10.3390/toxins9010022.","Luna-Ramirez K, Tonk M, Rahnamaeian M, Vilcinskas A.",Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus,18,15-18
DRAMP01304,SLIPHAINAVSAIAKHF,17,"Phylloseptin-6 (PS-6; Frogs, amphibians, animals)",P84571,Not found,psn6,Phyllomedusa hypochondrialis (Orange-legged leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15752569,Peptides. 2005 Apr;26(4):565-573.,"Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr. ",Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.,17,15-18
DRAMP01307,FLSLIPTAINAVSALAKHF,19,"Phylloseptin-8 (PS-8; Frogs, amphibians, animals)",P85883,Not found,psn-8,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17553595,Peptides. 2007 Jul;28(7):1331-1343.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,19,18-21
DRAMP01308,FLSLIPHAINAVSALAKHF,19,"Phylloseptin-8 (PS-8; Frogs, amphibians, animals)",P85447,Not found,Not found,Phyllomedusa tomopterna (Tiger-striped leaf frog) (Pithecopus tomopternus),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (FEB-2008) to UniProtKB,"de sa Mandel S.M, Mundim N.C.C.R, Freitas T, Silva L.P, Bloch C. Jr.",Dermaseptins and phylloseptins of Phyllomedusa (Hylidae) secretion.,19,18-21
DRAMP18318,ITSFIGCTPGCGKTGSFNSFCC,22,BacCH91(Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),bacCH91,Staphylococcus aureus CH-91,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,"Similar to Gallidermin and epidermin. The fourth residue was phenylalanine in BacCH91 but lysine in both epidermin and gallidermin, which explains the more hydrophobic character of BacCH91. ",,"The bacteriocin was not affected by any of the staphylococcal peptidases tested, particularly StpC. BacCH91 was unaffected by trypsin and proteinase K.",Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23196985,Appl Microbiol Biotechnol. 2013 Aug;97(16):7229-39.,"Wladyka B, Wielebska K, Wloka M, Bochenska O, Dubin G, Dubin A, Mak P.","Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91.",22,21-24
DRAMP01310,FLGLLPSIVSGAVSLVKKL,19,"Phylloseptin-9 (PS-9; Frogs, amphibians, animals)","Q0VZ38, P84905",Not found,psn-9,Phyllomedusa hypochondrialis (Orange-legged leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16713656,Peptides. 2006 Sep;27(9):2129-2136.,"Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.","Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.",19,18-21
DRAMP01311,FLSLLPSLVSGAVSLVKKL,19,"Phylloseptin-10 (PS-10; Frogs, amphibians, animals)","Q0VZ39, P84906",Not found,psn-10,Phyllomedusa hypochondrialis (Orange-legged leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16713656,Peptides. 2006 Sep;27(9):2129-2136.,"Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.","Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.",19,18-21
DRAMP01312,FLSLLPSLVSGAVSLVKIL,19,"Phylloseptin-11 (PS-11; Frogs, amphibians, animals)",Q0VZ40,Not found,psn-11,Phyllomedusa hypochondrialis (Orange-legged leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16713656,Peptides. 2006 Sep;27(9):2129-2136.,"Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.","Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.",19,18-21
DRAMP01313,FLSLIPHAINAVSALVHHF,19,"Phylloseptin-12 (PS-12; Frogs, amphibians, animals)",P84904,Not found,Not found,Phyllomedusa hypochondrialis (Orange-legged leaf frog),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (JUL-2006) to UniProtKB,"Silva L.P, Brand G.D, Bloch C. Jr.",High-throughput co-localization of peptides and proteins by imaging mass spectrometry.,19,18-21
DRAMP01315,FLSLIPHAINAVGVHAKHF,19,"Phylloseptin 13 (PS-13; Frogs, amphibians, animals)",P84938,Not found,psn13,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17553595,Peptides. 2007 Jul;28(7):1331-1343.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,19,18-21
DRAMP01316,FLSLIPAAISAVSALADHF,19,"Phylloseptin 14 (PS-14; Frogs, amphibians, animals)",P84939,Not found,psn14,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),Antimicrobial ,Protein level,Not found,Not found,,"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17553595,Peptides. 2007 Jul;28(7):1331-1343.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,19,18-21
DRAMP01317,LLSLVPHAINAVSAIAKHF,19,"Phylloseptin 15 (PS-15; Frogs, amphibians, animals)","Q0VKG9, P84940",Not found,psn15,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),Antimicrobial ,Transcript level,Not found,Not found,,"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17553595,Peptides. 2007 Jul;28(7):1331-1343.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,19,18-21
DRAMP01336,NILSSIVNGINRALSFFG,18,Amolopin-p1,C5H0C7,Not found,Not found,Amolops loloensis (Rufous-spotted torrent frog),Antimicrobial,Homology,Not found,Not found,,Function: defense response to bacterium.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,Pubmed ID is not available,Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.,"Wang A, Lai R.",cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.,18,15-18
DRAMP01337,NVLSSVANGINRALSFFG,18,Amolopin-p2,C5H0C8,Not found,Not found,Amolops loloensis (Rufous-spotted torrent frog),Antimicrobial,Homology,Not found,Not found,,Function: Amphibian defense peptide.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,Pubmed ID is not available,Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.,"Wang A, Lai R.",cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.,18,15-18
DRAMP01338,FLPMLAGLAANFLPKLFCKITKKC,24,"Amolopin-1a (Frogs, amphibians, animals)","A0SN41, A0SN38, A0SN39",Not found,Not found,Amolops loloensis (Rufous-spotted torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",24,21-24
DRAMP01343,FLPMLAGLAANLLPKLFCKITKKC,24,"Amolopin-1c (Frogs, amphibians, animals)",A0SN43,Not found,Not found,Amolops loloensis (Rufous-spotted torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",24,21-24
DRAMP01345,FLPMLAGLAANFLPELFCKITKKC,24,"Amolopin-1d (Frogs, amphibians, animals)",A0SN44,Not found,Not found,Amolops loloensis (Rufous-spotted torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Homology,Not found,Not found,,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",24,21-24
DRAMP01363,GFLDKLKKGASDFANALVNSIKGT,24,"Frenatin-4 (Frogs, amphibians, animals)",P82023,Not found,Not found,Litoria infrafrenata (Giant tree frog) (White-lipped tree frog),Antimicrobial,Protein level,Not found,Not found,,"Function: Wide spectrum antimicrobial peptide. Considered to interact with the outer lipid layer of the bacterial cell, penetrate the bacterial membrane, form ion channels, and ultimately kill the cell.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",Wide spectrum antimicrobial peptide.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9225251,J Pept Sci. 1996 Mar-Apr;2(2):117-124.,"Raftery MJ, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.,24,21-24
DRAMP01365,GLFGVLAKVASHVVPAIAEHFQA,23,"Maculatin-1.2 (Frogs, amphibians, animals)",P82067,Not found,Not found,Litoria genimaculata (Green-eyed tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Shows antibacterial activity against S. aureus and S. uberis.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus, Streptococcus uberis.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9620615,J Pept Sci. 1998 Apr;4(2):111-115.,"Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.",The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.,23,21-24
DRAMP01366,GLLGLLGSVVSHVVPAIVGHF,21,"Maculatin-1.3 (frog, amphibia, animals)",No entry found,Not found,Not found,Litoria eucnemis (Australian anurans),"Antimicrobial, Antibacterial, Antiviral",Not found,Not found,Not found,,Function: Has antiviral activity. The peptide is HIV inhibitory (EC50=4 µM).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15203252,Peptides. 2004; 25: 1035-1054.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",21,18-21
DRAMP01382,VEVQVRDKGKGIYGLSPLRQPAP,23,"Odorranain-L1 (OdL1; Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),Antimicrobial,Homology,Not found,Not found,,Function: Found no antimicrobial activity against the tested microbes and also has no hemolytic activity against red cell.,[Ref.17272268]Not detectable activity,[Ref:17272268]Non-hemolytic activity against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,23,21-24
DRAMP01385,AVPLIYNRPGIYVTKRPKGK,20,"Odorranain-O1 (OdO1; Frogs, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),Antimicrobial,Homology,Not found,Not found,,Function: Found no antimicrobial activity against the tested microbes and also has no hemolytic activity against red cell.,[Ref.17272268]Not detectable activity,[Ref:17272268]Non-hemolytic activity against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,20,18-21
DRAMP01404,GLFTFIKCAYKLRAPAVAC,19,"Odorranain-J2 antimicrobial peptide (Frogs, amphibians, animals)",A6MBN7,Not found,Not found,Odorrana grahami (Yunnanfu frog ),Antimicrobial,Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,19,18-21
DRAMP01406,AVPLIYNRPGIYAPKRPKGK,20,"Antimicrobial peptide odorranain-O3 (Frogs, amphibians, animals)",C3RTI0,Not found,Not found,Rana grahami (Yunnanfu frog),Antimicrobial,Homology,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases,"Ma Y, Lai R, Wu J, Li J.",Antimicrobial peptide from skin of Odorrana grahami.,20,18-21
DRAMP01425,GLLSGVLGVGKKVDCGLSGLC,21,"Nigrocin-OG21 (frog, amphibians, animals)",No entry found,Not found,Not found,Odorrana grahami (Yunnanfu frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Function: Showes an effect on HIV when applied in combination with OdK1.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,21,18-21
DRAMP01445,GLLSKVLGVGKKVLCGVSGLC,21,"Nigrocin-2 (Nigrocin-2LVa; Frogs, amphibians, animals)",P0C009,Not found,Not found,Rana nigromaculata (Black-spotted frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix,Not found,,"Function: Thanks to its single linear amphipathic alpha-helix, may integrate into membrane phospholipids, leading to lysis of the membrane. Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has weak hemolytic activity.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: Contains one disulfide bond 15-21. (By similarity)","[Ref.11682065]Gram-positive bacterium: Micrococcus luteus(MIC=2.5μg/ml);##Gram-negative bacteria: Shigella dysenteriae(MIC=10μg/ml), Klebsiella pneumoniae(MIC=10μg/ml), Pseudomonas aeruginosa(MIC=100μg/ml), Salmonella typhimurium(MIC=22.5μg/ml), Proteus mirabilis(MIC>200μg/ml), Serratia marcescens(MIC>200μg/ml);##Yeast: Candida albicans(MIC=150μg/ml).",[Ref:11682065] It has 0.9% hemolytic activity at 100μg/ml against human red blood cells,Cyclic,Free,Cyclization (Cys15 and Cys21),Disulfide bond between Cys15 and Cys21.,L,No cytotoxicity information found,Cell membrane,11682065,FEBS Lett. 2001 Oct 19;507(1):95-100.,"Park S, Park SH, Ahn HC, Kim S, Kim SS, Lee BJ, Lee BJ.","Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.",21,18-21
DRAMP18313,TPALAVVTTVLPAAAVTTAKSV,22,Sclerosin(Bacteriocin),No entry found,Belongs to the lipopeptides family,Not found,Pseudomonas sp. strain DF41 ,"Antimicrobial, Antibacterial",,Not found,"Warning: this peptide contains non-natural amino acids although they are represented using the closest standard 20 amino acids. Specifically, T1, T8, T17, and T18 are dehydrated into Dhb.  P12 is 3,4-dehydrated (Dhp). In total, five residues are dehydrated. Residue K20 is Dab (2,4-diaminobutyric acid). Finally, the acyl chain CH(3)-(CH(2))(6)-CH(OH)-CH(2)-CO is attached to the N-terminus. Thus, the entire sequence is CH(3)-(CH(2))(6)-CH",,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22838838,Can J Microbiol. 2012 Aug;58(8):1027-34. ,"Berry CL, Brassinga AK, Donald LJ, Fernando WG, Loewen PC, de Kievit TR.","Chemical and biological characterization of sclerosin, an antifungal lipopeptide.",22,21-24
DRAMP01498,GLFSKFAGKGIKNFLNKGVKHIGKE,25,"Esculentin-1-OA6 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana andersonii (Chinese odorous frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,25,24-27
DRAMP01512,QVFTLIKGATQLIRKTLGEQ,20,"Esculentin-2-OR6 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Odorrana rotodora (Chinese odorous frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,20,18-21
DRAMP01523,KGAAKGLLEVASCKLSKSC,19,"Rugosin A-like peptide (Frogs, amphibians, animals)",P84912,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana saharica (Sahara frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Stimulates insulin secretion by BRIN-BD11 cells in vitro. Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16269346,Peptides. 2005 Nov;26(11):2117-2123.,"Marenah L, Flatt P.R, Orr D.F, Shaw C, Abdel-Wahab Y.H.A.",Isolation and structural characterization of novel Rugosin A-like insulinotropic peptide from the skin secretions of Rana saharica frog.,19,18-21
DRAMP01527,FTMKKSLFLILFLGAIPLSMC,21,"Nigroain-L antimicrobial peptide (Frogs, amphibians, animals)",C0ILB3,Not found,Not found,Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata),Antimicrobial,Homology,Not found,Not found,,Function: Amphibian defensive peptide.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",21,18-21
DRAMP01528,FTMKKSLLFIFFLGTISLSLC,21,"Nigroain-H antimicrobial peptide (Frogs, amphibians, animals)",C0ILB0,Not found,Not found,Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata),Antimicrobial,Homology,Not found,Not found,,Function: Amphibian defensive peptide.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",21,18-21
DRAMP01529,FTMKKSLLLIFFLGTISLSLC,21,"Nigroain-H antimicrobial peptide (Frogs, amphibians, animals)",C0ILA9,Not found,Not found,Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata),Antimicrobial,Homology,Not found,Not found,,Function: Amphibian defensive peptide.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",21,18-21
DRAMP01530,FTMKKSPLLLFFLGTISLSLC,21,"Nigroain-E antimicrobial peptide (Frogs, amphibians, animals)","C0ILA0, C0ILA2",Not found,Not found,Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata),Antimicrobial,Homology,Not found,Not found,,Function: Amphibian defensive peptide.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",21,18-21
DRAMP01531,FTMKKSLLLIFFLGTISLSLCEQER,25,"Nigroain-D antimicrobial peptide (Frogs, amphibians, animals)","C0IL92, C0IL99, C0IL98",Not found,Not found,Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata),Antimicrobial,Homology,Not found,Not found,,Function: Amphibian defensive peptide.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",25,24-27
DRAMP01532,FTMKKSLFLLFFLGTISLSLC,21,"Nigroain-B antimicrobial peptide (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata),Antimicrobial,Predicted,Not found,Not found,,Function: Amphibian defensive peptide.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",21,18-21
DRAMP01534,CVISAGWDHKVRCKLTGNC,19,"Nigroain-B2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),Antimicrobial,Not found,Bridge,Not found,,PTM: Contains one disulfide bridge.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",19,18-21
DRAMP01535,CKIALPYHMRCRVLGRC,17,"Nigroain-B3 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),Antimicrobial,Not found,Bridge,Not found,,PTM: Contains one disulfide bridge.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",17,15-18
DRAMP01538,FKTWKRPPFQTSCSGIIKE,19,"Nigroain-C1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",19,18-21
DRAMP01540,CVHWQTNPARTSCIGP,16,"Nigroain-D1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),Antimicrobial,Not found,Not found,Not found,,PTM: Contains one disulfide bridge.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",16,15-18
DRAMP01541,CVHWQTNPARTSRIGP,16,"Nigroain-D2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),Antimicrobial,Not found,Not found,Not found,,PTM: Contains one disulfide bridge.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",16,15-18
DRAMP01544,GCTQWINNIHGRICVRN,17,"Nigroain-E2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",17,15-18
DRAMP01545,SFLSKFKDIALDVPRMRARVY,21,"Nigroain-I (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana nigrovittata (Black-striped frog),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",21,18-21
DRAMP01551,GLLGVLGSVAKHVLPHVVPVIAEHL,25,"Caerin-1.2 (Frogs, amphibians, animals)",P56227,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Australian frog),"Antimicrobial, Antibacterial,Antiviral",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.",[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 22	µM.,Not found,26026377##PubMed ID is not available,Peptides. 2015 Sep;71:296-303. ##J. Chem. Res. 1993; 138: 910-936.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.,25,24-27
DRAMP01556,GLFSVLGAVAKHVLPHVVPVIAEKL,25,"Caerin-1.6 (Frogs, amphibians, animals)","P62546, P56231, P81249, P62547",Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria xanthomera (Orange-thighed frog) (Litoria chloris),"Antimicrobial, Antibacterial,Antiviral",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility By similarity.
PTM: C-terminal amidation.",[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 10	µM.,Cell membrane,26026377##9230483##9204574##9516047,Peptides. 2015 Sep;71:296-303. ##J Pept Sci. 1997 May-Jun;3(3):181-185.##Rapid Commun Mass Spectrom. 1997;11(9):997-1000.##J Pept Res. 1998 Feb;51(2):121-126.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Steinborner ST, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ, Ramsay SL.##Steinborner ST, Waugh RJ, Bowie JH, Tyler MJ.##Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.",Inhibition of HIV infection by caerin 1 antimicrobial peptides.##New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera.##New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera. Part 2. Sequence determination using mass spectrometry and associated techniques.##New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.,25,24-27
DRAMP01557,GLFKVLGSVAKHLLPHVAPVIAEKL,25,"Caerin-1.7 (Frogs, amphibians, animals)","P62548, P62549, P56232, P81250",Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria xanthomera (Orange-thighed frog) (Litoria chloris),"Antimicrobial, Antibacterial,Antiviral",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity. 
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility By similarity.
PTM: C-terminal amidation.",[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,Free,L,[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 12.5 µM.,Cell membrane,26026377##9230483##9204574##9516047,Peptides. 2015 Sep;71:296-303. ##J Pept Sci. 1997 May-Jun;3(3):181-185.##Rapid Commun Mass Spectrom. 1997;11(9):997-1000.##J Pept Res. 1998 Feb;51(2):121-126.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Steinborner ST, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ, Ramsay SL.##Steinborner ST, Waugh RJ, Bowie JH, Tyler MJ.##Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.",Inhibition of HIV infection by caerin 1 antimicrobial peptides.##New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera.##New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera. Part 2. Sequence determination using mass spectrometry and associated techniques.##New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.,25,24-27
DRAMP01558,FKVLGSVAKHLLPHVAPVIAEK,22,Caerin-1.7.1 (Chain of Caerin-1.7),"P62549, P56232, P81250",Belongs to the frog skin active peptide (FSAP) family (Caerin subfamily),Not found,Litoria chloris (Blue-thighed frog),Not found,Protein level,Not found,Not found,,PTM: Caerin-1.7.1 does not have any antibacterial activity.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9516047,J Pept Res. 1998 Feb;51(2):121-126.,"Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.",New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.,22,21-24
DRAMP01559,GLFKVLGSVAKHLLPHVVPVIAEKL,25,"Caerin-1.8 (Frogs, amphibians, animals)",P81251,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria chloris (Blue-thighed frog),"Antimicrobial, Antibacterial, Antifungal, Antiviral",Protein level,Alpha helix ,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.",Litoria chloris,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9516047,J Pept Res. 1998 Feb;51(2):121-126.,"Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.",New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.,25,24-27
DRAMP01564,ALGGLLADVVKSKEQPA,17,Caerin-2.2.1 (Chain of Caerin-2.2),"P62570, P62571, P56234",Belongs to the frog skin active peptide (FSAP) family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog) (Litoria gilleni),Antimicrobial,Protein level,Not found,Not found,,"Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,Pubmed ID is not available,"J. Chem. Res. 1993,138:910-936.","Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",Peptides from Australian frogs. The structures of the caerins from Litoria caerula.,17,15-18
DRAMP01565,GLVSSIGKALGGLLADVVKTKEQPA,25,"Caerin-2.4 (Frogs, amphibians, animals)",P56236,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Chem. Res. 1993; 138: 910-936.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",Peptides from Australian frogs. The structures of the caerins from Litoria caerula.,25,24-27
DRAMP01566,GLVASIGRALGGLLADVVKSKEQPA,25,"Caerin-2.5 (Frogs, amphibians, animals)",P56237,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria gilleni (Centralian tree frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Chem. Res. 1993; 138: 910-936.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",Peptides from Australian frogs. The structures of the caerins from Litoria caerula.,25,24-27
DRAMP01569,GLWQKIKDKASELVSGIVEGVK,22,"Caerin-3.1 (Frogs, amphibians, animals)","P62562, P56238, P62563, P86505",Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria gilleni (Centralian tree frog) (Litoria splendida) (Litoria rothii),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation.",Gram-positive bacterium: Micrococcus luteus (MIC<0.4 µg/ml). (Ref.2),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available##15203252##16124032##195396,J. Chem. Res. 1993; 138: 910-936.##Peptides. 2004 Jun;25(6):1035-1054.##Rapid Commun Mass Spectrom. 2005;19(18):2716-2724.##Toxicon. 2009 Nov;54(6):828-835. ,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Brinkworth CS, Bowie JH, Bilusich D, Tyler MJ.##Sherman PJ, Jackway RJ, Nicholson E, Musgrave IF, Boontheung P, Bowie JH.","Peptides from Australian frogs. The structures of the caerins from Litoria caerula.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##The rothein peptides from the skin secretion of Roth's tree frog Litoria rothii. Sequence determination using positive and negative ion electrospray mass spectrometry.##Activities of seasonably variable caerulein and rothein skin peptides from the tree frogs Litoria splendida and Litoria rothii.",22,21-24
DRAMP01571,GLWEKIKEKANELVSGIVEGVK,22,"Caerin-3.3 (Frogs, amphibians, animals)",P56240,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Chem. Res. 1993; 138: 910-936.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",Peptides from Australian frogs. The structures of the caerins from Litoria caerula.,22,21-24
DRAMP01572,GLWEKIREKANELVSGIVEGVK,22,"Caerin-3.4 (Frogs, amphibians, animals)",P56241,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Chem. Res. 1993; 138: 910-936.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",Peptides from Australian frogs. The structures of the caerins from Litoria caerula.,22,21-24
DRAMP01575,GLWQKIKSAAGDLASGIVEAIKS,23,"Caerin-4.2 (Frogs, amphibians, animals)",P56243,Belongs to the frog skin active peptide family (Caerin subfamily),Not found,Litoria caerulea (Green tree frog); also L.caerulea/L.splendida hybrid,"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Chem. Res. 1993; 138: 910-936.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",Peptides from Australian frogs. The structures of the caerins from Litoria caerula.,23,21-24
DRAMP01579,GLFGILGSVAKHVLPHVVPVIAEHS,25,"Caerin 1.12 (Frogs, amphibians, animals)",Q800R8,Not found,Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12709067,Eur J Biochem. 2003 May;270(9):2068-2081.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.",Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,25,24-27
DRAMP01580,GLLSVLGSLKLIVPHVVPLIAEHL,24,"Caerin 1.13 (Frogs, amphibians, animals)",Q800R7,Not found,Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12709067,Eur J Biochem. 2003 May;270(9):2068-2081.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.",Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,24,21-24
DRAMP01581,SVLGKSVAKHLPHVVPVIAEKT,22,"Caerin 1.14 (Frogs, amphibians, animals)",Q800R6,Not found,Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12709067,Eur J Biochem. 2003 May;270(9):2068-2081.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.",Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,22,21-24
DRAMP01582,GLFGLAKGSVAKPHVVPVISQLV,23,"Caerin 1.15 (Frogs, amphibians, animals)",Q800R5,Not found,Not found,Litoria caerulea (Green tree frog),"Antimicrobial, Antibacterial",Homology,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12709067,Eur J Biochem. 2003 May;270(9):2068-2081.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.",Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,23,21-24
DRAMP01598,GLFDIIKKVASVVGLASP,18,"Citropin-1.2.4 (Frogs, amphibians, animals)",P81844,Not found,Not found,Litoria citropa (Australian blue mountains tree frog),Unknown,Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,18,15-18
DRAMP01599,GLFDIIKKVASVVGLASQ,18,"Citropin-1.2.5 (Frogs, amphibians, animals)",P81845,Not found,Not found,Litoria citropa (Australian blue mountains tree frog),Unknown,Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,18,15-18
DRAMP01604,GLFDVIKKVASVIGLASQ,18,"Citropin-1.1.4 (Frogs, amphibians, animals)",P81839,Not found,Not found,Litoria citropa (Australian blue mountains tree frog),Unknown,Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,18,15-18
DRAMP01605,DLFQVIKEKLKELTGGVIEGIQGV,24,"Citropin-3.1.2 (Frogs, amphibians, animals)","P81851, P81852, P81853",Not found,Not found,Litoria citropa (Australian blue mountains tree frog),Unknown,Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10504394,Eur J Biochem. 1999 Oct;265(2):627-637.,"Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.",Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,24,21-24
DRAMP01609,GLFDIVKKVVGALGSL,16,"Aurein-2.2 (Frogs, amphibians, animals)",P82389,Not found,Not found,Litoria aurea (Green; also golden bell frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",Protein level,Alpha helix,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=12 μg/ml), Micrococcus luteus (MIC=25 μg/ml), , Staphylococcus epidermidis (MIC=25 μg/ml), Streptococcus uberis (MIC=100 μg/ml), Staphylococcus aureus (MIC=25 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP01610,GLFDIVKKVVGAIGSL,16,"Aurein-2.3 (Frogs, amphibians, animals)",P82390,Not found,Not found,Litoria aurea (Green; also golden bell frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",Protein level,Alpha helix,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=25 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=25 μg/ml), Staphylococcus aureus (MIC=100 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP01611,GLFDIVKKVVGTLAGL,16,"Aurein-2.4 (Frogs, amphibians, animals)",P82391,Not found,Not found,Litoria aurea (Green; also golden bell frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",Protein level,Not found,Not found,,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=25 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=25 μg/ml), Streptococcus uberis (MIC=25 μg/ml), Staphylococcus aureus (MIC=25 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP01616,FDIVKKIAGHIAGSI,15,"Aurein-3.1.2 (Frogs, amphibians, animals)",P69021,Not found,Not found,Litoria aurea (Green and golden bell frog),"Antimicrobial, Antibacterial, Anti-cancer",Protein level,Not found,Not found,,"Function: 	  Has antimicrobial activity against L.lactis, L.innocua, M.luteus, S.aureus, S.epidermidis and S.uberis. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10951191,Eur J Biochem. 2000 Sep;267(17):5330-5341.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.",The antibiotic and anticancer active aurein peptides from the australian bell frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.,15,12-15
DRAMP01619,FDIVKKIAGHIVSSI,15,"Aurein-3.3.1 (Frogs, amphibians, animals)",P82396,Not found,Not found,Litoria raniformis (Southern bell frog),"Antimicrobial, Antibacterial, Anti-cancer",Protein level,Not found,Not found,,"Function: 	  Antimicrobial activity against L.lactis, M.luteus, P.multocida, S.aureus, S.epidermidis and S.uberis. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10951191,Eur J Biochem. 2000 Sep;267(17):5330-5341.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.",The antibiotic and anticancer active aurein peptides from the australian bell frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.,15,12-15
DRAMP01624,ILGPILGLVSNAGGLL,16,"Bombinin-H6 (bombinin H isomers; Frogs, amphibians, animals)",No entry found,Belongs to the bombinin family,Not found,Not found,"Antimicrobial, Antibacterial",Not found,Not found,Not found,,"Function: H6 shows the greatest activity, causing 60% hemolysis at a very low peptide concentration (4 µM).
PTM: C-terminal amidation.",H6 does not display any microbicidal activity against all the microorganisms tested.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11090921,Peptides. 2000 Nov;21(11):1673-1679.,"Mangoni ML, Grovale N, Giorgi A, Mignogna G, Simmaco M, Barra D.","Structure-Function: relationships in bombinins H, antimicrobial peptides from Bombina skin secretions.",16,15-18
DRAMP01629,GWMSKIASGIGTFLSGVQQG,20,"Phylloxin-S1 (Frogs, amphibians, animals)",No entry found,Belongs to the Phyllomedusinae subfamily,Not found,Phyllomedusa sauvagii (Waxy Monkey Leaf Frog),"Antimicrobial, Antibacterial, Antifungal, Antiviral",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18644413,Peptides. 2008 Nov;29(11):2074-2082.,"Amiche M, Ladram A, Nicolas P.",A consistent nomenclature of antimicrobial peptides isolated from frogs of the subfamily Phyllomedusinae.,20,18-21
DRAMP01653,ALWKDILKNAGKAALNEINQLVNQ,24,"Dermaseptin-B6 (Dermaseptin BVI; Frogs, amphibians, animals)","P81490, Q98TQ1",Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Possesses a potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9614066,J Biol Chem. 1998 Jun 12;273(24):14690-7.,"Charpentier S, Amiche M, Mester J, Vouille V, Le Caer JP, Nicolas P, Delfour A.","Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.",24,21-24
DRAMP18307,APVPFSCTRGCLTHLV,16,LMW peptide (Bacteriocin),No entry found,Not found,Not found,Pediococcus pentosaceus IE-3,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,Not found,,"Unlike pediocin-like bacteriocins, the low molecular weight peptide (LMW) showed resistance to different proteases. Moreover, peptide treated with reducing agent like dithiothreitol (DTT) exhibited increased activity against both Gram-positive and Gram-negative test strains in comparison to native peptide. However, peptide treated with oxidizing agent such as hydrogen peroxide (H2O2) did not show any antimicrobial activity.",Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,25158757,BMC Microbiol. 2014 Aug 27;14:226. ,"Singh PK, Sharma S, Kumari A, Korpole S.",A non-pediocin low molecular weight antimicrobial peptide produced by Pediococcus pentosaceus strain IE-3 shows increased activity under reducing environment.,16,15-18
DRAMP18306,KYYGNGVTXGKHSXXVDXG,19,Pediocin ACCEL(Bacteriocin),No entry found,Belongs to the class IIa bacteriocin,Not found,Pediococcus pentosaceus ACCEL,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,Not found,,It was inactivated by various proteases and stable at pH 2.0-6.0 and <100  Celsius degree. More than 80% activity was left even after 15 min of heating at 121  Celsius degree and pH 2.0-4.0.,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,14995112,J Agric Food Chem. 2004 Mar 10;52(5):1146-51.,"Wu CW, Yin LJ, Jiang ST.",Purification and characterization of bacteriocin from Pediococcus pentosaceus ACCEL.,19,18-21
DRAMP01676,ALWKDILKNAGKAALNEINQIVQ,23,"Dermaseptin-4 (DStar 04; Frogs, amphibians, animals)",P84924,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Phyllomedusa tarsius (Brownbelly leaf frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Antimicrobial peptide, active against the Gram-positive bacterium S. aureus, the Gram-negative bacteria E. coli and P. aeruginosa. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Swiss_Prot Entry P84924]Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis;##Gram-neagtive bacterium: Pseudomonas aeruginosa.",[Ref:PubMed ID is not available]5% hemolytic activity at 128 µg/ml,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (AUG-2006) to UniProtKB.,"Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.",Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).,23,21-24
DRAMP01677,GLWSKIKEAAKTAGKAAMGFVNEMV,25,"Dermaseptin-5 (DStar 05; Frogs, amphibians, animals)",P84925,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Phyllomedusa tarsius (Brownbelly leaf frog),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial peptide, active against the Gram-positive bacterium S. aureus, the Gram-negative bacteria E. coli and P. aeruginosa, and the yeasts C. albicans and P. brasiliensis. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Swiss_Prot Entry P84925]Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis;##Gram-neagtive bacterium: Pseudomonas aeruginosa;##Fungi: Candida albicans and Paracoccidioides brasiliensis.",[Ref:PubMed ID is not available]15% hemolytic activity at 128 µg/ml,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (AUG-2006) to UniProtKB.,"Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.",Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).,25,24-27
DRAMP01682,GLRSKIWLWVLLMIWQESNKFKKM,24,"Dermaseptin-S9 (DS9; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Phyllomedusa sauvagei (South American hylid frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16401077,Biochemistry. 2006 Jan 17;45(2):468-480.,"Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G, Nicolas P, Amiche M.","Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.",24,21-24
DRAMP01684,GLWSKIKEAAKTAGKMAMGFVNDMV,25,"Dermaseptin-S12 (DS12; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Phyllomedusa sauvagei (Sauvage's leaf frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16401077,Biochemistry. 2006 Jan 17;45(2):468-480.,"Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G, Nicolas P, Amiche M.","Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.",25,24-27
DRAMP01685,GLRSKIKEAAKTAGKMALGFVNDMA,25,"Dermaseptin-S13 (DS13; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Phyllomedusa sauvagei (Sauvage's leaf frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16401077,Biochemistry. 2006 Jan 17;45(2):468-480.,"Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G, Nicolas P, Amiche M.","Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.",25,24-27
DRAMP01695,GVVTDLLNTAGGLLGNLVGSLSG,23,"Dermaseptin PD-3-6 (Plasticin-DA1; Frogs, amphibians, animals)",O93454,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Pachymedusa dacnicolor (Giant mexican leaf frog),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9774745,Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.,Wechselberger C.,Cloning of cDNAs encoding new peptides of the dermaseptin-family.,23,21-24
DRAMP01696,LLGDLLGQTSKLVNDLTDTVGSIV,24,"Dermaseptin PD-3-7 (Frogs, amphibians, animals)",O93455,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Pachymedusa dacnicolor (Giant mexican leaf frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9774745,Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.,Wechselberger C.,Cloning of cDNAs encoding new peptides of the dermaseptin-family.,24,21-24
DRAMP01700,GLWSTIKNVAAAAGKAALGAL,21,"Dermaseptin-H3 (Dermaseptin-like peptide 3, DMS3; Frogs, amphibians, animals)",Q17UY8,Belongs to the frog skin active peptide family (Dermaseptin subfamily),dpp-H3,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Not found,,MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).,"Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, Micrococcus luteus.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17553595,Peptides. 2007 Jul;28(7):1331-43.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,21,18-21
DRAMP01711,ALWKNMLKGIGKLAGKAALGAVK,23,"Dermaseptin III-like peptide (Frogs, amphibians, animals)",P86281,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Not found,Phyllomedusa burmeisteri (Brazilian common walking leaf frog),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (APR-2009) to UniProtKB.,"Conceicao K, Klitzke C.F, Brito R.C, Andrade D.F, Junca F.A, Biondi I, Lopes-Ferreira M.",Identification of peptides from Phyllomedusa burmesteri skin secretomics by nano LC MS/MS.,23,21-24
DRAMP01767,FLPALAGIAGLLGKIFGK,18,"Temporin-She (Frogs, amphibians, animals)",D5GRW4,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-She,Pelophylax saharicus (Sahara frog) (Rana saharica),Antimicrobial,Homology,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Biol. Chem. 0:0-0(2010).,"Abbassi F, Lequin O, Piesse C, Goasdoue N, Foulon T, Nicolas P, Ladram A.","A. Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.",18,15-18
DRAMP01770,AVDLAKIANIANKVLSSLFGK,21,"Temporin-1SKc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana sakuraii (Japanese brown frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17174009,Peptides. 2007 Mar;28(3):505-514.,"Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.",Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,21,18-21
DRAMP01772,FLPLIGKILGTILGK,15,"Temporin-1Ob (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana ornativentris (Japanese mountain brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17147973,Peptides. 2007 Mar;28(3):524-532.,"Ohnuma A, Conlon JM, Yamaguchi K, Kawasaki H, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.",Antimicrobial peptides from the skin of the Japanese mountain brown frog Rana ornativentris: evidence for polymorphism among preprotemporin mRNAs.,15,12-15
DRAMP01778,FLPAALAGIGGILGKLFGK,19,"Temporin-1Sd (Frogs, amphibians, animals)",D4YWD0,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-1Sd,Pelophylax saharicus (Sahara frog) (Rana saharica),Antimicrobial,Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Biol. Chem. 2010;0:0-0.,"Abbassi F, Lequin O, Piesse C, Goasdoue N, Foulon T, Nicolas P, Ladram A.","A. Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.",19,18-21
DRAMP18302,SCNCVCGFCCSCSPSA,16,GE2270A(Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Nonomuraea,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Elongation Factor Tu  (EF-Tu),PubMed ID is not available,BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1997 JAN 13;230(2):320-326.,"Mohrle VG,Tieleman LN,Kraal B.",Elongation Factor Tu1 of the Antibiotic GE2270A Producer Planobispora rosea Has an Unexpected Resistance Profile against EF-Tu Targeted Antibiotics.,16,15-18
DRAMP01805,FIGPLISALASLFKG,15,"Temporin-CDYd (Frogs, amphibians, animals)",B3VZU5,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,Function: Antimicrobial activity againist Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. ,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",15,12-15
DRAMP01806,FIGPIISALASLFGG,15,"Temporin-CDYe (Frogs, amphibians, animals)",B3VZU6,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,Function: Antimicrobial activity againist Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. ,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",15,12-15
DRAMP04210,GIGKHVGKALKGLKGLLKGLGES,24,Adepantin-1 (Automatically Designed Peptide antibacterial 1; synthetic),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Helix,Not found,,Function: Antibacterial activity against Gram negative bacteria. Has hemolytic activity.,"[Ref.19947578] Gram-negative bacteria: Escherichia coli ATCC (MIC=2-4 μM), Pseudomonas aeruginosa (MIC=16 μM).",[Ref.19947578] HC50>800 μM against human red blood cells.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membranes,19947578,J Chem Inf Model. 2009 Dec;49(12):2873-82,"Juretić D, Vukicević D, Ilić N, Antcheva N, Tossi A.",Computational design of highly selective antimicrobial peptides.,23,21-24
DRAMP01826,RIGVLLARLPKLFSLFKLMGKKV,23,"RV-23 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana aurora draytonii (California red-legged frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Alpha helix,Not found,,[Ref.27271216]Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=12.5 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=6.25 μM)","[Ref.27271216] 60% hemolysis at 20 μM , 90% hemolysis at 40 μM , 100% hemolysis at 60 μM , 100% hemolysis at 100 μM against human red blood cells",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16307827##27271216,Peptides. 2006 Jun;27(6):1305-1312.##Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Conlon JM, Al-Ghafari N, Coquet L, Leprince J, Jouenne T, Vaudry H, Davidson C.##Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji","Evidence from peptidomic analysis of skin secretions that the red-legged frogs, Rana aurora draytonii and Rana aurora aurora, are distinct species.##Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity",23,21-24
DRAMP01126,ILGPVISKIGGVLGGLLKNL,20,"Maximin-H4 (Toads, amphibians, animals)","P83084, Q58T61, Q58T60",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity. ","[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=12 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=6 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=12 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=6 μg/ml).",[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP01125,ILGPVLGLVGNALGGLIKKI,20,"Maximin-H3 (Toads, amphibians, animals)","P83083, Q58T42, Q58T44, Q58T45, Q58T52, Q58T55, Q58T62, Q58T68, Q58T70",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity.","[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=20 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=10 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=20 μg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=5 μg/ml).",[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP18298,CCSCSCSTCTCTCTCASSAATKM,23,Listeriolysin S(Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Listeria monocytogenes F2365,Unknown,,Not found,Not found,,"Comment: A haemolytic and cytotoxic factor, designated Listeriolysin S, which contributes to virulence of the pathogen. This haemolysin is only induced under oxidative stress conditions and contributes to murine virulence and in survival in polymorphonuclear neutrophils.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18787690,PLoS Pathog. 2008 Sep 12;4(9):e1000144.,"Cotter PD, Draper LA, Lawton EM, Daly KM, Groeger DS, Casey PG, Ross RP, Hill C.","Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes.",23,21-24
DRAMP01835,GFRDVLKGAAKEFVKTVAGHIAN,23,"Ascaphin-1M (Frogs, amphibians, animals)",No entry found,Not found,Not found,A. montanus (North America inland frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18983817,Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.,"Conlon JM, Kolodziejek J, Nowotny N.",Antimicrobial peptides from the skins of North American frogs.,23,21-24
DRAMP01836,GFREVLKGAAKAFVKTVAGHIANI,24,"Ascaphin-3M (Frogs, amphibians, animals)",No entry found,Not found,Not found,A. montanus (North America inland frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18983817,Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.,"Conlon JM, Kolodziejek J, Nowotny N.",Antimicrobial peptides from the skins of North American frogs.,24,21-24
DRAMP01837,GFKDWIKGAAKKLIKTVASNIANQ,24,"Ascaphin-4M (Frogs, amphibians, animals)",No entry found,Not found,Not found,A. montanus (North America inland frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18983817,Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.,"Conlon JM, Kolodziejek J, Nowotny N.",Antimicrobial peptides from the skins of North American frogs.,24,21-24
DRAMP01838,GIKDWIKGAAKTLIKTVASHIANQ,24,"Ascaphin-5M (Frogs, amphibians, animals)",No entry found,Not found,Not found,A. montanus (North America inland frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18983817,Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.,"Conlon JM, Kolodziejek J, Nowotny N.",Antimicrobial peptides from the skins of North American frogs.,24,21-24
DRAMP01839,GFKDWIKSAAKKLIKTVASNIANQ,24,"Ascaphin-7M (Frogs, amphibians, animals)",No entry found,Not found,Not found,A. montanus (North America inland frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18983817,Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.,"Conlon JM, Kolodziejek J, Nowotny N.",Antimicrobial peptides from the skins of North American frogs.,24,21-24
DRAMP01841,GFRDVLKGAAKQFVKTVAGHIANI,24,"Ascaphin-2 (Frogs, amphibians, animals)",P0CJ26,Belongs to the ascaphin family,Not found,Ascaphus truei (Coastal tailed frog),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.,[Ref.15207717]Gram-negative bacterium: Escherichia coli,[Ref.15207717]Not found,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",24,21-24
DRAMP01843,GFKDWIKGAAKKLIKTVAANIANQ,24,"Ascaphin-4 (Frogs, amphibians, animals)",P0CJ28,Belongs to the ascaphin family,Not found,Ascaphus truei (Coastal tailed frog),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.,[Ref.15207717]Gram-negative bacterium: Escherichia coli,[Ref.15207717]Not found,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",24,21-24
DRAMP01845,GFKDWIKGAAKKLIKTVASSIANE,24,"Ascaphin-6 (Frogs, amphibians, animals)",P0CJ30,Belongs to the ascaphin family,Not found,Ascaphus truei (Coastal tailed frog),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands. 
Caution: May represent an artifactually modified form of ascaphin-7 arising from hydrolysis during the purification procedure.",[Ref.15207717]Gram-negative bacterium: Escherichia coli,[Ref.15207717]Not found,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",24,21-24
DRAMP01848,GFKKLLKGAAKALVKTVLF,19,[D4k]ascaphin-8,No entry found,Not found,Not found,Ascaphus truei (Coastal tailed frog),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22374306,Peptides. 2012 Apr;34(2):275-282.,"Popovic S, Urbán E, Lukic M, Conlon JM.",Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.,19,18-21
DRAMP01853,FLPLIAGLAANFLPKLFCKITKKC,24,"Brevinin-1-RAB2 antimicrobial peptide (Frogs, amphibians, animals)","D2K8D2, D2K8G7",Not found,Not found,Rana andersonii (golden crossband frog),Antimicrobial,Homology,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available##6292726,Submitted (OCT-2009) to the EMBL/GenBank/DDBJ databases.,"Yang X, Liang X, Zhang Y, Lee W.-H.","The highest antimicrobial peptide diversity, skin antimicrobialpeptides peptidomics of Amphibian, Rana andersonii.",24,21-24
DRAMP18295,WXIGVTGAALGTGKGVKNVI,20,Leucocin H alpha(Bacteriocin),No entry found,Belongs to the class IIb bacteriocin,Not found,Leuconostoc MF215B,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,No sequence homology to other known bacteriocins could be demonstrated. It also appeared that the two peptides themselves shared little or no sequence homology.,,Comment: No comments found on DRAMP database,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10387116,Curr Microbiol. 1999 Jul;39(1):43-8.,"Blom H, Katla T, Holck A, Sletten K, Axelsson L, Holo H.","Characterization, production, and purification of leucocin H, a two-peptide bacteriocin from Leuconostoc MF215B.",20,18-21
DRAMP01871,FLPIIASVAAKLIPSIVCRITKKC,24,"Brevinin-1SPc (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana septentrionalis (mink frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.,No MICs found in DRAMP database,[Ref.15556063]HC50=3 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,24,21-24
DRAMP01874,VIPFVASVAAEMMPHVYCAASRKC,24,"Brevinin-1Eba (Frogs, amphibians, animals)",No entry found,Not found,Transcript level,Rana esculenta,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-61.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,24,21-24
DRAMP01894,FFPIVAGVAGQVLKKIFCTISKKC,24,"Brevinin 1Pg (Frogs, amphibians, animals)",A9CBI5,Not found,Not found,Rana pipiens (Northern leopard frog),Antimicrobial,Homology,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17938991,J Mol Evol. 2007 Nov;65(5):605-615.,"Tennessen JA, Blouin MS.",Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.,24,21-24
DRAMP01895,FTSKKSMLLFFFLGTISLSLCQ,22,"Brevinin-2CE (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana chensinensis (Chinese brown frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21303203,Zoolog Sci. 2011 Feb;28(2):112-117.,"Zhao J, Sun Y, Li Z, Su Q.","Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",22,21-24
DRAMP01903,FLPLLAGLAANFLPKLFCKITKKC,24,"Brevinin-1E-OG1 (brevinin-1E-OG3; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana grahami (Yunnanfu frog),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,24,21-24
DRAMP01905,FLPLLAGLAANFLPKLFCKITRKC,24,"Brevinin-1E-OG5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana grahami (Yunnanfu frog),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,24,21-24
DRAMP01906,FLPFLAGLAANFLPKLFCKITRKC,24,"Brevinin-1E-OG4 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana grahami (Yunnanfu frog),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,24,21-24
DRAMP01907,FFPLIAGLAANFLPQILCKIARKC,24,"Antimicrobial peptide brevinin-1E-OG7 (Frogs, amphibians, animals)",C3RTH8,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana grahami (Yunnanfu frog),Antimicrobial,Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases,"Ma Y, Lai R, Wu J, Li J.",Antimicrobial peptide from skin of Odorrana grahami.,24,21-24
DRAMP01917,FFPNVASVPGQVLKKIFCAISKKC,24,"Brevinin-1PLa (Frogs, amphibians, animals)",B6CPR5,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana palustris (Pickerel frog),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Inhibit the growth of Batrachochytrium dendrobatidis (Bd) (MIC=50 µM), a fungus that might have played a role in killing many frogs.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18799711##11087945,Mol Biol Evol. 2008 Dec;25(12):2669-2680.##Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Tennessen JA, Blouin MS.##Basir YJ, Knoop FC, Dulka J, Conlon JM.","Balancing selection at a frog antimicrobial peptide locus: fluctuating immune effector alleles? ##Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",24,21-24
DRAMP01923,FFPAIFRLVAKVVPSIICSVTKKC,24,"Brevinin-1R (Frogs, amphibians, animals)",P86027,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Pelophylax ridibundus (Marsh frog) (Rana ridibunda),Antimicrobial ,Protein level,Not found,Not found,,Function: Antimicrobial peptide. Tissue specificity: Expressed by the skin glands. PTM: Contains one disulfide bond 18-24.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18855342##18855342,Mass Spectrom. 2007;4:79-88.##Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.,"Artemenko K.A, Samgina T.Y, Lebedev A.T, Doyle J.R, Llewellyn L.E, Bilusich D, Bowie J.H.##Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",Host-defence peptides from the skin secretion of the European marsh frog Rana ridibunda.##De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.,24,21-24
DRAMP01924,FLPAIFRMAAKVVPTIICSITKKC,24,"Brevinin-1Ea (Frogs, amphibians, animals)",P40835,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana esculenta (European frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.",[Swiss_Prot Entry P40835]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50=0.5 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,24,21-24
DRAMP01925,VIPFVASVAAEMQHVYCAASRKC,23,"Brevinin-1Eb (Frogs, amphibians, animals)",P40836,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana esculenta (European frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.",[Swiss_Prot Entry P40836]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50=0.5 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,23,21-24
DRAMP01926,FLPLLAGLAANFFPKIFCKITRKC,24,"Brevinin-1Ec (Frogs, amphibians, animals)",P86150,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana ridibunda (Laughing frog) (Marsh frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.",[Swiss_Prot Entry P86150]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.18855342]show hemolytic activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18855342,Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.,"Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.,24,21-24
DRAMP01930,VIPFVASVAAEMMHHVYCAASKRC,24,"Brevinin-1Ed (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana esculenta (Korea),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Alpha helix ,Not found,,This is a narrow spectrum AMP from the frog.,Gram-positive bacterium: Micrococcus luteus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15232222,Mol Cells. 2004 Jun 30;17(3):469-476.,"Won HS, Kim SS, Jung SJ, Son WS, Lee B, Lee BJ.",Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea.,24,21-24
DRAMP01945,FLPLVRGAAKLIPSVVCAISKRC,23,"Brevinin-1SE (Frogs, amphibians, animals)",P85056,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana sevosa (Dusky gopher frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Mast cell degranulating peptide. Causes histamine release from rat peritoneal mast cells in vitro.,Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16386333,Peptides. 2006 Jun;27(6):1313-1319.,"Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.","Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.",23,21-24
DRAMP01952,FMGGLIKAATKALPAAFCAITKKC,24,"Brevinin-1PTb (Frogs, amphibians, animals)",P0C8T2,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",24,21-24
DRAMP01960,FLPILASLAAKFGPKLFCLVTKKC,24,"Brevinin-1BYa (Frogs, amphibians, animals)",P84111,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana boylii (Foothill yellow-legged frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Has hemolytic activity.,[Ref.14531844]Gram-positive bacterium: Staphylococcus aureus(MIC=2 µM);##Gram-negative bacterium: Escherichia coli(MIC=17 µM);##Yeast: Candida albicans(MIC=3 µM),[Ref.14531844]HC50=4 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,14531844,J Pept Res. 2003 Nov;62(5):207-213.,"Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.",Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,24,21-24
DRAMP01961,FLPILASLAAKLGPKLFCLVTKKC,24,"Brevinin-1BYb (Frogs, amphibians, animals)",P84112,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana boylii (Foothill yellow-legged frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Has hemolytic activity.,[Ref.14531844]Gram-positive bacterium: Staphylococcus aureus(MIC=4 µM);##Gram-negative bacterium: Escherichia coli(MIC=16 µM);##Yeast: Candida albicans(MIC=16 µM).,[Ref.14531844]HC50=4 µM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,14531844,J Pept Res. 2003 Nov;62(5):207-213.,"Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.",Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,24,21-24
DRAMP01962,FLPILASLAATLGPKLLCLITKKC,24,"Brevinin-1BYc (Frogs, amphibians, animals)",P84113,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana boylii (Foothill yellow-legged frog),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans (weak activity).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,14531844,J Pept Res. 2003 Nov;62(5):207-213.,"Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.",Isolation of peptides of the brevinin-3 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,24,21-24
DRAMP01964,FLPIIAGVAAKVLPKIFCAISKKC,24,"Brevinin-1BLb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates blairi (leopard frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19254736,Toxicon. 2009 Jun;53(7-8):699-705.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",24,21-24
DRAMP01966,FLPVIAGVAANFLPKLFCAISKKC,24,"Brevinin-1Ya (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates yavapaiensis (North America leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.19254736] Gram-positive bacteria : Staphylococcus aureus(MIC=3 μM);##Gram-negative bacteria : Escherichia coli(MIC=50 μM);##Fungi : Candida albicans(MIC=12 μM),[Ref.19254736] LC50=18 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19254736,Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",24,21-24
DRAMP01967,FLPIIAGAAAKVVQKIFCAISKKC,24,"Brevinin-1Yb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates yavapaiensis (North America leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.19254736] Gram-positive bacteria : Staphylococcus aureus(MIC=3 μM);##Gram-negative bacteria : Escherichia coli(MIC=25 μM);##Fungi : Candida albicans(MIC=3 μM),[Ref.19254736] LC50=16 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19254736,Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",24,21-24
DRAMP01972,FLPLLPSALPSFLCLVFKKC,20,"Brevinin-1ZHc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana zhenhaiensis (Chinese brown frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",20,18-21
DRAMP01973,FLPLLLSALPSFSCLVFKKC,20,"Brevinin-1ZHd (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana zhenhaiensis (Chinese brown frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",20,18-21
DRAMP01975,VIPFVASVAAEMMQHVYCAASRRC,24,"Brevinin-1Ra (Frogs, amphibians, animals)",P86028,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Pelophylax ridibundus (Marsh frog) (Rana ridibunda),Antimicrobial ,Protein level,Not found,Not found,,"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18855342##18280749,Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.##J Am Soc Mass Spectrom. 2008 Apr;19(4):479-487.,"Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.##Samgina TY, Artemenko KA, Gorshkov VA, Poljakov NB, Lebedev AT.",De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.##Oxidation versus carboxamidomethylation of S-S bond in ranid frog peptides: pro and contra for de novo MALDI-MS sequencing.,24,21-24
DRAMP01978,KLKNFAIGVAQSLLNKASCKLSGQC,25,"Brevinin-2R (Frogs, amphibians, animals)",P85095,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Pelophylax ridibundus (Marsh frog) (Rana ridibunda),"Antimicrobial, Antibacterial, Anti-cancer",Protein level,Not found,Not found,,"Function: Cytotoxicity towards malignant cells, including Jurkat (T-cell leukemia), BJAB (B-cell lymphoma), HT29/219, SW742 (colon carcinomas), L929 (fibrosarcoma), MCF-7 (breast adenocarcinoma), A549 (lung carcinoma), acts via the activation of the lysosomal-mitochondrial death pathway and autophagy-like cell death. Does not show significant hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: contains one disulfide bond 19-25.","[Swiss_Prot Entry P85095]Cytotoxic to cancer cells, acts via the activation of the lysosomal-mitochondrial death pathway and autophagy-like cell death",[Ref.18494941]2.5% hemolytic activity at 200 μg/ml against sheep erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18494941,Cell Mol Med. 2008 Jun;12(3):1005-1022.,"Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB, Booy EP, Naderi-Manesh H, Los M.","Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway.",25,24-27
DRAMP01984,FLPLIASVAANLAPKIICKITKTC,24,"Brevinin-1HS2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Huia schmackeri (Chinese piebald odorous frog),Antimicrobial ,Not found,Not found,Not found,,"Function: Antimicrobial peptide homologs.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18423796,Peptides. 2008 Aug;29(8):1456-1460.,"Quan Z, Zhou M, Chen W, Chen T, Walker B, Shaw C.",Novel brevinins from Chinese piebald odorous frog (Huia schmackeri) skin deduced from cloned biosynthetic precursors.,24,21-24
DRAMP01988,FFGTALKIAANVLPTAICKILKKC,24,"Brevinin-1LTa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana latouchii (Chinese frog fauna),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Tissue specificity: Expressed by the skin glands.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrance,19022312,Peptides. 2009 Feb;30(2):273-282.,"Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.","The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).",24,21-24
DRAMP01989,FFGTALKIAANILPTAICKILKKC,24,"Brevinin-1LTb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana latouchii (Chinese frog fauna),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,"This peptide differs from Brevinin-1LTa by only one residue (I vs. V). This conservative change allows to predict that this peptide has all the activities of Brevinin-1LTa.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrance,19022312,Peptides. 2009 Feb;30(2):273-282.,"Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.","The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).",24,21-24
DRAMP01991,FFGSVLKVAAKVLPAALCQIFKKC,24,"Brevinin-1LT2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Hylarana latouchii (Chinese broad-folded frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19340924,Biochimie. 2009 Apr;91(4):540-547.,"Wang H, Yan X, Yu H, Hu Y, Yu Z, Zheng H, Chen Z, Zhang Z, Liu J.","Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).",24,21-24
DRAMP01992,FLPLVRVAAKLIPSVVCAISKRC,23,"Brevinin-1CPa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates capito (North American frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Function: Antimicrobial peptides.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19635516,Peptides. 2009 Oct;30(10):1775-1781.,"Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).,23,21-24
DRAMP01993,FLPVLARLAVKFLPSIVCAATKKC,24,"Brevinin-1Wa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Lithobates capito (the New World frog),Antimicrobial ,Not found,Not found,Not found,,Function: Antimicrobial peptides.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19635516,Peptides. 2009 Oct;30(10):1775-1781. ,"Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).,24,21-24
DRAMP18289,KRKKHRCRVYNNGMPTGMYRWC,22,Bactofencin A (Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Not found,Lactobacillus salivarius DPC6502,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,24169573,MBio. 2013 Oct 29;4(6):e00498-13. ,"O'Shea EF, O'Connor PM, O'Sullivan O, Cotter PD, Ross RP, Hill C.","Bactofencin A, a new type of cationic bacteriocin with unusual immunity.",22,21-24
DRAMP02002,FLPALIGIAAKALPSLLCKITKKC,24,"Brevinin-1P (Frogs, amphibians, animals)",Q2UXW0,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana fukienensis (Fukien gold-striped pond frog) (Rana plancyi fukienensis),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Antimicrobial peptide.(By similarity). It shows hemolytic activity against host erythrocytes.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16139929,Peptides. 2006 Jan;27(1):42-48. ,"Chen T, Li L, Zhou M, Rao P, Walker B, Shaw C.",Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: identification of novel brevinins from three species of Chinese frogs.,24,21-24
DRAMP02003,FFPAILRVAAKVGPAVLCAITKKC,24,"Brevinin-1S (Frogs, amphibians, animals)",Q2UXV9,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana schmackeri (Schmacker's frog) (Huia schmackeri),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Antimicrobial peptide.(By similarity)
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 18-24.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16139929,Peptides. 2006 Jan;27(1):42-48. ,"Chen T, Li L, Zhou M, Rao P, Walker B, Shaw C.",Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: identification of novel brevinins from three species of Chinese frogs.,24,21-24
DRAMP18283,KTKQQFLIKAQTQLFKVFGYTL,22,Plantaricin ZJ5 (Bacteriocin),T1WIT7,Belongs to the class IId bacteriocin,Not found,Lactobacillus plantarum ZJ5,"Antimicrobial, Antibacterial",,Not found,Not found,,Comment: 37% similar to Warnericin RK.The peptide activity was lost by treatment with pepsin and proteinase K (62%) but not affected by lipase or alpha-amylase. ,broad-spectrum,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,25147943,PLoS One. 2014 Aug 22;9(8):e105549. ,"Song DF, Zhu MY, Gu Q.","Purification and characterization of Plantaricin ZJ5, a new bacteriocin produced by Lactobacillus plantarum ZJ5.",22,21-24
DRAMP02012,VNPIILGVLPKFVCLITKKC,20,"Brevinin-1T (Brevinin-2T; Frogs, amphibians, animals)",P82232,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana temporaria (European common frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antibacterial activity against representative Gram-negative and Gram-positive bacteria: and exhibits a very high hemolytic activity.,[Swiss_Prot Entry P82232]Antibacterial activity against representative Gram-negative and Gram-positive bacteria,[Ref.10333736]Not found,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,10333736,Biopolymers. 1998;47(6):435-450.,"Simmaco M, Mignogna G, Barra D.",Antimicrobial peptides from amphibian skin: what do they tell us?,20,18-21
DRAMP02013,FITLLLRKFICSITKKC,17,"Brevinin-1Ta (Frogs, amphibians, animals)",P82233,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana temporaria (European common frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antibacterial activity against representative Gram-negative and Gram-positive bacteria: and exhibits no hemolytic activity.,[Swiss_Prot Entry P82233]Antibacterial activity against representative Gram-negative and Gram-positive bacteria,[Ref.10333736]Non-hemolytic,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,10333736,Biopolymers. 1998;47(6):435-450.,"Simmaco M, Mignogna G, Barra D.",Antimicrobial peptides from amphibian skin: what do they tell us?,17,15-18
DRAMP02016,FLSLALAALPKFLCLVFKKC,20,"Brevinin-1DYa (Frogs, amphibians, animals)",P0C5W6,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antimicrobial peptide. Has hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: contains one disulfide bond 14-20.,[Swiss_Prot Entry P0C5W6]Gram-positive bacterium: Staphylococcus aureus (low activity);##Gram-negative bacterium: Escherichia coli (MIC<15 µM).,[Ref.17688900]LC50<5 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17688900,Toxicon. 2007 Nov;50(6):746-756.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",20,18-21
DRAMP02018,FLSLALAALPKLFCLIFKKC,20,"Brevinin-1DYb (Brevinin-1CDYb; Frogs, amphibians, animals)",P0C5W7,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has low activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E. coli. Has hemolytic activity. Has a strong hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20.",[Swiss_Prot Entry P0C5W7]Gram-positive bacterium: Staphylococcus aureus (low activity);##Gram-negative bacterium: Escherichia coli (MIC<15 µM).,[Ref.17688900]LC50<6 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19539775##17688900,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.##Toxicon. 2007 Nov;50(6):746-756. ,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.##Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.##Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",20,18-21
DRAMP02020,FLPLLLAGLPKLLCLFFKKC,20,"Brevinin-1DYc (Frogs, amphibians, animals)",P0C5W8,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antimicrobial peptide. Has low activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E.coli (MIC<15 µM). Has hemolytic activity. 
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20.",[Swiss_Prot Entry P0C5W8]Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli (MIC<15 µM).,[Ref.17688900]LC50<7 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17688900,Toxicon. 2007 Nov;50(6):746-756.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",20,18-21
DRAMP02029,FLPLLLAGLPKLLCFLFKKC,20,"Brevinin-1CDYd (Frogs, amphibians, animals)",B3VZU1,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Antibacterial activity againist Gram-negative bacteria and Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. ,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",20,18-21
DRAMP02079,FLPLLAASFACTVTKKC,17,"Brevinin-1AVa (Frogs, amphibians, animals)",P86159,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana arvalis (Moor frog),Antimicrobial,Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18280749##19308951,J Am Soc Mass Spectrom. 2008 Apr;19(4):479-487.##Rapid Commun Mass Spectrom. 2009 May;23(9):1241-1248.,"Samgina TY, Artemenko KA, Gorshkov VA, Poljakov NB, Lebedev AT.##Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",Oxidation versus carboxamidomethylation of S-S bond in ranid frog peptides: pro and contra for de novo MALDI-MS sequencing.##Mass spectrometric study of peptides secreted by the skin glands of the brown frog Rana arvalis from the Moscow region.,17,15-18
DRAMP02080,FVPLLVSKLVCVVTKKC,17,"Brevinin-1AVb (Frogs, amphibians, animals)",P86160,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana arvalis (Moor frog),Antimicrobial,Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18280749##19308951,J Am Soc Mass Spectrom. 2008 Apr;19(4):479-487.##Rapid Commun Mass Spectrom. 2009 May;23(9):1241-1248.,"Samgina TY, Artemenko KA, Gorshkov VA, Poljakov NB, Lebedev AT.##Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",Oxidation versus carboxamidomethylation of S-S bond in ranid frog peptides: pro and contra for de novo MALDI-MS sequencing.##Mass spectrometric study of peptides secreted by the skin glands of the brown frog Rana arvalis from the Moscow region.,17,15-18
DRAMP18279,AYSLQMGATAIKQVKKLFKKWGW,23,Plantaricin A(Bacteriocin),P80214,Belongs to the class IIb bacteriocin,plnA,Lactobacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1),"Antimicrobial, Antibacterial, Anti-Gram+",,Alpha helix ,"Active plantaricin A is composed of an alpha chain and a beta chain. The sequence of alpha chain and beta chain, however, are essential identical with the only difference being one additional Ala at the N-terminus of chain b. The 3D structure of chain a in DPC micelles has been determined by NMR spectroscopy (J Biol Chem. 2005 Jun 17;280(24):22945-50). The helical region (residues 12-21) are good for membrane targeting as well as the ph",1YTR resolved by NMR,Active plantaricin A is composed of an alpha chain and a beta chain.,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8245827,J Gen Microbiol. 1993 Sep;139(9):1973-8.,"Nissen-Meyer J, Larsen AG, Sletten K, Daeschel M, Nes IF.","Purification and characterization of plantaricin A, a Lactobacillus plantarum bacteriocin whose activity depends on the action of two peptides.",23,21-24
DRAMP02087,FLPVLAGLTPSIVPKLVCLLTKKC,24,"Brevinin-1PRb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana pretiosa (North oregon spotted frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,The MIC of Ranatuerin-2PRe is >50 µM.,No MICs found in DRAMP database,[Ref.21295070] LC50=80μM against human erythrocytes.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,21295070,Dev Comp Immunol. 2011 Jun;35(6):644-649. ,"Conlon JM, Mechkarska M, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, Hayes MP, Padgett-Flohr G.",Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,24,21-24
DRAMP02088,FFPMLAGVAARVVPKVICLITKKC,24,"Brevinin-1PRc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana pretiosa (North oregon spotted frog),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,21295070,Dev Comp Immunol. 2011 Jun;35(6):644-649. ,"Conlon JM, Mechkarska M, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, Hayes MP, Padgett-Flohr G.",Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,24,21-24
DRAMP02089,FLPMLAGLAASMVPKLVCLITKKC,24,"Brevinin-1La (Brevinin-1PRd; Frogs, amphibians, animals)",P82825,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana luteiventris (Spotted frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Brevinin-1PRd isolated from the Oregon spotted frog shares the same sequence with this entry.,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP01124,ILGPVLSMVGSALGGLIKKI,20,"Maximin-H2 (Toads, amphibians, animals)",P83082,Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi.Shows strong hemolytic activity. ","[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=20 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=2 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=4 μg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=2 μg/ml).",[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP01123,ILGPVISTIGGVLGGLLKNL,20,"Maximin-H1 (Toads, amphibians, animals)","P83080, P83081, Q58T74, Q58T41",Belongs to the bombinin family,Not found,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity. ","[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=9 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=4.5 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=9 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=4.5 μg/ml).",[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,20,18-21
DRAMP02100,FLPIIASVAAKVFPKIFCAISKKC,24,"Brevinin-1Pe (Frogs, amphibians, animals)",P82845,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02103,FLGSLLGLVGKIVPTLICKISKKC,24,"Brevinin-1RTc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Amolops ricketti (Chinese sucker frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,"Function: Brevinin-2RTc has antibacterial activity.
PTM: Contains one disulfide bond 27-33.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,[Ref.22100518]Not found,22100518,Peptides. 2012 Jan;33(1):27-34.,"Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.",Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,24,21-24
DRAMP18354,ITSFSLCTPGCAKTGSFNSYCC,22,Hyicin 3682 (bacteriocin),No entry found,Belongs to the lantibiotic family.,Not found,Staphylococcus hyicus 3682,"Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,28285660,Microbiol Res. 2017 May;198:36-46.,"Carlin Fagundes P, Nascimento de Sousa Santos I, Silva Francisco M, Mattos Albano R, de Freire Bastos MD.","Genetic and biochemical characterization of hyicin 3682, the first bacteriocin reported for Staphylococcus hyicus.",22,21-24
DRAMP02123,FIGAILPAIAGLVHGLINR,19,"Hylin-b1 (Hy-b1; Frogs, amphibians, animals)",P84002,Not found,Not found,Hyla biobeba (Brazilian tree frog),Antimicrobial,Protein level,Not found,Not found,,"Function: Has hemolytic activity against human erythrocytes. May have antimicrobial activity.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,[Ref.15638808]Show hemolytic activity against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15638808,Protein Pept Lett. 2005 Jan;12(1):89-93.,"Castro MS, Matsushita RH, Sebben A, Sousa MV, Fontes W.",Hylins: bombinins H structurally related peptides from the skin secretion of the Brazilian tree-frog Hyla biobeba.,19,18-21
DRAMP02124,FIGAILPAIAGLVGGLINR,19,"Hylin-b2 (Hy-b2; Frogs, amphibians, animals)",P84003,Not found,Not found,Hyla biobeba (Brazilian tree frog),Antimicrobial,Protein level,Not found,Not found,,"Function: Has hemolytic activity against human erythrocytes. May have antimicrobial activity.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,[Ref.15638808]Show hemolytic activity against human red blood cells ,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15638808,Protein Pept Lett. 2005 Jan;12(1):89-93.,"Castro MS, Matsushita RH, Sebben A, Sousa MV, Fontes W.",Hylins: bombinins H structurally related peptides from the skin secretion of the Brazilian tree-frog Hyla biobeba.,19,18-21
DRAMP02132,GLASTLGSFLGKFAKGGAQAFLQPK,25,"Antimicrobial peptide 3 (XT-3; Levitide-like peptide; Frogs, amphibians, animals)",P84383,Belongs to the gastrin/cholecystokinin family (Magainin subfamily),Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity against Gram-positive bacterium S.aureus and Gram-negative bacterium E.coli, when in combination with XT1 and XT6.",Gram-positive bacteria: Staphylococcus aureus;##Gram-negative bacteria: E.coli (Combination with XT1 and XT6).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",25,24-27
DRAMP02134,GMATKAGTALGKVAKAVIGAAL,22,"Antimicrobial peptide 5 (XT-5; PGLa-like peptide; Frogs, amphibians, animals)",P84385,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus, Gram-negative bacterium E.coli and yeast C. albicans. Has strong hemolytic activity against human red blood cells.
Tissue specificity: Skin.",[Ref.11738090]Gram-positive bacteria: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacteria: Escherichia coli (MIC>100 µM);##Fungi: Candida albicans (MIC>100 µM),[Ref.11738090]HC50>150 μM against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",22,21-24
DRAMP02137,GLLKPLLKIAAKVGSNLL,18,"[G4K]XT-7 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22374306,Peptides. 2012 Apr;34(2):275-282.,"Popovic S, Urbán E, Lukic M, Conlon JM.",Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.,18,15-18
DRAMP02138,GWGDTFGKVLKNFAKVAGVKAAK,23,"XTG1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22188679,FEBS J. 2012 Mar;279(5):724-736.,"Tessera V, Guida F, Juretić D, Tossi A.",Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,23,21-24
DRAMP02139,GWGDTFLKTMAKIAKVGPKLLHS,23,"XTG2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22188679,FEBS J. 2012 Mar;279(5):724-736.,"Tessera V, Guida F, Juretić D, Tossi A.",Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,23,21-24
DRAMP02140,GFWSSALEGLKKFAKGGLEALTNPK,25,"XPF-SP1 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21498136,Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.,"Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.",Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,25,24-27
DRAMP02141,GLASTIGSLLGKFAKGGAQAFLQPK,25,"XPF-SP2 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21498136,Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.,"Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.",Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,25,24-27
DRAMP02159,FVGAALKVLANVLPPVISWIKQ,22,"Melittin-related peptide (Frogs, amphibians, animals)",P86158,Not found,Not found,Rana arvalis (Moor frog),Unknown,Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19308951,Rapid Commun Mass Spectrom. 2009 May;23(9):1241-1248. ,"Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",Mass spectrometric study of peptides secreted by the skin glands of the brown frog Rana arvalis from the Moscow region.,22,21-24
DRAMP02166,SNTALRRYNQWATGHFM,17,"Ranatensin-R (Frogs, amphibians, animals)",P08952,Belongs to the bombesin/neuromedin-B/ranatensin family,Not found,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),Unknown,Protein level,Not found,Not found,,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,445685,Chem Pharm Bull (Tokyo). 1979 Feb;27(2):492-498.,"Yasuhara T, Ishikawa O, Nakajima T.","The studies on the active peptide in the skin of Rana rugosa. II. The structure of ranatensin-R, the new ranatensin analogue, and granuliberin-R, the new mast cell degranulating peptide.",17,15-18
DRAMP02217,AAKLLLNPKFRCKAAFC,17,"Ranatuerin-2Ra (Frogs, amphibians, animals)",P86020,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Pelophylax ridibundus (Marsh frog) (Rana ridibunda),Antimicrobial ,Protein level,Not found,Not found,,"Function: Antimicrobial peptide (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 12-17.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18855342,Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.,"Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.,17,15-18
DRAMP02218,AVNIPFKVKFRCKAAFC,17,"Ranatuerin-2R (Frogs, amphibians, animals)",P86019,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Pelophylax ridibundus (Marsh frog) (Rana ridibunda),Antimicrobial ,Protein level,Not found,Not found,,"Function: Antimicrobial peptide (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 12-17.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18855342,Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.,"Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.,17,15-18
DRAMP02240,GMFSVLKNLGKVGLGFVACKINKQC,25,"Ranatuerin-1Gb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana grylio (North American pig frog),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10828493,Regul Pept. 2000 Jun 30;90(1-3):53-60.,"Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.",Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,25,24-27
DRAMP02086,FLPVLTGLTPSIVPKLVCLLTKKC,24,"Brevinin-1PRa (frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana pretiosa (North oregon spotted frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: activity against reference strains of Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella pneumoniae) and Gram-positive (Staphlococcus aureus) bacteria but displayed relatively low hemolytic activity. ",[Ref.15003829] Gram-negative bacterium: Escherichia coli(MIC>100μM);## Gram-positive bacterium: Staphylococcus aureus(MIC=13μM);## Yeast: Candida albicans(MIC=100μM).[Ref.21295070] Gram-negative bacterium: Escherichia coli(MIC>100μM);## Gram-positive bacterium: Staphylococcus aureus(MIC=50μM);## Yeast: Candida albicans(MIC=100μM).,[Ref.15003829] HC50=7μM against human erythrocytes.##[Ref.21295070] LC50= 150μM against human erythrocytes.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,15003829##21295070,Regul Pept. 2004 May 15;118(3):135-141.## Dev Comp Immunol. 2011 Jun;35(6):644-649. ,"Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, P","A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.## Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.",24,21-24
DRAMP02259,GIGKYLHSAKKFGKAWVGEIMNS,23,"Magainin 2 analogue (F5Y, F16W-MG2)",P11006,Belongs to the gastrin/cholecystokinin family (Magainin subfamily),Not found,Xenopus laevis (African clawed frog),Unknown,Protein level,Alpha helix (1 helices; 12 residues),"The peptide assumed α-helices in the lipid environment, as characterized by double minima around 208 and 222 nm. The [θ]222 value, a measure of helicity, of I (−17,900 deg cm2 dmol−1) was ca. 20% smaller than that of F16W-MG2 (−23,200 deg cm2 dmol−1).",1DUM resolved by NMR,"Membrane Permeabilization: The peptide-induced membrane permeabilization was examined on the basis of the efflux of the fluorescent dye calcein from egg PG LUVs. The mutant I (F5Y, F16W-MG2) showed a slightly weaker but comparable leakage activity compared with F16W-MG2.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11180056,Biopolymers. 2001 Apr 5;58(4):437-446.,"Hara T, Kodama H, Kondo M, Wakamatsu K, Takeda A, Tachi T, Matsuzaki K.",Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue.,23,21-24
DRAMP02260,GMASKAGTIAGKIAKTAIKLAL,22,PGLa-B1,No entry found,Not found,Not found,Xenopus borealis,Not found,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22036891,Gen Comp Endocrinol. 2012 May 1;176(3):513-518.,"Conlon JM, Mechkarska M, King JD.","Host-defense peptides in skin secretions of African clawed frogs (Xenopodinae, Pipidae).",22,21-24
DRAMP02261,GMASKAGSIVGKIAKIALGAL,21,PGLa-B2,No entry found,Not found,Not found,Xenopus borealis,Not found,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22036891,Gen Comp Endocrinol. 2012 May 1;176(3):513-518.,"Conlon JM, Mechkarska M, King JD.","Host-defense peptides in skin secretions of African clawed frogs (Xenopodinae, Pipidae).",21,18-21
DRAMP02263,GMASKAGSVLGKVAKVALKAAL,22,PGLa-AM1,No entry found,Not found,Not found,Xenopus amieti,Not found,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22326566,Int J Antimicrob Agents. 2012 Apr;39(4):317-320.,"Conlon JM, Sonnevend A, Pál T, Vila-Farrés X.",Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.,22,21-24
DRAMP02264,GIWKTIKSMGKVFAGKILQNL,21,[D4K]B2RP,No entry found,Not found,Not found,Lithobates septentrionalis,Not found,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22326566,Int J Antimicrob Agents. 2012 Apr;39(4):317-320.,"Conlon JM, Sonnevend A, Pál T, Vila-Farrés X.",Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.,21,18-21
DRAMP02270,GIGKFLHSAGKFGKAFVGEIMKS,23,"Magainin-1 (Magainin I; chain of Magainins; Frogs, amphibians, animals)",P11006,Belongs to the magainin family,magainins,Xenopus laevis (African clawed frog),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antimicrobial peptides that inhibit the growth of numerous species of bacteria and fungi and induce osmotic lysis of protozoa. Magainins are membrane lytic agents.
Tissue specificity: Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. It is stored as active, processed peptides in large granules within the granular gland secretions of the skin.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,3299384,Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449-5453.,Zasloff M.,"Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.",23,21-24
DRAMP02284,GLNTLKKVFQGLHEAIKLINNHVQ,24,"Pseudin-1 (Pseudin 1; Frogs, amphibians, animals)",P83188,Not found,Not found,Pseudis paradoxa (Paradoxical frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11689009,Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.,"Olson L 3rd, Soto AM, Knoop FC, Conlon JM.",Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,24,21-24
DRAMP02285,GLNALKKVFQGIHEAIKLINNHVQ,24,"Pseudin-2 (Pseudin 2; Frogs, amphibians, animals)",P83189,Not found,Not found,Pseudis paradoxa (Paradoxical frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus. Has low hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.",[Ref.11689009]Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##Yeast: Candida albicans,[Ref.11689009]50% hemolysis of human erythrocytes is >300 μM,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11689009,Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.,"Olson L 4rd, Soto AM, Knoop FC, Conlon JM.",Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,24,21-24
DRAMP02286,GINTLKKVIQGLHEVIKLVSNHE,23,"Pseudin-3 (Pseudin 3; Frogs, amphibians, animals)",P83190,Not found,Not found,Pseudis paradoxa (Paradoxical frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##yeast Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11689009,Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.,"Olson L 5rd, Soto AM, Knoop FC, Conlon JM.",Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,23,21-24
DRAMP02287,GINTLKKVIQGLHEVIKLVSNHA,23,"Pseudin-4 (Pseudin 4; Frogs, amphibians, animals)",P83191,Not found,Not found,Pseudis paradoxa (Paradoxical frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##yeast Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11689009,Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.,"Olson L 6rd, Soto AM, Knoop FC, Conlon JM.",Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,23,21-24
DRAMP02309,IIGHLIKTALGFLGL,15,"Signiferin-2.2 (Frogs, amphibians, animals)",P86132,Not found,Not found,Crinia signifera (Common eastern froglet),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity against a wide spectrum of Gram-positive bacteria. Lacks antibacterial activity against the Gram-negative bacteria E. cloacae and E. coli.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","Gram-negative bacteria: Enterobacter cloacae ATCC 13047 (MIC≤100 µM), Escherichia coli ATCC3 5218 (MIC≤100 µM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15317042##16470724##18601958,Rapid Commun Mass Spectrom. 2004;18(18):2155-2161.##Rapid Commun Mass Spectrom. 2006;20(5):797-803.##Regul Pept. 2008 Nov 29;151(1-3):80-87.,"Maselli VM, Brinkworth CS, Bowie JH, Tyler MJ.##Maselli VM, Bilusich D, Bowie JH, Tyler MJ.##Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.","Host-defence skin peptides of the Australian Common Froglet Crinia signifera: sequence determination using positive and negative ion electrospray mass spectra.##Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.##Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.",15,12-15
DRAMP02311,SGPVPSGCLRCICVVESGXRMPNPV,25,"Lysozyme (1,4-beta-N-acetylmuramidase; starfish, chordates, animals)",P37715,Belongs to the glycosyl hydrolase 22 family,Not found,Asterias rubens (Common European starfish) (Asterias vulgaris),Antimicrobial,Protein level,Not found,Not found,,Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1149747,Eur J Biochem. 1975 May;54(1):19-23.,"Jolles J, Jolles P.",The losozyme from Asterias rubens.,25,24-27
DRAMP02313,QIHLSLCGLCCNCCHNIGCGFCCKF,25,"Hepcidin-1 (fish, chordates, animals)",Q801Y3,Belongs to the hepcidin family,hamp1,Salmo salar (Atlantic salmon),Unknown,Homology,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12697315,Dev Comp Immunol. 2003 Jun-Jul;27(6-7):589-601.,"Douglas SE, Gallant JW, Liebscher RS, Dacanay A, Tsoi SC.",Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish.,25,24-27
DRAMP02323,LFGFLIPLLPHLIGAIPQVIGAIR,24,"Grammistin Pp4b (Group I grammistin; fish, chordates, animals)",P69838,Belongs to the grammistin family (Group 1 subfamily),Not found,Pogonoperca punctata (Clown grouper) (Bearded grouper),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"MOA: Thanks to its abundant amphiphilic alpha-helices, it may integrate into membrane phospholipids, leading to lysis of the membrane. Has also ichthyotoxic activity.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Phospholipids,PubMed ID is not available,Fish. Sci. 2001 Feb;67:163-169.,"Shiomi K, Yokota H, Nagashima Y, Ishida M.","Primary and secondary structures of grammistins, peptide toxins isolated from the skin secretion of the soapfish Pogonoperca punctata.",24,21-24
DRAMP02325,FFHHIFRGIVHVGKTIHKLVTGG,23,"Moronecidin 1 (fish, chordates, animals)",No entry found,Belongs to the pleurocidin family,Not found,Morone chrysops (white bass),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,"Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11739390,J Biol Chem. 2002 Feb 15;277(7):5030-5039.,"Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.","Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.",23,21-24
DRAMP02326,FFHHIFRGIVHVGKTIHRLVTGG,23,"Moronecidin 2 (fish, chordates, animals)",No entry found,Belongs to the pleurocidin family,Not found,Morone chrysops (white bass),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,"Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11739390,J Biol Chem. 2002 Feb 15;277(7):5030-5039.,"Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.","Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.",23,21-24
DRAMP02327,FFHHIFRGIVHVGRTIHKLVTGG,23,"Moronecidin 3 (fish, chordates, animals)",No entry found,Belongs to the pleurocidin family,Not found,Morone chrysops (white bass),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,"Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11739390,J Biol Chem. 2002 Feb 15;277(7):5030-5039.,"Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.","Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.",23,21-24
DRAMP02328,FFHHIFRGIVHVGRTIHRLVTGG,23,"Moronecidin 4 (fish, chordates, animals)",No entry found,Belongs to the pleurocidin family,Not found,Morone chrysops (white bass),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,"Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11739390,J Biol Chem. 2002 Feb 15;277(7):5030-5039.,"Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.","Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.",23,21-24
DRAMP02329,IFHHIFKGIVHVGKTIHRLVTG,22,"Moronecidin 5 (fish, chordates, animals)",No entry found,Belongs to the pleurocidin family,Not found,Morone chrysops (white bass),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,"Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11739390,J Biol Chem. 2002 Feb 15;277(7):5030-5039.,"Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.","Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.",22,21-24
DRAMP02332,FIHHIFRGIVHAGRSIGRFLTG,22,"Piscidin-3 (Pis-3; fish, chordates, animals)",P0C006,Belongs to the pleurocidin family,Not found,Morone chrysops x Morone saxatilis (white bass x striped sea-bass),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral",Protein level,Not found,Not found,,"Function: Exhibits broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. Has hemolytic activity.
Tissue specificity: Mast cells in gill, skin and gut, and in lining blood vessels in the viscera.",[Swiss_Prot Entry P0C006]broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria,[Ref.11713517]5% hemolytic activity at 100 μg/mL against human erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11713517,Nature. 2001 Nov 15;414(6861):268-269.,"Silphaduang U, Noga EJ.",Peptide antibiotics in mast cells of fish.,22,21-24
DRAMP02334,XSHLSLCRWCCNCCHNKGXGFCCKF,25,"Hepcidin (fish, chordates, animals)",Q9DFD6,Belongs to the hepcidin family,hamp,Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri),Antimicrobial,Homology,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11164886,Dev Comp Immunol. 2001 Apr;25(3):205-217.,"Bayne CJ, Gerwick L, Fujiki K, Nakao M, Yano T.","Immune-relevant (including acute phase) genes identified in the livers of rainbow trout, Oncorhynchus mykiss, by means of suppression subtractive hybridization.",25,24-27
DRAMP02335,SKGKKANKDVELARG,15,"Oncorhyncin I (Oncorhyncin 1; fish, chordates, animals)",P83287,Not found,Not found,Oncorhynchus mykiss (Rainbow trout),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,Planococcus citreus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10938737,Fish Shellfish Immunol. 2000 Apr;10(3):243-260.,"Smith VJ, Fernandes JM, Jones SJ, Kemp GD, Tatner MF.","Antibacterial proteins in rainbow trout, Oncorhynchus mykiss.",15,12-15
DRAMP02340,XXSVPAFGHYLPAXP,15,"Salmocidin-1 (fish, chordates, animals)",P81369,Not found,Not found,Oncorhynchus mykiss (Rainbow trout),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (MAY-1998) to UniProtKB.,"Henry M.A, Siegert K.J, Davidson I, Dunbar B, Mordue W, Secombes C.J.","Isolation and N-terminal sequencing of an antibacterial peptide in rainbow trout, Oncorhynchus mykiss.",15,12-15
DRAMP02343,XXPQQLGHVKAAXSDY,16,"Salmocidin-3 (fish, chordates, animals)",P82240,Not found,Not found,Oncorhynchus mykiss (Rainbow trout),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (DEC-1999) to UniProtKB.,"Henry M.A, Secombes C.J.","Purification and partial characterization of antibacterial peptides from rainbow trout, Oncorhynchus mykiss.",16,15-18
DRAMP02353,RSTEDIIKSISGGGFLNAMNA,21,"Pleurocidin-like peptide WFX (fish, chordates, animals; Predicted)",Q7T053,Not found,ple6,Pseudopleuronectes americanus (Winter flounder) (Pleuronectes americanus),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Predicted,Not found,Not found,,Function: Has antibacterial and antifungal activity.,"Gram-negative bacteria: Aeromonas salmonicida A449 field isolate (MIC>64 µg/ml), A. salmonicida 97-4 field isolate (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC>64 µg/ml), Escherichia coli (MIC>64 µg/ml), Salmonella typhimurium 14028s (MIC>64 µg/ml), S. typhimurium MS7953s (MIC>64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (human clinical isolates) (MIC>64 µg/ml), Staphylococcus aureus (MRSA) (MIC>64 µg/ml).##Fungi: Candida albica (MIC>64 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12950255,Eur J Biochem. 2003 Sep;270(18):3720-3730.,"Douglas SE, Patrzykat A, Pytyck J, Gallant JW.","Identification, structure and differential expression of novel pleurocidins clustered on the genome of the winter flounder, Pseudopleuronectes americanus (Walbaum).",21,18-21
DRAMP18267,GLEESPGHPGQPGPPGPPGAPGP,23,BacFL31(Bacteriocin),No entry found,Belongs to the class I bacteriocin,Not found,Enterococcus faecium FL31,"Antimicrobial, Antibacterial, Anti-Gram+, Antilisterial",,Pro-rich,"It is usual that even in the N-terminal 23 residues sequenced, six prolines at positions 6,9,12,15,18, and 21 are hydroxylated.  ",,"To our knowledge, BacFL31 is the first bacteriocin described as encompassing hydroxyproline residues. BacFL31 exerted bactericidal effect against L. monocytogenes and proved useful for the inhibition of the growth of L. monocytogenes in minced beef meat during storage at 4  Celsius degree. ",Gram-positive(certain),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,24583094,Anaerobe. 2014 Jun;27:1-6.,"Chakchouk-Mtibaa A, Elleuch L, Smaoui S, Najah S, Sellem I, Abdelkafi S, Mellouli L.",An antilisterial bacteriocin BacFL31 produced by Enterococcus faecium FL31 with a novel structure containing hydroxyproline residues.,23,21-24
DRAMP02356,FLGLIFHGLVHAGKLIHGLIHRNRG,25,"HKPLP (pleurocidin-like peptide; glycine-rich; fish, chordates, animals)",No entry found,Not found,Not found,Hippocampus kuda Bleeker (Sea horse),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22252202,J Antibiot (Tokyo). 2012 Mar;65(3):117-121.,"Sun D, Wu S, Jing C, Zhang N, Liang D, Xu A.","Identification, synthesis and characterization of a novel antimicrobial peptide HKPLP derived from Hippocampus kuda Bleeker.",25,24-27
DRAMP02372,QSHLSLCRFCCKCCRNKGCGYCCKF,25,"Hepcidin-1 (zebrafish, chordates, animals)",P61516,Belongs to the hepcidin family,hamp1,Danio rerio (Zebrafish) (Brachydanio rerio),Antimicrobial ,Homology,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15043943,Dev Comp Immunol. 2004 Jun;28(7-8):747-754.,"Shike H, Shimizu C, Lauth X, Burns JC.","Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates.",25,24-27
DRAMP02375,RQRVEELSKFSKKGAAARRRK,21,"Misgurin (weatherfish, chordates, animals)",P81474,Not found,Not found,Misgurnus anguillicaudatus (Oriental weatherfish) (Oriental weatherloach),"Antimicrobial, Antibacterial, Antifungal",Protein level,Alpha helix ,Not found,,Comment: No comments found on DRAMP database,"B.subtilus, Staphylococcus aureus, Streptococcus mutans, Streptococcus pneumoniae, Pseudomonas putida, Escherichia coli, Salmonella typhimurium, Serratia spps, Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisae.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9271200,FEBS Lett. 1997 Jul 14;411(2-3):173-178.,"Park CB, Lee JH, Park IY, Kim MS, Kim SC.","A novel antimicrobial peptide from the loach, Misgurnus anguillicaudatus.",21,18-21
DRAMP02384,SPAGCRFCCGCCPNMRGCGVCCRF,24,"Hepcidin AS-hepc2 (fish, chordates, animals)",Q68M56,Not found,Not found,Acanthopagrus schlegelii (Black porgy),Not found,Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21073978,Comp Biochem Physiol B Biochem Mol Biol. 2011 Feb;158(2):155-163.,"Yang M, Chen B, Cai JJ, Peng H, Ling-Cai, Yuan JJ, Wang KJ.",Molecular characterization of hepcidin AS-hepc2 and AS-hepc6 in black porgy (Acanthopagrus schlegelii): expression pattern responded to bacterial challenge and in vitro antimicrobial activity.,24,21-24
DRAMP02385,CRFCCRCCPRMRGCGLCCRF,20,"Hepcidin AS-hepc6 (fish, chordates, animals)",Q68M52,Not found,Not found,Acanthopagrus schlegelii (Black porgy),"Antimicrobial, Antibacterial",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,"Pdp11 (IC50=2.20 µM), 51M6 (IC50=14.61 µM), Bacillus subtilis CECT 35 (IC50=11.41 µM), Escherichia coli DH5Î± (IC50=18.66 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18164062,Mol Immunol. 2008 Apr;45(8):2333-2342.,"Cuesta A, Meseguer J, Esteban MA.",The antimicrobial peptide hepcidin exerts an important role in the innate immunity against bacteria in the bony fish giltherad seabream.,20,18-21
DRAMP02387,PDPAKTAPKKKSKKAVT,17,"Histone HIIb-3 (Antibacterial histone-like protein 3, HLP-3; catfishes, chordates, animals)",P81904,Belongs to the histone H2B family,Not found,Ictalurus punctatus (Channel catfish),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.","Aeromonas hydrophila, Saprolegnia spp.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9645227,Cell Mol Life Sci. 1998 May;54(5):467-475.,"Robinette D, Wada S, Arroll T, Levy MG, Miller WL, Noga EJ.",Antimicrobial activity in the skin of the channel catfish Ictalurus punctatus: characterization of broad-spectrum histone-like antimicrobial proteins.,17,15-18
DRAMP02388,PDPAKTAPKKGSKKAVTKXA,20,"Histone HIIb-1 (Antibacterial histone-like protein 1, HLP-1; catfishes, chordates, animals)",P81903,Belongs to the histone H2B family,Not found,Ictalurus punctatus (Channel catfish),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. ","Aeromonas hydrophila, vibrio alginolyticus, Escherichia coli D31, Saprolegnia spp.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9645227,Cell Mol Life Sci. 1998 May;54(5):467-475.,"Robinette D, Wada S, Arroll T, Levy MG, Miller WL, Noga EJ.",Antimicrobial activity in the skin of the channel catfish Ictalurus punctatus: characterization of broad-spectrum histone-like antimicrobial proteins.,20,18-21
DRAMP02389,FKVQNQHGQVVKIFHH,16,"Astacidin 1 (crayfish, Arthropods, animals)",No entry found,Not found,Not found,Not found,Not found,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17049601,Dev Comp Immunol. 2007;31(5):441-455. ,"Jiravanichpaisal P, Lee SY, Kim YA, Andrén T, Söderhäll I.",Antibacterial peptides in hemocytes and hematopoietic tissue from freshwater crayfish Pacifastacus leniusculus: characterization and expression pattern.,16,15-18
DRAMP02398,GPVGLLSSPGSLPPVGGAP,19,Antimicrobial peptide GP-19 (GP-19),B3A0L2,Not found,Not found,Xenorhabdus budapestensis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: GP-19 displays broad-spectrum antimicrobial activity against the tested bacteria and fungi.,"Gram-positive bacteria: Bacillus subtilis (IZ=19.04±0.2 mm), Bacillus megaterium (IZ=7.3±0.28 mm), Prototheca wickerhamii (IZ=10.3±0.33 mm);##Gram-negative bacteria: Xanthomonas campestris pv. vesicatoria (IZ=16.47±0.35 mm), Pseudomonas solanacearum (IZ=10.75±0.41 mm).##fungi: Phytophthora capsici (CD=16.62±1.07 mm), Verticillium dahlia (EC50=17.54 µg/ml), Fusarium graminearum (CD=12.04±0.87 mm), Fusarium omysporum (CD=21.64±0.4 mm).##NOTE: IZ = Inhibition Zone and CD = Colony diameter.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22497806,Peptides. 2012 Jun;35(2):253-260.,"Xiao Y, Meng F, Qiu D, Yang X.",Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.,19,18-21
DRAMP02399,EGPVGLADPDGPASAPLGAP,20,Antimicrobial peptide EP-20 (EP-20),B3A0L3,Not found,Not found,Xenorhabdus budapestensis,"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Function: EP-20 showes high inhibition against P. capsici but lower antibacterial activity.,"Fungi: Phytophthora capsici (EC50=3.14 µg/ml), Verticillium dahlia (CD=19.32±1.31 mm), Fusarium graminearum (CD=12.45±1.6 mm), Fusarium oxysporum (CD=21.29±1.1 mm).##NOTE: CD = Colony diameter.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22497806,Peptides. 2012 Jun;35(2):253-260.,"Xiao Y, Meng F, Qiu D, Yang X.",Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.,20,18-21
DRAMP02400,GCPQTPRCTNYAEKGQCPPN,20,Antimicrobial peptide AJN-10 (AJN-10),P0DJ30,Not found,Not found,Anguilla japonica (Japanese eel),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,Function: Displays antimicrobial activity against the Gram-negative bacterium A.hydrophila.,Gram-negative bacterium: Aeromonas hydrophila.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21796440,Protein J. 2011 Aug;30(6):413-421.,"Liang Y, Guan R, Huang W, Xu T.","Isolation and identification of a novel inducible antibacterial peptide from the skin mucus of Japanese eel, Anguilla japonica.",20,18-21
DRAMP02404,CPAIQRCCQQLRNIQPPCRCCQ,22,Chitin-binding protein 3 (Mo-CBP3),P86528,Not found,Not found,Moringa oleifera (Horseradish tree) (Moringa pterygosperma),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Chitin binding protein. Has antifungal activity against F. solani. Not toxic to mice. Acts as a flocculent.
PTM: Glycosylated; contains 2.5% carbohydrates.
Miscellaneous: On the 2D-gel the determined pI of this protein is: 10.8, its MW is: 14.34 kDa.",Fungi: Fusarium solani.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Chitin-binding,PubMed ID is not available,"Thesis (2010), Federal University of Ceara, Brazil",Gifoni J.M.,Isolation and biochemical characterization of a new thermostable antifungal chitin-binding protein from Moringa oleifera seeds.,22,21-24
DRAMP02405,QSERFEQQMQGQDFSHDERFLSQAA,25,Antifungal protein 1 (Pf-AFP1; Plants),P84884,Belongs to the 2S seed storage albumins family,Not found,Passiflora edulis (Passion fruit),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Function: Has strong antifungal activity against T. harzianum, F. oxysporum and A. fumigatus. Lacks antifungal activity against R. solani, P. brasiliensis and C. albicans.
Tissue specificity: Expressed in seed (at protein level). Not detected in pulp, stems and leaves.
Developmental stage: Expressed in dormant seed.","Fungi: Trichoderma harzianum (IC50=32 µg/ml), Fusarium oxysporum (IC50=34 µg/ml), Aspergillus fumigatus (IC50=40 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16766236,Biochim Biophys Acta. 2006 Jun;1764(6):1141-6.,"Pelegrini PB, Noronha EF, Muniz MA, Vasconcelos IM, Chiarello MD, Oliveira JT, Franco OL.",An antifungal peptide from passion fruit (Passiflora edulis) seeds with similarities to 2S albumin proteins.,25,24-27
DRAMP02407,PAQPFRIKKRQGPFERP,17,Napin-like polypeptide (Contains: Napin-like polypeptide small chain and large chain),P84782,Belongs to the 2S seed storage albumins family,Not found,Brassica oleracea var. alboglabra (Chinese kale) (Brassicaalboglabra),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Inhibits cell-free protein synthesis. Inhibits trypsin and chymotrypsin. Does not inhibit ribonuclease of protease activity. Has antibacterial activity except Gram-positive bacterium S. aureus or the Gram-negative bacteria E. coli, E. aerogenes, P. aeruginosa and P. vulgaris. Inhibits the proliferation of leukemia cells in vitro.
Subunit structure: The mature protein consists of a small and a large chain linked by disulfide bonds (sequence shown is small chain).
Biophysicochemical properties: This activity is preserved between pH 5 and pH 11, and between 10 and 40 degrees C. It falls to a low level at pH 3 and pH 13 and at 70 degrees C.","Gram-negative bacterium: Pseudomonas fluorescens (IC50=89±6.1 µM);##Gram-positive bacteria: Bacillus subtilis (IC50=278±12.9 µM), B. cereus (IC50=145±83 µM), Bacillus megaterium (IC50=156±8.4 µM), Megabacterium phlei (IC50=104±27 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15485558,J Pept Res. 2004 Nov;64(5):202-208.,"A napin-like polypeptide with translation-inhibitory, trypsin-inhibitory, antiproliferative and antibacterial activities from kale seeds.","A napin-like polypeptide with translation-inhibitory, trypsin-inhibitory, antiproliferative and antibacterial activities from kale seeds.",17,15-18
DRAMP02436,EQPGGDKVNLGYFTN,15,Chitinase,P84754,Belongs to the glycosyl hydrolase 18 family Chitinase (class,Not found,Streptomyces violaceus (Streptomyces venezuelae),"Antimicrobial, Antifungal",Protein level,Not found,Not found,,"Function: Has antifungal activity.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Enzyme regulation: Inhibited by divalent metal ions. Maximum inhibition observed with Ca2+ while the least inhibition was observed with Fe2+. Inhibited by high concentrations of GlcNAc.
Biophysicochemical properties: pH dependence (Optimum pH is 6-8. There is a 37.7% decrease in activity at pH 5 and a 39.8% decrease in activity at pH 9); Temperature dependence (Optimum temperature is 35 degrees Celsius).","Fungi: Aspergillus niger, Alternaria alternata, Hordeum sativum.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Chitin-binding,PubMed ID is not available##16972135,"Thesis (2005), Visva Bharati (Central University), India.##Curr Microbiol. 2006 Oct;53(4):265-269.","Mukherjee G.##Mukherjee G, Sen SK.","Extracellular production of chitinase by Streptomyces venezuelae.##Purification, characterization, and antifungal activity of chitinase from Streptomyces venezuelae P(10).",15,12-15
DRAMP02450,KIFTKCELARKLRAEGMDGF,20,"Lysozyme C (1,4-beta-N-acetylmuramidase C)",P37155,Belongs to the glycosyl hydrolase 22 family,LYZ,Felis catus (Cat) (Felis silvestris catus),Antimicrobial,Protein level,Not found,Not found,,"Function: Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents By similarity.
Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.
Miscellaneous: Lysozyme C is capable of both hydrolysis and transglycosylation; it shows also a slight esterase activity. It acts rapidly on both peptide-substituted and unsubstituted peptidoglycan, and slowly on chitin oligosaccharides By similarity.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2344734,Comp Biochem Physiol B. 1990;95(4):773-779.,"Halliday JA, Bell K, McKenzie HA, Shaw DC.","Feline whey proteins: identification, isolation and initial characterization of alpha-lactalbumin, beta-lactoglobulin and lysozyme.",20,18-21
DRAMP02452,KYFATRCDLVRELRKXGF,18,Lysozyme,P82175,Belongs to the glycosyl hydrolase 22 family,Not found,Estigmene acrea (Salt marsh moth),Antimicrobial,Protein level,Not found,Not found,,Function: Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte- macrophage system and enhance the activity of immunoagents (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9303271,Dev Comp Immunol. 1997 Jul-Aug;21(4):323-336.,"Wittwer D, Weise C, Götz P, Wiesner A.",LPS (lipopolysaccharide)-activated immune responses in a hemocyte cell line from Estigmene acraea (Lepidoptera).,18,15-18
DRAMP02455,ADSRNPLEEEFRETNYEEF,19,L-amino-acid oxidase (ACL-LAO; LAAO; LAO),P0CC16,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Not found,Agkistrodon contortrix laticinctus (Broad-banded copperhead)(Agkistrodon mokasen laticinctus),"Antimicrobial, Antibacterial, Antiparasitic",Protein level,Not found,Not found,,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids (L-Ile followed by L-Phe, L-Met, L-Val, L-Arg, L-Leu), thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage (minimum hemorrhagic dose of 10 µg), and apoptosis. May also induce hemolysis, edema, antibacterial and antiparasitic activities. May also regulate platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions.
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10441379,Arch Biochem Biophys. 1999 Aug 15;368(2):285-290.,"Souza DH, Eugenio LM, Fletcher JE, Jiang MS, Garratt RC, Oliva G, Selistre-de-Araujo HS.",Isolation and structural characterization of a cytotoxic L-amino acid oxidase from Agkistrodon contortrix laticinctus snake venom: preliminary crystallographic data.,19,18-21
DRAMP02457,ADVRNPLEEFRETDYEVL,18,"L-amino-acid oxidase (Balt-LAAO-I; LAAO; LAO; snakes, reptils, animals)",P0DI86,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Not found,Bothrops alternatus (Urutu),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as slight hemorrhage, Induction: of platelet aggregation, edema in the mouse paw and bactericidal activity against both Gram-positive (S.aureus) and Gram-negative (E.coli) bacteria. May also induce hemolysis, apoptosis of vascular endothelial cells or tumor cell lines, and may have antiparasitic activities. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. 
Tissue specificity: Expressed by the venom gland.",Gram-positive bacterium: S. aureus;##Gram-negative bacterium: E. coli.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15142548,Bioorg Med Chem. 2004 Jun 1;12(11):2881-2886.,"Stábeli RG, Marcussi S, Carlos GB, Pietro RC, Selistre-de-Araújo HS, Giglio JR, Oliveira EB, Soares AM.",Platelet aggregation and antibacterial effects of an L-amino acid oxidase purified from Bothrops alternatus snake venom.,18,15-18
DRAMP02465,ADDINPKEECFFEDDYYEFE,20,"L-amino-acid oxidase L1 (LAAO; LAAO-L1; LAO; Reptiles, animals)",P86535,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Not found,Daboia russelii (Russel's viper) (Vipera russelii),"Antimicrobial, Antibacterial, Antitumor, Antiparasitic",Protein level,Not found,Not found,,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions By similarity.
Tissue specificity: Expressed by the venom gland.
Biophysicochemical properties: Kinetic parameters (KM=0.297 mM for L-Met; KM=1.44 mM for L-Ile; KM=0.750 mM for L-Leu; KM=0.066 mM for L-Phe; KM=0.210 mM for L-Trp; KM=0.052 mM for L-Tyr; Vmax=8.96 µmol/min/mg enzyme toward L-Phe).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18384385##20203422,FEBS J. 2008 May;275(9):2078-2095.##Biomed Res. 2010 Feb;31(1):71-81.,"Mandal S, Bhattacharyya D.##Suzuki M, Itoh T, Anuruddhe BM, Bandaranayake IK, Shirani Ranasinghe JG, Athauda SB, Moriyama A.",Two L-amino acid oxidase isoenzymes from Russell's viper (Daboia russelli russelli) venom with different mechanisms of inhibition by substrate analogs.##Molecular diversity in venom proteins of the Russell's viper (Daboia russellii russellii) and the Indian cobra (Naja naja) in Sri Lanka.,20,18-21
DRAMP02466,ADDKNPLEECFCEDDDYCEG,20,"L-amino-acid oxidase L2 (LAAO; LAAO-L2; LAO; Reptiles, animals)",P0DI90,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Not found,Daboia russelii (Russel's viper) (Vipera russelii),"Antimicrobial, Antibacterial, Antitumor, Antiparasitic",Protein level,Not found,Not found,,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions By similarity.
Tissue specificity: Expressed by the venom gland.
Biophysicochemical properties: Kinetic parameters (KM=1.89 mM for L-Ile; KM=599.7 µM for L-Leu; KM=222.8 µM for L-Met; KM=49.3 µM for L-Phe; KM=235.1 µM for L-Trp; KM=538.2 µM for L-Tyr; Vmax=6.94 µmol/min/mg enzyme toward L-Phe).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18384385,FEBS J. 2008 May;275(9):2078-2095.,"Mandal S, Bhattacharyya D.",Two L-amino acid oxidase isoenzymes from Russell's viper (Daboia russelli russelli) venom with different mechanisms of inhibition by substrate analogs.,20,18-21
DRAMP02471,IASASCTTCICTCSCSS,17,Thiostrepton (Alaninamide; Bryamycin; Gargon; Thiactin),"P0C8P8, C4NCM0",Belongs to the thiocillin family,tpdA,Streptomyces azureus,"Antimicrobial, Antibacterial",Protein level,No secondary structure,Not found,"1E9W, 3CF5 resolved by X-ray.##1OLN, 2JQ7 resolved by NMR.","Function: Has bacteriocidal activity. Inhibits bacterial protein biosynthesis by acting on the elongation factor Tu (EF-Tu) (By similarity).
PTM: Maturation of thiazole and oxazole containing antibiotics involves the enzymic condensation of a Cys, Ser or Thr with the alpha-carbonyl of the preceding amino acid to form a thioether or ether bond, then dehydration to form a double bond with the alpha-amino nitrogen. Thiazoline or oxazoline ring are dehydrogenated to form thiazole or oxazole rings. Maturation of pyridinyl containing antibiotics involves the cross-linking of a Ser and a Cys-Ser pair usually separated by 7 or 8 residues along the peptide chain. The Ser residues are dehydrated to didehydroalanines, then bonded between their beta carbons. The alpha carbonyl of the Cys condenses with alpha carbon of the first Ser to form a pyridinyl ring. The ring may be multiply dehydrogenated to form a pyridine ring with loss of the amino nitrogen of the first Ser.
Pharmaceutical use: Available under the names Animax (Dechra) and Panolog (Fort Dodge), that combine thiostrepton with nystatin (antifungal), neomycin (antibiotic) and triamcinolone (corticosteroid). Used to treat cat and dog skin and ear disorders caused by",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,13355325##11320328,Antibiot Annu. 1955-1956;3:554-559.##Acta Crystallogr D Biol Crystallogr. 2001 May;57(Pt 5):755-758.,"DONOVICK R, PAGANO JF, STOUT HA, WEINSTEIN MJ.##Bond CS, Shaw MP, Alphey MS, Hunter WN.","Thiostrepton, a new antibiotic. I. In vitro studies.##Structure of the macrocycle thiostrepton solved using the anomalous dispersion contribution of sulfur.",17,15-18
DRAMP02488,ADDRNPLEEFRENNYEEFL,19,"L-amino-acid oxidase ACTX-8 (LAAO; LAO; Snakes, reptiles, animals)",P0DI85,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Not found,Deinagkistrodon acutus (Hundred-pace snake) (Agkistrodon acutus),"Antimicrobial, Antibacterial, Antitumor, Antiparasitic",Protein level,Not found,Not found,,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). Induces apoptosis in HeLa cervical cancer cells. Both the caspase-dependent and the mitochondrial pathways seem to be involved in apoptosis.
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17275856,Life Sci. 2007 Mar 6;80(13):1189-1197.,"Zhang L, Wei LJ.","ACTX-8, a cytotoxic L-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells.",19,18-21
DRAMP02513,KRRGSVTTRYQFLMIHLLRPKKLFA,25,EA-CATH1,No entry found,Not found,Not found,Equus asinus,Not found,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20423460,FEBS J. 2010 May;277(10):2329-2339.,"Lu Z, Wang Y, Zhai L, Che Q, Wang H, Du S, Wang D, Feng F, Liu J, Lai R, Yu H.",Novel cathelicidin-derived antimicrobial peptides from Equus asinus.,25,24-27
DRAMP18398,ISQSDAILSAIWSGIKSLF,19,"Um2 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)",No entry found,Not found,Not found,Urodacus manicatus,"Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,Active against M. luteus (MIC 4 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,28067810,"Toxins (Basel). 2017 Jan 6;9, 22. doi: 10.3390/toxins9010022.","Luna-Ramirez K, Tonk M, Rahnamaeian M, Vilcinskas A.",Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus,19,18-21
DRAMP02592,GXFGKAFXSVSNFAKKHKTA,20,"Styelin-A (Styelin A; invertebrates, animals)",P81469,Not found,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues.","Psychrobacter immobilis, Planococcus citreus",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9467865,Comp Biochem Physiol B Biochem Mol Biol. 1997 Nov;118(3):515-521.,"Lee IH, Cho Y, Lehrer RI.","Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.",20,18-21
DRAMP02593,GXFGPAFHSVSNFAKKHKTA,20,"Styelin-B (Styelin B; invertebrates, animals)",P81470,Not found,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9467865,Comp Biochem Physiol B Biochem Mol Biol. 1997 Nov;118(3):515-521.,"Lee IH, Cho Y, Lehrer RI.","Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.",20,18-21
DRAMP02597,VFQFLGKIIHHVGNFVHGFSHVF,23,"Clavanin-A (His-rich; chordates, animals)","P80710, O18490",Not found,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Alpha helix,Not found,,Function: Has antimicrobial activity.,Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9001389##9237689,FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.,"Lee IH, Zhao C, Cho Y, Harwig SSL, Cooper EL, Lehrer RI.##Zhao C, Lian H, Lee I.H, Lehrer R.I.","Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.##cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.",23,21-24
DRAMP02598,VFQFLGRIIHHVGNFVHGFSHVF,23,"Clavanin-B (His-rich; chordates, animals)",P80711,Not found,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial, Antifungal",Protein level,Alpha helix ,Not found,,"Function: Has antimicrobial activity.
PTM: C-terminal amidation.","Escherichia coli, L. monocytes, Candida albicans.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9001389, FEBS Lett. 1997 Jan 3;400(2):158-162.,"Lee IH, Zhao C, Cho Y, Harwig SS, Cooper EL, Lehrer RI.","Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.",23,21-24
DRAMP02599,VFHLLGKIIHHVGNFVYGFSHVF,23,"Clavanin-C (His-rich; chordates, animals)","O18493, P80712",Not found,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Alpha helix,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Hemocytes and pharyngeal tissues.",Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9001389##9237689,FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.,"Lee IH, Zhao C, Cho Y, Harwig SSL, Cooper EL, Lehrer RI.##Zhao C, Lian H, Lee I.H, Lehrer R.I.","Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.##cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.",23,21-24
DRAMP02600,AFKLLGRIIHHVGNFVYGFSHVF,23,"Clavanin-D (His-rich; chordates, animals)","P80713, O18491",Not found,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Alpha helix,Not found,,"Function: Has antimicrobial activity.
Tissue specificity: Hemocytes and pharyngeal tissues.",Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9237689##9001389,FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.,"Zhao C, Liaw L, Lee IH, Lehrer RI.##Lee IH, Zhao C, Cho Y, Harwig SS, Cooper EL, Lehrer RI.","cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.##Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.",23,21-24
DRAMP02601,LFKLLGKIIHHVGNFVHGFSHVF,23,"Clavanin E (His-rich; chordates, animals)",O18492,Not found,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Not found,Not found,,Function: Has antimicrobial activity.,Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9237689,FEBS Lett. 1997 Jun 30;410(2-3):490-492. ,"Zhao C, Liaw L, Lee IH, Lehrer RI.",cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes. ,23,21-24
DRAMP02602,FLRFIGSVIHGIGHLVHHIGVAL,23,"Clavaspirin (chordates, animals)",O97395,Not found,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Alpha helix ,Not found,,Function: Has potent hemolytic activity. ,[Swiss_Prot Entry O97395]Exhibits broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria,[Ref.12005415]has potent hemolytic activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12005415,J Pept Res. 2001 Dec;58(6):445-456.,"Lee IH, Zhao C, Nguyen T, Menzel L, Waring AJ, Sherman MA, Lehrer RI.","Clavaspirin, an antibacterial and haemolytic peptide from Styela clava.",23,21-24
DRAMP18249,DWTFANWSCLVCDDCSVNLTV,21,Bac-GM100  (Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Not found,Brevibacillus brevis strain GM100,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",,Not found,Not found,,The 21 N-terminal residues of Bac-GM100 displayed 65% homology with thurincin H from Bacillus thuringiensis. Bac-GM100 was extremely heat-stable and was stable within a pH range of 3-10. It proved sensitive to various proteases.,"Gram-positive, Gram-negative",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23291759,Biosci Biotechnol Biochem. 2013;77(1):151-60.,"Ghadbane M, Harzallah D, Laribi AI, Jaouadi B, Belhadj H.",Purification and biochemical characterization of a highly thermostable bacteriocin isolated from Brevibacillus brevis strain GM100.,21,18-21
DRAMP18246,GWVAXVGAXGTAALASGGV,19,"Thuricin 439A,439B(Bacteriocin)",No entry found,Not found,Not found,Bacillus thuringiensis strain B439,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,Based on its unique physical and biological characteristics we can conclude that thuricin 439 is a novel bacteriocin.,,"The two active peptides are likely to be encoded by a single gene, whose product may undergo one or more post translational modifications that result in two active products of different molecular masses.",Gram-positive (Narrow),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12644238,FEMS Microbiol Lett. 2003 Mar 14;220(1):127-31.,"Ahern M, Verschueren S, van Sinderen D.",Isolation and characterisation of a novel bacteriocin produced by Bacillus thuringiensis strain B439.,19,18-21
DRAMP02642,GFCRCLCRRGVCRCICTR,18,"Rhesus theta-defensin 1 (RTD-1; primates, mammals, animals)","P82271, P82270, Q9TU01",Belongs to the alpha-defensin family (Theta subfamily),Not found,Macaca mulatta (Rhesus macaque),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral",Protein level,Beta strand (4 strands; 10 residues),Not found,1HVZ resolved by NMR.,"Function: RTD-1 and RTD-2 have similar antimicrobial activities against the Gram-positive bacteria S. aureus 502A and L. monocytogenes, the Gram-negative bacterium S. typhimurium, and the fungi C. albicans 16820 and C. neoformans 271A. RTD-2 is 2-3-fold less active than RTD-1 against E. coli ML35.
Subunit structure: RTD-1 is a cyclic heterodimer composed of subunits A and B; disulfide-linked.
Tissue specificity: RTD-1 is expressed in bone marrow. Detected in promyelocytes, myelocytes and mature neutrophils and monocytes.
Developmental stage: RTD-1 expression begins early during granulocyte myelopoiesis.
PTM: Forms a cyclic peptide with 1 subunit B (RTD-2) or with 1 subunit A (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-2.","Gram-positive bacteria: Staphylococcus aureus 502a and Listeria monocytogenes;##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.",L,No cytotoxicity information found,Not found,10521339##1152799##11675394,Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.,"Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.","A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.",18,15-18
DRAMP02643,RCLCRRGVCRCLCRRGVC,18,"Rhesus theta-defensin 2 (RTD-2; primates, mammals, animals)",P82271,Belongs to the alpha-defensin family (Theta subfamily),Not found,Macaca mulatta (Rhesus macaque),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Protein level,Bridge,Not found,,"Function: RTD-1 and RTD-2 have similar antimicrobial activities against the Gram-positive bacteria S. aureus 502A and L. monocytogenes, the Gram-negative bacterium S. typhimurium, and the fungi C. albicans 16820 and C. neoformans 271A. RTD-2 is 2-3-fold less active than RTD-1 against E. coli ML35.
Subunit structure: RTD-2 is a cyclic homodimer composed of two subunits B; disulfide-linked.
PTM: Forms a cyclic peptide with 1 subunit B (RTD-2) or with 1 subunit A (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-2.","Gram-positive bacteria: Staphylococcus aureus 502a, Listeria monocytogenes; ##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10521339##1152799##11675394,Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.,"Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.","A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.",18,15-18
DRAMP02644,RCICTRGFCRCICTRGFC,18,"Rhesus theta-defensin 3 (RTD-3; primates, mammals, animals)","P82270, Q9TU01",Belongs to the alpha-defensin family (Theta subfamily),Not found,Macaca mulatta (Rhesus macaque),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral",Protein level,Bridge,Not found,,"Function: RTD-1 and RTD-3 have similar antimicrobial activities against the Gram-positive bacteria, the Gram-negative bacteria and the fungi C. albicans 16820 and C. neoformans 271A.
Subunit structure RTD-1 is a cyclic heterodimer composed of subunits A and B; disulfide-linked. RTD-3 is a cyclic homodimer composed of two subunits A; disulfide-linked.
PTM: Forms a cyclic peptide with subunit A (RTD-3) or with subunit B (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-3.","Gram-positive bacteria: Staphylococcus aureus 502a, Listeria monocytogenes;##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10521339##1152799##11675394,Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.,"Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.","A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.",18,15-18
DRAMP02645,GICRCICTRGFCRCICVL,18,"Rhesus theta-defensin 4 (RTD-4; primates, mammals, animals)",No entry found,Belongs to the alpha-defensin family (Theta subfamily),Not found,Macaca mulatta (Rhesus macaque),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Function: RTD-1 and RTD-5 are 3-fold more active than RTD-4.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21084627,J Leukoc Biol. 2011 Feb;89(2):283-290.,"Tongaonkar P, Tran P, Roberts K, Schaal J, Osapay G, Tran D, Ouellette AJ, Selsted ME.","Rhesus macaque {theta}-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities.",18,15-18
DRAMP02646,GICRCLCRRGVCRCICVL,18,"Rhesus theta-defensin 5 (RTD-5; primates, mammals, animals)",No entry found,Belongs to the alpha-defensin family (Theta subfamily),Not found,Macaca mulatta (Rhesus macaque),"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Function: RTD-1 and RTD-5 are 3-fold more active than RTD-4. RTD-6 has not be collected due to the lack of activity.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21084627,J Leukoc Biol. 2011 Feb;89(2):283-290.,"Tongaonkar P, Tran P, Roberts K, Schaal J, Osapay G, Tran D, Ouellette AJ, Selsted ME.","Rhesus macaque {theta}-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities.",18,15-18
DRAMP02713,DTHFPIYIFCCGCCHRSKCGMCCKT,25,"Hepcidin (primates, mammals, animals)",Q5NVR8,Belongs to the glycosyl hydrolase 22 family,HAMP,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),Antimicrobial ,Homology,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains three disulfide bonds 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases,The German cDNA consortium,Unknown,25,24-27
DRAMP02744,FWGTLAKLALKAVPAVMGMIKKE,23,"Dinoponeratoxin Da-2501 (ants, insects, animals)",P0CF01,Not found,Not found,Dinoponera australis (Giant neotropical hunting ant),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Dinoponeratoxin Da-2051 may have antibacterial activity.
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19879289,Toxicon. 2010 Apr 1;55(4):702-710.,"Johnson SR, Copello JA, Evans MS, Suarez AV.",A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.,23,21-24
DRAMP02745,ALKAVPAVMGMIKKE,15,"Dinoponeratoxin Da-1585 (ants, insects, animals)",P0CF01,Not found,Not found,Dinoponera australis (Giant neotropical hunting ant),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Dinoponeratoxin Da-1585 may have antibacterial activity.
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19879289,Toxicon. 2010 Apr 1;55(4):702-710.,"Johnson SR, Copello JA, Evans MS, Suarez AV.",A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.,15,12-15
DRAMP02747,FLGGLIGPLMSLIPGLLK,18,"Dinoponeratoxin Da-1837 (ants, insects, animals)",P0CF03,Not found,Not found,Dinoponera australis (Giant neotropical hunting ant),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: May have antibacterial activity.
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19879289,Toxicon. 2010 Apr 1;55(4):702-710.,"Johnson SR, Copello JA, Evans MS, Suarez AV.",A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.,18,15-18
DRAMP03743,RSVCRQIKICRRRGGCYYKCTNRPY,25,"Androctonin (Arthropods, animals)",P56684,Not found,Not found,Androctonus australis (Sahara scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Beta strand (2 strands; 8 residues),The structure of androctonin involves a well-defined highly twisted anti-parallel beta-sheet with strands connected by a more variable positively charged turn.,1CZ6 resolved by NMR.,"Function: Androctonin is a highly cationic antimicrobial peptide from scorpion exhibiting a broad spectrum of activities against bacteria (Gram-positive and Gram-negative) and filamentous fungi. Acts on the membrane of the bacterial cells. It destabilize a membrane by modifying its properties.
PTM: Contains two disulfide bonds 4-20; 10-16.","[Ref.10942757] Gram-positive bacteria: Micrococcus luteus (MIC=0.6-1.5 μM), Aerococcus viridans (MIC=0.3-0.6 μM), Staphylococcus aureus (MIC=15-30 μM);##Gram-negative bacteria: Escherichia coli D31 (MIC=3-6 μM),  Escherichia coli D22 (MIC=6-15 μM),  Escherichia coli 1106 (MIC=6-15 μM), Salmonella typhimurium (MIC=3-6 μM).##Fungi: Alternaria brassicola (MIC=3-6 μM), Fusarium culmorum (MIC=3-6 μM), Fusarium oxysporum (MIC=6-12 μM), Neurospora crassa (MIC=6-12 μM), Nectria haematococca (MIC=6-12 μM), Trichoderma viridae (MIC=6-12 μM);##Yeast: Candida albicans (MIC=1.6-3.15 μM).##[Ref.8939880] Gram-positive bacteria: Bacillus subtilis (MIC=1.5-3.0 μM);##Gram-negative bacteria: Escherichia coli D22 (MIC>30 μM), Pseudomonas syringae (MIC=1.5-3.0 μM), Pseudomonas syringae pv.syringae (MIC=15-22 μM), Pseudomonas syringae phaseoli (MIC=1.5-3.0 μM), Pseudomonas syringae pv.pisi (MIC=6-15 μM), Pseudomonas syringae pv. maculicola (MIC=3-6 μM), Phoma valerianella (MIC=15-22 μM), Xanthomonas compestris pv.compestris (MIC=3-6 μM), Xanthomonas vesicatoria 687.3 (MIC=1.5-3.0 μM), Xanthomonas vesicatoria B229RI (MIC=1.5-3.0 μM);##Fungi: Alternaria dauci (MIC=8-16 μM), Stemphylium (MIC=4-8 μM),  Fusarium oxysporum M. (MIC=2-4 μM), Fusarium oxysporum L. (MIC=2-4 μM), Botrytis cinerea (MIC=6-12 μM), B. petunia (MIC=4-8 μM), Verticilium toreilis (MIC=2-4 μM), Aspergillus fumigatus (MIC=25-50 μM).",[Ref.8939880] It exhibits no hemolytic activity on porcine or bovine erythrocytes at a concentration of up to 150 μM.,Cyclic,Free,Free,"Disulfide bond between Cys4 and Cys20,Cys10 and Cys16.",L,No cytotoxicity information found,Cell membrane,8939880##10563585##10942757,J Biol Chem. 1996 Nov 22;271(47):29537-29544.##J Biomol Struct Dyn. 1999 Oct;17(2):367-380.##J Biol Chem. 2000 Oct 27;275(43):33464-70.,"Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A, Bulet P.##Mandard N, Sy D, Maufrais C, Bonmatin JM, Bulet P, Hetru C, Vovelle F.##Silva PI Jr, Daffre S, Bulet P.","Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.##Androctonin, a novel antimicrobial peptide from scorpion Androctonus australis: solution structure and molecular dynamics simulations in the presence of a lipid monolayer.##Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.",25,24-27
DRAMP02758,GLVDVLGKVGGLIKKLLP,18,"Ponericin G6 (ants, insects, animals)",P82419,Not found,Not found,Pachycondyla goeldii (Ponerine ant),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has activity against Gram-positive bacteria and S. cerevisiae. Has non-hemolytic activity.
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a, B. megaterium ATCC 9885b, B. stearothermophilus CIP 675, B. stearothermophilus CIP 675, B. subtilis ATCC 6623, Lactococcus lactis ssp. cremoris I116, Streptococcus pyogenes CIP 561, S. sanguinis CIP 55128, Listeria monocytogenes ATCC 15313, Micrococcus luteus CIP 5345, Staphylococcus aureus CIP 677, S. epidermidis CIP 53134;##Gram-negative bacteria: Klebsiella pneumoniae CIP 8291, Pseudomonas aeruginosa CIP A22, Saccharomyces cerevisiae LMA 720.",[Ref.11279030]Non-hemolytic activity against horse and sheep erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",18,15-18
DRAMP02759,GLVDVLGKVGGLIKKLLPG,19,"Ponericin G7 (ants, insects, animals)",P82420,Not found,Not found,Pachycondyla goeldii (Ponerine ant),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Not found,Not found,,Function: Has activity against Gram-positive bacteria and S. cerevisiae. Tissue specificity: Expressed by the venom gland.,[Swiss_Prot Entry P82420]has activity against Gram-positive bacteria and S.cerevisiae,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",19,18-21
DRAMP02760,LLKELWTKMKGAGKAVLGKIKGLL,24,"Ponericin-L1 (ants, insects, animals)",P82421,Not found,Not found,Pachycondyla goeldii (Ponerine ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the venom gland.",[Swiss_Prot Entry P82421]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",24,21-24
DRAMP02761,LLKELWTKIKGAGKAVLGKIKGLL,24,"Ponericin-L2 (ants, insects, animals)",P82422,Not found,Not found,Pachycondyla goeldii (Ponerine ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral",Protein level,Alpha helix ,Not found,,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria. 
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 6.5mm), B. megaterium ATCC 9885b(Inhibition zone = 14mm), B. stearothermophilus CIP 675(Inhibition zone = 21mm), B. subtilis ATCC 6623(Inhibition zone = 13.5mm), Enterococcus faecalis CIP 636(Inhibition zone = 4mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 15.5mm), Streptococcus pyogenes CIP 561(Inhibition zone = 12.5mm), S. sanguinis CIP 55128(Inhibition zone = 6mm), Listeria ivanovii LMA 94d(Inhibition zone = 9.5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 9.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 10.5mm), Staphylococcus aureus CIP 677(Inhibition zone = 4.5mm), Staphylococcus aureus LMA(Inhibition zone = 11mm), S. epidermidis CIP 53134(Inhibition zone = 11.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 4mm), Enterobacter cloacae CIP 6085(Inhibition zone = 5mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 3.5mm), Proteus mirabilis LMA TP(Inhibition zone = 9mm), Salmonella enterica CIP 813(Inhibition zone = 1.5mm), Serratia marcescens LMA TP(Inhibition zone = 9mm), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 7mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).",[Ref.11279030]Not found,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",24,21-24
DRAMP02762,WLGSALKIGAKLLPSVVGLFKKKKQ,25,"Ponericin-W1 (ants, insects, animals)",P82423,Belongs to the ponericin-W family,Not found,Pachycondyla goeldii (Ponerine ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal, Antifungal",Protein level,Not found,Not found,,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 10mm), B. megaterium ATCC 9885b(Inhibition zone = 12.5mm), B. stearothermophilus CIP 675(Inhibition zone = 17mm), B. subtilis ATCC 6623(Inhibition zone = 12mm), Enterococcus faecalis CIP 636(Inhibition zone = 6mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 15mm), Streptococcus pyogenes CIP 561(Inhibition zone = 10mm), S. sanguinis CIP 55128(Inhibition zone = 7.5mm), Listeria ivanovii LMA 94d(Inhibition zone = 11.5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 9.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 11.5mm), Staphylococcus aureus CIP 677(Inhibition zone = 10mm), Staphylococcus aureus LMA(Inhibition zone = 13.5mm), S. epidermidis CIP 53134(Inhibition zone = 13.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 8mm), Enterobacter cloacae CIP 6085(Inhibition zone = 3mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 6.5mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(Inhibition zone = 3mm), Serratia marcescens LMA TP(no detected), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 6mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 16mm).",[Ref.11279030]2mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",25,24-27
DRAMP02763,WLGSALKIGAKLLPSVVGLFQKKKK,25,"Ponericin-W2 (ants, insects, animals)",P82424,Belongs to the ponericin-W family,Not found,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antifungal, Insecticidal, Antimicrobial",Protein level,Not found,Not found,,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria. Has insecticidal activities. 
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",25,24-27
DRAMP02766,FWGALIKGAAKLIPSVVGLFKKKQ,24,"Ponericin-W5 (ants, insects, animals)",P82427,Belongs to the ponericin-W family,Not found,Pachycondyla goeldii (Ponerine ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal, Antifungal",Protein level,Not found,Not found,,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 7mm), B. megaterium ATCC 9885b(Inhibition zone = 12mm), B. stearothermophilus CIP 675(Inhibition zone = 17mm), B. subtilis ATCC 6623(Inhibition zone = 13mm), Enterococcus faecalis CIP 636(Inhibition zone = 3mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 11mm), Streptococcus pyogenes CIP 561(Inhibition zone = 6.5mm), S. sanguinis CIP 55128(Inhibition zone = 4.5mm), Listeria ivanovii LMA 94d(Inhibition zone = 8mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 6.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 11mm), Staphylococcus aureus CIP 677(Inhibition zone = 7.5mm), Staphylococcus aureus LMA(Inhibition zone = 9mm), S. epidermidis CIP 53134(Inhibition zone = 7.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 3mm), Enterobacter cloacae CIP 6085(Inhibition zone = 11mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 6.5mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(no detected), Serratia marcescens LMA TP(Inhibition zone = 11mm), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 5mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).",[Ref.11279030]4mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",24,21-24
DRAMP02767,FIGTALGIASAIPAIVKLFK,20,"Ponericin-W6 (ants, insects, animals)",P82428,Not found,Not found,Pachycondyla goeldii (Ponerine ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Activity against Gram-positive bacteria. Has insecticidal and hemolytic activities.
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 9.5mm), B. megaterium ATCC 9885b(Inhibition zone = 17mm), B. stearothermophilus CIP 675(Inhibition zone = 18mm), B. subtilis ATCC 6623(Inhibition zone = 15mm), Enterococcus faecalis CIP 636(Inhibition zone = 3mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 11mm), Streptococcus pyogenes CIP 561(Inhibition zone = 9.5mm), S. sanguinis CIP 55128(Inhibition zone = 4mm), Listeria ivanovii LMA 94d(Inhibition zone = 5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 4mm), Micrococcus luteus CIP 5345(Inhibition zone = 11mm), Staphylococcus aureus CIP 677(Inhibition zone = 7mm), Staphylococcus aureus LMA(Inhibition zone = 10mm), S. epidermidis CIP 53134(Inhibition zone = 7mm);##Gram-negative bacteria: Serratia marcescens LMA TP(Inhibition zone = 13mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).",[Ref.11279030]3mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",20,18-21
DRAMP02769,GLLSKFGRLARKLARVIPKV,20,"Pilosulin 2 (ants, insects, animals)",No entry found,Not found,Not found,Not found,Not found,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9813247,Arch Biochem Biophys. 2005 Feb 15;434(2):358-364.,"Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.",Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.,20,18-21
DRAMP02770,IIGLVSKGTCVLVKTVCKKVLKQG,24,"Pilosulin 3 (ants, insects, animals)",Q68Y23,Belongs to the pilosulin family,Not found,Myrmecia banksi (Jack jumper ant) (Australian jumper ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Not found,,"Function: Shows moderate activity against E. coli and S. aureus (MIC<25 µM), slight activity against B. subtilis (MIC<50 µM), and no activity against L. garvieae, P. aeruginosa, C. albicans, and S. cerevisiae. Has no hemolytic nor cytolytic activity. Causes an IgE-independent histamine release. 
Tissue specificity: Expressed by the venom gland.","[Ref.15246874]Gram-negative bacteria: Escherichia coli (MIC<25 µM);##Gram-positive bacteria: Staphylococcus aureus(MIC<25 µM), Bacillus subtilis (MIC<50 µM).",[Ref.15246874]Non-hemolytic activity at 50 μM against human whole blood,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,IgE,15246874,Arch Biochem Biophys. 2004 Aug 15;428(2):170-178.,"Inagaki H, Akagi M, Imai HT, Taylor RW, Kubo T.","Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia.",24,21-24
DRAMP02812,AVVNGVNYVGETTAA,15,Endopeptidase L4,P85155,Not found,Not found,Lysobacter sp. strain XL1 (Gram-negative bacteria),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Biophysicochemical properties: Optimum pH is 8.0; Optimum temperature is 50-55 degrees Celsius. Retains 50% of its maximal activity after incubation at 52 degrees Celsius for 15 min.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16266276,Biochemistry (Mosc). 2005 Sep;70(9):1031.,"Stepnaya OA, Tsfasman IM, Logvina IA, Ryazanova LP, Muranova TA, Kulaev IS.",Isolation and characterization of a new extracellular bacteriolytic endopeptidase of Lysobacter sp. XL1.,15,12-15
DRAMP02814,FHPSLWVLIPQYIQLIRKILKS,22,Conolysin-Mt2,No entry found,Not found,Not found,Conus mustelinus (Weasel cone),"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17927208,Biochemistry. 2007 Nov 6;46(44):12586-12593. ,"Biggs J.S, Rosenfeld Y, Shai Y, Olivera B.M.",Conolysin-Mt: a conus peptide that disrupts cellular membranes.,22,21-24
DRAMP02825,SSMKLSFRARAYGFRGPGPQL,21,Catestatin,No entry found,Not found,Not found,Bos taurus (Bovine),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15723172,Cell Mol Life Sci. 2005 Feb;62(3):377-385.,"Briolat J, Wu SD, Mahata SK, Gonthier B, Bagnard D, Chasserot-Golaz S, Helle KB, Aunis D, Metz-Boutigue MH.",New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,21,18-21
DRAMP02826,RPKHPIKHQGLPQEVLNENLLRF,23,Isracidin,No entry found,Not found,Not found,Bos taurus (Bovine),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19054235,J Appl Microbiol. 2009 Jan;106(1):233-240.,"Birkemo GA, O'Sullivan O, Ross RP, Hill C.","Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.",23,21-24
DRAMP01356,FLGGLMKAFPALICAVTKKC,20,"Ranalexin-1Ca (Ranatuerin 1Ca; Frogs, amphibians, animals)",P82876,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Not found,Rana clamitans (Green frog) (Lithobates clamitans),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands.",[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=17 μM);##Gram-negative bacterium: Escherichia coli (MIC=4 μM).##Yeast: Candida albicans (MIC=14 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10822101,Peptides. 2000 Apr;21(4):469-476.,"Halverson T, Basir YJ, Knoop FC, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,20,18-21
DRAMP02874,YPGPQAKEDSEGPSQGPASREK,22,"Chromacin (mammals, animals)","P05059, P79392, Q2KJ52",Belongs to the chromogranin/secretogranin protein family,CHGA,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,Function: Has antibacterial activity against the Gram-positive bacterium M. luteus.,Gram-positive bacterium: Micrococcus luteus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Binds calcium with a low-affinity.,8910482,J Biol Chem. 1996 Nov 8;271(45):28533-28540.,"Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M, van Dorsselaer A, Aunis D, Metz-Boutigue MH.",Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules.,22,21-24
DRAMP02901,CLGVGSCNNFAGCGYAIVCFW,21,Tricyclic peptide MS-271,P85078,Not found,Not found,Streptomyces sp.,"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Inhibits chicken myosin light chain kinase with an IC50 of 8 M. Antibacterial activity against the Gram-positive bacteria. No antibacterial activity against the Gram-negative bacteria E. coli, K. pneumoniae, P. aeruginosa, P. vulgaris, S. sonnei and S. typhosa. No antifungal activity against C. albicans.
Caution: The isopeptide linked residue 9 is shown as Asn rather than Asp as mentioned in Ref.1, because it is not known whether Asp or Asn is encoded and the isopeptide bonds are almost always formed between the amides Asn or Gln and N6-lysine or alpha amino groups, with the liberation of an ammonia that makes the reaction essentially irreversible.
PTM: Contains two disulfide bonds and D-amino acid at position 21.","Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus, Enterococcus faecium.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8689231,Bioorg Med Chem. 1996 Jan;4(1):115-120.,"Yano K, Toki S, Nakanishi S, Ochiai K, Ando K, Yoshida M, Matsuda Y, Yamasaki M.","MS-271, a novel inhibitor of calmodulin-activated myosin light chain kinase from Streptomyces sp.--I. Isolation, structural determination and biological properties of MS-271.",21,18-21
DRAMP02917,DTHFPICIFCCGCCKTPKCGLCCKT,25,"Hepcidin (dogs, mammals, animals)","Q5U9D2, Q5EES0",Belongs to the glycosyl hydrolase 22 family,HAMP,Canis familiaris (Dog) (Canis lupus familiaris),Antimicrobial,Homology,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available##PubMed ID is not available,Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases##Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases,"Shi J, Wei Y, Boothe D.##Li XD, Zhao TZ, Sun M, Tian KG, Chen XZ.",Identification of dog hepcidin.##Identification of dog hepcidin in China.,25,24-27
DRAMP02935,RRWCFRVCYKGFCYRKCR,18,"Polyphemusin-2 (Polyphemusin II; crabs, Arthropods, animals)",P14216,Belongs to the tachyplesin/polyphemusin family,Not found,Limulus polyphemus (Atlantic horseshoe crab),"Antimicrobial, Antibacterial, Antifungal",Protein level,Bridge,Not found,,"Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria.
Tissue specificity: Hemocytes.
PTM: Contains two disulfide bonds 4-17; 8-13.",Yeast: Candida albicans M9.,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Amidation,"Disulfide bond between Cys4 and Cys17,Cys8 and Cys13.",L,No cytotoxicity information found,Not found,2514185##15134657,J Biochem. 1989 Oct;106(4):663-668.##Biochim Biophys Acta. 2004 May 6;1698(2):239-250.,"Miyata T, Tokunaga F, Yonega T, Yoshikawa K, Iwanaga S, Niwa M, Takao T, Shimonishi Y.##Powers J.P, Rozek A, Hancock R.E.","Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.##Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.",18,15-18
DRAMP02939,RWCFRVCYRGICYRKCR,17,"Tachyplesin-2 (Tachyplesin II; crabs, Arthropods, animals)",P14214,Belongs to the tachyplesin/polyphemusin family,Not found,Tachypleus tridentatus (Japanese horseshoe crab),"Antimicrobial, Antibacterial, Antifungal",Protein level,Bridge,Not found,,Comment: No comments found on DRAMP database,Yeast: Candida albicans M9.,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Amidation (Arg17),"Disulfide bond between Cys3 and Cys16,Cys7 and Cys12.",L,No cytotoxicity information found,Not found,2514185,J Biochem. 1989 Oct;106(4):663-668.,"Miyata T, Tokunaga F, Yonega T, Yoshikawa K, Iwanaga S, Niwa M, Takao T, Shimonishi Y.","Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.",17,15-18
DRAMP02940,KWCFRVCYRGICYRKCR,17,"Tachyplesin-3 (Tachyplesin III; crabs, Arthropods, animals)",P18252,Belongs to the tachyplesin/polyphemusin family,Not found,Tachypleus gigas (Southeast Asian horseshoe crab),"Antimicrobial, Antibacterial",Protein level,Bridge,Not found,,"Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria.
Tissue specificity: Hemocytes.
PTM: Contains two disulfide bonds 3-16; 7-12, and Arginine amide at R17.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Amidation (Arg17),"Disulfide bond between Cys3 and Cys16,Cys7 and Cys12.",L,No cytotoxicity information found,Not found,2229025,J Biochem. 1990 Aug;108(2):261-266.,"Muta T, Fujimoto T, Nakajima H, Iwanaga S.","Tachyplesins isolated from hemocytes of Southeast Asian horseshoe crabs (Carcinoscorpius rotundicauda and Tachypleus gigas): identification of a new tachyplesin, tachyplesin III, and a processing intermediate of its precursor.",17,15-18
DRAMP02955,LGAWLAGKVAGTVATYAWNRYV,22,"Hedistin (marine annelid, Metazoa)",Q1PG44,Not found,Not found,Hediste diversicolor,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MRSA);##Gram-negative bacterium: Vibrio alginolyticus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17210178,Dev Comp Immunol. 2007;31(8):749-762. ,"Tasiemski A, Schikorski D, Le Marrec-Croq F, Pontoire-Van Camp C, Boidin-Wichlacz C, Sautière PE.","Hedistin: A novel antimicrobial peptide containing bromotryptophan constitutively expressed in the NK cells-like of the marine annelid, Nereis diversicolor.",22,21-24
DRAMP02971,RGGRLCYCRRRFCICV,16,"Protegrin-2 (Protegrin 2; PG-2; pigs, mammals, animals)",P32195,Belongs to the cathelicidin family,NPG2,Sus scrofa (Pig),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Protein level,Bridge,Not found,2MUH resolved by NMR.,"Function: Microbicidal activity. Active against E.coli, Listeria monocytogenes and C.albicans, in vitro.
PTM: Contains two disulfide bonds 6-15; 8-13 and Valine amide at V16.",Gram-positive bacterium: Listeria moncyrogenes strain EGD (MIC>25 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35 (MIC>25 µg/ml).##Yeast: Candida albicans strain 820 (MIC>25 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8335113##8250892,FEBS Lett. 1993 Jul 26;327(2):231-236.##Biochem Biophys Res Commun. 1993 Nov 15;196(3):1363-1368.,"Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI.##Storici P, Zanetti M.",Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.##A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence.,16,15-18
DRAMP02972,RGGGLCYCRRRFCVCVGR,18,"Protegrin-3 (Protegrin 3; PG-3; pigs, mammals, animals)",P32196,Belongs to the cathelicidin family,NPG3,Sus scrofa (Pig),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Protein level,Bridge,Not found,2MZ6 resolved by NMR.,"Function: Microbicidal activity. Active against E.coli, Listeria monocytogenes and C.albicans, in vitro.
PTM: Probablely contains two disulfide bonds 6-15; 8-13 and Arginine amide at R18.",Gram-positive bacterium: Listeria moncyrogenes strain EGD;##Gram-negative bacterium: Escherichia coli ML-35.##Yeast: Candida albicans strain 820.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8335113,FEBS Lett. 1993 Jul 26;327(2):231-236.,"Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI.",Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.,18,15-18
DRAMP02973,RGGRLCYCRGWICFCVGR,18,"Protegrin-4 (Protegrin 4; PG-4; pigs, mammals, animals)",P49933,Belongs to the cathelicidin family,NPG4,Sus scrofa (Pig),"Antimicrobial, Antibacterial, Antifungal",Protein level,Bridge,Not found,,"Function: Microbicidal activity (By similarity).
PTM: Contains two disulfide bonds (By similarity).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8013647##12705830,FEBS Lett. 1994; 346: 285-288.##ochemistry. 2003 Apr 29;42(16):4669-4680.,"Zhao C, Liu L, Lehrer RI.##Yang Y, Sanchez JF, Strub MP, Brutscher B, Aumelas A.",Identification of a new member of the protegrin family by cDNA cloning.##NMR structure of the cathelin-like domain of the protegrin-3 precursor.,18,15-18
DRAMP02974,RGGRLCYCRPRFCVCVGR,18,"Protegrin-5 (Protegrin 5; PG-5; pigs, mammals, animals)",P49934,Belongs to the cathelicidin family,NPG5,Sus scrofa (Pig),"Antimicrobial, Antibacterial, Antifungal",Homology,Bridge,Not found,,"Function: Microbicidal activity (By similarity).
PTM: Contains two disulfide bonds (By similarity).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7628604,FEBS Lett. 1995 Jul 17;368(2):197-202.,"Zhao C, Ganz T, Lehrer RI.",The structure of porcine protegrin genes.,18,15-18
DRAMP02979,DTHFPICIFCCGCCRKAICGMCCKT,25,"Hepcidin (pigs, mammals, animals)",Q8MJ80,Belongs to the hepcidin family,HAMP,Sus scrofa (Pig),Antimicrobial,Homology,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases,"Sang Y, Ross C.R, Blecha F.","Cloning and characterization of porcine liver-expressed antimicrobial peptides, Hepcidin (pHAMP) and LEAP2.",25,24-27
DRAMP02987,AGFAAQAAASLAPVAIQQL,19,Tricholongin BII (Fungi),No entry found,Not found,Not found,Trichoderma longibrachiatum,"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1935961,Eur J Biochem. 1991 Nov 1;201(3):661-674.,"Rebuffat S, Prigent Y, Auvin-Guette C, Bodo B.","Tricholongins BI and BII, 19-residue peptaibols from Trichoderma longibrachiatum. Solution structure from two-dimensional NMR spectroscopy.",19,18-21
DRAMP02988,AGFAAQAAASLAPVAAQQL,19,Tricholongin BI (Fungi),No entry found,Not found,Not found,Trichoderma longibrachiatum,"Antimicrobial, Antibacterial, Antifungal",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1935961,Eur J Biochem. 1991 Nov 1;201(3):661-674.,"Rebuffat S, Prigent Y, Auvin-Guette C, Bodo B.","Tricholongins BI and BII, 19-residue peptaibols from Trichoderma longibrachiatum. Solution structure from two-dimensional NMR spectroscopy.",19,18-21
DRAMP02989,VNWKKVLGKIIKVAK,15,"Lasioglossin LL-I (Insects, animals)",No entry found,Not found,Not found,Lasioglossum laticeps (Eusocial Bee),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer",Not found,Not found,Not found,,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.8 μM), S. aureus(MIC=14.3 μM);##Gram-negative bacteria: P. aeruginosa(MIC=15.8 μM), E. coli(MIC=1.7 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2099.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP02990,VNWKKILGKIIKVAK,15,"Lasioglossin LL-II (Insects, animals)",No entry found,Not found,Not found,Lasioglossum laticeps (Eusocial Bee),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer",Not found,Not found,Not found,,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.7 μM), S. aureus(MIC=9.0 μM);##Gram-negative bacteria: P. aeruginosa(MIC=14.4 μM), E. coli(MIC=1.4 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2099.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP02991,VNWKKILGKIIKVVK,15,"Lasioglossin LL-III (Insects, animals)",No entry found,Not found,Not found,Lasioglossum laticeps (Eusocial Bee),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer",Not found,Not found,Not found,,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.7 μM), S. aureus(MIC=3.9 μM);##Gram-negative bacteria: P. aeruginosa(MIC=18.7 μM), E. coli(MIC=1.4 μM).",[Ref.19591185]LC50>220 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2099.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP03005,GNRPVYIPPPRPPHPRL,17,"Apidaecin (Insects, animals)",P81464,Belongs to the apidaecin family,Not found,Bombus pascuorum (Brown bumblebee),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial peptide against Gram-positive and Gram-negative bacteria.
Induction: By bacterial infection.",Gram-negative bacteria: Micrococcus luteus;##Gram-negative bacteria: Escherichia coli D22.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9219367,Insect Biochem Mol Biol. 1997 May;27(5):413-422.,"Rees JA, Moniatte M, Bulet P.","Novel antibacterial peptides isolated from a European bumblebee, Bombus pascuorum (Hymenoptera, Apoidea).",17,15-18
DRAMP03013,LNLTKWLGKLGVILSHLNK,19,"Bombolitin-6 (Insects, animals)",P0CD67,Belongs to the MCD family Bombolitin subfamily,Not found,Bombus lapidarius (Red-tailed bumblebee) (Apis lapidaria),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Mast cell degranulating peptide. May also display antibacterial and antifungal activities (By similarity).
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16626777,Toxicon. 2006 May;47(6):676-687.,"Favreau P, Menin L, Michalet S, Perret F, Cheneval O, Stöcklin M, Bulet P, Stöcklin R.",Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen.,19,18-21
DRAMP03014,LKLKDILGKIKVILSHLNK,19,"Bombolitin-7 (Insects, animals)",P0CD68,Belongs to the MCD family Bombolitin subfamily,Not found,Bombus lapidarius (Red-tailed bumblebee) (Apis lapidaria),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Mast cell degranulating peptide. May also display antibacterial and antifungal activities (By similarity).
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16626777,Toxicon. 2006 May;47(6):676-687.,"Favreau P, Menin L, Michalet S, Perret F, Cheneval O, Stöcklin M, Bulet P, Stöcklin R.",Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen.,19,18-21
DRAMP03015,LKLKSILGKLGVILSHLNK,19,"Bombolitin-8 (Insects, animals)",P0CD69,Belongs to the MCD family Bombolitin subfamily,Not found,Bombus lapidarius (Red-tailed bumblebee) (Apis lapidaria),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,"Function: Mast cell degranulating peptide. May also display antibacterial and antifungal activities (By similarity).
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16626777,Toxicon. 2006 May;47(6):676-687.,"Favreau P, Menin L, Michalet S, Perret F, Cheneval O, Stöcklin M, Bulet P, Stöcklin R.",Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen.,19,18-21
DRAMP18418,FIGMIPGLIGGLISAFK,17,ToAP1,A0A1D3IXR7,Derived from NDBP subfamily 4,Not found,Tityus obscurus,"Antimicrobial, Antifungal, Antibiofilm",Transcript level,Alpha helix,The peptide adopts a structure with 64.71% alpha helix,,Function: Antibacterial activity against the all Candida spp. Has hemolytic activity.,"[Ref.27917162] Fungi:Candida albicans (SC5314)(MIC=50μM), Candida tropicalis (ATCC 750)(MIC=12.5μM), Candida parapsilosis (ATCC 22019)(MIC=200μM), Candida glabrata (ATCC 90030)(MIC>400μM), Candida neoformans (H99 serotype A)(MIC=25μM)","[Ref.27917162] 20% hemolysis at 1.58 μM, 22% hemolysis at 3.16 μM, 23% hemolysis at 6.31 μM, 24% hemolysis at 12.59 μM, 28% hemolysis at 25.12 μM, 45% hemolysis at 50.11 μM , 50% hemolysis at 100μM against human red blood cell",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27917162,Front Microbiol. 2016 Nov 18;7:1844. eCollection 2016.,"Guilhelmelli F, Vilela N, Smidt KS, de Oliveira MA, da Cunha Morales ?lvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, de Freitas SM, Nicola AM, Franco OL, Derengowski LD, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I.",Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.,17,15-18
DRAMP03029,INWKKIKSIIKAAMN,15,"Mastoparan-V1 (Insects, animals)",P0C1Q8,Not found,Not found,Vespula vulgaris (Yellow jacket) (Wasp),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to erythrocytes and no mast cell degranulation activity at physiological concentrations. Potent antimicrobial peptide against Gram-positive and Gram-negative bacteria.
Expressed by the venom gland.
PTM: C-terminal amidation (Asparagine amide: N15).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12759486,Int Arch Allergy Immunol. 2003 May;131(1):25-32.,"King T.P, Jim S.Y, Wittkowski K.M.",Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1.,15,12-15
DRAMP03030,INWKKIKSLIKAAMS,15,"Mastoparan-V2 (Insects, animals)",P0C1Q9,Not found,Not found,Vespula vulgaris (Yellow jacket) (Wasp),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to erythrocytes and no mast cell degranulation activity at physiological concentrations. Potent antimicrobial peptide against Gram-positive and Gram-negative bacteria.
Expressed by the venom gland.
PTM: C-terminal amidation (Serine amide: S15).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12759486,Int Arch Allergy Immunol. 2003 May;131(1):25-32.,"King T.P, Jim S.Y, Wittkowski K.M.",Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1.,15,12-15
DRAMP03099,QRPYTQPLIYYPPPPTPPRIYRA,23,"Attacin-C (Insects, animals)",Q95NH6,Not found,AttC,Drosophila melanogaster (Fruit fly),"Antimicrobial, Antibacterial, Antifungal",Protein level,Rich,Not found,,Comment: No comments found on DRAMP database,"Agrobacterium tumefaciens (MIC>200 µM), Enterobacter cloacae b12 (MIC>200 µM), Escherichia coli SBS 363 (MIC>200 µM), Escherichia coli D31 (MIC>=200 µM), Escherichia coli D22 (MIC>=200 µM), Erwinia carotovora carotovora (MIC>200 µM), Pseudomonas aeruginosa (MIC>200 µM), Salmonella typhimurium (MIC>200 µM), Serratia marcescens (MIC>200 µM), Bacillus megaterium (MIC>200 µM), Micrococcus luteus(MIC>200 µM), Staphylococcus aureus (MIC>200 µM), Streptococcus pyogenes (MIC>200 µM), Neurospora crassa (MIC>200 µM), Aspergillus fumigatus (MIC>200 µM), Candida albicans (MIC>200 µM), Candida glabrata (MIC>200 µM), Cryptococcus neoformans (MIC>200 µM), Saccharomyces cerevisiae (MIC>200 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,14744858,J Biol Chem. 2004 Apr 9;279(15):14853-9. Epub 2004 Jan 26.,"Rabel D, Charlet M, Ehret-Sabatier L, Cavicchioli L, Cudic M, Otvos L Jr, Bulet P.",Primary structure and in vitro antibacterial properties of the Drosophila melanogaster attacin C Pro-domain.,23,21-24
DRAMP03157,ALLHHGLNCAKGVLA,15,Halocidin subunit B,P83706,Not found,Not found,Halocynthia aurantium (Sea peach),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has antimicrobial activity, possibly by attacking the bacterial cell membrane.",Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Pseudomonas aeruginosa.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12067731,FEBS Lett. 2002 Jun 19;521(1-3):81-86.,"Jang WS, Kim KN, Lee YS, Nam MH, Lee IH.","Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.",15,12-15
DRAMP03158,WLNALLHHGLNCAKGVLA,18,"Halocidin subunit A (invertebrates, animals; Preclinical)",P83705,Not found,Not found,Halocynthia aurantium (Sea peach),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antimicrobial activity against S.aureus and P.aeruginosa, possibly by attacking the bacterial cell membrane. Mouse model: A single intravenous injection of the modified chain A by itself into mice resulted in an significant therapeutic effect (Jang et al. 2007;51: 4148-4156).",Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Pseudomonas aeruginosa.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12067731,FEBS Lett. 2002 Jun 19;521(1-3):81-86.,"Jang WS, Kim KN, Lee YS, Nam MH, Lee IH.","Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.",18,15-18
DRAMP03174,RWCVYAYVRIRGVLVRYRRCW,21,"Arenicin-2 (Ar-2; marine polychaeta, animals)","Q5SC59, P84106",Not found,Not found,Arenicola marina (Lugworm) (Lumbricus marinus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Beta strand (2 strands; 16 residues),"NMR investigation shows that in water solution arenicin-2 displays a prolonged beta-hairpin, formed by two antiparallel beta-strands and stabilized by one disulfide and nine hydrogen bonds. A significant right-handed twist in the beta-sheet is deprived the peptide surface of amphipathicity. CD spectroscopic analysis indicates that arenicin-2 binds to the SDS and DPC micelles, and conformation of the peptide is significantly changed upon","2JNI, 2L8X resolved by NMR.","Function: Has antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteriua as well as yeast C. albicans. Bacterial killing occurs within minutes and is accompanied by membrane permeabilization, membrane detachment and release of cytoplasm. Interaction of arenicin with reconstituted membranes that mimic the lipopolysaccharide-containing outer membrane or the phospholipid-containing plasma membrane of Gram-negative bacteria exhibited no pronounced lipid specificity.
PTM: Contains one disulfide bond 3-20.
Domian: Contains 1 BRICHOS domain.",Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacterium: Escherichia coli ML-35p.##Yeast: Candida albicans 820.,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys3 and Cys20.,L,No cytotoxicity information found,Anionic lipid vesicles,15527787##17935487##17585874,FEBS Lett. 2004 Nov 5;577(1-2):209-214.##Biochem J. 2008 Feb 15;410(1):113-122.##Biochem Biophys Res Commun. 2007 Aug 17;360(1):156-162.,"Ovchinnikova TV, Aleshina GM, Balandin SV, Krasnosdembskaya AD, Markelov ML, Frolova EI, Leonova YF, Tagaev AA, Krasnodembsky EG, Kokryakov VN.##Andrä J, Jakovkin I, Grötzinger J, Hecht O, Krasnosdembskaya AD, Goldmann T, Gutsmann T, Leippe M.##Ovchinnikova TV, Shenkarev ZO, Nadezhdin KD, Balandin SV, Zhmak MN, Kudelina IA, Finkina EI, Kokryakov VN, Arseniev AS.","Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina.##Structure and mode of action of the antimicrobial peptide arenicin.##Recombinant expression, synthesis, purification, and solution structure of arenicin.",21,18-21
DRAMP03208,RCVCTRGFCRCVCRRGVC,18,"BTD-1 (theta-defensin; primates, mammals, animals)","B6ULW4, P86031, B6ULW5, P86032",Not found,Not found,Papio anubis (Olive baboon),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: BTD-1 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. ",Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,18852242,Infect Immun. 2008 Dec;76(12):5883-5891.,"Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.","Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",18,15-18
DRAMP03209,RCVCRRGVCRCVCRRGVC,18,"BTD-2 (theta-defensin; primates, mammals, animals)","B6ULW5, P86032",Not found,Not found,Papio anubis (Olive baboon),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: BTD-2 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. Among the five BTDs detected, the most potent peptide is BTD-2. BTD-2 is more effective against E. coli than BTD-1.",Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,18852242,Infect Immun. 2008 Dec;76(12):5883-5891.,"Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.","Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",18,15-18
DRAMP03211,RCVCTRGFCRCICLLGIC,18,"BTD-4 (theta-defensin; primates, mammals, animals)","B6ULW4, B6ULW6",Not found,Not found,Papio anubis (Olive baboon),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: BTD-4 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. Among the five BTD detected, BTD-4 is least positively charged (net charge +2). This may be responsible for its weaker antimicrobial activity observed in vitro. It disrupts E. coli membranes.",Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,18852242,Infect Immun. 2008 Dec;76(12):5883-5891.,"Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.","Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",18,15-18
DRAMP03212,RCVCTRGFCRCFCRRGVC,18,"BTD-7 (theta-defensin; primates, mammals, animals)","B6ULW4, B6ULW7",Not found,Not found,Papio anubis (Olive baboon),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: BTD-7 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. ",Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,18852242,Infect Immun. 2008 Dec;76(12):5883-5891.,"Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.","Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",18,15-18
DRAMP18217,WEEYNIIXQLGNKGQ,15,Licheniocin 50.2(Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Not found,Bacillus licheniformis VPS50.2,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,Not found,,"Fuction: The bacteriocin activity was insensitive to lysozyme and proteinase K, heat stable after incubation at 100 Celsius degree for 30 min and over wide range of pH (2",Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2423832,Laryngol Rhinol Otol (Stuttg). ,"Maier H, Adler D.",Treatment of chronic recurring parotitis with the protease inhibitor aprotinin (trasylol).,15,12-15
DRAMP18215,TTPLCVGVIIGITASIKICK,20,Cerecidin A7(Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),Not found,Bacillus cereus,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,Not found,,"Fuction: Active against Gram-positive bacteria B. cereus As 1.348, B. cereus As 1.352, B. thuringiensis 1.1013, B. thuringiensis 1.1014, B. subtilis 1.107, B. subtilis DB104, B. pumilus 1.1165, E. faecalis 1.14, E. faecalis V583, E. durans 1.2023, E. pernyi 1.1010, L. coprophilus 1.214, L. acidophilus 100-33, L. casei 1.575, L. rhamnosus 1.104, L. plantarum 1.551, L. brevis 1.2028, L. brevis 1.7, L. buchneri 1.40, L. lactis LM0230, L. lactis MG1363, L. curvatus LTH1.174, L. dextranicum 181 (zone inhibition 7-11 mm), M. flavus NCIB8166 (zone inhibition 18 mm), S. aureus 1-1, S. bovis LG42, S. gordonii 1.2496, S. salivarius 1.2498, S. thermophilus 1.1864 (Zone inhibition 7-11 mm), including resistant superbugs (MRSA and VRE).",Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,24532070,Appl Environ Microbiol. 2014 Apr;80(8):2633-43.,"Wang J, Zhang L, Teng K, Sun S, Sun Z, Zhong J.","Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity.",20,18-21
DRAMP03255,MIASHLAFEKLSKLGSKHTML,21,"M-lycotoxin-Ls4a (M-LCTX-Ls4a; Peptide 2340; spiders, Arthropods, animals)",P0C2V0,Not found,Not found,Lycosa singoriensis (Wolf spider) (Aranea singoriensis),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: May inhibit growth of bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,14991689,J Mass Spectrom. 2004 Feb;39(2):193-201.,"Budnik B.A, Olsen J.V, Egorov T.A, Anisimova V.E, Galkina T.G, Musolyamov A.K, Grishin E.V, Zubarev R.A.",De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.,21,18-21
DRAMP03256,AGIGKIGDFIKKAIAKYKN,19,"U1-lycotoxin-Ls1a (U1-LCTX-Ls1a; Peptide 2034; spiders, Arthropods, animals)",P0C2U9,Not found,Not found,Lycosa singoriensis (Wolf spider),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: May inhibit growth of bacteria.
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,14991689,J Mass Spectrom. 2004 Feb;39(2):193-201.,"Budnik B.A, Olsen J.V, Egorov T.A, Anisimova V.E, Galkina T.G, Musolyamov A.K, Grishin E.V, Zubarev R.A.",De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.,19,18-21
DRAMP18214,TTPLCVGVIIGLTTSIKICK,20,Cerecidin A1(Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),Not found,Bacillus cereus,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,Not found,,"Fuction: Active against multiple Gram-positive strains, B. cereus As 1.348, B. cereus As 1.352, B. thuringiensis 1.1013, B. thuringiensis 1.1014, B. subtilis 1.107, B. subtilis DB104, B. pumilus 1.1165, E. faecalis 1.14, E. faecalis V583, E. durans 1.2023, E. pernyi 1.1010, L. coprophilus 1.214, L. acidophilus 100-33, L. casei 1.575, L. rhamnosus 1.104, L. plantarum 1.551, L. brevis 1.2028, L. brevis 1.7, L. buchneri 1.40, L. lactis LM0230, L. lactis MG1363, L. curvatus LTH1.174, L. dextranicum 181 (zone inhibition 6-10 mm, M. flavus NCIB8166 (zone inhibition 15 mm), S. bovis LG42, S. gordonii 1.2496, S. salivarius 1.2498, and S. thermophilus 1.1864 (Zone inhibition 7-9 mm), including resistant superbugs (MRSA and VRE).",Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,24532070,Appl Environ Microbiol. 2014 Apr;80(8):2633-43.,"Wang J, Zhang L, Teng K, Sun S, Sun Z, Zhong J.","Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity.",20,18-21
DRAMP03281,LSCKRGTCHFGRCPSHLIKGSCSGG,25,"Turkey Heterophil Peptide 3 (Antimicrobial peptide THP3; Birds, animals)",P80393,Belongs to the beta-defensin family,Not found,Meleagris gallopavo (Common turkey),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Bridge,Not found,,Comment: No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7964174,J Leukoc Biol. 1994 Nov;56(5):661-665.,"Evans EW, Beach GG, Wunderlich J, Harmon BG.",Isolation of antimicrobial peptides from avian heterophils.,25,24-27
DRAMP03284,LPRHTLHCVAYHGYCFHSKV,20,"Beta-defensin (Birds, animals)",P86385,Belongs to the beta-defensin family,Not found,Dromaius novaehollandiae (Emu),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Has bactericidal activity (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22044478,Gene. 2012 Jan 15;492(1):244-249.,"Maehashi K, Matano M, Irisawa T, Uchino M, Kashiwagi Y, Watanabe T.",Molecular characterization of goose- and chicken-type lysozymes in emu (Dromaius novaehollandiae): evidence for extremely low lysozyme levels in emu egg white.,20,18-21
DRAMP18209,ASSGWVCTLTIECGTVICACR,21,NAI-802 (Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),Not found,Actinoplanes strains ID104802 and ID104771,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,"This peptide shares 19 residues with class II lantibiotic actagardine. In addition, it contains one extra Ala at the N-terminus and an extra Arg at the C-terminus. Actagardine, Ala(0)-actagardine, actagardine B, michiganin A, NAI-802 and Ala(0)-NAI-802 share three conserved thioether bridges within a core 19-aa peptide consisting of 14 invariant residues. ",,"As expected from the overall higher positive charge, NAI-802 was slightly more active than actagardine against staphylococci and streptococci. Further improvement of its antibacterial activity was achieved by adding one additional positive charge through conversion of the C-terminal carboxylate into the corresponding basic amide.",Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipid II,23168402,J Antibiot (Tokyo). 2013 Feb;66(2):73-8.,"Simone M, Monciardini P, Gaspari E, Donadio S, Maffioli SI.","Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.",21,18-21
DRAMP03313,VDKPDYRPRPWPRPN,15,"Metalnikowin-2A (Metalnikowin IIA; Insects, animals)",P80409,Not found,Not found,Palomena prasina (Green shield bug) (Cimex prasinus),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Insect Physiol. 1996; 42: 81-89.,"Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.",The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.,15,12-15
DRAMP03314,VDKPDYRPRPWPRNMI,16,"Metalnikowin-2B (Metalnikowin IIB; Insects, animals)",P80410,Not found,Not found,Palomena prasina (Green shield bug) (Cimex prasinus),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Insect Physiol. 1996; 42: 81-89.,"Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.",The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.,16,15-18
DRAMP03315,VDKPDYRPRPWPRPNM,16,"Metalnikowin-3 (Metalnikowin III; Insects, animals)",P80411,Not found,Not found,Palomena prasina (Green shield bug) (Cimex prasinus),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J. Insect Physiol. 1996; 42: 81-89.,"Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.",The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.,16,15-18
DRAMP18204,SNASVWECCSTGSWVPFTCC,20,Labyrinthopeptin A1(Bacteriocin),C0MP59,Belongs to the lantibiotics family (Class I bacteriocin),labA1,Actinomadura namibiensis DSM 6313,"Antimicrobial, Antiviral, Anti-HIV, Anti-HSV",,Not found,"LabyA1 contains a special amino acid labionin at positions 1, 4, 8, 10, 13, and 19. Labs 1,4 and labs 10, 13 are connected via a carbon-carbon bond, while labs 4, 8 and labs 13, 19 form normal thioether bonds. In addition, a disulfide bond occurs between C9 and C20.",,"Function: LabyA1 also demonstrated additive to synergistic effects in its anti-HIV-1 and anti-HSV-2 activity with anti(retro)viral drugs in dual combinations such as tenofovir, acyclovir, saquinavir, raltegravir and enfuvirtide.",HSV(EC50: 0.29,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23724015,PLoS One. 2013 May 28;8(5):e64010.,F,The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications,20,18-21
DRAMP18206,ASGWVCTLTIECGTLVCAC,19,Deoxyactagardine B(Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),ligA,Actinoplanes liguriae NCIMB41362,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,"Actagardine, Ala(0)-actagardine, actagardine B, michiganin A, NAI-802 and Ala(0)-NAI-802 share three conserved thioether bridges within a core 19-aa peptide consisting of 14 invariant residues. ",,Comment: No comments found on DRAMP database,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipid II,23168402,J Antibiot (Tokyo). 2013 Feb;66(2):73-8.,"Simone M, Monciardini P, Gaspari E, Donadio S, Maffioli SI.","Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.",19,18-21
DRAMP18205,SDWSLWECCSTGSLFACC,18,Labyrinthopeptin A2 (Bacteriocin),C0MP60,Belongs to the lantibiotics family (Class I bacteriocin),labA2,Actinomadura namibiensis DSM 6313,"Antimicrobial, Antiviral",,Not found,"This peptide contains a special amino acid labionin at positions 1, 4, 8, 10, 13, and 17. Labs 1,4 and labs 10, 13 are connected via a carbon-carbon bond, while labs 4, 8 and labs 13, 17 form normal thioether bonds. In addition, a disulfide bond occurs between C9 and C18. ",,Comment: No comments found on DRAMP database,HSV,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20191635,Angew Chem Int Ed Engl. 2010 Mar 22;49(13):2436-40.,M,In vitro biosynthesis of the prepeptide of type-III lantibiotic labyrinthopeptin A2 including formation of a C-C bond as a post-translational modification.,18,15-18
DRAMP03364,DTNFPICIFCCKCCNNSQCGICCKT,25,"Hepcidin (mammals, rodents, animals)",Q9EQ21,Not found,Hamp,Mus musculus (Mouse),Antimicrobial ,Protein level,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
Tissue specificity: Highly expressed in the liver and to a much lesser extent in the heart.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11113132##11447267,J Biol Chem. 2001 Mar 16;276(11):7811-7819.##Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8780-8785.,"Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal O.##Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S.","A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.##Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.",25,24-27
DRAMP03365,DINFPICRFCCQCCNKPSCGICCEE,25,"Hepcidin-2 (mammals, rodents, animals)","Q80T19, Q8BFW2",Not found,Hamp2,Mus musculus (Mouse),Antimicrobial ,Transcript level,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis.
Tissue specificity: Highly expressed in the liver and to a much lesser extent in the heart. Also expressed in pancreas.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12729891##16141072,FEBS Lett. 2003 May 8;542(1-3):22-26.##Science. 2005 Sep 2;309(5740):1559-1563.,"Ilyin G, Courselaud B, Troadec MB, Pigeon C, Alizadeh M, Leroyer P, Brissot P, Loréal O.##Carninci P, Kasukawa T, Katayama S, et al.",Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload.##The transcriptional landscape of the mammalian genome.,25,24-27
DRAMP03404,GEKLKKIGQKIKNFFQKL,18,Cramp 18 (CRAMP analogue),No entry found,Not found,Not found,Mus musculus (Mouse),Not found,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10973820,Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-909.,"Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.","CRAMP Analogues Having Potent Antibiotic Activity against Bacterial, Fungal, and Tumor Cells without Hemolytic Activity.",18,15-18
DRAMP03418,DTNFPICLFCCKCCKNSSCGLCCIT,25,"Hepcidin (mammals, rodents, animals)",Q99MH3,Not found,Hamp,Rattus norvegicus (Rat),Antimicrobial,Homology,Not found,Not found,,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11113132,J Biol Chem. 2001 Mar 16;276(11):7811-7819.,"Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal O.","A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.",25,24-27
DRAMP03469,MDVVRTLILCVCLFGLTFA,19,"Serine protease inhibitor Cvsi-1 (molluscs, animals)","Q30HU9, P84574",Not found,Not found,Crassostrea virginica (Eastern oyster),"Antimicrobial, Antibacterial, Antiparasitic",Protein level,Not found,Not found,,"Function: Slow-binding inhibitor of serine proteases. The inhibitor rapidly binds to the protease forming a weak enzyme-inhibitor complex, and this is followed by a slow isomerization forming a tight-binding enzyme-inhibitor complex. Active against subtilisin A, perkinsin and trypsin with dissociation constants of 0.29 nM, 13.7 nM and 17.7 nM respectively. Not active against thermolysin, papain or pepsin. Has antiparasitic activity against the protozoan P. marinus.
Tissue specificity: Detected in hemolymph (at protein level). In oysters collected in the summer the expression level is highest in the digestive gland with low levels of expression in gill, mantle, labial palp, style-sac midgut, gonad, heart, and hemocyte. In winter expression levels are higher in all tissues with highest expression levels observed in the digestive gland. Within the digestive gland expression is limited to the basophil cells of the digestive diverticula.",Subtilisin A and Prochlorococcus marinus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16872855##19720077,Comp Biochem Physiol B Biochem Mol Biol. 2006 Sep;145(1):16-26.##Dev Comp Immunol. 2010 Jan;34(1):84-92.,"Xue QG, Waldrop GL, Schey KL, Itoh N, Ogawa M, Cooper RK, Losso JN, La Peyre JF.##La Peyre JF, Xue QG, Itoh N, Li Y, Cooper RK.","A novel slow-tight binding serine protease inhibitor from eastern oyster (Crassostrea virginica) plasma inhibits perkinsin, the major extracellular protease of the oyster protozoan parasite Perkinsus marinus.##Serine protease inhibitor cvSI-1 potential role in the eastern oyster host defense against the protozoan parasite Perkinsus marinus.",19,18-21
DRAMP03476,ATRVVYCNRRSGSVVGGDDTVYYEG,25,"Eryngin (mushroom, fungi)",P84525,Not found,Not found,Pleurotus eryngii ,"Antimicrobial, Antifungal",Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,"Fungi: Fusarium oxysporum, Mycosphaerella arachidicola.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15003349,Peptides. 2004 Jan;25(1):1-5.,"Wang H, Ng TB.","Eryngin, a novel antifungal peptide from fruiting bodies of the edible mushroom Pleurotus eryngii.",25,24-27
DRAMP03487,QRFSQPTFKLPQGRLTLSRKF,21,"Lebocin Peptide 1A (LP1A; Insects, animals)",No entry found,Belongs to the cecropin family,Not found,Manduca sexta,"Antimicrobial, Antibacterial",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Dev Comp Immunol. 2010 Jun;34(6):638-647.,"Rayaprolu S, Wang Y, Kanost MR, Hartson S, Jiang H.",Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,21,18-21
DRAMP03499,QRFIHPTYRPPPQPRRPVIMRA,22,"Heliocin (Pro-rich; Insects, animals)",P83427,Belongs to the lebocin family,Not found,Heliothis virescens (Tobacco budworm moth),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Has antibacterial activity, preferentially against Gram-negative bacteria.
Tissue specificity: Hemolymph.
Induction: By bacterial infection.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (JUL-2002) to UniProtKB.,"Bulet P, Lamberty M, Charlet M, Sabatier L, Rabel D.",Unknown,22,21-24
DRAMP03506,TPDHREVPSFSSRWEPNFGLTFSK,24,"Attacin (Insects, animals)",P86359,Belongs to the attacin/sarcotoxin-2 family,Not found,Heliothis virescens (Tobacco budworm moth),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Hemolymph antibacterial protein (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (SEP-2009) to UniProtKB,Shelby KS.,Unknown,24,21-24
DRAMP18208,VSTLSVSSPCPGWPSSFTWSNC,22,NAI-112(Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),Not found,Actinoplanes sp.,"Antimicrobial, Antibacterial, Antinociceptive, Antiallodynic, Anti-Gram+",,Not found,"The structural data indicate that NAI-112 is a 22-aa, neutrally charged, glycosylated lanthipeptide containing N-terminal Lab and C-terminal MeLab residues separated by a 4-aa linker. It carries a 6-deoxyhexose moiety N-linked to a tryptophan residue. NAI-112 represents the ?rst occurrence of a lanthipeptide containing a MeLab and an N-glycosylation. NAI-112 and labyrinthopeptin A2 share a similar ring topology.",,Comment: No comments found on DRAMP database,Gram-positive (modest),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,24191663,ACS Chem Biol. 2014 Feb 21;9(2):398-404.,"Iorio M, Sasso O, Maffioli SI, Bertorelli R, Monciardini P, Sosio M, Bonezzi F, Summa M, Brunati C, Bordoni R, Corti G, Tarozzo G, Piomelli D, Reggiani A, Donadio S.","A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.",22,21-24
DRAMP18207,ASGWVCTLTIECGTLVCAC,19,Actagardine B(Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),Not found,Actinoplanes liguriae NCIMB41362,"Antimicrobial, Antibacterial, Anti-Gram+",,Not found,"Actagardine, Ala(0)-actagardine, actagardine B, michiganin A, NAI-802 and Ala(0)-NAI-802 share three conserved thioether bridges within a core 19-aa peptide consisting of 14 invariant residues. ",,Comment: No comments found on DRAMP database,Gram-positive,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipid II,23168402,J Antibiot (Tokyo). 2013 Feb;66(2):73-8.,"Simone M, Monciardini P, Gaspari E, Donadio S, Maffioli SI.","Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.",19,18-21
DRAMP03564,ICIFCCGCCHRSKCGMCCKT,20,"Human hepcidin-20 (Hepc20; one chain of Hepcidin; Human, mammals, animals)","P81172, Q1HE14, Q9BY68",Not found,HAMP,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Beta strand,Not found,1M4E resolved by NMR.,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. Has strong antimicrobial activity against E.coli ML35P N.cinerea and weaker against S.epidermidis, S.aureus and group b streptococcus bacteria. Active against the fungus C.albicans. No activity against P.aeruginosa.
Tissue specificity: Highest expression in liver and to a lesser extent in heart and brain. Low levels in lung, tonsils, salivary gland, trachea, prostate gland, adrenal gland and thyroid gland. Secreted into the urine.
PTM: Contains four disulfide bonds 2-18; 5-17; 6-14; 8-9.","Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, S. epidermidis, group B Streptococcus.##Fungi: Candida albicans, Aspergillus fumigatus, Aspergillus niger.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11113131##12138110##11034317,J Biol Chem. 2001 Mar 16;276(11):7806-7810.##J Biol Chem. 2002 Oct 4;277(40):37597-37603.##FEBS Lett. 2000 Sep 1;480(2-3):147-150.,"Park CH, Valore EV, Waring AJ, Ganz T.##Hunter HN, Fulton DB, Ganz T, Vogel HJ.##Krause A et al Adermann K.","Hepcidin, a urinary antimicrobial peptide synthesized in the liver.##The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.##LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. ref2) Hepcidin, a rinary antimicrobial peptide synthesized in the liver.",20,18-21
DRAMP03565,DTHFPICIFCCGCCHRSKCGMCCKT,25,"Human hepcidin-25 (Hepc25; one chain of Hepcidin; Human, mammals, animals)","P81172, Q1HE14, Q9BY68",Not found,HAMP,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Beta strand,N-terminus is a metal-binding site. disulfide bonds are essential for antibacterial activity by probably binding to DNA.,"1M4F, 2KEF resolved by NMR.##3H0T resolved by X-ray.","PTM: Contains four disulfide bonds 7-22; 10-13; 11-19; 14-22.
Tissue specificity: Highest expression in liver and to a lesser extent in heart and brain. Low levels in lung, tonsils, salivary gland, trachea, prostate gland, adrenal gland and thyroid gland. Secreted into the urine.
Function: It showed antimicrobial activities in vitro, this peptide might be the long-sought hormone that regulates iron homeostasis in humans. A pathogen will survive if it can figure out a way to steal iron from the host.","Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, S. epidermidis, group B Streptococcus.##Fungi: Candida albicans, Aspergillus fumigatus, Aspergillus niger.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,DNA,11034317##11113131##12138110##19553669,FEBS Lett. 2000 Sep 1;480(2-3):147-150.##J Biol Chem. 2001 Mar 16;276(11):7806-7810.##J Biol Chem. 2002 Oct 4;277(40):37597-37603.##J Biol Chem. 2009 Sep 4;284(36):24155-24167.,"Krause A et al Adermann K.##Park CH, Valore EV, Waring AJ, Ganz T.##Hunter HN, Fulton DB, Ganz T, Vogel HJ.##Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier PD, Harvey TS, Miranda LP, Cheetham J, Sasu BJ.","LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. ref2) Hepcidin, a rinary antimicrobial peptide synthesized in the liver.##Hepcidin, a urinary antimicrobial peptide synthesized in the liver.##The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.##Hepcidin revisited, disulfide connectivity, dynamics, and structure.",25,24-27
DRAMP03579,RKFHEKHHSHRGYRSNYLYDN,21,"Histatin-4 (His-rich; Human, mammals, animals)","P15516, Q16243, Q502Z1",Not found,Not found,Homo sapiens (Human),"Antimicrobial, Antifungal",Protein level,Rich,Not found,,An autoproteolytic product from Histatin 3.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,1528633,Oral Microbiol Immunol 1992; 7: 127-128.,"Xu L, Lal K, Pollock JJ.",Histatins 2 and 4 are autoproteolytic degradation products of human parotid saliva.,21,18-21
DRAMP03580,DSHAKRHHGYKRKFHEKHHSHRGY,24,His3-(20-43)-peptide (Histatin 5; derivatives: Dh-5; Clinical),"P15516, Q16243, Q502Z1",Not found,Not found,Homo sapiens (Human),"Antimicrobial, Antibacterial, Antifungal",Protein level,Alpha helix ,Not found,,"Histatin 5 is a proteolytic product of histatin 3. The active Domain: of histitin 5 (Dh-5) corresponding to residues 11-24 showed HIV inhibitory effects. However,the results with the Dh-5 mutants are mixed (Groot et al. 2006 J. Virol. 80: 9236-9243). The sequence of Dhvar4 is KRLFKKLLFSLRKY, a helical peptide which is active against bacteria and fungi. Dhvar5 has a sequence LLLFLLKKRKKRKY, which is active against bacteria and fungi (Ruissen AL et al 2002 Peptides 23:1391-9). P-113 is a 12-residue active peptide corresponding to residues 4-15 of histatin 5 (Rothstein DM et al. 2001 AAC 45: 1367). The His-His sequence is a good ligand for Cu2+ (Kulon K et al. 2008 J Inorg Biochem 102: 960-72). Derivatives were subjected to clinical trials.","Yeast: Candida albicans (100% inhibition at 54 nmol), Cryptococcus neoformans.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Metal-binding (Zinc),3286634,J Biol Chem. 1988 Jun 5;263(16):7472-7477.,"Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF.","Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.",24,21-24
DRAMP03581,DSHAKRHHGYKRKFHEKHHSHRGYR,25,"Histatin 6 (His-rich; Human, mammals, animals)","P15516, Q16243, Q502Z1",Not found,Not found,Homo sapiens (Human),"Antimicrobial, Antifungal",Protein level,Rich,Not found,,An autoproteolytic product from Histatin 3.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,J Dent Res 1990; 69: 2-6.,Troxler RF et al Oppenheim FG.,Structural relation between human salivary histatins.,25,24-27
DRAMP03588,LAHQKPFIRKSYKCLHKRCR,20,"Human MUC7 20-Mer (Human, mammals, animals)",No entry found,Not found,Not found,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix ,Not found,,"Function: MUC7 20-mer showes potent activity against a variety of fungi, including C. albicans, C. glabrata, C. krusei, C. neoformans, and S. cerevisae. In addition, it is also active against several drug-resistant strains, including azole-resistant C. albicans, fluconazole-resistant C. glabrata, and amphotericin B-resistant C. neoformans.","Gram-positive bacteria: Streptococcus mutans (EC50=1.39 µM), Streptococcus gordonii (EC50=2.43 µM);##Gram-negative bacteria: Escherichia coli (EC50=1.61 µM), Pseudomonas aeruginosa (EC50=4.41 µM), Porphyromonas gingivalis (EC50<1 µM).##Fungi: Candida albicans (DIS) (EC50=5.85 µM), C. albicans (azole resistant) (EC50=2.40 µM), Candida glabrata (EC50=5.02 µM), C. glabrata (fluconazole resistant) (EC50=12.3 µM), Candida krusei (EC50=5.16 µM), Cryptococcus neoformans (EC50=4.05 µM), Cryptococcus neoformans (amphotericin B resistant) (EC50=4.29 µM), Saccharomyces cerevisiae (EC50=5.23 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12543672,Antimicrob Agents Chemother 2003 Feb;47(2):643-652.,"Bobek LA, Situ H.","MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action.",20,18-21
DRAMP03590,VAIALKAAHYHTHKE,15,"Calcitermin (Human, mammals, animals)","P80511, P83219, Q5SY66",Belongs to the S-101 family,S100A12,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Alpha helix ,Not found,,"Function: S100A12 is a calcium-, zinc- and copper-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response. Possesses antifungal activity against C. albicans and is also active against E. coli and P. aeruginosa but not L. monocytogenes and S. aureus.
Tissue specificity: Predominantly expressed by neutrophils, monocytes and activated macrophages. Expressed by eosinophils and macrophages in asthmatic airways in regions where mast cells accumulate. Found in high concentrations in the serum of patients suffering from various inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and Kawasaki disease.
Domain: The hinge Domain: contributes significantly to its chemotactic properties.","Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.##Yeast: Candida albicans at pH 5.4.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11522286,FEBS Lett. 2001 Aug 24;504(1-2):5-10.,"Cole AM, Kim YH, Tahk S, Hong T, Weis P, Waring AJ, Ganz T.","Calcitermin, a novel antimicrobial peptide isolated from human airway secretions.",15,12-15
DRAMP18198,GFGSKPLDSFGLNFF,15,Chaxapeptin,A0A0F7VRL1,Not found,ls3A sle2_130,Streptomyces leeuwenhoekii Strain C58,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer",,Not found,Not found,2N5C resolved by NMR,"Function: Active against Gram-positive strains, S. aureus and B. subtilis (MIC 30-35 ug/mL), and no activity against the Gram-negative bacteria. It also showed dose dependent inhibition of A549 cancer cells.",S. aureus and B. subtilis (MIC 30-35 ug/mL),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,26402731,J Org Chem.80(20):10252-60(2015),"Elsayed SS, Trusch F, Deng H, Raab A, Prokes I, Busarakam K, Asenjo JA, Andrews BA, van West P, Bull AT, Goodfellow M, Yi Y, Ebel R, Jaspars M, Rateb ME.","Chaxapeptin, a Lasso Peptide from Extremotolerant Streptomyces leeuwenhoekii Strain C58 from the Hyperarid Atacama Desert.",15,12-15
DRAMP18140,VARGWKRKCPLFGKGG,16,VG16KRKP,No entry found,,,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-",Synthetic,,The solution-NMR structure of VG16KRKP in lipopolysaccharide features a folded conformation with a centrally located turn-type structure stabilized by aromatic-aromatic packing interactions with extended N- and C-termini.,"2MXG,2MXH resolved by NMR",VG16KRKP is capable of inhibiting bacterial disease progression in plants.,"Gram-negative: E. coli (MIC=8 uM), X. campestris  (MIC=10 uM), X. oryzae  (MIC=15 uM);##Gram-positive: B. subtilis (MIC=50 uM);##Fungi: Candida albicans  (MIC=2 uM), Cryptococcus grubii  (MIC=5 uM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,cell membrane,26144972,Sci Rep. 2015 Jul 6;5:11951.,"Datta A, Ghosh A, Airoldi C, etal.","Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control",16,15-18
DRAMP03637,ATFNFINNCPFTVWAAAVPG,20,Thaumatin-like protein (Actc2),P83958,Belongs to the thaumatin family,tlp,Actinidia chinensis (Kiwi) (Yangtao),"Antimicrobial, Antifungal, Antiviral",Protein level,Not found,Not found,,Function: Has antifungal activity. Inhibits HIV-1 reverse transcriptase.,"Botrytis cinerea, Coprinus comatus, Mycosphaerella arachidicola, Physalospora piricola, Candida albicans, Saccharomyces carlsbergensis, HIV-1 reverse transcriptase.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12165295##12417892##15536427,Phytochemistry. 2002 Sep;61(1):1-6.##J Allergy Clin Immunol. 2002 Nov;110(5):805-810.##J Allergy Clin Immunol. 2004 Nov;114(5):1169-1175.,"Wang H, Ng TB.##Gavrović-Jankulović M, ćIrković T, Vucković O, Atanasković-Marković M, Petersen A, Gojgić G, Burazer L, Jankov RM.##Bublin M, Mari A, Ebner C, Knulst A, Scheiner O, Hoffmann-Sommergruber K, Breiteneder H, Radauer C.",Isolation of an antifungal thaumatin-like protein from kiwi fruits.##Isolation and biochemical characterization of a thaumatin-like kiwi allergen.##IgE sensitization profiles toward green and gold kiwifruits differ among patients allergic to kiwifruit from 3 European countries.,20,18-21
DRAMP03639,GLSQGVEPDIGQTYFEESRINQD,23,Astexin-1 (lasso peptide),No entry found,Not found,Not found,Asticcacaulis excentricus CB 48 (Gram-negative bacteria),"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Beta strand (2 strands; 3 residues),The solution structure of astexin-1 was determined and found to have a nine-membered macrolactam ring followed by an 8-aa loop and a 6-aa tail. The extended length of the loop and tail regions allow for hydrogen-bonding interactions between the backbone and polar side chains of these regions of the peptide.,2LTI resolved by NMR.,"Function: Astexin-1 has weak antimicrobial activity against Caulobacter crescentus. No growth inhibition is observed
for any other strains of bacteria tested, and the growth inhibition of C. crescentus is quite modest.",Gram-negative bacterium: Caulobacter crescentus CB15.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22949633,Proc Natl Acad Sci U S A. 2012 Sep 4. ,"Maksimov MO, Pelczer I, Link AJ.",Precursor-centric genome-mining approach for lasso peptide discovery.,23,21-24
DRAMP03640,DSHEKRHHEHRRKFHEKHHSHRGY,24,Hcl-hst 5 (N.leucogenys histatin 5),No entry found,Not found,Not found,Nomascus leucogenys,"Antimicrobial, Antifungal",Not found,Alpha helix (CD),Not found,,Rich in histidines. Partial helical in 50% TFE.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20423320,Protein Pept Lett. 2010 Jul;17(7):909-918.,"Padovan L, Segat L, Pontillo A, Antcheva N, Tossi A, Crovella S.",Histatins In Non-Human Primates: Gene Variations and Functional Effects.,24,21-24
DRAMP03664,ADNKNPLEECFRETNYEEFLEIAR,24,"L-amino-acid oxidase (LAAO, LAO, TM-LAO; reptilia, animals)",P0C2D6,Not found,Not found,Trimeresurus mucrosquamatus (Taiwan habu) (Protobothrops mucrosquamatus),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Not found,Not found,,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis, and antiparasitic activities By similarity. This protein has antibacterial activity abd cytotoxic activity, as well as an ability to induce platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions.
Tissue specificity: Expressed by the venom gland. PTM: Contains one disulfide bond.","Gram-negative bacterium: E. coli;##S. aureus, B. dysenteriae.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12621545,Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Mar;35(3):219-224.,"Wei JF, Wei Q, Lu QM, Tai H, Jin Y, Wang WY, Xiong YL.","Purification, characterization and biological activity of an L-amino acid oxidase from Trimeresurus mucrosquamatus venom.",24,21-24
DRAMP03665,IAIQGGXGYLXQPGDGYKYA,20,Lysozyme,P85152,Not found,Not found,Lysobacter sp. (strain XL1),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Biophysicochemical properties: Optimum pH is 8.0; Optimum temperature is 60 degrees Celsius.
Also has Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (APR-2007) to UniProtKB.,"Muranova T.A, Stepnaya O.A, Tsfasman I.M, Kulaev I.S.",Identification of extracellular bacteriolytic enzymes from Lysobacter sp. XL1.,20,18-21
DRAMP03673,FFHHIFRGIVHVGKSIHKLVTG,22,Dicentracin (Dicentracine),P59906,Belongs to the pleurocidin family,Not found,Dicentrarchus labrax (European seabass) (Morone labrax),Antimicrobial,Homology,Not found,Not found,,Function: May have antimicrobial activity.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases,"Salerno G, Roch P, Sri Widada J.","Dicentracine, first antimicrobial peptide isolated from the fish Dicentrarchus labrax.",22,21-24
DRAMP03674,DTHISEKIIDCNDIG,15,Cystatin-1 (Cystatin-I),P84911,Belongs to the caerin subfamily,Not found,Capra hircus (Goat),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Inhibits papain, ficin and bromelain with an IC50 of 0.09 µM, 0.115 µM and 0.113 µM respectively. Has antibacterial activity against Gram-positive bacteria and against the Gram-negative bacteria. Reduced antibacterial activity against Gram-positive bacterium B.subtilis. No antibacterial activity against the Gram-negative bacterium P.fluorescens.
Miscellaneous: Stable in the pH range 5.0-9.0 at 37 degrees Celsius. Stable when incubated in the temperature range 25-75 degrees Celsius and pH 7.5.
Sequence uncertainty: K or Y at position 7.","[Swiss_Prot Entry P84911]has antibacterial activity against Gram-positive bacteria S.aureus and S.hemolyticus, and against the Gram-negative bacterium E.coli. Reduced antibacterial activity against Gram-positive bacterium B.subtilis. No antibacterial activity against the Gram-negative bacterium P.fluorescens",[Swiss_Prot Entry P84911]Not found,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16257555,Comp Biochem Physiol B Biochem Mol Biol. 2005 Dec;142(4):361-368. ,"Sadaf Z, Shahid PB, Bilqees B.","Isolation, characterization and kinetics of goat cystatins.",15,12-15
DRAMP18192,FLFSLIPNAISGLLSAFK,18,Antimicrobial peptide AcrAP2,A0A0A1I6N9, Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short an,Not found,Androctonus crassicauda (Arabian fat-tailed scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Not found,Not found,,Has antimicrobial activity against the Gram-positive bacteria S.aureus and the yeast C.albicans. Causes hemolysis on horse erythrocytes (64 uM for 100% hemolysis).,"Gram-positive bacteria: S.aureus (MIC=8 uM, MBC=32 uM);##Yeast: C.albicans (MIC=16 uM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,25332684,Int. J. Biol. Sci. 10:1097-1107(2014),"Du Q., Hou X., Ge L., Li R., Zhou M., Wang H., Wang L., Wei M.,Chen T., Shaw C.","Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1and AcrAP2, from the venom of the scorpion, Androctonus crassicauda,display potent growth modulation effects on human cancer cell lines.",18,15-18
DRAMP03689,GWINEEKIQKKIDEP,15,"Scorpine-like (Arthropods, animals)",P86121,Belongs to the Belongs to the long chain scorpion toxin famiy,Not found,Opisthacanthus cayaporum (South American scorpion),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Has antimicrobial activity against S. aureus (78% growth inhibition at 1.8 µM).
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds.",Gram-positive bacterium: Staphylococcus aureus.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18502464,Toxicon. 2008 Jun 15;51(8):1499-1508.,"Schwartz EF, Camargos TS, Zamudio FZ, Silva LP, Bloch C Jr, Caixeta F, Schwartz CA, Possani LD.","Mass spectrometry analysis, amino acid sequence and biological activity of venom components from the Brazilian scorpion Opisthacanthus cayaporum.",15,12-15
DRAMP03703,LFFLPSLIGGLISAFK,16,"Mucroporin-like peptide (NDBP13; Arthropods, animals)",D9U2B8,Belongs to the short cationic antimicrobial peptide family,Not found,Lychas mucronatus (Chinese swimming scorpion),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,20663230,BMC Genomics. 2010 Jul 28;11:452.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.",Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.,16,15-18
DRAMP03704,LFGLIPSMMGGLVSAFK,17,"Antimicrobial peptide 36.4 (Arthropods, animals)",P0CI89,Belongs to the short cationic antimicrobial peptide family,Not found,Lychas mucronatus (Chinese swimming scorpion),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,20663230,BMC Genomics. 2010 Jul 28;11:452.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.",Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.,17,15-18
DRAMP03705,LFFLPSLIGGLISAIK,16,"Antimicrobial peptide 143 (Arthropods, animals)",P0CI90,Belongs to the short cationic antimicrobial peptide family,Not found,Lychas mucronatus (Chinese swimming scorpion),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,20663230,BMC Genomics. 2010 Jul 28;11:452.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.",Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.,16,15-18
DRAMP03717,GRGREFMSNLKEKLSGVKEKMKNS,24,"Meucin-24 (Arthropods, animals)",P0CH57,Long chain scorpion toxin family (Class 2 subfamily),Not found,Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus),Antimalarial,Protein level,Alpha helix (1 helices; 17 residues),"Circular dichroism (CD) analysis of chemically synthesized peptides demonstrates that meucin-24 presents an essential random coil conformation in water, but its alpha-helical content largely increases in the presence of 50% trifluoroethanol, a membrane-mimicking environment.",2KFE resolved by NMR.,"Function: The synthetic meucin-24 inhibits the development of P. berghei ookinetes, kills intraerythrocytic P.falciparum, and is cytotoxic to the Drosophila S2 cell at micromolar concentrations. No hemolytic activities have been found at micromolar concentrations.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: The RNA coding for this protein is silently edited.
PTM: Contains three disulfide bonds (By similarity).",No MICs found in DRAMP database,[Ref.20097251]Non-hemolytic effect against mouse erythrocytes even at 100 μM ,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20097251,Biochimie. 2010 Apr;92(4):350-359.,"Gao B, Xu J, Rodriguez Mdel C, Lanz-Mendoza H, HernÃ¡ndez-Rivas R, Du W, Zhu S.",Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.,24,21-24
DRAMP03718,VKLIQIRIWIQYVTVLQMFSMKTKQ,25,"Meucin-25 (BeL-170; Arthropods, animals)",P0CH58,Not found,Not found,Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus),Antimalarial,Transcript level,Not found,"CD results indicate that meucin-25 mainly adopts a beta-sheet structure in water but TFE promotes its alpha-helical formation, suggesting its conformational flexibility.",,"Function: This synthetic cationic peptide inhibits the development of Plasmodium berghei ookinetes, kills intraerythrocytic P. falciparum, and is cytotoxic to the Drosophila S2 cell at micromolar concentrations. No hemolytic activities have been found at micromolar concentrations.
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,[Ref.20097251]Non-hemolytic effect against mouse erythrocytes even at 101 μM,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20097251,Biochimie. 2010 Apr;92(4):350-359.,"Gao B, Xu J, Rodriguez Mdel C, Lanz-Mendoza H, HernÃ¡ndez-Rivas R, Du W, Zhu S.",Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.,25,24-27
DRAMP03733,SIYERCELARELINR,15,"Lysozyme (Arthropods, animals)",P0C8X2,Belongs to the glycosyl hydrolase 22 family,Not found,Tityus stigmurus (Brazilian scorpion),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,"Function: Lysozymes have primarily a bacteriolytic Function: (By similarity).
Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.
Tissue specificity: Expressed by the venom gland.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17270501,Comp Biochem Physiol C Toxicol Pharmacol. 2007 Jul-Aug;146(1-2):147-157.,"Batista C.V.F, Roman-Gonzalez S.A, Salas-Castillo S.P, Zamudio F.Z, Gomez-Lagunas F, Possani L.D.",Proteomic analysis of the venom from the scorpion Tityus stigmurus: biochemical and physiological comparison with other Tityus species.,15,12-15
DRAMP03741,IFGSLFSLGSKLLPSVFKLFSRKKQ,25,"Ponericin-W-like 32.1 (Arthropods, animals)",P0CI91,Belongs to the ponericin-W family,Not found,Lychas mucronatus (Chinese swimming scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Insecticidal",Transcript level,Not found,Not found,,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities (By similarity).
Tissue specificity: Expressed by the venom gland.",[Swiss_Prot Entry P0CI91]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae,[Swiss_Prot Entry P0CI91]has hemolytic activities,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20663230,BMC Genomics. 2010 Jul 28;11:452.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.",Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.,25,24-27
DRAMP03742,IFGSLFSLGSKLLPTVFKLFSRKKQ,25,"Ponericin-W-like 32.2 (Arthropods, animals)",P0CI92,Belongs to the ponericin-W family,Not found,Lychas mucronatus (Chinese swimming scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Insecticidal",Transcript level,Not found,Not found,,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities (By similarity).
Tissue specificity: Expressed by the venom gland.",[Swiss_Prot Entry P0CI92]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae,[Swiss_Prot Entry P0CI92]has hemolytic activities,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20663230,BMC Genomics. 2010 Jul 28;11:452.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.",Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.,25,24-27
DRAMP03747,FLSSLIPSAISGLISAFK,18,"Peptide BmKb2 (Arthropods, animals)",Q2M591,Not found,Kb2,Mesobuthus martensii (Manchurian scorpion) (Buthus martensii),Antimicrobial,Homology,Not found,Not found,,Function: May be an antimicrobial peptide (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,cell membrane,16040157,Peptides. 2005 Dec;26(12):2427-2433.,"Luo F, Zeng XC, Hahin R, Cao ZJ, Liu H, Li WX.",Genomic organization of four novel nondisulfide-bridged peptides from scorpion Mesobuthus martensii Karsch: gaining insight into evolutionary mechanism.,18,15-18
DRAMP18191,FLFSLIPHAISGLISAFK,18,Antimicrobial peptide AcrAP1,A0A0A1I6E7, Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short an,Not found,Androctonus crassicauda (Arabian fat-tailed scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Protein level,Not found,Not found,,Has antimicrobial activity against the Gram-positive bacteria S.aureus and the yeast C.albicans. Causes hemolysis on horse erythrocytes (64 uM for 100% hemolysis).,"Gram-positive bacteria: S.aureus (MIC=8 uM, MBC=32 uM);##Yeast: C.albicans (MIC=16 uM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,25332684,Int. J. Biol. Sci. 10:1097-1107(2014),"Du Q., Hou X., Ge L., Li R., Zhou M., Wang H., Wang L., Wei M.,Chen T., Shaw C.","Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1and AcrAP2, from the venom of the scorpion, Androctonus crassicauda,display potent growth modulation effects on human cancer cell lines.",18,15-18
DRAMP03759,FFSLIPSLIGGLVFAIK,17,"Putative antimicrobial peptide clone 5 (Arthropods, animals)",Q5G8B4,Not found,Not found,Tityus costatus (Brazilian scorpion),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Antibacterial peptide.(By similarity)
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15683865,Toxicon. 2005 Mar 1;45(3):273-283.,"Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.","The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.",17,15-18
DRAMP03760,FFSLIPSLIGGLVSAIK,17,"Putative antimicrobial peptide clone 6 (Arthropods, animals)",Q5G8B3,Not found,Not found,Tityus costatus (Brazilian scorpion),"Antimicrobial, Antibacterial",Transcript level,Not found,Not found,,"Function: Antibacterial peptide.(By similarity)
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15683865,Toxicon. 2005 Mar 1;45(3):273-283.,"Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.","The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.",17,15-18
DRAMP03771,FWATLAKGALKLIPTIANAFSSKS,24,"Non-disulfide-bridged peptide 4.3 (NDBP-4.3; OcyC3; Arthropods, animals)",C5J888,Not found,Not found,Opisthacanthus cayaporum (South American scorpion),"Antimicrobial, Antibacterial",Protein level,Not found,Not found,,Function: Amphipathic peptide with probable antimicrobial activity.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19379768##18502464,Toxicon. 2009 Sep 1;54(3):252-261.##Toxicon. 2008 Jun 15;51(8):1499-508.,"Silva EC, Camargos TS, MaranhÃ£o AQ, Silva-Pereira I, Silva LP, Possani LD, Schwartz EF.##Schwartz EF, Camargos TS, Zamudio FZ, Silva LP, Bloch C Jr, Caixeta F, Schwartz CA, Possani LD.","Cloning and characterization of cDNA sequences encoding for new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum.##Mass spectrometry analysis, amino acid sequence and biological activity of venom components from the Brazilian scorpion Opisthacanthus cayaporum.",24,21-24
DRAMP03778,ANDPQCLYGNVAAKF,15,Agrocybin (Fungus),P84797,Not found,Not found,Agrocybe cylindracea (Toadstool),"Antimicrobial, Antibacterial, Antifungal, Antiviral",Protein level,Not found,Not found,,Function: Has mitogenic activity towards murine splenocytes. Lacks antiproliferative activity towards HepG2 hepatoma cells. ,"Mycosphaerella arachidicola (IC50=125 µM), HIV-1 reverse transcriptase (IC50=60 µM), Pseudomonas fluorescens.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15629530,Peptides. 2005 Feb;26(2):191-196.,"Ngai PH, Zhao Z, Ng TB.","Agrocybin, an antifungal peptide from the edible mushroom Agrocybe cylindracea.",15,12-15
DRAMP03782,CPCGRRRCCVRGLNVYCCF,19,Corticostatin-related peptide LCRP (alpha-defensin),Q10996,Belongs to the alpha-defensin family,Not found,Petromyzon marinus (Sea lamprey),Antimicrobial,Protein level,Not found,Not found,,"Function: May have microbicidal activities. May inhibit corticotropin (ACTH) stimulated steroidogenesis and the microbial actions of the corticostatins.
PTM: Problely contains three disulfide bonds 1-18; 3-9; 8-17.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8759287,Comp Biochem Physiol B Biochem Mol Biol. 1996 Jun;114(2):133-137.,"Conlon JM, Sower SA.",Isolation of a peptide structurally related to mammaliancorticostatins from the lamprey Petromyzon marinus.,19,18-21
DRAMP03010,IKIMDILAKLGKVLAHV,17,"Bombolitin III (insects, arthropods, invertebrates, animals)",P07494,Not found,Not found,Megabombus pennsylvanicus (Bumblebee),"Antimicrobial, Antibacterial, Anti Mammalian Cells",Protein level,Not found,Not found,,Function: Mast cell degranulating peptide. Has hemolytic activity.,No MICs found in DRAMP database,[Ref.2578459] Hemolysis: ED50=2.8±0.05 µg/ml. Histamine release: ED50=10.4±0.4 µg/ml against guinea pig erythrocytes.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2578459 ,J Biol Chem. 1985 Feb 10;260(3):1437-144.,"Argiolas A, Pisano JJ.","Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.",17,15-18
DRAMP03009,SKITDILAKLGKVLAHV,17,"Bombolitin II (insects, arthropods, invertebrates, animals)",P07493,Not found,Not found,Megabombus pennsylvanicus (Bumblebee),"Antimicrobial, Antibacterial, Anti Mammalian Cells",Protein level,Not found,Not found,,Function: Mast cell degranulating peptide. Has hemolytic activity.,No MICs found in DRAMP database,[Ref.2578459] Hemolysis: ED50=3.9±0.06 µg/ml. Histamine release: ED50=15.8±0.5 µg/ml against guinea pig erythrocytes.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2578459 ,J Biol Chem. 1985 Feb 10;260(3):1437-144.,"Argiolas A, Pisano JJ.","Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.",17,15-18
DRAMP03008,IKITTMLAKLGKVLAHV,17,"Bombolitin I (insects, arthropods, invertebrates, animals)",P10521,Not found,Not found,Megabombus pennsylvanicus (Bumblebee),"Antimicrobial, Antibacterial, Anti Mammalian Cells",Protein level,Not found,Not found,,Function: Mast cell degranulating peptide. Has hemolytic activity.,No MICs found in DRAMP database,[Ref.2578459] Hemolysis: ED50=4.0±0.05 µg/ml. Histamine release: ED50=16.3±0.5 µg/ml against guinea pig erythrocytes.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2578459 ,J Biol Chem. 1985 Feb 10;260(3):1437-144.,"Argiolas A, Pisano JJ.","Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.",17,15-18
DRAMP03850,FALALKALKKALKKLKKALKKAL,23,Antibacterial peptide/melittin homolog,No entry found,Not found,Not found,Synthetic construct ,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8714745,Scanning Microsc. 1995 Jun;9(2):501-507.,"Henk WG, Todd WJ, Enright FM, Mitchell PS.","The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli.",23,21-24
DRAMP03926,GWLRKLGAVLKVLTT,15,Cecropin B (1-7)-melittin (4-11)hybrid peptide (CBM),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Function: The hemolytic assays indicated CBM had no hemolytic in vivo and in vitro.,"[Ref.20111863]Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Bacillus subtilis, Bacillus thuringiensis, Salmonella derby.","[Ref.20111863]0.05% hemolytic activity at 5 mg/kg, 0.14% hemolytic activity at 10 mg/kg in vivo",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20111863,Curr Microbiol. 2010 Sep;61(3):169-175.,"Cao Y, Yu RQ, Liu Y, Zhou HX, Song LL, Cao Y, Qiao DR.","Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides.",15,12-15
DRAMP03942,RRRFPWVCWPFLRRR,15,Peptide 2 (Trp- and Arg-rich; derivative of Tritrpticin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Rich,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Proteus mirabilis;##Gram-positive bacteria: Staphylococcus epidermidis, Streptococcus group D.##Fungi: Aspergillus fumigatus.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8706838,FEBS Lett. 1996 Jul 15;390(1):95-98.,"Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K.",Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides.,15,12-15
DRAMP18396,FFWHHIGHALDAAKRVHGMLSG,22,"moroNC-NH2 (moronecidin-like peptide; fish, animals)",No entry found,Not found,Not found,Notothenia coriiceps,"Antimicrobial, Antibacterial, Antifungal",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against Gram- S. sonnei (ATCC 29930) (MIC 12.5 uM), Psychrobacter sp. (PAMC 25501) (MIC 5 uM), E. coli DH5alpha (MIC 12.5 uM), Gram+ S. pyogenes (ATCC 19615) (MIC 25 uM), S. aureus (ATCC 33591) (MIC 25 uM) , L. monocytogenes (ATCC 15313) (MIC 12.5 uM), and yeast C. tropicalis (ATCC 20115) (MIC 5 uM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,28122029,PLoS One. 2017 Jan 25;12(1):e0170821.,"Shin SC, Ahn IH, Ahn DH, Lee YM, Lee J, Lee JH, Kim HW, Park H.",Characterization of Two Antimicrobial Peptides from Antarctic Fishes (Notothenia coriiceps and Parachaenichthys charcoti),22,21-24
DRAMP03946,GLIKIVPAMICAVTKKC,17,Del 1-3 (Ranalexin analog),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC>256 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC>256 µg/ml), Pseudomonas aeruginosa (MIC>256 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",17,15-18
DRAMP03962,KWKLFKKIGIGKFLHSAKKF,20,Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide (CAMA),P01507,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Alpha helix ,Not found,"1F0D, 1D9J resolved by NMR.","MOA: The partial insertion of the Trp2 of CA-MA into the membrane, as well as the electrostatic interactions between the positively charged Lys residues at the N-terminus of the CA-MA and the anionic phospholipid headgroups, leads to the primary binding to the cell membrane. Then, the flexibility or bending potential induced by the Gly-Ile-Gly hinge sequence or the Pro residue in the central part of the peptides may allow the alpha-helix in the C-terminus to span the lipid bilayer.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11009597,Biochemistry. 2000 Oct 3;39(39):11855-11864.,"Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.","Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.",20,18-21
DRAMP03963,KWKLFKKIKFLHSAKKF,17,Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide analogue (P1),P01507,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Alpha helix (1 helices; 9 residues),Not found,1F0F resolved by NMR.,"P1 has significantly decreased lytic activities against bacterial and tumor cells and PC/PS vesicles (3:1, w/w), and reduced pore-forming activity on lipid bilayers.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11009597,Biochemistry. 2000 Oct 3;39(39):11855-11864.,"Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.","Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.",17,15-18
DRAMP03964,KWKLFKKIPKFLHSAKKF,18,Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide analogue (P2),P01507,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Alpha helix ,Not found,"1F0E, 1D9M resolved by NMR.",P2 retained effective lytic activities and pore-forming activity.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11009597,Biochemistry. 2000 Oct 3;39(39):11855-11864.,"Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.","Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.",18,15-18
DRAMP03965,KAKLFKKIGIGKFLHSAKKF,20,Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide analogue (P3),P01507,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Alpha helix (1 helices; 10 residues),Not found,1F0H resolved by NMR.,The N-terminal region of P3 has a flexible structure without any specific secondary structure. The P3 modification caused a drastic decrease in the antibiotic activities.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11009597,Biochemistry. 2000 Oct 3;39(39):11855-11864.,"Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.","Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.",20,18-21
DRAMP03966,KLKLFKKIGIGKFLHSAKKF,20,Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide analogue (P4),P01507,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Alpha helix ,Not found,"1F0G, 1D9P resolved by NMR.","The hydrophobic Leu side chain of P4 is at position 2, retained its activities.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11009597,Biochemistry. 2000 Oct 3;39(39):11855-11864.,"Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.","Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.",20,18-21
DRAMP02092,FLPAIAGMAAKFLPKIFCAISKKC,24,"Brevinin-1Bb (Frogs, amphibians, animals)",P82834,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=1 μM);##Gram-negative bacterium: Escherichia coli (MIC=3 μM).##Yeast: Candida albicans (MIC=10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP04008,GLLSGILNTAGGLLGNLIGSLSN,23,"Plasticin-C1 (PTC-C1; DRP-AC-1; frogs, amphibians, animals)",No entry found,Not found,Not found,Agalychnis callidryas,"Antimicrobial, Antibacterial, Antifungal, Antiviral",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12709067,Eur J Biochem. 2003 May;270(9):2068-2081.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.",Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,23,21-24
DRAMP04009,GLLSGILNSAGGLLGNLIGSLSN,23,"Plasticin-C2 (PTC-C2; DRP-AC-2; frogs, amphibians, animals)",No entry found,Not found,Not found,Agalychnis callidryas,"Antimicrobial, Antibacterial, Antifungal, Antiviral",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12709067,Eur J Biochem. 2003 May;270(9):2068-2081.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.",Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,23,21-24
DRAMP04010,GLVSDLLSTVTGLLGNLGGGGLKKI,25,"Plasticin-S1 (PTC-S1; frogs, amphibians, animals)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Antiviral",Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18644413,Peptides. 2008 Nov;29(11):2074-2082.,"Amiche M, Ladram A, Nicolas P.",A consistent nomenclature of antimicrobial peptides isolated from frogs of the subfamily Phyllomedusinae.,25,24-27
DRAMP04018,ALYKKFKKKLLKSLKRLG,18,Rp-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,"2RLH, 2RLG resolved by NMR.",Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria and the yeast candian ,"Gram-positive bacteria: Staphylococcus, Streptococcus, Bacillus species;##Gram-negative bacteria: Escherichia, Salmonella, Pseudomonas species.##Fungi: Candida and Cryptococcus species.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18712851,Biopolymers. 2009 Jan;91(1):1-13.,"Bourbigot S, Dodd E, Horwood C, Cumby N, Fardy L, Welch WH, Ramjan Z, Sharma S, Waring AJ, Yeaman MR, Booth V.",Antimicrobial peptide RP-1 structure and interactions with anionic versus zwitterionic micelles.,18,15-18
DRAMP04039,LKLLKKLLKLLKKLGK,16,Immobilized peptige E16KGL/H16KGL,No entry found,Not found,Not found,Synthetic construct ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,16,15-18
DRAMP04040,LKLLKKLLKLLKKLGGK,17,Immobilized peptide E17KGG,No entry found,Not found,Not found,Synthetic construct ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,17,15-18
DRAMP04041,LKLLKKLLKLLKKLGGGK,18,Immobilized peptide E18KGG,No entry found,Not found,Not found,Synthetic construct ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,18,15-18
DRAMP04042,KGLKKLLKLLKKLLKL,16,Immobilized peptide E16LKL,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,16,15-18
DRAMP04046,SNMIEGVFAKGFKKASHLFKGIG,23,Immobilized peptide E23GIG magainin2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,23,21-24
DRAMP04047,SNMIEGVFAKGFKKASH,17,Immobilized peptide E17HSA magainin 2 deletion,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,17,15-18
DRAMP04130,FVDLKKIANIINSIFKK,17,LK1 (Temporin-1CEa analog peptide),No entry found,Not found,Not found,Synthetic construct,Anti-cancer,Synthetic,Not found,Not found,,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=20.97 µM), Bcap-37 (IC50=18.7 µM), MDA-MB-231 (IC50=66.4 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23609760,Arch Pharm Res. 2013 Apr 23.,"Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.","Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.",17,15-18
DRAMP04131,FKDLKKIANIINSIFKK,17,LK2(5) (Temporin-1CEa analog peptide),No entry found,Not found,Not found,Synthetic construct,Anti-cancer,Synthetic,Not found,Not found,,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=44.7 µM), Bcap-37 (IC50=83.49 µM), MDA-MB-231 (IC50=894.7 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23609760,Arch Pharm Res. 2013 Apr 23.,"Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.","Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.",17,15-18
DRAMP04132,FVKLKKIANIINSIFKK,17,LK2(6) (Temporin-1CEa analog peptide),No entry found,Not found,Not found,Synthetic construct,Anti-cancer,Synthetic,Not found,Not found,,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=15.54 µM), MDA-MB-231 (IC50=85.41 µM), Bcap-37 (IC50=18.9 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23609760,Arch Pharm Res. 2013 Apr 23.,"Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.","Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.",17,15-18
DRAMP04133,FKKLKKIANIINSIFKK,17,LK3 (Temporin-1CEa analog peptide),No entry found,Not found,Not found,Synthetic construct,Anti-cancer,Synthetic,Not found,Not found,,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=27.72 µM), MDA-MB-231 (IC50=224.8 µM), Bcap-37 (IC50=25.04 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23609760,Arch Pharm Res. 2013 Apr 23.,"Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.","Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.",17,15-18
DRAMP04134,FVKLKKILNIINSIFKK,17,LK2(6)A(L) (Temporin-1CEa analog peptide),No entry found,Not found,Not found,Synthetic construct,Anti-cancer,Synthetic,Not found,Not found,,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=9.01 µM), MDA-MB-231 (IC50=34.74 µM), Bcap-37 (IC50=10.52 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23609760,Arch Pharm Res. 2013 Apr 23.,"Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.","Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.",17,15-18
DRAMP04135,FVKLKKILNIILSIFKK,17,LK2(6)AN(2L) (Temporin-1CEa analog peptide),No entry found,Not found,Not found,Synthetic construct,Anti-cancer,Synthetic,Not found,Not found,,Function: Has anticancer activity.,"Cancer cell lines: MCF-7 (IC50=11 µM), MDA-MB-231 (IC50=41.55 µM), Bcap-37 (IC50=9.39 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23609760,Arch Pharm Res. 2013 Apr 23.,"Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.","Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.",17,15-18
DRAMP04151,IKRFWPVVIRTVVAGYNLYRAIKKK,25,RL1 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,25,24-27
DRAMP04152,KRFWPVVIRTVVAGYNLYRAIKKK,24,RL2 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,24,21-24
DRAMP04153,RFWPVVIRTVVAGYNLYRAIKKK,23,RL3 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,23,21-24
DRAMP04154,FWPVVIRTVVAGYNLYRAIKKK,22,RL4 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,22,21-24
DRAMP04155,WPVVIRTVVAGYNLYRAIKKK,21,RL5 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,21,18-21
DRAMP04156,PVVIRTVVAGYNLYRAIKKK,20,RL6 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,20,18-21
DRAMP04157,VVIRTVVAGYNLYRAIKKK,19,RL7 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,19,18-21
DRAMP04158,VIRTVVAGYNLYRAIKKK,18,RL8 (homologue of Pc-CATH1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antifungal",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,18,15-18
DRAMP04197,RQIKIWFQNRRMKWKK,16,Penetratin,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-232.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.",Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.,16,15-18
DRAMP04198,RQIRIWFQNRRMRWRR,16,PenArg,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=8 μM),[Ref.23085001] HC50>128 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.",Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.,16,15-18
DRAMP04199,KQIKIWFQNKKMKWKK,16,PenLys,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Alpha helix,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=256 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=64 μM),[Ref.23085001] HC50>128 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.",Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.,16,15-18
DRAMP04200,RQIKIWFQNRRLKWKK,16,PenLeu,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=64 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM),[Ref.23085001] HC50>128 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.",Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.,16,15-18
DRAMP04204,RWFKIQMQIRRWKNKK,16,PenShuf,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=64 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM),[Ref.23085001] HC50>128 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.",Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.,16,15-18
DRAMP04205,RWFKIQLQIRRWKNKK,16,PenShufLeu,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM),[Ref.23085001] HC50=65±2.5 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.",Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.,16,15-18
DRAMP04206,KWFKIQLQIKKWKNKK,16,PenShufLysLeu,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=32 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM),[Ref.23085001] HC50=91±2.3 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.",Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.,16,15-18
DRAMP04207,RWFRIQLQIRRWRNRR,16,PenShufArgLeu,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=16 μM),[Ref.23085001] HC50=39±1.4 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.",Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.,16,15-18
DRAMP02126,FIGSALKVLAGVLPSIVSWVKQ,22,"Melittin-like peptide (MLP; Frogs, amphibians, animals)",P56924,Not found,Not found,Rana temporaria (European common frog),"Defense response, Anti-cancer, Protein kinase inhibitor activity",Protein level,Not found,Not found,,"Function: Peptide has cellular defense response,  inflammatory response, behavioral defense response, defense response to tumor cell,  defense response by callose deposition,  clearance of foreign intracellular nucleic acids, innate immune response, defense response by cell wall thickening, defense response to other organism, protein serine/threonine kinase inhibitor activity, calcium-dependent protein kinase inhibitor activity, protein tyrosine kinase inhibitor activity in GO analysis. Has hemolytic activity.
PTM: Glutamine amide at position 22.
Tissue specificity: Expressed by the skin dorsal glands.",No MICs found in DRAMP database,[Ref.9022710] LC=0.5 µM against human red blood cells. (LC: Lethal concentration),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9022710,Eur J Biochem. 1996 Dec 15;242(3):788-792.,"Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.","Temporins, antimicrobial peptides from the European red frog Rana temporaria.",22,21-24
DRAMP04211,GIGKHVGKALKGLKGLLKGLGEC,23,ADP2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23196344,Biochim Biophys Acta. 2013 Mar;1828(3):1004-1012.,"Ilić N, Novković M, Guida F, Xhindoli D, Benincasa M, Tossi A, Juretić D.","Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences.",23,21-24
DRAMP04212,GLKGLLGKALKGIGKHIGKAQGC,23,ADP3,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23196344,Biochim Biophys Acta. 2013 Mar;1828(3):1004-1012.,"Ilić N, Novković M, Guida F, Xhindoli D, Benincasa M, Tossi A, Juretić D.","Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences.",23,21-24
DRAMP04216,KQSHKKGGHSFPKEKIS,17,P1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23022146,Biochimie. 2013 Feb;95(2):231-240.,"Yamane ES, Bizerra FC, Oliveira EB, Moreira JT, Rajabi M, Nunes GL, de Souza AO, da Silva ID, Yamane T, Karpel RL, Silva PI Jr, Hayashi MA.",Unraveling the antifungal activity of a South American rattlesnake toxin crotamine.,17,15-18
DRAMP04218,KIFGAIWPLALGALKNLIK,19,Lys-a1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23340019,Peptides. 2013 Apr;42:78-83.,"da Silva BR, de Freitas VA, Carneiro VA, Arruda FV, Lorenzón EN, de Aguiar AS, Cilli EM, Cavada BS, Teixeira EH.",Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci.,19,18-21
DRAMP04222,KYYSRVRGGRSAVLSSLDK,19,CHRG06 (hBD3 derivative),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12936977,Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.,"Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.",Antimicrobial characterization of human beta-defensin 3 derivatives.,19,18-21
DRAMP04223,GIINTLQKYYSRVRGGR,17,CHRG07 (hBD3 derivative),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12936977,Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.,"Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.",Antimicrobial characterization of human beta-defensin 3 derivatives.,17,15-18
DRAMP04224,RPDKPRPYLPRPRPPRPVR,19,A3-APO,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20031377,Int J Antimicrob Agents. 2010 Apr;35(4):357-361.,"Szabo D, Ostorhazi E, Binas A, Rozgonyi F, Kocsis B, Cassone M, Wade JD, Nolte O, Otvos L Jr.",The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.,19,18-21
DRAMP04225,GKPRPYLPRPTSHPRPIRV,19,Dros-Pyrr-Dros,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Letters in Peptide Science. 2001;8(3-5):201-209.,"Bencivengo AM, Cudic M, Hoffmann R, Jr LO.","The efficacy of the antibacterial peptide, pyrrhocoricin, is finely regulated by its amino acid residues and active domains.",19,18-21
DRAMP04226,VDKGSYLPRPTSHPRPIRV,19,Pyrr-Pyrr-Dros,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Letters in Peptide Science. 2001;8(3-5):201-209.,"Bencivengo AM, Cudic M, Hoffmann R, Jr LO.","The efficacy of the antibacterial peptide, pyrrhocoricin, is finely regulated by its amino acid residues and active domains.",19,18-21
DRAMP04227,GLLRRLRKKIGEIFKKYG,18,PGG,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9428709,Eur J Biochem. 1997 Dec 1;250(2):549-558.,"Tossi A, Tarantino C, Romeo D.",Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.,18,15-18
DRAMP04228,GRFRRLGRKFKKLFKKYGP,19,PGP,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9428709,Eur J Biochem. 1997 Dec 1;250(2):549-558.,"Tossi A, Tarantino C, Romeo D.",Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.,19,18-21
DRAMP04229,GLLRRLRDFLKKIGEKFKKIGY,22,PGYa,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9428709,Eur J Biochem. 1997 Dec 1;250(2):549-558.,"Tossi A, Tarantino C, Romeo D.",Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.,22,21-24
DRAMP04230,GILSKLGKALKKAAKHAAKA,20,PGAa,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9428709,Eur J Biochem. 1997 Dec 1;250(2):549-558.,"Tossi A, Tarantino C, Romeo D.",Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.,20,18-21
DRAMP04231,GLRKRLRKARNKIKEKLKKI,20,C18A,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8313956,FEBS Lett. 1994 Feb 14;339(1-2):108-112.,"Tossi A, Scocchi M, Skerlavaj B, Gennaro R.","Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit Leukocytes.",20,18-21
DRAMP04232,GLRKRLRKFRNKIKQKLKKI,20,C18Q,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8313956,FEBS Lett. 1994 Feb 14;339(1-2):108-112.,"Tossi A, Scocchi M, Skerlavaj B, Gennaro R.","Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit Leukocytes.",20,18-21
DRAMP04247,KEEQIGKSSTRGRKSSRRKK,20,STRO06,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12936977,Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.,"Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.",Antimicrobial Characterization of Human -Defensin 3 Derivatives.,20,18-21
DRAMP04248,KIGAKIKIGAKIKIGAKI,18,(KIGAKI)3-NH2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11352918,J Biol Chem. 2001 Jul 27;276(30):27899-27906.,"Blazyk J, Wiegand R, Klein J, Hammer J, Epand RM, Epand RF, Maloy WL, Kari UP.",A Novel Linear Amphipathic b-Sheet Cationic Antimicrobial Peptide with Enhanced Selectivity for Bacterial Lipids.,18,15-18
DRAMP04249,KIAGKIAKIAGKIAKIAGKIA,21,(KIAGKIA)3-NH2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11352918,J Biol Chem. 2001 Jul 27;276(30):27899-27906.,"Blazyk J, Wiegand R, Klein J, Hammer J, Epand RM, Epand RF, Maloy WL, Kari UP.",A Novel Linear Amphipathic b-Sheet Cationic Antimicrobial Peptide with Enhanced Selectivity for Bacterial Lipids.,21,18-21
DRAMP04250,KLAGLAKKLAGLAKKLAGLAK,21,(KLAGLAK)3-NH2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11352918,J Biol Chem. 2001 Jul 27;276(30):27899-27906.,"Blazyk J, Wiegand R, Klein J, Hammer J, Epand RM, Epand RF, Maloy WL, Kari UP.",A Novel Linear Amphipathic b-Sheet Cationic Antimicrobial Peptide with Enhanced Selectivity for Bacterial Lipids.,21,18-21
DRAMP04251,RRWVRRVRRWVRRVVRVVRRWVRR,24,WLBU2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15616311,Antimicrob Agents Chemother. 2005 Jan;49(1):316-322.,"Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA.",De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,24,21-24
DRAMP04260,LALLKVLLRKIKKAL,15,CM-1,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04261,LULLLKILLLKKLKA,15,CM-2,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04262,ALKAALLAILKIVRVIKK,18,CM-3,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04263,LLAILLLALLALRKKVLA,18,CM-4,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04266,KWKSFIKKLPSAAKKVTTAAKPLTK,25,CPα1,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=43 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=24 μg/ml), Pseudomonas aeruginosa H744 (MIC=8 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,25,24-27
DRAMP04268,KKWKKFIKKIGIGAVLTTPGAKK,23,CPα3,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,23,21-24
DRAMP04274,KKWWKFIKKAVNSGTTGLQTLAS,23,CP206,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=8 μg/ml), Pseudomonas aeruginosa H744 (MIC=16 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,23,21-24
DRAMP04277,WKVFKSFIKKASSFAQSVLD,20,CP209,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=11 μg/ml), Pseudomonas aeruginosa Z61 (MIC=64 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,20,18-21
DRAMP04287,AASKAAKTLAKLLSSLLKL,19,MC-03,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,19,18-21
DRAMP04288,LLKKLLRAASKALSLL,16,MC-04,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,16,15-18
DRAMP04289,AAKKLSKLLKTLLKLL,16,MC-05,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,16,15-18
DRAMP04290,KALKKLLKLASSLLTAL,17,MC-08,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,17,15-18
DRAMP04291,AASKALRTASRLARSLLT,18,MC-10,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04292,LKLLKKLLKKLKKLL,15,MB-00,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04293,VSSKYLSKVKVKAGK,15,MB-03,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04294,ARLAKKALRRLAKKD,15,MB-04,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04296,ESLAKALSKEALKALK,16,MB-15,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,16,15-18
DRAMP04297,LKALKKLAKKLKKLA,15,MB-18,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04298,FASLLGKALKALAKQ,15,MB-21,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04300,LSSALSALSSALSSK,15,MB-25,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04301,EAALKAALDLAAKLA,15,MB-31,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04302,ERSAAKSAARSLARR,15,MB-32,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04303,EKTLARTAAKTALKK,15,MB-33,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04304,EKAAAKSAAAKTLARR,16,MB-34,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,16,15-18
DRAMP04305,VSSKYLSKALVKAGR,15,MB-35,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,15,12-15
DRAMP04306,FASLLGKALKALLAKLAKQ,19,MB-36,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,19,18-21
DRAMP04307,FASLLGKLAKKLAKKALK,18,MB-37,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04308,ESLKARSLKKSLKLKKLL,18,MB-38,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04309,ETELAKKALKALKLKKLA,18,MB-40,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04310,ELAKKALKALKKALKSAR,18,MB-41,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04311,ELAKKALRALKKALKSAK,18,MB-43,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04312,ETFAKKALKALEKLLKKG,18,MB-45,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04313,ESSLKKKALSKLSKLLKKG,19,MB-46,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,19,18-21
DRAMP04314,QKAASRLLRALSKLLEAF,18,MB-47,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04315,QKALAKLAKKALKALAKQ,18,MB-48,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04316,ESKAAKAAKKAAKAKASE,18,MB-50,No entry found,Not found,Not found,Synthetic construct (Computer-Aided Molecular Design),"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9879502,J Comput Aided Mol Des. 1998 Nov;12(6):543-556.,"Patel S, Stott IP, Bhakoo M, Elliott P.",Patenting computer-designed peptides.,18,15-18
DRAMP04335,FLFSLIPKAIGGLISAFK,18,AamAP-S1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22484288,Peptides. 2012 Jun;35(2):291-299.,"Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.","Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: Biochemical and functional characterization of natural peptides and a single site-substituted analog.",18,15-18
DRAMP04336,IGKEFKRIVQRIKDFLRNL,19,IG-19 (residues 13-31 of LL-37),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=16 μM), Salmonella typhimurium (KCTC 1926)(MIC=8 μM)",[Ref.22521196] MHC10=21.6 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04337,IGKKFKRIVQRIKDFLRNL,19,a1 (IG-19 analogs),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)",[Ref.22521196] MHC10=13.8 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04338,IGKKFKRIVQRIKKFLRNL,19,a2 (IG-19 analogs),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=8 μM)",[Ref.22521196] MHC10=11.2 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04339,IGKKFKRIVQRIKKFLRKL,19,a3 (IG-19 analogs),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.22521196] MHC10=23.7 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04340,IGKKFKRIVKRIKKFLRKL,19,a4 (IG-19 analogs),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)",[Ref.22521196] MHC10=33.2 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04341,IGKLFKRIVQRIKKFLRNL,19,a5 (IG-19 analogs),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.22521196] MHC10=3.0 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04342,IGKLFKRIVQRILKFLRNL,19,a6 (IG-19 analogs),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.22521196] MHC10=1.2 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04343,IGKLFKRIVKRILKFLRKL,19,a7 (IG-19 analogs),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.22521196] MHC10=1.1 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04344,ILKLFKRIVKRILKFLRKL,19,a8 (IG-19 analogs),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=8 μM)",[Ref.22521196] MHC10=1.6 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04345,IGKKWKRIVKRIKKFLRKL,19,a4-W1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)",[Ref.22521196] MHC10=9.2 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04346,IGKKFKRIVKRIKKWLRKL,19,a4-W2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)",[Ref.22521196] MHC10=8.4 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22521196,Peptides. 2012 Jun;35(2):239-247.,"Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.,19,18-21
DRAMP04347,RAGLQFPVGRLLRRLLRRLLR,21,Buforin,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22306477,Peptides. 2012 Apr;34(2):283-289.,"Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.",Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.,21,18-21
DRAMP04348,RAGLQWPIGRLLRRLLRRLLR,21,Buf IIIa,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22306477,Peptides. 2012 Apr;34(2):283-289.,"Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.",Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.,21,18-21
DRAMP04349,RVVRQWPIGRVVRRVVRRVVR,21,Buf IIIb,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22306477,Peptides. 2012 Apr;34(2):283-289.,"Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.",Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.,21,18-21
DRAMP04350,KLLKQWPIGKLLKKLLKKLLK,21,Buf IIIc,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22306477,Peptides. 2012 Apr;34(2):283-289.,"Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.",Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.,21,18-21
DRAMP04351,KVVKQWPIGKVVKKVVKKVVK,21,Buf IIId,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22306477,Peptides. 2012 Apr;34(2):283-289.,"Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.",Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.,21,18-21
DRAMP04354,GLFRALLRLLRSLWRLLLRA,20,PpTG20,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22819152,Int J Antimicrob Agents. 2012 Oct;40(4):337-343.,"Li L, Shi Y, Su G, Le G.",Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analogue.,20,18-21
DRAMP04355,GLRRALLRLLRSLRRLLLRA,20,P7,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22819152,Int J Antimicrob Agents. 2012 Oct;40(4):337-343.,"Li L, Shi Y, Su G, Le G.",Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analogue.,20,18-21
DRAMP04397,AIGNILKTLGNLAQKILGK,19,Antimicrobial peptide OGC2,C3RTH7,Not found,Not found,Odorrana grahami (Yunnanfu frog) (Rana grahami),Antimicrobial,Transcript level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases,"Ma Y, Lai R, Wu J, Li J.",Antimicrobial peptide from skin of Odorrana grahami.,19,18-21
DRAMP04485,RCICGRGICRCICGRGIC,18,Retrocyclin ,Q8TEZ3,Not found,DEFQ1,Homo sapiens (Human),Antimicrobial,Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11854483,Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1813-1818.,"Cole AM, Hong T, Boo LM, Nguyen T, Zhao C, Bristol G, Zack JA, Waring AJ, Yang OO, Lehrer RI.",Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.,18,15-18
DRAMP04494,GGYCSGIIKQTCTCYRN,17,Defensin ,B6UYK4,Not found,Not found,Dermacentor reticulatus,Antimicrobial,Predicted,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases,"Matejovska T, Golovchenko M, Rudenko N, Grubhoffer L.",Cloning and sequencing of defensins in hard and soft ticks.,17,15-18
DRAMP04540,EKKPPRPPQWAVGHFM,16,PR-bombesin,No entry found,Not found,Not found,Bombina maxima (Chinese red belly toad),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11835992,Peptides. 2002 Mar;23(3):437-442.,"Lai R, Liu H, Lee WH, Zhang Y.",A novel proline rich bombesin-related peptide (PR-bombesin) from toad Bombina maxima.,16,15-18
DRAMP04541,PSCVCSGFETSGIHFC,16,Bb-AMP4,No entry found,Not found,Not found,Bellamya bengalensis,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21262297,Peptides. 2011 Apr;32(4):691-696.,"Gauri SS, Mandal SM, Pati BR, Dey S.",Purification and structural characterization of a novel antibacterial peptide from Bellamya bengalensis: activity against ampicillin and chloramphenicol resistant Staphylococcus epidermidis.,16,15-18
DRAMP04547,NALSMPRNKCNRALMCFG,18,Shuchin 1,No entry found,Not found,Not found,Rana shuchinae,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20553780,Peptides. 2010 Sep;31(9):1674-1677.,"Zheng R, Yao B, Yu H, Wang H, Bian J, Feng F.",Novel family of antimicrobial peptides from the skin of Rana shuchinae.,18,15-18
DRAMP04548,NALSSPRNKCDRASSCFG,18,Shuchin 2,No entry found,Not found,Not found,Rana shuchinae,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20553780,Peptides. 2010 Sep;31(9):1674-1677.,"Zheng R, Yao B, Yu H, Wang H, Bian J, Feng F.",Novel family of antimicrobial peptides from the skin of Rana shuchinae.,18,15-18
DRAMP04549,WLNALLHHGLNCAKGVL,17,17Hc,No entry found,Not found,Not found,Halocynthia aurantium,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878508,Antimicrob Agents Chemother. 2003 Aug;47(8):2481-2486.,"Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH.","Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium.",17,15-18
DRAMP04550,WLNALLKKGLNCAKGVLA,18,18HcKK,No entry found,Not found,Not found,Halocynthia aurantium,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878508,Antimicrob Agents Chemother. 2003 Aug;47(8):2481-2486.,"Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH.","Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium.",18,15-18
DRAMP04551,KWLNALLHHGLNCAKGVLA,19,K19Hc,No entry found,Not found,Not found,Halocynthia aurantium,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878508,Antimicrob Agents Chemother. 2003 Aug;47(8):2481-2486.,"Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH.","Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium.",19,18-21
DRAMP04552,KWLNALLKKGLNCAKGVLA,19,K19HcKK,No entry found,Not found,Not found,Halocynthia aurantium,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,12878508,Antimicrob Agents Chemother. 2003 Aug;47(8):2481-2486.,"Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH.","Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium.",19,18-21
DRAMP04554,VDKPPYLPRPPPPRRIYNNR,20,Oncopeltus antibacterial peptide 4,No entry found,Not found,Not found,Oncopeltus fasciatus,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11812116,J Invertebr Pathol. 2001 Oct;78(3):135-140.,"Schneider M, Dorn A.","Differential infectivity of two Pseudomonas species and the immune response in the milkweed bug, Oncopeltus fasciatus (Insecta: Hemiptera).",20,18-21
DRAMP04555,VGKTWIKVIRGIGKSKIKWQ,20,Bactrocerin-1,No entry found,Not found,Not found,Bactrocera dorsalis,Antimicrobial,Not found,Not found,Not found,,"Function: Shows a very broad spectrum of anti-microbial activity against Gram-positive bacteria, Gram-negative bacteria, and fungi. ",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19479741,Arch Insect Biochem Physiol. 2009 Jul;71(3):117-129.,"Dang XL, Tian JH, Yang WY, Wang WX, Ishibashi J, Asaoka A, Yi HY, Li YF, Cao Y, Yamakawa M, Wen SY.",Bactrocerin-1: A novel inducible antimicrobial peptide from pupae of oriental fruit fly Bactrocera dorsalis Hendel.,20,18-21
DRAMP04556,GWANTLKNVAGGLCKITGAA,20,Parkerin,No entry found,Not found,Not found,Nanorana parkeri,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20153801,Biochimie. 2010 May;92(5):475-481.,"Lu Z, Zhai L, Wang H, Che Q, Wang D, Feng F, Zhao Z, Yu H.","Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.",20,18-21
DRAMP04557,GKLNLFLSRLEILKLFVGAL,20,Pelteobagrin,No entry found,Not found,Not found,Pelteobagrus fulvidraco (Yellow catfish),Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21073979,Comp Biochem Physiol B Biochem Mol Biol. 2011 Feb;158(2):149-154.,Su Y.,"Isolation and identification of pelteobagrin, a novel antimicrobial peptide from the skin mucus of Yellow catfish (Pelteobagrus fulvidraco).",20,18-21
DRAMP04558,GLRKRLRKFRNKIKEKLKKI,20,C18,No entry found,Not found,Not found,Oryctolagus cuniculus,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8313956,FEBS Lett. 1994 Feb 14;339(1-2):108-112.,"Tossi A, Scocchi M, Skerlavaj B, Gennaro R.","Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit Leukocytes.",20,18-21
DRAMP04559,GLRKALRKFRNKIKEALKKI,20,C18AA,No entry found,Not found,Not found,Oryctolagus cuniculus,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,8313956,FEBS Lett. 1994 Feb 14;339(1-2):108-112.,"Tossi A, Scocchi M, Skerlavaj B, Gennaro R.","Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit Leukocytes.",20,18-21
DRAMP04560,HVDKKVADKVLLLKQLRIMRL,21,Spingerin C-4,No entry found,Not found,Not found,Pseudacanthotermes spiniger,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11053427,J Biol Chem. 2001 Feb 9;276(6):4085-4092.,"Lamberty M, Zachary D, Lanot R, Bordereau C, Robert A, Hoffmann JA, Bulet P.",Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect.,21,18-21
DRAMP04561,ALRSAVRTVARVGRAVLPHVAI,22,Ci-PAP-A2,No entry found,Not found,Not found,Ciona intestinalis,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17658598,Dev Comp Immunol. 2008;32(3):286-298.,"Fedders H, Leippe M.",A reverse search for antimicrobial peptides in Ciona intestinalis: identification of a gene family expressed in hemocytes and evaluation of activity.,22,21-24
DRAMP04562,WRSLGRTLLRLSHALKPLARRSGW,24,Ci-MAM-A24,No entry found,Not found,Not found,Ciona intestinalis,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18598239,Biochem J. 2008 Nov 15;416(1):65-75.,"Fedders H, Michalek M, Grötzinger J, Leippe M.",An exceptional salt-tolerant antimicrobial peptide derived from a novel gene family of haemocytes of the marine invertebrate Ciona intestinalis.,24,21-24
DRAMP04563,RSQMQDGQLQSCCQELQNVEEQCQC,25,2S albumin large chain 25 ,No entry found,Not found,Not found,Taraxacum officinale,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19594427,Protein Pept Lett. 2010 Apr;17(4):522-529.,"Odintsova TI, Rogozhin EA, Sklyar IV, Musolyamov AK, Kudryavtsev AM, Pukhalsky VA, Smirnov AN, Grishin EV, Egorov TA.",Antifungal activity of storage 2S albumins from seeds of the invasive weed dandelion Taraxacum officinale Wigg.,25,24-27
DRAMP04564,FIFHIIKGLFHAGKMIHGLVTRRRH,25,"Epinecidin-1 (Epi-1; fish, animals)",No entry found,Not found,Not found,Epinephelus coioides (Orange-spotted grouper) (Epinephelus nebulosus),"Antimicrobial, Antibacterial, Antifungal, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17570764,DNA Cell Biol. 2007 Jun;26(6):403-413.,"Pan CY, Chen JY, Cheng YS, Chen CY, Ni IH, Sheen JF, Pan YL, Kuo CM.","Gene expression and localization of the epinecidin-1 antimicrobial peptide in the grouper (Epinephelus coioides), and its role in protecting fish against pathogenic infection.",25,24-27
DRAMP04565,GVVDILKGAAKDLAGHLATKVMNKL,25,Laticeptin,No entry found,Not found,Not found,Leptodatylus laticeps,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16712520,Protein Pept Lett. 2006;13(4):411-415.,"Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, King JD, Nielsen PF.","Purification and properties of laticeptin, an antimicrobial peptide from skin secretions of the South American frog Leptodactylus laticeps.",25,24-27
DRAMP04572,GVVKVSRLKGESLRARL,17,bullfrog pepsinogen A-derived antimicrobial peptide (bPaAP),No entry found,Not found,Not found,Rana catesbeiana,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9639668,Biochim Biophys Acta. 1998 Jul 1;1407(1):31-39.,"Minn I, Kim HS, Kim SC.","Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",17,15-18
DRAMP04609,GPIRRPKPRPRPRPE,15,Cg-lgPrp,No entry found,Not found,Not found,Crassostrea gigas,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22327168,Dev Comp Immunol. 2012 Jul;37(3-4):363-370.,"Schmitt P, de Lorgeril J, Gueguen Y, Destoumieux-Garzón D, Bachère E.","Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",15,12-15
DRAMP04610,GPIRRPKPRPRQRPE,15,Cg-lgPrp P/Q,No entry found,Not found,Not found,Crassostrea gigas,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22327168,Dev Comp Immunol. 2012 Jul;37(3-4):363-370.,"Schmitt P, de Lorgeril J, Gueguen Y, Destoumieux-Garzón D, Bachère E.","Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",15,12-15
DRAMP04613,IGCWTKSIPPRPCFVK,16,HV-BBI(3-18) (X),No entry found,Not found,Not found,Odorrana grahami,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22516177,Peptides. 2012 Jun;35(2):276-284.,"Dębowski D, Łukajtis R, Łęgowska A, Karna N, Pikuła M, Wysocka M, Maliszewska I, Sieńczyk M, Lesner A, Rolka K.","Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin.",16,15-18
DRAMP04614,AVNIPFKVHFRCKSIFC,17,"[Ser14,Ile15]OGTI (II)",No entry found,Not found,Not found,Odorrana grahami,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22516177,Peptides. 2012 Jun;35(2):276-284.,"Dębowski D, Łukajtis R, Łęgowska A, Karna N, Pikuła M, Wysocka M, Maliszewska I, Sieńczyk M, Lesner A, Rolka K.","Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin.",17,15-18
DRAMP04615,SVIGCWTKSIPPRPRCFVK,19,HV-BBI (IX),No entry found,Not found,Not found,Odorrana grahami,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22516177,Peptides. 2012 Jun;35(2):276-284.,"Dębowski D, Łukajtis R, Łęgowska A, Karna N, Pikuła M, Wysocka M, Maliszewska I, Sieńczyk M, Lesner A, Rolka K.","Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin.",19,18-21
DRAMP04616,GSAQPYKQLHKVVNWDPYG,19,Cancrin,No entry found,Not found,Not found,Fejervarya cancrivora,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17707909,Mol Immunol. 2008 Feb;45(3):678-681.,"Lu Y, Ma Y, Wang X, Liang J, Zhang C, Zhang K, Lin G, Lai R.",The first antimicrobial peptide from sea amphibian.,19,18-21
DRAMP04617,SFKKFWGGVKAIFKGARKGWK,21,Hfp1,No entry found,Not found,Not found,Gasterosteus aculeatus,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22188679,FEBS J. 2012 Mar;279(5):724-736.,"Tessera V, Guida F, Juretić D, Tossi A.",Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,21,18-21
DRAMP04618,FFKKFWGGVKAIFKGARKGWK,21,Hfp2,No entry found,Not found,Not found,Gasterosteus aculeatus,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22188679,FEBS J. 2012 Mar;279(5):724-736.,"Tessera V, Guida F, Juretić D, Tossi A.",Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,21,18-21
DRAMP04619,SVKKFWGGVKAIFKGARKGLK,21,Hfp3,No entry found,Not found,Not found,Gasterosteus aculeatus,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22188679,FEBS J. 2012 Mar;279(5):724-736.,"Tessera V, Guida F, Juretić D, Tossi A.",Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,21,18-21
DRAMP04620,FVKKFWGGVKAIFKGARKGLK,21,Hfp4,No entry found,Not found,Not found,Gasterosteus aculeatus,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22188679,FEBS J. 2012 Mar;279(5):724-736.,"Tessera V, Guida F, Juretić D, Tossi A.",Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,21,18-21
DRAMP04621,FALGAVTKLLPSLLCMITRKC,21,Hainanenin-1,No entry found,Not found,Not found,Amolops hainanensis,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22306820,Peptides. 2012 Feb;33(2):251-257.,"Zhang S, Guo H, Shi F, Wang H, Li L, Jiao X, Wang Y, Yu H.","Hainanenins: a novel family of�antimicrobial�peptides with strong activity from Hainan cascade-frog, Amolops hainanensis.",21,18-21
DRAMP04622,FALGAVTKRLPSLFCLITRKC,21,Hainanenin-5,No entry found,Not found,Not found,Amolops hainanensis,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22306820,Peptides. 2012 Feb;33(2):251-257.,"Zhang S, Guo H, Shi F, Wang H, Li L, Jiao X, Wang Y, Yu H.","Hainanenins: a novel family of�antimicrobial�peptides with strong activity from Hainan cascade-frog, Amolops hainanensis.",21,18-21
DRAMP04623,GFGSLGKALRLGANVL,16,X. clivii-C1,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,16,15-18
DRAMP04624,GVGKFLHSAKKFGQALVSEIMKS,23,X. clivii-C2,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,23,21-24
DRAMP04625,GFKQFVHSMGKFGKAFVGEIINPK,24,X. borealis-B1,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,24,21-24
DRAMP04626,GIGKFLHSAGKFGKAFLGEVMKS,23,X. borealis-B2,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,23,21-24
DRAMP04627,GLGSLLGSLFKFIPKLLPSIQQ,22,X. borealis-B3,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,22,21-24
DRAMP04628,GLLTNVLGFLKKAGKGVLSGLLPL,24,X. borealis-B4,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,24,21-24
DRAMP04629,GIKEFAHSLGKFGKAFVGGILNQ,23,X. amieti-AM1,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,23,21-24
DRAMP04630,GLGSVLGKILKMGANLLGGAPKGA,24,X. amieti-AM3,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,24,21-24
DRAMP04631,GLGSLVGNALRIGAKLL,17,X. amieti-AM4,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,17,15-18
DRAMP04632,GWASKIGQALGKVAKVGLQQFIQPK,25,XPF-C1,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,25,24-27
DRAMP04633,GFGSLLGKALRLGANVL,17,CPF-C1,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21199684,Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.,"Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.",Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).,17,15-18
DRAMP04639,GVSKILHSAGKFGKAFLGEIMKS,23,Magainin-AN2,No entry found,Not found,Not found,Xenopus clivii,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21498136,Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.,"Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.",Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,23,21-24
DRAMP04641,GWASKIGQTLGKMAKVGLQELIQPK,25,XPF-AN1,No entry found,Not found,Not found,Xenopus andrei,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21498136,Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.,"Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.",Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,25,24-27
DRAMP04642,GIGKFLHSAGKFGKAFIGEIMKS,23,Magainin-M1,No entry found,Not found,Not found,Xenopus muelleri,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21664395,Peptides. 2011 Jul;32(7):1502-1508.,"Mechkarska M, Ahmed E, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.",Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,23,21-24
DRAMP04644,GMASKAGSVLGKITKIALGAL,21,PGLa-MW1,No entry found,Not found,Not found,Xenopus muelleri,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21664395,Peptides. 2011 Jul;32(7):1502-1508.,"Mechkarska M, Ahmed E, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.",Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,21,18-21
DRAMP04647,GIGSLLAKAAKLGANLL,17,CPF-L1,No entry found,Not found,Not found,Xenopus lenduensis,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22123629,Peptides. 2012 Jan;33(1):35-43.,"King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.","Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",17,15-18
DRAMP04648,GIGSALAKAAKLVAGIV,17,CPF-L2,No entry found,Not found,Not found,Xenopus lenduensis,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22123629,Peptides. 2012 Jan;33(1):35-43.,"King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.","Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",17,15-18
DRAMP04653,GFGSLLGKALKIGTNLL,17,CPF-PG1,No entry found,Not found,Not found,Xenopus pygmaeus,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22123629,Peptides. 2012 Jan;33(1):35-43.,"King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.","Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",17,15-18
DRAMP04659,FKRLKKLFKKIWNWK,15,HPA3NT3(Derived from HP (2–20)),No entry found,Not found,Not found,Helicobacter pylori,"Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal",Not found,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli","[Ref.19642077] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Bacillus subtilis(MIC=4 μM), Listeria monocytogenes(MIC=22 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Salmonella typhimurium(MIC=2 μM), Pseudomonas aeruginosa(MIC=2 μM);##Fungi : Candida albicans(MIC=8 μM), Trichosporon beigelli(MIC=2-4 μM)","[Ref.19642077] 32% hemolysis at 50 μM , 46% hemolysis at 100 μM , 70% hemolysis at 200 μM against human red blood cells",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22982494##19642077,Biochim Biophys Acta. 2013 Feb;1828(2):443-454.##J Pept Sci. 2009 Sep;15(9):589-94. doi: 10.1002/psc.1155.,"Lee JK, Park SC, Hahm KS, Park Y.##Gopal R, Park SC, Ha KJ, Cho SJ, Kim SW, Song PI, Nah JW, Park Y, Hahm KS",Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.##Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide.,15,12-15
DRAMP04660,AKRLKKLFKKIWNWK,15,HPA3NT3-F1A (HPA3NT3 peptide analogs),No entry found,Not found,Not found,Helicobacter pylori,"Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal",Not found,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus","[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=2 μM), Listeria monocytogenes(MIC=2 μM), Staphylococcus epidermidis(MIC=2-4 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa(MIC=1 μM), Primula vulgaris(MIC=4 μM), Salmonella typhimurium(MIC=1 μM);##Fungi : Candida albicans(MIC=8 μM), Trichosporon beigelii(MIC=16 μM), Aspergillus awamori(MIC=16 μM), Aspergillus flavus(MIC=16 μM), Aspergillus fumigatus(MIC=8 μM), Aspergillus parasiticus(MIC=8 μM)",[Ref.22982494] 7.1% hemolysis at 250 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22982494,Biochim Biophys Acta. 2013 Feb;1828(2):443-454. doi: 10.1016/j.bbamem.2012.09.005,"Lee JK, Park SC, Hahm KS, Park Y.",Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.,15,12-15
DRAMP04661,FKRLKKLAKKIWNWK,15,HPA3NT3-F8A (HPA3NT3 peptide analogs),No entry found,Not found,Not found,Helicobacter pylori,"Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal",Not found,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus","[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Listeria monocytogenes(MIC=2 μM), Staphylococcus epidermidis(MIC=2-4 μM), Bacillus subtilis(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa(MIC=2 μM), Primula vulgaris(MIC=4 μM), Salmonella typhimurium(MIC=2 μM);##Fungi : Candida albicans(MIC=8 μM), Trichosporon beigelii(MIC=16 μM), Aspergillus awamori(MIC=16 μM), Aspergillus flavus(MIC=16 μM), Aspergillus fumigatus(MIC=8 μM), Aspergillus parasiticus(MIC=8 μM)",[Ref.22982494] 4.6% hemolysis at 250 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22982494,Biochim Biophys Acta. 2013 Feb;1828(2):443-454. doi: 10.1016/j.bbamem.2012.09.005,"Lee JK, Park SC, Hahm KS, Park Y.",Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.,15,12-15
DRAMP04662,AKRLKKLAKKIWNWK,15,HPA3NT3-F1AF8A (HPA3NT3 peptide analogs),No entry found,Not found,Not found,Helicobacter pylori,"Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal",Not found,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus","[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=16 μM), Listeria monocytogenes(MIC=2 μM), Staphylococcus epidermidis(MIC=16 μM), Bacillus subtilis(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=32 μM), Pseudomonas aeruginosa(MIC=2 μM), Primula vulgaris(MIC=4 μM), Salmonella typhimurium(MIC=2 μM);##Fungi : Candida albicans(MIC=16 μM), Trichosporon beigelii(MIC=32 μM), Aspergillus awamori(MIC=16 μM), Aspergillus flavus(MIC=32 μM), Aspergillus fumigatus(MIC=4 μM), Aspergillus parasiticus(MIC=8 μM)",[Ref.22982494] 0% hemolysis at 250 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22982494,Biochim Biophys Acta. 2013 Feb;1828(2):443-454. doi: 10.1016/j.bbamem.2012.09.005,"Lee JK, Park SC, Hahm KS, Park Y.",Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.,15,12-15
DRAMP04663,AKRLKKLAKKIWKWL,15,HPA3NT3-A1 (HPA3NT3 peptide analogs),No entry found,Not found,Not found,Helicobacter pylori,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus","[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=16 μM), Listeria monocytogenes(MIC=16 μM), Staphylococcus epidermidis(MIC=8 μM), Bacillus subtilis(MIC=8 μM);##Gram-negative bacteria : Escherichia coli(MIC=32 μM), Pseudomonas aeruginosa(MIC=32 μM), Primula vulgaris(MIC=8-16 μM), Salmonella typhimurium(MIC=8 μM);##Fungi : Candida albicans(MIC=16 μM), Trichosporon beigelii(MIC>128 μM), Aspergillus awamori(MIC=64 μM), Aspergillus flavus(MIC=64 μM), Aspergillus fumigatus(MIC=16 μM), Aspergillus parasiticus(MIC=16 μM)",[Ref.22982494] 20.9% hemolysis at 250 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22982494,Biochim Biophys Acta. 2013 Feb;1828(2):443-454. doi: 10.1016/j.bbamem.2012.09.005,"Lee JK, Park SC, Hahm KS, Park Y.",Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.,15,12-15
DRAMP04664,AKRLKKLAKKIWKWK,15,HPA3NT3-A2 (HPA3NT3 peptide analogs),No entry found,Not found,Not found,Helicobacter pylori,"Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal",Not found,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus","[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Listeria monocytogenes(MIC=2 μM), Staphylococcus epidermidis(MIC=2-4 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa(MIC=2 μM), Primula vulgaris(MIC=2-4 μM), Salmonella typhimurium(MIC=2 μM);##Fungi : Candida albicans(MIC=8 μM), Trichosporon beigelii(MIC=16 μM), Aspergillus awamori(MIC=8 μM), Aspergillus flavus(MIC=8 μM), Aspergillus fumigatus(MIC=4 μM), Aspergillus parasiticus(MIC=8 μM)",[Ref.22982494] 0% hemolysis at 250 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22982494##32781586,Biochim Biophys Acta. 2013 Feb;1828(2):443-454.  doi: 10.1016/j.bbamem.2012.09.005##Int J Mol Sci. 2020 Aug 6;21(16):5632. doi: 10.3390/ijms21165632,"Lee JK, Park SC, Hahm KS, Park Y.##Lee JK, Park Y.",Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.##All d-Lysine Analogues of the Antimicrobial Peptide HPA3NT3-A2 Increased Serum Stability and without Drug Resistance.,15,12-15
DRAMP04666,KKSLLAKAKNFGGKVITIFKA,21,LtTx-1a,No entry found,Not found,Not found,Lachesana tarabaevi,Antimicrobial,Not found,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23088912,Biochim Biophys Acta. 2013 Feb;1828(2):724-731.,"Kuzmenkov AI, Fedorova IM, Vassilevski AA, Grishin EV.",Cysteine-rich toxins from Lachesana tarabaevi spider venom with amphiphilic C-terminal segments.,21,18-21
DRAMP04673,PAAAAQAVAGLAPVAAEQ,18,Alamethicin (ALM; fungi),No entry found,Not found,Not found,Trichoderma viride,"Antimicrobial, Antibacterial, Antifungal, Antiparasitic",Not found,Alpha helix,The molecular conformation of the three crystallographically independent molecules is largely alpha-helical with a bend in the helix axis at an internal proline residue. The helix structure is highly amphipathic as most of the solvent-accessible polar atoms lie on a narrow strip of surface parallel to the helix axis.(Ref.2),1AMT resolved by X-ray.,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available##6292726,"Experientia, 1967; 23: 85-86.##Nature. 1982 Nov 25;300(5890):325-330.","Meyer CE, Reusser F.##Fox RO Jr, Richards FM.",Polypeptide anti-bacterial agent isolated from Trichoderma viride.##A voltage-gated ion channel model inferred from the crystal structure of alamethicin at 1.5-A resolution.,18,15-18
DRAMP04674,VYINKLTPPCGTMYYACEAV,20,Antiviral protein Y3 (Fungi),P83477,Not found,Not found,Pleurotus citrinopileatus (Golden oyster mushroom),"Antimicrobial, Antiviral",Protein level,Not found,Not found,,Miscellaneous: Has antiviral activity against Tobacco mosaic virus and antitumor activity against stomach cancer cells in vitro.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available##6292726,Chinese J Biochem Mol Biol 2008; 24(7):597-603.,"Wu LP, Wu ZJ, Lin D, Fang F, Lin QY, Xie LH.","Characterization and amino acid sequence of y3, an antiviral protein from mushroom Coprinus comatus.",20,18-21
DRAMP04684,NKPEALVDYTGVXNS,15,Bacteriocin BAC-IB17,C0HJE5,Not found,Not found,Bacillus subtilis,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Has bactericidal activity.
Miscellaneous: On the 2D-gel the determined pI of this protein is: 7.0, its MW is: 10.7 kDa.","Gram-positive bacteria: M. luteus, methicillin-resistant S. aureus, methicillin-sensitive S. aureus and B. stearothermophilus;##Gram- negative bacteria: E. coli, S. typhi.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (AUG-2013) to UniProtKB,"Ansari A, Siddiqui NN, Zohra RR, Aman A, Qader SA.","Isolation, purification and characterization of bacteriocin (BAC-IB17) produced from Bacillus subtilis KIBGE-IB17.",15,12-15
DRAMP04685,VAAGGWRPIESLNSAEVQDV,20,Cysteine proteinase inhibitor 1 (KCPI1; Phytocystatin; Plant defensin),P86472,"Belongs to the cystatin family (Phytocystatin subfamily
)",Not found,Actinidia chinensis (Kiwi) (Yangtao),Not found,Protein level,Not found,Not found,,Function: Specific inhibitor of papain family cysteine proteinases (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,IgE,14697268##15536427,Phytochemistry. 2004 Jan;65(1):19-30.##J Allergy Clin Immunol. 2004 Nov;114(5):1169-1175.,"Rassam M, Laing WA.##Bublin M, Mari A, Ebner C, Knulst A, Scheiner O, Hoffmann-Sommergruber K, Breiteneder H, Radauer C.",Purification and characterization of phytocystatins from kiwifruit cortex and seeds.##IgE sensitization profiles toward green and gold kiwifruits differ among patients allergic to kiwifruit from 3 European countries.,20,18-21
DRAMP04686,LSAGPNGGSIAKLSVK,16,Disease resistance response protein (Plant defensin),P85900,Belongs to the BetVI family,Not found,Pseudotsuga menziesii (Douglas-fir) (Abies menziesii),Not found,Protein level,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18602030,J Proteomics. 2008 Oct 7;71(4):425-438.,"Islam MA, Sturrock RN, Ekramoddoullah AK.",A proteomics approach to identify proteins differentially expressed in Douglas-fir seedlings infected by Phellinus sulphurascens.,16,15-18
DRAMP04687,GSNIEVMLGLPNSDVK,16,"Glucan endo-1,3-beta-glucosidase, basic vacuolar isoform (Plant defensin)",P86080,Belongs to the glycosyl hydrolase 17 family,Not found,Capsicum annuum var. annuum (Red pepper),"Antimicrobial, Antibacterial, Antifungal",Protein level,Not found,Not found,,Function: Implicated in the defense of plants against pathogens (By similarity).,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (JUL-2008) to UniProtKB,"Belchi-Navarro S, Almagro L, Pedreno MA.",No title found,16,15-18
DRAMP04695,ANIVFDVESATTGTYSTFLTSF,22,Dioicin-1 (Ribosome-inactivating protein; rRNA N-glycosidase; Plant defense),P86144,Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily),Not found,Phytolacca dioica (Bella sombra tree) (Phytolacca arborea),Toxin,Protein level,Not found,Not found,,Function: Nicks pBR322 dsDNA. Has adenine polynucleotide glycosidase activity on herring sperm ssDNA.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18704492,Planta. 2008 Nov;228(6):963-975.,"Parente A, Conforto B, Di Maro A, Chambery A, De Luca P, Bolognesi A, Iriti M, Faoro F.","Type 1 ribosome-inactivating proteins from Phytolacca dioica L. leaves: differential seasonal and age expression, and cellular localization.",22,21-24
DRAMP04697,DVTFSMLGANGATYYQFF,18,Ribosome-inactivating protein momorgrosvin (rRNA N-glycosidase; Plant defense),P83323,Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily),Not found,Siraitia grosvenorii (Monk's fruit) (Luo han guo),Toxin,Protein level,Not found,Not found,,"Function: Inhibits protein synthesis in the rabbit reticulocyte lysate system.
Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S rRNA.
PTM: Glycosylated.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11205869,Life Sci. 2001 Jan 5;68(7):773-784.,"Tsang KY, Ng TB.","Isolation and characterization of a new ribosome inactivating protein, momorgrosvin, from seeds of the monk's fruit Momordica grosvenorii.",18,15-18
DRAMP04702,VAVKATTTEEETEIPAK,17,38 kDa autolysin (Beta-glycosidase; Peptidoglycan hydrolase),P81528,Not found,lytA,Mycobacterium phlei,"Antimicrobial, Toxin",Protein level,Not found,Not found,,"Function: Hydrolyzes the cell walls of mycobacteria. May play an important role in cell wall growth and cell separation.
Biophysicochemical properties: pH dependence (Optimum pH is 7.5).
PTM: The N-terminus is blocked (Probable).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10206696,Microbiology. 1999 Jan;145 ( Pt 1):169-176.,"Li ZS, Beveridge TJ, Betts J, Clarke AJ.",Partial characterization of a major autolysin from Mycobacterium phlei.,17,15-18
DRAMP18116,QDFMKHLDKKTQTPKL,16,U2-segestritoxin-Sf1b (U2-SGTX-Sf1b; F5.7; Toxin SFI 2),P61096,Belongs to the spider toxin SFI family,Not found,Segestria florentina (Tube-web spider) (Segestria gracilis),Insecticidal,Protein level,Not found,Not found,,Function: Causes flaccid paralysis followed by death when injected into Heliothis virescens larvae. Does not induce any toxic effects when injected intravenously into adult mice at a dose of 1.25 mg/kg body weight.,Heliothis virescens (LD50=7 Î¼g/g),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11689233,Toxicon 40:125-130 (2002).,"Lipkin A., Kozlov S. , Nosyreva E., Blake A., Windass J.D., Grishin E.",Novel insecticidal toxins from the venom of the spider Segestriaflorentina.,16,15-18
DRAMP18118,AECMVDETVCYIHNHNNC,18,U2-segestritoxin-Sf1i (U2-SGTX-Sf1i; Toxin F5.5; Fragment),P61094,Belongs to the spider toxin SFI family,Not found,Segestria florentina (Tube-web spider) (Segestria gracilis),Insecticidal,Protein level,Not found,Not found,,Function: Insecticidal toxin. Causes flaccid paralysis followed by death when injected into Heliothis virescens larvae. Does not induce any toxic effects when injected intravenously into adult mice at a dose of 1.1 mg/kg body weight.,Heliothis virescens (LD50=4 Î¼g/g),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11689233,Toxicon 40:125-130 (2002).,"Lipkin A., Kozlov S. , Nosyreva E., Blake A., Windass J.D., Grishin E.",Novel insecticidal toxins from the venom of the spider Segestriaflorentina.,18,15-18
DRAMP18187,IWLTALKFLGKNLGKHLAKQQLAKL,25,Toxin LyeTx 1,C0HJU9,Not found,Not found,Lycosa erythrognatha (Spider) (Scaptocosa raptoria),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,7MMM,Function: Has hemolytic activity against rabbit erythrocytes. Forms pores in lipid bilayers in vitro; pore formation is reduced when cholesterol is present in the bilayers.,"[Ref.19946788]Gram-positive bacterium: S.aureus (MIC=3.79 μM);##Gram-negative bacterium: E.coli (MIC=7.81 μM);##Yeasts: C.krusei (MIC=26.3 μM), C.neoformans (MIC=13.2 μM).",[Ref.19946788]ED50=1.3 × 10−4 M against rabbit erythrocytes,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19946788,Amino Acids 39:135-144(2010),"Santos D.M., Verly R.M., Pilo-Veloso D., de Maria M.,de Carvalho M.A., Cisalpino P.S., Soares B.M., Diniz C.G.,Farias L.M., Moreira D.F., Frezard F., Bemquerer M.P., Pimenta A.M.,de Lima M.E.","LyeTx I, a potent antimicrobial peptide from the venom of the spiderLycosa erythrognatha.",25,24-27
DRAMP18132,ADPRNPLEECFRETD,15,L-amino-acid oxidase Bfon20 (LAAO; LAO),P0DMG9,Belongs to the flavin monoamine oxidase family,Not found,Bothrops fonsecai (Fonseca's lancehead) (Rhinocerophis fonsecai),"Antimicrobial, Antitumor, Antibacterial, Antiparasitic",Protein level,Not found,Not found,,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,18760386,J. Proteomics 71:473-485 (2008).,"Tashima A.K., Sanz L., Camargo A.C. , Serrano S. M. , Calvete J.J.",Snake venomics of the Brazilian pitvipers Bothrops cotiara andBothrops fonsecai. Identification of taxonomy markerS. ,15,12-15
DRAMP18185,FLPLFLPKIICVITKKC,17,Jingdongin-1,K7ZGS2, Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily,Not found,Amolops jingdongensis (Chinese torrent frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function: Has activity against Gram- negative bacterium and exhibits hemolytic activity. ,"[Ref.22828809]Gram-negative bacterium: B.dysenteriae (MIC=35 μg/ml);##Gram-positive bacteria: S.aureus ATCC 2592 (MIC=4.7 μg/ml), B.subtilis ATCC 6633 (MIC=9.38 μg/ml);##Fungus: C.albicans (MIC=18.75 μg/ml)","[Ref.22828809] It exhibits hemolysis of 1.32%, 5.37%, 6.35%, 16.55% at 25 μg/ml, 50 μg/ml, 100 μg/ml, 200 μg/ml against rabbit red blood cells",Cyclic,Free,Cyclization(Cys11 and Cys17).,Disulfide bond between Cys11 and Cys17.,L,No cytotoxicity information found,Not found,22828809,Amino Acids 44:481-487(2013),"He X., Yang S., Wei L., Liu R., Lai R., Rong M.","Antimicrobial peptide diversity in the skin of the torrent frog,Amolops jingdongensis.",17,15-18
DRAMP18143,EELEAKDVIESKALATLDEER,21,Toxin OAIP 5,P0DM69,Belongs to the huwentoxin-2 family,Not found,Selenotypus plumipes (Australian featherleg tarantula),Insecticidal,Protein level,Not found,Not found,,Function: Probable ion channel inhibitor. Shows insecticidal activity when injected into mealwormS.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23894279,PLoS ONE 8:E66279-E66279 (2013),"Wong E.S. , Hardy M. C. , Wood D., Bailey T., King G.F.",SVM-based prediction of propeptide cleavage sites in spider toxinsidentifies toxin innovation in an australian tarantula.,21,18-21
DRAMP18147,LKCNKLVPLFYKTCPAGKNL,20,Cytotoxin drCT-1 (drCT-I; Fragment),P0C5H4,Belongs to the snake three-finger toxin family,Not found,Daboia russelii (Russel's viper) (Vipera russelii),"Anti-cancer, Cytotoxic",Protein level,Not found,Not found,,"Function: This three-finger cytotoxin has antiproliferative, cytotoxic and apoptotic activitieS. Both in vivo and in vitro experimental results suggests that this protein possess anticancer potential. Also shows neurotoxicity, cardiotoxicity and myotoxicity.",IC50=8.9 Î¼g/ml for U937 and 6.7 Î¼g/ml for K562,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17055549##16511326,Toxicon 49:46-56 (2007).##Acta Crystallogr. F 62:292-294 (2006).,"Gomes A., Choudhury S. R., Saha A., Mishra R., Giri B., Biswas A.K., Debnath A., Gomes A.##Choudhury S. R., Gomes A., Gomes A., Dattagupta J.K., Sen U.","A heat stable protein toxin (drCT-I) from the Indian Viper (Daboiarusselli russelli) venom having antiproliferative, cytotoxic andapoptotic activitieS. ##Purification, crystallization and preliminary X-ray structuralstudies of a 7.2 kDa cytotoxin isolated from the venom of Daboiarusselli russelli of the Viperidae family.",20,18-21
DRAMP01297,SGYLPGKEYVYKYKGKVF,18,Longipin (Fragment),C0HJF8,Not found,Not found,Acutisoma longipes (Neotropical harvestman) (Goniosoma longipes),"Antimicrobial, Antifungal, Anti-Gram+",Protein level,Not found,Not found,,"Function: Has moderate antifungal activity. Has weak antimicrobial activity against the Gram-positive bacterium M. luteus A270 (MIC=83 Î¼M) but not against S. aureus ATCC 29213 and S. epidermidis ATCC 12228. Inactive against the Gram-negative bacteria P.aeruginosa ATCC 14502, E.coli ATCC 25922 and E.coli SBS 363. Has no hemolytic activity against human erythrocytes at the highest concentration tested (125 μM).##Introduction: Constitutively expressed.","[Swiss_Prot Entry C0HJF8]Fungi: C. albicans MDM8 (MIC=35 μM), C. tropicalis IOC 4560 (MIC=63 μM), C. guilliermondii IOC 4557 (MIC=32 μM), C. albicans IOC 4558 (MIC=125 μM);##Gram-positive bacterium: M. luteus A270 (MIC=83 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,PubMed ID is not available,Submitted (OCT-2013) to the EMBL/GenBank/DDBJ database,Sayegh R.S. R.,"Purification and characterization of antimicrobial peptides presentin the haemolymph of Acutisoma longipes (Gonyleptidae, Opiliones).",18,15-18
DRAMP18408,EVCEKASKTWSGNCGNTGHC,20,"Dm-AMP2 (Dahlia defensin, plants)",No entry found,Belongs to the defensin family.,Not found,"seeds, Dahlia merckii","Antimicrobial, Antifungal",,Bridge,Not found,,"Fuction: The sequence is not yet complete.In medium A supplemented with 1 mM CaCl2 and 50 mM KCl, the peptide is active against fungi B. cinerea (IC50 10 ug/ml), C. sphaerospermum (IC50 3 ug/ml), F. culmorum (IC50 3 ug/ml), L. maculans (IC50 1.0 ug/ml), P. digitatum (IC50 2 ug/ml), S. tritici (IC50 1 ug/ml), and V. albo-atrum (IC50 2 ug/ml).","Active against fungi B. cinerea (IC50 10 ug/ml), C. sphaerospermum (IC50 3 ug/ml), F. culmorum (IC50 3 ug/ml), L. maculans (IC50 1.0 ug/ml), P. digitatum (IC50 2 ug/ml), S. tritici (IC50 1 ug/ml), and V. albo-atrum (IC50 2 ug/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,7628617,FEBS Lett. 1995 Jul 17;368(2):257-62,"Attenborough S, Rees SB, Broekaert WF. ","Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",20,18-21
DRAMP18409,INWKKIKSIIKAAMN,15,"Mastoparan V1 (MP-V1, insects, arthropods, invertebrates, animals)",No entry found,Not found,Not found,"Venom; Social Wasp, Vespula vulgaris","Antimicrobial, Antibacterial, Antifungal",,Helix,Not found,,Weak hemolysis 6.6% at 50 uM (20% at 100 uM).,"Active against S. mutans, S. enterica, and S. aureus (MIC 50 uM), and C. albicans, C. grabrata (MIC 50 uM), and C. neoformans (MIC 0.5 uM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27104500,Molecules. 2016 Apr 19;21(4):512.,"Kim Y, Son M, Noh EY, Kim S, Kim C, Yeo JH, Park C, Lee KW, Bang WY.",MP-V1 from the Venom of Social Wasp Vespula vulgaris Is a de Novo Type of Mastoparan that Displays Superior Antimicrobial Activities.,15,12-15
DRAMP18410,ITCQQVTXELEPCVPYLTQGIP,22,"Cc-LTP2 (Coffea canephora lipid transfer protein 2, plants)",No entry found,Not found,Not found,"seeds, Coffea canephora Pierre","Antimicrobial, Antibacterial, Antifungal",,Not found,Not found,,The sequence is not yet complete.,"Active against Gram- bacteria X. euvesicatoria (inhibition zone of 0.25 mm at 75 ug/ml), and can permeate the memrbane of fungi F. solani at 200 ug/ml.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27813588,Genet Mol Res. 2016 Oct 24;15(4).,"Bard GC, Zottich U, Souza TA, Ribeiro SF, Dias GB, Pireda S, Da Cunha M, Rodrigues R, Pereira LS, Machado OL, Carvalho AO, Gomes VM.","Purification, biochemical characterization, and antimicrobial activity of a new lipid transfer protein from Coffea canephora seeds.",22,21-24
DRAMP18412,SGYLPGKEYVYKYKGKVF,18,"Longipin (arachnids, Chelicerata, arthropods, invertebrates, animals)",No entry found,Not found,Not found,"hemolymph, Acutisoma longipes","Antimicrobial, Antifungal",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against M. luteus A270, Gram- P. aeruginosa ATCC27853, S. marcescens ATCC4112 (MIC 60-120 uM), fungi C. albicans MDM8 (MIC 15-30 uM), C. albicans IOC4558 (7.5-15 uM), C. guilliermondii and C. tropicalis (MIC 3.8-7.5 uM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27997568,PLoS One. 2016 Dec 20;11(12):e0167953.,"Sayegh RS, Batista IF, Melo RL, Riske KA, Daffre S, Montich G, da Silva Junior PI",Longipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic Vesicles,18,15-18
DRAMP18413,FFSMIPKIAGGIASLVKNLG,20,"Phylloseptin-PBa (frog, amphibians, animals)",No entry found,Not found,Not found,"the Peruvian Purple-Sided Leaf Frog, Phyllomedusa baltea , South America","Antimicrobial, Antibacterial, Antifungal",,Not found,Not found,,"Fuction: It exhibited anti-proliferative activity against the human cancer cell lines, H460, PC3 and U251MG, but was less active against a normal human cell line (HMEC).","Active against S. aureus (MIC 8 ug/ml), E. coli (MIC 128 ug/ml) and C. albicans (MIC 8 ug/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,26633506,Toxins (Basel). 2015 Dec 1;7(12):5182-93,"Wan Y, Ma C, Zhou M, Xi X, Li L, Wu D, Wang L, Lin C, Lopez JC, Chen T, Shaw C",Phylloseptin-PBa--A Novel Broad-Spectrum Antimicrobial Peptide from the Skin Secretion of the Peruvian Purple-Sided Leaf Frog (Phyllomedusa Baltea) Which Exhibits Cancer Cell Cytotoxicity.,20,18-21
DRAMP18416,FIGMIPGLIGGLISAIK,17,"ToAP3 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)",No entry found,Not found,Not found,Tityus obscurus,"Antimicrobial, Antifungal",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against C. albicans SC5314 (MIC 25 uM), C. tropicalis ATCC 750 (MIC 12.5 uM), C. parapsilosis ATCC 22019 (MIC 100 uM), C. neoformans H99 serotype A (MIC 100 uM), and C. neoformans B3501 serotype D (MIC 25 uM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27917162,Front Microbiol. 2016 Nov 18;7:1844,"Guilhelmelli F, Vilela N, Smidt KS, de Oliveira MA, da Cunha Morales ?lvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, de Freitas SM, Nicola AM, Franco OL, Derengowski LD, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I.",Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms,17,15-18
DRAMP18426,GVIDIIKGAGKDLIAHAIGKLAEKV,25,"Ocellatin-PT3 (frog, amphibians, animals)",No entry found,Not found,Not found,"Skin Secretion, dorsal, Leptodactylus pustulatus",Antiparasitic,,Helix,Not found,,Fuction: It has leishmanicidal activity.,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,26107622##27463422,J Nat Prod. 2015 Jul 24;78(7):1495-504. ##Biopolymers. 2016 Dec;105(12):873-86.,"Marani MM, Dourado FS, Quelemes PV, de Araujo AR, Perfeito ML, Barbosa EA, V",Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.  ##Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.,25,24-27
DRAMP18427,DKGRRRSKFVLHRRQCAN,18,"MrDN (pellino-1 derived, Crustaceans, arthropods, invertebrates, animals)",No entry found,Not found,Not found,"Giant freshwater prawn, Macrobrachium rosenbergii","Antimicrobial, Antibacterial",,Not found,Not found,,Comment: No comments found on DRAMP database,No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27648859,Mol Immunol. 2016 Oct;78:171-182.,"Ravichandran G, Kumaresan V, Arasu MV, Al-Dhabi NA, Ganesh MR, Mahesh A, Dhayalan A, Pasupuleti M, Arockiaraj J","Pellino-1 derived cationic antimicrobial prawn peptide: Bactericidal activity, toxicity and mode of action",18,15-18
DRAMP18429,KRIGLIRLIGKILRGLRRLG,20,"Saha-CATH5 (cathelicidins; mammals, animals)",No entry found,Not found,Not found,"Tasmanian devil, Sarcophilus harrisii","Antimicrobial, Antibacterial, Antifungal",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against E. coli ATCC 25922, P. aeruginosa, E. faecalis, S. aureus ATCC 29213 (MRSA), S. pneumoniae ATCC 49619, S. pyogenes ATCC 19615, S. agalactiae ATCC 12386, S. agalactiae, S. anginosus, S. equi, and C. neoformans (MIC 32-64 ug/mL).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27725697,Sci Rep. 2016 Oct 11;6:35019,"Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K",Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,20,18-21
DRAMP18432,GLLSALRKMIPHILSHIKK,19,"Antapin (ANTP; insects, arthropods, invertebrates, animals)",No entry found,Not found,Not found,"wild bee, Anthophora plumipes","Antimicrobial, Antibacterial",,Helix,Not found,,"It became more helical in the presence of TFE, SDS, or anionic lipids.","Active against B. subtilis, E. coli, S. aureus, and P. aeruginosa.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,Not found,"J. Pept. Sci., 2014; 20:S263",S. Cujov,Structural study of a novel antimicrobial peptide isolated from the venom of bee Anthophora plumipes,19,18-21
DRAMP18443,IWSFLIKAATKLLPSLFGGGKKDS,24,"Smp24 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)",No entry found,Not found,Not found,"venom, Scorpio maurus palmatus","Antimicrobial, Antibacterial, Antifungal",,Helix,Not found,,Removal of the N-terminal four residues increases peptide cell selectivity.,"Active against B. subtilis NCIMB 8024, S. epidermidis sp., S. aureus SH100 (MIC 4-8 ug/ml), E. coli JM109 (MIC 64 ug/ml), and C. albicans (MIC 32 ug/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrance,27019370,Toxicon. 2016 Jul;117:30-6. ,"Harrison PL, Abdel-Rahman MA, Strong PN, Tawfik MM, Miller K.",Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus,24,21-24
DRAMP18447,RWRFLRKISSVHMFSVKALDDFRQL,25,Gm0025x00667(75,No entry found,Not found,Not found,"soybean, Glycine max","Antimicrobial, Antibacterial",,Not found,Not found,,"It inhibited the in vitro growth of X. axonopodis pv. glycines, the causative agent of the bacterial pustule disease, at 5 uM. Also active ex vivo and in vivo after vector transformation.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23029273,PLoS One. 2012;7(9):e45848.,"Brand GD, Magalh?es MT, Tinoco ML, Arag?o FJ, Nicoli J, Kelly SM, Cooper A, Bloch C Jr.",Probing protein sequences as sources for encrypted antimicrobial peptides.,25,24-27
DRAMP18449,AVNIPFKVHLRCKAAFC,17,"Kunitzin-OS (amphibians, animals)",No entry found,Not found,Not found,"Chinese frog, Odorrana schmackeri","Antibacterial, Enzyme inhibitor, Anti-Gram-, Antimicrobial",,Not found,Not found,,Comment: No comments found on DRAMP database,Gram-negative bacteria: E. coli (MIC 20 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27311856,Biochem Biophys Res Commun. 2016 Aug 19;477(2):302-9.,"Chen X, Wang H, Shen Y, Wang L, Zhou M, Chen T, Shaw C.",Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs,17,15-18
DRAMP18450,AAKIILNPKFRCKAAFC,17,"Kunitzin-RE (amphibians, animals)",No entry found,Not found,Not found,"European frog, Rana esculenta","Antibacterial, Enzyme inhibitor, Anti-Gram-, Antimicrobial",,Not found,Not found,,Fuction: A change of the last K to F reduced activity (MIC 160 uM). ,Gram-negative bacteria: E. coli (MIC 30 uM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27311856,Biochem Biophys Res Commun. 2016 Aug 19;477(2):302-9.,"Chen X, Wang H, Shen Y, Wang L, Zhou M, Chen T, Shaw C.",Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs,17,15-18
DRAMP18451,GFLDVVKHIGKAALGAVTHLINQ,23,"CZS-3 (cruzioseptin-3; frog, amphibians, animals)",No entry found,Not found,Not found,"the splendid leaf frog, Cruziohyla calcarifer, South America","Antimicrobial, Antibacterial, Antifungal",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against E. coli (13.3 uM), S. aureus (13.3 uM), and C. albicans (13.3 uM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27321580,J Proteomics. 2016 Sep 2;146:1-13. ,"Proa?o-Bola?os C, Zhou M, Wang L, Coloma LA, Chen T, Shaw C.","Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer.",23,21-24
DRAMP18452,GFLDVIKHVGKAALGVVTHLINQ,23,"CZS-2 (cruzioseptin-2; frog, amphibians, animals)",No entry found,Not found,Not found,"the splendid leaf frog, Cruziohyla calcarifer, South America","Antimicrobial, Antibacterial, Antifungal",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against E. coli (26.3 uM), S. aureus (6.6 uM), and C. albicans (13.2 uM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27321580,J Proteomics. 2016 Sep 2;146:1-13. ,"Proa?o-Bola?os C, Zhou M, Wang L, Coloma LA, Chen T, Shaw C.","Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer.",23,21-24
DRAMP18453,GFLDIVKGVGKVALGAVSKLF,21,"CZS-1 (cruzioseptin-1; frog, amphibians, animals)",No entry found,Not found,Not found,"the splendid leaf frog, Cruziohyla calcarifer, South America","Antimicrobial, Antibacterial, Antifungal",,Not found,Not found,,Comment: No comments found on DRAMP database,"Active against E. coli (15.1 uM), S. aureus (3.8 uM), and C. albicans (3.8 uM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,27321580,J Proteomics. 2016 Sep 2;146:1-13. ,"Proa?o-Bola?os C, Zhou M, Wang L, Coloma LA, Chen T, Shaw C.","Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer.",21,18-21
DRAMP18471,KKLALKALLLWLKALLKLAKLALKK,25,D-LAK60,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC>22.62 μM), Escherichia coli Top 10 (MIC=7.07±2.04 M), Pseudomonas aeruginosa (MIC>22.62 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",25,24-27
DRAMP18472,KKLALKALKLWLLALLKLAKLALKK,25,D-LAK80,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC>22.62 μM), Escherichia coli Top 10 (MIC=5.40±1.01 μM), Pseudomonas aeruginosa (MIC>22.62 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",25,24-27
DRAMP18473,KKLALKALKLWLLALKKLALLALKK,25,D-LAK100,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=4.14±1.03 μM), Escherichia coli Top 10 (MIC=1.51±0.23 M), Pseudomonas aeruginosa (MIC=7.92±2.06 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",25,24-27
DRAMP18474,KKLAKLALLKWLLALKKLALLALKK,25,D-LAK140,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=3.14±1.28 μM), Escherichia coli Top 10 (MIC=0.76±0.18 M), Pseudomonas aeruginosa (MIC=4.69±0.67 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",25,24-27
DRAMP18475,KKLAKLALLKWLLALKLLALKALKK,25,D-LAK160,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=3.85±0.64 μM), Escherichia coli Top 10 (MIC=1.49±0.56 μM), Pseudomonas aeruginosa (MIC=6.23±0.71 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",25,24-27
DRAMP18476,KKLAKALKLLALLWLKLAKALKKA,24,LAK80,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=13.05±0.13 μM),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18477,KKLAKAPKLLALLWLKLAKALKKA,24,LAK80-P7,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.97±0.15 μM), Escherichia coli Top 10 (MIC=1.26±0.49 μM), Pseudomonas aeruginosa (MIC=2.13±0.77 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18478,KKLAKALKLPALLWLKLAKALKKA,24,LAK80-P10,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.62±0.17 μM), Escherichia coli Top 10 (MIC=0.82±0.03 μM), Pseudomonas aeruginosa (MIC=1.18±0.53 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18479,KKLAKALKLLAPLWLKLAKALKKA,24,LAK80-P12,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.80±0.27 μM), Escherichia coli Top 10 (MIC=0.80±0.01 μM), Pseudomonas aeruginosa (MIC=0.86±0.09 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18480,KKLALALKKLALLWKKLALALKKA,24,LAK120,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.95±0.06 μM), Escherichia coli Top 10 (MIC=1.47±0.64 μM), Pseudomonas aeruginosa (MIC=4.20±0.92 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18481,KKLALAPKKLALLWKKLALALKKA,24,LAK120-P7,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.80±0.03 μM), Escherichia coli Top 10 (MIC=0.45±0.10 μM), Pseudomonas aeruginosa (MIC=4.45±0.19 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18482,KKLALALKKPALLWKKLALALKKA,24,LAK120-P10,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.78±0.01 μM), Escherichia coli Top 10 (MIC=0.47±0.15 μM), Pseudomonas aeruginosa (MIC=9.16±1.43 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18483,KKLALALKKLAPLWKKLALALKKA,24,LAK120-P12,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.97±0.06 μM), Escherichia coli Top 10 (MIC=0.68±0.14 μM), Pseudomonas aeruginosa (MIC=2.14±0.53 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18484,KKLKLALAKLALLWKALALKLKKA,24,LAK160,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.11±0.48 μM), Escherichia coli Top 10 (MIC=0.73±0.40 μM), Pseudomonas aeruginosa (MIC=2.23±0.41 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18485,KKLKLAPAKLALLWKALALKLKKA,24,LAK160-P7,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.79±0.41 μM), Escherichia coli Top 10 (MIC=0.46±0.11 μM), Pseudomonas aeruginosa (MIC=2.98±0.21 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18486,KKLKLALAKPALLWKALALKLKKA,24,LAK160-P10,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.22±0.63 μM), Escherichia coli Top 10 (MIC=0.45±0.24 μM), Pseudomonas aeruginosa (MIC=4.14±0.23 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18487,KKLKLALAKLAPLWKALALKLKKA,24,LAK160-P12,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.48±0.20 μM), Escherichia coli Top 10 (MIC=0.38±0.08 μM), Pseudomonas aeruginosa (MIC=1.69±0.09 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",24,21-24
DRAMP18488,FFGSLLSLGSKLLPSVFKLFQRKKE,25,"Css54 (Css from the species name below; scorpions, arachnids, Chelicerata, arthropods, invertebra",P0DL41,Not found,Not found,Centruroides suffusus (Mexican scorpion),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Cytolysis, Hemolytic",Not found,Not found,Not found,,"Function: Amphipathic peptide that shows antibacterial activity against Escherichia coli and Staphylococcus aureus. Increases efficacy of antibiotics when tested against S.aureus, probably by facilitating their incorporation into the bacteria. Has hemolytic activity against human erythrocytes.",[Ref.23093034]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=12.5 μg/ml).,"[Ref.23093034]30% hemolytic activity at 9 μM, 67% hemolytic activity at 17 μM against human erythrocytes",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23093034,J Antibiot (Tokyo). 2013 Jan;66(1):3-10.,"Garcia F, Villegas E, Espino-Solis GP, Rodriguez A, Paniagua-Solis JF, Sandoval-Lopez G, Possani LD, Corzo G.",Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics.,25,24-27
DRAMP03011,INIKDILAKLVKVLGHV,17,"Bombolitin IV (insects, arthropods, invertebrates, animals)",P07495,Not found,Not found,Megabombus pennsylvanicus (Bumblebee),"Antimicrobial, Antibacterial, Anti Mammalian Cells",Protein level,Not found,Not found,,Function: Mast cell degranulating peptide. Has hemolytic activity.,No MICs found in DRAMP database,[Ref.2578459] Hemolysis: ED50=1.8±0.05 µg/ml. Histamine release: ED50=12.5±0.7 µg/ml against guinea pig erythrocytes.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2578459 ,J Biol Chem. 1985 Feb 10;260(3):1437-144.,"Argiolas A, Pisano JJ.","Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.",17,15-18
DRAMP03012,INVLGILGLLGKALSHL,17,"Bombolitin V (insects, arthropods, invertebrates, animals)",P07496,Not found,Not found,Megabombus pennsylvanicus (Bumblebee),"Antimicrobial, Antibacterial, Anti Mammalian Cells",Protein level,Not found,Not found,,Function: Mast cell degranulating peptide. Has hemolytic activity.,No MICs found in DRAMP database,[Ref.2578459] Hemolysis: ED50=0.7±0.05 µg/ml. Histamine release: ED50=2.0±0.3 µg/ml against guinea pig erythrocytes.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,2578459 ,J Biol Chem. 1985 Feb 10;260(3):1437-144.,"Argiolas A, Pisano JJ.","Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.",17,15-18
DRAMP02081,FLPLLAGLAANFLPKIFCKITRKC,24,"Brevinin-1E (Frogs, amphibians, animals)",P32412 ,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Anti Mammalian Cells",Protein level,Alpha helix,Possess an intramo-lecular disulfide bridge located at the  carboxyl-terminal end.,,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and a very high hemolytic activity.","[Ref.8163497] Gram-negative bacteria: Escherichia coliD21 (MIC=1.8 µM), Pseudomonas aeruginosa ATCC15692 (MIC=30.6 µM);##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.4 µM), Staphylococcus aureus Cowan1 (MIC=0.6 µM);##Fungi: Candida albicans (MIC=4.7 µM);##Yeast: Saccharomyces cerevisiae (MIC=3.8 µM).",[Ref.8163497] LC50=0.5 µM against human red blood cell.,Cyclic,Free,Cyclization (Cys18 and Cys24),Disulfide bond between Cys18 and Cys24.,L,No cytotoxicity information found,Not found,8508915##8163497,FEBS Lett. 1993 Jun 14;324(2):159-161.##J Biol Chem. 1994 Apr 22;269(16):11956-11961. ,"Simmaco M, Mignogna G, Barra D, Bossa F.##Simmaco M, Mignogna G, Barra D, Bossa F.",Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.##Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,24,21-24
DRAMP02751,GRPNPVNNKPTPHPRL,16,"Formaecin-1 (Pro-rich; ants, insects, animals)",P81438,Not found,Not found,Myrmecia gulosa (Red bulldog ant),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Rich,Not found,,"Function: Antibacterial activity against E.coli but none against other Gram-negative bacteria and Gram-positive bacteria.
Induction: By bacterial infection.
PTM: O-linked glycan consists of a Gal-GalNAc disaccharide, O-glycosylation is essential for full biological activity.","[Ref.9497332] Gram-negative bacteria: Escherichia coli NCTC 8196, Escherichia coli BLR.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9497332,J Biol Chem. 1998 Mar 13;273(11):6139-6143.,"Mackintosh JA, Veal DA, Beattie AJ, Gooley AA.",Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides.,16,15-18
DRAMP02752,GRPNPVNTKPTPYPRL,16,"Formaecin-2 (Pro-rich; ants, insects, animals)",P81437 ,Not found,Not found,Myrmecia gulosa (Red bulldog ant),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Rich,Not found,,"Function: Antibacterial activity against E.coli but none against other Gram-negative bacteria and Gram-positive bacteria.
Induction: By bacterial infection.
PTM: O-linked glycan consists of a Gal-GalNAc disaccharide, O-glycosylation is essential for full biological activity.","[Ref.9497332] Gram-negative bacteria: Escherichia coli NCTC 8196, Escherichia coli BLR.",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9497332,J Biol Chem. 1998 Mar 13;273(11):6139-6143.,"Mackintosh JA, Veal DA, Beattie AJ, Gooley AA.",Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides.,16,15-18
DRAMP03097,GKPRPYSPRPTSHPRPIRV,19,"Drosocin (Glycopeptide,insects, arthropods, invertebrates, animals)",P36193,Belongs to the drosocin family,Dro,Drosophila melanogaster (Fruit fly),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Beta turns,"The NMR data clearly indicate a difference between the glycosylated and nonglycosylated forms, i.e., in the perturbation of a turn directly adjacent to the glycosylation site.",4EZR resolved by X-ray.,"Function: Antibacterial peptide with strong anti-Gram-negative bacteria activity.
PTM: O-glycosylation is essential for full biological activity.
Tissue specificity: In hemolymph 6 hours after immune challenge, levels of expression increase for first 24 hours and persist for the following two weeks.
Developmental stage: Expressed in larvae and in adults.
Induction: By bacterial infection.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9888811##8325867##9497332,"Biochemistry. 1999 Jan 12;38(2):705-14.##
J Biol Chem. 1993 Jul 15;268(20):14893-7.##J Biol Chem. 1998 Mar 13;273(11):6139-6143.","McManus AM, Otvos L Jr, Hoffmann R, Craik DJ.##
Bulet P, Dimarcq JL, Hetru C, Lagueux M, Charlet M, Hegy G, Van Dorsselaer A, Hoffmann JA.##Mackintosh JA, Veal DA, Beattie AJ, Gooley AA.","Conformational studies by NMR of the antimicrobial peptide, drosocin, and its non-glycosylated derivative: effects of glycosylation on solution conformation.##A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution.##Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides.",19,18-21
DRAMP02093,FLPFIAGVAAKFLPKIFCAISKKC,24,"Brevinin-1Bc (Frogs, amphibians, animals)",P82835,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria. 
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=13 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02094,FLPAIAGVAAKFLPKIFCAISKKC,24,"Brevinin-1Bd (Frogs, amphibians, animals)",P82836,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Gram-negative bacterium: Escherichia coli (MIC=7 μM).##Yeast: Candida albicans (MIC=7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02095,FLPAIVGAAAKFLPKIFCVISKKC,24,"Brevinin-1Be (Frogs, amphibians, animals)",P82837,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Gram-negative bacterium: Escherichia coli (MIC=15 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02096,FLPFIAGMAANFLPKIFCAISKKC,24,"Brevinin-1Bf (Frogs, amphibians, animals)",P82838,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=8 μM);##Gram-negative bacterium: Escherichia coli (MIC=19 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02097,FLPIIAGVAAKVFPKIFCAISKKC,24,"Brevinin-1Pa (Frogs, amphibians, animals)",P82841,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=7 μM);##Gram-negative bacterium: Escherichia coli (MIC=14 μM).##Yeast: Candida albicans (MIC=5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02098,FLPIIASVAAKVFSKIFCAISKKC,24,"Brevinin-1Pc (Frogs, amphibians, animals)",P82843,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=7 μM);##Gram-negative bacterium: Escherichia coli (MIC=5 μM).##Yeast: Candida albicans (MIC=7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP02099,FLPIIASVAANVFSKIFCAISKKC,24,"Brevinin-1Pd (Frogs, amphibians, animals)",P82844,Belongs to the frog skin active peptide family (Brevinin subfamily),Not found,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=27 μM);##Gram-negative bacterium: Escherichia coli (MIC=78 μM).##Yeast: Candida albicans (MIC=29 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",24,21-24
DRAMP18506,KKFFLKVLTKIRCKVAGGCRT,21,OG2 (Palustrin-OG1 peptide derivative),No entry found,Derived from Palustrin-OG1,Not found,Synthetic construct (Modified Palustrin-OG1),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Antibacterial activity against Gram-positive, Gram-negative bacteria, and lower hemolytic activity than OG1.","[Ref.22670762]Gram-positive bacteria: Bacillus subtilis 1A751 (MIC=128 μg/mL), Staphylococcus aureus ATCC25923 (MIC=8 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=8 μg/mL),Salmonella choleraesuis CMCC50020 (MIC=16 μg/mL)",[Ref.22670762]7%±2% hemolysis at 2-256 μg/mL against porcine red blood cells.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22670762,Protein Pept Lett. 2013 Jan;20(1):54-60.,"Xie YG, Luan C, Zhang HW, Han FF, Feng J, Choi YJ, Groleau D, Wang YZ.",Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.,21,18-21
DRAMP18508,KFAKKFKWFAKAAFKFFKK,19,gp41w-FKA (gp41 peptide derivative),No entry found,"Derived from the HIV glycoprotein, gp41",Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,"gp41w-FKA peptide to adopt a helical conformation in the cosolvent mixture of chloroform, methanol and water. The peptide formed a very well defined ",,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23019445]Gram-positive bacterium: Staphylococcus aureus (MIC<10 μg/ml, MBC=20-30 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=10-30 μg/ml, MBC=40-50 μg/ml)",[Ref.23019445]EC50=195 μg/mL against human red blood cells.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,gp41w-FKA binds at the interfacial region of a phospholipid bilayer.,23019445,Beilstein J Org Chem. 2012;8:1172-84. Epub 2012 Jul 24.,"Haney EF, Nguyen LT, Schibli DJ, Vogel HJ.","Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41.",19,18-21
DRAMP18510,KKLALLALKKWLLALKKLALLALKK,25,D-LAK120,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.48±0.53 μM), Escherichia coli Top 10 (MIC=0.62±0.15 μM), Pseudomonas aeruginosa (MIC=2.71±1.07 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.95±0.08 μM)",[Ref.22869378]HC50=4.06±1.30 μM against Not found (The literature does not mention),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",25,24-27
DRAMP18511,KKLALLALKKWLPALKKLALLALKK,25,D-LAK120-P13,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.54±0.97 μM), Escherichia coli Top 10 (MIC=0.58±0.18 μM), Pseudomonas aeruginosa (MIC=1.42±0.41 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=0.88±0.08 μM), Plasmodium falciparum C10 (EC50=2.18±0.41 μM), A549 (EC50=2.44±0.43 μM), RAW264.7 (EC50=3.80±0.34 μM)",[Ref.22869378]HC50=11.66±0.03 μM against Not found (The literature does not mention),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",25,24-27
DRAMP18512,KKLALALAKKWLALAKKLALALAKK,25,D-LAK120-A,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.23±0.47 μM), Escherichia coli Top 10 (MIC=0.38±0.21 μM), Pseudomonas aeruginosa (MIC=1.83±0.63 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.45±0.12 μM), Plasmodium falciparum C10 (EC50=2.13±0.14 μM), A549 (EC50=5.23±0.35 μM), RAW264.7 (EC50=7.31±2.13 μM)",[Ref.22869378]HC50=17.42±2.17 μM against Not found (The literature does not mention),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",25,24-27
DRAMP18513,KKLALALAKKWLPLAKKLALALAKK,25,D-LAK120-AP13,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.08±0.62 μM), Escherichia coli Top 10 (MIC=0.29±0.09 μM), Pseudomonas aeruginosa (MIC=1.22±0.19 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=0.88±0.06 μM), Plasmodium falciparum C10 (EC50=2.36±0.10 μM), A549 (EC50=3.11±0.57 μM), RAW264.7 (EC50=3.42±0.16 μM)",[Ref.22869378]HC50=58.61±10.41 μM against Not found (The literature does not mention),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",25,24-27
DRAMP18514,KKLALHALKKWLHALKKLAHLALKK,25,D-LAK120-H ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.54±0.01 μM), Escherichia coli Top 10 (MIC=0.40±0.01 μM), Pseudomonas aeruginosa (MIC=1.35±0.07 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.26±0.14 μM), Plasmodium falciparum C10 (EC50=4.43±0.33 μM), A549 (EC50=4.54±0.30 μM), RAW264.7 (EC50=5.21±0.57 μM)",[Ref.22869378]HC50=20.29±2.42 μM against Not found (The literature does not mention),Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",25,24-27
DRAMP18561,IWRIFRRIFRIFIRF,15,HFU5,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22699557]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Staphylococcus epidermidis ATCC 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Pseudomonas aeruginosa 27853 (MIC=16 μM)",[Ref.22699557]MHC=15.0 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22699557,Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7.,"Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY.",Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.,15,12-15
DRAMP18566,VNWKKSLGKSIKVVK,15,LL-IIIs-1 (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.7 μM), Bacillus cereus (MIC=0.8 μM), Staphylococcus aureus  (MIC=12.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=4.4 μM), Pseudomonas aeruginosa (MIC=78.7 μM);##Fungi: Candida albicans (MIC=100 μM)",[Ref.22526241]LC50=31.3 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,15,12-15
DRAMP18567,VNWKKILGKSIKVSK,15,LL-IIIs-2 (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus  (MIC=20.3 μM);##Gram-negative bacteria: Escherichia coli (MIC=8.8 μM), Pseudomonas aeruginosa (MIC=86.7 μM);##Fungi: Candida albicans (MIC=100 μM)",[Ref.22526241]LC50=69 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,15,12-15
DRAMP18568,VSWKKSLGKIIKVVK,15,LL-IIIs-3 (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.4 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=21.7 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.2 μM), Pseudomonas aeruginosa (MIC=76.3 μM);##Fungi: Candida albicans (MIC=93.3 μM)",[Ref.22526241]LC50=30 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,15,12-15
DRAMP18569,VNSKKISGKSIKVSK,15,LL-IIIs-4 (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=2 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=80 μM);##Gram-negative bacteria: Escherichia coli (MIC=20 μM).",[Ref.22526241]LC50>100 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,15,12-15
DRAMP18570,VNRKKILGKSIKVVK,15,LL-IIIs-5 cis (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=0.9 μM), Staphylococcus aureus  (MIC=45 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.5 μM), Pseudomonas aeruginosa (MIC=80 μM).",[Ref.22526241]LC50=100 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,15,12-15
DRAMP18571,VNRKKILGKSIKVVK,15,LL-IIIs-5 trans (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria .Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.1 μM), Bacillus cereus (MIC=1.3 μM), Staphylococcus aureus  (MIC=65 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.5 μM), Pseudomonas aeruginosa (MIC=80 μM).",[Ref.22526241]LC50>100 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,15,12-15
DRAMP18572,VNSKKISPKSIKVSK,15,LL-IIIs-6a (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=93 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM), Pseudomonas aeruginosa (MIC=93 μM).",[Ref.22526241]LC50>100 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,15,12-15
DRAMP18573,VNSKKISPKSIKVSK,15,LL-IIIs-6b (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=0.8 μM), Staphylococcus aureus  (MIC=50 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM), Pseudomonas aeruginosa (MIC=63 μM).",[Ref.22526241]LC50=82 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,15,12-15
DRAMP18574,GFLSILKKVLPKVXAHXK,18,MEP-N (melectin peptide derivative),No entry found,Derived from the peptide melectin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1 μM), Bacillus cereus (MIC=0.5 μM), Staphylococcus aureus (MIC=2.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.9 μM), Pseudomonas aeruginosa (MIC=17.3 μM);##Fungi: Candida albicans (MIC=15 μM)",[Ref.22526241]LC50=50 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,18,15-18
DRAMP18575,GFLSILKKVLPKSXAHSK,18,MEP-Ns-1 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.8 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus (MIC=10.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=77 μM);##Fungi: Candida albicans (MIC=30 μM)",[Ref.22526241]LC50=18.1 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,18,15-18
DRAMP18576,GFLSSLKKSLPKVXAHXK,18,MEP-Ns-2 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus  (MIC=37 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM).",[Ref.22526241]LC50=14.7 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,18,15-18
DRAMP18577,GFLSSLKKSLPKSXAHSK,18,MEP-Ns-3 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.3 μM), Bacillus cereus (MIC=1.2 μM) ;##Gram-negative bacteria: Escherichia coli (MIC=46.7 μM).",[Ref.22526241]LC50=13.9 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,18,15-18
DRAMP18578,GFRSILKKVSPKVXAHXK,18,MEP-Ns-4 cis (melectin peptide derivative),No entry found,Derived from the peptide melectin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.3 μM), Staphylococcus aureus (MIC=37 μM);##Gram-negative bacteria: Escherichia coli (MIC=8.1 μM).",[Ref.22526241]LC50=11 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,18,15-18
DRAMP18579,GFRSILKKVSPKVXAHXK,18,MEP-Ns-4 trans (melectin peptide derivative),No entry found,Derived from the peptide melectin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=2 μM), Bacillus cereus (MIC=1.7 μM), Staphylococcus aureus (MIC=63 μM);##Gram-negative bacteria: Escherichia coli (MIC=16.3 μM).",[Ref.22526241]LC50=20 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,18,15-18
DRAMP18580,GFLSSLKKSLGKSXAHSK,18,MEP-Ns-5 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus (MIC=57 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.6 μM).",[Ref.22526241]LC50=29 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,18,15-18
DRAMP18581,GFLSSLKKSLAKSXAHSK,18,MEP-Ns-6 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus (MIC=43 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.6 μM).",[Ref.22526241]LC50=39.5 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,18,15-18
DRAMP18583,KWCFCVCYRGICYCRCRG,18,"Tricystine cyclic cystine TP (ccTP, Tachyplesin-1 peptide derivative)",No entry found,Derived from the peptide Tachyplesin-1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Beta tile,"Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by β-turns, aromatic residues, disulfides and b-sheet structures, it is reasonable to conclude that all cyclic tachyplesins 2–6 as well as RTD display ordered structures in methanol.",,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria.Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.0 μM in low-salt; MIC=0.8 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.0 μM in low-salt; MIC=0.9 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=3.0 μM in low-salt; MIC=6.9 μM in high-salt), Pseudomonas aeruginosa (MIC=5.0 μM in low-salt; MIC=5.2 μM in high-salt), Primula vulgaris (MIC=6.0 μM in low-salt; MIC=14.4 μM in high-salt), Klebsiella oxytoca (MIC=2.1 μM in low-salt; MIC=7.8 μM in high-salt);##Fungi: Candida albicans (MIC=5.1 μM in low-salt; MIC=17.2 μM in high-salt), Candida kefyr (MIC=3.9 μM in low-salt; MIC=4.1 μM in high-salt), Candida tropicalis (MIC=5.2 μM in low-salt; MIC=1.1 μM in high-salt).",[Ref.10673369] EC25=3800 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.",L,No cytotoxicity information found,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,18,15-18
DRAMP18584,KWCFCVCYRGICRCRCRG,18,[Arg13]ccTP (ccTP peptide derivative),No entry found,Derived from the peptide ccTP,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.3 μM in low-salt; MIC=0.9 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.5 μM in high-salt), Enterococcus faecalis (MIC=1.9 μM in low-salt; MIC=1.3 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=10.4 μM in low-salt; MIC=0.9 μM in high-salt), Pseudomonas aeruginosa (MIC=6.2 μM in low-salt; MIC=10.4 μM in high-salt), Primula vulgaris (MIC=16.4 μM in low-salt; MIC=28.9 μM in high-salt), Klebsiella oxytoca (MIC=4.0 μM in low-salt; MIC=7.6 μM in high-salt);##Fungi: Candida albicans (MIC=24.2 μM in low-salt; MIC=30.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=4.3 μM in high-salt), Candida tropicalis (MIC=12.4 μM in low-salt; MIC=3.9 μM in high-salt).",[Ref.10673369] EC25=590 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.",L,No cytotoxicity information found,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,18,15-18
DRAMP18585,KWCRCVCRRGICYCRCRG,18,"[Arg4,8]ccTP (ccTP peptide derivative)",No entry found,Derived from the peptide ccTP,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Beta tile,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.3 μM in low-salt; MIC=0.3 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.7 μM in high-salt), Enterococcus faecalis (MIC=1.0 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=9.8 μM in low-salt; MIC=2.0 μM in high-salt), Pseudomonas aeruginosa (MIC=8.0 μM in low-salt; MIC=5.3 μM in high-salt), Primula vulgaris (MIC=26.7 μM in low-salt; MIC=56.2 μM in high-salt), Klebsiella oxytoca (MIC=6.1 μM in low-salt; MIC=7.8 μM in high-salt);##Fungi: Candida albicans (MIC=6.4 μM in low-salt; MIC=11.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=1.9 μM in high-salt), Candida tropicalis (MIC=2.8 μM in low-salt; MIC=4.2 μM in high-salt).",[Ref.10673369] EC25=910 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.",L,No cytotoxicity information found,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,18,15-18
DRAMP18586,KWCRCVCRRGICRCRCRG,18,"[Arg4,8,13]ccTP (ccTP peptide derivative)",No entry found,Derived from the peptide ccTP,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.7 μM in low-salt; MIC=1.3 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.8 μM in high-salt), Enterococcus faecalis (MIC=0.7 μM in low-salt; MIC=0.5 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=5.5 μM in low-salt; MIC=1.2 μM in high-salt), Pseudomonas aeruginosa (MIC=3.9 μM in low-salt; MIC=4.7 μM in high-salt), Primula vulgaris (MIC=16.8 μM in low-salt; MIC=55.6 μM in high-salt), Klebsiella oxytoca (MIC=2.4 μM in low-salt; MIC=5.4 μM in high-salt);##Fungi: Candida albicans (MIC=7.1 μM in low-salt; MIC=5.1 μM in high-salt), Candida kefyr (MIC=4.2 μM in low-salt; MIC=0.7 μM in high-salt), Candida tropicalis (MIC=1.9 μM in low-salt; MIC=4.8 μM in high-salt).",[Ref.10673369] EC25=920 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.",L,No cytotoxicity information found,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,18,15-18
DRAMP18587,KWCRCVCRRGICRCRCRK,18,"[Arg4,8,13][Lys18]ccTP (ccTP peptide derivative)",No entry found,Derived from the peptide ccTP,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.7 μM in low-salt; MIC=0.7 μM in high-salt), Micrococcus luteus (MIC=0.3 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.4 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=6.1 μM in low-salt; MIC=1.2 μM in high-salt), Pseudomonas aeruginosa (MIC=2.0 μM in low-salt; MIC=4.7 μM in high-salt), Primula vulgaris (MIC=17.0 μM in low-salt; MIC=39.8 μM in high-salt), Klebsiella oxytoca (MIC=4.1 μM in low-salt; MIC=4.1 μM in high-salt);##Fungi: Candida albicans (MIC=10.5 μM in low-salt; MIC=5.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=0.7 μM in high-salt), Candida tropicalis (MIC=2.3 μM in low-salt; MIC=1.9 μM in high-salt).",[Ref.10673369] EC25=3900 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.",L,No cytotoxicity information found,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,18,15-18
DRAMP18588,GFCRCLCRRGVCRCICTK,18,RTD,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.1 μM in low-salt; MIC=0.9 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.2 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=2.0 μM in low-salt; MIC=28.4 μM in high-salt), Pseudomonas aeruginosa (MIC=2.0 μM in low-salt; MIC=5.2 μM in high-salt), Primula vulgaris (MIC=10.2 μM in low-salt; MIC=50.4 μM in high-salt), Klebsiella oxytoca (MIC=2.0 μM in low-salt; MIC=12.8 μM in high-salt);##Fungi: Candida albicans (MIC=4.0 μM in low-salt; MIC=5.2 μM in high-salt), Candida kefyr (MIC=1.8 μM in low-salt; MIC=1.2 μM in high-salt), Candida tropicalis (MIC=2.8 μM in low-salt; MIC=1.0 μM in high-salt).",[Ref.10673369]EC25=2350 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,18,15-18
DRAMP18592,GWLDVAKKIGKAAFNVAKNFI,21,Ctx(Ile21)-Ha (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=1 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=4 μmol/L), Pseudomonas aeruginosa (MIC=8 μmol/L);##Fungi: Candida albicans (MIC=8 μmol/L), Candida krusei (MIC=8 μmol/L), Candida parapsilosis (MIC=4 μmol/L), Cryptococcus neoformans (MIC=8 μmol/L)",[Ref.22519531]HC50=26 μmol/L against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22519531,Protein Pept Lett. 2012 Jun 1;19(6):596-603.,"Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.",Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.,21,18-21
DRAMP18593,GWLDVAKKIGKAAFNVAKNFI,21,Ctx(Ile21)-Ha-VD16 (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. D-Valine to replace L-Valine at the position 16 on the peptide Ctx(Ile21)-Ha. Has hemolytic activity.","[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=2 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=4 μmol/L), Pseudomonas aeruginosa (MIC=16 μmol/L);##Fungi: Candida albicans (MIC=31 μmol/L), Candida krusei (MIC=16 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)",[Ref.22519531]HC50=18.7 μmol/L against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22519531,Protein Pept Lett. 2012 Jun 1;19(6):596-603.,"Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.",Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.,21,18-21
DRAMP18594,GWLDVAKKIGKAAFNVAKNFI,21,"Ctx(Ile21)-Ha-VD5,16 (Ctx-Ha peptide derivative)",No entry found,Derived from the peptide Ctx-Ha,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. D-Valine to replace L-Valine at the position 5 and 16 on the peptide Ctx(Ile21)-Ha.Has hemolytic activity.","[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=64 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=16 μmol/L), Pseudomonas aeruginosa (MIC=128 μmol/L);##Fungi: Candida albicans (MIC=16 μmol/L), Candida krusei (MIC=16 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)",[Ref.22519531]HC50=43.1 μmol/L against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22519531,Protein Pept Lett. 2012 Jun 1;19(6):596-603.,"Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.",Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.,21,18-21
DRAMP18595,GWLDVAKKKGKAAFNVAKNFI,21,Ctx(Ile21)-Ha-I9K (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. L-Lysine to replace L-Isoleucine at the position 9 on the peptide Ctx(Ile21)-Ha.Has hemolytic activity.","[Ref.22519531]Gram-negative bacteria: Escherichia coli (MIC=8 μmol/L), Pseudomonas aeruginosa (MIC=32 μmol/L);##Fungi: Candida albicans (MIC=16 μmol/L), Candida krusei (MIC=31 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)",[Ref.22519531]HC50=24.9 μmol/L against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22519531,Protein Pept Lett. 2012 Jun 1;19(6):596-603.,"Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.",Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.,21,18-21
DRAMP18596,NVWKKVLGKIIKVAK,15,LL-I/1 (Lasioglossin LL-I peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-I,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity. ,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=1.3 μM), Staphylococcus aureus (MIC=71.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=22.7 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2102.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18597,VNWKKVLAKIIKVAK,15,LL-I/2 (Lasioglossin LL-I peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-I,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.6 μM), Staphylococcus aureus (MIC=7.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.9 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2103.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18598,VNWKKVLKKIIKVAK,15,LL-I/3 (Lasioglossin LL-I peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-I,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=15.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=19.0 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2104.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18599,VNWKKVLPKIIKVAK,15,LL-I/4 (Lasioglossin LL-I peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-I,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.9 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.0 μM), Pseudomonas aeruginosa (MIC=100 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2105.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18600,NVWKKILGKIIKVAK,15,LL-II/1 (Lasioglossin LL-II peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-II,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=19.7 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.1 μM), Pseudomonas aeruginosa (MIC=23.3 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2106.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18601,VNWKKILAKIIKVAK,15,LL-II/2 (Lasioglossin LL-II peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-II,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Has hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=4.3 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=22.5 μM).",[Ref.19591185]LC50=66.5 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2107.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18602,VNWKKILKKIIKVAK,15,LL-II/3 (Lasioglossin LL-II peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-II,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=15.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.1 μM).",[Ref.19591185]LC50=88.2 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2108.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18603,VNWKKILPKIIKVAK,15,LL-II/4 (Lasioglossin LL-II peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-II,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=80 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=100 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2109.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18604,NVWKKILGKIIKVVK,15,LL-III/1 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=9.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.4 μM), Pseudomonas aeruginosa (MIC=23.1 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2110.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18605,VNWKKILAKIIKVVK,15,LL-III/2 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.6 μM), Staphylococcus aureus (MIC=2.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.4 μM), Pseudomonas aeruginosa (MIC=27.1 μM).",[Ref.19591185]LC50=55.1 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2111.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18606,VNWKKILKKIIKVVK,15,LL-III/3 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Has hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=9.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.1 μM).",[Ref.19591185]LC50=72.2 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2112.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18607,VNWKKILPKIIKVVK,15,LL-III/4 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.8 μM), Staphylococcus aureus (MIC=32.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.2 μM), Pseudomonas aeruginosa (MIC=100 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2113.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18608,VNWKKILGKIIKVVK,15,LL-III/5 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Weak hemolytic activity.
PTM: C-terminal hydroxyl modification","[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=1.2 μM), Staphylococcus aureus (MIC=40 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.5 μM), Pseudomonas aeruginosa (MIC=40 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2114.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18609,VNWKKILGKIIKVVK,15,LL-Ⅲ/6 (Lasioglossin LL-Ⅲ peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-Ⅲ,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
PTM: C-terminal methoxy modification","[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.5 μM), Staphylococcus aureus (MIC=2.1 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.0 μM), Pseudomonas aeruginosa (MIC=22.5 μM).",[Ref.19591185]LC50=79.3 μM against rat red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2115.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,15,12-15
DRAMP18627,KLKKLLKKWLKLLKKLLK,18,D4-K9L8W (D-amino acid substitution of K9L8W),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 12 and 16 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 4 and 8 on the peptide K9L8W. Weak hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=2 μM), Staphylococcus aureus (MIC=2 μM);##Gram-negative bacteria: Escherichia coli (MIC=2 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50>800 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,18,15-18
DRAMP18507,FSGGNCRGFRRRCFCTK,17,"SolyC (Plant defensin; tomato, plants)",No entry found,Belongs to the tomato defensin family,Not found,Tomato,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Beta sheet,Not found,,"Function: Antibacterial activity against a panel of human pathogens, including H.pylori, and displays anti-inflammatory activity in vitro. Weak hemolytic activity.","[Ref.23124812]Gram-positive bacteria: Staphylococcus aureus A170 (MIC=40 μg/mL), Staphylococcus epidermidis (MIC=40 μg/mL), Listeria monocytogenes (MIC=40 μg/mL);##Gram-negative bacteria: Salmonella enterica serovar Paratyphi (MIC=15 μg/mL), Escherichia coli (MIC=15 μg/mL), Helicobacter pylori VB1 (MIC=15 μg/mL), Helicobacter pylori VB2 (MIC=10 μg/mL), Helicobacter pylori VB3 (MIC=15 μg/mL), Helicobacter pylori VB4 (MIC=12 μg/mL), Helicobacter pylori VB5 (MIC=15 μg/mL), Helicobacter pylori VB6 (MIC=10 μg/mL), Helicobacter pylori VB7 (MIC=15 μg/mL), Helicobacter pylori VB8 (MIC=10 μg/mL), Helicobacter pylori VB9 (MIC=10 μg/mL), Helicobacter pylori VB10 (MIC=15 μg/mL).",[Ref.23124812]<5%  hemolysis at 50 μg/mL against mouse red blood cells.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23124812,J Pept Sci. 2012 Dec;18(12):755-62.,"Rigano MM, Romanelli A, Fulgione A, Nocerino N, D'Agostino N, Avitabile C, Frusciante L, Barone A, Capuano F, Capparelli R.",A novel synthetic peptide from a tomato defensin exhibits antibacterial activities against Helicobacter pylori.,17,15-18
DRAMP18618,RGLRRLGRKIAHGVKKY,17,SMAP-29(1-17) (SMAP-29 peptide derivative),No entry found,Derived from the peptide SMAP-29,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.","[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=8.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM);##[100 mM NaCl]: Bacillus subtilis (MIC=16.0 μM), Staphylococcus aureus (MIC=4.0 μM), Micrococcus luteus (MIC=4.0 μM), Staphylococcus epidermidis (MIC=2.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=8.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=8.0 μM);[100 mM NaCl]: Escherichia coli (MIC=16.0 μM), Salmonella typhimurium (MIC=8.0 μM), Pseudomonas aeruginosa (MIC=16.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=8.0 μM);[100 mM NaCl]: Candida albicans (MIC=16.0 μM).",[Ref.11467858]Non-hemolysis at 100 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11467858,Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.,"Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.",17,15-18
DRAMP18619,RKLRRLKRKIAHKVKKY,17,"[K2,7,13]-SMAP-29(1-17) (SMAP-29 peptide derivative)",No entry found,Derived from the peptide SMAP-29,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Not found,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.","[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM);[100 mM NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=1.0 μM), Staphylococcus epidermidis (MIC=1.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=3.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=6.0 μM);[100 mM NaCl]: Escherichia coli (MIC=6.0 μM), Salmonella typhimurium (MIC=4.0 μM), Pseudomonas aeruginosa (MIC=3.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=8.0 μM);[100 mM NaCl]: Candida albicans (MIC=8.0 μM).",[Ref.11467858]Non-hemolysis at 100 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,11467858,Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.,"Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.",17,15-18
DRAMP18620,KKTWWKTWWTKWSQPKKKRKV,21,Pep-1-K (Pep-1 peptide derivative),No entry found,Derived from the peptide Pep-1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria. No hemolytic activity.,"[Ref.16945333]Gram-positive bacteria: Bacillus subtilis (KCTC 3068) (MIC=2.0 μM), Staphylococcus aureus (KCTC 1621) (MIC=2.0 μM), Staphylococcus epidermidis (KCTC 1917) (MIC=1.0 μM);##Gram-negative bacteria: Escherichia coli (KCTC 1682) (MIC=2.0 μM), Salmonella typhimurium (KCTC 1926) (MIC=1.0 μM), Pseudomonas aeruginosa (KCTC 1637) (MIC=2.0 μM);##Antibiotic-resistant bacteria: MRSA 1 (CCARM 3001) (MIC=2.0 μM), MRSA 2 (CCARM 3089) (MIC=2.0 μM), MRSA 3 (CCARM 3543) (MIC=1.0 μM), MDRPA 1 (CCARM 2092) (MIC=8.0 μM), MDRPA 2 (CCARM 2095) (MIC=8.0 μM), MDRPA 3 (CCARM 2109) (MIC=8.0 μM).",[Ref.16945333]Non-hemolysis at 200 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16945333,Biochem Biophys Res Commun. 2006 Oct 20;349(2):769-74.,"Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY.",Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.,21,18-21
DRAMP18622,FLPIVAKLLSGLLGRKKRRQRRR,23,Temporin-PEb (Temporin-PE peptide derivative),No entry found,Derived from the peptide Temporin-PE,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal",Synthetic,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.29191658]Gram-positive bacteria: Staphylococcus aureus (MIC=1.0 μM), Methicillin-resistant Staphylococcus aureus (MIC=2.0 μM), Enterococcus faecalis (MIC=2.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.0 μM);##Fungus: Candida albicans (MIC=1.0 μM).##Cancer cell lines: NCI-H157 (IC50=3.464 μM), U251MG (IC50=3.087 μM), PC-3 (IC50=3.051 μM), MDA-MB-435s (IC50=3.483 μM), HMEC-1 (IC50=9.976 μM).",[Ref.29191658]HC50=44.64 μM against horse red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29191658,Biochem Biophys Res Commun. 2018 Jan 22;495(4):2539-2546.,"Sang M, Wu Q, Xi X, Ma C, Wang L, Zhou M, Burrows JF, Chen T.","Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus.",23,21-24
DRAMP18624,KLKKLLKKWLKLLKKLLK,18,K9L8W,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=4 μM), Staphylococcus epidermidis (MIC=8 μM), Staphylococcus aureus (MIC=8 μM);##Gram-negative bacteria: Escherichia coli (MIC=8 μM), Pseudomonas aeruginosa (MIC=8 μM), Salmonella typhimurium (MIC=4 μM).",[Ref.20363271]HC50=14 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,18,15-18
DRAMP18625,KLKKLLKKWLKLLKKLLK,18,D3-K9L8W-1 (D-amino acid substitution of K9L8W),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 6 and 12 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 18 on the peptide K9L8W. Has hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=2 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50=150 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,18,15-18
DRAMP18626,KLKKLLKKWLKLLKKLLK,18,D3-K9L8W-2 (D-amino acid substitution of K9L8W),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 5 and 10 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 15 on the peptide K9L8W. Has hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50=116 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,18,15-18
DRAMP18628,KLKKLLKKWLKLLKKLLK,18,D6-K9L8W (D-amino acid substitution of K9L8W),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 6 and 12 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 3,15 and 18 on the peptide K9L8W, D-Tryptophan replace L-Tryptophan at the position 9 on the peptide K9L8W. Weak hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=2 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50>800 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,18,15-18
DRAMP18629,KLKKLLKKWLKLLKKLLK,18,D9-K9L8W-1 (D-amino acid substitution of K9L8W),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 2,6,10,12 and 16 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 4,8,14 and 18 on the peptide K9L8W. Weak hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=2 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50>800 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,18,15-18
DRAMP18630,KLKKLLKKWLKLLKKLLK,18,D9-K9L8W-2 (D-amino acid substitution of K9L8W),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 10,12,13,16 and 17 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 11,14,15 and 18 on the peptide K9L8W. Has hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=2 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50=154 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,18,15-18
DRAMP18632,LSIRRLLAAGVLKQTKGVGA,20,Peptide H5 (71-90) (Histone H5 peptide derivative),No entry found,Derived from Histone H5,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria. ,[Ref.29402952] Gram-negative bacterium: Pseudomonas aeruginosa (MIC=26.7±14.1 μg/mL),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29402952,Sci Rep. 2018 Feb 5;8(1):2411.,"Jodoin J, Hincke MT.",Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,20,18-21
DRAMP18635,KLIPIASKTCPAGKNLCYKI,20,NCP-0,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Unordered structure,The peptide adopts overall content of unordered secondary structure that is 67% ,,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.29364903] Gram-negative bacteria: Burkholderia cepacia ATCC 17759(MBC=50μg/ml);Moraxella catarrhalis ATCC 25238(MBC=1.6μg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,20,18-21
DRAMP18636,KLIFILSKTIPAGKNLFYKI,20,NCP-3a (CTX-1 peptide derivative),No entry found,Derived from CTX-1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=12.5 μg/ml), Enterococcus hirae ATCC 10541 (MBC=6.3 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=3.1 μg/ml);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MBC=6.3 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=25 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=25 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=25 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=50 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=50 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=3.1 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=6.3 μg/mL), Candida glabrata ATCC 90030 (MBC=25 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,20,18-21
DRAMP18637,KLILILSKTIPAGKNLFYKI,20,NCP-3b (CTX-1 peptide derivative),No entry found,Derived from CTX-1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=50 μg/ml), Enterococcus hirae ATCC 10541 (MBC=12.5 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=12.5 μg/ml);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=25 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=25 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=25 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=25 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=25 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=12.5 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=12.5 μg/mL), Candida glabrata ATCC 90030 (MBC=100 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=25 μg/mL)",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,20,18-21
DRAMP18638,VYPFMWGGAYCFCDAELV,18,VT18-LV (VT18 peptide derivative),No entry found,Derived from VT18,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Double-stranded ,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. ,[Ref.29277569] Gram-positive bacteria: Streptococcus pneumoniae ATCC 700669 (MIC=207 μg/ml),No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29277569,Biochimie. 2018 Mar;146:139-147. ,"Yang R, Zhang G, Zhang F, Li Z, Huang C.",Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection.,18,15-18
DRAMP18639,CKCRRRKVHGPMIRIRKK,18,CTO17 (TO17 peptide derivative),No entry found,Derived from TO17,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.29183811] Gram-negative bacterium: Vibrio vulnificus (MIC=20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29183811,Fish Shellfish Immunol. 2018 Jan;72:639-645. ,"He SW, Wang GH, Yue B, Zhou S, Zhang M.","TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.",18,15-18
DRAMP18640,KCRRRKVHGPMIRIRKKNL,19,TO19 (TO17 peptide derivative),No entry found,Derived from TO17,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.29183811] Gram-negative bacterium: Vibrio vulnificus (MIC=20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29183811,Fish Shellfish Immunol. 2018 Jan;72:639-645.,"He SW, Wang GH, Yue B, Zhou S, Zhang M.","TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.",19,18-21
DRAMP18654,GIIKVIKSLIEQFTGK,16,"dPSMα1 (PSMα1 peptide derivative; bacteriocin; staphylococcus aureus, bacteria)","A9JX05, A8Z0V1, P0C7Y9, P0C7Y8, P0C7Y7, P0C7Y6, P0C7Y5, P0C7Y4, P0C7Y3",Belongs to the phenol-soluble modulin alpha peptides family.,psmA1,Truncated the peptide PSMα1 (from Staphylococcus aureus),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria. Peptide which can recruit, activate and subsequently lyse human neutrophils, thus eliminating the main cellular defense against infection. Stimulates the secretion of the chemotactic factor interleukin-8 (IL-8). The ensuing activation process triggers an inflammatory response in the host, thus contributing greatly to virulence. Also possesses hemolytic activity, which may contribute to the development of disease. Peptide production is higher in most prevalent community-associated MRSA strains than in hospital-associated MRSA strains.
Induction: Up-regulated by agr.","[Ref.22371493]Gram-positive bacteria: Staphylococcus epidermidis ATCC35984 (MIC=42 μM), Streptococcus serotype GAS M3 strain 4041-05 (MIC=11 μM).",[Ref.22371493]Non-hemolytic at 10μg/mL against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22371493,J Biol Chem. 2012 Apr 20;287(17):13889-98.,"Gonzalez DJ, Okumura CY, Hollands A, Kersten R, Akong-Moore K, Pence MA, Malone CL, Derieux J, Moore BS, Horswill AR, Dixon JE, Dorrestein PC, Nizet V.",Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,16,15-18
DRAMP18655,VGTIIKIIKAIIDIFAK,17,"dPSMα4 (PSMα4 peptide derivative; bacteriocin; staphylococcus aureus, bacteria)","A9JX08, P0C827, P0C826, P0C825, P0C824, P0C823, P0C822, P0C821, P0C820",Belongs to the phenol-soluble modulin alpha peptides family.,psmA4,Truncated the peptide PSMα4 (from Staphylococcus aureus),"Antimicrobial, Antibacterial, Anti-Gram+",Protein level,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria. Peptide which can recruit, activate and subsequently lyse human neutrophils, thus eliminating the main cellular defense against infection. Stimulates the secretion of the chemotactic factor interleukin-8 (IL-8). The ensuing activation process triggers an inflammatory response in the host, thus contributing greatly to virulence. Also possesses hemolytic activity, which may contribute to the development of disease. Peptide production is higher in most prevalent community-associated MRSA strains than in hospital-associated MRSA strains.
Induction: Up-regulated by agr.",[Ref.22371493]Gram-positive bacteria: Streptococcus serotype GAS M3 strain 4041-05 (MIC=10 μM).,[Ref.22371493]52% hemolysis at 10μg/mL against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22371493,J Biol Chem. 2012 Apr 20;287(17):13889-98.,"Gonzalez DJ, Okumura CY, Hollands A, Kersten R, Akong-Moore K, Pence MA, Malone CL, Derieux J, Moore BS, Horswill AR, Dixon JE, Dorrestein PC, Nizet V.",Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,17,15-18
DRAMP18661,GWLDVAKKIGKAAFNVAKNFL,21,"Ctx-Ha (Frogs, amphibians, animals)",No entry found,Belongs to the Ceratotoxin family,Not found,Hypsiboas albopunctatus,"Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-",Not found,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.",[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=1.7 μmol/L; MMC=6.8 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=3.4 μmol/L; MMC=3.4 μmol/L);##Fungi: Candida albicans (MIC=54.6 μmol/L; MMC<100 μmol/L),[Ref.22391524]HC50=37.3±1.4 μmol/L against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,22391524,Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.,"Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.",Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,21,18-21
DRAMP18662,LLAGLAANFLPKIFCKITRKC,21,"Brevinin 21 (Brevinin-1E truncated peptide 21; Frogs, amphibians, animals)",No entry found,Derived from the peptide Brevinin-1E ,Not found,Rana esculenta,"Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-",Not found,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=12.5 μg/ml), Methicillin resistant Staphylococcus aureus (MIC=25 μg/ml), Micrococcus luteus ATCC 9341 (MIC=6.25 μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 2592 (MIC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=12.5 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=6.25 μg/ml).",[Ref.9748603]HD50=77 μg/ml(oxidized); HD50=110 μg/ml(reduced) against mouse red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9748603,Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.,"Kwon MY, Hong SY, Lee KH.","Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.",21,18-21
DRAMP18663,GLAANFLPKIFCKITRKC,18,"Brevinin 18 (Brevinin-1E truncated peptide 18; Frogs, amphibians, animals)",No entry found,Derived from the peptide Brevinin-1E ,Not found,Rana esculenta,"Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-",Not found,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=25 μg/ml), Methicillin resistant Staphylococcus aureus (MIC=100 μg/ml), Micrococcus luteus ATCC 9341 (MIC=12.5 μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 2592 (MIC=25 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=12.5 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=25 μg/ml).",[Ref.9748603]HD50=146 μg/ml(oxidized); HD50=230 μg/ml(reduced) against mouse red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9748603,Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.,"Kwon MY, Hong SY, Lee KH.","Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.",18,15-18
DRAMP18664,ANFLPKIFCKITRKC,15,"Brevinin 15 (Brevinin-1E truncated peptide 15; Frogs, amphibians, animals)",No entry found,Derived from the peptide Brevinin-1E ,Not found,Rana esculenta,"Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-",Not found,Alpha helix ,Not found,,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=100 μg/ml), Micrococcus luteus ATCC 9341 (MIC=25 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 2592 (MIC=50 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=50 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=50 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9748603,Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.,"Kwon MY, Hong SY, Lee KH.","Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.",15,12-15
DRAMP18666,GLGSVFGRLARILGRVIPKV,20,"P1 (Pilosulin-1 1-20; Ant, insects, arthropods, invertebrates, animals)",Q07932,"Derived from the peptide Pilosulin-1, Belongs to the pilosulin family.",Not found,Myrmecia pilosula (Jumper ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-",Protein level,Alpha helix ,Not found,5X3L resolved by NMR.,"Function: Has strong cytotoxic and hemolytic activities. Is more potent against mononuclear leukocytes than against granulocytes. Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Adopts an alpha-helical structure.
Allergenic properties: Causes an allergic reaction in human. Binds to IgE.","[Ref.15639237]Gram-positive bacteria: Staphylococcus aureus 710A (MIC=4 μM), Bacillus megaterium BM11 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli ML-35 (MIC=2 μM), Pseudomonas aeruginosa ATCC27853 (MIC=8 μM), Salmonella typhimurium ATCC14028 (MIC=8 μM).##Drug resistant clinical isolates: Staphylococcus simulans 22 (MIC=2 μM), Micrococcus luteus (MIC=0.5 μM), Enterococcus spp. I-11305b (MIC=2 μM), Enterococcus spp. I-11054 (MIC=2 μM), Staphylococcus haemolyticus I-10925 (MIC=2 μM), Staphylococcus epidermidis LT1324 (MIC=2 μM), Staphylococcus aureus 5185 (MIC=2 μM), Staphylococcus aureus I-11574 (MIC=2 μM), Staphylococcus aureus LT1338 (MIC=3 μM), Staphylococcus aureus T1334 (MIC=1.5 μM), Citrobacter freundii I-11090 (MIC=2 μM), Klebsiella pneumoniae I-10910 (MIC=2 μM), Escherichia coli I-11276b (MIC=4 μM), Escherichia coli O-19592 (MIC=2 μM), Stenotrophomonas maltophilia O-16451 (MIC=2 μM), Stenotrophomonas maltophilia I-10717 (MIC=2 μM), Pseudomonas aeruginosa 4991 (MIC=4 μM), Pseudomonas aeruginosa I-10968 (MIC=4 μM), Candida albicans I-11301 (MIC=4 μM).","[Ref.15639237]20% hemolysis at 10μM, 100% hemolysis at 100μM against human red blood cells",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,15639237,Arch Biochem Biophys. 2005 Feb 15;434(2):358-64.,"Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.",Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.,20,18-21
DRAMP18667,KETWWETWWTEWSQPKKKRKV,21,Pep-1,No entry found,Not found,Not found,Derived from the nuclear localization sequence of simian virus 40 large T antigen and from reverse t,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria.No hemolytic activity.,"[Ref.16945333]Gram-positive bacteria: Bacillus subtilis (KCTC 3068) (MIC=8.0 μM), Staphylococcus aureus (KCTC 1621) (MIC=64.0 μM), Staphylococcus epidermidis (KCTC 1917) (MIC=64.0 μM);##Gram-negative bacteria: Escherichia coli (KCTC 1682) (MIC=32.0 μM);##Antibiotic-resistant bacteria: MDRPA 1 (CCARM 2092) (MIC=32.0 μM), MDRPA 3 (CCARM 2109) (MIC=32.0 μM).",[Ref.16945333]Non-hemolysis at 200 μM against human red blood cells,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,16945333,Biochem Biophys Res Commun. 2006 Oct 20;349(2):769-74.,"Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY.",Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.,21,18-21
DRAMP18668,PSVQGAAAQLTADVKK,16,AI-hemocidins 1 (Hb-1  truncated peptide),No entry found,Belongs to truncated Hb-1 ,Not found,Arca inflata,"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against the Gram-negative bacteria.,"[Ref.28661457] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=47.35 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=47.35 μM), Pseudomonas aeruginosa clinical isolate (MIC=47.35 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,28661457,Mar Drugs. 2017 Jun 29;15(7). pii: E205.,"Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.","Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata",16,15-18
DRAMP18669,ISAAEFGKINGPIKK,15,AI-hemocidins 3 (Hb-1  truncated peptide),No entry found,Belongs to truncated Hb-1 ,Not found,Arca inflata,"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.28661457] Gram-negative bacterium: Pseudomonas aeruginosa ATCC 27853 (MIC=95.37 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,28661457,Mar Drugs. 2017 Jun 29;15(7). pii: E205.,"Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.","Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata",15,12-15
DRAMP18671,KCRRRKVHGPMIRIRKK,17,TO17 (TFPI-1 C-terminal peptide),No entry found,Belongs to the TFPI-1 C-terminal peptide,Not found,Red drum (Sciaenops ocellatus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.29183811] Gram-positive bacteria: Micrococcus luteus (MIC=9 μM; MBC=18 μM), Staphylococcus aureus (MIC=4 μM; MBC=8 μM);##Gram-negative bacterium: Vibrio vulnificus (MIC= 80 μM; MBC=80 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,29183811,Fish Shellfish Immunol. 2018 Jan;72:639-645. ,"He SW, Wang GH, Yue B, Zhou S, Zhang M.","TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.",17,15-18
DRAMP18673,ELVRKNVDHLSTPDVLELV,19,"Peptide 3 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Not found,Not found,Marine snail Rapana venosa,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,19,18-21
DRAMP18674,SPPNQPSIMTFDYAKTNK,18,"Peptide 2 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Not found,Not found,Marine snail Rapana venosa,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,18,15-18
DRAMP18675,SLPPTLEEEFNMKKMG,16,"Peptide 4 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Not found,Not found,Marine snail Rapana venosa,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,16,15-18
DRAMP18677,SPPPGESKVDMSFNYALSNPAQ,22,"Peptide 6 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Not found,Not found,Marine snail Rapana venosa,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,22,21-24
DRAMP18679,FPPPGESAVDMSFFYALSNP,20,"Peptide 9 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Not found,Not found,Marine snail Rapana venosa,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,20,18-21
DRAMP18683,YIRDFITRRPPFGNI,15,"Ctri9194 (Scorpions, animals)",P0DMF5,Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant,Not found,Chaerilus tricostatus (Scorpion),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland.",[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23415044,Biomaterials. 2013 Apr;34(13):3511-22.,"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.",Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.,15,12-15
DRAMP18686,FLFNVIPHAINATASLIKK,19,"Ctri9610 (Scorpions, animals)",P0DME2,Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant,Not found,Chaerilus tricostatus (Scorpion),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland.",[Ref.23415044] The HCV RNA level is screened that between 1.E-01% and 1.E+00% of control(IFNα.2a) in Huh7.5.1 cells.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23415044,Biomaterials. 2013 Apr;34(13):3511-22.,"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.",Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.,19,18-21
DRAMP18687,FLVGILPRMRGFITPFLKKVR,21,"Ctri10033 (Scorpions, animals)",P0DME4,Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant,Not found,Chaerilus tricostatus (Scorpion),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland.",[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23415044,Biomaterials. 2013 Apr;34(13):3511-22.,"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.",Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.,21,18-21
DRAMP18688,FLWSLIPSAISAVTSLIKK,19,"Ctri10036 (Scorpions, animals)",P0DME3,Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant,Not found,Chaerilus tricostatus (Scorpion),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland.",[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,23415044,Biomaterials. 2013 Apr;34(13):3511-22.,"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.",Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.,19,18-21
DRAMP18692,LGPALITRKPLKGKP,15,"Hyposin-HA5 (Frogs, amphibians, animals)",P84958,Belongs to the Hyposins family,Not found,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),Antimicrobial,Protein level,Not found,Not found,,"Function: Has antimicrobial activity. 
Tissue specificity: Expressed by the skin glands.",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,17696382,J Proteome Res. 2007 Sep;6(9):3604-13.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.","Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.",15,12-15
DRAMP18696,FQWQRNMRKVRGPPVS,16,HLP1 (Lactotransferrin truncated peptide),"P02788, A0A161I202",Belongs to the Lactotransferrin,LTF,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,,"Function: Has antimicrobial activity, which depends on the extracellular cation concentration. Antimicrobial properties include bacteriostasis, which is related to its ability to sequester free iron and thus inhibit microbial growth, as well as direct bactericidal properties leading to the release of lipopolysaccharides from the bacterial outer membrane. Can also prevent bacterial biofilm development in P.aeruginosa infection. Has weak antifungal activity against C.albicans. HLP 1 corresponded to the loop region of human lactoferricin (residues 20 to 35).","[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 8007 (MIC=500 μM), Escherichia coli NCTC 10418 (MIC=500μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=500 μM);##Clinical isolates: Acinetobacter sp.(MIC=2 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9596699,Infect Immun. 1998 Jun;66(6):2434-40.,"Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.",Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.,16,15-18
DRAMP18701,FRSGILKLASKIPSVLCAVLKNC,23,"Pleurain-D4 (Frogs, amphibians, animals)",B5L1I4,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Not found,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Yeast: Candida albicans(MIC=25 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,23,21-24
DRAMP18706,CVHWMTNTARTACIAP,16,"Pleurain-R1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Not found,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=100 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 μg/ml), Bacillus subtilis (MIC=100 μg/ml);##Yeast: Candida albicans(MIC=50 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,16,15-18
DRAMP18712,GFGKAFHSVSNFAKKHKTA,19,"Styelin A (Tunicate, invertebrates, animals)",P81469,Belongs to the Cecropins family.,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Helix ,Not found,,"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues.","[Ref.9467865] Gram positive bacteria: Listeria monocytogenes EGD (MIC=2 µg/ml), Staphylococcus aureus 930918-3 (MIC=6 µg/ml), Enterococcus faecalis 94.132 (MIC=2 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa MR 3007 (MIC=4 µg/ml), Escherichia coli ML-35p (MIC=2.7 µg/ml), Salmonella typhimurium 14028S (MIC=5 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9467865,Comp. Biochem. Physiol. 1997; 118:515-521,"Lee IH, Cho Y, Lehrer RI.","Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.",19,18-21
DRAMP18713,GFGPAFHSVSNFAKKHKTA,19,"Styelin B (Tunicate, invertebrates, animals)",P81470,Belongs to the Cecropins family.,Not found,Styela clava (Sea squirt),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Helix ,Not found,,"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues.","[Ref.9467865] Gram positive bacteria: Listeria monocytogenes EGD (MIC=2 µg/ml), Staphylococcus aureus 930918-3 (MIC=6 µg/ml), Enterococcus faecalis 94.132 (MIC=2 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa MR 3007 (MIC=4.5 µg/ml), Escherichia coli ML-35p (MIC=2.7 µg/ml), Salmonella typhimurium 14028S (MIC=5 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9467865,Comp. Biochem. Physiol. 1997; 118:515-521,"Lee IH, Cho Y, Lehrer RI.","Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.",19,18-21
DRAMP18716,PDPAKTAPKKGSKKAVTKA,19,"Histone H2B-1(HLP-1) (fish, animals)",P81903,Belongs to the histone H2B family.,Not found,Ictalurus punctatus (Channel catfish) (Silurus punctatus),"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,The nucleosome is a histone octamer ,Not found,,"Function: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Has broad-spectrum antimicrobial and antibacterial activity. It is important in the antimicrobial defenses of fish skin and possesses strong activity against saprolegnia, the most common fungal infection in fish. It is also inhibitory to fish bacterial pathogens, such as aeromonas hydrophila, vibrio alginolyticus and Escherichia coli D31.
PTM: Monoubiquitination at the C-terminal Lys gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation. Phosphorylated during apoptosis; which facilitates apoptotic chromatin condensation. ",[Ref.9645227] Gram negative bacteria: Escherichia coli (MIC=0.37±0.023 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,9645227,Cell. Mol. Life Sci. 1998; 54:467-475,"Robinette D., Wada S., Arroll T., Levy MG., Miller WL., Noga EJ.",Antimicrobial activity in the skin of the channel catfish Ictalurus punctatus: characterization of broad-spectrum histone-like antimicrobial proteins.,19,18-21
DRAMP20782,FLSGILKLAFKIPSVLCAVLKNC,23,"Pleurain-D1  (Frogs,amphibians,animals)","B5L1C5, B5L1D1, B5L1C3, B5L1C9, B5L1C2, B5L1D4",Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Not found,Nidirana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Not found,,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675] Gram-negative bacteria: Escherichia coli (MIC=25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Yeast: Candida albicans(MIC=25 μg/ml)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.19028675] No cytotoxicity information found,Not found,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,23,21-24
DRAMP20784,FLKGCWTKWYSLKPKCPF,18,Megin 1,No entry found,Not found,Not found,Amphibian skin,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,The peptide contains an intra-molecular di-sulfide bridge,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27114317] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=25μg/mL);B. dysenteriae(MIC=3μg/mL);##Gram-positive bacteria:Staphylococcus aureus (ATCC 2592)(MIC=6.25μg/mL);Bacillus subtilis (ATCC 6633)(MIC=3μg/mL) ;##Fungi:C.albicans (ATCC 2002)(MIC=50μg/mL),[Ref.27114317] Human red blood cells: 2.3% hemolysis at 25μg/ml; 5.6% hemolysis at 50μg/ml; 18.7% hemolysis at 100μg/ml; 29.5% hemolysis at 200μg/ml. Rabbit red blood cells :3.1% hemolysis at 25μg/ml; 7.3% hemolysis at 50μg/ml; 20.5% hemolysis at 100μg/ml; 32.9% hemolysis at 200μg/ml,Cyclic,Free,Amidation,Disulfide bond between Cys5 and Cys16,L,No cytotoxicity information found,Not found,27114317,Chin J Nat Med. 2016 Apr;14(4):294-298. ,"Yang HL, Shen ZQ, Liu X, Kong Y.",Two novel antimicrobial peptides from skin venoms of spadefoot toad Megophrys minor.,18,15-18
DRAMP20786,RRLRPRRPRLPRPRPRPRPRPR,22,mini-ChBac7.5N alpha,No entry found,Not found,Not found,Capra hircus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27795854] Gram-negative bacteria: E.coli (ML35p)(MIC=0.3 ± 0.1μM without NaCl;MIC=1.5 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);E.coli (ATCC 25922)(MIC=0.6 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);E.coli (M17)(MIC=0.5 ± 0.1μM without NaCl;MIC=0.8 ± 0.1μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa (ATCC 27853)(MIC=1.1 ± 0.4μM without NaCl;MIC=3.7 ± 1.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa clinical isolate(MIC=2μM Broth microdilution assay);Klebsiella spp. clinical isolate(MIC=4μM Broth microdilution assay);Acinetobacter baumannii clinical isolate(MIC=2μM Broth microdilution assay);##Gram-positive bacteria:Listeria monocytogenes (EGD)(MIC=0.2 ± 0.1μM without NaCl;MIC=1.0 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Micrococcus luteus CIP A270(MIC=1μM Broth microdilution assay);Staphylococcus aureus (710A)(MIC=0.7 ± 0.2μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus aureus (ATCC 25923)(MIC>64μM Broth microdilution assay);MRSA (ATCC 33591)(MIC=0.7 ± 0.2μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus intermedius clin. isolate(MIC>64μM Broth microdilution assay);##Fungi:Candida albicans (820)(MIC=0.3 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC=64μM Broth microdilution assay);Candida parapsilosis clinical isolate(MIC>64μM Broth microdilution assay),[Ref.27818338] No hemolytic activity ,Linear,Free,Free,,L,"[Ref.27795854] The cytotoxicity values of the experimental samples are not significantly different from the values of the control samples over the entire range of concentrations:1-30 μM against various types of cultured human cells: namly, reythroleukemi",Not found,27795854,Acta Naturae. 2016 Jul-Sep;8(3):136-146.,"Shamova OV, Orlov DS, Zharkova MS, Balandin SV, Yamschikova EV, Knappe D, Hoffmann R, Kokryakov VN, Ovchinnikova TV.",Minibactenecins ChBac7.N,22,21-24
DRAMP20787,RRLRPRRPRLPRPRPRPRPRP,21,mini-ChBac7.5N beta,No entry found,Not found,Not found,Capra hircus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27795854] Gram-negative bacteria:E.coli (ML35p)(MIC=0.3 ± 0.1μM without NaCl;MIC=1.4 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);E.coli (ATCC 25922)(MIC=0.5 ± 0.2μM without NaCl;MIC=0.8 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);E.coli (M17)(MIC=0.5 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);Pseudomonas aeruginosa (ATCC 27853)(MIC=1.0 ± 0.3μM without NaCl;MIC=3.2 ± 0.8μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa clinical isolate(MIC=2μM Broth microdilution assay);Klebsiella spp. clinical isolate(MIC=4μM Broth microdilution assay);Acinetobacter baumannii clinical isolate(MIC=4μM Broth microdilution assay);##Gram-positive bacteria:Listeria monocytogenes (EGD)(MIC=0.2 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Micrococcus luteus CIP A270(MIC=1μM Broth microdilution assay);Staphylococcus aureus (710A)(MIC=0.6 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus aureus (ATCC 25923)(MIC>64μM Broth microdilution assay);MRSA (ATCC 33591)(MIC=0.5 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus intermedius clin. isolate(MIC>64μM Broth microdilution assay);##Fungi:Candida albicans (820)(MIC=0.3 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC=64μM Broth microdilution assay);Candida parapsilosis clinical isolate(MIC>64μM Broth microdilution assay),[Ref.27818338] No hemolytic activity ,Linear,Free,Free,,L,"[Ref.27795854] The cytotoxicity values of the experimental samples are not significantly different from the values of the control samples over the entire range of concentrations:1-30 μM against various types of cultured human cells: namly, reythroleukemi",Not found,27795854,Acta Naturae. 2016 Jul-Sep;8(3):136-146.,"Shamova OV, Orlov DS, Zharkova MS, Balandin SV, Yamschikova EV, Knappe D, Hoffmann R, Kokryakov VN, Ovchinnikova TV.",Minibactenecins ChBac7.N,21,18-21
DRAMP20792,GLFVGVLAKVAAHVVPAIAEHF,22,"Maculatin 1.1 (Frog, amphibians, animals)",P82066,Not found,Not found,Litoria genimaculata (Green-eyed tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Helix,Not found,2MMJ resolved by NMR,"Function: Maculatin-1.1 shows significant antibacterial activity against Gram-positive bacteria, less against Gram-negative bacteria. Maculatin-1.1.1 is inactive.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.9620615] Gram positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=25 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=12.5 μg/ml), Staphylococcus aureus (MIC=6-12.5 μg/ml), Staphylococcus epidermidis (MIC=12.5 μg/ml), Streptococcus faecalis (MIC=25 μg/ml), Streptococcus uberis (MIC=3 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=100 μg/ml), Pasteurella multocida (MIC=100 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.9620615] No cytotoxicity information found,Not found,9620615,J. Pept. Sci. 1998 Apr; 4(2): 111-115. ,"Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.",The maculatin peptide from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1,22,21-24
DRAMP20793,GLFVGLAKVAAHNNPAIAEHFQA,23,"Maculatin 1.2 (Frog, amphibians, animals)",P82067,Not found,Not found,Litoria genimaculata (Green-eyed tree frog),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,Helix,Not found,,"Function: Antibacterial activity against Staphylococcus aureus and Streptococcus uberis.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.9620615] Gram positive bacteria: Staphylococcus aureus (MIC=50 μg/ml), Streptococcus uberis (MIC=6 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.9620615] No cytotoxicity information found,Not found,9620615,J. Pept. Sci. 1998 Apr; 4(2): 111-115. ,"Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.",The maculatin peptide from the skin glands of the tree frog Litoria genimaculata. A comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1,23,21-24
DRAMP20794,LFCKRGTCHFGRCPSHLIKV,20,"Turkey Heterophil Peptide 2 (THP-2; avian beta-defensin, birds, animals)",P80392,Belongs to the beta-defensin family.,Not found,Meleagris gallopavo (Wild turkey),"Antimicrobial, Antibacterial",Protein level,Bridge,Not found,,"Function: Antibacterial activity against the Gram-positive bacterium Staphylococcus aureus. Lacks antibacterial activity against the Gram-negative bacterium Escherichia coli K-12.
Tissue specificity: Expressed in circulating heterophil granulocytes and bone marrow (at protein level).",No MICs found in DRAMP database,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.7964174] No cytotoxicity information found,Not found,7964174,J. Leukoc. Biol. 1994 Nov; 56: 661-665.,"Evans EW, Beach GG, Wunderlich J, Harmon BG.",Isolation of antimicrobial peptides from avian heterophils.,20,18-21
DRAMP20795,XTCESPSHKFKGPCATNRNCES,22,"So-D1 (S. oleracea defensin 1; spinach defensins, plants)",P81572,Belongs to the DEFL family. Group II subfamily.,Not found,Spinacia oleracea (Spinach),"Antimicrobial, Antibacterial",Protein level,Bridge ,Not found,,Function: Antimicrobial peptide. Active against Gram-positive and Gram-negative bacteria pathogens.,[Ref.9762899] Gram-positive bacterium: Clavibacter michiganensis (EC50=1 μM);##Gram-negative bacterium: Ralstonia solanacearum (EC50=15 μM). ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.9762899] No cytotoxicity information found,Not found,9762899,FEBS Lett. 1998 Sep 18;435(2-3): 159-162. ,"Segura A, Moreno M, Molina A, Garcia-Olmedo F",Novel defensin subfamily from spinach (Spinacia oleracea).,22,21-24
DRAMP20796,GIFSNMYXRTPAGYFRGPXGYXXN,24,"So-D6 (S. oleracea defensin 6, spinach defensins; plants)",P81567,Belongs to the DEFL family. Group II subfamily.,Not found,Spinacia oleracea (Spinach),"Antimicrobial, Antibacterial",Protein level,Bridge ,Not found,,"Function: Antimicrobial activity against Fungi, Gram-positive and Gram-negative bacteria.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.",[Ref.9762899] Gram-positive bacterium: Clavibacter michiganensis (EC50=1 μM);##Gram-negative bacterium: Ralstonia solanacearum (EC50=6 μM);##Fusarium solani (EC50=11 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.9762899] No cytotoxicity information found,Not found,9762899,FEBS Lett. 1998 Sep 18;435(2-3): 159-162. ,"Segura A, Moreno M, Molina A, Garcia-Olmedo F",Novel defensin subfamily from spinach (Spinacia oleracea).,24,21-24
DRAMP20797,GVIDAAKKVVNVLKNLF,17,"Uperin 3.6 (Toad, amphibians, animals)",P82043,Belongs to the frog skin active peptide (FSAP) family. Uperin subfamily.,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix ,Not found,,"Function: Antibacterial activity against B.cereus, L.lactis, L.innocua, M.luteus, S.aureus, S.epidermidis and S.uberis.
Tissue specificity: Expressed by the skin dorsal glands.
Mass spectrometry: Molecular mass is 1826 Da from positions 1 - 17. Determined by FAB.","[Ref.10461748] Gram positive bacteria: Bacillus cereus (MIC=25 μg/ml), Leuconostoc lactis  (MIC=3 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=50 μg/ml), Staphylococcus aureus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=12 μg/ml), Streptococcus uberis (MIC=12 μg/ml);##Gram-negative bacterium: Pasteurella haemolytica (MIC=25 μg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.10461748] No cytotoxicity information found,Not found,10461748,J Pept Res. 1999 Aug;54(2):137-45.,"Chia BC, Carver JA, Mulhern TD, Bowie JH","The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.",17,15-18
DRAMP20799,GCWSTVLGGLKKFAKGGLEAIVNPK,25,"XT-2 (frog, amphibians, animals)",No entry found,Belongs to the Pipidae family.,Not found,"Xenopus tropicalis (Diploid clawed frog, Africa)","Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-negative bacteria (Escherichia coli).,[Ref.11738090] Gram-negative bacteria: Escherichia coli (MIC=8μM).,[Ref.11738090] HC50 is not determined against human red blood cells.,Linear,Free,Free,,L,[Ref.11738090] No cytotoxicity information found,Not found,11738090,Biochim Biophys Acta 2001 Nov 26;1550(1):81-9.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",25,24-27
DRAMP20802,GLGSVLGKALKIGANLL,17,"CPF-AM1 (caerulein precursor fragment-AM1, frogs, amphibians, animals)",No entry found,Belongs to the CPF family.,Not found,"Xenopus amieti (skin secretions, Africa)","Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.20226221] Gram-positive bacteria: Staphylococcus aureus (MIC>200μM) ;##Gram-negative bacteria: Escherichia coli (MIC>200μM).,[Ref.20226221] LC50>200μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.20226221] No cytotoxicity information found,Cell membranes,20226221,Peptides. 2010 Jun;31(6):989-94. ,"Conlon JM, Al-Ghaferi N, Ahmed E, Meetani MA, Leprince J, Nielsen PF. ","Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae).",17,15-18
DRAMP20803,FFRNLWKGAKAAFRAGHAAWRA,22,moronecidin-like peptide,No entry found,Not found,Not found,Hippocampus comes ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix ,The peptide is Schiffer,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; antifungal activity.,"[Ref.30039186] Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC=3.12 μg/ml),Staphylococcus epidermidis ATCC 1435 (MIC=1.56 μg/ml),Staphylococcus aureus MRSA (MIC=3.12 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.25 μg/ml), Pseudomonas aeruginosa ATCC10662 (MIC=50 μg/ml),Acinetobacter baumannii clinical isolate (MIC=6.25 μg/ml);##Fungi:Candida albicans clinical isolate (MIC=6.25 μg/ml), Candida tropicalis clinical isolate (MIC=6.25 μg/ml)","[Ref.30039186] 50% hemolysis at 87.5μg/ml,25% hemolysis at 50μg/ml,60% hemolysis at 100μg/ml against human red cells",Linear,Free,Amidation,,L,[Ref.30039186] No cytotoxicity information found,Not found,30039186,Mar Biotechnol (NY). 2018 Dec;20(6):718-728.,"Mohammadi M, Taheri B, Momenzadeh N, Salarinia R, Nabipour I, Farshadzadeh Z, Bargahi A.",Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies,22,21-24
DRAMP20805,FSTKTRNWFSEHFKKVKEKLKDTFA,25,Apo5 APOC164-88 ,No entry found,Not found,Not found,American alligator,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,"Alpha helix,beta-sheet,beta-turn,random coil",Not found,,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.27542832] Gram-positive bacteria:Staphylococcus aureus ATCC BAA-1718 (EC50=4.96μg/ml), Staphylococcus aureus ATCC 33592 (EC50=0.0680μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 4157 (EC50=19.7μg/ml), Escherichia coli ATCC 51659 (EC50=13.9μg/ml), Pseudomonas aeruginosa PAO1 (EC50=0.0878μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (EC50=0.467μg/ml), Acinetobacter baumannii ATCC 9955 (EC50=0.644μg/ml), Acinetobacter baumannii ATCC BAA-1794 (EC50=0.234μg/ml)",[Ref.27542832] Not hemolytic to sheep red blood cells.,Linear,Free,Free,,L,"[Ref.27542832] The cell proliferation of A549 human lung epithelial cells is 175%, 170%, 145%, 173% and 120% at peptide concentrations of 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml",Not found,27542832,BMC Microbiol. 2016 Aug 19;16(1):189. ,"Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.",Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii,25,24-27
DRAMP20806,KTRNWFSEHFKKVKEKLKDTFA,22,Apo6 APOC167-88,No entry found,Not found,Not found,American alligator,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,"Alpha helix,beta-sheet,beta-turn,random coil",Not found,,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.27542832] Gram-positive bacteria:Staphylococcus aureus ATCC BAA-1718 (EC50=2.31μg/ml), Staphylococcus aureus ATCC 33592 (EC50=0.883μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 4157 (EC50=3.85μg/ml), Escherichia coli ATCC 51659 (EC50=9.07μg/ml), Pseudomonas aeruginosa PAO1 (EC50=1.17μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (EC50=0.130μg/ml), Acinetobacter baumannii ATCC 9955 (EC50=0.233μg/ml), Acinetobacter baumannii ATCC BAA-1794 (EC50=0.126μg/ml)",[Ref.27542832] Not hemolytic to sheep red blood cells.,Linear,Free,Free,,L,"[Ref.27542832] The cell proliferation of A549 human lung epithelial cells is 190%, 167%, 150%, 135% and 144% at peptide concentrations of 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml",Not found,27542832,BMC Microbiol. 2016 Aug 19;16(1):189. ,"Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.",Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii,22,21-24
DRAMP20808,RRLRKKTRKRLKKIGKVLKWI,21,RI21 (PMAP-36 peptide derivative),No entry found,Derived from PMAP-36,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,"Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..","[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=4 μM, MBC=4 μM), Staphylococcus aureus 25923 (MIC=4 μM, MBC=4 μM), Staphylococcus epidermidis 12228 (MIC=4 μM, MBC=8 μM), Bacillus subtilis 63501 (MIC=1 μM, MBC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM, MBC=8 μM), Escherichia coli EC183 (MIC=1 μM, MBC=2 μM), Escherichia coli 1005 (MIC=2 μM, MBC=2 μM), Salmonella typhimurium C77-31 (MIC=1 μM, MBC=2 μM);##Fungi: Candida albicans 2.2086 (MIC=8 μM, MFC=16 μM), Candida albicans CA276 (MIC=8 μM, MFC=32 μM), Candida tropicalis 2.1975 (MIC=1 μM, MFC=2 μM), Candida krusei 2.1857 (MIC=2 μM, MFC=4 μM).","[Ref.27251456] 5% hemolysis at 32 μM,  MHC=32 μM against human red blood cells.",Linear,Free,Amidation,,L,[Ref.27251456] No cytotoxicity information found,Not found,27251456,Sci Rep. 2016 Jun 2;6:27258. ,"Lyu Y, Yang Y, Lyu X, Dong N, Shan A.","Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.",21,18-21
DRAMP20809,RKKTRKRLKKIGKVLKWI,18,RI18 (PMAP-36 peptide derivative),No entry found,Derived from PMAP-36,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,"Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..","[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=4 μM, MBC=4 μM), Staphylococcus aureus 25923 (MIC=8 μM, MBC=8 μM), Staphylococcus epidermidis 12228 (MIC=4 μM, MBC=16 μM), Bacillus subtilis 63501 (MIC=1 μM, MBC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM, MBC=4 μM), Escherichia coli EC183 (MIC=1 μM, MBC=2 μM), Escherichia coli 1005 (MIC=2 μM, MBC=4 μM), Salmonella typhimurium C77-31 (MIC=2 μM, MBC=4 μM);##Fungi: Candida albicans 2.2086 (MIC=16 μM, MFC=32 μM), Candida albicans CA276 (MIC=8 μM, MFC=16 μM), Candida tropicalis 2.1975 (MIC=2 μM, MFC=4 μM), Candida krusei 2.1857 (MIC=4 μM, MFC=8 μM).","[Ref.27251456] 5% hemolysis at 128 μM, MHC=128 μM against human red blood cells.",Linear,Free,Amidation,,L,[Ref.27251456] No cytotoxicity information found,Not found,27251456,Sci Rep. 2016 Jun 2;6:27258. ,"Lyu Y, Yang Y, Lyu X, Dong N, Shan A.","Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.",18,15-18
DRAMP20810,TRKRLKKIGKVLKWI,15,TI15 (PMAP-36 peptide derivative),No entry found,Derived from PMAP-36,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,"Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..","[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=32 μM, MBC=128 μM), Staphylococcus aureus 25923 (MIC=32 μM, MBC=128 μM), Staphylococcus epidermidis 12228 (MIC=32 μM, MBC=64 μM), Bacillus subtilis 63501 (MIC=2 μM, MBC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=8 μM, MBC=16 μM), Escherichia coli EC183 (MIC=2 μM, MBC=4 μM), Escherichia coli 1005 (MIC=4 μM, MBC=8 μM), Salmonella typhimurium C77-31 (MIC=8 μM, MBC=32 μM);##Fungi: Candida albicans 2.2086 (MIC=64 μM, MFC=64 μM), Candida albicans CA276 (MIC=128 μM, MFC=128 μM), Candida tropicalis 2.1975 (MIC=2 μM, MFC=4 μM), Candida krusei 2.1857 (MIC=8 μM, MFC=16 μM).","[Ref.27251456] Non-hemolysis upto 128 μM, MHC>128 μM against human red blood cells.",Linear,Free,Amidation,,L,[Ref.27251456] No cytotoxicity information found,Not found,27251456,Sci Rep. 2016 Jun 2;6:27258. ,"Lyu Y, Yang Y, Lyu X, Dong N, Shan A.","Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.",15,12-15
DRAMP20821,FRIRVRVFKRIVQRIKDFLR,20,"FV-LL (FV7 and LL(LL-37,(17-29)) hybrid peptide)",No entry found,"FV7 and LL(LL-37,(17-29)) hybrid peptide",Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, random coil",The hybrid peptide displayed an unordered conformation in phosphate buffer.,,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2 μM), Streptococcus Faecalis ATCC 29212 (MIC=4 μM), Bacillus subtilis CMCC 63501 (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli UB 1005 (MIC=4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=2 μM), Salmonella typhimurium ATCC 7731 (MIC=2 μM).",[Ref.28178190] 2% hemolysis at 128 μM against human red cells,Linear,Free,Amidation,,L,[Ref.28178190] No cytotoxicity information found,Not found,28178190,Int J Mol Sci. 2017 Feb 6;18(2). ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,20,18-21
DRAMP20822,FRIRVRVAKKFGKAFVGEIM,20,FV-MA (FV7 and MA(Magainin 2 (9-21))  hybrid peptide),No entry found,FV7 and MA(Magainin 2 (9-21))  hybrid peptide,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, random coil",The hybrid peptide displayed an unordered conformation in phosphate buffer.,,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Streptococcus Faecalis ATCC 29212 (MIC=16 μM), Bacillus subtilis CMCC 63501 (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=8 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=8 μM), Escherichia coli UB 1005 (MIC=8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Salmonella typhimurium ATCC 7731 (MIC=4 μM).","[Ref.28178190] 1% hemolysis at 2 μM, 8% hemolysis at 4 μM, 10% hemolysis at 8 μM, 15% hemolysis at 16 μM, 20% hemolysis at 32 μM, 37% hemolysis at 64 μM, 55% hemolysis at 128 μM against human red cells",Linear,Free,Amidation,,L,[Ref.28178190] No cytotoxicity information found,Not found,28178190,Int J Mol Sci. 2017 Feb 6;18(2). ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,20,18-21
DRAMP20823,FRIRVRVKWKLFKKI,15,FV-CE (FV7 and CE(Cecropin A (1,No entry found,FV7 and CE(Cecropin A (1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil,The hybrid peptide displayed an unordered conformation in phosphate buffer.,,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Streptococcus Faecalis ATCC 29212 (MIC=1 μM), Bacillus subtilis CMCC 63501 (MIC=1 μM), Staphylococcus epidermidis ATCC 12228 (MIC=0.5 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=2 μM), Escherichia coli UB 1005 (MIC=2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=2 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Salmonella typhimurium ATCC 7731 (MIC=4 μM).","[Ref.28178190] 1% hemolysis at 2 μM, 5% hemolysis at 128 μM against human red cells",Linear,Free,Amidation,,L,[Ref.28178190] No cytotoxicity information found,Not found,28178190,Int J Mol Sci. 2017 Feb 6;18(2). ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,15,12-15
DRAMP20826,GLFKKLRRKIKKGFKKIFKRL,21,AM-CATH21,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, random coil",NA-CATH has previously been shown to be random coil in water or buffer and ,,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28089718] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=28μg/ml), Staphylococcus aureus ATCC 33592 (MIC=28μg/ml);##Gram-negative bacteria:Acinetobacter baumannii ATCC 9955 (MIC=42μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=10μg/ml), Escherichia coli ATCC 4157 (MIC=21μg/ml), Escherichia coli ATCC 51659 (MIC=140μg/ml), K. pneumoniae ATCC 33495 (MIC=5.2μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=28μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=10μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (MIC=42μg/ml)",[Ref.28089718] 0.5% hemolysis at 300μg/ml against sheep red cells,Linear,Free,Free,,L,[Ref.28089718] The survival rate of A549 human lung epithelial cells is 113% at a peptide concentration of 300 μg/ml,Not found,28089718,Dev Comp Immunol. 2017 May;70:135-144. ,"Barksdale SM, Hrifko EJ, van Hoek ML.",Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae,21,18-21
DRAMP20828,KKLLPIVANLLKSLL,15,TB_KKG6A,No entry found,Derived from TB,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,"Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,antifungal activity.","[Ref.28443279] Gram-positive bacteria: S.aureus ATCC 33591 (MIC=1.5μM), Staphylococcus epidermidis (MIC=1.5μM);##Gram-negative bacteria: Klebsiella pneumoniae ATCC BAA-1706 (MIC=3μM), Pseudomonas aeruginosa ATCC 27853 (MIC=3μM)","[Ref.28443279] 11% hemolysis at 48μM, 55% hemolysis at 96μM against human red cells",Linear,Free,Amidation,,L,[Ref.28443279] IC50 = 49 μM against PBMCs. ##IC50 = 16 μM against A549 cells,Not found,28443279,Front Chem. 2017 Apr 11;5:24,"Grassi L, Maisetta G, Maccari G, Esin S, Batoni G.",Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide,15,12-15
DRAMP20836,VLDKVLEELGKVSRKIAVGI,20,StII16-35 StII peptide derivative,No entry found,Not found,Not found,Synthetic construct,Candidacidal,Synthetic,Random coil conformation,The peptide displays a random coil conformation up to 1 mM and does not show any structure concentration,,Function: Antibacterial activity against the candida,No MICs found in DRAMP database,[Ref.29359791] HC50=128μM against human red blood cells,Linear,Free,Free,,L,[Ref.29359791] No cytotoxicity information found,Not found,29359791,Biopolymers. 2018 Jan 23.,"Lima de Oliveira A, Maffud Cilli E, Ros U, Crusca E Jr, Lanio ME, Alvarez C, Schreier S, Aguiar Pertinhez T, Spisni A.",Insights on the structure-activity relationship of peptides derived from Sticholysin II.,20,18-21
DRAMP20838,TRSRWRRFIRGAGRFARRYGWRIAL,25,Pb-CATH4 bivittatus  antimicrobial peptides peptide derivative ,No entry found,Derived from cathelicidin family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,"The peptide adopts arginine content of this peptide is 37.5%, and it contains two tryptophan residues (8.3%)",,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria,[Ref.28630199]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=1μg/ml);Pseudomonas aeruginosa (ATCC 27853)(MIC=3μg/ml);S. typhimurium (ATCC 14028)(MIC=0.5μg/ml);##Gram-positive bacteria:Staphylococcus aureus (ATCC 29213)(MIC>128μg/ml);B. cereus (ATCC 10876)(MIC=10μg/ml);##Clinical isolates:Escherichia coli(MIC=4.7μg/ml);K. pneumoniae(MIC=1.18μg/ml),[Ref.28630199] 0% hemolysis at 4μg/ml against human red blood cell; 1.4 ± 0.4% hemolysis at 8μg/ml against human red blood cell; 5.1 ± 0.5% hemolysis at 16μg/ml against human red blood cell;7.3 ± 0.6% hemolysis at 32μg/ml against human red blood cell; 12.2 ± 0.7% hemolysis at 64μg/ml against human red blood cell,Linear,Free,Free,,L,"[Ref.28630199] The cell viability of Pk15(pig kidney fibroblasts) is 103.8%, 124.6%, 94.7%,55.2% and 53.9% at peptide concentrations of 5, 10, 20, 30 and 64 μg/ml. ##The cell viability of HaCaT(human keratinocytes) is 106.9%, 94.6%, 66.2%, 58.1% and 51.",Not found,28630199,Antimicrob Agents Chemother. 2017 Aug 24;61(9). ,"Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.",Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,25,24-27
DRAMP20839,GFVALLKKLPLILKHLH,17,Xylopin ,C0HKQ5,Not found,Not found,Xylocopa appendiculata circumvolans,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Linear cationic alpha-helical,Not found,,"Function: Antimicrobial and mast cell degranulating peptide which probably acts by forming pores in membranes (PubMed:28546807, PubMed:28855917). Active against both Gram-negative and Gram-positive bacterial strains as well as against yeasts (PubMed:28546807, PubMed:28855917). Has leishmanicidal activity (IC50=25uM)(PubMed:28855917). Has little hemolytic activity (PubMed:28546807, PubMed:28855917)",[Ref.28855917]Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=15.0μM);Micrococcus luteus (ATCC 10240)(MIC=1.9μM);Bacillus subtilis (ATCC 6633)(MIC=3.75μM);Streptococcus pyogenes (CS)(MIC=3.75μM);Streptococcus agalactiae (CS)(MIC=3.75μM);Enterococcus. faecalis (CS)(MIC=15.0μM);##Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=3.75μM);Pseudomonas aeruginosa (ATCC 27853)(MIC=7.5μM);Stenotrophomonas maltophilia (ATCC 13637)(MIC=3.75μM);Shigella boydii (CS)(MIC=3.75μM);Klebsiella pneumoniae (CS)(MIC=7.5μM);Serratia marcescens (CS)(MIC=7.5μM);Enterobacter cloacae (CS)(MIC=7.5μM);Proteus mirabilis (CS)(MIC>30μM);Morganella morgannii (CS)(MIC=30μM);Acinetobacter baumanii/calcoaceticus (CS)(MIC=3.75μM) ;##Yeasts:Candida albicans (ATCC 90112)(MIC=7.5μM);Sacharomyces cerevisae(MIC=3.75μM),[Ref.28855917]IC50=25uM against human red blood cells,Linear,Free,Amidation,,L,[Ref.28855917] No cytotoxicity information found,Not found,28855917,J Venom Anim Toxins Incl Trop Dis. 2017 Aug 29;23:40.,"Kazuma K, Ando K, Nihei KI, Wang X, Rangel M, Franzolin MR, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.",Peptidomic analysis of the venom of the solitary bee Xylocopa appendiculata circumvolans.,17,15-18
DRAMP20840,PDRAIDTYRTSPVADQRYNA,20,SLAY-C1,No entry found,,,Synthetic construct,Non-antibacterial,Synthetic form,Unknown,Not mentioned,,Function: Non-antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC > 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC > 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] No hemolytic activity information found.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP20841,SKVWRHWRRFWHRAHRLH,18,C1b,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,"The peptide adopts an low alpha-helical content when dissolved in water.  However, the peptides displayed 3.23",,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=1.56μM);##Gram-positive bacteria:Staphylococcus aureus(MIC=3.13μM);B. cereus(MIC=3.13μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=1.56μM);E. faecium(MIC=3.13μM),[Ref.27060618] HC50>500μM against human red blood cells,Linear,Free,Free,,L,[Ref.27060618] No cytotoxicity information found,Not found,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-1b analogues.,18,15-18
DRAMP20852,ONNRPVYIPRPRPPHPRL,18,Api137 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=2μg/mL);K. pneumoniae (DSM 681)(MIC=16μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=256μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>256μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>256μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L),[Ref.27243004] 0.4 ± 0.5% hemolysis at 0.1 g/L; 1.0 ± 0.2% hemolysis at 0.6 g/L against human red blood cells,Linear,"Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)",Free,The 'O' in sequence is Ornithine,L,[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes. ##IC50 > 0.6g/L against HEK293. ##IC50 > 0.6g/L against HeLa.,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,18,15-18
DRAMP20853,OIORPVYOPRPRPPHPRL,18,Api755 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=8μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>64μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>128μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128μg/mL),No hemolysis information or data found in the reference(s) presented in this entry,Linear,"Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)",Free,The 'O' in sequence is Ornithine,L,[Ref.27243004] No cytotoxicity information found.,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,18,15-18
DRAMP20854,OWORPVYOPRPRPPHPRL,18,Api760 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=8μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>32μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>128μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128μg/mL),No hemolysis information or data found in the reference(s) presented in this entry,Linear,"Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)",Free,The 'O' in sequence is Ornithine,L,[Ref.27243004] No cytotoxicity information found.,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,18,15-18
DRAMP20855,OWOWORPVYOPRPRPPHPRL,20,Api793 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=16μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>64μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>64μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50=0.64 ± 0.05g/L);HeLa cells(IC50=0.64 ± 0.05g/L),[Ref.27243004] 1.3 ± 0.4% hemolysis at 0.1 g/L; 1.6 ± 0.5% hemolysis at 0.6 g/L against human red blood cells,Linear,"Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)",Free,The 'O' in sequence is Ornithine,L,[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 = 0.64 ± 0.05 g/L against HEK293. IC50 = 0.64 ± 0.15 g/L against HeLa.,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,20,18-21
DRAMP20856,OWOWOWORPVYOPRPRPPHPRL,22,Api794 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; highly active against Pseudomonas aeruginosa in vitro,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=16μg/mL);K. pneumoniae (DSM 681)(MIC=32μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>32μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>128μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L),[Ref.27243004] 1.7 ± 0.2% hemolysis at 0.1 g/L; 1.9 ± 0.3% hemolysis at 0.6 g/L against human red blood cells,Linear,"Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)",Free,The 'O' in sequence is Ornithine,L,[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 = 0.28 ± 0.03 g/L against HEK293. IC50 = 0.23 ± 0.09 g/L against HeLa.,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,22,21-24
DRAMP20857,OIOIORPVYOPRPRPPHPRL,20,Api795 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; highly active against Pseudomonas aeruginosa in vitro,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=8μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=8μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>32μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L),[Ref.27243004] 0.8 ± 0.4% hemolysis at 0.1 g/L; 0.0 ± 0.7% hemolysis at 0.6 g/L against human red blood cells,Linear,"Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)",Free,The 'O' in sequence is Ornithine,L,[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 > 0.6g/L against HEK293. IC50 > 0.6g/L against HeLa.,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,20,18-21
DRAMP20858,OIOIOIORPVYOPRPRPPHPRL,22,Api796 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=16μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=8μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>64μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>128μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L),[Ref.27243004] 0.8 ± 0.2% hemolysis at 0.1 g/L;μ0.1 ± 0.8 % hemolysis at 0.6 g/L against human red blood cells,Linear,"Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)",Free,The 'O' in sequence is Ornithine,L,[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 > 0.6g/L against HEK293. IC50 > 0.6g/L against HeLa.,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,22,21-24
DRAMP20859,KFRTRRSKSSSNGGRKGSKG,20,TT(1-24),No entry found,Derived from Cathelicidins,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Unconventional feature,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. TT(1,[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=32μM);A. salmonicida (ATCC 33658)(MIC=32-16μM);Y. ruckeri (NCIMB 1315)(MIC=32μM);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32μM);A. hydrophila (ATCC 7966)(MIC>32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=64μM);L. garvieae (ATCC 49156)(MIC=16-8μM),[Ref.27818338] No hemolytic activity to human,Linear,Free,Free,,L,[Ref.27818338] No cytotoxicity information found,Not found,27818338,Fish Shellfish Immunol. 2016 Dec;59:456-468. ,"D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.",Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.,20,18-21
DRAMP20865,(RRWQWR)2-K-(Ahx),14,the dimeric RRWQWR motif peptide molecule,No entry found,Derived from bovine LfcinB6,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29984236] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=14 μg/ml; MBC=110 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=55 μg/ml; MBC=110 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae ATCC 13883 (MIC=27 μg/ml; MBC=55 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=27 μg/ml; MBC=220 μg/ml)","[Ref.29984236] 0% hemolysis at 5 μM, 1% hemolysis at 12 μM, 2% hemolysis at 22 μM, 2% hemolysis at 50 μM, 4% hemolysis at 100 μM against human red blood cells",Branched,Free,Amidation,,L,[Ref.29984236] No cytotoxicity information found,Not found,29984236,Biomed Res Int. 2018 Jun 10;2018:5252891,"Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Martínez Baquero, Jaiver E. Rosas Pérez.",Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.,17,15-18
DRAMP20866,(RRWQWR)4-K2-(Ahx)2-C2,30,the tetrameric RRWQWR motif peptide molecule,No entry found,Derived from bovine LfcinB6,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29984236] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=29 μg/ml; MBC=57 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=57 μg/ml; MBC=57 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae ATCC 13883 (MIC=29 μg/ml; MBC=115 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=57 μg/ml; MBC=115 μg/ml)","[Ref.29984236] 5% haemolysis at 5 μM, 10% haemolysis at 12 μM, 10% haemolysis at 22 μM, 0% haemolysis at 50 μM, 2% haemolysis at 100 μM against human red blood cells",Branched,Free,Amidation,Disulfide bond which links two dimeric motif peptides,L,[Ref.29984237] No cytotoxicity information found,Not found,29984236,Biomed Res Int. 2018 Jun 10;2018:5252891,"Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Martínez Baquero, Jaiver E. Rosas Pérez.",Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.,22,21-24
DRAMP20874,SKVWRHWRRFWHRAHRKL,18,Chensinin-1b,No entry found,Derived from chensinin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, beta sheet and Random coil",The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 11.96 % beta-strands and 28.06 % alpha-helices in TFE solution,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma and MCF-7 breast carcinoma.,"[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=3.13 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=3.13 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=113.10μ±μ4.10 μM), MCF-7 breast carcinoma (IC50=51.85μ±μ0.88 μM)",[Ref.29549839] HC50>500 μM against human red blood cells,Linear,Free,Free,,L,[Ref.29549839] No cytotoxicity information found,Cell membrane (disrupted the bacterial cell membranes through a ,29549839,Eur J Med Chem. 2018 Apr 25;150:546-558.,"Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.",Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.,18,15-18
DRAMP20875,SKVWRHWRRFWHRAHRKL,18,OA-C1b,No entry found,Derived from Chensinin-1b,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 12.88 % beta-strands and 47.36 % alpha-helices in TFE solution,,"Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.","[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=1.56 μM), Streptococcus lactis (MIC=1.56 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=1.56 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.13 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=23.86μ±μ0.95 μM), A375 melanoma (IC50=50.97μ±μ1.45 μM), MCF-7 breast carcinoma (IC50=34.94μ±μ2.99 μM)",[Ref.29549839] HC50>500 μM against human red blood cells,Linear,Acylation (Ser1 conjugated with octanoic acid),Free,,L,[Ref.29549839] No cytotoxicity information found,Not found,29549839,Eur J Med Chem. 2018 Apr 25;150:546-558.,"Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.",Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.,18,15-18
DRAMP20876,SKVWRHWRRFWHRAHRKL,18,LA-C1b,No entry found,Derived from Chensinin-1b,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 6.31 % beta-strands and 32.16 % alpha-helices in TFE solution,,"Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.","[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=3.13 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=3.13 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=20.38μ±μ0.28 μM), A375 melanoma (IC50=21.25μ±μ1.51 μM), MCF-7 breast carcinoma (IC50=25.77μ±μ2.02 μM)",[Ref.29549839] HC50>500 μM against human red blood cells,Linear,Acylation (Ser1 conjugated with lauric acid),Free,,L,[Ref.29549839] No cytotoxicity information found,Not found,29549839,Eur J Med Chem. 2018 Apr 25;150:546-558.,"Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.",Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.,18,15-18
DRAMP20877,SKVWRHWRRFWHRAHRKL,18,PA-C1b,No entry found,Derived from Chensinin-1b,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 12.88 % beta-strands and 22.67 % alpha-helices in TFE solution,,"Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.","[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μM), Bacillus cereus (MIC=6.25 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC= 3.13 μM), Enterococcus faecium (MIC= 6.25 μM);##Gram-negative bacteria: Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=6.25 μM);##cancer cells: HeLa cervical carcinoma (IC50=21.04μ±μ0.18 μM), A375 melanoma (IC50=18.15μ±μ0.21 μM), MCF-7 breast carcinoma (IC50=20.63μ±μ0.47 μM)",[Ref.29549839] HC50>500 μM against human red blood cells,Linear,Acylation (Ser1 conjugated with palmitic acid),Free,,L,[Ref.29549839] No cytotoxicity information found,Not found,29549839,Eur J Med Chem. 2018 Apr 25;150:546-558.,"Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.",Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.,18,15-18
DRAMP20887,KLIPILSKTIPAGKNLFYKI,20,NCP-2 (CTX-1 peptide derivative),No entry found,Derived from CTX-1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,"The peptide adopts a conformational structure with 20 % alpha helix, 25 % beta sheet and 35 % random coil in the presence of DMPE-DMPG mixed vesicles.",,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29364903] Gram-positive bacteria: Staphylococcus aureus ATCC 22953 (MBC=50 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=12.5 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=12.5 μg/ml), Acinetobacter baumannii (herpetological, cloacal) (MBC=1.6 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=50 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=1.6 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=1.6 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=50 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL)","[Ref.29364903] 2% haemolysis at 12.5 μg/ml, 8% haemolysis at 100.0 μg/ml against sheep red blood cells",Linear,Free,Free,,L,[Ref.29364903] The cell death rate of Madin-Darby Bovine Kidney(MDBK) cells is 3 % and 5% at peptide concentrations of 12.5 and 100  μg/ml,Not found,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,20,18-21
DRAMP20888,KLIWILSKTIPAGKNLFYKI,20,NCP-3 (CTX-1 peptide derivative),No entry found,Derived from CTX-1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,The peptide adopts a conformational structure with 43 % beta sheet and 35 % random coil in the presence of DMPE-DMPG mixed vesicles.,,"Function: Antimicrobial activity against the Gram-positive bacteria, Gram-negative bacteria and fungi. NCP-3 completely inhibits the viral activity of BoHV-1 on MDBK cells at the concentration of 25 ","[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=1.6 μg/ml), Enterococcus hirae ATCC 10541 (MBC=1.6 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=1.6 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=12.5 μg/ml), Acinetobacter baumannii (herpetological, cloacal) (MBC=1.6 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=6.3 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=1.6 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=50 μg/ml), Enterobacter cloacae (herpetological, cloacal) (MBC=25 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=50 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=1.6 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=12.5 μg/mL), Candida glabrata ATCC 90030 (MBC=50 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL).","[Ref.29364903] 3% haemolysis at 12.5 μg/ml, 9% haemolysis at 100.0 μg/ml against sheep red blood cells",Linear,Free,Free,,L,[Ref.29364903] The cell death rate of Madin-Darby Bovine Kidney(MDBK) cells is 3 % and 7% at peptide concentrations of 12.5 and 100  μg/ml,Not found,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,20,18-21
DRAMP20889,VYPFMWGGAYCFCKAKLV,18,VT18-KKLV (VT18 peptide derivative),No entry found,Derived from VT18,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Double-stranded ,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. ,"[Ref.29277569] Gram-positive bacteria: Streptococcus pneumoniae ATCC 700669 (MIC=52 μg/ml), Streptococcus pneumoniae ATCC 49619  (MIC=105 μg/ml), Streptococcus pneumoniae ATCC 700677 (MIC=76 μg/ml)","[Ref.29277569] 0.5% hemolysis at 5 μg/ml, 1.0% hemolysis at 10μg/ml, 2.0% hemolysis at 20 μg/ml, 2.5% hemolysis at 50 μg/ml, 3.0% hemolysis at 100 μg/ml, 5.0% hemolysis at 250 μg/ml, 7.0% hemolysis at 500 μg/ml against human red blood cells",Linear,Free,Amidation,,L,"[Ref.29277569] The cell viability of NL-20 normal lung cell line is not affected (<20%) below 50 μg/ml.## The cell viability of NL-20 is 82%, 44%, 17% and 13% at peptide concentrations of 50, 100, 250 and 500 μg/ml.",Not found,29277569,Biochimie. 2018 Mar;146:139-147.,"Yang R, Zhang G, Zhang F, Li Z, Huang C.",Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection.,18,15-18
DRAMP20890,VYPFCWGGAYAFCKAKLV,18,VT18-CAKKLV (VT18 peptide derivative),No entry found,Derived from VT18,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Double-stranded ,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. ,"[Ref.29277569] Gram-positive bacteria: Streptococcus pneumoniae ATCC 700669 (MIC=58 μg/ml), Streptococcus pneumoniae ATCC 49619  (MIC=90 μg/ml), Streptococcus pneumoniae ATCC 700677 (MIC=72 μg/ml)","[Ref.29277569] 0.5% hemolysis at 5 μg/ml, 1.0% hemolysis at 10μg/ml, 1.5% hemolysis at 20 μg/ml, 2.0% hemolysis at 50 μg/ml, 3.8% hemolysis at 100 μg/ml, 4.5% hemolysis at 250 μg/ml, 6.8% hemolysis at 500 μg/ml against human red blood cells",Linear,Free,Amidation,,L,"[Ref.29277569] The cell viability of NL-20 normal lung cell line is not affected (<20%) below 50 μg/ml.## The cell viability of NL-20 is 86%, 48%, 19% and 11% at peptide concentrations of 50, 100, 250 and 500 μg/ml.",Not found,29277569,Biochimie. 2018 Mar;146:139-147.,"Yang R, Zhang G, Zhang F, Li Z, Huang C.",Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection.,18,15-18
DRAMP20891,VYPFCWGGAYAFCKAKLV,18,cVT18-CAKKLV (VT18 peptide derivative),No entry found,Derived from VT18,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic,Double-stranded ,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. The positions 4 and 13 of cVT18-CAKKLV have a  disulfide bond to form a cyclic peptide.,"[Ref.29277569] Gram-positive bacteria: Streptococcus pneumoniae ATCC 700669 (MIC=35 μg/ml), Streptococcus pneumoniae ATCC 49619  (MIC=67 μg/ml), Streptococcus pneumoniae ATCC 700677 (MIC=49 μg/ml)","[Ref.29277569] 0.5% hemolysis at 5 μg/ml, 0.5% hemolysis at 10 μg/ml, 0.6% hemolysis at 20 μg/ml, 1.0% hemolysis at 50 μg/ml, 1.9% hemolysis at 100 μg/ml, 2.5% hemolysis at 250 μg/ml, 3.5% hemolysis at 500 μg/ml against human red blood cell",Cyclic,Free,Amidation,Disulfide bond between Cys5 and Cys13.,L,"[Ref.29277569] The cell viability of NL-20 normal lung cell line is not affected (<20%) below 50 μg/ml.## The cell viability of NL-20 is 81%, 73%, 34% and 19% at peptide concentrations of 50, 100, 250 and 500 μg/ml.",Not found,29277569,Biochimie. 2018 Mar;146:139-147.,"Yang R, Zhang G, Zhang F, Li Z, Huang C.",Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection.,18,15-18
DRAMP20892,FIAAIIGGLFSAGKAIHRLIRRRRR,25,H3A/H4A,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=32 μg/ml; MBC=32 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=128 μg/ml; MBC=256 μg/ml);##Fungi: Candida albicans (MIC=512 μg/ml; MBC=512 μg/ml)","[Ref.29040295] 7% haemolysis at 1.56 μg/ml, 10% haemolysis at 3.13 μg/ml, 70% haemolysis at 6.25 μg/ml, 95% haemolysis at 12.50 μg/ml, 98% haemolysis at 25.00 μg/ml, 100% haemolysis at 50.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20893,FIHHIIGGLFSAGKAAHRLIRRRRR,25,I16A,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=64 μg/ml; MBC=128 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 10% haemolysis at 6.25 μg/ml, 20% haemolysis at 12.50 μg/ml, 35% haemolysis at 25.00 μg/ml, 80% haemolysis at 50.00 μg/ml, 95% haemolysis at 100.00 μg/ml, 100% haemolysis at 200.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20894,FIHHIIGGLFSAGKAIHRHHRRRRR,25,L19H/I20H,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 10% haemolysis at 6.25 μg/ml, 13% haemolysis at 12.50 μg/ml, 16% haemolysis at 25.00 μg/ml, 40% haemolysis at 50.00 μg/ml, 85% haemolysis at 100.00 μg/ml, 100% haemolysis at 200.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20895,AAHHIIGGLFSAGKAIHRLIRRRRR,25,F1A/I2A,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,5H2S,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC=256 μg/ml);##Fungi: Candida albicans (MIC=64 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 10% haemolysis at 12.50 μg/ml,  15% haemolysis at 25.00 μg/ml,  30% haemolysis at 50.00 μg/ml,  90% haemolysis at 100.00 μg/ml,  95% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20896,FIHHIIGGAASAGKAIHRLIRRRRR,25,L9A/F10A,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antifungal",Synthetic,Not found,Not found,,Function: Antifungal activity.,[Ref.29040295] Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 5% haemolysis at 25.00 μg/ml,  10% haemolysis at 50.00 μg/ml,  30% haemolysis at 100.00 μg/ml,  95% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml,  100% haemolysis at 800.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20897,FIHHIIGGLFSAGKARHRLIRRRRR,25,I16R,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antifungal",Synthetic,Not found,Not found,,Function: Antifungal activity.,[Ref.29040295] Fungi: Candida albicans (MIC=128 μg/ml; MBC=256 μg/ml),"[Ref.29040295] 10% haemolysis at 25.00 μg/ml,  20% haemolysis at 50.00 μg/ml,  30% haemolysis at 100.00 μg/ml,  75% haemolysis at 200.00 μg/ml,  95% haemolysis at 400.00 μg/ml,  100% haemolysis at 800.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20898,FIHHIIGGLFSAGKAEHRLIRRRRR,25,I16E,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antifungal",Synthetic,Not found,Not found,,Function: Antifungal activity.,[Ref.29040295] Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 5% haemolysis at 25.00 μg/ml,  15% haemolysis at 50.00 μg/ml,  40% haemolysis at 100.00 μg/ml,  65% haemolysis at 200.00 μg/ml,  85% haemolysis at 400.00 μg/ml,  90% haemolysis at 800.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20899,FIHHAAGGLFSAGKAIHRLIRRRRR,25,I5A/I6A,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-negative bacteria. Antifungal activity.,[Ref.29040295] Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC=512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 5% haemolysis at 25.00 μg/ml,  7% haemolysis at 50.00 μg/ml,  10% haemolysis at 100.00 μg/ml,  40% haemolysis at 200.00 μg/ml,  80% haemolysis at 400.00 μg/ml,  100% haemolysis at 800.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20900,FIHHIIGGLFSIGKIIHRLIRRRRR,25,A12I/A15I,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=64 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 0% haemolysis at 0.20 μg/ml,  5% haemolysis at 0.39 μg/ml,  25% haemolysis at 0.78 μg/ml,  85% haemolysis at 1.56 μg/ml,  95% haemolysis at 3.13 μg/ml,  100% haemolysis at 6.25 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20901,FIHHIIGGLFSVGKHIHRLIRRRRR,25,A12V/A15H,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=16 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=64 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=128 μg/ml; MBC=128 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 0% haemolysis at 0.78 μg/ml,  10% haemolysis at 1.56 μg/ml,  55% haemolysis at 3.13 μg/ml,  85% haemolysis at 6.25 μg/ml,  98% haemolysis at 12.50 μg/ml,  100% haemolysis at 25.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20902,FIHHIIGGLFSVGKHIHSLIHRRRR,25,VHSH,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=16 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=16 μg/ml; MBC=32 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 5% haemolysis at 1.56 μg/ml,  5% haemolysis at 3.13 μg/ml,  10% haemolysis at 6.25 μg/ml,  35% haemolysis at 12.50 μg/ml,  55% haemolysis at 25.00 μg/ml,  85% haemolysis at 50.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20903,FIHHIIGGLFSAGKAIHRLIRRR,23,dC2,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=32 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=32 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 2% haemolysis at 3.13 μg/ml,  5% haemolysis at 6.25 μg/ml,  25% haemolysis at 12.50 μg/ml,  65% haemolysis at 25.00 μg/ml,  90% haemolysis at 50.00 μg/ml,  100% haemolysis at 100.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",23,21-24
DRAMP20904,FIHHIIGGLFSAGKAIHSLIHRRRR,25,R18S/R21H,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=32 μg/ml; MBC=64 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=32 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC=512 μg/ml);##Fungi: Candida albicans (MIC=256 μg/ml; MBC=512 μg/ml)","[Ref.29040295] 8% haemolysis at 6.25 μg/ml,  10% haemolysis at 12.50 μg/ml,  15% haemolysis at 25.00 μg/ml,  40% haemolysis at 50.00 μg/ml,  80% haemolysis at 100.00 μg/ml,  100% haemolysis at 200.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",25,24-27
DRAMP20905,FIHHIIGGLFSAGKAIHRLIR,21,dC4,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=64 μg/ml; MBC=128 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=256 μg/ml; MBC=256 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=256 μg/ml)","[Ref.29040295] 5% haemolysis at 12.50 μg/ml,  10% haemolysis at 25.00 μg/ml,  45% haemolysis at 50.00 μg/ml,  80% haemolysis at 100.00 μg/ml,  100% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",21,18-21
DRAMP20906,HHIIGGLFSAGKAIHRLIRRRRR,23,dN2,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=512 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 5% haemolysis at 12.50 μg/ml,  5% haemolysis at 25.00 μg/ml,  20% haemolysis at 50.00 μg/ml,  65% haemolysis at 100.00 μg/ml,  90% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",23,21-24
DRAMP20907,IIGGLFSAGKAIHRLIRRRRR,21,dN4,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=128 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=64 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 10% haemolysis haemolysis at 12.50 μg/ml,  12% haemolysis haemolysis at 25.00 μg/ml,  20% haemolysis haemolysis at 50.00 μg/ml,  35% haemolysis haemolysis at 100.00 μg/ml,  75% haemolysis haemolysis at 200.00 μg/ml,  100% haemolysis haemolysis at 400.00 μg/ml,  100% haemolysis haemolysis at 800.00 μg/ml against mouse red blood cells",Linear,Free,Free,,L,[Ref.29040295] No cytotoxicity information found,Not found,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",21,18-21
DRAMP20912,FLGGLIKKWPWWPWRR,16,RN7-IN9(designed based on indolicidin and ranalexin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=7.81μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC=31.25μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=7.81–15.62μg/ml), Staphylococcus aureus ATCC 25923(MIC=7.81μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=7.81μg/ml), Enterococcus cloacae(MIC>250μg/ml), ",[Ref.26046345] The hemolytic activities of RN7-IN7 is 0.0% at 15.62μg/ml against human RBCs.,Linear,Free,Amidation,,L,"[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 31.25 μg/ml. The cell viability of NL-20 is 51%, 13% and 7% at peptide concentrations of 62.5, 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected",Not found,26046345,PLoS One. 2015 Jun 5;10(6):e0128532.,"Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.",Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.,16,15-18
DRAMP20933,FFSLIPSLVGGLISAFK,17,Stigmurin,No entry found,Derived from scorpion venom peptide,Not found,Tityus stigmurus,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal, Antiparasitic, Antiproliferative",Transcript level,Alpha helix ,Not found,,Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.,"[Ref.29670004] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=9.38 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM);##yeasts: Candida albicans ATCC 90028 (MIC=37.5 μM);##Stigmurin inhibit 90% of the epimastigote forms of Trypanosoma cruzi growth at 25 ?M;##HeLa cell line: IC50=7.98 μM","[Ref.29670004]Hemolysis 0% at 1.17 μM, hemolysis 1% at 2.34 μM, hemolysis 1% at 4.69 μM, hemolysis 0% at 9.38 μM, hemolysis 1% at 18.75 μM, hemolysis 1% at 37.50 μM, hemolysis 3% at 75.00 μM against human red blood cell",Linear,Free,Amidation,,L,"[Ref.29670004] The cell viability of HeLa cell lines is 56%, 66%, 66%, 81%, 78%, 66% and 30% at peptide concentrations of 2, 4, 8, 10, 15,  20 and 40 μM. ##The cell viability of 3T3 cell lines is 81%, 63%, 51%, 29%, 27%, 19% and 15% at peptide concentra",Not found,29670004,Toxins (Basel). 2018 Apr 18;10(4). pii: E161.,"Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.","Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity.",17,15-18
DRAMP20937,HRVKRNGFRKFMRRLKKFFAGG,22,Pb-CATH3,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.,"[Ref.28630199] Gram-positive bacteria: B. cereus ATCC 10876 (MIC=32 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), S. typhimurium ATCC 14028 (MIC=2 μg/ml);##Clinical isolates: Escherichia coli (4.7 μg/ml), K. pneumoniae (1.18 μg/ml)","[Ref.28630199]0% hemolysis at 8 μg/ml, 1.7 ± 0.5%  hemolysis at 16 μg/ml, 3.1 ± 0.5%  hemolysis at 32 μg/ml, 4.0 ± 0.2% hemolysis at 64 μg/ml against chicken red blood cells",Linear,Free,Free,,L,[Ref.28630199] No cytotoxicity information found,Not found,28630199,Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00530-17.,"Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.",Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity,22,21-24
DRAMP20945,KWKLFKKIFKRIVQRIKDFLRN,22,Recombinant  Cecropin A (1–8)–LL37 (17–30) (C–L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria,"[Ref.29925795] Gram-negative bacteria: Escherichia coli CVCC 245 (MIC=7.2 ± 0.14 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2.2 ± 0.05 μg/mL),L. mono. CVCC 1599 (MIC=2.1 ± 0.03 μg/mL)",[Ref.29925795] 50% hemolysis at 221 ± 3.45μg/ml against sheep red blood cells,Linear,Free,Free,,L,[Ref.29925795] No cytotoxicity information found,Not found,29925795,Molecules. 2018 Jun 20;23(6). pii: E1491. ,"Wei X, Wu R, Zhang L, Ahmad B, Si D, Zhang R.","Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity",22,21-24
DRAMP20946,TRSRWRRFIRGAGRFARRYGWRIA,24,ΔPb-CATH4 bivittatus  antimicrobial peptides peptide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial",Synthetic,Not found,Not found,,"Function: Antibacterial activity against the Gram-negative and Gram-negative bacteria. It is tested against the clinically isolated antibiotic resistance strains Escherichia coli and Klebsiella pneumoniae,which showed complete resistance particularly toward ampicillin and to a lesser extent with gentamicin",[Ref.28630199] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=1μg/ml);Pseudomonas aeruginosa (ATCC 27853)(MIC=3μg/ml);S. typhimurium (ATCC 14028)(MIC=0.5μg/ml);##Gram-positive bacteria: Staphylococcus aureus (ATCC 29213)(MIC>128μg/ml);B. cereus (ATCC 10876)(MIC=10μg/ml);##Clinical isolates:Escherichia coli(MIC=4.7μg/ml);K. pneumoniae(MIC=1.18μg/ml),[Ref.28630199]Hemolysis 0% at 4μg/ml against human red blood cell;Hemolysis 1.2 ± 0.3% at 8μg/ml against human red blood cell;Hemolysis 3.2 ± 0.4% at 16μg/ml against human red blood cell;Hemolysis 6.5 ± 0.4% at 32μg/ml against human red blood cell;Hemolysis 10.7 ± 0.2% at 64μg/ml against human red blood cell,Linear,Free,Free,,L,[Ref.28630199] No cytotoxicity information found,Not found,28630199,Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00530-17. ,"Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.",Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,24,21-24
DRAMP20957,FFSLIPKLVKGLISAFK,17,StigA6,No entry found,Derived from scorpion venom peptide,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antiproliferative",Synthetic,Alpha helix ,"The peptide adopts helical conformation with some random structure at the N- and C-terminals. In sodium phosphate buffer (PBS) and water they have a predominantly random structure, but in 20 mM sodium dodecyl sulfate (SDS) and 2,2,2-trifluoroethanol (TFE) they have a typical alpha-helix structure.",,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.,"[Ref.29670004] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2.34 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM), Enterococcus faecalis ATCC 4028 (MIC=1.17 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4.69 μM), Enterobacter cloacae ATCC 13047 (MIC=18.75 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=9.38 μM);##yeasts: Candida albicans ATCC 90028 (MIC=9.38 μM), Candida krusei ATCC 6258 (MIC=37.5 μM), Candida glabrata ATCC 90030 (MIC=18.75 μM);##StigA6 inhibit 100% of the epimastigote forms of Trypanosoma cruzi growth at 2.5 µM;##HeLa cell line: IC50=14.01 µM","[Ref.29670004] Hemolysis 0% at 1.17 μM, hemolysis 2% at 2.34 μM, hemolysis 15% at 4.69 μM, hemolysis 27% at 9.38 μM, hemolysis 30% at 18.75 μM, hemolysis 30% at 37.50 μM, hemolysis 27% at 75.00 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.29670004] The cell viability of HeLa cell lines is 19%, 15%, 11%, 29%, 9%, 13% and 8% at peptide concentrations of 2, 4, 8, 10, 15, 20 and 40 μM.  ##The cell viability of 3T3 cell lines is 81%, 73%, 69%, 61%, 51%, 20% and 15% at peptide concentrati",Not found,29670004,Toxins (Basel). 2018 Apr 18;10(4). pii: E161.,"Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.","Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity.",17,15-18
DRAMP20958,FFKLIPKLVKGLISAFK,17,StigA16,No entry found,Derived from scorpion venom peptide,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antiproliferative",Synthetic,Alpha helix ,"The peptide adopts helical conformation with some random structure at the N- and C-terminals. In sodium phosphate buffer (PBS) and water they have a predominantly random structure, but in 20 mM sodium dodecyl sulfate (SDS) and 2,2,2-trifluoroethanol (TFE) they have a typical alpha-helix structure.",,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.,"[Ref.29670004] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2.34 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM), Enterococcus faecalis ATCC 4028 (MIC=1.17 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2.34 μM), Enterobacter cloacae ATCC 13047 (MIC=9.38 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1.17 μM);##yeasts: Candida albicans ATCC 90028 (MIC=4.69 μM), Candida krusei ATCC 6258 (MIC=9.38 μM), Candida glabrata ATCC 90030 (MIC=9.38 μM);##StigA16 inhibit 100% of the epimastigote forms of Trypanosoma cruzi growth at 2.5 µM;##HeLa cell line: IC50=13.01 µM","[Ref.29670004] Hemolysis 0% at 1.17 [Ref.29670004] Hemolysis 0% at 1.17 μM, hemolysis 2% at 2.34 μM, hemolysis 10% at 4.69 μM, hemolysis 20% at 9.38 μM, hemolysis 35% at 18.75 μM, hemolysis 37% at 37.50 μM, hemolysis 40% at 75.00 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.29670004] The cell viability of HeLa cell lines is 15%, 21%, 16%, 9%, 8%, 10% and 11% at peptide concentrations of 2, 4, 8, 10, 15, 20 and 40 μM. ##The cell viability of 3T3 cell lines is 69%, 77%, 62%, 47%, 21%, 15% and 15% at peptide concentratio",Not found,29670004,Toxins (Basel). 2018 Apr 18;10(4). pii: E161.,"Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.","Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity.",17,15-18
DRAMP20964,KWKLFKKIFKRIVQRIKDFLRN,22,Synthesized Cecropin A (1–8)–LL37 (17–30) (C–L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.29920061] Gram-negative bacteria: Escherichia coli (CVCC 245)(MIC=7.0 ± 0.21μg/mL);##Gram-positive bacteria: Staphylococcus aureus (ATCC 25923)(MIC=2.0 ± 0.02μg/mL );L. mono. (CVCC 1599)(MIC=2.2 ± 0.05μg/mL),[Ref.29920061]HC50 =219 ± 2.98μg/mL against sheep erythrocyte cells,Linear,Free,Free,,L,[Ref.29925795] No cytotoxicity information found,Not found,29920061,Molecules. 2018 Jun 20;23(6). pii: E1491.,"Wei X, Wu R, Zhang L, Ahmad B, Si D, Zhang R.","Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity.",22,21-24
DRAMP20965,MNKVKEWIKYLKSLFSM,17,"LPcin-YK3 (bovine cathelicidin, cattle, ruminant, mammals, animals)",No entry found,Not found,Not found,Bovine Lactophoricin,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,"Random coil, alpha helix",LPcin-YK3 peptide is a random coil in aqueous solution and forms an ,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.30021422] Gram-positive bacteria : Streptococcus mutans KCCM 40105 (MIC=1.25 μg/ml), Propionibacteria acnes KCCM 41747 (MIC=1.25 μg/ml), Staphylococcus aureus KCTC 1621 (MIC=0.62 μg/ml);##Gram-negative bacteria : Porphyromonas gingvalis KCTC 5352 (MIC=0.62 μg/ml), Escherichia coli KCCM 41290 (MIC=1.25 μg/ml);##Fungi : Candida albicans KCTC 17712 (MIC=10.0 μg/ml)",[Ref.30021422] 0% hemolysis  at 40 μg/ml against mouse red blood cell,Linear,Free,Free,,L,[Ref.30021422] No cytotoxicity information found,Not found,30021422,J Microbiol Biotechnol.?2018 Aug 28;28(8):1299-1309. doi: 10.4014/jmb.1805.05001.,"Ji-Sun Kim,Ji-Ho Jeong, Jang-Hee Cho,Dong-Hee Lee and Yongae Kim",Antimicrobial Activity of Antimicrobial Peptide LPcin-YK3 Derived from Bovine Lactophoricin,17,15-18
DRAMP20968,MMRVMRRKTKVIWEKKDFIGLYSID,25,"Catesbeianin-1 (Ranidae, Anura, Amphibia, Animals)",C5IAX4,Not found,Not found,Lithobates catesbeiana (American bullfrog) (Rana catesbeiana),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Alpha helix,"Catesbeianin-1 is an amphi pathic a-helix and that the helical wheel is divided into two parts, namely, a hydrophobic face and a hydro philic face.",,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28258530] Gram-positive bacteria : Staphylococcus aureus ATCC 25923 (MIC=3.1 μg/ml;MBC=6.3 μg/ml), B. subtilis ATCC6633 (MIC=25 μg/ml;MBC=50 μg/ml), Streptococcus suis CVCC606 (MIC=3.1 μg/ml;MBC=12.5 μg/ml), Listeria monocytogenes ATCC19115 (MIC=12.5 μg/ml;MBC=25 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=3.1 μg/ml;MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC227853 (MIC=12.5 μg/ml;MBC=25 μg/ml), Salmonella spp. CVCC 3377 (MIC=6.3 μg/ml;MBC=25 μg/ml), Klebsiella pneumoniae H507 (MIC=25 μg/ml;MBC=100 μg/ml)","[Ref.28258530] 0% hemolysis at 0 μg/ml , hemolysis 3% at 25 μg/ml , 7% hemolysis at 50 μg/ml , 8% hemolysis at 100 μg/ml , 35% hemolysis at 200 μg/ml , 50% hemolysis at 300 μg/ml , 85% hemolysis at 400 μg/ml , 95% hemolysis at 500 μg/ml against human red blood cells",Linear,Free,Free,,L,"[Ref.28258530] The cell viability of HEK293T cells is 102%, 103%, 103%, 100%, 98% and 85% at peptide concentrations of 0, 20, 40, 60, 80 and 100 μg/ml. ##The cell viability of HL-7200 cells is 107%, 106%, 99%, 95% and 88% at peptide concentrations of 0,",Not found,28258530,Biotechnol Lett. 2017 Jun;39(6):897-903. doi: 10.1007/s10529-017-2312-7.,Huihui Xu . Yang Zhang . Xin Feng . Kunyuan Tie . Yuan Cao . Wenyu Han,"Catesbeianin-1, a novel antimicrobial peptide isolatedfrom the skin of Lithobates catesbeianus (American bullfrog)",25,24-27
DRAMP20970,VNFKLLSHSLLVTLASHL,18,"P3 (bovine cathelicidin, cattle, ruminant, mammals, animals)",P01966,Belongs to the globin family.,HBA,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.25753638] Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=25 μg/ml), Clinical Staphylococcus aureus (MIC=12.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=12.5 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=25 μg/ml);##Fungi : Candida albicans Clinical strain (MIC=25 μg/ml), Candida albicans ATCC 90029 (MIC=50 μg/ml)","[Ref.25753638] 3% hemolysis at 50 μg/ml , 5% hemolysis  at 100 μg/ml , 7% hemolysis at 200 μg/ml , 7.5% hemolysis at 300 μg/ml , 8% hemolysis at 400 μg/ml against human red blood cells",Linear,Free,Free,,L,"[Ref.25753638] The cell viability of HaCaT cell lines is 93% and 94% at peptide concentrations of 200 and 400 μg/ml. In kumning mice, the LD50 of P3 is 160 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. No mortality w",Not found,25753638,Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.,"Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu",Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model,18,15-18
DRAMP20973,VRFKLLSHSLLVTLASHL,18,JH-2 (Derived from  P3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.25753638] Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=12.5 μg/ml), Clinical Staphylococcus aureus (MIC=6.25 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=6.25 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml);##Fungi : Candida albicans ATCC 90029 (MIC=25 μg/ml), Candida albicans Clinical strain (MIC=25 μg/ml)","[Ref.25753638] 2% hemolysis at 50 [Ref.25753638] 2% hemolysis at 50 μg/ml , 2.5% hemolysis at 100 μg/ml , 3.5% hemolysis at 200 μg/ml , 4% hemolysis at 300 μg/ml , 4% hemolysis at 400 μg/ml against human red blood cells",Linear,Free,Free,,L,"[Ref.25753638] The cell viability of HaCaT cell lines is 88% and 84% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-2 is 133 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. no mortality",Not found,25753638,Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.,"Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu",Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model,18,15-18
DRAMP20974,RRFKLLSHSLLVTLASHL,18,JH-3 (Derived from  P3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.25753638]Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=6.25 μg/ml), Clinical Staphylococcus aureus (MIC=3.125 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=3.125 μg/ml), Clinical Escherichia coli (MIC=3.125 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml);##Fungi : Candida albicans ATCC 90029 (MIC=12.5 μg/ml), Candida albicans Clinical strain (MIC=6.25 μg/ml)","[Ref.25753638] 8% hemolysis at 50 μg/ml , 13% hemolysis at 100 μg/ml , 17% hemolysis at 200 μg/ml , 18% hemolysis at 300 μg/ml , 18.5% hemolysis at 400 μg/ml against human red blood cells",Linear,Free,Free,,L,"[Ref.25753638] The cell viability of HaCaT cell lines is 86% and 86% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-3 is 180 mg/kg for i.p. injection, , while the LD50 of PMB(served as a control) is 50 mg/kg. No mortali",Not found,25753638,Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.,"Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu",Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model,18,15-18
DRAMP20975,KFFKKLKKAVKKGFKKFAKV,20,OH-CM6 (Derived from  OH-CATH30),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.22491685] Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=12.5 μg/ml), Staphylococcuss aureus ATCC 43300 MRSA (MIC=3.125 μg/ml), Staphylococcuss aureus clinical strain 1 (MIC=6.25 μg/ml), Staphylococcuss aureus clinical strain 2 (MIC=3.125 μg/ml), Staphylococcuss aureus clinical strain 3 (MIC=12.5 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=25 μg/ml) ;##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=12.5 μg/ml), Escherichia coli ML-35p (MIC=6.25 μg/ml), Escherichia coli clinical strain 1 (MIC=12.5 μg/ml), Escherichia coli clinical strain 2 (MIC=3.125 μg/ml), Escherichia coli clinical strain 3 (MIC=1.56 μg/ml), Escherichia coli clinical strain 4 (MIC=12.5 μg/ml), Escherichia coli clinical strain 5 (MIC=6.25 μg/ml), Escherichia coli clinical strain 6 (MIC=3.125 μg/ml), Enterobacter cloacae ATCC 13047 (MIC>100 μg/ml), Enterobacter cloacae clinical strain (MIC>100 μg/ml), Enterobacter aerogenes clinical strain (MIC>100 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=12.5 μg/ml), Pseudomonas aeruginosa PA 01 (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain 1 (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain 2 (MIC=6.25 μg/ml), Haemophilus influenzae ATCC 49247 (MIC=3.125 μg/ml), Haemophilus influenzae ATCC 49766 (MIC=6.25 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=6.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=3.125 μg/ml) ;##Fungi : Candida albicans ATCC 2002 (MIC>200 μg/ml), Candida albicans clinical strain (MIC>200 μg/ml)","[Ref.22491685] 13% hemolysis at 100 μg/ml , 17% hemolysis at 200 μg/ml , 18% hemolysis at 300 μg/ml , 18.5% hemolysis at 400 μg/ml against human red blood cells",Linear,Free,Free,,L,"[Ref.22491685] The cell viability of HaCaT cell lines is 76%, 62% and 53% at peptide concentrations of 50, 100, 200 μg/ml. In Kunming mice, the LD50 of OH-CATH30 is 120 mg/kg for i.p. injection, while those of pexiganan(control 1) and PMB(control 2) are",Not found,22491685,Antimicrob Agents Chemother. 2012 Jun;56(6):3309-17. doi: 10.1128/AAC.06304-11.,"Sheng-An Li, Wen-Hui Lee, and Yun Zhang",Efficacy of OH-CATH30 and Its Analogs against Drug-ResistantBacteria In Vitro and in Mouse Models,20,18-21
DRAMP20976,RKYVRFLHRWVKYFRAYL,18,"adevonin (Derived from Adenanthera pavonina trypsin inhibitor (ApTI))
inhibitor (ApTI))",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,"Adevonin showed that its secondary structure varies according to the environment, acquiring ",,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.30570384]Gram-positive bacteria : Staphylococcus aureus ATCC 80958 (MIC=7.35 μM);##Gram-negative bacteria : Escherichia coli ATCC 35218 (MIC=7.35 μM), Klebsiella oxytoca ATCC 13182 (MIC=1.84 μM), Klebsiella pneumoniae ATCC 70603 (MIC=3.67 μM), Serratia marcesens ATCC 13880 (MIC=1.84 μM), Klebsiella pneumoniae KpC+ 001825971 (MIC=25.6 μM)","[Ref.30570384] 0% hemolysis at 43.75 μM , 72.5% hemolysis at 175 μM , 77% hemolysis at 350 μg/ml against human type O erythrocytes",Linear,Free,Free,,L,"[Ref.30570384] In fibroblasts, a significant reduction of cell viability, of 25% on average, is observed in each time interval(24,48 and 72h) in the highest peptide concentration(10 μM)",Not found,30570384,Pathog Glob Health.?2018 Dec;112(8):438-447. doi: 10.1080/20477724.2018.1559489.,"Mayara S. Rodrigues, Caio F. R. de Oliveira, Luís H. O. Almeida, Simone M.Neto, Ana Paula A. Boleti, Edson L. dos Santos, Marlon H. Cardoso, Suzana,M. Ribeiro, Octávio L. Franco, Fernando S. Rodrigues, Alexandre J. Macedo,Flávia R. Brust & Maria Lígia R. Macedo","Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence",18,15-18
DRAMP20981,GFGSLLGKALRLGANVL,17,"CPF-C1 (Frogs, Amphibians, Animals)",No entry found,Not found,Not found,Tetraploid frog Xenopus clivii,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,"Random coil, alpha helix","CPF-C1 revealed a random coil structure in PBS, displayed typical ",,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=4 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=32 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=128 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=4 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml , 7% hemolysis at 128 μg/ml , 15% hemolysis at 256 μg/ml , 57% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,L,[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20982,KFWSLLKKALRLWANVL,17,CPF-1 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,CPF-1 displayed typical ,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=32 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=32 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 0 μg/ml , 5% hemolysis at 4 μg/ml , 8% hemolysis at 8 μg/ml , 20% hemolysis at 16 μg/ml , 35% hemolysis at 32 μg/ml , 58% hemolysis at 64 μg/ml , 70% hemolysis at 128 μg/ml , 78% hemolysis at 256 μg/ml , 80% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,L,[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20983,kFwSLLkKALRLwANVL,17,CPF-2 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,CPF-2 displayed typical ,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 8% hemolysis at 16 μg/ml , 24% hemolysis at 32 μg/ml , 48% hemolysis at 64 μg/ml , 68% hemolysis at 128 μg/ml , 85% hemolysis at 256 μg/ml , 90% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,"Mixed(D-Lys1, D-Trp3, D-Lys7, D-Trp13)",[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20984,KFWKLLKKALRLWAKVL,17,CPF-3 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,CPF-3 displayed typical ,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 256 μg/ml , 5% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,L,[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20985,kFWKlLKkAlrLWAkVL,17,CPF-4 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=32 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml , 8% hemolysis at 128 μg/ml , 10% hemolysis at 256 μg/ml , 25% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,"Mixed(D-Lys1, D-Leu5, D-Lys8, D-Leu10, D-Arg11, D-Lys15)",[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20986,kFwKLLkKALrLwAkVL,17,CPF-5 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)","[Ref.28371431] 0% hemolysis at 16 μg/ml , 5% hemolysis at 32 μg/ml , 10% hemolysis at 64 μg/ml , 20% hemolysis at 128 μg/ml , 40% hemolysis at 256 μg/ml , 37% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,"Mixed(D-Lys1, D-Trp3, D-Lys7, D-Arg11, D-Trp13, D-Lys15)",[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20987,lFwKLLlKAlrLwAkVL,17,CPF-6 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC8=μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)","[Ref.28371431] 0% hemolysis at 4 μg/ml , 3% hemolysis at 8 μg/ml , 17.5% hemolysis at 16 μg/ml , 45% hemolysis at 32 μg/ml , 70% hemolysis at 64 μg/ml , 80% hemolysis at 128 μg/ml , 85% hemolysis at 256 μg/ml , 90% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,"Mixed(D-Leu1, D-Trp3, D-Leu7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)",[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20988,WFKKLLKKALRLWKKVL,17,CPF-7 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,CPF-7 displayed typical ,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=32 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 4 [Ref.28371431] 0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 23% hemolysis at 16 μg/ml , 50% hemolysis at 32 μg/ml , 70% hemolysis at 64 μg/ml , 95% hemolysis at 128 μg/ml , 90% hemolysis at 256 μg/ml , 100% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,L,[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20989,wFKKlLKkAlrLWKkVL,17,CPF-8 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)","[Ref.28371431]13% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 0% hemolysis at 16 μg/ml , 0% hemolysis at 32 μg/ml , 0% hemolysis at 64 μg/ml , 0% hemolysis at 128 μg/ml , 0% hemolysis at 256 μg/ml , 0% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,"Mixed(D-Trp1, D-Leu5, D-Lys8, D-Leu10, D-Arg11, D-Lys15)",[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20990,kFwKLLkKAlrLwKkVL,17,CPF-9 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)","[Ref.28371431]0% hemolysis at 256 μg/ml , 5% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,"Mixed(D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)",[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP20991,wFwKLLwKAlrLwWkVL,17,CPF-10 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=32 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=256 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=16 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431]0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 21% hemolysis at 16 μg/ml , 40% hemolysis at 32 μg/ml , 56% hemolysis at 64 μg/ml , 65% hemolysis at 128 μg/ml , 73% hemolysis at 256 μg/ml , 85% hemolysis at 512 μg/ml against human red blood cells",Linear,Free,Amidation,,"Mixed(D-Trp1, D-Trp3, D-Trp7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)",[Ref.28371431] No cytotoxicity information found,Not found,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,17,15-18
DRAMP21000,GCRRLCYKQRCVTYCRGR,18,cGm (Derived from Gm),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4 μM), Escherichia coli CGSC 5167 (MIC=0.06 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1-4 μM), Helicobacter pylori ATCC 43504 (MIC= μM);##Fungi : Candida albicans ATCC 90028 (MIC=4-8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)","[Ref.28741926] 5% hemolysis at 0.03 μM , 0% hemolysis at 1.1 μM , 10% hemolysis at 17 μM , 50% hemolysis at 100μM against human red blood cells",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bond between Cys2 and Cys15,Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 39.8 ± 1.0 μM against CRL-1739, CC50 = 2.9 ± 0.1 μM against MM96L, CC50 = 71.7 ± 9.2 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 15.3 ± 1.4 μM against MCF-7, CC50 = 2.7 ± 0.1 μM against K-562, CC50 = 12.7 ± 1.1 μM PBMCs.",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21001,GCRRLCWKQRCVTYCRGR,18,[Y7W]cGm (Derived from Gm),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM),[Ref.28741926] 35.1-55.5% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 23.3 ± 0.4 μM against CRL-1739, CC50 = 5.1 ± 0.3 μM against MM96L, CC50 = 39.7 ± 3.8 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 3.9 ± 0.2 μM against K-562. ",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21002,GCRRLCYKQRCVTWCRGR,18,[Y14W]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM),[Ref.28741926] 46.1-55.5% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 30.3 ± 1.1 μM against CRL-1739, CC50 = 4.0 ± 0.1 μM against MM96L, CC50 = 68.4 ± 9.6 μM against HFF-1, CC50 = 50.4 ± 2.4 μM against HeLa, CC50 = 2.7 ± 0.1 μM against K-562. ",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21003,GCRRLCYRQRCVTYCRGR,18,[K8R]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM),[Ref.28741926] 34.8-54.8% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 29.4 ± 1.1 μM against CRL-1739, CC50 = 5.0 ± 0.3 μM against MM96L, CC50 = 34.5 ± 3.6 μM against HFF-1, CC50 = 39.4 ± 2.6 μM against HeLa, CC50 = 3.1 ± 0.1 μM against K-562.",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21004,GCRRLCWRQRCVTWCRGR,18,"[Y7W, K8R, Y14W]cGm (Derived from Gm) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1 μM),[Ref.28741926] 42-49.8% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 31.6 ± 1.3 μM against CRL-1739, CC50 = 5.4 ± 0.3 μM against MM96L, CC50 = 31.3 ± 2.6 μM against HFF-1, CC50 = 41.0 ± 4.2 μM against HeLa, CC50 = 15.1 ± 1.4 μM against MCF-7, CC50 = 3.9 ± 0.1 μM against K-562.",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21005,GCRALCYKQRCVTYCRGA,18,"[R4A, R18A]cGm (Derived from Gm) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μM), Escherichia coli CGSC 5167 (MIC=0.5-1 μM), Klebsiella pneumoniae ATCC 700603 (MIC=32 μM), Acinetobacter baumannii ATCC 19606 (MIC=8-16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=32 μM), Cryptococcus neoformans ATCC 208821 (MIC=8-16 μM)","[Ref.28741926] 0% hemolysis at 17 μM , 3% hemolysis at 35 μM , 30-48.6% hemolysis at 64 μM , 40% hemolysis at 100 μM against human red blood cells",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 > 64 μM against CRL-1739, CC50 = 10.3 ± 1.1 μM against MM96L, CC50 = 51.2 ± 4.0 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 48.4 ± 0.7 μM against MCF-7, CC50 = 11.5 ± 0.6 μM against K-562, CC50 = 34.1 ± 3.9 μM against HL-60;CC50=30.8 ± 2.5μM against PBMCs.",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21006,KCRRLCYRQRCVTYCRGR,18,"[G1K, K8R]cGm (Derived from Gm) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=2 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=0.5-1 μM), Escherichia coli CGSC 5167 (MIC<0.015 μM), Klebsiella pneumoniae ATCC 700603 (MIC=8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC<0.25 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=2 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.125-0.25 μM)","[Ref.28741926] 0% hemolysis at 0.5 μM , 2.5% hemolysis at 0.6 μM , 20% hemolysis at 8 μM , 43.3-56.9% hemolysis at 64 μM , 50% hemolysis at 100 μM against human red blood cells",Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 19.5 ± 0.5 μM against CRL-1739, CC50 = 1.7 ± 0.1 μM against MM96L, CC50 = 9.0 ± 0.5 μM against HFF-1, CC50 = 44.2 ± 2.2μM against HeLa, CC50 = 6.7 ± 0.7 μM against MCF-7, CC50 = 2.1 ± 0.2 μM against K-562, CC50 = 9.0 ± 1.1μM against HL-60;CC50=5.1 ± 0.3μM against PBMCs.",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21007,GURRLUYKQRUVTYURGR,18,[C/U]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4-8 μM), Escherichia coli CGSC 5167 (MIC=0.03-0.06 μM), Klebsiella pneumoniae ATCC 700603 (MIC=8-16 μM), Acinetobacter baumannii ATCC 19606 (MIC=4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=2-4 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4-8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)",[Ref.28741926] 32.3-33.3% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between SeCys2 and SeCys15, SeCys6 and SeCys11. The 'U' in sequence is SelenoCys.",L,"[Ref.28741926] CC50 = 51.0 ± 4.6 μM against CRL-1739, CC50 = 4.6 ± 0.2 μM against MM96L, CC50 = 15.6 ± 3.6 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 37.5 ± 3.3 μM against MCF-7, CC50 = 1.4 ± 0.2 μM against K-562, CC50 = 38.5 ± 4.8 μM against HL-60;CC50=15.5 ± 0.8μM against PBMCs.",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21008,GCRRWCYKQRCVTYCRGR,18,[L5W]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8-16 μM),[Ref.28741926] 36.8-43.4% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 18.3 ± 1.4 μM against CRL-1739, CC50 = 4.0 ± 0.1 μM against MM96L, CC50 = 25.0 ± 2.9 μM against HFF-1, CC50 = 17.1 ± 0.7 μM against HeLa, CC50 = 1.0 ± 0.1 μM against K-562. ",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21009,GCRRLCYKQRCVTYCRGpPR,20,[D-P L-P]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4 μM), Klebsiella pneumoniae ATCC 700603 (MIC=1-4 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μM);##Fungi : Candida albicans ATCC 90028 (MIC=8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)",[Ref.28741926] 41.5-44.9% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 22.5 ± 3.3 μM against CRL-1739, CC50 = 3.0 ± 0.1 μM against MM96L, CC50 = 14.9 ± 0.8 μM against HFF-1, CC50 = 51.5 ± 3.9 μM against HeLa, CC50 = 3.9 ± 0.2 μM against K-562, CC50 = 14.1 ± 0.9 μM against PBMCs",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,20,18-21
DRAMP21010,KCRRYCYRQRCVTYCRGR,18,"[G1K, L5Y, K8R]cGm (Derived from Gm) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=0.5-1 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC<0.25-0.5 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5 μM)",[Ref.28741926] 20.6-32% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",L,"[Ref.28741926] CC50 = 26.5 ± 2.4 μM against CRL-1739, CC50 = 2.0 ± 0.1 μM against MM96L, CC50 = 14.7 ± 1.5 μM against HFF-1, CC50 = 20.9 ± 1.4 μM against HeLa, CC50 = 15.2 ± 1.9 μM against MCF-7, CC50 = 1.3 ± 0.1 μM against K-562, CC50 = 15.7 ±1.1μM against HL-60;CC50=10.4 ± 1.0μM against PBMCs.",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21011,KURRYUYRQRUVTYURGR,18,"[C/U, G1K, L5Y, K8R]cGm (Derived from Gm)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-16 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)",[Ref.28741926] 17.8-24% hemolysis at 64 μM against human red blood cells,Cyclic,No specific N-terminal,No specific C-terminal,"Disulfide bonds between SeCys2 and SeCys15, SeCys6 and SeCys11. The 'U' in sequence is SelenoCys.",L,"[Ref.28741926] CC50 = 46.2 ± 7.6 μM against CRL-1739, CC50 = 2.3 ± 0.2 μM against MM96L, CC50 = 30.8 ± 2.0 μM against HFF-1, CC50 = 36.2 ± 2.8 μM against HeLa, CC50 = 29.0 ± 3.7 μM against MCF-7, CC50 = 6.4 ± 0.6 μM against K-562, CC50 = 33.3 ±7.4μM against HL-60;CC50=9.5 ± 0.5μM against PBMCs.",Not found,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP21015,RIGSILGALAKGLPTLISWIKNR,23,A (A1R) (Derived from AR-23),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=6.25 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=12.5 μM)",[Ref.27271216] 100% hemolysis at  20μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 82%, 40%, 8%, 2% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,23,21-24
DRAMP21016,AIGSILGRLAKGLPTLISWIKNR,23,A (A8R) (Derived from AR-23),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=3.13 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)","[Ref.27271216] 80% hemolysis at 20 μM , 100% hemolysis at 40 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 97%, 58%, 10%, 2% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,23,21-24
DRAMP21017,AIGSILGALAKGLPTLKSWIKNR,23,A (I17K) (Derived from AR-23)  ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=50 μM), Staphylococcus epidermidis (MIC=12.5 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=25 μM), Klebsiella pneumoniae (MIC=50 μM)","[Ref.27271216] 5% hemolysis at 20 μM , 13% hemolysis at 40 μM , 20% hemolysis at 60 μM , 30% hemolysis at 80 μM , 35% hemolysis at 100 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 98%, 92%, 53%, 34% and 7.9% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,23,21-24
DRAMP21018,AIGSILGALAKGLPTLRSWIKNR,23,A (I17R) (Derived from AR-23)  ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=25 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=25 μM)","[Ref.27271216] 10% hemolysis at 20 μM , 15% hemolysis at 40 μM , 20% hemolysis at 60 μM , 30% hemolysis at 80 μM , 35% hemolysis at 100 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 85%, 68%, 21% and 6.6% at peptide concentrations of 6.25, 12.5, 25 and 50 μM. ",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,23,21-24
DRAMP21019,RIGSILGRLAKGLPTLISWIKNR,23,"A (A1R, A8R) (Derived from AR-23)  ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=12.5 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=6.25 μM)","[Ref.27271216] 58% hemolysis at 20 μM , 80% hemolysis at 40 μM , 100% hemolysis at 60 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 92%, 80%, 29%, 1% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,23,21-24
DRAMP21020,RIGSILGALAKGLPTLKSWIKNR,23,"A (A1R, I17K) (Derived from AR-23)  ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=25 μM)","[Ref.27271216] 2% hemolysis at 20 μM , 5% hemolysis at 40 μM , 10% hemolysis at  60 μM , 20% hemolysis at 80 μM , 30% hemolysis at 100 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 95%, 92%, 60%, 33% and 24% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji","Design of an Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",23,21-24
DRAMP21021,AIGSILGRLAKGLPTLKSWIKNR,23,"A (A8R, I17K) (Derived from AR-23)  ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=25 μM), Klebsiella pneumoniae (MIC=25 μM)","[Ref.27271216] 2% hemolysis at 20 [Ref.27271216] 2% hemolysis at 20 μM , 5% hemolysis at 40 μM , 10% hemolysis at  60 μM , 20% hemolysis at 80 μM , 30% hemolysis at 100 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 100%, 99%, 92%, 64% and 21.1% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,23,21-24
DRAMP21022,RIGSILGRLAKGLPTLKSWIKNR,23,"A (A1R, A8R, I17K) (Derived from AR-23)  ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)","[Ref.27271216] 0% hemolysis at 40 μM , 1% hemolysis at 60 μM , 2% hemolysis at  80 μM , 2% hemolysis at 100 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 96%, 95%, 92%, 68% and 31.4% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,23,21-24
DRAMP21023,RIGSILGRLAKGLPTLRSWIKNR,23,"A (A1R, A8R, I17R) (Derived from AR-23) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)","[Ref.27271216] 4% hemolysis at 40 μM , 10% hemolysis at 60 μM , 15% hemolysis at 80 μM , 20% hemolysis at 100 μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.27271216] In L929 cells, the cell viability is 92%, 92%, 80%, 60% and 12% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM ",Not found,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,23,21-24
DRAMP21024,FFSLIPSLVGGLISAFK,17,"Stigmurin (Tityus, Scorpionida, Arachnida)",No entry found,Not found,Not found,Scorpion Tityus stigmurus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei","[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=9.4 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=9.4 μM), Enterococcus faecalis (ATCC 4028)(MIC>150 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC>150 μM), Escherichia coli (ATCC 25922)(MIC>150 μM), Enterobacter cloacae (ATCC 13047)(MIC>150 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=37.5 μM), Candida glabrata (ATCC 90030)(MIC>150 μM), Candida krusei (ATCC 6258)(MIC>150 μM)","[Ref.30709056] 7% hemolysis at 1.2 μg/ml , 4% hemolysis at 2.3 μg/ml , 2% hemolysis at 4.7 μg/ml , 0% hemolysis at 9.4 μg/ml , 3% hemolysis at 18.8 μg/ml , 2% hemolysis at 37.5 μg/ml , 3% hemolysis at 75 μg/ml , 5% hemolysis at 150 μg/ml against human red blood cells",Linear,Free,Amidation,,L,[Ref.30709056] No cytotoxicity information found.,Not found,30709056,Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.,"Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa",Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin,17,15-18
DRAMP21025,FFSLIPSLVKKLIKAFK,17,StigA25 (Derived from Stigmurin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei","[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=1.2 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=2.3 μM), Enterococcus faecalis (ATCC 4028)(MIC=4.7 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC=4.7 μM), Escherichia coli (ATCC 25922)(MIC=2.3 μM), Enterobacter cloacae (ATCC 13047)(MIC=18.8 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=9.4 μM), Candida glabrata (ATCC 90030)(MIC=9.4 μM), Candida krusei (ATCC 6258)(MIC=9.4 μM)","[Ref.30709056] 1% hemolysis at 1.2 μg/ml , 5% hemolysis at 2.3 μg/ml , 9% hemolysis at 4.7 μg/ml , 19% hemolysis at 9.4 μg/ml , 33% hemolysis at 18.8 μg/ml , 60% hemolysis at 37.5 μg/ml , 78% hemolysis at 75 μg/ml , 93% hemolysis at 150 μg/ml against human red blood cells",Linear,Free,Amidation,,L,[Ref.30709056] No cytotoxicity information found.,Not found,30709056,Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.,"Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa",Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin,17,15-18
DRAMP21026,FFKLIPKLVKKLIKAFK,17,StigA31 (Derived from Stigmurin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei","[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=2.3 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=2.3 μM), Enterococcus faecalis (ATCC 4028)(MIC=1.2 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC=2.3 μM), Escherichia coli (ATCC 25922)(MIC=1.2 μM), Enterobacter cloacae (ATCC 13047)(MIC=4.7 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=4.7 μM), Candida glabrata (ATCC 90030)(MIC=4.7 μM), Candida krusei (ATCC 6258)(MIC=4.7 μM)","[Ref.30709056] 1% hemolysis at 1.2 μg/ml , 6% hemolysis at 2.3 μg/ml , 10% hemolysis at 4.7 μg/ml , 12 % hemolysis at 9.4 μg/ml , 23% hemolysis at 18.8 μg/ml , 45% hemolysis at 37.5 μg/ml , 65% hemolysis at 75 μg/ml , 70% hemolysis at 150 μg/ml against human red blood cells",Linear,Free,Amidation,,L,[Ref.30709056] No cytotoxicity information found.,Not found,30709056,Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.,"Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa",Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin,17,15-18
DRAMP21027,ALWKKILKNAGKAALNKINQIVQ,23,"K5, 17-DPS3 (Derived from dermaseptin-PS3 (DPS3))",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix","These three peptides existed in random coils in aqueous solution, they all adopted ",,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans",[Ref.30087268]Gram-positive bacteria : Staphylococcuss aureus (NCTC 10788)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (NCTC 10418)(MIC=8 μM);##Fungi : Candida albicans (NCYC 1467)(MIC=4 μM),"[Ref.30087268] 8% hemolysis at 0 μM , 40% hemolysis at 1 μM , 90% hemolysis at 2 μM against horse red blood cells",Linear,Free,Amidation,,L,[Ref.30087268] IC50 = 18.20 μM for H157. ##IC50 = 18.20 μM for PC3. ##IC50 = 132.10 μM for HMEC-1,Not found,30087268,Toxins (Basel). 2018 Aug 7;10(8). pii: E320. doi: 10.3390/toxins10080320.,"Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen","Biological Activities of Cationicity-Enhanced and Hydrophobicity-Optimized Analogues of an Antimicrobial Peptide, Dermaseptin-PS3, from the Skin Secretion of Phyllomedusa sauvagii",23,21-24
DRAMP21028,ALWKDILKNLLKAALNEINQIVQ,23,"L10, 11-DPS3 (Derived from dermaseptin-PS3 (DPS3))",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix","These three peptides existed in random coils in aqueous solution, they all adopted ",,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans",[Ref.30087268]Gram-positive bacteria : Staphylococcuss aureus (NCTC 10788)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (NCTC 10418)(MIC=16 μM);##Fungi : Candida albicans (NCYC 1467)(MIC=16 μM),"[Ref.30087268] 20% hemolysis at 0 μM , 70% hemolysis at 1 μM , 95% hemolysis at 2 μM against horse red blood cells",Linear,Free,Amidation,,L,[Ref.30087268] IC50 = 0.12 μM for H157. ##IC50 = 1.85 μM for PC3. ##IC50 = 8.76 μM for HMEC-1,Not found,30087268,Toxins (Basel). 2018 Aug 7;10(8). pii: E320. doi: 10.3390/toxins10080320.,"Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen","Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen",23,21-24
DRAMP21035,KAAKAAKKAAKAAWK,15,AC-UM-14W (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26235946]Gram-positive bacteria : Bacillus subtilis (MIC>200 μg/ml), Staphylococcus aureus (MIC>200 μg/ml), Staphylococcus epidermis (MIC>200 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC>200 μg/ml), Shigella dysentariae (MIC>200 μg/ml), Salmonella typhimurium (MIC>200 μg/ml), Klebsiella pneumonia (MIC>200 μg/ml), Pseudomonas aeruginosa (MIC>200 μg/ml)","[Ref.26235946] <1% hemolysis at 12.5 μM , <1% hemolysis at 25 μM against human red blood cells",Linear,Acylation (Conjugated with acetyl group),Amidation,,L,[Ref.26235946] No cytotoxic information found.,Not found,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053.,"Thuy T. T. Dinh , Do-Hee Kim , Huy X. Luong  , Bong-Jin Lee , Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,15,12-15
DRAMP21036,RWKIFKKIPKFLHSAKKF,18,PapMA (Derived from Papiliocin and Magainin 2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,PapMA and PapMA-k exhibited α-helical structures in 50 mM DPC micelles and 50% TFE/H2O but displayed unordered structures in aqueous solution.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26053120] Gram-positive bacteria : Bacillus subtilis(MIC=4.0 μM), Enterococcus faecalis(MIC=16 μM), Staphylococcus aureus(MIC=4.0 μM), ;##Gram-negative bacteria : Escherichia coli(MIC=2.0 μM), Pseudomonas aeruginosa(MIC=4.0 μM), Salmonella typhimurium(MIC=4.0 μM)",[Ref.26053120] MHC=100 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26053120] IC50 = 10 μM against mouse macrophage-derived RAW264.7 cells. ##IC50 = 9 μM for NIH3T3 fibroblasts.,Not found,26053120,Biochemistry. 2015 Jun 30;54(25):3921-31. doi: 10.1021/acs.biochem.5b00392.,"Areum Shin, Eunjung Lee,  Dasom Jeon, Young-Guen Park, Jeong Kyu Bang, Yong-Sun Park, Song Yub Shin, and Yangmee Kim",Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity,18,15-18
DRAMP21037,RWKIFKKIkKFLHSAKKF,18,PapMA-k (Derived from Papiliocin and Magainin 2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,PapMA and PapMA-k exhibited α-helical structures in 50 mM DPC micelles and 50% TFE/H3O but displayed unordered structures in aqueous solution.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26053120] Gram-positive bacteria : Bacillus subtilis(MIC=4.0 μM), Enterococcus faecalis(MIC=16 μM), Staphylococcus aureus(MIC=4.0 μM), ;##Gram-negative bacteria : Escherichia coli(MIC=2.0 μM), Pseudomonas aeruginosa(MIC=4.0 μM), Salmonella typhimurium(MIC=2.0 μM)",[Ref.26053120] MHC=200 μM against human red blood cells,Linear,Free,Amidation,The 'k'  in sequence is lysine peptoid,L,[Ref.26053120] IC50 = 42 μM against mouse macrophage-derived RAW264.7 cells. ##IC50 = 39 μM for NIH3T3 fibroblasts.,Not found,26053120,Biochemistry. 2015 Jun 30;54(25):3921-31. doi: 10.1021/acs.biochem.5b00392.,"Areum Shin, Eunjung Lee,  Dasom Jeon, Young-Guen Park, Jeong Kyu Bang, Yong-Sun Park, Song Yub Shin, and Yangmee Kim",Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity,18,15-18
DRAMP21038,WGRRGWGPGRRYVRN,15,analog 1 (Derived from  Ib-AMP1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, beta turn"," In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190-200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles",,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=16 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM) ",[Ref.19778562] MHC>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.19778562] No cytotoxicity information found.,Not found,19778562,Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.,"Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin",Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1,15,12-15
DRAMP21039,WGRRGWGpGRRYVRN,15,analog 2 (Derived from  Ib-AMP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, beta turn"," In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190-200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles",,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 ,[Ref.19778562] MHC>400 ,Linear,Free,Amidation,,Mixed(D-Pro8),[Ref.19778562] No cytotoxicity information found.,Not found,19778562,Peptides.?2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.,"Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin",Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1,15,12-15
DRAMP21040,WGRRGWGaGRRYVRW,15,analog 3 (Derived from  Ib-AMP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, beta turn"," In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190–200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles",,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=16 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM) ",[Ref.19778562] MHC>400 [Ref.19778562] MHC>400 μM against human red blood cells,Linear,Free,Amidation,The 'a' in sequence is Ala peptoid residue (Nala) (CH3–NH–CH2–COOH),L,[Ref.19778562] No cytotoxicity information found.,Not found,19778562,Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.,"Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin",Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1,15,12-15
DRAMP21041,WGRRGWGkGRRYVRW,15,analog 4 (Derived from  Ib-AMP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, beta turn"," In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190–200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles",,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM)",[Ref.19778562] MHC>400 μM against human red blood cells,Linear,Free,Amidation,The 'k' in sequence is Lys peptoid residue (Nlys) (NH2–CH2–CH2–CH2–CH2–NH–CH2–COOH).,L,[Ref.19778562] No cytotoxicity information found.,Not found,19778562,Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.,"Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin",Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1,15,12-15
DRAMP21048,GLLWKWGWKWKEFLRIVGY,19,peptide 6 (Derived from seq2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28236791] Gram-positive bacteria : Staphylococcus aureus(MIC>1024 μg/ml);##Gram-negative bacteria : Pseudomonas aeruginosa(MIC>1024 μg/ml),[Ref.28236791] 51.36% hemolysis at 128 μg/ml,Linear,Free,Amidation,,L,[Ref.28236791] No cytotoxicity information found.,Not found,28236791,Colloids Surf B Biointerfaces. 2017 May 1;153:152-159. doi: 10.1016/j.colsurfb.2017.02.003.,"P. Maturanaa, M. Martinez , M.E. Noguerac, N.C. Santos , E.A. Disalvoa, L. Semorile , P.C. Maffia , A. Hollmann",Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity,19,18-21
DRAMP21049,GLLRKWGKKWKEFLRRVWK,19,peptide 6.2 (Derived from seq2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,The spectra obtained confirmed an alpha-helix conversion in the presence of negatively charged micelles.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28236791] Gram-positive bacteria : Staphylococcus aureus(MIC=32 μg/ml);##Gram-negative bacteria : Pseudomonas aeruginosa(MIC=32 μg/ml),[Ref.28236791] 34.46% hemolysis at 128 μg/ml,Linear,Free,Amidation,,L,[Ref.28236791] No cytotoxicity information found.,Not found,28236791,Colloids Surf B Biointerfaces. 2017 May 1;153:152-159. doi: 10.1016/j.colsurfb.2017.02.003.,"P. Maturanaa, M. Martinez , M.E. Noguerac, N.C. Santos , E.A. Disalvoa, L. Semorile , P.C. Maffia , A. Hollmann",Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity,19,18-21
DRAMP21050,AWCFRVCYRGICYRRCR,17,TP1[K1A] (Derived from TP1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.125 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.125 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=2 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=2.1 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1,17,15-18
DRAMP21051,KACFRVCYRGICYRRCR,17,TP1[W2A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=8 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-2,17,15-18
DRAMP21052,KWAFRVCYRGICYRRSR,17,"TP1[C3A, C16S] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC>16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=8 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),Disulfide bond between Cys7 and Cys12.,L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-3,17,15-18
DRAMP21053,KWCARVCYRGICYRRCR,17,TP1[F4A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=40 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-4,17,15-18
DRAMP21054,KWCFAVCYRGICYRRCR,17,TP1[R5A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.06 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=2 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-5,17,15-18
DRAMP21055,KWCFRACYRGICYRRCR,17,TP1[V6A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=1.2 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-6,17,15-18
DRAMP21056,KWCFRVAYRGISYRRCR,17,"TP1[C7A, C12S] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 [Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=1 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),Disulfide bond between Cys3 and Cys16.,L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-7,17,15-18
DRAMP21057,KWCFRVCARGICYRRCR,17,TP1[Y8A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=0.125 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=1 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC= μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=8 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bond between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-8,17,15-18
DRAMP21058,KWCFRVCYAGICYRRCR,17,TP1[R9A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=1 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.125 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=2 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.06 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=1 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=2 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-9,17,15-18
DRAMP21059,KWCFRVCYRAICYRRCR,17,TP1[G10A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.6 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.6 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.06 μg/ml)",[Ref.28960954] MHC10=0.5 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-10,17,15-18
DRAMP21060,KWCFRVCYRGACYRRCR,17,TP1[I11A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=1 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=32 μg/ml against human red blood cells,Cyclic,Free,Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-11,17,15-18
DRAMP21061,KWCFRVSYRGIAYRRCR,17,"TP1[C7S, C12A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=1 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=8 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=0.6 μg/ml against human red blood cells,Cyclic,Free,Amidation,Disulfide bond between Cys3 and Cys16.,L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-12,17,15-18
DRAMP21062,KWCFRVCYRGICARRCR,17,TP1[Y13A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.06 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=1 [Ref.28960954] MHC10=1 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bond between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-13,17,15-18
DRAMP21063,KWCFRVCYRGICYARCR,17,TP1[R14A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=1 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.125 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.25 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=0.5 [Ref.28960954] MHC10=0.5 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-14,17,15-18
DRAMP21064,KWCFRVCYRGICYRACR,17,TP1[R15A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=0.45 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-15,17,15-18
DRAMP21065,KWSFRVCYRGICYRRAR,17,"TP1[C3S, C16A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=3 μg/ml against human red blood cells,Cyclic,Free,Amidation,Disulfide bond between Cys7 and Cys12.,L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-16,17,15-18
DRAMP21066,KWCFRVCYRGICYRRCA,17,TP1[R17A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.015 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.015 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=0.45 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-17,17,15-18
DRAMP21067,KWAFRVCYRGICYRRAR,17,"TP1[C3A, C16A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=8 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=40 μg/ml against human red blood cells,Cyclic,Free,Amidation,Disulfide bond between Cys7 and Cys12.,L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-18,17,15-18
DRAMP21068,KWCFRVAYRGIAYRRCR,17,"TP1[C7A, C12A] (Derived from TP1)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=8 μg/ml against human red blood cells,Cyclic,Free,Amidation,Disulfide bond between Cys3 and Cys16.,L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-19,17,15-18
DRAMP21069,KWAFRVAYRGIAYRRAR,17,"TP1[C3A, C7A, C12A, C16A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=1 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=4 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=4 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=0.24 μg/ml against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-20,17,15-18
DRAMP21070,KWCFRRCYAGICYRRCR,17,"TP1[V6R, R9A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=11 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-21,17,15-18
DRAMP21071,RWCFRVCYRGICYRRCR,17,TP1[K1R] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=1 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=1 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-22,17,15-18
DRAMP21072,KWCGRVCYRGICYRRCR,17,TP1[F4G] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=2 μg/ml)",[Ref.28960954] MHC10=0.47 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-23,17,15-18
DRAMP21073,KWCSRVCYRGICYRRCR,17,TP1[F4S] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=4 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=0.23 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-24,17,15-18
DRAMP21074,KWCFRVCGRGICYRRCR,17,TP1[Y8G] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=8 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=0.4 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-25,17,15-18
DRAMP21075,KWCFRVCYRGGCYRRCR,17,TP1[I11G] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 [Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-26,17,15-18
DRAMP21076,KWCARVCARGACYRRCR,17,"TP1[F4A, Y8A, I11A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC>16 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC>16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC>16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC>16 μg/ml)",[Ref.28960954] MHC10=0.9 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-27,17,15-18
DRAMP21077,KWCFVCYRGICYRRCG,16,"TP1[-R5, R17G] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=1 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC>16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=0.3 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-28,16,15-18
DRAMP21078,AWCARVCYRGICYRRCR,17,"TP1[K1A, F4A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=16 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=4 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=2 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=8 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC>16 μg/ml)",[Ref.28960954] MHC10=32 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-29,17,15-18
DRAMP21079,AWCFRVCARGICYRRCR,17,"TP1[K1A, Y8A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=2 μg/ml)",[Ref.28960954] MHC10=0.4 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-30,17,15-18
DRAMP21080,AWCFRVCYRGACYRRCR,17,"TP1[K1A, I11A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-31,17,15-18
DRAMP21081,KWCFRVCYAGICYRRCA,17,"TP1[R9A, R17A] (Derived from TP1)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.06 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",L,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Not found,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-32,17,15-18
DRAMP21082,KWCFCVCYRGICRCRCRG,18,ccTP 3 (Derived from TP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Beta tile,Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by ,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis","[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.3 μM(low-salt);MIC=0.9 μM(high-salt)), Micrococcus luteus(MIC=0.5 μM(low-salt);MIC=0.5 μM(high-salt)), Enterococcus faecalis(MIC=1.9 μM(low-salt);MIC=1.3 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=10.4 μM(low-salt);MIC=0.9 μM(high-salt)), Pseudomonas aeruginosa(MIC=6.2 μM(low-salt);MIC=10.4 μM(high-salt)), Primula vulgaris(MIC=16.4 μM(low-salt);MIC=28.9 μM(high-salt)), Klebsiella oxytoca(MIC=4.0 μM(low-salt);MIC=7.6 μM(high-salt));##Fungi : Candida albicans(MIC=24.2 μM(low-salt);MIC=30.2 μM(high-salt)), Candida kefyr(MIC=1.1 μM(low-salt);MIC=4.3 μM(high-salt)), Candida tropicalis(MIC=12.4 μM(low-salt);MIC=3.9 μM(high-salt))",[Ref.10673369] EC25=590 μM against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.",L,[Ref.10673369] No cytotoxicity information found.,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"James P. Tam, Yi-An Lu, and Jin-Long Yang",Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework,18,15-18
DRAMP21083,KWCRCVCRRGICRCFCRG,18,ccTP 5 (Derived from TP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Beta tile,Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by ,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis","[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.7 μM(low-salt);MIC=1.3 μM(high-salt)), Micrococcus luteus(MIC=0.5 μM(low-salt);MIC=0.8 μM(high-salt)), Enterococcus faecalis(MIC=0.7 μM(low-salt);MIC=0.5 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=5.5 μM(low-salt);MIC=1.2 μM(high-salt)), Pseudomonas aeruginosa(MIC=3.9 μM(low-salt);MIC=4.7 μM(high-salt)), Primula vulgaris(MIC=16.8 μM(low-salt);MIC=55.6 μM(high-salt)), Klebsiella oxytoca(MIC=2.4 μM(low-salt);MIC=5.4 μM(high-salt));##Fungi : Candida albicans(MIC=7.1 μM(low-salt);MIC=5.1 μM(high-salt)), Candida kefyr(MIC=4.2 μM(low-salt);MIC=0.7 μM(high-salt)), Candida tropicalis(MIC=1.9 μM(low-salt);MIC=4.8 μM(high-salt))",[Ref.10673369] EC25=920 μM against human red blood cells,Cyclic,Free,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.",L,[Ref.10673369] No cytotoxicity information found.,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"James P. Tam, Yi-An Lu, and Jin-Long Yang",Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework,18,15-18
DRAMP21084,GWCRCVCRRGICRCFCRK,18,ccTP 6 (Derived from TP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Beta tile,Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by ,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis","[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.7 μM(low-salt);MIC=0.7 μM(high-salt)), Micrococcus luteus(MIC=0.3 μM(low-salt);MIC=0.4 μM(high-salt)), Enterococcus faecalis(MIC=1.4 μM(low-salt);MIC=1.2 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=6.1 μM(low-salt);MIC=1.2 μM(high-salt)), Pseudomonas aeruginosa(MIC=2.0 μM(low-salt);MIC=4.7 μM(high-salt)), Primula vulgaris(MIC=17.0 μM(low-salt);MIC=39.8 μM(high-salt)), Klebsiella oxytoca(MIC=4.1 μM(low-salt);MIC=4.1 μM(high-salt));##Fungi : Candida albicans(MIC=10.5 μM(low-salt);MIC=5.2 μM(high-salt)), Candida kefyr(MIC=1.1 μM(low-salt);MIC=0.7 μM(high-salt)), Candida tropicalis(MIC=2.3 μM(low-salt);MIC=1.9 μM(high-salt))",[Ref.10673369] EC25=3900 μM against human red blood cells,Cyclic,Free,Amidation (Gly18),"Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.",L,No cytotoxicity information found,Not found,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"James P. Tam, Yi-An Lu, and Jin-Long Yang",Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework,18,15-18
DRAMP21085,RFRRLRWKTRWRLKKI,16,PRW4 (PR) (Derived from PMAP-36),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta Sheet",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=73.6 mg/L), Staphylococcus aureus 29213(MIC=9.2 mg/L), Staphylococcus epidermidis 12228(MIC=18.4 mg/L), Enterococcus faecalis 29212(MIC=9.2 mg/L), Bacillus subtilis 11060(MIC=18.4 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=9.2 mg/L), Escherichia coli K88(MIC=9.2 mg/L), Escherichia coli ER2566(MIC=18.4 mg/L), Escherichia coli 44102(MIC=18.4 mg/L), Escherichia coli 1515(MIC=9.2 mg/L), Escherichia coli 25922(MIC=9.2 mg/L), Escherichia coli UB1005(MIC=9.2 mg/L), Salmonella typhimurium 7731(MIC=18.4 mg/L), Salmonella typhimurium 1402(MIC=18.4 mg/L), Pseudomonas aeruginosa 21625(MIC=73.6 mg/L), Pseudomonas aeruginosa 21630(MIC=36.8 mg/L), Pseudomonas aeruginosa 10419(MIC=36.8 mg/L), Pseudomonas aeruginosa 27853(MIC>294.3 mg/L), Salmonella pullorum 7913(MIC>294.3 mg/L)",[Ref.25818457] 0 % hemolysis at 294.3 mg/L against human red blood cells,Linear,Free,Amidation,,L,"[Ref.25818457] The cell viability of PRW4 is 100%, 96%, 92%, 86%, 85%, 83%, 82%, 80% and 80% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml",Not found,25818457,Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.,"Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi","Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles",16,15-18
DRAMP21088,RFRRLRWKTRWRLKKIWWPFLRR,23,PR-TR (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta Sheet",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=26.7 mg/L), Staphylococcus aureus 29213(MIC=6.7 mg/L), Staphylococcus epidermidis 12228(MIC=13.4 mg/L), Enterococcus faecalis 29212(MIC=3.3 mg/L), Bacillus subtilis 11060(MIC=3.3 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=13.4 mg/L), Escherichia coli K88(MIC=1.7 mg/L), Escherichia coli ER2566(MIC=3.3 mg/L), Escherichia coli 44102(MIC=6.7 mg/L), Escherichia coli 1515(MIC=1.7 mg/L), Escherichia coli 25922(MIC=6.7 mg/L), Escherichia coli UB1005(MIC=3.3 mg/L), Salmonella typhimurium 7731(MIC=6.7 mg/L), Salmonella typhimurium 1402(MIC=13.4 mg/L), Pseudomonas aeruginosa 21625(MIC=6.7 mg/L), Pseudomonas aeruginosa 21630(MIC=13.4 mg/L), Pseudomonas aeruginosa 10419(MIC=6.7 mg/L), Pseudomonas aeruginosa 27853(MIC=13.4 mg/L), Salmonella pullorum 7913(MIC=13.4 mg/L)","[Ref.25818457] 0% hemolysis at 9.2 mg/L , 1% hemolysis at 18.4 mg/L , 4% hemolysis at 36.8mg/L  , 10% hemolysis at 73.6 mg/L , 17% hemolysis at 147.1 mg/L , 22% hemolysis at 294.3 mg/L against human red blood cells",Linear,Free,Amidation,,L,"[Ref.25818457] The cell viability of PR-TR is 94%, 89%, 83%, 77%, 74%, 71%, 68%, 66% and 60% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml",Not found,25818457,Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.,"Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi","Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles",23,21-24
DRAMP21089,RFRRLRCKTRCRLKKI,16,C4 (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=2 μM), Escherichia coli 1005(MIC>128 μM), Salmonella typhimurium 7731(MIC128 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Not found,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,16,15-18
DRAMP21090,RFRRLRDKTRDRLKKI,16,D4 (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC>128 μM), Escherichia coli 1005(MIC>128 μM), Salmonella typhimurium 7731(MIC>128 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Not found,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,16,15-18
DRAMP21091,RFRRLRIKTRIRLKKI,16,I4 (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=64 μM), Staphylococcus epidermidis 12228(MIC=16 μM), Enterococcus faecalis 29212(MIC=16 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=8 μM), Escherichia coli 1005(MIC=16 μM), Salmonella typhimurium 7731(MIC=16 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Not found,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,16,15-18
DRAMP21092,RFRRLRPKTRPRLKKI,16,P4 (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=32 μM), Escherichia coli 1005(MIC=32 μM), Salmonella typhimurium 7731(MIC=32 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Not found,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,16,15-18
DRAMP21093,RFRRLRwKTRwRLKKI,16,PRW4-d (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=8 μM), Staphylococcus epidermidis 12228(MIC=16 μM), Enterococcus faecalis 29212(MIC=4 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=4 μM), Escherichia coli 1005(MIC=8 μM), Salmonella typhimurium 7731(MIC=4 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,Linear,Free,Amidation,,"Mixed(D-Trp7, D-Trp11)",[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Not found,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,16,15-18
DRAMP21094,RFRRLRWRTRWRLRRI,16,PRW4-R (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=4 μM), Staphylococcus epidermidis 12228(MIC=4 μM), Enterococcus faecalis 29212(MIC=2 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=4 μM), Escherichia coli 1005(MIC=2 μM), Salmonella typhimurium 7731(MIC=4 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Not found,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,16,15-18
DRAMP21165,GIMSSLMKKLKKIIKK,16,HYL-11 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=54 μM), Staphylococcus epidermidis(MIC=1.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=22 μM), Pseudomonas aeruginosa 5482(MIC=7.1 μM);##Fungi : Candida albicans(MIC=6.3 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21166,GILSSLLKKLKKIIAK,16,HYL-12 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=16 μM), Staphylococcus epidermidis(MIC=1.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=10 μM)",[Ref.26998557] LC50=284 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21164,GIMSSLMKKLAKIIKK,16,HYL-10 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=33 μM), Staphylococcus epidermidis(MIC=2.9 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=5.2 μM);##Fungi : Candida albicans(MIC=7.6 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21158,GIMSSLMKKLKKHIAK,16,HYL-4 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC=10 μM);##Gram-negative bacteria : Escherichia coli(MIC=26 μM), Pseudomonas aeruginosa 5482(MIC=6.4 μM);##Fungi : Candida albicans(MIC=12 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21159,GIMISLMKKLAAHIAK,16,HYL-5 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=43 μM), Staphylococcus epidermidis(MIC=8.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=12 μM), Pseudomonas aeruginosa 5482(MIC=47 μM);##Fungi : Candida albicans(MIC=12 μM)",[Ref.26998557] LC50=320 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21160,GIMSSLMKKLAAIIAK,16,HYL-6 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=7.2 μM), Staphylococcus epidermidis(MIC=5 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.6 μM), Pseudomonas aeruginosa 5482(MIC=8 μM);##Fungi : Candida albicans(MIC=8.4 μM)",[Ref.26998557] LC50=93 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21161,GIMSSLMKKLAKIIAK,16,HYL-7 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=9 μM), Staphylococcus epidermidis(MIC=5 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.7 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=11 μM)",[Ref.26998557] LC50=88 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21162,GIMSSLMKKLKKIIAK,16,HYL-8 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=32 μM), Staphylococcus epidermidis(MIC=1.9 μM);##Gram-negative bacteria : Escherichia coli(MIC=9 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=5.2 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21163,gimsslmkklkkiiak,16,HYL-9 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=13 μM), Staphylococcus epidermidis(MIC=2.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=6.3 μM), Pseudomonas aeruginosa 5482(MIC=3.2 μM);##Fungi : Candida albicans(MIC=8 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,D,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21157,GIMSSLMKKLAAHIKK,16,HYL-3 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=85 μM), Staphylococcus epidermidis(MIC=11 μM);##Gram-negative bacteria : Escherichia coli(MIC=20 μM), Pseudomonas aeruginosa 5482(MIC=23 μM);##Fungi : Candida albicans(MIC=5 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21156,GIMSSLMKKLAKHIAK,16,HYL-2 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=63 μM), Staphylococcus epidermidis(MIC=6.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=7.9 μM);##Fungi : Candida albicans(MIC=14 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21155,GIMSSLMKKLKAHIAK,16,HYL-1 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(MIC=30 μM), Pseudomonas aeruginosa 5482(MIC=26 μM);##Fungi : Candida albicans(MIC=23 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21154,GIMSSLMKKLAAHIAK,16,"HYL (Bee, Insecta, Animals)",No entry found,Not found,Not found,Solitary wild bee Hylaeus signatus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=63 μM), Staphylococcus epidermidis(MIC=13 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=20 μM);##Fungi : Candida albicans(MIC=18 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21142,HKCAKIKWRGVHVKYCA,17,AMP2041 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta sheet, beta turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=3.71 μg/ml, 1.83 μM), MRSA(MBC=2.25 μg/ml, 1.11 μM), Streptococcus agalactiae(MBC>100 μg/ml, 55 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=4.35 μg/ml, 2.14 μM), Escherichia coli(MBC=1.79 μg/ml, 0.88 μM), Salmonella enteritidis(MBC=10.41 μg/ml, 5.13 μM), Stenotrophomonas maltophilia(MBC=7.00 μg/ml, 3.45 μM)","[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 5.73% hemolysis at 100 μg/ml , 6.4% hemolysis at 250 μg/ml , 9.4% hemolysis at 500 μg/ml against sheep red blood cells",Linear,Free,Free,,L,[Ref.23893489] The cytotoxicity (vs control) of P2041 is 6% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P2041 is 3% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/m,Not found,23893489,J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.,"Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS",In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,17,15-18
DRAMP21141,KWCRKWQWRGVKFIKCV,17,AMP126 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta sheet, beta turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=46.5 μg/ml, 20.65 μM), MRSA(MBC>100 μg/ml, 55 μM), Streptococcus agalactiae(MBC=2.81 μg/ml, 1.24 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=0.40 μg/ml, 0.17 μM), Escherichia coli(MBC=2.22 μg/ml, 0.98 μM), Salmonella enteritidis(MBC=10.8 μg/ml, 4.80 μM), Stenotrophomonas maltophilia(MBC=16.6 μg/ml, 7.37 μM)","[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 5.30% hemolysis at 100 μg/ml , 6.9% hemolysis at 250 μg/ml , 12.5% hemolysis at 500 μg/ml against sheep red blood cells",Linear,Free,Free,,L,[Ref.23893489] The cytotoxicity (vs control) of P126 is 5% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P126 is 6% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/ml.,Not found,23893489,J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.,"Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS",In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,17,15-18
DRAMP21140,KGCALVKVRGLTLKVCK,17,AMP72 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta sheet, beta turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=6.88 μg/ml, 3.78 μM), MRSA(MBC=1.72 μg/ml, 0.94 μM), Streptococcus agalactiae(MBC>55 μg/ml, 100 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=3.30 μg/ml, 1.81 μM), Escherichia coli(MBC=3.40 μg/ml, 1.87 μM), Salmonella enteritidis(MBC=3.20 μg/ml, 1.76 μM), Stenotrophomonas maltophilia(MBC=18.5 μg/ml, 10.19 μM)","[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 1.5% hemolysis at 100 μg/ml , 4.2% hemolysis at 250 μg/ml , 12.0% hemolysis at 500 μg/ml against sheep red blood cells",Linear,Free,Free,,L,[Ref.23893489] The cytotoxicity (vs control) of P72 is 3% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P72 is 4% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/ml. #,Not found,23893489,J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.,"Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS",In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,17,15-18
DRAMP21139,RLLRPLLQLLKQKLR,15,GNU7 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae","[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=2 mg/L), Enterococcus faecalis(MIC=2 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=2 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=2 mg/L), Pseudomonas aeruginosa(MIC=2 mg/L), Salmonella typhimurium(MIC=2 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=4 mg/L)",[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells,Linear,Free,Free,,L,"[Ref.23946320] The cell viability of hPBMCs is at peptide concentrations of 4, 8, 16, 32, 64 μg/ml",Not found,23946320,J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.,"Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho",De novo generation of short antimicrobial peptides with enhanced stability and cell specificity,15,12-15
DRAMP21138,RIIRPIIQIIKQKIR,15,GNU6 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae","[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=2 mg/L), Enterococcus faecalis(MIC=2 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=2 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=4 mg/L), Pseudomonas aeruginosa(MIC=2 mg/L), Salmonella typhimurium(MIC=4 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=4 mg/L)",[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells,Linear,Free,Free,,L,"[Ref.23946320] The cell viability of hPBMCs is 102.6%, 102.6%, 107.9%, 96.8% and 97.9% at peptide concentrations of 4, 8, 16, 32, 64 μg/ml",Not found,23946320,J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.,"Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho",De novo generation of short antimicrobial peptides with enhanced stability and cell specificity,15,12-15
DRAMP21137,RVVRPVVQVVKQKVR,15,GNU5 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae","[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=16 mg/L), Enterococcus faecalis(MIC=8 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=4 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=32 mg/L), Pseudomonas aeruginosa(MIC=8 mg/L), Salmonella typhimurium(MIC>64 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=2 mg/L)",[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells,Linear,Free,Free,,L,"[Ref.23946320] The cell viability of hPBMCs is at peptide concentrations of 4, 8, 16, 32, 64 μg/ml",Not found,23946320,J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.,"Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho",De novo generation of short antimicrobial peptides with enhanced stability and cell specificity,15,12-15
DRAMP21128,RFRRLRKKFRKRLKKI,16,T9F (Derived from RI16),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=64 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=64 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Not found,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,16,15-18
DRAMP21127,RFRRLRKKKRKRLKKI,16,T9K (Derived from RI16),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=128 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=256 μM), Pseudomonas aeruginosa 27853(MIC=128 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=256 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Not found,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,16,15-18
DRAMP21126,RFRRLRKKIRKRLKKI,16,T9I (Derived from RI16),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=256 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=256 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=64 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Not found,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,16,15-18
DRAMP21125,RFRRLRKKWRKRLKKI,16,T9W (Derived from RI16),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=64 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=64 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=2 μM), Pseudomonas aeruginosa 10419(MIC=4 μM), Pseudomonas aeruginosa 21625(MIC=4 μM), Pseudomonas aeruginosa 21630(MIC=4 μM), Pseudomonas aeruginosa LC(MIC=1 μM), Pseudomonas aeruginosa LCCI(MIC=2 μM), Pseudomonas aeruginosa LCGE(MIC=4 μM), Pseudomonas aeruginosa LCCE(MIC=4 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Not found,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,16,15-18
DRAMP21124,RFRRLRKKTRKRLKKI,16,RI16 (Derived from PMAP-36),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=32 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Not found,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,16,15-18
DRAMP21119,KWCFRVCYRGRCYRRCR,17,I11R (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=1.56 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=6.25 μM)",[Ref.26549611] MHC2=180 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26549611] No cytotoxicity information found.,Not found,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,17,15-18
DRAMP21118,KWCFRVCYRGSCYRRCR,17,I11S (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=0.8 μM), Pseudomonas aeruginosa PAO1(MIC=3.13 μM)",[Ref.26549611] MHC2=190 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.26549611] The cell viability of human embryonic fibroblasts HEF is 90.6%, 92.9%, 84.1%, 70.6% and 34.1% at peptide concentrations of 6.25, 12.5, 25, 50 and 100 μM.",Not found,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,17,15-18
DRAMP21117,KWCFRVCRRGICYRRCR,17,Y8R (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=6.25 μM)",[Ref.26549611] MHC2=195 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26549611] No cytotoxicity information found.,Not found,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,17,15-18
DRAMP21116,KWCFRVCSRGICYRRCR,17,Y8S (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=0.8 μM), Pseudomonas aeruginosa PAO1(MIC=3.13 μM)",[Ref.26549611] MHC2=310 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.26549611] The cell viability of human embryonic fibroblasts HEF is 100%, 92.9%, 87.1%, 72.9%, 60.0% and 45.0% at peptide concentrations of 0, 6.25, 12.5, 25, 50 and 100 μM.",Not found,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,17,15-18
DRAMP21115,KWCFRRCYRGICYRRCR,17,V6R (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC>50 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC>50 μM)",[Ref.26549611] MHC2=200 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26549611] No cytotoxicity information found.,Not found,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,17,15-18
DRAMP21114,KWCFRSCYRGICYRRCR,17,V6S (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=12.5 μM)",[Ref.26549611] MHC2=280 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26549611] No cytotoxicity information found.,Not found,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,17,15-18
DRAMP21109,GIGGALLSAKAALGLAKGLAEHFAN,25,"FPA-Bombinin-BO (toads, amphibians, animals)",No entry found,Not found,Not found,"Asian bombinid toad species, Bombina orientalis","Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.25056849] Gram-positive bacteria : Staphylococcus aureus(MIC=7 μM, MBC=14 μM);##Gram-negative bacteria : Escherichia coli(MIC=14 μM, MBC=14 μM);##Fungi : Candida albicans(MIC=7 μM, MBC=14 μM)",[Ref.25056849] 100% hemolysis at 125 mg/L against horse red blood cells,Linear,Free,Amidation,,L,[Ref.25056849] No cytotoxicity information found,Not found,25056849,Chem Biol Drug Des. 2015 Mar;85(3):259-67. doi: 10.1111/cbdd.12396.,"Xiaojuan Hou, Qiang Du, Renjie Li, Mei Zhou, Hui Wang, Lei Wang, Can Guo, Tianbao Chen and Chris Shaw","Feleucin-BO1: A Novel Antimicrobial Non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3",25,24-27
DRAMP21231,KKKKKKNGFAAWGAFGA,17,S-6K-F17-3GN (Derived from S-6K-F17),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Not found,"Substitutions with polar, known ‘helix-breaker’ Gly residues led to losses in helical character until finally the peptide containing 3 Gly and 1 Asn (S- 6K-F17-3GN) shows a severe loss in helical structure.",,Function: Antibacterial activity against Gram-negative bacteria,[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=4.2 μM),[Ref.29275987] MHC2=587 μM against human red blood cells,Cyclic,Free,Amidation (Ala17),The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.,L,No cytotoxicity information found,Not found,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.,"Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.,17,15-18
DRAMP21230,KKKKKKAGFAAWGAFGA,17,S-6K-F17-3G (Derived from S-6K-F17),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria,[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=4.2 μM),[Ref.29275987] MHC2=128 μM against human red blood cells,Cyclic,Free,Amidation (Ala17),The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.,L,No cytotoxicity information found,Not found,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.,"Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.,17,15-18
DRAMP21229,KKKKKKAGFAAWAAFGA,17,S-6K-F17-2G (Derived from S-6K-F17),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-negative bacteria,[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=1.6 μM),[Ref.29275987] MHC2=15 μM against human red blood cells,Cyclic,Free,Amidation (Ala17),The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.,L,No cytotoxicity information found,Not found,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.,"Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.,17,15-18
DRAMP21211,HLLKRVQRELIRWLDWLK,18,"AmyI-1-18 (N3L, G12R) (Derived from AmyI-1-18)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=2.9±0.2 μM),[Ref.27478151] 14% hemolysis at 50 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151] No cytotoxicity information found,Not found,27478151,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T",Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,18,15-18
DRAMP21208,HLNKRVQRLLIGWLDWLK,18,AmyI-1-18 (E9L) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=3.7±1.5 μM). ,[Ref.27478151] 5% hemolysis at 50 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151] No cytotoxicity information found,Not found,27478151,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T",Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-23 and its amino acid-substituted analogs.,18,15-18
DRAMP21209,HLNKRVQRLLIRWLDWLK,18,"AmyI-1-18 (E9L, G12R) (Derived from AmyI-1-18)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.9±0.5 μM),[Ref.27478151] 9% hemolysis at 50 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151] No cytotoxicity information found,Not found,27478151,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T",Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,18,15-18
DRAMP21205,HLNKRVQRELIRWLDWLK,18,AmyI-1-18 (G12R) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.6±1.1 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=61±8 μM),[Ref.27478151] 2% hemolysis at 50 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151##26850840] No cytotoxicity information found,Not found,27478151##26850840,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22819.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-20 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",18,15-18
DRAMP21210,HLLKRVQRLLIGWLDWLK,18,"AmyI-1-18 (N3L, E9L) (Derived from AmyI-1-18)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.2±0.5 μM),[Ref.27478151] 14% hemolysis at 50 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151] No cytotoxicity information found,Not found,27478151,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T",Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,18,15-18
DRAMP21207,HLLKRVQRELIGWLDWLK,18,AmyI-1-18 (N3L) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=2.5±0.7 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=58±22 μM),[Ref.27478151] 3% hemolysis at 50 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151##26850842] No cytotoxicity information found,Not found,27478151##26850842,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22821.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-22 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",18,15-18
DRAMP21206,HLNKRVQRELIGWLRWLK,18,AmyI-1-18 (D15R) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=11±1 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=31±4 μM),[Ref.27478151] 2% hemolysis at 50 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151##26850841] No cytotoxicity information found,Not found,27478151##26850841,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22820.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-21 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",18,15-18
DRAMP21204,HLNKRVQRELRGWLDWLK,18,AmyI-1-18 (I11R) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=10±2 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=62±2 μM),[Ref.27478151] 1% hemolysis at 50 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151##26850839] No cytotoxicity information found,Not found,27478151##26850839,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22818.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-19 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",18,15-18
DRAMP21203,HLNKRVQRELIGWLDWLK,18,"AmyI-1-18 (Oryza sativa L., Angiospermae, Plants)",P17654,Belongs to the glycosyl hydrolase 13 family.,AMY1.1,Oryza sativa subsp. japonica (Rice),"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Protein level,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity gaginst Candida albicans. Important for breakdown of endosperm starch during germination.,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=13±3 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=64±2 μM),[Ref.27478151] 0.1% hemolysis at 100 μM against human red blood cells,Linear,Free,Free,,L,[Ref.27478151##26850838] No cytotoxicity information found,Not found,27478151##26850838,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22817.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",18,15-18
DRAMP21202,FKKLKKLFKKILKLK,15,HPA3NT3-analog (Derived from HPA3NT3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli","[Ref.19642077] Gram-positive bacteria : Staphylococcus aureus(MIC=8 μM), Bacillus subtilis(MIC=8 μM), Listeria monocytogenes(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM), Salmonella typhimurium(MIC=1 μM), Pseudomonas aeruginosa(MIC=2 μM);##Fungi : Candida albicans(MIC=4-8 μM), Trichosporon beigelli(MIC=1 μM)","[Ref.19642077] 0% hemolysis at 100 μM , 3% hemolysis at 200 μM against human red blood cells",Linear,Free,Amidation,,L,[Ref.19642077] No cytotoxicity information found.,Not found,19642077,J Pept Sci. 2009 Sep;15(9):589-94. doi: 10.1002/psc.1155.,"Gopal R, Park SC, Ha KJ, Cho SJ, Kim SW, Song PI, Nah JW, Park Y, Hahm KS",Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide.,15,12-15
DRAMP21201,GIGKFLHSAKKWGKAFVGEIMNS,23,"Magainin 2a (M2a; Frogs, Amphibians, Animals)",No entry found,Belongs to the gastrin/cholecystokinin family. Magainin subfamily,,From frog,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=128 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=128 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=32 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,23,21-24
DRAMP21200,GYKYINNIIKYINKFFKYIW,20,GW-M4 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=8 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=32 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=4 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21199,GANAAKKFANLIKKIFNYIW,20,GW-M3 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=8 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21198,GANAAKKLATFAKKIFTAYW,20,GW-M1 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=64 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=64 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=32 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=32 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=256 μg/ml)",[Ref.18586467] MHC=64 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21197,GLTFLKKILNFAKKIYTAIW,20,GW-H3 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=8 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=32 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=32 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=64 μg/ml)",[Ref.18586467] MHC=8 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21196,GYNYAKKLANLAKKFANALW,20,GW-H1 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=32 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=16 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=8 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21195,GATYAKKIIKTITKIATTAW,20,GW-A5 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=64 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=32 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21194,GAKALTKAATAFTKFYKTIW,20,GW-A4 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=64 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=64 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21193,GAKYAKIIYNYLKKIANALW,20,GW-A2 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=32 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=128 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=8 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21192,GAKYAKYIYNFYKYIAKYIW,20,GW-A1 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=64 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=64 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=256 μg/ml)",[Ref.18586467] MHC=8 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21191,GIKIAKKAITIAKKIAKIYW,20,GW-Q6 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=32 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=4 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=32 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21190,GANALKKYFTILKKFFKLAW,20,GW-Q5 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=16 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=64 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=8 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)",[Ref.18586467] MHC=4 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21189,GANAAKKFATIAKKFINYLW,20,GW-Q4 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=8 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=8 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=64 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21188,GANLAKKFYTYINKFINYAW,20,GW-Q3 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=256 μg/ml), Streptococcus iniae (laboratory strain)(MIC=256 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=128 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=32 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=64 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,Linear,Free,Free,,L,[Ref.18586467] No cytotoxicity information found.,Not found,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,20,18-21
DRAMP21187,WLRAFRRLVRRLARLLRR,18,WRL4 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=6.65 μM), Staphylococcus aureus 1.160(MIC=1.66 μM), Listeria monocytogenes 21662(MIC=3.32 μM), Listeria monocytogenes 21633(MIC=3.32 μM), Bacillus cereus 63301(MIC=53.18 μM), Micrococcus luteus 28001(MIC=13.29 μM), Bacillus pumilus 63202(MIC=26.59 μM), Pseudomonas fluorescens 21620(MIC=53.18 μM), MRSA 43300(MIC=3.32 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=3.32 μM), Escherichia coli 25922(MIC=13.29 μM), Escherichia coli 35150(MIC=26.59 μM), Salmonella paratyphi-A 20501(MIC=6.65 μM), Salmonella paratyphi paratyphi-B 21495(MIC=3.32 μM), Salmonella paratyphi paratyphi-C 21512(MIC=6.65 μM), Shigella flexneri 51571(MIC=1.66 μM), Salmonella choleraesuis 13312(MIC=13.29 μM), Salmonella typhimurium 51005(MIC>53.18 μM), Salmonella enteritidis 21527(MIC>53.28 μM), Vibrio parahemolyticus 21617(MIC=6.65 μM);##Fungi : Candida albicans 10231(MIC=26.59 μM)",[Ref.28002968] MHC10=53.18 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL4 is 91.27%, 90.42%, 81.13%, 73.24%, 70.14%, 69.30%, 56.62%, 51.27% and 48.25% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,18,15-18
DRAMP21186,WLRAFRRLVRRLARGLRR,18,WRL3 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=0.43 μM), Staphylococcus aureus 1.160(MIC=0.43 μM), Listeria monocytogenes 21662(MIC=0.21 μM), Listeria monocytogenes 21633(MIC=0.21 μM), Bacillus cereus 63301(MIC=0.85 μM), Micrococcus luteus 28001(MIC=0.43 μM), Bacillus pumilus 63202(MIC=0.85 μM), Pseudomonas fluorescens 21620(MIC=0.43 μM), MRSA 43300(MIC=0.85 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=0.85 μM), Escherichia coli 25922(MIC=1.70 μM), Escherichia coli 35150(MIC=1.70 μM), Salmonella paratyphi-A 20501(MIC=0.43 μM), Salmonella paratyphi paratyphi-B 21495(MIC=0.85 μM), Salmonella paratyphi paratyphi-C 21512(MIC=0.43 μM), Shigella flexneri 51571(MIC=0.43 μM), Salmonella choleraesuis 13312(MIC=1.70 μM), Salmonella typhimurium 51005(MIC=6.81 μM), Salmonella enteritidis 21527(MIC=6.81 μM), Vibrio parahemolyticus 21617(MIC=1.70 μM);##Fungi : Candida albicans 10231(MIC=3.40 μM)",[Ref.28002968] MHC10=27.22 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL3 is 98.31%, 95.21%, 92.96%, 90.70%, 89.30%, 89.01%, 76.90%, 48.45% and 40.73% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,18,15-18
DRAMP21185,WGRAFRRLVRRLARGLRR,18,WRL2 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=3.49 μM), Staphylococcus aureus 1.160(MIC=1.74 μM), Listeria monocytogenes 21662(MIC=1.74 μM), Listeria monocytogenes 21633(MIC=1.74 μM), Bacillus cereus 63301(MIC=55.78 μM), Micrococcus luteus 28001(MIC=27.89 μM), Bacillus pumilus 63202(MIC=55.78 μM), Pseudomonas fluorescens 21620(MIC=55.78 μM), MRSA 43300(MIC=6.97 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=6.97 μM), Escherichia coli 25922(MIC=27.89 μM), Escherichia coli 35150(MIC=13.94 μM), Salmonella paratyphi-A 20501(MIC=3.49 μM), Salmonella paratyphi paratyphi-B 21495(MIC=6.97 μM), Salmonella paratyphi paratyphi-C 21512(MIC=3.49 μM), Shigella flexneri 51571(MIC=3.49 μM), Salmonella choleraesuis 13312(MIC=13.94 μM), Salmonella typhimurium 51005(MIC=13.94 μM), Salmonella enteritidis 21527(MIC>55.78 μM), Vibrio parahemolyticus 21617(MIC=13.94 μM);##Fungi : Candida albicans 10231(MIC=13.94 μM)",[Ref.28002968] MHC10>55.78 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL2 is 87.32%, 85.35%, 81.13%, 79.15%, 78.87%, 78.03%, 76.34%, 69.86% and 64.79% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,18,15-18
DRAMP21184,WGRAFRRGVRRLARGGRR,18,WR7 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=14.66 μM), Staphylococcus aureus 1.160(MIC=7.33 μM), Listeria monocytogenes 21662(MIC=7.33 μM), Listeria monocytogenes 21633(MIC=7.33 μM), Bacillus cereus 63301(MIC=14.66 μM), Micrococcus luteus 28001(MIC=7.33 μM), Bacillus pumilus 63202(MIC>58.64 μM), Pseudomonas fluorescens 21620(MIC=29.32 μM), MRSA 43300(MIC=14.66 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=3.67 μM), Escherichia coli 25922(MIC=14.66 μM), Escherichia coli 35150(MIC=29.32 μM), Salmonella paratyphi-A 20501(MIC=7.33 μM), Salmonella paratyphi paratyphi-B 21495(MIC=3.67 μM), Salmonella paratyphi paratyphi-C 21512(MIC=7.33 μM), Shigella flexneri 51571(MIC=7.33 μM), Salmonella choleraesuis 13312(MIC=14.66 μM), Salmonella typhimurium 51005(MIC>58.64 μM), Salmonella enteritidis 21527(MIC>58.64 μM), Vibrio parahemolyticus 21617(MIC=29.32 μM);##Fungi : Candida albicans 10231(MIC=29.32 μM)",[Ref.28002968] MHC10>58.64 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WR7 is 97.46%, 94.65%, 89.01%, 82.25%, 81.41%, 80.85%, 78.59%, 76.06% and 74.80% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,18,15-18
DRAMP21183,WGRAFSRGVRRLARGGRG,18,WR5 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=31.77 μM), Staphylococcus aureus 1.160(MIC=15.89 μM), Listeria monocytogenes 21662(MIC=15.89 μM), Listeria monocytogenes 21633(MIC=31.77 μM), Bacillus cereus 63301(MIC>63.54 μM), Micrococcus luteus 28001(MIC>63.54 μM), Bacillus pumilus 63202(MIC>63.54 μM), Pseudomonas fluorescens 21620(MIC>63.54 μM), MRSA 43300(MIC>63.54 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=7.94 μM), Escherichia coli 25922(MIC=31.77 μM), Escherichia coli 35150(MIC=31.77 μM), Salmonella paratyphi-A 20501(MIC=15.89 μM), Salmonella paratyphi paratyphi-B 21495(MIC=15.89 μM), Salmonella paratyphi paratyphi-C 21512(MIC=15.89 μM), Shigella flexneri 51571(MIC=15.89 μM), Salmonella choleraesuis 13312(MIC=15.89 μM), Salmonella typhimurium 51005(MIC>63.54 μM), Salmonella enteritidis 21527(MIC>63.54 μM), Vibrio parahemolyticus 21617(MIC>63.54 μM);##Fungi : Candida albicans 10231(MIC>63.54 μM)",[Ref.28002968] MHC10>63.54 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WR5 is 98.59%, 97.46%, 96.06%, 96.09%, 92.96%, 91.83%, 89.58%, 87.32% and 85.48% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,18,15-18
DRAMP21182,WGRAFSAGVHRLARGGRG,18,WR3 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>67.01 μM), Staphylococcus aureus 1.160(MIC>67.01 μM), Listeria monocytogenes 21662(MIC=33.50 μM), Listeria monocytogenes 21633(MIC=67.01 μM), Bacillus cereus 63301(MIC>67.01 μM), Micrococcus luteus 28001(MIC>67.01 μM), Bacillus pumilus 63202(MIC>67.01 μM), Pseudomonas fluorescens 21620(MIC>67.01 μM), MRSA 43300(MIC>67.01 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=16.75 μM), Escherichia coli 25922(MIC>67.01 μM), Escherichia coli 35150(MIC>67.01 μM), Salmonella paratyphi-A 20501(MIC=33.50 μM), Salmonella paratyphi paratyphi-B 21495(MIC>67.01 μM), Salmonella paratyphi paratyphi-C 21512(MIC>67.01 μM), Shigella flexneri 51571(MIC>67.01 μM), Salmonella choleraesuis 13312(MIC=33.50 μM), Salmonella typhimurium 51005(MIC>67.01 μM), Salmonella enteritidis 21527(MIC>67.01 μM), Vibrio parahemolyticus 21617(MIC>67.01 μM);##Fungi : Candida albicans 10231(MIC>67.01 μM)",[Ref.28002968] MHC10>67.01 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WR3 is 100%, 98.87%, 92.11%, 90.42%, 90.42%, 88.45%, 87.61%, 87.89% and 87.22% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,18,15-18
DRAMP21181,WGRAFSAGVHRLANGGNG,18,WR1 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>70.09s μM), Staphylococcus aureus 1.160(MIC=70.09 μM), Listeria monocytogenes 21662(MIC>70.09 μM), Listeria monocytogenes 21633(MIC>70.09 μM), Bacillus cereus 63301(MIC>70.09 μM), Micrococcus luteus 28001(MIC>70.09 μM), Bacillus pumilus 63202(MIC>70.09 μM), Pseudomonas fluorescens 21620(MIC>70.09 μM), MRSA 43300(MIC>70.09 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC>70.09 μM), Escherichia coli 25922(MIC>70.09 μM), Escherichia coli 35150(MIC>70.09 μM), Salmonella paratyphi-A 20501(MIC>70.09 μM), Salmonella paratyphi paratyphi-B 21495(MIC>70.09 μM), Salmonella paratyphi paratyphi-C 21512(MIC>70.09 μM), Shigella flexneri 51571(MIC>70.09 μM), Salmonella choleraesuis 13312(MIC>70.09 μM), Salmonella typhimurium 51005(MIC>70.09 μM), Salmonella enteritidis 21527(MIC>70.09 μM), Vibrio parahemolyticus 21617(MIC>70.09 μM);##Fungi : Candida albicans 10231(MIC>70.09 μM)",[Ref.28002968] MHC10>70.09 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WR1 is 99.44%, 96.62%, 95.21%, 94.08%, 92.96%, 92.99%, 92.68%, 87.04% and 77.58% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,18,15-18
DRAMP21180,WGEAFSAGVHRLANGGNG,18,WG18 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>71.15 μM), Staphylococcus aureus 1.160(MIC>71.15 μM), Listeria monocytogenes 21662(MIC>71.15 μM), Listeria monocytogenes 21633(MIC>71.15 μM), Bacillus cereus 63301(MIC>71.15 μM), Micrococcus luteus 28001(MIC>71.15 μM), Bacillus pumilus 63202(MIC>71.15 μM), Pseudomonas fluorescens 21620(MIC>71.15 μM), MRSA 43300(MIC>71.15 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC>71.15 μM), Escherichia coli 25922(MIC>71.15 μM), Escherichia coli 35150(MIC>71.15 μM), Salmonella paratyphi-A 20501(MIC>71.15 μM), Salmonella paratyphi paratyphi-B 21495(MIC>71.15 μM), Salmonella paratyphi paratyphi-C 21512(MIC>71.15 μM), Shigella flexneri 51571(MIC>71.15 μM), Salmonella choleraesuis 13312(MIC>71.15 μM), Salmonella typhimurium 51005(MIC>71.15 μM), Salmonella enteritidis 21527(MIC>71.15 μM), Vibrio parahemolyticus 21617(MIC>71.15 μM);##Fungi : Candida albicans 10231(MIC>71.15 μM)",[Ref.28002968] MHC10>71.15 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WG18 is 98.87%, 94.93%, 93.52%, 90.14%, 85.35%, 83.10%, 80.56%, 75.77% and 73.62% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,18,15-18
DRAMP21179,GILSSLWKKPKKIIAK,16,HYL-26 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC>100 μM);##Gram-negative bacteria : Escherichia coli(MIC>100μM), Pseudomonas aeruginosa 5482(MIC=98 μM);##Fungi : Candida albicans(MIC>100 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21178,GILSSLWKKLKKWIAK,16,HYL-25 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=2.5 μM), Staphylococcus epidermidis(MIC=1.6 μM);##Gram-negative bacteria : Escherichia coli(MIC=2.5 μM), Pseudomonas aeruginosa 5482(MIC=13 μM);##Fungi : Candida albicans(MIC=13 μM)",[Ref.26998557] LC50=57 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21177,GILSSLLKKLKKWIAK,16,HYL-24 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=8 μM), Staphylococcus epidermidis(MIC=1.6 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa 5482(MIC=8 μM);##Fungi : Candida albicans(MIC=16 μM)",[Ref.26998557] LC50=115 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21176,GILSSLLKKWKKIIAK,16,HYL-23 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=20 μM), Staphylococcus epidermidis(MIC=2.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=7.5 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=11 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21175,GKLSSLWKKLKKIIAK,16,HYL-22 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=26 μM), Staphylococcus epidermidis(MIC=2.5 μM);##Gram-negative bacteria : Escherichia coli(MIC=20 μM), Pseudomonas aeruginosa 5482(MIC=6.8 μM);##Fungi : Candida albicans(MIC=34 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21174,gilsslwkklkkiiak,16,HYL-21 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=6.3 μM), Staphylococcus epidermidis(MIC=1.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM), Pseudomonas aeruginosa 5482(MIC=6.7 μM);##Fungi : Candida albicans(MIC=8 μM)",[Ref.26998557] LC50=191 μM against human red blood cells,Linear,Free,Amidation,,D,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21173,GILSSLWKKLKKIIAK,16,HYL-20 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=5.3 μM), Staphylococcus epidermidis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.4 μM), Pseudomonas aeruginosa 5482(MIC=5.3 μM);##Fungi : Candida albicans(MIC=11 μM)",[Ref.26998557] LC50=197 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21172,GILSSWLKKLKKIIAK,16,HYL-19 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=16 μM), Staphylococcus epidermidis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=11 μM), Pseudomonas aeruginosa 5482(MIC=4 μM);##Fungi : Candida albicans(MIC=17 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21168,GILKSLLKKLKKIIAK,16,HYL-15 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=17 μM), Staphylococcus epidermidis(MIC=2.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=10 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=24 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21169,GILSKLLKKLKKIIAK,16,HYL-16 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=23 μM), Staphylococcus epidermidis(MIC=1.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=18 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=45 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21170,kILSSLLKKLKKIIAK,16,HYL-17 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=32 μM), Staphylococcus epidermidis(MIC=1.4 μM);##Gram-negative bacteria : Escherichia coli(MIC=16 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=25 μM)",[Ref.26998557] LC50=364 μM against human red blood cells,Linear,Free,Amidation,,Mixed(1 is D),[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21171,GIWSSLLKKLKKIIAK,16,HYL-18 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=20 μM), Staphylococcus epidermidis(MIC=1.5 μM);##Gram-negative bacteria : Escherichia coli(MIC=1.6 μM), Pseudomonas aeruginosa 5482(MIC=6.3 μM);##Fungi : Candida albicans(MIC=16 μM)",[Ref.26998557] LC50=165 μM against human red blood cells,Linear,Free,Amidation,,L,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21242,FIFHIIKGLFHAGKMI,16,Epinecidin-8 (Derived from Epinecidin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23598079] Gram-positive bacteria : Staphylococcus aureus(MIC=6.25 mg/L), Staphylococcus sp.(MIC=12.5 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=12.5 mg/L), Vibrio harveyi(MIC=6.25 mg/L)","[Ref.23598079] 0% hemolysis at 50 mg/L , 10% hemolysis at 100 mg/L , 20% hemolysis at 200 mg/L , 50% hemolysis at 400 mg/L against sheep red blood cells",Linear,Free,Free,,L,[Ref.23598079] No cytotoxicity information found.,Not found,23598079,Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004.,"Lin MC, Hui CF, Chen JY, Wu JL",Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.,16,15-18
DRAMP21241,GFIFHIIKGLFHAGKMIHGLV,21,Epinecidin-1 (Derived from Epinecidin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23598079] Gram-positive bacteria : Micrococcus luteus(MIC=6.25 mg/L), Staphylococcus aureus(MIC=50 mg/L), Streptococcus pneumoniae(MIC=50 mg/L), Streptococcus agalactiae(MIC>=100 mg/L), Staphylococcus sp.(MIC=6.25 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=6.25 mg/L), Vibrio harveyi(MIC=6.25 mg/L), Vibrio vulnificus(MIC=50 mg/L)","[Ref.23598079] 0% hemolysis at 25 mg/L , 10% hemolysis at 50 mg/L , 15% hemolysis at 100 mg/L , 30% hemolysis at 200 mg/L , 50% hemolysis at 400 mg/L against sheep red blood cells",Linear,Free,Free,,L,[Ref.23598079] No cytotoxicity information found.,Not found,23598079,Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004.,"Lin MC, Hui CF, Chen JY, Wu JL",Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.,21,18-21
DRAMP21167,gilssllkklkkiiak,16,HYL-13 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=5.7 μM), Staphylococcus epidermidis(MIC=3.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=4.5 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=9 μM)",[Ref.26998557] LC50=333 μM against human red blood cells,Linear,Free,Amidation,,D,[Ref.26998557] No cytotoxicity information found.,Not found,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,16,15-18
DRAMP21233,GIMDTVKNAAKNLAGQLLDKLK,22,R2PLx-22 (Derived from R2PLx),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",The CD spectra of both peptides shows the pattern of random coil in aqueous solution and a typical α-helix CD spectra in 50% of TFE solution.,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.30279210] Gram-positive bacteria : Staphylococcus aureus(NCTC 10788)(MIC=256 μM, MBC=256 μM), MRSA (ATCC 12493)(MIC>512 μM, MBC>512 μM), Enterococcus faecalis(NCTC 12697)(MIC>512 μM, MBC>512 μM);##Gram-negative bacteria : Escherichia coli(NCTC 10418)(MIC=128 μM, MBC=256 μM), Pseudomonas aeruginosa(ATCC 27853)(MIC= μM, MBC= μM);##Fungi : Candida albicans(NCTC 1467)(MIC=512 μM, MBC>512 μM)","[Ref.30279210] 3% hemolysis at 1 μM , 4% hemolysis at 2 μM , 1% hemolysis at 4 μM , 0% hemolysis at 8 μM , 2% hemolysis at 16 μM , 0% hemolysis at 32 μM , 0% hemolysis at 128 μM , 3% hemolysis at 256 μM , 13% hemolysis at 512 μM against human red blood cells",Linear,Free,Free,,L,[Ref.30279210] No cytotoxicity information found,Not found,30279210,Biosci Rep. 2018 Nov 9;38(6). pii: BSR20180710. doi: 10.1042/BSR20180710.,"Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T","A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells.",22,21-24
DRAMP21244,FLSLIPKLVKKIIKAFK,17,TsAP-S1 (Derived from TsAP-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer against H157, H838, MCF-7, PC3 and U251-MG","[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=2.5 μM, MBC=20 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM, MBC=20 μM);##Fungi : Candida albicans(MIC=2.5 μM, MBC=5 μM)","[Ref.23770440] 30% hemolysis at 5 μM , 85% hemolysis at 10 μM , 100% hemolysis at 20 μM against horse red blood cells",Linear,Free,Amidation,,L,[Ref.23770440] No cytotoxicity information found.,Not found,23770440,Biochimie. 2013 Sep;95(9):1784-94. doi: 10.1016/j.biochi.2013.06.003.,"Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C","Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",17,15-18
DRAMP21245,FLGMIPKLIKKLIKAFK,17,TsAP-S2 (Derived from TsAP-2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer against H157, H838, MCF-7, PC3 and U252-MG","[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=5 μM, MBC=20 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM, MBC=40 μM);##Fungi : Candida albicans(MIC=2.5 μM, MBC=10 μM)","[Ref.23770440] 30% hemolysis at 5 μM , 85% hemolysis at 10 μM , 100% hemolysis at 20 μM against horse red blood cells",Linear,Free,Amidation,,L,[Ref.23770440] No cytotoxicity information found.,Not found,23770440,Biochimie. 2013 Sep;95(9):1784-94. doi: 10.1016/j.biochi.2013.06.003.,"Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C","Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",17,15-18
DRAMP21247,KKWRWWLKALAKKLL,15,PV (Derived from pEM-2 and MP-VT1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=0.5 ± 0.0 mg/L, MBC=0.5 ± 0.0 mg/L), Enterococcus faecalis isolates(MIC=0.7 ± 0.3 mg/L, MBC=0.8 ± 0.3 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=1.2 ± 0.8 mg/L, MBC=1.3 ± 0.6 mg/L), Acinetobacter baumannii isolates(MIC=0.4 ± 0.1 mg/L, MBC=0.5 ± 0.0 mg/L)","[Ref.27591703] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 32 μg/ml , 8% hemolysis at 64 μg/ml against sheep red blood cells",Linear,Free,Amidation,,L,"[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.8%, 97.4%, 85.8%, 56.2%, 22.8%, 12.2% and 2.3% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.",Not found,27591703,Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.,"Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K","Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.",15,12-15
DRAMP21251,FLFSLIPSVIAGLVSAIRN,19,"AaeAP1 (Scorpionida, Arachricla, Arthropoda)",A0A060QQ43 ,Not found,AP1,Androctonus aeneas,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Transcript level,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria. Antifungal activity against Candida albicans,"[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=16 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>512 mg/L);##Fungi : Candida albicans(MIC=32 mg/L, MBC=64 mg/L)",[Ref.25626077] 100% hemolysis at 16 μg/ml against horse red blood cells,Linear,Free,Amidation,,L,[Ref.25626077] No cytotoxicity information found.,Not found,25626077,Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.,"Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C","AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.",19,18-21
DRAMP21252,FLFSLIPSAIAGLVSAIRN,19,"AaeAP2 (Scorpionida, Arachricla, Arthropoda)",A0A060QMQ0 ,Not found,AP2,Androctonus aeneas,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal",Transcript level,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria. Antifungal activity against Candida albicans,"[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=16 mg/L, MBC=16 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>512 mg/L);##Fungi : Candida albicans(MIC=32 mg/L, MBC=64 mg/L)",[Ref.25626077] 100% hemolysis at 64 μg/ml against horse red blood cells,Linear,Free,Amidation,,L,[Ref.25626077] No cytotoxicity information found.,Not found,25626077,Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.,"Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C","AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.",19,18-21
DRAMP21253,FLFKLIPKAIKGLVKAIRK,19,AaeAP1a (Derived from AaeAP1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=4 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=16 mg/L, MBC=32 mg/L);##Fungi : Candida albicans(MIC=4 mg/L, MBC=16 mg/L)",[Ref.25626077] 100% hemolysis at 32 μg/ml against horse red blood cells,Linear,Free,Amidation,,L,[Ref.25626077] No cytotoxicity information found.,Not found,25626077,Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.,"Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C","AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.",19,18-21
DRAMP21254,FLFKLIPKVIKGLVKAIRK,19,AaeAP2a (Derived from AaeAP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=4 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=16 mg/L, MBC=32 mg/L);##Fungi : Candida albicans(MIC=4 mg/L, MBC=16 mg/L)",[Ref.25626077] 100% hemolysis at 64 μg/ml against horse red blood cells,Linear,Free,Amidation,,L,[Ref.25626077] No cytotoxicity information found.,Not found,25626077,Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.,"Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C","AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.",19,18-21
DRAMP21256,WLSKTAKKLWLSKTAKKL,18,WL2 (Derived from CP-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC=128 μM), Staphylococcus aureus ATCC 43300(MIC=128 μM), Staphylococcus epidermidis ATCC 12228(MIC=128 μM), Bacillus subtilis CMCC 63501(MIC=64 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=8 μM), Escherichia coli UB1005(MIC=8 μM), Pseudomonas aeruginosa ATCC 27853(MIC=16 μM), Salmonella typhimurium ATCC 7731(MIC=32 μM), Salmonella pullorum C79-13(MIC=16 μM)",[Ref.29266746] MHC5>128 μM against human red blood cells,Linear,Free,Amidation,,L,"[Ref.29266746] The cell viability of IPEC-J2 cells induced by WL2 is 99.0%, 95.0%, 89%, 89.8%, 85.2%, 86.8% and 75.1% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is 77.",Not found,29266746,Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.,"Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J",Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.,18,15-18
DRAMP21264,LKKLLKLLKKLLKLAG,16,LK (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM),[Ref.23894079] MHC10=0.08 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21265,AKKLLKLLKKLLKLAG,16,LK-L1A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21266,LKKALKLLKKLLKLAG,16,LK-L4A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21267,LKKLAKLLKKLLKLAG,16,LK-L5A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21268,LKKLLKALKKLLKLAG,16,LK-L7A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21269,LKKLLKLAKKLLKLAG,16,LK-L8A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21270,LKKLLKLLKKALKLAG,16,LK-L11A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21271,LKKLLKLLKKLAKLAG,16,LK-L12A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=0.63 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21272,LKKLLKLLKKLLKAAG,16,LK-L14A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21273,LKKLLKLGKKLLKLAG,16,LK-L8G (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=10 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21274,LKKLLKLSKKLLKLAG,16,LK-L8S (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=20 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21275,LKKLLKLPKKLLKLAG,16,LK-L8P (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=160 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21276,LKKLLKLNKKLLKLAG,16,LK-L8N (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=640 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21277,LKKLLKLQKKLLKLAG,16,LK-L8Q (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=320 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21278,LKKLLKLDKKLLKLAG,16,LK-L8D (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=1280 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21279,LKKLLKLEKKLLKLAG,16,LK-L8E (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=320 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21280,LKKLLKLKKKLLKLAG,16,LK-L8K (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=160 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21281,LKKLLKLHKKLLKLAG,16,LK-L8H (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=80 μM against human red blood cells,Linear,Free,Free,,L,[Ref.23894079] No cytotoxicity information found.,Not found,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,16,15-18
DRAMP21303,RIIDLLARVRRPQKPKFVTVWVR,23,A7-PMAP-23 (Derived from PMAP-23),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Alpha helix, beta turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.10527878] Gram-positive bacteria : Bacillus subtilis (KCTC 1918)(MIC=1.56 μM), Streptococcus pyogenes (KCTC 3096)(MIC=1.56 μM), Staphylococcus aureus (KCTC 1621)(MIC=3.125 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=3.125 μM), Salmonella typhimurium (KCTC 1926)(MIC=1.56 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=1.56 μM)",[Ref.10527878] 0% hemolysis at 100 μM against human red blood cells,Linear,Free,Free,,L,[Ref.10527878] No cytotoxicity information found.,Not found,10527878,Biochem Biophys Res Commun. 1999 Oct 14;264(1):281-6.,"Kang JH, Shin SY, Jang SY, Kim KL, Hahm KS.",Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,23,21-24
DRAMP21304,RIIDLLWRVRRPQKPKFVTVAVR,23,A21-PMAP-23 (Derived from PMAP-23),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Alpha helix, beta turn",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.10527878] Gram-positive bacteria : Bacillus subtilis (KCTC 1918)(MIC=3.125 μM), Streptococcus pyogenes (KCTC 3096)(MIC=3.125 μM), Staphylococcus aureus (KCTC 1621)(MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=6.25 μM), Salmonella typhimurium (KCTC 1926)(MIC=3.125 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=3.125 μM)",[Ref.10527878] 0% hemolysis at 100 μM against human red blood cells,Linear,Free,Free,,L,[Ref.10527878] No cytotoxicity information found.,Not found,10527878,Biochem Biophys Res Commun. 1999 Oct 14;264(1):281-6.,"Kang JH, Shin SY, Jang SY, Kim KL, Hahm KS.",Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,23,21-24
DRAMP21336,SFLTTVKKLVTNLAAL,16,"RPb (Frogs, amphibians, animals)",No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"49.6% Helix, 7.6% antiparallel, 0% parallel, 9.8% turn and 33% others in 50% TFE/H2O. ##0.3% Helix, 25.4% antiparallel, 0% parallel, 19.4% turn and 55",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31242693] Gram-positive bacteria:Staphylococcus aureus (MIC=8 μM; MBC=8 μM), MRSA (MIC=16 μM; MBC=32 μM), Enterococcus faecalis (MIC=32 μM; MBC=128 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM; MBC=16 μM), Pseudomonas aeruginosa (MIC=64 μM; MBC=256 μM);##Fungi: Candida albicans (MIC=16 μM; MBC=16 μM)","[Ref.31242693] 7% hemolysis at 16 μM, 18% hemolysis at 32 μM, 20% hemolysis at 64 μM, 40% hemolysis at 128 μM, 70% hemolysis at 256 μM, 100% hemolysis at 512 μM on horse erythrocytes. ",Linear,Free,Amidation,,L,"[Ref.31242693] RPb only possessed inhibitory effect on the proliferation of H157 with the IC value of 6.856 μM, while showed no inhibitory effect on the proliferation of MCF-7, U251MG, PC-3 and MDA-MB-435s. DETAILED DATA: ①The cell viabillity of NCI-H157 induced by RPb is 98.7%, 102.5%, 96.9%, 98.1%, 38.1%, 9.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 95%, 89.4%, 41.2%, 16.2% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ②The cell viability of MCF-7 induced by RPb is 100.6%, 92.5%, 90%, 99.4%, 36.2% and 11.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, , while the cell viability induced by Melittin is 100%, 98.1%, 92.5%, 7.5%, 8.7% and 8.7% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ③The cell viability of U251-MG induced by RPb is 105%, 103.1%, 109.4%, 102.5%, 105.6% and 13.1% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 99.4%, 99.4%, 75.6%, 18.7%, 11.9% and 18.1% at 0.001, 0.01, 0.1, 1, 10, 100 μM.④The cell viability of PC-3 induced by RPa is 108.8%, 103.8%, 118.1%, 125.6%, 116.9% and 68.8% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 110%, 113.1%, 109.4%, 33.1%, 16.9% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ⑤The cell viability of MDA-MB-435S induced by RPa is 98.1%, 95%, 100.6%, 97.5%, 80.6% and 43.1%, while the cell viability induced by Melittin is 100%, 93.1%, 82.5%, 18.8%, 18.8% and 18.1%.",Not found,31242693,Biomolecules. 2019 Jun 25;9(6):249. doi: 10.3390/biom9060249.,"Zhou, XW; Shi, DN; Zhong, RM; Ye, ZM; Ma, CB; Zhou, M; Xi, XP; Wang, L; Chen, TB; Kwok, HF",Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues,16,15-18
DRAMP21349,IHHIHHHIHHIHHHIHHIHHH,21,2IH3 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,95% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=2μM), Escherichia coli UB1005 (MIC=2μM), Escherichia coli K88 (MIC=2μM), Escherichia coli K99 (MIC=2μM), Escherichia coli 078 (MIC=4μM), Escherichia coli 987P (MIC=2μM), Pseudomonas aeruginosa 27853 (MIC=0.5μM), Pseudomonas aeruginosa PAO1 (MIC=1μM), Salmonella typhimurium 14028 (MIC=16>64μM), Salmonella typhimurium 7731 (MIC=8μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH3 is 108.3%, 102.8%, 104.4%, 102.2%, 105%, 105.3% and 103.3% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH3 is 102.5%, 104.5%, 105.6%, 103.7%, 102.0%, 103.1% and 103.1% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Not found,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,21,18-21
DRAMP21353,IHHIHHIIHHIHHIIHHIHHI,21,3IH3 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,95% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=1μM), Escherichia coli UB1005 (MIC=1μM), Escherichia coli K88 (MIC=1μM), Escherichia coli K99 (MIC=1μM), Escherichia coli 078 (MIC=0.5μM), Escherichia coli 987P (MIC=0.5μM), Pseudomonas aeruginosa 27853 (MIC=1μM), Pseudomonas aeruginosa PAO1 (MIC=0.5μM), Salmonella typhimurium 14028 (MIC=2μM), Salmonella typhimurium 7731 (MIC=1μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",Linear,Free,Amidation,,L,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH3 is 103.6%, 102.2%, 102.8%, 105%, 103.1%, 104.2% and 105.8% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH3 is 103.9%, 103.1%, 103.9%, 102.2%, 104.2%, 103.1% and 101.7% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Not found,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,21,18-21
DRAMP21355,KKKKKAAFAKAWAAFAA,17,5Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=6.3μM), Pseudomonas aeruginosa PAO1(MIC=25μM), Pseudomonas aeruginosa PA214(MIC=25μM), Pseudomonas aeruginosa PA287(MIC=50μM), Pseudomonas aeruginosa PA330(MIC=50μM), Pseudomonas aeruginosa PA380(MIC=50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21356,KKKKAAFAKAWAKAFAA,17,4Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC=50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21357,KKKAAFAKAWAKAFKAA,17,3Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=25μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21358,KKAKAFAKAWAKAFKAA,17,2Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=25μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC=50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21359,KAAKKFAKAWAKAFKAA,17,1Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC>50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21360,KKKKKKALFALWLAFLA,17,6K-F17-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC>50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC=25μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 33% (± 22) hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21361,KKKKKALFLKLWAAFLA,17,5Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=3.1μM), Pseudomonas aeruginosa PAO1(MIC=12.5μM), Pseudomonas aeruginosa PA214(MIC=6.3μM), Pseudomonas aeruginosa PA287(MIC=6.3μM), Pseudomonas aeruginosa PA330(MIC=12.5μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 49% (± 22) hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21362,KKKKAAFLKLWLKLFAA,17,4Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC>50μM), Pseudomonas aeruginosa PA214(MIC>50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 8% (± 2.0) hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21363,KKKAAFLKLWAKLFKAL,17,3Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=3.1μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=3.1μM)",[Ref.31194548] 100% (± 4.5) hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21364,KKLKAFLKAWAKLFKAL,17,2Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=1.6μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=1.5μM)",[Ref.31194548] 89% (± 7.3) hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21365,KALKKFLKAWAKLFKAL,17,1Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=1.6μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=6.3μM)",[Ref.31194548] 81% (± 9.4) hemolysis at 40μM against human blood cells.,Linear,Free,Amidation,,L,[Ref.31194548] No cytotoxicity information found,Not found,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",17,15-18
DRAMP21390,RWKRHISEQLRRRDRLQR,18,K17 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=45.5-91 μM);##Gram-negative bacteria: Escherichia coli (MIC>120μM), Pseudomonas aeruginosa (MIC>120μM);##Fungi: Candida albicans (MIC>120μM)","[Ref.31145591] 2% hemolysis at 600 μM, 3% hemolysis at 700 μM, 4% hemolysis at 800 μM, 5% hemolysis at 900 μM, 6% hemolysis at 1000 μM, against mouse blood cells.",Linear,Free,Free,,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",18,15-18
DRAMP21391,RWKRHISEQLRRRDRLQRQAF,21,K18 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=28.8-57.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=60-120μM), Pseudomonas aeruginosa (MIC=60-120μM);##Fungi: Candida albicans (MIC>120μM)","[Ref.31145591] 3% hemolysis at 500μM, 16% hemolysis at 600 μM, 27% hemolysis at 700 μM, 38% hemolysis at 800 μM, 50% hemolysis at 900 μM, 62% hemolysis at 1000μM against mouse blood cells.",Linear,Free,Free,,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",21,18-21
DRAMP21392,RWKRHISEQLRRRDRLQRQAJ,21,K22 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=14.4-28.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=30-60μM), Pseudomonas aeruginosa (MIC=60-120μM);##Fungi: Candida albicans (MIC=60-120μM)","[Ref.31145591] 3% hemolysis at 500μM, 10% hemolysis at 600 μM, 13% hemolysis at 700 μM, 17% hemolysis at 800 μM, 20% hemolysis at 900 μM, 25% hemolysis at 1000μM against mouse blood cells.",Linear,Free,Free,The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",21,18-21
DRAMP21393,RWKRHISEQLRRRDRLQRQAJ,21,K22.2 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=4-8 μM);##Gram-negative bacteria: Escherichia coli (MIC=17.5-35μM), Pseudomonas aeruginosa (MIC=17.5-35μM);##Fungi: Candida albicans (MIC=60-120μM)","[Ref.31145591] 3% hemolysis at 500μM, 5% hemolysis at 600 μM, 10% hemolysis at 700 μM, 15% hemolysis at 800 μM, 17% hemolysis at 900 μM, 20% hemolysis at 1000μM against mouse blood cells.",Linear,Free,"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",21,18-21
DRAMP21394,RWKRHISEQLRRRDRLQRQAJ,21,K30 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Helix–loop–helix in the presence of anionic membrane lipids mimicking bacterial membranes.,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=0.9-1.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.4-12.8μM), Pseudomonas aeruginosa (MIC=13.5-27μM);##Fungi: Candida albicans (MIC=30-60μM)","[Ref.31145591] 3% hemolysis at 600μM, 4% hemolysis at 700 μM, 5% hemolysis at 800 μM, 6% hemolysis at 900 μM, 9% hemolysis at 1000 μM,against mouse blood cells.",Linear,Acylation (Arg1 conjugated with 4-methylhexanoyl group),"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",21,18-21
DRAMP21395,RWKRHISEQLRRRDRLQRQAJ,21,K31 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=3.2-6.4μM);##Fungi: Candida albicans (MIC=3.2-6.4μM)","[Ref.31145591] 50% hemolysis at 10μM, 70% hemolysis at 61μM, 75% hemolysis at 100 μM, 80% hemolysis at 200 μM, 85% hemolysis at 300 μM, 90% hemolysis at 900 μM, 92% hemolysis at 500μM against mouse blood cells.",Linear,Acylation (Arg1 conjugated with myristoyl group),"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",21,18-21
DRAMP21396,RWKRHISEQLRRRDRLQRQAJ,21,K33 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=1.8-3.7μM)","[Ref.31145591] 75% hemolysis at 10μM, 97% hemolysis at 123μM, 100% hemolysis at 500μM against mouse blood cells.",Linear,Acylation (Arg1 conjugated with palmitoyl group),"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",21,18-21
DRAMP21397,RWKRHISEQLRRRDRLQRQAJ,21,K36 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=0.9-1.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=15-30μM)","[Ref.31145591] 5% hemolysis at 200μM, 10% hemolysis at 300 μM, 17% hemolysis at 400 μM, 23% hemolysis at 500 μM, 30% hemolysis at 600μM, 32% hemolysis at 700 μM, 35% hemolysis at 800 μM, 40% hemolysis at 900 μM, 42% hemolysis at 1000μM against mouse blood cells.",Linear,Acylation (Arg1 conjugated with Fmoc group),"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",21,18-21
DRAMP21398,RWKRHISEQLRRRDRLQRQAJ,21,K46 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=30-60μM)","[Ref.31145591] 10% hemolysis at 200μM, 15% hemolysis at 500μM, 17% hemolysis at 600 μM, 20% hemolysis at 700 μM, 25% hemolysis at 800 μM, 30% hemolysis at 900 μM, 42% hemolysis at 1000μM against mouse blood cells.",Linear,Acylation (Arg1 conjugated with capryl group),"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,L,[Ref.31145591] No cytotoxicity information found,Not found,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",21,18-21
DRAMP21399,RRYGTCIYQGRLWAF,15,"Pep-H  (Human, mammals, animals)",No entry found,Belongs to the alpha-defensin family.,Not found,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram+",Not found,β-strand mainly (according to PDB entry 3HJ2),Not found,,Function: Antibacterial activity against Gram-positive bacteria.,[Ref.31133658] Gram-positive bacteria:M.tb H37Rv (MIC=10 μg/ml),"[Ref.31133658] 2.7% hemolysis at 1μg/ml, 5% hemolysis at 5μg/ml, 6% hemolysis at 50μg/ml, 8% hemolysis at 100 μg/ml against human blood cells.",Linear,Free,Free,,L,"[Ref.31133658] The cell viability of MDMs induced by Pep-H is 94.2%, 91.5%, 90.4%, 88.0% and 84.1% at peptide concentrations of 1, 5, 25, 50, 100 μg/mL",Not found,31133658,Sci Rep. 2019; 9: 7866. Published online 2019 May 27. doi: 10.1038/s41598-019-44256-6,"Richa Sharma， Ragini Raghav, Kumari Priyanka, Praveen Rishi, Sadhna Sharma, Sudha Srivastava, Indu Verma",Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1,15,12-15
DRAMP21400,CGIYRSLKLIKSLVLIK,17,NBC2253 (De Novo Synthesis) ,No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.31119600] Gram-positive bacteria:MRSA(MIC=6.7 ± 0.02µM);##Gram-negative bacteria:Escherichia coli O157:H7(MIC=25 ± 0.03µM),[Ref.31119600] No hemolytic activity against bovine blood cells,Linear,The sulfhydryl side chain of the cysteine residue was conjugated to AuNC(previously modified with SPDP) via a disulfide bond.,Free,,L,"[Ref.31119600] The cell viability of Vero ATCC CCL 1-81 cells induced by NBC2253 is 87.8%, 66.4%, 62.2%, 69.1% and 68.8% at peptide concentrations of 1.2, 3.7, 11.1, 33.3 and 100 μM.",Not found,31119600,Protein J. 2019 May 22. doi: 10.1007/s10930-019-09840-9.,"Prada YA, Guzmán F, Ortíz C, Cabanzo R, Torres R, Mejía-Ospino E",New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,17,15-18
DRAMP21401,CALKLTKAKRLVRKIGF,17,NBC2254 (De Novo Synthesis) ,No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.31119600] Gram-positive bacteria:MRSA(MIC=73 ± 0.02µM);##Gram-negative bacteria:Escherichia coli O157:H7(MIC=3.5 ± 0.05µM),[Ref.31119600] No hemolytic activity against bovine blood cells,Linear,The sulfhydryl side chain of the cysteine residue was conjugated to AuNC(previously modified with SPDP) via a disulfide bond.,Free,,L,"[Ref.31119600] The cell viability of Vero ATCC CCL 1-81 cells induced by NBC2254 is 93.7%, 90.1%, 89.5%, 95.9% and 78.6% at peptide concentrations of 1.2, 3.7, 11.1, 33.3 and 100 μM.",Not found,31119600,Protein J. 2019 May 22. doi: 10.1007/s10930-019-09840-9.,"Prada YA, Guzmán F, Ortíz C, Cabanzo R, Torres R, Mejía-Ospino E",New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,17,15-18
DRAMP21402,KFKKLFKKLSPVFKRIVQRIKDFLR,25,B1 (Derived from LL-37 and BMAP-27),No entry found,Belongs to the cathelicidin family.,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,88 % of the α-helices and 12% of the random coil was predicted using HNN,The helicity percentages of the secondary structure of B1 are predicted using HNN,,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31118709] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=20μM), Staphylococcus aureus ATCC 33591(MIC=20μM), Staphylococcus aureus ATCC 43300(MIC=20μM), Staphylococcus aureus ATCC BAA-41(MIC=20μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=20μM), Escherichia coli 35218 (MIC=20μM), Pseudomonas aeruginosa BAA-2114 (MIC=10μM)","[Ref.31118709] 0% hemolysis at 10μM, 8% hemolysis at 25μM, 19% hemolysis at 50μM, 23% hemolysis at 75μM, 30% hemolysis at 100μM, 38% hemolysis at 125μM, 40% hemolysis at 150μM, 43% hemolysis at 175μM, 50% hemolysis at 200μM against human blood cells.",Linear,Free,Free,,L,"[Ref.31118709] The cell viability of HEK293 mammalian cell line induced by B1 is 87.0%, 67.1%, 52.3%, 54.3%, 50.6% and 50% at peptide concentrations of 10, 20, 40, 60, 80 and 100 μM.",Not found,31118709,Infect Drug Resist. 2019; 12: 1035–1045. Published online 2019 Apr 30. doi: 10.2147/IDR.S199473,"Yara Al Tall, Ahmad Abualhaijaa, Mohammad Alsaggar, Ammar Almaaytah, Majed Masadeh, and Karem H Alzoub",Design and characterization of a new hybrid peptide from LL-37 and BMAP-27,25,24-27
DRAMP21403,ITEVITILLNRLTDRLEK,18,peptide 1 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM phosphate buffer, pH7.4",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31117348] Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC>100μM), Bacillus subtilis ATCC 6633(MIC>100μM);##Gram-negative bacteria:Escherichia coli ATCC 15597(MIC>100μM), Pseudomonas aeruginosa (MIC>100μM), Salmonella Typhimurium 6192(MIC>100μM), Klebsiella pneumoniae NCTC 5055(MIC>100μM)",[Ref.31117348] 5% hemolysis at 250 μM against human blood cells.,Linear,Free,Free,,L,[Ref.31117348] No cytotoxicity information found,Not found,31117348,ACS Infect Dis. 2019 May 30. doi: 10.1021/acsinfecdis.9b00157.,"Hammond K, Lewis H, Faruqui N, Russell C, Hoogenboom BW, Ryadnov MG",Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,18,15-18
DRAMP21404,ITKVITKLLNRLTKILSK,18,peptide 2 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM phosphate buffer, pH7.4",Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31117348] Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC=15 ± 2.5μM), Bacillus subtilis ATCC 6633(MIC=15 ± 2.5μM);##Gram-negative bacteria:Escherichia coli ATCC 15597(MIC=3.1μM), Pseudomonas aeruginosa (MIC=25μM), Salmonella Typhimurium 6192(MIC=40 ± 5μM), Klebsiella pneumoniae NCTC 5055(MIC=50μM)",[Ref.31117348] 5% hemolysis at 250 μM against human blood cells.,Linear,Free,Free,,L,"[Ref.31117348] ①The cell viability of MCF7 cells induced by peptide 2 is 94.2%, 88.6%, 82.0%, 55.0%, 44.0%, 32.4%, 15.3%, 15.8%, 12.8% and 1.2% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. EC50=22.5±0.7 μM. ②The cell viability of Hela cells induced by peptide 2 is 96.1%, 95.4%, 83.8%, 64.2%, 57.7%, 49.5%, 31.5%, 30.2%, 7.8% and 0.2% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. EC50=29.8±1 μM. ③The cell viabiity of HDF cells induced by peptide 2 is 96.3%, 89.7%, 89.9%, 92.7%, 95.0%, 93.4%, 93.1%, 96.1%, 88.6% and 67.4% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM.",Not found,31117348,ACS Infect Dis. 2019 May 30. doi: 10.1021/acsinfecdis.9b00157.,"Hammond K, Lewis H, Faruqui N, Russell C, Hoogenboom BW, Ryadnov MG",Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,18,15-18
DRAMP21415,LKKWWKTSKGLLGGLLGKVTSVIK,24,α4-short (Derived from α4),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30967458] Gram-positive bacteria: Staphylococcus aureus 467-1 (MIC=2μM), Staphylococcus aureus 0154-17 (MIC=2μM), Staphylococcus aureus 187-10 (MIC=16μM), Staphylococcus aureus 0194-19 (MIC=2μM), Staphylococcus aureus US300 (MIC=8μM), Staphylococcus aureus 122-12 (MIC=2μM), Enterococcus faecium 23614 (MIC=1μM), Enterococcus faecium 14678 (MIC=1μM), Enterococcus faecium 26125 (MIC=1μM);##Gram-negative bacteria:Pseudomonas aeruginosa 16-21 (MIC=2μM), Pseudomonas aeruginosa 16-72 (MIC=2μM), Pseudomonas aeruginosa 16-73 (MIC=2μM), Pseudomonas aeruginosa 0038-13 (MIC=2μM), Pseudomonas aeruginosa 0038-14 (MIC=1μM), Pseudomonas aeruginosa 0040-21 (MIC=2μM), Pseudomonas aeruginosa 0046-106 (MIC=8μM), Pseudomonas aeruginosa 0068-37 (MIC=16μM), Pseudomonas aeruginosa 0071-75 (MIC=2μM), Pseudomonas aeruginosa 97-5 (MIC=2μM), Pseudomonas aeruginosa 109-10 (MIC=2μM), Pseudomonas aeruginosa 16-21 (MIC=2μM)Pseudomonas aeruginosa 132-37 (MIC=2μM), Pseudomonas aeruginosa 129-5 (MIC=2μM), Pseudomonas aeruginosa 152-19 (MIC=2μM), Pseudomonas aeruginosa 159-30 (MIC=2μM), Pseudomonas aeruginosa 474-1 (MIC=2μM), Acinetobacter baumannii C3 (MIC=1μM), Acinetobacter baumannii D4 (MIC=2μM), Acinetobacter baumannii A2 (MIC=4μM), Escherichia coli YDC518 (MIC=1μM), Escherichia coli YDC575 (MIC=2μM), Escherichia coli YDC596 (MIC=1μM), Escherichia coli YDC107 (MIC=1μM), Escherichia coli YDC337 (MIC=1μM), Escherichia coli YDC748 (MIC=1μM), Klebsiella pneumoniae A2 (MIC=4μM), Klebsiella pneumoniae D4 (MIC=2μM), Klebsiella pneumoniae 438-16 (MIC=4μM)","[Ref.30967458] 1% hemolysis at 17 μM, 2% hemolysis at 30 μM, 3% hemolysis at 63 μM against human red blood cells",Linear,Free,Free,,L,"[Ref.30967458] The white blood cell toxicity of α4-short is ~0%, ~0%, ~0%, ~0%, ~0%, 1.8% and 3.1% at peptide concentrations of 1, 2, 4, 8, 16, 32 and 64 μM.",Not found,30967458,mBio. 2019 Mar-Apr; 10(2): e00226-19. Published online 2019 Apr 9. doi: 10.1128/mBio.00226-19,"Shasha Jiang, Berthony Deslouches, Chen Chen, Matthew E. Di, Y. Peter Di","Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α6-Short, in a Murine Model of Respiratory Infection",24,21-24
DRAMP21420,FLPKLFAKITKKNMAHIRC,19,AY1C (Derived from AY1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Helix-loop-helix derived from NMR,Not found,5YKL resolved by NMR,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=15μM), Escherichia coli  (MIC=17μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=12μM)","[Ref.30872680] 4% hemolysis at 10 μM, 9% hemolysis at 50 μM, 8% hemolysis at 100μM against human red blood cells",Linear,Free,Free,,L,[Ref.30872680] No cytotoxicity information found.,Not found,30872680,Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7,"Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS",A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria,19,18-21
DRAMP21421,FLPKLFAKITKKNMAHIRC,19,AY1C-AgNP (Derived from AY1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Helix-loop-helix derived from NMR,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=15μM), Escherichia coli  (MIC=12μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=10μM)","[Ref.30872680] 4% hemolysis at 10 μM, 6% hemolysis at 50 μM, 9% hemolysis at 100μM against human red blood cells",Linear,Free,Free,Conjugation with silver nanoparticles,L,[Ref.30872680] No cytotoxicity information found.,Not found,30872680,Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7,"Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS",A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria,19,18-21
DRAMP21422,CFLPKLFAKITKKNMAHIR,19,CAY1 (Derived from AY1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Helix-loop-helix derived from NMR,Not found,5YKQ resolved by NMR,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=10μM), Escherichia coli  (MIC=10μM), Salmonella typhi(MIC=Not know), Klebsiella pneumoniae(MIC=7μM)","[Ref.30872680] 4% hemolysis at 10 μM, 9% hemolysis at 50 μM, 10% hemolysis at 100μM against human red blood cells",Linear,Free,Free,,L,[Ref.30872680] No cytotoxicity information found.,Not found,30872680,Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7,"Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS",A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria,19,18-21
DRAMP21423,CFLPKLFAKITKKNMAHIR,19,CAY1-AgNP (Derived from AY1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Helix-loop-helix derived from NMR,Not found,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=10μM), Escherichia coli  (MIC=10μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=5μM)","[Ref.30872680] 3% hemolysis at 10 μM, 9% hemolysis at 50 μM, 9.5% hemolysis at 100μM against human red blood cells",Linear,Free,Free,Conjugation with silver nanoparticles,L,[Ref.30872680] No cytotoxicity information found.,Not found,30872680,Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7,"Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS",A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria,19,18-21
DRAMP21454,GILDWGKKVMDWIKDKM,17,"PLP1 (Insects, animals)",A0A348G6I7,Belongs to the formicidae venom precursor-01 superfamily.,Not found,Odontomachus monticola (Trap-jaw ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,α-helix predicted by Proteus,Not found,,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.,[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<3.1μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC<50μM),[Ref.30658410] 0% hemolysis at 50 μM against rat blood cells,Linear,Free,Amidation,,L,[Ref.30658410] No cytotoxicity information found.,Not found,30658410,Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050,"Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki",Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components,17,15-18
DRAMP21458,IWGALLGTLIPAITSAIQ,18,"PLP5 (Insects, animals)",A0A348G5W1,Belongs to the formicidae venom precursor-01 superfamily.,Not found,Odontomachus monticola (Trap-jaw ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,α-helix predicted by Proteus,Not found,,Function: Antibacterial activity against Gram-nagetive bacteria. ,[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC Negative);##Gram-negative bacteria:Escherichia coli (MIC<50μM);##Fungi:Saccharomyces cerevisiae (MIC Negative),[Ref.30658410] 6.9% hemolysis at 10μM and 94.8% at 50 μM against rat blood cells,Linear,Free,Amidation,,L,[Ref.30658410] No cytotoxicity information found.,Not found,30658410,Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050,"Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki",Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components,18,15-18
DRAMP21460,IHKFWRCRRRFCRWFKHI,18,PQ (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix predicted by I-Tasser,"In PBS, the α-helix content of PQ is 26.91% and the β-strand content of that is 11.16%. In SDS, the α-helix content of PQ is 32.02% and the β-strand of that is 6.15%. In TFE, the α-helix content of PQ is 36.82% and the β-strand of that is 4.28%.",,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=8μM), Staphylococcus aureus ATCC 43300(MIC=8μM), Staphylococcus epidermidis ATCC 12228(MIC=8μM), Streptococci faecalis ATCC 29212(MIC=16μM), Bacillus subtilis CMCC 63501(MIC=16μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=8μM), Salmonella typhimurium ATCC 7731(MIC=8μM), Salmonella Pulloru C79-13(MIC=8μM)",[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.,Linear,Free,Amidation,,L,"[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by PQ is 68.2%, 68.6%, 66.8%,63.6%, 69.1%, 62.2%, 55.8% and 28.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.",Not found,30538681,Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832,"Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu",Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability,18,15-18
DRAMP21467,GLLDFLKAAGKGLVSNLLEK,20,P3-Ll-2085 (De Novo Synthesis),No entry found,Not found,Not found, Leptodactylus latrans (Anura: Leptodactylidae),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Helix(L2-E19) predicted by PSIPRED and Helix(L3-A9, L13-L17) predicted by GOR V",Deconvolution spectra by SELCON and CONTILL method indicated more than 70% helical structure for P3-Ll-2085,,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.30423858] Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=15μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=15μM),[Ref.30423858] 100% hemolysis MHC=40μM against human blood cells,Linear,Free,Amidation,,L,[Ref.30423858] No cytotoxicity information found.,Not found,30423858,Molecules. 2018 Nov; 23(11): 2943. Published online 2018 Nov 11. doi: 10.3390/molecules23112943,"Alvaro Siano, Maria Veronica Humpola, Eliandre de Oliveira, Fernando Albericio, Arturo C Simonetta, Rafael Lajmanovich, Georgina G Tonarelli",Leptodactylus latrans Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides,20,18-21
DRAMP21481,KKKKKKAAFAAWAAFAA,17,6K-F17,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,①Random coils in aqueous buffer. ②α-helix in SDS detergent micelles.,"As previously reported, 6K-F17 adopts a random coil structure in aqueous buffer and an α helix in the presence of SDS detergent micelles.",,Function: Antibacterial activity against Gram-negative bacteria. No experiments about antibacterial activity against Gram-positive bacteria are recorded.,[Ref.29275987] Gram-negative bacteria: E. coli (MIC= 1.6 μM),[Ref.29275987] MHC = 320 μM against human red blood cells. Note: Minimum hemolytic concentration (MHC) is the minimum peptide concentration at which red blood cells undergo > 2% hemolysis.,Linear ,Free,Amidation,,L,No cytotoxicity information found in the reference,Not found,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020. Epub 2017 Oct 21.,"Tracy A Stone, Gregory B Cole, Huong Q Nguyen, Simon Sharpe, Charles M Deber",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides,17,15-18
DRAMP21494,GFLSILKKVLPKVJAHJK,18,MEP-N,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,①12% α-helical content in water.②43% α-helical content in 50% TFE. ③48% α-helical content in 8mM SDS.,No other descriptive information about the structure found in the literature,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria and Antifungal activity against Candida albicans.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1 μM), Bacillus subtilis (MIC = 0.5 μM), Staphylococcus aureus (MIC = 2.5 μM);##Gram-negative bacteria: E.coli (MIC = 0.9 μM), Pseudomonas aeruginosa (MIC = 17.3 μM);##Fungi: Candida albicans (MIC = 15 μM).",[Ref.22526241] LC50 = 50 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,Linear ,Free,Amidation,The J (position: 14 and 17) in sequence are norleucine. ,L,No cytotoxicity information found in the reference,Not found,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 27.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,18,15-18
DRAMP21596,KAAKAAKKAAKAAWK,15,Ac-UM-14W,No entry found,Not found,Not found,Synthetic construct,Non-antimicrobial,Synthetic form,Less α-helix content found in a 25mM potassium phosphate buffer solution at 20℃,Helix formation of unmodified analog Ac-UM-14W would be unfavorable due to the potential electrostatic repulsion among cationic side-chains of lysine residues in its helical conformation.,,Function: Non-antibacterial activity against Gram-positive or Gram-negative bacteria. Antibacterial activity is not noteable under 200 μM.,"[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC > 200 μM), Staphylococcus aureus ATCC 6538p (MIC > 200 μM), Staphylococcus epidermis ATCC 12228 (MIC > 200 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC > 200 μM), Shigella dysentariae ATCC 9752 (MIC > 200 μM), Salmonella typhimurium ATCC 14028 (MIC > 200 μM), Klebsiella pneumonia ATCC 10031 (MIC > 200 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 200 μM).",[Ref.26235946] <1% hemolysis against human red blood cells at 12.5 μM and <1% hemolysis at 25 μM.,Linear ,Acetylation,Amidation,,L,No cytotoxicity information found in the reference,Not found,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.,"Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,15,12-15
DRAMP21622,KLALKALKALKAALKLA,17,MAP-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②Ty","Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.",,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 16 μg/mL), Enterococcus faecalis (MIC = 256 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 16 μg/mL), Pseudomonas aeruginosa (MIC = 256 μg/mL)","[Ref.28921993] 1.6%, 0.8%, 0.6%, 0.4%, 0.7%, 1.8%, 0.4% and 0.1% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.",Linear,Free,Amidation,,L,[Ref.28921993] The toxicity of MAP-1 toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,Not found,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,17,15-18
DRAMP21626,GILDTLKQFAKGVGKWLVKGAAQ,23,E2EM23W,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic form,Typical random coil conformation with only 14% helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.,"E2EM23W showed circular dichroism spectra that are typical for a random coil, and its helical content was only 14%.",,Function: Antibacterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria is not noteable under 200 μg/mL.,"[Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 50 μg/mL), Staphylococcus aureus (MIC = 100 μg/mL), Staphylococcus epidermis (MIC > 200 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC > 200 μg/mL), Shigella dysentariae (MIC > 200 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC > 200 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC > 200 μg/mL).",[Ref.24211019] No hemolytic activity information found.,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference,Not found,24211019,Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.,"Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Truncated and constrained helical analogs of antimicrobial esculentin-2EM,23,21-24
DRAMP21627,TLKQFAKGVGKWLVK,15,E2EM15W,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil coformation with 4% helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.,"Circular dichroism also revealed that E2EM15W is even less structured under the same conditions, displaying a helical content of 4%; it is well established that the shorter a peptide is, the more difficult it is to form an α-helical conformation.",,Function: Antibacterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria is not noteable under 200 μg/mL.,"[Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 200 μg/mL), Staphylococcus aureus (MIC = 100 μg/mL), Staphylococcus epidermis (MIC > 200 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 200 μg/mL), Shigella dysentariae (MIC > 200 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC > 200 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC > 200 μg/mL).",[Ref.24211019] No hemolytic activity information found.,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference,Not found,24211019,Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.,"Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Truncated and constrained helical analogs of antimicrobial esculentin-2EM,15,12-15
DRAMP21631,RLVRILVSKRPVAIKPYFRL,20,SLAY-P1,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 2 μM), Acinetobacter baumannii 5075 (MBC ≤ 2 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 2 μM).",[Ref.29307492] The peptide showed 4.0% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21632,TTSIRRRYQVSLIRRHRGKR,20,SLAY-P2,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC ≤ 2 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).",[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21633,TCRTNRPCFYDLDLNVCRCS,20,SLAY-P3 cyclic,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC ≤ 2 μM), Acinetobacter baumannii 5075 (MBC = 4 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).",[Ref.29307492] The peptide showed 0.9% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Cyclic,Free,Free,"Disulfide bonds between Cys2 and Cys19, Cys8 and Cys17.",L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21634,SNGDGTLDAGSTCAPFYARA,20,SLAY-P4,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 2 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 4 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).",[Ref.29307492] The peptide showed 1.8% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21635,YYNPLPHDCGRDNNTDICSR,20,SLAY-P5 cyclic,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 8 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 2 μM).",[Ref.29307492] The peptide showed 1.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Cyclic,Free,Free,Disulfide bonds between Cys9 and Cys18,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21636,LSVDKRPVLHPEHIYGHNHY,20,SLAY-P6,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 32 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 128 μM).",[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21637,IHRDQQHESFLDARPEPGLTE,21,SLAY-P7,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 4 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).",[Ref.29307492] The peptide showed 0.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,21,18-21
DRAMP21638,TIDFGVRNINQSNLVYDTER,20,SLAY-P8,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 8 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC  > 128 μM).",[Ref.29307492] The peptide showed 10.8% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21639,PCNPDHDYRPFGNFRIAFTT,20,SLAY-P9,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 8 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 8 μM).",[Ref.29307492] The peptide showed 0% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21640,TRDTNDLISSRTAAPSMV,18,SLAY-P10,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 64 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).",[Ref.29307492] The peptide showed 8.4% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,18,15-18
DRAMP21641,LPLPSCSSHGGDADNTSQRN,20,SLAY-P11,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).",[Ref.29307492] The peptide showed 2.6% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21642,PNDPDSPCVYRMPNARGCSI,20,SLAY-P12,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 16 μM).",[Ref.29307492] The peptide showed 0.9% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21643,YDLSDSNCLPANRDKRYYVI,20,SLAY-P13,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21644,SMLAYVDKNDHINPPHSPRS,20,SLAY-P14,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 32 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 64 μM).",[Ref.29307492] The peptide showed 1.5% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21645,DATPHAALFFTVKDHTAGDN,20,SLAY-P15,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC = 64 μM), Pseudomonas aeruginosa 14 (MBC = 32 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 64 μM).",[Ref.29307492] The peptide showed 0.6% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21646,SDDAQRCYPHNRTPFTYTYI,20,SLAY-P16,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).",[Ref.29307492] The peptide showed 3.3% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21647,EPCSPKNNYHDLFYRT,16,SLAY-P17,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Slight antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] The peptide showed 1.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,16,15-18
DRAMP21648,CNPLNGADRRTDSFPRFTVI,20,SLAY-P18,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 64 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] The peptide showed 1.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21649,TCRTNRPCFYDLDLNVCRCS,20,SLAY-P3,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Slight antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC > 128 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC > 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] No hemolytic activity information found.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP21650,YYNPLPHDCGRDNNTDICSR,20,SLAY-P5,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,,Function: Slight antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC > 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] No hemolytic activity information found.,Linear,Free,Free,,L,No cytotoxicity information found,Unknown,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,20,18-21
DRAMP28985,GIKKFLKSXKKFVKXFK,17,peptide 1 (Derived from Mag2),No entry found,,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM,No detailed structure description,,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria,"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 12.5 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 3.125 μM), Pseudomonas aeruginosa (MIC = 3.125 μM), 
multiple-drug resistant P.aeruginosa (MIC = 3.125 μM)",[Ref.33466998] It has hemolysis against human red blood cells at 50 μM,Linear,Free,Amidation,The X (position: 9 and 15) in sequence indicate Aib residues (2-Aminoisobutyric acid),L,No cytotoxicity information found in the reference,,33466998,Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.,"Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu",Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence,17,15-18
DRAMP29006,GLFAVIKKVASVIKGL,16,A4K14-citropin1.1,No entry found,,,Synthetic construct,Anticancer,Synthetic form,"Helicity = 61.5% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)",[Ref.33363118] CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.,,"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.
A4K14-citropin 1.1 is a structurally optimized derivative of citropin-1.1 derived from amphibians' skin secreta peptide Citropin, which exhibits broad biological activities. Citropin-1.1 is Amphibian defense peptide with antibiotic and antimicrobial activity. Bowie and his team found that replacement of Asp4 and Gly14 with Ala and Lys (termed A4K14-CITROPIN 1.1) resulted in a more stable α-helix than Citropin on the C-terminal section, and it led to better biologicla activities","[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 29.05 μM), A549 (IC50 = 14.97 μM), U87 (IC50 = 14.8 μM), MCF-7 (14.16 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference,,33363118,Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.,"Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu ","Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides",16,15-18
DRAMP29028,KLLKKAGKLLKKAGKLLKKAG,21,Stripe,No entry found,,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-Helix content = 42% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate",No detailed structure description found,,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
The 'Stripe' is a rationally-designed amphipathic helical AMP comprising natural amino acids: the AMP has hydrophobic Ala/Leu on one side of the helix and cationic Lys residues on the other. It has great antimicrobial activity and weak hemolysis. However, Stripe was compeletely degraded within an hour after incubation with proteinase K at 37℃, which means a bad stability.","[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC = 12.5 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 3.125 μM), Pseudomonas aeruginosa NBRC13275 (MIC = 3.125 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC = 3.125 μM)",[Ref.33369262] Stripe showed no hemolytic activity up to a concentration of 100 μM.,Linear,Free,Free,,L,No cytotoxicity information found in the reference,,33369262,Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.,"Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu","Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling",21,18-21
DRAMP29029,KLLKKGGKLLKKGGKLLKKGG,21,Stripe-based foldamer peptide 1,No entry found,,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-Helix content = 25% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate","[Ref.33369262] Conversely, the Gly-substitutde peptide 1 showed weaker spectral intensity than other peptides, which suggests a decrease in helicity.",,"Function: Antibacterial activity against Gram-negative bacteria.
It is a helical foldmer peptide based on ""Stripe"" (an AMP  manually designed) by substituting Ala (position: 6, 13 and 20) with Gly. The peptide was less active than Stripe against four bacteria: S.aureus, E.coli, P.aeruginosa, MDRP. ","[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC > 50 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 12.5 μM), Pseudomonas aeruginosa NBRC13275 (MIC > 50 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC > 50 μM)",[Ref.33369262] Peptide 1 showed no hemolytic activity up to a concentration of 100 μM.,Linear,Free,Free,,L,No cytotoxicity information found in the reference,,33369262,Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.,"Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu","Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling",21,18-21
DRAMP29030,KLLKKXGKLLKKXGKLLKKXG,21,Stripe-based foldamer peptide 2,No entry found,,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-Helix content = 31% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate","[Ref.33369262] As shown in Figure 2, peptides 2, 3, 4 and 5 showed negative maxima at around 208 and 222nm, which suggests that they formed stable α-helical structures, similar to Stripe.",,"Function: Antibacterial activity against Gram-negative bacteria.
It is a helical foldmer peptide based on ""Stripe"" (an AMP  manually designed) by introducing hydrophobic α,α-disubstituted amino acids (Aib). The peptide exhibited two to four times higher antimicrobial activity than Stripe. Besides, it is much more stable than Stripe against proteinase K.","[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC = 3.125 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 1.56 μM), Pseudomonas aeruginosa NBRC13275 (MIC = 1.56 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC = 1.56 μM)",[Ref.33369262] Peptide 2 showed no hemolytic activity up to a concentration of 100 μM.,Linear,Free,Free,"The X (position: 6, 13 and 20) in sequence denote Aib residue.",L,No cytotoxicity information found in the reference,,33369262,Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.,"Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu","Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling",21,18-21
DRAMP29031,KLLKKZGKLLKKZGKLLKKZG,21,Stripe-based foldamer peptide 3,No entry found,,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-Helix content = 49% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate","[Ref.33369262] As shown in Figure 2, peptides 2, 3, 4 and 5 showed negative maxima at around 208 and 222nm, which suggests that they formed stable α-helical structures, similar to Stripe.",,"Function: Antibacterial activity against Gram-negative bacteria.
It is a helical foldmer peptide based on ""Stripe"" (an AMP  manually designed) by introducing hydrophobic α,α-disubstituted amino acids (1-aminocyclohexanecarboxylic acid Ac₆c). The peptide showed similar or silightly weaker activity than Stripe.","[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC = 6.25 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 3.125 μM), Pseudomonas aeruginosa NBRC13275 (MIC = 6.25 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC = 12.5 μM)",[Ref.33369262] It exhibits hemolysis at 1.56 μM agasint human red blood cells.,Linear,Free,Free,"The Z (position: 6, 13 and 20) in sequence denote Ac₆c residue (1-Aminocyclohexanecarboxylic acid).",L,No cytotoxicity information found in the reference,,33369262,Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.,"Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu","Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling",21,18-21
DRAMP29043,VDKPPYLPRPRPPRRIYNR,19,Oncocin (variant of Oncopeltus antibacterial peptide 4),No entry found,Not found,,"Synthetic construct (Oncocin is a variant of the 2 kDa Oncopeltus antibacterial peptide 4, which was originally isolated from oncopeltus fasciatus (milkweed bug))","Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Not found,Not found,,Comment: Oncocin inhibits bacterial protein translation by targeting the ribosome.,"[Ref.20565063] Gram-negative pathogens: P.aeruginosa DSM3227 (MIC = 4 μg/mL), P. aeruginosa Walter (MIC = 8 μg/mL), P. aeruginosa ATCC27853 (MIC = 4 μg/mL), P. aeruginosa PAO1 (MIC = 2 μg/mL), P. aeruginosa 60811001 (MIC = 2 μg/mL), P. aeruginosa 60909001 (MIC = 2 μg/mL), P. aeruginosa 61118003 (MIC = 2 μg/mL), P. aeruginosa 70108001 (MIC = 4 μg/mL), E. coli 70329001 (MIC = 1 μg/mL), E. coli 70430001 (MIC = 1 μg/mL), E. coli 70419002 (MIC = 8 μg/mL), E. coli 70502001 (MIC = 1 μg/mL), E. coli Neumann (MIC = 2 μg/mL), E. coli 205024 (MIC = 4 μg/mL), E. coli 455/7 (MIC = 0.5 μg/mL), E. coli 8474 (MIC = 0.5 μg/mL), K. pneumoniae DSM681 (MIC = 0.25 μg/mL), K. pneumoniae 57 USA (MIC = 0.25 μg/mL), K. pneumoniae 63 (MIC = 8 μg/mL), K. pneumoniae 8085 (MIC = 0.5 μg/mL), K. pneumoniae ATCC12657 (0.5 μg/mL), K. pneumoniae ATCC27799 (MIC = 1 μg/mL), A. baumannii ICB14067 (MIC = 1 μg/mL), A. baumannii ICB14072 (MIC = 1 μg/mL), A. baumannii ICB14073 (MIC = 2 μg/mL), A. baumannii ICB9250 (MIC = 0.5 μg/mL), A. baumannii M17 (MIC = 1 μg/mL), E. cloacae 34654 (MIC = 0.25 μg/mL), E. cloacae Ha088 (MIC = 0.125 μg/mL), E. cloacae Ha089 (0.125 μg/mL), E. cloacae Ha185 (MIC = 0.5 μg/mL), E. cloacae Ha89 (MIC = 0.25 μg/mL), P. vulgaris ICB9081 (MIC = 4 μg/mL), P. vulgaris ICB9095 (MIC = 4 μg/mL), Stenotrophomonas ICB308054 (MIC = 32 μg/mL), Stenotrophomonas ICB7569 (MIC = 8 μg/mL), Stenotrophomonas ICB7789 (MIC = 32 μg/mL)",[Ref.20565063]None of the tested peptides showed any hemolytic activity against human erythrocytes in the studied peptide concentration range up to 600 μg/mL.,Linear ,Free,Amidation,,L,"[Ref.20565063] Oncocin showed no toxic effects on HeLa- or neuronal-cell-like differentiated SH-SY5Y cells at a peptide concentration of 600 μg/mL, which was about 100-fold above their MIC-values against E.coli BL21 AI.",Bacterial ribosome,20565063##28575099,J Med Chem. 2010 Jul 22;53(14):5240-7. doi: 10.1021/jm100378b.##PLoS One. 2017 Jun 2;12(6):e0178943. doi: 10.1371/journal.pone.0178943.,"Daniel Knappe, Stefania Piantavigna, Anne Hansen, Adam Mechler, Annegret Binas, Oliver Nolte, Lisandra L Martin, Ralf Hoffmann##Böttger R, Hoffmann R, Knappe D","Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): A Novel Antibacterial Peptide Optimized against Gram-Negative Human Pathogens##Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum",19,18-21
DRAMP29047,ARLDVASEFRKKWNKWALSR,20,PAMP (Proadrenomedullin N-terminal 20 peptide),"P35318, E9PML4, L5L428",Belongs to the adrenomedullin family,ADM,Homo sapiens et.al,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,α-helical,Not found,2FLY,"Introduction: Proadrenomedullin N-terminal 20 peptide (PAMP) is a biologically active molecule (20 amino acid residues) produced by post-translational enzymatic processing of the common precursor of adrenomedullin (AM), a 185-amino acid proadrenomedullin molecule. PMAP can bee found in various types.  Function: AM and PAMP are potent hypotensive and vasodilatator agents. Numerous actions have been reported most related to the physiologic control of fluid and electrolyte homeostasis. In the kidney, am is diuretic and natriuretic, and both am and pamp inhibit aldosterone secretion by direct adrenal actions. In pituitary gland, both peptides at physiologically relevant doses inhibit basal ACTH secretion. Both peptides appear to act in brain and pituitary gland to facilitate the loss of plasma volume, actions which complement their hypotensive effects in blood vessels. PAMP can acts as an potent antimicrobial peptide which is more selective than melittin, and antimicrobial action of PAMP seems to exert via an intracellular target.","[Ref.32439180] Gram-negative bacteria: E. coli (MIC = 8 μM), P. aeruginosa (MIC = 32 μM), S. typhimurium (MIC = 16 μM)##Gram-positive bacteria:B. subtilis (MIC = 8 μM), S. epidermidis (MIC = 8 μM), S. aureus(MIC = 16 μM)",[Ref.32439180]HC10 > 256 μM against sheep RBCs.Note: HC10 is the minimum peptide concentration that caused >10% hemolysis of sheep red blood cells.,Linear ,Free,Amidation,,L,Not found,Bacterial DNA,32439180,Biochem Biophys Res Commun. 2020 Jun 30;527(3):744-750. doi: 10.1016/j.bbrc.2020.04.063. Epub 2020 May 18.,"Ajish C, Yang S, Kumar SD, Shin SY. ","Proadrenomedullin N-terminal 20 peptide (PAMP) and its C-terminal 12-residue peptide, PAMP(9-20): Cell selectivity and antimicrobial mechanism",20,18-21
DRAMP29051,KKRLKKIFKKPMVIGVTIPF,20,Ctn[15-34] (C-terminal fragment of crotalicidin),U5KJM4,Belongs to the cathelicidin family.,,Crotalus durissus terrificus (South American rattlesnake),"Antimicrobial, Antifungal",Protein level,α-helical, preserves helicity,,"Comment: Ctn[15-34] showed to be an effective antifungal peptide, displaying antibiofilm activity and, importantly, interacting with and disrupting fungal plasma membrane. Function: Potent antimicrobial peptide against Gram-negative (P.aeruginosa, K.pneumoniae, E.coli, A.baumannii) (PubMed:25100358, PubMed:26465972). Shows moderate activities against Gram-positive bacteria (E.faecalis, S.aureus, S.pyogenes) (PubMed:25100358, PubMed:26465972). Also shows antifungal activity against standard and clinical isolates of yeasts (MIC=10-40 µM) and dermatophytes (MIC=1-5 µM) (PubMed:27876749). Adopts an amphipathic alpha helical conformation, that may allow to partition into the target membrane (PubMed:26465972). Shows high toxicity towards human fibroblasts (micromolar ranges) (PubMed:26465972). Shows low hemolytic activities on human erythrocytes (PubMed:25100358, PubMed:26465972). Also shows toxicity (micromolar ranges) when tested on many leukemia cell lines (PubMed:26465972). In addition, when tested in vitro on the parasite Trypanosoma cruzi (responsible of the Chagas disease), is able to reduce the number of the three forms (epimastigote, trypomastigote and amastigote) by inducing cell death through necrosis (PubMed:29208061).","[Ref.33172206] Fungi: Candida albicans ATCC 90028 (MIC = 10 µM or 23.7 µg/mL), Candida albicans LABMIC 0125 (MIC = 10 µM or 23.7 µg/mL)",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Free,,L,Not found,Fungal plasma membrane,33172206,Int J Mol Sci. 2020 Nov 6;21(21):8339. doi: 10.3390/ijms21218339.,"Aguiar FLL, Santos NC, de Paula Cavalcante CS, Andreu D, Baptista GR, Gonçalves S. ",Antibiofilm Activity on Candida albicans and Mechanism of Action on Biomembrane Models of the Antimicrobial Peptide Ctn[15-34] ,20,18-21
DRAMP29052,FLGALFKVASKLVPAAICSISKKC,24,Brevinin-1GHd,A0A6M4CA40,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily,,Sylvirana guentheri (Gunther's frog) (Rana guentheri),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,α-helical,"The results of CD spectroscopy revealed that Brevinin-1GHd adopt a random coil structure in an aqueous environment, while forming an alpha-helix structure in a membrane-mimetic environment.",,"Comment: Brevinin-1GHd with its excellent antimicrobial and anticancer activities is a promising candidate for a novel antibiotic agent, and study of its structure activity relationships also provided a rational template for further research and peptide analog design. In the reference, the example of Brevinin-1GHd is used to challenge the importance of ""Rana-Box"", which appears in many AMPs originating from frogs and contains an intermolecular disulfide bridge at the C-terminus of the peptide and seven to nine amino acid residues.","[Ref.32347293] Gram-positive bacteria: S. aureus (MIC = 2 μM/MBC= 4 µM), MRSA(MIC = 4 μM/MBC = 4µM); ##Gram-negative: E. coli(MIC = 8 μM/MBC = 8 µM), P. aeruginosa(MIC = 32 μM/MBC = 32µM); ##Fungi: C. albicans(MIC = 4 μM/MBC = 8µM）","[Ref.32347293] Brevinin-1GHd displayed 13% hemolysis on horse red blood cells at its highest MIC/MBC value of the tested bacteria P. aeruginosa (32 µM). However, when the concentration increased above 64 μM, the hemolytic activity of Brevinin-1GHd also gradually increased. At the concentration of 64, 128, 256 and 512 μM, it displayed about 36%, 64%, 83% and 108% hemolysis.",Cyclic ,Free,Free,Free,L,"[Ref.32347293]Brevinin-1GHd showed significant cytotoxicity toward human HMEC-1 and HaCaT cells at concentrations of 0.00001 and 0.0001 M, respectively. Brevinin-1GHd induced one cell viability of 56% on HMEC-1 and the other cell viability of 75% on HaCat.",Cell membrane,32347293,Biosci Rep. 2020 May 29;40(5):BSR20200019. doi: 10.1042/BSR20200019.,"Jiang Y, Wu Y, Wang T, Chen X, Zhou M, Ma C, Xi X, Zhang Y, Chen T, Shaw C, Wang L. ",Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential ,24,21-24
DRAMP29056,LRCMCIKWWSGKHPK,15,TC19 (derived from the human thrombocidin-1-derived peptide L3),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,,"Comment: TC19 combined low cytotoxicity towards human fibroblasts with efficient and rapid killing in human plasma of MDR strains of several bacterial species of the ESKAPE panel. However, the hemolytic activity data and secondary structure is missing.","[Ref.32376222] Gram-positive bacteria: E. coli ESBL (LC99.9 = 3.75 μM in PT buffer, LC99.9 = 15 μM in PBS buffer); ##Gram-negative bacteria: S. aureus JAR060131 (LC99.9 = 3.75 μM in PT buffer, LC99.9 = 7.5-15 μM in PBS buffer, LC99.9 = 15-30 μM in 50% plasma).##Multi-drug resistant (MDR) gram-positive bacteria:  E.faecium LUH10330 (LC99.9 = 1.6(1.6-3.2) μM in PBS buffer, LC99.9 =6.4 (3.2-6.4) μM in 50% plasma), S.aureus LUH14616 (LC99.9 = 3.2(3.2-6.4) μM in PBS buffer, LC99.9 = 12.8 (3.2-12.8) μM in 50% plasma).##Multi-drug resistant (MDR) and pan-drug resistant (PDR) gram-negative bacteria: K.pneumoniae LUH8995 (LC99.9 = 1.6(0.8-1.6) μM in PBS buffer, LC99.9 = 3.2 μM in 50% plasma), A.baumannii RUH875 (LC99.9 = 1.6(1.6-3.2) μM in PBS buffer, LC99.9 =6.4 (6.4-12.8) μM in 50% plasma), P.aeruginosa LUH15100 (LC99.9 = 4.8(3.2-6.4) μM in PBS buffer, LC99.9 > 204.8 μM in 50% plasma), E.cloacae LUH15114 (LC99.9 = 25.6 μM in PBS buffer, LC99.9 = 204.8 μM in 50% plasma)##Note: Results are expressed as the lethal concentration (LC) 99.9%, i.e. the lowest peptide concentration that resulted in >= 99.9% killing of bacteria after 2 h of incubation in PT buffer (10 mM phosphate buffer, pH 7.0, with 1% (v/v) TSB), phosphate buffered saline (PBS, pH 7.4) and in PBS with 50% (v/v) human plasma (one experiment, performed in duplicate). ",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,,L,"[Ref.32891601]Up to 40 μM TC19 did not permeabilize human fibroblasts, whereas at 80 μM an increase in PI-positivity was recorded after 4 h of exposure. After 4h of incubation with TC19 at indicated concentration (80 μM), PI-uptake by normal human dermal fibroblasts (NHDF) had increased from 5% to 20% comparing to the result after 1h of incubation.",Bacterial membrane,32376222,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183282. doi: 10.1016/j.bbamem.2020.183282. Epub 2020 May 3.,"Riool M, de Breij A, Kwakman PHS, Schonkeren-Ravensbergen E, de Boer L, Cordfunke RA, Malanovic N, Drijfhout JW, Nibbering PH, Zaat SAJ.",Thrombocidin-1-derived antimicrobial peptide TC19 combats superficial multi-drug resistant bacterial wound infections ,15,12-15
DRAMP29057,RIVQRIKKWLLKWKKLGY,18,P5,No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helical,Not found,,Comment: This new peptide could be good candidates for future drug development for anti-biofilm and anti-infective therapy.,"[Ref.31778756] Gram-negative bacteria: P. aeruginosa (MIC = 64 μg/mL, MBC = 128 μg/mL); ##Gram-positive bacteria: S. aureus (MIC = 16 µg/mL, MBC = 64 μg/mL)",[Ref.31778756]P5 displayed less than 10% hemolysis in all the range tested (0-1024 μg/mL),Linear ,Free,Free,,L,Not found,Bacterial cytoplasmic membranes,31778756,Microb Pathog. 2020 Feb;139:103886. doi: 10.1016/j.micpath.2019.103886. Epub 2019 Nov 25.,"Martínez M, Polizzotto A, Flores N, Semorile L, Maffía PC","Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2 ",18,15-18
DRAMP29058,KGLLRKWGKKWKEFLRRVW,19,P6.2,No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helical,Not found,,Comment: This new peptide could be good candidates for future drug development for anti-biofilm and anti-infective therapy.,"[Ref.31778756] Gram-negative bacteria: P. aeruginosa (MIC = 16 μg/mL, MBC = 32 μg/mL); ##Gram-positive bacteria: S. aureus (MIC = 32 µg/mL, MBC = 128 μg/mL)","[Ref.31778756]P6.2 exhibited a concentration dependent hemolytic activity, reaching values of 30% at the highest concentration(1024 μg/mL), but remaining below 5% until 128 μg/ml, which is fourfold or eightfold the MIC obtained for S.aureus or P.aeruginosa, respectively.",Linear ,Free,Free,,L,Not found,Bacterial cytoplasmic membranes,31778756,Microb Pathog. 2020 Feb;139:103886. doi: 10.1016/j.micpath.2019.103886. Epub 2019 Nov 25.,"Martínez M, Polizzotto A, Flores N, Semorile L, Maffía PC","Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2 ",19,18-21
DRAMP29065,KTMMQSGGTFGTFMAIGMGIR,21,AMPR-11(derived from Romo1),P60602,Belongs to the MGR2 family.,ROMO1,Homo sapiens (Human),"Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+",Protein level,α-helical,"AMPR-11 formed a random coil structure in distilled water but formed an ordered conformation in 50% hexafluoro-2-propanol (HFIP), which has been used for implementing a membrane-mimic environment ",,"Comment: AMP derived from Romo1 (AMPR-11) is a promising agent for treatment of sepsis caused by MDR bacteria, and AMPR-11 could be combined with other potential antibiotics for clinical treatment.","[Ref.33291307] Gram-positive bacteria: S. aureus(MBC=100 μg/mL), B. subtilis(MBC=90 μg/mL), E. faecium(MBC=85 μg/mL), S. sindenensis(MBC=95 μg/mL), E. faecalis(MBC=85 μg/mL), S. pneumoniae(MBC=100 μg/mL)##Gram-negative bacteria: E. coli(MBC=85 μg/mL), P. aeruginosa(MBC=100 μg/mL), K. pneumoniae(MBC=100 μg/mL), A. baumannii(MBC=100 μg/mL), E. aerogenes(MBC=90 μg/mL)##Multi-drug resistant bacteria: Methicillin-resistant S. aureus(MBC=100 μg/mL), Carbapenem-resistant P. aeruginosa(MBC=110 μg/mL), Carbapenem-resistant A. baumannii(MBC=110 μg/mL), Carbapenem-resistant K. pneumoniae(MBC=100 μg/mL), Vancomycin-resistant S. aureus(MBC=120 μg/mL), Vancomycin-resistant E. faecium(MBC=100 μg/mL )","[Ref.33291307]At the concentration of 32 μg/mL, AMPR-11 induced a hemolysis of 20% on mouse red blood cells; At the concentration of 256 μg/mL, AMPR-11 induced a hemolysis of 23%.",Linear ,Free,Free,,L,"[Ref.33291307] ①The cell viability of HeLa cells was 90%, 87%, 83% and 79% at the concentration of 32, 64, 128 and 256 μg/mL. ②The cell viability of HEK293 cells was 86%, 83%, 80% and 78% at the concentration of 32, 64, 128 and 256 μg/mL. ③The cell viability of HeLa cells was 89%, 86%, 83% and 80% at the concentration of 32, 64, 128 and 256 μg/mL. ",Bacterial membrane,32291307,mBio. 2020 Apr 14;11(2):e03258-19. doi: 10.1128/mBio.03258-19.,"Lee HR, You DG, Kim HK, Sohn JW, Kim MJ, Park JK, Lee GY, Yoo YD",Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis ,21,18-21
DRAMP29066,GFAWNVCVYRNGVRVCHRRAN,21,Marine peptide-N6,No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+",Synthetic form,"β-turn, coil and antiparallel sheet","①The structure analysis showed that N6  have one rigid disulfide bridge Cys7-Cys16, which links the two β-strands (Cys3-Asn10 and Arg13-Cys20) and forms an anti-parallel β-sheet. ②The secondary structures of N6NH2 and N6 in ddH2O were characterized by a coil and antiparallel strand or β-turn with a negative minimum at 200 nm. N6NH2 showed a more significant increase in α-helix and antiparallel strand in SDS solution than N6. Similarly, the CD spectrum of N6 and N6NH2 in 50% TFE showed one negative dichroic band at approximately 205 nm, and the positive maximum at 180 nm (strong) and at 230 nm ",5Y0H,Comment: N6NH2 and N6 are different from common antimicrobial peptides in the secondary structure. N6 has good antimicrobial activity.,"[Ref.33348729] Gram-negative bacteria: Edwardsiella tarda(MIC = 6.4 μg/mL), Aeromonas veronii(MIC = 6.4 μg/mL), Escherichia coli CVCC195(MIC = 0.5 μg/mL), E. coli CVCC1515(MIC = 1 μg/mL), E. coli CVCC25922(MIC = 0.25 μg/mL), E. coli CVCCO157(MIC = 0.5 μg/mL), Salmonella typhimurium CVCC533(MIC = 1 μg/mL), S. typhimurium ATCC14028(MIC = 2 μg/mL), S. enteritidis CVCC3377(MIC = 0.25 μg/mL), S. pullorum CVCC1802(MIC = 0.5 μg/mL), S. pullorum CVCC1789(MIC = 0.5 μg/mL), Pseudomonas aeruginosa CICC21630(MIC = 4 μg/mL). ##Gram-positive bacteria: Staphylococcus aureus ATCC43300(MIC = 16 μg/mL), S. aureus ATCC546(MIC = 4 μg/mL), S. aureus ATCC25923(MIC = 0.25 μg/mL), S. hyicus 437-2(MIC = 64 μg/mL), S. hyicus 15095(MIC = 16 μg/mL).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic ,Free,Free,There is a disulfide bond between Cys7 and Cys16,L,[Ref.33348729]Had very low cytotoxicity to mouse peritoneal RAW 264.7 macrophages (cell survival rate >93.35%),Lipopolysaccharide (LPS) and genomic DNA,33348729,Mar Drugs. 2020 Dec 17;18(12):650. doi: 10.3390/md18120650.,"Han H, Li T, Wang Z, Teng D, Mao R, Hao Y, Yang N, Wang X, Wang J.",Improved Stability and Activity of a Marine Peptide-N6NH2 against Edwardsiella tarda and Its Preliminary Application in Fish ,21,18-21
DRAMP29067,GFAWNVCVYRNGVRVCHRRAN,21,N6NH2 (N6 amidated at its C-terminus),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+",Synthetic form,"β-turn, coil and antiparallel sheet","①The structure analysis showed that N6  have one rigid disulfide bridge Cys7-Cys16, which links the two β-strands (Cys3-Asn10 and Arg13-Cys20) and forms an anti-parallel β-sheet. ②The secondary structures of N6NH2 and N6 in ddH2O were characterized by a coil and antiparallel strand or β-turn with a negative minimum at 200 nm. N6NH2 showed a more significant increase in α-helix and antiparallel strand in SDS solution than N6. Similarly, the CD spectrum of N6 and N6NH2 in 50% TFE showed one negative dichroic band at approximately 205 nm, and the positive maximum at 180 nm (strong) and at 230 nm ",5Y0H,"Comment: In the model of fish peritonitis caused by E. tarda, superior to norfloxacin, N6NH2 improved the survival rate of fish, reduced the bacterial load on the organs, alleviated the organ injury and regulated the immunity of the liver and kidney. Amidation of the C-termini seems to be important in improving the lytic activity of the peptides against pathogenic bacteria. N6NH2 and N6 are different from common antimicrobial peptides in the secondary structure.","[Ref.33348729] Gram-negative bacteria: Edwardsiella tarda(MIC = 0.5 μg/mL), Aeromonas veronii(MIC = 2 μg/mL), Escherichia coli CVCC195(MIC = 0.06 μg/mL), E. coli CVCC1515(MIC = 0.06 μg/mL), E. coli CVCC25922(MIC = 0.06 μg/mL), E. coli CVCCO157(MIC = 0.06 μg/mL), Salmonella typhimurium CVCC533(MIC = 0.25 μg/mL), S. typhimurium ATCC14028(MIC = 0.06 μg/mL), S. enteritidis CVCC3377(MIC = 0.06 μg/mL), S. pullorum CVCC1802(MIC = 0.25 μg/mL), S. pullorum CVCC1789(MIC = 0.06 μg/mL), Pseudomonas aeruginosa CICC21630(MIC = 0.06 μg/mL). ##Gram-positive bacteria: Staphylococcus aureus ATCC43300(MIC = 1 μg/mL), S. aureus ATCC546(MIC = 1 μg/mL), S. aureus ATCC25923(MIC = 1 μg/mL), S. hyicus 437-2(MIC = 16 μg/mL), S. hyicus 15095 (MIC = 4 μg/mL).","[Ref.33348729]The hemolysis of N6NH2 towards mouse erythrocytes was 0.19% at a concentration of 256 μg/mL, lower than that of N6 (1.9%), indicating their low hemolytic activity ",Cyclic ,Free,Amidation,There is a disulfide bond between Cys7 and Cys16,L,[Ref.33348729]Had very low cytotoxicity to mouse peritoneal RAW 264.7 macrophages (cell survival rate >93.35%),Lipopolysaccharide (LPS) and genomic DNA,33348729,Mar Drugs. 2020 Dec 17;18(12):650. doi: 10.3390/md18120650.,"Han H, Li T, Wang Z, Teng D, Mao R, Hao Y, Yang N, Wang X, Wang J.",Improved Stability and Activity of a Marine Peptide-N6NH2 against Edwardsiella tarda and Its Preliminary Application in Fish ,21,18-21
DRAMP29068,kFwSLLkKAlrLwKkVL,17,CPF-2-1 (Variant of CPF-C1),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic form,α-helical (most likely),Not found,,"Comment: CPF-2 has potential as a lead compound to treat infections caused by S. aureus and MRSA, including the associated biofilms.","[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 16 μg/mL, MIC = 16 μg/mL in 10% serum, MIC = 32 μg/mL in 150 mM)","[Ref.32590058]It showed almost no hemolytic activity, even at concentrations up to 128 μg/ml.",Linear ,Free,Amidation,Introduction of D-amino acid(s). (Look at 'Stereochemistry'),"Mixed (D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13 and D-Lys15)",Not found,Bacterial membrane,32590058,Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.,"Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.",CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA ,17,15-18
DRAMP29069,kFwSLLkKAlrLwAkVL,17,CPF-2-2 (Variant of CPF-C1),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic form,α-helical (most likely),Not found,,"Comment: CPF-2 has potential as a lead compound to treat infections caused by S. aureus and MRSA, including the associated biofilms.","[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 8 μg/mL, MIC = 128 μg/mL in 10% serum, MIC = 8 μg/mL in 150 mM, MBIC50 = 16 μg/mL, MBIC90 = 16 μg/mL, MBEC = 16 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 16 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 16 μg/mL), S. aureus 794 (MIC = 8 μg/mL)","[Ref.32590058]It showed almost no hemolytic activity, even at concentrations up to 128 μg/ml",Linear ,Free,Amidation,Introduction of D-amino acid(s). (Look at 'Stereochemistry'),"Mixed (D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13 and D-Lys15)",Not found,Bacterial membrane,32590058,Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.,"Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.",CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA ,17,15-18
DRAMP29070,GFGSLLGKALRLWKKVL,17,CPF-13 (Variant of CPF-C1),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic form,α-helical,Not found,,Comment: CPF-13 showed improved antimicrobial activities against S. aureus and stabilities in serum and salt solution.,"[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 4 μg/mL, MIC = 8 μg/mL in 10% serum, MIC = 4 μg/mL in 150 mM, MBIC50 = 4 μg/mL, MBIC90 = 8 μg/mL, MBEC = 8 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 8 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 8 μg/mL), S. aureus 794 (MIC = 8 μg/mL)","[Ref.32590058]It showed significant toxicity at high concentrations. At the concentration of 16, 32, 64 and 128 μg/mL, CPF-13 displayed 2%, 10%, 72% and 72% hemolysis, respectively.",Linear ,Free,Amidation,,L,Not found,Bacterial membrane,32590058,Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.,"Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.",CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA ,17,15-18
DRAMP29071,GFGSLLGKALRLwKkVL,17,CPF-14 (Variant of CPF-C1),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic form,α-helical,Not found,,Comment: CPF-14 showed improved antimicrobial activities against S. aureus and stabilities in serum and salt solution.,"[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 8 μg/mL, MIC = 4 μg/mL in 10% serum, MIC = 8 μg/mL in 150 mM, MBIC50 = 16 μg/mL, MBIC90 = 16 μg/mL, MBEC = 32 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 8 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 8 μg/mL), S. aureus 794 (MIC = 8 μg/mL)",[Ref.32590058]It exhibited low hemolytic activity against mouse RBCs. CPF-14 displayed 4% and 13% hemolysis at the concentration of 64 and 128 μg/mL,Linear ,Free,Amidation,Introduction of D-amino acid(s). (Look at 'Stereochemistry'),Mixed (D-Trp13 and D-Lys15),Not found,Bacterial membrane,32590058,Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.,"Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.",CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA ,17,15-18
DRAMP29072,GFGSLLGKAlrLwKkVL,17,CPF-15 (Variant of CPF-C1),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+",Synthetic form,α-helical (most likely),Not found,,Comment: CPF-15 had low antimicrobial activity.,[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 64 μg/mL),"[Ref.32590058]It showed significant toxicity at high concentrations. CPF-15 displayed 5%, 12%, 23%, 50% and 67% at the concentrations of 8, 16, 32, 64, 128 μg/mL",Linear ,Free,Amidation,Introduction of D-amino acid(s). (Look at 'Stereochemistry'),"Mixed (D-Leu10, D-Arg11,D-Trp13 and D-Lys15)",Not found,Bacterial membrane,32590058,Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.,"Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.",CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA ,17,15-18
DRAMP29074,KRFWQLVPLAIKIYRAWKRR,20,dCATH (duck cathelicidin),A0A493U1S6,Not found,,Anas platyrhynchos platyrhynchos (Northern mallard),"Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+",Synthetic form,Unknown,"Initially, four analog peptides were designed by truncating two, four, six, and eight amino acids at the N-terminal ends of dCATH peptide. dCATH and its truncated analogs could not adopt the amphipathic α-helical structure since the hydrophobic and charged residues were dispersed all around the molecule. ",,Comment: The peptide induces potent antimicrobial activity.,"[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 8 μM), B. subtilis KCTC 3068 (MIC = 8 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 16 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 8 μM), VREF ATCC 51559(MIC = 16 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 8 μM), P. aeruginosa KCTC 1637(MIC = 16 μM), S. typhimurium KCTC 1926 (MIC = 4 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 16 μM), MDRPA CCARM 2109 (MIC = 16 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 16 μM).",[Ref.32698035] HC10 = 5.1 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).,Linear ,Free,Free,,L,"[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40 and 80 μM, the cell survival of dCATH against human bone marrow SH-SY5Y cells is 103%, 103%, 100%, 68%, 36%, 13% and 8%.",Not found,32698035,Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.,"Kumar SD, Shin SY",Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization ,20,18-21
DRAMP29075,FWQLVPLAIKIYRAWKRR,18,dCATH 18 (modified from dCATH),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+",Synthetic form,Unknown,"Initially, four analog peptides were designed by truncating two, four, six, and eight amino acids at the N-terminal ends of dCATH peptide. dCATH and its truncated analogs could not adopt the amphipathic α-helical structure since the hydrophobic and charged residues were dispersed all around the molecule. ",,Comment: The peptide induces potent antimicrobial activity.,"[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 16 μM), B. subtilis KCTC 3068 (MIC = 8 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 32 μM), VREF ATCC 51559(MIC = 32 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 16 μM), P. aeruginosa KCTC 1637(MIC = 16 μM), S. typhimurium KCTC 1926 (MIC = 8 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 32 μM), MDRPA CCARM 2109 (MIC = 32 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 16 μM), C. albicans KCTC 7121 (MIC = 16 μM).",[Ref.32698035] HC10 = 1.3 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).,Linear ,Free,Amidation,,L,"[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 18 against human bone marrow SH-SY5Y cells is 102%, 83%, 75%, 52%, 23%, 9%, 7%.",Not found,32698035,Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.,"Kumar SD, Shin SY",Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization ,18,15-18
DRAMP29076,QLVPLAIKIYRAWKRR,16,dCATH 16 (modified from dCATH),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+",Synthetic form,Unknown,"Initially, four analog peptides were designed by truncating two, four, six, and eight amino acids at the N-terminal ends of dCATH peptide. dCATH and its truncated analogs could not adopt the amphipathic α-helical structure since the hydrophobic and charged residues were dispersed all around the molecule. ",,Comment: The peptide induces potent antimicrobial activity.,"[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 16 μM), B. subtilis KCTC 3068 (MIC = 16 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 32 μM), VREF ATCC 51559(MIC = 32 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 32 μM), P. aeruginosa KCTC 1637(MIC = 16 μM), S. typhimurium KCTC 1926 (MIC = 16 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 32 μM), MDRPA CCARM 2109 (MIC = 32 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 16 μM).",[Ref.32698035] HC10 = 180 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).,Linear ,Free,Amidation,,L,"[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 16 against human bone marrow SH-SY5Y cells is 98%, 95%, 91%, 86%, 54%, 36%, 32%.",Not found,32698035,Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.,"Kumar SD, Shin SY",Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization ,16,15-18
DRAMP29084,GVTFNALKGVAKTVAAQLLKTAR,23,Brevinin-GR23,No entry found,Not found,,Hylarana guentheri,"Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+",Synthetic form,α-helical,Not found,,"Comment: Although B-GR23 did not show a potent antimicrobial and antibiofilm activity, the outstanding characteristic is the low toxicity on human blood red cells, which makes it an ideal template peptide to derive more powerful antimicrobial peptides","[Ref.31549575] Gram-positive bacteria: Staphylococcus aureus (MIC = 16 μM), Streptococcus mutans(MIC > 100 μM);##Gram-negative bacteria: Escherichia coli (MIC = 64 μM), Pseudomonas aeruginosa(MIC > 100 μM);##Yeast: Canidia albican (MIC > 100 μM)","[Ref.31549575]B-GR23 induced a hemolysis of 0.13%, 0.23%, 0.38%, 0.75%, 0.83% and 1.60% on human blood red cells at the concentrations of 25, 50, 75, 100, 150 and 200 μM.",Linear ,Free,Amidation,,L,Not found,Cell membrane,31549575,Biosci Biotechnol Biochem. 2020 Jan;84(1):143-153. doi: 10.1080/09168451.2019.1670045. Epub 2019 Sep 24.,"Hengren Zhong, Zhipeng Xie, Shuxia Zhang, Hanqi Wei, Yanting Song, Yingxia Zhang, Manchuriga Wang",Brevinin-GR23 from frog Hylarana guentheri with antimicrobial and antibiofilm activities against Staphylococcus aureus,23,21-24
DRAMP29085,GLVTDTLKGAAKTVAAELLRKAH,23,B-GH23-1 ,No entry found,Not found,,Hylarana guentheri,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Not found,Not found,,Comment: B-GH23-1 had slight antibacterial activity on S.aureus,"[Ref.31549575] Gram-positive bacteria: Staphylococcus aureus (MIC = 32-64 μM), Streptococcus mutans(MIC > 100 μM);##Gram-negative bacteria: Escherichia coli (MIC > 100 μM), Pseudomonas aeruginosa(MIC > 100 μM);##Yeast: Canidia albican (MIC > 100 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,,L,Not found,Cell membrane,31549575,Biosci Biotechnol Biochem. 2020 Jan;84(1):143-153. doi: 10.1080/09168451.2019.1670045. Epub 2019 Sep 24.,"Hengren Zhong, Zhipeng Xie, Shuxia Zhang, Hanqi Wei, Yanting Song, Yingxia Zhang, Manchuriga Wang",Brevinin-GR23 from frog Hylarana guentheri with antimicrobial and antibiofilm activities against Staphylococcus aureus,23,21-24
DRAMP29086,GVITDALKGAAKTVAAELPRKAH,23,B-GH23-2 ,No entry found,Not found,,Hylarana guentheri,Non-antimicrobial,Synthetic form,Not found,Not found,,Comment: B-GH23-2 did not have any antimicrobial activity.,"[Ref.31549575] Gram-positive bacteria: Staphylococcus aureus (MIC > 100 μM), Streptococcus mutans(MIC > 100 μM);##Gram-negative bacteria: Escherichia coli (MIC > 100 μM), Pseudomonas aeruginosa(MIC > 100 μM);##Yeast: Canidia albican (MIC > 100 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Linear ,Free,Amidation,,L,Not found,Cell membrane,31549575,Biosci Biotechnol Biochem. 2020 Jan;84(1):143-153. doi: 10.1080/09168451.2019.1670045. Epub 2019 Sep 24.,"Hengren Zhong, Zhipeng Xie, Shuxia Zhang, Hanqi Wei, Yanting Song, Yingxia Zhang, Manchuriga Wang",Brevinin-GR23 from frog Hylarana guentheri with antimicrobial and antibiofilm activities against Staphylococcus aureus,23,21-24
DRAMP29091,GRTSKQELCTWERGSVRQADKTIAG,25,Skh-AMP1,No entry found,"Belongs to the Lamiaceae family, subfamily Nepetoideae.",,Satureja khuzistanica,"Antimicrobial, Antifungal",Natural peptide,α-helical,"Evaluation of the peptide three-dimensional structure showed that, despite the unusual distribution of amino acids in the Wheel projection, Skh-AMP1 maybe forms a α-helix structure with more hydrophobic C-terminal than that of the N-terminal. ",,"Comment: The antifungal activity of Skh-AMP1 may be related to its ability to disrupt fungal cell membrane permeabilization and induce enhanced ROS production. Therefore, Skh-AMP1 can be introduced as a novel antifungal candidate for developing new therapeutic agents.","[Ref.31128493] Fungi: Candida albicans ATCC 10231 (MIC = 21.6 μM, MFC = 43.2 μM), Candida krusei DSM 70079 (MIC = 20.7 μM, MFC = 41.4 μM), Candida glabrata ATCC 90030 (MIC = 19.8 μM, MFC = 39.6 μM), Aspergillus niger ATCC 9029 (MIC = 22.5 μM, MFC = 45  μM), Aspergillus flavus PFCC 100 (MIC = 23.4 μM, MFC = 58.5 μM), Aspergillus fumigatus Af 293 (MIC = 20.7 μM, MFC = 41.4 μM)","[Ref.31128493] Using human erythrocytes, the hemolytic activity of Skh-AMP1 at concentrations from 3.6 μM to 72 μM was reported in the range of 0.19%–2.1%. At the MIC concentration of 25.2 μM, a very low hemolytic activity of 0.67% (SD = 0.02) was observed. Also, this peptide at MFC concentrations (36, 54 and 72 μM) showed 0.98%, 1.45% and 2.1% hemolytic activity for human erythrocytes.",Linear ,Free,Free,,L,"[Ref.31128493] Skh-AMP1 has about 3.6% cytotoxicity at the concentration of 25.2 μM in 48 h. Therefore, this peptide had no significant cytotoxic effect at the concentrations of 12.6 and 25.2 μM at 6, 24, and 48 h. However, Skh-AMP1 has about 12% and 27% cytotoxicity at the concentration of 50.4 μM and 63 μM, respectively",Fungal membrane,31704210##31128493,Peptides. 2020 Jan;123:170195. doi: 10.1016/j.peptides.2019.170195. Epub 2019 Nov 6.##Phytochemistry. 2019 Aug;164:136-143. doi: 10.1016/j.phytochem.2019.05.011. Epub 2019 May 23.,"Khani S, Seyedjavadi SS, Hosseini HM, Goudarzi M, Valadbeigi S, Khatami S, Ajdary S, Eslamifar A, Amani J, Imani Fooladi AA, Razzaghi-Abyaneh M##Soghra Khani, Sima Sadat Seyedjavadi, Hadi Zare-Zardini, Hamideh Mahmoodzadeh Hosseini, Mehdi Goudarzi, Shohreh Khatami, Jafar Amani, Abbas Ali Imani Fooladi, Mehdi Razzaghi-Abyaneh","Effects of the antifungal peptide Skh-AMP1 derived from Satureja khuzistanica on cell membrane permeability, ROS production, and cell morphology of conidia and hyphae of Aspergillus fumigatus. ##Isolation and functional characterization of an antifungal hydrophilic peptide, Skh-AMP1, derived from Satureja khuzistanica leaves",25,24-27
DRAMP29092,FKRLKKLISWIKRKRQQ,17,Hn-Mc (a chimeric peptide comprised of the N-terminus of HPA3NT3 and the C-terminus of melittin),No entry found,Not found,,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Anti-inflammatory",Synthetic construct,Random coil or α-helical structure,"Hn-Mc adopted a random coil structure in the SUVs containing a mammalian membrane and in the buffer; however, it adopted an α-helical structure in SUVs containing a fungal membrane, indicating that it was not bound to the mammalian membrane but rather adhered to or inserted in the fungal membrane. ",,"Comment: Hn-Mc has a high affinity for the fungal plasma membrane and induces apoptosis in fungal cells, and provide guidance for the development of new antifungal agents. Hn-Mc is an excellent model peptide with potent antibacterial activity and non-cytotoxicity.","[Ref.32731574]Yeast: C. albicans (MIC = 16 μM), C. krusei (MIC = 8 μM), C. parapsilosis (MIC = 16 μM), C. tropicalis (MIC = 4 μM), T. beigellii (MIC = 1 μM);##Mold: T. rubrum (MIC = 1-2 μM), F. moniliforme(MIC = 1-2 μM), F. solani(MIC = 1 μM), F. oxysporum(MIC = 1-2 μM), A. flavus(MIC = 2-4 μM), A. fumigatus(MIC = 2-4 μM). ##[Ref.26028561] Drug-susceptible gram-negative bacteria: E. coli (MIC = 1 μM), P. aeruginosa (MIC = 2 μM); ##Drug-susceptible gram-positive bacteria: S. aureus (MIC = 2 μM), B. subtilis(MIC = 2 μM);##Drug-resistant bacteria:  P. aeruginosa DRPA-001 (MIC = 1 μM),  P. aeruginosa DRPA-002 (MIC = 1 μM),  P. aeruginosa DRPA-003 (MIC = 1 μM),  P. aeruginosa DRPA-004 (MIC = 1 μM),  P. aeruginosa DRPA-005 (MIC = 2 μM), S. aureus DRSA-001 (MIC = 2 μM), S. aureus DRSA-002 (MIC = 2 μM), S. aureus DRSA-003 (MIC = 1 μM), S. aureus DRSA-004 (MIC = 2 μM), S. aureus DRSA-005 (MIC = 2 μM).","[Ref.26028561] HPA3NT3 and melittin revealed the hemolysis of 68.2% and 100% at 250 μM, respectively, but Hn-Mc was 1.1% at the same concentration",Linear ,Free,Amidation,,L,"[Ref.26028561] The IC50 of HPA3NT3, melittin and Hn-Mc against HaCaT cells were 49.5, 2.8 and 357.5 μM, respectively",Mitochondria (possibily),32731574##26028561,Antibiotics (Basel). 2020 Jul 28;9(8):454. doi: 10.3390/antibiotics9080454.##Biochem Biophys Res Commun. 2015 Jul 31;463(3):322-8. doi: 10.1016/j.bbrc.2015.05.063. Epub 2015 May 29.,"Kim JY, Park SC, Noh G, Kim H, Yoo SH, Kim IR, Lee JR, Jang MK.##Young-Min Kim, Nam-Hong Kim, Jong-Wan Lee, Jin-Sun Jang, Yung-Hoon Park, Seong-Cheol Park, Mi-Kyeong Jang",Antifungal Effect of A Chimeric Peptide Hn-Mc against Pathogenic Fungal Strains. ##Novel chimeric peptide with enhanced cell specificity and anti-inflammatory activity.,17,15-18
DRAMP29097,TQQAFQKFLAAVTSALGKQYH,21,SHβAP,No entry found,Not found,Not found,Katsuwonus pelamis,"Antimicrobial, Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal",Not found,Alpha helix,Not found,,Function:SHβAP showed broad spectrum antimicrobial activity without hemolytic activity.Antimicrobial activity of the peptide was heatstable and pH resistant but is sensitive to proteases and salt.The action mode of SHβAP is bacteriostatic process rather than bactericidal one.,[Ref.24495783]Gram-positive bacteria:B.subtilis KCTC1021(MEC=16.0 μg/mL); B.subtilis RM125(MEC=6.5 μg/mL); S.aureus KCTC1621(MEC=57.0 μg/mL);S.iniae FP5229(MEC=23.0 μg/mL);##Gram-negative bacteria:E.coli D31(MEC=15.0 μg/mL); E.coli KCTC1116(MEC=2.6 μg/mL); E.coli ML35p(MEC=6.2 μg/mL); P.aeruginosa KCTC2004(MEC=19.0 μg/mL); S.enterica KCTC2514(MEC=2.0 μg/mL); S.sonnei KCTC2009(MEC=6.0 μg/mL);A.hydrophila KCTC2358(MEC>125.0 μg/mL); V.parahaemolyticus HUFP91(MEC=1.9 μg/mL); V.parahaemolyticus KCCM41664(MEC=1.5 μg/mL);##Yeast:C.albicans KCTC7965(MEC=12.0 μg/mL).,[Ref.24495783]not cause hemolysis against RBCs up to 100 μg/mL concentration.,Linear,Free,Free,,L,[Ref.24495783]No cytotoxicity information found.,liposomes,24495783,Fish Shellfish Immunol. 2014 Mar;37(1):173-83. ,"Seo JK, Lee MJ, Jung HG, Go HJ, Kim YJ, Park NG. ","Antimicrobial function of SHβAP, a novel hemoglobin β chain-related antimicrobial peptide, isolated from the liver of skipjack tuna, Katsuwonus pelamis.",21,18-21
DRAMP29100,GIRDVLKGAAKAFVKTVAGHIAN,23,Ascaphin-1 [F2I],P0CJ25,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram-",Protein level,Not found,Not found,,Function:Antibacterial activity against Gram-positive bacteria,[Ref.19947578]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=4 µM).,[Ref.19947578]25% hemolysis against human erythrocytes at 100 µM.,Linear,Free,Amidation,,L,[Ref.19947578]No cytotoxicity information found.,liposomes,19947578,J Chem Inf Model. 2009 Dec;49(12):2873-82.,"Juretić D, Vukicević D, Ilić N, Antcheva N, Tossi A.",Computational design of highly selective antimicrobial peptides.,23,21-24
DRAMP29101,GFKDLLKGAAKALVKAVLF,19,Ascaphin-8 [T16A],P0CJ32,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Anti-cancer, Antifungal",Protein level,Alpha helix,45% α-helix was determined from the circular dichroism spectra recorded in 50% trifluoroethanol-water.,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=6 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=6 µM).##Cancer:human hepatoma‐derived cells HepG2 (LC50=9 µM).,[Ref.18554256]Hemolysis against human erythrocytes (LC50=22 µM).,Linear,Free,Amidation,,L,[Ref.18554256]Cytotoxicity:Mouse fibroblasts L929 (LC50=5 µM).,liposomes,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64. ,"Conlon JM, Galadari S, Raza H, Condamine E.","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",19,18-21
DRAMP29105,CLNLKALLAVAKKILC,16,c Mastoparan-C(cMP-C),P01516,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Anti-cancer,Antifungal",Protein level,"Alpha helix,random coil","76% α-helix was determined from the circular dichroism spectra recorded in 50% TFE/10mM NH4AC solution,28% of the secondary structure  retained an α-helical domain in an aqueous environment.",,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.29904274]Gram-positive bacteria:Staphylococcus aureus NCTC 10788(MIC=32 µM); Staphylococcus aureus NCTC 10788(MBC=64 µM); Staphylococcus aureus ATCC 12493(MRSA,MIC=128 µM); Staphylococcus aureus ATCC 12493(MRSA,MBC=128 µM); Enterococcus faecalis NCTC 12697(MIC=128 µM); Enterococcus faecalis NCTC 12697(MBC=128 µM);##Gram-negative bacteria:Escherichia coli NCTC 10418(MIC=32 µM); Escherichia coli NCTC 10418(MBC=128 µM); Pseudomonas aeruginosa ATCC 27853(MIC=32 µM); Pseudomonas aeruginosa ATCC 27853(MBC>512 µM);##Fungi:Candida albicans NCTC 1467(MIC=32 µM); Candida albicans NCTC 1467(MBC=128 µM);##Cancer:Human squamous lung carcinoma NCI-H157(IC50=7.02 µM);Human breast adenocarcinoma MDA-MB-435S(IC50=13.87 µM);Human prostate adenocarcinoma PC-3(IC50=13.87 µM);Human glioblastoma U251-MG(IC50=8.56 µM); Human breast adenocarcinoma MCF-7(IC50=13.66 µM).       ",[Ref.29904274]50% hemolysis against horse erythrocytes at 9.19 µM.    ,Cyclic,Free,Amidation,Disulfide bond (Cys1-Cys16),L,[Ref.29904274]Cytotoxicity:Human microvascular endothelial cells HMEC-1(IC50=39.53 µM).  ,liposomes,29904274,Int J Biol Sci. 2018 Apr 25;14(6):599-607.,"Chen X, Zhang L, Wu Y, Wang L, Ma C, Xi X, Bininda-Emonds ORP, Shaw C, Chen T, Zhou M.",Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.,16,15-18
DRAMP29106,RKKRRQRRRLNLKALLAVAKKIL,23,"t Mastoparan-C(tMP-C, Tat (49-57)-Mastoparan-C)","P01516,Q76PP9",Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Anti-cancer,Antifungal",Protein level,"Alpha helix,random coil","28% α-helix was determined from the circular dichroism spectra recorded in 50% TFE/10mM NH4AC solution,and it adopted a random coil structure in an aqueous environment.",,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.29904274]Gram-positive bacteria:Staphylococcus aureus NCTC 10788(MIC=4 µM); Staphylococcus aureus NCTC 10788(MBC=4 µM); Staphylococcus aureus ATCC 12493(MRSA,MIC=4 µM); Staphylococcus aureus ATCC 12493(MRSA,MBC=8 µM); Enterococcus faecalis NCTC 12697(MIC=8 µM); Enterococcus faecalis NCTC 12697(MBC=16 µM);##Gram-negative bacteria:Escherichia coli NCTC 10418(MIC=2 µM); Escherichia coli NCTC 10418(MBC=2 µM); Pseudomonas aeruginosa ATCC 27853(MIC=4 µM); Pseudomonas aeruginosa ATCC 27853(MBC=4 µM);##Fungi:Candida albicans NCTC 1467(MIC=2 µM); Candida albicans NCTC 1467(MBC=2 µM);##Cancer:Human squamous lung carcinoma NCI-H157(IC50=2.79 µM);Human breast adenocarcinoma MDA-MB-435S(IC50=3.86 µM);Human prostate adenocarcinoma PC-3(IC50=3.86 µM);Human glioblastoma U251-MG(IC50=3.36 µM); Human breast adenocarcinoma MCF-7(IC50=3.70 µM).     ",[Ref.29904274]50% hemolysis against horse erythrocytes at 77.94 µM.    ,Linear,Free,Amidation,,L,[Ref.29904274]Cytotoxicity:Human microvascular endothelial cells HMEC-1(IC50=9.18 µM).  ,liposomes,29904274,Int J Biol Sci. 2018 Apr 25;14(6):599-607.,"Chen X, Zhang L, Wu Y, Wang L, Ma C, Xi X, Bininda-Emonds ORP, Shaw C, Chen T, Zhou M.",Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.,23,21-24
DRAMP29131,KLLGPLLKIAAKVGSNLL,18,XT-7 [G1K],P84381,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=25 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=12.5 µM);##Fungi:Candida albicans ATCC 900280(MIC=50 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=230 µM).,[Ref.18554256]Hemolysis against human erythrocytes (LC50=400 µM).,Linear,Free,Amidation,,L,[Ref.18554256]No cytotoxicity information found.,liposomes,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E.","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",18,15-18
DRAMP29132,GLLGKLLKIAAKVGSNLL,18,XT-7 [P5K],P84381,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Alpha helix,53% α-helix was determined from the circular dichroism spectra recorded in 50% trifluoroethanol-water.,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=12.5 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=6 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=14 µM).,[Ref.18554256]Hemolysis against human erythrocytes (LC50=15 µM).,Linear,Free,Amidation,,L,[Ref.18554256]No cytotoxicity information found.,liposomes,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E.","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",18,15-18
DRAMP29133,GLLGPLLKIAKKVGSNLL,18,XT-7 [A11K],P84381,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=50 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=25 µM);##Fungi:Candida albicans ATCC 900280(MIC=25 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=65 µM).,[Ref.18554256]Hemolysis against human erythrocytes (LC50=350 µM).,Linear,Free,Amidation,,L,[Ref.18554256]No cytotoxicity information found.,liposomes,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E.","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",18,15-18
DRAMP29134,GLLGPLLKIAAKVGKNLL,18,XT-7 [S15K],P84381,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=12.5 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=25 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=24 µM).,[Ref.18554256]Hemolysis against human erythrocytes (LC50=110 µM).,Linear,Free,Amidation,,L,[Ref.18554256]No cytotoxicity information found.,liposomes,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E.","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",18,15-18
DRAMP29135,GLLGPLLKIAAKVGKKLL,18,"XT-7 [S15K,N16K]",P84381,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=50 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=6 µM);##Fungi:Candida albicans ATCC 900280(MIC=6 µM);##Cancer:hepatoma‐derived cells HepG2 (LC50=10 µM).,[Ref.18554256]Hemolysis against human erythrocytes (LC50=60 µM).,Linear,Free,Amidation,,L,[Ref.18554256]No cytotoxicity information found.,liposomes,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E.","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",18,15-18
DRAMP29136,GLLGPLLKIAAKVGSKLL,18,XT-7 [N16K],P84381,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.23094651]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=6.3 µM).##[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=12.5 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=12.5 µM);##Cancer: human hepatoma‐derived cells HepG2 (LC50=22 µM).,[Ref.23094651]50% hemolysis against rat erythrocytes at 142 µM.##[Ref.18554256]Hemolysis against human erythrocytes (LC50=80 µM).,Linear,Free,Amidation,,L,[Ref.18554256]No cytotoxicity information found.,liposomes,23094651##18554256, J Chem Inf Model. 2012 Dec 21;52(12):3341-51.##Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Kamech N, Vukičević D, Ladram A, Piesse C, Vasseur J, Bojović V, Simunić J, Juretić D.##Conlon JM, Galadari S, Raza H, Condamine E.","Improving the selectivity of antimicrobial peptides from anuran skin.##Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",18,15-18
DRAMP29137,GLLGKLLKIAAKVGKKLL,18,"XT-7 [P5K,S15K,N16K]",P84381,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=25 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=3 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=5 µM).,[Ref.18554256]Hemolysis against human erythrocytes (LC50=25 µM).,Linear,Free,Amidation,,L,[Ref.18554256]No cytotoxicity information found.,liposomes,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E.","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",18,15-18
DRAMP29138,GLLKKLLKIAAKVGKKLL,18,"XT-7 [G4K,P5K,S15K,N16K]",P84381,Not found,,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.,[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=12.5 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=6 µM);##Fungi:Candida albicans ATCC 900280(MIC=3 µM);##Cancer: human hepatoma‐derived cells HepG2 (LC50=6 µM).,[Ref.18554256]Hemolysis against human erythrocytes (LC50=25 µM).,Linear,Free,Amidation,,L,[Ref.18554256]No cytotoxicity information found.,liposomes,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E.","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.",18,15-18
DRAMP29141,GLKEVAHSAKKFAKGFISGLTGS,23,Pxt‐3,No entry found,Not found,Not found,Xenopus tropicalis,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Not found,"Alpha helix,random coil","0.5%,1.2%,2.0% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).",,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).##[Ref.23935531]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=64 µm);Pseudomonas aeruginosa ATCC 15692(MIC >256 µM);##Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC >256 µM);Micrococcus luteus(MIC=32 µM);##Fungi:Saccharomyces cerevisiae(MIC=128 µM);##Parasite:Trypanosoma brucei(LC95=8->256 µM).   ,[Ref.25312021]0.2% Hemolysis against Rat erythrocytes at 20 µM.##[Ref.23935531] Hemolysis against Mouse erythrocytes (HC50>256 µm).,Linear,Free,Free,,L,[Ref.23935531]Cytotoxicity against T-lymphocytes(IC50>256 µM).,Not found,25312021##23935531,FEBS J. 2015 Jan;282(1):102-13.##PLoS Genet. 2013;9(8):e1003662.,"Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.##Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F.",Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.##Origin and functional diversification of an amphibian defense peptide arsenal.,23,21-24
DRAMP29142,LKGASKLIPHLLPSRQQ,17,Pxt‐4,No entry found,Not found,Not found,Xenopus tropicalis,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-",Not found,"Alpha helix,random coil","1.8%,2.8%,3.9% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).",,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).,[Ref.25312021]0.1% Hemolysis against Rat erythrocytes at 20 µM.,Linear,Free,Free,,L,[Ref.25312021]No cytotoxicity information found.,Not found,25312021,FEBS J. 2015 Jan;282(1):102-13.,"Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.",Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.,17,15-18
DRAMP29144,IRPVPFFPPVHAKKVFPLH,19,Pxt‐6,No entry found,Not found,Not found,Xenopus tropicalis,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-",Not found,"Alpha helix,random coil","2.3%,5.1%,7.4% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).",,Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).,[Ref.25312021]0.3% Hemolysis against Rat erythrocytes at 20 µM.,Linear,Free,Free,,L,[Ref.25312021]No cytotoxicity information found.,Not found,25312021,FEBS J. 2015 Jan;282(1):102-13.,"Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.",Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.,19,18-21
DRAMP29147,NLLGSLLKTGLKVGSNLL,18,Pxt‐12(CPF-St7),P84386,Not found,,Xenopus tropicalis,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-,Antifungal",Protein level,"Alpha helix,random coil","0%,2.5%,6.6% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2);68.2%,57.4%,50.5% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 50% TFE.",,Induced a significant and dose-dependent histamine release. ,[Ref.26802742]Gram-negative bacteria:Escherichia coli NBRC 14237(MIC<12.5 µM);Pseudomonas aeruginosa NBRC 12582(MIC<50 µM);##Gram-positive bacteria:Staphylococcus aureus NBRC 12732(MIC<12.5 µM);Micrococcus luteus NBRC 12708(MIC<50 µM);##Fungi:Candida albicans NBRC 1594(ND). ##[Ref.23935531]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=128 µM);Pseudomonas aeruginosa ATCC 15692(MIC >256 µM);##Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM);Micrococcus luteus(MIC=2 µM);##Fungi:Saccharomyces cerevisiae(MIC=64 µM);##Parasite:Trypanosoma brucei(LC95=2-64 µM).     ,[Ref.26802742]0% Hemolysis against Rat erythrocytes at 50 µM.##[Ref.23935531]Hemolysis against Mouse erythrocytes(IC50=256 µM).,Linear,Free,Amidation ,,L,[Ref.23935531]Cytotoxicity against T-lymphocytes(IC50=128 µM). ,liposomes,26802742##23935531,J Biochem. 2016 Jun;159(6):619-29.##PLoS Genet. 2013;9(8):e1003662. ,"Shigeri Y, Horie M, Yoshida T, Hagihara Y, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.##Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F.",Physicochemical and biological characterizations of Pxt peptides from amphibian (Xenopus tropicalis) skin.##Origin and functional diversification of an amphibian defense peptide arsenal.,18,15-18
DRAMP29150,LLNSGVKLGTKLLSGLLN,18,Reverse Pxt-12,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal",Not found,"Alpha helix,random coil","0%,0%,2.0% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2);23.7%,21.0%,17.9% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 50% TFE.",,Induced a significant and dose-dependent histamine release. ,[Ref.26802742]Gram-negative bacteria:Escherichia coli NBRC 14237(ND);Pseudomonas aeruginosa NBRC 12582(ND);##Gram-positive bacteria:Staphylococcus aureus NBRC 12732(ND);Micrococcus luteus NBRC 12708(ND);##Fungi:Candida albicans NBRC 1594(ND). ,[Ref.26802742]0% Hemolysis against Rat erythrocytes at 50 µM.,Linear,Free,Amidation,,L,[Ref.26802742]No cytotoxicity information found.,liposomes,26802742,J Biochem. 2016 Jun;159(6):619-29.,"Shigeri Y, Horie M, Yoshida T, Hagihara Y, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.",Physicochemical and biological characterizations of Pxt peptides from amphibian (Xenopus tropicalis) skin.,18,15-18
DRAMP29184,IDRLNEVAKNLNESLIDLQELGK,23,IPB06(SARS-CoV-2-S (1183-1205)),"P59594,P0DTC2",Belongs to the betacoronaviruses spike protein family.,S,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",Protein level,Not found,Not found,,"Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.","[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50>5 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>25 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Chol,,L,No cytotoxicity information found in the reference(s) presented,liposomes,32376627,J Virol. 2020 Jul 1;94(14):e00635-20.,"Zhu Y, Yu D, Yan H, Chong H, He Y.","Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.",23,21-24
DRAMP29187,SVVNIQKEIDRLNEVAKNLNESLIK,25,IPB09(SARS-CoV-2-S (1175-1198)-K),"P59594,P0DTC2",Belongs to the betacoronaviruses spike protein family.,S,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",Protein level,Not found,Not found,,"Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.","[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50>5 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>25 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Chol,,L,No cytotoxicity information found in the reference(s) presented,liposomes,32376627,J Virol. 2020 Jul 1;94(14):e00635-20.,"Zhu Y, Yu D, Yan H, Chong H, He Y.","Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.",25,24-27
DRAMP29192,TFLDKFNHEAEDLFYQ,16,ACE2 (27-42)(SAP1),Q9BYF1,Belongs to the peptidase M2 family.,ACE2,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",Protein level,Not found,Not found,,Mechanism of action:Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.,[Ref.33356169]Virus:##SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50=2.39±0.20 mM);Inhibition of infection in 293T/ACE2/GFP cells(IC50=3 mM);##SARS-CoV:Inhibition of infection in 293T/ACE2 cells(80% inhibition at 3 mM);##Vesicular Stomatitis Virus (VSV):No nhibition of infection in 293T/ACE2 cells up to 3 mM;##HCoV-NL63:Inhibition of cytopathic effect in LLC-MK2 cells(30% Inhibition at 3 mM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,33356169,Bioconjug Chem. 2021 Jan 20;32(1):215-223.,"Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A.",Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.,16,15-18
DRAMP29210,RGAHIKGRWKSRCHRF,16,FBP,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antiviral(SARS-CoV-2)",Not found,Not found,Not found,,The fusion-inhibition peptide FBP could broadly inhibit influenza virus and SARS-CoV-2 by interfering the viral fusion by the endocytic pathway and showed potently antiviral activity against the influenza virus in mice and SARS-CoV-2 variants in hamsters.,"[Ref.35259078]Virus:A(H1N1)(IC50 = 3.9 μg/ml);A(H3N2)(IC50 = 1.6 μg/ml);FluB (IC50 = 7.1 μg/ml);SARS-CoV-2 (HKU001a):inhibition of infection in Vero-E6 cells(IC50=2.9 μg/ml);SARS-CoV-2 (B.1.1.63, D614G):inhibition of infection in Vero-E6 cells(IC50=3.0 μg/ml);SARS-CoV-2(Delta):inhibition of infection in Vera-E6 cells(IC50=3.9 μg/ml).",[Ref.35259078]No significant hemolysis against Turkey red blood cells (RBC).,Linear,Free,Free,,L,[Ref.35259078]No significant cytotoxicity was detected in MDCK(Madin Darby canine kidney) cells at 1 mg/ml(TC50 > 1 mg/ml).,liposomes,35259078,Emerg Microbes Infect. 2022 Dec;11(1):926-937.,"Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.","Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.",16,15-18
DRAMP29263,PVPNLTCAVACELKWESE,18,E1P37,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=41.0 ± 8.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. ,18,15-18
DRAMP29264,VPNLTCAVACELKWESEF,18,E1P37-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=80.0 ± 62.4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. ,18,15-18
DRAMP29265,PNLTCAVACELKWESEFR,18,E1P37-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=99.0 ± 22.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. ,18,15-18
DRAMP29266,NLTCAVACELKWESEFWR,18,E1P38,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. ,18,15-18
DRAMP29267,LTCAVACELKWESEFWRW,18,E1P38-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29268,TCAVACELKWESEFWRWT,18,E1P38-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29269,CAVACELKWESEFWRWTE,18,E1P39,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=11.3 ± 1.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29270,AVACELKWESEFWRWTEQ,18,E1P39-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=44.0 ± 13.9 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29271,VACELKWESEFWRWTEQL,18,E1P39-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=37.7 ± 7.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29272,ACELKWESEFWRWTEQLA,18,E1P40,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29273,CELKWESEFWRWTEQLAS,18,E1P40-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=34.0 ± 15.4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29274,ELKWESEFWRWTEQLASN,18,E1P40-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29275,LKWESEFWRWTEQLASNY,18,E1P41,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29276,KWESEFWRWTEQLASNYW,18,E1P41-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=66.7 ± 20.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29277,WESEFWRWTEQLASNYWI,18,E1P41-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=22.0 ± 0.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29278,ESEFWRWTEQLASNYWIL,18,E1P42,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=50.0 ± 8.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29279,SEFWRWTEQLASNYWILE,18,E1P42-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=31.0 ± 3.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29280,EFWRWTEQLASNYWILEY,18,E1P42-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29281,FWRWTEQLASNYWILEYL,18,E1P43,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=43.0 ± 10.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29282,WRWTEQLASNYWILEYLW,18,E1P43-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=6.8 ± 0.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29283,RWTEQLASNYWILEYLWK,18,E1P43-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=19.7 ± 9.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29284,WTEQLASNYWILEYLWKV,18,E1P44,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29285,TEQLASNYWILEYLWKVP,18,E1P44-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29286,EQLASNYWILEYLWKVPF,18,E1P44-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=90.3 ± 15.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29287,QLASNYWILEYLWKVPFD,18,E1P45,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=27.7 ±5.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29288,LASNYWILEYLWKVPFDF,18,E1P45-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=12.7 ±1.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29289,ASNYWILEYLWKVPFDFW,18,E1P45-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=11.3 ± 3.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29290,SNYWILEYLWKVPFDFWR,18,E1P46,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=19.7 ± 8.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29291,NYWILEYLWKVPFDFWRG,18,E1P46-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=12.3 ± 0.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29292,YWILEYLWKVPFDFWRGV,18,E1P46-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=32.3 ± 11.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29293,WILEYLWKVPFDFWRGVI,18,E1P47,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=2.7 ± 0.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29294,ILEYLWKVPFDFWRGVIS,18,E1P47-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=5.4 ± 0.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29295,LEYLWKVPFDFWRGVISL,18,E1P47-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=6.6± 0.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29296,EYLWKVPFDFWRGVISLT,18,E1P48,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=44.7 ± 3.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29297,YLWKVPFDFWRGVISLTP,18,E1P48-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=70.7 ±9.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29298,LWKVPFDFWRGVISLTPL,18,E1P48-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=14.7 ± 0.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29299,WKVPFDFWRGVISLTPLL,18,E1P49,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=17.3 ± 3.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29300,KVPFDFWRGVISLTPLLV,18,E1P49-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=63.3 ± 5.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29301,VPFDFWRGVISLTPLLVC,18,E1P49-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29302,PFDFWRGVISLTPLLVCV,18,E1P50,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29303,FDFWRGVISLTPLLVCVA,18,E1P50-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29304,DFWRGVISLTPLLVCVAA,18,E1P50-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29305,FWRGVISLTPLLVCVAAL,18,E1P51,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29306,WRGVISLTPLLVCVAALL,18,E1P51-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29307,RGVISLTPLLVCVAALLL,18,E1P51-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29308,GVISLTPLLVCVAALLLL,18,E1P52,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=55.7± 5.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29309,VISLTPLLVCVAALLLLE,18,E1P52-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29310,ISLTPLLVCVAALLLLEQ,18,E1P52-2,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial,Antiviral",Not found,Not found,Not found,,Function:Antiviral activity against Influenza virus.,[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,gp41,26905802,Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.,"Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.",Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.,18,15-18
DRAMP29950,MITHGCYTRTRHKHKLKKTL,20,SA-35,No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: It is likely that these peptides exert anti-RSV activity through a combination of two mechanisms: destabilization of the viral envelope and competitive inhibition of attachment/fusion of the virus with the target cell.,[Ref.32124885]Respiratory syncytial virus (RSV):SA-35 caused a significant decrease of the RSV infectivity by 33 times at concentrations 1 mg/ml.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.32124885]MA-104 cells:CC50= 2.1 ± 0.1 mg/ml.,Not found,32124885,J Mater Chem B. 2020 Apr 1;8(13):2607-2617,"Kozhikhova KV, Shilovskiy IP, Shatilov AA, Timofeeva AV, Turetskiy EA, Vishniakova LI, Nikolskii AA, Barvinskaya ED, Karthikeyan S, Smirnov VV, Kudlay DA, Andreev SM, Khaitov MR","Linear and dendrimeric antiviral peptides: design, chemical synthesis and activity against human respiratory syncytial virus.",20,18-21
DRAMP29951,KRRGGGKLLKLLLKLLLKLLKC,22,NC-783,No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: It is likely that these peptides exert anti-RSV activity through a combination of two mechanisms: destabilization of the viral envelope and competitive inhibition of attachment/fusion of the virus with the target cell.,[Ref.32124885]Respiratory syncytial virus (RSV):inhibition of viral infection in the MA-104 cell(IC50=0.04mg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.32124885]MA-104 cells:CC50= 0.04 ± 0.01 mg/ml.,Not found,32124885,J Mater Chem B. 2020 Apr 1;8(13):2607-2617,"Kozhikhova KV, Shilovskiy IP, Shatilov AA, Timofeeva AV, Turetskiy EA, Vishniakova LI, Nikolskii AA, Barvinskaya ED, Karthikeyan S, Smirnov VV, Kudlay DA, Andreev SM, Khaitov MR","Linear and dendrimeric antiviral peptides: design, chemical synthesis and activity against human respiratory syncytial virus.",22,21-24
DRAMP29952,gikefkrivqrikdflrnlv,20,GI-20D,No entry found,Filoviridae,Not found,Synthetic construct(derived from LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Act as CatB inhibitors to block the endosomal processing of EBOV GP, thus preventing virus entry.",[Ref.32252021]Ebola Virus(EBOV):inhibition of viral infection in Hela cells(IC50=0.99 µM);inhibition of viral infection in primary macrophages(IC50=2.2 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,D,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,32252021,iScience. 2020 Apr 24;23(4):100999.,"Yu Y, Cooper CL, Wang G, Morwitzer MJ, Kota K, Tran JP, Bradfute SB, Liu Y, Shao J, Zhang AK, Luo LG, Reid SP, Hinrichs SH, Su K.",Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection.,20,18-21
DRAMP29953,GXKRlVQRlKDXlRNLV,17,17BIPHE2,No entry found,Filoviridae,Not found,Synthetic construct(derived from LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Act as CatB inhibitors to block the endosomal processing of EBOV GP, thus preventing virus entry.",[Ref.32252021]Ebola Virus(EBOV):inhibition of viral infection in Hela cells(IC50=0.71 µM);inhibition of viral infection in primary macrophages(IC50=5.6 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,The 'X' at position 2 and 12 indicates biphenylalanine.,"Mixed(D-Leu5, 9, 13)",No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,32252021,iScience. 2020 Apr 24;23(4):100999.,"Yu Y, Cooper CL, Wang G, Morwitzer MJ, Kota K, Tran JP, Bradfute SB, Liu Y, Shao J, Zhang AK, Luo LG, Reid SP, Hinrichs SH, Su K.",Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection.,17,15-18
DRAMP29954,RGAHINGRWDSRCHRF,16,FBP1,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: FBP could have dual functions: blocked HA-mediated fusion by binding and inhibited endosomal acidification from interfering viral entry by the endocytic pathway.,[Ref.35259078]influenza A virus(H1N1): inhibition of viral multicycle growth in MDCK cells(>50% inhibition at 100 μg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA,35259078,Emerg Microbes Infect. 2022 Dec;11(1):926-937.,"Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.","Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. ",16,15-18
DRAMP29955,RGAHIKGRWDSRCHRF,16,FBP2,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: FBP could have dual functions: blocked HA-mediated fusion by binding and inhibited endosomal acidification from interfering viral entry by the endocytic pathway.,[Ref.35259078]influenza A virus(H1N1): inhibition of viral multicycle growth in MDCK cells(>50% inhibition at 50 μg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA,35259078,Emerg Microbes Infect. 2022 Dec;11(1):926-937.,"Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.","Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. ",16,15-18
DRAMP29956,IPLRGAFINGRWDSQCHRFS,20,U5,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Bind to the HA stem of group 1 influenza A virus.,[Ref.35259078]influenza A virus(H1N1): inhibition of viral replication in MDCK cells(IC50=12.9 μg/ml);,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA,35259078,Emerg Microbes Infect. 2022 Dec;11(1):926-937.,"Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.","Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. ",20,18-21
DRAMP29957,FINGRWDSQCHRFSNGAIACA,21,U4,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Bind to the HA stem of group 1 influenza A virus.,[Ref.35259078]influenza A virus(H1N1): inhibition of viral replication in MDCK cells(IC50=6.6 μg/ml);,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA,35259078,Emerg Microbes Infect. 2022 Dec;11(1):926-937.,"Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.","Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. ",21,18-21
DRAMP29967,SKVNGQSGRMEFFWTIAK,18,m15 /Leu17,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>60% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29968,SKVNGQSGRMEFFWTALK,18,m14 /lle16,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>10% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29969,SKVNGQSGRMAFFWTILK,18,m9 /Glu11,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>50% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29970,SKVNGQSGRMEFAWTILK,18,m11 /Phe13,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>80% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29971,SKVNGQSGRAEFFWTILK,18,m8 /Met10,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>80% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29972,SKVNGQAGRMEFFWTILK,18,m6 /Ser7,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(~60% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29973,SKVNGASGRMEFFWTILK,18,m5 /GIn6,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>60% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29974,SKVAGQSGRMEFFWTILK,18,m4 /Asn4,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>70% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29975,SKANGQSGRMEFFWTILK,18,m3 /Val3,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>50% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29976,SAVNGQSGRMEFFWTILK,18,m2 /Arg2 ,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(~20% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29977,AKVNGQSGRMEFFWTILK,18,m1 /Ser1,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>20% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP29987,LHQNIVDVQYMYGLS,15,"HCV gp (696–710), E2-79",Q99IB8,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.",[Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM,Envelope protein,28638089,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,"Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.",A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,15,12-15
DRAMP29988,GLLHLHQNIVDVQYM,15,"HCV gp (692–706), E2-78",Q99IB8,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.",[Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM,Envelope protein,28638089,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,"Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.",A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,15,12-15
DRAMP29989,FGCTWMNSTGFTKTC,15,"HCV gp (552–566), E2-43",Q99IB8,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.",[Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM,Envelope protein,28638089,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,"Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.",A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,15,12-15
DRAMP29990,QGSWFGCTWMNSTGF,18,"HCV gp (548–562), E2-42",Q99IB8,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.",[Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM,Envelope protein,28638089,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,"Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.",A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,15,12-15
DRAMP29992,CKIPFEIMDLEKRHV,15,P4(DENV-2 gp (613-627)),P14340,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: might be involved in blocking viral entry via occupying the binding site in the receptor on the host cell(β3 integrin).,"[Ref.29709564]DENV-2(dengue virus serotype 2): inhibition of virus entry in HUVECs(human umbilical vein endothelial cells)(70 ± 9% inhibition at 40 μM,44 ± 10% inhibition at 20 μM,40± 6% inhibition at 10 μM,IC50=19.08±2.52µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.29709564]No toxic effect on HUVEC(Human umbilical vein endothelial cells) at concentrations up to 100 µM,β3 integrin,29709564,Antiviral Res. 2018 Jul;155:20-27.,"Cui X, Wu Y, Fan D, Gao N, Ming Y, Wang P, An J.",Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin.,15,12-15
DRAMP29993,GNHILSLVQNAPYGLYFIHFSW,22,MHV (1096–1117)[Y1117W],P11224,,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: inhibits viral entry through coiled coil interactions.,[Ref.16616792]MHV(murine hepatitis virus): inhibition of virus infection in L2 cells(22% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxic at a concentration of 30 μM on L2 cells,cell membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,22,21-24
DRAMP29994,GYFVQDDGEWKFTGSSYYY,19,MHV (1144–1162),P11224,,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: inhibits viral entry through coiled coil interactions.,"[Ref.16616792]MHV(murine hepatitis virus): inhibition of virus infection in L2 cells(98% inhibition at 30 Μm, IC50=4 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxic at a concentration of 30 μM on L2cells,cell membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,19,18-21
DRAMP29996,GVFVFNGTSWFITQRNFFS,19,SARS-CoV (1075–1093),Q19QX0,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: inhibits viral entry through coiled coil interactions.,"[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(83% inhibition at 30 μM,IC50~2 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells,cell membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,19,18-21
DRAMP29997,GYHLMSFPQAAP-HGVVFLHVTW,22,SARS-CoV (1028–1049)[Y1049W],Q19QX0,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: inhibits viral entry through coiled coil interactions.,"[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(90% inhibition at 30 μM,IC50~2 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells,cell membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,23,21-24
DRAMP29998,ATAGWTFGAGAALQIPFAMQMAY,23,SARS-CoV (864-886),Q19QX0,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: inhibits viral entry through coiled coil interactions.,[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(39% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells,cell membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,23,21-24
DRAMP29999,TLKPIFKLPLGINITNFR,18,"SARS-CoV-S (215-232), peptide 9626",P59594,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Presumably inhibit virus entry by binding to Spike protein, hACE2, or an unknown co-receptor.",[Ref.19853613]SARS-COV: inhibition of SARS-CoV/HIV PsV virus infection in 293T/ACE2 cells (IC50=11µM); inhibition of SARS-CoV/HIV PsV virus entry in 293T/ACE2 cells(80% at 50µM) ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,not found,19853613,J Mol Biol. 2009 Dec 11;394(4):600-5.,"Guo Y, Tisoncik J, McReynolds S, Farzan M, Prabhakar BS, Gallagher T, Rong L, Caffrey M.",Identification of a new region of SARS-CoV S protein critical for viral entry.,18,15-18
DRAMP30000,MWKTPTLKYFGGFNFSQIL,19,SARS-CoV (770-788)[Y771W],Q19QX0,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: inhibits viral entry through coiled coil interactions.,[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(58% inhibition at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells,cell membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,19,18-21
DRAMP30004,GINASVVNIQKEIDRLNEVAKNL,23,P6(SARS-CoV (1153–1175)),P59594,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Binding to the HR1 region and blocking the formation of  a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.",[Ref.18983873]SARS-CoV:inhibition of cell fusion in Hela cells (IC50=1.04 ± 0.22 μM); inhibition of SARS-CoV infection in Vero-E6 cells (IC50=2.28 ± 0.81 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18983873]No discernable cytotoxicity on HeLa or VeroE6 cells at the concentrations of 25 μM.,membrane,18983873,Antiviral Res. 2009 Jan;81(1):82-7.,"Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.",Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,23,21-24
DRAMP30008,AWDFGSIGGVFNSIGRAVHQVF,22,JEV Ep (424–445),P0DOH7,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide prevented JEV infection in mice by reducing viral load and the inflammatory response in the brain, thereby improving the survival rate.",[Ref.28232248]Japanese encephalitis virus (JEV):inhibition of JEV infection in BHK-21 (baby hamster kidney) cells (IC50=3.93 nM);##Zika virus (ZIKV):inhibition of Zika virus (ZIKV) infection in Vero cells (IC50=3.27μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,28232248,Antiviral Res. 2017 May;141:140-149.,"Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.",Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,22,21-24
DRAMP30010,SIGGVFNSIGRAVHQVFGGAFRTL,24,JEV Ep (428–452),P0DOH7,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Peptide derived from protein E stem may inhibit virus infection by blocking virus entry.,[Ref.28232248]Japanese encephalitis virus (JEV):inhibition of JEV infection in BHK-21 (baby hamster kidney) cells (IC50=94.10 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,28232248,Antiviral Res. 2017 May;141:140-149.,"Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.",Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,24,21-24
DRAMP30015,GQGKAHNGRLITANP,15,DENV Envelope glycoprotein (340 – 354),Q5UB51##P17763,Flaviviridae,Not found,Synthetic construct(derived from DENV Envelope glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts as inhibitors by binding to the E protein, suppressing its conformational changes, and preventing its binding to the cellular receptor, thereby inhibiting viral entry.","[Ref.30508603]DENV-1:inhibition of virus infection in Vero cells(83%±3.72% inhibition at 50 μM,IC50=33 μM);##DENV-2:inhibition of virus infection in Vero cells(IC50=10 μM);##DENV-3:inhibition of virus infection in Vero cells(60% inhibition at 20μM);##DENV-4:inhibition of virus infection in Vero cells(55% inhibition at 20μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.30508603]<20% cytotoxicity against Vero and C6/36 cells at 200 μM.,E protein,30508603,Virus Res. 2019 Jan 15;260:142-150.,"John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P.",In vitro analysis of synthetic peptides in blocking the entry of dengue virus.,15,12-15
DRAMP30017,LEHGSCVTTMAKDKPTL,17,DENV Envelope glycoprotein (25-41),Q5UB51##P17763,Flaviviridae,Not found,Synthetic construct(derived from DENV Envelope glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts as inhibitors by binding to the E protein, suppressing its conformational changes, and preventing its binding to the cellular receptor, thereby inhibiting viral entry.","[Ref.30508603]DENV-1:inhibition of virus infection in Vero cells(58%±2.55% inhibition at 50 μM,IC50=10 μM);##DENV-2:inhibition of virus infection in Vero cells(IC50=10 μM);##DENV-3:inhibition of virus infection in Vero cells(60% inhibition at 20μM);##DENV-4:inhibition of virus infection in Vero cells(55% inhibition at 20μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.30508603]<20% cytotoxicity against Vero and C6/36 cells at 200 μM.,E protein,30508603,Virus Res. 2019 Jan 15;260:142-150.,"John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P.",In vitro analysis of synthetic peptides in blocking the entry of dengue virus.,17,15-18
DRAMP30021,RRRRRRRXGSLLGRMKGA,18,7R-Ahx-P3,,Hepadnaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.,[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=2.5 ±1.0 μM;EC90=8.6± 3.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,The 'X' at position 8 is 6-aminocaproic acid.,L,[Ref.21144865]HepG2.2.15:LC50=828.7 ± 50.3 μM.,DNA,21144865,Antiviral Res. 2011 Jan;89(1):109-14.,"Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X.",Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.,18,15-18
DRAMP30024,EEQAKTFLDKFNHEAEDLFYQSS,23,P4(ACE2 (4-26)),Q9BYF1,Coronaviridae,Not found,Synthetic construct(derived from angiotensin-converting enzyme 2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry.",[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(IC50=50 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,spike glycoprotein,16510163,Virology. 2006 Jun 20;350(1):15-25.,"Han DP, Penn-Nicholson A, Cho MW.",Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.,23,21-24
DRAMP30032,HGQVDCSPGIWQLDCTH,17,NL3 ,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 integrase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).",[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=1000 µM);inhibition of strand transfer catalyzed by integrase(IC50=1000 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,16854053,J Med Chem. 2006 Jul 27;49(15):4477-86.,"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.",Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,17,15-18
DRAMP30084,DFRELNKRTQDFWEVQLGIP,20,4277(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.",[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is very low.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30085,SPAIFQSSMTKILEPFRKQN,20,4285(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.",[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=35 µM);inhibition of strand transfer catalyzed by integrase(IC50=270 µM);inhibition of disintegration catalyzed by integrase(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30086,FRKQNPDIVIYQYMD,15,4286’-1(derived from the DNA-polymerase domain of HIV-1 RT (14-mer) ),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.",[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=119 µM);inhibition of strand transfer catalyzed by integrase(IC50=97 µM);inhibition of disintegration catalyzed by integrase(IC50>270 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,15,12-15
DRAMP30087,KILEPFRKQNPDIVIYQYMD,20,4286(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.",[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=4.8 µM);inhibition of strand transfer catalyzed by integrase(IC50=4.5 µM);inhibition of disintegration catalyzed by integrase(IC50=9.4 µM);##HIV-1:the level of peptide binding to HIV integrase is high.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30088,PDIVIYQYMDDLYVGSDLEI,20,"4287(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),34(derived from the HIV-1 HXB2 Pol region of the viral genome)",No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.","[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=22 µM);inhibition of strand transfer catalyzed by integrase(IC50=54 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM);##HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=6±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=10±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=28±2 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=23±2 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=41±2 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=20 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=5 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559##16879966,J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. ,20,18-21
DRAMP30089,DIQKLVGKLNWASQIYPGIK,20,4295(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.",[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30090,IAEIQKQGQGQWTYQIYQEP,20,4302(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.",[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30091,KQLTEAVQKITTEAnti-SIVIWGK,20,"4306(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),53(derived from the HIV-1 HXB2 Pol region of the viral genome)",No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.","[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=7±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=4±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=51±7 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=31±7 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=29±1 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=15 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=10 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559##16879966,J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. ,25,24-27
DRAMP30092,TPKFKLPIQKETWETWWTEY,20,4308(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.",[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30093,ETWETWWTEYWQATWIPEWE,20,"4309(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),56(derived from the HIV-1 HXB2 Pol region of the viral genome)",No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.","[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=6±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=13±2 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=9±2 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=126±3 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=27±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=25 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=5 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559##16879966,J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. ,20,18-21
DRAMP30094,GYVTNRGRQKVVTLTDTTNQ,20,4315(derived from the RNase H domain of HIV-1 RT (20-mes)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is very low,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30095,VVTLTDTTNQKTELQAIYLA,20,4316(derived from the RNase H domain of HIV-1 RT (20-mes)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30096,KTELQAIYLALQDSGLEVNI,20,4317(derived from the RNase H domain of HIV-1 RT (20-mes)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30097,LQDSGLEVNIVTDSQYALGI,20,"4318(derived from the RNase H domain of HIV-1 RT (20-mes)),65(derived from the HIV-1 HXB2 Pol region of the viral genome)",No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,"[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=11±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50>167 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=36±14 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=18±3 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=4±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50>167 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=20 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559##16879966,J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. ,20,18-21
DRAMP30098,VTDSQYALGIIQAQPDQSES,20,4319(derived from the RNase H domain of HIV-1 RT (20-mes)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30099,IQAQPDQSESELVNQIIEQL,20,4320(derived from the RNase H domain of HIV-1 RT (20-mes)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>120 µM);inhibition of strand transfer catalyzed by integrase(IC50>120 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30100,ELVNQIIEQLIKKEKVYLAW,20,"4321(derived from the RNase H domain of HIV-1 RT (20-mes)),64(derived from the HIV-1 HXB2 Pol region of the viral genome)",No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,"[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=6.9 µM);inhibition of strand transfer catalyzed by integrase(IC50=5 µM);inhibition of disintegration catalyzed by integrase(IC50>100 µM);##HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=15±2 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=14±4 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=113±11 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=83±5 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=136±5 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=7±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=45 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=15 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559##16879966,J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. ,20,18-21
DRAMP30102,IKKEKVYLAWVPAHKGIGN,19,4322(derived from the RNase H domain of HIV-1 RT (20-mes)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>120 µM);inhibition of strand transfer catalyzed by integrase(IC50>120 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,19,18-21
DRAMP30103,EQVDKLVSAGIRKVLFLDGI,20,4324(derived from the RNase H domain of HIV-1 RT (20-mes)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,20,18-21
DRAMP30104,ESELVSQIIEQLIKK,15,5628(derived from  RNase H domain of HIV-1 RT (15-mers)),No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Reverse Transcriptase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.,[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>120 µM);inhibition of strand transfer catalyzed by integrase(IC50=60 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,15790559,J Biol Chem. 2005 Jun 10;280(23):21987-96.,"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,15,12-15
DRAMP30105,LQQLLFIHFRIGCQH,15,Vpr 15,No entry found,Retroviridae,Not found,Synthetic construct(HIV-1 gene product),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.",[Ref.20586421]HIV-1:inhibition of strand transfer catalyzed by integrase(IC50=5.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20586421,J Med Chem. 2010 Jul 22;53(14):5356-60.,"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. ",Peptide HIV-1 integrase inhibitors from HIV-1 gene products.,15,12-15
DRAMP30110,LQQLLFIHFRIGRRRRRRRR,20,Vpr-3 R8,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 gene products(Vpr)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.",[Ref.20586421]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=0.004±0.0001 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.008±0.001 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20586421,J Med Chem. 2010 Jul 22;53(14):5356-60.,"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. ",Peptide HIV-1 integrase inhibitors from HIV-1 gene products.,20,18-21
DRAMP30112,TYGDTWAGVEAIIRI,15,Vpr 49-63 ,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 viral protein R (Vpr)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit  Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.,[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50>>150 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50>>150 µM);inhibit the activity of Rnase H(IC50>>200 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,17490682,J Mol Biol. 2007 Jun 22;369(5):1230-43.,"Gleenberg IO, Herschhorn A, Hizi A.",Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,15,12-15
DRAMP30113,TWAGVEAIIRILQQL,15,Vpr 53-67,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 viral protein R (Vpr)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.,[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.88 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50=0.88 µM);inhibit the activity of Rnase H(IC50=6.9 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50>200 µM);inhibition of strand transfer catalyzed by integrase(IC50=144 µM);inhibition of disintegration catalyzed by integrase(IC50=27 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,"Integrase,Reverse Transcriptase",17490682,J Mol Biol. 2007 Jun 22;369(5):1230-43.,"Gleenberg IO, Herschhorn A, Hizi A.",Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,15,12-15
DRAMP30114,VEAIIRILQQLLFIH,15,Vpr 57-71,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 viral protein R (Vpr)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.,[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.22 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50=0.22 µM);inhibit the activity of Rnase H(IC50=2 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50=7.8 µM);inhibition of strand transfer catalyzed by integrase(IC50=16 µM);inhibition of disintegration catalyzed by integrase(IC50=3 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,"Integrase,Reverse Transcriptase",17490682,J Mol Biol. 2007 Jun 22;369(5):1230-43.,"Gleenberg IO, Herschhorn A, Hizi A.",Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,15,12-15
DRAMP30115,IRILQQLLFIHFRIG,15,Vpr 61-75,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 viral protein R (Vpr)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.,[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.7 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50=1.3 µM);inhibit the activity of Rnase H(IC50=5.25 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50=1.3 µM);inhibition of strand transfer catalyzed by integrase(IC50=1 µM);inhibition of disintegration catalyzed by integrase(IC50=10 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,"Integrase,Reverse Transcriptase",17490682,J Mol Biol. 2007 Jun 22;369(5):1230-43.,"Gleenberg IO, Herschhorn A, Hizi A.",Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,15,12-15
DRAMP30116,QQLLFIHFRIGCQHS,15,Vpr 65-79 ,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 viral protein R (Vpr)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.,[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=33 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50=43 µM);inhibit the activity of Rnase H(IC50=16.5 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50=76 µM);inhibition of strand transfer catalyzed by integrase(IC50=14 µM);inhibition of disintegration catalyzed by integrase(IC50=10 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,"Integrase,Reverse Transcriptase",17490682,J Mol Biol. 2007 Jun 22;369(5):1230-43.,"Gleenberg IO, Herschhorn A, Hizi A.",Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,15,12-15
DRAMP30117,FIHFRIGCQHSRIGI,15,Vpr 69-83,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 viral protein R (Vpr)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.,[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50>>200 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50>>200 µM);inhibit the activity of Rnase H(IC50>>200 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50>>200 µM);inhibition of strand transfer catalyzed by integrase(IC50>>200 µM);inhibition of disintegration catalyzed by integrase(IC50>>200 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,"Integrase,Reverse Transcriptase",17490682,J Mol Biol. 2007 Jun 22;369(5):1230-43.,"Gleenberg IO, Herschhorn A, Hizi A.",Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,15,12-15
DRAMP30118,HFPRIWLHSLGQHIY,15,Vpr 33-47 ,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 viral protein R (Vpr)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and thus inhibit the replication of HIV-1.,[Ref.17490682]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=187 µM);inhibition of strand transfer catalyzed by integrase(IC50=41 µM);inhibition of disintegration catalyzed by integrase(IC50=73 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,17490682,J Mol Biol. 2007 Jun 22;369(5):1230-43.,"Gleenberg IO, Herschhorn A, Hizi A.",Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,15,12-15
DRAMP30141,TGEKVWDRGNVTLLCDCP,18,P11(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=439.7 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=162.1 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=484.5 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=208.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30142,LPAFCQAIGWGDPITHWS,18,P19(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=369.5 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=46.0 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=194.3 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=71.4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30143,FCQAIGWGDPITHWSHGQ,18,P20(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=347.6 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=70.1 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=125.5 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=111.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30144,AIGWGDPITHWSHGQNRW,18,P21(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=832.9 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=44.9 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=529.1 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=371.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30145,PITHWSHGQNRWPLSCPQ,18,P23(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=508.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30146,HGQNRWPLSCPQYVYGSV,18,P25(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=304.4 μM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30147,SWFASTGGRDSKIDVWSL,18,P34(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=237.4 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=411.2 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=118.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30148,SDRDTVVELSEWGVPCAT,18,P45(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=141.2 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=48.8 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=505.5 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=43.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30149,DTVVELSEWGVPCATCIL,18,P46(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=428.8 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=39.9 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=462.8 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=24.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30150,VELSEWGVPCATCILDRR,18,P47(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=330.8 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=58.6 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=140.3 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=20.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30151,RFPFHRCGAGPKLTKDLE,18,P59(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=529.6 μM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30152,LVRRRSELMGRRNPVCPG,18,P97(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=537.6 μM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30153,LQEVDAGNFIPPPRWLLL,18,P109(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=687.1 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=37.5 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=294.8 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=60.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30154,WVNQLAVLGLPAVDAAVA,18,P124(derived from E2 envelope protein of GB virus C),No entry found,Retroviridae,Not found,Synthetic construct(derived from E2 envelope protein of GB virus C),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.",[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=332.7 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=94.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20718496,J Med Chem. 2010 Aug 26;53(16):6054-63. ,"Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. ",Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,18,15-18
DRAMP30155,SAnti-VSVGMKPSPRP,12,VMI5,No entry found,Retroviridae,Not found,Synthetic construct(phage display),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:binding with vif proteins.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,17,15-18
DRAMP30160,WQVMIVWQVDRMRIR,15,vif 5-19,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30161,RHHYESTHPRISSEV,15,vif 41-55,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30162,ESTHPRISSEVHIPL,15,vif 45-59,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30163,HTGERDWHLGQGVSI,15,vif 73-87,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30164,RDWHLGQGVSIEWRK,15,vif 77-91,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30165,LGQGVSIEWRKKRYS,15,vif 81-95,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30166,RYSTQVDPDLADQLI,15,vif 93-107,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30167,QVDPDLADQLIHLYY,15,vif 97-111,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30168,DLADQLIHLYYFDCF,15,vif 101-115,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30169,QLIHLYYFDCFSESA,15,vif 105-119,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30170,LYYFDCFSESAIRKA,15,vif 109-123,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30171,ESAIRKAILGHIVSP,15,vif 117-131,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30172,RKAILGHIVSPRCEY,15,vif 121-135,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30173,VSPRCEYQAGHNKVG,15,vif 129-143,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30174,CEYQAGHNKVGSLQY,15,vif 133-147,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30175,AGHNKVGSLQYLALA,15,vif 137-151,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30176,KVGSLQYLALAALIT,15,vif 141-155,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30177,LQYLALAALITPKKI,15,vif 145-159,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30178,ALAALITPKKIKPPL,15,vif 149-163,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30179,LITPKKIKPPLPSVT,15,vif 153-167,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30180,KKIKPPLPSVTKLTE,15,vif 157-171,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30181,PPLPSVTKLTEDRWN,15,vif 161-175,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30182,SVTKLTEDRWNKPQK,15,vif 165-179,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30183,LTEDRWNKPQKTKGH,15,vif 169-183,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30184,RWNKPQKTKGHRGSH,15,vif 173-187,No entry found,Retroviridae,Not found,Synthetic construct(derived from HIV-1 Vif protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",[Ref.12480936]HIV-1:inhibit vif-vif binding.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Vif proteins,12480936,J Biol Chem. 2003 Feb 21;278(8):6596-602.,"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,15,12-15
DRAMP30185,PTGERVWDRGNVTLLCDCPN,20,P4,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=15.07 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=18.28 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30186,WDRGNVTLLCDCPNGPWVWV,20,P4-7,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=2.59 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=2.66 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30187,WDRGNVTLLCDCPNGPWVWV,20,P4-7,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(NL4-3):inhibition of HIV replication(IC50=3.0 μM);##HIV-1(YU-2):inhibition of HIV replication(IC50=5.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30188,GPWVWVPAFCQAVGWGDPIT,20,P6,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=16.80 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=3.57 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30189,TLLCDCPNGPWVWVPAFCQA,20,P6-1,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=2.36 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=1.29 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30190,LCDCPNGPWVWVPAFCQAVG,20,P6-2,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=3.33 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=1.32 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30191,LCDCPNGPWVWVPAFCQAVG,20,P6-2,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(NL4-3):inhibition of HIV replication(IC50=2.3 μM);##HIV-1(YU-2):inhibition of HIV replication(IC50=2.4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30192,DCPNGPWVWVPAFCQAVGWG,20,P6-3,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=4.00 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=2.00 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30193,PNGPWVWVPAFCQAVGWGDP,20,P6-4,No entry found,Retroviridae,Not found,Synthetic construct(derived from region of GB virus C glycoprotein E2),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.,[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=11.88 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=8.04 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21543477,J Virol. 2011 Jul;85(14):7037-47.,"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. ",Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.,20,18-21
DRAMP30194,RGTKALTEVIPLTEEAEC,18,PepA,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =35 ± 5 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,18,15-18
DRAMP30195,GTKALTEVIPLTEEAEC,17,P1,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.","[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =7.5±2.3 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=78.2 nM,associated with Pep-1).##NOTE:Ki: inhibition constants ",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30196,ATKALTEVIPLTEEAEC,17,P2,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =28 ±11 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30197,GAKALTEVIPLTEEAEC,17,P3,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =10.3 ± 2.1 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30198,GTAALTEVIPLTEEAEC,17,P4,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =15 ± 2.9 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30199,GTKGLTEVIPLTEEAEC,17,P5,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =20 ± 3.7 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30200,GTKAATEVIPLTEEAEC,17,P6,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.","[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =5.7 ± 2.3 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=170 nM,associated with Pep-1).##NOTE:Ki: inhibition constants ",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30201,GTKALAEVIPLTEEAEC,17,P7,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =13.5 ± 2.1 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30202,GTKALTAVIPLTEEAEC,17,P8,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.","[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =57 ± 19 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=290 nM,associated with Pep-1).##NOTE:Ki: inhibition constants ",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30203,GTKALTEAIPLTEEAEC,17,P9,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =15 ±7.3 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30204,GTKALTEVAPLTEEAEC,17,P10,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.","[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =7.3 ± 2.9 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=140 nM,associated with Pep-1).##NOTE:Ki: inhibition constants ",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30205,GTKALTEVIALTEEAEC,17,P11,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =7 ± 1.4 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30206,GTKALTEVIPATEEAEC,17,P12,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =22 ± 3 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30207,GTKALTEVIPLAEEAEC,17,P13,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =10.2 ± 2.5 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30208,GTKALTEVIPLTAEAEC,17,P14,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =14 ± 3 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30209,GTKALTEVIPLTEAAEC,17,P15,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =14 ± 2.2 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30215,KWLTEWIPLTAEAEC,15,P26,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.","[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50>1000 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =1.8± 0.7 μM).##NOTE:Ki: inhibition constants ",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,15,12-15
DRAMP30216,GTKWLTEWIPLTAEC,15,P27,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.","[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50<0.32 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =0.05 ± 0.01 μM).##NOTE:Ki: inhibition constants ",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,15,12-15
DRAMP30217,GTKWATEWAPLTAEAEC,17,P28,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =2 ± 0.6 μM).##NOTE:Ki: inhibition constants ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30219,GTKWLTEWIPLTAEAEC,17,PAW,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.","[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =0.7 ± 0.2 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=1.8 nM,associated with Pep-1).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30220,GAKTETLVIPETELEAC,17,Pscr,No entry found,Retroviridae,Not found,Synthetic construct(derived from Pep-A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.",[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =61 ± 12 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,18952602,J Biol Chem. 2009 Jan 2;284(1):254-264.,"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.",A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.,17,15-18
DRAMP30221,LEAIPMSIPPEVKFNKPFVF,20,VIRIP,No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=14.79±2.56 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30222,AEAIPMSIPPEVKFNKPFVF,20,VIRIP[A1],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30223,LAAIPMSIPPEVKFNKPFVF,20,VIRIP[A2],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30224,LEAAPMSIPPEVKFNKPFVF,20,VIRIP[A4],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30225,LEAIAMSIPPEVKFNKPFVF,20,VIRIP[A5],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=23.50±5.19 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30226,LEAIPASIPPEVKFNKPFVF,20,VIRIP[A6],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=13.00±1.04 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30227,LEAIPMSAPPEVKFNKPFVF,20,VIRIP[A8],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=23.46±0.28 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30228,LEAIPMSIAPEVKFNKPFVF,20,VIRIP[A9],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=16.33±4.34 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30229,LEAIPMSIPAEVKFNKPFVF,20,VIRIP[A10],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=9.72±1.66 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30230,LEAIPMSIPPAVKFNKPFVF,20,VIRIP[A11],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=11.00±4.75 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30231,LEAIPMSIPPEAKFNKPFVF,20,VIRIP[A12],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=10.64±2.23 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30232,LEAIPMSIPPEVAFNKPFVF,20,VIRIP[A13],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=4.73±0.61 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30233,LEAIPMSIPPEVKANKPFVF,20,VIRIP[A14],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=4.62±1.32 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30234,LEAIPMSIPPEVKFAKPFVF,20,VIRIP[A15],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=17.41±3.66 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30235,LEAIPMSIPPEVKFNAPFVF,20,VIRIP[A16],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=10.81±0.68 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30236,LEAIPMSIPPEVKFNKAFVF,20,VIRIP[A17],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=12.72±10.17 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30237,LEAIPMSIPPEVKFNKPAVF,20,VIRIP[A18],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30238,LEAIPMSIPPEVKFNKPFAF,20,VIRIP[A19],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30239,LEAIPMSIPPEVKFNKPFVA,20,VIRIP[A20],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30240,LEAIPMSIPPEVKFNKPFVF,20,N-Ac-VIRIP,No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30241,LEAIPMSIPPEVKFNKPFVF,20,VIRIP-amide,No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30242,LEAIPMSIPPEVKFNKPFVF,20,N-Ac-VIRIP-amide,No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30243,LEAIPMSIPPEVAFAKPFVF,20,"VIRIP[A13,A15]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=3.45±0.44 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30244,LEAIPMSIPPEVFFNKPFVF,20,VIRIP[F13],No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.66±0.06 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30245,LEAIPMCIPPECAFNKPFVF,20,"VIRIP[A13,C7,C12]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=1.00±0.21 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys7 and Cys12,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30246,LEAIPCSIPPCVAFNKPFVF,20,"VIRIP[A13,C6,C11]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.18±0.08 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30247,LEAIPCSIPpCVAFNKPFVF,20,"VIRIP[A13,C6,C11,p10]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.94±0.54 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,Mixed(D-Pro10),No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30248,LEAIPCSIPPCVGFGKPFVF,20,"VIRIP[C6,C11,G13,G15]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.73±0.13 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30249,LEAIPCSIPPCVLFNKPFVF,20,"VIRIP[C6,C11,L13]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.84±0.08 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30250,LEAIPCSIPPCVFFNKPFVF,20,"VIRIP[C6,C11,F13]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.93±0.05 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,L,[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30251,LEAIPCSIPPCFAFNKPFVF,20,"VIRIP[A13,C6,C11,F12]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.27±0.04 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,L,[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30252,LEAIPMSIPPEFLFGKPFVF,20,"VIRIP[F12,L13,G15]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=1.34±0.42 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30253,LEAIPCSIPPCVFFGKPFVF,20,"VIRIP[C6,C11,F13,G15]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.28±0.02 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30254,LEAIPCSIPPCFLFGKPFVF,20,"VIRIP[C6,C11,F12,L13,G15]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.39±0.13 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30255,LEAIPCSIPpCVFFNKPFVF,20,"VIRIP[C6,C11,p10,F13]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.33±0.07 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,Mixed(D-Pro10),No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30256,LEAIPCSIPpCFLFNKPFVF,20,"VIRIP[C6,C11,p10,F12,L13]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.20±0.04 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Free,Disulfide bond between Cys6 and Cys11,Mixed(D-Pro10),[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30257,LEAIPMGIPpEVXFNKPFVF,20,"VIRIP[G7,p10,L-Tic13]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.28±0.08 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,The 'X' at position 13 is L-tetrahydro-isoquinoline-3-carboxylic acid(Tic).,Mixed(D-Pro10),[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30258,LEKIPMSIPpEVXFNKPFVF,20,"VIRIP[K3,p10,L-Tic13]",No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.41±0.13 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,The 'X' at position 13 is L-tetrahydro-isoquinoline-3-carboxylic acid(Tic).,Mixed(D-Pro10),No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30259,KVINPEPIVEPFMSKPFALF,20,scrambled VIRIP,No entry found,Retroviridae,Not found,Synthetic construct(derived from α1-antitrypsin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.,[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.,membrane,17448989,Cell. 2007 Apr 20;129(2):263-75.,"Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.",Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.,20,18-21
DRAMP30303,ILGPVLGLVSRTLRRVLGIL,20,Maximin H5r3,No entry found,Retroviridae,Not found,Synthetic construct(derived from Maximin H5),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=2.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.20086159]CEM-SS cells:50% Cell death at 8.7 µM.,Not found,20086159,Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.,"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.",Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,20,18-21
DRAMP30304,GFNEIVQDIEDFLQNLV,17,GF-17−,No entry found,Retroviridae,Not found,Synthetic construct(derived from LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>25.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >25.1 µM.,Not found,20086159,Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.,"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.",Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,17,15-18
DRAMP30305,GLRSRIWLWVLLMIWQESNRFKRM,24,DRS S9r3,No entry found,Retroviridae,Not found,Synthetic construct(derived from Dermaseptin S9),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=1.25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >32.1 µM.,Not found,20086159,Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.,"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.",Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,24,21-24
DRAMP30306,GLRRLLGRLLRRLGRLLLR,19,GLR-19,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=4.4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.20086159]CEM-SS cells:50% Cell death at 25.7 µM.,Not found,20086159,Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.,"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.",Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,19,18-21
DRAMP30307,GLLSVLGSVAKHVLPHVVPVIAAAL,25,"Caerin 1.1 mod 7(Caerin 1.1 [E23A,H24A])",No entry found,Retroviridae,Not found,Sythetic construct(derived from Caerin 1.1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).,[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found in the reference(s) presented,virion envelope,26026377##33008028,Peptides. 2015 Sep;71:296-303. ##Antibiotics (Basel). 2020 Sep 30;9(10):661.,Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK.",25,24-27
DRAMP30308,GLLSVLGSVAKHVLPHVVPVIAKLH,25,"Caerin 1.1 mod 9(Caerin 1.1 [E23K,H24L,L25H])",No entry found,Retroviridae,Not found,Sythetic construct(derived from Caerin 1.1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).,[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 17	µM.,virion envelope,26026377,Peptides. 2015 Sep;71:296-303. ,Inhibition of HIV infection by caerin 1 antimicrobial peptides.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.",25,24-27
DRAMP30309,GLLKVLGSVAKKVLPKVVPVIAEKL,25,"Caerin 1.1 mod 10(Caerin 1.1 [S4K;H12K,H16K,H24K])",No entry found,Retroviridae,Not found,Sythetic construct(derived from Caerin 1.1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).,[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=4 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found in the reference(s) presented,virion envelope,26026377,Peptides. 2015 Sep;71:296-303. ,Inhibition of HIV infection by caerin 1 antimicrobial peptides.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.",25,24-27
DRAMP30310,GLFGVLGSIAKHLLPHVVPVIAEKL,25,Caerin 1.9 sm(Caerin 1.9 [V13L]),No entry found,Retroviridae,Not found,Sythetic construct(derived from Caerin 1.9),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).,[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=3 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 17.5 µM.,virion envelope,26026377##33008028,Peptides. 2015 Sep;71:296-303. ##Antibiotics (Basel). 2020 Sep 30;9(10):661.,Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK.",25,24-27
DRAMP30311,GLFGILGSVAKHVLPHVIPVVAEHL,25,Caerin 1.20,No entry found,Retroviridae,Not found,Litoria caerulea/Litoria splendida,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).,[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=7 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 25	µM;Human endocervical cells End1/E6E7:50% cell death at 22 µM.,virion envelope,26026377##33008028,Peptides. 2015 Sep;71:296-303.##Antibiotics (Basel). 2020 Sep 30;9(10):661.,Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.,"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK.",25,24-27
DRAMP30327,FVPWFSKFlXRILGGC,16,"Temporin L[Pro3,DLeu9,Nle10]-GGC-CHOL(TL6.2)",No entry found,"Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae",Not found,Synthetic construct(derived from Temporin-L),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.","[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=9.54 μM,IC90=47.95 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=12.12 μM μM,IC90=49.95 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=40.89 μM μM,IC90>50.00 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=21.12 μM,IC90=49.90 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,PEG4-Cholesterol-NH2,The 'X' at position 10 is norleucine.,Mixed(D-Leu9),[Ref.35216177]Vero cells:CC50>100.00 μM,membrane,35216177,Int J Mol Sci. 2022 Feb 13;23(4):2060.,"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. ",Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.,16,15-18
DRAMP30329,CGGFVPWFSKFlXRIL,16,"CHOL-CGG-Temporin L[Pro3,DLeu9,Nle10](TL6.4)",No entry found,"Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae",Not found,Synthetic construct(derived from Temporin-L),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.","[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.32 μM,IC90=8.21 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=1.02 μM μM,IC90=10.21 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=28.88 μM μM,IC90=49.90 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=6.02 μM,IC90=9.90 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Cholesterol-PEG4,Amidation,The 'X' at position 10 is norleucine.,Mixed(D-Leu9),[Ref.35216177]Vero cells:CC50>100.00 μM,membrane,35216177,Int J Mol Sci. 2022 Feb 13;23(4):2060.,"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. ",Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.,16,15-18
DRAMP30334,TLLKKVLKAAAKAALNAVLVGANA,24,Dermaseptin S4 (5-28),No entry found,Herpesviridae,Not found,Synthetic construct(derived from Dermaseptin S4),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=27.07 μM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=25.27 μM). ,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.23161023]Vero cells:CC50=34 μM.,Not found,23161023,J Med Virol. 2013 Feb;85(2):272-81.,"Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K. ", In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.,24,21-24
DRAMP30338,RLFFKCIYRFFEHGLKRG,18,M2 AH,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza virus M2 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: M2 AH is an α-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 AH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission.",[Ref.31375212]H1N1(A/Puerto Rico/8/34):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=870 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.31375212]Madin-Darby canine kidney epithelial(MDCK) cells:CC50=70.3 μM,membrane,31375212,Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.,"Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH. ",Envelope-deforming antiviral peptide derived from influenza virus M2 protein.,18,15-18
DRAMP30339,RKFFKKIYRFFRKLLKRL,18,M2 MH,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza virus M2 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: M2 MH is an α-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 MH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission.",[Ref.31375212]H1N1(A/Puerto Rico/8/34):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=53 nM);##H3N2(A/Sydney/5/97):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.058 μM);##H3N2(A/X31):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.016 μM);##H5N2(A/aquatic bird/Korea/w81/2005 ):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.066 μM);##H1N1(A/Swine/Iowa/15/30):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.053 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.31375212]Madin-Darby canine kidney epithelial(MDCK) cells:CC50=19.2 μM,membrane,31375212,Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.,"Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH. ",Envelope-deforming antiviral peptide derived from influenza virus M2 protein.,18,15-18
DRAMP30340,RLAAKCAARFAEHGLKRG,18,M2 NH,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza virus M2 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: M2 NH is an α-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 NH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission.",[Ref.31375212]H1N1:did not exhibit any inhibitory effect.,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.31375212]did not show apparent cytotoxicity against Madin-Darby canine kidney epithelial(MDCK) cells up to a concentration of 100 μM.,membrane,31375212,Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.,"Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH. ",Envelope-deforming antiviral peptide derived from influenza virus M2 protein.,18,15-18
DRAMP30342,FLPLILPAnti-SIVTALSSFLKQG,20,Hs-1,No entry found,Flaviviridae,Not found,Hypsiboas semilineatus,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: It was possible to observe that the viral particle lost its ability to infect because of the breakdown on the envelope as the peptide acted directly on the virus. ,[Ref.29153860]DENV2:reduced the number of lysis plaques by 100% at 125 µg/mL; by 60% at 7.81 μg/mL;##DENV3:reduced the number of lysis plaques by 100% at 125 µg/mL; by 50% at 7.81 μg/mL,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.29153860]No significant cytotoxicity agaisnt Vero cells up to 125μg/ mL.,envelope,29153860,Virology. 2018 Jan 15;514:79-87.,"Monteiro JMC, Oliveira MD, Dias RS, Nacif-Marçal L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO.",The antimicrobial peptide HS-1 inhibits dengue virus infection.,25,24-27
DRAMP30347,MVDRGWGNHAGLFGKGAnti-SIV,19,DN80,No entry found,Flaviviridae,Not found,Synthetic construct(derived from the E polyprotein of DENV),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.,[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(17±10% inhibition at 49.9 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,envelope,31351847,Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. ,"da Silva-Júnior EF, de Araújo-Júnior JX. ","Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.",24,21-24
DRAMP30349,AWLVHRQWFLDLPLPWLPG,19,DN81,No entry found,Flaviviridae,Not found,Synthetic construct(derived from the E polyprotein of DENV),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.,[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(25±8% inhibition at 42.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,envelope,31351847,Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. ,"da Silva-Júnior EF, de Araújo-Júnior JX. ","Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.",19,18-21
DRAMP30351,VVDRGWGNGAGLFGKGSID,19,WN82,No entry found,Flaviviridae,Not found,Synthetic construct(derived from the E polyprotein of WNV),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.,[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(4±13% inhibition at 52.5μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,envelope,31351847,Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. ,"da Silva-Júnior EF, de Araújo-Júnior JX. ","Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.",19,18-21
DRAMP30352,TFLVHREWFMDLNLPWSSAGSTVWR,25,WN53,No entry found,Flaviviridae,Not found,Synthetic construct(derived from the E polyprotein of WNV),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.,"[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(IC50~10μM,56.0±3.0% inhibition at 99μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.31351847]No cytotoxicity against LLCMK-2 monkey kidney epithelial cells at 100 mg/ml.,envelope,31351847,Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. ,"da Silva-Júnior EF, de Araújo-Júnior JX. ","Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.",25,24-27
DRAMP30353,TFLVHREWFMDLNLPWSSA,19,WN83,No entry found,Flaviviridae,Not found,Synthetic construct(derived from the E polyprotein of WNV),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.,"[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(IC50~10μM, 70.0±3.0% inhibition at 128 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.31351847]No cytotoxicity against LLCMK-2 monkey kidney epithelial cells at 100 mg/ml.,envelope,31351847,Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. ,"da Silva-Júnior EF, de Araújo-Júnior JX. ","Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.",19,18-21
DRAMP30355,QETAYFLLKLAGRWP,15,HIV-1 integrase(95-109),P04587,Retroviridae,Not found,Synthetic construct(derived from HIV-1 integrase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.,[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=3.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found in the reference(s) presented,Integrase,12643937,Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.,"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.",Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. ,15,12-15
DRAMP30357,HLKTAVQMAVFIHNFKR,17,HIV-1 integrase(171-187),P04587,Retroviridae,Not found,Synthetic construct(derived from HIV-1 integrase),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.,[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=3.0 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found in the reference(s) presented,Integrase,12643937,Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.,"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.",Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. ,17,15-18
DRAMP30389,LQQLLFIHFRIGRRRRRRRR,20,peptide 4,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30391,ILQQLLFIHFRIGRRRRRRRR,21,peptide 6,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.10 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,21,18-21
DRAMP30392,RILQQLLFIHFRIGRRRRRRRR,22,peptide 7,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.11 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,22,21-24
DRAMP30393,IRILQQLLFIHFRIGRRRRRRRR,23,peptide 8,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.26 ±0.04 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.11 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,23,21-24
DRAMP30394,IIRILQQLLFIHFRIGRRRRRRRR,24,peptide 9,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.11 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,24,21-24
DRAMP30395,AIIRILQQLLFIHFRIGRRRRRRRR,25,peptide 10,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.08 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.05 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,25,24-27
DRAMP30403,AQQLLFIHFRIGRRRRRRRR,20,peptide 18,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.12 ± 0.004 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.08 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30404,LAQLLFIHFRIGRRRRRRRR,20,peptide 19,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30405,LQALLFIHFRIGRRRRRRRR,20,peptide 20,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.10 ± 0.004 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30406,LQQALFIHFRIGRRRRRRRR,20,peptide 21,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.12 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30407,LQQLAFIHFRIGRRRRRRRR,20,peptide 22,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.003 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30408,LQQLLAIHFRIGRRRRRRRR,20,peptide 23,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.34 ± 0.06 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.18 ± 0.03 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30409,LQQLLFAHFRIGRRRRRRRR,20,peptide 24,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.33 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.22± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30410,LQQLLFIAFRIGRRRRRRRR,20,peptide 25,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30411,LQQLLFIHARIGRRRRRRRR,20,peptide 26,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.25 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.12± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30412,LQQLLFIHFAIGRRRRRRRR,20,peptide 27,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.11 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.05 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30413,LQQLLFIHFRAGRRRRRRRR,20,peptide 28,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.20 ± 0.03 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.16 ± 0.02µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30414,LQQLLFIHFRIARRRRRRRR,20,peptide 29,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.,[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.09 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.09 ± 0.01 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,20708407,Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.,"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.",Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.,20,18-21
DRAMP30418,RQLLSGIVQQQNNLLRAIEAQQHLL,25,C16- N25,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry.",[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=484±60 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,C16(hexadecanoic acid),Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20605950,FASEB J. 2010 Nov;24(11):4196-202. ,"Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y.",Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. ,25,24-27
DRAMP30419,RQLLSGIVQQQNNLLRAIEAQQH,23,C16- N23,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry.",[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=1931±187 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,C16(hexadecanoic acid),Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,20605950,FASEB J. 2010 Nov;24(11):4196-202. ,"Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y.",Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. ,23,21-24
DRAMP30420,XDLTXEMLSLQQVVKALNESY,21,P21S1,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 1 and 5) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (1) and X (5) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30421,LXLTYXMLSLQQVVKALNESY,21,P21S2,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.90 ± 1.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 2 and 6) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (2) and X (6) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30422,LDLXYEMXSLQQVVKALNESY,21,P21S3,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 4 and 8) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (4) and X (8) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30423,LDLTXEMLXLQQVVKALNESY,21,P21S4,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=7.14 ± 0.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 5 and 9) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (5) and X (9) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30424,LDLTYEMXSLQXVVKALNESY,21,P21S5,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.7±2.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 8 and 12) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (8) and X (12) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30425,LDLTYEMLXLQQXVKALNESY,21,P21S6,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 9 and 13) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (9) and X (13) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30426,LDLTYEMLSLXQVVXALNESY,21,P21S7,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 11 and 15) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (11) and X (15) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30427,LDLTYEMLSLQXVVKXLNESY,21,P21S8,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.26±0.05 μM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=3.03 ± 0.29 μM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=4.06± 0.34 μM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.98± 0.28 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.,L,[Ref.29442512]Calu-3 cell:CC50>100 μM,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30428,LDLTYEMLSLQQVVXALNXSY,21,P21S9,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=14.1 ± 2.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 15 and 19) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (15) and X (19) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30429,LDLTYEMLSLQQVVKXLNEXY,21,P21S10,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.33 ± 0.04 μM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=0.97± 0.08 μM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.82± 0.28 μM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=0.89± 0.07 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (16) and X (20) are cross-linked by hydrocarbon stapling.,L,[Ref.29442512]Calu-3 cell:CC50>100 μM,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30430,LXLTYXMLSLQQVVKALNESY,21,P21L2,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.9 ±1.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 2 and 6 are S5((S)-pentenyl alanine),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30431,LDLTXEMLXLQQVVKALNESY,21,P21L4,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=8.21 ±0.9 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 5 and 9 are S5((S)-pentenyl alanine),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30432,LDLTYEMXSLQXVVKALNESY,21,P21L5,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=4.49 ± 0.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 8 and 12 are S5((S)-pentenyl alanine),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30433,LDLTYEMLSLQXVVKXLNESY,21,P21L8,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=20.6± 3.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 12 and 16 are S5((S)-pentenyl alanine),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30434,LDLTYEMLSLQQVVXALNXSY,21,P21L9,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.9 ± 1.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 15 and 19 are S5((S)-pentenyl alanine),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30435,LDLTYEMLSLQQVVKXLNEXY,21,P21L10,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.55 ± 0.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 16 and 20 are S5((S)-pentenyl alanine),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30436,LDLTYEMLSLQXVVKXLNESY,21,P21R8,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=16.3 ± 1.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' at position 12 and 16 are R5 amino acids. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30437,LDLTYEZLSLQXVVKXLNESY,21,P21S8Z,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.63 ± 0.05 μM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=2.80 ± 0.74 μM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=4.15± 0.25 μM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=2.49±0.18 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling. The 'Z' at position 7 indicates R8 ((R)-octenyl alanine),L,[Ref.29442512]Calu-3 cell:CC50>100 μM,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30438,LDLTYEMLSLQXVVKXLNESF,21,P21S8F,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=2.16± 1.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30439,LDLTYEZLSLQXVVKXLNESF,21,P21S8ZF,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.89 ± 0.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,"①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.,The 'Z' at position 7 indicates R8 ((R)-octenyl alanine)",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30440,LDLTYEMLSLQQVVKALNESY,21,P21,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.,[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,29442512,J Med Chem. 2018 Mar 8;61(5):2018-2026.,"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.",Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. ,21,18-21
DRAMP30454,WEEWDKKIEEYTKKIEELIKKSEEQ,25,SC25EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=79.8±9.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=41.5±3.1 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,25,24-27
DRAMP30455,WEEWDKKIEEYTKKIEELIKKSEE,24,SC24EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=107.6±8 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=75.7±11.2 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,24,21-24
DRAMP30456,WEEWDKKIEEYTKKIEELIKKSE,23,SC23EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=105.1±15.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=94.2±12.3 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,23,21-24
DRAMP30457,WEEWDKKIEEYTKKIEELIKKS,22,SC22EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=66.9±15.9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=98.6±7.2 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,22,21-24
DRAMP30458,WEEWDKKIEEYTKKIEELIKK,21,SC21EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=113.2±8 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=105.4±12.8 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,21,18-21
DRAMP30459,WEEWDKKIEEYTKKIEELIK,20,SC20EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=126.6±10.7 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=202.4±5.4 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,20,18-21
DRAMP30460,WEEWDKKIEEYTKKIEELI,19,SC19EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=70.7±9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=217.2±16.5 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,19,18-21
DRAMP30461,WEEWDKKIEEYTKKIEEL,18,SC18EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50>2000 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>2000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,18,15-18
DRAMP30473,MTWEEWDKKIEEYTKKIEELIKKSE,25,MT-SC23EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=2.1±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.9±0.7 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,25,24-27
DRAMP30474,MTWEEWDKKIEEYTKKIEELIKKS,24,MT-SC22EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=2.4±0.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2.2±0.9 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,24,21-24
DRAMP30475,MTWEEWDKKIEEYTKKIEELIKK,23,MT-SC21EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=3.8±0.4 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3.1±1.2 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,23,21-24
DRAMP30476,MTWEEWDKKIEEYTKKIEELIK,22,MT-SC20EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=3.7±0.5 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3.3±1.4 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,22,21-24
DRAMP30477,MTWEEWDKKIEEYTKKIEELI,21,MT-SC19EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=5±0.9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=4.9±1.5 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,21,18-21
DRAMP30478,MTWEEWDKKIEEYTKKIEEL,20,MT-SC18EK,Q5DP94,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.,[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50>2000 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>2000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31277353,Viruses. 2019 Jul 3;11(7):609. ,"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.",Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.,20,18-21
DRAMP30491,EKINQSLAFIRKSDELLHNV,20,peptide 4(RSV fusion protein(497-515)),P03420,Paramyxoviridae,Not found,Synthetic construct(derived from RSV fusion protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50>50 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,31228294,Protein Sci. 2019 Aug;28(8):1501-1512.,"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.",Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.,20,18-21
DRAMP30492,EKINQSLXFIRXSDXLLHXV,20,peptide 4a(derived from RSV fusion protein(497-515)),No entry found,Paramyxoviridae,Not found,Synthetic construct(derived from RSV fusion protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.82±0.42 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30493,EKIXQSLXFIXKSDXLLHNV,20,peptide 4bb(derived from RSV fusion protein(497-515)),No entry found,Paramyxoviridae,Not found,Synthetic construct(derived from RSV fusion protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.74±0.27 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30494,EXINXSLXFIRXSDELLHNV,20,peptide 4ca(derived from RSV fusion protein(497-515)),No entry found,Paramyxoviridae,Not found,Synthetic construct(derived from RSV fusion protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.59±0.13 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 2 indicates R-pentenylalanine; The 'X' at position 5,8,12 indicates S-pentenylalanine, X(2) and X(5), X(8) and X(12) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30495,XKINQSLXFIRXSDELLHXV,20,peptide 4ef(derived from RSV fusion protein(497-515)),No entry found,Paramyxoviridae,Not found,Synthetic construct(derived from RSV fusion protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=3.07±1.45 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 1,8 indicates R-octenyl-alanine; The 'X' at position 12,19 indicates S-pentenylalanine, X(1) and X(8), X(12) and X(19) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30496,EKIXQSLXFIRXSDELLHXV,20,peptide 4bf(derived from RSV fusion protein(497-515)),No entry found,Paramyxoviridae,Not found,Synthetic construct(derived from RSV fusion protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=2.49±0.09 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 12 indicates R-octenyl-alanine; The 'X' at position 4,8,19 indicates S-pentenylalanine, X(4) and X(8), X(12) and X(19) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30497,EKIAQSLXFIRXSDXLLHXV,20,peptide 4a[N500A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=20.41±2.4 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30498,EKINQSLXFIAXSDXLLHXV,20,peptide 4a[R507A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=175±0.00 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30499,AKIXQSLXFIXKSDXLLHNV,20,peptide 4bb[E497A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.16±0.08 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30500,EAIXQSLXFIXKSDXLLHNV,20,peptide 4bb[K498A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.60±0.02 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30501,EKAXQSLXFIXKSDXLLHNV,20,peptide 4bb[I499A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.30±0.89 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30502,EKIXASLXFIXKSDXLLHNV,20,peptide 4bb[Q501A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.28±0.43 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30503,EKIXQALXFIXKSDXLLHNV,20,peptide 4bb[S502A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.66±0.26 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30504,EKIXQSAXFIXKSDXLLHNV,20,peptide 4bb[L503A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.95±0.53 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30505,EKIXQSLXAIXKSDXLLHNV,20,peptide 4bb[F505A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.39±0.10 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30506,EKIXQSLXFAXKSDXLLHNV,20,peptide 4bb[I506A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=10.44±2.97 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30507,EKIXQSLXFIXASDXLLHNV,20,peptide 4bb[K508A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=10.93±13.90 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30508,EKIXQSLXFIXKADXLLHNV,20,peptide 4bb[S509A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=82.04±1.56 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30509,EKIXQSLXFIXKSAXLLHNV,20,peptide 4bb[D510A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.10±0.08 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30510,EKIXQSLXFIXKSDXALHNV,20,peptide 4bb[L512A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.88±0.06 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30511,EKIXQSLXFIXKSDXLLANV,20,peptide 4bb[H514A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.52±0.07 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30512,EKIXQSLXFIXKSDXLLHAV,20,peptide 4bb[N515A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=2.71±2.93 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30513,EKIXQSLXFIXKSDXLLHNA,20,peptide 4bb[V516A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.60±0.03 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30514,EXINXSLXFIRXSDALLHNV,20,peptide 4ca[E511A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.,[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.00±0.03 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Free,"The 'X' at position 2 indicates R-pentenylalanine; The 'X' at position 5,8,12 indicates S-pentenylalanine, X(2) and X(5), X(8) and X(12) are cross-linked by hydrocarbon stapling.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,28137809,Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.,"Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.",A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,20,18-21
DRAMP30516,YTSLIEELIKKSEEQQKKNEEELKX,25,LP-54,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=149±48 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=301±26 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1796±340 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 25 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",25,24-27
DRAMP30519,WEQKIEELLKKAEEQQKKNEEEX,23,LP-57,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=213±21 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=178±38 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1917±440 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 23 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",23,21-24
DRAMP30520,WEQKIEELLKKAEEQQKKNEX,21,LP-58,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=143000±19911 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=110900±3715 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=107033±9473 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 21 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",21,18-21
DRAMP30521,WEQKIEELLKKAEEQQKX,18,LP-59,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>900000 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=240800±23649 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=210477±25537 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 18 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",18,15-18
DRAMP30523,IEELIKKSEEQQKKNEEELKKLEX,24,LP-61,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)","[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=85±9 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=43±9 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=126±63 pM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=144 pM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 24 is Lys-C16(palmitic acid),L,[Ref.30089693]TZM-bl cell:CC50=193.63±13.92 μM;##MT-4 cell:CC50=164.47±37.69 μM;##HEK293T cell:CC50=140.43± 10.7μM;##PBMC:CC50=46.43± 2.6 μM.,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",24,21-24
DRAMP30526,KIEELLKKAEEQQKKNEEELKKLEX,25,LP-64,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)","[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=128±27 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=36±1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=25±2 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.04 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.08-140.75 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.23-0.75 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.10-0.11 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=58 pM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 25 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",25,24-27
DRAMP30527,IEELLKKAEEQQKKNEEELKKLEX,24,LP-65,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)","[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14±3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=8±3 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=7±2 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.15-88.63 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.23-0.75 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.07-0.04 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=35 pM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 24 is Lys-C16(palmitic acid),L,[Ref.30089693]TZM-bl cell:CC50=256.23 ±14.58 μM;##MT-4 cell:CC50=213.4±59.59 μM;##HEK293T cell:CC50=208.43± 22.9μM;##PBMC:CC50=49.95± 2.97 μM.,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",24,21-24
DRAMP30528,EELLKKAEEQQKKNEEELKKLEX,23,LP-66,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1008±248 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=434±71 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1109±193 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 23 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",23,21-24
DRAMP30529,LLEQAEEQQKKNEEELKKLEX,21,LP-67,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3417±419 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=627±154 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1527±565 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 21 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",21,18-21
DRAMP30530,AEEQQKKNEEELKKLEX,17,LP-68,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>250000 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>250000 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>250000 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 17 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",17,15-18
DRAMP30531,IEELLKKAEEQQKKNEEELKX,21,LP-69,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)","[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=239±16 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=125±27 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=157±29 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.31 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=2.01-1815.67 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=9.83-152.28 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.56-11.91 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=1391 pM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 21 is Lys-C16(palmitic acid),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",21,18-21
DRAMP30545,YTSLIEELIKKSEEQQKKNEEELKK,25,P-54,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",25,24-27
DRAMP30546,WEQKIEELLKKAEEQQKKNEEELKK,25,P-55,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14.2±1.8 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=16.9±2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=32.3±9.9 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",25,24-27
DRAMP30547,WEQKIEELLKKAEEQQKKNEEEK,23,P-57,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",23,21-24
DRAMP30548,WEQKIEELLKKAEEQQKKNEK,21,P-58,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",21,18-21
DRAMP30549,WEQKIEELLKKAEEQQKK,18,P-59,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",18,15-18
DRAMP30553,KIEELLKKAEEQQKKNEEELKKLEK,25,P-64,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=7.6±1.3 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9.3±0.6 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=10.4±2.8 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",25,24-27
DRAMP30554,IEELLKKAEEQQKKNEEELKKLEK,24,P-65,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=17.9±2.2 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=25.7±1.3 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=25.8±1.9 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",24,21-24
DRAMP30555,IEELLKKAEEQQKKNEEELKK,21,P-69,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>7508 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",21,18-21
DRAMP30627,WQCLTLTHRGFVLLTITVLR,20,IN-1,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide can inhibit integrase and thus inhibit virus replication.,[Ref.18201721]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=38 µM);inhibition of strand transfer catalyzed by integrase(IC50=12 µM).##[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(77% inhibition at 62.5μM);inhibition of virus replication in TZM-bl cells(70% inhibition at 62.5μM);inhibition of intergration(63% inhibition at 62.5μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18201721]No cytotixic against HeLa cells and H9 T-lymphocyte cultured cells up to ~62.5 μM.,Integrase,18201721##19850483,J Mol Biol. 2008 Feb 29;376(4):971-82. ##Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.,"Armon-Omer A, Levin A, Hayouka Z, Butz K, Hoppe-Seyler F, Loya S, Hizi A, Friedler A, Loyter A. ##Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. ",Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.##Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.,20,18-21
DRAMP30649,EMTWEEWEKKIEEYTKKIEEILXX,24,LP-11,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=931±68 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=201±41 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=253±40 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'X' at position 24 is Lys-C16(palmitic acid),The 'X' at position 23 is Lys-PEG8.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",24,21-24
DRAMP30650,EMTWEEWEKKVEELEKKIEELLXX,24,LP-19,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)",[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=296±45 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=95±18 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=92±11 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'X' at position 24 is Lys-C16(palmitic acid),The 'X' at position 23 is Lys-PEG8.",L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30089693,J Virol. 2018 Sep 26;92(20):e01088-18.,"Chong H, Zhu Y, Yu D, He Y.","Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.",24,21-24
DRAMP30658,WEQKIEELLKKAEEQQKKNEEELKX,25,LP-93,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.","[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=6.27±1.26 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=6.55±1.97 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=7.57±0.62pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=9.89 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.006±0.001 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.012-2.17 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=1.244-3.514 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.013-0.773 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=14.51pM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 25 is Lys-Chol(cholesterol),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30867304,J Virol. 2019 May 15;93(11):e02312-18.,"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.",Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.,25,24-27
DRAMP30659,IEELLKKAEEQQKKNEEELKKLEX,24,LP-94,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.","[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=1.75±0.23 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=5.90±1.80 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=15.69±1.97 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=6.54 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.004±0.002 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.004-2.295 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.019-0.027 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.011-0.018 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=27.36 pM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 24 is Lys-Chol(cholesterol),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30867304,J Virol. 2019 May 15;93(11):e02312-18.,"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.",Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.,24,21-24
DRAMP30660,IEELLKKAEEQQKKNEEELKX,21,LP-95,P03377,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.","[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=199.92±32.69 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=24.36±0.15 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=4781.17±699.33 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=148.88 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.067±0.026 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.39-408.556 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=2.857-13.512 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.556-0.862 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=29.84 pM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'X' at position 21 is Lys-Chol(cholesterol),L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,30867304,J Virol. 2019 May 15;93(11):e02312-18.,"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.",Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.,21,18-21
DRAMP30688,ALWKTMLKKLGTMALHAGK,19,Dermaseptin-S1 (1-19),P24302,Herpesviridae,Not found,Synthetic construct(derived from Dermaseptin-S1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=9 µM).,[Ref.20718719]human red cells:HC50>100 µM.,Linear,Free,Amidation,,L,[Ref.20718719]Vero cells:CC50=80 µM;293TT(embryonic human culture cells):CC50=80 µM.,Not found,20718719,APMIS. 2010 Sep 1;118(9):674-80.,"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.",In vitro activity of dermaseptin S1 derivatives against genital pathogens. ,19,18-21
DRAMP30689,ALXKTMLKKLGTMAL,15,Dermaseptin-S1 (1-15)[W31NAL],P24302,Herpesviridae,Not found,Synthetic construct(derived from Dermaseptin-S1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=2.7 µM).,[Ref.20718719]human red cells:HC50=75 µM.,Linear,Free,Amidation,The 'X' at position 3 indicates Nal (3-[1-naphthyl]alanine).,L,[Ref.20718719]Vero cells:CC50=50 µM;293TT(embryonic human culture cells):CC50>100 µM.,Not found,20718719,APMIS. 2010 Sep 1;118(9):674-80.,"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.",In vitro activity of dermaseptin S1 derivatives against genital pathogens.,15,12-15
DRAMP30690,ALHKTMLKKLGTMAL,15,Dermaseptin-S1 (1-15)[W3H],P24302,Herpesviridae,Not found,Synthetic construct(derived from Dermaseptin-S1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=5 µM).,[Ref.20718719]human red cells:HC50=100 µM.,Linear,Free,Amidation,,L,[Ref.20718719]Vero cells:CC50>100 µM;293TT(embryonic human culture cells):CC50>100 µM.,Not found,20718719,APMIS. 2010 Sep 1;118(9):674-80.,"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.",In vitro activity of dermaseptin S1 derivatives against genital pathogens.,15,12-15
DRAMP30691,KALXKTMLKKLGTMAL,16,K-Dermaseptin-S1 (1-15)[W31NAL],P24302,Herpesviridae,Not found,Synthetic construct(derived from Dermaseptin-S1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=5 µM).,[Ref.20718719]human red cells:HC50=80 µM.,Linear,Free,Amidation,The 'X' at position 4 indicates Nal (3-[1-naphthyl]alanine).,L,[Ref.20718719]Vero cells:CC50=50 µM;293TT(embryonic human culture cells):CC50>100 µM.,Not found,20718719,APMIS. 2010 Sep 1;118(9):674-80.,"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.",In vitro activity of dermaseptin S1 derivatives against genital pathogens.,16,15-18
DRAMP30698,PACQDFLGAMIHLKAKTNISIR,22,3(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(28% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,22,21-24
DRAMP30699,LKAKTNISIREGPTLGNWAR,20,4(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(24% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30700,EGPTLGNWAREIWATLFKKA,20,5(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(100% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30701,EIWATLFKKATRQCRRGRIW,20,6(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(100% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30702,TRQCRRGRIWKRWNETITGP,20,7(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(94% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30703,SGCANNTCYNAnti-VSVIVPDYQC,20,9(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(24% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,25,24-27
DRAMP30704,YLDRVDTWLQGKINISLCLT,20,11(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(9% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30705,GKINISLCLTGGKMLYNKVT,20,12(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(10% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30706,GGKMLYNKVTKQLSYCTDPL,20,13(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30707,KQLSYCTDPLQIPLINYTFG,20,14(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(15% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30708,PNQTCMWNTSQIQDPEIPKC,20,16(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30709,QIQDPEIPKCGWWNQMAYYN,20,17(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(2% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30710,FHCQRTQSQPGSWFRAISSWKQ,22,20(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(4% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,22,21-24
DRAMP30711,GSWFRAISSWKQRNRWEWRPDF,22,21(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,22,21-24
DRAMP30712,KQRNRWEWRPDFKSKKVKISLPC,23,22(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,23,21-24
DRAMP30713,KSKKVKISLPCNSTKNLTFA,20,23(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(10% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30714,CNSTKNLTFAMRSSGDYGEV,20,24(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(25% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30715,MRSSGDYGEVTGAWIEFGCH,20,25(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(27% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30716,TGAWIEFGCHRNKSNLHTEA,20,26(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30717,RNKSNLHTEARFRIRCRAnti-WNV,20,27(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(2% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,25,24-27
DRAMP30718,RFRIRCRAnti-WNVGSDTSLIDTC,20,28(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(40% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,25,24-27
DRAMP30719,GSDTSLIDTCGNTPNVSGAN,20,29(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(12% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30720,PVDCTMYSNKMYNCSLQNGF,20,31(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(8% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30721,MYNCSLQNGFTMKVDDLIVH,20,32(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(33% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30722,TMKVDDLIVHFNMTKAVEMV,20,33(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(25% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30723,FNMTKAVEMVNIAGNWSCTS,20,34(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(15% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30724,NIAGNWSCTSDLPSSWGYMN,20,35(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(22% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30725,CTSDLPSSWGYMNCNCTNSSSS,22,36(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,22,21-24
DRAMP30726,CNCTNSSSSYSGTKMACPSNRG,22,37(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,22,21-24
DRAMP30727,SGTKMACPSNRGILRNWYNP,20,38(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(52% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30728,RGILRNWYNPFAGLRQSLEQ,20,39(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30729,VAGLRQSLEQYQVVKQPDYL,20,40(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(48% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30730,YQVVKQPDYLLVPEEVMEYK,20,41(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(38% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30731,PDYLLVPEEVMEYKPRRKRAAI,22,42(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(54% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,22,21-24
DRAMP30732,YKPRRKRAAIHVMLALATVLSI,22,43(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(52% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,22,21-24
DRAMP30733,HVMLALATVLSIAGAGTGATAI,22,44(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(58% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,22,21-24
DRAMP30734,AGAGTGATAIGMVTQYHQVL,20,45(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30735,GMVTQYHQVLATHQEAIEKV,20,46(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(43% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30736,ATHQEAIEKVTGALKINNLR,20,47(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(44% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30737,TGALKINNLRLVTLEHQVLV,20,48(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(73% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30738,LVTLEHQVLVIGLKVEAMEK,20,49(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(45% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30739,IGLKVEAMEKFLYTAFAMQE,20,50(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(74% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30740,FLYTAFAMQELGCNQNQFFC,20,51(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(18% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30741,LGCNQNQFFCKIPLELWTRY,20,52(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(21% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30742,NMTINQTIWNHGNITLGEWY,20,54(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(4% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30743,HGNITLGEWYNQTKDLQQKF,20,55(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(35% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30744,NQTKDLQQKFYEIIMDIEQN,20,56(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(68% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30745,YEIIMDIEQNNVQGKTGIQQ,20,57(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(37% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30746,NVQGKTGIQQLQKWEDWVRW,20,58(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(96% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30747,LQKWEDWVRWIGNIPQYLKG,20,59(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(98% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30748,IGNIPQYLKGLLGGILGIGL,20,60(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30749,LLGGILGIGLGVLLLILCLP,20,61(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(88% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30750,GVLLLILCLPTLVDCIRNCI,20,62(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(32% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30751,TLVDCIRNCIHKILGYTVIA,20,63(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(9% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30752,HKILGYTVIAMPEVEGEEIQ,20,64(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(8% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30753,MPEVEGEEIQPQMELRRNGR,20,65(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(7% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30754,PQMELRRNGRQCGMSEKEEE,20,66(derived from FIV envelope glycoprotein ),P16090,Retroviridae,Not found,Synthetic construct(derived from FIV envelope glycoprotein (gE)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.,[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Syncytium formation,8661378,Virology. 1996 Jun 15;220(2):274-84. ,"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.",Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.,20,18-21
DRAMP30897,AKDLEVVTSTYVLVEA,16,P189(derived from HCV polyprotein),P26662,Flaviviridae,Not found,Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication",[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 5±7% inhibition at 1 µM; 74±6% inhibition at 3 µM;  96±3% inhibition at 10 µM; IC50=2.3 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,NS3 protease,14694985,Antivir Chem Chemother. 2003 Sep;14(5):225-33.,"Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.",Peptide inhibitors of hepatitis C virus NS3 protease. ,16,15-18
DRAMP30898,AKDLEVVCSTYVLVEA,16,P190(derived from HCV polyprotein),P26662,Flaviviridae,Not found,Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication",[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 24 ±15% inhibition at 1 µM; 86 ±3% inhibition at 3 µM;  99 ±2% inhibition at 10 µM; IC50=1.8 µM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,NS3 protease,14694985,Antivir Chem Chemother. 2003 Sep;14(5):225-33.,"Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.",Peptide inhibitors of hepatitis C virus NS3 protease. ,16,15-18
DRAMP30900,swlrdiwdwicevlsdfk,18,2(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.32 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,D,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30901,SWLRDIWDWICEVLSD,16,3(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.98 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,16,15-18
DRAMP30906,LRDIWDWICEVLSDFK,16,9(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,16,15-18
DRAMP30911,SGSWLRDIWDWICEVLSDFK,20,14(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,20,18-21
DRAMP30912,GSWLRDIWDWICEVLSDFK,19,15(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.51 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,19,18-21
DRAMP30913,SWLRDIWDWICEVLSDFKT,19,16(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,19,18-21
DRAMP30914,SWLRDIWDWICEVLSDFKTW,20,17(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.51 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,20,18-21
DRAMP30915,SWRLIDWDWICEVLSDFK,18,18(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=4.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30916,SWRLDIWDWICESVLDFK,18,19(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30917,VLDLIYSLHKQINRGLKKIVL,21,22(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>36 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,21,18-21
DRAMP30918,KFDSLVECIWDWIDRLWS,18,23(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.85 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30919,KWLCRIWSWISDVLDDFE,18,25(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30920,SIWRDWVDLICEFLSDWK,18,26(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.40 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30921,SWLRDVWDWICTVLTDFK,18,27(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=3.9 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30922,SWLRDVWDWVCTILTDFK,18,28(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=2.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30923,DWLRIIWDWVCSVVSDFK,18,29(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.55 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30924,SWLWEVWDWVLHVLSDFK,18,30(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=7.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30925,TWLRAIWDWVCTALTDFK,18,31(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=7.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30926,SWLRDVWDWVCTVLSDFK,18,32(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=3.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30927,SWLRDIWDWISEVLSDFK,18,33[11S](derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=13.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30928,SWLRDIWDWIREVLSDFK,18,34[11R](derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=12.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30929,SWLRDIWDWIEEVLSDFK,18,35[11E](derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=13.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30930,SWLDDIWDWICEVLSDFE,18,36(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=4.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30931,SWLRDIWDWICKVLSDFK,18,38(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=6.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30932,SWLDRIWRWICKVLSRFE,18,39(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30933,SWLRDIWRWICKVLSRFK,18,40(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.84 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30934,SWLRRIWRWICKVLSRFK,18,41(derived from HCV C5A),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV non-structural protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.",[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.89 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane,18287023,Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.,"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.",A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.,18,15-18
DRAMP30935,RTQRRGRTGRGKPGIYR,17,HCVA(1484-1500),P26664,Flaviviridae,Not found,Synthetic construct(derived from HCV NS3 helicase protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.",[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=27.1±2.4 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=37.1±3.9 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=49.8±4.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,NTPase/helicase,18479669,Biochem Pharmacol. 2008 Jul 1;76(1):28-38. ,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,17,15-18
DRAMP30936,STQRRGRTGRGRRGIYR,17,HCVB(1484-1500),P26663,Flaviviridae,Not found,Synthetic construct(derived from HCV NS3 helicase protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.",[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=24.3±1.8 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=33.6±3.5 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=47.2±4.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,NTPase/helicase,18479669,Biochem Pharmacol. 2008 Jul 1;76(1):28-38. ,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,17,15-18
DRAMP30945,AAQRRGRIGRNPSQVGD,17,WNV(1956-1972),P06935,Flaviviridae,Not found,Synthetic construct(derived from WNV NS3 helicase protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.",[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=358±13.2 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,NTPase/helicase,18479669,Biochem Pharmacol. 2008 Jul 1;76(1):28-38. ,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,17,15-18
DRAMP30950,AAQRRGRVGRNPNQVGD,17,JEV(1959-1975),P27395,Flaviviridae,Not found,Synthetic construct(derived from JEV NS3 helicase protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.",[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=442±17.7 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,NTPase/helicase,18479669,Biochem Pharmacol. 2008 Jul 1;76(1):28-38. ,"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.",Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).,17,15-18
DRAMP30951,TTPKFTVAWDWVPKR,15,gB64(gB346-360),P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=85 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30952,KTTSSIEFARLQFTY,15,gB94(496-510),P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=6.5±1.3 µM);inhibition of virus entry in Vero cells(EC50>200 µM);inhibition of virus infection in Vero cells(EC50=165.0±71.9 µM);ability of inactive virus(EC50=125±11.4 µM);inhibition of virus attachment on Vero cells(EC50>200 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.19104014]Not cytotoxic for Vero cells up to 200 µM.,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30953,GHRRYFTFGGGYVYF,15,gB122(636-650),P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=15.0±2.2 µM);inhibition of virus entry in Vero cells(EC50=17.6±2.6 µM);inhibition of virus infection in Vero cells(EC50=71.5±17.4 µM);ability of inactive virus(EC50=118±11.6 µM);inhibition of virus attachment on Vero cells(EC50>200 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.19104014]Not cytotoxic for Vero cells up to 200 µM.,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30954,Anti-HeVVPLEVYTRHEIK,15,gB131(681-695),P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=18.7±2.70 µM);inhibition of virus entry in Vero cells(EC50=12.2±6.56 µM);inhibition of virus infection in Vero cells(EC50>200 µM);ability of inactive virus(EC50>200 µM);inhibition of virus attachment on Vero cells(EC50>200 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.19104014]Not cytotoxic for Vero cells up to 200 µM.,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,20,18-21
DRAMP30956,GHRAYFTFGGGYVYF,15,gB122R4A,P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=26.4 ± 13.5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30957,GHRRAFTFGGGYVYF,15,gB122Y5A,P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=119.2 ± 26.6 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30958,GHRRYATFGGGYVYF,15,gB122F6A,P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=67.6 ± 8.1 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30959,GHRRYFTAGGGYVYF,15,gB122F8A,P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=37.5 ± 4.2 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30960,GHRRYFTFGAGYVYF,15,gB122G10L,P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=25.1 ± 4.9 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30961,GHRRYFTFGGGYVAF,15,gB122Y14A,P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=58.0 ± 5.2 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30962,GHRRYFTFGGGYVYA,15,gB122F15A,P06437,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 B glycoprotein (gB)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=48.6 ± 6.2 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,19104014,Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.,"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.",Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.,15,12-15
DRAMP30967,MDVNPTLLFLKVPAQNAISTTFPYT,25,FluA-PB1(1-25),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=1.80 ±0.49 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,25,24-27
DRAMP30968,VNPTLLFLKVPAQNAISTTFPYT,23,FluA-PB1(3-25),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=661.77 ±22.08 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,23,21-24
DRAMP30969,PTLLFLKVPAQNAISTTFPYT,21,FluA-PB1(5-25),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=483.20 ±51.98 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,21,18-21
DRAMP30970,LLFLKVPAQNAISTTFPYT,19,FluA-PB1(7-25),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,19,18-21
DRAMP30971,FLKVPAQNAISTTFPYT,17,FluA-PB1(9-25),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,17,15-18
DRAMP30972,KVPAQNAISTTFPYT,15,FluA-PB1(11-25),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30973,MDVNPTLLFLKVPAQNAIST,20,FluA-PB1(1-20),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=33.80 ±5.53 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,20,18-21
DRAMP30974,MDVNPTLLFLKVPAQNAI,18,FluA-PB1(1-18),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=29.45 ±5.16 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,18,15-18
DRAMP30975,MDVNPTLLFLKVPAQN,16,FluA-PB1(1-16),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=45.86 ±4.22 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,16,15-18
DRAMP30985,MDVNPTLLFLKVPAQ,15,FluA-PB1(1-15),Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=43.32 ±5.31nM);##Influenza B(FluB):inhibition of PA-binding activity and virus replication(IC50>3000nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30986,MNINPYPLFIDVPIQ,15,PB1-1-15 B,Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=45.0 ±12.5 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30987,MNINPTLLFLKVPIQ,15,"PB1-1-15 A D2N,V3I,L14I",Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=6.69 ±1.73 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30988,MDVNPTLLFIDVPAQ,15,"PB1-1-15 A L10I,K11D",Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30989,MNINPTLLFLKVPAQ,15,"PB1-1-15 A D2N,V3I",Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=12.96 ±3.98 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30990,MDVNPYFLFLKVPAQ,15,"PB1-1-15 A T6Y,L7F",Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=7.51 ±0.71 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=345.0 ±81.5 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30991,MDVNPTFLFLKVPAQ,15,PB1-1-15 A L7F,Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30992,MDVNPYLLFLKVPAQ,15,PB1-1-15 A T6Y,Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=21.64 ±1.48 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=107.1 ±31.3 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30993,MDVNPFLLFLKVPAQ,15,PB1-1-15 A T6F,Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=2.84 ±0.48 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=750.4 ±249.6 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30994,MDVNPWLLFLKVPAQ,15,PB1-1-15 A T6W,Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=3.40 ±0.51 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=628.3 ±389.1 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30995,MDVNPHLLFLKVPAQ,15,PB1-1-15 A T6H,Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=292.16 ±34.04 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30996,MDVNPCLLFLKVPAQ,15,PB1-1-15 A T6C,Q6DNS6,Orthomyxoviridae,Not found,Synthetic construct(derived from INFV A polymerase (PB1)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.",[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=43.58 ±5.67 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,PA subunit,19841738,PLoS One. 2009 Oct 20;4(10):e7517.,"Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.",Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. ,15,12-15
DRAMP30997,GWWYKGRARPVSAVA,15,18-c01,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=3.2 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50>10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Alkylated(C18),Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP30998,RAVWRHSVATPSHSV,15,C18-c03,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=6.5 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=68 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Alkylated(C18),Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP30999,GAWYKGRARPVSAVA,15,C18-c01W2A,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=53 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Alkylated(C18),Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP31000,GWWYKGRARAVSAVA,15,C18-c01P10A,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=89 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Alkylated(C18),Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP31001,AVASVPRARGKYWWG,15,C18-c01r,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=44 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=17 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Alkylated(C18),Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP31002,DFRRLPGAFWQLRQP,15,C18-p1b,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=52 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=19 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Alkylated(C18),Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP31003,AETVESCLAKPHTEN,15,C18-cp3c,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=66 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50>100 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Alkylated(C18),Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP31004,GWWYKGRARPVSAVA,15,c01,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50>500 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP31005,RAVWRHSVATPSHSV,15,c03,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.,[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50>500 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information found in the reference(s) presented,sialylgalactose,19558186,J Med Chem. 2009 Jul 23;52(14):4247-56.,"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.",Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. ,15,12-15
DRAMP31007,RRKKVALLAVLLALLA,16,B7NP(B7 without prolines),P08620,Orthomyxoviridae,Not found,Synthetic construct(derived from FGF-4 signal sequence),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits influenza virus replication by preventing attachment to cells.,[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=0.3 ± 0.1 μM).,[Ref.21220525]>50% hemolysis agaisnt human red blood cells at 30 μM.,Linear,Free,Free,,L,[Ref.21220525]A549 cells:CD50=126.3± 23.0 μM;##MDCK cells:CD50=105.3 ± 8.0 μM.,Not found,21220525, Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. ",Identification of the minimal active sequence of an anti-influenza virus peptide. ,16,15-18
DRAMP31008,RRKKALLAVLLALLA,15,B8NP,P08620,Orthomyxoviridae,Not found,Synthetic construct(derived from FGF-4 signal sequence),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits influenza virus replication by preventing attachment to cells.,[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=0.4 ± 0.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,21220525, Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.,"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. ",Identification of the minimal active sequence of an anti-influenza virus peptide. ,15,12-15
DRAMP31009,LFRLIKSLIKRLVSAFK,17,Mucroporin-M1,B9UIY3,"Coronaviridae, Orthomyxoviridae, Paramyxoviridae",Not found,Synthetic construct(derived from Mucroporin),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Mucroporin-M1 may bind to the virus envelope by surface charge interactions and inhibits MeV, SARS-CoV and influenza H5N1 by direct virucidal action.",[Ref.21620914]measles virus (MeV):inhibition of MeV infection in Vero cells(EC50=7.15 μg/ml (3.52 μM));##SARS-CoV(pseudoviruse):inhibition of SARS-CoV infection in MDCK cells(EC50=14.46 μg/ml (7.12 μM));##H5N1(pseudovirus):inhibition of H5N1 infection in MDCK cells(EC50=2.10 μg/ml (1.03 μM)).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.21620914]Vero cells:CC50=70.46μg/ ml(34.70μM);##HeLa-ACE2 cells:CC50=61.58 μg/ml (30.31 μM);##MDCK cells:CC50=83.35 μg/ml (41.03 μM).,membrane,21620914,Peptides. 2011 Jul;32(7):1518-25.,"Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W. ","Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. ",17,15-18
DRAMP31010,KAKAKAKAKAKAKAKAKAKAK,21,RJ1,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.",[Ref.15498607]herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=53.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>455 μM.,Not found,15498607,Antiviral Res. 2004 Nov;64(2):119-26.,"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. ","A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.",21,18-21
DRAMP31011,KAAKKAAKAAKKAAKWAKKAA,21,RJ3,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.",[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=117.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>467 μM.,Not found,15498607,Antiviral Res. 2004 Nov;64(2):119-26.,"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. ","A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.",21,18-21
DRAMP31012,AKKAAKKAKKAAKKAKKAAKK,21,RJ5,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.",[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=41.0 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=14.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>468 μM.,Not found,15498607,Antiviral Res. 2004 Nov;64(2):119-26.,"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. ","A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.",21,18-21
DRAMP31013,AKKAAKKAKKAAKKAKKWAKK,21,RJ6,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.",[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=47.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>433 μM.,Not found,15498607,Antiviral Res. 2004 Nov;64(2):119-26.,"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. ","A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.",21,18-21
DRAMP31014,AKKAWKKAKKAAKKAKKWAKK,21,RJ7,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.",[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=40.8 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=44.9 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>412 μM.,Not found,15498607,Antiviral Res. 2004 Nov;64(2):119-26.,"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. ","A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.",21,18-21
DRAMP31015,ARRAWRRARRAARRARRAARR,21,RJ8,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.",[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=18.2 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=22.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>395 μM.,Not found,15498607,Antiviral Res. 2004 Nov;64(2):119-26.,"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. ","A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.",21,18-21
DRAMP31016,ARRAKRRARRAARRARRKARR,21,RJ9,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.",[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=13.0 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=46.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>433 μM.,Not found,15498607,Antiviral Res. 2004 Nov;64(2):119-26.,"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. ","A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.",21,18-21
DRAMP31017,ARRAKRRARRAKRRARRKKRR,21,RJ10,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.",[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=24.6 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=54.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>422 μM.,Not found,15498607,Antiviral Res. 2004 Nov;64(2):119-26.,"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. ","A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.",21,18-21
DRAMP31018,QLQKWEDWVRWIGNIPQYLKG,21,Peptide 59(FIV ectodomain 767-786),P16090,Retroviridae,Not found,Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.03 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.01 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.12610147]No detectable cytotoxicity on MBM cell viability and proliferation.,Not found,12610147,J Virol. 2003 Mar;77(6):3724-33.,"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.",Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.,21,18-21
DRAMP31036,TDVILMCFSIDSPDSLENI,19,77-95(wild type),P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=7.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31037,CSIELSDIPLSVDFNTMID,19,77-95(scrambled),P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31038,ADVILMCFSIDSPDSLENI,19,77-95[77A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.56 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31039,TAVILMCFSIDSPDSLENI,19,77-95[78A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.37 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31040,TDAILMCFSIDSPDSLENI,19,77-95[79A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.60 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31041,TDVALMCFSIDSPDSLENI,19,77-95[80A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=11.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31042,TDVIAMCFSIDSPDSLENI,19,77-95[81A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=5.42 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31043,TDVILACFSIDSPDSLENI,19,77-95[82A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.43 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31044,TDVILMAFSIDSPDSLENI,19,77-95[83A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31045,TDVILMCASIDSPDSLENI,19,77-95[84A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.29 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31046,TDVILMCFAIDSPDSLENI,19,77-95[85A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.82 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31047,TDVILMCFSADSPDSLENI,19,77-95[86A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=3.52 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31048,TDVILMCFSIASPDSLENI,19,77-95[87A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=4.36 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31049,TDVILMCFSIDAPDSLENI,19,77-95[88A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.26 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31050,TDVILMCFSIDSADSLENI,19,77-95[89A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=15.32 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31051,TDVILMCFSIDSPASLENI,19,77-95[90A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.61 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31052,TDVILMCFSIDSPDALENI,19,77-95[91A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.19 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31053,TDVILMCFSIDSPDSAENI,19,77-95[92A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.27 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31054,TDVILMCFSIDSPDSLANI,19,77-95[93A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=9.83 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31055,TDVILMCFSIDSPDSLEAI,19,77-95[94A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=18.47 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31056,TDVILMCFSIDSPDSLENA,19,77-95[95A],P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=4.89 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,19,18-21
DRAMP31059,TDVILMCFSIDSPDSL,16,77-92,P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=10.86 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,16,15-18
DRAMP31060,DVILMCFSIDSPDSLENI,18,78-95,P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.23 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,18,15-18
DRAMP31061,VILMCFSIDSPDSLENI,17,79-95,P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=16.95 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,17,15-18
DRAMP31062,ILMCFSIDSPDSLENI,16,80-95,P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=7.17 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,16,15-18
DRAMP31064,ILMCFSIDSPDSLEN,15,80-94,P08134,Paramyxoviridae,Not found,Synthetic construct(derived from RhoA protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.75 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,14576104,Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.,"Budge PJ, Lebowitz J, Graham BS. ",Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.,15,12-15
DRAMP31130,MANAGLQLLGFILAFLGW,18,CL58,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=2.1 ± 0.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.22378192]Huh7.5.1 cells:CC50~200 Μm.,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-15. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31131,GLQLLGFILAFLGWIGAI,18,CL58.1,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-16. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31132,LLGFILAFLGWIGAIVST,18,CL58.2,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=4.3 ± 0.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-17. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31133,FILAFLGWIGAIVSTALP,18,CL58.3,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=8.9± 1.0 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-18. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31134,AFLGWIGAIVSTALPQWR,18,CL58.4,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=12.5± 1.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-19. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31135,GWIGAIVSTALPQWRIYS,18,CL58.5,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=21.5± 1.9 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-20. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31136,GAIVSTALPQWRIYSYAG,18,CL58.6,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=23.8 ± 2.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-21. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31137,VSTALPQWRIYSYAGDNI,18,CL58.7,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-22. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31138,ALPQWRIYSYAGDNIVTA,18,CL58.8,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-23. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31140,MANAGLQLLGFILAFL,16,CL58-2,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=7.6± 0.9 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-25. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,16,15-18
DRAMP31141,MANAGLQLLGFILAFLGWIG,20,CL58+2,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=17.8 ± 1.1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-26. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,20,18-21
DRAMP31142,MANAGLQLLGFILAFLGWIGAI,22,CL58+4,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=4.0 ± 0.3 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-27. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,22,21-24
DRAMP31143,MANAGLQLLGFILAFLGWIGAIVS,24,CL58+6,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=5.1 ± 0.6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-28. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,24,21-24
DRAMP31144,managlqllgfilaflgw,18,CL58.d,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=1.8 ± 0.4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,D,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-29. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31145,AGALMFAWLLLGLQGIFN,18,CL58.S,O95832,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-29. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31146,MASAGMQILGVVLTLLGW,18,CL-6,P56747,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-30. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31147,MANSGLQLLGFSMALLGW,18,CL-7,Q3B794,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-31. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31148,MASTGLELLGMTLAVLGW,18,CL-9,O95484,Flaviviridae,Not found,Synthetic construct(derived from human claudin-1),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry in a postbinding step.,[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,membrane protein,22378192,Hepatology. 2012 Aug;56(2):507-32. ,"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. ",A human claudin-1-derived peptide inhibits hepatitis C virus entry.,18,15-18
DRAMP31154,CVRLASHLRKLRKRLLRDADDL,22,hEP-4,P02649,Flaviviridae,Not found,Synthetic construct(derived from human apolipoprotein E),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. ",[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,22334503,Hepatology. 2012 Aug;56(2):484-91.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,22,21-24
DRAMP31155,CIRLQAEAFQARLKSWFEPLV,21,hEP-5,P02649,Flaviviridae,Not found,Synthetic construct(derived from human apolipoprotein E),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. ",[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,22334503,Hepatology. 2012 Aug;56(2):484-91.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,21,18-21
DRAMP31158,EELRVRLASHLRKLRKRLLRDADDL,25,hEP-8,P02649,Flaviviridae,Not found,Synthetic construct(derived from human apolipoprotein E),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. ",[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,22334503,Hepatology. 2012 Aug;56(2):484-91.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,25,24-27
DRAMP31161,CLRVRLASHLRKLRKRLLRDADDL,24,hEP-11,P02649,Flaviviridae,Not found,Synthetic construct(derived from human apolipoprotein E),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. ",[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,22334503,Hepatology. 2012 Aug;56(2):484-91.,"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.",Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.,24,21-24
DRAMP31190,FRFKIKFRLKFRFKARFKFRAKFRA,25,D4C3,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.,[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=1.32 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.12208971]CrFK cell:TC50=3.81 μM.,Not found,12208971,J Virol. 2002 Oct;76(19):9952-61.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. ,25,24-27
DRAMP31195,FLFAFRIFKRVFKKFRKLFKRAF,23,D1A22,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.,[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=10.51 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.12208971]CrFK cell:TC50=10.79 μM.,Not found,12208971,J Virol. 2002 Oct;76(19):9952-61.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. ,23,21-24
DRAMP31198,FAIAIKAIKKAIKKIKKAIKKAI,23,D1D2,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.,[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=8.71 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.12208971]CrFK cell:TC50=5.87 μM.,Not found,12208971,J Virol. 2002 Oct;76(19):9952-61.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. ,23,21-24
DRAMP31199,FKVKAKVKAKVKAKVKAKKKK,21,D4B,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.,[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=2.85 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.12208971]CrFK cell:TC50=0.92 μM.,Not found,12208971,J Virol. 2002 Oct;76(19):9952-61.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. ,21,18-21
DRAMP31200,AVKRVGRRLKKLARKIARLGVAF,23,D5D,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.,[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.37 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,12208971,J Virol. 2002 Oct;76(19):9952-61.,"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.",Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. ,23,21-24
DRAMP31201,LPRRLHLEPAFLPYSVKAHECC,22,UL54(1221-1242),P08546,Herpesviridae,Not found,Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.",[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=11 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,DNA polymerase,12857903,J Virol. 2003 Aug;77(15):8336-44.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,22,21-24
DRAMP31202,PGGETARKDKFLHMVLPRRL,20,UL54(1206-1225),P08546,Herpesviridae,Not found,Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.",[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,DNA polymerase,12857903,J Virol. 2003 Aug;77(15):8336-44.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,20,18-21
DRAMP31203,EQVLKAVTNVLSPVFPGGET,20,UL54(1191-1210),P08546,Herpesviridae,Not found,Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.",[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=280 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,DNA polymerase,12857903,J Virol. 2003 Aug;77(15):8336-44.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,20,18-21
DRAMP31204,YVREHGVPIHADKYFEQVLK,20,UL54(1176-1195),P08546,Herpesviridae,Not found,Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.",[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,DNA polymerase,12857903,J Virol. 2003 Aug;77(15):8336-44.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,20,18-21
DRAMP31205,PPSAVCNYEVAEDPSYVREH,20,UL54(1161-1180),P08546,Herpesviridae,Not found,Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.",[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,DNA polymerase,12857903,J Virol. 2003 Aug;77(15):8336-44.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,20,18-21
DRAMP31206,RRLHLEPAFLPYSVKAHECC,20,UL54(1223-1242),P08546,Herpesviridae,Not found,Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.",[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,DNA polymerase,12857903,J Virol. 2003 Aug;77(15):8336-44.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,20,18-21
DRAMP31207,LPRRLHLEPAFLPYSVKAHEC,21,UL54(1221-1241),P08546,Herpesviridae,Not found,Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.",[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=75 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,DNA polymerase,12857903,J Virol. 2003 Aug;77(15):8336-44.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,21,18-21
DRAMP31208,LPRRLHLEPAFLPYSVKAHE,20,UL54(1221-1240),P08546,Herpesviridae,Not found,Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.",[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,DNA polymerase,12857903,J Virol. 2003 Aug;77(15):8336-44.,"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.",Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.,20,18-21
DRAMP31224,MWKTPTLKYFGGFNFSQI,18,SARSWW-I(770-788),P11224,Coronaviridae,Not found,Synthetic construct(derived from SARS-CoV spike protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(58% inhibition at ~30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.,membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. ",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein,18,15-18
DRAMP31225,ATAGWTFGAGAALQIPFAMQMAY,23,SARSWW-II(864-886),P11224,Coronaviridae,Not found,Synthetic construct(derived from SARS-CoV spike protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(39% inhibition at ~30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.,membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. ",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein,23,21-24
DRAMP31226,GYHLMSFPQAAPHGVVFLHVTW,22,SARSWW-III(1028-1049),P11224,Coronaviridae,Not found,Synthetic construct(derived from SARS-CoV spike protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(90% inhibition at ~30 μM,IC50=2 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.,membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. ",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein,22,21-24
DRAMP31227,GVFVFNGTSWFITQRNFFS,19,SARSWW-IV(1075-1093),P11224,Coronaviridae,Not found,Synthetic construct(derived from SARS-CoV spike protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(83% inhibition at ~30 μM,IC50=2 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.,membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. ",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein,19,18-21
DRAMP31229,GYFVQDDGEWKFTGSSYYY,19,MHVWW-IV(1144-1162),P11224,Coronaviridae,Not found,Synthetic construct(derived from MHV spike protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(IC50=4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.,membrane,16616792,Virus Res. 2006 Sep;120(1-2):146-55.,"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. ",Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein,19,18-21
DRAMP31231,AAHLIDALYAEFLGGRVLTT,20,gH493-512(derived from HSV-1 H glycoprotein),Q9DHD5,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 H glycoprotein (gH)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry and thus protects cells from infection.,[Ref.18572274]Herpes simplex virus type 1(HSV-1):inhibition of viral-entry in Vero cells(60% inhibition at 250μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18572274]No cytotoxicity against Vero cells up to 500 μM.,mambrane,18572274,Peptides. 2008 Sep;29(9):1461-71.,"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.",Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.,20,18-21
DRAMP31232,GLASTLTRWAHYNALIRAF,19,gH626-644(derived from HSV-1 H glycoprotein),Q9DHD5,Herpesviridae,Not found,Synthetic construct(derived from HSV-1 H glycoprotein (gH)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry and thus protects cells from infection.,[Ref.18572274]Herpes simplex virus type 1(HSV-1):inhibition of viral-entry in Vero cells(50-60% inhibition at 250μM-500μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18572274]No cytotoxicity against Vero cells up to 500 μM.,mambrane,18572274,Peptides. 2008 Sep;29(9):1461-71.,"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.",Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.,19,18-21
DRAMP31234,LNITNSHVSILQERPPLENRVL,22,Pcr-Δ8,P14075,Retroviridae,Not found,Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.,[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=5.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference(s) presented,membrane,19114713,J Biol Chem. 2009 Mar 6;284(10):6575-84. ,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,22,21-24
DRAMP31235,CFLNITNSHVSILQERPPLENRV,23,Pcr-Δ7,P14075,Retroviridae,Not found,Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.,[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=0.19± 0.01 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference(s) presented,membrane,19114713,J Biol Chem. 2009 Mar 6;284(10):6575-84. ,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,23,21-24
DRAMP31236,CFLNITNSHVSILQEAPPLENRV,23,Pcr-R416A,P14075,Retroviridae,Not found,Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.,[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=1.55 ± 0.08 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference(s) presented,membrane,19114713,J Biol Chem. 2009 Mar 6;284(10):6575-84. ,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,23,21-24
DRAMP31237,CFLNITNSHVSILQEAPPLENAV,23,Pcr-R422A,P14075,Retroviridae,Not found,Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.,[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=8.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference(s) presented,membrane,19114713,J Biol Chem. 2009 Mar 6;284(10):6575-84. ,"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.",Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.,23,21-24
DRAMP31241,CSICSNNPTCWAICKRIPNKKPGKK,25,G173-197(derived from RSV attachment glycoprotein),P03423,Paramyxoviridae,Not found,Synthetic construct(derived from RSV attachment glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>177 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,The peptide formed two disulfide bonds.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,25,24-27
DRAMP31245,KQRQNKPPSKPNNDFHFEVFN,21,G149-169(derived from RSV attachment glycoprotein),P03423,Paramyxoviridae,Not found,Synthetic construct(derived from RSV attachment glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>190 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,The peptide formed two disulfide bonds.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,21,18-21
DRAMP31246,KQRQNKPPSKPNNDFHF,17,G149-165(derived from RSV attachment glycoprotein),P03423,Paramyxoviridae,Not found,Synthetic construct(derived from RSV attachment glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>240 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,The peptide formed two disulfide bonds.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,17,15-18
DRAMP31247,KPPSKPNNDFHFEVFNFVP,19,G154-172(derived from RSV attachment glycoprotein),P03423,Paramyxoviridae,Not found,Synthetic construct(derived from RSV attachment glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=220 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,The peptide formed two disulfide bonds.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,19,18-21
DRAMP31248,KPPSKPNNDFHFEVFNFV,18,G154-171(derived from RSV attachment glycoprotein),P03423,Paramyxoviridae,Not found,Synthetic construct(derived from RSV attachment glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=14 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,The peptide formed two disulfide bonds.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,18,15-18
DRAMP31249,KPPSKPNNDFHFEVFNF,17,G154-170(derived from RSV attachment glycoprotein),P03423,Paramyxoviridae,Not found,Synthetic construct(derived from RSV attachment glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,The peptide formed two disulfide bonds.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,17,15-18
DRAMP31250,KPPSKPNNDFHFEVFN,16,G154-169(derived from RSV attachment glycoprotein),P03423,Paramyxoviridae,Not found,Synthetic construct(derived from RSV attachment glycoprotein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>510 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Acetylation,Amidation,The peptide formed two disulfide bonds.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,16,15-18
DRAMP31252,KPPSKPNNDFHFEVFNFVPBSIBG,24,G154-177,No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31253,KPNNDFHFEVFNFVPBSIBG,20,G158-177,No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 16,19 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,20,18-21
DRAMP31254,DFHFEVFNFVPBSIBG,16,G162-177,No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=60 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 12,15 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,16,15-18
DRAMP31257,KQRQNKPPSKPNNDFHFEVFNFVPB,25,G149-173,No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'B' at position 25 is S-acetamidomethyl cysteine.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,25,24-27
DRAMP31258,KPPSKPNNDFHFEVFNFVPBSIAG,24,G154-177[B176A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=6 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'B' at position 20 is S-acetamidomethyl cysteine.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31259,KPPSKPNNDFHFEVFNFVPBSABG,24,G154-177[I175A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=22 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31260,KPPSKPNNDFHFEVFNFVPBAIBG,24,G154-177[S174A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31261,KPPSKPNNDFHFEVFNFVPASIBG,24,G154-177[B173A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,The 'B' at position 23 is S-acetamidomethyl cysteine.,L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31262,KPPSKPNNDFHFEVFNFVABSIBG,24,G154-177[P172A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31263,KPPSKPNNDFHFEVFNFAPBSIBG,24,G154-177[V171A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31264,KPPSKPNNDFHFEVFNAVPBSIBG,24,G154-177[F170A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=22 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31265,KPPSKPNNDFHFEVFAFVPBSIBG,24,G154-177[N169A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31266,KPPSKPNNDFHFEVANFVPBSIBG,24,G154-177[F168A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=90 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31267,KPPSKPNNDFHFEAFNFVPBSIBG,24,G154-177[V167A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31268,KPPSKPNNDFHFAVFNFVPBSIBG,24,G154-177[E166A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=0.75 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31269,KPPSKPNNDFHAEVFNFVPBSIBG,24,G154-177[F165A],No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,"The 'B' at position 20,23 are S-acetamidomethyl cysteine.",L,No cytotoxicity information found in the reference(s) presented,Not found,11487583,J Biol Chem. 2001 Oct 19;276(42):38988-94.,"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. ",Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.,24,21-24
DRAMP31271,DTRACDVIALLCHLNT,16,P1,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P1 significantly inhibited WNV infectivity at a concentration of 1 mM,IC50=67.0 ± 0.1 μM);##Dengue virus serotype 2:inhibition of virus infection in Vero cells(99.3±0.7% inhibition at 200 μM)",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.17151121]No cytotoxicity against Vero cells up to 500μM.,E proteins,17151121,J Virol. 2007 Feb;81(4):2047-55. ,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",Antiviral peptides targeting the west nile virus envelope protein.,16,15-18
DRAMP31274,CDVIALLCHLNTPSF,15,P10,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P10 significantly inhibited WNV infectivity).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,E proteins,17151121,J Virol. 2007 Feb;81(4):2047-55. ,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",Antiviral peptides targeting the west nile virus envelope protein.,15,12-15
DRAMP31275,CDVIALLCHLNTPSFNTTHYRESWY,25,P11,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P10 significantly inhibited WNV infectivity).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,E proteins,17151121,J Virol. 2007 Feb;81(4):2047-55. ,"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.",Antiviral peptides targeting the west nile virus envelope protein.,25,24-27
DRAMP31276,SSCNMGWDTPAAnti-CCVWFPYWV,20,A4,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.,[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(70% inhibition).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,pUL84(nonconventional nuclear localization signal of the essential viral replication factor),19740994,J Virol. 2009 Nov;83(22):11902-13. ,"Kaiser N, Lischka P, Wagenknecht N, Stamminger T.",Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.,25,24-27
DRAMP31277,MAVGLVLCDWWLGEYLLEA,19,A8,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.,[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(70% inhibition).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,pUL84(nonconventional nuclear localization signal of the essential viral replication factor),19740994,J Virol. 2009 Nov;83(22):11902-13. ,"Kaiser N, Lischka P, Wagenknecht N, Stamminger T.",Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.,19,18-21
DRAMP31278,PVLQPALSLSCGPEPLLLSC,20,A56,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.,[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(40% inhibition).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,pUL84(nonconventional nuclear localization signal of the essential viral replication factor),19740994,J Virol. 2009 Nov;83(22):11902-13. ,"Kaiser N, Lischka P, Wagenknecht N, Stamminger T.",Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.,20,18-21
DRAMP31279,IEVTFVNRRGDGAELWYLSA,20,A110,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.,[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(35% inhibition).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,pUL84(nonconventional nuclear localization signal of the essential viral replication factor),19740994,J Virol. 2009 Nov;83(22):11902-13. ,"Kaiser N, Lischka P, Wagenknecht N, Stamminger T.",Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.,20,18-21
DRAMP31280,SFAIKWEYVLLLFLL,15,Peptide 75(710-725)[Δ1],P26663,Flaviviridae,Not found,Synthetic construct(derived from HCV envelope protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits a post-binding step in HCV entry.,[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(91% inhibition at 50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,envelope protein,20156485,Antiviral Res. 2010 May;86(2):172-9.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. ,15,12-15
DRAMP31286,VSFAIKWEYVLLLFL,15,Peptide 75(710-725)[Δ16],P26663,Flaviviridae,Not found,Synthetic construct(derived from HCV envelope protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits a post-binding step in HCV entry.,[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(63% inhibition at 50 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,envelope protein,20156485,Antiviral Res. 2010 May;86(2):172-9.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. ,15,12-15
DRAMP31291,VSFAIKWEYVLLLFLL,16,Peptide 75(710-725),P26663,Flaviviridae,Not found,Synthetic construct(derived from HCV envelope protein),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits a post-binding step in HCV entry.,"[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(EC50=0.3 ± 0.4 μM,EC90=14 ± 12 μM);inhibition of virus infection in primary human hepatocytes(EC50=0.3μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.20156485]No cytotoxicity against Huh-7 cells.,envelope protein,20156485,Antiviral Res. 2010 May;86(2):172-9.,"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.",A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. ,16,15-18
DRAMP31293,RQMRAWGQDYQHGGMGYSC,19,DN81opt,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide blocks virus:cell binding, interfere with a step during viral entry, alter the surface structure of dengue viral particles, and that they interact directly with dengue virus envelope protein.","[Ref.20582308]dengue 2 virus(DENV-2):inhibition of virus infection in LLC-MK2 cells(IC50=36±6  μM,57% inhibition at 50μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,E glycoprotein,20582308,PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721. ,"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF.",Structural optimization and de novo design of dengue virus entry inhibitory peptides.,19,18-21
DRAMP31294,FWFTLIKTQAKQPARYRRFC,20,1OAN1,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide blocks virus:cell binding, interfere with a step during viral entry, alter the surface structure of dengue viral particles, and that they interact directly with dengue virus envelope protein.","[Ref.20582308]dengue 2 virus(DENV-2):inhibition of virus infection in LLC-MK2 cells(IC50=7±4  μM,99% inhibition at 50 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.20582308]the peptide showed no toxic to LLC-MK2 cells at 50 µM.,E glycoprotein,20582308,PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721. ,"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF.",Structural optimization and de novo design of dengue virus entry inhibitory peptides.,20,18-21
DRAMP31295,LLDCWVRLGRYLLRRLKT,18,GBVA1(1-18),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=10 μM,88% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31296,LLDCWVRLGRYLLRRLKTPFTRL,23,GBVA2(1-23),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=15 μM,50% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,23,21-24
DRAMP31297,LLDCWVRLGRYLLRRLKTPFT,21,GBVA3(1-21),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM,0% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,21,18-21
DRAMP31298,LLDCWVRLGRYLLRRLKTP,19,GBVA4(1-19),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=3 μM,99% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,19,18-21
DRAMP31299,LLDCWVRLGRYLLRRLK,17,GBVA5(1-17),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=5 μM,99% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,17,15-18
DRAMP31300,LDCWVRLGRYLLRRLKTPFTRL,22,GBVA6(2-23),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM,0 inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,22,21-24
DRAMP31301,CWVRLGRYLLRRLKTPFTRL,20,GBVA7(4-23),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 μM,89% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,20,18-21
DRAMP31302,LDCWVRLGRYLLRRLKTP,18,GBVA8(2-19),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=4 μM,99% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31303,DCWVRLGRYLLRRLKTPF,18,GBVA9(3-20),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 μM,90% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31304,CWVRLGRYLLRRLKTPFT,18,GBVA10(4-21),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2 μM,100% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31305,WVRLGRYLLRRLKTPFTR,18,GBVA11(5-22),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 μM,58% inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31306,VRLGRYLLRRLKTPFTRL,18,GBVA12(6-23),Q69422,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM,0 inhibition at 20 μM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31307,CWVRLGRYKLRRLKTPFT,18,GBVA10-1(L9K),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175360,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31308,CWVRLGRYSLRRLKTPFT,18,GBVA10-2(L9S),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=18 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31309,CWVRLGRYALRRLKTPFT,18,GBVA10-3(L9A),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31310,CWVRLGRYVLRRLKTPFT,18,GBVA10-4(L9V),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=16 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31311,CWVRLARYLLRRLKTPFT,18,GBVA10-5(G6A),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2.5 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31312,CWVRLVRYLLRRLKTPFT,18,GBVA10-6(G6V),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31313,CWVRLLRYLLRRLKTPFT,18,GBVA10-7(G6L),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31314,CWVRLLRYLLRRLKTLFT,18,GBVA10-8(G6L/P16L),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31315,CWVRLGRYLLRRLKTLFT,18,GBVA10-9(P16L),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: GBVA10-9 can inhibit virus entry at a postattachment step.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=0.16 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.23175359]HepG2 cell:LC50=90 μM(4h of treatment);##HeLa cell:LC50=40 μM(4h of treatment);##Huh7.5.1 cell:LC50=90 μM(4h of treatment);LC50=50 μM(24h of treatment).,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31316,CWVRLGRYILRRLKTPFT,18,GBVA10-10(L9I),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31317,CWVRLGRYILRRIKTPFT,18,GBVA10-11(L9I/L13I),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=0.63 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31318,CWVRIGRYILRRIKTPFT,18,GBVA10-12(L5I/L9I/L13I),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31319,KWVRLGRKLLRRLKKPFK,18,GBVA10-13(C1K/Y8K/T15K/T18K),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175361,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31320,KWVRLGRKLLRRLKKPFT,18,GBVA10-14(C1K/Y8K/T15K),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31321,CWVRLGRKLLRRLKKPFT,18,GBVA10-15(Y8K/T15K),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31322,CWVRLGRKLLRRLKTPFT,19,GBVA10-16(Y8K),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31323,EWVRLGRELLRRLKEPFT,18,GBVA10-17(C1E/Y8E/T15E),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31324,EWVRLGRELLRRLKEPFE,19,GBVA10-18(C1E/Y8E/T15E/T18E),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31325,CWVRLGRELLRRLKEPFT,18,GBVA10-19(Y8E/T15E),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31326,CWVRLGRELLRRLKTPFT,18,GBVA10-20(Y8E),No entry found,Flaviviridae,Not found,Synthetic construct(derived from GBVA non-structutal protein 5A),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide inhibits virus entry.,[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information found in the reference(s) presented,Not found,23175359,J Virol. 2013 Feb;87(3):1649-57.,"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.",Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.,18,15-18
DRAMP31327,IPESSELTLQELLGEERR,18,E6ap18,No entry found,Papillomaviridae,Not found,Synthetic construct(derived from E6-associated protein (E6AP)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=10.5±1.4 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference(s) presented,E6 protein,15182185,Biochemistry. 2004 Jun 15;43(23):7421-31. ,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,18,15-18
DRAMP31330,ALQELLGQWLKDGGPSSGRPPPS,23,E6apn1,No entry found,Papillomaviridae,Not found,Synthetic construct(derived from E6-associated protein (E6AP)),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=36.8±3.2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Acetylation,Amidation,,L,No cytotoxicity information found in the reference(s) presented,E6 protein,15182185,Biochemistry. 2004 Jun 15;43(23):7421-31. ,"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.",Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.,23,21-24
DRAMP31335,LLGDLLRKSKEKIGKEFKRIVQR,23,LL-23,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>35.4 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50>35.4 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,23,21-24
DRAMP31336,SKEKIGKEFKRIVQRIKDFLR,21,SK-21,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=10.8 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50=22.5 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,21,18-21
DRAMP31337,SKVNGQSGRMEFFWTILK,18,HA-pep25,No entry found,Orthomyxoviridae,Not found,Synthetic construct(derived from influenza viral HA),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.,[Ref.27623031]Influenza A Virus(A/PuertoRico/8/1934):inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(IC50=34.0 ± 11.5μM);##AInfluenza A Virus(/Vietnam/1203/2004):inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(IC50=12.0 ± 2.1μM);##influenza A virus(A/Goose/Qinghai/59/2005):inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(IC50=34.8 ± 1.5μM);##influenza A virus(A/Duck/Anhui/SC702/2013):inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(IC50=51.0 ± 0.6μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA receptor binding domain (RBD),27623031,ACS Infect Dis. 2016 Mar 11;2(3):187-93,"Chen Q, Guo Y",Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor,18,15-18
DRAMP31338,GFKRIVQRiKDFLRNLV,17,GF-17d1,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>47.5 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,Mixed(D-Ile9),[Ref.18591279]CEM-SS cells:TC50=22.7 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,17,15-18
DRAMP31339,GFKRIVQRiKDFlRNLV,17,GF-17d2,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>47.5μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,"Mixed(D-Ile9,D-Leu13)",[Ref.18591279]CEM-SS cells:TC50>47.5 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,17,15-18
DRAMP31340,GIKEFKRIVQRIKDFLRNLV,20,GI-20,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=1.08 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50=22.7 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,20,18-21
DRAMP31341,GIKEXKRIVQRIKDFLRNLV,20,GI-20X17,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>40.6 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,The 'X' at position 5 is phenylglycine,L,[Ref.18591279]CEM-SS cells:TC50=7.3 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,20,18-21
DRAMP31342,GIKEWKRIVQRIKDFLRNLV,20,GI-20W17,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=7.4 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50=23.6 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,20,18-21
DRAMP31343,GIKQFKRIVQRIKDFLRNLV,20,GI-20Q16,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.91 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50=13.7 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,20,18-21
DRAMP31344,GIKEFKREFQRIKDFLRNLV,20,GI-20EF,No entry found,Retroviridae,Not found,Synthetic construct(derived from human cathelicidin LL-37),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=1.6 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50=9.9 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,20,18-21
DRAMP31345,GRFKRFRKKFKKLFKKIS,18,BMAP-18,No entry found,Retroviridae,Not found,Synthetic construct(derived from BMAP-27),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.35 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50=8.45 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,18,15-18
DRAMP31346,GRFKRFRKPFKKLFKKIS,18,BMAP-18P9,No entry found,Retroviridae,Not found,Synthetic construct(derived from BMAP-27),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=3.20 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50=18.9 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,18,15-18
DRAMP31347,GRFKRXRKKXKKLFKKIS,18,BMAP-18X6X10,No entry found,Retroviridae,Not found,Synthetic construct(derived from BMAP-27),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.68 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,The 'X' at position 6 and 10 are phenylglycine,L,[Ref.18591279]CEM-SS cells:TC50=10.2 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,18,15-18
DRAMP31348,GRFKRIRKKLKKLFKKIS,18,BMAP-18I6L10,No entry found,Retroviridae,Not found,Synthetic construct(derived from BMAP-27),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>44.0 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50=2.79 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,18,15-18
DRAMP31349,GRFKRFRKKFKKLFK,15,BMAP-15,No entry found,Retroviridae,Not found,Synthetic construct(derived from BMAP-27),"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>49.6 μM).(EC50:50% effective concentration for inhibition of virus replication),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.18591279]CEM-SS cells:TC50>49.6 μM.(TC50:the concentration that reduced cell viability by 50%),Not found,18591279,Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. ,"Wang G, Watson KM, Buckheit RW Jr. ",Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.,15,12-15
DRAMP31352,GVCRCLCRRGVCRCLCRR,18,"RTD-2 (RTD 2, rhesus theta-defensin 2)",P82271,Retroviridae,Not found,Macaca mulatta (Rhesus macaque),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide binds to gp120 and CD4, thereby inhibiting HIV entry.",[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=5.20 ± 1.58 µg/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=1.78± 0.57 µg/ml);##HIV-1 C:inhibition of infection in JC53-BL cells(IC50=6.74 ± 1.27 µg/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=3.66 ± 0.69 µg/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=3.02 ± 0.10 µg/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=3.08 ± 1.35 µg/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=5.16 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Cyclization (N termini to C termini),Cyclization (N termini to C termini),"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.",L,No cytotoxicity information found in the reference(s) presented,"gp120,CD4",15210812,J Immunol. 2004 Jul 1;173(1):515-20.,"Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI.",Activity of alpha- and theta-defensins against primary isolates of HIV-1. ,18,15-18
DRAMP31353,GFCRCICTRGFCRCICTR,18,RTD-3 (rhesus theta defensin 3),"P82270,Q9TU01",Retroviridae,Not found,Macaca mulatta (Rhesus macaque),"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide binds to gp120 and CD4, thereby inhibiting HIV entry.",[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=3.26 ± 0.58 µg/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=1.74± 0.40 µg/ml);##HIV-1 C:inhibition of infection in JC53-BL cells(IC50=4.31 ± 0.90 µg/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=2.09 ± 0.60 µg/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=2.31 ± 0.21 µg/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=3.04 ± 0.64 µg/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=0.89 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Cyclization (N termini to C termini),Cyclization (N termini to C termini),"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.",L,No cytotoxicity information found in the reference(s) presented,"gp120,CD4",15210812,J Immunol. 2004 Jul 1;173(1):515-20.,"Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI.",Activity of alpha- and theta-defensins against primary isolates of HIV-1. ,18,15-18
DRAMP31356,KFRRQRPRLSHKGPMPF,17,Apelin-17,Q9TUI9##K7GLR4,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.",[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=4.8 μg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,APJ receptor,10802050,FEBS Lett. 2000 May 4;473(1):15-8.,"Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H.",Apelin peptides block the entry of human immunodeficiency virus (HIV).,17,15-18
DRAMP31358,RRQRPRLSHKGPMPF,15,Apelin-15,Q9TUI9,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.",[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=12μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,APJ receptor,11090199,J Virol. 2000 Dec;74(24):11972-6.,"Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J.","Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. ",15,12-15
DRAMP31359,RRKFRRQRPRLSHKGPMPF,19,Apelin-19,Q9TUI9,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.",[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=4.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,APJ receptor,11090199,J Virol. 2000 Dec;74(24):11972-6.,"Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J.","Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. ",19,18-21
DRAMP31366,KGEAMHGQVDCSPGIWQLDC,20,#4330 derived from HIV-1 integrase,P04587,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.,[Ref.17257575]HIV-1:inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(IC50=4 μM);inhibition of reverse transcriptase(DNA-dependent DNA polymerase) activity(IC50=6.8 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,17257575,Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.,"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.",Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,20,18-21
DRAMP31367,ASCDKCQLKGEAMHG,15,#5649 derived from HIV-1 integrase,P04587,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.,[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(91.5 ± 2.5% residual DNA polymerase activity at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,17257575,Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.,"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.",Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,15,12-15
DRAMP31368,KCQLKGEAMHGQVDC,15,#5650 derived from HIV-1 integrase,P04587,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.,[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(63± 3% residual DNA polymerase activity at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,17257575,Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.,"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.",Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,15,12-15
DRAMP31369,KGEAMHGQVDCSPGI,15,#5651 derived from HIV-1 integrase,P04587,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.,[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(99 ± 6% residual DNA polymerase activity at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,17257575,Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.,"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.",Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,15,12-15
DRAMP31370,MHGQVDCSPGIWQLD,15,#5652 derived from HIV-1 integrase,P04587,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.,[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(79 ± 3% residual DNA polymerase activity at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,17257575,Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.,"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.",Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,15,12-15
DRAMP31371,VDCSPGIWQLDCTHL,15,#5653 derived from HIV-1 integrase,P04587,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.,[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(58 ± 3% residual DNA polymerase activity at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,17257575,Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.,"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.",Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,15,12-15
DRAMP31372,PGIWQLDCTHLEGKI,15,#5654 derived from HIV-1 integrase,P04587,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.,[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(62.5 ± 0.5% residual DNA polymerase activity at 30 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Reverse Transcriptase,17257575,Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.,"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.",Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,15,12-15
DRAMP31373,SWLRDLWDWICEVLSDFK,18,NS5A-derived peptide C5A [I6L],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40±0.13 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).,[Ref.21801309]Human erythrocytes:MHC=13.84 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31374,SWLRDIWDWLCEVLSDFK,18,NS5A-derived peptide C5A [I10L],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20±0.09 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=1.84±0.16 μM).,[Ref.21801309]Human erythrocytes:MHC=6.92 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31375,SWLRDIWDWICELLSDFK,18,NS5A-derived peptide C5A [V13L],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20±0.11 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.76±0.19 μM).,[Ref.21801309]Human erythrocytes:MHC=3.44 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31376,SWLRDLWDWLCEVLSDFK,18,"NS5A-derived peptide C5A [I6L,I10L]",V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40±0.15 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).,[Ref.21801309]Human erythrocytes:MHC=6.92 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31377,SWLRDLWDWICELLSDFK,18,"NS5A-derived peptide C5A [I6L,V13L]",V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=0.78±0.07 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=3.31±0.31 μM).,[Ref.21801309]Human erythrocytes:MHC=53.75 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31378,SWLRDIWDWLCELLSDFK,18,"NS5A-derived peptide C5A [I10L,V13L]",V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=0.82±0.10 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.58±0.22 μM).,[Ref.21801309]Human erythrocytes:MHC=3.44 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31379,SWLRDLWDWLCELLSDFK,18,"NS5A-derived peptide C5A [I6L,I10L,V13L]",V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20±0.14 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=0.59±0.03 μM).,[Ref.21801309]Human erythrocytes:MHC=107.50 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31380,SWLRDIWDWVCEVLSDFK,18,NS5A-derived peptide C5A [I10V],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40±0.117 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=1.86±0.25 μM).,[Ref.21801309]Human erythrocytes:MHC=13.93 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31381,SWLRDIWDWACEVLSDFK,18,NS5A-derived peptide C5A [I10A],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=4.00±0.36 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.21±0.28 μM).,[Ref.21801309]Human erythrocytes:MHC=14.10 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31382,SWLRDIWDWGCEVLSDFK,18,NS5A-derived peptide C5A [I10G],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=3.50±0.36 μM).,[Ref.21801309]Human erythrocytes:MHC=28.38 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31383,SWLRDIWDWSCEVLSDFK,18,NS5A-derived peptide C5A [I10S],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).,[Ref.21801309]Human erythrocytes:MHC=28.00 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31384,SWLRDIWDWECEVLSDFK,18,NS5A-derived peptide C5A [I10E],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).,[Ref.21801309]Human erythrocytes:MHC=214.91 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31385,SWLRDIWDWKCEVLSDFK,18,NS5A-derived peptide C5A [I10K],V5RF15,"Flaviviridae, Retroviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.",[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).,[Ref.21801309]Human erythrocytes:MHC=214.81 μM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,membrane,21801309,Chem Biol Drug Des. 2011 Nov;78(5):835-43.,"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.",Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,18,15-18
DRAMP31386,TRQARRNRRRRWRERQR,17,Rev (34-50),P05866,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,1ULL,Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. ,[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=1.7±0.25 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,20580677,Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.,"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.","Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",17,15-18
DRAMP31387,TRQARRNRRRRWRERQRAAAAC,22,Rev (34-50) -A4C,P05866,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. ,[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=0.35±0.07 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,20580677,Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.,"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.","Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",22,21-24
DRAMP31389,MPKTRRRPRRSQRKRPPTPWP,21,Rex (1-21),P0C207,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. ,[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,20580677,Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.,"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.","Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",21,18-21
DRAMP31391,RPRGRRGSRPSGAERRRRRAAAA,23,RSG-P2G4,No entry found,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. ,[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=2.2±0.51 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,20580677,Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.,"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.","Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",23,21-24
DRAMP31392,RSQKEGLHYTCSSHFPYSQYQFWK,24,CCR5 ECL2 (168-191),P51681,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide binds gp120 and inhibits virus entry.,[Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=136 ± 49 μM);##HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=138± 36 μM);##HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=89±31 μM);##HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=103±37 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,gp120,22403408,J Biol Chem. 2012 Apr 27;287(18):15076-86.,"Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA.",Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,24,21-24
DRAMP31394,QKEGLHYTCSSHFPYSQYQF,20,CCR5 ECL2 (170-189),P51681,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide binds gp120 and inhibits virus entry.,[Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=237 ± 31 μM);##HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=612± 21 μM);##HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=374±28 μM);##HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=600±24 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,gp120,22403408,J Biol Chem. 2012 Apr 27;287(18):15076-86.,"Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA.",Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,20,18-21
DRAMP31396,RRWYRWWRRRWYRWWR,16,MU89 (Octa 1 dp),No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.",[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=8.3 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,17681018,FEBS J. 2007 Sep;274(17):4511-25.,"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.",Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,16,15-18
DRAMP31400,YRWWRWARRWYRWWRWARRW,20,MU94 (Deca 1 dp),No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.",[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=5 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,17681018,FEBS J. 2007 Sep;274(17):4511-25.,"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.",Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,20,18-21
DRAMP31401,APKAMRLLRRLLRRLLR,17,N-[RLLR]3,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.",[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=7.3 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,17681018,FEBS J. 2007 Sep;274(17):4511-25.,"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.",Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,17,15-18
DRAMP31402,RRRRRRRWWWRRRRRRRR,18,MU103,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.",[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,17681018,FEBS J. 2007 Sep;274(17):4511-25.,"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.",Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,18,15-18
DRAMP31403,RRRRRRRRRRRRRRRWWW,18,MU104,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.",[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=9.25 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,17681018,FEBS J. 2007 Sep;274(17):4511-25.,"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.",Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,18,15-18
DRAMP31404,WRKWRKRWWWRKWRKRWW,18,ApoEdpL-W,No entry found,"Herpesviridae, Retroviridae, Rhabdoviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.",[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=3.1 µM);##HIV-1:inhibition of virus replication(>80% inhibition at 10 µM).,[Ref.17681018]15% hemolysis against human red blood cells at 35 μM.,Linear,Free,Free,,L,[Ref.17681018]No significant cytotoxicity against Vero cells up to 40 μM.,Not found,17681018,FEBS J. 2007 Sep;274(17):4511-25.,"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.",Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,18,15-18
DRAMP31414,LLMVNEATRFQTVSGFV,17,BPIP,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide inhibits Mpro, a protein crucial for viral replication.",[Ref.35896605]SARS-CoV-2: inhibition of Mpro (IC50= 0.52 nM).,[Ref.35896605]BRIP is not hemolytic at 500 nM and slightly hemolytic at 50 µM.,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Mpro,35896605,Sci Rep. 2022 Jul 27;12(1):12802,"Kashyap P, Bhardwaj VK, Chauhan M, Chauhan V, Kumar A, Purohit R, Kumar A, Kumar S",A ricin-based peptide BRIP from Hordeum vulgare inhibits Mpro of SARS-CoV-2,17,15-18
DRAMP31424,DSGEGDFLAEGGGVR,15,D15R,P02671,Picornaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"[Ref.30654366]Coxsackie virus B5:inhibition of viral replication in Vero cells (82% inhibition at 10 µg/ml, 85% inhibition at 50 µg/ml, 93% inhibition at 100 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100μg/ mL.,Not found,30654366,Intervirology. 2018;61(4):166-173.,"Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C",Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. ,15,12-15
DRAMP31425,GLEEELQFSLGSKINVK,17,G17K,P0C0L5,Picornaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"[Ref.30654366]Coxsackie virus B5:inhibition of viral replication in Vero cells (60% inhibition at 10 µg/ml, 75% inhibition at 50 µg/ml, 88% inhibition at 100 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100μg/ mL.,Not found,30654366,Intervirology. 2018;61(4):166-173.,"Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C",Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. ,17,15-18
DRAMP31426,SEETKENEGFTVTAEGK,17,S17K,P01024,Adenoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"[Ref.30654366]Adenovirus:inhibition of viral replication in Vero cells (60% inhibition at 10 µg/ml, 65% inhibition at 50 µg/ml, 80% inhibition at 100 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100μg/ mL.,Not found,30654366,Intervirology. 2018;61(4):166-173.,"Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C",Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. ,17,15-18
DRAMP31461,WLVFFVIFYFFRRRKK,16,FP3,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.,[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=0.00003 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA,22258859,J Gen Virol. 2012 May;93(Pt 5):980-986.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. ",A novel family of peptides with potent activity against influenza A viruses. ,16,15-18
DRAMP31462,RRKKWLVFFVIFYFFR,16,FP4,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.,[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=0.00004 µM);##influenza A virus PR8/Eng09 (H1N1):inhibition of viral replication in MDCK cells(IC50=0.0778 µM);##influenza A virus PR8/Vic (H3N2):inhibition of viral replication in MDCK cells(IC50=0.0535 µM);##influenza A virus PR8/Viet (H5N1):inhibition of viral replication in MDCK cells(IC50=0.1325 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,HA,22258859,J Gen Virol. 2012 May;93(Pt 5):980-986.,"Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. ",A novel family of peptides with potent activity against influenza A viruses. ,16,15-18
DRAMP31469,GCKKYRRFRWKFKGKFWFWG,20,Pep19-2.5,No entry found,"Retroviridae,Herpesviridae, Flaviviridae, Hepadnaviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: SALPs block entry of a variety of human pathogenic enveloped viruses, such as HIV-1, HBV, HCV, and HSV 1 and 2 by blocking heparan sulfate on the host cell plasma membrane, which serves as a the docking molecule for these pathogens.",[Ref.22457281]HIV-1 BaL:inhibition of viral entry in 293T cells(IC50=8 µg/ml);##HIV-1 NL4-3:inhibition of viral entry in 293T cells(IC50=16 µg/ml);##HSV-1:inhibition of viral entry in Vero cells(IC50=0.42 µg/ml);##Hepatitis C virus (HCV):inhibition of viral entry in 293T cells(IC50=40 µg/ml);##Hepatitis B virus (HBV):inhibition of viral entry in 293T cells(IC50=1 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,"[Ref.22457281]No significant cytotoxicity to Vero, TZM-bl and Jurkat cells even at a high concentration of 20 μg/mL.",membrane,22457281,J Infect Dis. 2012 Jun;205(11):1654-64.,"Krepstakies M, Lucifora J, Nagel CH, Zeisel MB, Holstermann B, Hohenberg H, Kowalski I, Gutsmann T, Baumert TF, Brandenburg K, Hauber J, Protzer U.",A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.,20,18-21
DRAMP31470,GKKYRRFRWKFKFGKWFWFG,20,Pep19-4,No entry found,"Retroviridae,Herpesviridae, Flaviviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: SALPs block entry of a variety of human pathogenic enveloped viruses, such as HIV-1, HBV, HCV, and HSV 1 and 2 by blocking heparan sulfate on the host cell plasma membrane, which serves as a the docking molecule for these pathogens.",[Ref.22457281]HIV-1 BaL:inhibition of viral entry in 293T cells(IC50=22 µg/ml);##HIV-1 NL4-3:inhibition of viral entry in 293T cells(IC50=10 µg/ml);##HSV-1:inhibition of viral entry in Vero cells(IC50=1.8 µg/ml);##Hepatitis C virus (HCV):inhibition of viral entry in 293T cells(IC50=37 µg/ml).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,"[Ref.22457281]No significant cytotoxicity to Vero, TZM-bl and Jurkat cells even at a high concentration of 20 μg/mL.",membrane,22457281,J Infect Dis. 2012 Jun;205(11):1654-64.,"Krepstakies M, Lucifora J, Nagel CH, Zeisel MB, Holstermann B, Hohenberg H, Kowalski I, Gutsmann T, Baumert TF, Brandenburg K, Hauber J, Protzer U.",A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.,20,18-21
DRAMP31472,SISNALNKLEESNRNLDKVNVKLT,24,C24,No entry found,Paramyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: By binding to the opposite HR region in the F protein, peptides would inhibit fusion from the initial steps (lipid- and contents-mixing), blocking the conformational changes in the fusion protein required for triggering fusion.",[Ref.12127571]Newcastle disease virus (NDV):inhibition of syncytium formation between NDV-infected cells(IC50=3.27 μM),No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,F protein,12127571,Int J Biochem Cell Biol. 2002 Oct;34(10):1207-20.,"San Román K, Villar E, Muñoz-Barroso I.",Mode of action of two inhibitory peptides from heptad repeat domains of the fusion protein of Newcastle disease virus.,24,21-24
DRAMP31476,AGDDQGLDKCVPNSKEK,17,,No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The peptide may bind with HA  and precent the attachment to target cells.,[Ref.22595270]Influenza A virus (A/Roma-ISS/2/08 H1N1):inhibition of viral  replication in MDCK cells(EC50=3.7±0.35 pM);##Influenza A virus (A/Parma/24/09 H1N1):inhibition of viral  replication in MDCK cells(EC50=3.4±0.14 pM);##Influenza A virus (A/Parma/05/06 H3N2):inhibition of viral  replication in MDCK cells(EC50=7.3±0.65 pM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.22595270]MDCK cells:CC50>25 μM.,HA,22595270,Pathog Glob Health. 2012 Mar;106(1):12-9.,"Ammendolia MG, Agamennone M, Pietrantoni A, Lannutti F, Siciliano RA, De Giulio B, Amici C, Superti F.",Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.,17,15-18
DRAMP31484,GLLYFAIFFVAAWHIRGR,18,H2-2,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.26251517]Hepatitis C Virus(HCV):inhibition of viral infection in Huh7.5.1 cells(EC50=1.60 ± 0.11 μM); inhibition of post-infection in Huh7.5.1 cells(EC50=2.19 ± 0.16 μM).,[Ref.26251517]<10% hemolysis even at 400 μM against human erythrocytes.,Linear,Free,Amidation,,L,[Ref.26251517]Huh7.5.1 cells: CC50=83.64 ± 6.95 μM;##Bel7402 cells:CC50~200 μM;##HeLa cells:CC50~200 μM.,Not found,26251517,J Biol Chem. 2015 Sep 18;290(38):23254-63.,"Hong W, Lang Y, Li T, Zeng Z, Song Y, Wu Y, Li W, Cao Z. ",A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro. ,18,15-18
DRAMP31485,HGLLYFAIFFVAAWHIRGR,19,H2-3,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.26251517]Hepatitis C Virus(HCV):inhibition of viral infection in Huh7.5.1 cells(EC50=0.54 ± 0.08 μM); inhibition of post-infection in Huh7.5.1 cells(EC50=1.09 ± 0.11 μM);H2-3 peptide inactivated HCV(EC50=82.11 nM).,[Ref.26251517]<10% hemolysis even at 400 μM against human erythrocytes.,Linear,Free,Amidation,,L,[Ref.26251517]Huh7.5.1 cells: CC50=115.99 ± 16.68 μM;##Bel7402 cells:CC50~200 μM;##HeLa cells:CC50~200 μM.,Not found,26251517,J Biol Chem. 2015 Sep 18;290(38):23254-63.,"Hong W, Lang Y, Li T, Zeng Z, Song Y, Wu Y, Li W, Cao Z. ",A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro. ,19,18-21
DRAMP31487,LYGNEGCGWAGWLLSPRG,18,SL173,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19264632]hepatitis C virus(J6/JFH1):inhibition of viral infection in Huh-7.5 cells(80% inhibition at 20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,19264632,J Gen Virol. 2009 Jun;90(Pt 6):1319-1328.,"Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD. ",Peptide inhibitors of hepatitis C virus core oligomerization and virus production.,18,15-18
DRAMP31488,GWAGWLLSPRGSRPSWGP,18,SL174,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19264632]hepatitis C virus(J6/JFH1):inhibition of viral infection in Huh-7.5 cells(15% inhibition at 20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,19264632,J Gen Virol. 2009 Jun;90(Pt 6):1319-1328.,"Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD. ",Peptide inhibitors of hepatitis C virus core oligomerization and virus production.,18,15-18
DRAMP31489,GWAGWLLSPRGSRPS,15,SL175,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.19264632]hepatitis C virus(J6/JFH1):inhibition of viral infection in Huh-7.5 cells(50% inhibition at 20 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,19264632,J Gen Virol. 2009 Jun;90(Pt 6):1319-1328.,"Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD. ",Peptide inhibitors of hepatitis C virus core oligomerization and virus production.,15,12-15
DRAMP31492,TLLFLKVPAQ NAISTTFPYT,21,PB1 (6–25),No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.",[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=129 ± 2 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,25446335,Antiviral Res. 2015 Jan;113:4-10.,"Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.",Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.,21,18-21
DRAMP31495,LPVGGNEKKA KLANVVRKMM,21,PB1 (271–290),No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.",[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=33 ± 1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,25446335,Antiviral Res. 2015 Jan;113:4-10.,"Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.",Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.,21,18-21
DRAMP31498,FNESTRKKIE KIRPLLVEGT,21,PB1 (381–400),No entry found,Orthomyxoviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.",[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=23 ± 1 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Not found,25446335,Antiviral Res. 2015 Jan;113:4-10.,"Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.",Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.,21,18-21
DRAMP31523,LNLFKKTINGLISDSLVIR,19,AVP-p,No entry found,Arenaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: that untimely deployment of fusion machinery by the peptide could render virions less able to engage in on-pathway receptor binding or endosomal fusion. ,[Ref.24850726]Pichinde virus (PICV):inhibition of viral infection in Vero cells(IC50=7.05 ± 2.19 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.24850726]No significant loss of viability was observed in Vero cells or human foreskin fibroblasts (HFF) up to 100 μM.,Not found,24850726,J Virol. 2014 Aug;88(15):8556-64.,"Spence JS, Melnik LI, Badani H, Wimley WC, Garry RF. ",Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism. ,19,18-21
DRAMP31533,SWLVNRDWFHDLNLPWTGSSAGTWQ,25,TP1,No entry found,Flaviviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: TP1 functions through a mechanism that involves release of the viral genome and interference with cellular TMUV binding,[Ref.32456819]Tembusu virus (TMUV):inhibition of viral infection in BHK-21 cells(IC50=14.19 mg/L).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.32456819]No cytotoxicity against BHK-21 cells up to 150mg / L.,Not found,32456819,Vet Microbiol. 2020 Jun;245:108708.,"Zhao D, Zhang L, Han K, Liu Q, Yang J, Huang X, Liu Y, Li Y, Zhao P. ",Peptide inhibitors of tembusu virus infection derived from the envelope protein. ,25,24-27
DRAMP31535,RRRQRRKKRGYGFVNLLFLVVE,22,TAT-Kα2,No entry found,"Herpesviridae,Paramyxoviridae,Orthomyxoviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: display virucidal activity by disrupting viral envelopes.,[Ref.28687749]Vesicular stomatitis virus(VSV):inhibition of viral infection in 293T cells(IC50=2.9 μM);##Respiratory Syncytial Virus(RSV):inhibition of viral infection in Hep2 cells(IC50=3.4 μM);##Newcastle disease virus(NDV):inhibition of viral infection(IC50=0.8 μM);##Parainfluenza virus:inhibition of viral infection(IC50=2.4 μM);##Influenza virus (H1N1) A/Puerto Rico/8/34:inhibition of viral infection(IC50=0.5 μM);##Influenza virus (H5N2) A/bird/Korea/W81/2005:inhibition of viral infection(IC50=0.8 μM);##Influenza virus (H7N3) A/Aquatic bird/Korea/W44/2005:inhibition of viral infection(IC50=1.2 μM);##Influenza virus (H9N2) A/Chicken/Korea/116/2004:inhibition of viral infection(IC50=0.7 μM);##Porcine epidemic diarrhea virus:inhibition of viral infection(IC50=3.5 μM);##Herpes simplex virus:inhibition of viral infection(IC50=5.7 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.28687749]No cytotoxicity against MDCK cells up to 100 μM.,Envolope,28687749,Sci Rep. 2017 Jul 7;7(1):4875.,"Moon HJ, Nikapitiya C, Lee HC, Park ME, Kim JH, Kim TH, Yoon JE, Cho WK, Ma JY, Kim CJ, Jung JU, Lee JS.",Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses,22,21-24
DRAMP31536,MGRFKRFRKKFKKLFKKLS,19,Bomidin,P54228,"Flaviviridae,Herpesviridae,Coronaviridae",Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: bomidin readily disrupted viral membranes (with components similar to those in the endoplasmic reticulum) and bacterial membranes but did not alter the overall structures of the cell membranes,[Ref.35663971]Dengue virus 2(DENV2):inhibition of viral infection in Huh7 cells(50% inhibition at 10 μM);##HSV:inhibition of viral infection in Huh7 cells(50% inhibition at 10 μM);##SARS-CoV-2:inhibition of viral infection in Huh7 cells(80% inhibition at 10 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.35663971]Vero E6 cells:CC50=169.6 ± 1.1 µM.,membrane,35663971,Front Immunol. 2022 May 19;13:851642.,"Liu R, Liu Z, Peng H, Lv Y, Feng Y, Kang J, Lu N, Ma R, Hou S, Sun W, Ying Q, Wang F, Gao Q, Zhao P, Zhu C, Wang Y, Wu X. ",Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses.,19,18-21
DRAMP31537,DHVTPDIAYNPRTYM,15,Pep-RTYM,No entry found,Flaviviridae,Not found,Acacia catechu,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: the biding of peptide to virus particles might disrupt the ability of the virus to bind to the host cell receptor or possibly block the internalization of the virus into the host cells.,[Ref.33172110]Dengue virus 2(DENV2):inhibition of viral infection in Vero cells(IC50=7.9 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.33172110]No cytotoxicity against Vero cells up to 1000 μM.,Not found,33172110,Viruses. 2020 Nov 6;12(11):1267.,"Panya A, Sawasdee N, Songprakhon P, Tragoolpua Y, Rotarayanont S, Choowongkomon K, Yenchitsomanus PT. ",Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant Acacia catechu Binds to Dengue Virus and Inhibits Cell Entry.,15,12-15
DRAMP31538,DHVTPDIAYNPWAYF,15,Pep-WAYF,No entry found,Flaviviridae,Not found,Acacia catechu,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: the biding of peptide to virus particles might disrupt the ability of the virus to bind to the host cell receptor or possibly block the internalization of the virus into the host cells.,[Ref.33172110]Dengue virus 2(DENV2):inhibition of viral infection in Vero cells(IC50=15.67 μM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.33172110]No cytotoxicity against Vero cells up to 1000 μM.,Not found,33172110,Viruses. 2020 Nov 6;12(11):1267.,"Panya A, Sawasdee N, Songprakhon P, Tragoolpua Y, Rotarayanont S, Choowongkomon K, Yenchitsomanus PT. ",Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant Acacia catechu Binds to Dengue Virus and Inhibits Cell Entry.,15,12-15
DRAMP31544,ALWKTLLKKVLKAAAK,16,Dermaseptin S4 (1-16)[M4K],P80280,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,"Mechanism: exerts a selective activity on viral particles and disturbs their organization by breaking the viral membrane, leading to the exposure of HIV-1 core and its dissociation. ",[Ref.15780876]human immunodeficiency virus type 1 (HIV-1):Inhibition of viral infection in Vero P4-CCR5 cells(IC50=28 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.15780876]P4-CCR5 cells:CC50>100 μM.,viral membrane,15780876,Virology. 2005 Apr 10;334(2):264-75. ,"Lorin C, Saidi H, Belaid A, Zairi A, Baleux F, Hocini H, Bélec L, Hani K, Tangy F.",The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. ,16,15-18
DRAMP31546,QSHLSLCRWCCNCCRSNKGC,20,Hepcidin TH2-3,I3KHK3,Picornaviridae,Not found,Oreochromis mossambicus,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"[Ref.30012343]Foot-and-Mouth Disease virus(FMDV):Inhibition of viral replication in BHK-21 cells(IC50=25.1±1.5 µg/ml, IC90=78.5±7.6 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Cyclic,Free,Cyclization(Cys7 and Cys20),"Disulfide bonds between Cys7 and Cys20, Cys10 and Cys13, Cys11 and Cys14.",L,[Ref.30012343]Baby Hamster Kidney cells BHK-21:CC50=120.2±2.5 µg/ml.,Not found,30012343,Peptides. 2018 Aug;106:91-95.,"Huang HN, Pan CY, Chen JY. ",Grouper (Epinephelus coioides) antimicrobial peptide epinecidin-1 exhibits antiviral activity against foot-and-mouth disease virus in vitro.,20,18-21
DRAMP31547,FIHHIIGGLFSVGKHIHSLIHGH,23,"Tilapia piscidin 3, TP3",L0CMD2,Picornaviridae,Not found,Oreochromis niloticus,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,"[Ref.30012343]Foot-and-Mouth Disease virus(FMDV):Inhibition of viral replication in BHK-21 cells(IC50=2.5±0.2 µg/ml, IC90=25.0±3.2 µg/ml).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,[Ref.30012343]Baby Hamster Kidney cells BHK-21:CC50=39.0±1.2 µg/ml.,Not found,30012343,Peptides. 2018 Aug;106:91-95.,"Huang HN, Pan CY, Chen JY. ",Grouper (Epinephelus coioides) antimicrobial peptide epinecidin-1 exhibits antiviral activity against foot-and-mouth disease virus in vitro.,23,21-24
DRAMP31548,AKKAAKKAKKAAKKIEKAAKK,21,RJ5-I15E16,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=112 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.,Not found,16923027,Chem Biol Drug Des. 2006 Jul;68(1):58-66.,"Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.","Prediction of activity, synthesis and biological testing of anti-HSV active peptides. ",21,18-21
DRAMP31549,AKKAKKKAKKAAKKIKKKAKK,21,RJ9-I15,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=11 µM); inhibition of viral infection in MRC-5 cells(IC50=119 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.,Not found,16923027,Chem Biol Drug Des. 2006 Jul;68(1):58-66.,"Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.","Prediction of activity, synthesis and biological testing of anti-HSV active peptides. ",21,18-21
DRAMP31550,ARRARRRARRAARRARRGARR,21,RJ8-R5G18,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=1.9 µM); inhibition of viral infection in MRC-5 cells(IC50=4.8 µM);##Herpes simplex virus 2(HSV-2):inhibition of viral infection in MRC-5 cells(IC50=96 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.,Not found,16923027,Chem Biol Drug Des. 2006 Jul;68(1):58-66.,"Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.","Prediction of activity, synthesis and biological testing of anti-HSV active peptides. ",21,18-21
DRAMP31551,ARRARRRARRAARRARRWARR,21,RJ8-R5W18,No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=9.2 µM); inhibition of viral infection in MRC-5 cells(IC50=2.8 µM);##Herpes simplex virus 2(HSV-2):inhibition of viral infection in MRC-5 cells(IC50=162 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.,Not found,16923027,Chem Biol Drug Des. 2006 Jul;68(1):58-66.,"Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.","Prediction of activity, synthesis and biological testing of anti-HSV active peptides. ",21,18-21
DRAMP31552,KAAKKAAKWAKKAAKWAKKAA,21,"RJ2-W9,16",No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=111 µM); inhibition of viral infection in MRC-5 cells(IC50=32 µM);##Herpes simplex virus 2(HSV-2):inhibition of viral infection in MRC-5 cells(IC50=48 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.,Not found,16923027,Chem Biol Drug Des. 2006 Jul;68(1):58-66.,"Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.","Prediction of activity, synthesis and biological testing of anti-HSV active peptides. ",21,18-21
DRAMP31553,KYAKKAAKYAKKAAKYAKKAA,21,"RJ2-Y2,9,16",No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=146 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.,Not found,16923027,Chem Biol Drug Des. 2006 Jul;68(1):58-66.,"Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.","Prediction of activity, synthesis and biological testing of anti-HSV active peptides. ",21,18-21
DRAMP31554,AAKAWKKAKAWKKAKWWKKAA,21,"RJ2-A1,4,8; K3,6,7,9,13; W5,11,17",No entry found,Herpesviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Comment: No comments found on DRAMP database,[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=238 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.,Not found,16923027,Chem Biol Drug Des. 2006 Jul;68(1):58-66.,"Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.","Prediction of activity, synthesis and biological testing of anti-HSV active peptides. ",21,18-21
DRAMP31558,STSQKAnti-SIVAYTM,12,"SARS-CoV S (668–679), SP-10",P59594,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: block the binding of S protein to ACE2.,[Ref.16337697]SARS-CoV:Inhibition of pseudovirus infection in Vero cells(IC50=1.88 ± 0.52 nM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,ACE2,16337697,Antiviral Res. 2006 Feb;69(2):70-6.,"Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY.",Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.,17,15-18
DRAMP31561,IHAEIKNSLKIDNLDVNRCIEAL,23,LEDGF/p75 (355-377),O75475,Retroviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: The LEDGF/p75 peptide modestly inhibited IN catalysis and was dependent on IN–DNA assembly. The peptide was also effective at disrupting LEDGF/p75–IN complex formation.,[Ref.18331842]Human immunodeficiency virus (HIV): Inhibition of integrase activity (3' end processing)(IC50=165±28 µM); inhibition of integrase activity(strand transfer)(IC50=153±28 µM).,No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Free,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Integrase,18331842,FEBS Lett. 2008 Apr 30;582(10):1425-30. ,"Al-Mawsawi LQ, Christ F, Dayam R, Debyser Z, Neamati N.",Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.,23,21-24
DRAMP31563,QDKHEEDYQMYNKGDKED,18,Peptide2,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.,"[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=18 ± 2 nM, 95% inhibition at 0.39 µM, 100% inhibition at 25 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Spike protein,34328726,J Med Chem. 2022 Feb 24;65(4):2836-2847. ,"Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.",Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein,18,15-18
DRAMP31564,DKFNHEAEDLFYQSSLASWNYNT,23,Peptide3,Q9BYF1,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.,"[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=6 ± 4 nM, 100% inhibition at 25 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Spike protein,34328726,J Med Chem. 2022 Feb 24;65(4):2836-2847. ,"Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.",Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein,23,21-24
DRAMP31565,IDENARSYIDKFQHDAEEMWYQ,22,Peptide4,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.,"[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=32 ± 2 nM, 95% inhibition at 0.39 µM, 100% inhibition at 25 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Spike protein,34328726,J Med Chem. 2022 Feb 24;65(4):2836-2847. ,"Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.",Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein,22,21-24
DRAMP31566,IYALLENAEDYNLVN,15,Peptide5,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.,"[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=9 ± 4 nM, 100% inhibition at 25 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Spike protein,34328726,J Med Chem. 2022 Feb 24;65(4):2836-2847. ,"Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.",Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein,15,12-15
DRAMP31567,SRDKHEEHEKENDRGQ,16,Peptide6,No entry found,Coronaviridae,Not found,Synthetic construct,"Antimicrobial, Antiviral",Not found,Not found,Not found,,Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.,"[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=10 ± 5 nM, 100% inhibition at 25 µM).",No hemolysis information or data found in the reference(s) presented in this entry,Linear,Free,Amidation,,L,No cytotoxicity information or data found in the reference(s) presented in this entry,Spike protein,34328726,J Med Chem. 2022 Feb 24;65(4):2836-2847. ,"Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.",Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein,16,15-18
DRAMP31568,KWKLFKKIGPGKFLHSAKKF,20,CA-MA3,Not available,,Not found,Ceropin-Magainin hybrid peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=75 µM); A549 (IC50>100 µM); K562 (IC50>100 µM); MDA-MB-361 (IC50>100 µM),Human erythrocytes: Hemolysis 0% (100 μM),Linear,Free,Amidation,,L,NIH-3T3 fibroblast: IC50>100 μM,Not available,10675500,Biochim Biophys Acta. 2000 Feb 15;1463(2):209-18.,"Shin SY, Kang JH, Jang SY, Kim Y, Kim KL, Hahm KS.","Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells",20,18-21
DRAMP31569,KWKFKKIPKFLHLAKKF,17,P18,Not available,,Not found,Ceropin A,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=3.5 µM); Jurkat (IC50=4 µM); MDA-MB-361 (IC50=8 µM),Human erythrocytes: hemolysis: 0%=100 µM; hemolysis: 0%=50 µM; hemolysis: 0%=25.0 µM; hemolysis: 0%=12.5 µM; hemolysis: 0%=6.25 µM; hemolysis: 0%=3.125 µM; hemolysis: 0%=1.56 µM; hemolysis: 0%=0.78 µM,Linear,Free,Amidation,,L,NIH 3T3: IC50=75 µM,Not available,12005420,J Pept Res. 2001 Dec;58(6):504-14.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs",17,15-18
DRAMP31570,PAWFKARRWAWRMKKLAA,18,L2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Meth A (IC50=144 µM); MT-1 (IC50>254 µM); HT-29 (IC50>440 µM),Human red blood cells: EC50>440 µM,Linear,Free,Free,,L,Fibroblas: IC50>440 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31571,PAWRKAFRWAWRMKKLAA,18,L3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (IC50=141 µM); MT-1 (IC50=18 µM); Meth A (IC50=32 µM),Human red blood cells: EC50>440 µM,Linear,Free,Free,,L,Fibroblas: IC50=163 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31572,PAWFKARRWAWRMLKKAA,18,L4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (IC50=16 µM); Meth A (IC50=31 µM); HT-29 (IC50=57 µM),Human red blood cells: EC50>440 µM,Linear,Free,Free,,L,Fibroblas: IC50=299 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31573,PAWRKAFRWAWRMLKKAA,18,L5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (IC50=14 µM); A549 (IC50=3 ± 1 μM(pH=7.4); IC50=4 ± 1 μM(pH=5.5)); Meth A (IC50=6.6 µM); MT-1 (IC50=8 µM),Human red blood cells: EC50=33 µM,Linear,Free,Free,,L,Fibroblas: IC50=17 µM; CHO: IC50=5 ± 1 μM(pH=7.4); IC50=5 ± 1 μM(pH=5.5),Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31574,PAWRKAFRWAARMLKKAA,18,L6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Meth A (IC50=11 µM); MT-1 (IC50=12 µM); HT-29 (IC50=15 µM),Human red blood cells: EC50=278 µM,Linear,Free,Free,,L,Fibroblas: IC50=46 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31575,PAWRKAFRAAWRMLKKAA,18,L7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (IC50=11 µM); HT-29 (IC50=16 µM); Meth A (IC50=16 µM),Human red blood cells: EC50=382 µM,Linear,Free,Free,,L,Fibroblas: IC50=46 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31576,PAWAKAFRAAARMKLKAA,18,L8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Meth A (IC50=110 µM); HT-29 (IC50=180 µM); MT-1 (IC50=87 µM),Human red blood cells: EC50>489 µM,Linear,Free,Free,,L,Fibroblas: IC50>489 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31577,PAWRKAARWAWRMLKKAA,18,L9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (IC50=32 µM); Meth A (IC50=35 µM); HT-29 (IC50=52 µM),Human red blood cells: EC50>455 µM,Linear,Free,Free,,L,Fibroblas: IC50=289 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31578,PAARKAFRWAWRMLKKAA,18,L10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (IC50=20 µM); Meth A (IC50=24 µM); HT-29 (IC50=35 µM),Human red blood cells: EC50>463 µM,Linear,Free,Free,,L,Fibroblas: IC50=190 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31579,PAARKAARWAWRMLKKGA,18,L11,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Meth A (IC50=116 µM); HT-29 (IC50=248 µM); MT-1 (IC50=75 µM),Human red blood cells: EC50>480 µM,Linear,Free,Free,,L,Fibroblas: IC50>480 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31580,PAWRKAFRWAKRMLKKAA,18,L12,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (IC50=10 µM); HT-29 (IC50=25 µM); Meth A (IC50=7.9 µM),Human red blood cells: EC50>451 µM,Linear,Free,Free,,L,Fibroblas: IC50=31 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31581,PAWRKAFRKAWRMLKKAA,18,L13,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (IC50=12 µM); Meth A (IC50=14 µM); HT-29 (IC50=29 µM),Human red blood cells: EC50>451 µM,Linear,Free,Free,,L,Fibroblas: IC50=59 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31582,PAWRKARRWAWRMKKLAA,18,L14,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Meth A (IC50=125 µM); MT-1 (IC50=141 µM); HT-29 (IC50=423 µM),Human red blood cells: EC50>438 µM,Linear,Free,Free,,L,Fibroblas: IC50>438 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31583,PAWRKARRWARRMKKLAA,18,L15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (IC50=178 µM); Meth A (IC50=87 µM); MT-1 (IC50=92 µM),Human red blood cells: EC50>444 µM,Linear,Free,Free,,L,Fibroblas: IC50>444 µM,Not available,12366526,J Pept Res. 2002 Oct;60(4):187-97.,"Yang N, Stensen W, Svendsen JS, Rekdal Ø.",Enhanced antitumor activity and selectivity of lactoferrin-derived peptides,18,15-18
DRAMP31584,GIGKFLHSAKKWGKAFVGQIMNC,23,MG2d,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (30-40% viablity=100 µM ),Not available,Linear,Free,Amidation,,L,Not available,Not available,12417587,J Biol Chem. 2003 Jan 10;278(2):1310-5.,"Takeshima K, Chikushi A, Lee KK, Yonehara S, Matsuzaki K.",Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes,23,21-24
DRAMP31585,TRSSRAGLQWPVGRVHRLLRKGGC,24,BF2d,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (80-90% viablity=100 µM ),Not available,Linear,Free,Amidation,,L,Not available,Not available,12417587,J Biol Chem. 2003 Jan 10;278(2):1310-5.,"Takeshima K, Chikushi A, Lee KK, Yonehara S, Matsuzaki K.",Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes,24,21-24
DRAMP31586,glfdvikkvasviggl,16,Citropin 1.1D,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Not available,Linear,Free,Amidation,,D,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31587,GLFDVIKAVASVIGGL,16,Citropin 5,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Lung cancer group (NCI) (IC50=1 μM); Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>100 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31588,GLFDVIKKVAAVIGGL,16,Citropin 7,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31589,GLFDVIKKVASVIKGL,16,Citropin 11,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31590,GLFDVIKKVASVIKKL,16,Citropin 13,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31591,GLFAVIKKVAAVIKKL,16,Citropin 17,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31592,GLFAVIKKVAAVIRRL,16,Citropin 18,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31593,GLFAVIKKVAKVIKKL,16,Citropin 19,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Melanoma cancer group (NCI) (IC50=1 μM); Ovarian cancer group (NCI) (IC50=1 μM); Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31594,GLFKVIKKVASVIGGL,16,Citropin 22,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50>10 μM); Leukemia group (NCI) (IC50>10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31595,GLFKVIKKVAKVIKKL,16,Citropin 23,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31596,LGGIVSAVKKIVDFLG,16,Citropin retro,Not available,,Not found,Amphibian skin secretions,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CNS cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Breast cancer group (NCI) (IC50>10 μM); Colon cancer group (NCI) (IC50>10 μM); Leukemia group (NCI) (IC50>10 μM); Ovarian cancer group (NCI) (IC50>10 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12631273,Eur J Biochem. 2003 Mar;270(6):1141-53.,"Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.","nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications",16,15-18
DRAMP31598,KLlRLLkkLlRLlLK,15,"l3,10,13K7,8K4R2L9",Not available,,Not found,Diastereomeric peptide,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: B16-F10 (LC50=2.5 µM); D122 (LC50=4.5 µM),Human erythrocyte: Hemolysis% at 50 μm peptide LC50=0 µM,Linear,Free,Free,l=D-Leucine; k=D-Lysine,Mix,NIH-3T3: LC50=40 µM,Not available,12646578, J Biol Chem. 2003 Jun 6;278(23):21018-23. ,"Papo N, Shahar M, Eisenbach L, Shai Y. ",Designed antimicrobial and antitumor peptides with high selectivity,15,12-15
DRAMP31599,AIGKFLHSAKKFGKAFVGEIMNS,23,Magainin A,C0HKN6##P11006,,Not found,African clawed frog Xenopus laevis skin,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H735 (IC50=10.4 µM); NCI-H526 (IC50=11.7 µM); U-937 (IC50=16 µg/ml); RPMI-8402 (IC50=18 µg/ml); Raji (IC50=20 µg/ml); SSKT-1 (IC50=23 µg/ml); Daudi (IC50=30 µg/ml); MLA (IC50=34 µg/ml); K562 (IC50=40 µg/ml); CHP-100 (IC50=45 µg/ml); MCF-7 (IC50=49 µg/ml); PC-3 (IC50=53 µg/ml); NCI-H678 (IC50=6.23 µM); NCI-H889 (IC50=6.56 µM); NCI-H82 (IC50=7.28 µM); NCI-H841 (IC50=9.7 µM),Detectable but low hemolytic activity,Linear,Beta-alanine,Amidation,,L,Not available,Not available,1319823,Cancer Res. 1992 Jul 1;52(13):3534-8.,"Ohsaki Y, Gazdar AF, Chen HC, Johnson BE.",Antitumor activity of magainin analogues against human lung cancer cell lines,23,21-24
DRAMP31600,LLAGLAANFLPTIICKISYKC,21,PTP1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50>100 µg/ml); Hep 3B (IC50>100 µg/ml); MCF-7 (IC50>100 µg/ml); PC-3 (IC50>100 µg/ml),Human RBCs: less than 6% hemolysis at 100 μg/ml,Cyclic,Free,Amidation,,L,HEK293: IC50>100 µg/ml,Not available,14499271,Peptides. 2003 Jul;24(7):945-53.,"Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.",In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines,21,18-21
DRAMP31601,FAGLAANFLPTIICKISYKC,20,PTP2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50>100 µg/ml); Hep 3B (IC50>100 µg/ml); MCF-7 (IC50>100 µg/ml); PC-3 (IC50>100 µg/ml),Human RBCs: less than 6% hemolysis at 100 μg/ml,Cyclic,Free,Amidation,,L,HEK293: IC50>100 µg/ml,Not available,14499271,Peptides. 2003 Jul;24(7):945-53.,"Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.",In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines,20,18-21
DRAMP31602,FLKLLKKLAAKFLPTIICKISYKC,24,PTP4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=13.71 ± 2.12 µg/ml); MCF-7 (IC50=18.10 ± 2.13 µg/ml); Hep 3B (IC50=18.18 ± 3.31 µg/ml); PC-3 (IC50=18.63 ± 0.99 µg/ml),Human RBCs: 45.17% hemolysis at 100 μg/ml,Linear,Free,Amidation,,L,HEK293: IC50=26.15 ± 6.23 µg/ml,Not available,14499271,Peptides. 2003 Jul;24(7):945-53.,"Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.",In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines,24,21-24
DRAMP31609,HHPHGHHPHGHHPHGHHPHG,20,Ac-(HHPHG)4 -NH2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Bind to Tropomyosin and Have Antiangiogenic and Antitumor Activities,Tumor cells: 3LL (The 50 mg/kg dose in the 3LL model significantly inhibited tumor growth by 48%); B16-F1 (The 50 mg/kg dose in the 3LL model significantly inhibited tumor growth by 48%),Not available,Linear,Acetylation,Amidation,,L,Not available,Tropomyosin,15313924,Cancer Res. 2004 Aug 15;64(16):5812-7.,"Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.",Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities,20,18-21
DRAMP31610,CVKVKVKVGSGVKVKVKVC,19,V1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: THP-1 (IC50=45 µM),Human erythrocytes: 50% Hemolysis=880 µM,Cyclic,Acetylization,Amidation,,L,Not available,Not available,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.,"Frecer V, Ho B, Ding JL.",De novo design of potent antimicrobial peptides,19,18-21
DRAMP31611,CWMSPRHLGTCGRKKRRQRRRPPQ,24,CIGB-300 (P15-Tat),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"CIGB-300 is a cyclic synthetic peptide that induces apoptosis in malignant cells, elicits antitumor activity in cancer animal models",Tumor cells: SiHa (IC50=135±10 µmol/L); HeLa (IC50=136±16  µmol/L); 3LL (IC50=143±4 µmol/L); A549 (IC50=171±12 µmol/L); Ca Ski (IC50=182±6  µmol/L); NCI-H82 (IC50=20±3 µmol/L); PC-3 (IC50=201±16 µmol/L); HL-60 (IC50=30±3 µmol/L); NCI-H125 (IC50=36±9  µmol/L); TC-1 (IC50=71±15  µmol/L); Jurkat (IC50=89±3  µmol/L),Not available,Cyclic,Free,Free,,L,Not available,Not available,15466209,Cancer Res. 2004 Oct 1;64(19):7127-9.,"Perea SE, Reyes O, Puchades Y, Mendoza O, Vispo NS, Torrens I, Santos A, Silva R, Acevedo B, López E, Falcón V, Alonso DF.",Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2),24,21-24
DRAMP31612,GRKKRRQRRRGGWMWVTNLRTD,22,TAT-Ras-GAP317-326,Not available,,Not found,RasGAP-derived peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Enhances genotoxin-induced cytotoxicity in tumor cells,"Tumor cells: HeLa (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); H-Meso-1  (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); MCF-7 (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); U2OS (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone )",Not available,Linear,Free,Free,,L,Not available,Not available,15467750,Oncogene. 2004 Nov 25;23(55):8971-8.,"Michod D, Yang JY, Chen J, Bonny C, Widmann C.",A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells,22,21-24
DRAMP31615,HSHRDFQPVLHLVALNSPLSGGMRG,25,hP1,P39060,,Not found,Human endostatin peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (39% inhibition at 7 mg/kg/d),Not available,Linear,Free,Free,,L,Not available,"α5β1 integrin, metalloproteinases",15867360,Cancer Res. 2005 May 1;65(9):3656-63.,"Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.",A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity,25,24-27
DRAMP31616,MRGIRGADFQAFQQARAVGLAGTFR,25,hP2,Not available,,Not found,Human endostatin peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (19% inhibition at 7 mg/kg/d),Not available,Linear,Free,Free,,L,Not available,"α5β1 integrin, metalloproteinases",15867360,Cancer Res. 2005 May 1;65(9):3656-63.,"Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.",A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity,25,24-27
DRAMP31617,TFRAFLSSRLQDLYSIVRRADRAAV,25,hP3,P39060,,Not found,Human endostatin peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Not available,Linear,Free,Free,,L,Not available,"α5β1 integrin, metalloproteinases",15867360,Cancer Res. 2005 May 1;65(9):3656-63.,"Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.",A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity,25,24-27
DRAMP31618,AAVPIVNLKDELLFPSWEALFSGSE,25,hP4,P39060,,Not found,Human endostatin peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Not available,Linear,Free,Free,,L,Not available,"α5β1 integrin, metalloproteinases",15867360,Cancer Res. 2005 May 1;65(9):3656-63.,"Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.",A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity,25,24-27
DRAMP31619,GSEGPLKPGARIFSFDGKDVLRHPT,25,hP5,P39060,,Not found,Human endostatin peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (29% inhibition at 7 mg/kg/d),Not available,Linear,Free,Free,,L,Not available,"α5β1 integrin, metalloproteinases",15867360,Cancer Res. 2005 May 1;65(9):3656-63.,"Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.",A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity,25,24-27
DRAMP31620,HPTWPQKSVWHGSDPNGRRLTESY,24,hP6,P39060,,Not found,Human endostatin peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Not available,Linear,Free,Free,,L,Not available,"α5β1 integrin, metalloproteinases",15867360,Cancer Res. 2005 May 1;65(9):3656-63.,"Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.",A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity,24,21-24
DRAMP31621,ETWRTEAPSATGQASSLLGGRLLGQ,25,hP7,P39060,,Not found,Human endostatin peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"Inhibition of endothelial cell proliferation, migration, and tube formation",Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d),Not available,Linear,Free,Free,,L,Not available,"α5β1 integrin, metalloproteinases",15867360,Cancer Res. 2005 May 1;65(9):3656-63.,"Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.",A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity,25,24-27
DRAMP31634,LKlLKKLlkKLLkLL,15,D-K6L9,Not available,,Not found,Host Defense lytic Peptide,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,The exclusive selectivity of the peptide towards cancer derives from its specific binding to surface phosphatidylserine and the killing of the cancer cells via cytoplasmic membrane depolarization,Tumor cells: CL-1 (LC50=3 μmol/L); MDA-MB-231 (LC50=3 μmol/L); 22Rv1 (LC50=6 μmol/L),Not available,Linear,Free,Amidation,l=D-Leucine; k=D-Lysine,Mix,Not available,surface phosphatidylserine,16707464,Cancer Res. 2006 May 15;66(10):5371-8.,"Papo N, Seger D, Makovitzki A, Kalchenko V, Eshhar Z, Degani H, Shai Y.",Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide,15,12-15
DRAMP31656,FLGALFKVASKVLPSVKCAITKKC,24,Gaegurin-5,Not available,,Not found,Rana rugosa,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (IC50=113.31 µg/ml); A498 (IC50=138.06 µg/ml); A549 (IC50=145.72 µg/ml); MCF-7 (IC50=183.74 µg/ml); MKN 45 (IC50=34.96 µg/ml); SK-OV-3 (IC50=38.28 µg/ml); NCI-H630 (IC50=41.85 µg/ml); PC-3 (IC50=43.64 µg/ml); SK-MEL-2 (IC50=47.47 µg/ml),Human erythrocytes: 7% Hemolysis=100 µg/ml,Linear,Free,Free,,L,Not available,Not available,16884301,J Med Chem. 2006 Aug 10;49(16):4886-95.,"Won HS, Seo MD, Jung SJ, Lee SJ, Kang SJ, Son WS, Kim HJ, Park TK, Park SJ, Lee BJ.",Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5,24,21-24
DRAMP31659,ALSKALSKALSKALSKALSKALSK,24,Z44,Not available,,Not found,Xenopus laevis,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,magainin 2 and synthetic analogues can rapidly and irreversibly lyse hematopoietic tumor and solid tumor ,Tumor cells: SSKT-1 (IC50=107 µg/ml); Daudi (IC50=115 µg/ml); RPMI-8402 (IC50=60 µg/ml); Raji (IC50=64 µg/ml); MLA (IC50=80 µg/ml); U-937 (IC50=97 µg/ml); K562 (IC50=98 µg/ml),Not available,Linear,Free,Amidation,,L,Not available,Not available,1708887,Proc Natl Acad Sci U S A. 1991 May 1;88(9):3792-6.,"Cruciani RA, Barker JL, Zasloff M, Chen HC, Colamonici O.",Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation,24,21-24
DRAMP31660,AKSKAKSKAKSKAKSKAKSKAKSK,24,Z24,Not available,,Not found,Xenopus laevis,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,magainin 2 and synthetic analogues can rapidly and irreversibly lyse hematopoietic tumor and solid tumor ,Tumor cells: MLA (IC50=102 µg/ml); SSKT-1 (IC50=109 µg/ml); K562 (IC50=112 µg/ml); U-937 (IC50=123 µg/ml); Daudi (IC50=143 µg/ml); Raji (IC50=72 µg/ml); RPMI-8402 (IC50=83 µg/ml),Not available,Linear,Free,Amidation,,L,Not available,Not available,1708887,Proc Natl Acad Sci U S A. 1991 May 1;88(9):3792-6.,"Cruciani RA, Barker JL, Zasloff M, Chen HC, Colamonici O.",Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation,24,21-24
DRAMP31661,KILRGVSKKIMRTFLRRILTGKK,23,NK23c,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (Not active up to 100 µg/ml),Human erythrocytes: 15% Hemolysis=100 µg/ml,Linear,Free,Free,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,23,21-24
DRAMP31666,KISKKIMRTFLRRISKDILTGKK,23,NK23a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (Not active up to 100 µg/ml),Human erythrocytes: <5% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,23,21-24
DRAMP31669,LLGMIPLAISAISALSKL,18,Phylloseptin-L1,A0A5Q0MU22##P0DQK9##L0P329,,Not found,skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Cytolytic,Tumor cells: Hep-G2 (LC50=35 μM),Human erythrocytes: LC50=200 μM,Linear,Free,Free,,L,Not available,Not available,17561225,Toxicon. 2007 Sep 15;50(4):498-506.,"Conlon JM, Woodhams DC, Raza H, Coquet L, Leprince J, Jouenne T, Vaudry H, Rollins-Smith LA.",Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae),18,15-18
DRAMP31670,FKCRRWQWRMKKLGAPSITCVR,22,Pep1,P24627,,Not found,Bovine lactoferrin (Lf-B),"Antimicrobial, Anticancer",Not found,Not found,Not found,1LFC,Pep1 may kill cancer cells by activating an apoptosis-inducing pathway,Tumor cells: HL-60 (IC50=77 µM),Not available,Linear,Free,Free,,L,Not available,Not available,18425992,J Pept Sci. 2008 Sep;14(9):1032-8.,"Onishi J, Roy MK, Juneja LR, Watanabe Y, Tamai Y.",A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60),22,21-24
DRAMP31671,RKAFRWAWRMLKKAAPSITCVR,22,mPep1,Not available,,Not found,Bovine lactoferrin (Lf-B),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,mPep1 causes necrotic cell death by destroying cellular membrane structure ,Tumor cells: HL-60 (IC50=8 µM),Not available,Linear,Free,Free,,L,Not available,Not available,18425992,J Pept Sci. 2008 Sep;14(9):1032-8.,"Onishi J, Roy MK, Juneja LR, Watanabe Y, Tamai Y.",A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-61),22,21-24
DRAMP31673,KAQIRAMECNILGRKKRRQRRR,22,Tat-a5,Not available,,Not found,HIV-Tat (49-57),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Tat-a5 could arrest cancer cells at G2/M phase and make them apoptotic; Tat-a5 would have the potential to inhibit tumor angiogenesis,Tumor cells: HCT 116 (~80% Cytotoxicity at 100 µM),Not available,Linear,Free,Free,,L,Not available,HIV-Tat,18656352,Bioorg Med Chem Lett. 2008 Aug 15;18(16):4633-7.,"Lou H, Gao Y, Zhai M, Qi Y, Chen L, Lv H, Yu J, Li Y.",A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-59) with cytotoxic and apoptotic effects against human cancer cells,22,21-24
DRAMP31678,FVDLKKIANIINSIF,15,Temporin-CEa,Not available,,Not found,"skin of the Chinese brown frog, Rana chensinensis","Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=12 µM); MCF-7 (IC50=27.84 μM); MCF-7 (IC50=31.78 μM); MCF-7 (IC50=31.91 μM); MCF-7 (IC50=34.5 μM); HeLa (IC50=36.31 μM); BEL-7402 (IC50=36.9 μM); BEL-7402 (IC50=37.1 μM); BCaP-37 (IC50=37.33 μM); BCaP-37 (IC50=38.39 μM); BCaP-37 (IC50=38.5 μM); HeLa (IC50=38.96 μM); BEL-7402 (IC50=38.98 μM); BCaP-37 (IC50=39.42 μM); BEL-7402 (IC50=40.16 μM); HeLa (IC50=40.6 μM); HeLa (IC50=43.87 μM); SMMC-7721 (IC50=44.92 μM); SMMC-7721 (IC50=46.73 μM); SMMC-7721 (IC50=47.73 μM); SMMC-7721 (IC50=50.32 μM); A549 (IC50=52.09 μM); A549 (IC50=52.82 μM); A549 (IC50=53.12 μM); A549 (IC50=53.31 μM); MDA-MB-231 (IC50=54.95 μM); BGC-823 (IC50=55.16 μM); BGC-823 (IC50=56.47 μM); MDA-MB-231 (IC50=57.94 μM); LK-2 (IC50=58.32 μM); NCI-H446 (IC50=59.45 μM); MDA-MB-231 (IC50=60.38 μM); LK-2 (IC50=61.57 μM); BGC-823 (IC50=61.63 μM); LK-2 (IC50=61.73 μM); HO-8910 (IC50=62.84 μM); BGC-823 (IC50=63.2 μM); MDA-MB-231 (IC50=63.26 μM); LK-2 (IC50=63.4 μM); HO-8910 (IC50=64.75 μM); NCI-H446 (IC50=64.81 μM); NCI-H446 (IC50=65.29 μM); HO-8910 (IC50=66.55 μM); HO-8910 (IC50=66.68 μM); NCI-H446 (IC50=67.66 μM); HT-29 (IC50=88.91 μM); HT-29 (IC50>100 μM); HT-29 (IC50>100 μM); HT-29 (IC50>100 μM),Human erythrocytes: LD50=230 μM,Linear,Free,Amidation,,L,Not available,Not available,19341344,Zoolog Sci. 2009 Mar;26(3):220-6. ,"Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.","Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis",15,12-15
DRAMP31681,KAAKKAAKAAKKAAKAAKKAA,21,KW5,Not available,,Not found,Bovine lactoferrin (Lf-B),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Peptides induce lysis of cancer cells through interactions with the plasma membrane,Tumor cells: FEMX-I (IC50=30±3 µM); HT-29 (IC50=55±14 µM),Not available,Linear,Free,Free,,L,Not available,Not available,19527490,BMC Cancer. 2009 Jun 15;9:183.,"Fadnes B, Rekdal O, Uhlin-Hansen L.",The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells,21,18-21
DRAMP31684,GKLIKKFGRKAISYAVKKARGKH,23,Ltc-2a (4-26),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (EC50>36 µM),Human erythrocytes: 50% Hemolysis>36 µM,Linear,Free,Free,,L,Not available,Not available,19563807,FEBS Lett. 2009 Jul 21;583(14):2425-8.,"Polyansky AA, Vassilevski AA, Volynsky PE, Vorontsova OV, Samsonova OV, Egorova NS, Krylov NA, Feofanov AV, Arseniev AS, Grishin EV, Efremov RG.",N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins,23,21-24
DRAMP31685,GKMKEYFKKFGASFKRRFANLKKRL,25,Ltc-5 (4-28),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (EC50>36 µM),Human erythrocytes: 50% Hemolysis>36 µM,Linear,Free,Amidation,,L,Not available,Not available,19563807,FEBS Lett. 2009 Jul 21;583(14):2425-8.,"Polyansky AA, Vassilevski AA, Volynsky PE, Vorontsova OV, Samsonova OV, Egorova NS, Krylov NA, Feofanov AV, Arseniev AS, Grishin EV, Efremov RG.",N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins,25,24-27
DRAMP31690,ACDCRGDCFCGGGGIVRRADRAAVP,25,AP,Not available,,Not found,Endostatin derived Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: B16-F10 (40% inhibition at 5µg/ml); B16-F10 (50% inhibition at 2.5µg/ml); B16-F10 (75% inhibition at 10µg/ml),Not available,Linear,Free,Free,,L,Not available,integrin αvβ3,20515045,Bioconjug Chem. 2010 Jul 21;21(7):1142-7.,"Yin R, Zheng H, Xi T, Xu HM.",Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide,25,24-27
DRAMP31691,ACDCRGDCFCGGGGIVRRADRAAVP,25,AP,Not available,,Not found,Endostatin derived Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: B16-F10 (40% inhibition at 2.5µg/ml); B16-F10 (42% inhibition at 5µg/ml); B16-F10 (52% inhibition at 10µg/ml),Not available,Linear,Free,Free,,L,Not available,integrin αvβ3,20515045,Bioconjug Chem. 2010 Jul 21;21(7):1142-7.,"Yin R, Zheng H, Xi T, Xu HM.",Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide,25,24-27
DRAMP31692,ACDCRGDCFCGGGGIVRRADRAAVP,25,AP(O),Not available,,Not found,Endostatin derived Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: B16-F10 (40% inhibition at 5µg/ml); B16-F10 (50% inhibition at 2.5µg/ml); B16-F10 (75% inhibition at 10µg/ml),Not available,Cyclic,Free,Free,,L,Not available,integrin αvβ3,20515045,Bioconjug Chem. 2010 Jul 21;21(7):1142-7.,"Yin R, Zheng H, Xi T, Xu HM.",Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide,25,24-27
DRAMP31693,ACDCRGDCFCGGGGIVRRADRAAVP,25,AP(O),Not available,,Not found,Endostatin derived Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: B16-F10 (40% inhibition at 2.5µg/ml); B16-F10 (42% inhibition at 5µg/ml); B16-F10 (52% inhibition at 10µg/ml),Not available,Cyclic,Free,Free,,L,Not available,integrin αvβ3,20515045,Bioconjug Chem. 2010 Jul 21;21(7):1142-7.,"Yin R, Zheng H, Xi T, Xu HM.",Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide,25,24-27
DRAMP31694,IVRRADRAAVPGGGGACDCRGDCFC,25,IC,Not available,,Not found,Endostatin derived Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: B16-F10 (60% inhibition at 11µg/ml),Not available,Linear,Free,Free,,L,Not available,integrin αvβ4,20515045,Bioconjug Chem. 2010 Jul 21;21(7):1142-7.,"Yin R, Zheng H, Xi T, Xu HM.",Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide,25,24-27
DRAMP31708,VDKPPYLPRPRPPRXXYNX,19,"Oncocin [R15,19Orn][I16Tle]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml),Human erythrocytes: Not active up to 600 µg/ml,Linear,Free,Amidation,X(15)=Orn; X(16)=L-tert-leucine; X(19)=Orn,L,Not available,Not available,21387510,Chembiochem. 2011 Apr 11;12(6):874-6.,"Knappe D, Zahn M, Sauer U, Schiffer G, Sträter N, Hoffmann R.",Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex,19,18-21
DRAMP31709,VDKPPYLPRPRPXRXIYNX,19,Oncocin [P13Hyp][R15Hyp][R19Orn],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml),Human erythrocytes: Not active up to 600 µg/ml,Linear,Free,Amidation,X(13)= 4-Hydroxyproline; X(15)= 4-Hydroxyproline; X(19)=Orn,L,Not available,Not available,21387510,Chembiochem. 2011 Apr 11;12(6):874-6.,"Knappe D, Zahn M, Sauer U, Schiffer G, Sträter N, Hoffmann R.",Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex,19,18-21
DRAMP31710,VDKPPYLPRPRPXRXXYNX,19,"Oncocin [P13Hyp,R15Hyp,I16Tle,R19Orn]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml),Human erythrocytes: Not active up to 600 µg/ml,Linear,Free,Amidation,X(13)= 4-Hydroxyproline; X(15)= 4-Hydroxyproline; X(16)=L-tert-leucine; X(19)=Orn,L,Not available,Not available,21387510,Chembiochem. 2011 Apr 11;12(6):874-6.,"Knappe D, Zahn M, Sauer U, Schiffer G, Sträter N, Hoffmann R.",Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex,19,18-21
DRAMP31731,GVGSPYVSRLLGICL,15,p776,P04626##O18735##P06494##P70424,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Disrupting tumor-mediated mechanisms suppressing host immunity,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,21928125,Cancer Immunol Immunother. 2012 Mar;61(3):397-407.,"Gritzapis AD, Voutsas IF, Baxevanis CN.",Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice,15,12-15
DRAMP31734,GIIKKIIIKKIIIKKI,16,Cationic Amphiphilic,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=15 µM); HL-60 (IC50=25 µM),"Human red blood cells: over the active concentration ranges against bacteria and cancer cells, there is little activity or toxicity against hRBCs",Linear,Free,Amidation,,L,NIH 3T3: low toxic,Not available,21955251,Biomacromolecules. 2011 Nov 14;12(11):3839-43.,"Hu J, Chen C, Zhang S, Zhao X, Xu H, Zhao X, Lu JR.",Designed antimicrobial and antitumor peptides with high selectivity,16,15-18
DRAMP31735,GIIKKIIIKKIIIKKIIIKKI,21,Cationic Amphiphilic,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HL-60 (IC50=10 µM); HeLa (IC50=4 µM),"Human red blood cells: over the active concentration ranges against bacteria and cancer cells, there is little activity or toxicity against hRBCs",Linear,Free,Amidation,,L,NIH 3T3: low toxic,Not available,21955251,Biomacromolecules. 2011 Nov 14;12(11):3839-43.,"Hu J, Chen C, Zhang S, Zhao X, Xu H, Zhao X, Lu JR.",Designed antimicrobial and antitumor peptides with high selectivity,21,18-21
DRAMP31736,AAKKWAKAKWAKAKKWAKAA,20,Z10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (EC50>211 µM); Meth A (EC50>211 µM); MT-1 (EC50>211 µM),Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,20,18-21
DRAMP31737,AAWKWAWAKKWAKAKKWAKAA,21,Z9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (EC50=13 µM); MT-1 (EC50=16 µM); Meth A (EC50=9 µM),MRC-5: EC58=14 μM,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP31738,AWKKWAKAWKWAKAKWWAKAA,21,Z8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (EC50=14 µM); Meth A (EC50=19 µM); HT-29 (EC50=23 µM),MRC-5: EC57=17 μM,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP31739,KAAKKAWKAAKKAAKWWKKAA,21,Z4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Meth A (EC50=155 µM); HT-29 (EC50=173 µM); MT-1 (EC50=68 µM),MRC-5: EC53=78 μM,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP31740,KAAKKAWKAAKKAWKAAKKAA,21,Z7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Meth A (EC50=15 µM); MT-1 (EC50=15 µM); HT-29 (EC50=21 µM),MRC-5: EC56=20 μM,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP31741,KAAKKAWKAWKKAAKAAWKKAA,22,Z3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (EC50=128 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM),Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,22,21-24
DRAMP31742,KAAKKAWKWAKKAAKWAKKAA,21,Z5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (EC50=28 µM); Meth A (EC50=42 µM); HT-29 (EC50=67 µM),MRC-5: EC54=27 μM,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP31743,KAAKKWAKAAKKAAKAWKKAA,21,Z1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (EC50=186 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM),Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP31744,KAAKKWAKAWKKAAKAWKKAA,21,Z2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (EC50=173 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM),Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP31745,KWWKKAAKAAKKAAKAAKKWA,21,Z6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MT-1 (EC50=16 µM); Meth A (EC50=17 µM); HT-29 (EC50=31 µM),MRC-5: EC55=23 μM,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244.,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP31747,IELLQARGGCXGGRRRRRRRR,21,Peptide-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H358 (IC50=2.19 µM); HL-60 (IC50=2.64 µM),Not available,Linear,Free,Amidation,X(11)=Pemetrexed,L,Not available,Not available,22076954,J Pept Sci. 2011 Dec;17(12):805-11.,"Miklán Z, Orbán E, Bánóczi Z, Hudecz F.","New pemetrexed-peptide conjugates: synthesis, characterization and in vitro cytostatic effect on non-small cell lung carcinoma (NCI-H358) and human leukemia (HL-60) cells",21,18-21
DRAMP31770,GTGLPMSERRKIMLMMR,17,MAC2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CCRF-CEM (IC50=32 µM); HeLa (IC50> 100 µM); SW480 (IC50> 100 µM),Human erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50> 100 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,17,15-18
DRAMP31772,KNWKKXLKKXIKXVK,15,LL-III/22,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=11±7 µM); CCRF-CEM (IC50=25±4 µM); SW480 (IC50> 100 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,X=Aib=1-amino-isobutyric acid,L,HUVEC: IC50> 100 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31773,KNWKKILGKIIKVVK,15,LL-III/10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CCRF-CEM (IC50=9 µM); HeLa (IC50=9±4 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=35±11 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31774,KNWKKILKKIIKVVK,15,LL-III/18,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=3 µM); CCRF-CEM (IC50=7±2 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=22±8 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31776,NKWKKILGKIIKVVK,15,LL-III/34,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=37 µM); HeLa (IC50=5±2 µM); CCRF-CEM (IC50=5±3 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=52±7 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31777,VNFKKLLGKLLKVVK,15,LL-III/15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=42 µM); HeLa (IC50=7±1 µM); CCRF-CEM (IC50=9±3 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=≥70 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31778,VNXKKLLGKLLKVVK,15,LL-III/16,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=6±1 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,X=Nal=3-(1-naphthyl)alanine,L,HUVEC: IC50=15±1 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31779,VNWKKXLGKXIKXVK,15,LL-III/19,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=28 µM); HeLa (IC50=3±1 µM); CCRF-CEM (IC50=8±2 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,X=Aib=1-amino-isobutyric acid,L,HUVEC: IC50=38±6 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31780,VNWKKIILGKIIKVVK,16,LL-III/11,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CCRF-CEM (IC50=4±1 µM); SW480 (IC50=48 µM); HeLa (IC50=8±1 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=50± μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,16,15-18
DRAMP31781,vnwkkilgkiikvvk,15,LL-III/12,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=20 µM); CCRF-CEM (IC50=5±2 µM); HeLa (IC50=6±2 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,D,HUVEC: IC50=17±3 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31782,VNWKKVLAKIIKVVK,15,LL-III/37,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=13 µM); CCRF-CEM (IC50=4±1 µM); SW480 (IC50=5±1 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=18±2 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31783,VNWKKILGKIKKVVK,15,LL-III/4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CCRF-CEM (IC50=18 µM); HeLa (IC50=7±1 µM); SW480 (IC50> 40 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50> 80 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31784,VNWKKLLGKLLKVVK,15,LL-III/23,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=15 µM); HeLa (IC50=4 µM); CCRF-CEM (IC50=6 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=12±3 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31785,vnwkkllgkllkvvk,15,LL-III/25,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=20 µM); CCRF-CEM (IC50=4 µM); HeLa (IC50=4±2 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,D,HUVEC: IC50=12±3 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31786,VNWKKVLGKVVKVVK,15,LL-III/27,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=13±2 µM); CCRF-CEM (IC50=18 µM); SW480 (IC50> 100 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50> 100 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31787,VNWXXILGXIIXVVX,15,LL-III/24,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=20 µM); HeLa (IC50=3±1 µM); CCRF-CEM (IC50=5±2 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,X=Ornithine,L,HUVEC: IC50=20±4 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31788,VNWRRILGRIIRVVR,15,LL-III/17,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=9 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=11±4 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31789,VYWKKILGKIIKVVK,15,LL-III/26,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=30 µM); HeLa (IC50=5±1 µM); CCRF-CEM (IC50=6 µM),Rat erythrocytes: IC50>200 μM,Linear,Free,Amidation,,L,HUVEC: IC50=18±1 μM,Not available,22100226,Peptides. 2012 Jan;33(1):18-26.,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP31790,KVKVKVKVpPTKVKVKVK,18,SVS-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=4.9±0.6µM); MDA-MB-436 (IC50=5.6±0.5µM); KB (IC50=6.3±0.7µM); MCF-7 (IC50=8.1±0.8µM),Human erythrocytes: 50% Hemolysis=80.8±12.8µM,Linear,Free,Free,p=D-Pro,Mix,Not available,Not available,22413859,J Am Chem Soc. 2012 Apr 11;134(14):6210-7.,"Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP.",Anticancer ?-hairpin peptides: membrane-induced folding triggers activity,18,15-18
DRAMP31791,kvkvkvkvPptkvkvkvk,18,SVS-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-436 (IC50=3.2±0.4µM); A549 (IC50=3.2±0.6µM); KB (IC50=4.5±0.5µM); MCF-7 (IC50=4.7±0.4µM),Not available,Linear,Free,Free,k=D-Lys; v=D-Val; p=D-Pro; t=D-Thr,Mix,Not available,Not available,22413859,J Am Chem Soc. 2012 Apr 11;134(14):6210-7.,"Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP.",Anticancer ?-hairpin peptides: membrane-induced folding triggers activity,18,15-18
DRAMP31792,KVKVKVKVPPTKVKVKVK,18,SVS-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50>100µM); KB (IC50>100µM); MCF-7 (IC50>100µM); MDA-MB-436 (IC50>100µM),Not available,Linear,Free,Free,,L,Not available,Not available,22413859,J Am Chem Soc. 2012 Apr 11;134(14):6210-7.,"Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP.",Anticancer ?-hairpin peptides: membrane-induced folding triggers activity,18,15-18
DRAMP31799,RGDLLRHVVKILEKYL,16,RGD-La,Not available,,Not found,Arg-Gly-Asp(RGD) tripeptide ana temporins,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,A membrane-disturbing action seems to be the major mechanism for cell death,Tumor cells: MEC (19.76 Inhibition ratio at 50 µg/ml); HL-7702(L-02) (36.25 Inhibition ratio at 50 µg/ml); A549 (47.26Inhibition ratio at 50 µg/ml); Hep-G2 (60.22 Inhibition ratio at 50 µg/ml); BGC-823 (62.49 Inhibition ratio at 50 µg/ml); SMMC-7721 (70.39 Inhibition ratio at 50 µg/ml); SW1116 (72.69 Inhibition ratio at 50 µg/ml); HeLa (73.09 Inhibition ratio at 50 µg/ml),Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml,Linear,Free,Free,,L,"Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml",Not available,22641352,J Pept Sci. 2012 Jul;18(7):476-86.,"Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X, Gu J, Yao C, Liu S, Sun C, Pan F.",Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain,16,15-18
DRAMP31800,RGDLLRHVVKILSKYL,16,RGD-Las,Not available,,Not found,Arg-Gly-Asp(RGD) tripeptide ana temporins,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,A membrane-disturbing action seems to be the major mechanism for cell death,Tumor cells: MEC (29.33 Inhibition ratio at 50 µg/ml); HL-7702(L-02) (38.13 Inhibition ratio at 50 µg/ml); A549 (52.50 Inhibition ratio at 50 µg/ml); Hep-G2 (73.07 Inhibition ratio at 50 µg/ml); BGC-823 (73.705 Inhibition ratio at 50 µg/ml); HeLa (78.045 Inhibition ratio at 50 µg/ml); SW1116 (81.465 Inhibition ratio at 50 µg/ml); SMMC-7721 (86.175 Inhibition ratio at 50 µg/ml),Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml,Linear,Free,Free,,L,"Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml",Not available,22641352,J Pept Sci. 2012 Jul;18(7):476-86.,"Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X, Gu J, Yao C, Liu S, Sun C, Pan F.",Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain,16,15-18
DRAMP31832,YGRKKRRQRRRREADFFWSLCTA,23,KilerFLIP-E ,Not available,,Not found,The C-terminal domain of c-FLIP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,"Tumor cells: LNCaP (At 20 μM,  about 30% Trypan blue-negative cells); PC-3-TR (At 20 μM,  about 30% Trypan blue-negative cells); RS4;11 (At 20 μM, 10.4% Trypan blue-negative cells); MV4-11 (At 20 μM, 10.8% Trypan blue-negative cells); HCT 115 (At 20 μM, 40% Trypan blue-negative cells); K562 (At 20 μM, 7.7% Trypan blue-negative cells); PC-3 (At 20 μM, about 50% Trypan blue-negative cells); HCT 116 (At 20 μM, about 70% Trypan blue-negative cells)",Not available,Linear,Free,Free,,L,"No toxicity was observed in epithelial and endothelial cells (HPDE and HUVEC, respectively)",Not available,24176852,Cell Death Dis. 2013 Oct 31;4(10):e894.,"Pennarun B, Gaidos G, Bucur O, Tinari A, Rupasinghe C, Jin T, Dewar R, Song K, Santos MT, Malorni W, Mierke D, Khosravi-Far R.",killerFLIP: a novel lytic peptide specifically inducing cancer cell death,23,21-24
DRAMP31835,GIIKKIIKKIIKKIIKKI,18,Short α-helical peptides,Not available,,Not found,Alpha-helical proteins,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"In addition to rapid membrane-permeabilizing capacities, the peptides can also induce the programmed cell death of cancer cells via both mitochondrial pathway and death receptor pathway, without inducing non-specific immunogenic responses.",Tumor cells: HL-60 (70% Cytotoxicity at 5 µM Approx); HeLa (80% Cytotoxicity at 4 µM Approx),Not available,Linear,Free,Amidation,,L,Not available,Not available,24246647,Biomaterials. 2014 Feb;35(5):1552-61.,"Chen C, Hu J, Zeng P, Pan F, Yaseen M, Xu H, Lu JR.",Molecular mechanisms of anticancer action and cell selectivity of short α-helical peptides,18,15-18
DRAMP31836,CREKAKKLFKKILKKL,16,BP327,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=74.7±8.8µM); CAPAN-1 (IC50=76.2±0.8µM),Not available,Linear,Free,Amidation,,L,NIH 3T3: IC50=74.5±4.1µM,Not available,24480922,Org Biomol Chem. 2014 Mar 14;12(10):1652-63.,"Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M.",Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties,16,15-18
DRAMP31839,FFGRLKSVWSAVKHGWKAAKSR,22,Trichoplaxin,Not available,,Not found,Trichoplax adhaerens,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=45-50µM),Rat erythrocytes:20% Hemolysis=800µM,Linear,Free,Free,,L,Not available,Not available,24530880,Biochim Biophys Acta. 2014 May;1838(5):1430-8.,"Simunić J, Petrov D, Bouceba T, Kamech N, Benincasa M, Juretić D.",Trichoplaxin - a new membrane-active antimicrobial peptide from placozoan Cdna,22,21-24
DRAMP31843,TKPRKTKPRKTKPRKTKPR,19,T Peptide,Not available,,Not found,Tuftsin derivative,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: BGC-823 (67.2% maximum inhibitory rate at 8 mg/kg); Hep-G2 (69.6% maximum inhibitory rate at 8 mg/kg); HT-29 (70% maximum inhibitory rate at 8 mg/kg),Not available,Linear,Free,Free,,L,Not available,Not available,24714081,Anticancer Drugs. 2014 Sep;25(8):857-67.,"An Y, Li L, Yang D, Jia N, Xu C, Wang Q, Wang S, Yuan S.",Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors,19,18-21
DRAMP31849,KILRGVAKKIMRTFLRRILTGKK,23,C7A-Δ,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (Cell viability >50% at 12.5μM approx); HCT 116 (Cell viability >50% at 12.5μM approx.); HROC40 (Cell viability >50% at 25μM approx); HROC60 (Cell viability >50% at 25μM approx); HROC24 (Cell viability >60% at 25μM approx); HROC107 (Cell viability >70% at 12.5μM approx); HROC113 (Cell viability >70% at 12.5μM approx); HROC24 (Cell viability >70% at 12.5μM approx); HROC60 (Cell viability >70% at 12.5μM approx); HROC18 (Cell viability >75% at 12.5μM approx); HROC32 (Cell viability >85% at 12.5μM approx); HROC40 (Cell viability >85% at 12.5μM approx); HROC32 (Cell viability=50% at 12.5μM approx.),Whole blood cells: experiments revealed absent or minimal hemolysis,Linear,Free,Amidation,,L,lymphotoxic effects in vitro,Not available,24962950,Oncotarget. 2014 Jun 30;5(12):4467-79.,"Maletzki C, Klier U, Marinkovic S, Klar E, Andrä J, Linnebacher M. ",Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis,23,21-24
DRAMP31858,VKRFKKFFRKLKKAV,15,B1-Ala,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=8.6 µM); MCF-7 (IC50=8.9 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=87.1 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31859,VKRFKKFFRKLKKDV,15,B1-Asp,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B3,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=19.9 µM); K562 (IC50=44.7 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=120.2 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31860,VKRFKKFFRKLKKEV,15,B1-Glu,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B3,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=36.6 µM); MCF-7 (IC50=38.9 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=104.5 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31861,VKRFKKFFRKLKKFV,15,B1-Phe,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=1.3 µM); K562 (IC50=3.7 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=107.2 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31862,VKRFKKFFRKLKKGV,15,B1-Gly,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=14.8 µM); MCF-7 (IC50=15.8 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=107.2 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31863,VKRFKKFFRKLKKHV,15,B1-His,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B3,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=10.5 µM); MCF-7 (IC50=5.0 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=104.7 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31864,VKRFKKFFRKLKKKV,15,B1-Lys,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B3,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=5.5 µM); K562/Adr (IC50=5.5 µM); MCF-7 (IC50=8.3 µM); MCF-7/ADM (IC50=8.6 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=123.0 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31865,VKRFKKFFRKLKKLV,15,B1-Leu,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=1.1 µM); K562/Adr (IC50=3.3. µM); MCF-7 (IC50=3.6 µM); MCF-7/ADM (IC50=4.4 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=77.6 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31866,VKRFKKFFRKLKKQV,15,B1-Gln,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B3,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=14.5 µM); K562 (IC50=16.2 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=102.3 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31867,VKRFKKFFRKLKKRV,15,B1-Arg,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B3,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=5.5 µM); K562 (IC50=8.7 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=93.3 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31868,VKRFKKFFRKLKKSV,15,B1,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=102.3 µM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP31869,VKRFKKFFRKLKKSV,15,B1,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Not available,Linear,Free,Amidation,,L,GES-1: IC50=102.3 µM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP31870,VKRFKKFFRKLKKSV,15,B1,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=102.3 µM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP31871,VKRFKKFFRKLKKSV,15,B1,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=102.3 µM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP31872,VKRFKKFFRKLKKSV,15,B1,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=102.3 µM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP31873,VKRFKKFFRKLKKSV,15,B1,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=102.3 µM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP31874,VKRFKKFFRKLKKTV,15,B1-Thr,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B3,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=17.0 µM); MCF-7 (IC50=19.1 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=109.6 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31875,VKRFKKFFRKLKKVV,15,B1-Val,Not available,,Not found,Cathelicidin-BF15 C-terminal amidated derivative B1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=4.9 µM); K562 (IC50=5.0 µM),Not available,Linear,Free,Amidation,,L,GES-1: IC50=64.6 µM,Not available,25462264,Eur J Med Chem. 2015 Jan 7;89:540-8.,"Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.","Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities",15,12-15
DRAMP31898,KGIRDWLRGFNKLRKWFLRLIKGL,24,m3,Not available,,Not found,membrane disrupting antimicrobial peptide KL15,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=60 mg/ml),Not available,Linear,Free,Free,,L,Not available,Not available,26147829,Cancer Biol Ther. 2015;16(8):1172-83.,"Chen YC, Tsai TL, Ye XH, Lin TH.",Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15,24,21-24
DRAMP31899,KRKLYKWFAHLIKGL,15,KL15,Not available,,Not found,membrane disrupting antimicrobial peptide KL15,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CaCo-2 (IC50=50 mg/ml); SW480 (IC50=50 mg/ml),Not available,Linear,Free,Free,,L,"H184B5F5/M10: IC50=150 μg/ml, testing time is 24h",Not available,26147829,Cancer Biol Ther. 2015;16(8):1172-83.,"Chen YC, Tsai TL, Ye XH, Lin TH.",Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15,15,12-15
DRAMP31900,LRLLDRWLRLFNRLLRWLRLLRGL,24,m5,Not available,,Not found,membrane disrupting antimicrobial peptide KL15,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=100 mg/ml),Not available,Linear,Free,Free,,L,Not available,Not available,26147829,Cancer Biol Ther. 2015;16(8):1172-83.,"Chen YC, Tsai TL, Ye XH, Lin TH.",Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15,24,21-24
DRAMP31901,LRRLDRWLRLFNRLRRWFLRLLRGL,25,m4,Not available,,Not found,membrane disrupting antimicrobial peptide KL15,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=110 mg/ml),Not available,Linear,Free,Free,,L,Not available,Not available,26147829,Cancer Biol Ther. 2015;16(8):1172-83.,"Chen YC, Tsai TL, Ye XH, Lin TH.",Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15,25,24-27
DRAMP31902,RLWRLAWRLYRLWRLTL,17,m2,Not available,,Not found,membrane disrupting antimicrobial peptide KL15,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=70 mg/ml),Not available,Linear,Free,Free,,L,Not available,Not available,26147829,Cancer Biol Ther. 2015;16(8):1172-83.,"Chen YC, Tsai TL, Ye XH, Lin TH.",Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15,17,15-18
DRAMP31903,RLYRLYFRLYRLWRRLTL,18,m1,Not available,,Not found,membrane disrupting antimicrobial peptide KL15,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=60 mg/ml),Not available,Linear,Free,Free,,L,Not available,Not available,26147829,Cancer Biol Ther. 2015;16(8):1172-83.,"Chen YC, Tsai TL, Ye XH, Lin TH.",Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15,18,15-18
DRAMP31907,FWQRRIRRWRRFWQRRIRRWRR,22,DIM-LF11-318,Not available,,Not found,Human lactoferricin derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: A-375 (LC50=9.3±0.8 µM ); SBcl-2 (LC50=9.4±0.5 µM ),Not available,Linear,Free,Amidation,,L,Normal Human Dermal Fibroblasts (NHDF): LC50=13.9±0.4 µM,Not available,26239537,Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.,"Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.",Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine,22,21-24
DRAMP31908,PFWRIRIRRPRRIRIRWFP,19,R-DIM-P-LF11-322,Not available,,Not found,Human lactoferricin derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: SBcl-2 (LC50=10.4±0.7 µM ); A-375 (LC50=23.3±1.7 µM ),Not available,Linear,Free,Amidation,,L,Normal Human Dermal Fibroblasts (NHDF):LC50>101 µM,Not available,26239537,Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.,"Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.",Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine,19,18-21
DRAMP31909,PFWRRRIRIRRRRIRIRRRWFP,22,R-DIM-LF11-337,Not available,,Not found,Human lactoferricin derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: SBcl-2 (LC50=5.0±0.4 µM ); A-375 (LC50=61.8±0.1 µM ),Not available,Linear,Free,Amidation,,L,Normal Human Dermal Fibroblasts (NHDF): LC50=22.8±0.1 µM,Not available,26239537,Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.,"Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.",Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine,22,21-24
DRAMP31910,RWKRINRQWFFWQRNIRKWR,20,R-DIM-LF11-316,Not available,,Not found,Human lactoferricin derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: SBcl-2 (LC50=16.0±0.5 µM ); A-375 (LC50=21.0±1.2 µM ),Not available,Linear,Free,Amidation,,L,Normal Human Dermal Fibroblasts (NHDF): LC50=61.8±0.1 µM ,Not available,26239537,Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.,"Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.",Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine,20,18-21
DRAMP31911,WWRRWWRRWRRWWRRWWR,18,RW-AH,Not available,,Not found,Human lactoferricin derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin,Tumor cells: A-375 (LC50=13.9±0.4 µM ); SBcl-2 (LC50=4.6±0.2 µM ),Not available,Linear,Free,Amidation,,L,Normal Human Dermal Fibroblasts (NHDF): LC50=9.6±0.2 µM ,Not available,26239537,Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.,"Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.",Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine,18,15-18
DRAMP31920,FKKLKKLFSKLWNWK,15,HPRP-A1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=3.5±0.03 μM); SGC-7901 (IC50=5.2±0.14 μM); B16 (IC50=6.1±0.02 μM); Hep-G2 (IC50=7.7±0.23 μM),Human RBC: MHC=64±6.80 μM,Linear,Acetylation,Amidation,,L,Not available,Not available,26405806,PLoS One. 2015 Sep 25;10(9):e0138911.,"Hao X, Yan Q, Zhao J, Wang W, Huang Y, Chen Y.",TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy,15,12-15
DRAMP31921,FKKLKKLFSKLWNWK,15,HPRP-A1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H460 (IC50=13.3 µM); BGC-823 (IC50=14.1 µM); A549 (IC50=14.8 µM); MCF-7 (IC50=15.7 µM); MDA-MB-231 (IC50=22.9 µM),Human RBC: MHC=64±6.80 μM,Linear,Acetylation,Amidation,,L,Not available,Not available,26405806,PLoS One. 2015 Sep 25;10(9):e0138911.,"Hao X, Yan Q, Zhao J, Wang W, Huang Y, Chen Y.",TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy,15,12-15
DRAMP31922,FKKLKKLFSKLWNWKRKKRRQRRR,24,HPRP-A1-TAT,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=1.8±0.02 μM); B16 (IC50=3.5±0.03 μM); SGC-7901 (IC50=4.8±0.08 μM); Hep-G2 (IC50=5.8±0.36 μM),Human RBC: MHC>500 μM,Linear,Acetylation,Amidation,,L,Not available,Not available,26405806,PLoS One. 2015 Sep 25;10(9):e0138911.,"Hao X, Yan Q, Zhao J, Wang W, Huang Y, Chen Y.",TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy,24,21-24
DRAMP31923,fkklkklfsklwnwk,15,HPRP-A2,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SGC-7901 (IC50=10.42±0.30 μM ); B16 (IC50=19.16±0.38 μM ); PC-3 (IC50=21.38±0.56 μM ); BGC-823 (IC50=8.65 ±0.38 μM ),Human red blood cells: low toxicity,Linear,Free,Free,,L,Not available,Not available,26422386,PLoS One. 2015 Sep 30;10(9):e0139578. ,"Zhao J, Hao X, Liu D, Huang Y, Chen Y.",In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines,15,12-15
DRAMP31924,fkklkklfsklwnwk,15,HPRP-A2,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Human red blood cells: low toxicity,Linear,Free,Free,,L,Not available,Not available,26422386,PLoS One. 2015 Sep 30;10(9):e0139578. ,"Zhao J, Hao X, Liu D, Huang Y, Chen Y.",In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines,15,12-15
DRAMP31931,FFSMIPKIAGGIASLVKNL,19,Phylloseptin-Pba,Not available,,Not found,Phyllomedusa baltea,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-251MG (IC50=1.8µM); PC-3 (IC50=2.9µM); NCI-H460 (IC50=4.3µM),Horse erythrocytes: 1.4% Hemolysis=8µg/ml; Human erythrocytes: 80% Hemolysis=128µg/ml,Linear,Free,Amidation,,L,HMEC-1: IC50=36.6µM,Not available,26633506,Toxins (Basel). 2015 Dec 1;7(12):5182-93. ,"Wan Y, Ma C, Zhou M, Xi X, Li L, Wu D, Wang L, Lin C, Lopez JC, Chen T, Shaw C. ",Phylloseptin-PBa--A Novel Broad-Spectrum Antimicrobial Peptide from the Skin Secretion of the Peruvian Purple-Sided Leaf Frog (Phyllomedusa Baltea) Which Exhibits Cancer Cell Cytotoxicity,19,18-21
DRAMP31937,FKIGGFIKKLWRSKLA,16,ZXR-1,N0EAL3,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available," ZXR-1 could internalize into cells by endocytosis, target on mitochondria, and induce cell apoptosis",Tumor cells: Hep-G2 (IC50=141.7±12.2 µM); SACC-83 (IC50=27.9±7.7 µM); HeLa (IC50=62.6±8.4 µM); PC-3 (IC50=69.1±1.6 µM); Huh-7 (IC50=77.9±0.9 µM),Not available,Linear,Free,Free,,L,HEK293T: IC50=186.7±13.1 µM; WPMY-1: IC50=283.3±19.0 µM,Not available,27207743,Biochim Biophys Acta. 2016 Aug;1858(8):1914-25. ,"Zhou XR, Zhang Q, Tian XB, Cao YM, Liu ZQ, Fan R, Ding XF, Zhu Z, Chen L, Luo SZ. ",From a pro-apoptotic peptide to a lytic peptide: One single residue mutation,16,15-18
DRAMP31938,FKIGGFIKKLWRSLLA,16,ZXR-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,ZXR-2 could cause cell membrane lysis,Tumor cells: PC-3 (IC50=14.2±0.5 µM); PC-3 (IC50=14.8±1.6 μM ); Hep-G2 (IC50=7.5±1.2 µM); HeLa (IC50=8.1±1.6 µM); HeLa (IC50=8.1±1.6 μM ); Huh-7 (IC50=8.4±1.1 µm); SACC-83 (IC50=9.9±1.7 µM),Not available,Linear,Free,Free,,L,HEK293T: IC50=6.3±0.7 µM; WPMY-1: IC50=12.4±2.0 µM,Not available,27207743,Biochim Biophys Acta. 2016 Aug;1858(8):1914-25. ,"Zhou XR, Zhang Q, Tian XB, Cao YM, Liu ZQ, Fan R, Ding XF, Zhu Z, Chen L, Luo SZ. ",From a pro-apoptotic peptide to a lytic peptide: One single residue mutation,16,15-18
DRAMP31939,XIXIXIXRPVYXPRPRPPHPRL,22,Api796,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50>600µg/ml),Human erythrocytes:0% Hemolysis=100-600µg/ml,Linear,"gu=N , N , N ', N'-tetramethylguanidino)",Free,X=Orn,L,HEK293: 50% Cell death>600µg/ml,Not available,27243004,Front Cell Dev Biol. 2016 May 10;4:39.,"Bluhm ME, Schneider VA, Schäfer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R. ",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa,22,21-24
DRAMP31940,XIXIXRPVYXPRPRPPHPRL,20,Api795,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50>600µg/ml),Human erythrocytes:0% Hemolysis=100-600µg/ml,Linear,"gu=N , N , N ', N'-tetramethylguanidino)",Free,X=Orn,L,HEK293: 50% Cell death>600µg/ml,Not available,27243004,Front Cell Dev Biol. 2016 May 10;4:39.,"Bluhm ME, Schneider VA, Schäfer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R. ",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa,20,18-21
DRAMP31941,XWXWXRPVYXPRPRPPHPRL,20,Api793,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=640±150µg/ml),Human erythrocytes:1% Hemolysis=100µg/ml; Human erythrocytes:2% Hemolysis=600µg/ml,Linear,"gu=N , N , N ', N'-tetramethylguanidino)",Free,X=Orn,L,HEK293: 50% Cell death=640±50µg/ml,Not available,27243004,Front Cell Dev Biol. 2016 May 10;4:39.,"Bluhm ME, Schneider VA, Schäfer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R. ",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa,20,18-21
DRAMP31942,XWXWXWXRPVYXPRPRPPHPRL,22,Api794,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=230 ± 90µg/ml),Human erythrocytes:2% Hemolysis=100-600µg/ml,Linear,"gu=N , N , N ', N'-tetramethylguanidino)",Free,X=Orn,L,HEK293: 50% Cell death=280±30µg/ml,Not available,27243004,Front Cell Dev Biol. 2016 May 10;4:39.,"Bluhm ME, Schneider VA, Schäfer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R. ",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa,22,21-24
DRAMP31953,MQFITDLIKKAVDFFKGLFDNK,22,Warnericin RK [G20D],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (LD50=5.39µM),Human erythrocytes:10% Hemolysis=12.36µM,Linear,Free,Free,,L,Not available,Not available,27598770,PLoS One. 2016 Sep 6;11(9):e0162007. ,"Loiseau C, Augenstreich J, Marchand A, Harté E, Garcia M, Verdon J, Mesnil M, Lecomte S, Berjeaud JM.",Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging,22,21-24
DRAMP31954,MQFITDLIKKAVDVFKGLFGNK,22,Warnericin RK [F14V],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (LD50=8.79µM),Human erythrocytes:10% Hemolysis=12.5µM,Linear,Free,Free,,L,Not available,Not available,27598770,PLoS One. 2016 Sep 6;11(9):e0162007. ,"Loiseau C, Augenstreich J, Marchand A, Harté E, Garcia M, Verdon J, Mesnil M, Lecomte S, Berjeaud JM.",Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging,22,21-24
DRAMP31957,KRIGLIRLIGKILRGLRRLG,20,Saha-CATH5,Not available,,Not found,Sarcophilus harrisii,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (Not active up to 500 µg/ml),Human erythrocytes:5% Hemolysis=1-31.25µg/ml; 7% Hemolysis=62.5µg/ml; 12% Hemolysis=125µg/ml; 30% Hemolysis=250µg/ml,Linear,Free,Free,,L,Not available,Not available,27725697,Sci Rep. 2016 Oct 11;6:35019. ,"Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. ",Cathelicidins in the Tasmanian devil (Sarcophilus harrisii),20,18-21
DRAMP31969,CTKSIPPICRFwKTW,15,SFTI-SST-02,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (IC50=43.29±0.04 μM); MCF-7 (IC50=55.13±0.07 μM); PC-3 (IC50>100 μM),Human red blood cells:  no hemolytic activity(as show in Fig.4),Cyclic,Free,Free,w=D-Tryptophane,Mix,HUVEC: IC50>100 μM,pigment epithelium-derived factor; somatostatin,27734947,Sci Rep. 2016 Oct 11;6:35019. ,"Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. ",Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy,15,12-15
DRAMP31970,CTKSIPPICRRKRRR,15,SFTI-polyR-L2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=41.84±0.07 μM); HT-29 (IC50>100 μM); PC-3 (IC50>100 μM),Human red blood cells:  no hemolytic activity(as show in Fig.4),Cyclic,Free,Free,,L,HUVEC: IC50>100 μM,pigment epithelium-derived factor; somatostatin,27734947,Sci Rep. 2016 Oct 11;6:35019. ,"Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. ",Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy,15,12-15
DRAMP31971,CTKSIPPICYHLNQPF,16,SFTI-PEDF,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM),Human red blood cells:  no hemolytic activity(as show in Fig.4),Cyclic,Free,Free,,L,HUVEC: IC50=27.89±0.11 μM,pigment epithelium-derived factor; somatostatin,27734947,Sci Rep. 2016 Oct 11;6:35019. ,"Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. ",Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy,16,15-18
DRAMP31977,FKAGGFIKKLWRSLLA,16,IL-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PC-3 (IC50=58.4±13.7 μM); HeLa (IC50=73.9±13.6 μM),Not available,Linear,Free,Free,,L,HEK293T: IC50=24.1±3.2 μM; WPMY-1: IC50=43.2±4.9 μM,Not available,27778166,Amino Acids. 2017 Jan;49(1):193-202.,"Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. ","Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide",16,15-18
DRAMP31978,FKIGGFAKKLWRSLLA,16,IL-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PC-3 (IC50=43.6±7.9 μM); HeLa (IC50=52.0±5.8 μM),Not available,Linear,Free,Free,,L,HEK293T: IC50=40.0±5.5 μM; WPMY-1: IC50=19.4±5.3 μM,Not available,27778166,Amino Acids. 2017 Jan;49(1):193-202.,"Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. ","Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide",16,15-18
DRAMP31979,FKIGGFIKKAWRSLLA,16,IL-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PC-3 (IC50=74.9±13.3 μM); HeLa (IC50=93.5±19.4 μM),Not available,Linear,Free,Free,,L,HEK293T: IC50=48.5±4.9 μM; WPMY-1: IC50=40.1±6.9 μM,Not available,27778166,Amino Acids. 2017 Jan;49(1):193-202.,"Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. ","Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide",16,15-18
DRAMP31980,FKIGGFIKKLWRSALA,16,IL-4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PC-3 (IC50=35.5±3.9 μM); HeLa (IC50=54.4±3.0 μM),Not available,Linear,Free,Free,,L,HEK293T: IC50=36.1±4.7 μM; WPMY-1: IC50=19.9±6.3 μM,Not available,27778166,Amino Acids. 2017 Jan;49(1):193-202.,"Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. ","Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide",16,15-18
DRAMP31981,FKIGGFIKKLWRSLAA,16,IL-5,N0EAL3,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PC-3 (IC50=22.0±2.6 μM); HeLa (IC50=28.0±4.6 μM),Not available,Linear,Free,Free,,L,HEK293T: IC50=27.6±2.7 μM; WPMY-1: IC50=12.7±3.1 μM,Not available,27778166,Amino Acids. 2017 Jan;49(1):193-202.,"Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. ","Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide",16,15-18
DRAMP31983,RYRRKKKMKKALQYIKLLKE,20,Peptide 35409,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (Not active up to 44 µg/ml); HepG2 (Not active up to 44 µg/ml),Human erythrocytes: 14% Hemolysis=350µM,Linear,Free,Free,,L,Not available,Not available,28066341,Front Microbiol. 2016 Dec 20;7:2006. ,"Barreto-Santamaría A, Curtidor H, Arévalo-Pinzón G, Herrera C, Suárez D, Pérez WH, Patarroyo ME.",A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35,20,18-21
DRAMP31985,ASVVNKLTGGVAGLLK,16,Bacteriocin TP,Not available,,Not found,Bacillus subtilis,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NB4 (IC50=11.479µM); MKN 45 (IC50=4.686µM),Mouse erythrocytes: <10% Hemolysis=160µM; 10% Hemolysis=320µM,Linear,Free,Free,,L,Not available,Not available,28254375,Int J Antimicrob Agents. 2017 Apr;49(4):427-436.,"Xin H, Ji S, Peng J, Han P, An X, Wang S, Cao B.",Isolation and characterisation of a novel antibacterial peptide from a native swine intestinal tract-derived bacterium,16,15-18
DRAMP32017,FRRFFKWFRRFFKFF,15,FR-15,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (IC50=2.5 μM); MDA-MB-231 (IC50=3.15 μM); HeLa (IC50=4.9 μM); DLD-1 (IC50=6.7 μM),Not available,Linear,Free,Free,,L,Not available,Not available,28483698,Acta Biomater. 2017 Jul 15;57:170-186.,"Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.",Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat,15,12-15
DRAMP32018,FRRFFKWFRRPFKFF,15,FR11P,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=11 μM); DLD-1 (IC50=12.9 μM); Hep-G2 (IC50=4.8 μM); MDA-MB-231 (IC50=7.0 μM),Not available,Linear,Free,Free,,L,Not available,Not available,28483698,Acta Biomater. 2017 Jul 15;57:170-186.,"Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.",Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat,15,12-15
DRAMP32019,FRRFFKWPRRFFKFF,15,FR8P,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=10.5 μM); DLD-1 (IC50=10.8 μM); Hep-G2 (IC50=4.2 μM); MDA-MB-231 (IC50=6.4 μM),Not available,Linear,Free,Free,,L,Not available,Not available,28483698,Acta Biomater. 2017 Jul 15;57:170-186.,"Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.",Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat,15,12-15
DRAMP32020,FRRFFKWPRRPFKFF,15,"FR8, 11P",Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (IC50=15 μM); HeLa (IC50=18.9 μM); DLD-1 (IC50=22 μM); MDA-MB-231 (IC50=27 μM),Not available,Linear,Free,Free,,L,Not available,Not available,28483698,Acta Biomater. 2017 Jul 15;57:170-186.,"Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.",Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat,15,12-15
DRAMP32021,FRRPFKWFRRFFKFF,15,FR4P,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (IC50=2.5 μM); MDA-MB-231 (IC50=6.3 μM); HeLa (IC50=7.7 μM); DLD-1 (IC50=9.4 μM),Not available,Linear,Free,Free,,L,Not available,Not available,28483698,Acta Biomater. 2017 Jul 15;57:170-186.,"Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.",Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat,15,12-15
DRAMP32022,FRRPFKWPRRFFKFF,15,"FR4, 8P",Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=13.8 μM); DLD-1 (IC50=15.3 μM); MDA-MB-231 (IC50=15.4 μM); Hep-G2 (IC50=5 μM),Not available,Linear,Free,Free,,L,Not available,Not available,28483698,Acta Biomater. 2017 Jul 15;57:170-186.,"Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.",Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat,15,12-15
DRAMP32033,IIGPVLGLIGKALGGLL,17,Bombinin H-BO,Not available,,Not found,"skin secretion of Oriental fire-bellied toad, Bombina orientalis","Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SK-HEP-1 (IC50=0.99 μM); Huh-7 (IC50=1.81 μM); Hep-G2 (IC50=2.88 μM),"Human erythrocytes: Bombinin H-BO was found to lyse 38% of erythrocytes at concentration of 80.0 μm (128 mg/ml), and up to 85% at the concentration of 159.7 μm (256 mg/ml).",Linear,Free,Amidation,,L,Not available,Not available,28636781,Chem Biol Drug Des. 2018 Jan;91(1):50-61. ,"Zhou C, Wang Z, Peng X, Liu Y, Lin Y, Zhang Z, Qiu Y, Jin M, Wang R, Kong D. ","Discovery of two bombinin peptides with antimicrobial and anticancer activities from the skin secretion of Oriental fire-bellied toad, Bombina orientalis",17,15-18
DRAMP32037,LVKRFKKFFRKLKKSVLL,18,I-3,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.3±0.3 μM); K562/ADM (IC50=12.9±0.3 μM); K562 (IC50=15.1±1.1 μM); HeLa (IC50=6.5±0.3 μM); MCF-7 (IC50=7.0±0.2 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=80.84±3.9 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,18,15-18
DRAMP32038,LVRRFRRFFRRLRRSVLL,18,I-7,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=14.3±0.2 μM); HeLa (IC50=4.2±0.8 μM); MCF-7 (IC50=5.9±0.1 μM); K562 (IC50=6.9±0.2 μM); K562/ADM (IC50=7.6±0.3 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=85.24±3.4 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,18,15-18
DRAMP32040,VKRFKKFFRKLKKSVL,16,I-1,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=12.7±2.5 μM); K562/ADM (IC50=19.3±0.8 μM); K562 (IC50=26.5±0.9 μM); MCF-7/Taxol (IC50=31.1±5.1 μM); HeLa (IC50=9.8±1.5 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=50.62±6.1 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,16,15-18
DRAMP32041,VKRFKKFFRKLKKSVLL,17,I-2,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=10.2±0.8 μM); MCF-7 (IC50=10.5±1.2 μM); K562 (IC50=20.4±3.3 μM); K562/ADM (IC50=20.7±1.1 μM); MCF-7/Taxol (IC50=30.2±2.4 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=64.15±3.7 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,17,15-18
DRAMP32043,VRRFRLFFRRLRRSV,15,I-11,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=11.5±0.5 μM); HeLa (IC50=19.0±1.1 μM); K562/ADM (IC50=23.2±1.7 μM); MCF-7/Taxol (IC50=35.7±1.5 μM); K562 (IC50=9.46±0.5 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=70.73±3.5 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP32044,VRRFRRFFLRLRRSV,15,I-10,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=13.5±1.4 μM); MCF-7 (IC50=16.2±3.8 μM); MCF-7/Taxol (IC50=21.5±2.7 μM); K562 (IC50=25.6±3.3 μM); K562/ADM (IC50=43.5±4.2 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=70.07±2.1 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP32045,VRRFRRFFRRLRRSV,15,I-4,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=10.7±0.5 μM); MCF-7 (IC50=16.9±2.1 μM); K562 (IC50=17.9±0.2 μM); K562/ADM (IC50=22.7±0.5 μM); MCF-7/Taxol (IC50=40.6±5.1 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=69.74±2.9 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,15,12-15
DRAMP32046,VRRFRRFFRRLRRSVL,16,I-5,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562/ADM (IC50=10.5±0.7 μM); MCF-7/Taxol (IC50=16.8±0.8 μM); K562 (IC50=20.4±0.7 μM); HeLa (IC50=3.3±1.1 μM); MCF-7 (IC50=7.5±0.9 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=75.84±6.8 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,16,15-18
DRAMP32047,VRRFRRFFRRLRRSVLL,17,I-6,Not available,,Not found,cationic host defense peptides,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562/ADM (IC50=10.3±0.3 μM); MCF-7/Taxol (IC50=15.1±1.0 μM); MCF-7 (IC50=3.8±0.4 μM); HeLa (IC50=7.9±0.9 μM); K562 (IC50=8.5±1.1 μM),Rabbit red blood cells: modest hemolytic activity(as show in Fig.2),Linear,Free,Amidation,,L,HUVEC: IC50=82.37±4.4 μM,Not available,28664269,Amino Acids. 2017 Sep;49(9):1601-1610.,"Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. ",Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane,17,15-18
DRAMP32053,FLGAIAQALTSLLGKL,16,temporin-ITa,C0HL49,,Not found,skin secretions of the Italian stream frog Rana italica (Ranidae),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (LC50=100 μM); MDA-MB-231 (LC50=40 μM); A549 (LC50=45 μM),mouse erythrocytes: LC50=22 μM,Linear,Free,α-amidated residue at the C-terminus,α-amidated residue at the C-terminus,L,Not available,Not available,28699258,J Pept Sci. 2017 Oct;23(10):769-776. ,"Conlon JM, Musale V, Attoub S, Mangoni ML, Leprince J, Coquet L, Jouenne T, Abdel-Wahab YHA, Flatt PR, Rinaldi AC. ",Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae),16,15-18
DRAMP32054,IVPFLLGMVPKLVCLITKKC,20,Brevinin-1ITa,C0HL47,,Not found,skin secretions of the Italian stream frog Rana italica (Ranidae),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=18 μM); HT-29 (LC50=18 μM); MDA-MB-231 (LC50=8 μM),mouse erythrocytes: LC50=7 μM,Linear,Free,Free,,L,Not available,Not available,28699258,J Pept Sci. 2017 Oct;23(10):769-776. ,"Conlon JM, Musale V, Attoub S, Mangoni ML, Leprince J, Coquet L, Jouenne T, Abdel-Wahab YHA, Flatt PR, Rinaldi AC. ",Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae),20,18-21
DRAMP32055,GXRRLXYKQRXVTYXRGR,18,"Cyclic Gomesin [PYA1G, C2,6,11,15SeCys]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (CC50=1.4±0.2µM); MCF-7 (CC50=37.5±3.3µM); HL-60 (CC50=38.5±4.8µM); MM96L (CC50=4.6±0.2µM); CRL-1739 (CC50=51.0±4.6µM); HeLa (CC50>64µM),Human erythrocytes: 32.8±0.5% Hemolysis=64µM,Cyclic,Free,Free,X=Se-Cys,L,HFF-1: CC50=15.6±3.6µM; PBMC: CC50=15.5±0.8µM,Not available,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334.,"Troeira Henriques S, Lawrence N, Chaousis S, Ravipati AS, Cheneval O, Benfield AH, Elliott AG, Kavanagh AM, Cooper MA, Chan LY, Huang YH, Craik DJ. ",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP32056,KXRRYXYRQRXVTYXRGR,18,"Cyclic Gomesin [PYA1K;C2,6,11,15SeCys;L5Y;K8R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MM96L (CC50=2.3±0.2µM); MCF-7 (CC50=29.0±3.7µM); HL-60 (CC50=33.3±7.4µM); HeLa (CC50=36.2±2.8µM); CRL-1739 (CC50=46.2±7.6µM); K562 (CC50=6.4±0.6µM),Human erythrocytes: 20.9±3.1% Hemolysis=64µM,Cyclic,Free,Free,X=Se-Cys,L,HFF-1: CC50=30.8±2.0µM; PBMC: CC50=9.5±0.5µM,Not available,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334.,"Troeira Henriques S, Lawrence N, Chaousis S, Ravipati AS, Cheneval O, Benfield AH, Elliott AG, Kavanagh AM, Cooper MA, Chan LY, Huang YH, Craik DJ. ",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,18,15-18
DRAMP32058,WDPYFAGVKKLTKAILAVRA,20,Lavracin,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-7 (EC50=(50-100)µM); MEC-7 (Not active up to 100 µM),Not available,Linear,Free,Amidation,,L,HDME: Not active up to 100 µM,Not available,28799716,Small. 2017 Oct;13(40).,"Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.",Rational Design of Membrane-Pore-Forming Peptides.,20,18-21
DRAMP32059,WGKFFAGVKKLTKAILAVRA,20,"Lavracin [D2G,P3K,Y4F]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-7 (EC50=25µM),Not available,Linear,Free,Amidation,,L,HDME: Not active up to 100 µM,Not available,28799716,Small. 2017 Oct;13(40).,"Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.",Rational Design of Membrane-Pore-Forming Peptides.,20,18-21
DRAMP32060,WDPYFAGVKKLTKAILGEIA,20,"Lavracin [A17G,V18E,R19I]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-7 (Not active up to 100 µM),Not available,Linear,Free,Amidation,,L,HDME: Not active up to 100 µM,Not available,28799716,Small. 2017 Oct;13(40).,"Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.",Rational Design of Membrane-Pore-Forming Peptides.,20,18-21
DRAMP32061,WGKFFAGVKKLTKAILGEIA,20,"Lavracin [D2G,P3K,Y4F,A17G,V18E,R19I]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-7 (EC50=25µM),Not available,Linear,Free,Amidation,,L,HDME: Not active up to 100 µM,Not available,28799716,Small. 2017 Oct;13(40).,"Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.",Rational Design of Membrane-Pore-Forming Peptides.,20,18-21
DRAMP32063,FLSLIPAAISAVSALANHF,19,Phylloseptin-PHa,Not available,,Not found,Pithecopus hypochondrialis,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (LD50=24.05µM); MDA-MB-435S (LD50=28.48µM); U-251MG (LD50=34.67µM); HCT 116 (LD50=36.64µM); NCI-H157 (LD50=37.61µM); PC-3 (LD50=37.96µM),Horse erythrocytes: 10% Hemolysis=76.5µM; 50% Hemolysis=109.5µM; 50% Hemolysis=52.17µM,Linear,Free,Amidation,,L,Not available,Not available,28850103,Molecules. 2017 Aug 29;22(9):1428. ,"Liu J, Wu Q, Li L, Xi X, Wu D, Zhou M, Chen T, Shaw C, Wang L. ","Discovery of Phylloseptins that Defense against Gram-Positive Bacteria and Inhibit the Proliferation of the Non-Small Cell Lung Cancer Cell Line, from the Skin Secretions of Phyllomedusa Frogs",19,18-21
DRAMP32064,FLSLIPKIAGGIAALAKHL,19,Phylloseptin-PT,Not available,,Not found,Phyllomedusa baltea,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H157 (IC50=6.73µM),Horse erythrocytes: 10% Hemolysis=7.79µM; 50% Hemolysis=22.8µM,Linear,Free,Amidation,,L,Not available,Not available,28850103,Molecules. 2017 Aug 29;22(9):1428. ,"Liu J, Wu Q, Li L, Xi X, Wu D, Zhou M, Chen T, Shaw C, Wang L. ","Discovery of Phylloseptins that Defense against Gram-Positive Bacteria and Inhibit the Proliferation of the Non-Small Cell Lung Cancer Cell Line, from the Skin Secretions of Phyllomedusa Frogs",19,18-21
DRAMP32106,RRWQWRRRWQWRKXC,15,LfcinB (20–25)4,Not available,,Not found,Bovine Lactoferricin,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=15 μM); MDA-MB-468 (IC50=6 μM),Not available,Tetrameric,Free,Free,X=Ahx,L,Not available,Not available,28961215,Molecules. 2017 Sep 29;22(10):1641. ,"Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. ",Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines,15,12-15
DRAMP32107,RWQWRMKKLGRWQWRMKKLGKX,22,LfcinB (20–30)2,Not available,,Not found,Bovine Lactoferricin,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=14 μM); MDA-MB-468 (IC50=5 μM),Not available,Linear,Free,Free,X=Ahx,L,Not available,Not available,28961215,Molecules. 2017 Sep 29;22(10):1641. ,"Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. ",Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines,22,21-24
DRAMP32108,RWQWRMKKLGRWQWRMKKLGKXC,23,LfcinB (20–30)4,Not available,,Not found,Bovine Lactoferricin,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-468 (IC50=2 μM); MDA-MB-231 (IC50=6 μM),Not available,Tetrameric,Free,Free,X=Ahx,L,Not available,Not available,28961215,Molecules. 2017 Sep 29;22(10):1641. ,"Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. ",Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines,23,21-24
DRAMP32109,CFKARRWQWRMKKLGAXC,18,LfcinB (17-31)cyc,Not available,,Not found,Bovine Lactoferricin,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (IC50>88 μM); MDA-MB-468 (IC50>88 μM),Not available,Linear,Free,Free,X=Ahx,L,Not available,Not available,28961215,Molecules. 2017 Sep 29;22(10):1641. ,"Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. ",Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines,18,15-18
DRAMP32115,ALWKEVLKNAGKAALNEINNLVQ,23,Dermaseptin-PH,Not available,,Not found,Phyllomedusa hypochondrialis,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=0.69µM); PC-3 (IC50=11.8µM); NCI-H157 (IC50=2.01µM); U-251MG (IC50=2.36µM); MDA-MB-435S (IC50=9.94µM),Horse erythrocytes: 1% Hemolysis=16µM; 3% Hemolysis=64µM; 10% Hemolysis=128µM; 45% Hemolysis=256µM; 100% Hemolysis=512µM,Linear,Free,Amidation,,L,HMEC-1: IC50=4.85µM,Not available,29064402,Molecules. 2017 Oct 24;22(10):1805.,"Huang L, Chen D, Wang L, Lin C, Ma C, Xi X, Chen T, Shaw C, Zhou M. ","Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis",23,21-24
DRAMP32116,GIGSAILSAGKSIIKGLAKGLAEHF,25,Bombinin-BO1,Not available,,Not found,Bombina orientalis,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SK-HEP-1 (IC50=0.76µM); HepG2 (IC50=3.75µM); Huh-7 (IC50=3.91µM),Human erythrocytes: 2.89% Hemolysis=26.3µM; Human erythrocytes=38.05% Hemolysis=52.5µM,Linear,Free,Amidation,,L,Not available,Not available,29098406,Amino Acids. 2018 Feb;50(2):241-253,"Peng X, Zhou C, Hou X, Liu Y, Wang Z, Peng X, Zhang Z, Wang R, Kong D. ","Molecular characterization and bioactivity evaluation of two novel bombinin peptides from the skin secretion of Oriental fire-bellied toad, Bombina orientalis",25,24-27
DRAMP32117,GIGSAILSAGKSIIKGLAKGLA,22,Bombinin-BO1,A0A219CMY0,,Not found,"skin secretion of Oriental fire-bellied toad, Bombina orientalis","Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (IC50=0.76 μM); SK-HEP-1 (IC50=3.75 μM); Huh-7 (IC50=3.91 μM),Human Red cells: only 2.89% hemolysis of the red cells at a concentration of 26.3 μM and 38.05% hemolysis at 52.5 μM,Linear,Free,Amidation,,L,Not available,Not available,29098406,Amino Acids. 2018 Feb;50(2):241-253,"Peng X, Zhou C, Hou X, Liu Y, Wang Z, Peng X, Zhang Z, Wang R, Kong D. ","Molecular characterization and bioactivity evaluation of two novel bombinin peptides from the skin secretion of Oriental fire-bellied toad, Bombina orientalis",22,21-24
DRAMP32118,IIGPVLGLVGKALGGLL,17,Bombinin H-BO1 ,Not available,,Not found,"skin secretion of Oriental fire-bellied toad, Bombina orientalis","Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (IC50=3.61 μM); SK-HEP-1 (IC50=8.08 μM); Huh-7 (IC50=8.42 μM),Human Red cells: caused 42.03% hemolysis of the red cells at a concentration of 40.3 μM while reaching 100% hemolysis at 161.1 μM,Linear,Free,Amidation,,L,Not available,Not available,29098406,Amino Acids. 2018 Feb;50(2):241-253,"Peng X, Zhou C, Hou X, Liu Y, Wang Z, Peng X, Zhang Z, Wang R, Kong D. ","Molecular characterization and bioactivity evaluation of two novel bombinin peptides from the skin secretion of Oriental fire-bellied toad, Bombina orientalis",17,15-18
DRAMP32119,FLSLIPKIATGIAALAKHL,19,PSN-PC,Not available,,Not found,Phyllomedusa camba,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H157 (IC50=2.85µM),Horse erythrocytes: 100% Hemolysis=64µM; Horse erythrocytes=50% Hemolysis=23µM,Linear,Free,Amidation,,L,HMEC-1: IC50=51.83µM,Not available,29112170,Molecules. 2017 Nov 7;22(11):1896.,"Wu X, Pan J, Wu Y, Xi X, Ma C, Wang L, Zhou M, Chen T.",PSN-PC: A Novel Antimicrobial and Anti-Biofilm Peptide from the Skin Secretion of Phyllomedusa-camba with Cytotoxicity on Human Lung Cancer Cell,19,18-21
DRAMP32120,HLRRINKLLTRIGLYRHAFG,20,Lynronne-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (Not active up to 128 µg/ml),Human erythrocytes: 20% Hemolysis=500µg/ml; Sheep erythrocytes: 25% Hemolysis=500µg/ml,Linear,Free,Free,,L,HUVEC: Not active up to 128 µg/ml,Not available,29214045,NPJ Biofilms Microbiomes. 2017 Dec 1;3:33.,"Oyama LB, Girdwood SE, Cookson AR, Fernandez-Fuentes N, Privé F, Vallin HE, Wilkinson TJ, Golyshin PN, Golyshina OV, Mikut R, Hilpert K, Richards J, Wootton M, Edwards JE, Maresca M, Perrier J, Lundy FT, Luo Y, Zhou M, Hess M, Mantovani HC, Creevey CJ, Huws SA. ",The rumen microbiome: an underexplored resource for novel antimicrobial discovery,20,18-21
DRAMP32121,LPRRNRWSKIWKKVVTVFS,19,Lynronne-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (IC50=45.9µg/ml),Human erythrocytes: 20% Hemolysis=500µg/ml; Sheep erythrocytes: 10% Hemolysis=500µg/ml; Horse erythrocytes:0% Hemolysis=536µg/ml,Linear,Free,Free,,L,HUVEC: LC50=98.1µg/ml,Not available,29214045,NPJ Biofilms Microbiomes. 2017 Dec 1;3:33.,"Oyama LB, Girdwood SE, Cookson AR, Fernandez-Fuentes N, Privé F, Vallin HE, Wilkinson TJ, Golyshin PN, Golyshina OV, Mikut R, Hilpert K, Richards J, Wootton M, Edwards JE, Maresca M, Perrier J, Lundy FT, Luo Y, Zhou M, Hess M, Mantovani HC, Creevey CJ, Huws SA. ",The rumen microbiome: an underexplored resource for novel antimicrobial discovery,19,18-21
DRAMP32122,NRFTARFRRTPWRLCLQFRQ,20,Lynronne-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (IC50=24.4µg/ml),Human erythrocytes: 45% Hemolysis=500µg/ml; Sheep erythrocytes: 0% Hemolysis=500µg/ml,Linear,Free,Free,,L,HUVEC: LC50>128µg/ml,Not available,29214045,NPJ Biofilms Microbiomes. 2017 Dec 1;3:33.,"Oyama LB, Girdwood SE, Cookson AR, Fernandez-Fuentes N, Privé F, Vallin HE, Wilkinson TJ, Golyshin PN, Golyshina OV, Mikut R, Hilpert K, Richards J, Wootton M, Edwards JE, Maresca M, Perrier J, Lundy FT, Luo Y, Zhou M, Hess M, Mantovani HC, Creevey CJ, Huws SA. ",The rumen microbiome: an underexplored resource for novel antimicrobial discovery,20,18-21
DRAMP32132,GALKGCWTKSIPPKPCK,17,PE-BBI,Not available,,Not found,skin secretion of Pelophylax esculentus (PE) named PE-BBI,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (IC50=35.4 μM); DLD-1 (IC50=50.1 μM ); DKs-8 (IC50=9.8 μM ),Not available,Linear,Free,Amidation,,L,HKE3: IC50=50.2 μM,Not available,30267012,Sci Rep. 2018 Sep 28;8(1):14502. ,"Lyu P, Ge L, Ma R, Wei R, McCrudden CM, Chen T, Shaw C, Kwok HF.",Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide-PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer,17,15-18
DRAMP32133,GIMDTVKNAAKNLAGQLLDKLK ,23,R2PLx-22,Not available,,Not found,skin secretions of the pickerel frog (Rana palustris),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-251MG (IC50=104.10 μM); MCF-7 (IC50=109.30 μM); PC-3 (IC50=283.90 μM); NCI-H157 (IC50=843.40 μM); MDA-MB-435S (IC50=872.70 μM),Horse erythrocytes: Low haemolytic activity,Linear,Free,Free,,Mix,HMEC-1: IC50=588.20 μM,Not available,30279210, Biosci Rep. 2018 Nov 9;38(6):BSR20180710. ,"Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T. ","A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells",23,21-24
DRAMP32142,PMKKLKLALRLAAKIAPVW,19,"P-MerP fragment [F5K,A6L,A9R,V13K,V14I]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (Not active up to 100 µM); MCF-7 (Not active up to 100 µM); PC-3 (Not active up to 100 µM),Human erythrocytes: Not active up to 100 µM,Linear,Free,Free,,L,3T3-L1: Not active up to 100 µM; HUVEC: Not active up to 100 µM,Not available,30346140,ACS Infect Dis. 2018 Dec 14;4(12):1727-1736. ,"Cardoso MH, Cândido ES, Chan LY, Der Torossian Torres M, Oshiro KGN, Rezende SB, Porto WF, Lu TK, de la Fuente-Nunez C, Craik DJ, Franco OL.",A Computationally Designed Peptide Derived from Escherichia coli as a Potential Drug Template for Antibacterial and Antibiofilm Therapies,19,18-21
DRAMP32143,IWLTALKFLGKNLGKLAKQQLAKL,24,LyeTxI-b,Not available,,Not found,Lycosa erythrognatha spider venom,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-373MG ATCC (IC50=20.94±5.18 μM ); U-87MG ATCC (IC50=29.20±7.96 μM); SH-SY5Y (IC50=93.80±2.17 μM ),hRBC(human blood red cells): IC50=155±13.04 μM (testing time is 48 h),Linear,Free,Free,,L,Vero(African green monkey kidney): IC50≥100 μM (testing time is 48 h); PBMC(Peripheral Blood Mononuclear Cells): IC50=4.16±1.94 μM (testing time is 48 h); GM00637: IC50 ≥ 100 μM ,Not available,30449002,Amino Acids. 2019 Mar;51(3):433-449. ,"Abdel-Salam MAL, Carvalho-Tavares J, Gomes KS, Teixeira-Carvalho A, Kitten GT, Nyffeler J, Dias FF, Dos Reis PVM, Pimenta AMC, Leist M, de Lima ME, de Souza-Fagundes EM. ",The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells,24,21-24
DRAMP32145,RRGCFRVCYRGFCFQRCR,18,PM III,Not available,,Not found,horseshoe crab Limulus polyphemus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HL-60 (IC50=2.5±0.1 μM); HeLa (IC50=6.0±0.2 μM); A549 (IC50=7.3±0.5 μM); SK-BR-3 (IC50=9.9±0.1 μM),Human red blood cells (hBRC): HC50=46 µM,Linear,Free,Free,,L,HEK 293T: IC50=7.3±0.4 μM; HEF: IC50=7.0±0.4 μM; NHA: IC50=7.5±0.5 μM,Not available,30486233,Mar Drugs. 2018 Nov 26;16(12):466.,"Marggraf MB, Panteleev PV, Emelianova AA, Sorokin MI, Bolosov IA, Buzdin AA, Kuzmin DV, Ovchinnikova TV.",Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III,18,15-18
DRAMP32146,FKKLKKLFSKLWNWK,15,HPRP-A1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=3.5±0.03 μM); SGC-7901 (IC50=5.2±0.14 μM); B16 (IC50=6.1±0.02 μM); Hep-G2 (IC50=7.7±0.23 μM),"Human red blood cells: MHC=32 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).",Linear,Free,Free,,L,HUVEC: IC50=24.2 μM,Not available,30592418, Mol Pharm. 2019 Feb 4;16(2):561-572.,"Hu C, Huang Y, Chen Y. ","Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation",15,12-15
DRAMP32147,FKKLKKLFSKLWNWK,15,HPRP-A1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H460 (IC50=13.3 µM); BGC-823 (IC50=14.1 µM); A549 (IC50=14.8 µM); MCF-7 (IC50=15.7 µM); MDA-MB-231 (IC50=22.9 µM),"Human red blood cells: MHC=32 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).",Linear,Free,Free,,L,HUVEC: IC50=24.2 μM,Not available,30592418, Mol Pharm. 2019 Feb 4;16(2):561-572.,"Hu C, Huang Y, Chen Y. ","Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation",15,12-15
DRAMP32148,FKKLKKLFSKLWNWKCRGDKGPDC,24,HPRP-A1-iRGD,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=14.3 µM); MCF-7 (IC50=14.8 µM); NCI-H460 (IC50=15.2 µM); BGC-823 (IC50=18.5 µM); MDA-MB-231 (IC50=22.5 µM),"Human red blood cells: MHC=125 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).",Linear,Free,Free,,L,HUVEC: IC50=26.5 μM,Not available,30592418, Mol Pharm. 2019 Feb 4;16(2):561-572.,"Hu C, Huang Y, Chen Y. ","Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation",24,21-24
DRAMP32150,FKKLKKLFSKLWNWKGGRGD,20,HPRP-A1-GG-RGD,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=11.1 µM); MCF-7 (IC50=11.8 µM); BGC-823 (IC50=15.7 µM); NCI-H460 (IC50=19.5 µM); MDA-MB-231 (IC50=27 µM),"Human red blood cells: MHC=125 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).",Linear,Free,Free,,L,HUVEC: IC50=29.1 μM,Not available,30592418, Mol Pharm. 2019 Feb 4;16(2):561-572.,"Hu C, Huang Y, Chen Y. ","Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation",20,18-21
DRAMP32151,FKKLKKLFSKLWNWKRGD,18,HPRP-A1-RGD,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: BGC-823 (IC50=10.8 µM); MCF-7 (IC50=11.8 µM); NCI-H460 (IC50=14.6 µM); MDA-MB-231 (IC50=15.6 µM); A549 (IC50=8.4 µM),"Human red blood cells: MHC=125 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).",Linear,Free,Free,,L,HUVEC: IC50=31.6 μM,Not available,30592418, Mol Pharm. 2019 Feb 4;16(2):561-572.,"Hu C, Huang Y, Chen Y. ","Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation",18,15-18
DRAMP32157,NGVQPKYKWWKWWKKWW,17,KT2,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"KT2 interacts with the plasma membrane and is then internalized into cells. Moreover, the KT2 peptide increases membrane permeability and induces cytotoxicity against cancer cells through DNA condensation, the increase of apoptotic factor protein levels, and autophagy suppression.",Tumor cells: A431 (34% Cytotoxicity=10 µM); HCT 116 (IC50=50 µM); MDA-MB-231 (Not active up to 10 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,31073999, J Cell Physiol. 2019 Dec;234(12):22116-22129.,"Maraming P, Klaynongsruang S, Boonsiri P, Peng SF, Daduang S, Leelayuwat C, Pientong C, Chung JG, Daduang J. ",The cationic cell-penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells,17,15-18
DRAMP32158,KWCVYAYVKVKGVLVKYKKCW,21,"Arenicin-1 [R1,9,11,16,18,19K]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=7.7 µM),Human erythrocytes: 15% Hemolysis=10.1 µM; 50% Hemolysis=63 µM,Cyclic,Free,Free,,L,Not available,Not available,31234579,Mar Drugs. 2019 Jun 23;17(6):376.,"Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.","Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization",21,18-21
DRAMP32162,RFRPPIRRPPIRPPFWP,17,Bac5 (1-17)[Y16W],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (19% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32163,RFRPPIRRPPIRPPFYR,17,Bac5 (1-17)[P17R],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32164,RFRPPIRRPPIRPPFYW,17,Bac5 (1-17)[P17W],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32165,RFRRPIRRPPIRPPFYR,17,"Bac5 (1-17)[P4,17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (9% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32166,RFRRPIRRPPIRPPWYP,17,"Bac5 (1-17)[P4R,F15W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (32% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32167,RFRRPIRRRPIRPPFWR,17,"Bac5 (1-17)[P4,9,17R; Y16W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (10% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32168,RFRRPIRRRPIRPPFYP,17,"Bac5 (1-17)[P4,9R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (Not active up to 32 µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32169,RFRRPIRRRPIRPPFYR,17,"Bac5 (1-17)[P4,9,17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (13% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32170,RFRRPIRRRPIRPPWYR,17,"Bac5 (1-17)[P4,9,17R; F15W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32171,RFRWPIRRPPIRPPFYR,17,"Bac5 (1-17)[P4W, P4R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (Not active up to 32 µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32172,RFRWPIRRPPIRPPWYP,17,"Bac5 (1-17)[P4W, F15W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (7% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32173,RFRWPIRRRPIRPPFWR,17,"Bac5 (1-17)[P4W; P9,17R; Y16W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (20% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32174,RFRWPIRRRPIRPPFYP,17,"Bac5 (1-17)[P4W, P9R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (2% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32175,RFRWPIRRRPIRPPFYR,17,"Bac5 (1-17)[P4W; P9,17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (16% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32176,RFRWPIRRRPIRPPFYW,17,"Bac5 (1-17)[P4,17W; P9R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (22% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32177,RFRWPIRRRPIRPPWYR,17,"Bac5 (1-17)[P4W, P9R, F15W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (28% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32178,RRRRPIRRRPIRPPFYR,17,"Bac5 (1-17)[F2R;P4,9,17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (Not active up to 32 µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32179,RRRRPIRRRPIRPPWYP,17,"Bac5 (1-17)[F2R; P4,9R; F15W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32180,RRRRPIRRRPIRPPWYR,17,"Bac5 (1-17)[F2R;P4,9,17R;F15W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (5% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32181,RRRRPWRRRPIRPPFYW,17,"Bac5 (1-17)[F2R; P4,9R; I6W; P17W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (23% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32182,RWRPPIRRPPIRPPWYP,17,"Bac5 (1-17)[F2,15W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (25% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32183,RWRRPIRRPPIRPPFYP,17,"Bac5 (1-17)[F2W, P4R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (16% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32184,RWRRPIRRPPIRPPFYR,17,"Bac5 (1-17)[F2W; P4,17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (11% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32185,RWRRPIRRPPIRPPWYP,17,"Bac5 (1-17)[F2,15W; P4R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (17% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32186,RWRRPIRRRPIRPPFWR,17,"Bac5 (1-17)[F2W; P4,9,17R; Y16W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (4% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32187,RWRRPIRRRPIRPPFYP,17,"Bac5 (1-17)[F2W; P4,9R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (1% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32188,RWRRPIRRRPIRPPFYR,17,"Bac5 (1-17)[F2W; P4,9,17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (1% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32189,RWRRPIRRRPIRPPFYW,17,"Bac5 (1-17)[F2W; P4,9R; P17W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (19% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32190,RWRRPIRRRPIRPPWYP,17,"Bac5 (1-17)[F2,15W; P4,9R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (9% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32191,RWRRPIRRRPIRPPWYR,17,"Bac5 (1-17)[F2,15W; P4,9,17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (9% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32192,RWRRPWRRRPIRPPFYR,17,"Bac5 (1-17)[F2W; P4,9,17R; I6W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (22% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32193,RWRWPIRRPPIRPPFYP,17,"Bac5 (1-17)[F2W, P4W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (8% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32194,RWRWPIRRPPIRPPFYR,17,"Bac5 (1-17)[F2W, P4W, P17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (14% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32195,RWRWPIRRPPIRPPWYP,17,"Bac5 (1-17)[F2,15W; P4W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (10% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32196,RWRWPIRRRPIRPPFWR,17,"Bac5 (1-17)[F2W; P4W; P9,17R; Y16W]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (27% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32197,RWRWPIRRRPIRPPWYR,17,"Bac5 (1-17)[F2,15W; P4W; P9,17R]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MEC-1 (41% Killing=32µM),Not available,Linear,Free,Free,,L,Not available,Not available,31692278, ChemMedChem. 2019 Dec 17;14(24):2025-2033.,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",17,15-18
DRAMP32198,KSCFRVCYRGICYRRCRG,18,[W2S]cTI,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-435S (CC50=18.9±0.9 µM ); MM96L (CC50=2.0±0.1 µM ); K562 (CC50=2.7±0.2 µM ); HeLa (CC50=22.5±2.1 µM ); HT-144 (CC50=3.0±0.2 µM ); WM164 (CC50=3.9±0.2 µM ),Human RBCs: CC50>32 µM ,Cyclic,Free,Free,,L,HaCaT: CC50=41.4±2.6 µM ,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32199,KWCFKVCYKGICYKKCKG,18,[R/K]cTI ,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (CC50=13.4±1.9 µM ); K562 (CC50=2.5±0.1 µM ); MDA-MB-435S (CC50=3.5±0.4 µM ); WM164 (CC50=4.3±0.3 µM ),Human RBCs: CC50>32 µM ,Cyclic,Free,Free,,L,HaCaT: CC50=31.1±2.1 µM ,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32200,KWCFRVCSRGSCYRRCRG,18,[Y8S-I11S]cTI,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (CC50>32 µM ); K562 (CC50>32 µM ); MDA-MB-435S (CC50>32 µM ); MM96L (CC50>32 µM ); WM164 (CC50>32 µM ); HT-144 (CC50>64 µM ),Human RBCs: CC50>32 µM ,Cyclic,Free,Free,,L,HaCaT: CC50>64 µM ,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32201,KWCFRVCYRGFCYRRCRK,18,[I11F-G18K]cTI,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MM96L (CC50=1.3±0.1 µM ); K562 (CC50=1.9±0.1 µM ); WM164 (CC50=2.9±0.2 µM ); HT-144 (CC50=3.2±0.1 µM ); HeLa (CC50=5.1±0.3 µM ),Human RBCs: CC50=8.4±1.2 µM,Cyclic,Free,Free,,L,HaCaT: CC50=4.1±0.1 µM,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32202,KWCFRVCYRGICYRRCRG,18,cTI ,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MM96L (CC50=1.3±0.1 µM ); HT-144 (CC50=1.4±0.1µM ); K562 (CC50=2.0±0.1 µM ); WM164 (CC50=2.7±0.1 µM ); MDA-MB-435S (CC50=2.7±0.3 µM ); MCF-7 (CC50=6.4±0.6 µM ); HeLa (CC50=6.7±0.6 µM ),Human RBCs: CC50=107±21 µM ,Cyclic,Free,Free,,L,HaCaT: CC50=7.9±0.5 µM ,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32203,KWCFRVCYRGICYRRCRK,18,[G18K]cTI,P14213##P69135,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,6PIN##1WO0##1MA2,Not available,Tumor cells: MM96L (CC50=1.0±0.1 µM ); K562 (CC50=1.7±0.1 µM ); WM164 (CC50=2.7±0.2 µM ); HT-144 (CC50=3.2±0.1 µM ); HeLa (CC50=6.7±1.1 µM ),Human RBCs: CC50=6.9±0.3 µM ,Cyclic,Free,Free,,L,HaCaT: CC50>64 µM ,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32204,KWCFRVCYRGICYRRCSG,18,[R17S]cTI,P69135,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,1WO0##1MA2,Not available,Tumor cells: HT-144 (CC50=1.2±0.1 µM ); MM96L (CC50=1.8±0.1 µM ); WM164 (CC50=1.8±0.1 µM ); HeLa (CC50=12.2±0.4 µM ); MDA-MB-435S (CC50=4.5±0.3 µM ),Human RBCs: CC50=10.3±0.4 µM ,Cyclic,Free,Free,,L,HaCaT: CC50>64 µM ,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32205,KWCFRVCYRGICYSRCRG,18,[R14S]cTI,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MM96L (CC50=1.7±0.1 µM ); HT-144 (CC50=2.3±0.2 µM ); WM164 (CC50=2.7±0.1 µM ); MDA-MB-435S (CC50=3.5±0.3 µM ); HeLa (CC50=7.5±0.3 µM ),Human RBCs: CC50=5.3±0.3 µM ,Cyclic,Free,Free,,L,HaCaT: CC50>64 µM ,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32206,KWCFRVCYSGICYRRCRG,18,[R9S]cTI ,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-435S (CC50=5.3±0.6 µM ),Human RBCs: CC50>64 µM ,Cyclic,Free,Free,,L,Not available,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32207,KWCFRVCYSGICYSRCSG,18,[R9S-R14S-R17S]cTI,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: WM164 (CC50=11.1±0.9 µM ); HT-144 (CC50=11.8±0.9 µM ); K562 (CC50=4.8±0.3 µM ),Human RBCs: CC50=15.3±1.4 µM,Cyclic,Free,Free,,L,Not available,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32208,KWCSRVCYRGICSRRCRG,18,[F4S-Y13S]cTI,Not available,,Not found,host defense peptide from the horseshoe crab Tachypleus tridentatus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (CC50=13.2±0.9 µM ); MM96L (CC50=17.3±1.0 µM ); HT-144 (CC50=27.8±2.2 µM ); WM164 (CC50=28.2±2.0 µM ); HeLa (CC50>32 µM ); MCF-7 (CC50>32 µM ); MDA-MB-435S (CC50>64 µM ),Human RBCs: CC50>64 µM ,Cyclic,Free,Free,,L,HaCaT: CC50>64 µM ,Not available,31714739,ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. ,"Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.",Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties,18,15-18
DRAMP32219,GWWRRTVAKVRNAGRK,16,EeCentrocin 1 Chain A (1-16)[D8A],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Human erythrocytes: 0% Hemolysis=25 µM; 5% Hemolysis=200 µM,Linear,Free,Amidation,,L,MRC-5: IC50>200 µM,Not available,31802582, J Pept Sci. 2020 Feb;26(2):e3233,"Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. ",Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus,16,15-18
DRAMP32220,GWWRRTVDKVRNAGRK,16,EeCentrocin 1 Chain A (1-16),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A2058 (IC50>200µM),Human erythrocytes: 0% Hemolysis=25-200 µM,Linear,Free,Free,,L,MRC-5: IC50>200 µM,Not available,31802582, J Pept Sci. 2020 Feb;26(2):e3233,"Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. ",Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus,16,15-18
DRAMP32221,SNGYRPAYRPAYRPSYRP,18,Astacidin PcAst-1a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: T24 (IC50>100 µM); MEC-1 (Not active up to 100 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,31884202,Dev Comp Immunol. 2020 Apr;105:103574.,"Rončević T, Čikeš-Čulić V, Maravić A, Capanni F, Gerdol M, Pacor S, Tossi A, Giulianini PG, Pallavicini A, Manfrin C.","Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852)",18,15-18
DRAMP32222,SNVYRPPPYRPVYRPLRRPGYRP,23,Astacidin PcAst-1b/c,Not available,,Not found,Procambarus clarkii; Procambarus clarkii,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: T24 (IC50>100 µM); MEC-1 (Not active up to 100 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,31884202,Dev Comp Immunol. 2020 Apr;105:103574.,"Rončević T, Čikeš-Čulić V, Maravić A, Capanni F, Gerdol M, Pacor S, Tossi A, Giulianini PG, Pallavicini A, Manfrin C.","Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852)",23,21-24
DRAMP32229,CLBCREKAKKLFKKILKKL,19,BP329,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CAPAN-1 (IC50=33.0 ± 1.0 µM); MCF-7 (IC50=35.2 ± 1.8 µM); 22Rv1 (LC50=50 µM); CL1 (LC50>100 µM),Not available,Linear,Free,Amidation,,L,NIH 3T3: IC50=33.7 ± 1.9 µM,Not available,24480922,Org Biomol Chem. 2014 Mar 14;12(10):1652-63. ,"Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M.",Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties,19,18-21
DRAMP32285,FIQHLIPLIPHAIQGIKDIF,20,Kassinatuerin-3 ,Not available,,Not found,"Skin Secretion of the African Frog, Kassina senegalensis","Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H460 (IC50=1.67 μM); NCI-H838 (IC50=10.3 μM); U-251MG (IC50=13.20 μM ); NCI-H157 (IC50=21.54 μM); LNCaP (IC50=3.79 μM); NCI-H23 (IC50=4.52 μM),Human RBCs: Kassinatuerin-3 produced no detectable hemolysis activity up to a concentration of 160 μM,Linear,Free,Amidation,,L,Not available,Not available,32630734,Biology (Basel). 2020 Jul 2;9(7):148.,"Wang H, He H, Chen X, Zhou M, Wei M, Xi X, Ma C, Du Q, Chen T, Shaw C, Wang L. ","A Novel Antimicrobial Peptide (Kassinatuerin-3) Isolated from the Skin Secretion of the African Frog, Kassina senegalensis",20,18-21
DRAMP32294,GIFSKLAGKKIKNLLISGLKG,21,Esculentin (1-21),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (50% Cell death=150 µM),Sheep erythrocytes: 10% Hemolysis=64 µM,Linear,Free,Amidation,,L,HaCat: 20% Killing=64 µM,Not available,32722535, Antibiotics (Basel). 2020 Jul 26;9(8):448.,"Casciaro B, Loffredo MR, Cappiello F, Verrusio W, Corleto VD, Mangoni ML. ",Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities,21,18-21
DRAMP32295,GIFSKLAGKKIKNlLIsGLKG,21,"Esculentin (1-21)[L14l,S17s]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (10% Cell death=150 µM),Not available,Linear,Free,Amidation,l=D-Leu; s=D-Ser,Mix,Not available,Not available,32722535, Antibiotics (Basel). 2020 Jul 26;9(8):448.,"Casciaro B, Loffredo MR, Cappiello F, Verrusio W, Corleto VD, Mangoni ML. ",Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities,21,18-21
DRAMP32296,GIFSKLAGKKLKNLLISG,18,Esculentin (1-18),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (20% Killing=64 µM),Sheep erythrocytes: 10% Hemolysis=64 µM,Linear,Free,Amidation,,L,HaCat: 20% Killing=64 µM,Not available,32722535, Antibiotics (Basel). 2020 Jul 26;9(8):448.,"Casciaro B, Loffredo MR, Cappiello F, Verrusio W, Corleto VD, Mangoni ML. ",Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities,18,15-18
DRAMP32300,FALGAVTKVLPKLFCLITRKC,21,Brevinin-1H,Not available,,Not found,skin secretion of Amolops hainanensis ,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (IC50=2.599 μM); NCI-H157 (IC50=3.37 μM); MDA-MB-435S (IC50=3.47 μM); PC-3 (IC50=5.87 μM),Not available,Linear,Free,Free,,L,Horse blood cells: HC50=53.12 µM,Not available,32812694,Chem Biol Drug Des. 2021 Feb;97(2):273-282.,"Pei X, Gong Z, Wu Q, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M.","Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues",21,18-21
DRAMP32301,FALGAVTCLIRTKCKVLPKLF,21,Brevinin-1Ha,Not available,,Not found,skin secretion of Amolops hainanensis ,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PC-3 (IC50=186.9 μM); MDA-MB-435S (IC50=214.7 μM); NCI-H157 (IC50=278.9 μM); HCT 116 (IC50=342.8 μM),Not available,Linear,Free,Free,,L,Horse blood cells: only over 20% at a concentration of 128 µM,Not available,32812694,Chem Biol Drug Des. 2021 Feb;97(2):273-282.,"Pei X, Gong Z, Wu Q, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M.","Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues",21,18-21
DRAMP32302,FALGAVTKVLYKLFCLITRKC,21,Brevinin-1HY,Not available,,Not found,skin secretion of Amolops hainanensis ,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-435S (IC50=2.243 μM); NCI-H157 (IC50=2.811 μM); HCT 116 (IC50=3.583 μM); PC-3 (IC50=5.425 μM),Not available,Linear,Free,Free,,L,Horse blood cells: The haemolysis at the MIC of Brevinin-1HY (28.48%) was more than threefold at the MIC for the parent peptide,Not available,32812694,Chem Biol Drug Des. 2021 Feb;97(2):273-282.,"Pei X, Gong Z, Wu Q, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M.","Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues",21,18-21
DRAMP32303,GFQKVKAQAATCNHTVMA,18,B18K,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/2 signaling and mitochondrial events.",Tumor cells: MCF-7 (IC50>131.0 µM ); MCF-7/G11-TR1 (IC50>131.0 µM ); MCF-7/G11-TR5 (IC50>131.0 µM ); MDA-MB-231 (IC50>131.0 µM ); MDA-MB-468 (IC50>131.0 µM ); SK-BR-3 (IC50>131.0 µM ); T-47D  (IC50>131.0 µM ); ZR-75-1 (IC50>131.0 µM ),Not available,Linear,Free,Free,,L,IC50 on PBMCs was = 92.0 ± 39.6 μM,Not available,32872253,. Cancers (Basel). 2020 Aug 28;12(9):2448. ,"Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.",Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead,18,15-18
DRAMP32304,GFQKAKAKALACLAKALA,18,B18KA,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/18 signaling and mitochondrial events.",Tumor cells: MDA-MB-468 (IC50=135.6±9.3 µM); SK-BR-3 (IC50=43.5±11.5 µM); MCF-7/G11-TR5 (IC50=56.4±5.0 µM); ZR-75-1 (IC50=58.9±2.0 µM); MCF-7 (IC50=61.8±3.9 µM); MCF-7/G11-TR1 (IC50=61.8±5.1 µM); T-47D  (IC50=78.5±20.9 µM); MDA-MB-231 (IC50=83.7±20.1 µM),Not available,Linear,Free,Free,,L,IC50 on PBMCs was = 92.0 ± 39.6 μM,Not available,32872253,. Cancers (Basel). 2020 Aug 28;12(9):2448. ,"Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.",Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead,18,15-18
DRAMP32305,GFQKVKAQALTCLHTVMA,18,B18KL,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/10 signaling and mitochondrial events.",Tumor cells: MCF-7 (IC50>128.5 µM); MCF-7/G11-TR1 (IC50>128.5 µM); MCF-7/G11-TR5 (IC50>128.5 µM); MDA-MB-231 (IC50>128.5 µM); MDA-MB-468 (IC50>128.5 µM); SK-BR-3 (IC50>128.5 µM); T-47D  (IC50>128.5 µM); ZR-75-1 (IC50>128.5 µM),Not available,Linear,Free,Free,,L,IC50 on PBMCs was = 92.0 ± 39.6 μM,Not available,32872253,. Cancers (Basel). 2020 Aug 28;12(9):2448. ,"Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.",Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead,18,15-18
DRAMP32306,GIGKAIAKAIACIAKAIA,18,B18I,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/34 signaling and mitochondrial events.",Tumor cells: T-47D  (IC50 >148.5 µM); ZR-75-1 (IC50=10.1±1.8 µM); MCF-7/G11-TR1 (IC50=10.8±2.0 µM); MCF-7 (IC50=16.0±1.6 µM); MCF-7/G11-TR5 (IC50=16.1±4.9 µM); MDA-MB-468 (IC50=16.6±1.5 µM); SK-BR-3 (IC50=18.1±4.7 µM); MDA-MB-231 (IC50=18.6±2.4 µM),Not available,Linear,Free,Free,,L,IC50 on PBMCs was = 92.0 ± 39.6 μM,Not available,32872253,. Cancers (Basel). 2020 Aug 28;12(9):2448. ,"Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.",Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead,18,15-18
DRAMP32307,GLGKALAKALACLAKALA,18,B18L,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/26 signaling and mitochondrial events.",Tumor cells: MDA-MB-468 (IC50=12.4±1.4 µM); T-47D  (IC50=17.5±6.5 µM); MCF-7/G11-TR5 (IC50=3.8±0.3 µM); ZR-75-1 (IC50=5.2±1.0 µM); MCF-7 (IC50=5.9±0.5 µM); MCF-7/G11-TR1 (IC50=6.2±0.8 µM); MDA-MB-231 (IC50=7.2±0.8 µM); SK-BR-3 (IC50=7.2±1.0 µM),"Human red blood cells: EC 50=21.2±3.2 μM, testing time is 24 h",Linear,Free,Free,,L,IC50 on PBMCs was = 92.0 ± 39.6 μM,Not available,32872253,. Cancers (Basel). 2020 Aug 28;12(9):2448. ,"Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.",Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead,18,15-18
DRAMP32308,FLPALAGIAGLLGKIF,16,Temporin-SHe,Not available,,Not found,Pelophylax saharicus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: THP-1 (45% Killing=12.5µM; 96% Killing=25µM),Human erythrocytes: 22% Hemolysis=12.5µM; 84% Hemolysis=25µM,Linear,Free,Amidation,,L,Not available,Not available,32933215,Int J Mol Sci. 2020 Sep 13;21(18):6713.,"André S, Raja Z, Humblot V, Piesse C, Foulon T, Sereno D, Oury B, Ladram A.","Functional Characterization of Temporin-SHe, a New Broad-Spectrum Antibacterial and Leishmanicidal Temporin-SH Paralog from the Sahara Frog ( Pelophylax saharicus)",16,15-18
DRAMP32309,FIGTLIPLALGALTKLFK,18,Figainin 1 ,A0A2L2DDE6 ,,Not found,B. raniceps skin secretion,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: B16-F10 (IC50=10.5 µM (0.020 g/L)); HeLa (IC50=11.1 µM (0.021 g/L)); MCF-7 (IC50=13.7 µM (0.026 g/L)),Human red blood cells: HC50 =10 µM (0.019 g/L) (testing time is 24 h),Linear,Free,Free,,L,NIH 3T3: IC50=13 µM (0.025 g/L) (testing time is 24 h),Not available,32967114,Antibiotics (Basel). 2020 Sep 21;9(9):625,"Santana CJC, Magalhães ACM, Dos Santos Júnior ACM, Ricart CAO, Lima BD, Álvares ADCM, Freitas SM, Pires OR Jr, Fontes W, Castro MS.","Figainin 1, a Novel Amphibian Skin Peptide with Antimicrobial and Antiproliferative Properties",18,15-18
DRAMP32317,WRRRYRRWRRRRRWRRRPRR,20,vCPP 2319,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (IC50=5.02±1.04 µM),Human erythrocytes: 50% Hemolysis>200µM,Linear,Free,Amidation,,L,Not available,Not available,33015016,Front Bioeng Biotechnol. 2020 Sep 9;8:552035,"Cavaco M, Pérez-Peinado C, Valle J, Silva RDM, Correia JDG, Andreu D, Castanho MARB, Neves V.",To What Extent Do Fluorophores Bias the Biological Activity of Peptides? A Practical Approach Using Membrane-Active Peptides as Models,20,18-21
DRAMP32330,CGAISLAPKAQIKES,15,HS1,Q15116,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CT26 (IC50=19.2±2.3 µM),Not available,Linear,Free,Free,,L,Not available,programmed cell death protein 1,33360579,Bioorg Med Chem. 2021 Jan 15;30:115951.,"Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. ","Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy",15,12-15
DRAMP32331,CGAISLAPKLQIKES,15,HS2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CT26 (IC50=93.5±10.7 µM),Not available,Linear,Free,Free,,L,Not available,programmed cell death protein 1,33360579,Bioorg Med Chem. 2021 Jan 15;30:115951.,"Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. ","Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy",15,12-15
DRAMP32336,OLeu-V-NMeLeu-FL,16,MSSV,Not available,,Not found,Fusarium spp. isolated from Korean potato,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"MSSV inhibited the proliferation of both bladder cancer 5637 and T24 cells, which was attributed to the G1-phase cell cycle arrest, apoptosis induction, and alteration of mitogen-activated protein kinases (MAPKs) and protein kinase b (AKT) signaling pathways.",Tumor cells: 5637 (IC50=20 μg/mL); T24 (IC50=20 μg/mL),Not available,Cyclic,,,OLeu=leucic acid component; NMeLeu=N-methylleucine; ,Mix,Not available,Not available,33430488, Cancers (Basel). 2021 Jan 7;13(2):191.,"Song JH, Park J, Park SL, Hwang B, Kim WJ, Lee C, Moon SK. ","N-Methylsansalvamide, a cytotoxic cyclic depsipeptide from a marine fungus of the genus fusarium",16,15-18
DRAMP32338,DVNFLLHKIYGNIRY,15,LvHemB1,Not available,,Not found,Litopenaeus vannamei,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: EC109 (49.01% decrease=50μg/mL); HepG2  (53.26% decrease=50μg/mL); HeLa (70.30% decrease=50μg/mL); EJ (78.44% decrease=50μg/mL),Not available,Linear,Free,Free,,L,THLE-3: 30.83% decrease=50μg/mL,Not available,33630204, Cell Biol Toxicol. 2022 Feb;38(1):87-110.,"Liu S, Aweya JJ, Zheng L, Zheng Z, Huang H, Wang F, Yao D, Ou T, Zhang Y. ","LvHemB1, a novel cationic antimicrobial peptide derived from the hemocyanin of Litopenaeus vannamei, induces cancer cell death by targeting mitochondrial voltage-dependent anion channel 1",15,12-15
DRAMP32339,FFPLIAGLAARFLPKIFCSITKRC,24,Brevinin-1RL1,Not available,,Not found,Frog Skin Secretion,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW480 (IC50=10.37±0.40 µM ); MDA-MB-231 (IC50=5.44±0.33 µM ); A549 (IC50=5.81±0.23 µM ); HCT 116 (IC50=5.87±0.15 µM ); B16-F10 (IC50=6.65±0.33 µM ); SMMC-7721 (IC50=6.87±0.51 µM ),Human erythrocytes: Moderate Hemolysis,Linear,Free,Free,,L,NCM460: IC50=16.84±0.56 µM; BEAS-2B: IC50=16.57±0.29 µM; HaCaT: IC50=28.67±0.36 µM ,Not available,33916789,Molecules. 2021 Apr 3;26(7):2059,"Ju X, Fan D, Kong L, Yang Q, Zhu Y, Zhang S, Su G, Li Y.",Antimicrobial Peptide Brevinin-1RL1 from Frog Skin Secretion Induces Apoptosis and Necrosis of Tumor Cells,24,21-24
DRAMP32341,CIIKKIIKKIIKKII,15,CI-15,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=2.7±0.5 µM); HCT 116 (IC50=7.7±0.2 µM),Not available,Linear,Free,Free,,L,HDF: IC50=83±5 µM,Not available,34509120,J Colloid Interface Sci. 2022 Feb;607(Pt 1):488-501.,"Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X.",Rationally designed short cationic α-helical peptides with selective anticancer activity,15,12-15
DRAMP32345,KKRKKKAFALKFVVDLI,17,PCC-1,Not available,,Not found,insect-derived peptide,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"PCC-1 induces cell proliferation inhibition, apoptosis, and cell cycle arrest by downregulating Sp1 expression in the melanoma cell lines SK-MEL-28 and G361.",Tumor cells: SK-MEL-28 (IC50=50.8 µM); G-361 (IC50=57.8 µM),Not available,Linear,Free,Amidation,,L,HaCaT: not induce toxicity ,Not available,34531430, Sci Rep. 2021 Sep 16;11(1):18445. ,"Lee RH, Oh JD, Hwang JS, Lee HK, Shin D.",Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways,17,15-18
DRAMP32354,FLPLLISALTSLFPKLGK,18,SSTP1,Not available,,Not found,Skin Secretion of Indosylvirana aurantiaca,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"In IL6Rα-overexpressing cancer cells, SSTP1 induces apoptosis at low concentration through JNK pathway, without causing significant membrane disruption.",Tumor cells: HSC-4 (IC50=10.22 μM); MDA-MB-231 (IC50=4.5 μM),Human red blood cell: SSTP1-induced hemolysis at 5 μM was only-0.25%,Linear,Free,Free,,L,"HEK293: IC50=21.72 μM, lower cytotoxicity",IL6/IL6Rα/gp130 complex,34867962,Front Immunol. 2021 Nov 19;12:740620. ,"Gopalakrishnan S, Uma SK, Mohan G, Mohan A, Shanmugam G, Kumar VTV, J S, Chandrika SK, Vasudevan D, Nori SRC, Sathi SN, George S, Maliekal TT.","SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells",18,15-18
DRAMP32357,GFIATLCTKVLDFGIDKLIQLIEDK,25,EH-APP(40-64),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (LC50=60 µM); U-937 (LC50=80 µM),Human erythrocytes: 10% Hemolysis=10 µm,Linear,Free,Free,,L,Not available,Not available,8146160,Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2602-6.,"Leippe M, Andrä J, Müller-Eberhard HJ. ","Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica",25,24-27
DRAMP32358,GIGKFLKKAKKFAKAFVKIINN,22,MSI-136,Not available,,Not found,African clawed frog Xenopus laevis skin,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,A mechanism which appears to be related to short duration non-receptor-driven contact with target cell membranes.,Tumor cells: A549 (IC50=10 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,8319212,Cancer Res. 1993 Jul 1;53(13):3052-7.,"Baker MA, Maloy WL, Zasloff M, Jacob LS. ",Anticancer efficacy of Magainin2 and analogue peptides,22,21-24
DRAMP32359,gigkflkkakkfakafvkiinn,22,MSI-238,Not available,,Not found,African clawed frog Xenopus laevis skin,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,A mechanism which appears to be related to short duration non-receptor-driven contact with target cell membranes.,Tumor cells: A549 (IC50=6 µM),Not available,Linear,Free,Amidation,,D,Not available,Not available,8319212,Cancer Res. 1993 Jul 1;53(13):3052-7.,"Baker MA, Maloy WL, Zasloff M, Jacob LS. ",Anticancer efficacy of Magainin2 and analogue peptides,22,21-24
DRAMP32360,KWKLFKKIGIGAVLKVLKKG,20,P1,Not available,,Not found,Ceropin A-Magainin 2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=3.4 µM); NCI-H128 (IC50=3.5 µM); NCI-H146 (IC50=4.5 µM),Human red blood cells: hemolysis 0.3%(50 μg/mL); hemolysis 1%(100 μg/mL),Linear,Free,Amidation,,L,Not available,Not available,9352466,J Pept Res. 1997 Oct;50(4):279-85.,"Shin SY, Lee MK, Kim KL, Hahm KS. ",Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 14 and cecropin A-melittin hybrid peptides,20,18-21
DRAMP32361,KWKLFKKIGIGKFLHSATTF,20,P2,Not available,,Not found,Ceropin A-Magainin 2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=36.2 µM); NCI-H128 (IC50=37.9 µM); NCI-H146 (IC50=47.7 µM),Human red blood cells: hemolysis 0.2%(50 μg/mL); hemolysis 1%(100 μg/mL),Linear,Free,Amidation,,L,Not available,Not available,9352466,J Pept Res. 1997 Oct;50(4):279-85.,"Shin SY, Lee MK, Kim KL, Hahm KS. ",Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 15 and cecropin A-melittin hybrid peptides,20,18-21
DRAMP32362,KWKLFKKIGIGAFLHSAKKF,20,P3,Not available,,Not found,Ceropin A-Magainin 2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H146 (IC50=10.9 µM); NCI-H128 (IC50=9.3 µM); NCI-H69 (IC50=9.3 µM),Human red blood cells: hemolysis 0.1%(50 μg/mL); hemolysis 0.2%(100 μg/mL),Linear,Free,Amidation,,L,Not available,Not available,9352466,J Pept Res. 1997 Oct;50(4):279-85.,"Shin SY, Lee MK, Kim KL, Hahm KS. ",Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 16 and cecropin A-melittin hybrid peptides,20,18-21
DRAMP32363,KWKLFKKIGIGKFLHLAKKF,20,P4,Not available,,Not found,Ceropin A-Magainin 2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H128 (IC50=1.3 µM); NCI-H69 (IC50=1.9 µM); NCI-H146 (IC50=2.8 µM),Human red blood cells: hemolysis 0.2%(50 μg/mL); hemolysis 0.7%(100 μg/mL),Linear,Free,Amidation,,L,Not available,Not available,9352466,J Pept Res. 1997 Oct;50(4):279-85.,"Shin SY, Lee MK, Kim KL, Hahm KS. ",Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 17 and cecropin A-melittin hybrid peptides,20,18-21
DRAMP32364,KWKLFKKIGIGAFLHLAKKF,20,P5,Not available,,Not found,Ceropin A-Magainin 2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H128 (IC50=2.9 µM); NCI-H69 (IC50=2.9 µM); NCI-H146 (IC50=3.2 µM),Human red blood cells: hemolysis 1.5%(50 μg/mL); hemolysis 8%(100 μg/mL),Linear,Free,Amidation,,L,Not available,Not available,9352466,J Pept Res. 1997 Oct;50(4):279-85.,"Shin SY, Lee MK, Kim KL, Hahm KS. ",Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 18 and cecropin A-melittin hybrid peptides,20,18-21
DRAMP32365,KWKLFKKIGIGKFKLAKKF,19,P6,Not available,,Not found,Ceropin A-Magainin 2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.7 µM); NCI-H128 (IC50=2 µM); NCI-H146 (IC50=3.1 µM),Human red blood cells: hemolysis 0.2%(50 μg/mL); hemolysis 1.2%(100 μg/mL),Linear,Free,Amidation,,L,Not available,Not available,9352466,J Pept Res. 1997 Oct;50(4):279-85.,"Shin SY, Lee MK, Kim KL, Hahm KS. ",Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 19 and cecropin A-melittin hybrid peptides,19,18-21
DRAMP32366,KWKLFAKIGIGKFLHLAKKF,20,P7,Not available,,Not found,Ceropin A-Magainin 2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H128 (IC50=2.4 µM); NCI-H146 (IC50=2.4 µM); NCI-H69 (IC50=3.1 µM),Human red blood cells: hemolysis 0.4%(50 μg/mL); hemolysis 2.4%(100 μg/mL),Linear,Free,Amidation,,L,Not available,Not available,9352466,J Pept Res. 1997 Oct;50(4):279-85.,"Shin SY, Lee MK, Kim KL, Hahm KS. ",Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 20 and cecropin A-melittin hybrid peptides,20,18-21
DRAMP32367,KWKKFLKIGIGKFLHLAKKF,20,P8,Not available,,Not found,Ceropin A-Magainin 2,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H146 (IC50=1.8 µM); NCI-H128 (IC50=2.3 µM); NCI-H69 (IC50=2.6 µM),Human red blood cells: hemolysis 2.4%(50 μg/mL); hemolysis 13.7%(100 μg/mL),Linear,Free,Amidation,,L,Not available,Not available,9352466,J Pept Res. 1997 Oct;50(4):279-85.,"Shin SY, Lee MK, Kim KL, Hahm KS. ",Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 21 and cecropin A-melittin hybrid peptides,20,18-21
DRAMP32370,SLPQNIPPLTQTPVVVPPF,19,P19,Not available,,Not found,Synbiotic yoghurt,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,"Tumor cells: HT-29 (Antiproliferative acitivity (%)=38.55±1.75%,  Peptide concentration 3 mg/mL)",Not available,Linear,Free,Free,,L,Not available,Not available,Not available,,,Antioxidant peptides isolated from synbiotic yoghurt exhibit antiproliferative activities against HT-29 colon cancer cells,19,18-21
DRAMP32371,YQEPVLGPVRGPFPIIV,17,P17,Q9TSI0##P02666,,Not found,Synbiotic yoghurt,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,"Tumor cells: HT-29 (Antiproliferative acitivity (%)=41.49±2.18%,  Peptide concentration 3 mg/mL)",Not available,Linear,Free,Free,,L,Not available,Not available,Not available,,,Antioxidant peptides isolated from synbiotic yoghurt exhibit antiproliferative activities against HT-29 colon cancer cells,17,15-18
DRAMP32374,GIKCRFCCGCCTPGICGVCCRF,22,Hepcidin TH1-5,Not available,,Not found,"Skin Secretion of the African Frog, Kassina senegalensis","Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=20 μg/mL ),Not available,Linear,Free,Free,,L,Not available,Not available,Not available,,,Hepcidin TH1-5 Induces Apoptosis and Activate Caspase-9 in MCF-7 Cells,22,21-24
DRAMP32388,VWLSALKFIGKHLAKHQLSKL,21,Lycosin-II,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Lycosin-II Suppresses the Growth of Tumor Cells and Kills them Through Membrane Disruption and Apoptosis Induction,Tumor cells: HCT 116 (IC50=70.79 µg/mL ),Not available,Linear,Free,Free,,L,IC50 on PBMCs was = 92.0 ± 39.6 μM,Not available,Not available,,,Lycosin-II Suppresses the Growth of Tumor Cells and Kills them Through Membrane Disruption and Apoptosis Induction,21,18-21
DRAMP32444,XPAXXFXPAXXLXXLXXLX,19,Ⅰ,Not available,,Not found,Peptaibols,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: BEL-7402 (IC50=1.98 μM); BGC-823 (IC50=2.11 μM); A549 (IC50=2.30 μM); A2780 (IC50>10 μM); HCT 8 (IC50>10 μM),Not available,Linear,Acetylation,Aminoethanol,X(1/4/5/16/17)=Aib=1-amino-isobutyric acid; X(7/13)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine,L,Not available,Not available,Not available,,,Not available,19,18-21
DRAMP32445,XPAXXFXPAXXLXXLXXLX,19,Ⅰ,Not available,,Not found,Peptaibols,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: BGC-823 (IC50=1.03 μM); BEL-7402 (IC50=1.94 μM); A549 (IC50=2.08 μM); A2780 (IC50=3.79 μM); HCT 8 (IC50=5.93 μM),Not available,Linear,Acetylation,Aminoethanol,X(1/4/5/16/17)=Aib=1-amino-isobutyric acid; X(7/13)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine,L,Not available,Not available,Not available,,,Not available,19,18-21
DRAMP32446,XPAXXFXPAXXLXXLXXLX,19,Ⅱ,Not available,,Not found,Peptaibols,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: BEL-7402 (IC50=1.98 μM); BGC-823 (IC50=2.11 μM); A549 (IC50=2.30 μM); A2780 (IC50>10 μM); HCT 8 (IC50>10 μM),Not available,Linear,Acetylation,Aminoethanol,X(1/4/5/17)=Aib=1-amino-isobutyric acid; X(7/13/16)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine,L,Not available,Not available,Not available,,,Not available,19,18-21
DRAMP32447,XPAXXFXPAXXLXXLXXLX,19,Ⅱ,Not available,,Not found,Peptaibols,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: BGC-823 (IC50=1.03 μM); BEL-7402 (IC50=1.94 μM); A549 (IC50=2.08 μM); A2780 (IC50=3.79 μM); HCT 8 (IC50=5.93 μM),Not available,Linear,Acetylation,Aminoethanol,X(1/4/5/17)=Aib=1-amino-isobutyric acid; X(7/13/16)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine,L,Not available,Not available,Not available,,,Not available,19,18-21
DRAMP32453,AIMSSLMKKLAAHIAK,16,HYL-1,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=19.72±0.38 µmol/L); Hep-G2 (IC50=30.78±0.24 µmol/L); HCT 116 (IC50=47.25±0.33 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32454,GAMSSLMKKLAAHIAK,16,HYL-2,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=39.57±0.12 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32455,GIASSLMKKLAAHIAK,16,HYL-3,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=28.97±0.27 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32457,GIMASLMKKLAAHIAK,16,HYL-4,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (IC50=10.66±0.25 µmol/L); HCT 116 (IC50=18.50±0.22 µmol/L); A549 (IC50=6.01±0.15 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32459,GIMSALMKKLAAHIAK,16,HYL-5,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (IC50=12.75±0.26 µmol/L); A549 (IC50=5.32±0.47 µmol/L); Hep-G2 (IC50=7.57±0.18 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32460,GIMSSAMKKLAAHIAK,16,HYL-6,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32461,GIMSSLAKKLAAHIAK,16,HYL-7,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=28.32±0.28 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32463,GIMSSLMAKLAAHIAK,16,HYL-8,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=15.17±0.34 µmol/L); Hep-G2 (IC50=17.09±0.26 µmol/L); HCT 116 (IC50=19.81±0.20 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32465,GIMSSLMKALAAHIAK,16,HYL-9,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=4.75±0.33 µmol/L); HCT 116 (IC50=7.22±0.21 µmol/L); Hep-G2 (IC50=8.04±0.27 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32466,GIMSSLMKKAAAHIAK,16,HYL-10,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32468,GIMSSLMKKLAAAIAK,16,HYL-11,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=5.18±0.37 µmol/L); Hep-G2 (IC50=7.35±0.34 µmol/L); HCT 116 (IC50=7.99±0.22 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32469,GIMSSLMKKLAAHAAK,16,HYL-12,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32470,GIMSSLMKKLAAHIAA,16,HYL-13,Not available,,Not found,AMP,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=11.84±0.17 µmol/L); HCT 116 (IC50=16.80±0.34 µmol/L); Hep-G2 (IC50=16.84±0.28 µmol/L),Not available,Linear,Free,Amidation,,L,Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL,Not available,Not available,,,Structural modification and antitumor activity of antimicrobial peptide HYL,16,15-18
DRAMP32773,GRKKRRQRRRPQSKRKKNKKGKRK,24,CP-EPS8-NLS,Not available,,Not found,Derived from the NLS of EPS8,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: KG-1a (~45%Cellular viability=105 µM),Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,29357910, J Exp Clin Cancer Res. 2018 Jan 22;37(1):12.,"Chen Y, Xie X, Wu A, Wang L, Hu Y, Zhang H, Li Y.",A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia,24,21-24
DRAMP32777,FLPLLLAGLPSFLCLVFKKC,20,Amurin-2a,Not available,,Not found,Rana amurensis,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=302.1 µM),Horse erythrocytes: 50% Hemolysis=439.0 µM,Cyclic,Free,Free,,L,HMEC-1: IC50=1545 µM,Not available,29366784,Biochem Biophys Res Commun. 2018 Mar 18;497(4):943-949.,"Zhang L, Chen X, Zhang Y, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T.","Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues",20,18-21
DRAMP32778,FLPKLLAGLPSFLCLVFKKC,20,Amurin-2a [L4K],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=41.6 µM),Horse erythrocytes: 50% Hemolysis=31.0	 µM,Cyclic,Free,Free,,L,HMEC-1: IC50=85.2 µM,Not available,29366784,Biochem Biophys Res Commun. 2018 Mar 18;497(4):943-949.,"Zhang L, Chen X, Zhang Y, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T.","Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues",20,18-21
DRAMP32779,FLPLLLAGLPKFLCLVFKKC,20,Amurin-2a [S11K],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (IC50=310.6 µM),Horse erythrocytes: 50% Hemolysis=29.1	 µM,Cyclic,Free,Free,,L,HMEC-1: IC50=52.1 µM,Not available,29366784,Biochem Biophys Res Commun. 2018 Mar 18;497(4):943-949.,"Zhang L, Chen X, Zhang Y, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T.","Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues",20,18-21
DRAMP32803,GKEFKRIVWLSKTAKKL,17,"LL37 (14-21)+Cecropin-P1 (2-9), LC",P49913##P14661,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (Not active up to 128 µM),Human erythrocytes: 5%Hemolysis>128 µM,Linear,Free,Amidation,,L,Not available,Not available,29282543,Amino Acids. 2018 Apr;50(3-4):453-468.,"Dong N, Li XR, Xu XY, Lv YF, Li ZY, Shan AS, Wang JL. ","Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides",17,15-18
DRAMP32804,GKEFKRIVKWPWWPWRR,17,"LL37 (14-21)+Indolicidin (5-13), LI",P49913##P33046,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (87.5% Killing=128µM),Human erythrocytes: 5%Hemolysis>128 µM,Linear,Free,Amidation,,L,Not available,Not available,29282543,Amino Acids. 2018 Apr;50(3-4):453-468.,"Dong N, Li XR, Xu XY, Lv YF, Li ZY, Shan AS, Wang JL. ","Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides",17,15-18
DRAMP32805,GKEFKRIVGRIYRLCCR,17,"LL37 (14-21)+NP-1 (23-31), LN",P49913##Q62716,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Hep-G2 (80% Killing=128µM),Human erythrocytes: 5%Hemolysis>128 µM,Linear,Free,Amidation,,L,Not available,Not available,29282543,Amino Acids. 2018 Apr;50(3-4):453-468.,"Dong N, Li XR, Xu XY, Lv YF, Li ZY, Shan AS, Wang JL. ","Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides",17,15-18
DRAMP32813,FLSLIPKAISAVSALANHF,19,Phylloseptin-PHa [A7K],A0A2I2KHV2,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-251MG (LD50=33.65 µM),Horse erythrocytes:50% Hemolysis=197.7µM,Linear,Free,Amidation,,L,Not available,Not available,30774309,Drug Des Devel Ther. 2019 Jan 23;13:447-458,"Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. ","Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities",19,18-21
DRAMP32814,FLSLIPKAISAISALANHF,19,"Phylloseptin-Pha [A7K, V12I]",A0A2I2KHV2,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-251MG (LD50=36.46 µM),Horse erythrocytes:50% Hemolysis=34.86µM,Linear,Free,Amidation,,L,Not available,Not available,30774309,Drug Des Devel Ther. 2019 Jan 23;13:447-458,"Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. ","Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities",19,18-21
DRAMP32815,FLSLIPKAISAISALINHF,19,"Phylloseptin-PHa [A7K, V12I, A16I]",A0A2I2KHV2,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-251MG (LD50=10.85 µM),Horse erythrocytes:50% Hemolysis=9.266µM,Linear,Free,Amidation,,L,Not available,Not available,30774309,Drug Des Devel Ther. 2019 Jan 23;13:447-458,"Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. ","Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities",19,18-21
DRAMP32816,FLSLIPKIISAISALINHF,19,"Phylloseptin-PHa [A7K, A8I, V12I, A16I]",A0A2I2KHV2,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-251MG (LD50=9.547 µM),Horse erythrocytes:50% Hemolysis=2.766µM,Linear,Free,Amidation,,L,Not available,Not available,30774309,Drug Des Devel Ther. 2019 Jan 23;13:447-458,"Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. ","Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities",19,18-21
DRAMP32817,FLSLIPKIISAISALIKHF,19,"Phylloseptin-PHa [A7K, A8I, V12I, A16I, N17K]",A0A2I2KHV2,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-251MG (LD50=4.059 µM),Horse erythrocytes:50% Hemolysis=1.074µM,Linear,Free,Amidation,,L,Not available,Not available,30774309,Drug Des Devel Ther. 2019 Jan 23;13:447-458,"Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. ","Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities",19,18-21
DRAMP32818,WFGKLYRGKTKVVKKVKGLLKG,22,"Chionodracine [F1W; H4,15,17K; I9K; S11,21K]",K4Q515,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SH-SY5Y (0% Killing=64 µM),Human erythrocytes: 5% Hemolysis=3µM; 30% Hemolysis=50µM,Linear,Free,Free,,L,HUVEC: 3.84% Killing=64 µM,Not available,30790604,Dev Comp Immunol. 2019 Jul;96:9-17.,"Buonocore F, Picchietti S, Porcelli F, Della Pelle G, Olivieri C, Poerio E, Bugli F, Menchinelli G, Sanguinetti M, Bresciani A, Gennari N, Taddei AR, Fausto AM, Scapigliati G.",Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens,22,21-24
DRAMP32819,QLGKKKHRRRPSKKKRHW,18,"HEXIM1 (147-164), BR",O94992,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (5%Killing=100 µM),Not available,Linear,Free,Free,,L,HaCat: Not active up to 100 µM,Not available,26734838,Oncotarget. 2016 Feb 2;7(5):5483-94.,"Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. ",Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy,18,15-18
DRAMP32820,QLGRRRHRRRPSRRRRHW,18,"HEXIM1 (147-164)[K4,5,6,13,14,15R], BR-RRR12",O94992,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (25%Killing=100 µM),Not available,Linear,Free,Free,,L,HaCat: Not active up to 100 µM,Not available,26734838,Oncotarget. 2016 Feb 2;7(5):5483-94.,"Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. ",Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy,18,15-18
DRAMP32826,LTVSPWYGCGMPFSTGKRIMLGE,23,LTV-X13,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: OPM-2 (0%Killing=50 µM),Not available,Linear,Free,Free,,L,CHO-K1: 0%Killing=50 µM; HFF: 0%Killing=50 µM; WI-38: 0%Killing=50 µM,Not available,26734838,Oncotarget. 2016 Feb 2;7(5):5483-94.,"Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. ",Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy,23,21-24
DRAMP32827,LTVSPWYGCGKLAKLAKKLAKLAK,24,"LTV-PAP, LTV-KLA",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: OPM-2 (78%Killing=10 µM; 100%Killing=50 µM),Not available,Linear,Free,Free,,L,CHO-K1: 100%Killing=50 µM; HFF: 80%Killing=50 µM; WI-38: 55%Killing=50 µM,Not available,26734838,Oncotarget. 2016 Feb 2;7(5):5483-94.,"Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. ",Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy,24,21-24
DRAMP32830,ALFGILKKAFGKILTIFAGLPGVV,24,1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50=8.6 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,30953170, J Mol Model. 2019 Apr 5;25(5):112.,"Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.",De novo design of anticancer peptides by ensemble artificial neural networks,24,21-24
DRAMP32832,GLKDPLKSVAKHLVK,15,3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,30953170, J Mol Model. 2019 Apr 5;25(5):112.,"Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.",De novo design of anticancer peptides by ensemble artificial neural networks,15,12-15
DRAMP32836,GIVTILKGAVGVILGGL,17,7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,30953170, J Mol Model. 2019 Apr 5;25(5):112.,"Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.",De novo design of anticancer peptides by ensemble artificial neural networks,17,15-18
DRAMP32844,GLLALLGELAEHLGSKI,17,17,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>100 μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,30953170, J Mol Model. 2019 Apr 5;25(5):112.,"Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.",De novo design of anticancer peptides by ensemble artificial neural networks,17,15-18
DRAMP32848,GIKKWLHSAKKFGKKFVKKIXNS,23,"Magainin-2 [G3,18K; F5W; A15K; E19K; M21Nle]",P11006,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PANC-1 (EC50=9.1±3 µM(pH=7.4)),Human kidney-derived GM cells: EC50=7.6±2.1 µM(pH=6); EC50=25.6±4.5 µM(pH=7.4),Linear,Free,Amidation,X=Nle,L,HEK293: EC50=15.7±1.8 µM(pH=7.4),Not available,31161686,Chembiochem. 2019 Aug 16;20(16):2109-2117. ,"Tanishiki N, Yano Y, Matsuzaki K. ","Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues",23,21-24
DRAMP32849,GIKXWLHSAKKFGXKFVKKIXNS,23,"Magainin-2 [G3,18K; K4,14Dap; F5W; A15K; E19K; M21Nle]",P11006,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PANC-1 (EC50=14.7±0.6 µM(pH=7.4)),Human kidney-derived GM cells: EC50=25.9±0.6 µM(pH=6); EC50=50.3±0.9 µM(pH=7.4),Linear,Free,Amidation,X(4/14)=Dap; X(21)=Nle,L,HEK293: EC50=27.2±3.1 µM(pH=7.4),Not available,31161686,Chembiochem. 2019 Aug 16;20(16):2109-2117. ,"Tanishiki N, Yano Y, Matsuzaki K. ","Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues",23,21-24
DRAMP32850,GIKXWLHSAXKFGXKFVKXIXNS,23,"Magainin-2 [G3,18K; K4,10,14Dap; F5W; A15K; E19Dap; M21Nle]",P11006,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PANC-1 (EC50=35.7±0.7 µM(pH=7.4)),Human kidney-derived GM cells: EC50=21.1±0.3 µM(pH=6); EC50=91.6±5.9 µM(pH=7.4),Linear,Free,Amidation,X(4/10/14/19)=Dap; X(21)=Nle,L,HEK293: EC50>100 µM(pH=7.4),Not available,31161686,Chembiochem. 2019 Aug 16;20(16):2109-2117. ,"Tanishiki N, Yano Y, Matsuzaki K. ","Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues",23,21-24
DRAMP32851,GIKXWLHSAXXFGXKFVXXIXNS,23,"Magainin-2 [G3K; K4,10,11,14Dap; F5W; A15K; G18Dap; E19Dap; M21Nle]",P11006,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PANC-1 (EC50=55±1.8 µM(pH=7.4)),Human kidney-derived GM cells: EC50=	19.8±0.3 µM(pH=6); EC50>100 µM(pH=7.4),Linear,Free,Amidation,X(4/10/11/14/18/19)=Dap; X(21)=Nle,L,HEK293: EC50>100 µM(pH=7.4),Not available,31161686,Chembiochem. 2019 Aug 16;20(16):2109-2117. ,"Tanishiki N, Yano Y, Matsuzaki K. ","Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues",23,21-24
DRAMP32852,GIXXWLHSAXXFGXXFVXXIXNS,23,"Magainin-2 [G3,18Dap; K4,10,11,14Dap; F5W; A15Dap; E19Dap; M21Nle]",P11006,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: PANC-1 (EC50=61.4±1.7 µM(pH=7.4)),Human kidney-derived GM cells: EC50=7.6±2.1 µM(pH=6); EC50=25.6±4.5 µM(pH=7.4),Linear,Free,Amidation,X(3/4/10/11/14/15/18/19)=Dap; X(21)=Nle,L,HEK293: EC50=15.7±1.8 µM(pH=7.4),Not available,31161686,Chembiochem. 2019 Aug 16;20(16):2109-2117. ,"Tanishiki N, Yano Y, Matsuzaki K. ","Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues",23,21-24
DRAMP32853,LAANFLPQILCKIARKC,17,B1CTcu5-LIAG,E3SYG2##D2K8D1##C3RTH8,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Human erythrocytes: 30% Hemolysis=200 µM,Cyclic,Free,Amidation,,L,HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity>100 µg/ml,Not available,25997127,PLoS One. 2015 May 21;10(5):e0124210.,"Abraham P, Sundaram A, R A, V R, George S, Kumar KS. ",Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides,17,15-18
DRAMP32854,KIAGLAANFLPQILCKIARKC,21,B1CTcu5K,E3SYG2##D2K8D1##C3RTH8,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Human erythrocytes: 15% Hemolysis=200 µM,Cyclic,Free,Amidation,,L,HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=74.5±2.44 µg/ml,Not available,25997127,PLoS One. 2015 May 21;10(5):e0124210.,"Abraham P, Sundaram A, R A, V R, George S, Kumar KS. ",Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides,21,18-21
DRAMP32855,WIAGLAANFLPQILCKIARKC,21,B1CTcu5W,E3SYG2##D2K8D1##C3RTH8,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Human erythrocytes: 39.11% Hemolysis=200 µM,Linear,Free,Amidation,,L,HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity>100 µg/ml,Not available,25997127,PLoS One. 2015 May 21;10(5):e0124210.,"Abraham P, Sundaram A, R A, V R, George S, Kumar KS. ",Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides,21,18-21
DRAMP32856,RIAGLAANFLPQILCKIARKC,21,B1CTcu5R,E3SYG2##D2K8D1##C3RTH8,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Human erythrocytes: 17.4% Hemolysis=200 µM,Linear,Free,Amidation,,L,HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=75.1±1.46 µg/ml,Not available,25997127,PLoS One. 2015 May 21;10(5):e0124210.,"Abraham P, Sundaram A, R A, V R, George S, Kumar KS. ",Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides,21,18-21
DRAMP32857,HIAGLAANFLPQILCKIARKC,21,B1CTcu5H,E3SYG2##D2K8D1##C3RTH8,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Human erythrocytes: 30.4% Hemolysis=200 µg/ml,Linear,Free,Amidation,,L,HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=90±2.56 µg/ml,Not available,25997127,PLoS One. 2015 May 21;10(5):e0124210.,"Abraham P, Sundaram A, R A, V R, George S, Kumar KS. ",Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides,21,18-21
DRAMP32858,liaGlaanflpqilckiarkc,21,B1CTcu5D,E3SYG2##D2K8D1##C3RTH8,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A431 (50% Cytotoxicity>100 µg/ml),Human erythrocytes: 40.22% Hemolysis=200 µg/ml,Cyclic,Free,Amidation,,D,HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=71.4±2.3 µg/ml,Not available,25997127,PLoS One. 2015 May 21;10(5):e0124210.,"Abraham P, Sundaram A, R A, V R, George S, Kumar KS. ",Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides,21,18-21
DRAMP32867,KLWKKIEKLIKKLLTSIR,18,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=47±3 µM),Human erythrocytes: 50% Hemolysis=236±13 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,18,15-18
DRAMP32868,YIWARAERVWLWWGKFLSL,19,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=56±3 µM),Human erythrocytes: Not active up to 400 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,19,18-21
DRAMP32869,DLFKQLQRLFLGILYCLYKIW,21,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=47±4 µM),Human erythrocytes：50% Hemolysis=132±16 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,21,18-21
DRAMP32870,AIKKFGPLAKIVAKV,15,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=95±4 µM),Human erythrocytes: Not active up to 400 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,15,12-15
DRAMP32871,RWNGRIIKGFYNLVKIWKDLKG,22,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=42±4 µM),Human erythrocytes：50% Hemolysis=89±6 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,22,21-24
DRAMP32872,KVWKIKKNIRRLLHGIKRGWKG,22,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=34±4 µM),Human erythrocytes: Not active up to 400 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,22,21-24
DRAMP32873,GFWARIGKVFAAVKNL,16,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=101±4 µM),Human erythrocytes: Not active up to 400 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,16,15-18
DRAMP32874,AFLYRLTRQIRPWWRWLYKW,20,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=45.5±0.8 µM),Human erythrocytes: 50% Hemolysis=34±5 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,20,18-21
DRAMP32875,RIWGKHSRYIKIVKRLIQ,18,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=50±10 µM),Human erythrocytes: Not active up to 400 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,18,15-18
DRAMP32876,QIWHKIRKLWQIIKDGF,17,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=16.1±0.3 µM),Human erythrocytes: 50% Hemolysis=23±5 µM,Linear,Free,Amidation,,L,Not available,Not available,29679519,ChemMedChem. 2018 Jul 6;13(13):1300-1302.,"Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. ",Designing Anticancer Peptides by Constructive Machine Learning,17,15-18
DRAMP32904,CVRRFPWWYPFLRRC,15,Tritrp DiSu,Not available,,Not found,porcine cathelicidin peptide,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=12.3 µM),RBC: IC50=20.9 µM,Cyclic,Free,Amidation,,L,PBMC: IC50=26.2 µM,Not available,32126228,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. ,"Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. ",Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin,15,12-15
DRAMP32909,GIGKWLHSAKKFGKAFVGEIMNS,23,MagaininF5W-Lys,Not available,,Not found,porcine cathelicidin peptide,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=16.8 µM),RBC: IC50 ≥ 65 µM,Linear,Free,Amidation,,L,PBMC: IC50 ≥ 65 µM,Not available,32126228,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. ,"Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. ",Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin,23,21-24
DRAMP32912,GIGRWLHSARRFGRAFVGEIMNS,23,MagaininF5W-Arg,Not available,,Not found,porcine cathelicidin peptide,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=16.8 µM),RBC: IC50 ≥ 65 µM,Linear,Free,Amidation,,L,PBMC: IC50 ≥ 65 µM,Not available,32126228,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. ,"Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. ",Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin,23,21-24
DRAMP32936,KYLNFAKWLKGANLAKYANA,20,GW-H1-scr,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: AGS (IC50>500 µM),Not available,Linear,Free,Free,,L,NIH 3T3: IC50>500 μM,Not available,25380626,Mol Cell Biochem. 2015 Feb;400(1-2):77-86. ,"Pan WR, Chen YL, Hsu HC, Chen WJ. ",Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy,20,18-21
DRAMP32937,ILKKLLSTAAGLLSNL,16,Alyteserin-2a [G3K],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=100 μM),Human erythrocytes: 50% Hemolysis=105 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32938,ILGKLLKTAAGLLSNL,16,Alyteserin-2a [S7K],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=35 μM),Human erythrocytes: 50% Hemolysis=28 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32939,ILGKLLkTAAGLLSNL,16,Alyteserin-2a [S7k],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50>100 μM),Human erythrocytes: 50% Hemolysis=105 µM,Linear,Free,Amidation,k=D-Lys,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32940,ILGKLLSTAAKLLSNL,16,Alyteserin-2a [G11K],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=20 μM),Human erythrocytes: 50% Hemolysis=24 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32941,ILGKLLSTAAkLLSNL,16,Alyteserin-2a [G11k],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=28 μM),Human erythrocytes: 50% Hemolysis=42 µM,Linear,Free,Amidation,k=D-Lys,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32942,ILGKLLSTAAGLLKNL,16,Alyteserin-2a [S14K],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=30 μM),Human erythrocytes: 50% Hemolysis=55 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32943,ILGKLLSTAAGLLSKL,16,Alyteserin-2a [N15K],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=13 μM); HepG2 (LC50=17 μM); MDA-MB-231 (LC50=18 μM); HT-29 (LC50=32 μM),Human erythrocytes: 50% Hemolysis=50 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32944,ILGKLLSTAAGLLSkL,16,Alyteserin-2a [N15k],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HT-29 (LC50=125 μM); A549 (LC50=75 μM); MDA-MB-231 (LC50=80 μM); HepG2 (LC50=90 μM),Human erythrocytes: 50% Hemolysis=310 µM,Linear,Free,Amidation,k=D-Lys,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32945,ILGKLLKTAAKLLSNL,16,"Alyteserin-2a [S7K, G11K]",Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=20 μM),Human erythrocytes: 50% Hemolysis=38 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32946,ILGKLLkTAAkLLSNL,16,"Alyteserin-2a [S7k, G11k]",Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=65 μM),Human erythrocytes: 50% Hemolysis=185 µM,Linear,Free,Amidation,k=D-Lys,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32947,ILGKLLSTAAKLLSKL,16,"Alyteserin-2a [G11K, N15K]",Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (LC50=10 μM); HT-29 (LC50=18 μM); A549 (LC50=6 μM); HepG2 (LC50=8 μM),Human erythrocytes: 50% Hemolysis=16 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32948,ILGKLLSTAAkLLSKL,16,"Alyteserin-2a [G11k, N15K]",Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=15 μM); MDA-MB-231 (LC50=20 μM); HepG2 (LC50=26 μM); HT-29 (LC50=28 μM),Human erythrocytes: 50% Hemolysis=195 µM,Linear,Free,Amidation,k=D-Lys,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32949,ILGKLLSWAAGLLSNL,16,Alyteserin-2a [T8W],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=12 μM),Human erythrocytes: 50% Hemolysis=13 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32950,ILGKLLSTWAGLLSNL,16,Alyteserin-2a [A9W],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=21 μM),Human erythrocytes: 50% Hemolysis=39 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32951,ILGKLLSTAWGLLSNL,16,Alyteserin-2a [A10W],Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=7 μM),Human erythrocytes: 50% Hemolysis=11 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32952,ILGKLLSTAWkLLSNL,16,"Alyteserin-2a [A10W, G11k]",Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=17 μM),Human erythrocytes: 50% Hemolysis=21 µM,Linear,Free,Amidation,k=D-Lys,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32953,ILGKLLSTAWGLLSKL,16,"Alyteserin-2a [A10W, N15K]",Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=6 μM),Human erythrocytes: 50% Hemolysis=6 µM,Linear,Free,Amidation,,L,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32954,ILGKLLSTAWALLSkL,16,"Alyteserin-2a [A10W, N15k]",Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=20 μM),Human erythrocytes: 50% Hemolysis=27 µM,Linear,Free,Amidation,k=D-Lys,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP32955,ILGKLLSTAWkLLSkL,16,"Alyteserin-2a [A10W, G11k, N15k]",Not available,,Not found,Synthetic (Derived from Alyteserin-2a),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=17 μM),Human erythrocytes: 50% Hemolysis=68 µM,Linear,Free,Amidation,k=D-Lys,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. ","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP33022,RIIDLLWRVWRPQKPKFVTVWVR,23,PMAP-23 [R10W],P49930,,Not found,Synthetic (Derived from PMAP-23),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=19 µM); SNU-601 (IC50=28 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12054589,Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.,"Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.","Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid",23,21-24
DRAMP33023,RIIDLLWRVRRPWKPKFVTVWVR,23,PMAP-23 [Q13W],P49930,,Not found,Synthetic (Derived from PMAP-23),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=20 µM); SNU-601 (IC50=30 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12054589,Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.,"Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.","Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid",23,21-24
DRAMP33024,RIIDLLWRVRRPQWPKFVTVWVR,23,PMAP-23 [K14W],P49930,,Not found,Synthetic (Derived from PMAP-23),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=29 µM); SNU-601 (IC50=39 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12054589,Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.,"Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.","Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid",23,21-24
DRAMP33025,RIIDLLWRVRRPWWPKFVTVWVR,23,PMAP-23 [Q13W][K14W],P49930,,Not found,Synthetic (Derived from PMAP-23),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=23 µM); SNU-601 (IC50=37 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12054589,Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.,"Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.","Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid",23,21-24
DRAMP33026,RIIDLLWRVWRPWKPKFVTVWVR,23,PMAP-23 [R10W][Q13W],P49930,,Not found,Synthetic (Derived from PMAP-23),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=16 µM); SNU-601 (IC50=21 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12054589,Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.,"Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.","Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid",23,21-24
DRAMP33027,RIIDLLWRVWRPWWPKFVTVWVR,23,PMAP-23 [R10W][Q13W][K14W],P49930,,Not found,Synthetic (Derived from PMAP-23),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SNU-601 (IC50=10 µM); Jurkat (IC50=11 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,12054589,Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.,"Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.","Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid",23,21-24
DRAMP33028,GKKLKKIGQKIKNFFQKL,18,CRAMP-18[E2K],P51437,,Not found,Synthetic (Derived from CRAMP-18),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=20 µM); A549 (IC50=25 µM); K562 (IC50=34 µM),Human erythrocytes: Not active up to 100 µM,Linear,Free,Free,,L,Not available,Not available,10973820,Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9. ,"Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.","CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",18,15-18
DRAMP33029,GEKLKKIGKKIKNFFQKL,18,CRAMP-18[Q9K],P51437,,Not found,Synthetic (Derived from CRAMP-18),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (IC50=66 µM); K562 (IC50=85 µM); A549 (IC50=88 µM),Human erythrocytes: Not active up to 100 µM,Linear,Free,Free,,L,Not available,Not available,10973820,Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9. ,"Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.","CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",18,15-18
DRAMP33030,GEKLKKIGQKIKKFFQKL,18,CRAMP-18[N13K],P51437,,Not found,Synthetic (Derived from CRAMP-18),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=100 µM); Jurkat (IC50=78 µM); A549 (IC50=93 µM),Human erythrocytes: Not active up to 100 µM,Linear,Free,Free,,L,Not available,Not available,10973820,Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9. ,"Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.","CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",18,15-18
DRAMP33031,GEKLKKIGQKIKNFFKKL,18,CRAMP-18[Q16K],P51437,,Not found,Synthetic (Derived from CRAMP-18),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50>100 µM); Jurkat (IC50>100 µM); K562 (IC50>100 µM),Human erythrocytes: 0.2% Hemolysis=100 µM,Linear,Free,Free,,L,Not available,Not available,10973820,Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9. ,"Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.","CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",18,15-18
DRAMP33186,FLPILASLAAKFGPKLFXLVTKKX,24,"DC-brevinin-1BYa, peak 1 (cis)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50=4 μM ); MDA-MB-231 (LC50=7 μM ),Human erythrocytes: LC50=4 μM ,Cyclic,Free,Free,X=Allylglycine,L,Not available,Not available,21312033,Eur Biophys J. 2011 Apr;40(4):555-64.,"Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.","Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa",24,21-24
DRAMP33187,FLPILASLAAKFGPKLFXLVTKKX,24,"DC-brevinin-1BYa, peak 1 (cis)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Human erythrocytes: LC50=4 μM ,Cyclic,Free,Free,X=Allylglycine,L,Not available,Not available,21312033,Eur Biophys J. 2011 Apr;40(4):555-64.,"Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.","Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa",24,21-24
DRAMP33188,FLPILASLAAKFGPKLFXLVTKKX,24,"DC-brevinin-1BYa, peak 2 (trans)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50=4 μM ); MDA-MB-231 (LC50=7 μM ),Human erythrocytes: LC50=4 μM ,Cyclic,Free,Free,X=Allylglycine,L,Not available,Not available,21312033,Eur Biophys J. 2011 Apr;40(4):555-64.,"Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.","Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa",24,21-24
DRAMP33189,FLPILASLAAKFGPKLFXLVTKKX,24,"DC-brevinin-1BYa, peak 2 (trans)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Human erythrocytes: LC50=4 μM ,Cyclic,Free,Free,X=Allylglycine,L,Not available,Not available,21312033,Eur Biophys J. 2011 Apr;40(4):555-64.,"Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.","Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa",24,21-24
DRAMP33190,FLPILASLAAKFGPKLFSLVTKKS,24,"[Ser18,Ser24]-brevinin-1BYa",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50=10 μM ); MDA-MB-231 (LC50=13 μM ),Human erythrocytes: LC50=75 μM ,Cyclic,Free,Free,,L,Not available,Not available,21312033,Eur Biophys J. 2011 Apr;40(4):555-64.,"Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.","Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa",24,21-24
DRAMP33191,GQSQWRDVCRNFMRR,15,Granulysin (37-51) [R38Q][R40Q],P22749,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Jurkat (Not active at 20 µM),Not available,Linear,Free,Free,,L,Not available,Not available,10903754,J Immunol. 2000 Aug 1;165(3):1486-90. ,"Wang Z, Choice E, Kaspar A, Hanson D, Okada S, Lyu SC, Krensky AM, Clayberger C. ",Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin,15,12-15
DRAMP33192,FLSLIPHIVSGVASLAKHF,19,PLS-S2,Not available,,Not found,Phyllomedusa sauvagii,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: THP-1 (IC50=22.5 µM),Human erythrocytes: LC50=25 µM,Linear,Free,Amidation,,L,Not available,Not available,23967105, PLoS One. 2013 Aug 13;8(8):e70782. ,"Raja Z, André S, Piesse C, Sereno D, Nicolas P, Foulon T, Oury B, Ladram A. ","Structure, antimicrobial activities and mode of interaction with membranes of novel [corrected] phylloseptins from the painted-belly leaf frog, Phyllomedusa sauvagii",19,18-21
DRAMP33193,FLSMIPHIVSGVAALAKHL,19,PLS-S4,Not available,,Not found,Phyllomedusa sauvagii,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: THP-1 (IC50=23 µM),Human erythrocytes: LC50=33 µM,Linear,Free,Amidation,,L,Not available,Not available,23967105, PLoS One. 2013 Aug 13;8(8):e70782. ,"Raja Z, André S, Piesse C, Sereno D, Nicolas P, Foulon T, Oury B, Ladram A. ","Structure, antimicrobial activities and mode of interaction with membranes of novel [corrected] phylloseptins from the painted-belly leaf frog, Phyllomedusa sauvagii",19,18-21
DRAMP33211,Cklaklakklaklak,15,C-D-PAP,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LD50>256 µg/ml; 32% Killing=250 µg/ml),Not available,Linear,Free,Free,k=D-Lys; l=D-Leu; a=D-Ala,Mix,Not available,Not available,33335804,PeerJ. 2020 Nov 30;8:e10176.,"Ohno MK, Kirikae T, Yoshihara E, Kirikae F, Ishida I.","Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [D(KLAKLAK)2] increases antimicrobial activities against multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli",15,12-15
DRAMP33212,klaklakklaklakC,15,D-PAP-C,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LD50=192 µg/ml),Not available,Linear,Free,Free,k=D-Lys; l=D-Leu; a=D-Ala,Mix,Not available,Not available,33335804,PeerJ. 2020 Nov 30;8:e10176.,"Ohno MK, Kirikae T, Yoshihara E, Kirikae F, Ishida I.","Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [D(KLAKLAK)2] increases antimicrobial activities against multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli",15,12-15
DRAMP33213,GLWNSIKIAGKKLFVNVLDKIR,22,GL-22,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 (IC50=128.89 μM); NCI-H838 (IC50=25.25 μM); U-251MG (IC50=40.58 μM); H157 (IC50=9.36 μM),Horse erythrocytes: 10% Hemolysis=87.304 µM; 50% Hemolysis=254.11 µM,Linear,Free,Amidation,,L,Human keratinocytes HaCat: IC50=38.90 µM,Not available,36009917,Antibiotics (Basel). 2022 Aug 3;11(8):1048. ,"Liu S, Lin Y, Liu J, Chen X, Ma C, Xi X, Zhou M, Chen T, Burrows JF, Wang L. ","Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb",22,21-24
DRAMP33227,PAWHHAFHWAWRMLKKAA,18,L5a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=19 ± 3 μM(pH=7.4); IC50=10 ± 2 μM(pH=5.5)),Not available,Linear,Free,Free,,L,CHO: IC50=13 ± 2 μM(pH=7.4); IC50=8 ± 1 μM(pH=5.5),Not available,19464332,Peptides. 2009 Aug;30(8):1523-8.,"Tu Z, Volk M, Shah K, Clerkin K, Liang JF. ",Constructing bioactive peptides with pH-dependent activities,18,15-18
DRAMP33228,PAWRKAFRWAWHMLHHAA,18,L5b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=12 ± 2 μM(pH=7.4); IC50=7 ± 2 μM(pH=5.5)),Not available,Linear,Free,Free,,L,CHO: IC50=12 ± 1 μM(pH=7.4); IC50=6 ± 2 μM(pH=5.5),Not available,19464332,Peptides. 2009 Aug;30(8):1523-8.,"Tu Z, Volk M, Shah K, Clerkin K, Liang JF. ",Constructing bioactive peptides with pH-dependent activities,18,15-18
DRAMP33229,PAWRHAFHWAWHMLHKAA,18,L5c,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50>80 μM(pH=7.4); IC50=12 ± 2 μM(pH=5.5)),Not available,Linear,Free,Free,,L,CHO: IC50=67 ± 3 μM(pH=7.4); IC50=7 ± 2 μM(pH=5.5),Not available,19464332,Peptides. 2009 Aug;30(8):1523-8.,"Tu Z, Volk M, Shah K, Clerkin K, Liang JF. ",Constructing bioactive peptides with pH-dependent activities,18,15-18
DRAMP33230,GLFAVIHKVASVIGGL,16,Citropin-a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=56±3 μM(pH=7.4); IC50=44±3 μM(pH=5.5)),Not available,Linear,Free,Free,,L,CHO: IC50=78 ± 2 μM(pH=7.4); IC50=47 ± 3 μM(pH=5.5),Not available,19464332,Peptides. 2009 Aug;30(8):1523-8.,"Tu Z, Volk M, Shah K, Clerkin K, Liang JF. ",Constructing bioactive peptides with pH-dependent activities,16,15-18
DRAMP33231,GLFAVIKHVASVIGGL,16,Citropin-b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=97 ± 4 μM(pH=7.4); IC50=61±3 μM(pH=5.5)),Not available,Linear,Free,Free,,L,CHO: IC50=76 ± 4 μM(pH=7.4); IC50=41 ± 5 μM(pH=5.5),Not available,19464332,Peptides. 2009 Aug;30(8):1523-8.,"Tu Z, Volk M, Shah K, Clerkin K, Liang JF. ",Constructing bioactive peptides with pH-dependent activities,16,15-18
DRAMP33232,GLFAVIHHVASVIGGL,16,Citropin-c,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=156 ± 7 μM(pH=7.4); IC50=36 ± 2 μM(pH=5.5)),Not available,Linear,Free,Free,,L,CHO: IC50>120 μM(pH=7.4); IC50>120 μM(pH=5.5),Not available,19464332,Peptides. 2009 Aug;30(8):1523-8.,"Tu Z, Volk M, Shah K, Clerkin K, Liang JF. ",Constructing bioactive peptides with pH-dependent activities,16,15-18
DRAMP33325,GFKDLLKKAAKALVKTVLF,19,[Lys8] Ascaphin-8,P0CJ32,,Not found,Synthetic (Derived from Ascaphin-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50=8 µM),Human erythrocytes: LC50=11 µM,Linear,Free,Amidation,,L,L929 fibroblast-derived cells: LC50=5 µM,Not available,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E. ","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7",19,18-21
DRAMP33326,GFKDLLKGAKKALVKTVLF,19,[Lys10] Ascaphin-8,P0CJ32,,Not found,Synthetic (Derived from Ascaphin-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50>200 µM),Human erythrocytes: LC50>500 µM,Linear,Free,Amidation,,L,L929 fibroblast-derived cells: LC50>200 µM,Not available,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E. ","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7",19,18-21
DRAMP33327,GFKDLLKGAAKALKKTVLF,19,[Lys14] Ascaphin-8,P0CJ32,,Not found,Synthetic (Derived from Ascaphin-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50=200 µM),Human erythrocytes: LC50>500 µM,Linear,Free,Amidation,,L,L929 fibroblast-derived cells: LC50=110 µM,Not available,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E. ","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7",19,18-21
DRAMP33328,GFKDLLKGAAKALVKTVKF,19,[Lys18] Ascaphin-8,P0CJ32,,Not found,Synthetic (Derived from Ascaphin-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50=200 µM),Human erythrocytes: LC50>500 µM,Linear,Free,Amidation,,L,L929 fibroblast-derived cells: LC50=55 µM,Not available,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E. ","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7",19,18-21
DRAMP33329,GFKDLLKkAAKALVKTVLF,19,[D-Lys8] Ascaphin-8,P0CJ32,,Not found,Synthetic (Derived from Ascaphin-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50=15 µM),Human erythrocytes: LC50=150 µM,Linear,Free,Amidation,,Mix,L929 fibroblast-derived cells: LC50=9 µM,Not available,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E. ","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7",19,18-21
DRAMP33330,GFKDLLKGAkKALVKTVLF,19,[D-Lys10] Ascaphin-8,P0CJ32,,Not found,Synthetic (Derived from Ascaphin-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50>200 µM),Human erythrocytes: LC50>500 µm,Linear,Free,Amidation,,Mix,L929 fibroblast-derived cells: LC50>200 µM,Not available,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E. ","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7",19,18-21
DRAMP33331,GFKDLLKGAAKALkKTVLF,19,[D-Lys14] Ascaphin-8,P0CJ32,,Not found,Synthetic (Derived from Ascaphin-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50>200 µM),Human erythrocytes: LC50>500 µM,Linear,Free,Amidation,,Mix,L929 fibroblast-derived cells: LC50=140 µM,Not available,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E. ","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7",19,18-21
DRAMP33332,GFKDLLKGAAKALVKTVkF,19,[D-Lys18] Ascaphin-8,P0CJ32,,Not found,Synthetic (Derived from Ascaphin-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (LC50=140 µM),Human erythrocytes: LC50>500 µM,Linear,Free,Amidation,,Mix,L929 fibroblast-derived cells: LC50=65 µM,Not available,18554256,Chem Biol Drug Des. 2008 Jul;72(1):58-64.,"Conlon JM, Galadari S, Raza H, Condamine E. ","Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7",19,18-21
DRAMP33355,NGRKACLNPASPIVKKIIEKMLNS,24,Chemokinostatin-1,P09341,,Not found,Homo sapiens (CXCL1/Gro-α),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,CXCR,18307172, J Cell Biochem. 2008 Jul 1;104(4):1356-63.,"Karagiannis ED, Popel AS.",Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines,24,21-24
DRAMP33356,NGKKACLNPASPMVQKIIEKIL,22,Chemokinostatin-3,P19876,,Not found,Homo sapiens (CXCL3/Gro-γ),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,CXCR,18307172, J Cell Biochem. 2008 Jul 1;104(4):1356-63.,"Karagiannis ED, Popel AS.",Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines,22,21-24
DRAMP33357,NGKEICLDPEAPFLKKVIQKILD,23,Chemokinostatin-5,P42830,,Not found,Homo sapiens (CXCL5/ENA-78),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,CXCR,18307172, J Cell Biochem. 2008 Jul 1;104(4):1356-63.,"Karagiannis ED, Popel AS.",Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines,23,21-24
DRAMP33358,NGKQVCLDPEAPFLKKVIQKILDS,24,Chemokinostatin-6,P80162,,Not found,Homo sapiens (CXCL6/GCP-2),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,CXCR,18307172, J Cell Biochem. 2008 Jul 1;104(4):1356-63.,"Karagiannis ED, Popel AS.",Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines,24,21-24
DRAMP33359,DGRKICLDPDAPRIKKIVQKKL,22,Chemokinostatin-7,P02775,,Not found,Homo sapiens (CXCL7/PBP),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,CXCR,18307172, J Cell Biochem. 2008 Jul 1;104(4):1356-63.,"Karagiannis ED, Popel AS.",Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines,22,21-24
DRAMP33360,DGRELCLDPKENWVQRVVEKFLK,23,Chemokinostatin-8,P10145,,Not found,Homo sapiens (CXCL8/IL-8),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,CXCR,18307172, J Cell Biochem. 2008 Jul 1;104(4):1356-63.,"Karagiannis ED, Popel AS.",Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines,23,21-24
DRAMP33361,KILRGVSKKIMRTFLRR,17,N17,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Human erythrocytes: <5% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,17,15-18
DRAMP33363,KKIMRTFLRRISKDILTGKK,20,C20,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Human erythrocytes: <5% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,20,18-21
DRAMP33364,KKIMRTFLRRISKKILTGKK,20,C20-DK,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Human erythrocytes: <5% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,20,18-21
DRAMP33365,KILRGVSKKIMRRISKDILTGKK,23,N23b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Human erythrocytes: <5% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,23,21-24
DRAMP33366,KILGVSKKIMRRISKDILTGKK,22,N22b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Human erythrocytes: <5% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,22,21-24
DRAMP33367,KISKKIMRTFLRRILTGKK,19,NK19a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (21.1 ± 4.0% Cytotoxicity=100 μg/ml),Human erythrocytes: 100% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,19,18-21
DRAMP33368,KILRGVSKKIMRRILTGKK,19,NK19b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Human erythrocytes: <5% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,19,18-21
DRAMP33369,RILRGVSRRIMRRILTGRR,19,NK19b-KR,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (6.6 ± 7.9% Cytotoxicity=100 μg/ml),Human erythrocytes: <10% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,19,18-21
DRAMP33370,KILRGVSKRILTGKK,15,NK15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 100μg/ml),Human erythrocytes: <5% Hemolysis=100 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,17389605,J Biol Chem. 2007 May 18;282(20):14719-28.,"Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. ",Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens,15,12-15
DRAMP33377,KWKKLLKKLLKLLKKLLK,18,KLW,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (IC50=0.6 µM); SK-OV-3 (IC50=0.6 µM); SK-MEL-2 (IC50=0.7 µM),Human erythrocytes: 55% Hemolysis=100 µM,Linear,Free,Amidation,,L,NIH 3T3: IC50=1.8 µM,Not available,16142907, Biochemistry. 2005 Sep 13;44(36):12094-106. ,"Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. ",Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues,18,15-18
DRAMP33378,KWKKLLKKXLKLLKKLLK,18,KLW-L9-Nala,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SK-OV-3 (IC50=1.7 µM); A549 (IC50=2 µM); SK-MEL-2 (IC50=2.1 µM),Human erythrocytes: 5% Hemolysis=100 µM,Linear,Free,Amidation,X=NAla,L,NIH 3T3: IC50=7.1 µM,Not available,16142907, Biochemistry. 2005 Sep 13;44(36):12094-106. ,"Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. ",Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues,18,15-18
DRAMP33379,KWKKLLKKLXKLLKKLLK,18,KLW-L10-Nala,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SK-OV-3 (IC50=0.9 µM); A549 (IC50=1 µM); SK-MEL-2 (IC50=1.3 µM),Human erythrocytes: 23% Hemolysis=100 µM,Linear,Free,Amidation,X=NAla,L,NIH 3T3: IC50=2 µM,Not available,16142907, Biochemistry. 2005 Sep 13;44(36):12094-106. ,"Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. ",Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues,18,15-18
DRAMP33380,KWKKLLKKLLXLLKKLLK,18,KLW-K11-Nala,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SK-OV-3 (IC50=0.5 µM); A549 (IC50=0.6 µM); SK-MEL-2 (IC50=0.6 µM),Human erythrocytes: 50% Hemolysis=100 µM,Linear,Free,Amidation,X=NAla,L,NIH 3T3: IC50=1 µM,Not available,16142907, Biochemistry. 2005 Sep 13;44(36):12094-106. ,"Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. ",Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues,18,15-18
DRAMP33381,KWKKLLKKXLKLXKKLLK,18,"KLW-L9,13-Nala",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SK-OV-3 (IC50=31.9 µM); SK-MEL-2 (IC50=38.7 µM); A549 (IC50=75.5 µM),Human erythrocytes: 0% Hemolysis=100 µM,Linear,Free,Amidation,X=NAla,L,NIH 3T3: IC50>100 µM,Not available,16142907, Biochemistry. 2005 Sep 13;44(36):12094-106. ,"Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. ",Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues,18,15-18
DRAMP33382,KWKKLLXKLLXLLKKLLK,18,"KLW-K7,11-Nala",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SK-OV-3 (IC50=0.7 µM); A549 (IC50=1 µM); SK-MEL-2 (IC50=1.1 µM),Human erythrocytes: 27% Hemolysis=100 µM,Linear,Free,Amidation,X=NAla,L,NIH 3T3: IC50=2 µM,Not available,16142907, Biochemistry. 2005 Sep 13;44(36):12094-106. ,"Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. ",Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues,18,15-18
DRAMP33386,GFXGXKKXGXFXGXGKKXKKKK,22,AMP 1A analogs1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.9 μM ); RL (IC50=2 μM ); UACC-62 (IC50=2.6 μM ); A498 (IC50=3 μM ); COLO 205 (IC50=5.4 μM ); MCF-7  (IC50=6.2 μM ); A549 (IC50=7.2 μM ); Mia PaCa-2 (IC50=7.3 μM ); CFPAC-1 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ),Not available,Linear,Acetylation,Amidation,X=A6c (1-aminocyclohexane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,22,21-24
DRAMP33387,GFXGXRXGXFXGXGRXRRRR,20,AMP 1A analogs2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=1.1 μM ); NCI-H69 (IC50=2 μM ); CFPAC-1 (IC50=2.6 μM ); Mia PaCa-2 (IC50=5 μM ); A498 (IC50=5.6 μM ); IGROV-1 (IC50=6 μM ); A549 (IC50=6.4 μM ); DLD-1 (IC50=6.4 μM ); UACC-62 (IC50=6.4 μM ); COLO 205 (IC50=6.6 μM ); MCF-7  (IC50=7 μM ); PC-3 (IC50=7.4 μM ),Not available,Linear,Acetylation,Amidation,X=A6c (1-aminocyclohexane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33388,GFXGXRXGXFXGXGRXRRRR,20,AMP 1A analogs2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=3.7 μM); NCI-H69 (IC50=7.1 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X=A6c (1-aminocyclohexane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33389,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33390,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM),Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33391,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33392,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33393,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM),Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33394,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33395,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33396,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM),Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33397,GFXGXXXGXFXGXGXXXXXX,20,AMP 1A analogs5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33398,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM ),Not available,Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33399,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33400,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33401,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33402,GFXGXRXGXFXGXGRXRRRR,20,AMP 1A analogs7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=1.1 μM ); NCI-H69 (IC50=2 μM ); CFPAC-1 (IC50=2.6 μM ); Mia PaCa-2 (IC50=5 μM ); A498 (IC50=5.6 μM ); IGROV-1 (IC50=6 μM ); A549 (IC50=6.4 μM ); DLD-1 (IC50=6.4 μM ); UACC-62 (IC50=6.4 μM ); COLO 205 (IC50=6.6 μM ); MCF-7  (IC50=7 μM ); PC-3 (IC50=7.4 μM ),Not available,Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33403,GFXGXRXGXFXGXGRXRRRR,20,AMP 1A analogs7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=3.7 μM); NCI-H69 (IC50=7.1 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X=A5c (1-aminocyclopentane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33404,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM ),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33405,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33406,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33407,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33408,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM ),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33409,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33410,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33411,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33412,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM ),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33413,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33414,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33415,GFXGXKXGXFXGXGKXKKKK,20,AMP 1A analogs10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33416,KKKKGFXGXKXGXFXGXGKX,20,AMP 1A analogs11,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: NCI-H69 (IC50=2.2 μM); RL (IC50=3.7 μM); A498 (IC50=4.2 μM); UACC-62 (IC50=6.4 μM); COLO 205 (IC50=6.7 μM); A549 (IC50=7.2 μM); MCF-7  (IC50=7.3 μM); CFPAC-1 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM),Not available,Linear,Acetylation,Amidation,X=A6c (1-aminocyclohexane carboxylic acid),L,Not available,Not available,27387357,Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.,Hicks RP. ,Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids,20,18-21
DRAMP33467,KKLIKVWAKGFKKAKKLFKGIG,22,PBP,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (21% Cytotoxicity=15 µM),Sheep erythrocytes: 10% Hemolysis=15 µM,Linear,Free,Free,,L,Not available,Not available,30637367,Pept Sci (Hoboken). 2018 Jul;110(4):e24074.,"Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.",Antimicrobial activity of a porphyrin binding peptide,22,21-24
DRAMP33468,KKLIKVFAKGWKKAKKLFKGIG,22,PBP-W11,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (52% Cytotoxicity=15 µM),Sheep erythrocytes: 0% Hemolysis=15 µM,Linear,Free,Free,,L,Not available,Not available,30637367,Pept Sci (Hoboken). 2018 Jul;110(4):e24074.,"Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.",Antimicrobial activity of a porphyrin binding peptide,22,21-24
DRAMP33469,KKLIKVFAKGFKKAKKLWKGIG,22,PBP-W18,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (52% Cytotoxicity=15 µM),Sheep erythrocytes: 0% Hemolysis=15 µM,Linear,Free,Free,,L,Not available,Not available,30637367,Pept Sci (Hoboken). 2018 Jul;110(4):e24074.,"Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.",Antimicrobial activity of a porphyrin binding peptide,22,21-24
DRAMP33470,XXLIXVWAXGFXXAXXLFXGIG,22,PBP-X,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (8% Cytotoxicity=15 µM),Sheep erythrocytes: 0% Hemolysis=15 µM,Linear,Free,Free,X=Diaminopropionic acid,L,Not available,Not available,30637367,Pept Sci (Hoboken). 2018 Jul;110(4):e24074.,"Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.",Antimicrobial activity of a porphyrin binding peptide,22,21-24
DRAMP33471,KKAAKAWAKGAKKAKKLAKGAG,22,PBP-A,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (12% Cytotoxicity=15 µM),Sheep erythrocytes: 0% Hemolysis=15 µM,Linear,Free,Free,,L,Not available,Not available,30637367,Pept Sci (Hoboken). 2018 Jul;110(4):e24074.,"Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.",Antimicrobial activity of a porphyrin binding peptide,22,21-24
DRAMP33478,GWKDWFRKAKKVGKTVGGLALNHYL,25,NRC-123,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HL-60 (50% Cell death=16 µg/ml),Human erythrocytes: 50% Hemolysis>256 µg/ml,Linear,Free,Amidation,,L,"Zebrafish embryos: >10% Killing=5 µg/ml (4, 28, 52hpf embryo)",Not available,21729875,Dis Model Mech. 2011 Sep;4(5):622-33.,"Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.",The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents,25,24-27
DRAMP33479,GIRKWFKKAAHVGKEVGKVALNACL,25,NRC-124,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HL-60 (50% Cell death=128 µg/ml),Human erythrocytes: 50% Hemolysis>256 µg/ml,Linear,Free,Free,,L,"Zebrafish embryos: >10% Killing=5 µg/ml (4, 52hpf embryo); >10% Killing=25 µg/ml (28hpf embryo)",Not available,21729875,Dis Model Mech. 2011 Sep;4(5):622-33.,"Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.",The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents,25,24-27
DRAMP33480,GLKKWFKKAVHVGKKVGKVALNAYL,25,NRC-125,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HL-60 (50% Cell death=16 µg/ml),Human erythrocytes: 50% Hemolysis>256 µg/ml,Linear,Free,Amidation,,L,"Zebrafish embryos: >10% Killing=5 µg/ml (4, 28, 52hpf embryo)",Not available,21729875,Dis Model Mech. 2011 Sep;4(5):622-33.,"Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.",The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents,25,24-27
DRAMP33481,GWRKWIKKATHVGKHIGKAALDAYI,25,NRC-126,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HL-60 (50% Cell death=32 µg/ml),Human erythrocytes: 50% Hemolysis>256 µg/ml,Linear,Free,Amidation,,L,"Zebrafish embryos: >10% Killing=5 µg/ml (4, 52hpf embryo)",Not available,21729875,Dis Model Mech. 2011 Sep;4(5):622-33.,"Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.",The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents,25,24-27
DRAMP33482,GCKKWFKKAAHVGKNVGKVALNAYL,25,NRC-127,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HL-60 (50% Cell death=32 µg/ml),Human erythrocytes: 50% Hemolysis>256 µg/ml,Linear,Free,Amidation,,L,"Zebrafish embryos: >10% Killing=5 µg/ml (4, 28hpf embryo); >10% Killing=25 µg/ml (52hpf embryo)",Not available,21729875,Dis Model Mech. 2011 Sep;4(5):622-33.,"Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.",The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents,25,24-27
DRAMP33483,GIRKWFKKAAHVGKKVGKVALNAYL,25,NRC-128,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HL-60 (50% Cell death=64 µg/ml),Human erythrocytes: 50% Hemolysis>256 µg/ml,Linear,Free,Amidation,,L,"Zebrafish embryos: >10% Killing=5 µg/ml (28, 52hpf embryo); >10% Killing=25 µg/ml (4hpf embryo)",Not available,21729875,Dis Model Mech. 2011 Sep;4(5):622-33.,"Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.",The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents,25,24-27
DRAMP33485,GLVGTLLGHIGKAILG,16,Frenatin 2.1S,Not available,,Not found,Sphaenorhynchus lacteus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=80 ± 6 μM ),Human erythrocytes: HC50=167 ± 8 µM,Linear,Free,Amidation,,L,Not available,Not available,24704757, Peptides. 2014 Jun;56:132-40.,"Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.",A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae),16,15-18
DRAMP33486,GLVGTLLGHIGKAILG,16,Frenatin 2.1S,Not available,,Not found,Sphaenorhynchus lacteus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50>100 μM ),Human erythrocytes: HC50=167 ± 8 µM,Linear,Free,Amidation,,L,Not available,Not available,24704757, Peptides. 2014 Jun;56:132-40.,"Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.",A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae),16,15-18
DRAMP33487,GLVGTLLGHIGKAILS,16,Frenatin 2.2S,Not available,,Not found,Sphaenorhynchus lacteus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=65 ± 5 μM ),Human erythrocytes: HC50=169 ± 7 µM,Linear,Free,Amidation,,L,Not available,Not available,24704757, Peptides. 2014 Jun;56:132-40.,"Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.",A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae),16,15-18
DRAMP33488,GLVGTLLGHIGKAILG,16,Frenatin 2.3S,Not available,,Not found,Sphaenorhynchus lacteus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50=80 ± 6 μM ),Human erythrocytes: HC50=404 ± 11 µM,Linear,Free,Free,,L,Not available,Not available,24704757, Peptides. 2014 Jun;56:132-40.,"Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.",A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae),16,15-18
DRAMP33489,GLVGTLLGHIGKAILG,16,Frenatin 2.3S,Not available,,Not found,Sphaenorhynchus lacteus,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (LC50>100 μM ),Human erythrocytes: HC50=404 ± 11 µM,Linear,Free,Free,,L,Not available,Not available,24704757, Peptides. 2014 Jun;56:132-40.,"Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.",A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae),16,15-18
DRAMP33500,VKRFKKFFRKLKKSV,15,B1-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33501,VKRFKKFFRKLKKSV,15,B1-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33502,VKRFKKFFRKLKKSV,15,B1-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33503,VKRFKKFFRKLKKSV,15,B1-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33504,VKRFKKFFRKLKKSV,15,B1-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33505,VKRFKKFFRKLKKSV,15,B1-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33506,VKRFKKFFRKLKKSV,15,B1-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33507,VKRFKKFFRKLKKSV,15,B1-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33508,VKRFKKFFRKLKKSV,15,B1-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33509,VKRFKKFFRKLKKSV,15,B1-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33510,VKRFKKFFRKLKKSV,15,B1-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33511,VKRFKKFFRKLKKSV,15,B1-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33512,VKRFKKFFRKLKKSV,15,B1-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33513,VKRFKKFFRKLKKSV,15,B1-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33514,VKRFKKFFRKLKKSV,15,B1-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33515,VKRFKKFFRKLKKSV,15,B1-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33516,VKRFKKFFRKLKKSV,15,B1-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33517,VKRFKKFFRKLKKSV,15,B1-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33518,VKRFKKFFRKLKKSV,15,B1-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33519,VKRFKKFFRKLKKSV,15,B1-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33520,VKRFKKFFRKLKKSV,15,B1-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33521,VKRFKKFFRKLKKSV,15,B1-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33522,VKRFKKFFRKLKKSV,15,B1-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33523,VKRFKKFFRKLKKSV,15,B1-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33524,VKRFKKFFRKLKKSV,15,B1-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33525,VKRFKKFFRKLKKSV,15,B1-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM ),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33526,VKRFKKFFRKLKKSV,15,B1-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33527,VKRFKKFFRKLKKSV,15,B1-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33528,VKRFKKFFRKLKKSV,15,B1-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33529,VKRFKKFFRKLKKSV,15,B1-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",15,12-15
DRAMP33530,GGVKRFKKFFRKLKKSV,17,B1-GG-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33531,GGVKRFKKFFRKLKKSV,17,B1-GG-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33532,GGVKRFKKFFRKLKKSV,17,B1-GG-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33533,GGVKRFKKFFRKLKKSV,17,B1-GG-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33534,GGVKRFKKFFRKLKKSV,17,B1-GG-C10,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)8CO, Decanoic acid",Amidation,,L,GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33535,GGVKRFKKFFRKLKKSV,17,B1-GG-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33536,GGVKRFKKFFRKLKKSV,17,B1-GG-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33537,GGVKRFKKFFRKLKKSV,17,B1-GG-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33538,GGVKRFKKFFRKLKKSV,17,B1-GG-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33539,GGVKRFKKFFRKLKKSV,17,B1-GG-C12,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)10CO, Dodecanoic acid",Amidation,,L,GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33540,GGVKRFKKFFRKLKKSV,17,B1-GG-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33541,GGVKRFKKFFRKLKKSV,17,B1-GG-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33542,GGVKRFKKFFRKLKKSV,17,B1-GG-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33543,GGVKRFKKFFRKLKKSV,17,B1-GG-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33544,GGVKRFKKFFRKLKKSV,17,B1-GG-C14,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)12CO, Myristic acid",Amidation,,L,GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33545,GGVKRFKKFFRKLKKSV,17,B1-GG-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33546,GGVKRFKKFFRKLKKSV,17,B1-GG-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33547,GGVKRFKKFFRKLKKSV,17,B1-GG-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33548,GGVKRFKKFFRKLKKSV,17,B1-GG-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33549,GGVKRFKKFFRKLKKSV,17,B1-GG-C16,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)14CO, Palmitic acid",Amidation,,L,GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33550,GGVKRFKKFFRKLKKSV,17,B1-GG-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33551,GGVKRFKKFFRKLKKSV,17,B1-GG-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33552,GGVKRFKKFFRKLKKSV,17,B1-GG-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33553,GGVKRFKKFFRKLKKSV,17,B1-GG-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33554,GGVKRFKKFFRKLKKSV,17,B1-GG-C18,B6D434,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM),Human erythrocytes: <20% Hemolysis	=160 µM,Linear,"CH3(CH2)16CO, Octadecanoic acid",Amidation,,L,GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM,Not available,26083110,Org Biomol Chem. 2015 Jul 28;13(28):7673-80. ,"Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.","Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability",17,15-18
DRAMP33562,GNNKPVYRPQPRPPHPRL,18,"Apidaecin-1B [R4K, I8R]",P35581,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A431 (30% Cytotoxicity=10 µM); MDA-MB-231 (Not active up to 10 µM),Not available,Linear,Free,Free,,L,Not available,Not available,31209863,Biotechnol Bioeng. 2019 Oct;116(10):2439-2450.,"Lai PK, Tresnak DT, Hackel BJ. ",Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery,18,15-18
DRAMP33563,VDKGSYRPRPTPPKPIYNRN,20,"Pyrrhocoricin [L7R, R14K]",P37362,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A431 (<10% Cytotoxicity=10 µM); MDA-MB-231 (Not active up to 10 µM),Not available,Linear,Free,Free,,L,Not available,Not available,31209863,Biotechnol Bioeng. 2019 Oct;116(10):2439-2450.,"Lai PK, Tresnak DT, Hackel BJ. ",Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery,20,18-21
DRAMP33564,VDKPPYLPRPRPPRXIYNX,19,Oncocin Onc72,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 600 µg/ml); HepG2 (Not active up to 600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml),Not available,Linear,Free,Amidation,X=Orn,L,HEK293: Not active up to 600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33565,VRKPPYLPRPRWPRXIYNX,19,Oncocin Onc72 analog a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SH-SY5Y (<5% Cytotoxicity=600 µg/ml); HeLa  (25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml),Not available,Linear,Free,Amidation,X=Orn,L,HEK293: Not active up to 600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33566,VXKPPYLPRPRWPRXIYNX,19,Oncocin Onc72 analog b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml),Not available,Linear,Free,Amidation,X=Orn,L,HEK293: Not active up to 600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33567,VrKPPYLPRPRWPRXIYNX,19,Oncocin Onc72 analog c,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml),Not available,Linear,Free,Amidation,r=D-Arg; X=Orn,Mix,HEK293: Not active up to 600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33568,VDKPPYLPRPRPxRxXYNX,19,Oncocin Onc110,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SH-SY5Y (<5% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml),Not available,Linear,Free,Amidation,x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn,Mix,HEK293: Not active up to 600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33569,VRKPPYLPRPRWxRxjYNX,19,Oncocin Onc110 analog a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (<10% Cytotoxicity=600 µg/ml); HeLa  (10-20% Cytotoxicity=600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml),Not available,Linear,Free,Amidation,x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn,Mix,HEK293: Not active up to 600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33570,VXKPPYLPRPRWxRxjYNX,19,Oncocin Onc110 analog b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (10-20% Cytotoxicity=600 µg/ml),Not available,Linear,Free,Amidation,x=trans-4-hydroxyproline; X(16)=tert-Leu; X(2/19)=Orn,Mix,HEK293: Not active up to 600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33571,VrKPPYLPRPRWxRxjYNX,19,Oncocin Onc110 analog c,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (10-20% Cytotoxicity=600 µg/ml); SH-SY5Y (5% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml),Not available,Linear,Free,Amidation,r=D-Arg; x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn,Mix,HEK293: Not active up to 600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33572,VRKPPYLPRPRWPRrIYNr,19,Oncocin Onc112 analog a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (50-60% Cytotoxicity=600 µg/ml),Not available,Linear,Free,Amidation,r=D-Arg,Mix,HEK293: 50-60% Cytotoxicity=600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33573,VXKPPYLPRPRWPRrIYNr,19,Oncocin Onc112 analog b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SH-SY5Y (<10% Cytotoxicity=600 µg/ml); HepG2 (10% Cytotoxicity=600 µg/ml); HeLa  (40% Cytotoxicity=601 µg/ml),Not available,Linear,Free,Amidation,r=D-Arg; X=Orn,Mix,HEK293: 50-60% Cytotoxicity=600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33574,VrKPPYLPRPRWPRrIYNr,19,Oncocin Onc112 analog c,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (<10% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (50-60% Cytotoxicity=600 µg/ml),Not available,Linear,Free,Amidation,r=D-Arg,Mix,HEK293: 50-60% Cytotoxicity=600 µg/ml,Not available,26334348,Amino Acids. 2016 Jan;48(1):269-80.,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP33624,FLWIKLGKLAGAVLKLILGLKKVV,24,Helical1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (EC50=4.4 ± 1.3 µM ); A549 (EC50=8.3 ± 2.0 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,24,21-24
DRAMP33625,GLWAIAVKAGKVILKLIVFIWIRV,24,Helical2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>50 µM ); MCF-7  (EC50>50 µM ),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,24,21-24
DRAMP33626,GLLDIAGGNAETLAGHAV,18,Helical3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM ),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,18,15-18
DRAMP33627,GLFDVIGSQAGGAAPHFLG,19,Helical4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM ),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,19,18-21
DRAMP33628,KWVKKVHNWLRRWIKVFEALFG,22,AmphiArc1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50=18.4 ± 0.7 µM); MCF-7 (EC50=7.0 ± 0.5 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,22,21-24
DRAMP33629,KIFKKFKTIIKKVWRIFGRF,20,AmphiArc2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=5.7 ± 0.7 µM); A549 (EC50=9.3 ± 1.5 µM),Human erythrocytes: HC50=16 ± 2 µM,Linear,Free,Amidation,,L,HDMEC: EC50=3.3 ± 0.2 µM ,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33630,AFRHSVKEELNYIRRRLERFPNRL,24,AmphiArc3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM ),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,24,21-24
DRAMP33631,RIENGLRKRLQSIYRHLEE,19,AmphiArc4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM ),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,19,18-21
DRAMP33632,KWVRIWIKVLRGLFVWVWFF,20,Gradient1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM ),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33633,AWLKRIKKFLKALFWVWVW,19,Gradient2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=19.0 ± 1.8 µM); A549 (EC50>50 µM),Not available,Linear,Free,Amidation,,L,Not available,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,19,18-21
DRAMP33636,RVFKKFHPIYHRVWRLWGHL,20,AmphiArc2 Off1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=27.4 ± 0.5 µM); A549 (EC50=49 ± 2 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=56 ± 7 µM ,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33637,HIIKKIRTWYRKAWHVLGKV,20,AmphiArc2 Off2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=10 ± 2 µM); A549 (EC50=17.0 ± 0.6 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=32 ± 3 µM ,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33638,KLYKKFRHILKKVWHYVGKI,20,AmphiArc2 Off3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=10 ± 1 µM); A549 (EC50=14 ± 3 µM),Human erythrocytes: HC50=29 ± 3 µM,Linear,Free,Free,,L,HDMEC: EC50=10 ± 3 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33639,KYIRHLKTWFKKVFKLIGEV,20,AmphiArc2 Off4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=11 ± 2 µM); A549 (EC50=15.0 ± 0.1 µM),Human erythrocytes: HC50=20 ± 3 µM,Linear,Free,Free,,L,HDMEC: EC50=7.1 ± 0.1 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33640,KIFKKFKDFLKKIFQYLGKV,20,AmphiArc2 Off5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=12.4 ± 0.4 µM); A549 (EC50=17.4 ± 0.1 µM),Human erythrocytes: HC50=15 ± 2 µM,Linear,Free,Free,,L,HDMEC: EC50=10.1 ± 0.2 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33641,HIFKKVKTYWKKLFRILGRF,20,AmphiArc2 Off6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=12 ± 3 µM); A549 (EC50=18 ± 2 µM),Human erythrocytes: HC50=16 ± 2 µM,Linear,Free,Free,,L,HDMEC: EC50=5.0 ± 0.7 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33642,RLIKRLKTFVRKTWKWVGHF,20,AmphiArc2 Off7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=39 ± 3 µM); A549 (EC50=52 ± 2 µM),Human erythrocytes: HC50=95 ± 7 µM,Linear,Free,Free,,L,HDMEC: EC50=12 ± 3 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33643,RFLKHFKTVYKRYWKVLGRL,20,AmphiArc2 Off8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=11.9 ± 0.1 µM); A549 (EC50=17 ± 4 µM),Human erythrocytes: HC50=144 ± 4 µM,Linear,Free,Free,,L,HDMEC: EC50=14.3 ± 0.2 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33644,KLIHRLKTVFKKVWHFLGHL,20,AmphiArc2 Off9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=18.9 ± 0.2 µM); A549 (EC50=22 ± 4 µM),Human erythrocytes: HC50=41 ± 3 µM,Linear,Free,Free,,L,HDMEC: EC50=22 ± 3 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33645,HRIRQLKTTIKKFWEIWPKI,20,AmphiArc2 Off10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=56 ± 5 µM); A549 (EC50=83 ± 11 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=58.1 ± 0.3 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33646,QVFKKFRPFYRRPWELFGKL,20,AmphiArc2 Off2.1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=91 ± 2 µM); A549 (EC50>100 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=173 ± 1 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33647,QIIKKIRTWYRKAWHVLGKV,20,AmphiArc2 Off2.2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=11.6 ± 0.8 µM); A549 (EC50=20 ± 1 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=42 ± 7 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33648,TLYKKFRHFLKKPWHVVGKI,20,AmphiArc2 Off2.3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=65 ± 3 µM); A549 (EC50>100 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=167 ± 13 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33649,HYIRHLKTWFHKPFKLIGKV,20,AmphiArc2 Off2.4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=169 ± 28 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33650,KIFKKFKDWFKKAFHVLGKV,20,AmphiArc2 Off2.5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=10.4 ± 0.8 µM); A549 (EC50=14.8 ± 0.7 µM),Human erythrocytes: HC50>100 µM,Linear,Free,Free,,L,HDMEC: EC50=22 ± 1 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33651,QIFKKVKTWYKKAFQILGRL,20,AmphiArc2 Off2.6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50=12.4 ± 0.1 µM); MCF-7 (EC50=9.3 ± 0.2 µM),Human erythrocytes: HC50>100 µM,Linear,Free,Free,,L,HDMEC: EC50=21 ± 2 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33652,RLIKRIKTWYRKAWKVVGKF,20,AmphiArc2 Off2.7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=11.2 ± 0.7 µM); A549 (EC50=15 ± 1 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=23 ± 5 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33653,RFLKHLHTYYERAWHVIGHL,20,AmphiArc2 Off2.8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=2 ± 2 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33654,HLIHRLHTYWHKPWHYLGKL,20,AmphiArc2 Off2.9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=135 ± 2 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33655,QRIRQLHTWIKKAWHIWPKI,20,AmphiArc2 Off2.10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=28.6 ± 0.1 µM); A549 (EC50=40 ± 2 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=39.7 ± 0.3 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33656,QVVKKIRTWYHKAWHVLGKV,20,AmphiArc2 Off2.2.1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=76 ± 15 µM); A549 (EC50>100 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=96 ± 7 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33657,QLIHKIRTWYRKAWHVLGKV,20,AmphiArc2 Off2.2.2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=13 ± 1 µM); A549 (EC50=20 ± 2 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=28 ± 3 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33658,HLLKKWRTWLRKAWHIVGKV,20,AmphiArc2 Off2.2.3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=7 ± 1 µM); A549 (EC50=9 ± 1 µM),Human erythrocytes: HC50=59 ± 6 µM,Linear,Free,Free,,L,HDMEC: EC50=6.1 ± 0.5 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33659,QVLKKVRTWYRKAFHVIGKV,20,AmphiArc2 Off2.2.4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=68 ± 5 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50>100 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33660,QLLKKVRTWYRKAWHLYGKV,20,AmphiArc2 Off2.2.5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=16 ± 2 µM); A549 (EC50=29.3 ± 0.9 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=27.2 ± 0.5 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33661,QLIKKLRTWYRKAWHVLGKL,20,AmphiArc2 Off2.2.6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50=10.6 ± 0.8 µM); MCF-7 (EC50=6.5 ± 0.2 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=9 ± 1 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33662,QIIKKVRTWIKKAWHLIGKI,20,AmphiArc2 Off2.2.7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (EC50=12 ± 2 µM); MCF-7 (EC50=8 ± 1 µM),Human erythrocytes: HC50>100 µM,Linear,Free,Free,,L,HDMEC: EC50=17 ± 1 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33663,QYLRRVRTWLRRAWHILGKV,20,AmphiArc2 Off2.2.8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=11.0 ± 0.2 µM); A549 (EC50=16.5 ± 0.2 µM),Human erythrocytes: HC50=21 ± 1 µM,Linear,Free,Free,,L,HDMEC: EC50=10.3 ± 0.3 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33664,QLLKKIRTWYRKAWHVYGKV,20,AmphiArc2 Off2.2.9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=13 ± 1 µM); A549 (EC50=28 ± 3 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=21 ± 2 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33665,QIYKKYRTWYRKAWKVLGKV,20,AmphiArc2 Off2.2.10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (EC50=16.9 ± 0.8 µM); A549 (EC50=36 ± 7 µM),Human erythrocytes: HC50>200 µM,Linear,Free,Free,,L,HDMEC: EC50=71 ± 12 µM,Not available,31375699, Sci Rep. 2019 Aug 2;9(1):11282.,"Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. ",In silico design and optimization of selective membranolytic anticancer peptides,20,18-21
DRAMP33666,CXGRCLLIIKLAKLAKKLAKLAK,23,CDAK,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"AMPs containing CisoDGRC selectively kill CD13-/αvβ3+ breast cancer cells by inducing apoptosis and inhibiting proliferation. Furthermore, the vivo experiments showed that AMPs containing CisoDGRC could significantly inhibited CD13-/αvβ3+ tumor progression and angiogenesis.",Tumor cells: MCF-7  (IC50=190 µg/ml); MDA-MB-231 (IC50=212 µg/ml),Not available,Cyclic,Free,Free,X=iso-Asp,L,HUVEC: IC50=861 µg/ml; HFF: IC50=912 µg/ml,CD13-/αvβ3+ tumor cells,23326440,PLoS One. 2013;8(1):e53491.,"Hou L, Zhao X, Wang P, Ning Q, Meng M, Liu C.",Antitumor Activity of Antimicrobial Peptides Containing CisoDGRC in CD13 Negative Breast Cancer Cells,23,21-24
DRAMP33673,RFRLPFRRPPIRIPPPFYPPFRRFL,25,ChBac3.4 (H-),P85170,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-937 (IC50=11.5 ± 0.5 μM); K562 (IC50=25.0 ± 3.5 μM),Human erythrocytes: <5% Hemolysis=64 µM,Linear,Free,Amidation,,L,Human PBMC: IC50=34.7 ± 7.3 µM,Not available,33194795,Front Cell Infect Microbiol. 2020 Oct 19;10:552905. ,"Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.",Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs,25,24-27
DRAMP33674,RIHPPPFYPPFRRFL,15,ChBac3.4 (12-26),P85170,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-937 (IC50=17.0 ± 1.1 μM); K562 (IC50=39.4 ± 2.3 μM),Human erythrocytes: <5% Hemolysis=64 µM,Linear,Free,Amidation,,L,Human PBMC: IC50=43.3 ± 7.7 µM,Not available,33194795,Front Cell Infect Microbiol. 2020 Oct 19;10:552905. ,"Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.",Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs,15,12-15
DRAMP33675,RFRLPFRRPPIRIHPPPFY,19,ChBac3.4 (1-19)-NH2,P85170,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=28.0 ± 6.5 μM); U-937 (IC50>64 μM),Human erythrocytes: <5% Hemolysis=64 µM,Linear,Free,Amidation,,L,Human PBMC: IC50>64 µM,Not available,33194795,Front Cell Infect Microbiol. 2020 Oct 19;10:552905. ,"Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.",Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs,19,18-21
DRAMP33677,RFRRFRLPFRRPPIRIH,17,RFR-ChBac3.4 (1-14)-NH2,P85170,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: K562 (IC50=39.4 ± 6.6 μM); U-937 (IC50>64 μM),Human erythrocytes: <5% Hemolysis=64 µM,Linear,Free,Amidation,,L,Human PBMC: IC50>64 µM,Not available,33194795,Front Cell Infect Microbiol. 2020 Oct 19;10:552905. ,"Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.",Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs,17,15-18
DRAMP33683,ILKPKLWKLTVVARKIIK,18,Modifed Opero3,A0A0L7LPN7,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (CC50=200 μM),Human erythrocytes: <10% Hemolysis=50 µM,Linear,Free,Free,,L,Not available,Not available,33063186,Amino Acids. 2020 Oct;52(10):1403-1412,"Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. ","Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes",18,15-18
DRAMP33684,IVIKSLGKFLKNVGGFAG,18,Modifed Pyro1,O58222,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (CC50>200 μM),Human erythrocytes: <10% Hemolysis=50 µM,Linear,Free,Free,,L,Not available,Not available,33063186,Amino Acids. 2020 Oct;52(10):1403-1412,"Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. ","Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes",18,15-18
DRAMP33685,FKLVWKLLKKLALKL,15,Modifed Aper1,Q9Y8Y1,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: CaCo-2 (CC50=12.5 μM); A549 (CC50=25 μM),Human erythrocytes: 10% Hemolysis=5.96 µM,Linear,Free,Free,,L,Not available,Not available,33063186,Amino Acids. 2020 Oct;52(10):1403-1412,"Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. ","Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes",15,12-15
DRAMP33686,ITKWLLNAIKKGFKL,15,Modifed Thermo1,B6YW36,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (CC50>200 μM),Human erythrocytes: 10% Hemolysis=21.9 µM,Linear,Free,Free,,L,Not available,Not available,33063186,Amino Acids. 2020 Oct;52(10):1403-1412,"Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. ","Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes",15,12-15
DRAMP33687,IHKLVKLWLNLGKKF,15,Modifed Thermo2,B6YTI2,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (CC50>200 μM),Human erythrocytes: 10% Hemolysis=39.3 µM,Linear,Free,Free,,L,Not available,Not available,33063186,Amino Acids. 2020 Oct;52(10):1403-1412,"Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. ","Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes",15,12-15
DRAMP33688,LFSIIWKLNRKLIKA,15,Modifed Thermo3,B6YWQ6,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: A549 (CC50>200 μM); CaCo-2 (CC50>200 μM),Human erythrocytes: 10% Hemolysis=37.3 µM,Linear,Free,Free,,L,Not available,Not available,33063186,Amino Acids. 2020 Oct;52(10):1403-1412,"Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. ","Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes",15,12-15
DRAMP33705,AFALIAGALYRIFHRR,16,LHH1,Q036I7,,Not found,Lactobacillus casei HZ1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: C666-1 (IC50=18.27 μM ); MGC-803 (IC50=31.55 μM ); HCT 116 (IC50=40.83 μM ),Goat erythrocytes: HC50=187.2 µM ,Linear,Free,Free,,L,Not available,Not available,33175275,AMB Express. 2020 Nov 11;10(1):204. ,"He JF, Jin DX, Luo XG, Zhang TC. ","LHH1, a novel antimicrobial peptide with anti-cancer cell activity identified from Lactobacillus casei HZ1",16,15-18
DRAMP33710,GLAKVMREVLGYERNSYKKFFLR,23,Ixosin [H3A],Q2LKX9,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (8% Killing=16 µM),Not available,Linear,Free,Amidation,,L,HEK-293: Not active up to 16 µM,Not available,27622949,"Libardo MD, Gorbatyuk VY, Angeles-Boza AM.","Libardo MD, Gorbatyuk VY, Angeles-Boza AM.",Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B,23,21-24
DRAMP33711,KVMREVLGYERNSYKKFFLR,20,Ixosin (4-23),Q2LKX9,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (19% Killing=128 µM),Not available,Linear,Free,Amidation,,L,HEK-293: Not active up to 128 µM,Not available,27622949,"Libardo MD, Gorbatyuk VY, Angeles-Boza AM.","Libardo MD, Gorbatyuk VY, Angeles-Boza AM.",Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B,20,18-21
DRAMP33712,GLHKVMRKVLGYLRNVYK,18,"Ixosin [E8K,E13L,S16V], Ixosin-pch",Q2LKX9,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (24% Killing=1 µM),Not available,Linear,Free,Amidation,,L,HEK-293: 14% Killing=1 µM,Not available,27622949,"Libardo MD, Gorbatyuk VY, Angeles-Boza AM.","Libardo MD, Gorbatyuk VY, Angeles-Boza AM.",Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B,18,15-18
DRAMP33713,GLAKVMRKVLGYLRNVYK,18,"Ixosin [H3A,E8K,E13L,S16V], Ixosin-pch-H3A",Q2LKX9,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (28% Killing=2-4 µM),Not available,Linear,Free,Amidation,,L,HEK-293: 23% Killing=2-4 µM,Not available,27622949,"Libardo MD, Gorbatyuk VY, Angeles-Boza AM.","Libardo MD, Gorbatyuk VY, Angeles-Boza AM.",Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B,18,15-18
DRAMP33714,KVMRKVLGYLRNVYK,15,"Ixosin (4-18)[E8K,E13L,S16V], Ixosin-pch4–18",Q2LKX9,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (19% Killing=2 µM),Not available,Linear,Free,Amidation,,L,HEK-293: 15% Killing=2 µM,Not available,27622949,"Libardo MD, Gorbatyuk VY, Angeles-Boza AM.","Libardo MD, Gorbatyuk VY, Angeles-Boza AM.",Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B,15,12-15
DRAMP33717,GLHKVMREVLGYERNSYK,18,Ixosin (1-18),Q2LKX9,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (13% Killing=128 µM),Not available,Linear,Free,Amidation,,L,HEK-293: 6% Killing>128 µM,Not available,27622949,"Libardo MD, Gorbatyuk VY, Angeles-Boza AM.","Libardo MD, Gorbatyuk VY, Angeles-Boza AM.",Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B,18,15-18
DRAMP33718,KVMREVLGYERNSYK,15,Ixosin (4-18),Q2LKX9,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (3% Killing=128 µM),Not available,Linear,Free,Amidation,,L,HEK-293: 14% Killing>128 µM,Not available,27622949,"Libardo MD, Gorbatyuk VY, Angeles-Boza AM.","Libardo MD, Gorbatyuk VY, Angeles-Boza AM.",Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B,15,12-15
DRAMP33749,GWFKKTFHKVSHAVKSGIHA,20,CEN1 HC (1–20),D8WN02,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: THP-1 (Weak active up to 125 mg/L),Not available,Linear,Free,Free,,L,Not available,Not available,23237525,AMB Express. 2012 Dec 13;2(1):67.,"Björn C, Håkansson J, Myhrman E, Sjöstrand V, Haug T, Lindgren K, Blencke HM, Stensvåg K, Mahlapuu M. ","Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis",20,18-21
DRAMP33755,ALWMTLLKKVLKAAAKAALNAVLV,24,Dermaseptin S4 (1-24)a,P80280,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW620 (71.48±4.81% Cytotoxicity=256 µg/ml),Human erythrocytes: 57.1±6.34% Hemolysis=256 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,33774792,Environ Sci Pollut Res Int. 2021 Aug;28(30):40908-40916.,"Belaid A, Braiek A, Alibi S, Hassen W, Beltifa A, Nefzi A, Mansour HB. ",Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620,24,21-24
DRAMP33756,ALWMTLLKKVLKAAAKAALNAV,22,Dermaseptin S4 (1-22)a,P80280,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW620 (66.21±20.07% Cytotoxicity=256 µg/ml),Human erythrocytes: 80±1.12% Hemolysis=256 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,33774792,Environ Sci Pollut Res Int. 2021 Aug;28(30):40908-40916.,"Belaid A, Braiek A, Alibi S, Hassen W, Beltifa A, Nefzi A, Mansour HB. ",Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620,22,21-24
DRAMP33758,LKKVLKAAAKAALNAVLVGANA,22,Dermaseptin S4 (7-28),P80280,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SW620 (35.72±18.49% Cytotoxicity=256 µg/ml),Human erythrocytes: 35.4±6.28% Hemolysis=256 µg/ml,Linear,Free,Amidation,,L,Not available,Not available,33774792,Environ Sci Pollut Res Int. 2021 Aug;28(30):40908-40916.,"Belaid A, Braiek A, Alibi S, Hassen W, Beltifa A, Nefzi A, Mansour HB. ",Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620,22,21-24
DRAMP33759,GLRKRLRKFFNKIKEK,16,sC18 [R10F],P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7  (<20% Killing=40 µM); HeLa  (Not active up to 40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: <20% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,16,15-18
DRAMP33760,GLRKRLRKFRNKIKFK,16,sC18 [E15F],P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (Not active up to 40 µM); MCF-7  (Not active up to 40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: <10% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,16,15-18
DRAMP33761,GLRKRLRKFRNKIKEF,16,sC18 [K16F],P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (<20% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: Not active up to 40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,16,15-18
DRAMP33762,GLEKRKRKFFNKIKFK,16,"sC18 [R10F,E15F]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (60% Killing=40 µM); HeLa  (75% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: 20% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,16,15-18
DRAMP33763,GLRKRLRKFFNKIKEF,16,"sC18 [R10F,K16F]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (>50% Killing=40 µM); HeLa  (40% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: <5% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,16,15-18
DRAMP33764,GLRKRLRKFRNKIKFF,16,"sC18 [E15F,K16F]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MCF-7 (40% Killing=40 µM); HeLa  (80% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: Not active up to 40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,16,15-18
DRAMP33765,GLRKRLRKFFNKIKFF,16,"sC18 [E15F,E15F,K16F]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (80% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: 40% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,16,15-18
DRAMP33766,GLRKRLRKFRNKIKK,15,sC18 [E15Del],P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (35% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: <10% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33767,GLRKRLRKFFNKIKF,15,"sC18 [R10F,E15Del,K16F]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,,L,HEK293: 20% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33768,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 4-F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=4-F-Phe,L,HEK293: <10% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33769,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 4-F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=4-F-Phe,L,HEK293: <10% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33770,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 4-F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=4-F-Phe,L,HEK293: <10% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33771,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 2F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=2-F-Phe,L,HEK293: 20% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33772,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 2F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=2-F-Phe,L,HEK293: 20% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33773,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 2F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=2-F-Phe,L,HEK293: 20% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33774,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 5F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=5-F-Phe,L,HEK293: <25% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33775,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 5F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=5-F-Phe,L,HEK293: <25% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33776,GLRKRLRKFXNKIKX,15,"sC18 [R10,K16 5F-Phe,E15Del]",P25230,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM),Human erythrocytes: <10% Hemolysis	=40 µM,Linear,Free,Amidation,X=5-F-Phe,L,HEK293: <25% Killing=40 µM,Not available,33313751, Biochem J. 2021 Jan 15;478(1):63-78. ,"Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.",Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity,15,12-15
DRAMP33824,VWKPPYLPRPRPPRrIYNr,19,"Oncocin Onc112 [D2W], Onc245",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (40% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 32% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33825,VDRPPYLPRPRPPRrIYNr,19,"Oncocin Onc112 [K3R], Onc246",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 42% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33826,VDKKPYLPRPRPPRrIYNr,19,"Oncocin Onc112 [P4K], Onc247",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (50% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 42% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33827,VDKFPYLPRPRPPRrIYNr,19,"Oncocin Onc112 [P4F], Onc248",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (39% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 48% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33828,VDKYPYLPRPRPPRrIYNr,19,"Oncocin Onc112 [P4Y], Onc249",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (30% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 45% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33829,VDKPFYLPRPRPPRrIYNr,19,"Oncocin Onc112 [P5F], Onc250",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (34% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 44% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33830,VDKPYYLPRPRPPRrIYNr,19,"Oncocin Onc112 [P5Y], Onc251",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (35% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 45% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33831,VDKPHYLPRPRPPRrIYNr,19,"Oncocin Onc112 [P5H], Onc252",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (34% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 46% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33832,VDKPRYLPRPRPPRrIYNr,19,"Oncocin Onc112 [P5R], Onc253",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (40% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 42% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33833,VDKPPWLPRPRPPRrIYNr,19,"Oncocin Onc112 [Y6W], Onc254",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (34% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 55% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33834,VDKPPFLPRPRPPRrIYNr,19,"Oncocin Onc112 [Y6F], Onc255",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (44% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 45% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33835,VDKPPHLPRPRPPRrIYNr,19,"Oncocin Onc112 [Y6H], Onc256",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 56% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33836,VDKPPXLPRPRPPRrIYNr,19,"Oncocin Onc112 [Y6Dit], Onc257",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (58% Killing=600 µg/ml),Not available,Linear,Free,Amidation,"X=3,5‐Diiodotyrosine",Mix,HEK293: 44% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33837,VDKPPXLPRPRPPRrIYNr,19,"Oncocin Onc112 [Y6Dit], Onc257",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (54% Killing=600 µg/ml),Not available,Linear,Free,Amidation,"X=3,5‐Diiodotyrosine",Mix,HEK293: 44% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33838,VDKPPXLPRPRPPRrIYNr,19,"Oncocin Onc112 [Y6Nty], Onc258",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (58% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=3‐Nitrotyrosine,Mix,HEK293: 45% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33839,VDKPPXLPRPRPPRrIYNr,19,"Oncocin Onc112 [Y6Nty], Onc258",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (54% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=3‐Nitrotyrosine,Mix,HEK293: 45% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33840,VDKPPYXPRPRPPRrIYNr,19,"Oncocin Onc112 [L7Nle], Onc259",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=nor-Leu,Mix,HEK293: 60% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33841,VDKPPYXPRPRPPRrIYNr,19,"Oncocin Onc112 [L7Nle], Onc259",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (43% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=nor-Leu,Mix,HEK293: 60% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33842,VDKPPYXPRPRPPRrIYNr,19,"Oncocin Onc112 [L7Tle], Onc260",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=tert‐Leu,Mix,HEK293: 52% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33843,VDKPPYXPRPRPPRrIYNr,19,"Oncocin Onc112 [L7Tle], Onc260",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (43% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=tert‐Leu,Mix,HEK293: 52% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33844,VDKPPYRPRPRPPRrIYNr,19,"Oncocin Onc112 [L7R], Onc261",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (42% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 42% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33845,VDKPPYMPRPRPPRrIYNr,19,"Oncocin Onc112 [L7M], Onc262",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 50% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33846,VDKPPYFPRPRPPRrIYNr,19,"Oncocin Onc112 [L7F], Onc263",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (32% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 38% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33847,VDKPPYLPRWRPPRrIYNr,19,"Oncocin Onc112 [P10W], Onc264",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 43% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33848,VDKPPYLPRPWPPRrIYNr,19,"Oncocin Onc112 [R11W], Onc265",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (44% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 43% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33849,VDKPPYLPRPHPPRrIYNr,19,"Oncocin Onc112 [R11H], Onc266",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 50% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33850,VDKPPYLPRPKPPRrIYNr,19,"Oncocin Onc112 [R11K], Onc267",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (58% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 59% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33851,VDKPPYLPRPFPPRrIYNr,19,"Oncocin Onc112 [R11F], Onc268",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (50% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 38% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33852,VDKPPYLPRPXPPRrIYNr,19,"Oncocin Onc112 [R11Har], Onc269",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (43% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=Homoarginine,Mix,HEK293: 41% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33853,VDKPPYLPRPRPPRrIXNr,19,"Oncocin Onc112 [Y17Dit], Onc270",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Not available,Linear,Free,Amidation,"X=3,5‐Diiodotyrosine",Mix,HEK293: 44% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33854,VDKPPYLPRPRPPRrIXNr,19,"Oncocin Onc112 [Y17Dit], Onc270",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Not available,Linear,Free,Amidation,"X=3,5‐Diiodotyrosine",Mix,HEK293: 44% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33855,VDKPPYLPRPRPPRrIXNr,19,"Oncocin Onc112 [Y17Nty], Onc271",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=3‐Nitrotyrosine,Mix,HEK293: 34% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33856,VDKPPYLPRPRPPRrIXNr,19,"Oncocin Onc112 [Y17Nty], Onc271",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=3‐Nitrotyrosine,Mix,HEK293: 34% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33857,VDKPPYLPRPRWPRrIYNr,19,"Oncocin Onc112 [P12W], Onc272",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 38% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33858,VDKPPYLPRPRWERrIYNr,19,"Oncocin Onc112 [P12W, P13E], Onc273",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (46% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 38% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33859,VDKPPYLPRPRWRRrIYNr,19,"Oncocin Onc112 [P12W, P13R], Onc274",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (43% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 44% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33860,VDKPPYLPRPRWWRrIYNr,19,"Oncocin Onc112 [P12W, P13W], Onc275",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (64% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 57% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33861,VDKPPYLPRPRWKRrIYNr,19,"Oncocin Onc112 [P12W, P13K], Onc276",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (48% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 48% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33862,VDKPPYLPRPRWHRrIYNr,19,"Oncocin Onc112 [P12W, P13H], Onc277",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (51% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 50% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33863,VDKPPYLPRPRWIRrIYNr,19,"Oncocin Onc112 [P12W, P13I], Onc278",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (56% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 44% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33864,VDKPPYLPRPRWFRrIYNr,19,"Oncocin Onc112 [P12W, P13F], Onc279",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (61% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 48% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33865,VDKPPYLPRPRWLRrIYNr,19,"Oncocin Onc112 [P12W, P13L], Onc280",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (50% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 44% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33866,VDKPPYLPRPRWARrIYNr,19,"Oncocin Onc112 [P12W, P13A], Onc281",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (48% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 46% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33867,VDKPPYLPRPRWNRrIYNr,19,"Oncocin Onc112 [P12W, P13N], Onc282",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (54% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 42% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33868,VDKPPYLPRPRWVRrIYNr,19,"Oncocin Onc112 [P12W, P13V], Onc283",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (25% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 28% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33869,VDKPPYLPRPRWGRrIYNr,19,"Oncocin Onc112 [P12W, P13G], Onc284",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (27% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 28% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33870,VDKPPYLPRPRWSRrIYNr,19,"Oncocin Onc112 [P12W, P13S], Onc285",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (38% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 34% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33871,VDKPPYLPRPRWQRrIYNr,19,"Oncocin Onc112 [P12W, P13Q], Onc286",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (41% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 36% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33872,VDKPPYLPRPRWYRrIYNr,19,"Oncocin Onc112 [P12W, P13Y], Onc287",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (30% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 42% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33873,VDKPPYLPRPRWDRrIYNr,19,"Oncocin Onc112 [P12W, P13D], Onc288",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (28% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 28% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33874,VDKPPYLPRPRWTRrIYNr,19,"Oncocin Onc112 [P12W, P13T], Onc289",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (22% Killing=600 µg/ml),Not available,Linear,Free,Amidation,,Mix,HEK293: 38% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33875,VDKPPYLPRPRWXRrIYNr,19,"Oncocin Onc112 [P12W, P13O], Onc290",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HepG2 (34% Killing=600 µg/ml),Not available,Linear,Free,Amidation,X=Orn,Mix,HEK293: 42% Killing=600 µg/ml,Not available,34902208,Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP33889,EQWAREIGAQLRRMADDLNA,20,Puma-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=1.006 ± 0.337 μM); OCI-Ly1 (Bcl-2 dependent) (EC50=1.967 ± 0.48 μM),Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,20,18-21
DRAMP33890,RPEIWYAQGLKRFGDEFNAYYAR,23,XXA1-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: OCI-Ly1 (Bcl-2 dependent) (EC50=228 ± 56 nM); MDA-MB-231 (Bc1-xL dependent) (EC50=50 ± 16 nM),Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,23,21-24
DRAMP33891,RPEIWYAQWLKRFGDQFNAYYAR,23,XXA4-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,23,21-24
DRAMP33892,RPEIWIAQGLKRFGDEFNAYYAR,23,XXA1_Y2dI-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,23,21-24
DRAMP33893,RPEIWYAQELKRFGDEFNAYYAR,23,XXA1_G2gE-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=12 ± 4 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=37 ± 9 nM),Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,23,21-24
DRAMP33894,RPEIWYAQGLRRFGDEFNAYYAR,23,XXA1_K3bR-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,23,21-24
DRAMP33895,RPEIWYAQGLKRIGDEFNAYYAR,23,XXA1_F3dI-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,23,21-24
DRAMP33896,RPEIWYAQGLKRFGDEFNAYKAR,23,XXA1_Y4eK-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=82 ± 27 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=911 ± 222 nM),Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,23,21-24
DRAMP33897,IWYAQGLKRFGDEFNAYK,18,Y4eK_18-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: OCI-Ly1 (Bcl-2 dependent) (EC50=3.325 ± 0.812 μM); MDA-MB-231 (Bc1-xL dependent) (EC50=847 ± 284 nM),Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,18,15-18
DRAMP33898,RPEIWYAQGLKRFGDEFNAYK,21,Y4eK_21-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=159 ± 53 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=3.435 ± 0.839 μM),Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,21,18-21
DRAMP33899,LRPEIRYAQELRRIGDEFNE,20,BimEL-I146Y,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33900,LWAAIRIAQELRRIGDEFNE,20,Bim-WAA,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33901,LRPEIRIARELRRIGDEFNE,20,BimEL-Q148R,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33902,LRPEIRIAQELRRMGDEFNE,20,BimEL-I153M,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33903,LRPEIRYARELRRIGDEFNE,20,BimEL-I146Y-Q148R,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33904,LRPEIRYAQELRRMGDEFNE,20,BimEL I146Y-I153M,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33905,PQMVILQLLRFIFRLVWRRH,20,BimEL-CTS,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33906,PQMVELQLLRFIFRLVWRRH,20,BimEL-I181E,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33907,PQMVILQLERFIFRLVWRRH,20,BimEL-L185E,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33908,PQMVILQLLRFEFRLVWRRH,20,BimEL-I188E,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33909,PQMVILQLLRFIFRLEWRRH,20,BimEL-V192E,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33910,PQMVILQLLAFIFALVWRRH,20,BimEL-CST-2A (R186A-R190A),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,30860026,Elife. 2019 Mar 12;8:e37689. ,"Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. ",Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2,20,18-21
DRAMP33911,IWIAQELRRIGDEFNA,16,Bim SM-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U-937 (18% Killing= 50 μM); HL-60 (23% Killing= 50 μM); K562 (25% Killing= 50 μM),Not available,Linear,Acetylation,Amidation,,L,Not available,Bcl-2,Not available,,,Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain,16,15-18
DRAMP33924,EIWIAQELRRRGDSFNAYYAR,21,"Bim BH3 (I155R, E158S)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,26136077,Cell Death Dis. 2015 Jul 2;6(7):e1804.,"Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. ",Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain,21,18-21
DRAMP33925,EIWIAQELRRRGDXFNAYYAR,21,"p-Bim BH3 (I155R, E158S)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,X=Phosphorylated-Ser,L,Not available,Bcl-2/Bcl-xL,26136077,Cell Death Dis. 2015 Jul 2;6(7):e1804.,"Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. ",Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain,21,18-21
DRAMP33926,EIWIAQELRRRGDAFNAYYAR,21,"Bim BH3 (I155R, E158A)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,26136077,Cell Death Dis. 2015 Jul 2;6(7):e1804.,"Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. ",Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain,21,18-21
DRAMP33927,EIWIAQELRSRGDSFNAYYAR,21,"Bim BH3 (R154S, I155R, E158S)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,26136077,Cell Death Dis. 2015 Jul 2;6(7):e1804.,"Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. ",Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain,21,18-21
DRAMP33928,EIWIAQELRSRGDXFNAYYAR,21,"p-Bim BH3 (R154S, I155R, E158S)",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,X=Phosphorylated-Ser,L,Not available,Bcl-2/Bcl-xL,26136077,Cell Death Dis. 2015 Jul 2;6(7):e1804.,"Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. ",Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain,21,18-21
DRAMP33929,EIWIAQELRRIGDSFNAYYAR,21,Bim BH3 (E158S),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-2/Bcl-xL,26136077,Cell Death Dis. 2015 Jul 2;6(7):e1804.,"Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. ",Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain,21,18-21
DRAMP33930,LWAAQRYGRELRRMSDEFEGSFKGL,25,Bad-BH3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Bcl-xL,25451027,J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.,"Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.",Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL,25,24-27
DRAMP33931,RPEIWMTQGLRRLGDEINAYYAR,23,MS1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33932,RPEIWLTQSLQRLGDEINAYYAR,23,MS2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33933,RPEIWLTQHLQRLGDEINAYYAR,23,MS3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33934,RPEIWMGQGLRRLGDEINAYYAR,23,A12,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33935,RPEIWLGQSLQRLGDEINAYYAR,23,B3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33936,RPEIWLGQHLQRLGDEINAYYAR,23,G9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33937,AELPPEFAAQLRKIGDKVYC,20,NoxaA,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,20,18-21
DRAMP33938,RPEIWIAQELRRIGDEFNAYYAR,23,Bim,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33939,RPEIWITQELRRIGDEFNAYYAR,23,Bim-A2eT,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33940,RPEIWMTQELRRIGDEFNAYYAR,23,Bim-A2eT-I2dM,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33941,RPEIWITQGLRRIGDEFNAYYAR,23,Bim-A2eT-E2gG,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33942,RPEIWITQELRRLGDEFNAYYAR,23,Bim-A2eT-I3dL,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33943,RPEIWITQELRRIGDEINAYYAR,23,Bim-A2eT-F4aI,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5/6-Fluorescein amidite,Amidation,,L,Not available,Mcl-1,25052212,ACS Chem Biol. 2014 Sep 19;9(9):1962-8.,"Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.",Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells,23,21-24
DRAMP33944,RPEIWLAQYLRRLGDQINAYYAR,23,Bim-FD1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Bfl-1,23363053,ACS Chem Biol. 2013 Apr 19;8(4):778-88.,"Dutta S, Chen TS, Keating AE.",Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening,23,21-24
DRAMP33945,RPEIWMAQVLRRFGDLLNAYYAR,23,Bim-FD2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Bfl-1,23363053,ACS Chem Biol. 2013 Apr 19;8(4):778-88.,"Dutta S, Chen TS, Keating AE.",Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening,23,21-24
DRAMP33946,RPEIWIAQELRRAGDVLNAYYAR,23,Bim-FA1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Bfl-1,23363053,ACS Chem Biol. 2013 Apr 19;8(4):778-88.,"Dutta S, Chen TS, Keating AE.",Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening,23,21-24
DRAMP33947,RPEIWIAQGLRRIGDTWNAYYAR,23,Bim-FW1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Bfl-1,23363053,ACS Chem Biol. 2013 Apr 19;8(4):778-88.,"Dutta S, Chen TS, Keating AE.",Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening,23,21-24
DRAMP34306,LKlLKkLlkKLLkLL,15,"Amphipathic-1d, 5D-K6L9",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,35759644,J Med Chem. 2022 Jul 14;65(13):9050-9062,"Ben Hur D, Kapach G, Wani NA, Kiper E, Ashkenazi M, Smollan G, Keller N, Efrati O, Shai Y.",Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients,15,12-15
DRAMP34317,FKRiVQRiKDFlRNLV,16,D LL-37 (17-32),P49913,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,16637646,J Am Chem Soc. 2006 May 3;128(17):5776-85.,"Li X, Li Y, Han H, Miller DW, Wang G. ",Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region,16,15-18
DRAMP34318,vnwkkilGkiikvvk,15,Lasioglossin LL-III-D,C0HK44,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,Not available,,,The antifungal effect of peptides from hymenoptera venom and their analogs,15,12-15
DRAMP34319,vnwkkllGkllkvvk,15,Lasioglossin LL-III/25,C0HK44,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,22100226, Peptides. 2012 Jan;33(1):18-26. ,"Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.",Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells,15,12-15
DRAMP34322,ILGKLLSTAWGLLSkL,16,Alyteserin-2a [A10W][N15k],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,22965637,Amino Acids. 2013 Feb;44(2):715-23. ,"Conlon JM, Mechkarska M, Prajeep M, Arafat K, Zaric M, Lukic ML, Attoub S.","Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",16,15-18
DRAMP34325,gwgsffkkaahvgkhvgkaalthyl,25,D-Pleurocidin,P81941,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: Calu-3 (IC50=41.9 ± 1.8 μg/ml); HeLa (IC50=47.1 ± 2.1 μg/ml); A549 (IC50=79.3 ± 7.2 μg/ml),Not available,Linear,Free,Amidation,,D,HEK293: IC50=61.4 ± 3.9 µg/ml,Not available,33247193, Commun Biol. 2020 Nov 27;3(1):697. ,"Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ. ","A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy",25,24-27
DRAMP34328,RRIRPRPPRLPRPRPRPLPFPRP,23,Bactenecin-7 (1-23),P19661,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,35578204,BMC Biol. 2022 May 16;20(1):114.,"Koch P, Schmitt S, Heynisch A, Gumpinger A, Wüthrich I, Gysin M, Shcherbakov D, Hobbie SN, Panke S, Held M. ",Optimization of the antimicrobial peptide Bac7 by deep mutational scanning,23,21-24
DRAMP34330,RAGLQFPVGRLLRRLLR,17,Buforin-2 (5-13)[17-20]2,P55897,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23776609,PLoS One. 2013 Jun 11;8(6):e66084. ,"Lim KJ, Sung BH, Shin JR, Lee YW, Kim DJ, Yang KS, Kim SC.","A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells",17,15-18
DRAMP34359,NGVQPKYRWWRWWRRWW,17,Leucrocin I RT2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30031283,Environ Toxicol Pharmacol. 2018 Sep;62:164-176.,"Maijaroen S, Jangpromma N, Daduang J, Klaynongsruang S.",KT2 and RT2 modified antimicrobial peptides derived from Crocodylus siamensis Leucrocin I show activity against human colon cancer HCT-116 cells,17,15-18
DRAMP34366,RAGLQFPVGRVHRLLRK,17,"Buforin-2 (5-21), sh-Buforin",P55897,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,25891844,Biochimie. 2015 Jun;113:143-55.,"Libardo MD, Paul TJ, Prabhakar R, Angeles-Boza AM.",Hybrid peptide ATCUN-sh-Buforin: Influence of the ATCUN charge and stereochemistry on antimicrobial activity,17,15-18
DRAMP34367,VIHRAGLQFPVGRVHRLLRK,20,"VIH-Buforin-2 (5-21), VIH-sh-Buforin",P55897,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,25891844,Biochimie. 2015 Jun;113:143-55.,"Libardo MD, Paul TJ, Prabhakar R, Angeles-Boza AM.",Hybrid peptide ATCUN-sh-Buforin: Influence of the ATCUN charge and stereochemistry on antimicrobial activity,20,18-21
DRAMP34368,RCpGRTRQIGTIFpGRIKCRSW,22,"Act Beta-defensin 2 (18-40)[C12I,G14p,P15G,C-del]",P46160,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Free,,Mix,Not available,Not available,25791057,Biophys Chem. 2015 Apr;199:25-33.,"Krishnakumari V, Nagaraj R. ",N-terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine ?-defensin-2 results in salt-resistant antibacterial activity,22,21-24
DRAMP34375,ILPIIGKILSTIFGK,15,Temporin-1CEe,F1AEM7,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,21303203,Zoolog Sci. 2011 Feb;28(2):112-7. ,"Zhao J, Sun Y, Li Z, Su Q.","Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis",15,12-15
DRAMP34380,CNGRCGGKLAKLAKKLAKLAK,21,CK21,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,25990455,Tumour Biol. 2015 Sep;36(10):8167-75.,"hang Z, Hou L, Feng L, Huang S, Luo M, Shao S, Zhang X, Gu S, Zhao X.",An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13,21,18-21
DRAMP34382,KGIRGYKGGYCKGAFKQTCKCY,22,OsDef2 (16-37),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,34866278,J Pept Sci. 2022 May;28(5):e3383. ,"Mbuayama KR, Taute H, Strӧmstedt AA, Bester MJ, Gaspar ARM.",Antifungal activity and mode of action of Synthetic peptide peptides derived from the tick OsDef2 defensin,22,21-24
DRAMP34383,KGIRGYKGGYKGAFKQTKY,19,"OsDef2 (16-37)[C26,34,36Del]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,Not available,,,Antifungal activity and mode of action of Synthetic peptide peptides derived from the tick OsDef2 defensin,19,18-21
DRAMP34384,"ELLVDLL,ELLVDLL",15,Gageostatin A - Gageostatin B,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"3-OH-Me-C13,3-OH-DiMe-C13",Free,,Mix,Not available,Not available,24492520,Mar Drugs. 2014 Jan 31;12(2):871-85.,"Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.","Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis",15,12-15
DRAMP34393,PMLRVRLASHLRKLRKRLLR,20,rApoE (133-150),P02649,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,27028511,FEBS J. 2016 Jun;283(11):2115-31.,"Pane K, Sgambati V, Zanfardino A, Smaldone G, Cafaro V, Angrisano T, Pedone E, Di Gaetano S, Capasso D, Haney EF, Izzo V, Varcamonti M, Notomista E, Hancock RE, Di Donato A, Pizzo E.",A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells,20,18-21
DRAMP34394,LRVRLASHLRKLRKRLLR,18,ApoE (133-150),P02649,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,27028511,FEBS J. 2016 Jun;283(11):2115-31.,"Pane K, Sgambati V, Zanfardino A, Smaldone G, Cafaro V, Angrisano T, Pedone E, Di Gaetano S, Capasso D, Haney EF, Izzo V, Varcamonti M, Notomista E, Hancock RE, Di Donato A, Pizzo E.",A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells,18,15-18
DRAMP34401,FLPAALAGIGGILGKLF,17,Temporin-SHd,D4YWD0,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,23116712,Biochimie. 2013 Feb;95(2):388-99.,"Abbassi F, Raja Z, Oury B, Gazanion E, Piesse C, Sereno D, Nicolas P, Foulon T, Ladram A. ","Antibacterial and leishmanicidal activities of temporin-SHd, a 17-residue long membrane-damaging peptide",17,15-18
DRAMP34414,fkklkklfsklwnwk,15,"D-HPRP-A1, HPRP-A2",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: SGC-7901 (IC50=10.42±0.30 μM ); B16 (IC50=19.16±0.38 μM ); PC-3 (IC50=21.38±0.56 μM ); BGC-823 (IC50=8.65 ±0.38 μM ),Not available,Linear,Acetylation,Amidation,,D,Not available,Not available,31686873,Infect Drug Resist. 2019 Oct 15;12:3227-3239.,"Zhu J, Huang Y, Chen M, Hu C, Chen Y.",Functional Synergy Of Antimicrobial Peptides And Chlorhexidine Acetate Against Gram-Negative/Gram-Positive Bacteria And A Fungus In Vitro And In Vivo,15,12-15
DRAMP34415,fkklkklfsklwnwk,15,"D-HPRP-A1, HPRP-A2",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,D,Not available,Not available,31686873,Infect Drug Resist. 2019 Oct 15;12:3227-3239.,"Zhu J, Huang Y, Chen M, Hu C, Chen Y.",Functional Synergy Of Antimicrobial Peptides And Chlorhexidine Acetate Against Gram-Negative/Gram-Positive Bacteria And A Fungus In Vitro And In Vivo,15,12-15
DRAMP34416,ADMDFTGIAESIIKKIKETNAKPPA,25,TistH,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,27267248,Toxicon. 2016 Sep 1;119:362-70.,"Machado RJ, Estrela AB, Nascimento AK, Melo MM, Torres-Rêgo M, Lima EO, Rocha HA, Carvalho E, Silva-Junior AA, Fernandes-Pedrosa MF.","Characterization of TistH, a multifunctional peptide from the scorpion Tityus stigmurus: Structure, cytotoxicity and antimicrobial activity",25,24-27
DRAMP34417,GrkkrrqrrrGGwmwvtnlrtd,22,TAT-RasGAP317-326,P20936##L0HA15,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,Mix,Not available,Not available,33852935,J Glob Antimicrob Resist. 2021 Jun;25:227-231.,"Heinonen T, Hargraves S, Georgieva M, Widmann C, Jacquier N.",The antimicrobial peptide TAT-RasGAP 317-326 inhibits the formation and expansion of bacterial biofilms in vitro,22,21-24
DRAMP34434,CKILSKTIKCRIPCGRRKEY,20,PTN (42-61),C3Z937,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,30096337,Dev Comp Immunol. 2018 Dec;89:31-43.,"Gao Z, Qu B, Yao L, Ma Z, Cui P, Zhang S.",Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies,20,18-21
DRAMP34435,KRCKNKMEGDDVAVSGRGARKAAKK,25,PTNr1 (42-66),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,30096337,Dev Comp Immunol. 2018 Dec;89:31-43.,"Gao Z, Qu B, Yao L, Ma Z, Cui P, Zhang S.",Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies,25,24-27
DRAMP34438,GRKKRRQRRRGALWKSLLKNVGKA,24,"TAT(48-57)-G-Dermaseptin DRS-DU-1 (1-13), DP-2",P04610,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: H157 (IC50=21.6μM); PC-3 (IC50=6.75μM),Not available,Linear,Free,Amidation,,L,Not available,Not available,30258724,PeerJ. 2018 Sep 19;6:e5635.,"Zhu H, Ding X, Li W, Lu T, Ma C, Xi X, Wang L, Zhou M, Burden R, Chen T. ",Discovery of two skin-derived dermaseptins and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy cells,24,21-24
DRAMP34448,KCVRQNNKRVCKGLRKRLRKFRNK,24,"Cathelicidin (135-146)-CAP7 (1-12), Tylotoin-sC18*",W0FJD1,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30389988, Sci Rep. 2018 Nov 2;8(1):16279.,"Horn M, Neundorf I. ",Design of a novel cell-permeable chimeric peptide to promote wound healing,24,21-24
DRAMP34451,GLLEALAELLEGRKKRRQRRRPPQ,24,"Hemagglutinin (347-367)[E4G,E7A]-Tat (48-60); N-E5L-Tat (48-60)",D2DUQ8,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,27713223,Pharmaceuticals (Basel). 2009 Sep 25;2(2):49-65.,"Neundorf I, Rennert R, Hoyer J, Schramm F, Löbner K, Kitanovic I, Wölfl S. ","Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity",24,21-24
DRAMP34454,PKILNKILGKILRLAAAFK,19,"PKIL+L39e (4-18)[P6I,K10I], PaDBS1R1",Q8ZTX6,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,30463701,Biochim Biophys Acta Biomembr. 2019 Jan;1861(1):178-190.,"Irazazabal LN, Porto WF, Fensterseifer ICM, Alves ESF, Matos CO, Menezes ACS, Felício MR, Gonçalves S, Santos NC, Ribeiro SM, Humblot V, Lião LM, Ladram A, Franco OL. ","Fast and potent bactericidal membrane lytic activity of PaDBS1R1, a novel cationic antimicrobial peptide",19,18-21
DRAMP34455,LVPFIGRTLGGLLARF,16,RTemp_4.3_210,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30578771,Biochim Biophys Acta Biomembr. 2019 Mar 1;1861(3):651-659.,"Rončević T, Krce L, Gerdol M, Pacor S, Benincasa M, Guida F, Aviani I, Čikeš-Čulić V, Pallavicini A, Maravić A, Tossi A. ",Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing,16,15-18
DRAMP34456,LLGAALSALSSVIPSVISWFQK,22,RArv_10.1_19,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30578771,Biochim Biophys Acta Biomembr. 2019 Mar 1;1861(3):651-659.,"Rončević T, Krce L, Gerdol M, Pacor S, Benincasa M, Guida F, Aviani I, Čikeš-Čulić V, Pallavicini A, Maravić A, Tossi A. ",Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing,22,21-24
DRAMP34461,RQIKIWFQNRRMKWK,15,pAntp (43-57),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,15,12-15
DRAMP34464,MDAQTRRRERRAEKQAQWKAANGC,24,LAMBDA N (1-22),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Conjugation with fluorescein by C-terminal Gly Cys amide,,L,Not available,Not available,11084031,J Biol Chem. 2001 Feb 23;276(8):5836-40.,"Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. ",Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.,24,21-24
DRAMP34472,ALWKTLLKKVLKAPKKKRKV,20,S4(13)-PV,Not available,,Not found,Chimeric,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,,L,Not available,Not available,12119035,iochemistry. 2002 Jul 23;41(29):9208-14.,"Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.",Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.,20,18-21
DRAMP34476,RGGRLSYSRRRFSTSTGR,18,SynB1,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,NBD and TAMRA,Free,,L,Not available,Not available,12783857,J Biol Chem. 2003 Aug 15;278(33):31192-201.,"Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. ",Studies on the internalization mechanism of cationic cell-penetrating peptides.,18,15-18
DRAMP34477,RHIKIWFQNRRMKWKK,16,PDX -1-PTD,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,FITC,Free,,L,Not available,Not available,12829640,Diabetes. 2003 Jul;52(7):1732-7.,"Noguchi H, Kaneto H, Weir GC, Bonner-Weir S. ",PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells.,16,15-18
DRAMP34484,GLFDIVKKVVGTIAGL,16,Aurein-2.4,P82391,,Not found,Litoria aurea,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Amidation,,L,Not available,Not available,15203252,Peptides. 2004 Jun;25(6):1035-54.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE. ","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",16,15-18
DRAMP34486,HHPHGHHPHGHHPHG,15,(HHPHG)3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Acetylation,,L,Not available,Not available,15313924,Cancer Res. 2004 Aug 15;64(16):5812-7,"Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.",Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.,15,12-15
DRAMP34490,RKKRRRESRKKRRRES,16,DPV3,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Cys addition,Free,,L,Not available,Not available,15859953,Biochem J. 2005 Sep 1;390(Pt 2):407-18.,"De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. ",Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.,16,15-18
DRAMP34491,AXQNMEILEXTPLTXVX,17,Dermaseptin-PH,Not available,,Not found,Anabaena laxa,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,15875779,In Vivo. 2005 May-Jun;19(3):577-82.,"Gbankoto A, Vigo J, Dramane K, Banaigs B, Aina E, Salmon JM. ",Cytotoxic effect of Laxaphycins A and B on human lymphoblastic cells (CCRF-CEM) using digitised videomicrofluorometry.,17,15-18
DRAMP34494,YTAIAWVKAFIRKLRK,16,YTA2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,fluorescein,Amidation,,L,Not available,Not available,16376307,Biochem Pharmacol. 2006 Feb 14;71(4):416-25.,"Lindgren M, Rosenthal-Aizman K, Saar K, Eiríksdóttir E, Jiang Y, Sassian M, Ostlund P, Hällbrink M, Langel U. ",Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.,16,15-18
DRAMP34498,VNADIKATTVFGGKYVSLTTP,21,"Inv1, rMce1a (1-21)",Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,21,18-21
DRAMP34507,YLKNYRIATFKNWPF,15,msurvivin,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,17142738, J Immunol. 2006 Dec 15;177(12):8410-21.,"Charalambous A, Oks M, Nchinda G, Yamazaki S, Steinman RM. ",Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4,15,12-15
DRAMP34510,LIRLWSHLIHIWFQNRRLKWKKK,23,EB-1,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,17463227,FASEB J. 2007 Sep;21(11):2664-71. ,"Lundberg P, El-Andaloussi S, Sütlü T, Johansson H, Langel U. ",Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.,23,21-24
DRAMP34511,MVTVLFRRLRIRRACGPPRVRV,22,M918,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,17622242,Mol Ther. 2007 Oct;15(10):1820-6.,"El-Andaloussi S, Johansson HJ, Holm T, Langel U.","A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. ",22,21-24
DRAMP34512,MVTVLFRRLRIRRACGPPRVRV,22,M918,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,17622242,Mol Ther. 2007 Oct;15(10):1820-6.,"El-Andaloussi S, Johansson HJ, Holm T, Langel U.","A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. ",22,21-24
DRAMP34513,vrlpppvrlpppvrlppp,18,D form of Sweat Arrow Protein (SAP),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Free,,D,Not available,Not available,17635150,Biochem Soc Trans. 2007 Aug;35(Pt 4):794-6.,"Pujals S, Sabidó E, Tarragó T, Giralt E.",all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study.,18,15-18
DRAMP34516,MVRRFLVTLRIRRACGPPRVRV,22,ARF(1-22),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,fluorescein,Amidation,,L,Not available,Not available,17984975,Mol Ther. 2008 Jan;16(1):115-23. ,"Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. ",Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.,22,21-24
DRAMP34522,KLKNFAKGVAQSLLNKASCKLSGQC,25,Brevinin 2R,P40841##P85095,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,18494941, J Cell Mol Med. 2008 Jun;12(3):1005-22.,"Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB, Booy EP, Naderi-Manesh H, Los M.","Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway",25,24-27
DRAMP34525,AAPFLECQGRQGTCHFFAN,19,Tetrastatin-3,Not available,,Not found,Homo sapiens (α4 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34543,HARIKPTFRRLKWKYKGKFW,20,"Anti-lipopolysaccharide factor (32-51)[Y2A], L-2",P07086,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23401744,J Amino Acids. 2013;2013:251398. ,"Fernández Massó JR, Oliva Argüelles B, Tejeda Y, Astrada S, Garay H, Reyes O, Delgado-Roche L, Bollati-Fogolín M, Vallespí MG. ",The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells,20,18-21
DRAMP34545,ALWKEVLKNAGKAALNEINNLV,22,Dermaseptin-PH ,Not available,,Not found,,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,29064402,Molecules. 2017 Oct 24;22(10):1805.,"Huang L, Chen D, Wang L, Lin C, Ma C, Xi X, Chen T, Shaw C, Zhou M.","Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis.",22,21-24
DRAMP34546,HARIKpTFRRlKWKYKGKFW,20,"Anti-lipopolysaccharide factor (32-51)[Y2A,P6p,L11l], CIGB-552",P07086,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Free,,Mix,Not available,Not available,29601540,Molecules. 2018 Mar 30;23(4):801.,"Astrada S, Fernández Massó JR, Vallespí MG, Bollati-Fogolín M",Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic peptide Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity,20,18-21
DRAMP34548,IETFLKQLRSAANKIVGL,18,Citrus-amp1,A0A067DL46,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,30192822,PLoS One. 2018 Sep 7;13(9):e0203451. ,"Inui Kishi RN, Stach-Machado D, Singulani JL, Dos Santos CT, Fusco-Almeida AM, Cilli EM, Freitas-Astúa J, Picchi SC, Machado MA.",Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus,18,15-18
DRAMP34550,GFWSSVWDGAKNVGTAI,17,Nicomicin-1 (1-17),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,30360541,Mar Drugs. 2018 Oct 23;16(11):401.,"Panteleev PV, Tsarev AV, Bolosov IA, Paramonov AS, Marggraf MB, Sychev SV, Shenkarev ZO, Ovchinnikova TV.",Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain,17,15-18
DRAMP34553,FLSLLPHIASGIASLVSKF,19,"Phylloseptin-PBa2, Phylloseptin-PBu",A0A2K4P1U8,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30612735, Biochem Biophys Res Commun. 2019 Feb 12;509(3):664-673. ,"Wu Y, Wang L, Zhou M, Chen T, Shaw C.","Phylloseptin-PBa1, -PBa2, -PBa3: Three novel antimicrobial peptides from the skin secretion of Burmeister's leaf frog (Phyllomedusa burmeisteri)",19,18-21
DRAMP34554,FLSLIPHIASGIASLVKNF,19,"Phylloseptin-PBa1, Phylloseptin-PBu",A0A5B7LGG0,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30612735,Biochem Biophys Res Commun. 2019 Feb 12;509(3):664-673.,"Wu Y, Wang L, Zhou M, Chen T, Shaw C.","Phylloseptin-PBa1, -PBa2, -PBa3: Three novel antimicrobial peptides from the skin secretion of Burmeister's leaf frog (Phyllomedusa burmeisteri)",19,18-21
DRAMP34555,RWCRRYRVRVRGVLVYAYVCW,21,"Arenicin-1 [V4R; Y5,7R; A6Y; R16,18Y; Y17A; R19V]",Q5SC60,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31234579, Mar Drugs. 2019 Jun 23;17(6):376. ,"Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.","Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization",21,18-21
DRAMP34556,RWRPPIRRPPIRPPFYP,17,Bac5 (1-17)[F2W],P19660,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31692278,ChemMedChem. 2019 Dec 17;14(24):2025-2033,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E Coli, K Pneumoniae, and A Baumannii",17,15-18
DRAMP34557,CVRRFPWWWPFLRRC,15,C-Tritrpticin-C,P51524,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,32126228,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. ,"Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. ",Selective anticancer activity of Synthetic peptide peptides derived from the host defence peptide tritrpticin,15,12-15
DRAMP34569,QIKIWFQNRRMKWKK,15,pAntp (44-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,15,12-15
DRAMP34576,AQIKIWFQNRRMKWKK,16,Ala43 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34577,RAIKIWFQNRRMKWKK,16,Ala44 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34578,RQAKIWFQNRRMKWKK,16,Ala45 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34579,RQIAIWFQNRRMKWKK,16,Ala46 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34580,RQIKAWFQNRRMKWKK,16,Ala47 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34581,RQIKIAFQNRRMKWKK,16,Ala48 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34582,RQIKIWAQNRRMKWKK,16,Ala49 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34583,RQIKIWFANRRMKWKK,16,Ala50 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34584,RQIKIWFQARRMKWKK,16,Ala51 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34585,RQIKIWFQNARMKWKK,16,Ala52 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34586,RQIKIWFQNRAMKWKK,16,Ala53 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34587,RQIKIWFQNRRAKWKK,16,Ala54 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34588,RQIKIWFQNRRMAWKK,16,Ala55 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34589,RQIKIWFQNRRMKAKK,16,Ala56 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34590,RQIKIWFQNRRMKWAK,16,Ala57 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34591,RQIKIWFQNRRMKWKA,16,Ala58 substitution mutant of pAntp (43-58),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-beta-Alanine),Amidation,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,16,15-18
DRAMP34592,CRQIKIWFPNRRMKWKKC,18,Reduced linear penetratin,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation (Labeled with Biotinyl-Ahx),Unknown,,L,Not available,Not available,10784032,J Pept Res. 2000 Feb;55(2):163-72.,"Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.",Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.,18,15-18
DRAMP34620,PKKKRKVALWKTLLKKVLKA,20,PV-S4(13),Not available,,Not found,Chimeric,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,,L,Not available,Not available,12119035,iochemistry. 2002 Jul 23;41(29):9208-14.,"Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.",Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.,20,18-21
DRAMP34621,VKRKKKPALWKTLLKKVLKA,20,PV reverse-S4(13),Not available,,Not found,Chimeric,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,,L,Not available,Not available,12119035,iochemistry. 2002 Jul 23;41(29):9208-14.,"Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.",Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.,20,18-21
DRAMP34622,RQARRNRRRALWKTLLKKVLKA,22,RR-S4(13),Not available,,Not found,Chimeric,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Rhodamine B,Amidation,,L,Not available,Not available,12119035,iochemistry. 2002 Jul 23;41(29):9208-14.,"Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.",Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.,22,21-24
DRAMP34629,rggrlsysrrrfststgr,18,D-SynB1,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,NBD,Free,,D,Not available,Not available,12783857,J Biol Chem. 2003 Aug 15;278(33):31192-201.,"Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. ",Studies on the internalization mechanism of cationic cell-penetrating peptides.,18,15-18
DRAMP34632,RGGRLAYLRRRWAVLGR,17,SynB5,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,NBD and TAMRA,Free,,L,Not available,Not available,12783857,J Biol Chem. 2003 Aug 15;278(33):31192-201.,"Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. ",Studies on the internalization mechanism of cationic cell-penetrating peptides.,17,15-18
DRAMP34635,KWKLKPLLKKLLKKL,15,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Amidation,,L,Not available,Not available,14514057,Biotechnol Lett. 2003 Aug;25(16):1305-10.,"Park Y, Lee DG, Hahm KS. ",Antibiotic activity of Leu-Lys rich model peptides,15,12-15
DRAMP34638,VRLPPPVRLPPPVRLPPP,18,PolyP 3 (SAP),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Free,,L,Not available,Not available,15054781,Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.,"Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.",Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.,18,15-18
DRAMP34641,VHLPPPVHLPPPVHLPPP,18,PolyP 6,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Free,,L,Not available,Not available,15054781,Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.,"Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.",Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.,18,15-18
DRAMP34644,VKLPPPVKLPPPVKLPPP,18,PolyP 9,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Free,,L,Not available,Not available,15054781,Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.,"Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.",Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.,18,15-18
DRAMP34648,GLLSVLGSVAKHVLGHVVGVIAEHL,25,Caerin 1.1 Modification,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,15203252,Peptides. 2004 Jun;25(6):1035-54.,"Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE. ","Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance",25,24-27
DRAMP34653,GRPRESGKKRKRKRLKP,17,DPV6,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Cys addition,Free,,L,Not available,Not available,15859953,Biochem J. 2005 Sep 1;390(Pt 2):407-18.,"De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. ",Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.,17,15-18
DRAMP34654,GKRKKKGKLGKKRPRSR,17,DPV7b,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Cys addition,Free,,L,Not available,Not available,15859953,Biochem J. 2005 Sep 1;390(Pt 2):407-18.,"De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. ",Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.,17,15-18
DRAMP34655,RKKRRRESRRARRSPRHL,18,DPV3/10,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Cys addition,Free,,L,Not available,Not available,15859953,Biochem J. 2005 Sep 1;390(Pt 2):407-18.,"De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. ",Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.,18,15-18
DRAMP34656,SRRARRSPRESGKKRKRKR,19,DPV10/6,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Cys addition,Free,,L,Not available,Not available,15859953,Biochem J. 2005 Sep 1;390(Pt 2):407-18.,"De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. ",Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.,19,18-21
DRAMP34657,VKRGLKLRHVRPRVTRMDV,19,DPV1047,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Cys addition,Free,,L,Not available,Not available,15859953,Biochem J. 2005 Sep 1;390(Pt 2):407-18.,"De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. ",Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.,19,18-21
DRAMP34659,LRRERQSRLRRERQSR,16,DPV15,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Cys addition,Free,,L,Not available,Not available,15859953,Biochem J. 2005 Sep 1;390(Pt 2):407-18.,"De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. ",Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.,16,15-18
DRAMP34660,GAYDLRRRERQSRLRRRERQSR,22,DPV15b,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Cys addition,Free,,L,Not available,Not available,15859953,Biochem J. 2005 Sep 1;390(Pt 2):407-18.,"De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. ",Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.,22,21-24
DRAMP34665,IAWVKAFIRKLRKGPLG,17,YTA4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,fluorescein,Amidation,,L,Not available,Not available,16376307,Biochem Pharmacol. 2006 Feb 14;71(4):416-25.,"Lindgren M, Rosenthal-Aizman K, Saar K, Eiríksdóttir E, Jiang Y, Sassian M, Ostlund P, Hällbrink M, Langel U. ",Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.,17,15-18
DRAMP34673,GKYVSLTTPKNPTKRRITPKDV,22,"Inv2, rMce1a (13-34)",Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,22,21-24
DRAMP34674,TKRRITPKDVIDVRSVTTEINT,22,"Inv3, rMce1a (25-46)",Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,22,21-24
DRAMP34675,RSVTTEINTLFQTLTSIAEKVDP,23,"Inv4, rMce1a (38-60)",Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,23,21-24
DRAMP34683,TKRRITPDDVIDVRSVTTEINT,22,Inv3.3,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,22,21-24
DRAMP34684,TKRRITPKKVIDVRSVTTEINT,22,Inv3.4,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,22,21-24
DRAMP34685,TKRRITPKDVIDVRSVTTKINT,22,Inv3.5,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,22,21-24
DRAMP34687,TKRRITPKDVIDVESVTTEINT,22,Inv3.7,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,22,21-24
DRAMP34688,TARRITPKDVIDVRSVTTEINT,22,Inv3.8,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,22,21-24
DRAMP34689,TKAARITPKDVIDVRSVTTEINT,23,Inv3.9,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free (peptide coated FITC labelled microspheres),Free,,L,Not available,Not available,16620748,Anal Biochem. 2006 Jun 1;353(1):7-14.,"Lu S, Tager LA, Chitale S, Riley LW. ",A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.,23,21-24
DRAMP34696,CDSDSDITWDQLWDLMK,17,E-selectin-binding peptide,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,17121909,Mol Cancer Ther. 2006 Nov;5(11):2624-33. ,"Cai W, Rao J, Gambhir SS, Chen X. ",How molecular imaging is speeding up antiangiogenic drug development,17,15-18
DRAMP34697,FLKDHRISTFKNWPF,15,hsurvivin,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,17142738, J Immunol. 2006 Dec 15;177(12):8410-21.,"Charalambous A, Oks M, Nchinda G, Yamazaki S, Steinman RM. ",Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4,15,12-15
DRAMP34710,FVTRGCPRRLVARLIRVMVPRR,22,ARF(1-22) scr,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,fluorescein,Amidation,,L,Not available,Not available,17984975,Mol Ther. 2008 Jan;16(1):115-23. ,"Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. ",Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.,22,21-24
DRAMP34718,ASWSACSVSCGGGARQRTR,19,Fibulostatin-6.2,Not available,,Not found,Homo sapiens (Fibulin-6),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34719,ATPFIECSGARGTCHYFAN,19,Hexastatin-1,Not available,,Not found,Homo sapiens (α6 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34720,FCNINNVCNFASRNDYSYW,19,Pentastatin-2,Not available,,Not found,Homo sapiens (α5 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34721,GPWAPCSASCGGGSQSRS,18,Papilostatin-1,Not available,,Not found,Homo sapiens (Papilin),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,18,15-18
DRAMP34722,GPWEDCSVSCGGGEQLRSR,19,Scospondistatin,Not available,,Not found,Homo sapiens (SCO-spondin),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34723,GPWEPCSVTCSKGTRTRRR,19,Properdistatin,Not available,,Not found,Homo sapiens (Properdin),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,CD36,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34724,GPWERCTAQCGGGIQARRR,19,Semastatin-5A.1,Not available,,Not found,Homo sapiens (Sema 5A),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34725,GPWGDCSRTCGGGVQFSSR,19,Adamtsostatin-4,Not available,,Not found,Homo sapiens (ADAMTS-4),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34726,GPWGPCSGSCGPGRRLRRR,19,Cartilostatin-2,Not available,,Not found,Homo sapiens (CILP-2),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34727,LPRFSTMPFIYCNINEVCHY,20,Hexastatin-3,Not available,,Not found,Homo sapiens (α6 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,20,18-21
DRAMP34728,LPVFSTLPFAYCNIHQVCH,19,Tetrastatin-1,Not available,,Not found,Homo sapiens (α4 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34729,LRRFSTMPFMFCNINNVCNF,20,Pentastatin-1,Not available,,Not found,Homo sapiens (α5 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,"αvβ3, αvβ1",18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,20,18-21
DRAMP34730,QPWGTCSESCGKGTQTRAR,19,Fibulostatin-6.3,Not available,,Not found,Homo sapiens (Fibulin-6),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34731,QPWSQCSATCGDGVRERRR,19,Thrombostatin con-1,Not available,,Not found,Homo sapiens (TSRC-1),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34732,SAPFIECHGRGTCNYYANS,19,Pentastatin-3,Not available,,Not found,Homo sapiens (α5 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34733,SAWRACSVTCGKGIQKRSR,19,Fibulostatin-6.1,Not available,,Not found,Homo sapiens (Fibulin-6),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34734,SEWSDCSVTCGKGMRTRQR,19,Spondinstatin-1,Not available,,Not found,Homo sapiens (F-spondin ),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34735,SKWSECSRTCGGGVKFQER,19,Adamtsostatin-18,Not available,,Not found,Homo sapiens (ADAMTS-18),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34736,SPWSKCSAACGQTGVQTRTR,20,Cartilostatin-1,Not available,,Not found,Homo sapiens (CILP-1),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,20,18-21
DRAMP34737,SPWSPCSGNCSTGKQQRTR,19,Thrombostatin con-3,Not available,,Not found,Homo sapiens (TSRC-3),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34738,SPWSPCSTSCGLGVSTR,17,Wispostatin-1,Not available,,Not found,Homo sapiens (WISP-1),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,17,15-18
DRAMP34739,SPWSQCSVRCGRGQRSRQVR,20,Adamtsostatin-like-4,Not available,,Not found,Homo sapiens (TSRC1),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,20,18-21
DRAMP34740,SPWSQCTASCGGGVQTR,17,Adamtsostatin-16,Not available,,Not found,Homo sapiens (ADAMTS-16),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,17,15-18
DRAMP34741,SPWTKCSATCGGGHYMRTR,19,Semastatin-5A.2,Not available,,Not found,Homo sapiens (Sema 5A),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34742,SQWSPCSRTCGGGVSFRER,19,Papilostatin-2,Not available,,Not found,Homo sapiens (Papilin),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34743,TAWGPCSTTCGLGMATRV,18,Wispostatin-2,Not available,,Not found,Homo sapiens (WISP-2),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,18,15-18
DRAMP34744,TEWSACNVRCGRGWQKRSR,19,Netrinstatin-5D,Not available,,Not found,Homo sapiens (UNC-5D),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34745,TEWSACSKTCGMGISTRV,18,Connectostatin,Not available,,Not found,Homo sapiens (CTGF),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,18,15-18
DRAMP34746,TEWSVCNSRCGRGYQKRTR,19,Netrinstatin-5C,Not available,,Not found,Homo sapiens (UNC-5C),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34747,TEWTACSKSCGMGFSTRV,18,Nephroblastostatin,Not available,,Not found,Homo sapiens (NOVH),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,18,15-18
DRAMP34748,TKWTPCSRTCGMGISNRV,18,Wispostatin-3,Not available,,Not found,Homo sapiens (WISP-3),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,18,15-18
DRAMP34749,TLPFAYCNIHQVCHYAQRNDRSYWL,25,Tetrastatin-2,Not available,,Not found,Homo sapiens (α4 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,αvβ3,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,25,24-27
DRAMP34750,TQWTSCSKTCNSGTQSRHR,19,Complestatin-C6,Not available,,Not found,Homo sapiens (Complement comp. C6),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34751,TSWSPCSASCGGGHYQRTR,19,Semastatin-5B,Not available,,Not found,Homo sapiens (Sema 5B),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,19,18-21
DRAMP34752,TSWSQCSKTCGTGISTRV,18,Cyrostatin ,Not available,,Not found,Homo sapiens (CYR61),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,18,15-18
DRAMP34753,WTRCSSSCGRGVSVRSR,17,Thrombostatin con-6,Not available,,Not found,Homo sapiens (TSRC-6),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,17,15-18
DRAMP34754,YCNINEVCHYARRNDKSYWL,20,Hexastatin-2,Not available,,Not found,Homo sapiens (α6 CIV),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,18780781,Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. ,"Karagiannis ED, Popel AS. ",A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells,20,18-21
DRAMP34761,FFSLLPSLIGGLVSAIK,17,Imcroporin ,Not available,,Not found,,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Amidation,,L,Not available,Not available,19451300,Antimicrob Agents Chemother. 2009 Aug;53(8):3472-7.,"Zhao Z, Ma Y, Dai C, Zhao R, Li S, Wu Y, Cao Z, Li W. ","Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.",17,15-18
DRAMP34764,TRQARRNRRRRWRERQRGC,19,HIV-1 Rev (34-50),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,Not available,Not available,19707187,Mol Ther. 2009 Nov;17(11):1868-76.,"Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.",Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.,19,18-21
DRAMP34765,RRRRNRTRRNRRRVRGC,17,FHV coat (35-49),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,Not available,Not available,19707187,Mol Ther. 2009 Nov;17(11):1868-77.,"Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.",Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.,17,15-18
DRAMP34766,KMTRAQRRAAARRNRWTARGC,21,BMV Gag (7-25),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,Not available,Not available,19707187,Mol Ther. 2009 Nov;17(11):1868-78.,"Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.",Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.,21,18-21
DRAMP34767,TRRQRTRRARRNRGC,15,HTLV-II Rex (4-16),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,Conjugation with Alexa 488 at glycyl cysteine sequence,L,Not available,Not available,19707187,Mol Ther. 2009 Nov;17(11):1868-79.,"Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.",Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.,15,12-15
DRAMP34778,KCFQWQRNMRKVRGPPVSC,19,M1,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,19858187,J Biol Chem. 2009 Dec 25;284(52):36099-36108.,"Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.",A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.,19,18-21
DRAMP34779,KCFQWQRNMRKVRGPPVSSIKR,22,M2,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,19858187,J Biol Chem. 2009 Dec 25;284(52):36099-36109.,"Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.",A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.,22,21-24
DRAMP34781,QWQRNMRKVRGPPVSCIKR,19,M5,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,19858187,J Biol Chem. 2009 Dec 25;284(52):36099-36111.,"Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.",A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.,19,18-21
DRAMP34783,KCFMWQEMLNKAGVPKLRCARK,22,rLF,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,19858187,J Biol Chem. 2009 Dec 25;284(52):36099-36113.,"Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.",A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.,22,21-24
DRAMP34784,KLWMRWYSPTTRRYG,15,No.14,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,,L,Not available,Not available,19956900,Int J Mol Med. 2010 Jan;25(1):41-51. ,"Kamide K, Nakakubo H, Uno S, Fukamizu A.",Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.,15,12-15
DRAMP34785,RTLVNEYKNTLKFSK,15,No.63,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,,L,Not available,Not available,19956900,Int J Mol Med. 2010 Jan;25(1):41-52. ,"Kamide K, Nakakubo H, Uno S, Fukamizu A.",Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.,15,12-15
DRAMP34786,IPSRWKDQFWKRWHY,15,No.143,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,,L,Not available,Not available,19956900,Int J Mol Med. 2010 Jan;25(1):41-53. ,"Kamide K, Nakakubo H, Uno S, Fukamizu A.",Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.,15,12-15
DRAMP34787,GYGNCRHFKQKPRRD,15,No. 440,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,,L,Not available,Not available,19956900,Int J Mol Med. 2010 Jan;25(1):41-54. ,"Kamide K, Nakakubo H, Uno S, Fukamizu A.",Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.,15,12-15
DRAMP34788,KNAWKHSSCHHRHQI,15,No. 2028,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,,L,Not available,Not available,19956900,Int J Mol Med. 2010 Jan;25(1):41-55. ,"Kamide K, Nakakubo H, Uno S, Fukamizu A.",Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.,15,12-15
DRAMP34789,RVREWWYTITLKQES,15,No. 2175,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,,L,Not available,Not available,19956900,Int J Mol Med. 2010 Jan;25(1):41-56. ,"Kamide K, Nakakubo H, Uno S, Fukamizu A.",Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.,15,12-15
DRAMP34790,QQHLLIAINGYPRYN,15,No. 2510,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,,L,Not available,Not available,19956900,Int J Mol Med. 2010 Jan;25(1):41-57. ,"Kamide K, Nakakubo H, Uno S, Fukamizu A.",Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.,15,12-15
DRAMP34791,WKCRRQCFRVLHHWN,15,JF06,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein,Free,,L,Not available,Not available,19956900,Int J Mol Med. 2010 Jan;25(1):41-58. ,"Kamide K, Nakakubo H, Uno S, Fukamizu A.",Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.,15,12-15
DRAMP34793,DDDDDNDKIPDDRDN,15,TSP-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,20056600,J Biol Chem. 2010 Mar 19;285(12):8733-42. ,"Colombo G, Margosio B, Ragona L, Neves M, Bonifacio S, Annis DS, Stravalaci M, Tomaselli S, Giavazzi R, Rusnati M, Presta M, Zetta L, Mosher DF, Ribatti D, Gobbi M, Taraboletti G.",Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds,15,12-15
DRAMP34794,KWFETWFTEWPKKRK,15,Pep-3,Not available,,Not found,Chimeric,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Cysteamide,,L,Not available,Not available,20188697,Biochim Biophys Acta. 2010 Dec;1798(12):2274-85.,"Kurzawa L, Pellerano M, Morris MC. ",PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.,15,12-15
DRAMP34795,GLWWRLWWRLRSWFRLWFRA,20,CADY2,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Cysteamide,,L,Not available,Not available,20188697,Biochim Biophys Acta. 2010 Dec;1798(12):2274-86.,"Kurzawa L, Pellerano M, Morris MC. ",PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.,20,18-21
DRAMP34796,ECKFTVKPYLKRFQVYYKGRMWCP,24,SALF,Not available,,Not found,Penaeus monodon,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"SALF can induce apoptotic gene expressions, enhance antitumor activity of cisplatin in vitro, and inhibit tumor growth in nude mice.",Tumor cells: HeLa (65% Inhibition=100μg/ml),Not available,Cyclic,Acetylation,Amidation,,L,Not available,Not available,20214941,Peptides. 2010 Jun;31(6):1019-25. ,"Lin MC, Lin SB, Chen JC, Hui CF, Chen JY.",Shrimp anti-lipopolysaccharide factor peptide enhances the antitumor activity of cisplatin in vitro and inhibits HeLa cells growth in nude mice,24,21-24
DRAMP34805,TPATPTVAQFVIQGSTICLVC,21,Cypemycin,E5KIB6,,Not found,Streptomyces,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,20805503,Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16297-302.,"Claesen J, Bibb M. ",Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides.,21,18-21
DRAMP34807,VELPPPVELPPPVELPPP,18,Sweet Arrow Protein (SAP) (E),Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein/ Rhodamine B,Free,,L,Not available,Not available,21365733,Chembiochem. 2011 Apr 11;12(6):896-903.,"Martín I, Teixidó M, Giralt E.","Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E). ",18,15-18
DRAMP34861,ARPAKAAATQKKVERKAPDA,20,Fibrinogen derived,Not available,,Not found,Fibrinogen,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,αvβ3,21470139,Curr Pharm Biotechnol. 2011 Aug;12(8):1101-17.,"Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS",Anti-angiogenic peptides for cancer therapeutics,20,18-21
DRAMP34869,FLSSRLQDLYSIVRRADRAA,20,Endostatin peptide fragment I (180–199),Not available,,Not found,Collagen XVIII,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,21470139,Curr Pharm Biotechnol. 2011 Aug;12(8):1101-25.,"Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS",Anti-angiogenic peptides for cancer therapeutics,20,18-21
DRAMP34871,KSVRGKGKGQKRKRKKSRYK,20,VEGFderived peptide,Not available,,Not found,Exon 6a of VEGF gene,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,VEGFR2,21470139,Curr Pharm Biotechnol. 2011 Aug;12(8):1101-27.,"Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS",Anti-angiogenic peptides for cancer therapeutics,20,18-21
DRAMP34872,NGREACLDPEAPMVQKIVQKMLKG,24,Chemokinostatin-1,Not available,,Not found,CXCL1,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,CXCR3,21470139,Curr Pharm Biotechnol. 2011 Aug;12(8):1101-28.,"Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS",Anti-angiogenic peptides for cancer therapeutics,24,21-24
DRAMP34873,NGRKISLDLRAPLYKKIIKKLLES,24,PF4 derived,Not available,,Not found,PF4,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,VEGF FGF2,21470139,Curr Pharm Biotechnol. 2011 Aug;12(8):1101-29.,"Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS",Anti-angiogenic peptides for cancer therapeutics,24,21-24
DRAMP34877,KWKKLLKKPLLKKLLKKL,18,P5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Acetylation,,L,Not available,Not available,21741801, Int J Antimicrob Agents. 2011 Sep;38(3):237-42.,"Dawson RM, Fox MA, Atkins HS, Liu CQ. ",Potent antimicrobial peptides with selectivity for Bacillus anthracis over human erythrocytes,18,15-18
DRAMP34880,RXRXRXRXRXRXRXRXB,17,(RX)8B,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,X=6-aminohexanoic acid (Ahx); B=Beta-Alanine,L,Not available,Not available,21765469,Oncogene. 2012 Feb 23;31(8):1024-33. ,"Ma W, Lin Y, Xuan W, Iversen PL, Smith LJ, Benchimol S.",Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.,17,15-18
DRAMP34901,RKKRRQRRRHRRKKR,15,dTAT,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,21856394,Int J Pharm. 2012 May 1;427(1):134-42. ,"Baoum A, Ovcharenko D, Berkland C. ","Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.",15,12-15
DRAMP34903,rqikiwfqnrrmkwkk,16,d-Penetratin {pAntp-(43-58)},Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,D,Not available,Not available,21867915, Chem Biol. 2011 Aug 26;18(8):1000-11. ,"Verdurmen WP, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hällbrink M, van Kuppevelt TH, Brock R. ",Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.,16,15-18
DRAMP34904,KCFQWQRNMRKVRGPPVSCIKR,22,hLF(38-59) peptide,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,21867915, Chem Biol. 2011 Aug 26;18(8):1000-12. ,"Verdurmen WP, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hällbrink M, van Kuppevelt TH, Brock R. ",Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.,22,21-24
DRAMP34905,kcfqwqrnmrkvrgppvscikr,22,hLF(38-59) peptide,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,D,Not available,Not available,21867915, Chem Biol. 2011 Aug 26;18(8):1000-13. ,"Verdurmen WP, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hällbrink M, van Kuppevelt TH, Brock R. ",Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.,22,21-24
DRAMP34912,KLALKLALKALKAALKLAGC,20,MAP,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,fluorescein,,L,Not available,Not available,21875799,Bioorg Med Chem Lett. 2011 Oct 1;21(19):5688-91.,"Wada S, Tsuda H, Okada T, Urata H. ",Cellular uptake of Aib-containing amphipathic helix peptide.,20,18-21
DRAMP34913,KLULKLULKULKAULKLUGC,20,MAP (Aib),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,fluorescein,"U=Aib, α-aminoisobutyric acid",L,Not available,Not available,21875799,Bioorg Med Chem Lett. 2011 Oct 1;21(19):5688-92.,"Wada S, Tsuda H, Okada T, Urata H. ",Cellular uptake of Aib-containing amphipathic helix peptide.,20,18-21
DRAMP34917,GLRKRLRKFRNKIKEK,16,CF-sC18,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Carboxyfluorescein ,Free,,L,Not available,Not available,21956822,ChemMedChem. 2012 Jan 2;7(1):57-61.,"Splith K, Bergmann R, Pietzsch J, Neundorf I.",Specific targeting of hypoxic tumor tissue with nitroimidazole-peptide conjugates.,16,15-18
DRAMP34918,BGLRKXRLRKFRNKIKEK,18,CF-sC18(NIA),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Amidation,Free,"B=Beta-Alanine; X=NIA, 2-(2-nitroimidazol-1-yl)acetic acid",L,Not available,Not available,21956822,ChemMedChem. 2012 Jan 2;7(1):57-62.,"Splith K, Bergmann R, Pietzsch J, Neundorf I.",Specific targeting of hypoxic tumor tissue with nitroimidazole-peptide conjugates.,18,15-18
DRAMP34919,KAAKKWAKAAKKWAKAWKKAA,21,Z1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-244. ,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP34920,KAAKKAWKAWKKAAKAWKKAA,21,Z3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-245. ,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP34921,KAAKKAWKAAKKAWKAWKKAA,21,Z7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-246. ,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP34922,KWAKKAAKWAKKAAKWAKKAA,21,Z8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-247. ,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP34923,KAWKKAWKAAKKAWKAAKKAA,21,Z9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-248. ,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP34924,AAKKWAKAKKWAKAKKWAKAA,21,Z10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22057278,J Biol Chem. 2012 Jan 2;287(1):233-249. ,"Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. ",Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity,21,18-21
DRAMP34928,LSQETFSDLWKLLPEN,16,WT p53,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Mdm2,22148351,J Am Chem Soc. 2012 Jan 11;134(1):103-6. ,"Baek S, Kutchukian PS, Verdine GL, Huber R, Holak TA, Lee KW, Popowicz GM.",Structure of the stapled p53 peptide bound to Mdm2,16,15-18
DRAMP34939,FLHHIVGLIHHGLSLFGDRAD,21,Pis2 ,Not available,,Not found,Gadus morhua,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,22178249,Fish Shellfish Immunol. 2012 Mar;32(3):396-406.,"Ruangsri J, Salger SA, Caipang CM, Kiron V, Fernandes JM.",Differential expression and biological activity of two piscidin paralogues and a novel splice variant in Atlantic cod (Gadus morhua L.).,21,18-21
DRAMP34945,RRRRRRRRRGPGVTWTPQAWFQWV,24,RV24,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22326265,Biochem Biophys Res Commun. 2012 Mar 9;419(2):170-4. ,"Lo SL, Wang S. ",Evaluation of the use of amphipathic peptide-based protein carrier for in vitro cancer research.,24,21-24
DRAMP34949,FFLIPKGRRRRRRRR,15,PasR8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,22486588, Mol Pharm. 2012 May 7;9(5):1222-30. ,"Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.",A protein transduction method using oligo-arginine (4R) for the delivery of transcription factors into cell nuclei.,15,12-15
DRAMP34950,LILIGRRRRRRRRGC,15,LILIR8 (Alexa),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,22486588, Mol Pharm. 2012 May 7;9(5):1222-31. ,"Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.",A protein transduction method using oligo-arginine (5R) for the delivery of transcription factors into cell nuclei.,15,12-15
DRAMP34953,FFFFFFGRRRRRRRR,15,F6R8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,22486588, Mol Pharm. 2012 May 7;9(5):1222-34. ,"Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.",A protein transduction method using oligo-arginine (8R) for the delivery of transcription factors into cell nuclei.,15,12-15
DRAMP34954,fflipkgrrrrrrrr,15,dPasR8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,D,Not available,Not available,22486588, Mol Pharm. 2012 May 7;9(5):1222-35. ,"Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.",A protein transduction method using oligo-arginine (9R) for the delivery of transcription factors into cell nuclei.,15,12-15
DRAMP34957,GCGGGYGRKKRRQRRR,16,Tat,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22531849, Int J Pharm. 2012 Jul 1;430(1-2):372-80.,"Wang C, Qiao L, Zhang Q, Yan H, Liu K.",Enhanced cell uptake of superparamagnetic iron oxide nanoparticles through direct chemisorption of FITC-Tat-PEG₆₀₀-b-poly(glycerol monoacrylate).,16,15-18
DRAMP34958,YGRKKRRQRRRGTALDWSWLQTE,23,TAT-NBD,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22580115,J Control Release. 2012 Aug 10;161(3):893-902. ,"Liu R, Xi L, Luo D, Ma X, Yang W, Xi Y, Wang H, Qian M, Fan L, Xia X, Li K, Wang D, Zhou J, Meng L, Wang S, Ma D. ",Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD.,23,21-24
DRAMP34968,CHHHHHRRRRRRRRRHHHHHC,21,HR9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22669044,Gene. 2012 Aug 15;505(1):37-46. ,"Liu BR, Lin MD, Chiang HJ, Lee HJ.",Arginine-rich cell-penetrating peptides deliver gene into living human cells.,21,18-21
DRAMP34969,FFLIPKGRRRRRRRRR,16,PR9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22669044,Gene. 2012 Aug 15;505(1):37-47. ,"Liu BR, Lin MD, Chiang HJ, Lee HJ.",Arginine-rich cell-penetrating peptides deliver gene into living human cells.,16,15-18
DRAMP34970,CGGGYGRKKRRQRRR,15,AgNP-TAT,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22682937,Biomaterials. 2012 Sep;33(26):6155-61. ,"Liu J, Zhao Y, Guo Q, Wang Z, Wang H, Yang Y, Huang Y.",TAT-modified nanosilver for combating multidrug-resistant cancer.,15,12-15
DRAMP34971,GLWWKAWWKAWWKSLWWRKRKRKA,24,CADY-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22688249,Int J Pharm. 2012 Sep 15;434(1-2):209-14. ,"Li Y, Zheng X, Cao Z, Xu W, Zhang J, Gong M.",Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin.,24,21-24
DRAMP34972,AGYLLGKLLOOLAAAALOOLL,21,PF14,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,,L,Not available,Not available,22698942,J Control Release. 2012 Aug 20;162(1):1-8.,"Ezzat K, Zaghloul EM, El Andaloussi S, Lehto T, El-Sayed R, Magdy T, Smith CI, Langel U.",Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.,21,18-21
DRAMP34974,DSLKSYWYLQKFSWR,15,2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22805558,Nat Commun. 2012 Jul 17;3:952. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP34975,KLWMRWWSPTTRRYG,15,7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22805558,Nat Commun. 2012 Jul 17;3:953. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP34976,RLWMRWYSPWTRRWG,15,10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22805558,Nat Commun. 2012 Jul 17;3:954. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP34977,RLIMRIYAPTTRRYG,15,28,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22805558,Nat Commun. 2012 Jul 17;3:955. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP34978,RLYMRYYSPTTRRYG,15,30,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22805558,Nat Commun. 2012 Jul 17;3:956. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP34979,RLWMRWYSPRTRAYG,15,33,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22805558,Nat Commun. 2012 Jul 17;3:957. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP34980,KRPTMRFRYTWNPMK,15,44,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Resisting chymotrypsin hydrolysis,Not available,Not available,Linear,Free,Free,,L,Not available,Chymotrypsin hydrolysis,22805558,Nat Commun. 2012 Jul 17;3:958. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP34981,WKCRRQAFRVLHHWN,15,47,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22805558,Nat Commun. 2012 Jul 17;3:959. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP34982,WKARRQCFRVLHHWN,15,48,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,22805558,Nat Commun. 2012 Jul 17;3:960. ,"Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. ",Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.,15,12-15
DRAMP35007,BENPESILDEHVQRVM,16,fAxWT,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Inhibit wnt/β-catenin signaling pathway,Not available,Not available,Linear,FITC,Amidation,B=β-Ala,L,Not available,β-catenin,23071338, Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17942-7.,"Grossmann TN, Yeh JT, Bowman BR, Chu Q, Moellering RE, Verdine GL.",Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin,16,15-18
DRAMP35032,YGRKKRRQRRRENAEYLR,18,Tat-ENAEYLR,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,"X=acp, Epsilon-aminocaproic acid",L,Not available,Not available,23085023,Eur J Pharmacol. 2013 Jan 5;698(1-3):87-95. ,"Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. ",Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A550 cells.,18,15-18
DRAMP35033,YGRKKRRQRRRQNAQYLR,18,Tat-QNAQYLR,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,"X=acp, Epsilon-aminocaproic acid",L,Not available,Not available,23085023,Eur J Pharmacol. 2013 Jan 5;698(1-3):87-96. ,"Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. ",Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A551 cells.,18,15-18
DRAMP35034,YGRKKRRQRRRDYQQD,16,Tat-DYQQD,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,"X=acp, Epsilon-aminocaproic acid",L,Not available,Not available,23085023,Eur J Pharmacol. 2013 Jan 5;698(1-3):87-97. ,"Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. ",Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A552 cells.,16,15-18
DRAMP35035,YGRKKRRQRRRNYQQN,16,Tat-NYQQN,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,"X=acp, Epsilon-aminocaproic acid",L,Not available,Not available,23085023,Eur J Pharmacol. 2013 Jan 5;698(1-3):87-98. ,"Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. ",Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A553 cells.,16,15-18
DRAMP35037,rrrrrrrrrcqcrrkn,16,R9-GO-203,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,D,Not available,Not available,23114713, Cancer Biol Ther. 2013 Feb;14(2):127-34. ,"Uchida Y, Raina D, Kharbanda S, Kufe D.",Inhibition of the MUC1-C oncoprotein is synergistic with cytotoxic agents in the treatment of breast cancer cells.,16,15-18
DRAMP35038,CALNNYGRKKRRQRRR,16,Tat,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23184894,Adv Healthc Mater. 2013 Feb;2(2):352-60. ,"Liu X, Zhu H, Jin Q, Zhou W, Colvin VL, Ji J.",Small and stable phosphorylcholine zwitterionic quantum dots for weak nonspecific phagocytosis and effective Tat peptide functionalization.,16,15-18
DRAMP35039,AGYLLGXLLOOLAAAALOOLL,21,PF15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,"X=Lys(ε-Mtt), Trifluoromethylquinoline moietie is added at amino froup of Lys7",L,Not available,Not available,23200958,Int J Pharm. 2013 Jan 30;441(1-2):242-7.,"Lindberg S, Muñoz-Alarcón A, Helmfors H, Mosqueira D, Gyllborg D, Tudoran O, Langel U. ","PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors.",21,18-21
DRAMP35041,GXFKKTFHKVSHAVKSGIHA,20,"Centrocin 1a heavy chain, CEN1 HC (1-20)",D8WN02,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23237525,AMB Express. 2012 Dec 13;2(1):67. ,"Björn C, Håkansson J, Myhrman E, Sjöstrand V, Haug T, Lindgren K, Blencke HM, Stensvåg K, Mahlapuu M. ","Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis",20,18-21
DRAMP35045,RRRRRRRGGIYLATALAKWALKQGF,25,P7-4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23262194, Biochim Biophys Acta. 2013 Mar;1828(3):1047-56.,Lemeshko VV.,Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.,25,24-27
DRAMP35046,IYLATALAKWALKQGFGGRRRRRRR,25,P7-5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23262194, Biochim Biophys Acta. 2013 Mar;1828(3):1047-57.,Lemeshko VV.,Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.,25,24-27
DRAMP35047,RRRRRRRGGIYLATALAKWALKQ,23,P7-6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23262194, Biochim Biophys Acta. 2013 Mar;1828(3):1047-58.,Lemeshko VV.,Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.,23,21-24
DRAMP35048,IYLATALAKWALKQGGRRRRRRR,23,P7-7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23262194, Biochim Biophys Acta. 2013 Mar;1828(3):1047-59.,Lemeshko VV.,Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.,23,21-24
DRAMP35049,RRRRRRRGGKLAKLAKKLAKLAK,23,R7-KLA,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23262194, Biochim Biophys Acta. 2013 Mar;1828(3):1047-60.,Lemeshko VV.,Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.,23,21-24
DRAMP35050,KLAKLAKKLAKLAKGGRRRRRRR,23,KLA-R7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23262194, Biochim Biophys Acta. 2013 Mar;1828(3):1047-61.,Lemeshko VV.,Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.,23,21-24
DRAMP35060,DGRCLLIIKLAKLAKKLAKLAK,22,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23326440,PLoS One. 2013;8(1):e53491.,"Hou L, Zhao X, Wang P, Ning Q, Meng M, Liu C. ",Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells,22,21-24
DRAMP35065,AGYLLGXINLKALAALAKKIL,21,NF51,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,X=Ornithine,L,Not available,Not available,23357356,Biochim Biophys Acta. 2013 May;1828(5):1365-73.,"Arukuusk P, Pärnaste L, Oskolkov N, Copolovici DM, Margus H, Padari K, Möll K, Maslovskaja J, Tegova R, Kivi G, Tover A, Pooga M, Ustav M, Langel U.","New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.",21,18-21
DRAMP35066,AGYLLGXINLKALAALAKKIL,21,NF51,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,X=Ornithine,L,Not available,Not available,23357356,Biochim Biophys Acta. 2013 May;1828(5):1365-73.,"Arukuusk P, Pärnaste L, Oskolkov N, Copolovici DM, Margus H, Padari K, Möll K, Maslovskaja J, Tegova R, Kivi G, Tover A, Pooga M, Ustav M, Langel U.","New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.",21,18-21
DRAMP35067,AGYLLGXINLKALAALAKKIL,21,NF51,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,X=Ornithine,L,Not available,Not available,23357356,Biochim Biophys Acta. 2013 May;1828(5):1365-73.,"Arukuusk P, Pärnaste L, Oskolkov N, Copolovici DM, Margus H, Padari K, Möll K, Maslovskaja J, Tegova R, Kivi G, Tover A, Pooga M, Ustav M, Langel U.","New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.",21,18-21
DRAMP35068,AGYLLGXINLKALAALAKKIL,21,NF51,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,X=Ornithine,L,Not available,Not available,23357356,Biochim Biophys Acta. 2013 May;1828(5):1365-73.,"Arukuusk P, Pärnaste L, Oskolkov N, Copolovici DM, Margus H, Padari K, Möll K, Maslovskaja J, Tegova R, Kivi G, Tover A, Pooga M, Ustav M, Langel U.","New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.",21,18-21
DRAMP35069,RLLRLLRRLLRLLRRLLRC,19,PL,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23384441,Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-64.,"Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. ",Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.,19,18-21
DRAMP35070,RGDRGDRRDLRLDRGDLRC,19,PD1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23384441,Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-65.,"Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. ",Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.,19,18-21
DRAMP35071,RGDRLDRRDLRLDRRDLRC,19,PD2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23384441,Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-66.,"Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. ",Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.,19,18-21
DRAMP35072,RGERGERRELRLERGELRC,19,PE1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23384441,Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-67.,"Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. ",Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.,19,18-21
DRAMP35073,RGERLERRELRLERRELRC,19,PE2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23384441,Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-68.,"Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. ",Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.,19,18-21
DRAMP35086,KLAKLAKKLAKLAKGRKKRRQRRRP,25,KLA-TAT(47-57),Not available,,Not found,Chimeric,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23469189, PLoS One. 2013;8(3):e57329. ,"Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.",A novel cell-penetrating peptide derived from human eosinophil cationic protein.,25,24-27
DRAMP35087,KLAKLAKKLAKLAKNYRWRCKNQN,24,KLA-ECP(32-41),Not available,,Not found,Chimeric,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23469189, PLoS One. 2013;8(3):e57330. ,"Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.",A novel cell-penetrating peptide derived from human eosinophil cationic protein.,24,21-24
DRAMP35088,KETWWETWWTEWSQPKKKRKVC,22,FP-lipo,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23515421,Int J Nanomedicine. 2013;8:1155-65. ,"Kang MJ, Park SH, Kang MH, Park MJ, Choi YW. ",Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.,22,21-24
DRAMP35090,GLKKLAELFHKLLKLG,16,TAMARA-peptide 1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"TAMRA, 5-(and-6)-carboxytetramethylrhodamine",Amidation,,L,Not available,Not available,23545289,Biomaterials. 2013 Jul;34(20):4872-9. ,"Park H, Tsutsumi H, Mihara H.",Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.,16,15-18
DRAMP35091,GLKKLAELFHKLLKLG,16,TAMARA-peptide 1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"TAMRA, 5-(and-6)-carboxytetramethylrhodamine",Amidation,,L,Not available,Not available,23545289,Biomaterials. 2013 Jul;34(20):4872-9. ,"Park H, Tsutsumi H, Mihara H.",Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.,16,15-18
DRAMP35092,LKKLAELAHKLLKLG,15,TAMARA-peptide 2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,TAMRA,Amidation,,L,Not available,Not available,23545289,Biomaterials. 2013 Jul;34(20):4872-10. ,"Park H, Tsutsumi H, Mihara H.",Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.,15,12-15
DRAMP35093,GLKKLAELFHKLLKLG,16,Peptide 1N- GNS,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Conjugated to nanoparticles,Amidation,,L,Not available,Not available,23545289,Biomaterials. 2013 Jul;34(20):4872-11. ,"Park H, Tsutsumi H, Mihara H.",Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.,16,15-18
DRAMP35094,GLKKLAELFHKLLKLG,16,Peptide 1N- GNS,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Conjugated to nanoparticles,Amidation,,L,Not available,Not available,23545289,Biomaterials. 2013 Jul;34(20):4872-11. ,"Park H, Tsutsumi H, Mihara H.",Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.,16,15-18
DRAMP35095,GLKKLAELAHKLLKLG,16,Peptide 2N- GNS,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Conjugated to nanoparticles,Amidation,,L,Not available,Not available,23545289,Biomaterials. 2013 Jul;34(20):4872-12. ,"Park H, Tsutsumi H, Mihara H.",Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.,16,15-18
DRAMP35104,YGRKKRRQRRREILSRXPAYRKIL,24,CF-TAT-substrate,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Free,X=ATP-binding site inhibitors,L,Not available,Not available,23621550, ACS Chem Biol. 2013 Jul 19;8(7):1479-87. ,"van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.",Cell-penetrating bisubstrate-based protein kinase C inhibitors.,24,21-24
DRAMP35105,YGRKKRRQRRREILSRXPAYRKIL,24,CF-TAT-substrate,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Free,X=ATP-binding site inhibitors,L,Not available,Not available,23621550, ACS Chem Biol. 2013 Jul 19;8(7):1479-87. ,"van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.",Cell-penetrating bisubstrate-based protein kinase C inhibitors.,24,21-24
DRAMP35106,YGRKKRRQRRREILSRXPAYRKIL,24,Ac-TAT-substrate,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Free,X=ATP-binding site inhibitors,L,Not available,Not available,23621550, ACS Chem Biol. 2013 Jul 19;8(7):1479-88. ,"van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.",Cell-penetrating bisubstrate-based protein kinase C inhibitors.,24,21-24
DRAMP35107,YGRKKRRQRRREILSRXPAYRKIL,24,Ac-TAT-substrate,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Free,X=ATP-binding site inhibitors,L,Not available,Not available,23621550, ACS Chem Biol. 2013 Jul 19;8(7):1479-88. ,"van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.",Cell-penetrating bisubstrate-based protein kinase C inhibitors.,24,21-24
DRAMP35113,AYLLGKINLKALAALAKKIL,20,TP10,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,,L,Not available,Not available,23669260, J Control Release. 2013 Aug 28;170(1):83-91.,"Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.",Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.,20,18-21
DRAMP35114,AXLYLLGKINLKALAALAKKIL,22,TP10 2GL,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"X=L-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine",L,Not available,Not available,23669260, J Control Release. 2013 Aug 28;170(1):83-92.,"Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.",Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.,22,21-24
DRAMP35115,AGYXLGKINLKALAALAKKIL,21,TP10 4LL,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"X=L-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine",L,Not available,Not available,23669260, J Control Release. 2013 Aug 28;170(1):83-93.,"Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.",Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.,21,18-21
DRAMP35116,axlyllgkinlkalaalakkil,22,TP10 2GD,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"x=D-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine",D,Not available,Not available,23669260, J Control Release. 2013 Aug 28;170(1):83-94.,"Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.",Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.,22,21-24
DRAMP35117,agyxlgkinlkalaalakkil,21,TP10 4LD,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,5(6)-Carboxyfluorescein,Amidation,"x=D-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine",D,Not available,Not available,23669260, J Control Release. 2013 Aug 28;170(1):83-95.,"Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.",Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.,21,18-21
DRAMP35118,"IGGYCSWLRL,IGGYCSWLRL",21,"Harmoniasin A4, HaA4",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,23732481,Int J Oncol. 2013 Aug;43(2):622-8.,"Kim IW, Lee JH, Kwon YN, Yun EY, Nam SH, Ahn MY, Kang DC, Hwang JS.","Anticancer activity of a Synthetic peptide peptide derived from harmoniasin, an antibacterial peptide from the ladybug Harmonia axyridis",21,18-21
DRAMP35122,AGYLLGHINLHHLAHLHHILC,21,TH peptide,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23891517,Biomaterials. 2013 Oct;34(32):7980-93. ,"Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q. ",A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. ,21,18-21
DRAMP35123,AGYLLGHINLHHLAHLHHIL,20,TH peptide,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,23891517,Biomaterials. 2013 Oct;34(32):7980-94. ,"Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q. ",A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. ,20,18-21
DRAMP35124,AGYLLGKINLKKLAKLLLIL,20,TK peptide,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,23891517,Biomaterials. 2013 Oct;34(32):7980-95. ,"Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q. ",A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. ,20,18-21
DRAMP35126,TPWWRLWTKWHHKRRDLPRKPEGC,24,FITC-Rath,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,23937069,J Drug Target. 2013 Nov;21(9):801-8. ,"Kuo JH, Lin CW.",Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells.,24,21-24
DRAMP35138,RXRRXRILFQYRXRRXR,17,LB1_1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-30. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35139,RXRRXRYQFLIRXRRXR,17,LB1_2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-31. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35140,RXRRXRFLQIYRXRRXR,17,LB1_3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-32. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35141,RXRRXRAAAAARXRRXR,17,LB1_4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-33. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35142,RXRRXRIKFQYRXRRXR,17,LB1_5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-34. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35143,RXRRXRIEFQYRXRRXR,17,LB1_6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-35. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35144,RXRRXRIWFQYRXRRXR,17,LB1_7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-36. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35145,RXRRXRIPFQYRXRRXR,17,LB1_8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-37. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35146,KXRKXRILFQYKXRKXR,17,LB1_9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-38. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35147,HXRHXRILFQYHXRHXR,17,LB1_10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-39. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35148,SXRSXRILFQYSXRSXR,17,LB1_11,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-40. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35149,EXREXRILFQYEXREXR,17,LB1_12,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-41. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35150,RMKWKKILFQYRXRRXR,17,LB1_13,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-42. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35151,RXRRXRILFQYRMKWKK,17,LB1_14,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-43. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35152,KKWKMRILFQYRXRRXR,17,LB1_15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-44. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35153,RXRRXRILFQYKKWKMR,17,LB1_16,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,N-terminal alkyne is introduced using 4-pentynoic acid,Amidation,X=aminohexyl residue,L,Not available,Not available,24105028, Org Biomol Chem. 2013 Nov 21;11(43):7621-45. ,"Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. ",Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.,17,15-18
DRAMP35155,KLULKLULKULKAULKLU,18,MAP(Aib),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,U=α-amino isobutyric acid (Aib),L,Not available,Not available,24216093,Bioorg Med Chem. 2013 Dec 15;21(24):7669-73,"Wada S, Hashimoto Y, Kawai Y, Miyata K, Tsuda H, Nakagawa O, Urata H. ",Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.,18,15-18
DRAMP35162,KCFQAQRNMRKVRGPPVSCIKR,22,hLF W5A,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-29. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35163,KCFQWARNMRKVRGPPVSCIKR,22,hLF Q6A,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-30. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35164,KCFQWQRNARKVRGPPVSCIKR,22,hLF M9A,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-31. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35165,KCFQWQRNMRKVRGAPVSCIKR,22,hLF P15A,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-32. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35166,KCFQWQRNMRKRRGPPVSCIKR,22,hLF V12R,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-33. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35167,KCFQWQANMRKVRGPPVSCIKR,22,hLF R7A,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-34. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35168,KCFQWQRNMRKVAGPPVSCIKR,22,hLF R13A,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-35. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35169,KCFQWQANMRKRRGPPVSCIKR,22,hLF R7A/V12R,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-36. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35170,KCFQWQRNMRKVAGRPVSCIKR,22,hLF R13A/P15R,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-37. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35171,KCFRWQRNRRKVRGRPVRCIKR,22,hLF +4R,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-38. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35172,KRFRWQRNMRKVRGRPVRSIKR,22,hLF lin+4R,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-39. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35173,RCFQWQRNMRRVRGPPVSCIRR,22,hLF R7,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-40. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35174,KCFQWQKNMKKVKGPPVSCIKK,22,hLF K7,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,,L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-41. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35175,KXFQWQRNMRKVRGPPVSXIKR,22,hLF Hcy,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Fluorescein,Amidation,"X=Hcy, homocysteine in which the side chain is one methylene group longer than in cysteine",L,Not available,Not available,24270856,Cell Mol Life Sci. 2014 Jul;71(14):2717-42. ,"Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.",The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.,22,21-24
DRAMP35181,CELAGIGILTVRKKRRQRRR,20,Alexa488-Melan-A-TAT,Not available,,Not found,Chimeric,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Conjugation with Alexa488 C5 maleimide,Free,,L,Not available,Not available,24372650, Exp Dermatol. 2014 Jan;23(1):20-6. ,"Buhl T, Braun A, Forkel S, Möbius W, van Werven L, Jahn O, Rezaei-Ghaleh N, Zweckstetter M, Mempel M, Schön MP, Haenssle HA. ",Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.,20,18-21
DRAMP35182,CELAGIGILTVKKKKKQKKK,20,Alexa488-Melan-A-polyLys (control peptide),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24372650, Exp Dermatol. 2014 Jan;23(1):20-7. ,"Buhl T, Braun A, Forkel S, Möbius W, van Werven L, Jahn O, Rezaei-Ghaleh N, Zweckstetter M, Mempel M, Schön MP, Haenssle HA. ",Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.,20,18-21
DRAMP35186,GRGDSPRRKKKKSPRRKKKKSPRR,24,Pep3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Free,Phosphorylation,L,Not available,Not available,24462902,J Control Release. 2014 Apr 10;179:1-11. ,"Remaut K, Symens N, Lucas B, Demeester J, De Smedt SC. ",Cell division responsive peptides for optimized plasmid DNA delivery: the mitotic window of opportunity?,24,21-24
DRAMP35187,GRGDGPRRKKKKGPRRKKKKGPRR,24,Pep3(Mutant),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Free,,L,Not available,Not available,24462902,J Control Release. 2014 Apr 10;179:1-12. ,"Remaut K, Symens N, Lucas B, Demeester J, De Smedt SC. ",Cell division responsive peptides for optimized plasmid DNA delivery: the mitotic window of opportunity?,24,21-24
DRAMP35196,BXRXRXXRXRXXRXRX,16,FAM-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"FAM, fluorescein",Amidation,B=Beta-Alanine; X=α-amino isobutyric acid,L,Not available,Not available,24661993,Bioorg Med Chem. 2014 Apr 15;22(8):2403-11. ,"Yamashita H, Demizu Y, Shoda T, Sato Y, Oba M, Tanaka M, Kurihara M.",Amphipathic short helix-stabilized peptides with cell-membrane penetrating ability.,16,15-18
DRAMP35199,GGGGRRRRRRRRRLLLL,17,m9R,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Maleimide addition,Free,,L,Not available,Not available,24696462,Genome Res. 2014 Jun;24(6):1020-7. ,"Ramakrishna S, Kwaku Dad AB, Beloor J, Gopalappa R, Lee SK, Kim H.",Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.,17,15-18
DRAMP35200,CGGGRRRRRRRRRLLLL,17,sgRNA-CPP,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24696462,Genome Res. 2014 Jun;24(6):1020-8. ,"Ramakrishna S, Kwaku Dad AB, Beloor J, Gopalappa R, Lee SK, Kim H.",Gene disruption by cell-penetrating peptide-mediated delivery of Cas10 protein and guide RNA.,17,15-18
DRAMP35201,XACSGSGSGCGSGSGSCG,18,IA0 (Bicyclic) (integral arginine peptides),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-64.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35202,XACSGRGSGCGSGRGSCG,18,IA2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-65.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35203,XACRGSGRGCGRGSGRCG,18,IA4a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-66.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35204,XACSGRGRGCGRGRGSCG,18,IA4b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-67.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35205,XACRGRGRGCGRGRGRCG,18,IA6a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-68.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35206,XACGRGRGRCRGRGRGCG,18,IA6b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-69.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35207,XACRGRGRGCRGRGRGCG,18,IA6c,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-70.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35208,XACGRGRGRCGRGRGRCG,18,IA6d,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-71.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35209,XACRGRRRGCGRRRGRCG,18,IA8a,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-72.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35210,XACRRSRRGCGRRSRRCG,18,IA8b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-73.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35211,XACRRSRRGCGRRSRRCG,18,IA8b,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-73.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35212,XACSDRFRNCPADEALCG,18,kCA2 (Kallikrein inhibitor with internal arginines),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-74.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35213,XACRDRFRNCPADEALCG,18,kCA3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-75.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35214,XACRDRFRNCPADERLCG,18,kCA4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-76.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35215,XACRDRFRRCPADERLCG,18,kCA5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-77.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35216,XACRDRFRRCPADRRLCG,18,kCA6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-78.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35217,XACSGRGRGCGSGSGSCG,18,CA2 (Control internal arginine ),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-79.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35218,XACRGRGRGCGSGSGSCG,18,CA3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-80.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35219,XACRGRGRGCGSGSRSCG,18,CA4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-81.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35220,XACRGRGRRCGSGSRSCG,18,CA5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-82.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35221,XACRGRGRRCGSGRRSCG,18,CA6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-83.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35222,XACRGRGRRCGSGRRSCG,18,CA6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-83.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35223,XARCSGSGSGCGSGSGSCGR,20,EA2x1 (External arginines),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-84.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,20,18-21
DRAMP35224,XARRCSGSGSGCGSGSGSCGRR,22,EA2x2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-85.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,22,21-24
DRAMP35225,XARRRCSGSGSGCGSGSGSCGRRR,24,EA2x3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-86.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,24,21-24
DRAMP35229,XARCSDRFRNCPADEALCGR,20,kEA2x1 (Kallikrein inhibitor with external arginines),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-89.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,20,18-21
DRAMP35230,XARRCSDRFRNCPADEALCGRR,22,kEA2x2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-90.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,22,21-24
DRAMP35231,XARRRCSDRFRNCPADEALCGRRR,24,kEA2x3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-91.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,24,21-24
DRAMP35235,XACRRSRRGCGRRSRRCG,18,IA8b L (Linear variants),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-94.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35236,XACRRSRRGCGRRSRRCG,18,IA8b L (Linear variants),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-94.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35237,XACRGRGRRCGSGRRSCG,18,CA6 L,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-95.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35238,XACRGRGRRCGSGRRSCG,18,CA6 L,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-95.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35245,XACHGRRWGCGRHRGRCG,18,IA5_2H1W,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,FITC,Amidation,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,24697151,ioconjug Chem. 2014 May 21;25(5):955-100.,"Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.",Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. ,18,15-18
DRAMP35254,IPLVVPLRRRRRRRRC,16,RIPL peptide,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24704199,Eur J Pharm Biopharm. 2014 Aug;87(3):489-100. ,"Kang MH, Park MJ, Yoo HJ, hyuk KY, Lee SG, Kim SR, Yeom DW, Kang MJ, Choi YW. ",RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.,16,15-18
DRAMP35259,WELVVLGKLYGRKKRRQRRR,20,pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-26. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,20,18-21
DRAMP35260,ELVVLGKLYGRKKRRQRRR,19,N-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-27. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,19,18-21
DRAMP35261,LVVLGKLYGRKKRRQRRR,18,N2-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-28. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,18,15-18
DRAMP35262,VVLGKLYGRKKRRQRRR,17,N3-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-29. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,17,15-18
DRAMP35263,WELVVLGKYGRKKRRQRRR,19,C1-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-30. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,19,18-21
DRAMP35264,WELVVLGYGRKKRRQRRR,18,C2-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-31. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,18,15-18
DRAMP35265,WELVVLYGRKKRRQRRR,17,C3-pep5-cpp*,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-32. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,17,15-18
DRAMP35266,WELVVLYGRKKRRQRRR,17,C3-pep5-cpp*,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-32. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,17,15-18
DRAMP35267,WELVVYGRKKRRQRRR,16,C4-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-33. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,16,15-18
DRAMP35268,WELVYGRKKRRQRRR,15,C5-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-34. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,15,12-15
DRAMP35271,WELVVAYGRKKRRQRRR,17,A,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-37. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,17,15-18
DRAMP35272,WEAVVLYGRKKRRQRRR,17,B,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-38. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,17,15-18
DRAMP35273,WEAVVAYGRKKRRQRRR,17,C,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-39. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,17,15-18
DRAMP35274,WELVVLYGRKKRRQRRR,17,Ac-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-40. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,17,15-18
DRAMP35275,WELVVLYGRKKRRQRRR,17,Ac-pep5-cpp,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Free,,L,Not available,Not available,24764300, J Biol Chem. 2014 Jun 13;289(24):16711-40. ,"de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. ",A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.,17,15-18
DRAMP35277,CRQIKIWFQNRRMKWKK,17,Penetratin,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,24796502,Biochim Biophys Acta. 2014 Aug;1838(8):2087-98.,"Alves ID, Carré M, Montero MP, Castano S, Lecomte S, Marquant R, Lecorché P, Burlina F, Schatz C, Sagan S, Chassaing G, Braguer D, Lavielle S. ",A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth.,17,15-18
DRAMP35300,CRRLRHLRHHYRRRWHRFRC,20,Mgpe-9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,Addition of cysteine in Mgpe3 sequence makes Mgpe9,L,Not available,Not available,24816284, Biomaterials. 2014 Aug;35(24):6563-75. ,"Sharma R, Nisakar D, Shivpuri S, Ganguli M.",Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides.,20,18-21
DRAMP35301,CLLYWFRRRHRHHRRRHRRC,20,Mgpe-10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,Addition of cysteine in Mgpe4 sequence makes Mgpe10,L,Not available,Not available,24816284, Biomaterials. 2014 Aug;35(24):6563-76. ,"Sharma R, Nisakar D, Shivpuri S, Ganguli M.",Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides.,20,18-21
DRAMP35302,RRLRHLRHHYRRRWHRFR,18,Mgpe-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24816284, Biomaterials. 2014 Aug;35(24):6563-77. ,"Sharma R, Nisakar D, Shivpuri S, Ganguli M.",Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides.,18,15-18
DRAMP35303,LLYWFRRRHRHHRRRHRR,18,Mgpe-4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,24816284, Biomaterials. 2014 Aug;35(24):6563-78. ,"Sharma R, Nisakar D, Shivpuri S, Ganguli M.",Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides.,18,15-18
DRAMP35304,GLKKLARLFHKLLKLGC,17,RF,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,24867193,Org Biomol Chem. 2014 Jul 14;12(26):4673-81.,"Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. ",Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.,17,15-18
DRAMP35305,GLKKLAELFHKLLKLGC,17,EF,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,24867193,Org Biomol Chem. 2014 Jul 14;12(26):4673-82.,"Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. ",Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.,17,15-18
DRAMP35306,GLKKLARLAHKLLKLGC,17,RA,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,24867193,Org Biomol Chem. 2014 Jul 14;12(26):4673-83.,"Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. ",Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.,17,15-18
DRAMP35307,GLKKLAELAHKLLKLGC,17,EA,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,24867193,Org Biomol Chem. 2014 Jul 14;12(26):4673-84.,"Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. ",Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.,17,15-18
DRAMP35332,XGLFGCGRKKRRQRRRPPQ,19,NTD,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,X=Doxorubicin,L,Not available,Not available,24892976,J Control Release. 2014 Oct 10;191:123-30.,"Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW Jr, Lin YA, Cui H. ",Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.,19,18-21
DRAMP35335,XCGRKKRRQRRRPPQ,15,n-NTD,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,X=Doxorubicin,L,Not available,Not available,24892976,J Control Release. 2014 Oct 10;191:123-33.,"Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW Jr, Lin YA, Cui H. ",Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.,15,12-15
DRAMP35336,XGLFGXGRKKRRQRRRPPQ,19,C16NTD,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,"X(1)=Doxorubicin; X(6)=(C16)Cys, Cys-Palmitoylation",L,Not available,Not available,24892976,J Control Release. 2014 Oct 10;191:123-34.,"Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW Jr, Lin YA, Cui H. ",Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.,19,18-21
DRAMP35343,KXGRKKRRQRRRPPQY,16,Tat-Dex,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,"X=Dex, dexamethasone",L,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-48. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,16,15-18
DRAMP35351,RRRRRRRRRXDEXLI,15,R9-PCP,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,"Φ=L-2-naphthylalanine; X(10)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(13)=Pcap, phosphocoumaryl aminopropionic acid",L,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-54. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,15,12-15
DRAMP35352,RKKRRQRRRXDEXLI,15,Tat-PCP,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,"Φ=L-2-naphthylalanine; X(10)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(13)=Pcap, phosphocoumaryl aminopropionic acid",L,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-55. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,15,12-15
DRAMP35353,RQIKIWFQNRRMKWKKXDEXLI,22,Antp-PCP,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,"Φ=L-2-naphthylalanine; X(17)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(20)=Pcap, phosphocoumaryl aminopropionic acid",L,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-56. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,22,21-24
DRAMP35354,XAAAAAKRRRRΦFXKX,16,bicyclo(FΦR4-A5)Rho,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,Free,Amidation,"X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B",Mix,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-57. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,16,15-18
DRAMP35355,XAAAAAAAKRRRRΦFXKX,18,bicyclo(FΦR4-A7)Rho,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,Free,Amidation,"X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(16)=L-2,3-diaminopropionic acid; X(18)=Rho, rhodamine B",Mix,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-58. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,18,15-18
DRAMP35356,XRARARKRRRRΦFXKX,16,bicyclo(FΦR4-RARAR)Rho,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,Free,Amidation,"X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B",Mix,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-59. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,16,15-18
DRAMP35357,XDADADKRRRRΦFXKX,16,bicyclo(FΦR4-DADAD)Rho,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,Free,Amidation,"X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B",Mix,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-60. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,16,15-18
DRAMP35359,AAAAAAARRRRΦFKX,15,monocyclo(FΦR4-A7)Rho,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Cyclic,Free,Amidation,"Φ=L-2-naphthylalanine; X=Rho, rhodamine B",Mix,Not available,Not available,24896852,Biochemistry. 2014 Jun 24;53(24):4034-62. ,"Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. ",Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.,15,12-15
DRAMP35370,PKKKRKVWKLLQQFFGLM,18,NS,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,24958615,J Pept Sci. 2014 Oct;20(10):785-93.,"Zhang Y, Song J, Zhang W, Liang R, Ma Y, Zhang L, Wei X, Ni J, Wang R.",Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery. ,18,15-18
DRAMP35371,PKKKRKVWKLLQQFFGLM,18,NS,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,24958615,J Pept Sci. 2014 Oct;20(10):785-93.,"Zhang Y, Song J, Zhang W, Liang R, Ma Y, Zhang L, Wei X, Ni J, Wang R.",Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery. ,18,15-18
DRAMP35372,PKKKRKVWKLLQQFFGLM,18,Stearyl-NS,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,,L,Not available,Not available,24958615,J Pept Sci. 2014 Oct;20(10):785-94.,"Zhang Y, Song J, Zhang W, Liang R, Ma Y, Zhang L, Wei X, Ni J, Wang R.",Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery. ,18,15-18
DRAMP35373,PKKKRKVWKLLQQFFGLM,18,Stearyl-NS,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,,L,Not available,Not available,24958615,J Pept Sci. 2014 Oct;20(10):785-94.,"Zhang Y, Song J, Zhang W, Liang R, Ma Y, Zhang L, Wei X, Ni J, Wang R.",Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery. ,18,15-18
DRAMP35395,YGRKKRRQRRRPPQG,15,TAT,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Conjugation with Alexa Flour 488,Free,,L,Not available,Not available,24985034,Eur J Med Chem. 2014 Dec 17;88:10-22.,"D'Souza C, Henriques ST, Wang CK, Craik DJ.",Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.,15,12-15
DRAMP35396,EEEEEEEEPLGLAGRRRRRRRRN,23,ACPP,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,25000246,PLoS One. 2014 Jul 7;9(7):e100670. ,"Li S, Chen J, Xu H, Long J, Xie X, Zhang Y",The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates.,23,21-24
DRAMP35398,LKKLCKLLKKLCKLAG,16,LK-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,25056130,Angew Chem Int Ed Engl. 2014 Sep 15;53(38):10086-9. ,"Jang S, Hyun S, Kim S, Lee S, Lee IS, Baba M, Lee Y, Yu J. ","Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.",16,15-18
DRAMP35399,FSGSGSGSGRRRRRRRRGC,19,F(SG)4R8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,25108152,J Control Release. 2014 Dec 10;195:55-62.,"Sayers EJ, Cleal K, Eissa NG, Watson P, Jones AT. ","Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.",19,18-21
DRAMP35400,GSGSGSGSGRRRRRRRRGC,19,G(SG)4R8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,25108152,J Control Release. 2014 Dec 10;195:55-63.,"Sayers EJ, Cleal K, Eissa NG, Watson P, Jones AT. ","Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.",19,18-21
DRAMP35405,AGYLLGKTNLKALAALAKKIL,21,NF1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Stearylation,  CH3(CH2)16CO",Amidation,,L,Not available,Not available,25135660,Biochim Biophys Acta. 2014 Dec;1838(12):3118-29.,"Vasconcelos L, Madani F, Arukuusk P, Pärnaste L, Gräslund A, Langel U.",Effects of cargo molecules on membrane perturbation caused by transportan10 based cell-penetrating peptides.,21,18-21
DRAMP35406,VTPHHVLVDEYTGEWVDSQFK,21,VG-21,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,25154664, Biomaterials. 2014 Nov;35(35):9484-94. ,"iwari PM, Eroglu E, Bawage SS, Vig K, Miller ME, Pillai S, Dennis VA, Singh SR. ",Enhanced intracellular translocation and biodistribution of gold nanoparticles functionalized with a cell-penetrating peptide (VG-21) from vesicular stomatitis virus.,21,18-21
DRAMP35414,HHHHHHHHRRRRRRRR,16,STR-H8R8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,,L,Not available,Not available,25193363,Nanomedicine. 2015 Feb;11(2):435-46.,"Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.",Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.,16,15-18
DRAMP35415,HHHHHHHHRRRRRRRRRRRRRRR,23,H8R15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,25193363,Nanomedicine. 2015 Feb;11(2):435-47.,"Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.",Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.,23,21-24
DRAMP35416,HHHHHHHHRRRRRRRRRRRRRRR,23,H8R15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,25193363,Nanomedicine. 2015 Feb;11(2):435-47.,"Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.",Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.,23,21-24
DRAMP35417,HHHHHHHHRRRRRRRRRRRRRRR,23,STR-H8R15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,,L,Not available,Not available,25193363,Nanomedicine. 2015 Feb;11(2):435-48.,"Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.",Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.,23,21-24
DRAMP35418,HHHHHHHHRRRRRRRRRRRRRRR,23,STR-H8R15,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Stearylation,Amidation,,L,Not available,Not available,25193363,Nanomedicine. 2015 Feb;11(2):435-48.,"Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.",Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.,23,21-24
DRAMP35425,MAARLCCQLDPARDVLCLRP,20,N-terminus of X-Pep,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,25251474,Biochem Biophys Res Commun. 2014 Oct 10;453(1):64-8,"Montrose K, Yang Y, Krissansen GW. ","X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.",20,18-21
DRAMP35426,MAARLCCQLDPARDV,15,N-terminus of X-Pep,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,25251474,Biochem Biophys Res Commun. 2014 Oct 10;453(1):64-9,"Montrose K, Yang Y, Krissansen GW. ","X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.",15,12-15
DRAMP35449,FLFKLIPKAIKGLLKAFK,18,"AcrAP2 [S4K,N8K,S11K,S15K]",A0A0A1I6N9,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,25332684, Int J Biol Sci. 2014 Sep 21;10(10):1097-107. ,"Du Q, Hou X, Ge L, Li R, Zhou M, Wang H, Wang L, Wei M, Chen T, Shaw C.","Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1 and AcrAP2, from the venom of the scorpion, Androctonus crassicauda, display potent growth modulation effects on human cancer cell lines",18,15-18
DRAMP35459,KKKKKKNKKLQQRGD,15,P1,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,,L,Not available,Not available,25459448,Eur J Pharm Biopharm. 2015 Jan;89:93-106.,"Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.",Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.,15,12-15
DRAMP35460,RGDGPRRRPRKRRGR,15,P2,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,,L,Not available,Not available,25459448,Eur J Pharm Biopharm. 2015 Jan;89:93-107.,"Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.",Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.,15,12-15
DRAMP35461,RRRQKRIVVRRRLIR,15,P3,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,,L,Not available,Not available,25459448,Eur J Pharm Biopharm. 2015 Jan;89:93-108.,"Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.",Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.,15,12-15
DRAMP35462,RRVWRRYRRQRWCRR,15,P4,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,,L,Not available,Not available,25459448,Eur J Pharm Biopharm. 2015 Jan;89:93-109.,"Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.",Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.,15,12-15
DRAMP35463,RRARRPRRLRPAPGR,15,P5,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,,L,Not available,Not available,25459448,Eur J Pharm Biopharm. 2015 Jan;89:93-110.,"Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.",Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.,15,12-15
DRAMP35464,LLRARWRRRRSRRFR,15,P6,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,,L,Not available,Not available,25459448,Eur J Pharm Biopharm. 2015 Jan;89:93-111.,"Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.",Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.,15,12-15
DRAMP35465,RGPRRQPRRHRRPRR,15,P7,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,,L,Not available,Not available,25459448,Eur J Pharm Biopharm. 2015 Jan;89:93-112.,"Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.",Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.,15,12-15
DRAMP35466,RRWRRWNRFNRRRCR,15,P8,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"Ahx, 6-aminohexamoic acid",Free,,L,Not available,Not available,25459448,Eur J Pharm Biopharm. 2015 Jan;89:93-113.,"Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.",Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.,15,12-15
DRAMP35467,RKKRRQRRRRKKRRQRRR,18,Tat2-Nat,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,FITC,Natamycin,,L,Not available,Not available,25467959,Pharm Res. 2015 Jun;32(6):1920-30. ,"Jain A, Shah SG, Chugh A.","Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.",18,15-18
DRAMP35468,AKKRRQRRRAKKRRQRRR,18,MTat2-Nat,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,FITC,Natamycin,,L,Not available,Not available,25467959,Pharm Res. 2015 Jun;32(6):1920-31. ,"Jain A, Shah SG, Chugh A.","Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.",18,15-18
DRAMP35487,KWSFRVSYRGISYRRSRGK,19,MTpl-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation,Free,,L,Not available,Not available,25514997, FEBS J. 2015 Feb;282(4):732-45. ,"Jain A, Yadav BK, Chugh A. ",Marine antimicrobial peptide tachyplesin as an efficient nanocarrier for macromolecule delivery in plant and mammalian cells.,19,18-21
DRAMP35488,KWFRVYRGIYRRRGK,15,MTpl-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation,Free,,L,Not available,Not available,25514997, FEBS J. 2015 Feb;282(4):732-46. ,"Jain A, Yadav BK, Chugh A. ",Marine antimicrobial peptide tachyplesin as an efficient nanocarrier for macromolecule delivery in plant and mammalian cells.,15,12-15
DRAMP35489,KWCFAVCYAGICYAACAGK,19,MTpl-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Biotinylation,,,L,Not available,Not available,25514997, FEBS J. 2015 Feb;282(4):732-47. ,"Jain A, Yadav BK, Chugh A. ",Marine antimicrobial peptide tachyplesin as an efficient nanocarrier for macromolecule delivery in plant and mammalian cells.,19,18-21
DRAMP35499,YKQCHKKGGXKKGSG,15,NrTP2,Not available,,Not found,Protein derived,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Rhodamine B,Free,"X=Ahx, 6-aminohexanoic acid",L,Not available,Not available,25620660,Biopolymers. 2015 Mar;104(2):101-9. ,"Rodrigues M, Andreu D, Santos NC.",Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types.,15,12-15
DRAMP35529,FCTCNVKGFNAKNKRGIIYP,20,Scolopendrasin VII ,Not available,,Not found,,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Amidation,,L,Not available,Not available,25907065,J Microbiol Biotechnol. 2015 Aug;25(8):1275-80.,"Lee JH, Kim IW, Kim SH, Kim MA, Yun EY, Nam SH, Ahn MY, Kang D, Hwang JS.","Anticancer Activity of the Antimicrobial Peptide Scolopendrasin VII Derived from the Centipede, Scolopendra subspinipes mutilans.",20,18-21
DRAMP35537,VRKPPYLPRPRWXRXXYNX,19,"Oncocin [D2R,P12W,P13Hyp,R15Hyp,I16Tle,R19Orn]",A0A2R7WNA0,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (15% loss of viability=600μg/mL),Not available,Linear,Free,Amidation,,L,Not available,Not available,26334348, Amino Acids. 2016 Jan;48(1):269-80. ,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K. ",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP35538,VXKPPYLPRPRWXRXXYNX,19,"Oncocin [D2Orn,P12W,P13Hyp,R15Hyp,I16Tle,R19Orn]",A0A2R7WNA0,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (15% loss of viability=600μg/mL),Not available,Linear,Free,Amidation,,L,Not available,Not available,26334348, Amino Acids. 2016 Jan;48(1):269-81. ,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K. ",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP35539,VrKPPYLPRPRWXRXXYNX,19,"Oncocin [D2r,P12W,P13Hyp,R15Hyp,I16Tle,R19Orn]",A0A2R7WNA0,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (15% loss of viability=600μg/mL),Not available,Linear,Free,Amidation,,Mix,Not available,Not available,26334348, Amino Acids. 2016 Jan;48(1):269-82. ,"Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K. ",Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus,19,18-21
DRAMP35541,ARCCLVMPVPPFACVKFCS,19,"Transmembrane protein (17-35), RCB-1",B9T5G6,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,2MTM,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,26509914,J Nat Prod. 2015 Nov 25;78(11):2545-51.,"Boldbaatar D, Gunasekera S, El-Seedi HR, Göransson U. ","Synthesis, Structural Characterization, and Bioactivity of the Stable Peptide RCB-1 from Ricinus communis",19,18-21
DRAMP35544,DDEKEQFLYHLLSFNAV,17,wtR6IP,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Not available,Linear,Fluorescein-O2OC-,Free,,L,Not available,Rab8a GTPase,27336832,ACS Chem Biol. 2016 Aug 19;11(8):2375-82. ,"Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.",Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase,17,15-18
DRAMP35545,DDEⓍEQFⓍYHLLSFNAV,17,StRIP3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Not available,Cyclic (Stapled),Fluorescein-O2OC-,Free,Ⓧ=(S)-2-(4-pentenyl)alanine,L,Not available,Rab8a GTPase,27336832,ACS Chem Biol. 2016 Aug 19;11(8):2375-83. ,"Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.",Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase,17,15-18
DRAMP35546,DDEⓍEQFⓍYHLLSFNAV,17,StRIP3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Not available,Cyclic (Stapled),Fluorescein-O2OC-,Free,Ⓧ=(S)-2-(4-pentenyl)alanine,L,Not available,Rab8a GTPase,27336832,ACS Chem Biol. 2016 Aug 19;11(8):2375-83. ,"Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.",Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase,17,15-18
DRAMP35547,DDEⓍEQFⓍYHLLSFNAV,17,StRIP3 open,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Not available,Linear,Fluorescein-O2OC-,Free,Ⓧ=(S)-2-(4-pentenyl)alanine,L,Not available,Rab8a GTPase,27336832,ACS Chem Biol. 2016 Aug 19;11(8):2375-84. ,"Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.",Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase,17,15-18
DRAMP35548,DDEⓍEQFⓍYHLLSFNAV,17,StRIP3 open,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.,,Not available,Linear,Fluorescein-O2OC-,Free,Ⓧ=(S)-2-(4-pentenyl)alanine,L,Not available,Rab8a GTPase,27336832,ACS Chem Biol. 2016 Aug 19;11(8):2375-84. ,"Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.",Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase,17,15-18
DRAMP35614,GGGGGGGRGDLPETGGS,17,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,28351594,Bioorg Med Chem Lett. 2017 May 1;27(9):1911-1913,"Wu Z, Cheng X, Hong H, Zhao X, Zhou Z.",New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation,17,15-18
DRAMP35615,GGGGRGDRGDLPETGGS,17,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,28351594,Bioorg Med Chem Lett. 2017 May 1;27(9):1911-1914,"Wu Z, Cheng X, Hong H, Zhao X, Zhou Z.",New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation,17,15-18
DRAMP35616,GRGDRGDRGDLPETGGS,17,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,28351594,Bioorg Med Chem Lett. 2017 May 1;27(9):1911-1915,"Wu Z, Cheng X, Hong H, Zhao X, Zhou Z.",New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation,17,15-18
DRAMP35617,RRRQRRKKRGGGDTRLNTVWMW,22,TAT-RasGAP317-326 ,Not available,,Not found,,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,,Free,Free,,L,Not available,Not available,28638371,Front Microbiol. 2017 Jun 7;8:994.,"Heulot M, Jacquier N, Aeby S, Le Roy D, Roger T, Trofimenko E, Barras D, Greub G, Widmann C. ",Anticancer Peptide TAT-RasGAP317-326 Exerts Broad Antimicrobial Activity.,22,21-24
DRAMP35624,YLARAIRRTLARLLL,15,NN2_0018,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,29259134, J Biol Chem. 2018 Mar 9;293(10):3492-3509. ,"Nagarajan D, Nagarajan T, Roy N, Kulkarni O, Ravichandran S, Mishra M, Chakravortty D, Chandra N. ",Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria,15,12-15
DRAMP35625,SWKKFFKKARSLPKLF,16,NN2_0050,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,29259134,J Biol Chem. 2018 Mar 9;293(10):3492-3509.,"Nagarajan D, Nagarajan T, Roy N, Kulkarni O, Ravichandran S, Mishra M, Chakravortty D, Chandra N. ",Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria,16,15-18
DRAMP35633,XCRRLCYRNRCVTYCRGR,18,"X-hexatoxin-Hi1a, Hi Gomesin",A0A1D0BZI2,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30068931,Sci Rep. 2018 Aug 1;8(1):11519.,"Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales RAV, Brust A, Sánchez L, Alewood PF, Ramm GA, Miles JJ, King GF.",Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation,18,15-18
DRAMP35634,ECRRLCYKQRCVTYCRGR,18,Gomesin [PYA1E],P82358,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,1KFP,Not available,Not available,Not available,,Amidation,Amidation,,L,Not available,Not available,30068931,Sci Rep. 2018 Aug 1;8(1):11520.,"Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales RAV, Brust A, Sánchez L, Alewood PF, Ramm GA, Miles JJ, King GF.",Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation,18,15-18
DRAMP35638,LESLASSAVRTANKARAKL,19,Citrus-amp2,Q4JIY4,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,30192822,PLoS One. 2018 Sep 7;13(9):e0203452. ,"Inui Kishi RN, Stach-Machado D, Singulani JL, Dos Santos CT, Fusco-Almeida AM, Cilli EM, Freitas-Astúa J, Picchi SC, Machado MA.",Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus,19,18-21
DRAMP35641,FLFKLIPKAIKGLIKAFK,18,"AcrAP1 [S4K,H8K,S11K,S15K]",A0A0A1I6E7,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30268502,Biophys Res Commun. 2018 Oct 28;505(2):478-484. ,"Lee MY, Park SC, Jung M, Shin MK, Kang HL, Baik SC, Cheong GW, Jang MK, Lee WK. ","Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1 and AcrAP2, from the venom of the scorpion, Androctonus crassicauda, display potent growth modulation effects on human cancer cell lines",18,15-18
DRAMP35646,IKNAKVCVYAVCVSHK,16,Nicomicin-1 (18-33),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,30360541,Mar Drugs. 2018 Oct 23;16(11):401.,"Panteleev PV, Tsarev AV, Bolosov IA, Paramonov AS, Marggraf MB, Sychev SV, Shenkarev ZO, Ovchinnikova TV",Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain,16,15-18
DRAMP35653,VKAWAKVLKGFGKLLKGFGKL,21,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30506920,Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1682.,"Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. ",Simulated Molecular Evolution for Anticancer Peptide Design,21,18-21
DRAMP35654,FHAWAKLLKGVGRFFKGIGRW,21,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30506920,Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1683.,"Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. ",Simulated Molecular Evolution for Anticancer Peptide Design,21,18-21
DRAMP35655,IRAWAKVLKGVGKILKGVGRW,21,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30506920,Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1684.,"Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. ",Simulated Molecular Evolution for Anticancer Peptide Design,21,18-21
DRAMP35656,WRAWAKIYHGVGKLLKGVGRW,21,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30506920,Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1685.,"Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. ",Simulated Molecular Evolution for Anticancer Peptide Design,21,18-21
DRAMP35660,FLSLIPHIVSGVAALANHL,19,"Phylloseptin-PBa3, Phylloseptin-PBu",A0A5B7LGI9,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,30612735,,"Wu Y, Wang L, Zhou M, Chen T, Shaw C.","Phylloseptin-PBa1, -PBa2, -PBa3: Three novel antimicrobial peptides from the skin secretion of Burmeister's leaf frog (Phyllomedusa burmeisteri)",19,18-21
DRAMP35663,FIVPSIFLLKKAFCIALKKC,20,Japonicin-2LF,A0A482F245,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,30802593, Biochim Biophys Acta Gen Subj. 2019 May;1863(5):849-856.,"Yuan Y, Zai Y, Xi X, Ma C, Wang L, Zhou M, Shaw C, Chen T.",A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model,20,18-21
DRAMP35668,RRWCVYAYVRVRGVRVYAYVCW,22,"R-Arenicin-1 [L15R; R17,19Y; Y18A; R20V]",Q5SC60,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31234579, Mar Drugs. 2019 Jun 23;17(6):376. ,"Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.","Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization",22,21-24
DRAMP35669,WCRRYRVLVRGVLVRYRRCW,20,"Arenicin (2-21) [V3R; Y4,6R; A5Y; R8L]",Q5SC60,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31234579, Mar Drugs. 2019 Jun 23;17(6):376. ,"Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.","Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization",20,18-21
DRAMP35670,"RWCVYAYVRVXX,RWCVYAYVRV",23,Arenicin-1 (1-10)-Orn-Dap + Arenicin-1 (1-10),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,31234579, Mar Drugs. 2019 Jun 23;17(6):376. ,"Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.","Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization",23,21-24
DRAMP35671,"WCRRYRVLVXX,WCRRYRVLV",21,Invert Arenicin-1 (13-21)-Orn-Dap + Invert Arenicin-1 (13-21),Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,31234579, Mar Drugs. 2019 Jun 23;17(6):376. ,"Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.","Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization",21,18-21
DRAMP35672,RFCVYAYVRVRGVLVRYRRCF,21,"Arenicin-1 [W2,21F]",Q5SC60,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31234579, Mar Drugs. 2019 Jun 23;17(6):376. ,"Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.","Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization",21,18-21
DRAMP35673,RWXVYAYVRVRGVLVRYRRXW,21,"Linear Arenicin-1 [C3,20IAA-Cys]",Q5SC60,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31234579, Mar Drugs. 2019 Jun 23;17(6):376. ,"Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.","Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization",21,18-21
DRAMP35674,SRSSRAGLQFPVGRIHRLLRK,21,"Histone H2A (1-21), Fi-Histin",A0A1X9ZM18,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31252047,Fish Shellfish Immunol. 2019 Sep;92:667-679. ,"Sruthy KS, Nair A, Antony SP, Puthumana J, Singh ISB, Philip R. ","A histone H2A derived antimicrobial peptide, Fi-Histin from the Indian White shrimp, Fenneropenaeus indicus: Molecular and functional characterization",21,18-21
DRAMP35676,RKKRRQRRRCWTKSIPPKPC,20,Tat (48-56) + PPF-BBI [5-15],C3RSZ6,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: H157 (50% viability=100μM); H460 (50% viability=100μM),Not available,Linear,Free,Free,,L,Not available,Not available,31337113,Biomolecules. 2019 Jul 14;9(7):280.,"Miao Y, Chen G, Xi X, Ma C, Wang L, Burrows JF, Duan J, Zhou M, Chen T.",Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor,20,18-21
DRAMP35677,RKKAIKLVKKLVKKLKKALK,20,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,,,,L,Not available,Not available,31355341,Sci Adv. 2019 Jul 24;5(7):eaax1946.,"Nagarajan D, Roy N, Kulkarni O, Nanajkar N, Datey A, Ravichandran S, Thakur C, T S, Aprameya IV, Sarma SP, Chakravortty D, Chandra N. ",Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii.,20,18-21
DRAMP35678,FLKAIKKFGKEFKKIGAKLK,20,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,,,,L,Not available,Not available,31355341,Sci Adv. 2019 Jul 24;5(7):eaax1947.,"Nagarajan D, Roy N, Kulkarni O, Nanajkar N, Datey A, Ravichandran S, Thakur C, T S, Aprameya IV, Sarma SP, Chakravortty D, Chandra N. ",Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii.,20,18-21
DRAMP35679,RWCFRVCYRGICYRKCRG,18,Cyclic Tachyplesin-2,P14214,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,6PIO,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31455019, Int J Mol Sci. 2019 Aug 26;20(17):4184. ,"Vernen F, Harvey PJ, Dias SA, Veiga AS, Huang YH, Craik DJ, Lawrence N, Troeira Henriques S.",Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties,18,15-18
DRAMP35680,KWCFRVCYRGICYRKCRG,18,Cyclic Tachyplesin-3,P14214,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,6PIP,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31455019, Int J Mol Sci. 2019 Aug 26;20(17):4185. ,"Vernen F, Harvey PJ, Dias SA, Veiga AS, Huang YH, Craik DJ, Lawrence N, Troeira Henriques S.",Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties,18,15-18
DRAMP35686,WCVASpPLSYCGXTXXXlLXXT,22,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,Mix,Not available,Not available,31645764,Nature. 2019 Dec;576(7787):452-459.,"Luther A, Urfer M, Zahn M, Müller M, Wang SY, Mondal M, Vitale A, Hartmann JB, Sharpe T, Monte FL, Kocherla H, Cline E, Pessi G, Rath P, Modaresi SM, Chiquet P, Stiegeler S, Verbree C, Remus T, Schmitt M, Kolopp C, Westwood MA, Desjonquères N, Brabet E, Hell S, LePoupon K, Vermeulen A, Jaisson R, Rithié V, Upert G, Lederer A, Zbinden P, Wach A, Moehle K, Zerbe K, Locher HH, Bernardini F, Dale GE, Eberl L, Wollscheid B, Hiller S, Robinson JA, Obrecht D. ",Chimeric peptidomimetic antibiotics against Gram-negative bacteria,22,21-24
DRAMP35687,RFRWPIRRPPIRPPFYP,17,Bac5 (1-17)[P4W],P19660,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31692278,ChemMedChem. 2019 Dec 17;14(24):2025-2033,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E Coli, K Pneumoniae, and A Baumannii",17,15-18
DRAMP35688,RFRPPIRRPPIRPPWYP,17,Bac5 (1-17)[F15W],P19660,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31692278,ChemMedChem. 2019 Dec 17;14(24):2025-2033,"Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.","Proline-Rich Peptides With Improved Antimicrobial Activity Against E Coli, K Pneumoniae, and A Baumannii",17,15-18
DRAMP35706,FLFKLIKHAIKGLIKAFK,18,"AcrAP1 [S4,11,15K;P7K], AP1-Z5b",A0A0A1I6E7,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,31909181,Mol Ther Oncolytics. 2019 Dec 10;16:7-19.,"Ma R, Wong SW, Ge L, Shaw C, Siu SWI, Kwok HF. ",In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide,18,15-18
DRAMP35712,FWRIRIRRPRRIRIRWF,17,R-DIM-P-LF11-215,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,32151609,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183264.,"Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.",Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies,17,15-18
DRAMP35713,PFWRIRIRRPFWRIRIRR,18,DIM-LF11-322,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,32151609,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183265.,"Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.",Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies,18,15-18
DRAMP35714,PWRIRIRRPRRIRIWP,16,R-DIM-P-LF11-334,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,32151609,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183266.,"Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.",Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies,16,15-18
DRAMP35715,PWRIRIRRRRIRIRWPPWRIRIRR,24,R-DIM-LF11-334-LF11-334,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,32151609,Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183267.,"Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.",Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies,24,21-24
DRAMP35737,FLSLIPKIAGGIAALVKNL,19,"Phylloseptin-PV1, PPV1",Not available,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,33193152,Front Microbiol. 2020 Oct 26;11:565158. ,"Liu Y, Shi D, Wang J, Chen X, Zhou M, Xi X, Cheng J, Ma C, Chen T, Shaw C, Wang L.","A Novel Amphibian Antimicrobial Peptide, Phylloseptin-PV1, Exhibits Effective Anti- staphylococcal Activity Without Inducing Either Hepatic or Renal Toxicity in Mice",19,18-21
DRAMP35742,GWGSFFRRAAHVGRHVGRAALTHYL,25,Pleurocidin KR,P81941,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,6RSF,Not available,Tumor cells: HeLa (IC50=30.7 ± 2.6 μg/ml),Not available,Linear,Free,Amidation,,L,HEK293: IC50=40.1 ± 4.1 µg/ml,Not available,33247193, Commun Biol. 2020 Nov 27;3(1):697.,"Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.","A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy",25,24-27
DRAMP35743,gwgsffrraahvgrhvgraalthyl,25,D-Pleurocidin KR,P81941,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=25.3 ± 2.2 μg/ml); Calu-3 (IC50=39.1 ± 1.8 μg/ml); A549 (IC50=56.5 ± 4.5 μg/ml),Not available,Linear,Free,Amidation,,D,HEK293: IC50=36.4 ± 4.3 µg/ml,Not available,33247193, Commun Biol. 2020 Nov 27;3(1):698.,"Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.","A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy",25,24-27
DRAMP35744,GWGSFFKKAAHAGKHAGKAALTHYL,25,Pleurocidin VA,P81941,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,6RSG,Not available,Tumor cells: HeLa (IC50>400 μg/ml),Not available,Linear,Free,Amidation,,L,HEK293: IC50~400 µg/ml,Not available,33247193, Commun Biol. 2020 Nov 27;3(1):699.,"Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.","A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy",25,24-27
DRAMP35745,gwgsffkkaahagkhagkaalthyl,25,D-Pleurocidin VA,P81941,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (IC50=198.2 ± 10.2 μg/ml); A549 (IC50>250 μg/ml); Calu-3 (IC50>250 μg/ml),Not available,Linear,Free,Amidation,,D,HEK293: IC50=217.3 ± 46.5 µg/ml,Not available,33247193, Commun Biol. 2020 Nov 27;3(1):700.,"Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.","A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy",25,24-27
DRAMP35746,GSRGWGFEPGVRCLIWCD,18,Lasso peptide Felipeptin A1,Not available,,Not found,Bacteria,"Antimicrobial, Anticancer",Not found,Not found,Not found,6XTH,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,33294793,iScience. 2020 Nov 10;23(12):101785.,"Guerrero-Garzón JF, Madland E, Zehl M, Singh M, Rezaei S, Aachmann FL, Courtade G, Urban E, Rückert C, Busche T, Kalinowski J, Cao YR, Jiang Y, Jiang CL, Selivanova G, Zotchev SB. ",Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin,18,15-18
DRAMP35747,GGGGRGYEYNKQCLIFC,17,Lasso peptide Felipeptin A2,Not available,,Not found,Bacteria,"Antimicrobial, Anticancer",Not found,Not found,Not found,6XTI,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,33294793,iScience. 2020 Nov 10;23(12):101786.,"Guerrero-Garzón JF, Madland E, Zehl M, Singh M, Rezaei S, Aachmann FL, Courtade G, Urban E, Rückert C, Busche T, Kalinowski J, Cao YR, Jiang Y, Jiang CL, Selivanova G, Zotchev SB. ",Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin,17,15-18
DRAMP35752,LWKIWKKIWRVGWNWR,16,"Cecropin A-like 4 (3-18)[K2W,G5W,E9W,Q13W,H14N,T15W]",A0A1I8M6I1,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,33401476,Antibiotics (Basel). 2021 Jan 1;10(1):36.,"Peng J, Mishra B, Khader R, Felix L, Mylonakis E.",Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus,16,15-18
DRAMP35753,LWKIWKKIWRVWKNWR,16,"Cecropin A-like 4 (3-18)[K2W;G5,12W;E9W;Q13K;H14N;T15W]",A0A1I8M6I1,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,33401476,Antibiotics (Basel). 2021 Jan 1;10(1):37.,"Peng J, Mishra B, Khader R, Felix L, Mylonakis E.",Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus,16,15-18
DRAMP35754,LWKIGKKIWRVLWNWR,16,"Cecropin A-like 4 (3-18)[K2W,E9W,G12L,Q13W,H14N,T15W]",A0A1I8M6I1,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,33401476,Antibiotics (Basel). 2021 Jan 1;10(1):38.,"Peng J, Mishra B, Khader R, Felix L, Mylonakis E.",Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus,16,15-18
DRAMP35755,LWKIWWKIWRVWKNWR,16,"Cecropin A-like 4 (3-18)[K2W;G5,12W;K6W;E9W;Q13K;H14N;T15W]",A0A1I8M6I1,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,33401476,Antibiotics (Basel). 2021 Jan 1;10(1):39.,"Peng J, Mishra B, Khader R, Felix L, Mylonakis E.",Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus,16,15-18
DRAMP35760,"ELlVDlL,ExYxEaPQyI",18,Fengycin-Surfactin,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,"3-OH-Me-C14,3-OH-C16",Free,,Mix,Not available,Not available,33505362, Front Microbiol. 2021 Jan 11;11:561063. ,"Kourmentza K, Gromada X, Michael N, Degraeve C, Vanier G, Ravallec R, Coutte F, Karatzas KA, Jauregi P.",Antimicrobial Activity of Lipopeptide Biosurfactants Against Foodborne Pathogen and Food Spoilage Microorganisms and Their Cytotoxicity,18,15-18
DRAMP35762,GKLRLIKKLWVKKWKKKGWKA,21,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,33677023,Eur J Pharm Sci. 2021 Jun 1;161:105784. ,"Thankappan B, Sivakumar J, Asokan S, Ramasamy M, Pillai MM, Selvakumar R, Angayarkanni J. ",Dual antimicrobial and anticancer activity of a novel synthetic α-helical antimicrobial peptide,21,18-21
DRAMP35772,YNKKYMKHLKPCKKA,15,"Basic phospholipase A2 BmTX-I (103-117), pBmTxJ",P0C8M1,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34130109, Bioorg Chem. 2021 Sep;114:105042.,"eña-Carrillo MS, Pinos-Tamayo EA, Mendes B, Domínguez-Borbor C, Proaño-Bolaños C, Miguel DC, Almeida JR. ","Dissection of phospholipases A 2 reveals multifaceted peptides targeting cancer cells, Leishmania and bacteria",15,12-15
DRAMP35773,YNKKYRYHLKSCKKADK,17,"Basic phospholipase A2 BmjeTX-I (103-119), pBmje",P86803,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34130109, Bioorg Chem. 2021 Sep;114:105043.,"eña-Carrillo MS, Pinos-Tamayo EA, Mendes B, Domínguez-Borbor C, Proaño-Bolaños C, Miguel DC, Almeida JR. ","Dissection of phospholipases A 2 reveals multifaceted peptides targeting cancer cells, Leishmania and bacteria",17,15-18
DRAMP35781,KKMMKKGGKFGTFMAIGMGIR,21,"Romo1 (58-78)[T2,9K;Q5K;S6K]",P60603,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,34361008,Int J Mol Sci. 2021 Jul 31;22(15):8243.,"You DG, Lee HR, Kim HK, Lee GY, Yoo YD. ",A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria,21,18-21
DRAMP35782,KKMMKKGGKFGTFMAIGGIR,20,"Romo1 (58-78)[T2,9K;Q5K;S6K;M18del]",P60603,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,34361008,Int J Mol Sci. 2021 Jul 31;22(15):8244.,"You DG, Lee HR, Kim HK, Lee GY, Yoo YD. ",A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria,20,18-21
DRAMP35786,LKLKLKLTGKLKLKL,15,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34506975,Biomater. 2021 Nov;135:214-224.,"Tram NDT, Selvarajan V, Boags A, Mukherjee D, Marzinek JK, Cheng B, Jiang ZC, Goh P, Koh JJ, Teo JWP, Bond PJ, Ee PLR.",Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria,15,12-15
DRAMP35787,LKLKLKVpPTKLKLKL,16,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,34506975,Biomater. 2021 Nov;135:214-225.,"Tram NDT, Selvarajan V, Boags A, Mukherjee D, Marzinek JK, Cheng B, Jiang ZC, Goh P, Koh JJ, Teo JWP, Bond PJ, Ee PLR.",Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria,16,15-18
DRAMP35789,LKLKLKINGKKLKLKL,16,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34506975,Biomater. 2021 Nov;135:214-227.,"Tram NDT, Selvarajan V, Boags A, Mukherjee D, Marzinek JK, Cheng B, Jiang ZC, Goh P, Koh JJ, Teo JWP, Bond PJ, Ee PLR.",Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria,16,15-18
DRAMP35791,LCXIIKKIIKKIIKKII,17,,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34509120,J Colloid Interface Sci. 2022 Feb;607(Pt 1):488-501.,"Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. ",Rationally designed short cationic α-helical peptides with selective anticancer activity,17,15-18
DRAMP35792,KWKLFKKIGAVLKVLC,16,"Cecropin A (1-7)+Melittin (2-9)-C, CAMA",P01507,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,34528343,Environ Microbiol. 2022 Jun;24(6):2747-2758.,"Nishanth MAD, Bhoomika S, Gourkhede D, Dadimi B, Vergis J, Malik SVS, Barbuddhe SB, Rawool DB. ",Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium,16,15-18
DRAMP35793,KWKLFKKLGAVLKVLC,16,"Cecropin A (1-7)+Melittin (2-9)[I2L]-C, CAMA-CPP",P01507,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,34528343,Environ Microbiol. 2022 Jun;24(6):2747-2759.,"Nishanth MAD, Bhoomika S, Gourkhede D, Dadimi B, Vergis J, Malik SVS, Barbuddhe SB, Rawool DB. ",Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium,16,15-18
DRAMP35794,GLRRALLRLLRSLRRLLLRAC,21,P7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,34528343,Environ Microbiol. 2022 Jun;24(6):2747-2760.,"Nishanth MAD, Bhoomika S, Gourkhede D, Dadimi B, Vergis J, Malik SVS, Barbuddhe SB, Rawool DB. ",Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium,21,18-21
DRAMP35795,GLARALTRLLRQLTRQLTRAC,21,APP,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,34528343,Environ Microbiol. 2022 Jun;24(6):2747-2761.,"Nishanth MAD, Bhoomika S, Gourkhede D, Dadimi B, Vergis J, Malik SVS, Barbuddhe SB, Rawool DB. ",Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium,21,18-21
DRAMP35813,VRKPPYLPRPRPPRrIYNr,19,"Oncocin [R15,19r; D2R], Onc244",A0A2R7WNA0,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,Mix,Not available,Not available,34902208, Chembiochem. 2022 Mar 4;23(5):e202100609.,"Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.","Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112",19,18-21
DRAMP35817,GLWSKIKNVAAAAGKAALGAL,21,Dermaseptin t-DPH1,Not available,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34943741,Antibiotics (Basel). 2021 Dec 14;10(12):1529. ,"Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. ","Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies",21,18-21
DRAMP35818,GLWKKIKNVAAAAGKAALGAL,21,Dermaseptin t-DPH1 [S4K],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34943741,Antibiotics (Basel). 2021 Dec 14;10(12):1530. ,"Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. ","Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies",21,18-21
DRAMP35819,GLWKKIKNVAKAAGKAALGAL,21,"Dermaseptin t-DPH1 [S4K,A11A]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34943741,Antibiotics (Basel). 2021 Dec 14;10(12):1531. ,"Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. ","Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies",21,18-21
DRAMP35820,GLWKKIKNVAKAAGKAAKGAL,21,"Dermaseptin t-DPH1 [S4K,A11A,L18K]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34943741,Antibiotics (Basel). 2021 Dec 14;10(12):1532. ,"Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. ","Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies",21,18-21
DRAMP35821,WLWKKIKNVAKAAGKAAKGAL,21,"Dermaseptin t-DPH1 [G1W,S4K,A11A,L18K]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,34943741,Antibiotics (Basel). 2021 Dec 14;10(12):1533. ,"Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. ","Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies",21,18-21
DRAMP35822,Gikefkrivqrikdflrnlv,20,"D-LL-37 (13-32)[I13G,G14I]",P49913,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HeLa (50% Cytotoxicity=18.9µM),Not available,Linear,Free,Amidation,,Mix,Not available,Not available,34959645,Pharmaceuticals (Basel). 2021 Nov 30;14(12):1246,"Zhang Y, Lakshmaiah Narayana J, Wu Q, Dang X, Wang G. ",Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37,20,18-21
DRAMP35837,SYEKKINRHFKILKKNLKKK,20,"Grasscarp interferon (137-156), GcIFN-20",Q5KR62,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,35289673,Microbiol Spectr. 2022 Apr 27;10(2):e0201321.,"Xiao X, Lu H, Zhu W, Zhang Y, Huo X, Yang C, Xiao S, Zhang Y, Su J. ",A Novel Antimicrobial Peptide Derived from Bony Fish IFN1 Exerts Potent Antimicrobial and Anti-Inflammatory Activity in Mammals,20,18-21
DRAMP35847,FKGLAKLLKIGLKALAKVIQ,9,Ak-N’,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,,,,Mix,Not available,Not available,35432369,Front Immunol. 2022 Apr 1;13:821070. ,"Shin MK, Lee B, Kim ST, Yoo JS, Sung JS.",Designing a Novel Functional Peptide With Dual Antimicrobial and Anti-inflammatory Activities via in Silico Methods,20,18-21
DRAMP35848,NKGLAKLLKIGLKALESVIQ,20,Ak-N’m,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,35432369,Front Immunol. 2022 Apr 1;13:821071. ,"Shin MK, Lee B, Kim ST, Yoo JS, Sung JS.",Designing a Novel Functional Peptide With Dual Antimicrobial and Anti-inflammatory Activities via in Silico Methods,20,18-21
DRAMP35856,RRIRIRPPRLPRPRPRPYFMPRP,23,"Bactenecin-7 (1-23)[P5I,L18Y,P19F,F20M], Bac7PS",P19661,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,35578204,BMC Biol. 2022 May 16;20(1):114. ,"Koch P, Schmitt S, Heynisch A, Gumpinger A, Wüthrich I, Gysin M, Shcherbakov D, Hobbie SN, Panke S, Held M.",Optimization of the antimicrobial peptide Bac7 by deep mutational scanning,23,21-24
DRAMP35857,GLLGKILGAGKKVLCGVSGLC,21,Nigrocin-PN,Not available,,Not found,Animalia,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,35606468,J Genet Eng Biotechnol. 2022 May 23;20(1):76. ,"Lu C, Liu L, Ma C, Di L, Chen T. ",A novel antimicrobial peptide found in Pelophylax nigromaculatus,21,18-21
DRAMP35858,GLLGKILGAGKKVLLGVSGLL,21,"Nigrocin-PN [C15,21L]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,35606468,J Genet Eng Biotechnol. 2022 May 23;20(1):77. ,"Lu C, Liu L, Ma C, Di L, Chen T. ",A novel antimicrobial peptide found in Pelophylax nigromaculatus,21,18-21
DRAMP35859,MKKLLLILFCLALALAGCKKAP,22,HG2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,35835775,NPJ Biofilms Microbiomes. 2022 Jul 14;8(1):58.,"Oyama LB, Olleik H, Teixeira ACN, Guidini MM, Pickup JA, Hui BYP, Vidal N, Cookson AR, Vallin H, Wilkinson T, Bazzolli DMS, Richards J, Wootton M, Mikut R, Hilpert K, Maresca M, Perrier J, Hess M, Mantovani HC, Fernandez-Fuentes N, Creevey CJ, Huws SA.",In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus,22,21-24
DRAMP35860,VLGLALIVGGALLIKKKQAKS,21,HG4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,35835775,NPJ Biofilms Microbiomes. 2022 Jul 14;8(1):59.,"Oyama LB, Olleik H, Teixeira ACN, Guidini MM, Pickup JA, Hui BYP, Vidal N, Cookson AR, Vallin H, Wilkinson T, Bazzolli DMS, Richards J, Wootton M, Mikut R, Hilpert K, Maresca M, Perrier J, Hess M, Mantovani HC, Fernandez-Fuentes N, Creevey CJ, Huws SA.",In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus,21,18-21
DRAMP35861,WKRFHPFRVVRKIFRRRIKR,20,PA-Win,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,36090084,Front Microbiol. 2022 Aug 24;13:971503. ,"Lee B, Shin MK, Yoo JS, Jang W, Sung JS.",Identifying novel antimicrobial peptides from venom gland of spider Pardosa astrigera by deep multi-task learning,20,18-21
DRAMP35862,rlfrrvkkvagkiakriwk,19,D-AP19,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,D,Not available,Not available,36151303, Sci Rep. 2022 Sep 23;12(1):15852. ,"Jariyarattanarach P, Klubthawee N, Wongchai M, Roytrakul S, Aunpad R. ",Novel D-form of hybrid peptide (D-AP19) rapidly kills Acinetobacter baumannii while tolerating proteolytic enzymes,19,18-21
DRAMP35863,KLLPSVVGLFKKKKQ,15,"Ponericin-W1 (11-25), At1",P82423,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112841.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35864,KLLKKVVKLFKKKKK,15,"Ponericin-W1 (11-25) [P4K; S5K; G8K; Q15K], At2",P82423,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112842.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35865,KLLKKVVKLFKKLLK,15,"Ponericin-W1 (11-25) [P4K; S5K; G8K; K13L; Q15K], At3",P82423,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112843.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35866,KLLKKLLKLLKKLLK,15,At4,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112844.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35867,KIIKKIIKIIKKIIK,15,At5,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112845.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35868,KVVKKVVKVVKKVVK,15,At6,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112846.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35869,KIIKKIKKKIKKIIK,15,At7,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112847.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35870,KLLKKLKKKLKKLLK,15,At8,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112848.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35871,KVVKKVKKKVKKVVK,15,At9,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112849.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35872,IKKIIKIIKKIIKKI,15,At10,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112850.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35873,IIIKKIKKKIKKIII,15,At11,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112851.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35874,KIIIKIKKKIKIIIK,15,At12,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Acetylation,Amidation,,L,Not available,Not available,36174494,Colloids Surf B Biointerfaces. 2022 Dec;220:112852.,"Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. ",Anticancer effect of rationally designed α-helical amphiphilic peptides,15,12-15
DRAMP35875,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6681.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35876,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6681.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35877,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-1,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6681.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35878,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6682.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35879,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6682.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35880,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6682.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35881,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6683.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35882,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6683.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35883,TSFAEYWALLSXLAXYXP,18,PMI-HIF1-3,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM),Not available,Linear,Acetylation,Amidation,"X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine",L,Not available,"MDM2, MDMX",36185610,Theranostics. 2022 Sep 11;12(15):6665-6683.,"Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.",Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression,18,15-18
DRAMP35936,RRRRRRRRGGQGLTIYFYNSNRDFQ,25,2C(Q44-Q58),Not available,,Not found,Synthetic (STAP-2 PH domain–derived peptide),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Not available,Linear,Free,Free,,L,Not available,EGFR ,36410436,J Biol Chem. 2023 Jan;299(1):102727.,"Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. ",A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling,25,24-27
DRAMP35937,RRRRRRRRGGQGLTIYFYNSNR,22,2D(Q44-R55),Not available,,Not found,Synthetic (STAP-2 PH domain–derived peptide),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Not available,Linear,Free,Free,,L,Not available,EGFR ,36410436,J Biol Chem. 2023 Jan;299(1):102728.,"Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. ",A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling,22,21-24
DRAMP35938,RRRRRRRRGGQGLTIYFY,18,2D2(Q44-Y51),Not available,,Not found,Synthetic (STAP-2 PH domain–derived peptide),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Not available,Linear,Free,Free,,L,Not available,EGFR ,36410436,J Biol Chem. 2023 Jan;299(1):102729.,"Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. ",A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling,18,15-18
DRAMP35939,RRRRRRRRGGGLTIYFYN,18,2D3(G45-N52),Not available,,Not found,Synthetic (STAP-2 PH domain–derived peptide),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Not available,Linear,Free,Free,,L,Not available,EGFR ,36410436,J Biol Chem. 2023 Jan;299(1):102730.,"Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. ",A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling,18,15-18
DRAMP35940,RRRRRRRRGGGLTIYFY,17,2D5(G45-Y51),Not available,,Not found,Synthetic (STAP-2 PH domain–derived peptide),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Not available,Linear,Free,Free,,L,Not available,EGFR ,36410436,J Biol Chem. 2023 Jan;299(1):102731.,"Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. ",A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling,17,15-18
DRAMP35942,RRRRRRRRGGILTVVELRVP,20,6F (I113-P122),Not available,,Not found,Synthetic (STAP-2 PH domain–derived peptide),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.,Not available,Not available,Linear,Free,Free,,L,Not available,EGFR ,36410436,J Biol Chem. 2023 Jan;299(1):102733.,"Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. ",A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling,20,18-21
DRAMP35943,GIFDVLKNLAKGVITSLAS,19,Ocellatin-3N,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,36426386,J Pept Sci. 2023 Apr;29(4):e3463. ,"Conlon JM, Hunter L, Attoub S, Casciaro B, Mechkarska M, Abdel-Wahab YHA.","Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs",19,18-21
DRAMP35944,GIFKVLKNLAKGVITSLAS,19,Ocellatin-3N [D4K],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,36426386,J Pept Sci. 2023 Apr;29(4):e3464. ,"Conlon JM, Hunter L, Attoub S, Casciaro B, Mechkarska M, Abdel-Wahab YHA.","Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs",19,18-21
DRAMP35945,GIFDVLKNLAKGVITSLKS,19,Ocellatin-3N [A18K],Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Amidation,,L,Not available,Not available,36426386,J Pept Sci. 2023 Apr;29(4):e3465. ,"Conlon JM, Hunter L, Attoub S, Casciaro B, Mechkarska M, Abdel-Wahab YHA.","Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs",19,18-21
DRAMP35946,GIFKVLKNLAKGVITSLKS,19,"Ocellatin-3N [D4K,A18K]",Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,36426386,J Pept Sci. 2023 Apr;29(4):e3466. ,"Conlon JM, Hunter L, Attoub S, Casciaro B, Mechkarska M, Abdel-Wahab YHA.","Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs",19,18-21
DRAMP35948,FAKKLAKLKKKLAKLALAL,19,AC-P19,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,36555235,Int J Mol Sci. 2022 Dec 9;23(24):15594. ,"Shin MK, Jang BY, Bu KB, Lee SH, Han DH, Oh JW, Sung JS.","De Novo Design of AC-P19M, a Novel Anticancer Peptide with Apoptotic Effects on Lung Cancer Cells and Anti-Angiogenic Activity",19,18-21
DRAMP35949,FAKKLAKLKKKLAKLAKKR,19,AC-P19M,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,Not available,36555235,Int J Mol Sci. 2022 Dec 9;23(24):15595. ,"Shin MK, Jang BY, Bu KB, Lee SH, Han DH, Oh JW, Sung JS.","De Novo Design of AC-P19M, a Novel Anticancer Peptide with Apoptotic Effects on Lung Cancer Cells and Anti-Angiogenic Activity",19,18-21
DRAMP35954,NAVPNLRGDLQVLAQKVART,20,A20FMDV2,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Not available,Not available,Linear,Free,Free,,L,Not available,"αvβ6, αvβ8",36594095,Int J Biol Sci. 2023 Jan 1;19(1):156-170.,"Monieri M, Rainone P, Sacchi A, Gori A, Gasparri AM, Coliva A, Citro A, Ferrara B, Policardi M, Valtorta S, Pocaterra A, Alfano M, Sheppard D, Piemonti L, Moresco RM, Corti A, Curnis F.",A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins,20,18-21
DRAMP35968,FLPLLAGLAANFLPQIICKIARKC,24,B1AW,Not available,,Not found,"Skin secretions of the Wuyi torrent frog, Amolops wuyiensis (A. wuyiensisi)","Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: H838 (IC50=32.15µM); PC-3 (IC50=33.46µM); U251MG (IC50=33.56µM),Not available,Linear,Free,Free,,L,HMEC-1: IC50=32.96μM; HaCaT: IC50=44.09μM,Not available,37228702, Comput Struct Biotechnol J. 2023 May 6;21:2960-2972. ,"Qin H, Zuo W, Ge L, Siu SWI, Wang L, Chen X, Ma C, Chen T, Zhou M, Cao Z, Kwok HF.",Discovery and analysis of a novel antimicrobial peptide B1AW from the skin secretion of Amolops wuyiensis and improving the membrane-binding affinity through the construction of the lysine-introduced analogue,24,21-24
DRAMP35969,FLPLLAGLAANFLPKIICKIARKC,24,B1AW-K,Not available,,Not found,Synthetic (derived from B1AW),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: U251MG (IC50=3.86µM); PC-3 (IC50=4.283µM); H838 (IC50=5.15µM),Not available,Linear,Free,Free,,L,HMEC-1: IC50=26.45μM; HaCaT: IC50=20.53μM,Not available,37228702, Comput Struct Biotechnol J. 2023 May 6;21:2960-2973. ,"Qin H, Zuo W, Ge L, Siu SWI, Wang L, Chen X, Ma C, Chen T, Zhou M, Cao Z, Kwok HF.",Discovery and analysis of a novel antimicrobial peptide B1AW from the skin secretion of Amolops wuyiensis and improving the membrane-binding affinity through the construction of the lysine-introduced analogue,24,21-24
DRAMP35972,RIIDRLWLVRRPOKPKFVLVWVL,23,PMAP-NC,Not available,,Not found,Synthetic (derived from PMAP-23),"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"A unique structure with an amphipathic N-helix, a central hinge, and a hydrophobic C-helix is responsible for bactericidal and anticancer activity of PMAP-NC. ",Tumor cells: MDA361 (IC50=6.4µM); A549 (IC50=7.1µM),Not available,Linear,Free,Free,,L,Not available,Not available,37310533, Amino Acids. 2023 Aug;55(8):1013-1022.,"Lee H, Shin SH, Yang S. ",Rationally designed PMAP-23 derivatives with enhanced bactericidal and anticancer activity based on the molecular mechanism of peptide-membrane interactions,23,21-24
DRAMP35976,LLLLLLLLLLLLLLLLLLLLLLLLL,25,C6-PLL25,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: C26 (IC50=41µg/mL),Not available,Linear,C6,Free,,L,HUVEC: IC50=77µg/mL,Not available,37605903,2023 Sep 26;11(19):6611-6619,"Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.",Synthetic lipo-polylysine with anti-cancer activity,25,24-27
DRAMP35984,LLLLLLLLLLLLLLLLLLLLLLLL,24,C16-PLL24,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: C26 (IC50=25µg/mL),Not available,Linear,C16,Free,,L,HUVEC: IC50=18µg/mL,Not available,37605903,2023 Sep 26;11(19):6611-6625,"Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.",Synthetic lipo-polylysine with anti-cancer activity,24,21-24
DRAMP35987,LLLLLLLLLLLLLLLLLLLLLLL,23,C18-PLL23,Not available,,Not found,Synthetic,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,Not available,Tumor cells: C26 (IC50=25µg/mL),Not available,Linear,C18,Free,,L,HUVEC: IC50=91µg/mL,Not available,37605903,2023 Sep 26;11(19):6611-6628,"Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.",Synthetic lipo-polylysine with anti-cancer activity,23,21-24
DRAMP35990,GAGIVVASIDTGVRVSHE,18,GE18,Not available,,Not found,Virulence factor of aquatic pathogenic fungus Aphanomyces invadans,"Antimicrobial, Anticancer",Not found,Not found,Not found,Not available,"GE18 affects the cellular morphology, which triggers the cells to undergo apoptosis for biological cellular elimination",Tumor cells: MCF-7  (IC50=29.06μM); MCF-7  (IC50=35.34μM),Not available,Linear,Amidation,Acetylation,,L,Rat skeletal myoblast cell line (L6): 91.73 ± 2% viability = 10 µM; 90.65 ± 2.9% viability = 20 µM; 87.91 ± 3.05% viability = 30 µM; 87.29 ± 1.9% viability = 40 µM; 84.44 ± 3.8% viability = 50 µM,Not available,37764521, Molecules. 2023 Sep 21;28(18):6746. ,"Velayutham M, Priya PS, Sarkar P, Murugan R, Almutairi BO, Arokiyaraj S, Kari ZA, Tellez-Isaias G, Guru A, Arockiaraj J.",Aquatic Peptide: The Potential Anti-Cancer and Anti-Microbial Activity of GE18 Derived from Pathogenic Fungus Aphanomyces invadans,18,15-18
